Citrus Sinensis ID: 011138
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 492 | 2.2.26 [Sep-21-2011] | |||||||
| Q96287 | 472 | Shaggy-related protein ki | yes | no | 0.945 | 0.985 | 0.766 | 0.0 | |
| O04160 | 468 | Shaggy-related protein ki | N/A | no | 0.924 | 0.972 | 0.740 | 0.0 | |
| Q8VZD5 | 410 | Shaggy-related protein ki | no | no | 0.819 | 0.982 | 0.736 | 0.0 | |
| Q40518 | 409 | Shaggy-related protein ki | N/A | no | 0.817 | 0.982 | 0.732 | 0.0 | |
| P43289 | 409 | Shaggy-related protein ki | no | no | 0.817 | 0.982 | 0.725 | 0.0 | |
| P43288 | 405 | Shaggy-related protein ki | no | no | 0.808 | 0.982 | 0.734 | 0.0 | |
| P51139 | 411 | Glycogen synthase kinase- | N/A | no | 0.813 | 0.973 | 0.725 | 0.0 | |
| P51137 | 411 | Glycogen synthase kinase- | N/A | no | 0.821 | 0.982 | 0.718 | 0.0 | |
| P51138 | 411 | Glycogen synthase kinase- | N/A | no | 0.808 | 0.968 | 0.720 | 0.0 | |
| O23145 | 431 | Shaggy-related protein ki | no | no | 0.876 | 1.0 | 0.644 | 0.0 |
| >sp|Q96287|KSG8_ARATH Shaggy-related protein kinase theta OS=Arabidopsis thaliana GN=ASK8 PE=2 SV=3 | Back alignment and function desciption |
|---|
Score = 777 bits (2006), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/492 (76%), Positives = 414/492 (84%), Gaps = 27/492 (5%)
Query: 1 MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELE-VNGEANLVERSASSLEQHMAST 59
MNVMRRLKSIASGRTSISSDPGGD +KRAK+D+E + + + V++++S E
Sbjct: 1 MNVMRRLKSIASGRTSISSDPGGDYALKRAKLDQENDNLCVDPMQVDQNSSCFEMKADVL 60
Query: 60 SLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAG 119
S E VA TS V +E+ DQLP M EM+IRDE+N N +DKD+E ++VNG+GTE G
Sbjct: 61 SQESVAGTSNVPAV--SEKPVDDQLPDVMIEMKIRDERNANREDKDMETTVVNGSGTETG 118
Query: 120 QVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR 179
QVI TTVGGR+G+PKQTISYMA+RVVGTGSFGVVFQAKCLETG+ VAIKKVLQDKRYKNR
Sbjct: 119 QVITTTVGGRDGKPKQTISYMAQRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNR 178
Query: 180 ELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
ELQIMRL +HPNVV L+H FFSTT+KDELYLNLVLEY+ ETVYR SKHYT+MNQH+PI++
Sbjct: 179 ELQIMRLQDHPNVVRLRHSFFSTTDKDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIF 238
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY 299
VQLYTYQICRALNYLH VVGVCHRDIKPQNLLVNP THQLKICDFGSAKMLVPGEPNISY
Sbjct: 239 VQLYTYQICRALNYLHRVVGVCHRDIKPQNLLVNPQTHQLKICDFGSAKMLVPGEPNISY 298
Query: 300 ICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTP 359
ICSRYYRAPELIFGATEYT AIDMWS GCV+AELLLGQPLFPGESG+DQLVEIIKILGTP
Sbjct: 299 ICSRYYRAPELIFGATEYTNAIDMWSGGCVMAELLLGQPLFPGESGIDQLVEIIKILGTP 358
Query: 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419
TREEI+CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEA+DLVSRLLQYSP+LRCTALEACA
Sbjct: 359 TREEIRCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACA 418
Query: 420 HPFFDDLRDPNTCLPNGRPLPTLFNFTAQGKLILCFSYFGFSSYFLPHANCLAELAGASN 479
HPFFDDLRDPN LPNGR LP LFNFTAQ ELAGAS
Sbjct: 419 HPFFDDLRDPNVSLPNGRALPPLFNFTAQ------------------------ELAGAST 454
Query: 480 ELRQRLIPEHAR 491
ELRQRLIP H +
Sbjct: 455 ELRQRLIPAHCQ 466
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O04160|KSGT_BRANA Shaggy-related protein kinase theta OS=Brassica napus PE=2 SV=2 | Back alignment and function description |
|---|
Score = 744 bits (1921), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 369/498 (74%), Positives = 403/498 (80%), Gaps = 43/498 (8%)
Query: 1 MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELEVNGEANLVERSASSLE----QHM 56
MNVMRRLKSIASGRTSISSDPG DS +KR K+D++ + NL R ++ M
Sbjct: 1 MNVMRRLKSIASGRTSISSDPGVDSSLKRPKLDQDND-----NLSSRGDDPMQVDQSTDM 55
Query: 57 ASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEK---NVNHDDKDLEPSIVNG 113
S + VA TS DQLP+ MN+MR+R+++ N +DKD+EP IVNG
Sbjct: 56 VVVSQDTVAGTSNVPPPP-------DQLPEVMNDMRLREDEPHANRGEEDKDMEPPIVNG 108
Query: 114 NGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD 173
GTE GQVI TTVGGR+G+PKQTISYMA+RVVGTGSFGVVFQAKCLETG+ VAIKKVLQD
Sbjct: 109 CGTETGQVITTTVGGRDGKPKQTISYMAQRVVGTGSFGVVFQAKCLETGEQVAIKKVLQD 168
Query: 174 KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ 233
KRYKNRELQIMRL +HPNVV L+H FFSTT+KDELYLNLVLE++ ETVYR KHYT+MNQ
Sbjct: 169 KRYKNRELQIMRLQDHPNVVRLRHSFFSTTDKDELYLNLVLEFVPETVYRALKHYTKMNQ 228
Query: 234 HVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293
H+PI+ VQLYTYQICRALNYLH VVGVCHRDIKPQNLLVN HTHQLKICDFGSAKMLVPG
Sbjct: 229 HMPIILVQLYTYQICRALNYLHRVVGVCHRDIKPQNLLVNTHTHQLKICDFGSAKMLVPG 288
Query: 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEII 353
EPNISYICSRYYRAPELIFGATEYT AIDMWS GCV+AELLLGQPLFPGESG+DQLVEII
Sbjct: 289 EPNISYICSRYYRAPELIFGATEYTNAIDMWSGGCVMAELLLGQPLFPGESGIDQLVEII 348
Query: 354 KILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT 413
KILGTPTREEI+CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEA+DLVSRLLQYSP+LRCT
Sbjct: 349 KILGTPTREEIRCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 408
Query: 414 ALEACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQGKLILCFSYFGFSSYFLPHANCLAE 473
ALEACAHPFFDDLR PN LPNGR LP LFNFTAQ E
Sbjct: 409 ALEACAHPFFDDLRAPNVSLPNGRALPPLFNFTAQ------------------------E 444
Query: 474 LAGASNELRQRLIPEHAR 491
LAGAS ELRQRLIP H +
Sbjct: 445 LAGASTELRQRLIPAHCQ 462
|
May mediate extracellular signals to regulate transcription in differentiating cells. Brassica napus (taxid: 3708) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VZD5|KSG5_ARATH Shaggy-related protein kinase epsilon OS=Arabidopsis thaliana GN=ASK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 667 bits (1722), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 322/437 (73%), Positives = 359/437 (82%), Gaps = 34/437 (7%)
Query: 56 MASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNG 115
MAS P +S AT ++LP+ +NEM+I+D DK++E ++V+GNG
Sbjct: 1 MASVGTLPASSM---ATKQSNASICAEKLPEGINEMKIKD-------DKEMEAAVVDGNG 50
Query: 116 TEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR 175
TE G +I TT+GG+NGQPKQTISYMAER+VG GSFG+VFQAKCLETG++VAIKKVLQDKR
Sbjct: 51 TETGHIIVTTIGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGETVAIKKVLQDKR 110
Query: 176 YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV 235
YKNRELQ MRLL+HPNVVSLKHCFFSTTEKDELYLNLVLEY+ ETVYRVSKHY+R NQ +
Sbjct: 111 YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSKHYSRANQRM 170
Query: 236 PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295
PI+YV+LYTYQICRAL Y+H VGVCHRDIKPQNLLVNPHTHQ+K+CDFGSAK+LV GEP
Sbjct: 171 PIIYVKLYTYQICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 230
Query: 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKI 355
NISYICSRYYRAPELIFGATEYTT ID+WS GCVLAELLLGQPLFPGESGVDQLVEIIK+
Sbjct: 231 NISYICSRYYRAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 290
Query: 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL 415
LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKR PPEA+DLVSRLLQYSP+LR TA+
Sbjct: 291 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQYSPNLRSTAM 350
Query: 416 EACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQGKLILCFSYFGFSSYFLPHANCLAELA 475
EA HPFFD+LRDPNT LPNGR LP LFNF Q EL
Sbjct: 351 EAIVHPFFDELRDPNTRLPNGRALPPLFNFKPQ------------------------ELK 386
Query: 476 GASNELRQRLIPEHARK 492
GAS EL +LIP+HARK
Sbjct: 387 GASLELLSKLIPDHARK 403
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q40518|MSK1_TOBAC Shaggy-related protein kinase NtK-1 OS=Nicotiana tabacum GN=NTK-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 667 bits (1721), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 320/437 (73%), Positives = 360/437 (82%), Gaps = 35/437 (8%)
Query: 56 MASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNG 115
M S L PV+ E+++ G D+LP+EMN+MRIRD DK++E +IV+GNG
Sbjct: 1 MTSVGLAPVSGLRESSS----HSVGVDRLPEEMNDMRIRD-------DKEIEAAIVDGNG 49
Query: 116 TEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR 175
TE G +I TT+GGR+GQPKQTISYMAER+VG GSFGVVFQAKCLETG++VAIKKVLQDKR
Sbjct: 50 TETGHIIVTTIGGRHGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR 109
Query: 176 YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV 235
YKNRELQ MRLL+HPNVV LKHCFFSTTEKDE+YLNLVLEY+ ETV+RV KHY ++NQ +
Sbjct: 110 YKNRELQTMRLLDHPNVVCLKHCFFSTTEKDEVYLNLVLEYVPETVHRVIKHYNKLNQRM 169
Query: 236 PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295
P++ V+LYTYQI RAL+Y+HH +GVCHRDIKPQNLLVNPHTHQ+K+CDFGSAK+LV GEP
Sbjct: 170 PLILVKLYTYQIFRALSYIHHTIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
Query: 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKI 355
NISYICSRYYRAPELIFGATEYTTAID+WS GCVLAELLLGQPLFPGESGVDQLVEIIK+
Sbjct: 230 NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 289
Query: 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL 415
LGTPTREEIKCMNPNY EFKFPQIKAHPWHKIFHKRMPPEA+DLVSRLLQYSP+LRCTAL
Sbjct: 290 LGTPTREEIKCMNPNYNEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL 349
Query: 416 EACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQGKLILCFSYFGFSSYFLPHANCLAELA 475
EA H FFD+LRDPNT LPNGR LP LFNF A EL
Sbjct: 350 EAVTHAFFDELRDPNTRLPNGRVLPPLFNFKAH------------------------ELK 385
Query: 476 GASNELRQRLIPEHARK 492
G S E +L+PEHARK
Sbjct: 386 GVSAENLLKLVPEHARK 402
|
May mediate extracellular signals to regulate transcription in differentiating cells. Nicotiana tabacum (taxid: 4097) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43289|KSG3_ARATH Shaggy-related protein kinase gamma OS=Arabidopsis thaliana GN=ASK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 658 bits (1697), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 317/437 (72%), Positives = 360/437 (82%), Gaps = 35/437 (8%)
Query: 56 MASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNG 115
MAS +EP A+ E+ + D+LP+EM +M+I+D DK++E +IVNGN
Sbjct: 1 MASVGIEPSAAVRESTGNV----TDADRLPEEMKDMKIQD-------DKEMEATIVNGNV 49
Query: 116 TEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR 175
TE G +I TT+GGRNGQPKQTISYMAERVVG GSFGVVFQAKCLETG++VAIKKVLQD+R
Sbjct: 50 TETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRR 109
Query: 176 YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV 235
YKNRELQ MRLL+HPNVVSLKHCFFSTTEKDELYLNLVLEY+ ETV+RV KHY ++NQ +
Sbjct: 110 YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRM 169
Query: 236 PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295
P++YV+LYTYQI R+L+Y+H +GVCHRDIKPQNLLVNPHTHQ+K+CDFGSAK+LV GEP
Sbjct: 170 PLVYVKLYTYQIFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
Query: 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKI 355
NISYICSRYYRAPELIFGATEYTTAID+WS GCVLAELLLGQPLFPGESGVDQLVEIIK+
Sbjct: 230 NISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 289
Query: 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL 415
LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEA+DLVSRLLQYSP+LRC AL
Sbjct: 290 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCAAL 349
Query: 416 EACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQGKLILCFSYFGFSSYFLPHANCLAELA 475
++ HPFFD+LRDPN LPNGR LP LFNF PH EL
Sbjct: 350 DSLVHPFFDELRDPNARLPNGRFLPPLFNFK-------------------PH-----ELK 385
Query: 476 GASNELRQRLIPEHARK 492
G E+ +L+PEHARK
Sbjct: 386 GVPVEMVAKLVPEHARK 402
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43288|KSG1_ARATH Shaggy-related protein kinase alpha OS=Arabidopsis thaliana GN=ASK1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 657 bits (1696), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 315/429 (73%), Positives = 356/429 (82%), Gaps = 31/429 (7%)
Query: 64 VASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAGQVIA 123
+AS A + +G D+LP+EMN+M+IRD DK++E ++V+GNGTE G +I
Sbjct: 1 MASVGIAPNPGARDSTGVDKLPEEMNDMKIRD-------DKEMEATVVDGNGTETGHIIV 53
Query: 124 TTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQI 183
TT+GGRNGQPKQTISYMAERVVG GSFGVVFQAKCLETG++VAIKKVLQD+RYKNRELQ
Sbjct: 54 TTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQT 113
Query: 184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY 243
MRLL+HPNVVSLKHCFFSTTEKDELYLNLVLEY+ ETV+RV KHY ++NQ +P++YV+LY
Sbjct: 114 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLY 173
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR 303
TYQI RAL+Y+H +GVCHRDIKPQNLLVNPHTHQ+K+CDFGSAK+LV GEPNISYICSR
Sbjct: 174 TYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 233
Query: 304 YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363
YYRAPELIFGATEYTTAID+WS GCVLAELLLGQPLFPGESGVDQLVEIIK+LGTPTREE
Sbjct: 234 YYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 293
Query: 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEA+DLVSRLLQYSP+LR AL+ HPFF
Sbjct: 294 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSAALDTLVHPFF 353
Query: 424 DDLRDPNTCLPNGRPLPTLFNFTAQGKLILCFSYFGFSSYFLPHANCLAELAGASNELRQ 483
D+LRDPN LPNGR LP LFNF PH EL G E+
Sbjct: 354 DELRDPNARLPNGRFLPPLFNFK-------------------PH-----ELKGVPLEMVA 389
Query: 484 RLIPEHARK 492
+L+PEHARK
Sbjct: 390 KLVPEHARK 398
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51139|MSK3_MEDSA Glycogen synthase kinase-3 homolog MsK-3 OS=Medicago sativa GN=MSK-3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 656 bits (1693), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 319/440 (72%), Positives = 359/440 (81%), Gaps = 40/440 (9%)
Query: 56 MASTSLEPVAS--TSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEP-SIVN 112
MAS + P + A++V G ++LP+EMN+M+IRD DK++E +IV+
Sbjct: 1 MASGGVAPASGFIDKNASSV------GVEKLPEEMNDMKIRD-------DKEMEAATIVD 47
Query: 113 GNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ 172
GNGTE G +I TT+GG+NGQPKQTISYMAERVVG GSFGVVFQAKCLETG++VAIKKVLQ
Sbjct: 48 GNGTETGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQ 107
Query: 173 DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMN 232
DKRYKNRELQ MRLL+HPNVVSLKHCFFSTTEKDELYLNLVLEY+ ETV RV +HY +MN
Sbjct: 108 DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVSRVIRHYNKMN 167
Query: 233 QHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292
Q +P++YV+LY+YQICRAL Y+H+ +GVCHRDIKPQNLLVNPHTHQLKICDFGSAK+LV
Sbjct: 168 QRMPMIYVKLYSYQICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVK 227
Query: 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEI 352
GEPNISYICSRYYRAPELIFGATEYTTAID+WS GCVL ELLLGQPLFPGESGVDQLVEI
Sbjct: 228 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLGELLLGQPLFPGESGVDQLVEI 287
Query: 353 IKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC 412
IK+LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEA+DLVSRLLQYSP+LR
Sbjct: 288 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRS 347
Query: 413 TALEACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQGKLILCFSYFGFSSYFLPHANCLA 472
TALEA HPF+DD+RDPNT LPNGR LP LFNF
Sbjct: 348 TALEALVHPFYDDVRDPNTRLPNGRFLPPLFNFKVN------------------------ 383
Query: 473 ELAGASNELRQRLIPEHARK 492
EL G E+ +L+P HARK
Sbjct: 384 ELKGVPAEMLVKLVPPHARK 403
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51137|MSK1_MEDSA Glycogen synthase kinase-3 homolog MsK-1 OS=Medicago sativa GN=MSK-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 649 bits (1674), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 314/437 (71%), Positives = 356/437 (81%), Gaps = 33/437 (7%)
Query: 56 MASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNG 115
MAS + P + E + E D LP+EM++M+IRD D+++E ++V+GNG
Sbjct: 1 MASVGVAPTSGFREV--LGDGEIGVDDILPEEMSDMKIRD-------DREMEATVVDGNG 51
Query: 116 TEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR 175
TE G +I TT+GGRNGQPKQTISYMAERVVG GSFGVVFQAKCLETG++VAIKKVLQDKR
Sbjct: 52 TETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKR 111
Query: 176 YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV 235
YKNRELQ MRLL+HPNVVSLKHCFFSTTEKDELYLNLVLEY+ ETV+RV KHY+++NQ +
Sbjct: 112 YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYSKLNQRM 171
Query: 236 PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295
P++YV+LYTYQI RAL+Y+H +GVCHRDIKPQNLLVNPHTHQ+K+CDFGSAK+LV GEP
Sbjct: 172 PMIYVKLYTYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 231
Query: 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKI 355
NISYICSRYYRAPELIFGATEYTTAID+WS+GCVLAELLLGQPLFPGE GVDQLVEIIK+
Sbjct: 232 NISYICSRYYRAPELIFGATEYTTAIDVWSVGCVLAELLLGQPLFPGERGVDQLVEIIKV 291
Query: 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL 415
LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMP EA+DLVSRLLQYSP+LRC AL
Sbjct: 292 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPAEAVDLVSRLLQYSPNLRCQAL 351
Query: 416 EACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQGKLILCFSYFGFSSYFLPHANCLAELA 475
+ HPFFD+LRDPN LP GR LP LFNF PH EL
Sbjct: 352 DCLTHPFFDELRDPNARLPTGRFLPPLFNFK-------------------PH-----ELK 387
Query: 476 GASNELRQRLIPEHARK 492
G E +L+PEHARK
Sbjct: 388 GVPVETLMKLVPEHARK 404
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51138|MSK2_MEDSA Glycogen synthase kinase-3 homolog MsK-2 OS=Medicago sativa GN=MSK-2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 645 bits (1664), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 309/429 (72%), Positives = 348/429 (81%), Gaps = 31/429 (7%)
Query: 64 VASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAGQVIA 123
VA S V + D+LP E+ MRI+D DK++E +V+GN TEAG VI
Sbjct: 6 VAPASGIVDVNASSAIAVDKLPDEILGMRIKD-------DKEMEAHVVDGNSTEAGHVIV 58
Query: 124 TTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQI 183
TT+GG+NGQPKQTISYMAER VG GSFGVVFQAKCLETG++VAIKKVLQDKRYKNRELQ
Sbjct: 59 TTIGGKNGQPKQTISYMAERAVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT 118
Query: 184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY 243
MRLL+HPNVV+LKHCFFSTTEKDELYLNLVLE++ ETV+RV +HY++MNQ +P++YV+LY
Sbjct: 119 MRLLDHPNVVTLKHCFFSTTEKDELYLNLVLEFVPETVHRVIRHYSKMNQRMPLIYVKLY 178
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR 303
+YQICR+L Y+H+ VGV HRDIKPQNLLVNPHTHQLK+CDFGSAK+LV GEPNISYICSR
Sbjct: 179 SYQICRSLAYIHNCVGVSHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 238
Query: 304 YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363
YYRAPELIFGATEYT+AID+WS GCVL ELLLGQPLFPG SGVDQLVEIIK+LGTPTREE
Sbjct: 239 YYRAPELIFGATEYTSAIDIWSAGCVLGELLLGQPLFPGASGVDQLVEIIKVLGTPTREE 298
Query: 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
IKCMNPNYTEFKFPQIKAHPWHKIF KRMPPEA+DLVSRLLQYSP+LR TALEA HPFF
Sbjct: 299 IKCMNPNYTEFKFPQIKAHPWHKIFRKRMPPEAVDLVSRLLQYSPNLRSTALEALVHPFF 358
Query: 424 DDLRDPNTCLPNGRPLPTLFNFTAQGKLILCFSYFGFSSYFLPHANCLAELAGASNELRQ 483
D+LRDPNT LPNGR LP LFNF A EL G E+
Sbjct: 359 DELRDPNTRLPNGRHLPPLFNFKAN------------------------ELKGVPAEMLV 394
Query: 484 RLIPEHARK 492
+L+P HARK
Sbjct: 395 KLVPSHARK 403
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O23145|KSG2_ARATH Shaggy-related protein kinase beta OS=Arabidopsis thaliana GN=ASK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 639 bits (1648), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 317/492 (64%), Positives = 365/492 (74%), Gaps = 61/492 (12%)
Query: 1 MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELEVNGEANLVERSASSLEQHMASTS 60
MNV+RRL SIASGR +SSD G++ R+K ++ +
Sbjct: 1 MNVVRRLTSIASGRNFVSSDNVGETETPRSKPNQN---------------------REET 39
Query: 61 LEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAGQ 120
++ E +V+ +E S D LPKE+ E D++ I+ GNGTE+G+
Sbjct: 40 ESTETTSYEKDSVSSSENS--DHLPKEIRE--------------DMDCGIIKGNGTESGR 83
Query: 121 VIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRE 180
+I T G N Q +TISY AE V+GTGSFGVVFQAKCLET + VAIKKVLQDKRYKNRE
Sbjct: 84 IITTKKKGLNDQKDKTISYRAEHVIGTGSFGVVFQAKCLETEEKVAIKKVLQDKRYKNRE 143
Query: 181 LQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYV 240
LQIMR+L+HPNVV LKH FFSTTEKDELYLNLVLEY+ ET+YR S+ YT+MNQH+P++Y+
Sbjct: 144 LQIMRMLDHPNVVELKHSFFSTTEKDELYLNLVLEYVPETIYRASRSYTKMNQHMPLIYI 203
Query: 241 QLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYI 300
QLYTYQICRA+NYLH VVGVCHRDIKPQNLLVN TH++KICDFGSAKML+PGEPNISYI
Sbjct: 204 QLYTYQICRAMNYLHQVVGVCHRDIKPQNLLVNNVTHEVKICDFGSAKMLIPGEPNISYI 263
Query: 301 CSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPT 360
CSRYYRAPELIFGATEYT+AIDMWS+GCV+AEL LG PLFPGE+ VDQLVEIIKILGTP
Sbjct: 264 CSRYYRAPELIFGATEYTSAIDMWSVGCVMAELFLGHPLFPGETSVDQLVEIIKILGTPA 323
Query: 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420
REEIK MNP Y +FKFPQIKA PWHKIF +++ PEA+DL SRLLQYSP+LRCTALEACAH
Sbjct: 324 REEIKNMNPRYNDFKFPQIKAQPWHKIFRRQVSPEAMDLASRLLQYSPNLRCTALEACAH 383
Query: 421 PFFDDLRDPNTCLPNGRPLPTLFNFTAQGKLILCFSYFGFSSYFLPHANCLAELAGASNE 480
PFFDDLRDP LPNGR LP LF+FTAQ ELAGAS E
Sbjct: 384 PFFDDLRDPRASLPNGRALPPLFDFTAQ------------------------ELAGASVE 419
Query: 481 LRQRLIPEHARK 492
LR RLIPEHARK
Sbjct: 420 LRHRLIPEHARK 431
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 492 | ||||||
| 255541478 | 474 | Glycogen synthase kinase-3 beta, putativ | 0.951 | 0.987 | 0.806 | 0.0 | |
| 449454478 | 469 | PREDICTED: shaggy-related protein kinase | 0.947 | 0.993 | 0.809 | 0.0 | |
| 449522286 | 469 | PREDICTED: shaggy-related protein kinase | 0.947 | 0.993 | 0.809 | 0.0 | |
| 225453724 | 468 | PREDICTED: shaggy-related protein kinase | 0.947 | 0.995 | 0.791 | 0.0 | |
| 356520459 | 470 | PREDICTED: shaggy-related protein kinase | 0.949 | 0.993 | 0.762 | 0.0 | |
| 356504991 | 470 | PREDICTED: shaggy-related protein kinase | 0.949 | 0.993 | 0.756 | 0.0 | |
| 224130108 | 438 | predicted protein [Populus trichocarpa] | 0.882 | 0.990 | 0.816 | 0.0 | |
| 62857012 | 467 | Ser/Thr protein kinase [Lotus japonicus] | 0.943 | 0.993 | 0.752 | 0.0 | |
| 1617200 | 471 | NSK6 [Nicotiana tabacum] | 0.949 | 0.991 | 0.752 | 0.0 | |
| 15236918 | 472 | Shaggy-related protein kinase theta [Ara | 0.945 | 0.985 | 0.766 | 0.0 |
| >gi|255541478|ref|XP_002511803.1| Glycogen synthase kinase-3 beta, putative [Ricinus communis] gi|223548983|gb|EEF50472.1| Glycogen synthase kinase-3 beta, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 832 bits (2148), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 399/495 (80%), Positives = 434/495 (87%), Gaps = 27/495 (5%)
Query: 1 MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELE--VNGEANLVERSASSLEQHMAS 58
MN+MRRLKSIASGRTSISSDPGGDS KR KVD+E E ++GE ER+A+ LEQHMAS
Sbjct: 1 MNMMRRLKSIASGRTSISSDPGGDSLTKRVKVDQETEQKIDGEVYSDERNATGLEQHMAS 60
Query: 59 TSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEA 118
TSLE ASTS +A+V +TE+SGFDQLPKEM+EMRI+D+K +HD+KD+E +IV+G GTE
Sbjct: 61 TSLENPASTSNSASVVKTEKSGFDQLPKEMHEMRIKDDKTTSHDEKDMEAAIVSGTGTET 120
Query: 119 GQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN 178
G +IATT+GGRNGQPKQTIS+MAERVVGTGSFGVV+QAKCLETG++VAIKKVLQD+RYKN
Sbjct: 121 GHIIATTLGGRNGQPKQTISFMAERVVGTGSFGVVYQAKCLETGEAVAIKKVLQDRRYKN 180
Query: 179 RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMN-QHVPI 237
RELQIMRLL HPNVV LKHCF STTEKDELYLNLVLEYI ETVYRVS+HY +MN QH+PI
Sbjct: 181 RELQIMRLLGHPNVVELKHCFISTTEKDELYLNLVLEYIPETVYRVSRHYNKMNHQHMPI 240
Query: 238 LYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI 297
+YVQLY YQICR L+YLHHVVGVCHRDIKPQNLLVNP TH+LKICDFGSAKMLVPGEPNI
Sbjct: 241 IYVQLYAYQICRGLSYLHHVVGVCHRDIKPQNLLVNPQTHELKICDFGSAKMLVPGEPNI 300
Query: 298 SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILG 357
SYICSRYYRAPELIFGAT YT AIDMWS GCVLAELLLGQPLFPGESGVDQLVEIIK+LG
Sbjct: 301 SYICSRYYRAPELIFGATTYTNAIDMWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 360
Query: 358 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEA 417
TPTREEIKCMNPNYTEFKFPQIKAHPWHK+FHKRMPPEA+DLVSRLLQYSP+LRCTALEA
Sbjct: 361 TPTREEIKCMNPNYTEFKFPQIKAHPWHKLFHKRMPPEAVDLVSRLLQYSPNLRCTALEA 420
Query: 418 CAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQGKLILCFSYFGFSSYFLPHANCLAELAGA 477
CAHPFFDDLRDPN CLPNGR LP LFNFTAQ ELAGA
Sbjct: 421 CAHPFFDDLRDPNACLPNGRALPPLFNFTAQ------------------------ELAGA 456
Query: 478 SNELRQRLIPEHARK 492
S ELRQRLIPEHARK
Sbjct: 457 SAELRQRLIPEHARK 471
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449454478|ref|XP_004144981.1| PREDICTED: shaggy-related protein kinase theta-like [Cucumis sativus] gi|449473157|ref|XP_004153803.1| PREDICTED: shaggy-related protein kinase theta-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 820 bits (2118), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 399/493 (80%), Positives = 436/493 (88%), Gaps = 27/493 (5%)
Query: 1 MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELE--VNGEANLVERSASSLEQHMAS 58
MN+MRRLKSIASGRTSISSDPGGD GIKRAKVD+E E V G ++ V R+AS L +S
Sbjct: 1 MNMMRRLKSIASGRTSISSDPGGDFGIKRAKVDQETEQKVGGVSDDVGRAASGLGLDSSS 60
Query: 59 TSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEA 118
+SL+ VASTS +++A E+SGFD LP+EM EMRI+DEK+ NHD+KDLEP++VNGNGTEA
Sbjct: 61 SSLDNVASTSNISSIAGAEKSGFDHLPREMREMRIKDEKS-NHDEKDLEPAVVNGNGTEA 119
Query: 119 GQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN 178
GQ+IATTVGGRNG+PKQTISYMAERVVGTGSFGVVFQAKCLET ++VAIKKVLQDKRYKN
Sbjct: 120 GQIIATTVGGRNGKPKQTISYMAERVVGTGSFGVVFQAKCLETNEAVAIKKVLQDKRYKN 179
Query: 179 RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPIL 238
RELQIMR+L+H N+V LKHCFFSTT+KDELYLNLVLEYISETVY+VSKHY RMN+ +PI+
Sbjct: 180 RELQIMRMLDHSNIVQLKHCFFSTTDKDELYLNLVLEYISETVYKVSKHYIRMNRSMPII 239
Query: 239 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS 298
YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML+PGEPNIS
Sbjct: 240 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLMPGEPNIS 299
Query: 299 YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358
YICSRYYRAPELIFGATEYT AIDMWS+GCV+AELLLGQPLFPGESGVDQLVEIIKILGT
Sbjct: 300 YICSRYYRAPELIFGATEYTNAIDMWSVGCVMAELLLGQPLFPGESGVDQLVEIIKILGT 359
Query: 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC 418
PTREEIKCMNPNYTEFKFPQIKAHPWHKIFH RMP EA+DLVSRLLQYSP+LRCTALEAC
Sbjct: 360 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHMRMPVEAIDLVSRLLQYSPNLRCTALEAC 419
Query: 419 AHPFFDDLRDPNTCLPNGRPLPTLFNFTAQGKLILCFSYFGFSSYFLPHANCLAELAGAS 478
AHPFFDDLRDPN CLPNG+ LP LFNFTAQ ELAGAS
Sbjct: 420 AHPFFDDLRDPNACLPNGQALPPLFNFTAQ------------------------ELAGAS 455
Query: 479 NELRQRLIPEHAR 491
ELRQRLIPEHA+
Sbjct: 456 TELRQRLIPEHAQ 468
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449522286|ref|XP_004168158.1| PREDICTED: shaggy-related protein kinase theta-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 819 bits (2116), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 399/493 (80%), Positives = 435/493 (88%), Gaps = 27/493 (5%)
Query: 1 MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELE--VNGEANLVERSASSLEQHMAS 58
MN+MRRLKSIASGRTSISSDPGGD GIKRAKVD+E E V G ++ V R+AS L +S
Sbjct: 1 MNMMRRLKSIASGRTSISSDPGGDFGIKRAKVDQETEQKVGGVSDDVGRAASGLGLDSSS 60
Query: 59 TSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEA 118
+SL+ VASTS +++A E+SGFD LP+EM EMRI+DEK+ NHD+KDLEP++VNGNGTEA
Sbjct: 61 SSLDNVASTSNISSIAGAEKSGFDHLPREMREMRIKDEKS-NHDEKDLEPAVVNGNGTEA 119
Query: 119 GQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN 178
GQ+IATTVGGRNG+PKQTISYMAERVVGTGSFGVVFQAKCLET ++VAIKKVLQDKRYKN
Sbjct: 120 GQIIATTVGGRNGKPKQTISYMAERVVGTGSFGVVFQAKCLETNEAVAIKKVLQDKRYKN 179
Query: 179 RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPIL 238
RELQIMR+L H N+V LKHCFFSTT+KDELYLNLVLEYISETVY+VSKHY RMN+ +PI+
Sbjct: 180 RELQIMRMLEHSNIVQLKHCFFSTTDKDELYLNLVLEYISETVYKVSKHYIRMNRSMPII 239
Query: 239 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS 298
YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML+PGEPNIS
Sbjct: 240 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLMPGEPNIS 299
Query: 299 YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358
YICSRYYRAPELIFGATEYT AIDMWS+GCV+AELLLGQPLFPGESGVDQLVEIIKILGT
Sbjct: 300 YICSRYYRAPELIFGATEYTNAIDMWSVGCVMAELLLGQPLFPGESGVDQLVEIIKILGT 359
Query: 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC 418
PTREEIKCMNPNYTEFKFPQIKAHPWHKIFH RMP EA+DLVSRLLQYSP+LRCTALEAC
Sbjct: 360 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHMRMPVEAIDLVSRLLQYSPNLRCTALEAC 419
Query: 419 AHPFFDDLRDPNTCLPNGRPLPTLFNFTAQGKLILCFSYFGFSSYFLPHANCLAELAGAS 478
AHPFFDDLRDPN CLPNG+ LP LFNFTAQ ELAGAS
Sbjct: 420 AHPFFDDLRDPNACLPNGQALPPLFNFTAQ------------------------ELAGAS 455
Query: 479 NELRQRLIPEHAR 491
ELRQRLIPEHA+
Sbjct: 456 TELRQRLIPEHAQ 468
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225453724|ref|XP_002272112.1| PREDICTED: shaggy-related protein kinase theta isoform 1 [Vitis vinifera] gi|296089061|emb|CBI38764.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 817 bits (2111), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 391/494 (79%), Positives = 433/494 (87%), Gaps = 28/494 (5%)
Query: 1 MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELE--VNGEANLVERSASSLEQHMAS 58
MNVMRRLKSIASGR+S+S DPGGDS KRAKVD+E E V E + VE+S +SLEQHMAS
Sbjct: 1 MNVMRRLKSIASGRSSVS-DPGGDSSTKRAKVDQEAEQKVADETHSVEKS-TSLEQHMAS 58
Query: 59 TSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEA 118
TS E ASTS +++ARTE+SG+DQLPKEM++M+IRDEK HDDKD EP++V+G+GTE
Sbjct: 59 TSQETAASTSNVSSIARTEQSGYDQLPKEMHDMKIRDEKVDPHDDKDAEPTVVSGSGTET 118
Query: 119 GQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN 178
GQ+IATT+GGRNGQPKQT+SYMAERVVGTGSFGVVFQAKCLETG++VAIKKVLQDKRYKN
Sbjct: 119 GQIIATTIGGRNGQPKQTVSYMAERVVGTGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN 178
Query: 179 RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPIL 238
RELQIMR+L+HPNVV LKHCFFST+EKD +YLNLVLEY+SETVYRVS+H++RMNQH+PI+
Sbjct: 179 RELQIMRVLDHPNVVQLKHCFFSTSEKDVVYLNLVLEYVSETVYRVSRHHSRMNQHMPII 238
Query: 239 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS 298
YVQLY YQICRALNY+H V+GVCHRDIKPQNLLVNP THQLKICDFGSAK LVPGEPNIS
Sbjct: 239 YVQLYAYQICRALNYMHSVIGVCHRDIKPQNLLVNPQTHQLKICDFGSAKKLVPGEPNIS 298
Query: 299 YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358
YICSRYYRAPELIFGATEYTTAIDMWS GCV+AELLLGQPLFPGESGVDQLVEIIKILGT
Sbjct: 299 YICSRYYRAPELIFGATEYTTAIDMWSAGCVVAELLLGQPLFPGESGVDQLVEIIKILGT 358
Query: 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC 418
PTREEIKCMNPNY EFKFPQIKAHPWHK+FHKRMPPEA+DLVSRLLQYSP+LRCTALEAC
Sbjct: 359 PTREEIKCMNPNYNEFKFPQIKAHPWHKLFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 418
Query: 419 AHPFFDDLRDPNTCLPNGRPLPTLFNFTAQGKLILCFSYFGFSSYFLPHANCLAELAGAS 478
AH FFDDLR+ N CLPNGRPLP LFNFT Q EL ++
Sbjct: 419 AHHFFDDLRETNACLPNGRPLPPLFNFTPQ------------------------ELVHST 454
Query: 479 NELRQRLIPEHARK 492
ELRQRLIPEHARK
Sbjct: 455 PELRQRLIPEHARK 468
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356520459|ref|XP_003528879.1| PREDICTED: shaggy-related protein kinase theta-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 797 bits (2059), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 376/493 (76%), Positives = 423/493 (85%), Gaps = 26/493 (5%)
Query: 1 MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELE--VNGEANLVERSASSLEQHMAS 58
MN+MRRLKSIASGRTSISSDPGGDS KRAK + E E + + N +E + EQ + +
Sbjct: 1 MNMMRRLKSIASGRTSISSDPGGDSNSKRAKFEPETEGKADEKTNTIETICTDQEQPIDT 60
Query: 59 TSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEA 118
+ TS+ +TVARTE+SGFD+LPKE+NEM+IRDEK+ N+++KD+E ++V+GNGTE
Sbjct: 61 SKETSNVGTSDVSTVARTEKSGFDELPKELNEMKIRDEKSKNNNEKDIEATVVSGNGTET 120
Query: 119 GQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN 178
GQ+I T +GGR+GQPKQTISYMAERVVGTGSFGVVFQAKCLETG+SVAIKKVLQD+RYKN
Sbjct: 121 GQIITTAIGGRDGQPKQTISYMAERVVGTGSFGVVFQAKCLETGESVAIKKVLQDRRYKN 180
Query: 179 RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPIL 238
RELQ+MR ++HPNVV LKH FFSTT+KDELYLNLVLEY+ ETVY+VSKHY RM+QH+PI+
Sbjct: 181 RELQVMRTVDHPNVVKLKHYFFSTTDKDELYLNLVLEYVPETVYKVSKHYVRMHQHMPII 240
Query: 239 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS 298
YVQLYTYQICRALNYLH V+GVCHRDIKPQNLLVNP THQLKICDFGSAK+LVPGEPNIS
Sbjct: 241 YVQLYTYQICRALNYLHQVIGVCHRDIKPQNLLVNPQTHQLKICDFGSAKVLVPGEPNIS 300
Query: 299 YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358
YICSRYYRAPELIFGATEYT AIDMWS+GCVLAELLLGQPLFPGESGVDQLVEIIK+LGT
Sbjct: 301 YICSRYYRAPELIFGATEYTIAIDMWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 360
Query: 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC 418
PTREEI+CMNPNY EFKFPQIKAHPWHK+FHKRMPPEA+DLVSRLLQYSP+LRCTAL AC
Sbjct: 361 PTREEIRCMNPNYNEFKFPQIKAHPWHKVFHKRMPPEAVDLVSRLLQYSPNLRCTALAAC 420
Query: 419 AHPFFDDLRDPNTCLPNGRPLPTLFNFTAQGKLILCFSYFGFSSYFLPHANCLAELAGAS 478
AHPFF+DLRDPN CLPNGRPLP LFNFT+Q ELA A
Sbjct: 421 AHPFFNDLRDPNACLPNGRPLPPLFNFTSQ------------------------ELANAP 456
Query: 479 NELRQRLIPEHAR 491
ELRQRLIPEHAR
Sbjct: 457 EELRQRLIPEHAR 469
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356504991|ref|XP_003521276.1| PREDICTED: shaggy-related protein kinase theta [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 790 bits (2040), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/493 (75%), Positives = 420/493 (85%), Gaps = 26/493 (5%)
Query: 1 MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELEVNGE--ANLVERSASSLEQHMAS 58
MN+MRRLKSIASGRTSISSDPGGDS KRAK + E EV + N E + EQ + +
Sbjct: 1 MNMMRRLKSIASGRTSISSDPGGDSNSKRAKFEPETEVKADEKTNTTETICTDQEQLIDT 60
Query: 59 TSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEA 118
+ TS+ +TVARTE+SGF++LPKE+NEM+IRDEK+ N+ +KD+E ++V+GNGTE
Sbjct: 61 SKETSNVGTSDVSTVARTEKSGFEELPKELNEMKIRDEKSKNNSEKDIEATVVSGNGTET 120
Query: 119 GQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN 178
GQ+I T +GGR+GQPKQTISYMAERVVGTGSFG+VFQAKCLETG+SVAIKKVLQD+RYKN
Sbjct: 121 GQIITTAIGGRDGQPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKN 180
Query: 179 RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPIL 238
RELQ+MR +++ NVV LKH FFSTT+KDELYLNLVLEY+ ETVY+VSKHY RM+QH+PI+
Sbjct: 181 RELQVMRTVDNSNVVKLKHYFFSTTDKDELYLNLVLEYVPETVYKVSKHYVRMHQHMPII 240
Query: 239 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS 298
YVQLYTYQICRALNYLH V+GVCHRDIKPQNLLVN THQLKICDFGSAK+LVPGEPNIS
Sbjct: 241 YVQLYTYQICRALNYLHQVIGVCHRDIKPQNLLVNTQTHQLKICDFGSAKVLVPGEPNIS 300
Query: 299 YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358
YICSRYYRAPELIFGATEYTTAIDMWS+GCVLAELLLGQPLFPGESG+DQLVEIIKILGT
Sbjct: 301 YICSRYYRAPELIFGATEYTTAIDMWSVGCVLAELLLGQPLFPGESGIDQLVEIIKILGT 360
Query: 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC 418
PTREEI+CMNPNY EFKFPQIKAHPWHK+FHKRMPPEA+DLVSRLLQYSP+LRCTAL AC
Sbjct: 361 PTREEIRCMNPNYNEFKFPQIKAHPWHKVFHKRMPPEAVDLVSRLLQYSPNLRCTALAAC 420
Query: 419 AHPFFDDLRDPNTCLPNGRPLPTLFNFTAQGKLILCFSYFGFSSYFLPHANCLAELAGAS 478
AHPFFDDLRDPN CLPNGRPLP LFNFT+Q ELA A
Sbjct: 421 AHPFFDDLRDPNACLPNGRPLPPLFNFTSQ------------------------ELANAP 456
Query: 479 NELRQRLIPEHAR 491
ELRQRLIPE+AR
Sbjct: 457 EELRQRLIPEYAR 469
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224130108|ref|XP_002320754.1| predicted protein [Populus trichocarpa] gi|222861527|gb|EEE99069.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 789 bits (2038), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 375/459 (81%), Positives = 405/459 (88%), Gaps = 25/459 (5%)
Query: 35 ELEVNGEANLVERSASSLEQHMASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIR 94
E +++GE+ LVERS + EQHMASTS E AS S +V RTE+ G+DQLPKEM+EM+IR
Sbjct: 2 EQKIDGESYLVERSVTEQEQHMASTSQENAASASNVTSVTRTEKPGYDQLPKEMHEMKIR 61
Query: 95 DEKNVNHDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVF 154
D+KN NHD+KD+E +IV+GNGTE GQ+IATTVGGRNGQPKQ ISYMAERVVGTGSFGVV+
Sbjct: 62 DDKNTNHDEKDMEAAIVSGNGTETGQIIATTVGGRNGQPKQIISYMAERVVGTGSFGVVY 121
Query: 155 QAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214
QAKCLETG++VAIKKVLQDKRYKNRELQIMRLL+HPNVV LKHCF+STTEKDELYLNLVL
Sbjct: 122 QAKCLETGEAVAIKKVLQDKRYKNRELQIMRLLDHPNVVQLKHCFYSTTEKDELYLNLVL 181
Query: 215 EYISETVYRVSKHYTRMNQ-HVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN 273
EYISETV+RVS+H+ RMNQ H PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN
Sbjct: 182 EYISETVHRVSRHFNRMNQQHTPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN 241
Query: 274 PHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAEL 333
PHTHQLKICDFGSAKMLVPGE NISYICSRYYRAPELIFGATEYTTAID+WS+GCVLAEL
Sbjct: 242 PHTHQLKICDFGSAKMLVPGETNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAEL 301
Query: 334 LLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMP 393
LLG PLFPGESGVDQLVEIIK+LGTPTREEIKCMNPNYTEFKFPQIK HPW+KIFHKRMP
Sbjct: 302 LLGHPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKTHPWYKIFHKRMP 361
Query: 394 PEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQGKLIL 453
PEA+DLVSRLLQYSP+LRCTALEACAHPFFDDLRD N CLPNGR LP LFNFTAQ
Sbjct: 362 PEAVDLVSRLLQYSPNLRCTALEACAHPFFDDLRDANACLPNGRALPPLFNFTAQ----- 416
Query: 454 CFSYFGFSSYFLPHANCLAELAGASNELRQRLIPEHARK 492
ELAGAS ELRQRLIPEHARK
Sbjct: 417 -------------------ELAGASAELRQRLIPEHARK 436
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|62857012|dbj|BAD95891.1| Ser/Thr protein kinase [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 780 bits (2014), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 371/493 (75%), Positives = 421/493 (85%), Gaps = 29/493 (5%)
Query: 1 MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELE--VNGEANLVERSASSLEQHMAS 58
MN+MRRLKSIASGRTSISSDPGGDS KRAK+D+E E VN E + EQH+
Sbjct: 1 MNMMRRLKSIASGRTSISSDPGGDSNSKRAKLDQETEKKVNEETKTL--GGKDQEQHV-D 57
Query: 59 TSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEA 118
S E TS+ +TVA+TE+SGFD+LPKE++EM+I+DEK+ N+++KD+E SIV+GNGTE
Sbjct: 58 ASKESTVGTSDVSTVAKTEKSGFDELPKELHEMKIKDEKSKNNNEKDIEASIVSGNGTET 117
Query: 119 GQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN 178
GQ+I T +GGR+GQPKQTISYMAERVVGTGSFGVVFQAKCLETG++VAIKKVLQDKRYKN
Sbjct: 118 GQIITTAIGGRDGQPKQTISYMAERVVGTGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN 177
Query: 179 RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPIL 238
RELQ+MR ++HPN+V LKHCFFSTT+KDELYLNLVLE++ ETVY+VSK Y R++QH+PI+
Sbjct: 178 RELQVMRTVDHPNIVKLKHCFFSTTDKDELYLNLVLEFVPETVYKVSKQYIRVHQHMPII 237
Query: 239 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS 298
YVQLY YQICRALNYLH V+GVCHRDIKPQNLLVNP THQLKICDFGSAKMLVPGEPNIS
Sbjct: 238 YVQLYIYQICRALNYLHQVIGVCHRDIKPQNLLVNPQTHQLKICDFGSAKMLVPGEPNIS 297
Query: 299 YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358
YICSRYYRAPELIFGATEYTTAIDMWS+GCVLAELLLG PLFPGESGVDQLVEIIK+LGT
Sbjct: 298 YICSRYYRAPELIFGATEYTTAIDMWSVGCVLAELLLGHPLFPGESGVDQLVEIIKVLGT 357
Query: 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC 418
PTREEI+CMNP+Y EFKFPQIKAHPWHK+F+KRMPPEA+DLVSRLLQYSP+LRCTAL AC
Sbjct: 358 PTREEIRCMNPHYNEFKFPQIKAHPWHKVFYKRMPPEAVDLVSRLLQYSPNLRCTALAAC 417
Query: 419 AHPFFDDLRDPNTCLPNGRPLPTLFNFTAQGKLILCFSYFGFSSYFLPHANCLAELAGAS 478
AHPFF+DLRDPN LPNG+PLP LFNFT + ELA A
Sbjct: 418 AHPFFNDLRDPNASLPNGQPLPPLFNFTPE------------------------ELAHAP 453
Query: 479 NELRQRLIPEHAR 491
+ELR RLIPEHAR
Sbjct: 454 DELRLRLIPEHAR 466
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|1617200|emb|CAA69899.1| NSK6 [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 778 bits (2008), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/496 (75%), Positives = 424/496 (85%), Gaps = 29/496 (5%)
Query: 1 MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELE--VNGEANLVERSASSLEQHMAS 58
MNVMRRLKSIASGR+S+S DPGGDS IKR KV++E++ V GE + ER + + + +
Sbjct: 1 MNVMRRLKSIASGRSSVS-DPGGDSSIKRVKVEQEVDQRVVGETQMEERCTTIVPKEDMA 59
Query: 59 TSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDD--KDLEPSIVNGNGT 116
++ + + S + R E S FD+LPKEM+EM+I+DEK +H+D KD+EP++V+GNGT
Sbjct: 60 STSKGTTTGSTSTMDTRPENSEFDELPKEMHEMKIKDEKADSHEDNLKDMEPAVVSGNGT 119
Query: 117 EAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRY 176
E GQ+I TTV GRNGQ KQT+SYMAERVVGTGSFG VFQAKCLETG+SVAIKKVLQD+RY
Sbjct: 120 ETGQIIVTTVSGRNGQQKQTLSYMAERVVGTGSFGTVFQAKCLETGESVAIKKVLQDRRY 179
Query: 177 KNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVP 236
KNRELQIMR L+HPNVV L+HCF+STTEK+E+YLNLVLEY+SETVYRVS+HY+RMNQH+P
Sbjct: 180 KNRELQIMRTLDHPNVVKLRHCFYSTTEKNEVYLNLVLEYVSETVYRVSRHYSRMNQHMP 239
Query: 237 ILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN 296
I+YVQLYTYQICRALNY+H V+GVCHRDIKPQNLLVNPHTHQLK+CDFGSAKMLVPGEPN
Sbjct: 240 IIYVQLYTYQICRALNYMHGVLGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKMLVPGEPN 299
Query: 297 ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKIL 356
ISYICSRYYRAPELIFGATEYTTAIDMWS GCV+AELLLGQPLFPGESGVDQLVEIIKIL
Sbjct: 300 ISYICSRYYRAPELIFGATEYTTAIDMWSAGCVMAELLLGQPLFPGESGVDQLVEIIKIL 359
Query: 357 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALE 416
GTPTREEI+CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEA+DLVSRLLQYSP+LRCTALE
Sbjct: 360 GTPTREEIRCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPTLRCTALE 419
Query: 417 ACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQGKLILCFSYFGFSSYFLPHANCLAELAG 476
ACAHPFFD LR+PN CLPNGRPLP LFNFTAQ EL+G
Sbjct: 420 ACAHPFFDPLREPNACLPNGRPLPPLFNFTAQ------------------------ELSG 455
Query: 477 ASNELRQRLIPEHARK 492
A +LR+RLIPEH RK
Sbjct: 456 APADLRKRLIPEHMRK 471
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15236918|ref|NP_191981.1| Shaggy-related protein kinase theta [Arabidopsis thaliana] gi|12643793|sp|Q96287.3|KSG8_ARATH RecName: Full=Shaggy-related protein kinase theta; AltName: Full=ASK-theta gi|1944518|emb|CAA69156.1| Shaggy-like kinase tetha [Arabidopsis thaliana] gi|3047105|gb|AAC13616.1| protein kinase [Arabidopsis thaliana] gi|7267411|emb|CAB80881.1| Shaggy related protein kinase tetha [Arabidopsis thaliana] gi|17063158|gb|AAL32976.1| AT4g00720/F6N23_11 [Arabidopsis thaliana] gi|21700933|gb|AAM70590.1| AT4g00720/F6N23_11 [Arabidopsis thaliana] gi|110740517|dbj|BAE98364.1| Shaggy related protein kinase theta [Arabidopsis thaliana] gi|332656525|gb|AEE81925.1| Shaggy-related protein kinase theta [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 777 bits (2006), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/492 (76%), Positives = 414/492 (84%), Gaps = 27/492 (5%)
Query: 1 MNVMRRLKSIASGRTSISSDPGGDSGIKRAKVDKELE-VNGEANLVERSASSLEQHMAST 59
MNVMRRLKSIASGRTSISSDPGGD +KRAK+D+E + + + V++++S E
Sbjct: 1 MNVMRRLKSIASGRTSISSDPGGDYALKRAKLDQENDNLCVDPMQVDQNSSCFEMKADVL 60
Query: 60 SLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAG 119
S E VA TS V +E+ DQLP M EM+IRDE+N N +DKD+E ++VNG+GTE G
Sbjct: 61 SQESVAGTSNVPAV--SEKPVDDQLPDVMIEMKIRDERNANREDKDMETTVVNGSGTETG 118
Query: 120 QVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR 179
QVI TTVGGR+G+PKQTISYMA+RVVGTGSFGVVFQAKCLETG+ VAIKKVLQDKRYKNR
Sbjct: 119 QVITTTVGGRDGKPKQTISYMAQRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNR 178
Query: 180 ELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
ELQIMRL +HPNVV L+H FFSTT+KDELYLNLVLEY+ ETVYR SKHYT+MNQH+PI++
Sbjct: 179 ELQIMRLQDHPNVVRLRHSFFSTTDKDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIF 238
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY 299
VQLYTYQICRALNYLH VVGVCHRDIKPQNLLVNP THQLKICDFGSAKMLVPGEPNISY
Sbjct: 239 VQLYTYQICRALNYLHRVVGVCHRDIKPQNLLVNPQTHQLKICDFGSAKMLVPGEPNISY 298
Query: 300 ICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTP 359
ICSRYYRAPELIFGATEYT AIDMWS GCV+AELLLGQPLFPGESG+DQLVEIIKILGTP
Sbjct: 299 ICSRYYRAPELIFGATEYTNAIDMWSGGCVMAELLLGQPLFPGESGIDQLVEIIKILGTP 358
Query: 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419
TREEI+CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEA+DLVSRLLQYSP+LRCTALEACA
Sbjct: 359 TREEIRCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACA 418
Query: 420 HPFFDDLRDPNTCLPNGRPLPTLFNFTAQGKLILCFSYFGFSSYFLPHANCLAELAGASN 479
HPFFDDLRDPN LPNGR LP LFNFTAQ ELAGAS
Sbjct: 419 HPFFDDLRDPNVSLPNGRALPPLFNFTAQ------------------------ELAGAST 454
Query: 480 ELRQRLIPEHAR 491
ELRQRLIP H +
Sbjct: 455 ELRQRLIPAHCQ 466
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 492 | ||||||
| TAIR|locus:2126993 | 472 | SK32 "shaggy-like protein kina | 0.906 | 0.944 | 0.786 | 1.8e-196 | |
| TAIR|locus:2222642 | 410 | SK13 "shaggy-like kinase 13" [ | 0.778 | 0.934 | 0.783 | 1.6e-173 | |
| TAIR|locus:2832141 | 405 | SK 11 "AT5G26751" [Arabidopsis | 0.762 | 0.925 | 0.790 | 4.7e-172 | |
| TAIR|locus:2074464 | 409 | ATSK12 [Arabidopsis thaliana ( | 0.770 | 0.926 | 0.784 | 7.7e-172 | |
| TAIR|locus:2098896 | 438 | AT3G61160 [Arabidopsis thalian | 0.796 | 0.894 | 0.720 | 1.7e-168 | |
| TAIR|locus:2024341 | 421 | SK41 "shaggy-like protein kina | 0.796 | 0.931 | 0.720 | 7.4e-163 | |
| TAIR|locus:2202255 | 407 | GSK1 "GSK3/SHAGGY-like protein | 0.697 | 0.842 | 0.787 | 1.1e-161 | |
| TAIR|locus:2052861 | 412 | SKdZeta "SHAGGY-related protei | 0.699 | 0.834 | 0.787 | 1.4e-161 | |
| TAIR|locus:2124082 | 380 | BIN2 "BRASSINOSTEROID-INSENSIT | 0.699 | 0.905 | 0.776 | 1.3e-158 | |
| UNIPROTKB|Q91757 | 420 | gsk3b "Glycogen synthase kinas | 0.729 | 0.854 | 0.641 | 8.9e-125 |
| TAIR|locus:2126993 SK32 "shaggy-like protein kinase 32" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1851 (656.6 bits), Expect = 1.8e-196, Sum P(2) = 1.8e-196
Identities = 353/449 (78%), Positives = 388/449 (86%)
Query: 1 MNVMRRLKSIASGRTXXXXXXXXXXXXKRAKVDKELE-VNGEANLVERSASSLEQHMAST 59
MNVMRRLKSIASGRT KRAK+D+E + + + V++++S E
Sbjct: 1 MNVMRRLKSIASGRTSISSDPGGDYALKRAKLDQENDNLCVDPMQVDQNSSCFEMKADVL 60
Query: 60 SLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAG 119
S E VA TS V+ E+ DQLP M EM+IRDE+N N +DKD+E ++VNG+GTE G
Sbjct: 61 SQESVAGTSNVPAVS--EKPVDDQLPDVMIEMKIRDERNANREDKDMETTVVNGSGTETG 118
Query: 120 QVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR 179
QVI TTVGGR+G+PKQTISYMA+RVVGTGSFGVVFQAKCLETG+ VAIKKVLQDKRYKNR
Sbjct: 119 QVITTTVGGRDGKPKQTISYMAQRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNR 178
Query: 180 ELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY 239
ELQIMRL +HPNVV L+H FFSTT+KDELYLNLVLEY+ ETVYR SKHYT+MNQH+PI++
Sbjct: 179 ELQIMRLQDHPNVVRLRHSFFSTTDKDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIF 238
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY 299
VQLYTYQICRALNYLH VVGVCHRDIKPQNLLVNP THQLKICDFGSAKMLVPGEPNISY
Sbjct: 239 VQLYTYQICRALNYLHRVVGVCHRDIKPQNLLVNPQTHQLKICDFGSAKMLVPGEPNISY 298
Query: 300 ICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTP 359
ICSRYYRAPELIFGATEYT AIDMWS GCV+AELLLGQPLFPGESG+DQLVEIIKILGTP
Sbjct: 299 ICSRYYRAPELIFGATEYTNAIDMWSGGCVMAELLLGQPLFPGESGIDQLVEIIKILGTP 358
Query: 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419
TREEI+CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEA+DLVSRLLQYSP+LRCTALEACA
Sbjct: 359 TREEIRCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACA 418
Query: 420 HPFFDDLRDPNTCLPNGRPLPTLFNFTAQ 448
HPFFDDLRDPN LPNGR LP LFNFTAQ
Sbjct: 419 HPFFDDLRDPNVSLPNGRALPPLFNFTAQ 447
|
|
| TAIR|locus:2222642 SK13 "shaggy-like kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1641 (582.7 bits), Expect = 1.6e-173, Sum P(2) = 1.6e-173
Identities = 308/393 (78%), Positives = 343/393 (87%)
Query: 56 MASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNG 115
MAS P +S AT ++LP+ +NEM+I+D DK++E ++V+GNG
Sbjct: 1 MASVGTLPASSM---ATKQSNASICAEKLPEGINEMKIKD-------DKEMEAAVVDGNG 50
Query: 116 TEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR 175
TE G +I TT+GG+NGQPKQTISYMAER+VG GSFG+VFQAKCLETG++VAIKKVLQDKR
Sbjct: 51 TETGHIIVTTIGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGETVAIKKVLQDKR 110
Query: 176 YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV 235
YKNRELQ MRLL+HPNVVSLKHCFFSTTEKDELYLNLVLEY+ ETVYRVSKHY+R NQ +
Sbjct: 111 YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSKHYSRANQRM 170
Query: 236 PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295
PI+YV+LYTYQICRAL Y+H VGVCHRDIKPQNLLVNPHTHQ+K+CDFGSAK+LV GEP
Sbjct: 171 PIIYVKLYTYQICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 230
Query: 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKI 355
NISYICSRYYRAPELIFGATEYTT ID+WS GCVLAELLLGQPLFPGESGVDQLVEIIK+
Sbjct: 231 NISYICSRYYRAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 290
Query: 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL 415
LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKR PPEA+DLVSRLLQYSP+LR TA+
Sbjct: 291 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQYSPNLRSTAM 350
Query: 416 EACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQ 448
EA HPFFD+LRDPNT LPNGR LP LFNF Q
Sbjct: 351 EAIVHPFFDELRDPNTRLPNGRALPPLFNFKPQ 383
|
|
| TAIR|locus:2832141 SK 11 "AT5G26751" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1636 (581.0 bits), Expect = 4.7e-172, Sum P(2) = 4.7e-172
Identities = 302/382 (79%), Positives = 340/382 (89%)
Query: 64 VASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAGQVIA 123
+AS A + +G D+LP+EMN+M+IRD DK++E ++V+GNGTE G +I
Sbjct: 1 MASVGIAPNPGARDSTGVDKLPEEMNDMKIRD-------DKEMEATVVDGNGTETGHIIV 53
Query: 124 TTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQI 183
TT+GGRNGQPKQTISYMAERVVG GSFGVVFQAKCLETG++VAIKKVLQD+RYKNRELQ
Sbjct: 54 TTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQT 113
Query: 184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY 243
MRLL+HPNVVSLKHCFFSTTEKDELYLNLVLEY+ ETV+RV KHY ++NQ +P++YV+LY
Sbjct: 114 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLY 173
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR 303
TYQI RAL+Y+H +GVCHRDIKPQNLLVNPHTHQ+K+CDFGSAK+LV GEPNISYICSR
Sbjct: 174 TYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 233
Query: 304 YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363
YYRAPELIFGATEYTTAID+WS GCVLAELLLGQPLFPGESGVDQLVEIIK+LGTPTREE
Sbjct: 234 YYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 293
Query: 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEA+DLVSRLLQYSP+LR AL+ HPFF
Sbjct: 294 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSAALDTLVHPFF 353
Query: 424 DDLRDPNTCLPNGRPLPTLFNF 445
D+LRDPN LPNGR LP LFNF
Sbjct: 354 DELRDPNARLPNGRFLPPLFNF 375
|
|
| TAIR|locus:2074464 ATSK12 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1634 (580.3 bits), Expect = 7.7e-172, Sum P(2) = 7.7e-172
Identities = 306/390 (78%), Positives = 346/390 (88%)
Query: 56 MASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNG 115
MAS +EP A+ E+ T T+ D+LP+EM +M+I+D DK++E +IVNGN
Sbjct: 1 MASVGIEPSAAVRES-TGNVTDA---DRLPEEMKDMKIQD-------DKEMEATIVNGNV 49
Query: 116 TEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR 175
TE G +I TT+GGRNGQPKQTISYMAERVVG GSFGVVFQAKCLETG++VAIKKVLQD+R
Sbjct: 50 TETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRR 109
Query: 176 YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV 235
YKNRELQ MRLL+HPNVVSLKHCFFSTTEKDELYLNLVLEY+ ETV+RV KHY ++NQ +
Sbjct: 110 YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRM 169
Query: 236 PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295
P++YV+LYTYQI R+L+Y+H +GVCHRDIKPQNLLVNPHTHQ+K+CDFGSAK+LV GEP
Sbjct: 170 PLVYVKLYTYQIFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
Query: 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKI 355
NISYICSRYYRAPELIFGATEYTTAID+WS GCVLAELLLGQPLFPGESGVDQLVEIIK+
Sbjct: 230 NISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 289
Query: 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL 415
LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEA+DLVSRLLQYSP+LRC AL
Sbjct: 290 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCAAL 349
Query: 416 EACAHPFFDDLRDPNTCLPNGRPLPTLFNF 445
++ HPFFD+LRDPN LPNGR LP LFNF
Sbjct: 350 DSLVHPFFDELRDPNARLPNGRFLPPLFNF 379
|
|
| TAIR|locus:2098896 AT3G61160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1529 (543.3 bits), Expect = 1.7e-168, Sum P(3) = 1.7e-168
Identities = 291/404 (72%), Positives = 333/404 (82%)
Query: 46 ERSASSLEQHMASTSLEPVASTS-EAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDK 104
E S Q+ T E +TS E +V+ +E S D LPKE+ E+ + D DK
Sbjct: 26 ETPRSKPNQNREET--ESTETTSYEKDSVSSSENS--DHLPKEIREVGLGD-------DK 74
Query: 105 DLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDS 164
D++ I+ GNGTE+G++I T G N Q +TISY AE V+GTGSFGVVFQAKCLET +
Sbjct: 75 DMDCGIIKGNGTESGRIITTKKKGLNDQKDKTISYRAEHVIGTGSFGVVFQAKCLETEEK 134
Query: 165 VAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRV 224
VAIKKVLQDKRYKNRELQIMR+L+HPNVV LKH FFSTTEKDELYLNLVLEY+ ET+YR
Sbjct: 135 VAIKKVLQDKRYKNRELQIMRMLDHPNVVELKHSFFSTTEKDELYLNLVLEYVPETIYRA 194
Query: 225 SKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284
S+ YT+MNQH+P++Y+QLYTYQICRA+NYLH VVGVCHRDIKPQNLLVN TH++KICDF
Sbjct: 195 SRSYTKMNQHMPLIYIQLYTYQICRAMNYLHQVVGVCHRDIKPQNLLVNNVTHEVKICDF 254
Query: 285 GSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES 344
GSAKML+PGEPNISYICSRYYRAPELIFGATEYT+AIDMWS+GCV+AEL LG PLFPGE+
Sbjct: 255 GSAKMLIPGEPNISYICSRYYRAPELIFGATEYTSAIDMWSVGCVMAELFLGHPLFPGET 314
Query: 345 GVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLL 404
VDQLVEIIKILGTP REEIK MNP Y +FKFPQIKA PWHKIF +++ PEA+DL SRLL
Sbjct: 315 SVDQLVEIIKILGTPAREEIKNMNPRYNDFKFPQIKAQPWHKIFRRQVSPEAMDLASRLL 374
Query: 405 QYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQ 448
QYSP+LRCTALEACAHPFFDDLRDP LPNGR LP LF+FTAQ
Sbjct: 375 QYSPNLRCTALEACAHPFFDDLRDPRASLPNGRALPPLFDFTAQ 418
|
|
| TAIR|locus:2024341 SK41 "shaggy-like protein kinase 41" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1545 (548.9 bits), Expect = 7.4e-163, Sum P(2) = 7.4e-163
Identities = 283/393 (72%), Positives = 334/393 (84%)
Query: 56 MASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNG 115
MAS+ L TS +A ++ S D L +++ E RIRD+ + D++D EP I++G G
Sbjct: 1 MASSGLGNGVGTSRSAKGLKSSSSSVDWLTRDLAETRIRDKVETD-DERDSEPDIIDGAG 59
Query: 116 TEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR 175
E G VI TT+ GRNGQ +QT+SY++E VVGTGSFG+VFQAKC ETG+ VAIKKVLQDKR
Sbjct: 60 AEPGHVIRTTLRGRNGQSRQTVSYISEHVVGTGSFGMVFQAKCRETGEVVAIKKVLQDKR 119
Query: 176 YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV 235
YKNRELQIM++L+HPN V+LKH FFS T+ +E+YLNLVLE++ ETV RV++ Y+R NQ +
Sbjct: 120 YKNRELQIMQMLDHPNAVALKHSFFSRTDNEEVYLNLVLEFVPETVNRVARSYSRTNQLM 179
Query: 236 PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295
P++YV+LYTYQICRAL Y+H+ G+CHRDIKPQNLLVNPHTHQLKICDFGSAK+LV GEP
Sbjct: 180 PLIYVKLYTYQICRALAYIHNSFGLCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEP 239
Query: 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKI 355
N+SYICSRYYRAPELIFGA+EYTTAID+WS GCV+AELLLGQPLFPGESGVDQLVEIIK+
Sbjct: 240 NVSYICSRYYRAPELIFGASEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 299
Query: 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL 415
LGTPTREEIKCMNPNYTEFKFPQIK HPWHK+F KR+PPEA+DL+ R QYSP+LRCTAL
Sbjct: 300 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCRFFQYSPNLRCTAL 359
Query: 416 EACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQ 448
EAC HP FD+LRDPNT LPNGRPLP LFNF Q
Sbjct: 360 EACIHPLFDELRDPNTRLPNGRPLPPLFNFKPQ 392
|
|
| TAIR|locus:2202255 GSK1 "GSK3/SHAGGY-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1526 (542.2 bits), Expect = 1.1e-161, Sum P(2) = 1.1e-161
Identities = 270/343 (78%), Positives = 313/343 (91%)
Query: 103 DKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETG 162
DK++ +++ GN G +I+TT+GG+NG+PKQTISYMAERVVGTGSFG+VFQAKCLETG
Sbjct: 34 DKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETG 93
Query: 163 DSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVY 222
+SVAIKKVLQD+RYKNRELQ+MR ++HPNV+SLKHCFFSTT +DEL+LNLV+EY+ ET+Y
Sbjct: 94 ESVAIKKVLQDRRYKNRELQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETLY 153
Query: 223 RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC 282
RV +HYT NQ +PI YV+LYTYQI R L Y+H V GVCHRD+KPQNLLV+P THQ+K+C
Sbjct: 154 RVLRHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 213
Query: 283 DFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPG 342
DFGSAK+LV GEPNISYICSRYYRAPELIFGATEYT +ID+WS GCVLAELLLGQPLFPG
Sbjct: 214 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQPLFPG 273
Query: 343 ESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSR 402
E+ VDQLVEIIK+LGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL SR
Sbjct: 274 ENSVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASR 333
Query: 403 LLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTLFNF 445
LLQYSPSLRCTALEACAHPFF++LR+PN LPNGRPLP LFNF
Sbjct: 334 LLQYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNF 376
|
|
| TAIR|locus:2052861 SKdZeta "SHAGGY-related protein kinase dZeta" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1524 (541.5 bits), Expect = 1.4e-161, Sum P(2) = 1.4e-161
Identities = 271/344 (78%), Positives = 313/344 (90%)
Query: 102 DDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLET 161
+DK++ +++ GN G +I+TT+GG+NG+PKQTISYMAERVVGTGSFG+VFQAKCLET
Sbjct: 35 NDKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET 94
Query: 162 GDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETV 221
G+SVAIKKVLQD+RYKNRELQ+MRL++HPNVVSLKHCFFSTT +DEL+LNLV+EY+ ET+
Sbjct: 95 GESVAIKKVLQDRRYKNRELQLMRLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETL 154
Query: 222 YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKI 281
YRV KHYT NQ +PI YV+LYTYQI R L Y+H GVCHRD+KPQNLLV+P THQ K+
Sbjct: 155 YRVLKHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTAPGVCHRDVKPQNLLVDPLTHQCKL 214
Query: 282 CDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFP 341
CDFGSAK+LV GE NISYICSRYYRAPELIFGATEYT++ID+WS GCVLAELLLGQPLFP
Sbjct: 215 CDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFP 274
Query: 342 GESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVS 401
GE+ VDQLVEIIK+LGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL S
Sbjct: 275 GENSVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 334
Query: 402 RLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTLFNF 445
RLLQYSPSLRCTALEACAHPFF++LR+PN LPNGRPLP LFNF
Sbjct: 335 RLLQYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNF 378
|
|
| TAIR|locus:2124082 BIN2 "BRASSINOSTEROID-INSENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1506 (535.2 bits), Expect = 1.3e-158, Sum P(2) = 1.3e-158
Identities = 267/344 (77%), Positives = 313/344 (90%)
Query: 102 DDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLET 161
DDK++ ++V+G+ G +I+TT+GG+NG+PKQTISYMAERVVGTGSFG+VFQAKCLET
Sbjct: 3 DDKEMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET 62
Query: 162 GDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETV 221
G++VAIKKVLQD+RYKNRELQ+MR+++HPNVV LKHCFFSTT KDEL+LNLV+EY+ E++
Sbjct: 63 GETVAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPESL 122
Query: 222 YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKI 281
YRV KHY+ NQ +P++YV+LY YQI R L Y+H+V GVCHRD+KPQNLLV+P THQ+KI
Sbjct: 123 YRVLKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQVKI 182
Query: 282 CDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFP 341
CDFGSAK LV GE NISYICSR+YRAPELIFGATEYTT+ID+WS GCVLAELLLGQPLFP
Sbjct: 183 CDFGSAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 242
Query: 342 GESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVS 401
GE+ VDQLVEIIK+LGTPTREEI+CMNP+YT+F+FPQIKAHPWHKIFHKRMPPEA+D S
Sbjct: 243 GENAVDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDFAS 302
Query: 402 RLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTLFNF 445
RLLQYSPSLRCTALEACAHPFFD+LR+PN LPNGRP P LFNF
Sbjct: 303 RLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNF 346
|
|
| UNIPROTKB|Q91757 gsk3b "Glycogen synthase kinase-3 beta" [Xenopus laevis (taxid:8355)] | Back alignment and assigned GO terms |
|---|
Score = 1226 (436.6 bits), Expect = 8.9e-125, P = 8.9e-125
Identities = 236/368 (64%), Positives = 293/368 (79%)
Query: 114 NGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD 173
+G++ V+AT G+ +Q ++Y +V+G GSFGVV+QAK +TG+ VAIKKVLQD
Sbjct: 33 DGSKVTTVVATP--GQGPDRQQEVTYTDTKVIGNGSFGVVYQAKLCDTGELVAIKKVLQD 90
Query: 174 KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK-DELYLNLVLEYISETVYRVSKHYTRMN 232
KR+KNRELQIMR L+H N+V L++ F+S+ EK DE+YLNLVL+Y+ ETVYRV++HY+R
Sbjct: 91 KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 150
Query: 233 QHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292
Q +PI+YV+LY YQ+ R+L Y+H G+CHRDIKPQNLL++P T LK+CDFGSAK LV
Sbjct: 151 QALPIIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPETAVLKLCDFGSAKQLVR 209
Query: 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEI 352
GEPN+SYICSRYYRAPELIFGAT+YT++ID+WS GCVLAELLLGQP+FPG+SGVDQLVEI
Sbjct: 210 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 269
Query: 353 IKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC 412
IK+LGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F R PPEA+ L SRLL+Y+P+ R
Sbjct: 270 IKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRARTPPEAIALCSRLLEYTPTSRL 329
Query: 413 TALEACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQGKLILCFSYFGFSSYFLP-HANCL 471
T L+ACAH FFD+LRDPN LPNGR P LFNFT Q +L S SS +P HA
Sbjct: 330 TPLDACAHSFFDELRDPNLKLPNGREFPALFNFTTQ-ELS---SNPSLSSILIPAHARNQ 385
Query: 472 AELAGASN 479
A ++ SN
Sbjct: 386 AAVSTTSN 393
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P43289 | KSG3_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7254 | 0.8170 | 0.9828 | no | no |
| P43288 | KSG1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7342 | 0.8089 | 0.9827 | no | no |
| Q96287 | KSG8_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7662 | 0.9451 | 0.9851 | yes | no |
| Q10452 | GSK3_SCHPO | 2, ., 7, ., 1, 1, ., 1 | 0.5664 | 0.6930 | 0.8811 | yes | no |
| Q9U2Q9 | GSK3_CAEEL | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6404 | 0.6626 | 0.9005 | yes | no |
| Q40518 | MSK1_TOBAC | 2, ., 7, ., 1, 1, ., 1 | 0.7322 | 0.8170 | 0.9828 | N/A | no |
| Q9WV60 | GSK3B_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.6686 | 0.6788 | 0.7952 | yes | no |
| P51136 | GSK3_DICDI | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6028 | 0.6666 | 0.7023 | yes | no |
| P51137 | MSK1_MEDSA | 2, ., 7, ., 1, 1, ., 1 | 0.7185 | 0.8211 | 0.9829 | N/A | no |
| P51138 | MSK2_MEDSA | 2, ., 7, ., 1, 1, ., 1 | 0.7202 | 0.8089 | 0.9683 | N/A | no |
| P51139 | MSK3_MEDSA | 2, ., 7, ., 1, 1, ., 1 | 0.725 | 0.8130 | 0.9732 | N/A | no |
| O04160 | KSGT_BRANA | 2, ., 7, ., 1, 1, ., 1 | 0.7409 | 0.9247 | 0.9722 | N/A | no |
| P18266 | GSK3B_RAT | 2, ., 7, ., 1, 1, ., 1 | 0.6715 | 0.6788 | 0.7952 | yes | no |
| Q8VZD5 | KSG5_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7368 | 0.8191 | 0.9829 | no | no |
| P49841 | GSK3B_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.6686 | 0.6788 | 0.7952 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.979 |
| 3rd Layer | 2.7.11 | 0.983 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 492 | |||
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-132 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-95 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-86 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-85 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-82 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-81 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-81 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-78 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-77 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-75 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-72 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-72 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-71 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-70 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-67 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-67 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-64 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-64 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-63 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-62 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-61 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-61 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-61 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-59 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-59 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-57 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-56 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-55 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-55 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-55 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-54 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-54 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-54 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 9e-54 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-53 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-53 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-53 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-53 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-53 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-53 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-52 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-51 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-50 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-50 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-47 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-47 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-47 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-47 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-47 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-46 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-45 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-45 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-45 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-45 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-42 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-40 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-40 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-39 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-37 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-37 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-36 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-36 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-36 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-35 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-35 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-34 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-34 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-34 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-34 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-34 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-32 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-32 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-31 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-31 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-30 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-29 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-29 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-29 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-28 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-28 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-27 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-27 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-27 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-26 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-26 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-26 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-25 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-24 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-24 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-24 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-24 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-24 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-23 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-23 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-23 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-22 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-22 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-22 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-22 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-22 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-22 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-21 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-21 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-21 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-21 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-20 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-20 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-20 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-20 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-20 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-19 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-19 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-19 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-19 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-19 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-19 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 9e-19 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-18 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-18 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-18 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-18 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-18 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-18 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 9e-18 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-17 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-17 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-17 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-17 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-17 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-17 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-16 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-16 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-16 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-16 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-16 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-16 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-16 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-16 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-16 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-16 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-16 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-15 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-15 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-15 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-15 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-15 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-15 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-14 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-14 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-14 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-14 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-13 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-13 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-13 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-13 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-12 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-12 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-12 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-12 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 8e-12 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-11 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-11 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-11 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-11 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-10 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-10 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-10 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-10 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-09 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-09 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-09 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-09 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-08 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-08 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-08 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-08 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 9e-08 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-08 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-07 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-07 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-07 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-06 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-06 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-06 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-06 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-06 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-06 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-06 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-06 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-05 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-05 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-05 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-04 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-04 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-04 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-04 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-04 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-04 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-04 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-04 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 9e-04 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 0.002 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 0.002 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 0.002 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 390 bits (1002), Expect = e-132
Identities = 174/339 (51%), Positives = 240/339 (70%), Gaps = 7/339 (2%)
Query: 112 NGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL 171
N N E N P + SY ++G GSFGVV++A C++T + VAIKKVL
Sbjct: 43 NNNAGEDEDEEKMIDNDINRSPNK--SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVL 100
Query: 172 QDKRYKNRELQIMRLLNHPNVVSLKHCFFSTT-EKDE--LYLNLVLEYISETVYRVSKHY 228
QD +YKNREL IM+ LNH N++ LK +++ +K+E ++LN+V+E+I +TV++ KHY
Sbjct: 101 QDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHY 160
Query: 229 TRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288
R N +P+ V+LY+YQ+CRAL Y+H +CHRD+KPQNLL++P+TH LK+CDFGSAK
Sbjct: 161 ARNNHALPLFLVKLYSYQLCRALAYIHSKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219
Query: 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQ 348
L+ G+ ++SYICSR+YRAPEL+ GAT YTT ID+WS+GC++AE++LG P+F G+S VDQ
Sbjct: 220 NLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ 279
Query: 349 LVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSP 408
LV II++LGTPT +++K MNPNY + KFP +K K+F K P +A++ +S+ L+Y P
Sbjct: 280 LVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEP 339
Query: 409 SLRCTALEACAHPFFDDLRDPNTCLPNG-RPLPTLFNFT 446
R +EA A PFFDDLRDP LP LP LFNF
Sbjct: 340 LKRLNPIEALADPFFDDLRDPCIKLPKYIDKLPDLFNFC 378
|
Length = 440 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 291 bits (748), Expect = 2e-95
Identities = 116/307 (37%), Positives = 175/307 (57%), Gaps = 24/307 (7%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNV 192
Y + +G+G++GVV A TG VAIKK+ L D + RE++++R L H N+
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 193 VSLKHCF--FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
+ L S + +++Y+ V E + +++V + Q + ++Q + YQI R
Sbjct: 62 IGLLDILRPPSPEDFNDVYI--VTELMETDLHKV----IKSPQPLTDDHIQYFLYQILRG 115
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS----YICSRYYR 306
L YLH V HRD+KP N+LVN LKICDFG A+ + P E Y+ +R+YR
Sbjct: 116 LKYLHSA-NVIHRDLKPSNILVN-SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR 173
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366
APEL+ ++ YT AID+WS+GC+ AELL +PLFPG +DQL I+++LGTP+ E++K
Sbjct: 174 APELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233
Query: 367 M-NPNYTEF--KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+ + + P+ P K+F PEA+DL+ ++L + P R TA EA AHP+
Sbjct: 234 ITSEKARNYLKSLPKKPKKPLSKLF-PGASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292
Query: 424 DDLRDPN 430
L DP
Sbjct: 293 AQLHDPE 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 267 bits (684), Expect = 1e-86
Identities = 115/295 (38%), Positives = 171/295 (57%), Gaps = 22/295 (7%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR---YKN---RELQIMRLLNHPNV 192
Y +G G++GVV++A+ TG+ VAIKK+ RE+++++ LNHPN+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
+ L F K +LYL V E++ +Y++ K R +P ++ Y YQ+ + L
Sbjct: 61 IKLLDVFR---HKGDLYL--VFEFMDTDLYKLIKDRQR---GLPESLIKSYLYQLLQGLA 112
Query: 253 YLH-HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYRAPEL 310
+ H H G+ HRD+KP+NLL+N LK+ DFG A+ P P Y+ +R+YRAPEL
Sbjct: 113 FCHSH--GILHRDLKPENLLINTEG-VLKLADFGLARSFGSPVRPYTHYVVTRWYRAPEL 169
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370
+ G Y+T +D+WS+GC+ AELL +PLFPG+S +DQL +I + LGTP E
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL 229
Query: 371 --YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+F FP+ P K+F P+ALDL+S++L Y P R TA +A AHP+F
Sbjct: 230 ARNYKFSFPKKAGMPLPKLF-PNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 263 bits (676), Expect = 2e-85
Identities = 108/295 (36%), Positives = 171/295 (57%), Gaps = 35/295 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--------RELQIMRLLNHPNVVSLK 196
+G G++GVV++A+ +TG+ VA+KK+ D + RE+ +++ L HPN+V L
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHPNIVKLL 64
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
+ + +LYL V EY + K+ + + ++ YQ+ R L Y H
Sbjct: 65 DVIHT---ERKLYL--VFEYCD---MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAPELIFG 313
+ HRD+KPQN+L+N LK+ DFG A+ G P +Y + + +YRAPE++ G
Sbjct: 117 H-RILHRDLKPQNILIN-RDGVLKLADFGLARAF--GIPLRTYTHEVVTLWYRAPEILLG 172
Query: 314 ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373
+ Y+TA+D+WS+GC+ AE++ G+PLFPG+S +DQL +I +ILGTPT E P T+
Sbjct: 173 SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESW----PGVTK 228
Query: 374 FK-----FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
FP+ K+ R+ PE +DL+S++LQY+P+ R +A EA HP+F
Sbjct: 229 LPDYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 254 bits (652), Expect = 4e-82
Identities = 105/291 (36%), Positives = 155/291 (53%), Gaps = 43/291 (14%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-----LQDKRYKNRELQIMRLLNHPNVV 193
Y +G GSFG V+ A+ +TG VAIK + +D+ RE++I++ L HPN+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L F ++D+LYL V+EY ++ + K R+++ + Y QI AL
Sbjct: 61 RLYDVF---EDEDKLYL--VMEYCEGGDLFDLLKKRGRLSEDE----ARFYLRQILSALE 111
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIF 312
YLH G+ HRD+KP+N+L++ H +K+ DFG A+ L PGE +++ + Y APE++
Sbjct: 112 YLHSK-GIVHRDLKPENILLDEDGH-VKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL 169
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372
G Y A+D+WS+G +L ELL G+P FPG+ DQL+E+ K +G P
Sbjct: 170 G-KGYGKAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKPK------------ 213
Query: 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
P + PEA DL+ +LL P R TA EA HPFF
Sbjct: 214 ----------PPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 252 bits (645), Expect = 5e-81
Identities = 98/289 (33%), Positives = 141/289 (48%), Gaps = 39/289 (13%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSL 195
R +G+GSFG V++AK TG VA+K + + RE++I+R L+HPN+V L
Sbjct: 4 LRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRL 63
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
F +KD LYL V+EY Y + + QI R L YLH
Sbjct: 64 IDAF---EDKDHLYL--VMEYCEGGDL---FDYLSRGGPLSEDEAKKIALQILRGLEYLH 115
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYRAPELIFGA 314
G+ HRD+KP+N+L++ +KI DFG AK L +++ + +Y APE++ G
Sbjct: 116 SN-GIIHRDLKPENILLD-ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173
Query: 315 TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEF 374
Y +D+WS+G +L ELL G+P F GE+ +DQL I +ILG P
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPL-------------- 219
Query: 375 KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+ + EA DL+ + L PS R TA E HP+F
Sbjct: 220 --------EFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 252 bits (645), Expect = 9e-81
Identities = 110/292 (37%), Positives = 164/292 (56%), Gaps = 23/292 (7%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLK 196
+G G+ G+VF+AK ETG++VA+KKV + RE++ ++ HP VV L
Sbjct: 6 GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
F LV+EY+ + V + R +P V+ Y + + + Y+H
Sbjct: 66 DVF-----PHGSGFVLVMEYMPSDLSEVLRDEER---PLPEAQVKSYMRMLLKGVAYMHA 117
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY--ICSRYYRAPELIFGA 314
G+ HRD+KP NLL++ LKI DFG A++ EP + + +R+YRAPEL++GA
Sbjct: 118 N-GIMHRDLKPANLLISADGV-LKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175
Query: 315 TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE---EIKCMNPNY 371
+Y +D+W++GC+ AELL G PLFPGE+ ++QL + + LGTP E + + P+Y
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL-PDY 234
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+ FP+ K P +IF PEALDL+ LL Y PS R +A EA HP+F
Sbjct: 235 NKITFPESKPIPLEEIFPD-ASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 246 bits (629), Expect = 2e-78
Identities = 111/291 (38%), Positives = 164/291 (56%), Gaps = 21/291 (7%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQ---DKRYKN---RELQIMRLLNHPNVVSLKH 197
VVG G++GVV + + TG+ VAIKK + D+ K RE++++R L H N+V+LK
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
F K LYL V EY+ T+ + + +P V+ Y +Q+ +A+ Y H
Sbjct: 68 AFRR---KGRLYL--VFEYVERTLLELLE---ASPGGLPPDAVRSYIWQLLQAIAYCHSH 119
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV--PGEPNISYICSRYYRAPELIFGAT 315
+ HRDIKP+N+LV+ LK+CDFG A+ L P P Y+ +R+YRAPEL+ G T
Sbjct: 120 -NIIHRDIKPENILVSESG-VLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177
Query: 316 EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILG--TPTREEIKCMNPNYTE 373
Y +D+W+IGC++AELL G+PLFPG+S +DQL I K LG P+ +E+ NP +
Sbjct: 178 NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237
Query: 374 FKFPQIKA-HPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
FP+ + + ++ ALD + L+ P R T E HP+F
Sbjct: 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 244 bits (624), Expect = 2e-77
Identities = 116/314 (36%), Positives = 165/314 (52%), Gaps = 37/314 (11%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---------RELQIMRLLNH 189
Y + +G G++ VV++A+ ETG VAIKK+ +R + RE+++++ L H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYIS---ETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
PN++ L F K +NLV E++ E V + K + + Y
Sbjct: 62 PNIIGLLDVF---GHKS--NINLVFEFMETDLEKVIK-DKSIVLTPADI-----KSYMLM 110
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC---SR 303
R L YLH + HRD+KP NLL+ LK+ DFG A+ G PN +R
Sbjct: 111 TLRGLEYLHSN-WILHRDLKPNNLLIASDG-VLKLADFGLARSF--GSPNRKMTHQVVTR 166
Query: 304 YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363
+YRAPEL+FGA Y +DMWS+GC+ AELLL P PG+S +DQL +I + LGTPT E
Sbjct: 167 WYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEEN 226
Query: 364 IKCMN--PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHP 421
+ P+Y EFK P +IF +ALDL+ RLL +P+ R TA +A HP
Sbjct: 227 WPGVTSLPDYVEFKP--FPPTPLKQIF-PAASDDALDLLQRLLTLNPNKRITARQALEHP 283
Query: 422 FFDDLRDPNTCLPN 435
+F + DP P+
Sbjct: 284 YFSN--DPAPTPPS 295
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 238 bits (609), Expect = 2e-75
Identities = 108/293 (36%), Positives = 172/293 (58%), Gaps = 26/293 (8%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQ-IMRLLNHPNVVS 194
+ +G G+FG V+ A+ ETG+ VAIKK+ + ++ + RE++ + +L HPN+V
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKK--KFYSWEECMNLREVKSLRKLNEHPNIVK 62
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
LK F E DELY V EY+ +Y++ K R + ++ YQI + L ++
Sbjct: 63 LKEVF---RENDELYF--VFEYMEGNLYQLMK--DRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA 314
H G HRD+KP+NLLV+ +KI DFG A+ + P Y+ +R+YRAPE++ +
Sbjct: 116 HKH-GFFHRDLKPENLLVSGPE-VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRS 173
Query: 315 TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE----IKCMNPN 370
T Y++ +D+W++GC++AEL +PLFPG S +DQL +I +LGTPT+++ K +
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK- 232
Query: 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
F+FPQ H++ PEA+DL+ +L++ P R TA +A HP+F
Sbjct: 233 -LGFRFPQFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 232 bits (594), Expect = 2e-72
Identities = 107/309 (34%), Positives = 172/309 (55%), Gaps = 31/309 (10%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL------QDKRYKNRELQIM---RLLNH 189
Y + +G G++G+V++A T + VA+KK+ D + RE IM L +H
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFRE--IMFLQELGDH 66
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
PN+V L + + +KD +YL V EY+ ++ V + + H + YQ+ +
Sbjct: 67 PNIVKLLNVIKAENDKD-IYL--VFEYMETDLHAVIRANILEDVHK-----RYIMYQLLK 118
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS------YICSR 303
AL Y+H V HRD+KP N+L+N +K+ DFG A+ L E N Y+ +R
Sbjct: 119 ALKYIHSG-NVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVATR 176
Query: 304 YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363
+YRAPE++ G+T YT +DMWS+GC+L E+LLG+PLFPG S ++QL +II+++G P+ E+
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236
Query: 364 IKCMNPNYTEF---KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420
I+ + + P P ++ + +ALDL+ +LL ++P+ R TA EA H
Sbjct: 237 IESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEH 295
Query: 421 PFFDDLRDP 429
P+ +P
Sbjct: 296 PYVAQFHNP 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 229 bits (587), Expect = 5e-72
Identities = 94/291 (32%), Positives = 153/291 (52%), Gaps = 22/291 (7%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSLKH 197
+G G++G V++A+ +TG+ VA+KK+ + K RE+++++ L HPN+V LK
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRME-NEKEGFPITAIREIKLLQKLRHPNIVRLKE 65
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
T K + + +V EY+ + + ++ Y Q+ L YLH
Sbjct: 66 I---VTSKGKGSIYMVFEYMDHDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN 119
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI--SYICSRYYRAPELIFGAT 315
G+ HRDIK N+L+N LK+ DFG A+ + + + +YR PEL+ GAT
Sbjct: 120 -GILHRDIKGSNILINNDGV-LKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT 177
Query: 316 EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE---EIKCMNPNYT 372
Y +DMWS+GC+LAEL LG+P+F G + ++QL +I ++ G+PT E + + P +
Sbjct: 178 RYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL-PWFE 236
Query: 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
K + + F + P ALDL+ +LL P R +A +A H +F
Sbjct: 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 229 bits (585), Expect = 4e-71
Identities = 111/308 (36%), Positives = 173/308 (56%), Gaps = 28/308 (9%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNV 192
Y +G G++G+V A TG VAIKK+ +R RE++I+R H N+
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQR-TLREIKILRRFKHENI 65
Query: 193 VSLKHCFFSTT--EKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
+ + + +++Y+ V E + +Y++ K N H+ Q + YQI R
Sbjct: 66 IGILDIIRPPSFESFNDVYI--VQELMETDLYKLIKTQHLSNDHI-----QYFLYQILRG 118
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS----YICSRYYR 306
L Y+H V HRD+KP NLL+N LKICDFG A++ P + Y+ +R+YR
Sbjct: 119 LKYIHSA-NVLHRDLKPSNLLLN-TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366
APE++ + YT AID+WS+GC+LAE+L +PLFPG+ + QL I+ +LGTP++E++ C
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236
Query: 367 M-NP---NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
+ + NY + P PW+K+F P+ALDL+ ++L ++P R T EA AHP+
Sbjct: 237 IISLRARNYIK-SLPFKPKVPWNKLF-PNADPKALDLLDKMLTFNPHKRITVEEALAHPY 294
Query: 423 FDDLRDPN 430
+ DP+
Sbjct: 295 LEQYHDPS 302
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 226 bits (577), Expect = 5e-70
Identities = 115/315 (36%), Positives = 171/315 (54%), Gaps = 27/315 (8%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKK------VLQDKRYKNRELQIMRLLNHPN 191
Y +G+G++GVV A +G VAIKK V + REL+I+R H N
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+++++ D + +V++ + ++ H +Q + +++ + YQ+ R L
Sbjct: 66 IIAIRD-ILRPPGADFKDVYVVMDLMESDLH----HIIHSDQPLTEEHIRYFLYQLLRGL 120
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV--PGEPN---ISYICSRYYR 306
Y+H V HRD+KP NLLVN L+I DFG A+ L P E Y+ +R+YR
Sbjct: 121 KYIHSA-NVIHRDLKPSNLLVNEDCE-LRIGDFGMARGLSSSPTEHKYFMTEYVATRWYR 178
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366
APEL+ EYTTAIDMWS+GC+ AE+L + LFPG++ V QL I+ +LG+P+ E +
Sbjct: 179 APELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238
Query: 367 MNP----NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
+ Y + P+ + PW KIF K PEALDL+S++LQ+ P R T +A HPF
Sbjct: 239 IGSDRVRKYIQ-NLPRKQPVPWSKIFPKA-SPEALDLLSQMLQFDPEERITVEQALQHPF 296
Query: 423 FDDLRDPN---TCLP 434
DP+ TC P
Sbjct: 297 LAQYHDPDDEPTCPP 311
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 217 bits (556), Expect = 2e-67
Identities = 104/297 (35%), Positives = 168/297 (56%), Gaps = 38/297 (12%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
+G G++GVV++A+ TG+ VA+KK+ + + RE+ +++ LNHPN+V L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY-----VQLYTYQICRALNY 253
S + LYL V E++ + K Y M+ P+ ++ Y YQ+ + + Y
Sbjct: 67 VHSENK---LYL--VFEFLDLDL----KKY--MD-SSPLTGLDPPLIKSYLYQLLQGIAY 114
Query: 254 LH-HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAPE 309
H H V HRD+KPQNLL++ LK+ DFG A+ G P +Y + + +YRAPE
Sbjct: 115 CHSH--RVLHRDLKPQNLLID-REGALKLADFGLARAF--GVPVRTYTHEVVTLWYRAPE 169
Query: 310 LIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE---EIKC 366
++ G+ +Y+T +D+WSIGC+ AE++ +PLFPG+S +DQL I + LGTP + +
Sbjct: 170 ILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS 229
Query: 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+ P+Y FP+ K+ + + LDL+S++L Y P+ R +A A HP+F
Sbjct: 230 L-PDYKP-TFPKWARQDLSKVV-PNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 219 bits (561), Expect = 2e-67
Identities = 104/305 (34%), Positives = 163/305 (53%), Gaps = 26/305 (8%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KR-YKNRELQIMRLLNHP 190
Y VG+G++G V A +TG VAIKK+ + KR Y REL++++ ++H
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY--RELRLLKHMDHE 74
Query: 191 NVVSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
NV+ L F + ++ + LV + + + K + H+ L YQI R
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFL-----VYQILR 129
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPE 309
L Y+H G+ HRD+KP N+ VN +LKI DFG A+ + Y+ +R+YRAPE
Sbjct: 130 GLKYIHSA-GIIHRDLKPSNIAVNEDC-ELKILDFGLARHT--DDEMTGYVATRWYRAPE 185
Query: 310 LIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369
++ Y +D+WS+GC++AELL G+ LFPG +DQL I+ ++GTP E ++ ++
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245
Query: 370 ----NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425
NY + PQ+ + ++F P A+DL+ ++L P R TA EA AHP+ +
Sbjct: 246 ESARNYIQ-SLPQMPKKDFKEVF-SGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303
Query: 426 LRDPN 430
DP
Sbjct: 304 YHDPE 308
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 211 bits (538), Expect = 4e-64
Identities = 113/319 (35%), Positives = 180/319 (56%), Gaps = 25/319 (7%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNV 192
Y+ + +G G++G+V AK ET + VAIKK+ D + RE++++R L+H NV
Sbjct: 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENV 66
Query: 193 VSLKHCFFSTTEK--DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
+++K + +++Y+ V E + ++++ R +Q + + Q + YQ+ R
Sbjct: 67 IAIKDIMPPPHREAFNDVYI--VYELMDTDLHQI----IRSSQTLSDDHCQYFLYQLLRG 120
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM-LVPGEPNISYICSRYYRAPE 309
L Y+H V HRD+KP NLL+N + LKICDFG A+ G+ Y+ +R+YRAPE
Sbjct: 121 LKYIHSA-NVLHRDLKPSNLLLNANC-DLKICDFGLARTTSEKGDFMTEYVVTRWYRAPE 178
Query: 310 LIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM-N 368
L+ +EYTTAID+WS+GC+ AELL +PLFPG+ V QL I ++LG+P+ E++ + N
Sbjct: 179 LLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238
Query: 369 PNYTEF--KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426
+ P + ++F P A+DL+ ++L + PS R T EA AHP+ L
Sbjct: 239 EKARRYIRSLPYTPRQSFARLF-PHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297
Query: 427 RDPNTCLPNGRPLPTLFNF 445
DP+ T F+F
Sbjct: 298 HDPSD----EPVCQTPFSF 312
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 209 bits (533), Expect = 6e-64
Identities = 107/292 (36%), Positives = 165/292 (56%), Gaps = 30/292 (10%)
Query: 148 GSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHCFFS 201
G++GVV++A+ +TG+ VA+KK+ +K + RE+ I+ L HPN+V++K
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75
Query: 202 TTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVC 261
+ D++Y+ V+EY+ + + + M Q V+ Q+ + +LH +
Sbjct: 76 SNL-DKIYM--VMEYVEHDLKSLMET---MKQPFLQSEVKCLMLQLLSGVAHLHDN-WIL 128
Query: 262 HRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAPELIFGATEYT 318
HRD+K NLL+N + LKICDFG A+ G P Y + + +YRAPEL+ GA EY+
Sbjct: 129 HRDLKTSNLLLN-NRGILKICDFGLAREY--GSPLKPYTQLVVTLWYRAPELLLGAKEYS 185
Query: 319 TAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQ 378
TAIDMWS+GC+ AELL +PLFPG+S +DQL +I K+LGTPT + P ++E +
Sbjct: 186 TAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW----PGFSELPGAK 241
Query: 379 IKAHPWH-------KIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
K + K + DL++RLL Y P+ R +A +A HP+F
Sbjct: 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 208 bits (530), Expect = 5e-63
Identities = 123/324 (37%), Positives = 180/324 (55%), Gaps = 27/324 (8%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNV 192
Y + V+G GS+GVV A TG+ VAIKK+ + D RE++++RLL HP++
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
V +KH + ++ + +V E + +++V K N + + Q + YQ+ RAL
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIK----ANDDLTPEHHQFFLYQLLRALK 117
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN----ISYICSRYYRAP 308
Y+H V HRD+KP+N+L N +LKICDFG A++ P Y+ +R+YRAP
Sbjct: 118 YIH-TANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175
Query: 309 ELIFGA--TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI-K 365
EL G+ ++YT AID+WSIGC+ AE+L G+PLFPG++ V QL I +LGTP+ E I +
Sbjct: 176 ELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234
Query: 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMP---PEALDLVSRLLQYSPSLRCTALEACAHPF 422
N + K P F ++ P P AL L+ RLL + P R TA EA A P+
Sbjct: 235 VRNEKARRYLSSMRKKQP--VPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292
Query: 423 FDDLRDPNTCLPNGRPLPTL-FNF 445
F L P+ +P+ L F F
Sbjct: 293 FKGLAKVER-EPSAQPITKLEFEF 315
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 204 bits (522), Expect = 2e-62
Identities = 101/287 (35%), Positives = 152/287 (52%), Gaps = 21/287 (7%)
Query: 146 GTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLN-HPNVVSLKH 197
G G+F V +A+ +TG AIK + K +K+ RE+Q +R L+ HPN++ L
Sbjct: 8 GEGTFSEVLKAQSRKTGKYYAIKCM--KKHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
F L LV E + +Y + K R +P V+ Y YQ+ ++L+++H
Sbjct: 66 VLFDRKTGR---LALVFELMDMNLYELIKGRKR---PLPEKRVKSYMYQLLKSLDHMHRN 119
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEY 317
G+ HRDIKP+N+L+ LK+ DFGS + + P YI +R+YRAPE + Y
Sbjct: 120 -GIFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYY 176
Query: 318 TTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP-NYTEFKF 376
+D+W++GCV E+L PLFPG + +DQ+ +I +LGTP E +K + + F
Sbjct: 177 GPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236
Query: 377 PQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
P K K+ E LDL+ +LL Y P R TA +A HP+F
Sbjct: 237 PSKKGTGLRKLLPN-ASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 202 bits (515), Expect = 2e-61
Identities = 114/290 (39%), Positives = 168/290 (57%), Gaps = 21/290 (7%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQ---DKRYKN---RELQIMRLLNHPNVVSLKH 197
+VG GS+G+V + K ETG VAIKK L+ DK K RE+++++ L H N+V+L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
F K LYL V E++ TV + Y + V+ Y +QI R + + H
Sbjct: 68 VF---RRKKRLYL--VFEFVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSH 119
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV-PGEPNISYICSRYYRAPELIFGATE 316
+ HRDIKP+N+LV+ + +K+CDFG A+ L PGE Y+ +R+YRAPEL+ G T+
Sbjct: 120 -NIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK 177
Query: 317 YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT--PTREEIKCMNPNYTEF 374
Y A+D+W++GC++ E+L G+PLFPG+S +DQL IIK LG P +EI NP +
Sbjct: 178 YGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237
Query: 375 KFPQIK-AHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+ P++K P K F K + LDL + L+ P R ++ + H FF
Sbjct: 238 RLPEVKEIEPLEKRFPK-LSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 203 bits (519), Expect = 2e-61
Identities = 111/304 (36%), Positives = 172/304 (56%), Gaps = 25/304 (8%)
Query: 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNH 189
T Y+ + VG G+FG+V A+ TG +VAIKK+++ + REL++++ L H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
N++SL F S E ++Y V E + ++R+ Q ++Q + YQI R
Sbjct: 69 ENIISLSDIFISPLE--DIYF--VTELLGTDLHRLLTSRPLEKQ-----FIQYFLYQILR 119
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS-YICSRYYRAP 308
L Y+H GV HRD+KP N+L+N + LKICDFG A+ +P ++ Y+ +RYYRAP
Sbjct: 120 GLKYVHSA-GVVHRDLKPSNILINENC-DLKICDFGLAR---IQDPQMTGYVSTRYYRAP 174
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM- 367
E++ +Y +D+WS GC+ AE+L G+PLFPG+ V+Q I +LGTP + I +
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234
Query: 368 NPNYTEF--KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425
+ N F P+ + P+ + F K P A+DL+ ++L + P R +A EA AHP+
Sbjct: 235 SENTLRFVQSLPKREPVPFSEKF-KNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAP 293
Query: 426 LRDP 429
DP
Sbjct: 294 YHDP 297
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 201 bits (514), Expect = 3e-61
Identities = 106/289 (36%), Positives = 160/289 (55%), Gaps = 21/289 (7%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHC 198
+G GS+GVVF+ + ETG VAIKK ++ K+ RE+++++ L HPN+V+L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
F + + L+LV EY TV + R VP ++ +Q +A+N+ H
Sbjct: 69 F-----RRKRKLHLVFEYCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKH- 119
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS-YICSRYYRAPELIFGATEY 317
HRD+KP+N+L+ Q+K+CDFG A++L + + Y+ +R+YRAPEL+ G T+Y
Sbjct: 120 NCIHRDVKPENILITKQ-GQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQY 178
Query: 318 TTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILG--TPTREEIKCMNPNYTEFK 375
+D+W+IGCV AELL GQPL+PG+S VDQL I K LG P ++I N +
Sbjct: 179 GPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS 238
Query: 376 FPQIKA-HPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
P+ + P F + AL + LQ P+ R + E HP+F
Sbjct: 239 IPEPETREPLESKFPN-ISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 197 bits (502), Expect = 3e-59
Identities = 111/306 (36%), Positives = 163/306 (53%), Gaps = 26/306 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
+G G++G+V++A+ +G+ VA+KKV D RE+ ++ L HPN+V LK
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
D ++L V+EY + + + + M V+ Q+ R L YLH
Sbjct: 75 VVGK-HLDSIFL--VMEYCEQDLASLLDN---MPTPFSESQVKCLMLQLLRGLQYLHENF 128
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYRAPELIFGATEY 317
+ HRD+K NLL+ LKI DFG A+ +P +P + + +YRAPEL+ G T Y
Sbjct: 129 -IIHRDLKVSNLLLTDKGC-LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTY 186
Query: 318 TTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN--PNYTEFK 375
TTAIDMW++GC+LAELL +PL PG+S ++QL II++LGTP + P +F
Sbjct: 187 TTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFT 246
Query: 376 FPQIKAHPWHKIFHKRMP--PEA-LDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTC 432
P+ P++ + HK P EA L L++ LL Y P R TA EA +F + P C
Sbjct: 247 LPK---QPYNNLKHK-FPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE--KPLPC 300
Query: 433 LPNGRP 438
P P
Sbjct: 301 EPEMMP 306
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 196 bits (499), Expect = 5e-59
Identities = 97/293 (33%), Positives = 158/293 (53%), Gaps = 19/293 (6%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
+G G++G V++A+ TG VA+KK + + RE+ ++++L+ +
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68
Query: 199 FFSTTEKD-ELYLNLVLEYISETVYRVSKHYTRMNQH-VPILYVQLYTYQICRALNYLHH 256
EK+ + L LV EY+ + + R +P ++ + YQ+ + + + H
Sbjct: 69 VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK 128
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYRAPELIFGAT 315
GV HRD+KPQNLLV+ LKI D G +P + I + +YRAPE++ G+T
Sbjct: 129 H-GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGST 187
Query: 316 EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFK 375
Y+T +D+WS+GC+ AE+ QPLFPG+S + QL+ I K+LGTPT + P ++ +
Sbjct: 188 HYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW----PGVSKLR 243
Query: 376 ----FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424
FPQ K + + PE LDL+ ++L+Y P+ R +A A HP+FD
Sbjct: 244 DWHEFPQWKPQDLSRAV-PDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 191 bits (487), Expect = 9e-57
Identities = 111/306 (36%), Positives = 157/306 (51%), Gaps = 31/306 (10%)
Query: 145 VGTGSFGVVFQAKCLETGDS--VAIKKV-------LQDKRYKNRELQIMRLL-NHPNVVS 194
+G G++G+V A+ ET + VAIKK+ + KR REL+++R H N+
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKR-ALRELKLLRHFRGHKNITC 66
Query: 195 LKHCFFSTTEK-DELYLNLVL-EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L +ELYL L E + R + T + H Q + YQI L
Sbjct: 67 LYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLT--DAHF-----QSFIYQILCGLK 119
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG----EPNIS-YICSRYYRA 307
Y+H V HRD+KP NLLVN +LKICDFG A+ ++ Y+ +R+YRA
Sbjct: 120 YIHSA-NVLHRDLKPGNLLVNADC-ELKICDFGLARGFSENPGENAGFMTEYVATRWYRA 177
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE---EI 364
PE++ YT AID+WS+GC+LAELL +P+F G+ VDQL +I+++LGTP E I
Sbjct: 178 PEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237
Query: 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424
P I P+ IF P ALDL+ +LL + P+ R + EA HP+
Sbjct: 238 GSPKAQNYIRSLPNIPKKPFESIFPN-ANPLALDLLEKLLAFDPTKRISVEEALEHPYLA 296
Query: 425 DLRDPN 430
DP+
Sbjct: 297 IWHDPD 302
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 188 bits (480), Expect = 8e-56
Identities = 111/319 (34%), Positives = 161/319 (50%), Gaps = 50/319 (15%)
Query: 145 VGTGSFGVVFQAKCLE--TGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSL 195
+G G++G V++AK G AIKK DK RE+ ++R L H NVVSL
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQH-VPILYVQLYTYQICRALNYL 254
F +K +YL + +Y ++++ K + + + +P V+ +QI ++YL
Sbjct: 68 VEVFLEHADK-SVYL--LFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124
Query: 255 H--HVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSA----KMLVP---GEPNISYICS 302
H V+ HRD+KP N+LV P +KI D G A L P +P + I
Sbjct: 125 HSNWVL---HRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI-- 179
Query: 303 RYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESG---------VDQLVEII 353
+YRAPEL+ GA YT AID+W+IGC+ AELL +P+F G DQL I
Sbjct: 180 -WYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238
Query: 354 KILGTPTREE---IKCMNPNY----TEFKFPQIKAHPWHKIFHKRMP--PEALDLVSRLL 404
++LGTPT ++ IK M P Y +FK ++ K K + DL+ +LL
Sbjct: 239 EVLGTPTEKDWPDIKKM-PEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLL 297
Query: 405 QYSPSLRCTALEACAHPFF 423
+Y P+ R TA EA HP+F
Sbjct: 298 EYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 2e-55
Identities = 103/293 (35%), Positives = 159/293 (54%), Gaps = 30/293 (10%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
+G G++G VF+AK ET + VA+K+V D + RE+ +++ L H N+V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HV 257
S + L LV EY + + K++ N + V+ + +Q+ + L + H H
Sbjct: 68 LHSDKK-----LTLVFEYCDQDL---KKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH- 118
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAPELIFGA 314
V HRD+KPQNLL+N + +LK+ DFG A+ G P Y + + +YR P+++FGA
Sbjct: 119 -NVLHRDLKPQNLLINKNG-ELKLADFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGA 174
Query: 315 TEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN--PNY 371
Y+T+IDMWS GC+ AEL G+PLFPG DQL I ++LGTPT E ++ P+Y
Sbjct: 175 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234
Query: 372 TEF-KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+ +P + + ++ DL+ LL +P R +A EA HP+F
Sbjct: 235 KPYPMYPATTS--LVNVV-PKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 2e-55
Identities = 103/299 (34%), Positives = 159/299 (53%), Gaps = 26/299 (8%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKR----YKNRELQIMRLLNHPNV 192
+Y +G GS+ V++ + TG VA+K++ L+ + RE +++ L H N+
Sbjct: 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI 65
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY---VQLYTYQICR 249
V+L H T + L LV EY + K Y M+ L V+L+ +Q+ R
Sbjct: 66 VTL-HDIIHTKKT----LTLVFEY----LDTDLKQY--MDDCGGGLSMHNVRLFLFQLLR 114
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYRAP 308
L Y H V HRD+KPQNLL++ +LK+ DFG A+ VP + + + + +YR P
Sbjct: 115 GLAYCHQR-RVLHRDLKPQNLLIS-ERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPP 172
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGV-DQLVEIIKILGTPTREEIK-- 365
+++ G+TEY+T++DMW +GC+ E+ G+PLFPG + V DQL +I ++LGTPT E
Sbjct: 173 DVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGV 232
Query: 366 CMNPNYTEFKFPQIKAHPWHKIFHK-RMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
NP + + FP P + P +L + LQY P R +A EA HP+F
Sbjct: 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 186 bits (473), Expect = 3e-55
Identities = 100/290 (34%), Positives = 165/290 (56%), Gaps = 24/290 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVVSLKHCF 199
+G G++ V++ + TG+ VA+K++ D RE+ +M+ L H N+V L H
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL-HDV 66
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQH---VPILYVQLYTYQICRALNYLHH 256
T K L LV EY+ + + K Y + + V+ +TYQ+ + + + H
Sbjct: 67 IHTENK----LMLVFEYMDKDL----KKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYRAPELIFGAT 315
V HRD+KPQNLL+N +LK+ DFG A+ +P + + + +YRAP+++ G+
Sbjct: 119 N-RVLHRDLKPQNLLINKRG-ELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSR 176
Query: 316 EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN--PNYTE 373
Y+T+ID+WS+GC++AE++ G+PLFPG + DQL++I +I+GTPT ++ P Y +
Sbjct: 177 TYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY-K 235
Query: 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
FP+ ++F P +DL+ RLLQ +P LR +A +A HP+F
Sbjct: 236 PTFPRYPPQDLQQLF-PHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 1e-54
Identities = 103/299 (34%), Positives = 169/299 (56%), Gaps = 42/299 (14%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
+G G++GVV++A+ TG+ VA+KK+ D + RE+ +++ LNHPN+V L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ--HVPILYVQLYTYQICRALNYLH- 255
+ +++LYL V E++ + + K + + +P+ ++ Y +Q+ + L + H
Sbjct: 68 IHT---ENKLYL--VFEFLHQDL----KKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAPELIF 312
H V HRD+KPQNLL+N +K+ DFG A+ G P +Y + + +YRAPE++
Sbjct: 119 H--RVLHRDLKPQNLLINTEGA-IKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILL 173
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372
G Y+TA+D+WS+GC+ AE++ + LFPG+S +DQL I + LGTP + P T
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV----VWPGVT 229
Query: 373 EFK-----FPQIKAHPWHKIFHKRMPP---EALDLVSRLLQYSPSLRCTALEACAHPFF 423
FP+ + K+ +PP + DL+S++L Y P+ R +A A AHPFF
Sbjct: 230 SLPDYKPSFPKWARQDFSKV----VPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 2e-54
Identities = 100/297 (33%), Positives = 164/297 (55%), Gaps = 37/297 (12%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN----------RELQIMRLLNHPNVVS 194
+G G++GVV++ + +TG VA+KK+ R ++ RE+ +++ L HPN+V
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI----RLESEEEGVPSTAIREISLLKELQHPNIVC 63
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHY---TRMNQHVPILYVQLYTYQICRAL 251
L+ ++ LYL + E++S + K Y Q++ V+ Y YQI + +
Sbjct: 64 LQDVLM---QESRLYL--IFEFLSMDL----KKYLDSLPKGQYMDAELVKSYLYQILQGI 114
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAP 308
+ H V HRD+KPQNLL++ + +K+ DFG A+ G P Y + + +YRAP
Sbjct: 115 LFCHSR-RVLHRDLKPQNLLID-NKGVIKLADFGLARAF--GIPVRVYTHEVVTLWYRAP 170
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368
E++ G+ Y+T +D+WSIG + AE+ +PLF G+S +DQL I +ILGTPT + +
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVT 230
Query: 369 --PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
P+Y FP+ K K + + LDL+ ++L Y P+ R +A +A HP+F
Sbjct: 231 SLPDYKN-TFPKWKKGSLRSAV-KNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 6e-54
Identities = 102/303 (33%), Positives = 169/303 (55%), Gaps = 27/303 (8%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
Y +G G++GVV++A+ T +++A+KK+ ++ + RE+ +++ + H N+
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYR---VSKHYTRMNQHVPILYVQLYTYQICR 249
V L+ S E L LV EY+ + + S + + N + ++ Y YQI R
Sbjct: 64 VRLQDVVHS-----EKRLYLVFEYLDLDLKKHMDSSPDFAK-NPRL----IKTYLYQILR 113
Query: 250 ALNYLH-HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYRA 307
+ Y H H V HRD+KPQNLL++ T+ LK+ DFG A+ +P + + +YRA
Sbjct: 114 GIAYCHSH--RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRA 171
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367
PE++ G+ Y+T +D+WS+GC+ AE++ +PLFPG+S +D+L +I +ILGTP E +
Sbjct: 172 PEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGV 231
Query: 368 N--PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425
P+Y FP+ + + P +DL+S++L+ PS R TA A H +F D
Sbjct: 232 TSLPDYKS-AFPKWPPKDLATVV-PTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289
Query: 426 LRD 428
L D
Sbjct: 290 LGD 292
|
Length = 294 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 9e-54
Identities = 101/322 (31%), Positives = 152/322 (47%), Gaps = 71/322 (22%)
Query: 146 GTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSLKHC 198
G G+FG V++A+ ++TG VA+KK+L K+ RE++I++ L HPNVV L
Sbjct: 17 GEGTFGEVYKARQIKTGRVVALKKILM-HNEKDGFPITALREIKILKKLKHPNVVPL--- 72
Query: 199 FFSTTEKDELYLNLVLEYISET------VYRVSK----------HYTRMNQHVPILYVQL 242
+++ +E ++ VY V+ + ++
Sbjct: 73 -----------IDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTES--QIKC 119
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK---------MLVPG 293
Y Q+ +NYLH + HRDIK N+L++ + LKI DFG A+ G
Sbjct: 120 YMLQLLEGINYLHEN-HILHRDIKAANILID-NQGILKIADFGLARPYDGPPPNPKGGGG 177
Query: 294 EPNISY---ICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLV 350
Y + +R+YR PEL+ G YTTA+D+W IGCV AE+ +P+ G+S +DQL
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH 237
Query: 351 EIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWH---------KIFHKRMPPEALDLVS 401
I K+ GTPT E P + P H + ++ PE LDL+S
Sbjct: 238 LIFKLCGTPTEETW----PGWR--SLP--GCEGVHSFTNYPRTLEERFGKLGPEGLDLLS 289
Query: 402 RLLQYSPSLRCTALEACAHPFF 423
+LL P R TA +A HP+F
Sbjct: 290 KLLSLDPYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 2e-53
Identities = 103/298 (34%), Positives = 166/298 (55%), Gaps = 24/298 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-------LQDKRYKNRELQIMRLLNHPNVVSLKH 197
VG+G++G V A TG VAIKK+ L KR REL++++ + H NV+ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKR-AYRELRLLKHMKHENVIGLLD 81
Query: 198 CFFSTTEKDELY-LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
F D + LV+ ++ + ++ KH ++++ +Q YQ+ + L Y+H
Sbjct: 82 VFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH-EKLSED----RIQFLVYQMLKGLKYIH- 135
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATE 316
G+ HRD+KP NL VN +LKI DFG A+ Y+ +R+YRAPE+I
Sbjct: 136 AAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQ--TDSEMTGYVVTRWYRAPEVILNWMH 192
Query: 317 YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP----NYT 372
YT +D+WS+GC++AE+L G+PLF G +DQL+EI+K+ GTP++E ++ + NY
Sbjct: 193 YTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYV 252
Query: 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430
+ K P+ + + + P A++++ ++L R TA EA AHP+F++ DP
Sbjct: 253 K-KLPRFRKKDFRSLL-PNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPE 308
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 182 bits (463), Expect = 3e-53
Identities = 109/332 (32%), Positives = 158/332 (47%), Gaps = 55/332 (16%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------------------RELQIMR 185
+G G++G V +A TG VAIKKV + N REL+IM
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKV-KIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75
Query: 186 LLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
+ H N++ L + E D ++NLV++ ++ + +V R+ V+
Sbjct: 76 EIKHENIMGLVDVY---VEGD--FINLVMDIMASDLKKVVDRKIRLT----ESQVKCILL 126
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK-----MLVPGEPNISYI 300
QI LN LH + HRD+ P N+ +N KI DFG A+ +
Sbjct: 127 QILNGLNVLHKWYFM-HRDLSPANIFINSKG-ICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 301 CSR----------YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLV 350
R +YRAPEL+ GA +Y A+DMWS+GC+ AELL G+PLFPGE+ +DQL
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244
Query: 351 EIIKILGTPTRE---EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYS 407
I ++LGTP + + K + P YTEF + K K +A+DL+ LL+ +
Sbjct: 245 RIFELLGTPNEDNWPQAKKL-PLYTEFTPRKPKD---LKTIFPNASDDAIDLLQSLLKLN 300
Query: 408 PSLRCTALEACAHPFFDDLRDPNTCLPNGRPL 439
P R +A EA H +F DP C P+ P
Sbjct: 301 PLERISAKEALKHEYFKS--DPLPCDPSQLPF 330
|
Length = 335 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 182 bits (462), Expect = 4e-53
Identities = 102/303 (33%), Positives = 161/303 (53%), Gaps = 23/303 (7%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
Y + + VG+G++G V A TG+ VAIKK+ Q + + R EL +++ + H NV
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+ L F S DE LV+ Y+ + ++ M + VQ YQ+ L
Sbjct: 77 IGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKI------MGHPLSEDKVQYLVYQMLCGL 130
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
Y+H G+ HRD+KP NL VN +LKI DFG A+ Y+ +R+YRAPE+I
Sbjct: 131 KYIHSA-GIIHRDLKPGNLAVNEDC-ELKILDFGLARH--ADAEMTGYVVTRWYRAPEVI 186
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN--- 368
Y +D+WS+GC++AE+L G+ LF G+ +DQL +I+K+ G P E ++ +
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246
Query: 369 -PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427
+Y + P+ + +F + P+A+DL+ ++L+ R TA EA HP+FD R
Sbjct: 247 AKSYIK-SLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304
Query: 428 DPN 430
D +
Sbjct: 305 DAD 307
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 5e-53
Identities = 100/309 (32%), Positives = 157/309 (50%), Gaps = 58/309 (18%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN----------RELQIMRLL---NHPN 191
+G G++G V++A+ L TG VA+KKV R RE+ +++ L HPN
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKV----RVPLSEEGIPLSTLREIALLKQLESFEHPN 62
Query: 192 VVSLKH-CFFSTTEKDELYLNLVLEYISE--TVY--RVSKHYTRMNQHVPILYVQLYTYQ 246
+V L C T++ EL L LV E++ + Y + K +P ++ Q
Sbjct: 63 IVRLLDVCHGPRTDR-ELKLTLVFEHVDQDLATYLSKCPK------PGLPPETIKDLMRQ 115
Query: 247 ICRALNYLH-HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYY 305
+ R +++LH H + HRD+KPQN+LV Q+KI DFG A++ S + + +Y
Sbjct: 116 LLRGVDFLHSHRI--VHRDLKPQNILVT-SDGQVKIADFGLARIYSFEMALTSVVVTLWY 172
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365
RAPE++ ++ Y T +DMWS+GC+ AEL +PLF G S DQL +I ++G P+ EE
Sbjct: 173 RAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE-- 229
Query: 366 CMNPNYTEFKFPQIKAHPWHKIFHKR-----------MPPEALDLVSRLLQYSPSLRCTA 414
+P+ + P F + E LDL+ ++L ++P R +A
Sbjct: 230 ----------WPRNVSLPRSS-FPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISA 278
Query: 415 LEACAHPFF 423
EA HP+F
Sbjct: 279 FEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 6e-53
Identities = 69/247 (27%), Positives = 116/247 (46%), Gaps = 40/247 (16%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVVSLKHCF 199
+G G FG V+ A+ +TG VAIK + ++ RE++I++ LNHPN+V L F
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 200 FSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
+DE +L LV+EY ++ + + QI L YLH
Sbjct: 61 -----EDENHLYLVMEYCEGGSLK---DLLKENEGKLSEDEILRILLQILEGLEYLHSN- 111
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELIFGATEY 317
G+ HRD+KP+N+L++ ++K+ DFG +K+L + + I + Y APE++ G Y
Sbjct: 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYY 171
Query: 318 TTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE-FKF 376
+ D+WS+G +L EL +L ++I+ K + + +
Sbjct: 172 SEKSDIWSLGVILYEL-------------PELKDLIR----------KMLQKDPEKRPSA 208
Query: 377 PQIKAHP 383
+I H
Sbjct: 209 KEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 7e-53
Identities = 99/318 (31%), Positives = 161/318 (50%), Gaps = 42/318 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKK-VLQDKR---YKNRELQIMRLLNHPNVVS 194
YM R +G GS G+VF A + VA+KK VL D + + RE++I+R L+H N+V
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66
Query: 195 LKHCFFST-----------TEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY 243
+ + TE + +Y+ V EY+ + V + +H +L+
Sbjct: 67 VYEVLGPSGSDLTEDVGSLTELNSVYI--VQEYMETDLANVLEQGPLSEEHA-----RLF 119
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYI--- 300
YQ+ R L Y+H V HRD+KP N+ +N LKI DFG A+++ P + Y+
Sbjct: 120 MYQLLRGLKYIHSA-NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG 178
Query: 301 -CSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQL---VEIIKIL 356
+++YR+P L+ YT AIDMW+ GC+ AE+L G+PLF G ++Q+ +E + ++
Sbjct: 179 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238
Query: 357 GTPTREEIKCMNPNYTEFKFPQIKAHPW--HKIFHKRMP---PEALDLVSRLLQYSPSLR 411
R E+ + P++ ++ + +P PEALD + ++L ++P R
Sbjct: 239 REEDRNELLNVIPSF-------VRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDR 291
Query: 412 CTALEACAHPFFDDLRDP 429
TA EA HP+ P
Sbjct: 292 LTAEEALMHPYMSCYSCP 309
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 1e-52
Identities = 92/292 (31%), Positives = 141/292 (48%), Gaps = 48/292 (16%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN-----RELQIMRLLNHPNVVSLK 196
++G GSFG V+ A +TG+ +A+K V L + RE++I+ L HPN+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV--- 62
Query: 197 HCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+ S ++++ LN+ LEY+S ++ + K + ++ + V ++ YT QI L YLH
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV----IRKYTRQILEGLAYLH 118
Query: 256 -HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML---VPGEPNISYICSRYYRAPELI 311
+ G+ HRDIK N+LV+ +K+ DFG AK L GE S + Y+ APE+I
Sbjct: 119 SN--GIVHRDIKGANILVDS-DGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
G EY A D+WS+GC + E+ G+P + + I G P
Sbjct: 176 RG-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP------------ 222
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
P+I H + EA D + + L+ P R TA E HPF
Sbjct: 223 -----PEIPEH---------LSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 2e-51
Identities = 114/292 (39%), Positives = 166/292 (56%), Gaps = 24/292 (8%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKH 197
VVG G++GVV + + ET + VAIKK K REL+++R L N+V LK
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
F + +LYL V EY+ + + + + M VP V+ Y YQ+ +A+++ H
Sbjct: 68 AF---RRRGKLYL--VFEYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKN 119
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG-EPNIS-YICSRYYRAPELIFGAT 315
+ HRDIKP+NLL++ H LK+CDFG A+ L G N + Y+ +R+YR+PEL+ GA
Sbjct: 120 -DIVHRDIKPENLLIS-HNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177
Query: 316 EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM--NPNYTE 373
Y A+DMWS+GC+L EL GQPLFPGES +DQL I K+LG E++K NP +
Sbjct: 178 -YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236
Query: 374 FKFPQIKAHP--WHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+FP + HP + + + LDL+ LL+ +P+ R + HP F
Sbjct: 237 LRFPAV-NHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 3e-50
Identities = 105/306 (34%), Positives = 160/306 (52%), Gaps = 35/306 (11%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKK---VLQD----KRYKNRELQIMRLLNHPNVVS 194
+R +G G+FGVV+ G VA+KK V Q+ KR REL+++ H NV+S
Sbjct: 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF-RELKMLCFFKHDNVLS 63
Query: 195 --------LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
F +E+Y+ V E + ++++ Q + +V+++ YQ
Sbjct: 64 ALDILQPPHIDPF------EEIYV--VTELMQSDLHKI----IVSPQPLSSDHVKVFLYQ 111
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI--SYICSRY 304
I R L YLH G+ HRDIKP NLLVN + LKICDFG A++ P E + ++Y
Sbjct: 112 ILRGLKYLHSA-GILHRDIKPGNLLVNSNC-VLKICDFGLARVEEPDESKHMTQEVVTQY 169
Query: 305 YRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364
YRAPE++ G+ YT+A+D+WS+GC+ AELL + LF +S + QL I +LGTP+ E +
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAM 229
Query: 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPP---EALDLVSRLLQYSPSLRCTALEACAHP 421
+ P + + EA+ L+ R+L + P R +A +A AHP
Sbjct: 230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP 289
Query: 422 FFDDLR 427
+ D+ R
Sbjct: 290 YLDEGR 295
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 175 bits (443), Expect = 5e-50
Identities = 92/321 (28%), Positives = 138/321 (42%), Gaps = 48/321 (14%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHP 190
SY R +G GSFG V+ A+ + VA+K + + K+ RE+QI+ LNHP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 191 -NVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
N+V L F +DE L LV+EY+ + QI
Sbjct: 58 PNIVKLYDFF-----QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI-------SYICS 302
AL YLH G+ HRDIKP+N+L++ +K+ DFG AK+L + + +
Sbjct: 113 ALEYLHSK-GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171
Query: 303 RYYRAPELIFGATE--YTTAIDMWSIGCVLAELLLGQPLFPGESG---VDQLVEIIKILG 357
Y APE++ G + +++ D+WS+G L ELL G P F GE Q ++II L
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231
Query: 358 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEA 417
TP A P + + A DL+ +LL P R ++
Sbjct: 232 TP-------------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSD 272
Query: 418 CAHPFFDDLRDPNTCLPNGRP 438
+H L+ + L +
Sbjct: 273 LSHDLLAHLKLKESDLSDLLK 293
|
Length = 384 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 2e-47
Identities = 103/311 (33%), Positives = 170/311 (54%), Gaps = 29/311 (9%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
+Y+ +G G++ V++ + T + VA+K++ + RE+ +++ L H N+
Sbjct: 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHY-----TRMNQHVPILYVQLYTYQI 247
V+L TEK L LV EY+ + + K Y +N H V+L+ +Q+
Sbjct: 67 VTLHDIIH--TEKS---LTLVFEYLDKDL----KQYLDDCGNSINMH----NVKLFLFQL 113
Query: 248 CRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYR 306
R LNY H V HRD+KPQNLL+N +LK+ DFG A+ +P + + + + +YR
Sbjct: 114 LRGLNYCHRR-KVLHRDLKPQNLLINERG-ELKLADFGLARAKSIPTKTYSNEVVTLWYR 171
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366
P+++ G+T+Y+T IDMW +GC+ E+ G+PLFPG + +QL I +ILGTPT E
Sbjct: 172 PPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 231
Query: 367 M--NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424
+ N + + +P+ +A H R+ + +L+S+LLQ+ R +A EA HP+F
Sbjct: 232 ILSNEEFKSYNYPKYRADCLHN-HAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH 290
Query: 425 DLRDPNTCLPN 435
L + LP+
Sbjct: 291 CLGERIHKLPD 301
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 3e-47
Identities = 108/327 (33%), Positives = 171/327 (52%), Gaps = 54/327 (16%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKR-YKNRELQIMRLLNHP 190
Y + +G+G+ G+V A TG +VAIKK V KR Y REL +M+L+NH
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY--RELVLMKLVNHK 75
Query: 191 NVVSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMN-QHVPILYVQLYTYQ 246
N++ L + F S E ++YL V+E + + +V +M+ H + Y+ YQ
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYL--VMELMDANLCQV----IQMDLDHERMSYL---LYQ 126
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK------MLVPGEPNISYI 300
+ + +LH G+ HRD+KP N++V LKI DFG A+ M+ P Y+
Sbjct: 127 MLCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTP------YV 178
Query: 301 CSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPT 360
+RYYRAPE+I G Y +D+WS+GC++ E++ G LFPG +DQ +II+ LGTP+
Sbjct: 179 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS 237
Query: 361 REEIKCMNP---NYTEFKFPQIKAHPWHKIF------------HKRMPPEALDLVSRLLQ 405
E + + P NY E + P+ + + ++F +K +A DL+S++L
Sbjct: 238 DEFMSRLQPTVRNYVENR-PKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLV 296
Query: 406 YSPSLRCTALEACAHPFFDDLRDPNTC 432
P R + +A HP+ + DP+
Sbjct: 297 IDPEKRISVDDALQHPYINVWYDPSEV 323
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 3e-47
Identities = 95/292 (32%), Positives = 140/292 (47%), Gaps = 55/292 (18%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKR--YKNRELQIMRLLNHPNVVSLKH 197
+G GSFG V + +TG A+K K+++ K + E I+ +NHP +V L +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 198 CFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
F + E L LVLEY E +SK R ++ + Y +I AL YLH
Sbjct: 61 AF-----QTEEKLYLVLEYAPGGELFSHLSKE-GRFSEER----ARFYAAEIVLALEYLH 110
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELIFGA 314
+ G+ +RD+KP+N+L++ H +K+ DFG AK L + C + Y APE++ G
Sbjct: 111 SL-GIIYRDLKPENILLDADGH-IKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK 168
Query: 315 TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEF 374
Y A+D WS+G +L E+L G+P F E ++ E KIL
Sbjct: 169 -GYGKAVDWWSLGVLLYEMLTGKPPFYAED-RKEIYE--KIL--------------KDPL 210
Query: 375 KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC---AHPFF 423
+FP + + PEA DL+S LLQ P+ R + A AHPFF
Sbjct: 211 RFP------------EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 5e-47
Identities = 101/304 (33%), Positives = 157/304 (51%), Gaps = 24/304 (7%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNV 192
Y VG+G++G V A VA+KK+ L R REL++++ + H NV
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENV 76
Query: 193 VSLKHCFFSTT---EKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
+ L F T +E+YL V + + + K ++HV Q YQ+ R
Sbjct: 77 IGLLDVFTPATSIENFNEVYL--VTNLMGADLNNIVKCQKLSDEHV-----QFLIYQLLR 129
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPE 309
L Y+H G+ HRD+KP N+ VN +L+I DFG A+ + Y+ +R+YRAPE
Sbjct: 130 GLKYIHSA-GIIHRDLKPSNVAVNEDC-ELRILDFGLARQ--ADDEMTGYVATRWYRAPE 185
Query: 310 LIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369
++ Y +D+WS+GC++AELL G+ LFPG +DQL I++++GTP+ E +K ++
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245
Query: 370 NYTEFKF---PQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426
+ P + KIF + P A+DL+ ++L R +A EA AHP+F
Sbjct: 246 EHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304
Query: 427 RDPN 430
DP
Sbjct: 305 HDPE 308
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 6e-47
Identities = 101/298 (33%), Positives = 156/298 (52%), Gaps = 24/298 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKK-------VLQDKRYKNRELQIMRLLNHPNVVSLKH 197
VG+G++G V A +TG VA+KK ++ KR REL++++ + H NV+ L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 83
Query: 198 CFFSTTEKDELY-LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
F +E + LV + + + K + HV Q YQI R L Y+H
Sbjct: 84 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-----QFLIYQILRGLKYIHS 138
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATE 316
+ HRD+KP NL VN +LKI DFG A+ + Y+ +R+YRAPE++
Sbjct: 139 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 194
Query: 317 YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP----NYT 372
Y +D+WS+GC++AELL G+ LFPG +DQL I++++GTP E +K ++ NY
Sbjct: 195 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 254
Query: 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430
+ Q+ + +F P A+DL+ ++L R TA +A AH +F DP+
Sbjct: 255 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 310
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 2e-46
Identities = 81/287 (28%), Positives = 129/287 (44%), Gaps = 46/287 (16%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN---RELQIMRLLNHPNVVSLKHC 198
+G G FG V++A+ TG VAIK + L+ K K E+QI++ HPN+V
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 199 FFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-- 255
+ +KDEL+ +V+E+ S ++ + K + I YV ++ + L YLH
Sbjct: 66 YL---KKDELW--IVMEFCSGGSLKDLLKSTNQTLTESQIAYV---CKELLKGLEYLHSN 117
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGAT 315
++ HRDIK N+L+ ++K+ DFG + L + + + + Y+ APE+I G
Sbjct: 118 GII---HRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-K 172
Query: 316 EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFK 375
Y D+WS+G EL G+P + E + + I G P +
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPPY-SELPPMKALFKIATNGPPG-------------LR 218
Query: 376 FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
P W F D + + LQ +P R TA + HPF
Sbjct: 219 NP----EKWSDEFK--------DFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 1e-45
Identities = 101/300 (33%), Positives = 163/300 (54%), Gaps = 31/300 (10%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
+Y+ +G G++ VF+ + T + VA+K++ + RE+ +++ L H N+
Sbjct: 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI 65
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHY-----TRMNQHVPILYVQLYTYQI 247
V+L H T E L LV EY+ + K Y M+ H V+++ +Q+
Sbjct: 66 VTL-HDIIHT----ERCLTLVFEYLDSDL----KQYLDNCGNLMSMH----NVKIFMFQL 112
Query: 248 CRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM-LVPGEPNISYICSRYYR 306
R L+Y H + HRD+KPQNLL+N +LK+ DFG A+ VP + + + + +YR
Sbjct: 113 LRGLSYCHKR-KILHRDLKPQNLLINEKG-ELKLADFGLARAKSVPTKTYSNEVVTLWYR 170
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK- 365
P+++ G+TEY+T IDMW +GC+L E+ G+P+FPG + ++L I ++LGTPT E
Sbjct: 171 PPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPG 230
Query: 366 -CMNPNYTEFKFPQIKAHPWHKIFH-KRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
N + + FPQ +A P I H R+ + +DL+S LL Y R +A A H +F
Sbjct: 231 ITSNEEFRSYLFPQYRAQPL--INHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 160 bits (405), Expect = 2e-45
Identities = 102/300 (34%), Positives = 161/300 (53%), Gaps = 28/300 (9%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPN 191
SY+ +G GS+ V++ G VA+K V+ K + RE +++ L H N
Sbjct: 6 SYLNLEKLGEGSYATVYKGISRINGQLVALK-VISMKTEEGVPFTAIREASLLKGLKHAN 64
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY---VQLYTYQIC 248
+V L H T E L V EY+ + + M QH L+ V+L+ +Q+
Sbjct: 65 IVLL-HDIIHTKET----LTFVFEYMHTDLAQY------MIQHPGGLHPYNVRLFMFQLL 113
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYRA 307
R L Y+H + HRD+KPQNLL++ + +LK+ DFG A+ +P + S + + +YR
Sbjct: 114 RGLAYIHGQ-HILHRDLKPQNLLIS-YLGELKLADFGLARAKSIPSQTYSSEVVTLWYRP 171
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGV-DQLVEIIKILGTPTREEIKC 366
P+++ GAT+Y++A+D+W GC+ E+L GQP FPG S V +QL +I +LG PT +
Sbjct: 172 PDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPG 231
Query: 367 MN--PNYTEFKFPQIKAHPWHKIFHK-RMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
++ PNY F K ++ + PP+A DL S++L P R +A +A HP+F
Sbjct: 232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 4e-45
Identities = 95/306 (31%), Positives = 147/306 (48%), Gaps = 45/306 (14%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKH 197
+G G++G V++A+ +TG+ VA+KKV D + RE++I+R LNH N+V+LK
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73
Query: 198 CFFSTTE-----KDELYLNLVLEYISETVYRV--SKHYTRMNQHVPILYVQLYTYQICRA 250
+ KD+ LV EY+ + + S H+ QL
Sbjct: 74 IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLL-----EG 128
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE--PNISYICSRYYRAP 308
LNY H HRDIK N+L+N + Q+K+ DFG A++ E P + + + +YR P
Sbjct: 129 LNYCHKK-NFLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPP 186
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368
EL+ G Y AID+WS GC+L EL +P+F + QL I ++ G+P +
Sbjct: 187 ELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC----PAVW 242
Query: 369 PNYTEFKFPQIKAHPWHKIFHKRM------------PPEALDLVSRLLQYSPSLRCTALE 416
P+ + + ++ + K+ P ALDL+ +L PS RCTA E
Sbjct: 243 PDVIKLPY-------FNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEE 295
Query: 417 ACAHPF 422
A P+
Sbjct: 296 ALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 7e-45
Identities = 101/299 (33%), Positives = 167/299 (55%), Gaps = 23/299 (7%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
+Y+ +G G++ VF+ + T + VA+K++ + RE+ +++ L H N+
Sbjct: 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY-VQLYTYQICRAL 251
V+L H T + L LV EY+ + + K Y ++ ++ V+++ YQI R L
Sbjct: 67 VTL-HDIVHTDKS----LTLVFEYLDKDL----KQYMDDCGNIMSMHNVKIFLYQILRGL 117
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYRAPEL 310
Y H V HRD+KPQNLL+N +LK+ DFG A+ VP + + + + +YR P++
Sbjct: 118 AYCHRR-KVLHRDLKPQNLLINERG-ELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV 175
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370
+ G++EY+T IDMW +GC+ E+ G+PLFPG + D+L I ++LGTPT E ++ N
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN 235
Query: 371 --YTEFKFPQIKAHPWHKIFHK-RMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426
+ + FP+ K P I H R+ E ++L+++ LQY R +A EA H +F L
Sbjct: 236 DEFKNYNFPKYKPQPL--INHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 2e-42
Identities = 85/306 (27%), Positives = 130/306 (42%), Gaps = 70/306 (22%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNV 192
Y + +G GSFG V+ + G +K++ +++ E++I++ LNHPN+
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVP---ILYVQLYTYQIC 248
+ F EK L +V+EY + + K + + P IL + Q+C
Sbjct: 62 IKYYESFE---EKG--KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILD---WFVQLC 113
Query: 249 RALNYLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML---------VPGEPNI 297
AL YLH ++ HRDIKPQN+ + +K+ DFG +K+L V G P
Sbjct: 114 LALKYLHSRKIL---HRDIKPQNIFLT-SNGLVKLGDFGISKVLSSTVDLAKTVVGTP-- 167
Query: 298 SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILG 357
YY +PEL Y D+WS+GCVL EL + F GE+ + +L KIL
Sbjct: 168 ------YYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGEN-LLELAL--KIL- 216
Query: 358 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEA 417
+ + + Y E +LVS LLQ P R + +
Sbjct: 217 ---KGQYPPIPSQY---------------------SSELRNLVSSLLQKDPEERPSIAQI 252
Query: 418 CAHPFF 423
PF
Sbjct: 253 LQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 147 bits (371), Expect = 2e-40
Identities = 101/305 (33%), Positives = 161/305 (52%), Gaps = 32/305 (10%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKR----YKNRELQIMRLLNHPNV 192
SY +G GS+ V++ K G VA+K + LQ++ RE +++ L H N+
Sbjct: 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY---VQLYTYQICR 249
V L H T E L LV EY+ + + M++H L+ V+L+ +Q+ R
Sbjct: 66 VLL-HDIIHTKET----LTLVFEYVHTDLCQY------MDKHPGGLHPENVKLFLFQLLR 114
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM-LVPGEPNISYICSRYYRAP 308
L+Y+H + HRD+KPQNLL++ T +LK+ DFG A+ VP + + + +YR P
Sbjct: 115 GLSYIHQRY-ILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPP 172
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGV-DQLVEIIKILGTPTREEIKCM 367
+++ G+TEY+T +DMW +GC+ E++ G FPG + DQL I +LGTP + +
Sbjct: 173 DVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGV 232
Query: 368 N--PNYTEFKFPQIKA----HPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHP 421
+ P++ +F W+K+ + A DL S+LLQ P R +A A +H
Sbjct: 233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVN---HAEDLASKLLQCFPKNRLSAQAALSHE 289
Query: 422 FFDDL 426
+F DL
Sbjct: 290 YFSDL 294
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 5e-40
Identities = 90/300 (30%), Positives = 141/300 (47%), Gaps = 30/300 (10%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKH- 197
+G G+FG VF+A+ +T VA+KKVL + + RE++I++LL H NVV+L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 198 CFFSTTE----KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY--QICRAL 251
C T K YL V E+ + + N++V ++ + L
Sbjct: 80 CRTKATPYNRYKGSFYL--VFEFCEHDLAGLLS-----NKNVKFTLSEIKKVMKMLLNGL 132
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV---PGEPN--ISYICSRYYR 306
Y+H + HRD+K N+L+ LK+ DFG A+ +PN + + + +YR
Sbjct: 133 YYIHRN-KILHRDMKAANILITKDG-ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYR 190
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI-K 365
PEL+ G +Y IDMW GC++AE+ P+ G + QL I ++ G+ T E
Sbjct: 191 PPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPG 250
Query: 366 CMN-PNYTEFKFPQ-IKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+ + + PQ K ++ P ALDL+ +LL P+ R A A H FF
Sbjct: 251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 8e-39
Identities = 90/323 (27%), Positives = 138/323 (42%), Gaps = 83/323 (25%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRE----------LQIMRLLN 188
+ +++G GSF V AK ET AI K+L DKR +E + RL
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAI-KIL-DKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQI 247
HP ++ L + F +DE L VLEY + + + Y +++ + Y +I
Sbjct: 61 HPGIIKLYYTF-----QDEENLYFVLEYAPNGELLQYIRKYGSLDEKC----TRFYAAEI 111
Query: 248 CRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML----VPGEPNISYICSR 303
AL YLH G+ HRD+KP+N+L++ H +KI DFG+AK+L P
Sbjct: 112 LLALEYLHS-KGIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 304 Y-----------------YRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGV 346
Y +PEL+ + D+W++GC++ ++L G+P F G +
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN-- 226
Query: 347 DQLV--EIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLL 404
+ L +I+K+ E+ FP PP+A DL+ +LL
Sbjct: 227 EYLTFQKILKL-----------------EYSFPPN------------FPPDAKDLIEKLL 257
Query: 405 QYSPSLRCTALEAC----AHPFF 423
P R E AHPFF
Sbjct: 258 VLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 1e-37
Identities = 85/292 (29%), Positives = 139/292 (47%), Gaps = 50/292 (17%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN-----RELQIMRLLNHPNVVSLKHC 198
+G G+FG V+ A L+TG+ +A+K++ +QD K E++++ LL HPN+V
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK---Y 64
Query: 199 FFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
+ ++++Y + +EY S T+ + +H +++HV +++YT Q+ L YLH
Sbjct: 65 YGVEVHREKVY--IFMEYCSGGTLEELLEHGRILDEHV----IRVYTLQLLEGLAYLHS- 117
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-----VPGEPNISYICSRYYRAPELIF 312
G+ HRDIKP N+ ++ H +K+ DFG A L GE S + Y APE+I
Sbjct: 118 HGIVHRDIKPANIFLD-HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 313 GAT--EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370
G + A D+WS+GCV+ E+ G+ + Q++ + P
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPP---------- 226
Query: 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
P ++ PE D + R L+ P R TA E HPF
Sbjct: 227 -----IPD----------SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 9e-37
Identities = 97/312 (31%), Positives = 160/312 (51%), Gaps = 31/312 (9%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
Y + +G+G+ G+V A G +VA+KK+ Q++ + R EL +++ +NH N+
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+SL + F +E + LV+E + + +V H ++ + L YQ+ +
Sbjct: 83 ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYLL-----YQMLCGI 136
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
+LH G+ HRD+KP N++V LKI DFG A+ Y+ +RYYRAPE+I
Sbjct: 137 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI 194
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP-- 369
G Y +D+WS+GC++ EL+ G +F G +DQ ++I+ LGTP+ E + + P
Sbjct: 195 LG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253
Query: 370 -NYTEFKFPQIKAHPWHKIFHKRMPP-----------EALDLVSRLLQYSPSLRCTALEA 417
NY E + PQ + ++F + P +A DL+S++L P R + EA
Sbjct: 254 RNYVENR-PQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA 312
Query: 418 CAHPFFDDLRDP 429
HP+ DP
Sbjct: 313 LRHPYITVWYDP 324
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 2e-36
Identities = 89/290 (30%), Positives = 138/290 (47%), Gaps = 48/290 (16%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVL---QDKRYK------NRELQIMRLLNHPNVV 193
++G+GSFG V++ L+ GD A+K+V + + +E+ ++ L HPN+V
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
+ TE++E L + LE + ++ ++ K Y + V ++LYT QI L
Sbjct: 66 Q-----YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPV----IRLYTRQILLGLE 116
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIF 312
YLH HRDIK N+LV+ +K+ DFG AK +V S+ S Y+ APE+I
Sbjct: 117 YLHDR-NTVHRDIKGANILVDT-NGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIA 174
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372
Y A D+WS+GC + E+ G+P + S ++ + + KI + I
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKIGRSKELPPI-------- 223
Query: 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
P H + EA D + + LQ PSLR TA E HPF
Sbjct: 224 ----------PDH------LSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 4e-36
Identities = 99/312 (31%), Positives = 162/312 (51%), Gaps = 31/312 (9%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
Y + +G+G+ G+V A +VAIKK+ Q++ + R EL +M+ +NH N+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+SL + F +E + LV+E + + +V + H + Y+ YQ+ +
Sbjct: 79 ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYL---LYQMLCGI 132
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
+LH G+ HRD+KP N++V LKI DFG A+ Y+ +RYYRAPE+I
Sbjct: 133 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP-- 369
G Y +D+WS+GC++ E++ + LFPG +DQ ++I+ LGTP E +K + P
Sbjct: 191 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249
Query: 370 -NYTEFKFPQIKAHPWHKIFHKRMPP-----------EALDLVSRLLQYSPSLRCTALEA 417
NY E + P+ + K+F + P +A DL+S++L P+ R + EA
Sbjct: 250 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEA 308
Query: 418 CAHPFFDDLRDP 429
HP+ + DP
Sbjct: 309 LQHPYINVWYDP 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 5e-36
Identities = 92/301 (30%), Positives = 136/301 (45%), Gaps = 63/301 (20%)
Query: 148 GSFGVVFQAKCLETGDSVAIKKV-LQDKRYKNR------ELQIMRLLNHPNVVSLKHCFF 200
G++G VF AK TGD AIK + D KN+ E I+ P VV L ++
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL---YY 60
Query: 201 STTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
S K LYL V+EY+ + + ++ +++ V ++Y +I AL YLH G
Sbjct: 61 SFQGKKNLYL--VMEYLPGGDLASLLENVGSLDEDV----ARIYIAEIVLALEYLHSN-G 113
Query: 260 VCHRDIKPQNLLVNPHTHQLKICDFG---------SAKMLVPGEPNISYICSRYYRAPEL 310
+ HRD+KP N+L++ + H LK+ DFG + + + + + Y APE+
Sbjct: 114 IIHRDLKPDNILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370
I G ++ +D WS+GC+L E L+G P F GE T EEI
Sbjct: 173 ILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGE----------------TPEEI------ 209
Query: 371 YTEFKFPQIKAH--PWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL---EACAHPFFDD 425
F I W + + EA+DL+S+LL P R A E HPFF
Sbjct: 210 -----FQNILNGKIEWPEDVE--VSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262
Query: 426 L 426
+
Sbjct: 263 I 263
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 97/312 (31%), Positives = 160/312 (51%), Gaps = 31/312 (9%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR---ELQIMRLLNHPNV 192
Y + +G+G+ G+V A +VAIKK+ Q++ + R EL +M+ +NH N+
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 193 VSLKHCFFSTTEKDELY-LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+ L + F +E + +V+E + + +V + H + Y+ YQ+ +
Sbjct: 86 IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMEL---DHERMSYL---LYQMLCGI 139
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
+LH G+ HRD+KP N++V LKI DFG A+ Y+ +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP-- 369
G Y +D+WS+GC++ E++ G LFPG +DQ ++I+ LGTP E +K + P
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 370 -NYTEFKFPQIKAHPWHKIFHKRMPP-----------EALDLVSRLLQYSPSLRCTALEA 417
Y E + P+ + + K+F + P +A DL+S++L S R + EA
Sbjct: 257 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 418 CAHPFFDDLRDP 429
HP+ + DP
Sbjct: 316 LQHPYINVWYDP 327
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 2e-35
Identities = 81/288 (28%), Positives = 139/288 (48%), Gaps = 48/288 (16%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN-----RELQIMRLLNHPNVVSLKH 197
++G G+FGVV++ LETGD VAIK++ L+ + + +E+ +++ L HPN+V
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 198 CFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
+ L ++LEY ++ ++ K + + + +YV YQ+ + L YLH
Sbjct: 67 SI-----ETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYV----YQVLQGLAYLHE 117
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSA-KMLVPGEPNISYICSRYYRAPELIFGAT 315
GV HRDIK N+L +K+ DFG A K+ + + S + + Y+ APE+I +
Sbjct: 118 -QGVIHRDIKAANILTTKDGV-VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM-S 174
Query: 316 EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFK 375
+TA D+WS+GC + ELL G P + ++ + + +I+
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPY---YDLNPMAALFRIVQDD---------------- 215
Query: 376 FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
H + + PE D + + Q P+LR TA + HP+
Sbjct: 216 ---------HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 84/299 (28%), Positives = 139/299 (46%), Gaps = 60/299 (20%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYK--NRELQIMRLLNHPNVVSL 195
+ +GTGSFG V + +G A+K K+++ K+ + E +I++ + HP +V+L
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNL 66
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
F +D+ L LV+EY+ E + R + P + Y Q+ AL Y
Sbjct: 67 YGSF-----QDDSNLYLVMEYVPGGELF-----SHLRKSGRFPEPVARFYAAQVVLALEY 116
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELIF 312
LH + + +RD+KP+NLL++ + +KI DFG AK + + +C + Y APE+I
Sbjct: 117 LHS-LDIVYRDLKPENLLLDSDGY-IKITDFGFAKRV---KGRTYTLCGTPEYLAPEIIL 171
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372
Y A+D W++G ++ E+L G P F ++ Q+ E KIL
Sbjct: 172 S-KGYGKAVDWWALGILIYEMLAGYPPFFDDN-PIQIYE--KILE--------------G 213
Query: 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA-----HPFFDDL 426
+ +FP P+A DL+ LLQ + R L+ HP+F +
Sbjct: 214 KVRFP------------SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGI 260
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 4e-34
Identities = 94/292 (32%), Positives = 153/292 (52%), Gaps = 23/292 (7%)
Query: 145 VGTGSFGVVFQAKCLETGDS-VAIKKVLQDKRYKN------RELQIMRLLN---HPNVVS 194
+G G++G VF+A+ L+ G VA+K+V + RE+ ++R L HPNVV
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 195 L-KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
L C S T++ E L LV E++ + + VP ++ +Q+ R L++
Sbjct: 69 LFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDF 125
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFG 313
LH V HRD+KPQN+LV + Q+K+ DFG A++ S + + +YRAPE++
Sbjct: 126 LHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 183
Query: 314 ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373
++ Y T +D+WS+GC+ AE+ +PLF G S VDQL +I+ ++G P E+ P
Sbjct: 184 SS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW----PRDVA 238
Query: 374 FKFPQIKAHPWHKI--FHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+ I F + DL+ + L ++P+ R +A A +HP+F
Sbjct: 239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 6e-34
Identities = 88/292 (30%), Positives = 136/292 (46%), Gaps = 54/292 (18%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVL----QDKRYK-NRELQIMRLLNHPNVVSLKHC 198
V+G GS GVV++ + TG A+KK+ ++ R + REL+ +R P VV
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 199 FFSTTEKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
F+ E +++VLEY +++ + +V K +P + QI + L+Y
Sbjct: 68 FYK-----EGEISIVLEYMDGGSLADLLKKVGK--------IPEPVLAYIARQILKGLDY 114
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG-EPNISYICSRYYRAPELIF 312
LH + HRDIKP NLL+N ++KI DFG +K+L + +++ + Y +PE I
Sbjct: 115 LHTKRHIIHRDIKPSNLLIN-SKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQ 173
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQ-P-LFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370
G + Y+ A D+WS+G L E LG+ P L PG+ +L++ I C P
Sbjct: 174 GES-YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI------------CDGPP 220
Query: 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
+ PE D +S LQ P R +A E HPF
Sbjct: 221 P----SLP----------AEEFSPEFRDFISACLQKDPKKRPSAAELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 8e-34
Identities = 83/294 (28%), Positives = 142/294 (48%), Gaps = 28/294 (9%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN----------RELQIMRLL---NHPN 191
+G G++G V++A+ +G VA+K V R + RE+ +++ L +HPN
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSV----RVQTNEDGLPLSTVREVALLKRLEAFDHPN 63
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRM--NQHVPILYVQLYTYQICR 249
+V L ++ E + LV E++ + + + Y +P ++ Q R
Sbjct: 64 IVRLMDVCATSRTDRETKVTLVFEHVDQDL----RTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPE 309
L++LH + HRD+KP+N+LV Q+K+ DFG A++ + + +YRAPE
Sbjct: 120 GLDFLH-ANCIVHRDLKPENILVTSGG-QVKLADFGLARIYSCQMALTPVVVTLWYRAPE 177
Query: 310 LIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369
++ +T Y T +DMWS+GC+ AE+ +PLF G S DQL +I ++G P ++ +
Sbjct: 178 VLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDV 235
Query: 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
F P + L+ +L ++P R +A A HPFF
Sbjct: 236 TLPRGAFSPRGPRPVQS-VVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 8e-34
Identities = 81/288 (28%), Positives = 133/288 (46%), Gaps = 48/288 (16%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN--RELQIMRLLNHPNVVSLKHCFF 200
+G G+ G V++A TG VAIKK+ L+ + + E+ IM+ HPN+V +
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSY- 84
Query: 201 STTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH--H 256
L +V+EY+ +++++ RMN+ I YV ++ + L YLH +
Sbjct: 85 ----LVGDELWVVMEYMDGGSLTDIITQNFVRMNEP-QIAYVCR---EVLQGLEYLHSQN 136
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN-ISYICSRYYRAPELIFGAT 315
V+ HRDIK N+L++ +K+ DFG A L + S + + Y+ APE+I
Sbjct: 137 VI---HRDIKSDNILLS-KDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR-K 191
Query: 316 EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFK 375
+Y +D+WS+G + E+ G+P + E + L +I G P +K NP
Sbjct: 192 DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF-LITTKGIP---PLK--NPE----- 240
Query: 376 FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+ PE D +++ L P R +A E HPF
Sbjct: 241 ---------------KWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 124 bits (315), Expect = 1e-32
Identities = 68/236 (28%), Positives = 109/236 (46%), Gaps = 44/236 (18%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
+ +G G+FG V++ GD VA+K + +D + RE +IMR L+HPN+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRA 250
V L TE++ L +V+EY+ Y R N+ + L + QI R
Sbjct: 64 VKLLGV---CTEEEPLM--IVMEYMP---GGDLLDYLRKNRPKELSLSDLLSFALQIARG 115
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR---- 306
+ YL HRD+ +N LV +KI DFG ++ L + YY+
Sbjct: 116 MEYLES-KNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDD---------YYKVKGG 164
Query: 307 -------APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIK 354
APE + ++T+ D+WS G +L E+ LG+ +PG S +++E +K
Sbjct: 165 KLPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS-NAEVLEYLK 218
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 101/316 (31%), Positives = 158/316 (50%), Gaps = 44/316 (13%)
Query: 145 VGTGSFGVVFQAKCLETGDS--VAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFF 200
VG G++G V++AK + D A+K++ RE+ ++R L HPNV+SL+ F
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 201 STTEKDELYLNLVLEYISETVYRVSKHY--TRMNQ---HVPILYVQLYTYQICRALNYLH 255
S ++ + L+ +Y ++ + K + ++ N+ +P V+ YQI ++YLH
Sbjct: 69 SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 256 HVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSAKM----LVPGEPNISYICSRYYRAP 308
V HRD+KP N+LV P ++KI D G A++ L P + + +YRAP
Sbjct: 126 -ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLF---------PGESGVDQLVEIIKILGTP 359
EL+ GA YT AID+W+IGC+ AELL +P+F DQL I ++G P
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 244
Query: 360 TR---EEIKCMNPNYTEFK-FPQ--------IKAHPWHKIFHKRMPPEALDLVSRLLQYS 407
E+IK M + T K F + IK HK+ + +A L+ +LL
Sbjct: 245 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV---KPDSKAFHLLQKLLTMD 301
Query: 408 PSLRCTALEACAHPFF 423
P R T+ +A P+F
Sbjct: 302 PIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 4e-31
Identities = 97/314 (30%), Positives = 159/314 (50%), Gaps = 40/314 (12%)
Query: 145 VGTGSFGVVFQAKCLETGDS--VAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFF 200
VG G++G V++AK + D A+K++ RE+ ++R L HPNV++L+ F
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 201 STTEKDELYLNLVLEYISETVYRVSKHY--TRMNQ---HVPILYVQLYTYQICRALNYLH 255
S +++ + L+ +Y ++ + K + ++ N+ +P V+ YQI ++YLH
Sbjct: 69 SHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 256 HVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSAKM----LVPGEPNISYICSRYYRAP 308
V HRD+KP N+LV P ++KI D G A++ L P + + +YRAP
Sbjct: 126 -ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLF---------PGESGVDQLVEIIKILGTP 359
EL+ GA YT AID+W+IGC+ AELL +P+F DQL I ++G P
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFP 244
Query: 360 TR---EEIKCMNPNY----TEFKFPQIKAHPWHKIFHK-RMPPEA--LDLVSRLLQYSPS 409
E+I+ M P Y +F+ K K ++ P++ L+ +LL P+
Sbjct: 245 ADKDWEDIRKM-PEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPT 303
Query: 410 LRCTALEACAHPFF 423
R T+ +A P+F
Sbjct: 304 KRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 4e-31
Identities = 73/291 (25%), Positives = 124/291 (42%), Gaps = 47/291 (16%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVL--QDKRYKN---RELQIMRLLNHPNVVSLKH 197
+G G+ GVV + TG +A+K + ++ + REL I+ N P +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
F++ + +++ +EY+ + K + +P + + + L YLH
Sbjct: 67 AFYNNGD-----ISICMEYMDGG--SLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEY 317
+ HRD+KP N+LVN Q+K+CDFG + LV +++ + Y APE I G +Y
Sbjct: 120 HKIIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQG-NDY 176
Query: 318 TTAIDMWSIGCVLAELLLGQPLFPGESG-----VDQLVEIIKILGTPTREEIKCMNPNYT 372
+ D+WS+G L EL G+ +P E+ + L I+ P
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN------------EPP--- 221
Query: 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
P++ + + P+ D V+ L P R + E HPF
Sbjct: 222 ----PRLPSGKF--------SPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 70/235 (29%), Positives = 112/235 (47%), Gaps = 43/235 (18%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
+ +G G+FG V++ K G VA+K + +D + RE +IMR L+HPNV
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQH-VPILYVQLYTYQICRAL 251
V L TE++ LY +V+EY+ Y R N+ + + + + QI R +
Sbjct: 64 VKLLGV---CTEEEPLY--IVMEYME---GGDLLSYLRKNRPKLSLSDLLSFALQIARGM 115
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR----- 306
YL HRD+ +N LV +KI DFG ++ L + YYR
Sbjct: 116 EYLES-KNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDD---------YYRKRGGK 164
Query: 307 ------APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIK 354
APE + ++T+ D+WS G +L E+ LG+ +PG S ++++E +K
Sbjct: 165 LPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS-NEEVLEYLK 217
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 87/294 (29%), Positives = 133/294 (45%), Gaps = 58/294 (19%)
Query: 148 GSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKNRELQIMRLLNH---PNVVSLKHCF 199
G+FG V+ AK TGD AIK ++ + N + + ++ P V L +
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL---Y 63
Query: 200 FSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+S KD YL LV+EY++ ++ + +P + + Y ++ + LH
Sbjct: 64 YSFQSKD--YLYLVMEYLNGGDCASL-------IKTLGGLPEDWAKQYIAEVVLGVEDLH 114
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGAT 315
G+ HRDIKP+NLL++ H LK+ DFG ++ G N ++ + Y APE I G
Sbjct: 115 QR-GIIHRDIKPENLLIDQTGH-LKLTDFGLSRN---GLENKKFVGTPDYLAPETILGVG 169
Query: 316 EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFK 375
+ D WS+GCV+ E L G P F E+ D + + IL I N+ E
Sbjct: 170 D-DKMSDWWSLGCVIFEFLFGYPPFHAET-PDAVFD--NIL----SRRI-----NWPEEV 216
Query: 376 FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA---LEACAHPFFDDL 426
PEA+DL++RLL P+ R A E +HPFF +
Sbjct: 217 KEFCS-------------PEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI 257
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 3e-29
Identities = 78/292 (26%), Positives = 131/292 (44%), Gaps = 50/292 (17%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN--RELQIMRLLNHPNVVSL 195
RV+G G+FG V + +T A+K K ++ +N E +I++ LNHP +V+L
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 196 KHCFFSTTEKDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+ F +DE + LV++ + + Y +S+ + ++ V+ + +I AL Y
Sbjct: 66 WYSF-----QDEENMYLVVDLLLGGDLRYHLSQK-VKFSEEQ----VKFWICEIVLALEY 115
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFG 313
LH G+ HRDIKP N+L++ H + I DF A + P S + Y APE++
Sbjct: 116 LHSK-GIIHRDIKPDNILLDEQGH-VHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR 173
Query: 314 ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373
Y+ A+D WS+G E L G+ + G S R++I+
Sbjct: 174 QG-YSVAVDWWSLGVTAYECLRGKRPYRGHS-------------RTIRDQIRAKQETADV 219
Query: 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR--CTALEACAHPFF 423
+P EA+D +++LL+ P R + HP+F
Sbjct: 220 -LYP--ATW----------STEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 6e-29
Identities = 78/295 (26%), Positives = 126/295 (42%), Gaps = 50/295 (16%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-------LQDKRYKNRELQIMRLLNHPNVVSLKH 197
+G G FG V K + A+K V + + E +I+ NHP +V L +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-Y 59
Query: 198 CFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
F KD+ Y+ +++EY ++ R + Y + A YLH+
Sbjct: 60 RTF----KDKKYIYMLMEYCLGGELW----TILRDRGLFDEYTARFYIACVVLAFEYLHN 111
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATE 316
G+ +RD+KP+NLL++ +K+ DFG AK L G+ ++ + Y APE+I
Sbjct: 112 R-GIIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKG- 168
Query: 317 YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKF 376
Y ++D WS+G +L ELL G+P F GE D + +I N +F
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPPF-GEDDEDPME---------IYNDILKGNGKL---EF 215
Query: 377 PQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA-----HPFFDDL 426
P + A DL+ +LL+ +P R L+ H +F+
Sbjct: 216 PNY------------IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF 258
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 60/232 (25%), Positives = 100/232 (43%), Gaps = 51/232 (21%)
Query: 143 RVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
+ +G G+FG V++ G+ VA+K + + + E IM+ L+HPN+V
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVS-KHYTRMNQHVPILYVQL--YTYQICRA 250
L T+ + LY +V EY + + R + + L QI +
Sbjct: 65 RLLGVC---TQGEPLY--IVTEY----MPGGDLLDFLRKHGE-KLTLKDLLQMALQIAKG 114
Query: 251 LNYLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR-- 306
+ YL + V HRD+ +N LV +KI DFG ++ + + YYR
Sbjct: 115 MEYLESKNFV---HRDLAARNCLVT-ENLVVKISDFGLSRDIYEDD---------YYRKR 161
Query: 307 ----------APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD 347
APE + ++T+ D+WS G +L E+ LG+ +PG S +
Sbjct: 162 GGGKLPIKWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE 212
|
Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 6e-28
Identities = 59/225 (26%), Positives = 106/225 (47%), Gaps = 22/225 (9%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNVVSLKH 197
+G GSFG V + + G + K++ ++K+ E+ I+R L HPN+V
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 198 CFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
+ + L +V+EY + ++ + + +++ ++ Q+ AL H+
Sbjct: 67 RIIDRSNQT---LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 257 VVG----VCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI---SYICSRYYRAPE 309
V HRD+KP N+ ++ + +K+ DFG AK+L G + +Y+ + YY +PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAKIL--GHDSSFAKTYVGTPYYMSPE 180
Query: 310 LIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIK 354
+ + Y D+WS+GC++ EL P F QL IK
Sbjct: 181 QLNHMS-YDEKSDIWSLGCLIYELCALSPPFTA-RNQLQLASKIK 223
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 1e-27
Identities = 75/288 (26%), Positives = 120/288 (41%), Gaps = 49/288 (17%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLNHPNVVSLKHCFFS 201
+G GS+G V++A ETG VAIK V ++ + +E+ I++ + P +V +F
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK 69
Query: 202 TTEKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
T+ L +V+EY +S+ + +K T + YQ + L YLH
Sbjct: 70 NTD-----LWIVMEYCGAGSVSDIMKITNKTLTEEE-------IAAILYQTLKGLEYLHS 117
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYRAPELIFGAT 315
HRDIK N+L+N Q K+ DFG S ++ + I + ++ APE+I
Sbjct: 118 -NKKIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-I 174
Query: 316 EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFK 375
Y D+WS+G E+ G+P + + + I P T
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN-------------KPPPT-LS 220
Query: 376 FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
P W F+ D V + L P R +A++ HPF
Sbjct: 221 DP----EKWSPEFN--------DFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 8e-27
Identities = 83/297 (27%), Positives = 139/297 (46%), Gaps = 51/297 (17%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKV--------LQDKRYKN--RELQIMRLLNHPNV 192
+ +GTG+F +QA+ ++TG +A+K+V Q++ + +E+++M LNHP++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+ +T E + NL +E+++ +V + Y + V I Y T Q+ R L
Sbjct: 66 I---RMLGATCEDS--HFNLFVEWMAGGSVSHLLSKYGAFKEAVIINY----TEQLLRGL 116
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP-----GEPNISYICSRYYR 306
+YLH + HRD+K NLL++ +L+I DFG+A L GE + + +
Sbjct: 117 SYLHEN-QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366
APE++ G +Y + D+WS+GCV+ E+ +P + E + L I KI T
Sbjct: 176 APEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA----- 229
Query: 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
P I H + P D+ R L+ P R + E HP F
Sbjct: 230 ----------PSIPEH---------LSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 8e-27
Identities = 64/227 (28%), Positives = 99/227 (43%), Gaps = 44/227 (19%)
Query: 143 RVVGTGSFGVVFQAKCLETGDS---VAIKKVLQDKRYKNR-----ELQIMRLLNHPNVVS 194
+ +G G+FG V++ K VA+K + +D + R E ++M+ L HPNVV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 195 LKHCFFSTTEKDELYLNLVLEYISE----TVYRVSKHYTRMNQHVPILYVQL--YTYQIC 248
L TE++ LY LVLEY+ R S+ + + L + QI
Sbjct: 61 LLGV---CTEEEPLY--LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR-- 306
+ + YL HRD+ +N LV +KI DFG ++ + + YYR
Sbjct: 116 KGMEYLAS-KKFVHRDLAARNCLVG-EDLVVKISDFGLSRDVYDDD---------YYRKK 164
Query: 307 ----------APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPG 342
APE + +T+ D+WS G +L E+ LG +PG
Sbjct: 165 TGGKLPIRWMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATPYPG 210
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 82/298 (27%), Positives = 121/298 (40%), Gaps = 56/298 (18%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVVSLKHC 198
V+G G+ VV+ A CL + VAIK++ +K + +E+Q M NHPNVV +
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY-YT 66
Query: 199 FFSTTEKDELYLNLVLEYISE-TVYRVSKH-YTRMNQHVPILYVQLYTYQICRALNYLHH 256
F DEL+ LV+ Y+S ++ + K Y R I+ L ++ + L YLH
Sbjct: 67 SF--VVGDELW--LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL--KEVLKGLEYLHS 120
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS-----YICSRYYRAPELI 311
G HRDIK N+L+ +KI DFG + L G ++ + + APE++
Sbjct: 121 -NGQIHRDIKAGNILLGEDG-SVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQP----LFPGESGVDQLVEIIKILGT--PTREEIK 365
Y D+WS G EL G P + ++ L P+ E
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-------LMLTLQNDPPSLETGA 231
Query: 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
F+ ++S LQ PS R TA E H FF
Sbjct: 232 DYKKYSKSFR----------------------KMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 87/331 (26%), Positives = 140/331 (42%), Gaps = 86/331 (25%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ-------IMRLLNHPNVVSLK 196
V+G G+FG V+ + +TG A+K + + K ++ I+ + P +V L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL- 66
Query: 197 HCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
+ F +DE +L LV+EY+ + + + + P + Y ++ AL+ +
Sbjct: 67 YYSF----QDEEHLYLVMEYMPGGDLMNLLIRKDV-----FPEETARFYIAELVLALDSV 117
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK-----------------------MLV 291
H + G HRDIKP N+L++ H +K+ DFG K +LV
Sbjct: 118 HKL-GFIHRDIKPDNILIDADGH-IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175
Query: 292 PGEPNISYICSRY-------YRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES 344
+ Y APE++ G T Y D WS+G +L E+L G P F ++
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDT 234
Query: 345 GVDQLVEIIKILGTPTREEIKCMNPNYTE-FKFPQIKAHPWHKIFHKRMPPEALDLVSRL 403
L E T +I N+ E +FP + PEA+DL+ RL
Sbjct: 235 ----LQE--------TYNKII----NWKESLRFPP----------DPPVSPEAIDLICRL 268
Query: 404 LQYSPSLR-CTALEACAHPFF-----DDLRD 428
L P R + E +HPFF ++LR+
Sbjct: 269 LC-DPEDRLGSFEEIKSHPFFKGIDWENLRE 298
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 9e-26
Identities = 71/223 (31%), Positives = 109/223 (48%), Gaps = 35/223 (15%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKNR---ELQIMRLLNHPN 191
+ E+ +G G F VV++A CL G VA+KKV + D + + E+ +++ L+HPN
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
V+ F E LN+VLE + R+ KH+ + + +P + Y Q+C A
Sbjct: 64 VIKYLASFIENNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG----------SAKMLVPGEPNISYI 300
L ++H + HRDIKP N+ + T +K+ D G +A LV G P
Sbjct: 119 LEHMHS-KRIMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLV-GTP----- 170
Query: 301 CSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGE 343
YY +PE I Y D+WS+GC+L E+ Q F G+
Sbjct: 171 ---YYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 5e-25
Identities = 71/243 (29%), Positives = 114/243 (46%), Gaps = 28/243 (11%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNH---PNVVSL 195
++G G++G V++ K + TG VA+K + D + RE+ ++ L PN+
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPI--LYVQLYTYQICRALNY 253
+ L +++EY R T M PI Y+ + ++ AL Y
Sbjct: 68 YGSYLKGPR-----LWIIMEYAEGGSVR-----TLMKAG-PIAEKYISVIIREVLVALKY 116
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE-PNISYICSRYYRAPELIF 312
+H V GV HRDIK N+LV +T +K+CDFG A +L +++ + Y+ APE+I
Sbjct: 117 IHKV-GVIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVIT 174
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT-PTREEIKCMNPNY 371
Y T D+WS+G + E+ G P + S VD ++ I + P R E +
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPPY---SDVDAFRAMMLIPKSKPPRLEDNGYSKLL 231
Query: 372 TEF 374
EF
Sbjct: 232 REF 234
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 88/297 (29%), Positives = 141/297 (47%), Gaps = 47/297 (15%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR------ELQIMRLLNHPNVVSLKHC 198
+G GS G+V A TG VA+KK+ D R + R E+ IMR HPN+V +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFNEVVIMRDYQHPNIVEM--- 81
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
+ S DEL++ V+E++ +TRMN+ I V L + +AL++LH
Sbjct: 82 YSSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEE-QIATVCL---AVLKALSFLH-AQ 134
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN-ISYICSRYYRAPELIFGATEY 317
GV HRDIK ++L+ ++K+ DFG + P S + + Y+ APE+I Y
Sbjct: 135 GVIHRDIKSDSILLT-SDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI-SRLPY 192
Query: 318 TTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFP 377
T +D+WS+G ++ E++ G+P + E + + + I+ P P
Sbjct: 193 GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM------------KRIRDNLP-------P 233
Query: 378 QIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLP 434
++K HK+ P + R+L P+ R TA E HPF P++ +P
Sbjct: 234 KLKNL--HKV-----SPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPSSIVP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 87/308 (28%), Positives = 142/308 (46%), Gaps = 67/308 (21%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL-------QDKRYKN------RELQIMR 185
++ ++G+GSFG V+ +G+ +A+K+V R ++ RE+ +++
Sbjct: 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61
Query: 186 LLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYT 244
L H N+V D +LN+ LEY+ +V + +Y + + V+ +
Sbjct: 62 ELQHENIVQYLGS-----SLDADHLNIFLEYVPGGSVAALLNNYGAFEETL----VRNFV 112
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI------- 297
QI + LNYLH+ G+ HRDIK N+LV+ + +KI DFG +K L E N
Sbjct: 113 RQILKGLNYLHNR-GIIHRDIKGANILVD-NKGGIKISDFGISKKL---EANSLSTKTNG 167
Query: 298 ---SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIK 354
S S ++ APE++ T YT D+WS+GC++ E+L G+ FP QL I K
Sbjct: 168 ARPSLQGSVFWMAPEVV-KQTSYTRKADIWSLGCLVVEMLTGKHPFP---DCTQLQAIFK 223
Query: 355 ILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA 414
I E P+I ++ + EA+D + + + + R TA
Sbjct: 224 I----------------GENASPEIPSN---------ISSEAIDFLEKTFEIDHNKRPTA 258
Query: 415 LEACAHPF 422
E HPF
Sbjct: 259 AELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 80/294 (27%), Positives = 136/294 (46%), Gaps = 58/294 (19%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-LQDK---RYKNRELQIMRLLNHPNVVSLKHCFF 200
+G+G++G V++A+ + TG+ VAIK + L+ +E+ +++ HPN+V+ +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 201 STTEKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+D+L+ +V+EY + + +Y+V++ Q I YV T + L YLH
Sbjct: 71 R---RDKLW--IVMEYCGGGSLQD-IYQVTRGPLSELQ---IAYVCRETLK---GLAYLH 118
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYRAPELIFGA 314
G HRDIK N+L+ +K+ DFG SA++ S+I + Y+ APE+ A
Sbjct: 119 E-TGKIHRDIKGANILLTEDGD-VKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVA--A 174
Query: 315 TE----YTTAIDMWSIGCVLAELLLGQ-PLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369
E Y D+W++G EL Q P+F + ++ L ++
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPPMFD--------LHPMRALFLISKS------- 219
Query: 370 NYTEFKFPQIKA-HPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
F P++K W +FH D + + L P R TA + HPF
Sbjct: 220 ---NFPPPKLKDKEKWSPVFH--------DFIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 82/295 (27%), Positives = 128/295 (43%), Gaps = 48/295 (16%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVSLK 196
+G G FG V + TG A KK L KR K R E +I+ ++ +VSL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKK-LDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLA 59
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
+ F + KD+L L + L + Y + ++ Y QI L +LH
Sbjct: 60 YAFET---KDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIF---YAAQIICGLEHLHQ 113
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATE 316
+ +RD+KP+N+L++ H + ++I D G A L G+ + Y APE++ G
Sbjct: 114 R-RIVYRDLKPENVLLDDHGN-VRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGE-V 170
Query: 317 YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKF 376
Y ++D +++GC L E++ G+ F Q E ++ +EE+K ++
Sbjct: 171 YDFSVDWFALGCTLYEMIAGRSPF------RQRKEKVE------KEELKRRTLE-MAVEY 217
Query: 377 PQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDL 426
P + PEA DL LLQ P R +A E HP F DL
Sbjct: 218 PD------------KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDL 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 8e-24
Identities = 87/300 (29%), Positives = 126/300 (42%), Gaps = 62/300 (20%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKNR-----ELQIMRLLNHPNV 192
Y+ RV+G G+FG + E V K+V L K R E+ I+ LL HPN+
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
++ + F D+ L + +EY + T+Y + Q V Y +QI A+
Sbjct: 62 IAYYNHFM-----DDNTLLIEMEYANGGTLYDKIVR--QKGQLFEEEMVLWYLFQIVSAV 114
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML---------VPGEPNISYICS 302
+Y+H G+ HRDIK N+ + +K+ DFG +K+L V G P
Sbjct: 115 SYIHKA-GILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSEYSMAETVVGTP------- 165
Query: 303 RYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362
YY +PEL G +Y D+W++GCVL ELL + F + L ++KI
Sbjct: 166 -YYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTF---DATNPLNLVVKI------- 213
Query: 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
+ NYT E + LV LLQ P R TA E P
Sbjct: 214 ----VQGNYTPVVSVYSS--------------ELISLVHSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 78/298 (26%), Positives = 125/298 (41%), Gaps = 49/298 (16%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSL 195
R +G GSFG V+ A+ + T + VAIKK+ + N +E++ ++ L HPN +
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
K C+ E LV+EY + + + + + Q V I + + + L YLH
Sbjct: 81 KGCYLR-----EHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAI---CHGALQGLAYLH 132
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGAT 315
HRDIK N+L+ +K+ DFGSA ++ P S++ + Y+ APE+I
Sbjct: 133 S-HERIHRDIKAGNILLTEPG-TVKLADFGSASLVSPAN---SFVGTPYWMAPEVILAMD 187
Query: 316 E--YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373
E Y +D+WS+G EL +P + + L I +
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------------------AQ 228
Query: 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431
P + ++ W F + V LQ P R ++ E H F R P
Sbjct: 229 NDSPTLSSNDWSDYFR--------NFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTV 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 2e-23
Identities = 78/297 (26%), Positives = 132/297 (44%), Gaps = 57/297 (19%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNR------ELQIMRLLNHPNVV 193
+++G G+FG V+ ++TG +A+K+V K E+Q+++ L H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
C +D+ L++ +EY+ +V K Y + + V + YT QI +
Sbjct: 68 QYYGC-----LRDDETLSIFMEYMPGGSVKDQLKAYGALTETV----TRKYTRQILEGVE 118
Query: 253 YLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML----VPGEPNISYICSRYYR 306
YLH +V HRDIK N+L + +K+ DFG++K L G S + Y+
Sbjct: 119 YLHSNMIV---HRDIKGANILRDS-AGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366
+PE+I G Y D+WS+GC + E+L +P + + + + I KI PT
Sbjct: 175 SPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTN----- 225
Query: 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
PQ+ +H + P+A + + R + R +A E H F
Sbjct: 226 ----------PQLPSH---------VSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 2e-23
Identities = 85/304 (27%), Positives = 139/304 (45%), Gaps = 55/304 (18%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV--------LQDKRYK------NRELQIM 184
++ ++G G++G V+ A + TG+ +A+K+V D R K E++ +
Sbjct: 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62
Query: 185 RLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLY 243
+ L+H N+V E E YL++ LEY+ ++ + Y R + + V+ +
Sbjct: 63 KDLDHLNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL----VRFF 113
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM---LVPGEPNISYI 300
T Q+ L YLH G+ HRD+K NLLV+ KI DFG +K + + N+S
Sbjct: 114 TEQVLEGLAYLHSK-GILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMSMQ 171
Query: 301 CSRYYRAPELIFGATE-YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTP 359
S ++ APE+I ++ Y+ +D+WS+GCV+ E+ G+ + E
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE---------------- 215
Query: 360 TREEIKCMNPNYTEFK-FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC 418
E I M FK + A P + P ALD ++ +P R TA E
Sbjct: 216 --EAIAAM------FKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELL 267
Query: 419 AHPF 422
HPF
Sbjct: 268 QHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 4e-23
Identities = 81/297 (27%), Positives = 130/297 (43%), Gaps = 57/297 (19%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIK----KVLQDKRYKNRELQ---IMRLLNHPNVVSLKH 197
VG G +G VF AK +TG+ VA+K +L L I+ +V L +
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 198 CFFSTTEKDELYLNLVLEYISETVYR--------VSKHYTRMNQHVPILYVQLYTYQICR 249
F +D+ YL L +EY+ +R +S+ + R Y ++
Sbjct: 69 AF-----QDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHAR-----------FYMAEMFE 112
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPE 309
A++ LH + G HRD+KP+N L++ H +K+ DFG +K +V S + S Y APE
Sbjct: 113 AVDALHEL-GYIHRDLKPENFLIDASGH-IKLTDFGLSKGIV--TYANSVVGSPDYMAPE 168
Query: 310 LIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369
++ G Y +D WS+GC+L E L G P F G + + + T R P
Sbjct: 169 VLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR-------P 220
Query: 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426
Y + +F + EA DL+++L+ + + HPFF ++
Sbjct: 221 VYDDPRF--------------NLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 4e-23
Identities = 86/291 (29%), Positives = 127/291 (43%), Gaps = 61/291 (20%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--RYKNRELQIMR----LLN---HPNVV 193
+V+G GSFG V AK G A+ KVLQ K K + IM LL HP +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAV-KVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
L H F T +K LY VL+Y++ E + H R + P + Y +I AL
Sbjct: 60 GL-HYSFQTADK--LY--FVLDYVNGGELFF----HLQR-ERSFPEPRARFYAAEIASAL 109
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPEL 310
YLH + + +RD+KP+N+L++ H + + DFG K + S C + Y APE+
Sbjct: 110 GYLHS-LNIIYRDLKPENILLDSQGH-VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEV 167
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370
+ Y +D W +G VL E+L G P F ++ + IL P R + PN
Sbjct: 168 LR-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-TAEMYD--NILNKPLR-----LKPN 218
Query: 371 YT---------------------EFKFPQIKAHP------WHKIFHKRMPP 394
+ + F +IK H W + +K++ P
Sbjct: 219 ISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITP 269
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 3e-22
Identities = 77/285 (27%), Positives = 118/285 (41%), Gaps = 48/285 (16%)
Query: 146 GTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKNR-----ELQIMRLLNHPNVVSLKHCF 199
G GS+G V++ K L A+K+V L K R E++I+ +NHPN++S K F
Sbjct: 9 GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF 68
Query: 200 FSTTEKDELYLNLVLEY--ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
D L +V+EY + +SK + +P + Q+ R L LH
Sbjct: 69 L-----DGNKLCIVMEYAPFGDLSKAISKRKKKRKL-IPEQEIWRIFIQLLRGLQALHEQ 122
Query: 258 VGVCHRDIKPQN-LLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATE 316
+ HRD+K N LLV +KI D G +K+L + I + +Y APE ++
Sbjct: 123 -KILHRDLKSANILLVAND--LVKIGDLGISKVLKKNMAK-TQIGTPHYMAPE-VWKGRP 177
Query: 317 YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKF 376
Y+ D+WS+GC+L E+ P F S D K+ K+
Sbjct: 178 YSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY---KVQRG----------------KY 218
Query: 377 PQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHP 421
P I + + + +LQ P LR + A P
Sbjct: 219 PPIPP---------IYSQDLQNFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 3e-22
Identities = 70/215 (32%), Positives = 109/215 (50%), Gaps = 17/215 (7%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKN---RELQIMRLLNHP 190
++ E+ +G G F V++A CL G VA+KKV L D + + +E+ +++ LNHP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
NV+ F E LN+VLE + + R+ KH+ + + +P V Y Q+C
Sbjct: 63 NVIKYYASFIEDNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI-SYICSRYYRAP 308
AL ++H V HRDIKP N+ + T +K+ D G + S + + YY +P
Sbjct: 118 ALEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGE 343
E I Y D+WS+GC+L E+ Q F G+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 4e-22
Identities = 68/291 (23%), Positives = 114/291 (39%), Gaps = 47/291 (16%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-----LQDKRYKNRELQIMRLLNHPNVV 193
+ +G GSFG V++A T VAIK + + +E+Q + P +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
F ++ L +++EY + + K ++ + ++ L
Sbjct: 63 KYYGSFLKGSK-----LWIIMEYCGGGSCLDLLKPGKLDETYIAFI-----LREVLLGLE 112
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYRAPELI 311
YLH G HRDIK N+L++ +K+ DFG S ++ +++ + ++ APE+I
Sbjct: 113 YLHEE-GKIHRDIKAANILLSEEG-DVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVI 170
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
+ Y D+WS+G EL G+P + L I K NP
Sbjct: 171 KQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK------------NNP-- 215
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
P ++ + + K F D VS L P R +A E H F
Sbjct: 216 -----PSLEGNKFSKPFK--------DFVSLCLNKDPKERPSAKELLKHKF 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 4e-22
Identities = 63/213 (29%), Positives = 105/213 (49%), Gaps = 16/213 (7%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR------ELQIMRLLNHPNV 192
Y RVVG G+FG+V + V IK++ ++ K+ E Q+++LL+HPN+
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+ F L +V+EY T+ + R N + + + QI AL
Sbjct: 62 IEYYENFLEDKA-----LMIVMEYAPGGTLAEYIQK--RCNSLLDEDTILHFFVQILLAL 114
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
+++H + + HRD+K QN+L++ H +KI DFG +K+L + + + Y +PEL
Sbjct: 115 HHVHTKL-ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELC 173
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGES 344
G Y D+W++GCVL EL + F +
Sbjct: 174 EG-KPYNQKSDIWALGCVLYELASLKRAFEAAN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 4e-22
Identities = 83/297 (27%), Positives = 124/297 (41%), Gaps = 48/297 (16%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVS 194
RV+G G FG V + TG A KK L+ KR K R E QI+ +N VVS
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 64
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
L + + KD L L L L + + + Y N Y +I L L
Sbjct: 65 LAYAY---ETKDALCLVLTLMNGGDLKFHI---YNMGNPGFDEERAVFYAAEITCGLEDL 118
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA 314
H + +RD+KP+N+L++ + H ++I D G A + GE + + Y APE++
Sbjct: 119 HRE-RIVYRDLKPENILLDDYGH-IRISDLGLAVEIPEGETIRGRVGTVGYMAPEVV-KN 175
Query: 315 TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEF 374
YT + D W +GC++ E++ G+ F E +K REE++ E
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSPFRQRK------EKVK------REEVERRVKEDQE- 222
Query: 375 KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR--C---TALEACAHPFFDDL 426
+ ++ A + +LL P R C A E AHPFF
Sbjct: 223 ------------EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 7e-22
Identities = 87/304 (28%), Positives = 142/304 (46%), Gaps = 57/304 (18%)
Query: 143 RVVGTGSFGVVFQAKCL---ETGDSVAIK-----KVLQDKR---YKNRELQIMRLLNH-P 190
RV+GTG++G VF + + + G A+K ++Q + + E Q++ + P
Sbjct: 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ--HVPILYVQLYTYQIC 248
+V+L H F T K L+L+L+Y+ + +T + Q H V++Y +I
Sbjct: 66 FLVTL-HYAFQTDTK----LHLILDYV-----NGGELFTHLYQREHFTESEVRVYIAEIV 115
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN--ISYICSRYYR 306
AL++LH + G+ +RDIK +N+L++ H + + DFG +K + E S+ + Y
Sbjct: 116 LALDHLHQL-GIIYRDIKLENILLDSEGH-VVLTDFGLSKEFLAEEEERAYSFCGTIEYM 173
Query: 307 APELIFGATE-YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365
APE+I G + + A+D WS+G + ELL G F + + EI +R +K
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI-------SRRILK 226
Query: 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC---TALEACAHPF 422
P FP K M EA D + +LL+ P R A E HPF
Sbjct: 227 SKPP------FP------------KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPF 268
Query: 423 FDDL 426
F +
Sbjct: 269 FQGI 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 7e-22
Identities = 67/218 (30%), Positives = 106/218 (48%), Gaps = 37/218 (16%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR-----ELQIMRLL-NHPNVVSLKH 197
V+G G++G V++A+ +TG VAIK + D E I+R NHPN+ +
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIK--IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70
Query: 198 CFF---STTEKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
F D+L+ LV+E +++ V + K R+ + I Y+ + R
Sbjct: 71 AFIKKNPPGNDDQLW--LVMELCGGGSVTDLVKGLRKKGKRLKEEW-IAYI---LRETLR 124
Query: 250 ALNYLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYR 306
L YLH V+ HRDIK QN+L+ ++K+ DFG SA++ ++I + Y+
Sbjct: 125 GLAYLHENKVI---HRDIKGQNILLT-KNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWM 180
Query: 307 APELIFGATE------YTTAIDMWSIGCVLAELLLGQP 338
APE+I A + Y D+WS+G EL G+P
Sbjct: 181 APEVI--ACDEQPDASYDARSDVWSLGITAIELADGKP 216
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 8e-22
Identities = 80/297 (26%), Positives = 128/297 (43%), Gaps = 58/297 (19%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKK-----VLQDKRYK--NRELQIMRLL-NHPNVVS 194
+V+G GSFG V A+ T + A+K +LQD + E +++ L HP +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L H F T KD L+ V+EY++ + ++ + + R ++ Y +I L
Sbjct: 61 L-HSCFQT--KDRLFF--VMEYVNGGDLMFHIQR-SGRFDEPRARFYAA----EIVLGLQ 110
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELI 311
+LH G+ +RD+K N+L++ H +KI DFG K + G S C + Y APE++
Sbjct: 111 FLHER-GIIYRDLKLDNVLLDSEGH-IKIADFGMCKEGILGGVTTSTFCGTPDYIAPEIL 168
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
Y A+D W++G +L E+L GQ F G+ D+L
Sbjct: 169 SY-QPYGPAVDWWALGVLLYEMLAGQSPFEGD-DEDEL---------------------- 204
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA-----HPFF 423
F I + + + EA ++ L +P R L HPFF
Sbjct: 205 ----FQSILEDEVR--YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 1e-21
Identities = 87/299 (29%), Positives = 133/299 (44%), Gaps = 55/299 (18%)
Query: 142 ERVV-GTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYK---NRELQIMRLLNHPNVVSLK 196
ERVV G G++G+V+ A+ L T +AIK++ +D RY + E+ + L H N+V
Sbjct: 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYL 71
Query: 197 HCFFSTTEKDELYLNLVLEYI---SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+E + + +E + S + SK + I++ YT QI L Y
Sbjct: 72 GSD---SENG--FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIF---YTKQILEGLKY 123
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI-SYICSRYYRAPELI- 311
LH + HRDIK N+LVN ++ +KI DFG++K L P ++ + Y APE+I
Sbjct: 124 LHDN-QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVID 182
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
G Y D+WS+GC + E+ G+P F I+ P
Sbjct: 183 KGPRGYGAPADIWSLGCTIVEMATGKPPF-----------------------IELGEPQA 219
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD-LRDP 429
FK K HP +I PE+L ++ + LRC + D L+DP
Sbjct: 220 AMFKVGMFKIHP--EI------PESLSAEAK----NFILRCFEPDPDKRASAHDLLQDP 266
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 3e-21
Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 17/215 (7%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKN---RELQIMRLLNHP 190
++ E+ +G G F V++A CL VA+KKV + D + + +E+ +++ LNHP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
NV+ F E LN+VLE + ++ K++ + + +P V Y Q+C
Sbjct: 63 NVIKYLDSFIEDNE-----LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI-SYICSRYYRAP 308
A+ ++H V HRDIKP N+ + T +K+ D G + S + + YY +P
Sbjct: 118 AVEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGE 343
E I Y D+WS+GC+L E+ Q F G+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 5e-21
Identities = 84/311 (27%), Positives = 140/311 (45%), Gaps = 65/311 (20%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKNR------ELQIMRLLNHPNVVSL 195
+++ G++G V+ + ET A+KK+ Q+ +N+ E I+ +P VVS+
Sbjct: 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSM 66
Query: 196 KHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
C F T +L +V+EY+ + K+ + P+ ++Y + AL YL
Sbjct: 67 -FCSFETKR----HLCMVMEYVEGGDCATLLKNIGAL----PVDMARMYFAETVLALEYL 117
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM-LVPGEPNI--------------SY 299
H+ G+ HRD+KP NLL+ H +K+ DFG +K+ L+ N+
Sbjct: 118 HNY-GIVHRDLKPDNLLITSMGH-IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ 175
Query: 300 IC-SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358
+C + Y APE+I Y +D W++G +L E L+G F G++ + ++I
Sbjct: 176 VCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS---- 230
Query: 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC---TAL 415
++I P E +P +A DL+SRLL+ +P R A
Sbjct: 231 ---DDI--EWPEGDE-----------------ALPADAQDLISRLLRQNPLERLGTGGAF 268
Query: 416 EACAHPFFDDL 426
E H FF L
Sbjct: 269 EVKQHRFFLGL 279
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 6e-21
Identities = 77/298 (25%), Positives = 130/298 (43%), Gaps = 47/298 (15%)
Query: 146 GTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNRELQIMRLLNHPNVVSLK--HCFF 200
G G++GVV + + + TG +A+K++ + + K RLL ++ S++ C +
Sbjct: 10 GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQK-------RLLMDLDI-SMRSVDCPY 61
Query: 201 STTEKDELYLN----LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
+ T L+ + +E + ++ + K +P + I +AL YLH
Sbjct: 62 TVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATE 316
+ V HRD+KP N+L+N Q+K+CDFG + LV + Y APE I
Sbjct: 122 KLSVIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELN 180
Query: 317 ---YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373
Y D+WS+G + EL G+ FP +S TP +++K
Sbjct: 181 QKGYDVKSDVWSLGITMIELATGR--FPYDS-----------WKTPF-QQLK-------- 218
Query: 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431
Q+ P ++ ++ PE D V++ L+ + R E HPFF+ NT
Sbjct: 219 ----QVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNT 272
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-20
Identities = 84/285 (29%), Positives = 135/285 (47%), Gaps = 47/285 (16%)
Query: 143 RVVGTGSFGVVFQAKCLETGDS--VAIKKVLQDKRYKNR-------ELQIMRLLNHPNVV 193
+V+G GSFG VF + + D+ + KVL+ K R E I+ +NHP +V
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY--VQLYTYQICRAL 251
L H F T K L L+L+++ R +TR+++ V V+ Y ++ AL
Sbjct: 62 KL-HYAFQTEGK----LYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALAL 111
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY-YRAPEL 310
++LH + G+ +RD+KP+N+L++ H +K+ DFG +K + E C Y APE+
Sbjct: 112 DHLHSL-GIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 169
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKI-LGTPT--------- 360
+ +T + D WS G ++ E+L G F G+ + + I+K LG P
Sbjct: 170 V-NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSL 228
Query: 361 -REEIKCMNPNYTEFKFPQ----IKAHP------WHKIFHKRMPP 394
R K NP P IK HP W+K++ + + P
Sbjct: 229 LRALFK-RNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKP 272
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 78/286 (27%), Positives = 124/286 (43%), Gaps = 36/286 (12%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVVSLKHCF 199
+G G+ G V + K + TG +A K V + RELQIM P +VS F
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 200 FSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
+ E + + +E++ ++ R+ K + + + + L YL++V
Sbjct: 73 LN-----ENNICMCMEFMDCGSLDRIYKKGGPIPVEI----LGKIAVAVVEGLTYLYNVH 123
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYT 318
+ HRDIKP N+LVN Q+K+CDFG + L+ + +++ + Y +PE I G +YT
Sbjct: 124 RIMHRDIKPSNILVNSRG-QIKLCDFGVSGELINSIAD-TFVGTSTYMSPERIQGG-KYT 180
Query: 319 TAIDMWSIGCVLAELLLGQ-PLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFP 377
D+WS+G + EL LG+ P D + + IL
Sbjct: 181 VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL-----------------LQ 223
Query: 378 QIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
QI P ++ P + D V L P+ R T + CA P F
Sbjct: 224 QIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 4e-20
Identities = 92/310 (29%), Positives = 147/310 (47%), Gaps = 50/310 (16%)
Query: 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR------ELQIM 184
G P++ + + +G GS G+V A TG VA+KK+ D R + R E+ IM
Sbjct: 18 GDPREYLDSFIK--IGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIM 73
Query: 185 RLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYT 244
R +H NVV + + S DEL++ V+E++ +TRMN+ +
Sbjct: 74 RDYHHENVVDM---YNSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEE----QIATVC 124
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN-ISYICSR 303
+ RAL+YLH+ GV HRDIK ++L+ ++K+ DFG + P S + +
Sbjct: 125 LSVLRALSYLHNQ-GVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKSLVGTP 182
Query: 304 YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363
Y+ APE+I Y T +D+WS+G ++ E++ G+P + E + + I R+
Sbjct: 183 YWMAPEVI-SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI--------RDN 233
Query: 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+ P++K HK+ + LDL +L PS R TA E HPF
Sbjct: 234 LP-----------PRVKDS--HKV--SSVLRGFLDL---MLVREPSQRATAQELLQHPFL 275
Query: 424 DDLRDPNTCL 433
L P +C+
Sbjct: 276 -KLAGPPSCI 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 4e-20
Identities = 71/280 (25%), Positives = 123/280 (43%), Gaps = 73/280 (26%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-------LQDKRYKNRELQIMRLLNHPNVVSLKH 197
VGTG+FG V + + A+K + L+ +++ + E ++++ ++HP ++ L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF- 67
Query: 198 CFFSTTEKDELYLNLVLEYISE----TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
TE D+ +L +++EY+ + R S ++ Y +I AL Y
Sbjct: 68 ----WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTG-------LFYASEIVCALEY 116
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP------GEPNISYICSRYYRA 307
LH + +RD+KP+N+L++ H +K+ DFG AK L G P Y A
Sbjct: 117 LHSK-EIVYRDLKPENILLDKEGH-IKLTDFGFAKKLRDRTWTLCGTPE--------YLA 166
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEII-KILGTPTREEIKC 366
PE+I + + A+D W++G ++ E+L+G P F D I KIL
Sbjct: 167 PEVI-QSKGHNKAVDWWALGILIYEMLVGYPPFFD----DNPFGIYEKILA--------- 212
Query: 367 MNPNYTEFKFPQIKAHPWHKI-FHKRMPPEALDLVSRLLQ 405
K+ F + + A DL+ +LL
Sbjct: 213 ------------------GKLEFPRHLDLYAKDLIKKLLV 234
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 5e-20
Identities = 88/311 (28%), Positives = 139/311 (44%), Gaps = 49/311 (15%)
Query: 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR------ELQIM 184
G P+ + + +G GS G+V A +G VA+KK+ D R + R E+ IM
Sbjct: 16 GDPRTYLDNFIK--IGEGSTGIVCIATVKSSGKLVAVKKM--DLRKQQRRELLFNEVVIM 71
Query: 185 RLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYT 244
R H NVV + + + DEL++ V+E++ +TRMN+ +
Sbjct: 72 RDYQHENVVEMYNSYLV---GDELWV--VMEFLEGGALTDIVTHTRMNEE----QIAAVC 122
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN-ISYICSR 303
+ +AL+ LH GV HRDIK ++L+ H ++K+ DFG + P S + +
Sbjct: 123 LAVLKALSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSLVGTP 180
Query: 304 YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363
Y+ APELI Y +D+WS+G ++ E++ G+P + E P +
Sbjct: 181 YWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKA 224
Query: 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+K + N P K HK + P + RLL P+ R TA E HPF
Sbjct: 225 MKMIRDNLP----------PKLKNLHK-VSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 273
Query: 424 DDLRDPNTCLP 434
P+ +P
Sbjct: 274 AKAGPPSCIVP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 6e-20
Identities = 86/295 (29%), Positives = 135/295 (45%), Gaps = 55/295 (18%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ-------IMRLLNHPNVVSLKH 197
+G GSFG V Q + +T A+K + + E+ ++ +N P +V LK
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59
Query: 198 CFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
FS ++LYL VL +I+ E + + + R + + YT ++ AL LH
Sbjct: 60 --FSFQSPEKLYL--VLAFINGGELFHHLQRE-GRFDLS----RARFYTAELLCALENLH 110
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELIFGA 314
V +RD+KP+N+L++ + + +CDFG K+ + + + C + Y APEL+ G
Sbjct: 111 KF-NVIYRDLKPENILLD-YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGH 168
Query: 315 TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEF 374
YT A+D W++G +L E+L G P F E+ V+++ KIL P R
Sbjct: 169 G-YTKAVDWWTLGVLLYEMLTGLPPFYDEN-VNEMYR--KILQEPLR------------- 211
Query: 375 KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC---TALEACAHPFFDDL 426
FP +A DL+ LL P+ R A E HPFF L
Sbjct: 212 -FPD------------GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 87/300 (29%), Positives = 132/300 (44%), Gaps = 61/300 (20%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAI--KKVLQ---------DKRYKNRELQIMRLLNHPN 191
+V+G G +G VFQ + + D+ I KVL+ D + E I+ + HP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
+V L F T K LYL +LEY+S E + + M Y +I
Sbjct: 62 IVDL-IYAFQTGGK--LYL--ILEYLSGGELFMHLEREGIFMED-----TACFYLSEISL 111
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY-YRAP 308
AL +LH G+ +RD+KP+N+L++ H +K+ DFG K + C Y AP
Sbjct: 112 ALEHLHQQ-GIIYRDLKPENILLDAQGH-VKLTDFGLCKESIHEGTVTHTFCGTIEYMAP 169
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368
E I + + A+D WS+G ++ ++L G P F E+ + +I+K K
Sbjct: 170 E-ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK---------GKLNL 219
Query: 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFF 423
P Y + PEA DL+ +LL+ +PS R A E +HPFF
Sbjct: 220 PPY--------------------LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF 259
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 80/299 (26%), Positives = 131/299 (43%), Gaps = 35/299 (11%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKV-LQDK-RYKN---RELQIMRLLNHPNVVSLKHC 198
+G G+ GVV + +G +A K + L+ K +N REL+++ N P +V
Sbjct: 8 ELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGA 67
Query: 199 FFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
F+S E +++ +E++ ++ +V K R +P + + + R L YL
Sbjct: 68 FYSDGE-----ISICMEHMDGGSLDQVLKKAGR----IPENILGKISIAVLRGLTYLREK 118
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEY 317
+ HRD+KP N+LVN ++K+CDFG + L+ N S++ +R Y +PE + G T Y
Sbjct: 119 HKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THY 175
Query: 318 TTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFP 377
T D+WS+G L E+ +G+ P E+ + G P E + P
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYPIPPPDA----KELEAMFGRPVSEGEAKESHRPVSGHPP 231
Query: 378 Q-------------IKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
I P K+ E D V + L+ +P R E HPF
Sbjct: 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 2e-19
Identities = 89/307 (28%), Positives = 140/307 (45%), Gaps = 62/307 (20%)
Query: 143 RVVGTGSFGVVF--------------QAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLN 188
+V+GTG++G VF K L+ V K ++ R + L+ +R
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVR--Q 63
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ--HVPILYVQLYTYQ 246
P +V+L H F T K L+L+L+Y+S + +T + Q + V+ Y+ +
Sbjct: 64 SPFLVTL-HYAFQTEAK----LHLILDYVSG-----GEMFTHLYQRDNFSEDEVRFYSGE 113
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY-IC-SRY 304
I AL +LH + G+ +RDIK +N+L++ H + + DFG +K + E +Y C +
Sbjct: 114 IILALEHLHKL-GIVYRDIKLENILLDSEGH-VVLTDFGLSKEFLSEEKERTYSFCGTIE 171
Query: 305 YRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364
Y APE+I G + A+D WS+G ++ ELL G F E + E+ +R +
Sbjct: 172 YMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV-------SRRIL 224
Query: 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA----- 419
KC P F + PEA DL+ +LL+ P R A A
Sbjct: 225 KCDPP------------------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266
Query: 420 HPFFDDL 426
HPFF L
Sbjct: 267 HPFFKGL 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 86/291 (29%), Positives = 134/291 (46%), Gaps = 54/291 (18%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYK--NRELQIMRLLNHPNVVSLKH 197
+GTGSFG V AK TG+ AIK ++L+ K+ + +E I+ L+HP +V++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
F +++ +Y +LE++ + H R P + Y ++ A YLH
Sbjct: 86 SF---QDENRVYF--LLEFVVGG--ELFTHL-RKAGRFPNDVAKFYHAELVLAFEYLHSK 137
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEY 317
+ +RD+KP+NLL++ H +K+ DFG AK VP + + + Y APE+I + +
Sbjct: 138 -DIIYRDLKPENLLLDNKGH-VKVTDFGFAKK-VP-DRTFTLCGTPEYLAPEVI-QSKGH 192
Query: 318 TTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFP 377
A+D W++G +L E + G P F + TP R K + KFP
Sbjct: 193 GKAVDWWTMGVLLYEFIAGYPPFFDD--------------TPFRIYEKILA---GRLKFP 235
Query: 378 QIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA-----HPFF 423
W F R A DLV LLQ + R L+ HP+F
Sbjct: 236 N-----W---FDGR----ARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYF 274
|
Length = 329 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-19
Identities = 83/301 (27%), Positives = 133/301 (44%), Gaps = 52/301 (17%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSL 195
R +G GSFG V+ A+ + T + VAIKK+ + N +E++ ++ + HPN +
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
K C+ E LV+EY + + + + + Q V I + T+ + L YLH
Sbjct: 91 KGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAI---THGALQGLAYLH 142
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGAT 315
+ HRDIK N+L+ Q+K+ DFGSA + P S++ + Y+ APE+I
Sbjct: 143 S-HNMIHRDIKAGNILLT-EPGQVKLADFGSASIASPAN---SFVGTPYWMAPEVILAMD 197
Query: 316 E--YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373
E Y +D+WS+G EL +P + + L I +
Sbjct: 198 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------------------AQ 238
Query: 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD-PNTC 432
+ P ++++ W F + V LQ P R T+ E H F LR+ P T
Sbjct: 239 NESPTLQSNEWSDYFR--------NFVDSCLQKIPQDRPTSEELLKHMFV--LRERPETV 288
Query: 433 L 433
L
Sbjct: 289 L 289
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 5e-19
Identities = 74/303 (24%), Positives = 130/303 (42%), Gaps = 56/303 (18%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKN--RELQIMRLLNHPNVVSLKHCF 199
+G G++G V++ TG ++A+K++ L + ++ EL I+ P +V F
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 200 FSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
F E + + +EY+ + +Y + + V ++ TY + + L +L
Sbjct: 69 FI-----EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDV----LRRITYAVVKGLKFLK 119
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI---- 311
+ HRD+KP N+LVN + Q+K+CDFG + LV + C Y APE I
Sbjct: 120 EEHNIIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLVASLAKTNIGCQSYM-APERIKSGG 177
Query: 312 -FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD---QLVEIIKILGTPTREEIKCM 367
YT D+WS+G + E+ LG+ +P E+ + QL I+ G P +
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDPPT-----L 230
Query: 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427
Y+ +A D V++ L P+ R T + HP+ +
Sbjct: 231 PSGYS---------------------DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269
Query: 428 DPN 430
+ +
Sbjct: 270 NAD 272
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 8e-19
Identities = 86/299 (28%), Positives = 135/299 (45%), Gaps = 51/299 (17%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR------ELQIMRLLNHPNVVSLKHC 198
+G GS G+V A+ +G VA+K + D R + R E+ IMR H NVV +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVK--MMDLRKQQRRELLFNEVVIMRDYQHQNVVEM--- 83
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY--QICRALNYLHH 256
+ S +EL++ ++E++ TR+N+ Q+ T + +AL YLH
Sbjct: 84 YKSYLVGEELWV--LMEFLQGGALTDIVSQTRLNEE------QIATVCESVLQALCYLH- 134
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN-ISYICSRYYRAPELIFGAT 315
GV HRDIK ++L+ ++K+ DFG + P S + + Y+ APE+I T
Sbjct: 135 SQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI-SRT 192
Query: 316 EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFK 375
Y T +D+WS+G ++ E++ G+P + +S V + + R+
Sbjct: 193 PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--------RDS------------ 232
Query: 376 FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLP 434
P K HKI P D + R+L P R TA E HPF P +P
Sbjct: 233 -PPPKLKNAHKI-----SPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECLVP 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 8e-19
Identities = 77/294 (26%), Positives = 121/294 (41%), Gaps = 49/294 (16%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSLKH 197
+G GSFG V+ A T + VA+KK+ + N +E++ ++ L HPN + K
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
C+ E LV+EY + + + + + Q V I + T+ + L YLH
Sbjct: 89 CYLK-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAI---THGALQGLAYLHSH 140
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATE- 316
+ HRDIK N+L+ Q+K+ DFGSA P S++ + Y+ APE+I E
Sbjct: 141 NMI-HRDIKAGNILLT-EPGQVKLADFGSASKSSPAN---SFVGTPYWMAPEVILAMDEG 195
Query: 317 -YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFK 375
Y +D+WS+G EL +P + + L I +
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------------------AQND 236
Query: 376 FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429
P ++++ W F V LQ P R + E H F R
Sbjct: 237 SPTLQSNEWTDSFRG--------FVDYCLQKIPQERPASAELLRHDFVRRDRPA 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 8e-19
Identities = 80/301 (26%), Positives = 132/301 (43%), Gaps = 63/301 (20%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKK----VLQDKR---YKNRELQIMRLLNHPNVVSLK 196
+VG G FG V + TGD A+K VL + + E I+ + N P + L+
Sbjct: 8 LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67
Query: 197 HCFFSTTEKDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
+ F +KD LYL V+EY + + ++++ + ++ + Q Y ++ A++ +
Sbjct: 68 YAF---QDKDNLYL--VMEYQPGGDLLSLLNRYEDQFDEDM----AQFYLAELVLAIHSV 118
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA------KMLVPGEPNISYICSRYYRAP 308
H + G HRDIKP+N+L++ H +K+ DFGSA KM+ P + + Y AP
Sbjct: 119 HQM-GYVHRDIKPENVLIDRTGH-IKLADFGSAARLTANKMVNSKLP----VGTPDYIAP 172
Query: 309 ELI-----FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363
E++ G Y D WS+G + E++ G+ F + I+
Sbjct: 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA---KTYNNIM------- 222
Query: 364 IKCMNPNYTEF-KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
N+ F KFP+ ++ + LDL+ LL R C HPF
Sbjct: 223 ------NFQRFLKFPE----------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPF 265
Query: 423 F 423
F
Sbjct: 266 F 266
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 9e-19
Identities = 76/283 (26%), Positives = 122/283 (43%), Gaps = 50/283 (17%)
Query: 146 GTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFF 200
G G+ G V + + TG A+K + D ++ REL+I + P +V F
Sbjct: 10 GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF- 68
Query: 201 STTEKDELYLNLVLEYIS----ETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
++ + + +EY +++Y +V K R+ + V + + + + L+YLH
Sbjct: 69 --LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKV-LGKI---AESVLKGLSYLH 122
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS----YICSRYYRAPELI 311
+ HRDIKP N+L+ Q+K+CDFG V GE S + + +Y APE I
Sbjct: 123 SR-KIIHRDIKPSNILLTRKG-QVKLCDFG-----VSGELVNSLAGTFTGTSFYMAPERI 175
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGES----GVDQLVEIIKILGTPT------- 360
G Y+ D+WS+G L E+ + FP E G +L+ I + P
Sbjct: 176 QGKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234
Query: 361 ----REEIK-----CMNPNYTEFKFP-QIKAHPWHKIFHKRMP 393
EE K C+ + T P + HPW K K+
Sbjct: 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKV 277
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 86/299 (28%), Positives = 132/299 (44%), Gaps = 66/299 (22%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKK-----VLQDKRYKNR--ELQIMRL-LNHPNVVS 194
+V+G GSFG V A+ T + AIK VL+D + E +++ L HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--------ETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
L C F T E +L V+EY++ ++ R + R Y +
Sbjct: 61 L-FCTFQTKE----HLFFVMEYLNGGDLMFHIQSSGRFDEARAR-----------FYAAE 104
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYY 305
I L +LH G+ +RD+K N+L++ H +KI DFG K + GE S C + Y
Sbjct: 105 IICGLQFLHKK-GIIYRDLKLDNVLLDKDGH-IKIADFGMCKENMNGEGKASTFCGTPDY 162
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365
APE++ G +Y ++D WS G +L E+L+GQ F GE D+L + I +
Sbjct: 163 IAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGE-DEDELFDSI-------LNDR- 212
Query: 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-TALEACAHPFF 423
P F + + EA D +S+L + P+ R + HPFF
Sbjct: 213 -----------------PH---FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFF 251
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 69/210 (32%), Positives = 105/210 (50%), Gaps = 26/210 (12%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ---------IMRLLNHPNVV 193
+V+G GSFG V AK G A+K VLQ K NR+ Q +++ + HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVK-VLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
L H F TTEK L VL++++ E + + + + P + Y +I AL
Sbjct: 60 GL-HYSFQTTEK----LYFVLDFVNGGELFFHLQRERS-----FPEPRARFYAAEIASAL 109
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPEL 310
YLH + + +RD+KP+N+L++ H + + DFG K + + C + Y APE+
Sbjct: 110 GYLHSI-NIVYRDLKPENILLDSQGH-VVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEV 167
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQPLF 340
I Y +D W +G VL E+L G P F
Sbjct: 168 I-RKQPYDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 1e-18
Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
Y RVVG GSFG + + + A+K++ K +E ++ + HPN+V
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+ K F + + +L +V+EY + + ++ ++ IL Q + Q+C +
Sbjct: 62 AFKESF-----EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTIL--QWFV-QMCLGV 113
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV-PGEPNISYICSRYYRAPEL 310
++H V HRDIK +N+ + ++K+ DFGSA++L PG +Y+ + YY PE
Sbjct: 114 QHIHEK-RVLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPE- 170
Query: 311 IFGATEYTTAIDMWSIGCVLAEL 333
I+ Y D+WS+GC+L EL
Sbjct: 171 IWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 85/308 (27%), Positives = 143/308 (46%), Gaps = 63/308 (20%)
Query: 143 RVVGTGSFGVVFQAKCL---ETGDSVAIK-----------KVLQDKRYKNRELQIMRLLN 188
+V+GTG++G VF + + ++G A+K K + R + + L+ +R
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR--Q 63
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
P +V+L + F + T+ L+L+L+YI+ E +S+ R + VQ+Y+ +
Sbjct: 64 SPFLVTLHYAFQTDTK-----LHLILDYINGGELFTHLSQR-ERFKEQ----EVQIYSGE 113
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY-ICSRY- 304
I AL +LH + G+ +RDIK +N+L++ + H + + DFG +K E +Y C
Sbjct: 114 IVLALEHLHKL-GIIYRDIKLENILLDSNGH-VVLTDFGLSKEFHEDEVERAYSFCGTIE 171
Query: 305 YRAPELIFGA-TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363
Y AP+++ G + A+D WS+G ++ ELL G F + + EI +R
Sbjct: 172 YMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI-------SRRI 224
Query: 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEAC 418
+K P +PQ M A D++ RLL P R A E
Sbjct: 225 LKSEPP------YPQ------------EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIK 266
Query: 419 AHPFFDDL 426
HPFF +
Sbjct: 267 KHPFFQKI 274
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 22/205 (10%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSL 195
R +G GSFG V+ A+ + + VAIKK+ + N +E++ ++ L HPN +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+ C+ E LV+EY + + + + + Q V I V T+ + L YLH
Sbjct: 81 RGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV---THGALQGLAYLH 132
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGAT 315
+ HRD+K N+L++ +K+ DFGSA ++ P ++ + Y+ APE+I
Sbjct: 133 S-HNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPAN---XFVGTPYWMAPEVILAMD 187
Query: 316 E--YTTAIDMWSIGCVLAELLLGQP 338
E Y +D+WS+G EL +P
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 3e-18
Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 29/209 (13%)
Query: 143 RVVGTGSFGVVFQAKCLE-----TGDSVAIKK-----VLQDKRYKNRELQIMRLLNHPNV 192
+ +G G FG V + TG+ VA+K Q + RE++I+R L+H N+
Sbjct: 10 KQLGEGHFGKVELC-RYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
V K + L L++EY+ R R ++ L L++ QIC+ ++
Sbjct: 69 VKYKGVCEKPGGRS---LRLIMEYLPSGSLRDYLQRHRDQINLKRLL--LFSSQICKGMD 123
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG-------EPNISYICSRYY 305
YL HRD+ +N+LV +KI DFG AK+L EP S I +Y
Sbjct: 124 YLGS-QRYIHRDLAARNILVE-SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI--FWY 179
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELL 334
APE + + +++A D+WS G L EL
Sbjct: 180 -APECLRTSK-FSSASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 4e-18
Identities = 85/297 (28%), Positives = 126/297 (42%), Gaps = 48/297 (16%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVS 194
RV+G G FG V + TG A KK L+ KR K R E QI+ +N VVS
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGESMALNEKQILEKVNSRFVVS 64
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
L + + KD L L L L + + + Y Y +IC L L
Sbjct: 65 LAYAY---ETKDALCLVLTLMNGGDLKFHI---YHMGEAGFEEGRAVFYAAEICCGLEDL 118
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA 314
H + +RD+KP+N+L++ H H ++I D G A + G+ + + Y APE++
Sbjct: 119 HQE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV-KN 175
Query: 315 TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEF 374
YT + D W++GC+L E++ GQ F Q + IK REE++ + E
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEVERLVKEVQE- 222
Query: 375 KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDL 426
+ ++ P+A L LL P R A E HP F +
Sbjct: 223 ------------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 7e-18
Identities = 70/208 (33%), Positives = 104/208 (50%), Gaps = 34/208 (16%)
Query: 145 VGTGSFGVVFQAKCL------ETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVS 194
+G G+FG V C TG+ VA+KK+ R RE++I++ L H N+V
Sbjct: 12 LGKGNFGSV--ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRALN 252
K +S ++ L LV+EY+ R + KH R++ H +L LY QIC+ +
Sbjct: 70 YKGVCYSAGRRN---LRLVMEYLPYGSLRDYLQKHRERLD-HRKLL---LYASQICKGME 122
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-------VPGEPNISYICSRYY 305
YL V HRD+ +N+LV +KI DFG K+L EP S I ++
Sbjct: 123 YLGSKRYV-HRDLATRNILVESENR-VKIGDFGLTKVLPQDKEYYKVREPGESPI---FW 177
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAEL 333
APE + ++++ A D+WS G VL EL
Sbjct: 178 YAPESL-TESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 9e-18
Identities = 77/297 (25%), Positives = 131/297 (44%), Gaps = 59/297 (19%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNREL-------QIMRLLNHPNVVSL 195
+++G G+FG V + TG A+K + ++ E+ ++++ HP + +L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
K+ F D L V+EY + E + +S+ + Y +I AL Y
Sbjct: 61 KYSF---QTHD--RLCFVMEYANGGELFFHLSRERVFSEDRA-----RFYGAEIVSALGY 110
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELIF 312
LH V +RD+K +NL+++ H +KI DFG K + + C + Y APE +
Sbjct: 111 LHSC-DVVYRDLKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VL 167
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQ-PLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
+Y A+D W +G V+ E++ G+ P + + ++L E+I + EEI
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILM------EEI------- 212
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFF 423
+FP + + PEA L++ LL+ P R A E H FF
Sbjct: 213 ---RFP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 66/213 (30%), Positives = 109/213 (51%), Gaps = 26/213 (12%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM----RLLN----HPNVVS 194
+++G GSFG VF A+ T AIK + +D + +++ R+L+ HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRV-SKHYTRMNQHVPILYVQLYTYQICRAL 251
L +C F T E L V+EY++ + ++ + S H + + Y +I L
Sbjct: 61 L-YCTFQTKE----NLFFVMEYLNGGDLMFHIQSCHKFDLPR------ATFYAAEIICGL 109
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPEL 310
+LH G+ +RD+K N+L++ H +KI DFG K + G+ C + Y APE+
Sbjct: 110 QFLHSK-GIVYRDLKLDNILLDTDGH-IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEI 167
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQPLFPGE 343
+ G +Y T++D WS G +L E+L+GQ F G
Sbjct: 168 LLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGH 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 86/325 (26%), Positives = 142/325 (43%), Gaps = 55/325 (16%)
Query: 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN---RELQIMRL 186
G PK+ Y +G G+ G V+ A + TG VAIK++ LQ + K E+ +MR
Sbjct: 15 GDPKK--KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 187 LNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
HPN+V+ + DEL+ +V+EY++ T M++ + +
Sbjct: 73 NKHPNIVNYLDSYLVG---DELW--VVMEYLAGGSLTDVVTETCMDEGQ----IAAVCRE 123
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS-YICSRYY 305
+AL +L H V HRDIK N+L+ +K+ DFG + P + S + + Y+
Sbjct: 124 CLQALEFL-HSNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365
APE++ Y +D+WS+G + E++ G+P + E+ + L +I GTP
Sbjct: 182 MAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTP------ 233
Query: 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425
E + P+ ++ D ++R L+ R +A E HPF
Sbjct: 234 -------ELQNPE------------KLSAIFRDFLNRCLEMDVEKRGSAKELLQHPF--- 271
Query: 426 LRDPNTCLPNGRPLPTLFNFTAQGK 450
L +PL +L A K
Sbjct: 272 -------LKIAKPLSSLTPLIAAAK 289
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 79/300 (26%), Positives = 131/300 (43%), Gaps = 60/300 (20%)
Query: 146 GTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVVSLKHCFF 200
G G+FG V++A+ ETG A K++Q + + E+ I+ HPN+V L +F
Sbjct: 14 GDGAFGKVYKAQHKETG-LFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 201 STTEKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+++L++ ++E+ + + + + T ++ Q+ ALN+LH
Sbjct: 73 Y---ENKLWI--LIEFCDGGALDSIMLELERGLTEP-------QIRYVCRQMLEALNFLH 120
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYRAPELI--- 311
V HRD+K N+L+ +K+ DFG SAK + ++I + Y+ APE++
Sbjct: 121 SHK-VIHRDLKAGNILLTLDG-DVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACE 178
Query: 312 -FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT--PTREEIKCMN 368
F Y D+WS+G L EL +P P ++ + ++KIL + PT +
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQMEP--P-HHELNPMRVLLKILKSEPPTLD-----Q 230
Query: 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428
P W F+ D + L P R TA E HPF D D
Sbjct: 231 P------------SKWSSSFN--------DFLKSCLVKDPDDRPTAAELLKHPFVSDQSD 270
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 27/218 (12%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSL 195
+V+G G+FG V + + A+K + + + K E IM N +V L
Sbjct: 49 KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL 108
Query: 196 KHCFFSTTEKDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
H F +D+ YL +V+EY+ + V +S N +P + + YT ++ AL+
Sbjct: 109 -HYAF----QDDKYLYMVMEYMPGGDLVNLMS------NYDIPEKWARFYTAEVVLALDA 157
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA-KMLVPGEPNISY-ICSRYYRAPELI 311
+H + G HRD+KP N+L++ H LK+ DFG+ KM G + + Y +PE++
Sbjct: 158 IHSM-GFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVL 215
Query: 312 F---GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGV 346
G Y D WS+G L E+L+G F +S V
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-17
Identities = 76/291 (26%), Positives = 132/291 (45%), Gaps = 49/291 (16%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNVVSLK 196
+ +G GSFG ++ AK + IK++ +++K +E+ ++ + HPN+V+
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF- 64
Query: 197 HCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
F S E L++ V+EY + + R+++ + IL + QI L ++
Sbjct: 65 --FASFQENGRLFI--VMEYCDGGDLMKRINRQRGVLFSEDQIL---SWFVQISLGLKHI 117
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC--SRYYRAPELIF 312
H + HRDIK QN+ ++ + K+ DFG A+ L ++Y C + YY +PE I
Sbjct: 118 HDR-KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLSPE-IC 174
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372
Y D+WS+GCVL EL + F G + + QLV +KI + ++PN++
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLV--LKI----CQGYFAPISPNFS 227
Query: 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+ L+S+L + SP R + PF
Sbjct: 228 R---------------------DLRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 4e-17
Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 28/215 (13%)
Query: 145 VGTGSFGVVFQAKCLETGDS-VAIKKVL-------QDKRYKNR-------ELQIMR-LLN 188
+G+G+FG V++ + G + +A+K++ +DKR +++ E+ I++ L
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRM---NQHVPILYVQLYTY 245
HPN+V F E D LY+ V++ I +H+ + Q +
Sbjct: 68 HPNIVRYYKTF---LENDRLYI--VMDLIEGAPLG--EHFNSLKEKKQRFTEERIWNIFV 120
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYY 305
Q+ AL YLH + HRD+ P N+++ ++ I DFG AK P S + + Y
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLG-EDDKVTITDFGLAKQKQPESKLTSVVGTILY 179
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLF 340
PE++ Y D+W+ GC+L ++ QP F
Sbjct: 180 SCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 77/266 (28%), Positives = 123/266 (46%), Gaps = 39/266 (14%)
Query: 143 RVVGTGSFGVVFQAKCLETGD--SVAIKKVLQDKRYKNR-------ELQIMRLLNHPNVV 193
R +GTGSFG V A + D VAIK+ + K K + E +I+ +NHP V
Sbjct: 36 RTLGTGSFGRVILAT-YKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCV 94
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+L F KDE YL LVLE++ + + R N+ P Y QI Y
Sbjct: 95 NLYGSF-----KDESYLYLVLEFVIGGEFFT---FLRRNKRFPNDVGCFYAAQIVLIFEY 146
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELIF 312
L + + +RD+KP+NLL++ +K+ DFG AK++ + +C + Y APE++
Sbjct: 147 LQSL-NIVYRDLKPENLLLDKDGF-IKMTDFGFAKVV---DTRTYTLCGTPEYIAPEILL 201
Query: 313 GATEYTTAIDMWSIGCVLAELLLG-------QPLFPGESGVDQLVEIIKILGTPTREEIK 365
+ A D W++G + E+L+G +PL + ++ ++ K L + +K
Sbjct: 202 NVG-HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMK 260
Query: 366 C-----MNPNYTEFK--FPQIKAHPW 384
+ Y K +K HPW
Sbjct: 261 KLLSHDLTKRYGNLKKGAQNVKEHPW 286
|
Length = 340 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 5e-17
Identities = 66/231 (28%), Positives = 108/231 (46%), Gaps = 26/231 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV--LQDKRYKNRELQ----IMRLLNHPNVVSLKHC 198
+G G+FG V + +G +A+K++ D++ + R L +MR + P +V
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 199 FFSTTEKD-----ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
F E D EL +++ L+ + VY V + +P + +ALNY
Sbjct: 72 LF--REGDCWICMEL-MDISLDKFYKYVYEV------LKSVIPEEILGKIAVATVKALNY 122
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI-- 311
L + + HRD+KP N+L++ + + +K+CDFG + LV R Y APE I
Sbjct: 123 LKEELKIIHRDVKPSNILLDRNGN-IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDP 181
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPG-ESGVDQLVEIIKILGTPTR 361
Y D+WS+G L E+ G+ +P S DQL +++K G P
Sbjct: 182 SARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK--GDPPI 230
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 6e-17
Identities = 82/294 (27%), Positives = 142/294 (48%), Gaps = 56/294 (19%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM----RLL----NHPNVVS 194
+V+G GSFG V A+ G+ A+K + +D + +++ R+L +P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILY-VQLYTYQICRAL 251
L +C F T K+ L+ V+E+++ + ++ + R + LY Y +I L
Sbjct: 61 L-YCTFQT--KEHLFF--VMEFLNGGDLMFHIQDK-GRFD-----LYRATFYAAEIVCGL 109
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPEL 310
+LH G+ +RD+K N++++ H +KI DFG K V G+ S C + Y APE+
Sbjct: 110 QFLHSK-GIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRASTFCGTPDYIAPEI 167
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370
+ G +YT ++D WS G +L E+L+GQ F G+ D+L E I++ TP
Sbjct: 168 LQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIRV-DTP----------- 213
Query: 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL-EACAHPFF 423
+P+ W + E+ D++ +L + P+ R + HPFF
Sbjct: 214 ----HYPR-----W-------ITKESKDILEKLFERDPTRRLGVVGNIRGHPFF 251
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 7e-17
Identities = 81/298 (27%), Positives = 135/298 (45%), Gaps = 45/298 (15%)
Query: 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR----ELQIMRL 186
G PK+ Y +G G+ G VF A + TG VAIK++ K+ K E+ +M+
Sbjct: 15 GDPKK--KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72
Query: 187 LNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
L +PN+V+ F DEL++ V+EY++ T M++ + +
Sbjct: 73 LKNPNIVNFLDSFLV---GDELFV--VMEYLAGGSLTDVVTETCMDE----AQIAAVCRE 123
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS-YICSRYY 305
+AL +LH V HRDIK N+L+ +K+ DFG + P + S + + Y+
Sbjct: 124 CLQALEFLH-ANQVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYW 181
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365
APE++ Y +D+WS+G + E++ G+P + E+ + L +I GTP +
Sbjct: 182 MAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTP-----E 234
Query: 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
NP +++ P D ++R L+ R +A E HPF
Sbjct: 235 LQNP--------------------EKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 8e-17
Identities = 71/229 (31%), Positives = 113/229 (49%), Gaps = 27/229 (11%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-------DKRYKNRELQIMRLLNHPN 191
Y +V+G G+FG V + + A+K + + D + E IM N P
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
VV L C F +D+ YL +V+EY+ + V +S N VP + + YT ++
Sbjct: 105 VVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMS------NYDVPEKWAKFYTAEVVL 153
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA-KMLVPGEPNI-SYICSRYYRA 307
AL+ +H + G+ HRD+KP N+L++ H H LK+ DFG+ KM G + + + Y +
Sbjct: 154 ALDAIHSM-GLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVRCDTAVGTPDYIS 211
Query: 308 PELIF---GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEII 353
PE++ G Y D WS+G L E+L+G F +S V +I+
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 9e-17
Identities = 83/324 (25%), Positives = 137/324 (42%), Gaps = 79/324 (24%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK---KVLQDKRYKNR----ELQIMRLLNHPNVVSL 195
+++G G G VF + TG A+K K KR K + E +I+ L+HP + +L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 196 KHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
F + T YL LV++Y ++R+ + + + + + Y ++ AL YL
Sbjct: 67 YASFQTET-----YLCLVMDYCPGGELFRLLQ--RQPGKCLSEEVARFYAAEVLLALEYL 119
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDF-------------------GSAKMLV---- 291
H ++G+ +RD+KP+N+L++ H + + DF GS + V
Sbjct: 120 H-LLGIVYRDLKPENILLHESGH-IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177
Query: 292 -------PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES 344
P + S++ + Y APE+I G + +A+D W++G +L E+L G F G +
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSN 236
Query: 345 GVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLL 404
+ I+K E FP + A DL+ +LL
Sbjct: 237 RDETFSNILK-----------------KEVTFPG----------SPPVSSSARDLIRKLL 269
Query: 405 QYSPSLRC----TALEACAHPFFD 424
PS R A E HPFF
Sbjct: 270 VKDPSKRLGSKRGAAEIKQHPFFR 293
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 18/208 (8%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVS 194
RV+G G FG V + TG A K+ L+ KR K R E QI+ +N VV+
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKR-LEKKRIKKRKGESMALNEKQILEKVNSQFVVN 64
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
L + + KD L L L + + + + Y N Y +I L L
Sbjct: 65 LAYAY---ETKDALCLVLTIMNGGDLKFHI---YNMGNPGFEEERALFYAAEILCGLEDL 118
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA 314
H +RD+KP+N+L++ + H ++I D G A + GE + + Y APE++
Sbjct: 119 HRE-NTVYRDLKPENILLDDYGH-IRISDLGLAVKIPEGESIRGRVGTVGYMAPEVL-NN 175
Query: 315 TEYTTAIDMWSIGCVLAELLLGQPLFPG 342
YT + D W +GC++ E++ GQ F G
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 81/301 (26%), Positives = 136/301 (45%), Gaps = 59/301 (19%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKK-----VLQDKRYK--NRELQIMRLL-NHPNVVS 194
RV+G GSFG V A+ E+G A+K +LQD + E +I+ L NHP +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L +C F T ++ L V+E+++ + ++ + K R ++ + Y +I AL
Sbjct: 61 L-YCCFQTPDR----LFFVMEFVNGGDLMFHIQKS-RRFDEA----RARFYAAEITSALM 110
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELI 311
+LH G+ +RD+K N+L++ H K+ DFG K + S C + Y APE I
Sbjct: 111 FLHD-KGIIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPE-I 167
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
Y ++D W++G +L E+L G F E+ D L E I +E+
Sbjct: 168 LQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI------LNDEV------- 213
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR--CTALEA----CAHPFFDD 425
++ + +A+D++ + +P++R L HPFF +
Sbjct: 214 ---------------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKE 258
Query: 426 L 426
L
Sbjct: 259 L 259
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 64/236 (27%), Positives = 115/236 (48%), Gaps = 27/236 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR---------ELQIMRLLNHPNVV 193
+++G G+FG V+ +TG +A+K+V D E+Q+++ L H +V
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
C E+ L++ +E++ ++ K Y + ++V + YT QI ++
Sbjct: 68 QYYGCLRDPMERT---LSIFMEHMPGGSIKDQLKSYGALTENV----TRKYTRQILEGVS 120
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML----VPGEPNISYICSRYYRAP 308
YLH + + HRDIK N+L + +K+ DFG++K L + G S + Y+ +P
Sbjct: 121 YLHSNM-IVHRDIKGANILRDS-VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364
E+I G Y D+WS+GC + E+L +P + + + + I KI PT +
Sbjct: 179 EVISGEG-YGRKADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTNPVL 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 64/236 (27%), Positives = 117/236 (49%), Gaps = 27/236 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR---------ELQIMRLLNHPNVV 193
+++G G+FG V+ +TG +A+K+V D + E+Q+++ L H +V
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 194 SLKHCFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
C EK L++ +EY+ ++ K Y + ++V + YT QI + ++
Sbjct: 68 QYYGCLRDPEEKK---LSIFVEYMPGGSIKDQLKAYGALTENV----TRRYTRQILQGVS 120
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML----VPGEPNISYICSRYYRAP 308
YLH + + HRDIK N+L + +K+ DFG++K + + G S + Y+ +P
Sbjct: 121 YLHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364
E+I G Y D+WS+ C + E+L +P + + + + I KI PT+ +
Sbjct: 179 EVISGEG-YGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTKPML 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 70/220 (31%), Positives = 111/220 (50%), Gaps = 23/220 (10%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKNR--ELQIMRLLNHPNVVSLK 196
V+G GSFG V A+ T + AIK V+QD + E +++ L + P ++
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 197 HCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
H F T D LY V+EY++ + +Y H ++ + V Y +I L +L
Sbjct: 67 HSCFQTV--DRLYF--VMEYVNGGDLMY----HIQQVGKFKEPQAV-FYAAEISVGLFFL 117
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK-MLVPGEPNISYICSRYYRAPELIFG 313
H G+ +RD+K N++++ H +KI DFG K +V G ++ + Y APE+I
Sbjct: 118 HRR-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII-A 174
Query: 314 ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEII 353
Y ++D W+ G +L E+L GQP F GE D+L + I
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 62/231 (26%), Positives = 120/231 (51%), Gaps = 34/231 (14%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRE----LQIMRLL-----NHPNVV 193
RV+G GS+ V + L+ + + KV++ + + E +Q + + NHP +V
Sbjct: 1 RVIGRGSYAKVLLVR-LKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 59
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
L CF + E L V+EY++ + ++ + + + +P + + Y+ +I AL
Sbjct: 60 GLHSCF-----QTESRLFFVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLAL 109
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM-LVPGEPNISYICSRYYRAPEL 310
NYLH G+ +RD+K N+L++ H +K+ D+G K L PG+ ++ + Y APE+
Sbjct: 110 NYLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI 167
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQPLF--------PGESGVDQLVEII 353
+ G +Y ++D W++G ++ E++ G+ F P ++ D L ++I
Sbjct: 168 LRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 217
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 64/236 (27%), Positives = 121/236 (51%), Gaps = 32/236 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNH--------PNVVS 194
RV+G GS+ V + + A+K V ++ + + ++ ++ H P +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L CF +T+ L LV+EY++ + ++ + + + +P + + Y +IC ALN
Sbjct: 61 LHSCFQTTSR-----LFLVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYAAEICIALN 110
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM-LVPGEPNISYICSRYYRAPELI 311
+LH G+ +RD+K N+L++ H +K+ D+G K L PG+ ++ + Y APE++
Sbjct: 111 FLHER-GIIYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEIL 168
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLF------PGESGVDQLVEIIKILGTPTR 361
G EY ++D W++G ++ E++ G+ F P + D L ++ IL P R
Sbjct: 169 RGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV--ILEKPIR 221
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 61/229 (26%), Positives = 109/229 (47%), Gaps = 32/229 (13%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQD--------KRYK--NRELQIMRLLNHPNVV 193
V+G G++G V+ G +A+K+V D K Y+ E+ +++ L H N+V
Sbjct: 7 VLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+ T D+ +++ +E++ +S R ++ + YT QI + Y
Sbjct: 66 Q-----YLGTCLDDNTISIFMEFVPGG--SISSILNRFGPLPEPVFCK-YTKQILDGVAY 117
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYI-------CSRYYR 306
LH+ V HRDIK N+++ P +K+ DFG A+ L + ++ + Y+
Sbjct: 118 LHNNC-VVHRDIKGNNVMLMP-NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKI 355
APE+I + Y D+WSIGC + E+ G+P + +D+L + I
Sbjct: 176 APEVI-NESGYGRKSDIWSIGCTVFEMATGKPPL---ASMDRLAAMFYI 220
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 80/286 (27%), Positives = 126/286 (44%), Gaps = 51/286 (17%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ---------IMRLLNHPNVV 193
+V+G GSFG V AK G A+K VLQ K ++ Q +++ L HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVK-VLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
L H F T EK L VL+Y++ E + + + + + Y ++ A+
Sbjct: 60 GL-HYSFQTAEK----LYFVLDYVNGGELFFHLQRERCFLEPRA-----RFYAAEVASAI 109
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPEL 310
YLH + + +RD+KP+N+L++ H + + DFG K V E S C + Y APE
Sbjct: 110 GYLHSL-NIIYRDLKPENILLDSQGHVV-LTDFGLCKEGVEPEETTSTFCGTPEYLAPE- 166
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEII----------------K 354
+ Y +D W +G VL E+L G P F V Q+ + I
Sbjct: 167 VLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-VSQMYDNILHKPLQLPGGKTVAACD 225
Query: 355 ILGTPTREEIKCMNPNYTEFKFPQIKAH------PWHKIFHKRMPP 394
+L ++ + +F +IK H W ++HKR+ P
Sbjct: 226 LLVGLLHKDQRRRLGAKADFL--EIKNHVFFSPINWDDLYHKRITP 269
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-16
Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 18/218 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-LQ--DKRYKN---RELQIMRLLNHPNVVSLKHC 198
+G GSFGVVF+ A+K++ L ++R + E +++ L+ ++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 199 FFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
F D+ LN+V+EY ++++ K + +P V + QI L +LH
Sbjct: 68 FL-----DKGKLNIVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELIFGATE 316
+ HRDIK NL ++ + +KI D G AK+L + I + YY +PEL
Sbjct: 121 -KILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELC-EDKP 177
Query: 317 YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIK 354
Y D+W++G VL E G+ F + +++II+
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 56/183 (30%), Positives = 97/183 (53%), Gaps = 19/183 (10%)
Query: 179 RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPI 237
RELQ++ N P +V F+S E +++ +E++ ++ +V K R+ + +
Sbjct: 52 RELQVLHECNSPYIVGFYGAFYSDGE-----ISICMEHMDGGSLDQVLKEAKRIPEEI-- 104
Query: 238 LYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI 297
+ + + R L YL + HRD+KP N+LVN ++K+CDFG + L+ N
Sbjct: 105 --LGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN- 160
Query: 298 SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ-PLFPGESGVDQLVEIIKIL 356
S++ +R Y +PE + G T Y+ D+WS+G L EL +G+ P+ P ++ E+ I
Sbjct: 161 SFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAK-----ELEAIF 214
Query: 357 GTP 359
G P
Sbjct: 215 GRP 217
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 3e-16
Identities = 68/242 (28%), Positives = 117/242 (48%), Gaps = 27/242 (11%)
Query: 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR---------ELQIMRLL 187
I++ +++G G+FG V+ ++TG +A K+V D E+Q+++ L
Sbjct: 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61
Query: 188 NHPNVVSLKHCFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
H +V C EK L + +EY+ +V K Y + + V + YT Q
Sbjct: 62 QHERIVQYYGCLRDRAEKT---LTIFMEYMPGGSVKDQLKAYGALTESV----TRKYTRQ 114
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML----VPGEPNISYICS 302
I ++YLH + + HRDIK N+L + +K+ DFG++K L + G S +
Sbjct: 115 ILEGMSYLHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172
Query: 303 RYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362
Y+ +PE+I G Y D+WS+GC + E+L +P + + + + I KI PT
Sbjct: 173 PYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQPTNP 228
Query: 363 EI 364
++
Sbjct: 229 QL 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 70/274 (25%), Positives = 131/274 (47%), Gaps = 39/274 (14%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQ-DKRYKN----RELQIMRLLNH--PNVVSLKH 197
+G+G+ G V++ + +TG +A+K++ + + +N +L ++ L +H P +V
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVV-LKSHDCPYIVKCYG 81
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
F + ++ + + +E +S + ++ K R+ +P + T I +AL+YL
Sbjct: 82 YFITDSD-----VFICMELMSTCLDKLLK---RIQGPIPEDILGKMTVAIVKALHYLKEK 133
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI-SYICSRYYRAPELIFGAT- 315
GV HRD+KP N+L++ + +K+CDFG + LV + S C+ Y APE I
Sbjct: 134 HGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAAYM-APERIDPPDP 191
Query: 316 --EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT-----PTREE----- 363
+Y D+WS+G L EL GQ FP ++ + + KIL P E
Sbjct: 192 NPKYDIRADVWSLGISLVELATGQ--FPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDF 249
Query: 364 ----IKCMNPNYTEF-KFPQIKAHPWHKIFHKRM 392
C+ ++ + K+ ++ HP+ + +
Sbjct: 250 CSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAE 283
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 4e-16
Identities = 64/230 (27%), Positives = 117/230 (50%), Gaps = 32/230 (13%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVA---IKKVL----QDKRYKNRELQIMRLL-NHPNVVS 194
RV+G GS+ V + +T A IKK L +D + E + NHP +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L CF + + L V+E++S + ++ H R + +P + + Y+ +I ALN
Sbjct: 61 LHSCFQTESR-----LFFVIEFVSGGDLMF----HMQR-QRKLPEEHARFYSAEISLALN 110
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM-LVPGEPNISYICSRYYRAPELI 311
+LH G+ +RD+K N+L++ H +K+ D+G K + PG+ ++ + Y APE++
Sbjct: 111 FLHER-GIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEIL 168
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLF--------PGESGVDQLVEII 353
G +Y ++D W++G ++ E++ G+ F P ++ D L ++I
Sbjct: 169 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI 217
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 64/229 (27%), Positives = 118/229 (51%), Gaps = 23/229 (10%)
Query: 145 VGTGSFGVVFQAKCLETGDSVA-------IKKVLQDKRYKNRELQIMRLLNHPNVVSLKH 197
+G G+ GVVF+ +G +A IK ++++ RELQ++ N P +V
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 70
Query: 198 CFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
F+S E +++ +E++ ++ +V K R+ + + + + + + L YL
Sbjct: 71 AFYSDGE-----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLRE 121
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATE 316
+ HRD+KP N+LVN ++K+CDFG + L+ N S++ +R Y +PE + G T
Sbjct: 122 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 178
Query: 317 YTTAIDMWSIGCVLAELLLGQ-PLFPGESGVDQLVEIIKILGTPTREEI 364
Y+ D+WS+G L E+ +G+ P+ P ++ +L+ + G P E
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESET 227
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 4e-16
Identities = 64/234 (27%), Positives = 96/234 (41%), Gaps = 47/234 (20%)
Query: 145 VGTGSFGVVFQAKCLETGDS---VAIK-----KVLQDKRYKNRELQIMRLLNHPNVVSLK 196
+G G+FG V + L VA+K + K+ RE +M L+HP +V L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL- 61
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
+ + L LV+E Y + + +P+ ++ +Q+ + YL
Sbjct: 62 ---IGVCKGEPLM--LVMELAPLGPLL---KYLKKRREIPVSDLKELAHQVAMGMAYLES 113
Query: 257 VVGVCHRDIKPQN-LLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR--------- 306
V HRD+ +N LLVN HQ KI DFG ++ L G S YYR
Sbjct: 114 KHFV-HRDLAARNVLLVN--RHQAKISDFGMSRALGAG--------SDYYRATTAGRWPL 162
Query: 307 ---APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKIL 356
APE I +++ D+WS G L E G + G E+I +L
Sbjct: 163 KWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKG----AEVIAML 211
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 78/300 (26%), Positives = 128/300 (42%), Gaps = 59/300 (19%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ-------IMRLLN---HPNVV 193
V+G G FG V A+ +TG+ AIK + + E++ I N HP +V
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+L CF +D + V+EY + + H ++ Y + L Y
Sbjct: 66 NLFACF---QTEDHVCF--VMEYAAGGDLMMHIHTDVFSEP----RAVFYAACVVLGLQY 116
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM-LVPGEPNISYICSRYYRAPELIF 312
LH + +RD+K NLL++ +KI DFG K + G+ ++ + + APE++
Sbjct: 117 LHEN-KIVYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLT 174
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372
T YT A+D W +G ++ E+L+G+ FPG+ EE+
Sbjct: 175 E-TSYTRAVDWWGLGVLIYEMLVGESPFPGD----------------DEEEV-------- 209
Query: 373 EFKFPQIKA-HPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA-----HPFFDDL 426
F I + F + EA+ ++ RLL+ +P R + E A PFF D+
Sbjct: 210 ---FDSIVNDEVRYPRF---LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 69/210 (32%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRY--KNRELQIMRLLN-------HPNVV 193
+V+G GSFG V A+ A+K VLQ K K E IM N HP +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVK-VLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
L H F T +K L VL+YI+ E Y + + + + Y +I AL
Sbjct: 60 GL-HFSFQTADK----LYFVLDYINGGELFYHLQRERCFLEPRA-----RFYAAEIASAL 109
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPEL 310
YLH + + +RD+KP+N+L++ H + + DFG K + S C + Y APE+
Sbjct: 110 GYLHSL-NIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEV 167
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQPLF 340
+ Y +D W +G VL E+L G P F
Sbjct: 168 LH-KQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 8e-16
Identities = 74/286 (25%), Positives = 128/286 (44%), Gaps = 52/286 (18%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ-------IMRLLNHPNVVSLK 196
V+G GSFG V A+ T + AIK + +D ++ +++ ++ L P ++
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 197 HCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
H F T D LY V+EY++ + +Y + + + + + Y +I L +L
Sbjct: 67 HSCFQTM--DRLYF--VMEYVNGGDLMYHIQQ-VGKFKEPHAVFYAA----EIAIGLFFL 117
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM-LVPGEPNISYICSRYYRAPELIFG 313
H G+ +RD+K N++++ H +KI DFG K + G+ ++ + Y APE+I
Sbjct: 118 HSK-GIIYRDLKLDNVMLDAEGH-IKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII-A 174
Query: 314 ATEYTTAIDMWSIGCVLAELLLGQPLFPGE-------SGVDQLVEIIKILGTPTREEIKC 366
Y ++D W+ G +L E+L GQP F GE S ++ V K L ++E +
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSL---SKEAVSI 231
Query: 367 MNPNYTEFKFP------------QIKAHP------WHKIFHKRMPP 394
T K P I+ H W K+ + + P
Sbjct: 232 CKGLLT--KHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQP 275
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 8e-16
Identities = 81/289 (28%), Positives = 130/289 (44%), Gaps = 49/289 (16%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVL----QDKRYKNRELQIMRLLNHPNVVSLKHCFF 200
+G+G++G V++A+ + TG+ AIK + +D +E+ +M+ H N+V+ F
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAY---FG 73
Query: 201 STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGV 260
S +D+L++ +E+ + H T I YV T Q L YLH G
Sbjct: 74 SYLRRDKLWIC--MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQ---GLYYLHS-KGK 127
Query: 261 CHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYRAPELIFGATE--- 316
HRDIK N+L+ + H +K+ DFG SA++ S+I + Y+ APE+ A E
Sbjct: 128 MHRDIKGANILLTDNGH-VKLADFGVSAQITATIAKRKSFIGTPYWMAPEV--AAVERKG 184
Query: 317 -YTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEF 374
Y D+W++G EL L P+F + ++ L T+ + F
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFD--------LHPMRALFLMTK----------SNF 226
Query: 375 KFPQIKAH-PWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
+ P++K W FH V L +P R TA + HPF
Sbjct: 227 QPPKLKDKMKWSNSFHH--------FVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 8e-16
Identities = 70/293 (23%), Positives = 125/293 (42%), Gaps = 41/293 (13%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHC 198
++G G+ G V++A L T +A+K + D ++ EL+I+ + P ++
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
FF E +++ E++ V Y ++ +HV + + + L YL +
Sbjct: 68 FFV-----ENRISICTEFMDGGSLDV---YRKIPEHV----LGRIAVAVVKGLTYLWSL- 114
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYT 318
+ HRD+KP N+LVN Q+K+CDFG + LV +Y+ + Y APE I G +Y
Sbjct: 115 KILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVNSIAK-TYVGTNAYMAPERISG-EQYG 171
Query: 319 TAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQ 378
D+WS+G EL LG+ +P + +++L E+ P
Sbjct: 172 IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP------------PV 219
Query: 379 IKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431
+ + + F + +++ ++ P R HPF D N
Sbjct: 220 LPVGQFSEKF--------VHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNA 264
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 88/324 (27%), Positives = 137/324 (42%), Gaps = 60/324 (18%)
Query: 116 TEAGQVIATTVGGRNGQPKQTISYMA-ERV--VGTGSFGVVFQAKCLETGDSVAIKKVLQ 172
+ +++ P S ERV +G+G+ G V++ TG A+K +
Sbjct: 50 PSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYG 109
Query: 173 D-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKH 227
+ +R RE++I+R +NHPNVV F E + ++LE++ S
Sbjct: 110 NHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGE-----IQVLLEFMD----GGSLE 160
Query: 228 YTRMNQHVPILYVQLYTYQICRALNYLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285
T + ++ QI + YLH H+V HRDIKP NLL+N +KI DFG
Sbjct: 161 GTHIADE---QFLADVARQILSGIAYLHRRHIV---HRDIKPSNLLINS-AKNVKIADFG 213
Query: 286 SAKMLVPG-EPNISYICSRYYRAPELI-----FGATEYTTAIDMWSIGCVLAELLLGQ-P 338
+++L +P S + + Y +PE I GA + A D+WS+G + E LG+ P
Sbjct: 214 VSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYD-GYAGDIWSLGVSILEFYLGRFP 272
Query: 339 LFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALD 398
G G D + I CM+ P+ A E
Sbjct: 273 FGVGRQG-DWASLMCAI----------CMSQP------PEAPAT---------ASREFRH 306
Query: 399 LVSRLLQYSPSLRCTALEACAHPF 422
+S LQ P+ R +A++ HPF
Sbjct: 307 FISCCLQREPAKRWSAMQLLQHPF 330
|
Length = 353 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 24/207 (11%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKN--RELQIMRLLNHPNV 192
Y+ + +G GSFG K E G IK++ + K + +E+ ++ + HPN+
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY----VQLYTYQIC 248
V + F E LY+ V++Y Y ++N +L+ + + QIC
Sbjct: 62 VQYQESF---EENGNLYI--VMDYCEG-----GDLYKKINAQRGVLFPEDQILDWFVQIC 111
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG-EPNISYICSRYYRA 307
AL ++H + HRDIK QN+ + +K+ DFG A++L E + I + YY +
Sbjct: 112 LALKHVHDR-KILHRDIKSQNIFLTKDG-TIKLGDFGIARVLNSTVELARTCIGTPYYLS 169
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELL 334
PE I Y D+W++GCVL E+
Sbjct: 170 PE-ICENRPYNNKSDIWALGCVLYEMC 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 70/229 (30%), Positives = 111/229 (48%), Gaps = 27/229 (11%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-------DKRYKNRELQIMRLLNHPN 191
Y +V+G G+FG V + T A+K + + D + E IM N P
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
VV L + F +D+ YL +V+EY+ + V +S N VP + + YT ++
Sbjct: 105 VVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMS------NYDVPEKWARFYTAEVVL 153
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA-KMLVPGEPNI-SYICSRYYRA 307
AL+ +H + G HRD+KP N+L++ H LK+ DFG+ KM G + + + Y +
Sbjct: 154 ALDAIHSM-GFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 211
Query: 308 PELIF---GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEII 353
PE++ G Y D WS+G L E+L+G F +S V +I+
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 67/222 (30%), Positives = 115/222 (51%), Gaps = 25/222 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKNR--ELQIMRL-LNHPNVVS 194
+V+G GSFG V A+ T + AIK +LQD E +I+ L HP + +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L HC F T ++ L V+EY++ + ++++ + + ++ + Y ++ AL
Sbjct: 61 L-HCCFQTKDR----LFFVMEYVNGGDLMFQIQRS-RKFDEP----RSRFYAAEVTLALM 110
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM-LVPGEPNISYICSRYYRAPELI 311
+LH GV +RD+K N+L++ H K+ DFG K ++ G ++ + Y APE I
Sbjct: 111 FLHRH-GVIYRDLKLDNILLDAEGH-CKLADFGMCKEGILNGVTTTTFCGTPDYIAPE-I 167
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEII 353
EY ++D W++G ++ E++ GQP F ++ D L E I
Sbjct: 168 LQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-DDLFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 83/345 (24%), Positives = 127/345 (36%), Gaps = 116/345 (33%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-DKRYKNR------ELQIMRLLNHPNVVSL 195
+V+G G+FG V + +TG A+KK+ + + K + E I+ ++P VV L
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66
Query: 196 KHCFFSTTEKDELYLNLVLEYI---------------SETVYRVSKHYTRMNQHVPILYV 240
+ F +DE YL L++EY+ +E
Sbjct: 67 YYSF-----QDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE------------------T 103
Query: 241 QLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG------------SAK 288
+ Y + A++ +H + G HRDIKP NLL++ H +K+ DFG +
Sbjct: 104 RFYIAETILAIDSIHKL-GYIHRDIKPDNLLLDAKGH-IKLSDFGLCTGLKKSHRTEFYR 161
Query: 289 MLVPGEPNISYICSR--------------------Y-------YRAPELIFGATEYTTAI 321
+L P+ Y Y APE +F T Y
Sbjct: 162 ILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE-VFLQTGYNKEC 220
Query: 322 DMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKA 381
D WS+G ++ E+L+G P F + P K +N T +FP
Sbjct: 221 DWWSLGVIMYEMLVGYPPFCSD--------------NPQETYRKIINWKET-LQFPD--- 262
Query: 382 HPWHKIFHKRMPPEALDLVSRLLQYSPSLRC---TALEACAHPFF 423
+ PEA DL+ RL R E +HPFF
Sbjct: 263 -------EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFF 299
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 2e-15
Identities = 80/298 (26%), Positives = 135/298 (45%), Gaps = 45/298 (15%)
Query: 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN---RELQIMRL 186
G PK+ Y +G G+ G V+ A + TG VAIK++ LQ + K E+ +MR
Sbjct: 15 GDPKK--KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 187 LNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
+PN+V+ + DEL++ V+EY++ T M++ + +
Sbjct: 73 NKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTETCMDEG----QIAAVCRE 123
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS-YICSRYY 305
+AL++LH V HRDIK N+L+ +K+ DFG + P + S + + Y+
Sbjct: 124 CLQALDFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365
APE++ Y +D+WS+G + E++ G+P + E+ + L +I GTP +
Sbjct: 182 MAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTP-----E 234
Query: 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
NP +R+ D ++R L+ R +A E HPF
Sbjct: 235 LQNP--------------------ERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 4e-15
Identities = 64/242 (26%), Positives = 111/242 (45%), Gaps = 31/242 (12%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVSLK 196
+G G FG V + TG A KK L KR K + E +I+ +N P +V+L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKK-LDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59
Query: 197 HCFFSTTEKDELYLNLVLEYISET-----VYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+ F S T +L LV+ ++ +Y V + M + V Y+ QI +
Sbjct: 60 YAFESKT-----HLCLVMSLMNGGDLKYHIYNVGERGLEMER------VIHYSAQITCGI 108
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
+LH + + +RD+KP+N+L++ ++ D G A L G+ + Y APE I
Sbjct: 109 LHLHSM-DIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTITQRAGTNGYMAPE-I 165
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
Y+ +D +++GC + E++ G+ F + V ++ +E+K + N+
Sbjct: 166 LKEEPYSYPVDWFAMGCSIYEMVAGRTPF---KDHKEKVAKEELKRRTLEDEVKFEHQNF 222
Query: 372 TE 373
TE
Sbjct: 223 TE 224
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 5e-15
Identities = 66/285 (23%), Positives = 119/285 (41%), Gaps = 46/285 (16%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRE-----------LQIMRLLNHPNV 192
++G G FG V+ + +TG A+K L KR K ++ L ++ + P +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
V + + F + D+L L L + Y +S+H + + Y +I L
Sbjct: 60 VCMSYAFHT---PDKLSFILDLMNGGDLHYHLSQHGVFSEAEM-----RFYAAEIILGLE 111
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIF 312
++H V +RD+KP N+L++ H H ++I D G A +P+ S + + Y APE++
Sbjct: 112 HMH-NRFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQ 168
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQ----------------------PLFPGESGVDQLV 350
Y ++ D +S+GC+L +LL G P +
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 228
Query: 351 EIIKILGTPTREEIKCMNPNYTEFK-FPQIKAHPWHKIFHKRMPP 394
+ +L + C+ E K P ++ W +F ++ PP
Sbjct: 229 LLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPP 273
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 8e-15
Identities = 66/216 (30%), Positives = 102/216 (47%), Gaps = 45/216 (20%)
Query: 143 RVVGTGSFGVV----FQAKCLETGDSVAIKKVLQDKRYKNR-----ELQIMRLLNHPNVV 193
RV+G G FG V + TG+ VA+K + ++ +N E+ I++ L H N+V
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRAL 251
K C +E+ L L++EY+ R + KH + Q + L+ QIC +
Sbjct: 70 KYKGC---CSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQ------LLLFAQQICEGM 120
Query: 252 NYLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPE 309
YLH H + HRD+ +N+L++ + +KI DFG AK + G YYR E
Sbjct: 121 AYLHSQHYI---HRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGH--------EYYRVRE 168
Query: 310 -----LIFGATE------YTTAIDMWSIGCVLAELL 334
+ + A E ++ A D+WS G L ELL
Sbjct: 169 DGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 8e-15
Identities = 82/299 (27%), Positives = 132/299 (44%), Gaps = 62/299 (20%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----------KRYKNRELQIMRLLNHPNV 192
+++G G+FG V K TG A+K + ++ +NR LQ R HP +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 57
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
+LK+ F T ++ L V+EY + E + +S+ + Y +I A
Sbjct: 58 TALKYSF-QTHDR----LCFVMEYANGGELFFHLSRERVFSEDRA-----RFYGAEIVSA 107
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPE 309
L+YLH V +RD+K +NL+++ H +KI DFG K + + C + Y APE
Sbjct: 108 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 166
Query: 310 LIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369
+ +Y A+D W +G V+ E++ G+ F + ++L E+I + EEI+
Sbjct: 167 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---- 214
Query: 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFF 423
F + + PEA L+S LL+ P R A E H FF
Sbjct: 215 ------------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 9e-15
Identities = 79/304 (25%), Positives = 132/304 (43%), Gaps = 48/304 (15%)
Query: 129 RNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR-----ELQI 183
R+ P + + E +G G+FG V++AK ETG ++A KV++ K + E++I
Sbjct: 6 RDLDPNEVWEIIGE--LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYMVEIEI 62
Query: 184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY 243
+ NHP +V L F+ + L +++E+ V +++ + +Q+
Sbjct: 63 LATCNHPYIVKLLGAFYWDGK-----LWIMIEFCPGGA--VDAIMLELDRGLTEPQIQVI 115
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICS 302
Q+ AL YLH + + HRD+K N+L+ +K+ DFG SAK + + S+I +
Sbjct: 116 CRQMLEALQYLHS-MKIIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSFIGT 173
Query: 303 RYYRAPELIFGAT----EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358
Y+ APE++ T Y D+WS+G L E+ +P
Sbjct: 174 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP-------------------- 213
Query: 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC 418
P E +NP K K+ P + E D + L P R +A +
Sbjct: 214 PHHE----LNPMRVLLKIA--KSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLL 267
Query: 419 AHPF 422
HPF
Sbjct: 268 EHPF 271
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 75/299 (25%), Positives = 124/299 (41%), Gaps = 57/299 (19%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRE----------LQIMRLLNHPNVVS 194
+G G+FG V+Q + +T A+K + + + +E L L P +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
LK FS +LYL V +Y+S E + + K + Y ++ AL
Sbjct: 61 LK---FSFQTDSDLYL--VTDYMSGGELFWHLQK-----EGRFSEDRAKFYIAELVLALE 110
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELI 311
+LH + +RD+KP+N+L++ H + +CDFG +K + + C + Y APE++
Sbjct: 111 HLHKY-DIVYRDLKPENILLDATGH-IALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVL 168
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
YT +D WS+G ++ E+ G F E Q+ I +
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-TQQMYRNIA----------------F 211
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC----TALEACAHPFFDDL 426
+ +FP+ + E V LL +P R A+E HPFF D+
Sbjct: 212 GKVRFPK-----------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI 259
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 63/206 (30%), Positives = 97/206 (47%), Gaps = 18/206 (8%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVS 194
RV+G G FG V + TG A KK L+ KR K R E +I+ +N VVS
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKRILEKVNSRFVVS 64
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
L + + KD L L L + + + + Y N Y ++C L L
Sbjct: 65 LAYAY---ETKDALCLVLTIMNGGDLKFHI---YNMGNPGFDEQRAIFYAAELCCGLEDL 118
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA 314
+ +RD+KP+N+L++ H ++I D G A + GE + + Y APE+I
Sbjct: 119 QRE-RIVYRDLKPENILLDDRGH-IRISDLGLAVQIPEGETVRGRVGTVGYMAPEVI-NN 175
Query: 315 TEYTTAIDMWSIGCVLAELLLGQPLF 340
+YT + D W +GC++ E++ GQ F
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 83/307 (27%), Positives = 133/307 (43%), Gaps = 64/307 (20%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMR-----LLNHPN--VVSL 195
+V+G G+FG V K TG A+K + + + K E R L+N + +L
Sbjct: 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+ F +DE L LV++Y + + +SK +P + Y ++ A++
Sbjct: 67 HYAF-----QDENNLYLVMDYYVGGDLLTLLSK----FEDRLPEDMARFYLAEMVLAIDS 117
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP----------GEPNISYICSR 303
+H + G HRDIKP N+L++ + H +++ DFGS L+ G P+ YI
Sbjct: 118 VHQL-GYVHRDIKPDNVLLDKNGH-IRLADFGSCLRLLADGTVQSNVAVGTPD--YISPE 173
Query: 304 YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363
+A E G Y D WS+G + E+L G+ F ES V+ +I+
Sbjct: 174 ILQAME--DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM---------- 221
Query: 364 IKCMNPNYTE-FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC---TALEACA 419
N+ E F+FP + EA DL+ RL+ SP R +
Sbjct: 222 ------NHKEHFQFPPDVTD---------VSEEAKDLIRRLI-CSPETRLGRNGLQDFKD 265
Query: 420 HPFFDDL 426
HPFF+ +
Sbjct: 266 HPFFEGI 272
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 3e-14
Identities = 70/293 (23%), Positives = 123/293 (41%), Gaps = 71/293 (24%)
Query: 148 GSFGVVFQAKCLETGDS-VAIKKVLQDKRYKNREL---QIMRLLNHPNVVSLKHCFFSTT 203
G FG V K + ++K+++ K + E Q+M+ ++PN + L + TT
Sbjct: 27 GKFGKVSVLK--HKPTQKLFVQKIIKAKNFNAIEPMVHQLMK--DNPNFIKLYYSV--TT 80
Query: 204 EKDELYLNLVLEYIS-----ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH--H 256
K + L+++YI + + + + V+ Q+ ALN LH +
Sbjct: 81 LKGHV---LIMDYIKDGDLFDLL--------KKEGKLSEAEVKKIIRQLVEALNDLHKHN 129
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY-----YRAPELI 311
++ H DIK +N+L + ++ +CD+G K++ G P S Y Y +PE I
Sbjct: 130 II---HNDIKLENVLYDRAKDRIYLCDYGLCKII--GTP------SCYDGTLDYFSPEKI 178
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
G Y + D W++G + ELL G+ P + D E + +++ +
Sbjct: 179 KGHN-YDVSFDWWAVGVLTYELLTGK--HPFKEDED---EEL---------DLESLLKRQ 223
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA-HPFF 423
+ K P F K + A D V +L+Y+ + R T HPF
Sbjct: 224 -QKKLP----------FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 3e-14
Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 21/206 (10%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPN 191
+Y RVVG GS+G V + G IKK+ ++++ +E Q++ L HPN
Sbjct: 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
+V+ + + E ++ L +V+ + +Y K + + +P V + QI A
Sbjct: 61 IVAYRESW----EGEDGLLYIVMGFCEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMA 114
Query: 251 LNYLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS-YICSRYYRA 307
L YLH H++ HRD+K QN+ + T+ +K+ D G A++L S I + YY +
Sbjct: 115 LQYLHEKHIL---HRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMS 170
Query: 308 PELIFGATEYTTAIDMWSIGCVLAEL 333
PEL F Y D+W++GC + E+
Sbjct: 171 PEL-FSNKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 5e-14
Identities = 68/249 (27%), Positives = 122/249 (48%), Gaps = 20/249 (8%)
Query: 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN---RELQIMRL 186
G PK+ Y +G G+ G V+ A + TG VAI+++ LQ + K E+ +MR
Sbjct: 16 GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 187 LNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
+PN+V+ + DEL++ V+EY++ T M++ + +
Sbjct: 74 NKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTETCMDEG----QIAAVCRE 124
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS-YICSRYY 305
+AL +LH V HRDIK N+L+ +K+ DFG + P + S + + Y+
Sbjct: 125 CLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365
APE++ Y +D+WS+G + E++ G+P + E+ + L +I GTP + +
Sbjct: 183 MAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNPE 240
Query: 366 CMNPNYTEF 374
++ + +F
Sbjct: 241 KLSAIFRDF 249
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 9e-14
Identities = 77/299 (25%), Positives = 133/299 (44%), Gaps = 57/299 (19%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNREL-------QIMRLLNHPNVVSL 195
+++G G+FG V + TG A+K + ++ E+ ++++ HP + +L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
K+ F T ++ L V+EY + E + +S+ + + Y +I AL Y
Sbjct: 61 KYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEERA-----RFYGAEIVSALEY 110
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELIF 312
LH V +RDIK +NL+++ H +KI DFG K + + C + Y APE +
Sbjct: 111 LHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VL 167
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372
+Y A+D W +G V+ E++ G+ F + ++L E+I + EEI+
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR------- 213
Query: 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDL 426
F + + PEA L++ LL+ P R A E H FF +
Sbjct: 214 ---------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 257
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 23/208 (11%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRE-----------LQIMRLLNHPNV 192
++G G FG V+ + +TG A+K L KR K ++ L ++ + P +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
V + + F + D+L L L + Y +S+H + + + Y +I L
Sbjct: 60 VCMTYAFHT---PDKLCFILDLMNGGDLHYHLSQHGVFSEKEM-----RFYATEIILGLE 111
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIF 312
++H+ V +RD+KP N+L++ H H ++I D G A +P+ S + + Y APE++
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQ 168
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQPLF 340
T Y ++ D +S+GC+L +LL G F
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 73/295 (24%), Positives = 127/295 (43%), Gaps = 30/295 (10%)
Query: 148 GSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207
GS G VF A D V +K + K E +++ +NHP+V+ +K S
Sbjct: 77 GSEGRVFVATKPGQPDPVVLK--IGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGA---- 130
Query: 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKP 267
+VL + S +Y + T+ ++ +PI + QI L YLH + HRD+K
Sbjct: 131 -ITCMVLPHYSSDLY---TYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ-RIIHRDVKT 185
Query: 268 QNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIG 327
+N+ +N Q+ I D G+A+ V + + APE + +Y + D+WS G
Sbjct: 186 ENIFIN-DVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPE-VLARDKYNSKADIWSAG 243
Query: 328 CVLAELLL----------GQPLFPGESGVDQLVEIIKILGT-----PTREEIKCMNPNYT 372
VL E+L P +S L++II L P + + +
Sbjct: 244 IVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR-LVRGFI 302
Query: 373 EFKFPQIKAHPWHKIFHK-RMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426
E+ + + + + F + +P + LV ++L + ++R +A E +P F L
Sbjct: 303 EYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357
|
Length = 357 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 93/373 (24%), Positives = 150/373 (40%), Gaps = 52/373 (13%)
Query: 84 LPKEMNEMRIRDEKNVNHDDKDLEPSIVN----GNGTEAGQVIATTVGGRNGQPKQTISY 139
P EMN I + + ++DK ++ I + + ++A +A R G K S
Sbjct: 38 FPSEMNP-GIESDDDCLYEDKHMDIDIFDIFADEDESDADASLALCAEARAGIEKAGFSI 96
Query: 140 MAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCF 199
+ G+ G F +T + V IK + E I+R +NHP+++ LK F
Sbjct: 97 L--ETFTPGAEGFAFACIDNKTCEHVVIKA--GQRGGTATEAHILRAINHPSIIQLKGTF 152
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
T K + L+L +Y Y +++ I + + RA+ YLH
Sbjct: 153 --TYNK---FTCLILPRYKTDLY----CYLAAKRNIAICDILAIERSVLRAIQYLHEN-R 202
Query: 260 VCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYY--------RAPELI 311
+ HRDIK +N+ +N H + + DFG+A V N +YY APEL+
Sbjct: 203 IIHRDIKAENIFIN-HPGDVCLGDFGAACFPVDINAN------KYYGWAGTIATNAPELL 255
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD-------QLVEIIKILGTPTREEI 364
Y A+D+WS G VL E+ + G+D Q+ II+ GT E
Sbjct: 256 -ARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314
Query: 365 KCMNPNYTEFKFPQIK-------AHP-WHKIFHKRMPPEALDLVSRLLQYSPSLRCTALE 416
N E K + P W ++ +P + L+ ++L + R +A
Sbjct: 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLY--ELPIDLEYLICKMLAFDAHHRPSAEA 372
Query: 417 ACAHPFFDDLRDP 429
F D+ DP
Sbjct: 373 LLDFAAFQDIPDP 385
|
Length = 391 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 64/229 (27%), Positives = 103/229 (44%), Gaps = 36/229 (15%)
Query: 143 RVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
+V+G+G+FG V++ + G+ VAIK + ++ K E +M ++HP+VV
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 194 SLKH-CFFSTTEKDELYLNL--VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
L C S + + L +L+Y V H + Y+ + QI +
Sbjct: 73 RLLGICLSSQVQLITQLMPLGCLLDY-------VRNHKDNIGS----QYLLNWCVQIAKG 121
Query: 251 LNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY---Y 305
++YL +V HRD+ +N+LV H +KI DFG AK+L E + +
Sbjct: 122 MSYLEEKRLV---HRDLAARNVLVKTPQH-VKITDFGLAKLLDVDEKEYHAEGGKVPIKW 177
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD--QLVE 351
A E I YT D+WS G + EL+ G + G V+ L+E
Sbjct: 178 MALESIL-HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (177), Expect = 3e-13
Identities = 67/252 (26%), Positives = 118/252 (46%), Gaps = 45/252 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ---DKRYKNR---ELQIMRLLNHPNV 192
Y + +G G FG VF K T + K + +R K++ E+ +MR L H N+
Sbjct: 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNI 74
Query: 193 VSLKHCFFSTTEKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILYVQLYTYQI 247
V F + + +LY+ ++E+ +S + + K + ++ +H + T Q+
Sbjct: 75 VRYIDRFLNKANQ-KLYI--LMEFCDAGDLSRNIQKCYKMFGKIEEHA----IVDITRQL 127
Query: 248 CRALNYLHHVVG------VCHRDIKPQNLLVNPHTHQL----------------KICDFG 285
AL Y H++ V HRD+KPQN+ ++ + KI DFG
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187
Query: 286 SAKMLVPGEPNISYIC--SRYYRAPELIFGATE-YTTAIDMWSIGCVLAELLLGQPLFPG 342
+K + G ++++ C + YY +PEL+ T+ Y DMW++GC++ EL G+ F
Sbjct: 188 LSKNI--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245
Query: 343 ESGVDQLVEIIK 354
+ QL+ +K
Sbjct: 246 ANNFSQLISELK 257
|
Length = 1021 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-13
Identities = 67/220 (30%), Positives = 107/220 (48%), Gaps = 23/220 (10%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKNR--ELQIMRLLNHPNVVSLK 196
V+G GSFG V A+ T + AIK V+QD + E +++ L P ++
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 197 HCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
H F T D LY V+EY++ + +Y++ + H Y +I L +L
Sbjct: 67 HSCFQTM--DRLYF--VMEYVNGGDLMYQIQQVGRFKEPHA-----VFYAAEIAIGLFFL 117
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM-LVPGEPNISYICSRYYRAPELIFG 313
H G+ +RD+K N++++ H +KI DFG K + G ++ + Y APE+I
Sbjct: 118 HSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII-A 174
Query: 314 ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEII 353
Y ++D W+ G +L E+L GQ F GE D+L + I
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 86/340 (25%), Positives = 140/340 (41%), Gaps = 97/340 (28%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMR----LL---NHPNVVSL 195
+V+G G+FG V + +TG A+K +L+ + +K +L ++ +L + P VVSL
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 196 KHCFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
+ F +D YL L++E++ + + Y ++ V + Y + A+ +
Sbjct: 67 YYSF-----QDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV----TRFYMAECVLAIEAV 117
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFG------------SAKMLVPGEPNISYICS 302
H + G HRDIKP N+L++ H +K+ DFG + L+ G+ N + I +
Sbjct: 118 HKL-GFIHRDIKPDNILIDRGGH-IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDN 175
Query: 303 RY------------------------------------YRAPELIFGATEYTTAIDMWSI 326
R Y APE IF Y D WS+
Sbjct: 176 RNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQQGYGQECDWWSL 234
Query: 327 GCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE-FKFPQIKAHPWH 385
G ++ E L+G P F E+ + +II N+ E FP H
Sbjct: 235 GAIMFECLIGWPPFCSENSHETYRKII----------------NWRETLYFPD-DIH--- 274
Query: 386 KIFHKRMPPEALDLVSRLLQYSPSL--RCTALEACAHPFF 423
+ EA DL+ RL+ + + R A E +HPFF
Sbjct: 275 ------LSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFF 308
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 77/292 (26%), Positives = 122/292 (41%), Gaps = 54/292 (18%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR-----ELQIMRLLNHPNVVSLKHCF 199
+G G+FG V++A+ ETG +A KV+ K + E+ I+ +HPN+V L F
Sbjct: 13 LGDGAFGKVYKAQNKETG-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
+ E L +++E+ + V + + + +++ Q ALNYLH
Sbjct: 72 YY-----ENNLWILIEFCAGGA--VDAVMLELERPLTEPQIRVVCKQTLEALNYLHE-NK 123
Query: 260 VCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYRAPELIFGATE-- 316
+ HRD+K N+L +K+ DFG SAK + S+I + Y+ APE++ T
Sbjct: 124 IIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182
Query: 317 --YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEF 374
Y D+WS+G L E+ +P P E +NP
Sbjct: 183 RPYDYKADVWSLGITLIEMAQIEP--------------------PHHE----LNPMRVLL 218
Query: 375 KF----PQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
K P A P R E D + + L+ + R T + HPF
Sbjct: 219 KIAKSEPPTLAQP------SRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 28/217 (12%)
Query: 143 RVVGTGSFGVVFQAKCLETGDS-----VAIKKVLQDKRYKNR-----ELQIMRLL-NHPN 191
+ +G G+FG V +A S VA+K + R EL+IM L NH N
Sbjct: 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICR 249
+V+L + T + + + EY Y ++ R + + L ++YQ+ +
Sbjct: 101 IVNL---LGACTIGGPILV--ITEY---CCYGDLLNFLRRKRESFLTLEDLLSFSYQVAK 152
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY---YR 306
+ +L + HRD+ +N+L+ H +KICDFG A+ ++ + +R +
Sbjct: 153 GMAFLASKNCI-HRDLAARNVLLT-HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWM 210
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPG 342
APE IF YT D+WS G +L E+ LG +PG
Sbjct: 211 APESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 59/221 (26%), Positives = 108/221 (48%), Gaps = 24/221 (10%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNREL-------QIMRLLNHPNVVSL 195
+++G G+FG V + +G A+K + ++ E+ ++++ HP + SL
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
K+ F KD L V+EY++ E + +S+ + Y +I AL+Y
Sbjct: 61 KYSF---QTKDRLCF--VMEYVNGGELFFHLSRERVFSEDRT-----RFYGAEIVSALDY 110
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELIF 312
LH + +RD+K +NL+++ H +KI DFG K + + C + Y APE +
Sbjct: 111 LHSG-KIVYRDLKLENLMLDKDGH-IKITDFGLCKEGITDAATMKTFCGTPEYLAPE-VL 167
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEII 353
+Y A+D W +G V+ E++ G+ F + ++L E+I
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELI 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 66/243 (27%), Positives = 102/243 (41%), Gaps = 68/243 (27%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIK--------KVLQDKRYKNR 179
P + ++ E +G G+FG V++ + + SVAIK KV Q+ R +
Sbjct: 3 PLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR---Q 57
Query: 180 ELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS-----ETVYRVSKH------- 227
E ++M L HPN+V C K++ L EY++ E + R S H
Sbjct: 58 EAELMSDLQHPNIV----CLLGVCTKEQPTCML-FEYLAHGDLHEFLVRNSPHSDVGAES 112
Query: 228 YTRMNQHV--PILYVQLYTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICD 283
+ ++ + QI + YL HH V HRD+ +N LV +KI D
Sbjct: 113 GDETVKSSLDCSDFLHI-AIQIAAGMEYLSSHHFV---HRDLAARNCLVGEG-LTVKISD 167
Query: 284 FGSAKMLVPGEPNISYICSRYYR------------APELI-FGATEYTTAIDMWSIGCVL 330
FG ++ + + YYR PE I +G ++TT D+WS G VL
Sbjct: 168 FGLSRDIYSAD---------YYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVL 216
Query: 331 AEL 333
E+
Sbjct: 217 WEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVL----QDKRYKNRELQIMRLLNHPNVVSLKHCFF 200
VG+G++G V++A+ L TG+ A+K + D +E+ +++ H N+V+ F
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAY---FG 73
Query: 201 STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGV 260
S +++L+ + +EY + H T + I YV T Q L YL H G
Sbjct: 74 SYLSREKLW--ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQ---GLAYL-HSKGK 127
Query: 261 CHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYRAPELIFGATE--- 316
HRDIK N+L+ + +K+ DFG +AK+ S+I + Y+ APE+ A E
Sbjct: 128 MHRDIKGANILLTDNG-DVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV--AAVEKNG 184
Query: 317 -YTTAIDMWSIGCVLAELLLGQP 338
Y D+W++G EL QP
Sbjct: 185 GYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 33/215 (15%)
Query: 143 RVVGTGSFGVVFQAKCLETGD---SVAIKKVLQDKRYKNREL-----QIMRLLNHPNVVS 194
R +G G FG V+Q + + +VA+K RE IMR +HP++V
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQH-VPILYVQLYTYQICRALNY 253
L ++ +++ + L + E + Y ++N++ + + + LY+YQ+ AL Y
Sbjct: 72 L----IGVITENPVWIVMELAPLGEL-----RSYLQVNKYSLDLASLILYSYQLSTALAY 122
Query: 254 LHHVVGVCHRDIKPQNLLV-NPHTHQLKICDFGSAKMLVPGEPNISYICSR-----YYRA 307
L V HRDI +N+LV +P +K+ DFG ++ L E Y S+ + A
Sbjct: 123 LESKRFV-HRDIAARNVLVSSPDC--VKLGDFGLSRYL---EDESYYKASKGKLPIKWMA 176
Query: 308 PELIFGATEYTTAIDMWSIG-CVLAELLLG-QPLF 340
PE I +T+A D+W G C+ L+LG +P
Sbjct: 177 PESI-NFRRFTSASDVWMFGVCMWEILMLGVKPFQ 210
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 65/247 (26%), Positives = 115/247 (46%), Gaps = 55/247 (22%)
Query: 145 VGTGSFGVVFQAKCLETGD-----SVAIKKVLQDKRYKN-----RELQIMRLL-NHPNVV 193
+G G+FG V +A+ + + +VA+K + D K+ E+++M+++ H N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYR--------VSKHYTRMNQHVPILYVQLY-- 243
+L T++ LY+ V+EY + R ++ + + P +
Sbjct: 80 NLLGV---CTQEGPLYV--VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 244 ---TYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYI 300
YQ+ R + +L + HRD+ +N+LV H +KI DFG A+ +I +I
Sbjct: 135 VSFAYQVARGMEFLASKKCI-HRDLAARNVLVT-EDHVMKIADFGLAR-------DIHHI 185
Query: 301 CSRYYR------------APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD 347
YYR APE +F YT D+WS G +L E+ LG +PG V+
Sbjct: 186 --DYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIP-VE 241
Query: 348 QLVEIIK 354
+L +++K
Sbjct: 242 ELFKLLK 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 4e-12
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 27/208 (12%)
Query: 143 RVVGTGSFGVV----FQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
R +G G FG V + + TG+ VA+K + + + +E++I+R L H N+V
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
K TE + L++E++ + ++ R + + Y QIC+ ++Y
Sbjct: 70 KYKGI---CTEDGGNGIKLIMEFLPSG--SLKEYLPRNKNKINLKQQLKYAVQICKGMDY 124
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR-------YYR 306
L V HRD+ +N+LV HQ+KI DFG K + E + Y + ++
Sbjct: 125 LGSRQYV-HRDLAARNVLVE-SEHQVKIGDFGLTKAI---ETDKEYYTVKDDLDSPVFWY 179
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELL 334
APE + + Y A D+WS G L ELL
Sbjct: 180 APECLIQSKFY-IASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 67/223 (30%), Positives = 110/223 (49%), Gaps = 20/223 (8%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFST 202
+V+G G+FG V K T A+K + + + K E R NV+ C + T
Sbjct: 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFR--EERNVLVNGDCQWIT 64
Query: 203 TE----KDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
T +DE YL LV++Y + + +SK R+ + + Y+ I +++ LH+
Sbjct: 65 TLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAI-HSIHQLHY 123
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSA-KMLVPGEPNISY-ICSRYYRAPELIF-- 312
V HRDIKP N+L++ + H +++ DFGS KM G S + + Y +PE++
Sbjct: 124 V----HRDIKPDNVLLDMNGH-IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAM 178
Query: 313 --GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEII 353
G +Y D WS+G + E+L G+ F ES V+ +I+
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 6e-12
Identities = 67/319 (21%), Positives = 117/319 (36%), Gaps = 38/319 (11%)
Query: 143 RVVGTGSFG--VVFQAKCLETGDSVAIKKVLQDKRYKNR------ELQIMRLLNHPNVVS 194
++G +V AK T VA+KK+ D K E+ R L HPN++
Sbjct: 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 195 LKHCFFSTTEKDELYLNLVL-EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
F ELY+ L Y S + H+ + +P L + + AL+Y
Sbjct: 64 YVTSF---IVDSELYVVSPLMAYGSCEDL-LKTHF---PEGLPELAIAFILKDVLNALDY 116
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA--------KMLVPGEPNISYICSRYY 305
+H G HR +K ++L++ + + + + V + S + + +
Sbjct: 117 IHS-KGFIHRSVKASHILLSGDGK-VVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPW 174
Query: 306 RAPELIFGATE-YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTR--- 361
+PE++ + Y D++S+G EL G F L+E K+ GT
Sbjct: 175 LSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE--KVRGTVPCLLD 232
Query: 362 -----EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALE 416
M+ + + + P + + + V LQ P R +A +
Sbjct: 233 KSTYPLYEDSMSQSRSSNEHPNNRDSV-DHPYTRTFSEHFHQFVELCLQRDPESRPSASQ 291
Query: 417 ACAHPFFDDLRDPNTCLPN 435
H FF + NT L +
Sbjct: 292 LLNHSFFKQCKRRNTSLLD 310
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 7e-12
Identities = 64/246 (26%), Positives = 98/246 (39%), Gaps = 60/246 (24%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQAKC--LETGDS---VAIKKVLQD------KRYKNREL 181
+ TI R +G G+FG VF +C LE + VA+ K L++ ++ RE
Sbjct: 3 QRDTIVLK--RELGEGAFGKVFLGECYHLEPENDKELVAV-KTLKETASNDARKDFEREA 59
Query: 182 QIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEY-----ISETVYRVSKHYTRM----N 232
+++ H N+V TE D +V EY +++ + + +
Sbjct: 60 ELLTNFQHENIVKFYGV---CTEGDPPI--MVFEYMEHGDLNKFLRSHGPDAAFLKSPDS 114
Query: 233 QHVPILYVQLY--TYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288
+ QL QI + YL H V HRD+ +N LV + +KI DFG ++
Sbjct: 115 PMGELTLSQLLQIAVQIASGMVYLASQHFV---HRDLATRNCLVG-YDLVVKIGDFGMSR 170
Query: 289 MLVPGEPNISYICSRYYR------------APELIFGATEYTTAIDMWSIGCVLAELLL- 335
+ Y YYR PE I +TT D+WS G VL E+
Sbjct: 171 DV--------YTTD-YYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTY 220
Query: 336 -GQPLF 340
QP +
Sbjct: 221 GKQPWY 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 8e-12
Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 33/207 (15%)
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLL-------VNPHTHQ--------LKICDFGSAKM 289
+Q AL+Y H + + H D+KP+N+L V+P T++ ++ICD G
Sbjct: 238 FQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC-- 295
Query: 290 LVPGEPNISYICSRYYRAPELIFG-ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQ 348
+ + +R+YR+PE++ G Y+T DMWS+GC++ EL G+ L+ ++
Sbjct: 296 CDERHSRTAIVSTRHYRSPEVVLGLGWMYST--DMWSMGCIIYELYTGKLLYDTHDNLEH 353
Query: 349 LVEIIKILGT-PTREEIKCMNPN----YTEFKFPQIKAHPWH--KIFHKRMPPEAL---- 397
L + K LG P+ +C Y + P H +I R E +
Sbjct: 354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDL 413
Query: 398 --DLVSRLLQYSPSLRCTALEACAHPF 422
DL+ LL Y R A + HP+
Sbjct: 414 LCDLIYGLLHYDRQKRLNARQMTTHPY 440
|
Length = 467 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 72/296 (24%), Positives = 122/296 (41%), Gaps = 63/296 (21%)
Query: 142 ERVVGTGSFGVVFQ--AKCLETGDS---VAIKKVLQDKRYKNR-----ELQIMRLLNHPN 191
R +G GSFG+V++ AK + G+ VAIK V ++ + R E +M+ N +
Sbjct: 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHH 70
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRM----NQHV----PILYVQLY 243
VV L +T + L +V+E +++ K Y R ++ P +
Sbjct: 71 VVRLLG--VVSTGQPTL---VVMELMAKGDL---KSYLRSRRPEAENNPGLGPPTLQKFI 122
Query: 244 TY--QICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC 301
+I + YL HRD+ +N +V +KI DFG + +I
Sbjct: 123 QMAAEIADGMAYLAAK-KFVHRDLAARNCMVA-EDLTVKIGDFGMTR-------DIYE-- 171
Query: 302 SRYYR------------APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQ 348
+ YYR APE + +TT D+WS G VL E+ L + + G S ++
Sbjct: 172 TDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSN-EE 229
Query: 349 LVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLL 404
+++ + G E C + + W ++ +M P L++VS L
Sbjct: 230 VLKFVIDGGHLDLPE-NCPDKLLELMR------MCWQ--YNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 58/219 (26%), Positives = 92/219 (42%), Gaps = 48/219 (21%)
Query: 144 VVGTGSFGVVFQAK----CLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVV 193
+G G FG VF AK E G+++ + K LQ + +N REL + R L+H NVV
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYT--YQI 247
L E + Y ++LEY + R +K + P+ Q QI
Sbjct: 72 RL---LGLCREAEPHY--MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126
Query: 248 CRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYY 305
+++L V HRD+ +N LV + Q + K+ + Y S YY
Sbjct: 127 ALGMDHLSNARFV---HRDLAARNCLV---SSQRE------VKVSLLSLSKDVY-NSEYY 173
Query: 306 R-----------APELIFGATEYTTAIDMWSIGCVLAEL 333
+ APE + +++T D+WS G ++ E+
Sbjct: 174 KLRNALIPLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 41/230 (17%)
Query: 145 VGTGSFGVVFQAKCLETGD---SVAIKKVLQDKRYKN-----RELQIMRLLNHPNVVSL- 195
+G GSFGVV + + +G VA+K + DK +E IM L+H N++ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 196 ----KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
H TE L +L+ R+ K H I + Y QI +
Sbjct: 63 GVVLTHPLMMVTELAPL--GSLLD-------RLRKDALG---HFLISTLCDYAVQIANGM 110
Query: 252 NYLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR--- 306
YL + HRD+ +N+L+ ++KI DFG + L E + Y+ + +
Sbjct: 111 RYLESKRFI---HRDLAARNILL-ASDDKVKIGDFGLMRALPQNEDH--YVMEEHLKVPF 164
Query: 307 ---APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEI 352
APE + T ++ A D+W G L E+ G+ + G SG L +I
Sbjct: 165 AWCAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 88/341 (25%), Positives = 138/341 (40%), Gaps = 93/341 (27%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVS 194
+ +G G+FG V A ++T A+K L+ K NR E I+ ++ VV
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMK-TLRKKDVLNRNQVAHVKAERDILAEADNEWVVK 65
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
L ++S +KD LY V++YI + RM + P + + Y ++ A+ +
Sbjct: 66 L---YYSFQDKDNLYF--VMDYIPGG--DMMSLLIRM-EVFPEVLARFYIAELTLAIESV 117
Query: 255 HHVVGVCHRDIKPQNLLVNPH----------------THQLKICDFGSAKMLVPGEPNI- 297
H + G HRDIKP N+L++ TH K GS EP+
Sbjct: 118 HKM-GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDL 176
Query: 298 ------------------------------SYICSRYYRAPELIFGATEYTTAIDMWSIG 327
S + + Y APE++ YT D WS+G
Sbjct: 177 WDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWSVG 235
Query: 328 CVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKI 387
+L E+L+GQP F + TPT ++K +N T PQ+K
Sbjct: 236 VILFEMLVGQPPF--------------LAPTPTETQLKVINWENTLHIPPQVK------- 274
Query: 388 FHKRMPPEALDLVSRLLQYSPSL--RCTALEACAHPFFDDL 426
+ PEA+DL+++L + R A + AHPFF ++
Sbjct: 275 ----LSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 82/348 (23%), Positives = 125/348 (35%), Gaps = 117/348 (33%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVS 194
+ +G G+FG V + ++T A+K L+ R E I+ ++ VV
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKT-LRKADVLMRNQAAHVKAERDILAEADNEWVVK 65
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
L ++S +KD LY V++YI + R+ + Y ++ A+ +
Sbjct: 66 L---YYSFQDKDNLYF--VMDYIPGG--DMMSLLIRLGI-FEEDLARFYIAELTCAIESV 117
Query: 255 HHVVGVCHRDIKPQNLLVNPH----------------THQLK------------------ 280
H + G HRDIKP N+L++ TH K
Sbjct: 118 HKM-GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176
Query: 281 ICDFGSAKM------------------LVPGEPNISYICSRYYRAPELIFGATEYTTAID 322
+ ++ LV G PN Y APE++ T YT D
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLV-GTPN--------YIAPEVLL-RTGYTQLCD 226
Query: 323 MWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAH 382
WS+G +L E+L+GQP F + TP ++K +N
Sbjct: 227 WWSVGVILYEMLVGQPPFLAD--------------TPAETQLKVIN-------------- 258
Query: 383 PWHKIFH----KRMPPEALDLVSRLLQYSPSLRC---TALEACAHPFF 423
W H ++ EA DL+ RL R A E AHPFF
Sbjct: 259 -WETTLHIPSQAKLSREASDLILRLCC-GAEDRLGKNGADEIKAHPFF 304
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 67/227 (29%), Positives = 113/227 (49%), Gaps = 28/227 (12%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMR-----LLNHPN--VVS 194
+V+G G+FG V K L+ D V K+L + K E R L+N N + +
Sbjct: 7 KVIGRGAFGEVAVVK-LKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITT 65
Query: 195 LKHCFFSTTEKDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L + F +DE L LV++Y + + +SK R+ + + Y+ I +++
Sbjct: 66 LHYAF-----QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAI-DSVH 119
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA-KMLVPGEPNISY-ICSRYYRAPEL 310
LH+V HRDIKP N+L++ + H +++ DFGS K++ G S + + Y +PE+
Sbjct: 120 QLHYV----HRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 174
Query: 311 IF----GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEII 353
+ G +Y D WS+G + E+L G+ F ES V+ +I+
Sbjct: 175 LQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 7e-11
Identities = 60/228 (26%), Positives = 107/228 (46%), Gaps = 42/228 (18%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNH 189
P++++ ER +G G FG V+ T VA+K + +E QIM+ L H
Sbjct: 4 PRESLKL--ERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQEAQIMKKLRH 60
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYIS-----ETVYRVSKHYTRMNQHVPILYVQLYT 244
+V L + +E++ +Y +V EY+S + + R+ Q V +
Sbjct: 61 DKLVQL---YAVCSEEEPIY--IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM------A 109
Query: 245 YQICRALNYL---HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI--SY 299
QI + YL +++ HRD+ +N+LV + KI DFG A+++ E + +
Sbjct: 110 AQIAEGMAYLESRNYI----HRDLAARNILVGEN-LVCKIADFGLARLI---EDDEYTAR 161
Query: 300 ICSRY---YRAPELI-FGATEYTTAIDMWSIGCVLAELL-LGQPLFPG 342
+++ + APE +G +T D+WS G +L E++ G+ +PG
Sbjct: 162 EGAKFPIKWTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVPYPG 207
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 8e-11
Identities = 67/296 (22%), Positives = 129/296 (43%), Gaps = 50/296 (16%)
Query: 139 YMAERVVGTGSFGVVF--QAKCLETGDSVAIKKVL-------QDKRYKNRELQIMRLLNH 189
Y+ ++ +G GSFG V+ + K + + + K + + N+E Q++ L+H
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVS-KHYTRMNQHVPILYVQLYTYQIC 248
P +V F E+D + + EY + + + V + Q+
Sbjct: 62 PAIVKFHASFL---ERDAFCI--ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLL 116
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI--SYICSRYYR 306
++Y+H + HRD+K +N+ + + LKI DFG +++L+ G ++ ++ + YY
Sbjct: 117 LGVHYMH-QRRILHRDLKAKNIFLK--NNLLKIGDFGVSRLLM-GSCDLATTFTGTPYYM 172
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366
+PE + Y + D+WS+GC+L E+ F G+ + L +++I+ PT
Sbjct: 173 SPEAL-KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ---NFLSVVLRIVEGPT------ 222
Query: 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
P+ E + ++ +L PSLR +A E +PF
Sbjct: 223 --PSLPE-----------------TYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 27/204 (13%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVSLK 196
+G G FG V + TG A KK L KR K R E +I+ ++ +VSL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKK-LNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA 59
Query: 197 HCFFSTTEKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+ F + T+ L LV+ + +Y V + + Y T QI L
Sbjct: 60 YAFQTKTD-----LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFY----TAQIISGL 110
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI-SYICSRYYRAPEL 310
+LH + +RD+KP+N+L++ + ++I D G A L G+ Y + + APEL
Sbjct: 111 EHLHQR-RIIYRDLKPENVLLDNDGN-VRISDLGLAVELKDGQSKTKGYAGTPGFMAPEL 168
Query: 311 IFGATEYTTAIDMWSIGCVLAELL 334
+ G EY ++D +++G L E++
Sbjct: 169 LQG-EEYDFSVDYFALGVTLYEMI 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 62/228 (27%), Positives = 107/228 (46%), Gaps = 30/228 (13%)
Query: 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVV 193
+++M E +G+G FGVV K VAIK + + + E ++M L+HP +V
Sbjct: 6 LTFMKE--LGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLV 62
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ-ICRALN 252
L + T++ LY+ V E++ +Y R Q + L Q +C +
Sbjct: 63 QL---YGVCTQQKPLYI--VTEFMENGCLL---NYLRQRQGKLSKDMLLSMCQDVCEGME 114
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR------YYR 306
YL HRD+ +N LV+ T +K+ DFG + ++ E Y S +
Sbjct: 115 YLERN-SFIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDE----YTSSSGAKFPVKWS 168
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEII 353
PE +F ++Y++ D+WS G ++ E+ G+ F +S ++VE+I
Sbjct: 169 PPE-VFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-EVVEMI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 69/296 (23%), Positives = 115/296 (38%), Gaps = 70/296 (23%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYK----NRELQIMRLLNHPNVVSLKHCF 199
+G GSFG VF+ T VAIK + L++ + +E+ ++ + P V +
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY--QICRALNYLHHV 257
T+ L +++EY+ + + P Q+ T +I + L+YLH
Sbjct: 72 LKGTK-----LWIIMEYLG------GGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE 120
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE-PNISYICSRYYRAPELIFGATE 316
+ HRDIK N+L++ +K+ DFG A L + +++ + ++ APE+I +
Sbjct: 121 KKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSA 177
Query: 317 YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKF 376
Y + D+WS+G EL G+P
Sbjct: 178 YDSKADIWSLGITAIELAKGEP-------------------------------------- 199
Query: 377 PQIKAHPWHKIFH-KRMPPEAL---------DLVSRLLQYSPSLRCTALEACAHPF 422
P HP +F + P L + + L PS R TA E H F
Sbjct: 200 PNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 64/244 (26%), Positives = 106/244 (43%), Gaps = 58/244 (23%)
Query: 143 RVVGTGSFGVVFQAKCLE-----TGDS-VAIKK-----VLQDKRYKNRELQIMRLLNHPN 191
+G+G+FG V++ + +G VA+K Q+K+ +E +M NHPN
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 192 VVS-LKHCFFSTTEKDELYLNL-------VLEYISETVYRVSKHYTRMNQHVPILYVQLY 243
+V L C + Y+ + +L Y+ + RV + + +L + L
Sbjct: 61 IVKLLGVCL----LNEPQYIIMELMEGGDLLSYLRDA--RVERFGPPLLTLKELLDICLD 114
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQ----LKICDFGSAKMLVPGEPNISY 299
+ C L +H + HRD+ +N LV+ + +KI DFG A+ +
Sbjct: 115 VAKGCVYLEQMHFI----HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK------- 163
Query: 300 ICSRYYR------------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESG 345
S YYR APE L+ G +TT D+WS G ++ E+L LGQ +P +
Sbjct: 164 --SDYYRKEGEGLLPVRWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPALNN 219
Query: 346 VDQL 349
+ L
Sbjct: 220 QEVL 223
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 58/216 (26%), Positives = 106/216 (49%), Gaps = 33/216 (15%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK--KVLQDKRYK-NRELQIMRLLN-HPNVVSLKHC 198
VVG G++G V++ + ++TG AIK V +D+ + E+ +++ + H N+ +
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 199 FFSTT---EKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
F + D+L+ LV+E+ +++ V + + + ++ +I R
Sbjct: 82 FIKKSPPGHDDQLW--LVMEFCGAGSVTDLVKNTKGNALKED------WIAYICREILRG 133
Query: 251 LNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML--VPGEPNISYICSRYYR 306
L +L H V+ HRDIK QN+L+ + ++K+ DFG + L G N ++I + Y+
Sbjct: 134 LAHLHAHKVI---HRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWM 188
Query: 307 APELIF----GATEYTTAIDMWSIGCVLAELLLGQP 338
APE+I Y D+WS+G E+ G P
Sbjct: 189 APEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 55/202 (27%), Positives = 99/202 (49%), Gaps = 22/202 (10%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYK----NRELQIMRLLNHPNVVSLKHCF 199
+G GSFG VF+ T VAIK + L++ + +E+ ++ + P V +
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY--QICRALNYLHHV 257
T+ L +++EY+ + + P+ Q+ T +I + L+YLH
Sbjct: 72 LKDTK-----LWIIMEYLG------GGSALDLLEPGPLDETQIATILREILKGLDYLHSE 120
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS-YICSRYYRAPELIFGATE 316
+ HRDIK N+L++ H ++K+ DFG A L + + ++ + ++ APE+I +
Sbjct: 121 KKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSA 177
Query: 317 YTTAIDMWSIGCVLAELLLGQP 338
Y + D+WS+G EL G+P
Sbjct: 178 YDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 70/217 (32%), Positives = 104/217 (47%), Gaps = 21/217 (9%)
Query: 139 YMAERVVGTGSFGVVFQA-KCLETGDSVAIKKV-LQDKR---YKNRELQIMRLLNHPNVV 193
Y+ +VG F A + + + V K V L D+R Y EL + +H +V
Sbjct: 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIV 128
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYT-RMNQHVPI--LYVQLYTYQICRA 250
KH F + D+ L L++EY S ++K R+ +H+P V L YQI A
Sbjct: 129 --KH--FDDFKSDDKLL-LIMEYGSGG--DLNKQIKQRLKEHLPFQEYEVGLLFYQIVLA 181
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML---VPGEPNISYICSRYYRA 307
L+ +H + HRD+K N+ + P T +K+ DFG +K V + S+ + YY A
Sbjct: 182 LDEVHSRK-MMHRDLKSANIFLMP-TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLA 239
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES 344
PEL + Y+ DMWS+G +L ELL F G S
Sbjct: 240 PEL-WERKRYSKKADMWSLGVILYELLTLHRPFKGPS 275
|
Length = 478 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 63/221 (28%), Positives = 105/221 (47%), Gaps = 20/221 (9%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNV 192
Y RV+G+G+ G V AK + G+ A+K V DK E+ + + ++
Sbjct: 34 YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSI 93
Query: 193 VSLKHCFFSTTEKDE---LYLNLVLEYISETVYRVS-KHYTRMNQHVPILYVQLYTYQIC 248
V F ++ L + LVL+Y + R K + N+ L Q+
Sbjct: 94 VKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVL 153
Query: 249 RALNYLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML---VPGEPNISYICSR 303
A++++H H++ HRDIK N+L+ + +K+ DFG +KM V + ++ +
Sbjct: 154 LAVHHVHSKHMI---HRDIKSANILLCSNG-LVKLGDFGFSKMYAATVSDDVGRTFCGTP 209
Query: 304 YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES 344
YY APE I+ Y+ DM+S+G +L ELL + F GE+
Sbjct: 210 YYVAPE-IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249
|
Length = 496 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 6e-10
Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 35/211 (16%)
Query: 142 ERVVGTGSFGVVFQAKCLETGD---SVAIKKV---LQDKRYKN--RELQIMRLLNHPNVV 193
E+V+G G FG V + + G VAIK + DK+ + E IM +HPN++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
L+ + + ++ EY+ + R + + Q V +L I
Sbjct: 69 RLEGVVTKSRP-----VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLR------GIAS 117
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY------ICSR 303
+ YL + V HRD+ +N+LVN + K+ DFG ++ L + +Y I R
Sbjct: 118 GMKYLSEMNYV-HRDLAARNILVNSNL-VCKVSDFGLSRRL--EDSEATYTTKGGKIPIR 173
Query: 304 YYRAPELIFGATEYTTAIDMWSIGCVLAELL 334
+ APE I ++T+A D+WS G V+ E++
Sbjct: 174 W-TAPEAI-AYRKFTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 9e-10
Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 38/220 (17%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKK-----VLQDKRYKNRELQIMRLLNHPNVVSLKH 197
+G G+FG V++ L+ VA+K KR +E +I++ +HPN+V L
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL-- 57
Query: 198 CFFSTTEKDELYLNLVLEYISE----TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+K +Y+ V+E + T R K+ + + + + + + Y
Sbjct: 58 -IGVCVQKQPIYI--VMELVPGGSLLTFLRKKKNRLTVKKLLQM------SLDAAAGMEY 108
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR------- 306
L + HRD+ +N LV + LKI DFG ++ E Y S +
Sbjct: 109 LESKNCI-HRDLAARNCLVG-ENNVLKISDFGMSRE----EEGGIYTVSDGLKQIPIKWT 162
Query: 307 APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGES 344
APE L +G YT+ D+WS G +L E LG +PG S
Sbjct: 163 APEALNYG--RYTSESDVWSYGILLWETFSLGDTPYPGMS 200
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 53/201 (26%), Positives = 95/201 (47%), Gaps = 30/201 (14%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHCFFS 201
+G+G FGVV K D VAIK + + ++ E ++M L+HPN+V L +
Sbjct: 12 LGSGQFGVVHLGKWRGKID-VAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQL---YGV 67
Query: 202 TTEKDELYLNLVLEYISE----TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
T++ +++ V EY++ R K +L + +C A+ YL
Sbjct: 68 CTKQRPIFI--VTEYMANGCLLNYLRERKGKLGTEW---LLDMCS---DVCEAMEYLESN 119
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR-----APELIF 312
G HRD+ +N LV + +K+ DFG A+ ++ + Y S+ + AP +F
Sbjct: 120 -GFIHRDLAARNCLVG-EDNVVKVSDFGLARYVLDDQ----YTSSQGTKFPVKWAPPEVF 173
Query: 313 GATEYTTAIDMWSIGCVLAEL 333
+ +++ D+WS G ++ E+
Sbjct: 174 DYSRFSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 33/209 (15%)
Query: 143 RVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYK-NREL----QIMRLLNHPNVV 193
+V+G+G+FG V++ + G+ VAIK++ + K N+E+ +M +++P+V
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 194 SLKH-CFFSTTE--KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
L C ST + + +L+Y+ E + Y +N + QI +
Sbjct: 73 RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-LN----------WCVQIAKG 121
Query: 251 LNYLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY---Y 305
+NYL +V HRD+ +N+LV H +KI DFG AK+L E + +
Sbjct: 122 MNYLEERRLV---HRDLAARNVLVKTPQH-VKITDFGLAKLLGADEKEYHAEGGKVPIKW 177
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELL 334
A E I YT D+WS G + EL+
Sbjct: 178 MALESILHRI-YTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 1e-09
Identities = 60/209 (28%), Positives = 108/209 (51%), Gaps = 21/209 (10%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIK--KVLQDKRYK-NRELQIMRLLN-HPNVVSLKHCF 199
+VG G++G V++ + ++TG AIK V D+ + +E+ +++ + H N+ + F
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 200 FSTTE---KDELYLNLVLEYI-SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
D+L+ LV+E+ + +V + K+ T+ N + ++ +I R L++LH
Sbjct: 73 IKKNPPGMDDQLW--LVMEFCGAGSVTDLIKN-TKGNT-LKEEWIAYICREILRGLSHLH 128
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML--VPGEPNISYICSRYYRAPELIF- 312
V HRDIK QN+L+ + ++K+ DFG + L G N ++I + Y+ APE+I
Sbjct: 129 Q-HKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIAC 185
Query: 313 ---GATEYTTAIDMWSIGCVLAELLLGQP 338
Y D+WS+G E+ G P
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 58/238 (24%), Positives = 104/238 (43%), Gaps = 49/238 (20%)
Query: 143 RVVGTGSFGVVFQAKCLETG-----DSVAIKKVLQDK-----RYKNRELQIMRLLNHPNV 192
+ +G G FG V +A +VA+K + ++ R E +++ +NHP+V
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL---------- 242
+ L + + ++ L L ++EY Y + + R ++ V Y+
Sbjct: 66 IKL---YGACSQDGPLLL--IVEYAK---YGSLRSFLRESRKVGPSYLGSDGNRNSSYLD 117
Query: 243 --------------YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288
+ +QI R + YL + V HRD+ +N+LV ++KI DFG ++
Sbjct: 118 NPDERALTMGDLISFAWQISRGMQYLAEMKLV-HRDLAARNVLV-AEGRKMKISDFGLSR 175
Query: 289 MLVPGEPNISYICSRY---YRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPG 342
+ + + R + A E +F YTT D+WS G +L E++ LG +PG
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 54/203 (26%), Positives = 83/203 (40%), Gaps = 38/203 (18%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR---ELQIMRLLNHPNVVSLKHCFFS 201
+G G FG V G VA+K + D E +M L HPN+V L
Sbjct: 14 IGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL- 70
Query: 202 TTEKDELYLNLVLEYISETVY------RVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+ + LY+ V EY+++ R T Q + +C + YL
Sbjct: 71 --QGNPLYI--VTEYMAKGSLVDYLRSRGRAVITLAQQL-------GFALDVCEGMEYLE 119
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQL--KICDFGSAKMLVPGEPNISYICSRY---YRAPEL 310
V HRD+ +N+LV + L K+ DFG AK E + + + APE
Sbjct: 120 EKNFV-HRDLAARNVLV---SEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEA 170
Query: 311 IFGATEYTTAIDMWSIGCVLAEL 333
+ +++T D+WS G +L E+
Sbjct: 171 L-REKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 14/205 (6%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ----IMRLL-NHPNVVSLKHCF 199
+G G++G V++ + G S+A K+L + E++ I++ L NHPNVV F
Sbjct: 30 IGKGTYGKVYKVTNKKDG-SLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 200 FSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
+ + L LVLE + +V + K Q + + Y L +LH+
Sbjct: 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN-N 147
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYRAPELIFGATEY 317
+ HRD+K N+L+ +K+ DFG SA++ + + + ++ APE+I +Y
Sbjct: 148 RIIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQY 206
Query: 318 TTA----IDMWSIGCVLAELLLGQP 338
+ D+WS+G EL G P
Sbjct: 207 DYSYDARCDVWSLGITAIELGDGDP 231
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 3e-09
Identities = 51/196 (26%), Positives = 83/196 (42%), Gaps = 45/196 (22%)
Query: 234 HVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293
++P V+ + ++ AL+ LH VC RD+ P N+L++ H +++ F +
Sbjct: 81 NIPEECVKRWAAEMVVALDALHREGIVC-RDLNPNNILLDDRGH-IQLTYFSRWSEVEDS 138
Query: 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGE-SGVDQLVEI 352
+ Y APE + G +E T A D WS+G +L ELL G+ L SG++
Sbjct: 139 CDGEA--VENMYCAPE-VGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINT---- 191
Query: 353 IKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC 412
+T P+ + EA L+ +LLQ++P+ R
Sbjct: 192 ------------------HTTLNIPEW------------VSEEARSLLQQLLQFNPTERL 221
Query: 413 TALEAC-----AHPFF 423
A A +HPFF
Sbjct: 222 GAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 34/216 (15%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR----ELQIMRLLNHPNVVSLKH 197
ER +G+G FG V++ VAIK + D K + E+Q ++ L H +++SL
Sbjct: 11 ERKLGSGYFGEVWEGLWKNR-VRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL-- 67
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVS-KHYTRM--NQHVPILYVQLYTYQICRALNYL 254
F + + +Y+ I+E + + S + R Q +P+ + Q+ + YL
Sbjct: 68 -FAVCSVGEPVYI------ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL 120
Query: 255 --HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-----VPGEPNISYICSRYYRA 307
+ + HRD+ +N+LV K+ DFG A+++ + + I Y + A
Sbjct: 121 EEQNSI---HRDLAARNILVGEDL-VCKVADFGLARLIKEDVYLSSDKKIPY----KWTA 172
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPG 342
PE ++T D+WS G +L E+ GQ +PG
Sbjct: 173 PEAA-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPG 207
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 60/244 (24%), Positives = 106/244 (43%), Gaps = 52/244 (21%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMR----LLNHPNVVSLKHC 198
+V+G G+FG V + +TG A+K + + + ++ +R +L + + +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66
Query: 199 FFSTTEKDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
F+S +K LYL ++E++ + + + K T + Q Y + A++ +H
Sbjct: 67 FYSFQDKLNLYL--IMEFLPGGDMMTLLMKKDTLTEEET-----QFYIAETVLAIDSIHQ 119
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML---------------VPGEPNISYIC 301
+ G HRDIKP NLL++ H +K+ DFG L +P + +
Sbjct: 120 L-GFIHRDIKPDNLLLDSKGH-VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177
Query: 302 SRY---------------------YRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLF 340
S+ Y APE +F T Y D WS+G ++ E+L+G P F
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 341 PGES 344
E+
Sbjct: 237 CSET 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 60/210 (28%), Positives = 88/210 (41%), Gaps = 42/210 (20%)
Query: 160 ETGDSVAIKKVLQD--------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211
TG VAIK + D R++ RE + L HPN+V+L + E L
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFR-RETALCARLYHPNIVAL----LDSGEAPPGLLF 55
Query: 212 LVLEYIS-ETVYRVSKHYTRMNQHV--PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQ 268
V EY+ T+ V +L Q+ AL H+ G+ HRD+KPQ
Sbjct: 56 AVFEYVPGRTLREVLA-----ADGALPAGETGRLML-QVLDALACAHNQ-GIVHRDLKPQ 108
Query: 269 NLLVN-----PHTHQLKICDFGSAKMLVPGEPNI---------SYICSRYYRAPELIFGA 314
N++V+ PH K+ DFG +L PG + + + Y APE + G
Sbjct: 109 NIMVSQTGVRPHA---KVLDFGIGTLL-PGVRDADVATLTRTTEVLGTPTYCAPEQLRGE 164
Query: 315 TEYTTAIDMWSIGCVLAELLLGQPLFPGES 344
T D+++ G + E L GQ + G S
Sbjct: 165 PV-TPNSDLYAWGLIFLECLTGQRVVQGAS 193
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 70/303 (23%), Positives = 127/303 (41%), Gaps = 54/303 (17%)
Query: 148 GSFGVVFQAKCLETGDSV---AIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTE 204
GS G VF C + GD I K + + RE+ I++ ++H +++L H +
Sbjct: 103 GSEGEVFV--CTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAY----- 155
Query: 205 KDELYLNLVLEYISETVYRVSKH--YTRMNQHVPILYVQLYTYQ--ICRALNYLHHVVGV 260
+ + V V K +T +++ P+ Q T Q + AL YLH G+
Sbjct: 156 ---RWKSTVC-----MVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR-GI 206
Query: 261 CHRDIKPQNLLVNPHTHQLKICDFGSAKMLV--PGEPN-ISYICSRYYRAPELIFGATEY 317
HRD+K +N+ ++ + + + DFG+A L P P + + +PEL+ Y
Sbjct: 207 IHRDVKTENIFLDEPENAV-LGDFGAACKLDAHPDTPQCYGWSGTLETNSPELL-ALDPY 264
Query: 318 TTAIDMWSIGCVLAELLLGQ-PLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEF-- 374
D+WS G VL E+ + LF + +K + R I+CM + EF
Sbjct: 265 CAKTDIWSAGLVLFEMSVKNVTLFGKQ---------VKSSSSQLRSIIRCMQVHPLEFPQ 315
Query: 375 -----------KFPQIKAHPWH--KIFHKRMPPEALD-LVSRLLQYSPSLRCTALEACAH 420
++ + P+ + K ++ L++++L + R +A + +
Sbjct: 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375
Query: 421 PFF 423
P F
Sbjct: 376 PLF 378
|
Length = 392 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 5e-09
Identities = 72/281 (25%), Positives = 122/281 (43%), Gaps = 41/281 (14%)
Query: 143 RVVGTGSFGVVFQAKCLETGDS---VAIKKV-----LQDKRYKNRELQIMRLLNHPNVVS 194
RV+G G FG V+ +++ A+K + L++ +E IM+ +HPNV+S
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL-YTYQICRALNY 253
L E +VL Y+ R ++ R H P + + + Q+ + + Y
Sbjct: 61 L----LGICLPSEGSPLVVLPYMKHGDLR---NFIRSETHNPTVKDLIGFGLQVAKGMEY 113
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPEL--I 311
L V HRD+ +N +++ + +K+ DFG A+ + E Y + +L
Sbjct: 114 LASKKFV-HRDLAARNCMLD-ESFTVKVADFGLARDIYDKE----YYSVHNHTGAKLPVK 167
Query: 312 FGATE------YTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEI 364
+ A E +TT D+WS G +L EL+ G P +P D V +++ G +
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ--GRRLLQPE 225
Query: 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQ 405
C +P Y ++ WH R P +LVSR+ Q
Sbjct: 226 YCPDPLY------EVMLSCWHPKPEMR--PTFSELVSRIEQ 258
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 60/244 (24%), Positives = 105/244 (43%), Gaps = 52/244 (21%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMR----LLNHPNVVSLKHC 198
+V+G G+FG V + +TG A+K + + + ++ +R +L + +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66
Query: 199 FFSTTEKDELYLNLVLEYI--SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
F+S +K LYL ++E++ + + + K T + Q Y + A++ +H
Sbjct: 67 FYSFQDKRNLYL--IMEFLPGGDMMTLLMKKDTLSEEAT-----QFYIAETVLAIDAIHQ 119
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSA------------KMLVPGEPN-------- 296
+ G HRDIKP NLL++ H +K+ DFG + L P+
Sbjct: 120 L-GFIHRDIKPDNLLLDAKGH-VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 297 ----------------ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLF 340
S + + Y APE +F T Y D WS+G ++ E+L+G P F
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 341 PGES 344
E+
Sbjct: 237 CSET 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 6e-09
Identities = 74/282 (26%), Positives = 123/282 (43%), Gaps = 56/282 (19%)
Query: 145 VGTGSFGVVFQAKCL-------ETGDSVAIKKVLQDKRYKN-----RELQIMRLL-NHPN 191
+G G FG V A+ L + +VA+K + D K+ E+++M+++ H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYR------------VSKHYTRMNQHVPILY 239
+++L + T+ LY+ ++EY S+ R S R+ + +
Sbjct: 83 IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYSYDIARVPDE-QMTF 136
Query: 240 VQLY--TYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI 297
L TYQ+ R + YL + HRD+ +N+LV + +KI DFG A+ + NI
Sbjct: 137 KDLVSCTYQVARGMEYLASQKCI-HRDLAARNVLVT-ENNVMKIADFGLARDV----NNI 190
Query: 298 SYICSRY-------YRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQL 349
Y + APE +F YT D+WS G ++ E+ LG +PG V++L
Sbjct: 191 DYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEEL 248
Query: 350 VEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKR 391
+++K G + C N Y + WH I R
Sbjct: 249 FKLLK-EGHRMDKPANCTNELYMMMR------DCWHAIPSHR 283
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 7e-09
Identities = 55/217 (25%), Positives = 101/217 (46%), Gaps = 14/217 (6%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ----IMRLL- 187
P + ++ +G G++G VF+ + G A+K +L + E++ I++ L
Sbjct: 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALS 72
Query: 188 NHPNVVSLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
+HPNVV ++ K+ L LVLE + +V + K + + + + + ++
Sbjct: 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYY 305
L +L HV HRD+K N+L+ +K+ DFG SA++ + + + ++
Sbjct: 133 ALMGLQHL-HVNKTIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFW 190
Query: 306 RAPELIFGA----TEYTTAIDMWSIGCVLAELLLGQP 338
APE+I + Y D+WS+G EL G P
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 9e-09
Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 142 ERVVGTGSFGVVFQAKCLETGD---SVAIKKV---LQDKRYKN--RELQIMRLLNHPNVV 193
E+V+G G FG V + G VAIK + +K+ ++ E IM +HPN++
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
L+ T K + +V EY+ + + + ++ + I + Y
Sbjct: 69 HLEGVV--TKSKPVM---IVTEYMENG--SLDAFLRKHDGQFTVIQLVGMLRGIASGMKY 121
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR-----YYRAP 308
L + G HRD+ +N+LVN + K+ DFG +++L +P +Y + AP
Sbjct: 122 LSDM-GYVHRDLAARNILVNSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTAP 178
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELL 334
E I ++T+A D+WS G V+ E++
Sbjct: 179 EAI-AYRKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 28/209 (13%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS---VAIKKVLQDKRYKNR-----ELQIMRLLNHPNVV 193
E V+G G FG V + + G VAIK + K R E IM +HPN++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMN--QHVPILYVQLYTYQICRAL 251
L+ + + ++ E++ + R N Q I V + I +
Sbjct: 69 HLEGVVTKSRP-----VMIITEFMENGAL---DSFLRQNDGQFTVIQLVGMLR-GIAAGM 119
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR------YY 305
YL + V HRD+ +N+LVN + K+ DFG ++ L + +Y S +
Sbjct: 120 KYLSEMNYV-HRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW 177
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELL 334
APE I ++T+A D+WS G V+ E++
Sbjct: 178 TAPEAI-AYRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 54/211 (25%), Positives = 104/211 (49%), Gaps = 29/211 (13%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSL------ 195
+G G +G V++ + +VA+K + +D +E +M+ + HPN+V L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+ F+ TE Y NL L+Y+ E + +N ++ + + T QI A+ YL
Sbjct: 74 EPPFYIITEF-MTYGNL-LDYLREC------NRQEVN---AVVLLYMAT-QISSAMEYLE 121
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY---YRAPELIF 312
HRD+ +N LV + H +K+ DFG +++ + G+ ++ +++ + APE +
Sbjct: 122 K-KNFIHRDLAARNCLVGEN-HLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESL- 177
Query: 313 GATEYTTAIDMWSIGCVLAEL-LLGQPLFPG 342
+++ D+W+ G +L E+ G +PG
Sbjct: 178 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 16/165 (9%)
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICS 302
Y++Q+ + + +L + HRD+ +N+L++ + +KICDFG A+ + + +
Sbjct: 184 YSFQVAKGMEFLASRKCI-HRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDA 241
Query: 303 RY---YRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGT 358
R + APE IF YT D+WS G +L E+ LG +PG V+I +
Sbjct: 242 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCR 293
Query: 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRL 403
+E + P+YT + Q WH +R P +LV L
Sbjct: 294 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR--PTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 55/227 (24%), Positives = 101/227 (44%), Gaps = 38/227 (16%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHCF 199
R +G G FG V++ T VA+K + E QIM+ L HP ++ L +
Sbjct: 12 RKLGAGQFGEVWEGLWNNT-TPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQL---Y 67
Query: 200 FSTTEKDELYL-------NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
T ++ +Y+ +LEY+ R K + Q + + Q+ +
Sbjct: 68 AVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALK----LPQLIDM------AAQVASGMA 117
Query: 253 YL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY---YRA 307
YL + + HRD+ +N+LV + + K+ DFG A+++ + +++ + A
Sbjct: 118 YLEAQNYI---HRDLAARNVLVGEN-NICKVADFGLARVIKEDIYE-AREGAKFPIKWTA 172
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESG--VDQLVE 351
PE ++ D+WS G +L E++ G+ +PG + V Q V+
Sbjct: 173 PEAAL-YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD 218
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 5e-08
Identities = 70/242 (28%), Positives = 96/242 (39%), Gaps = 60/242 (24%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKV-----LQDKRYKNRELQ 182
P+ I Y R +G G+FG VFQA+ E VA+K + + RE
Sbjct: 3 PRNNIEY--VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60
Query: 183 IMRLLNHPNVVSL--------KHC--FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMN 232
+M +HPN+V L C F D LN L + S H T
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGD---LNEFLRHRSPRAQCSLSHSTSSA 117
Query: 233 QHVPILYVQLY-TYQICRALN------YL--HHVVGVCHRDIKPQNLLVNPHTHQLKICD 283
+ + + L T Q+C A YL V HRD+ +N LV + +KI D
Sbjct: 118 RKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV---HRDLATRNCLVGENM-VVKIAD 173
Query: 284 FGSAKMLVPGEPNISYICSRYYRA------------PELIFGATEYTTAIDMWSIGCVLA 331
FG ++ NI + YY+A PE IF YTT D+W+ G VL
Sbjct: 174 FGLSR-------NI--YSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLW 223
Query: 332 EL 333
E+
Sbjct: 224 EI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 51/202 (25%), Positives = 96/202 (47%), Gaps = 22/202 (10%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYK----NRELQIMRLLNHPNVVSLKHCF 199
+G GSFG V++ T + VAIK + L++ + +E+ ++ + P + +
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPI--LYVQLYTYQICRALNYLHHV 257
T+ L +++EY+ + + P+ Y+ +I + L+YLH
Sbjct: 72 LKGTK-----LWIIMEYLG------GGSALDLLKPGPLEETYIATILREILKGLDYLHSE 120
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE-PNISYICSRYYRAPELIFGATE 316
+ HRDIK N+L++ +K+ DFG A L + +++ + ++ APE+I +
Sbjct: 121 RKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSA 177
Query: 317 YTTAIDMWSIGCVLAELLLGQP 338
Y D+WS+G EL G+P
Sbjct: 178 YDFKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 44/168 (26%), Positives = 78/168 (46%), Gaps = 15/168 (8%)
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICS 302
Y++Q+ R + +L + HRD+ +N+L++ + +KICDFG A+ + + +
Sbjct: 179 YSFQVARGMEFLASRKCI-HRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGSA 236
Query: 303 RY---YRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGT 358
R + APE IF YTT D+WS G +L E+ LG +PG V+I +
Sbjct: 237 RLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQINEEFCQ 288
Query: 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMP-PEALDLVSRLLQ 405
++ + P + +I W +R ++++ LLQ
Sbjct: 289 RLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 37/104 (35%), Positives = 55/104 (52%), Gaps = 7/104 (6%)
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS---Y 299
+TYQ+ R + +L V HRD+ +N+L+ +KICDFG A+ ++ +S
Sbjct: 242 FTYQVARGMEFLASKNCV-HRDLAARNVLLA-QGKIVKICDFGLARDIMHDSNYVSKGST 299
Query: 300 ICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPG 342
+ APE IF YTT D+WS G +L E+ LG +PG
Sbjct: 300 FLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 9e-08
Identities = 66/249 (26%), Positives = 110/249 (44%), Gaps = 57/249 (22%)
Query: 145 VGTGSFGVVFQAKCLETGDS-------VAIKKVLQDKRYKN-----RELQIMRLL-NHPN 191
+G G FG V A+ + VA+K + D K+ E+++M+++ H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYR--------VSKHYTRMNQHVPILYVQLY 243
+++L + T+ LY+ ++EY S+ R Y VP +
Sbjct: 86 IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 244 -----TYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS 298
YQ+ R + YL + HRD+ +N+LV + +KI DFG A+ +I
Sbjct: 141 DLVSCAYQVARGMEYLASKKCI-HRDLAARNVLVT-EDNVMKIADFGLAR-------DIH 191
Query: 299 YICSRYYR------------APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESG 345
+I YY+ APE +F YT D+WS G +L E+ LG +PG
Sbjct: 192 HI--DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVP- 247
Query: 346 VDQLVEIIK 354
V++L +++K
Sbjct: 248 VEELFKLLK 256
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 9e-08
Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 28/208 (13%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS---VAIKKVLQDKRYKNR-----ELQIMRLLNHPNVV 193
++V+G G FG VF+ G VAIK + K R E IM +H N++
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMN--QHVPILYVQLYTYQICRAL 251
L+ T K + ++ EY+ Y R + + V + I +
Sbjct: 70 RLEGVV--TKFKPAM---IITEYMENGAL---DKYLRDHDGEFSSYQLVGMLR-GIAAGM 120
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR-----YYR 306
YL + V HRD+ +N+LVN + K+ DFG +++L +P +Y S +
Sbjct: 121 KYLSDMNYV-HRDLAARNILVN-SNLECKVSDFGLSRVL-EDDPEGTYTTSGGKIPIRWT 177
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELL 334
APE I ++T+A D+WS G V+ E++
Sbjct: 178 APEAI-AYRKFTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 51/199 (25%), Positives = 95/199 (47%), Gaps = 26/199 (13%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHCFFS 201
+GTG FGVV K D VAIK + + ++ E ++M L+H +V L +
Sbjct: 12 LGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQL---YGV 67
Query: 202 TTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRALNYL--HHV 257
T++ +Y +V EY+S +Y R + QL +C + YL
Sbjct: 68 CTKQRPIY--IVTEYMSNGCLL---NYLREHGKRFQP-SQLLEMCKDVCEGMAYLESKQF 121
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY---YRAPELIFGA 314
+ HRD+ +N LV+ +K+ DFG ++ ++ E S + S++ + PE +
Sbjct: 122 I---HRDLAARNCLVDDQG-CVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPE-VLLY 175
Query: 315 TEYTTAIDMWSIGCVLAEL 333
+++++ D+W+ G ++ E+
Sbjct: 176 SKFSSKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 77/349 (22%), Positives = 135/349 (38%), Gaps = 89/349 (25%)
Query: 144 VVGTG--SFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSL 195
V+G G V A+ TG+ V ++++ + + EL + +L NHPN+V
Sbjct: 5 VIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPY 64
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+ F + E L +V +++ + + H+ + I Y+ + +AL+Y
Sbjct: 65 RATFIADNE-----LWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQ---GVLKALDY 116
Query: 254 LHHVVGVCHRDIKPQNLLVN-----------------PHTHQLKIC-DFG--SAKMLVPG 293
+HH +G HR +K ++L++ H +L++ DF S K+L
Sbjct: 117 IHH-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVL--- 172
Query: 294 EPNISYICSRYYRAPELIFGATE-YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEI 352
P +S PE++ + Y D++S+G EL G F L+E
Sbjct: 173 -PWLS---------PEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE- 221
Query: 353 IKILGT------------------PTR--------EEIKCMNPNYTEFKFPQIKAHPWHK 386
K+ GT P+R E P + + +HP+++
Sbjct: 222 -KLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSN---GESSSHPYNR 277
Query: 387 IFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL-RDPNTCLP 434
F P V + LQ +P R +A H FF + R + LP
Sbjct: 278 TF----SPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALP 322
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 55/219 (25%), Positives = 85/219 (38%), Gaps = 67/219 (30%)
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY- 304
QI AL+ LH G+ HRD+KPQN++ + + KI D G+A L G I+YI +
Sbjct: 263 QILFALDGLHST-GIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVG---INYIPKEFL 318
Query: 305 ----YRAPELIFGATEYTTA---------------------IDMWSIGCVLAELLLGQPL 339
Y APE +T+ +A D++S G L+ Q
Sbjct: 319 LDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG-----LIFLQMA 373
Query: 340 FPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPP----- 394
FP L++ ++K + + W K+ R P
Sbjct: 374 FPNLRSDSNLIQF--------NRQLKRNDYDLVA----------WRKLVEPRASPDLRRG 415
Query: 395 -EALD--------LVSRLLQYSPSLRCTALEACAHPFFD 424
E LD L+ ++++ R +A A AHP+FD
Sbjct: 416 FEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFD 454
|
Length = 566 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 60/240 (25%), Positives = 104/240 (43%), Gaps = 43/240 (17%)
Query: 145 VGTGSFGVVFQA--KCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLK 196
+G+G+FG V + K ++ +VA+K + D K RE +M+ L++P +V +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM- 61
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
E + L + L + + + N+HV + +Q+ + YL
Sbjct: 62 ---IGICEAESWMLVMELAELGPL-----NKFLQKNKHVTEKNITELVHQVSMGMKYLEE 113
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR---------- 306
V HRD+ +N+L+ H KI DFG +K L E YY+
Sbjct: 114 TNFV-HRDLAARNVLLVTQ-HYAKISDFGLSKALGADE--------NYYKAKTHGKWPVK 163
Query: 307 --APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESG--VDQLVEIIKILGTPTR 361
APE + ++++ D+WS G ++ E GQ + G G V Q++E + + P R
Sbjct: 164 WYAPECM-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQR 222
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 29/207 (14%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK---KVLQDKRY--KNREL----QIMRLLNHPNVV 193
+V+G+G+FG V++ + G++V I KVL++ N+E+ +M + P V
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 194 SLKH-CFFSTTE--KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
L C ST + + +L+Y+ E R+ +N + QI +
Sbjct: 73 RLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDL-LN----------WCVQIAKG 121
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY---YRA 307
++YL V V HRD+ +N+LV H +KI DFG A++L E + + A
Sbjct: 122 MSYLEEVRLV-HRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADGGKVPIKWMA 179
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELL 334
E I +T D+WS G + EL+
Sbjct: 180 LESIL-HRRFTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 5e-07
Identities = 60/232 (25%), Positives = 105/232 (45%), Gaps = 54/232 (23%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNR---ELQIMRLLNHPNVVSL 195
R++G G G V+ A VA+KK+ +D K R E +I L HP +V +
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 196 KHCFFSTTEKDELYLNL------VLEYISETVYR---VSKHY---TRMNQHVPILYVQLY 243
+ ++ D +Y + L+ + ++V++ +SK T + + I +
Sbjct: 68 ---YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH---- 120
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM----------LVPG 293
+IC + Y+H GV HRD+KP N+L+ + I D+G+A +
Sbjct: 121 --KICATIEYVHSK-GVLHRDLKPDNILLGLFGEVV-ILDWGAAIFKKLEEEDLLDIDVD 176
Query: 294 EPNISY---------ICSRYYRAPELIFG--ATEYTTAIDMWSIGCVLAELL 334
E NI Y + + Y APE + G A+E T D++++G +L ++L
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASEST---DIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 5e-07
Identities = 52/199 (26%), Positives = 97/199 (48%), Gaps = 26/199 (13%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKNRELQIMRLLNHPNVVSLKHCFF 200
+G+G FG+V+ LE VAIK + + ++ + E Q+M L+HP +V L +
Sbjct: 12 IGSGQFGLVWLGYWLEK-RKVAIKTIREGAMSEEDFI-EEAQVMMKLSHPKLVQL---YG 66
Query: 201 STTEKDELYLNLVLEYISE---TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
TE+ + L V E++ + Y ++ + +L + L +C + YL
Sbjct: 67 VCTERSPICL--VFEFMEHGCLSDYLRAQRGKFSQE--TLLGMCL---DVCEGMAYLESS 119
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY---YRAPELIFGA 314
V HRD+ +N LV +K+ DFG + V + S +++ + +PE +F
Sbjct: 120 -NVIHRDLAARNCLVG-ENQVVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPE-VFSF 175
Query: 315 TEYTTAIDMWSIGCVLAEL 333
++Y++ D+WS G ++ E+
Sbjct: 176 SKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 6e-07
Identities = 52/223 (23%), Positives = 90/223 (40%), Gaps = 47/223 (21%)
Query: 144 VVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKNRELQIMRLL---------NHP 190
++ G+FG +F ++ V +K V E+Q+ LL +H
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS----EIQVTLLLQESCLLYGLSHQ 68
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYT------ 244
N++ + H E + + K + + + Q +
Sbjct: 69 NILPILHVCIEDGEPPFVLYPY-------MNWGNLKLFLQQCRLGEANNPQALSTQQLVH 121
Query: 245 --YQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC- 301
QI ++YLH GV H+DI +N +++ Q+KI D ++ L P + Y C
Sbjct: 122 MAIQIACGMSYLHKR-GVIHKDIAARNCVID-EELQVKITDNALSRDLFPMD----YHCL 175
Query: 302 ----SRYYR--APELIFGATEYTTAIDMWSIGCVLAELL-LGQ 337
+R + A E + EY++A D+WS G +L EL+ LGQ
Sbjct: 176 GDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQ 217
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 49/168 (29%), Positives = 76/168 (45%), Gaps = 22/168 (13%)
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICS 302
Y++Q+ R + +L + HRD+ +N+L++ + +KICDFG A+ + + Y+
Sbjct: 178 YSFQVARGMEFLASRKCI-HRDLAARNILLS-ENNVVKICDFGLARDIYK---DPDYVRK 232
Query: 303 RYYR------APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKI 355
R APE IF YTT D+WS G +L E+ LG +PG V+I +
Sbjct: 233 GDARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQIDEE 284
Query: 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRL 403
+E + P Y + I WH R P +LV L
Sbjct: 285 FCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDR--PTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 49/190 (25%), Positives = 78/190 (41%), Gaps = 42/190 (22%)
Query: 166 AIKKVLQDKRYKNRELQIMRLLNHPNVVSL-------KHCFFSTTEKDELY-LNLVL-EY 216
A +D +E++I+ L+ PN+ L E E LN L ++
Sbjct: 58 ASDNAREDFL---KEVKILSRLSDPNIARLLGVCTVDPPLCM-IMEYMENGDLNQFLQKH 113
Query: 217 ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT 276
++ET ++ +LY+ QI + YL + V HRD+ +N LV
Sbjct: 114 VAETSG--LACNSKSLSFSTLLYMAT---QIASGMRYLESLNFV-HRDLATRNCLVGK-N 166
Query: 277 HQLKICDFGSAKMLVPGEPNISYICSRYY----RAP--------ELIFGATEYTTAIDMW 324
+ +KI DFG ++ L Y YY RAP E + ++TT D+W
Sbjct: 167 YTIKIADFGMSRNL--------YSSD-YYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVW 216
Query: 325 SIGCVLAELL 334
+ G L E+L
Sbjct: 217 AFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 53/201 (26%), Positives = 93/201 (46%), Gaps = 17/201 (8%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLNHPNVVSLKHCFFS 201
++G G FG V Q + TG VA+K + D + E +M L+H N+V L
Sbjct: 13 IIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 202 TTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVC 261
L +V+E +S+ V+ TR V ++ + ++ + + YL +
Sbjct: 71 NG------LYIVMELMSKGNL-VNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK-KLV 122
Query: 262 HRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAI 321
HRD+ +N+LV+ K+ DFG A++ G N + APE + ++++
Sbjct: 123 HRDLAARNILVS-EDGVAKVSDFGLARVGSMGVDNSKLPVK--WTAPEAL-KHKKFSSKS 178
Query: 322 DMWSIGCVLAELL-LGQPLFP 341
D+WS G +L E+ G+ +P
Sbjct: 179 DVWSYGVLLWEVFSYGRAPYP 199
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 31/213 (14%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK---KVLQDKRYKNRELQ------IMRLLNHPNVV 193
+V+G+G+FG V++ + G++V I K+L + ++ IM ++HP++V
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 194 SLKHCFFSTTEKDELYL---NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
L S T + L +L+Y+ E H + + + + QI +
Sbjct: 73 RLLGVCLSPTIQLVTQLMPHGCLLDYVHE-------HKDNIGSQLLLNWC----VQIAKG 121
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY---YRA 307
+ YL + HRD+ +N+LV H +KI DFG A++L E + + + A
Sbjct: 122 MMYLEE-RRLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMA 179
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLL--GQP 338
E I ++T D+WS G + EL+ G+P
Sbjct: 180 LECIH-YRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 48/162 (29%), Positives = 81/162 (50%), Gaps = 21/162 (12%)
Query: 148 GSFGVVFQAKCLETGDSVAIKKVLQ-DKRYKNRELQI------MRLLNHPNVVSLKHCFF 200
G+FG V+ + A+K V + D KN Q+ + L P +V L ++
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHL---YY 71
Query: 201 STTEKDELYLNLVLEY-ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HVV 258
S + +YL V+EY I V + Y ++ + + Y+ ++ AL+YLH H
Sbjct: 72 SLQSANNVYL--VMEYLIGGDVKSLLHIYGYFDEEMAVKYIS----EVALALDYLHRH-- 123
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYI 300
G+ HRD+KP N+L++ H +K+ DFG +K+ + E N+ I
Sbjct: 124 GIIHRDLKPDNMLISNEGH-IKLTDFGLSKVTLNRELNMMDI 164
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 33/107 (30%), Positives = 54/107 (50%), Gaps = 13/107 (12%)
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICS 302
++ Q+ + +++L HRD+ +N+L+ KICDFG A+ + + +Y+
Sbjct: 217 FSSQVAQGMDFLA-SKNCIHRDVAARNVLLT-DGRVAKICDFGLARDI---MNDSNYVVK 271
Query: 303 RYYR------APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPG 342
R APE IF YT D+WS G +L E+ LG+ +PG
Sbjct: 272 GNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 81/319 (25%), Positives = 130/319 (40%), Gaps = 77/319 (24%)
Query: 145 VGTGSFGVVFQAKCL-------ETGDSVAIKKVLQDKRYKN-----RELQIMRLL-NHPN 191
+G G FG V A+ + +VA+K + D K+ E+++M+++ H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYV---------QL 242
+++L + T+ LY+ ++EY S+ R Y R + + Y QL
Sbjct: 80 IINL---LGACTQDGPLYV--LVEYASKGNLR---EYLRARRPPGMDYSFDTCKLPEEQL 131
Query: 243 Y-------TYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295
YQ+ R + YL + HRD+ +N+LV + +KI DFG A+ +
Sbjct: 132 TFKDLVSCAYQVARGMEYLASQKCI-HRDLAARNVLVT-EDNVMKIADFGLARDV----H 185
Query: 296 NISYICSRY-------YRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD 347
NI Y + APE +F YT D+WS G +L E+ LG +PG V+
Sbjct: 186 NIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIP-VE 243
Query: 348 QLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKR---------------- 391
+L +++K E + P + I WH + +R
Sbjct: 244 ELFKLLK-------EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296
Query: 392 -MPPEALDLVSRLLQYSPS 409
E LDL QYSP
Sbjct: 297 TSTDEYLDLSVPFEQYSPG 315
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 35/107 (32%), Positives = 55/107 (51%), Gaps = 13/107 (12%)
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICS 302
++YQ+ + +++L HRD+ +N+L+ H KICDFG A+ + + +Y+
Sbjct: 219 FSYQVAKGMSFLASK-NCIHRDLAARNILLT-HGRITKICDFGLARDI---RNDSNYVVK 273
Query: 303 RYYR------APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPG 342
R APE IF YT D+WS G +L E+ LG +PG
Sbjct: 274 GNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPG 319
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 4e-06
Identities = 77/316 (24%), Positives = 135/316 (42%), Gaps = 72/316 (22%)
Query: 145 VGTGSFGVVFQAKCL-------ETGDSVAIKKVLQDKRYKN-----RELQIMRLLN-HPN 191
+G G FG V +A+ + +VA+K + + K+ E+++M+L+ H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYR------------VSKHYTRMNQHVPILY 239
+++L T++ LY+ ++EY ++ R + T++ + + +
Sbjct: 80 IINL---LGVCTQEGPLYV--IVEYAAKGNLREFLRARRPPGPDYTFDITKVPEE-QLSF 133
Query: 240 VQLYT--YQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI 297
L + YQ+ R + YL + HRD+ +N+LV + +KI DFG A+ G +I
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCI-HRDLAARNVLVT-EDNVMKIADFGLAR----GVHDI 187
Query: 298 SYICSRY-------YRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQL 349
Y + APE +F YT D+WS G ++ E+ LG +PG +
Sbjct: 188 DYYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGIP----V 242
Query: 350 VEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKR----------------MP 393
E+ K+L RE + P+ + + WH + +R +
Sbjct: 243 EELFKLL----REGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS 298
Query: 394 PEALDLVSRLLQYSPS 409
E LDL QYSPS
Sbjct: 299 EEYLDLSMPFEQYSPS 314
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 5e-06
Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 32/206 (15%)
Query: 145 VGTGSFGVVFQA--KCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLK 196
+G+G+FG V + K + VAIK VL+++ K+ RE +IM L++P +V +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIK-VLKNENEKSVRDEMMREAEIMHQLDNPYIVRM- 60
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
E + L L V+E S ++K + + + V +Q+ + YL
Sbjct: 61 ---IGVCEAEALML--VMEMASGG--PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG 113
Query: 257 VVGVCHRDIKPQN-LLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY-------YRAP 308
V HRD+ +N LLVN H KI DFG +K L + SY +R + AP
Sbjct: 114 KNFV-HRDLAARNVLLVN--QHYAKISDFGLSKALGADD---SYYKARSAGKWPLKWYAP 167
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELL 334
E I ++++ D+WS G + E
Sbjct: 168 ECI-NFRKFSSRSDVWSYGITMWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 6e-06
Identities = 58/240 (24%), Positives = 114/240 (47%), Gaps = 46/240 (19%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQA----------KCLETGDSVAIKKVLQDKRYKNRELQ 182
P+++I + + +G G FG V+ K L+ G +++++ L+ E
Sbjct: 4 PRESIKLV--KKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLE-------EAN 53
Query: 183 IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL 242
+M+ L H +V L + T+++ +Y+ + EY+++ + + ++ +L +L
Sbjct: 54 LMKTLQHDKLVRL---YAVVTKEEPIYI--ITEYMAKGSLL---DFLKSDEGGKVLLPKL 105
Query: 243 --YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYI 300
++ QI + Y+ HRD++ N+LV+ + KI DFG A+++ E Y
Sbjct: 106 IDFSAQIAEGMAYIERK-NYIHRDLRAANVLVS-ESLMCKIADFGLARVIEDNE----YT 159
Query: 301 CSR------YYRAPELI-FGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEI 352
+ APE I FG+ +T D+WS G +L E++ G+ +PG S D + +
Sbjct: 160 AREGAKFPIKWTAPEAINFGS--FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL 217
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 6e-06
Identities = 67/294 (22%), Positives = 108/294 (36%), Gaps = 63/294 (21%)
Query: 143 RVVGTGSFGVVFQAKCL-ETGDS----VAIKKVLQDKRYKNR-----ELQIMRLLNHPNV 192
R +G G+FG V++ GD+ VA+K + + ++ E IM NH N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVP-------ILYVQLYTY 245
V + E+ + ++LE ++ + R P +L+
Sbjct: 72 V---RLIGVSFERLPRF--ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQ--LKICDFGSAKMLVPGEPNISYICSR 303
+ C+ L H + HRDI +N L+ KI DFG A+ + +
Sbjct: 127 KGCKYLEENHFI----HRDIAARNCLLTCKGPGRVAKIADFGMARDIYR---------AS 173
Query: 304 YYR-----------APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESG--VDQL 349
YYR P F +T+ D+WS G +L E+ LG +PG + V +
Sbjct: 174 YYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF 233
Query: 350 VEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRL 403
V L P C P Y +I W R P ++ R+
Sbjct: 234 VTGGGRLDPPK----GCPGPVY------RIMTDCWQHTPEDR--PNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-06
Identities = 39/138 (28%), Positives = 57/138 (41%), Gaps = 46/138 (33%)
Query: 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEI 352
G PN Y APE++ T YT D WS+G +L E+L+GQP F ++ ++ +++
Sbjct: 210 GTPN--------YIAPEVLL-RTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKV 260
Query: 353 IKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFH----KRMPPEALDLVSRLLQYSP 408
I W H ++ PEA DL+ +L + P
Sbjct: 261 IN-----------------------------WQTSLHIPPQAKLSPEASDLIIKLCR-GP 290
Query: 409 SLRC---TALEACAHPFF 423
R A E AHPFF
Sbjct: 291 EDRLGKNGADEIKAHPFF 308
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 6e-06
Identities = 49/205 (23%), Positives = 90/205 (43%), Gaps = 25/205 (12%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK---KVLQDKRYKNRELQI------MRLLNHPNVV 193
+++G+G FG V + + GDS+ I K +QD+ + +I M L+H +V
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
L L L L + + V +H ++ P + + QI + + Y
Sbjct: 73 RL----LGICPGASLQLVTQLSPLGSLLDHVRQHRDSLD---PQRLLN-WCVQIAKGMYY 124
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY----ICSRYYRAPE 309
L + HR++ +N+L+ + ++I DFG A +L P + Y ++
Sbjct: 125 LEEH-RMVHRNLAARNILLKSDS-IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALES 182
Query: 310 LIFGATEYTTAIDMWSIGCVLAELL 334
++FG YT D+WS G + E++
Sbjct: 183 ILFG--RYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 7e-06
Identities = 53/169 (31%), Positives = 82/169 (48%), Gaps = 40/169 (23%)
Query: 180 ELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV--LEYISETVYRVSKHYTRMNQHV-P 236
E +++R L+HP V++L L + +V L + YR S YT + + P
Sbjct: 210 EARLLRRLSHPAVLAL------------LDVRVVGGLTCLVLPKYR-SDLYTYLGARLRP 256
Query: 237 ILYVQL--YTYQICRALNYLHHVVGVCHRDIKPQNLLVN-PHTHQLKIC--DFGSAKMLV 291
+ Q+ Q+ A++Y+H G+ HRDIK +N+LVN P IC DFG+A
Sbjct: 257 LGLAQVTAVARQLLSAIDYIHGE-GIIHRDIKTENVLVNGPE----DICLGDFGAA-CFA 310
Query: 292 PGEPNISYICSRYY--------RAPELIFGATEYTTAIDMWSIGCVLAE 332
G S+ +Y APE++ G YT ++D+WS G V+ E
Sbjct: 311 RG----SWSTPFHYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 8e-06
Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 45/197 (22%)
Query: 165 VAIKKVLQD--KRYKN---RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE 219
VA+K + D K +N +E++IM L +PN++ L S L ++ EY+
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDP-----LCMITEYMEN 101
Query: 220 -------TVYRVSKHYTRMNQHVPILYVQLYTY---QICRALNYLHHVVGVCHRDIKPQN 269
+ + +T N ++P + + Y QI + YL + V HRD+ +N
Sbjct: 102 GDLNQFLSQREIESTFTHAN-NIPSVSIANLLYMAVQIASGMKYLASLNFV-HRDLATRN 159
Query: 270 LLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR------------APELIFGATEY 317
LV H + +KI DFG ++ L G+ YYR A E I ++
Sbjct: 160 CLVGNH-YTIKIADFGMSRNLYSGD---------YYRIQGRAVLPIRWMAWESIL-LGKF 208
Query: 318 TTAIDMWSIGCVLAELL 334
TTA D+W+ G L E+
Sbjct: 209 TTASDVWAFGVTLWEMF 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 9e-06
Identities = 58/221 (26%), Positives = 97/221 (43%), Gaps = 29/221 (13%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNH 189
P++T+ + +G G FG V+ VAIK + Q E +M+ L H
Sbjct: 4 PRETLKL--VKKLGAGQFGEVWMG-YYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQH 60
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
P +V L ++ ++ +Y+ + EY+ E V T + I + QI
Sbjct: 61 PRLVRL----YAVVTQEPIYI--ITEYM-ENGSLVDFLKTPEGIKLTINKLIDMAAQIAE 113
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR------ 303
+ ++ HRD++ N+LV+ T KI DFG A+++ E Y
Sbjct: 114 GMAFIE-RKNYIHRDLRAANILVS-ETLCCKIADFGLARLIEDNE----YTAREGAKFPI 167
Query: 304 YYRAPELI-FGATEYTTAIDMWSIGCVLAELL-LGQPLFPG 342
+ APE I +G +T D+WS G +L E++ G+ +PG
Sbjct: 168 KWTAPEAINYGT--FTIKSDVWSFGILLTEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 37/216 (17%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLL---NHPNVVSLKHC 198
++G G+FG VF+ L+ VA+K +D + K + L R+L +HPN+V L
Sbjct: 2 LLGKGNFGEVFKGT-LKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKL--- 57
Query: 199 FFSTTEKDELYLNLVLEYISE----TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
T++ +Y +V+E + + R K + Q V + + YL
Sbjct: 58 IGVCTQRQPIY--IVMELVPGGDFLSFLRKKKDELKTKQLVK------FALDAAAGMAYL 109
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY------YRAP 308
HRD+ +N LV + LKI DFG ++ E + Y S + AP
Sbjct: 110 -ESKNCIHRDLAARNCLVG-ENNVLKISDFGMSRQ----EDDGIYSSSGLKQIPIKWTAP 163
Query: 309 E-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPG 342
E L +G Y++ D+WS G +L E LG +PG
Sbjct: 164 EALNYG--RYSSESDVWSYGILLWETFSLGVCPYPG 197
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 27/220 (12%)
Query: 143 RVVGTGSFGVVFQAKCLETGDS---VAIK--KVLQDKRYKN----RELQIMRLLNHPNVV 193
+ +G G FG V + + L DS VA+K K+ R + E M+ +HPNV+
Sbjct: 5 KTLGEGEFGSVMEGQ-LNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVM 63
Query: 194 SLKHCFFSTTEKDELYLNLV-LEYISETVYRVSKHYTRMN---QHVPILYVQLYTYQICR 249
L T E + +V L ++ Y+R+ Q++P + + I
Sbjct: 64 RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPE 309
+ YL HRD+ +N ++N + + + + DFG +K + G+ Y R + P
Sbjct: 124 GMEYL-SSKSFIHRDLAARNCMLNENMN-VCVADFGLSKKIYNGD---YYRQGRIAKMP- 177
Query: 310 LIFGATE------YTTAIDMWSIGCVLAELLL-GQPLFPG 342
+ + A E YTT D+WS G + E+ GQ +PG
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 52/183 (28%), Positives = 80/183 (43%), Gaps = 17/183 (9%)
Query: 229 TRMNQHVPILYVQL--YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286
T +N+ + Y+ L ++YQ+ + +L V HRD+ +N+L+ +KICDFG
Sbjct: 228 TLINESPALSYMDLVGFSYQVANGMEFLASKNCV-HRDLAARNVLIC-EGKLVKICDFGL 285
Query: 287 AKMLVPGEPNIS---YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPG 342
A+ ++ IS + APE IF YTT D+WS G +L E+ LG +P
Sbjct: 286 ARDIMRDSNYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPE 344
Query: 343 ESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAL-DLVS 401
+Q IK + P + + +I W + F R L LV
Sbjct: 345 LPMNEQFYNAIK-------RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVG 397
Query: 402 RLL 404
LL
Sbjct: 398 DLL 400
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 27/213 (12%)
Query: 142 ERVVGTGSFGVVFQAKCLETG--DSVAIKKVLQ-----DKRYKNRELQIM-RLLNHPNVV 193
+ V+G G+FG V +A+ + G AIK++ + D R EL+++ +L +HPN++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 194 SLKHCFFSTTEKDELYLNL-------VLEYISET-VYRVSKHYTRMNQHVPILYVQ---L 242
+ + + LYL + +L+++ ++ V + N L Q
Sbjct: 72 ---NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 128
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYIC 301
+ + R ++YL + HRD+ +N+LV + KI DFG S V + + +
Sbjct: 129 FAADVARGMDYLSQKQFI-HRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKKTMGRLP 186
Query: 302 SRYYRAPELIFGATEYTTAIDMWSIGCVLAELL 334
R+ L + YTT D+WS G +L E++
Sbjct: 187 VRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 67/288 (23%), Positives = 114/288 (39%), Gaps = 50/288 (17%)
Query: 143 RVVGTGSFGVVFQAKCLETGDS---VAIKKVLQDKRYKN------RELQIMRLLNHPNVV 193
R++G G FG V +A+ S VA+K + D + RE M+ +HPNV+
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 194 SLKHCFFSTTEKDELYLNLV-LEYISETVYRVSKHYTRMNQH---VPILYVQLYTYQICR 249
L + K L + +V L ++ +R+ + +P+ + + I
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC--DFGSAKMLVPGEPNISYICSRYYR- 306
+ YL HRD+ +N ++N + +C DFG +K + G+ YYR
Sbjct: 125 GMEYLSS-KNFIHRDLAARNCMLN---ENMTVCVADFGLSKKIYSGD---------YYRQ 171
Query: 307 --APELIFG--ATE------YTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKI 355
A +L A E YTT D+W+ G + E++ GQ + G + +IK
Sbjct: 172 GCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK- 230
Query: 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRL 403
G ++ C+ Y ++ W R P L +L
Sbjct: 231 -GNRLKQPPDCLEDVY------ELMCQCWSPEPKCR--PSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 65/246 (26%), Positives = 108/246 (43%), Gaps = 38/246 (15%)
Query: 136 TISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQDK-----RYKNRELQIMR 185
T+ +M E +G FG V++ E +VAIK L+DK R + + +MR
Sbjct: 6 TVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIK-TLKDKAEGPLREEFKHEAMMR 62
Query: 186 L-LNHPNVVSL---------KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV 235
L HPN+V L FS +L+ LV+ V T +
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 236 PILYVQLYTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293
P +V + T QI + +L HHV H+D+ +N+LV + +KI D G + +
Sbjct: 123 PADFVHIVT-QIAAGMEFLSSHHV---VHKDLATRNVLVFDKLN-VKISDLGLFREVYAA 177
Query: 294 E----PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQ 348
+ S + R+ +++G +++ D+WS G VL E+ G + G S D
Sbjct: 178 DYYKLMGNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD- 234
Query: 349 LVEIIK 354
++E+I+
Sbjct: 235 VIEMIR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 50/228 (21%), Positives = 96/228 (42%), Gaps = 42/228 (18%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK---KVLQDKRYKNRELQ-------IMRLLNHPNV 192
+++G G FG V + + L D +K K ++ + E++ M+ +HPNV
Sbjct: 5 KILGEGEFGSVMEGQ-LSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNV 63
Query: 193 VSLKHCFFSTTEKDELYLNLV-LEYISETVYRVSKHYTRMN---QHVPILYVQLYTYQIC 248
+ L F + ++ +V L ++ Y+R+ + +P+ + + I
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC--DFGSAKMLVPGEPNISYICSRYYR 306
+ YL + HRD+ +N ++ + +C DFG +K + G+ YYR
Sbjct: 124 LGMEYLSN-RNFIHRDLAARNCMLR---EDMTVCVADFGLSKKIYSGD---------YYR 170
Query: 307 APELI-----FGATE------YTTAIDMWSIGCVLAELL-LGQPLFPG 342
+ + A E YT+ D+W+ G + E+ GQ +PG
Sbjct: 171 QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG 218
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 44/150 (29%), Positives = 75/150 (50%), Gaps = 17/150 (11%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-DKRYKNR------ELQIMRLLNHPNVVSL 195
+ +G G+FG V A+ ++T A+K + + D +N+ E I+ ++ VV L
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
++S +KD LY V++YI + RM P + Y ++ A+ +H
Sbjct: 67 ---YYSFQDKDNLYF--VMDYIPGG--DMMSLLIRMGI-FPEDLARFYIAELTCAVESVH 118
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285
+ G HRDIKP N+L++ H +K+ DFG
Sbjct: 119 KM-GFIHRDIKPDNILIDRDGH-IKLTDFG 146
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 6e-05
Identities = 39/121 (32%), Positives = 57/121 (47%), Gaps = 29/121 (23%)
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYY 305
QI + YL + V HRD+ +N LV + +KI DFG ++ L G+ YY
Sbjct: 146 QIASGMKYLSSLNFV-HRDLATRNCLVGENLT-IKIADFGMSRNLYAGD---------YY 194
Query: 306 R------------APELIFGATEYTTAIDMWSIGCVLAELLL---GQPLFPGESGVDQLV 350
R A E I ++TTA D+W+ G L E+L+ QP GE +Q++
Sbjct: 195 RIQGRAVLPIRWMAWECIL-MGKFTTASDVWAFGVTLWEILMLCKEQPY--GELTDEQVI 251
Query: 351 E 351
E
Sbjct: 252 E 252
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 8e-05
Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 39/226 (17%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNH 189
P++++ E +G G FG V+ T VAIK + +E Q+M+ L H
Sbjct: 4 PRESLRL--EVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRH 60
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYIS-----ETVYRVSKHYTRMNQHVPILYVQLYT 244
+V L ++ ++ +Y+ V EY+S + + Y R+ Q V
Sbjct: 61 EKLVQL----YAVVSEEPIYI--VTEYMSKGSLLDFLKGEMGKYLRLPQLVD------MA 108
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR- 303
QI + Y+ + V HRD++ N+LV + K+ DFG A+++ E Y +
Sbjct: 109 AQIASGMAYVERMNYV-HRDLRAANILVGENL-VCKVADFGLARLIEDNE----YTARQG 162
Query: 304 -----YYRAPEL-IFGATEYTTAIDMWSIGCVLAELLL-GQPLFPG 342
+ APE ++G +T D+WS G +L EL G+ +PG
Sbjct: 163 AKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 57/225 (25%), Positives = 89/225 (39%), Gaps = 54/225 (24%)
Query: 145 VGTGSFGVVFQAKC---LETGDSV-----AIKKVLQDKRYK-NRELQIMRLLNHPNVVSL 195
+G G+FG VF A+C L D + A+K+ + R RE +++ +L H ++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR- 71
Query: 196 KHCFFSTTEKDELYLNLVLEYISE-------TVYRVSKHYTRMNQHVPILYVQL-----Y 243
F+ + L +V EY+ + + V + L
Sbjct: 72 ---FYGVCTEGRP-LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 244 TYQICRALNYLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC 301
QI + YL H V HRD+ +N LV +KI DFG ++ + +
Sbjct: 128 ASQIASGMVYLASLHFV---HRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTD------- 176
Query: 302 SRYYRA------------PELIFGATEYTTAIDMWSIGCVLAELL 334
YYR PE I ++TT D+WS G VL E+
Sbjct: 177 --YYRVGGRTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 60/234 (25%), Positives = 107/234 (45%), Gaps = 47/234 (20%)
Query: 142 ERVVGTGSFGVVFQA----------KCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPN 191
E+ +G G FG V+ A K ++ G S++++ L E +M+ L H
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLA-------EANVMKTLQHDK 62
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
+V L + K+ +Y+ + E++++ ++ K Q +P L ++ QI
Sbjct: 63 LVKLH----AVVTKEPIYI--ITEFMAKGSLLDFLKSDEGSKQPLPKLID--FSAQIAEG 114
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR------Y 304
+ ++ HRD++ N+LV+ KI DFG A+++ E Y
Sbjct: 115 MAFIEQR-NYIHRDLRAANILVSASL-VCKIADFGLARVIEDNE----YTAREGAKFPIK 168
Query: 305 YRAPELI-FGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKIL 356
+ APE I FG+ +T D+WS G +L E++ G+ +PG S E+I+ L
Sbjct: 169 WTAPEAINFGS--FTIKSDVWSFGILLMEIVTYGRIPYPGMSN----PEVIRAL 216
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 28/201 (13%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-------LQDKRYKNRELQIMRLLNHPNVVSLKH 197
+G G+FG VF + VA+K L+ K + E +I++ +HPN+V L
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQ--EARILKQYSHPNIVRL-- 58
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
T+K +Y +V+E + + T + P L V+ + A + ++
Sbjct: 59 -IGVCTQKQPIY--IVMELVQGGDFL-----TFLRTEGPRLKVKELIQMVENAAAGMEYL 110
Query: 258 VGVC--HRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY---YRAPE-LI 311
HRD+ +N LV + LKI DFG ++ G + + + APE L
Sbjct: 111 ESKHCIHRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALN 169
Query: 312 FGATEYTTAIDMWSIGCVLAE 332
+G Y++ D+WS G +L E
Sbjct: 170 YG--RYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 28/69 (40%), Positives = 37/69 (53%), Gaps = 5/69 (7%)
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG---EPNISYICS 302
Q+ L LH + G+ HRDIKP+NLLV Q+KI DFG+A + G P +
Sbjct: 317 QVLTGLRKLHRI-GIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPLYGMLDP 374
Query: 303 RYYRAPELI 311
RY EL+
Sbjct: 375 RYSPPEELV 383
|
Length = 507 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 29/217 (13%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVS 194
S + +G G FG V+ VA+K + E QIM+ L H +V
Sbjct: 7 SLQLIKKLGNGQFGEVWMGTWNGN-TKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQ 65
Query: 195 LKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
L ++ ++ +Y+ V EY+S+ ++ K +P L V + Q+ + Y
Sbjct: 66 L----YAVVSEEPIYI--VTEYMSKGSLLDFLKDGEGRALKLPNL-VDMAA-QVAAGMAY 117
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR------YYRA 307
+ + HRD++ N+LV KI DFG A+++ E Y + + A
Sbjct: 118 IERM-NYIHRDLRSANILVG-DGLVCKIADFGLARLIEDNE----YTARQGAKFPIKWTA 171
Query: 308 PEL-IFGATEYTTAIDMWSIGCVLAELLL-GQPLFPG 342
PE ++G +T D+WS G +L EL+ G+ +PG
Sbjct: 172 PEAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 61/237 (25%), Positives = 95/237 (40%), Gaps = 57/237 (24%)
Query: 142 ERVVGTGSFGVVFQAKCLE---TGDS--VAIKKV----LQDKRYKNRELQIMRLLNHPNV 192
+R +G G+FG VF A+C T D VA+K + L ++ RE +++ L H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS-------------ETVYRVSKHYTRMNQHVPILY 239
V F D L +V EY+ + + V + + +
Sbjct: 70 VK-----FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124
Query: 240 VQLYTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI 297
+ QI + YL H V HRD+ +N LV + +KI DFG ++
Sbjct: 125 MLHIASQIASGMVYLASQHFV---HRDLATRNCLVGANL-LVKIGDFGMSR--------- 171
Query: 298 SYICSRYYRA------------PELIFGATEYTTAIDMWSIGCVLAELLL--GQPLF 340
+ YYR PE I ++TT D+WS G +L E+ QP F
Sbjct: 172 DVYSTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWF 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 35/217 (16%)
Query: 142 ERVVGTGSFGVVFQAKCLETGD--SVAIKKVLQ-----DKRYKNRELQIM-RLLNHPNVV 193
E V+G G+FG V +A + G + AIK + + D R EL+++ +L +HPN++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 194 SLKHCFFSTTEKDELYLNL-------VLEYISET-VYRVSKHYTRMNQHVPILYVQLYTY 245
+L + + LY+ + +L+++ ++ V + + + L Q
Sbjct: 67 NL---LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123
Query: 246 QICRALNYLHHVVG--VCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR 303
+ ++ HRD+ +N+LV + KI DFG ++ GE Y+
Sbjct: 124 FASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS-KIADFGLSR----GEE--VYVKKT 176
Query: 304 YYRAPELIFGATE------YTTAIDMWSIGCVLAELL 334
R P + + A E YTT D+WS G +L E++
Sbjct: 177 MGRLP-VRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 53/200 (26%), Positives = 90/200 (45%), Gaps = 26/200 (13%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLNHPNVVSLKHCF 199
+ +G G FG V G+ VA+K + D + E +M L H N+V L
Sbjct: 11 LQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 200 FSTTEKDELYLNLVLEYISETV---YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
EK LY+ V EY+++ Y S+ + + + + + +C A+ YL
Sbjct: 69 --VEEKGGLYI--VTEYMAKGSLVDYLRSRGRSVLGGDCLLKF----SLDVCEAMEYLEA 120
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY---YRAPELIFG 313
V HRD+ +N+LV+ + K+ DFG K E + + + + APE +
Sbjct: 121 NNFV-HRDLAARNVLVS-EDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEAL-R 172
Query: 314 ATEYTTAIDMWSIGCVLAEL 333
+++T D+WS G +L E+
Sbjct: 173 EKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 9e-04
Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 37/214 (17%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHCFFS 201
+G G FG V+ T VAIK + +E QIM+ L H +V L ++
Sbjct: 14 LGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPL----YA 68
Query: 202 TTEKDELYLNLVLEYIS-----ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
++ +Y+ V E++ + + Y ++ Q V + QI + Y+
Sbjct: 69 VVSEEPIYI--VTEFMGKGSLLDFLKEGDGKYLKLPQLVDM------AAQIADGMAYIER 120
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR------YYRAPEL 310
+ HRD++ N+LV + KI DFG A+++ E Y + + APE
Sbjct: 121 M-NYIHRDLRAANILVGDNL-VCKIADFGLARLIEDNE----YTARQGAKFPIKWTAPEA 174
Query: 311 -IFGATEYTTAIDMWSIGCVLAELLL-GQPLFPG 342
++G +T D+WS G +L EL+ G+ +PG
Sbjct: 175 ALYG--RFTIKSDVWSFGILLTELVTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 9e-04
Identities = 80/331 (24%), Positives = 135/331 (40%), Gaps = 85/331 (25%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQ--AKCLETGDS---VAIKKVLQDKRYKNR-----ELQ 182
++ I+ + E +G GSFG+V++ A+ + G++ VA+K V + + R E
Sbjct: 4 SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 183 IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPIL 238
+M+ +VV L K + L +V+E ++ ++ R + N P
Sbjct: 62 VMKGFTCHHVVRL----LGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPP 116
Query: 239 YVQ---LYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295
+Q +I + YL+ V HRD+ +N +V H +KI DFG + + +
Sbjct: 117 TLQEMIQMAAEIADGMAYLNAKKFV-HRDLAARNCMV-AHDFTVKIGDFGMTRDIYETD- 173
Query: 296 NISYICSRYYR------------APELIFGATEYTTAIDMWSIGCVLAEL--LLGQPLFP 341
YYR APE + +TT+ DMWS G VL E+ L QP +
Sbjct: 174 --------YYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQP-YQ 223
Query: 342 GESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVS 401
G S +Q+++ + M+ Y + P P DL+
Sbjct: 224 GLSN-EQVLKFV-------------MDGGYLD--------QP------DNCPERVTDLMR 255
Query: 402 RLLQYSPSLRCTALEACA------HPFFDDL 426
Q++P +R T LE HP F ++
Sbjct: 256 MCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 53/233 (22%), Positives = 98/233 (42%), Gaps = 46/233 (19%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQAKC----LETGDSVAIKKVLQDKRYKN--------RE 180
P + +M E +G +FG +++ ++ VAIK + K N +E
Sbjct: 3 PLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTL---KDINNPQQWGEFQQE 57
Query: 181 LQIMRLLNHPNVVSLKHC---------FFSTTEKDELYLNLVLEYISETVYRVSKHYTRM 231
+M L+HPN+V L F + +L+ L++ V S +
Sbjct: 58 ASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTV 117
Query: 232 NQ---HVPILYVQLYTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286
H L++ + QI + YL H V H+D+ +N+L+ H +KI D G
Sbjct: 118 KSSLDHGDFLHIAI---QIAAGMEYLSSHFFV---HKDLAARNILIGEQLH-VKISDLGL 170
Query: 287 AKMLVPG-----EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELL 334
++ + +P S + R+ +++G ++++ D+WS G VL E+
Sbjct: 171 SREIYSADYYRVQPK-SLLPIRWMPPEAIMYG--KFSSDSDIWSFGVVLWEIF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.002
Identities = 58/230 (25%), Positives = 91/230 (39%), Gaps = 60/230 (26%)
Query: 142 ERVVGTGSFGVVFQAKCL----ETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNV 192
+R +G G+FG VF A+C E + K L+D ++ +RE +++ L H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISE--------------TVYRVSKHYTRMNQHVPIL 238
V + E D L + V EY+ + + Q +
Sbjct: 70 VKF---YGVCVEGDPLIM--VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 239 YVQLYTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN 296
Q QI + YL H V HRD+ +N LV + +KI DFG ++
Sbjct: 125 IAQ----QIAAGMVYLASQHFV---HRDLATRNCLVGENL-LVKIGDFGMSR-------- 168
Query: 297 ISYICSRYYRA------------PELIFGATEYTTAIDMWSIGCVLAELL 334
+ YYR PE I ++TT D+WS+G VL E+
Sbjct: 169 -DVYSTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 64/235 (27%), Positives = 97/235 (41%), Gaps = 38/235 (16%)
Query: 145 VGTGSFGVVFQAKCLETGDSVA--IKKVLQDKRYKNRELQIM------RLLNHPNVVS-L 195
+G G FG V + G S A + K L+ + +L + R LNHPNV+ L
Sbjct: 3 IGNGWFGKVLLGE-AHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ-----ICRA 250
C S YL LVLE+ K+Y R N+ + Q Q +
Sbjct: 62 GQCIESIP-----YL-LVLEFCP---LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASG 112
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY---YRA 307
L +LH + H D+ +N + +KI D+G A P + I+ C + A
Sbjct: 113 LLWLHQADFI-HSDLALRNCQLTADL-SVKIGDYGLALEQYPEDYYITKDCHAVPLRWLA 170
Query: 308 PEL--IFGA----TEYTTAIDMWSIGCVLAEL--LLGQPLFPGESGVDQLVEIIK 354
PEL I G + T ++WS+G + EL QP +P S L ++++
Sbjct: 171 PELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP-YPDLSDEQVLKQVVR 224
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 492 | |||
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.92 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.9 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.82 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.82 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.8 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.78 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.62 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.57 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.56 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.44 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.43 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.39 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.38 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.35 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.33 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.31 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.19 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.17 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.1 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.05 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.04 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.02 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.98 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.91 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.87 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.78 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.56 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.52 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.49 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.47 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.47 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.41 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.32 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.25 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.15 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.02 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.02 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.99 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.91 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.67 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.65 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.56 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.55 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.54 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.52 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.49 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.42 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.4 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.36 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.3 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.23 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.13 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.03 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.93 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.74 | |
| PLN02236 | 344 | choline kinase | 96.7 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.67 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.67 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.57 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.56 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.41 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.16 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.15 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.8 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.14 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.9 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.64 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 93.59 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 93.15 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 92.1 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 91.26 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 91.15 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 91.12 |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-75 Score=552.97 Aligned_cols=346 Identities=74% Similarity=1.194 Sum_probs=329.4
Q ss_pred eeeeecCCCCCCCccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchhhHHHHHHHHHHcCCCCccccceeee
Q 011138 121 VIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFF 200 (492)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 200 (492)
...+...+.....+....|...+++|.|+||.||+|+...+++.||||++..+.+...+|+.||+.++|||||+|..+|.
T Consensus 8 ~~~~~~~~~~~~~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~ 87 (364)
T KOG0658|consen 8 VIQTVAEGRNDGKKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFS 87 (364)
T ss_pred EEEEEeecCCCCcceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEE
Confidence 34445556666777888999999999999999999999999999999999999999999999999999999999999998
Q ss_pred eccCCCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEE
Q 011138 201 STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLK 280 (492)
Q Consensus 201 ~~~~~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vk 280 (492)
...+.+..++.+||||++.++++.++++...+..++...++.|++||++||.|||+ .||+||||||+|+|+|.+.+.+|
T Consensus 88 ~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~-~~IcHRDIKPqNlLvD~~tg~LK 166 (364)
T KOG0658|consen 88 SSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS-HGICHRDIKPQNLLVDPDTGVLK 166 (364)
T ss_pred ecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh-cCcccCCCChheEEEcCCCCeEE
Confidence 88877788999999999999999999999999999999999999999999999997 99999999999999999988999
Q ss_pred EeeecCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 011138 281 ICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPT 360 (492)
Q Consensus 281 L~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~ 360 (492)
|||||.|+.+..+++..++++|++|+|||++.|...|+.++||||.||++.||+-|++.|+|.+..+|+..|++++|.|+
T Consensus 167 icDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt 246 (364)
T KOG0658|consen 167 ICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPT 246 (364)
T ss_pred eccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCCCCCCCCCCCC
Q 011138 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLP 440 (492)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~~~~~~~~~~~ 440 (492)
.+++.+|++++.+.++|+++..+|...+.+.+++++.+|+.++|+++|.+|.++.|+|.||||+.+++++..++++.++|
T Consensus 247 ~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g~~lp 326 (364)
T KOG0658|consen 247 REDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNGRPLP 326 (364)
T ss_pred HHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCCCcCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCcccccccccccccccccccCccchhHHHhcCCHHHHhhcccccccC
Q 011138 441 TLFNFTAQGKLILCFSYFGFSSYFLPHANCLAELAGASNELRQRLIPEHARK 492 (492)
Q Consensus 441 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 492 (492)
++++|+.. | .+..+|++..++|+|.|+
T Consensus 327 ~lf~f~~~------------------------e-~~~~~~~~~~l~p~~~~~ 353 (364)
T KOG0658|consen 327 PLFNFKRA------------------------E-LGISPELVNVLIPEHLRE 353 (364)
T ss_pred CccCchHH------------------------H-hccchHHHHhhccHhhhh
Confidence 99999965 3 388999999999999874
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-60 Score=439.40 Aligned_cols=279 Identities=37% Similarity=0.684 Sum_probs=249.8
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchh------hHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR------YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~------~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
.|+...++|+|+||+||+|+++.||+.||||++...+. ...||+++|++|+|+|+|.|+++| .....++
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrklh 77 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKLH 77 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----HhcceeE
Confidence 58888899999999999999999999999999965433 345899999999999999999999 7777799
Q ss_pred EEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
||+|||+.++++.+.+ ....++...++.|++|++.|+.|+|+ +++||||||||||||+.++ .+||||||+|+.+.
T Consensus 78 LVFE~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk-~n~IHRDIKPENILit~~g-vvKLCDFGFAR~L~ 152 (396)
T KOG0593|consen 78 LVFEYCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHK-NNCIHRDIKPENILITQNG-VVKLCDFGFARTLS 152 (396)
T ss_pred EEeeecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhh-cCeecccCChhheEEecCC-cEEeccchhhHhhc
Confidence 9999999988876554 45679999999999999999999997 9999999999999999988 89999999999987
Q ss_pred -CCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh--hcC
Q 011138 292 -PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK--CMN 368 (492)
Q Consensus 292 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~--~~~ 368 (492)
+++..+.++.|++|+|||++.|...|+..+||||+||++.||++|.+.|+|.++.+++..|.+.+|.-.+.... ..+
T Consensus 153 ~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 153 APGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred CCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 77778889999999999999998899999999999999999999999999999999999999999987776554 557
Q ss_pred CCCcccCCCcccCCC-cccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 369 PNYTEFKFPQIKAHP-WHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
+-|..+.+|...... +...+ +.++.-+.||+++||..||.+|++.+|+|.||||+++.
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~ 291 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFI 291 (396)
T ss_pred CceeeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHH
Confidence 888999999876543 33334 56788999999999999999999999999999997654
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-60 Score=461.29 Aligned_cols=283 Identities=37% Similarity=0.657 Sum_probs=254.7
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-----hhHHHHHHHHHHcC-CCCccccceeeeeccCCCceE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-----~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~~~~ 209 (492)
..+|.+.+.||.|.||.||+|+.+.+|+.||||++++.- -...||+.-|++|+ |||||+|.+++.+.. ..
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~----~~ 84 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND----RI 84 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC----ce
Confidence 357999999999999999999999999999999886532 22348999999999 999999999984322 17
Q ss_pred EEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
+|+|||||+..|+++++.. +..|++..++.|++||+.||+|+|+ +|+.||||||||||+.... .|||+|||+|+.
T Consensus 85 L~fVfE~Md~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk-~GfFHRDlKPENiLi~~~~-~iKiaDFGLARe 159 (538)
T KOG0661|consen 85 LYFVFEFMDCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHK-HGFFHRDLKPENILISGND-VIKIADFGLARE 159 (538)
T ss_pred EeeeHHhhhhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHh-cCcccccCChhheEecccc-eeEecccccccc
Confidence 9999999999999988764 6789999999999999999999997 9999999999999999655 799999999999
Q ss_pred cCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC-
Q 011138 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN- 368 (492)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~- 368 (492)
+....+.+.++.|++|+|||+++....|+.++||||+|||++|+.+-++.|+|.+..+++.+|+.++|+|....|....
T Consensus 160 v~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 160 VRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred cccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 9888899999999999999999999999999999999999999999999999999999999999999999988876532
Q ss_pred -CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 369 -PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 369 -~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
.....+.||+.+..++...++. .++++.+||.+||.+||.+||||.|+|+||||+....
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA 299 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence 2334578898888888887766 9999999999999999999999999999999986543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-60 Score=450.79 Aligned_cols=256 Identities=34% Similarity=0.523 Sum_probs=213.6
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-----------hhHHHHHHHHHHcCCCCccccceeeeeccCC
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-----------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 205 (492)
..|.+.+.||+|+||.|-+|..+.||+.||||++.+.. ...++|++||++|+|||||+++++| .
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f-----~ 246 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF-----E 246 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee-----e
Confidence 35889999999999999999999999999999985432 1235899999999999999999999 5
Q ss_pred CceEEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCC--CcEEEe
Q 011138 206 DELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT--HQLKIC 282 (492)
Q Consensus 206 ~~~~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~--~~vkL~ 282 (492)
...+.||||||++|| |.+.+- .++.+.+..-+.+++||+.|+.|||+ +||+||||||+|||+..+. -.+||+
T Consensus 247 ~~ds~YmVlE~v~GGeLfd~vv----~nk~l~ed~~K~~f~Qll~avkYLH~-~GI~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 247 VPDSSYMVLEYVEGGELFDKVV----ANKYLREDLGKLLFKQLLTAVKYLHS-QGIIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred cCCceEEEEEEecCccHHHHHH----hccccccchhHHHHHHHHHHHHHHHH-cCcccccCCcceEEeccCCcceEEEec
Confidence 555689999999965 444332 35667777889999999999999997 9999999999999997652 269999
Q ss_pred eecCccccCCCCCCccceeccCccCchhhcCC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCC
Q 011138 283 DFGSAKMLVPGEPNISYICSRYYRAPELIFGA--TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD-QLVEIIKILGTP 359 (492)
Q Consensus 283 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~-~~~~i~~~~g~p 359 (492)
|||+|+....+....+.||||.|.|||++.+. ..+..++|+||+||+||-+|+|.+||....... ...+|.+
T Consensus 322 DFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~----- 396 (475)
T KOG0615|consen 322 DFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK----- 396 (475)
T ss_pred ccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc-----
Confidence 99999998888888899999999999999643 345668999999999999999999998876555 3444433
Q ss_pred CHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
..+. +....|..+++++++||.+||+.||++|||++|+|+||||+...
T Consensus 397 ------------G~y~--------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 397 ------------GRYA--------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred ------------Cccc--------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 1111 12234567999999999999999999999999999999999764
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-58 Score=416.86 Aligned_cols=276 Identities=39% Similarity=0.724 Sum_probs=242.7
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
+|...+.||+|.||.||+|++..||+.||||++...+ ...-||++.|+.++|+||+.++++| .....+.
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F-----~~~~~l~ 77 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF-----PHKSNLS 77 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc-----cCCCceE
Confidence 5888999999999999999999999999999996432 2345899999999999999999999 5555689
Q ss_pred EEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
||+||++.+|...++. ....++...++.|+.++++||+|||+ +.|+||||||+|+||++++ .+||+|||+|+.+.
T Consensus 78 lVfEfm~tdLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~-~~IlHRDlKPnNLLis~~g-~lKiADFGLAr~f~ 152 (318)
T KOG0659|consen 78 LVFEFMPTDLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHS-KWILHRDLKPNNLLISSDG-QLKIADFGLARFFG 152 (318)
T ss_pred EEEEeccccHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHh-hhhhcccCCccceEEcCCC-cEEeecccchhccC
Confidence 9999999998887654 34678899999999999999999997 9999999999999999998 89999999999875
Q ss_pred CCCC-CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC--
Q 011138 292 PGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN-- 368 (492)
Q Consensus 292 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~-- 368 (492)
+... ....+.|.+|+|||+++|...|+..+||||.|||+.||+.|.+.|+|.++.+|+..|++.+|+|.++.|+++.
T Consensus 153 ~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 153 SPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred CCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 4433 3344889999999999999999999999999999999999999999999999999999999999999999875
Q ss_pred CCCcccC-CCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 369 PNYTEFK-FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 369 ~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
++|..++ +|.. +... +.+..++++.||+.+||.+||.+|+|+.|+|.|+||+...
T Consensus 233 pdY~~~~~~P~~---~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P 288 (318)
T KOG0659|consen 233 PDYVKIQQFPKP---PLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP 288 (318)
T ss_pred ccHHHHhcCCCC---cccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence 6666665 3332 2222 3456789999999999999999999999999999999754
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-57 Score=467.08 Aligned_cols=311 Identities=54% Similarity=1.016 Sum_probs=273.9
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchhhHHHHHHHHHHcCCCCccccceeeeecc---CCCceEEEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTT---EKDELYLNLV 213 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~---~~~~~~~~lV 213 (492)
.+|.+++.||+|+||.||+|.+..+++.||||++..+.....+|+.+|+.++|||||+++++|+... .....++++|
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lv 145 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV 145 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEE
Confidence 4699999999999999999999999999999999777777778999999999999999999876542 1334578899
Q ss_pred eeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCC
Q 011138 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (492)
Q Consensus 214 ~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (492)
|||+++++...+.........+++..++.++.||+.||.|||+ +||+||||||+|||++.++..+||+|||+|+.....
T Consensus 146 mE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~-~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~ 224 (440)
T PTZ00036 146 MEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS-KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG 224 (440)
T ss_pred EecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCcCHHHEEEcCCCCceeeeccccchhccCC
Confidence 9999998888777666667789999999999999999999997 999999999999999977657999999999877665
Q ss_pred CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 011138 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373 (492)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~ 373 (492)
......+||+.|+|||++.+...|+.++|||||||++|||++|.+||.+.+..+.+..+++.+|.|..+.+..+++.+..
T Consensus 225 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~ 304 (440)
T PTZ00036 225 QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYAD 304 (440)
T ss_pred CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhc
Confidence 55667789999999999987767999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCCCCCCC-CCCCCCCCCCCcc
Q 011138 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPN-GRPLPTLFNFTAQ 448 (492)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~~~~~~-~~~~~~~~~~~~~ 448 (492)
+.+|.+....+...++...++++++||.+||++||.+|||+.|+|+||||++++++...++. ...+|.+++|...
T Consensus 305 ~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (440)
T PTZ00036 305 IKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLPKYIDKLPDLFNFCDA 380 (440)
T ss_pred ccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcccccCCCCCCCCCCCcCCCHH
Confidence 99998887778778888899999999999999999999999999999999998876544443 2456666666654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-57 Score=454.79 Aligned_cols=251 Identities=33% Similarity=0.543 Sum_probs=223.2
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
..|..+++||+|||++||.+++..+|+.||+|++.+. .....+|++|.+.|+|||||+++++| +|..+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecCCc
Confidence 4699999999999999999999999999999998552 23456899999999999999999999 88889
Q ss_pred EEEEeeechhhHH-HHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 210 LNLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 210 ~~lV~E~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
+|||+|+|..+.+ .+++ ..+.+++.+++.|++||+.||.|||+ ++|||||||..|+|++.+. +|||+|||+|.
T Consensus 93 VYivLELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~-~~IiHRDLKLGNlfL~~~~-~VKIgDFGLAt 166 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHS-LGIIHRDLKLGNLFLNENM-NVKIGDFGLAT 166 (592)
T ss_pred eEEEEEecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHh-cCceecccchhheeecCcC-cEEecccceee
Confidence 9999999996543 3333 35789999999999999999999997 9999999999999999988 79999999999
Q ss_pred ccCC-CCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 289 MLVP-GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 289 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
.+.. ++...+.||||.|+|||++... .++..+||||+|||||.||+|+|||...+-.+.+..|..
T Consensus 167 ~le~~~Erk~TlCGTPNYIAPEVl~k~-gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~------------- 232 (592)
T KOG0575|consen 167 QLEYDGERKKTLCGTPNYIAPEVLNKS-GHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL------------- 232 (592)
T ss_pred eecCcccccceecCCCcccChhHhccC-CCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh-------------
Confidence 8864 4778899999999999999754 489999999999999999999999999988888888866
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
.++.+|. .++.++++||.+||+.||.+|||++++|.|+||+.-.-
T Consensus 233 ----~~Y~~P~------------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~ 277 (592)
T KOG0575|consen 233 ----NEYSMPS------------HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFT 277 (592)
T ss_pred ----cCccccc------------ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCc
Confidence 4555553 68999999999999999999999999999999965433
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-58 Score=433.22 Aligned_cols=289 Identities=40% Similarity=0.704 Sum_probs=252.7
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEecc------chhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ------DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~------~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
.|...+.||.|+||.|+.|.++.+|+.||||++.. +.....||+.+|+.++|+||+.+++.+.........-+|
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY 102 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY 102 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence 36667899999999999999999999999999852 123345899999999999999999998764444555689
Q ss_pred EEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
+|+|+|+.+|...++. ++.++...++.+++||++||+|+|+ .||+||||||.|+|++.+. .+||+|||+|+...
T Consensus 103 iV~elMetDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHS-AnViHRDLKPsNll~n~~c-~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 103 LVFELMETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHS-ANVIHRDLKPSNLLLNADC-DLKICDFGLARYLD 176 (359)
T ss_pred EehhHHhhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhc-ccccccccchhheeeccCC-CEEeccccceeecc
Confidence 9999999888887654 4558999999999999999999997 8999999999999999998 79999999999875
Q ss_pred C---CCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 292 P---GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 292 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
+ ....+.++.|.+|+|||++.....|+.++||||+|||+.|||+|++.|+|.+..+|+..|+..+|+|.++.+....
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~ 256 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR 256 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence 3 3445678999999999999988899999999999999999999999999999999999999999999999887654
Q ss_pred CC-Cc--ccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCCCCC
Q 011138 369 PN-YT--EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCL 433 (492)
Q Consensus 369 ~~-~~--~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~~~~ 433 (492)
.. .. -...|..+..+|...|+ ++++++.||+.+||++||.+|+|++|+|+||||..+.++....
T Consensus 257 s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 257 SEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred cHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence 21 11 12467777788888776 8999999999999999999999999999999999999987754
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-57 Score=422.94 Aligned_cols=285 Identities=34% Similarity=0.579 Sum_probs=250.7
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchh------hHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR------YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~------~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
...|+....|++|+||.||+|+++.|++.||+|+++.++. ...||+.+|.+++|||||.+..+.....- + .
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~-d--~ 151 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM-D--K 151 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc-c--e
Confidence 3469999999999999999999999999999999966542 12489999999999999999998766542 2 3
Q ss_pred EEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
+|||||||+.++..++.. ..++|...+++.++.|+++||+|||+ +.|+||||||+|+|++..| .+||+|||+|+.
T Consensus 152 iy~VMe~~EhDLksl~d~---m~q~F~~~evK~L~~QlL~glk~lH~-~wilHRDLK~SNLLm~~~G-~lKiaDFGLAR~ 226 (419)
T KOG0663|consen 152 IYIVMEYVEHDLKSLMET---MKQPFLPGEVKTLMLQLLRGLKHLHD-NWILHRDLKTSNLLLSHKG-ILKIADFGLARE 226 (419)
T ss_pred eeeeHHHHHhhHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHHhh-ceeEecccchhheeeccCC-cEEecccchhhh
Confidence 889999999998887654 34789999999999999999999997 9999999999999999777 899999999998
Q ss_pred cCCC-CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 290 LVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 290 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
+... .+.+..+.|.+|+|||+++|...|+.++|+||+|||+.||+++++.|+|.+..+++.+|++.+|.|.+..|+...
T Consensus 227 ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 227 YGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred hcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 7443 335667889999999999999999999999999999999999999999999999999999999999999987654
Q ss_pred --CCCcccCCCcccCCCcccccCCC-CChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 369 --PNYTEFKFPQIKAHPWHKIFHKR-MPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 369 --~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
+.+..+.|+......+...|... +++...+|+..+|.+||.+|+||.|+|+|+||.+...
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~ 369 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPL 369 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCC
Confidence 33445677777777777777665 7899999999999999999999999999999998654
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-57 Score=443.04 Aligned_cols=284 Identities=37% Similarity=0.623 Sum_probs=241.3
Q ss_pred CccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCC
Q 011138 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (492)
Q Consensus 133 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 206 (492)
+.....|+..+.||+|.||.||+|++..||+.||+|++..+. ....||+.||++|+||||++|.+..... .
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~ 189 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---L 189 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---C
Confidence 455668999999999999999999999999999999996554 2345899999999999999999988653 3
Q ss_pred ceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 207 ~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
...+|||+|||+.+|..++. ...-.|++.+++.|+.||+.||+|||+ +||+|||||..|||||.+| .+||+|||+
T Consensus 190 ~~siYlVFeYMdhDL~GLl~---~p~vkft~~qIKc~mkQLl~Gl~~cH~-~gvlHRDIK~SNiLidn~G-~LKiaDFGL 264 (560)
T KOG0600|consen 190 SGSIYLVFEYMDHDLSGLLS---SPGVKFTEPQIKCYMKQLLEGLEYCHS-RGVLHRDIKGSNILIDNNG-VLKIADFGL 264 (560)
T ss_pred CceEEEEEecccchhhhhhc---CCCcccChHHHHHHHHHHHHHHHHHhh-cCeeeccccccceEEcCCC-CEEeccccc
Confidence 45699999999998877653 234579999999999999999999997 9999999999999999888 899999999
Q ss_pred ccccCCCC--CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 011138 287 AKMLVPGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (492)
Q Consensus 287 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~ 364 (492)
|+.+.... ..+..+.|.+|+|||+++|...|+.++|+||+||||.||++|++.|+|.+..+|+..|++.+|.|.+..|
T Consensus 265 Ar~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W 344 (560)
T KOG0600|consen 265 ARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYW 344 (560)
T ss_pred eeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcc
Confidence 99765443 4667899999999999999999999999999999999999999999999999999999999999999988
Q ss_pred hhcC-CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCC
Q 011138 365 KCMN-PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (492)
Q Consensus 365 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~ 425 (492)
.... |.+..++-...-....... ...+++.+.+|+..||..||.+|.||.++|+|+||+.
T Consensus 345 ~~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 345 PVSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred ccccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 7222 2222222221111122222 3568999999999999999999999999999999943
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-55 Score=416.93 Aligned_cols=254 Identities=32% Similarity=0.511 Sum_probs=218.8
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
...+|++.++||+|+||+||+++.+.|++.||+|++.+. ......|..||..++||+||+++..| ++.
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Qt~ 97 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----QTE 97 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----ccC
Confidence 345799999999999999999999999999999988654 23445799999999999999999988 666
Q ss_pred eEEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 208 LYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 208 ~~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
..+|||+||+.|| |...+ .....+++..++.|+.+|+.||.|||+ +|||||||||+|||+|.+| .|+|+|||+
T Consensus 98 ~kLylVld~~~GGeLf~hL----~~eg~F~E~~arfYlaEi~lAL~~LH~-~gIiyRDlKPENILLd~~G-Hi~LtDFgL 171 (357)
T KOG0598|consen 98 EKLYLVLDYLNGGELFYHL----QREGRFSEDRARFYLAEIVLALGYLHS-KGIIYRDLKPENILLDEQG-HIKLTDFGL 171 (357)
T ss_pred CeEEEEEeccCCccHHHHH----HhcCCcchhHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHeeecCCC-cEEEecccc
Confidence 6799999999975 33322 235789999999999999999999997 9999999999999999999 599999999
Q ss_pred cccc-CCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 011138 287 AKML-VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (492)
Q Consensus 287 a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~ 365 (492)
++.. ..+....++|||+.|||||++.+. .|+.++|+|||||++|||++|.+||.+.+....+.+|.+.-
T Consensus 172 ~k~~~~~~~~t~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k--------- 241 (357)
T KOG0598|consen 172 CKEDLKDGDATRTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK--------- 241 (357)
T ss_pred chhcccCCCccccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc---------
Confidence 9854 344556678999999999999876 49999999999999999999999999999888888886621
Q ss_pred hcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcC----CHHHhhCCCCCCCCCC
Q 011138 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC----TALEACAHPFFDDLRD 428 (492)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~----t~~e~l~Hp~f~~~~~ 428 (492)
.. ..+..++.++++||+++|+.||++|. .+.++.+||||.++..
T Consensus 242 --------~~-----------~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW 289 (357)
T KOG0598|consen 242 --------LP-----------LPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINW 289 (357)
T ss_pred --------CC-----------CCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCH
Confidence 00 01234799999999999999999996 6889999999998765
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-54 Score=426.63 Aligned_cols=255 Identities=34% Similarity=0.608 Sum_probs=223.7
Q ss_pred ccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHc-CCCCccccceeeeeccCC
Q 011138 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK 205 (492)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~ 205 (492)
+...+|..++.||.|+|++|++|+++.+++.||||++.+. ..+..+|..+|.+| .||.|++|+..| +
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF-----Q 144 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF-----Q 144 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----e
Confidence 3445799999999999999999999999999999987443 23455799999999 799999999999 7
Q ss_pred CceEEEEEeeech-hhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeee
Q 011138 206 DELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (492)
Q Consensus 206 ~~~~~~lV~E~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DF 284 (492)
|...+|+|+||++ |+|+.++.++ +.|++..+++|+.||+.||+|||+ +|||||||||||||||.|+ .+||+||
T Consensus 145 D~~sLYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~-~GIIHRDlKPENILLd~dm-hikITDF 218 (604)
T KOG0592|consen 145 DEESLYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHS-NGIIHRDLKPENILLDKDG-HIKITDF 218 (604)
T ss_pred cccceEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeEcCCC-cEEEeec
Confidence 7778999999998 5677777664 668999999999999999999997 9999999999999999999 6999999
Q ss_pred cCccccCCCCC--------------CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 011138 285 GSAKMLVPGEP--------------NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLV 350 (492)
Q Consensus 285 G~a~~~~~~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~ 350 (492)
|.|+.+.+... ..+++||..|.+||++.. ...+..+|+|+||||||+|+.|.+||.+.+..-.+.
T Consensus 219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFq 297 (604)
T KOG0592|consen 219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQ 297 (604)
T ss_pred cccccCChhhccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHH
Confidence 99988743211 146899999999999954 458999999999999999999999999999999999
Q ss_pred HHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCC
Q 011138 351 EIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (492)
Q Consensus 351 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~ 429 (492)
+|+++ ++.|| +..+++++|||+++|..||.+|+|+.||.+||||..+...
T Consensus 298 kI~~l-----------------~y~fp------------~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~ 347 (604)
T KOG0592|consen 298 KIQAL-----------------DYEFP------------EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWE 347 (604)
T ss_pred HHHHh-----------------cccCC------------CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChh
Confidence 99883 44444 4688999999999999999999999999999999987653
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-54 Score=397.81 Aligned_cols=252 Identities=29% Similarity=0.506 Sum_probs=221.9
Q ss_pred ccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCC
Q 011138 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (492)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 206 (492)
....+|+..+.||.|+||+|.+++.+.+|..+|+|++.+.+ +...+|..+|+.+.||+++++++.| .|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d 115 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KD 115 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----cc
Confidence 34457999999999999999999999999999999886543 3344799999999999999999988 78
Q ss_pred ceEEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeec
Q 011138 207 ELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (492)
Q Consensus 207 ~~~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG 285 (492)
..++||||||++|+ +... .+..+.|++..+++|+.||+.||+|||+ ++|++|||||||||+|.+| .+||+|||
T Consensus 116 ~~~lymvmeyv~GGElFS~----Lrk~~rF~e~~arFYAAeivlAleylH~-~~iiYRDLKPENiLlD~~G-~iKitDFG 189 (355)
T KOG0616|consen 116 NSNLYMVMEYVPGGELFSY----LRKSGRFSEPHARFYAAEIVLALEYLHS-LDIIYRDLKPENLLLDQNG-HIKITDFG 189 (355)
T ss_pred CCeEEEEEeccCCccHHHH----HHhcCCCCchhHHHHHHHHHHHHHHHHh-cCeeeccCChHHeeeccCC-cEEEEecc
Confidence 88899999999976 3333 3335789999999999999999999997 9999999999999999999 69999999
Q ss_pred CccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 011138 286 SAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (492)
Q Consensus 286 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~ 365 (492)
+|+.+. ....+.||||.|+|||++... .|+.++|+|||||++|||+.|.+||.+.+....+.+|+.
T Consensus 190 FAK~v~--~rT~TlCGTPeYLAPEii~sk-~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~----------- 255 (355)
T KOG0616|consen 190 FAKRVS--GRTWTLCGTPEYLAPEIIQSK-GYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILE----------- 255 (355)
T ss_pred ceEEec--CcEEEecCCccccChHHhhcC-CCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHh-----------
Confidence 999874 336789999999999999654 599999999999999999999999999999999999987
Q ss_pred hcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcC-----CHHHhhCCCCCCCCCC
Q 011138 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLRD 428 (492)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----t~~e~l~Hp~f~~~~~ 428 (492)
..++||. .++++++|||+++|+.|-.+|. ...+|.+||||+.+..
T Consensus 256 ------~~v~fP~------------~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W 305 (355)
T KOG0616|consen 256 ------GKVKFPS------------YFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDW 305 (355)
T ss_pred ------CcccCCc------------ccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccH
Confidence 4555554 5899999999999999999995 5779999999998765
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-54 Score=410.76 Aligned_cols=258 Identities=31% Similarity=0.518 Sum_probs=213.0
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
+.+....||+|..|+||+++++.|++.+|+|.+... .+...+|++|++.++|||||++|++|+.... .++|
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~----~isI 155 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE----EISI 155 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc----eEEe
Confidence 456667899999999999999999999999999432 3445689999999999999999999976542 4889
Q ss_pred EeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 213 V~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
+||||+++.++.+.. ..+.+++.....++.+|++||.|||+.++||||||||+||||+..| +|||||||.++.+.+
T Consensus 156 ~mEYMDgGSLd~~~k---~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG-eVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILK---RVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG-EVKICDFGVSGILVN 231 (364)
T ss_pred ehhhcCCCCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC-CEEeccccccHHhhh
Confidence 999999876654332 2367999999999999999999999548999999999999999988 899999999998866
Q ss_pred CCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 011138 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGE--SGVDQLVEIIKILGTPTREEIKCMNPN 370 (492)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~--~~~~~~~~i~~~~g~p~~~~~~~~~~~ 370 (492)
. ...+++||..|||||.+.+.. |+.++||||||++++||.+|+.||... .....+..+..+...|++.
T Consensus 232 S-~a~tfvGT~~YMsPERi~g~~-Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~-------- 301 (364)
T KOG0581|consen 232 S-IANTFVGTSAYMSPERISGES-YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPR-------- 301 (364)
T ss_pred h-hcccccccccccChhhhcCCc-CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCC--------
Confidence 5 667899999999999997764 999999999999999999999999874 1222333333322222211
Q ss_pred CcccCCCcccCCCcccccCC-CCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCC
Q 011138 371 YTEFKFPQIKAHPWHKIFHK-RMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430 (492)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~-~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~ 430 (492)
++. ..|+++++||..||++||.+|+++.|+++|||+++...++
T Consensus 302 -----------------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~ 345 (364)
T KOG0581|consen 302 -----------------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPN 345 (364)
T ss_pred -----------------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccccc
Confidence 122 2799999999999999999999999999999999876543
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-53 Score=404.48 Aligned_cols=290 Identities=34% Similarity=0.690 Sum_probs=243.9
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchh------hHHHHHHHHHHcCCCC-ccccceeeeeccC-CCce
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR------YKNRELQIMRLLNHPN-VVSLKHCFFSTTE-KDEL 208 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~------~~~~E~~il~~l~h~n-Iv~l~~~~~~~~~-~~~~ 208 (492)
..|...++||+|+||+||+|+.+.+|+.||+|++.-+.. ...||+.+|+.|+|+| ||.|++++..... ....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 358888889999999999999999999999999865432 3468999999999999 9999999865442 2334
Q ss_pred EEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 209 ~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
.+++|+||+.-++...+.......+.++...++.+++||+.||+|||+ +||+||||||+||||++++ .+||+|||+|+
T Consensus 91 ~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~-~~IlHRDLKPQNlLi~~~G-~lKlaDFGlAr 168 (323)
T KOG0594|consen 91 KLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS-HGILHRDLKPQNLLISSSG-VLKLADFGLAR 168 (323)
T ss_pred eEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCcceEEECCCC-cEeeeccchHH
Confidence 689999999988877766544333567778999999999999999997 9999999999999999987 89999999998
Q ss_pred ccC-CCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 289 MLV-PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 289 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
... +....+..++|.+|+|||++.|...|+..+||||+|||++||+++++.|++.++.+++..|++.+|+|..+.|+..
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 765 4555677899999999999999988999999999999999999999999999999999999999999999988754
Q ss_pred C--CCCcccCCCccc-CCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCC
Q 011138 368 N--PNYTEFKFPQIK-AHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430 (492)
Q Consensus 368 ~--~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~ 430 (492)
. +.|.. .|+... ...+.... +...+++.+|+.+||++||.+|+|+..+|.||||..+..+.
T Consensus 249 ~~~~~~k~-~f~~~~~~~~l~~~~-~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~ 312 (323)
T KOG0594|consen 249 SSLPDYKA-PFPKWPGPKDLSSIL-PKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKS 312 (323)
T ss_pred cccccccc-cCcCCCCccchHHhc-cccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccch
Confidence 3 33332 344433 22233322 34457999999999999999999999999999999886543
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-56 Score=399.68 Aligned_cols=288 Identities=28% Similarity=0.417 Sum_probs=242.1
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEec------cchhhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL------QDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~------~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
..+.|.+.++||+|.|+.||++.+..+|+.+|+|++. .+.+.+++|+.|.+.|+|||||+|++.+ ....
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~~ 83 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEES 83 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----cccc
Confidence 3456999999999999999999999999999999873 2345677999999999999999999988 6677
Q ss_pred EEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCC--CCcEEEeeec
Q 011138 209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH--THQLKICDFG 285 (492)
Q Consensus 209 ~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~--~~~vkL~DFG 285 (492)
+.|||+|++.|+ +...+-. ..-+++..+..+++||+.||.|+|. +||||||+||+|+|+-+. +.-+||+|||
T Consensus 84 ~~ylvFe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~-n~IvHRDvkP~nllLASK~~~A~vKL~~FG 158 (355)
T KOG0033|consen 84 FHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHS-NGIVHRDLKPENLLLASKAKGAAVKLADFG 158 (355)
T ss_pred eeEEEEecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeeeeccCCCceeecccc
Confidence 899999999975 3322222 1346788899999999999999997 999999999999999433 3369999999
Q ss_pred CccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 011138 286 SAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (492)
Q Consensus 286 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~ 365 (492)
+|..+..+......+|||.|||||++.. ..|+..+|||+.|||||.||.|.+||++.+....+..|++
T Consensus 159 vAi~l~~g~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~----------- 226 (355)
T KOG0033|consen 159 LAIEVNDGEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKA----------- 226 (355)
T ss_pred eEEEeCCccccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhc-----------
Confidence 9999887777778899999999999965 4599999999999999999999999999998888888877
Q ss_pred hcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 011138 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTLFNF 445 (492)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~~~~~~~~~~~~~~~~ 445 (492)
..+++|. ..++++++++++||++||..||.+|+|+.|+|+|||+.+-..-.........+..|+.|
T Consensus 227 ------g~yd~~~--------~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~dtvd~lrkf 292 (355)
T KOG0033|consen 227 ------GAYDYPS--------PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRERVASAIHRQDTVDCLKKF 292 (355)
T ss_pred ------cccCCCC--------cccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHHHHHHhhhHHHHHHHHHh
Confidence 3444443 24467999999999999999999999999999999999765555556666778888888
Q ss_pred Ccccccccccccc
Q 011138 446 TAQGKLILCFSYF 458 (492)
Q Consensus 446 ~~~~~~~~~~~~~ 458 (492)
....|+.-+.+-.
T Consensus 293 NarRKLKgavLta 305 (355)
T KOG0033|consen 293 NARRKLKGAILTT 305 (355)
T ss_pred hHHHHHHHHHHHH
Confidence 8888776555433
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-53 Score=417.13 Aligned_cols=257 Identities=31% Similarity=0.525 Sum_probs=218.5
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchhh-------HHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRY-------KNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-------~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
...+|.++..||+|+||.||+|+.+.||..+|+|++.+.... ...|..||...++|+||+||..| +|.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD~ 213 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QDK 213 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cCC
Confidence 456799999999999999999999999999999999775432 34699999999999999999999 888
Q ss_pred eEEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 208 LYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 208 ~~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
.++||||||++|| +-.++. ....+++..+++|+.+++.|++.||+ .|||||||||+|+|||..| .+||+|||+
T Consensus 214 ~~LYLiMEylPGGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~-~gyIHRDIKPdNlLiD~~G-HiKLSDFGL 287 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQ-LGYIHRDIKPDNLLIDAKG-HIKLSDFGL 287 (550)
T ss_pred CeeEEEEEecCCccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHH-cCcccccCChhheeecCCC-CEeeccccc
Confidence 8999999999976 333332 25679999999999999999999998 9999999999999999999 599999999
Q ss_pred ccccCC-----------------------CCC-----C--------------------ccceeccCccCchhhcCCCCCC
Q 011138 287 AKMLVP-----------------------GEP-----N--------------------ISYICSRYYRAPELIFGATEYT 318 (492)
Q Consensus 287 a~~~~~-----------------------~~~-----~--------------------~~~~gt~~y~aPE~~~~~~~~~ 318 (492)
++.+.. ... . .+.+|||.|||||++.+.+ |+
T Consensus 288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~ 366 (550)
T KOG0605|consen 288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YG 366 (550)
T ss_pred cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CC
Confidence 843211 000 0 1468999999999998876 99
Q ss_pred cchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhh
Q 011138 319 TAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALD 398 (492)
Q Consensus 319 ~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 398 (492)
..+|+||||||+||||.|.+||.+.+..+...+|+... ..+.||.- ..++++++|
T Consensus 367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr---------------~~l~fP~~----------~~~s~eA~D 421 (550)
T KOG0605|consen 367 KECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWR---------------ETLKFPEE----------VDLSDEAKD 421 (550)
T ss_pred ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh---------------hhccCCCc----------CcccHHHHH
Confidence 99999999999999999999999999999999987721 22344431 346899999
Q ss_pred hhccccccCCCCcCC---HHHhhCCCCCCCCCCC
Q 011138 399 LVSRLLQYSPSLRCT---ALEACAHPFFDDLRDP 429 (492)
Q Consensus 399 Li~~~L~~dP~~R~t---~~e~l~Hp~f~~~~~~ 429 (492)
||.+||. ||.+|+. ++||.+||||+.+...
T Consensus 422 LI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~ 454 (550)
T KOG0605|consen 422 LITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWD 454 (550)
T ss_pred HHHHHhc-CHHHhcCcccHHHHhcCCccccCCcc
Confidence 9999999 9999995 8999999999988764
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-53 Score=424.86 Aligned_cols=253 Identities=33% Similarity=0.523 Sum_probs=226.1
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
-|.+++.||.|+-|.|.+|++..||+.+|||++.+. ....++|+-||+.+.||||+++|+++ ++..++
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~~~l 87 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENKQHL 87 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccCceE
Confidence 499999999999999999999999999999999765 34567999999999999999999999 666679
Q ss_pred EEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 211 ~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
|+|+||++|| |++.+ ...+.+++.+++.+++||+.|+.|+|. .+|+||||||+|+|+|.++ +|||+|||+|..
T Consensus 88 ylvlEyv~gGELFdyl----v~kG~l~e~eaa~ff~QIi~gv~yCH~-~~icHRDLKpENlLLd~~~-nIKIADFGMAsL 161 (786)
T KOG0588|consen 88 YLVLEYVPGGELFDYL----VRKGPLPEREAAHFFRQILDGVSYCHA-FNICHRDLKPENLLLDVKN-NIKIADFGMASL 161 (786)
T ss_pred EEEEEecCCchhHHHH----HhhCCCCCHHHHHHHHHHHHHHHHHhh-hcceeccCCchhhhhhccc-CEeeeccceeec
Confidence 9999999864 44433 335789999999999999999999997 8999999999999999888 699999999998
Q ss_pred cCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
-.++.-..+.||+|+|.|||++.|..+.+.++||||+|||||.||+|+.||++++....+.++.+
T Consensus 162 e~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~--------------- 226 (786)
T KOG0588|consen 162 EVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR--------------- 226 (786)
T ss_pred ccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc---------------
Confidence 88888888999999999999999999889999999999999999999999998887777777755
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~ 430 (492)
..|..| ..++.++++||.+||++||++|+|..||+.|||+.......
T Consensus 227 --G~f~MP------------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~ 273 (786)
T KOG0588|consen 227 --GVFEMP------------SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLP 273 (786)
T ss_pred --CcccCC------------CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCC
Confidence 233333 46899999999999999999999999999999999877643
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-52 Score=400.80 Aligned_cols=259 Identities=28% Similarity=0.469 Sum_probs=223.3
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchh-------hHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-------YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-------~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
....|++.+.||.|.-|+||+|+...++..+|+|++.+... ..+.|.+||..++||.++.||+.| +.+
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et~ 149 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ETD 149 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----ecc
Confidence 34469999999999999999999999999999999965432 234699999999999999999999 777
Q ss_pred eEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 208 ~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
.|.|+|||||+|+-+..+.+ .+.++.+++..+++|+.+|+.||+||| +.|||+||||||||||.++| .|.|+||.++
T Consensus 150 ~~~cl~meyCpGGdL~~Lrq-kQp~~~fse~~aRFYaAEvl~ALEYLH-mlGivYRDLKPENILvredG-HIMLsDFDLS 226 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQ-KQPGKRFSESAARFYAAEVLLALEYLH-MLGIVYRDLKPENILVREDG-HIMLSDFDLS 226 (459)
T ss_pred ceeEEEEecCCCccHHHHHh-hCCCCccchhhHHHHHHHHHHHHHHHH-hhceeeccCCcceeEEecCC-cEEeeecccc
Confidence 78999999999876655444 455788999999999999999999999 59999999999999999999 5999999986
Q ss_pred cccC----------------------------------C-----------------------CCCCccceeccCccCchh
Q 011138 288 KMLV----------------------------------P-----------------------GEPNISYICSRYYRAPEL 310 (492)
Q Consensus 288 ~~~~----------------------------------~-----------------------~~~~~~~~gt~~y~aPE~ 310 (492)
.... . +....+++||-.|+|||+
T Consensus 227 ~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEv 306 (459)
T KOG0610|consen 227 LRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEV 306 (459)
T ss_pred ccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccccee
Confidence 3220 0 011235789999999999
Q ss_pred hcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCC
Q 011138 311 IFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHK 390 (492)
Q Consensus 311 ~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (492)
|.|.+ .+.++|||+|||++||||.|..||.|.+..+.+.+|+. .+.+||.. +
T Consensus 307 I~G~G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~-----------------~~l~Fp~~----------~ 358 (459)
T KOG0610|consen 307 IRGEG-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG-----------------QPLKFPEE----------P 358 (459)
T ss_pred eecCC-CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc-----------------CCCcCCCC----------C
Confidence 98876 79999999999999999999999999999999999876 45666653 2
Q ss_pred CCChhHhhhhccccccCCCCcCC----HHHhhCCCCCCCCCCC
Q 011138 391 RMPPEALDLVSRLLQYSPSLRCT----ALEACAHPFFDDLRDP 429 (492)
Q Consensus 391 ~~s~~~~~Li~~~L~~dP~~R~t----~~e~l~Hp~f~~~~~~ 429 (492)
.++..++|||+++|.+||.+|+. |.||.+||||+.+...
T Consensus 359 ~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 359 EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA 401 (459)
T ss_pred cchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChh
Confidence 57899999999999999999998 9999999999998875
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-52 Score=422.02 Aligned_cols=280 Identities=37% Similarity=0.623 Sum_probs=231.6
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchhhHH---HHHHHHHHcC-C-----CCccccceeeeeccCCCce
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLN-H-----PNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~---~E~~il~~l~-h-----~nIv~l~~~~~~~~~~~~~ 208 (492)
+|.+.++||+|+||.|.+|.+..|++.||||+++....+.+ .|+.||..|+ | -|||+++++| ....
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F-----~fr~ 261 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF-----YFRN 261 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc-----cccc
Confidence 69999999999999999999999999999999988876654 5899999987 3 4899999999 5555
Q ss_pred EEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcC-CCCcEEEeeecCc
Q 011138 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP-HTHQLKICDFGSA 287 (492)
Q Consensus 209 ~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~-~~~~vkL~DFG~a 287 (492)
++|||+|.++.+|+++++... ...++...++.++.||+.||.+||+ .||||+|||||||||.. +...|||+|||+|
T Consensus 262 HlciVfELL~~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~-l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 262 HLCIVFELLSTNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHE-LGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred ceeeeehhhhhhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCChhheeeccCCcCceeEEecccc
Confidence 699999999999999987644 3569999999999999999999997 89999999999999953 3347999999999
Q ss_pred cccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
... .....+++.++.|+|||+|+|.. |+.+.||||||||++||++|.+.|+|.+..+++..|+.++|.|+...+...
T Consensus 339 c~~--~q~vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 339 CFE--SQRVYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred ccc--CCcceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 865 33334899999999999999865 999999999999999999999999999999999999999999998877543
Q ss_pred CCCC---cc-cCCCc-----------------------------c-cCCCcccccCCCCChhHhhhhccccccCCCCcCC
Q 011138 368 NPNY---TE-FKFPQ-----------------------------I-KAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT 413 (492)
Q Consensus 368 ~~~~---~~-~~~~~-----------------------------~-~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t 413 (492)
.... .. .-++. . ....|...+...-...+.|||++||++||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 2111 11 00000 0 1112222222233346799999999999999999
Q ss_pred HHHhhCCCCCCCCCC
Q 011138 414 ALEACAHPFFDDLRD 428 (492)
Q Consensus 414 ~~e~l~Hp~f~~~~~ 428 (492)
+.|+|+||||+....
T Consensus 496 p~qal~Hpfl~~~~~ 510 (586)
T KOG0667|consen 496 PAQALNHPFLTGTSL 510 (586)
T ss_pred HHHHhcCcccccccc
Confidence 999999999996554
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-52 Score=399.93 Aligned_cols=255 Identities=33% Similarity=0.556 Sum_probs=216.2
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
..+|.+.+.||.|+||+||+|+.+.++..||||.+.+.. ..+..|+.||+.++|||||++++|+ .+..+
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~~~ 83 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDDDF 83 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecCCe
Confidence 456999999999999999999999999999999986542 3346899999999999999999999 55568
Q ss_pred EEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCC-C----CcEEEeee
Q 011138 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH-T----HQLKICDF 284 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~-~----~~vkL~DF 284 (492)
+|||||||.|+.+.. +.+..+.+++..++.++.||+.||++||+ ++||||||||+||||+.. + ..+||+||
T Consensus 84 i~lVMEyC~gGDLs~---yi~~~~~l~e~t~r~Fm~QLA~alq~L~~-~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADF 159 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSD---YIRRRGRLPEATARHFMQQLASALQFLHE-NNIIHRDLKPQNILLSTTARNDTSPVLKIADF 159 (429)
T ss_pred EEEEEEeCCCCCHHH---HHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCcceEEeccCCCCCCCceEEeccc
Confidence 999999999654432 23334579999999999999999999997 999999999999999764 2 25899999
Q ss_pred cCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 011138 285 GSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (492)
Q Consensus 285 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~ 364 (492)
|+|+.+.++....+.||++.|||||++.. ..|+.|+|+||+|+|||+|++|++||...+..+.+..+.+.-
T Consensus 160 GfAR~L~~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~-------- 230 (429)
T KOG0595|consen 160 GFARFLQPGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGN-------- 230 (429)
T ss_pred chhhhCCchhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccc--------
Confidence 99999998888889999999999999964 459999999999999999999999999999888777554411
Q ss_pred hhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
...| .++..+++...+|+..+|+.||..|.+..+-+.|+++..-
T Consensus 231 ---------~~~~---------~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~ 274 (429)
T KOG0595|consen 231 ---------EIVP---------VLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAAN 274 (429)
T ss_pred ---------cccC---------chhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccC
Confidence 1111 1223467778899999999999999999999999999754
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-52 Score=415.92 Aligned_cols=250 Identities=34% Similarity=0.517 Sum_probs=217.7
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc---------hhhHHHHHHHHHHcC-CCCccccceeeeeccCC
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---------KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEK 205 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~---------~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~ 205 (492)
...|.+++.||+|+||+|+.|.+..+|+.||+|++.+. .....+|+.+++.+. ||||+++++++..
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t---- 91 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT---- 91 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec----
Confidence 34699999999999999999999999999999976543 223458999999999 9999999999843
Q ss_pred CceEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCC-CCcEEEee
Q 011138 206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH-THQLKICD 283 (492)
Q Consensus 206 ~~~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~-~~~vkL~D 283 (492)
...+|+|||||.| +|++.+.. ...+.+..++.+++||+.|++|||+ +||+||||||||||++.+ + ++||+|
T Consensus 92 -~~~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~-~gi~HRDLK~ENilld~~~~-~~Kl~D 164 (370)
T KOG0583|consen 92 -PTKIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHS-RGIVHRDLKPENILLDGNEG-NLKLSD 164 (370)
T ss_pred -CCeEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEecCCCC-CEEEec
Confidence 3348999999996 56654433 5678889999999999999999997 999999999999999988 6 899999
Q ss_pred ecCcccc-CCCCCCccceeccCccCchhhcCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 011138 284 FGSAKML-VPGEPNISYICSRYYRAPELIFGAT-EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTR 361 (492)
Q Consensus 284 FG~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~ 361 (492)
||++... ..+....+.+||+.|+|||++.+.. +-+.++||||+||+||.|++|+.||...+....+..|.+
T Consensus 165 FG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~------- 237 (370)
T KOG0583|consen 165 FGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK------- 237 (370)
T ss_pred cccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc-------
Confidence 9999987 4667778899999999999998877 557899999999999999999999999887777777655
Q ss_pred HHHhhcCCCCcccCCCcccCCCcccccCCCC-ChhHhhhhccccccCCCCcCCHHHhhCCCCCCC
Q 011138 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRM-PPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (492)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~ 425 (492)
..+.+|. .+ ++++++||.+||..||.+|+|+.+++.||||+.
T Consensus 238 ----------~~~~~p~------------~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 238 ----------GEFKIPS------------YLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred ----------CCccCCC------------CcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 3444443 45 999999999999999999999999999999996
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-53 Score=386.84 Aligned_cols=255 Identities=29% Similarity=0.530 Sum_probs=213.4
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
..|.+.++||+|+||.||++.+..+|..||.|.+.-+ ....-.|+.+|++|+|||||+++++-+. ++...+
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~---~~~evl 95 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI---EDNEVL 95 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh---ccchhh
Confidence 4699999999999999999999999999999988532 3344579999999999999999984332 333348
Q ss_pred EEEeeech-hhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHh--hC-CcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 211 NLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH--VV-GVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 211 ~lV~E~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~--~~-givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
+||||||+ |+|.++++++....+.+++..++.++.|+|.||..+|+ .+ -|+||||||.||+|+.+| .|||+|||+
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g-vvKLGDfGL 174 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG-VVKLGDFGL 174 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC-ceeeccchh
Confidence 89999998 67889999999999999999999999999999999995 22 289999999999999888 899999999
Q ss_pred ccccCCCCC-CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 011138 287 AKMLVPGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (492)
Q Consensus 287 a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~ 365 (492)
++.+..... ..+++|||+||+||.+.+.+ |+.++||||+||++|||+.-++||.|.+-.+...+|.++
T Consensus 175 ~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg---------- 243 (375)
T KOG0591|consen 175 GRFLSSKTTFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG---------- 243 (375)
T ss_pred HhHhcchhHHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC----------
Confidence 998855443 34689999999999997665 999999999999999999999999999766666666542
Q ss_pred hcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
.+|.++ ....|.++..||..|+..||..||+. ||++.++..
T Consensus 244 ---------d~~~~p--------~~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~~ 284 (375)
T KOG0591|consen 244 ---------DYPPLP--------DEHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQS 284 (375)
T ss_pred ---------CCCCCc--------HHHhhhHHHHHHHHHccCCcccCCCc-----chHHHHHHH
Confidence 111111 13578999999999999999999987 666665543
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=394.14 Aligned_cols=259 Identities=30% Similarity=0.445 Sum_probs=218.3
Q ss_pred CCccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------------------hhHHHHHHHHHHcCCCCcc
Q 011138 132 QPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------------------RYKNRELQIMRLLNHPNVV 193 (492)
Q Consensus 132 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------------------~~~~~E~~il~~l~h~nIv 193 (492)
..++.++|++.+.||+|.||.|.+|++..+++.||||++.+.+ +...+|+.||++|.|||||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 3456678999999999999999999999999999999985432 2335799999999999999
Q ss_pred ccceeeeeccCCCceEEEEEeeechhhHHHHhhhhhhcCCC-cCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEE
Q 011138 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQH-VPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV 272 (492)
Q Consensus 194 ~l~~~~~~~~~~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~-~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl 272 (492)
+|+++.-+ .....+|||+|||..+-... ...... +++.+++.|++.++.||+|||. +|||||||||.|+||
T Consensus 172 ~LiEvLDD---P~s~~~YlVley~s~G~v~w----~p~d~~els~~~Ar~ylrDvv~GLEYLH~-QgiiHRDIKPsNLLl 243 (576)
T KOG0585|consen 172 KLIEVLDD---PESDKLYLVLEYCSKGEVKW----CPPDKPELSEQQARKYLRDVVLGLEYLHY-QGIIHRDIKPSNLLL 243 (576)
T ss_pred EEEEeecC---cccCceEEEEEeccCCcccc----CCCCcccccHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEE
Confidence 99998733 33446899999999664432 222344 8999999999999999999996 999999999999999
Q ss_pred cCCCCcEEEeeecCccccCCCC------CCccceeccCccCchhhcC---CCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 011138 273 NPHTHQLKICDFGSAKMLVPGE------PNISYICSRYYRAPELIFG---ATEYTTAIDMWSIGCVLAELLLGQPLFPGE 343 (492)
Q Consensus 273 ~~~~~~vkL~DFG~a~~~~~~~------~~~~~~gt~~y~aPE~~~~---~~~~~~~~DvwSlGvil~ell~G~~pf~~~ 343 (492)
+.++ +|||+|||.+.....+. .....+|||.|+|||.+.+ ....+.+.||||+||+||+|+.|+.||-+.
T Consensus 244 ~~~g-~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~ 322 (576)
T KOG0585|consen 244 SSDG-TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD 322 (576)
T ss_pred cCCC-cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence 9997 89999999987663321 2234789999999999976 334578999999999999999999999999
Q ss_pred ChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 344 SGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 344 ~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
...+.+.+|+. ..+.||.. +.+.++++|||.+||++||++|+++.++..|||.
T Consensus 323 ~~~~l~~KIvn-----------------~pL~fP~~----------pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 323 FELELFDKIVN-----------------DPLEFPEN----------PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred hHHHHHHHHhc-----------------CcccCCCc----------ccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 99999998877 45566653 2478999999999999999999999999999999
Q ss_pred CCC
Q 011138 424 DDL 426 (492)
Q Consensus 424 ~~~ 426 (492)
..-
T Consensus 376 t~~ 378 (576)
T KOG0585|consen 376 TRD 378 (576)
T ss_pred ccC
Confidence 865
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=411.02 Aligned_cols=255 Identities=30% Similarity=0.506 Sum_probs=221.5
Q ss_pred CccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcC-CCCccccceeeeeccC
Q 011138 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLN-HPNVVSLKHCFFSTTE 204 (492)
Q Consensus 133 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~ 204 (492)
+....+|.+.++||+|+||+|+++..+.+++.||||.++++. .....|..|+.... ||.+++++.+|
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f----- 438 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF----- 438 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----
Confidence 344567999999999999999999999999999999987653 33457888888776 99999999999
Q ss_pred CCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeee
Q 011138 205 KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (492)
Q Consensus 205 ~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DF 284 (492)
+...++|+||||+.|+.+ .+ ......|++..+++|+..|+.||.|||+ +||||||||.+|||+|.+| .+||+||
T Consensus 439 QT~~~l~fvmey~~Ggdm---~~-~~~~~~F~e~rarfyaAev~l~L~fLH~-~~IIYRDlKLdNiLLD~eG-h~kiADF 512 (694)
T KOG0694|consen 439 QTKEHLFFVMEYVAGGDL---MH-HIHTDVFSEPRARFYAAEVVLGLQFLHE-NGIIYRDLKLDNLLLDTEG-HVKIADF 512 (694)
T ss_pred ccCCeEEEEEEecCCCcE---EE-EEecccccHHHHHHHHHHHHHHHHHHHh-cCceeeecchhheEEcccC-cEEeccc
Confidence 566679999999998752 12 2234779999999999999999999998 9999999999999999999 5999999
Q ss_pred cCccccC-CCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 011138 285 GSAKMLV-PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (492)
Q Consensus 285 G~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~ 363 (492)
|+++... .+....++||||.|||||++.+.. |+.++|+|||||+|||||.|+.||.|++..+.+..|+.
T Consensus 513 GlcKe~m~~g~~TsTfCGTpey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~--------- 582 (694)
T KOG0694|consen 513 GLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN--------- 582 (694)
T ss_pred ccccccCCCCCccccccCChhhcChhhhccCc-ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc---------
Confidence 9998765 566777899999999999997665 99999999999999999999999999999998888876
Q ss_pred HhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCC-----HHHhhCCCCCCCCCC
Q 011138 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-----ALEACAHPFFDDLRD 428 (492)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-----~~e~l~Hp~f~~~~~ 428 (492)
.+.. |+..+|.++.++++++|..||++|+. +.+|..||||+.+..
T Consensus 583 --------d~~~------------yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w 632 (694)
T KOG0694|consen 583 --------DEVR------------YPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDW 632 (694)
T ss_pred --------CCCC------------CCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCH
Confidence 2333 33468999999999999999999996 578999999998764
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=391.16 Aligned_cols=276 Identities=33% Similarity=0.632 Sum_probs=230.3
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
.+|.+.+.||.|+||.||+|.+..++..||+|.+... .....+|+.+++.++||||+++++++ .+..+++
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~ 79 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-----HTERCLT 79 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeEE
Confidence 4699999999999999999999999999999988532 12345799999999999999999988 4445689
Q ss_pred EEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
+||||+.+++...+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++...
T Consensus 80 lv~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~~~-~~kl~DfG~~~~~~ 154 (288)
T cd07871 80 LVFEYLDSDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHK-RKILHRDLKPQNLLINEKG-ELKLADFGLARAKS 154 (288)
T ss_pred EEEeCCCcCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCC-CEEECcCcceeecc
Confidence 9999999877765432 23457888999999999999999997 9999999999999999887 79999999987543
Q ss_pred CCC-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC--
Q 011138 292 PGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN-- 368 (492)
Q Consensus 292 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~-- 368 (492)
... ......+|+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+.+.++.|+.+.+....
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 155 VPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred CCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence 222 23346789999999999776678999999999999999999999999999999999999999999988876543
Q ss_pred CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
..+..+.+|.....++.. ....++++++|||++||++||.+|||+.|+++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 235 EEFRSYLFPQYRAQPLIN-HAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hhhhccccCccCCCchHH-hCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 233344455443333332 224678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-51 Score=402.36 Aligned_cols=250 Identities=32% Similarity=0.525 Sum_probs=216.4
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
.+|.+.+.||+|+||+||+|+.+.+.+.||||.+.+.. +...+|++|++.|+|||||.++++| +....+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceE
Confidence 36889999999999999999999999999999986543 2356899999999999999999999 556669
Q ss_pred EEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 211 ~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
++|.|||.|+|..++.. ...+++..++.+++|++.||.|||+ .+|+|||+||.|||++.++ .+|+||||+|+.+
T Consensus 77 ~vVte~a~g~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs-~rilhrd~kPqniLl~~~~-~~KlcdFg~Ar~m 150 (808)
T KOG0597|consen 77 WVVTEYAVGDLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHS-NRILHRDMKPQNILLEKGG-TLKLCDFGLARAM 150 (808)
T ss_pred EEEehhhhhhHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHh-cCcccccCCcceeeecCCC-ceeechhhhhhhc
Confidence 99999999988876554 6789999999999999999999997 9999999999999999888 7999999999987
Q ss_pred CCCCC-CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 291 VPGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 291 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
..+.. .....|||.|||||++.+ ..|+..+|+||+|||+|||++|++||...+-.+....|.+
T Consensus 151 ~~~t~vltsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~--------------- 214 (808)
T KOG0597|consen 151 STNTSVLTSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILK--------------- 214 (808)
T ss_pred ccCceeeeeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhc---------------
Confidence 55443 345689999999999975 4599999999999999999999999988776655555544
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
.+.+ .+..++.++++|+..+|++||.+|+|..+++.|||++.-.
T Consensus 215 --d~v~------------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 215 --DPVK------------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred --CCCC------------CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhh
Confidence 1111 1236899999999999999999999999999999998644
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=362.83 Aligned_cols=252 Identities=31% Similarity=0.467 Sum_probs=221.4
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
..++|.+++.||+|-||.||+|+.+.++-.||+|++.+.. ..+.||++|...|+||||+++|++| .|.
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f-----hd~ 94 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF-----HDS 94 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe-----ecc
Confidence 3457999999999999999999999999999999986543 4566899999999999999999999 677
Q ss_pred eEEEEEeeech-hhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 208 LYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 208 ~~~~lV~E~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
..+||++||.. |.++..+. ......+++..+..|++|++.||.|+|. ++||||||||+|+|++.++ .+||+|||.
T Consensus 95 ~riyLilEya~~gel~k~L~--~~~~~~f~e~~~a~Yi~q~A~Al~y~h~-k~VIhRdiKpenlLlg~~~-~lkiAdfGw 170 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQ--EGRMKRFDEQRAATYIKQLANALLYCHL-KRVIHRDIKPENLLLGSAG-ELKIADFGW 170 (281)
T ss_pred ceeEEEEEecCCchHHHHHH--hcccccccccchhHHHHHHHHHHHHhcc-CCcccCCCCHHHhccCCCC-CeeccCCCc
Confidence 78999999998 45555443 1235668889999999999999999997 9999999999999999888 899999999
Q ss_pred ccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 011138 287 AKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (492)
Q Consensus 287 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~ 366 (492)
+.... .....+.|||..|.+||++.+.. ++..+|+|++|++.||++.|.+||...+..+.+.+|.+
T Consensus 171 sV~~p-~~kR~tlcgt~dyl~pEmv~~~~-hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k------------ 236 (281)
T KOG0580|consen 171 SVHAP-SNKRKTLCGTLDYLPPEMVEGRG-HDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK------------ 236 (281)
T ss_pred eeecC-CCCceeeecccccCCHhhcCCCC-ccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH------------
Confidence 87543 66677899999999999997655 89999999999999999999999999998888888877
Q ss_pred cCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
.++.+| ..++.++.|||.+||.++|.+|.+..|++.|||+...
T Consensus 237 -----~~~~~p------------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 237 -----VDLKFP------------STISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred -----ccccCC------------cccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 344444 4689999999999999999999999999999998754
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-50 Score=390.45 Aligned_cols=256 Identities=32% Similarity=0.510 Sum_probs=206.7
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
.+|..++.||+|+||.||++.+..+|+..|||.+... ...+.+|+.+|++|+|||||++++....... ..++|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---DEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---eeeEe
Confidence 3588889999999999999999999999999988665 4456899999999999999999987433221 46889
Q ss_pred EeeechhhHH-HHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcC-CCCcEEEeeecCcccc
Q 011138 213 VLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP-HTHQLKICDFGSAKML 290 (492)
Q Consensus 213 V~E~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~-~~~~vkL~DFG~a~~~ 290 (492)
.|||++++.+ +++.. ....+++..++.+++||+.||+|||+ +|||||||||+|||++. ++ .+||+|||+++..
T Consensus 94 ~mEy~~~GsL~~~~~~---~g~~l~E~~v~~ytr~iL~GL~ylHs-~g~vH~DiK~~NiLl~~~~~-~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKR---YGGKLPEPLVRRYTRQILEGLAYLHS-KGIVHCDIKPANILLDPSNG-DVKLADFGLAKKL 168 (313)
T ss_pred eeeccCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCcccceEEEeCCCC-eEEeccCcccccc
Confidence 9999997544 33332 22269999999999999999999997 99999999999999998 56 8999999999876
Q ss_pred CC----CCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCHHHHh
Q 011138 291 VP----GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGE-SGVDQLVEIIKILGTPTREEIK 365 (492)
Q Consensus 291 ~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~-~~~~~~~~i~~~~g~p~~~~~~ 365 (492)
.. ........||+.|||||++........++|||||||++.||+||.+||... ...+.+..+...
T Consensus 169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~---------- 238 (313)
T KOG0198|consen 169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRE---------- 238 (313)
T ss_pred ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhcc----------
Confidence 53 122345789999999999975322345999999999999999999999873 333333333221
Q ss_pred hcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
...| .++..+|+++++||.+||.+||++||||+++|+|||.+...
T Consensus 239 --------~~~P---------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 239 --------DSLP---------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred --------CCCC---------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 0111 23456899999999999999999999999999999998754
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=341.61 Aligned_cols=277 Identities=36% Similarity=0.670 Sum_probs=235.6
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
.|...++||+|.||+||+|++..+++.||+|.+.-+. ....||+.+++.|+|.|||++++.. ..+..+-
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl-----hsdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh-----ccCceeE
Confidence 3666788999999999999999999999999986543 3346899999999999999999987 4445588
Q ss_pred EEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
+|+|||..++.. .+...++.++...++.++.|+++||.|+|+ +++.||||||+|+||+.++ ++||+|||+++.+.
T Consensus 78 lvfe~cdqdlkk---yfdslng~~d~~~~rsfmlqllrgl~fchs-hnvlhrdlkpqnllin~ng-elkladfglarafg 152 (292)
T KOG0662|consen 78 LVFEFCDQDLKK---YFDSLNGDLDPEIVRSFMLQLLRGLGFCHS-HNVLHRDLKPQNLLINRNG-ELKLADFGLARAFG 152 (292)
T ss_pred EeHHHhhHHHHH---HHHhcCCcCCHHHHHHHHHHHHhhhhhhhh-hhhhhccCCcceEEeccCC-cEEecccchhhhcC
Confidence 999999987664 455668889999999999999999999997 9999999999999999998 89999999998763
Q ss_pred CCC-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC-
Q 011138 292 PGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN- 368 (492)
Q Consensus 292 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell-~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~- 368 (492)
-.- -....+.|.+|++|.+++|..-|+...|+||.|||+.|+. .|++.|++.+-.+++..|++.+|.|.++.|+.+.
T Consensus 153 ipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~ 232 (292)
T KOG0662|consen 153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK 232 (292)
T ss_pred CceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence 222 2234577999999999999999999999999999999999 5999999999999999999999999999998765
Q ss_pred -CCCcccCCCcccC-CCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 369 -PNYTEFKFPQIKA-HPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 369 -~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
++|.. +|.... ..|..+ -++++...+||++++|..+|.+|++++++++||||.+..
T Consensus 233 lpdyk~--yp~ypattswsqi-vp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s 290 (292)
T KOG0662|consen 233 LPDYKP--YPIYPATTSWSQI-VPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS 290 (292)
T ss_pred CCCCcc--cCCccccchHHHH-hhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence 33332 333222 234433 356778899999999999999999999999999999754
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-49 Score=395.39 Aligned_cols=254 Identities=35% Similarity=0.574 Sum_probs=218.9
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcC-CCCccccceeeeeccCCCce
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~~~ 208 (492)
..|.+++.||+|.||.||+|..+.||+.+|+|.+.+.. ....+|+.||+++. |||||++++.| ++..
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~-----e~~~ 109 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF-----EDPD 109 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE-----EcCC
Confidence 46999999999999999999999999999999986543 35678999999999 99999999999 5555
Q ss_pred EEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCC---CcEEEeee
Q 011138 209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT---HQLKICDF 284 (492)
Q Consensus 209 ~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~---~~vkL~DF 284 (492)
.+++|||+|.|+ +++.+... .+++..+..++.||+.++.|||+ .||+||||||+|+|+.... ..+|++||
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~-~gvvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHS-LGVVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred eEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 799999999954 55544432 39999999999999999999997 9999999999999996442 27999999
Q ss_pred cCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 011138 285 GSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (492)
Q Consensus 285 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~ 364 (492)
|++.....+......+||++|+|||++.+ ..|+..+||||+||++|.|++|.+||.+.+......+|..
T Consensus 184 Gla~~~~~~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~---------- 252 (382)
T KOG0032|consen 184 GLAKFIKPGERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILR---------- 252 (382)
T ss_pred CCceEccCCceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc----------
Confidence 99998877667778999999999999954 4599999999999999999999999999998888777655
Q ss_pred hhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
..+.|+ ...|..++..+++||++||..||.+|+|+.++|+|||++...
T Consensus 253 -------~~~~f~--------~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 253 -------GDFDFT--------SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG 300 (382)
T ss_pred -------CCCCCC--------CCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence 222222 223456899999999999999999999999999999998763
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=369.17 Aligned_cols=255 Identities=29% Similarity=0.485 Sum_probs=217.8
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------------hhhHHHHHHHHHHcC-CCCccccceeeeeccC
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------------KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTE 204 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------------~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~ 204 (492)
.|.-.++||.|.-++|.+|..+.+|+.+|+|++... .....+|+.||+++. ||+|+++.++|
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y----- 92 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY----- 92 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec-----
Confidence 477888999999999999999999999999988321 122347999999985 99999999999
Q ss_pred CCceEEEEEeeech-hhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEee
Q 011138 205 KDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICD 283 (492)
Q Consensus 205 ~~~~~~~lV~E~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~D 283 (492)
+...++++|+|.|+ |.|.+.+.. .-.+++...+.|++|++.|++|||. ++||||||||+|||++.+. ++||+|
T Consensus 93 es~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa-~~IVHRDLKpENILlddn~-~i~isD 166 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHA-RNIVHRDLKPENILLDDNM-NIKISD 166 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHH-hhhhhcccChhheeecccc-ceEEec
Confidence 66778999999998 556654432 4568899999999999999999996 9999999999999999887 899999
Q ss_pred ecCccccCCCCCCccceeccCccCchhhc-----CCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 011138 284 FGSAKMLVPGEPNISYICSRYYRAPELIF-----GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358 (492)
Q Consensus 284 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~ 358 (492)
||+|+.+.+++.....||||.|+|||.+. +...|+..+|+||+|||||.||.|.+||+.....-.+..|+.
T Consensus 167 FGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Ime---- 242 (411)
T KOG0599|consen 167 FGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIME---- 242 (411)
T ss_pred cceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHh----
Confidence 99999999999999999999999999983 445699999999999999999999999988776666666665
Q ss_pred CCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 359 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
..+.|.. . -|.+++.+++|||.+||+.||.+|+|+.|+|+||||.++..
T Consensus 243 -------------GkyqF~s---p-----eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~ 291 (411)
T KOG0599|consen 243 -------------GKYQFRS---P-----EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQ 291 (411)
T ss_pred -------------cccccCC---c-----chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHH
Confidence 2333332 2 23568999999999999999999999999999999976543
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=385.31 Aligned_cols=281 Identities=31% Similarity=0.554 Sum_probs=220.5
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++ .+..++|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~ 79 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII-----HTKETLT 79 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEE-----ecCCeEE
Confidence 46999999999999999999999999999999885332 2345799999999999999999988 4445689
Q ss_pred EEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
+||||+.++++..+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++....
T Consensus 80 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~ 154 (303)
T cd07869 80 LVFEYVHTDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQ-RYILHRDLKPQNLLISDTG-ELKLADFGLARAKS 154 (303)
T ss_pred EEEECCCcCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEECCCCcceecc
Confidence 9999999887765532 23568888999999999999999997 9999999999999999887 79999999987542
Q ss_pred C-CCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHhhcC-
Q 011138 292 P-GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESG-VDQLVEIIKILGTPTREEIKCMN- 368 (492)
Q Consensus 292 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~-~~~~~~i~~~~g~p~~~~~~~~~- 368 (492)
. ........||+.|+|||++.+...++.++|||||||++|+|++|..||.+..+ .+.+..+...++.|....+....
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 155 VPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred CCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence 2 22233467899999999987766789999999999999999999999987544 45667777777887766554322
Q ss_pred -CCCcccCCCcccCCCcccccC-CCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 369 -PNYTEFKFPQIKAHPWHKIFH-KRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 369 -~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
+.+....+.......+...+. ...++++++||.+||++||.+|||+.|+++||||+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 111111111111111111111 13567899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-48 Score=389.33 Aligned_cols=285 Identities=40% Similarity=0.689 Sum_probs=226.6
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++||||+++++++..........+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 489999999999999999999999999999988532 22345799999999999999999988665544445689
Q ss_pred EEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
+||||+++++...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++...
T Consensus 81 lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~-~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELMESDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHT-ANVFHRDLKPKNILANADC-KLKICDFGLARVAF 154 (338)
T ss_pred EEEecCCCCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCC-cEEEccCccccccc
Confidence 9999999887765542 3468899999999999999999997 9999999999999999888 79999999997543
Q ss_pred CCCC----CccceeccCccCchhhcCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 011138 292 PGEP----NISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (492)
Q Consensus 292 ~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~ 366 (492)
.... .....||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+...++..+...+|.|+...+..
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 2221 1345789999999998542 4589999999999999999999999999998888888888889888775543
Q ss_pred cCCCCcc-c--CCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCC
Q 011138 367 MNPNYTE-F--KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (492)
Q Consensus 367 ~~~~~~~-~--~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~ 429 (492)
....-.. + ........++...+ +.+++++.+||.+||+.||++|||+.|+++||||+++...
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~ 299 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKV 299 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCcc
Confidence 3211000 0 00000001111111 3468899999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-48 Score=377.47 Aligned_cols=275 Identities=40% Similarity=0.719 Sum_probs=223.5
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
+|.+.+.||+|+||.||+|++..+++.||||++... .....+|+.+++.++||||+++++++ ....++|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 76 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKLY 76 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEEE
Confidence 599999999999999999999999999999988543 22345799999999999999999988 4445689
Q ss_pred EEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
+||||++++++..+.. ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++....
T Consensus 77 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~ 151 (287)
T cd07848 77 LVFEYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHK-NDIVHRDIKPENLLISHND-VLKLCDFGFARNLS 151 (287)
T ss_pred EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-cEEEeeccCccccc
Confidence 9999999887765432 24568899999999999999999997 9999999999999999887 79999999998764
Q ss_pred CCC--CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc--
Q 011138 292 PGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM-- 367 (492)
Q Consensus 292 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~-- 367 (492)
... ......||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+..+....+..+...+...
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07848 152 EGSNANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS 230 (287)
T ss_pred ccccccccccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence 322 223457899999999997654 899999999999999999999999999888888888888887776655432
Q ss_pred CCCCcccCCCcccC-CCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 368 NPNYTEFKFPQIKA-HPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 368 ~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
++.+....++.... ..+...+...++.++++||++||++||++|||++++|+||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 22222222322211 112223334578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=399.12 Aligned_cols=282 Identities=23% Similarity=0.373 Sum_probs=214.8
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc---hhhHHHHHHHHHHcCCC------CccccceeeeeccCCC
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHP------NVVSLKHCFFSTTEKD 206 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~---~~~~~~E~~il~~l~h~------nIv~l~~~~~~~~~~~ 206 (492)
..+|.+.+.||+|+||+||+|.+..+++.||||++... ......|+.+++.++|. +|++++++|.. +
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~----~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN----E 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc----C
Confidence 45799999999999999999999999999999998543 22345688888887654 47888887742 2
Q ss_pred ceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCC---------
Q 011138 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH--------- 277 (492)
Q Consensus 207 ~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~--------- 277 (492)
..++|+|||++++.++..+.. ...+++..++.|+.||+.||.|||+..|||||||||+|||++.++.
T Consensus 204 ~~~~~iv~~~~g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 204 TGHMCIVMPKYGPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred CceEEEEEeccCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 346889999998888776543 3568899999999999999999995149999999999999986542
Q ss_pred ------cEEEeeecCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 011138 278 ------QLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVE 351 (492)
Q Consensus 278 ------~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~ 351 (492)
.+||+|||.+... .......+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..
T Consensus 280 ~~~~~~~vkl~DfG~~~~~--~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDE--RHSRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred cCCCCceEEECCCCccccC--ccccccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 4999999988643 2334467899999999999765 489999999999999999999999999999999999
Q ss_pred HHHHhCCCCHHHHhhcCCC-----CcccC--CCcccCCCcccc-----c-CCCCChhHhhhhccccccCCCCcCCHHHhh
Q 011138 352 IIKILGTPTREEIKCMNPN-----YTEFK--FPQIKAHPWHKI-----F-HKRMPPEALDLVSRLLQYSPSLRCTALEAC 418 (492)
Q Consensus 352 i~~~~g~p~~~~~~~~~~~-----~~~~~--~~~~~~~~~~~~-----~-~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l 418 (492)
+.+.+|.++.......... +.... .+......+... . .....+.+.|||.+||++||.+|||+.|+|
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 9999988776543211100 00000 000000000000 0 001246788999999999999999999999
Q ss_pred CCCCCCCCCC
Q 011138 419 AHPFFDDLRD 428 (492)
Q Consensus 419 ~Hp~f~~~~~ 428 (492)
+||||.....
T Consensus 437 ~Hp~~~~~~~ 446 (467)
T PTZ00284 437 THPYVLKYYP 446 (467)
T ss_pred cCccccccCC
Confidence 9999998653
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-49 Score=391.59 Aligned_cols=251 Identities=28% Similarity=0.471 Sum_probs=215.5
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
.|.....||+|+-|.||.|....+++.||||++... ++.+-+|+.+|+..+|+|||.+++.|+..+ .+++|
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d-----eLWVV 348 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGD-----ELWVV 348 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccc-----eeEEE
Confidence 588888999999999999999999999999998543 345568999999999999999999996654 38999
Q ss_pred eeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCC
Q 011138 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (492)
Q Consensus 214 ~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (492)
|||++|+.+..+-. ...+++.++..|+++++.||+|||. +||+|||||.+|||++.++ .+||+|||++..+...
T Consensus 349 MEym~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~-~gIiHrDIKSDnILL~~~g-~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHA-RGIIHRDIKSDNILLTMDG-SVKLTDFGFCAQISEE 422 (550)
T ss_pred EeecCCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHh-cceeeeccccceeEeccCC-cEEEeeeeeeeccccc
Confidence 99999876544332 3458899999999999999999997 9999999999999999998 7999999998877555
Q ss_pred C-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 011138 294 E-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372 (492)
Q Consensus 294 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~ 372 (492)
. ...+.+|||+|||||++.. ..|+.++||||||++++||+-|.+||-.++....+..|... |.|.
T Consensus 423 ~~KR~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~------------ 488 (550)
T KOG0578|consen 423 QSKRSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPK------------ 488 (550)
T ss_pred cCccccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCC------------
Confidence 4 5678899999999999964 45999999999999999999999999998887777776552 3322
Q ss_pred ccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
++ .+..+|++++|||.+||+.|+.+|++|.|+|+||||+..
T Consensus 489 -lk------------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 489 -LK------------NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred -cC------------CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence 11 235689999999999999999999999999999999643
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=376.29 Aligned_cols=279 Identities=34% Similarity=0.579 Sum_probs=221.5
Q ss_pred ceeEeeeeccCCceEEEEEEEcC-CCCEEEEEEeccch------hhHHHHHHHHHHc---CCCCccccceeeeeccCCCc
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLE-TGDSVAIKKVLQDK------RYKNRELQIMRLL---NHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~-~g~~vAiK~~~~~~------~~~~~E~~il~~l---~h~nIv~l~~~~~~~~~~~~ 207 (492)
+|.+.+.||+|+||.||+|.+.. +|..||+|.+.... ....+|+.+++.+ +||||+++++++........
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 59999999999999999999865 46889999875321 2334678877766 69999999998854443445
Q ss_pred eEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 208 ~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
..+++||||+.+++...+... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 82 ~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~-~~iiH~dlkp~Nil~~~~~-~~kl~Dfg~~ 157 (290)
T cd07862 82 TKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSG-QIKLADFGLA 157 (290)
T ss_pred CcEEEEEccCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEcCCC-CEEEccccce
Confidence 568899999998877665432 23458889999999999999999997 9999999999999999887 7999999999
Q ss_pred cccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
+............||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+.+..++...+.|....+...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 158 RIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred EeccCCcccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 876544444566789999999999654 4899999999999999999999999999999999999998888877655321
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
.. .....+......+... +.+.+++.+++||.+||+.||++|||+.++|+||||
T Consensus 237 ~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 237 VA-LPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hc-ccchhccCCCCCCHHH-HccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 11 0111111111111111 234578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=381.72 Aligned_cols=256 Identities=28% Similarity=0.459 Sum_probs=226.7
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
.+-|.+.+.||+|.|.+|-+|++.-||+.||||++.+.+ ..+.+|++.|+.++|||||+||++. .....
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-----DTQTK 91 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-----DTQTK 91 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-----cccce
Confidence 345999999999999999999999999999999996543 3345799999999999999999988 44445
Q ss_pred EEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 210 ~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
+|||+|+..+ ++++++.. ....+.+..++.|+.||+.|+.|+|+ ..+|||||||+||.+-+..+-|||+|||++.
T Consensus 92 lyLiLELGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHq-LHVVHRDLKPENVVFFEKlGlVKLTDFGFSN 167 (864)
T KOG4717|consen 92 LYLILELGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQ-LHVVHRDLKPENVVFFEKLGLVKLTDFGFSN 167 (864)
T ss_pred EEEEEEecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhh-hhhhcccCCcceeEEeeecCceEeeeccccc
Confidence 9999999986 66665443 35678999999999999999999998 8999999999999876665589999999999
Q ss_pred ccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
.+.++....+.||+..|-|||+++|..+..+++||||||||||.|++|++||+..++.+.+-.|+.+
T Consensus 168 kf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDC------------- 234 (864)
T KOG4717|consen 168 KFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDC------------- 234 (864)
T ss_pred cCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcc-------------
Confidence 9999999999999999999999999998888999999999999999999999999999999998773
Q ss_pred CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCC
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~ 429 (492)
.+.+| ..++.+++|||.+||+.||.+|.+.++|..|+|++....+
T Consensus 235 ----KYtvP------------shvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 235 ----KYTVP------------SHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRG 279 (864)
T ss_pred ----cccCc------------hhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCC
Confidence 33333 4689999999999999999999999999999999987543
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=378.15 Aligned_cols=280 Identities=33% Similarity=0.639 Sum_probs=229.5
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
..|.+.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++||||+++++++. .....+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 80 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH-----TDKSLT 80 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEe-----eCCeEE
Confidence 46999999999999999999999999999999885322 23457999999999999999999883 344689
Q ss_pred EEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
+||||+++++...+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++....
T Consensus 81 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~ 155 (309)
T cd07872 81 LVFEYLDKDLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHR-RKVLHRDLKPQNLLINERG-ELKLADFGLARAKS 155 (309)
T ss_pred EEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEECccccceecC
Confidence 9999999877765432 23457888999999999999999997 9999999999999999887 79999999987543
Q ss_pred CCC-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC-
Q 011138 292 PGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP- 369 (492)
Q Consensus 292 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~- 369 (492)
... ......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+.+.++.|....+.....
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07872 156 VPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN 235 (309)
T ss_pred CCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcch
Confidence 222 223457899999999987766789999999999999999999999999999999999999999998887765432
Q ss_pred -CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 370 -NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 370 -~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
.+..+.++.....++.. ....+++++++||.+||+.||.+|||+.|+++||||+.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 236 DEFKNYNFPKYKPQPLIN-HAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhhhhhcCccCCCchhh-hccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 12223333332222222 2245789999999999999999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=370.74 Aligned_cols=272 Identities=25% Similarity=0.427 Sum_probs=220.4
Q ss_pred CCCCccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccC
Q 011138 130 NGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE 204 (492)
Q Consensus 130 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 204 (492)
...+.....|.+..+||.|.-++||+|++..+++.||||++.-+ -..+.+|+..|+.++||||++++.+|..
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv--- 95 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV--- 95 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe---
Confidence 34555666899999999999999999999999999999998543 2556789999999999999999999944
Q ss_pred CCceEEEEEeeech-hhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEee
Q 011138 205 KDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICD 283 (492)
Q Consensus 205 ~~~~~~~lV~E~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~D 283 (492)
+..+|+||.||. |+++++++.+.. ..+.+..+..|++++++||.|||+ +|.||||||+.||||+.+| .|||+|
T Consensus 96 --~~~LWvVmpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~-~G~IHRdvKAgnILi~~dG-~VkLad 169 (516)
T KOG0582|consen 96 --DSELWVVMPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQ-NGHIHRDVKAGNILIDSDG-TVKLAD 169 (516)
T ss_pred --cceeEEeehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHh-cCceecccccccEEEcCCC-cEEEcC
Confidence 345999999998 567777765543 559999999999999999999997 9999999999999999998 899999
Q ss_pred ecCccccCCCCC-----CccceeccCccCchhh-cCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 011138 284 FGSAKMLVPGEP-----NISYICSRYYRAPELI-FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILG 357 (492)
Q Consensus 284 FG~a~~~~~~~~-----~~~~~gt~~y~aPE~~-~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g 357 (492)
||.+-.+..... ..+++||++|||||++ .....|+.|+||||||++..||.+|+.||......+.+..-++ +
T Consensus 170 Fgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq--n 247 (516)
T KOG0582|consen 170 FGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ--N 247 (516)
T ss_pred ceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc--C
Confidence 998765543221 1456899999999995 3445699999999999999999999999998877665554333 3
Q ss_pred CCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCC
Q 011138 358 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (492)
Q Consensus 358 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~ 429 (492)
.|+.... ........+..+..++.+|..||++||.+|||++++|.|+||+..+..
T Consensus 248 ~pp~~~t-----------------~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~ 302 (516)
T KOG0582|consen 248 DPPTLLT-----------------SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK 302 (516)
T ss_pred CCCCccc-----------------ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence 4432110 001111123467789999999999999999999999999999987653
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-47 Score=384.65 Aligned_cols=287 Identities=32% Similarity=0.559 Sum_probs=229.1
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccC-CCceE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY 209 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~-~~~~~ 209 (492)
.+|.+.+.||+|+||.||+|.+..+++.||||++... .....+|+.+++.++||||+++++++..... .....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~ 103 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 103 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence 4699999999999999999999999999999988542 1234579999999999999999998744321 23345
Q ss_pred EEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
+|+||||+++++...+. ..++...+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 104 ~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~ 175 (364)
T cd07875 104 VYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLART 175 (364)
T ss_pred EEEEEeCCCCCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEECCCC-cEEEEeCCCccc
Confidence 78999999988776542 247788889999999999999997 9999999999999999887 799999999986
Q ss_pred cCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
...........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..++..++.|..+.+....+
T Consensus 176 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (364)
T cd07875 176 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254 (364)
T ss_pred cCCCCcccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence 6444444566899999999999764 489999999999999999999999999999999999999999888765544322
Q ss_pred ----------CCcccCCCcc---cCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCCCC
Q 011138 370 ----------NYTEFKFPQI---KAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTC 432 (492)
Q Consensus 370 ----------~~~~~~~~~~---~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~~~ 432 (492)
.+..+.+... ...++........+.++++||.+||+.||.+|||+.|+|+||||..+.++...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~ 330 (364)
T cd07875 255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEA 330 (364)
T ss_pred HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcccC
Confidence 1111111110 00111122223356789999999999999999999999999999987765443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=384.82 Aligned_cols=284 Identities=32% Similarity=0.565 Sum_probs=225.4
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccC-CCceE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY 209 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~-~~~~~ 209 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++||||++++++|..... .....
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 100 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD 100 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence 4799999999999999999999999999999998532 2334579999999999999999998854332 22345
Q ss_pred EEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
+|+||||+++++...+. ..++...+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 101 ~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NIl~~~~~-~~kl~Dfg~a~~ 172 (359)
T cd07876 101 VYLVMELMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLART 172 (359)
T ss_pred eEEEEeCCCcCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCC-CEEEecCCCccc
Confidence 78999999988766432 347788899999999999999997 9999999999999999887 799999999976
Q ss_pred cCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc--
Q 011138 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM-- 367 (492)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~-- 367 (492)
...........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+++.++.|..+.+...
T Consensus 173 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (359)
T cd07876 173 ACTNFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251 (359)
T ss_pred cccCccCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence 5444444567889999999999664 4899999999999999999999999999988888889998888876543321
Q ss_pred --------CCCCcccCCCcccCCCc----ccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCC
Q 011138 368 --------NPNYTEFKFPQIKAHPW----HKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430 (492)
Q Consensus 368 --------~~~~~~~~~~~~~~~~~----~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~ 430 (492)
.+.+....+...- ..| ........++++++||.+||+.||++|||+.|+|+||||+.+.++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~ 325 (359)
T cd07876 252 TVRNYVENRPQYPGISFEELF-PDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPA 325 (359)
T ss_pred HHHHHHhhCCCCCCcchhhhc-cccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCcc
Confidence 1111111111100 000 0112234578899999999999999999999999999999776654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-47 Score=370.35 Aligned_cols=279 Identities=29% Similarity=0.527 Sum_probs=222.4
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHc---CCCCccccceeeeeccCCCce
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLL---NHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l---~h~nIv~l~~~~~~~~~~~~~ 208 (492)
+|.+.+.||+|+||+||+|.++.+|+.||+|.+.... ....+|+.+++.+ +||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4899999999999999999999999999999885321 2344677777765 699999999988655444456
Q ss_pred EEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 209 ~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
.+++||||+.+++...+... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++.
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~~~-~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTSGG-QVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccccCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-CEEECccCccc
Confidence 78999999998777655432 23458999999999999999999997 9999999999999999887 79999999998
Q ss_pred ccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
............||..|+|||++.+. .++.++|||||||++|+|++|.+||.+....+.+.++....+.+....+....
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 157 IYSCQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred cccCcccCCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence 76544444456789999999999654 48999999999999999999999999998888999999988887766554211
Q ss_pred CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
. .....+.......+. .+.+.+++++.+||.+||++||.+|||+.|++.||||
T Consensus 236 ~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 236 T-LPRGAFSPRGPRPVQ-SVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred c-ccccccCCCCCCchH-HhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 001111111111111 1224578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=387.54 Aligned_cols=280 Identities=36% Similarity=0.595 Sum_probs=225.2
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++||||+++++++..........+|+
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 81 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV 81 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence 77889999999999999999999999999987532 123457999999999999999999885443222336899
Q ss_pred EeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 213 V~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
||||+.+++...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++....
T Consensus 82 v~e~~~~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nili~~~~-~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 82 VTELMQSDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHS-AGILHRDIKPGNLLVNSNC-VLKICDFGLARVEEP 155 (372)
T ss_pred EeeccccCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHHEEECCCC-CEEeccccceeeccc
Confidence 999999877665432 4568899999999999999999997 9999999999999999887 899999999976533
Q ss_pred CC--CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 011138 293 GE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (492)
Q Consensus 293 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 370 (492)
.. ......+|+.|+|||++.+...++.++|||||||++|||++|++||.+.+..+++..+...+|.|+.+.+......
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 22 2234578999999999987667899999999999999999999999999999999999999999988765432110
Q ss_pred Cc------ccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 371 YT------EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 371 ~~------~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
.. ....+.. .....+....++++.+||.+||+.||.+|||+.|+++||||+..+
T Consensus 236 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 236 ARAHILRGPHKPPSL---PVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHHHHHhCCCCCCch---HHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 00 0000100 000012345688999999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-47 Score=374.02 Aligned_cols=248 Identities=25% Similarity=0.408 Sum_probs=207.1
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++||||+++++++ .+..++
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~ 76 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRFL 76 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCeE
Confidence 589999999999999999999999999999988532 22345799999999999999999887 555679
Q ss_pred EEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 211 ~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
|+||||+.++ +.+.+. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 77 ~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~NIli~~~~-~~kl~Dfg~~~~ 150 (291)
T cd05612 77 YMLMEYVPGGELFSYLR----NSGRFSNSTGLFYASEIVCALEYLHS-KEIVYRDLKPENILLDKEG-HIKLTDFGFAKK 150 (291)
T ss_pred EEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCC-CEEEEecCcchh
Confidence 9999999865 444332 24568889999999999999999997 9999999999999999887 799999999986
Q ss_pred cCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 151 ~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~-------------- 213 (291)
T cd05612 151 LRD--RTWTLCGTPEYLAPEVIQSK-GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG-------------- 213 (291)
T ss_pred ccC--CcccccCChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 533 23346799999999998654 4899999999999999999999999988766655555431
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCC-----HHHhhCCCCCCCCCC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-----ALEACAHPFFDDLRD 428 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-----~~e~l~Hp~f~~~~~ 428 (492)
... ++..+++.+++||++||+.||.+|++ ++++++||||+.+..
T Consensus 214 ---~~~------------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 262 (291)
T cd05612 214 ---KLE------------FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW 262 (291)
T ss_pred ---CcC------------CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence 111 22346889999999999999999995 999999999987654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-48 Score=370.16 Aligned_cols=247 Identities=27% Similarity=0.454 Sum_probs=217.8
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
.+|++.+.||+|.||.|-+|.+...|+.||||.|.+++ ..+++|++||..|+||||+++|++| ++...
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----ENkdK 127 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----ENKDK 127 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----cCCce
Confidence 46999999999999999999999999999999886653 2356899999999999999999999 55566
Q ss_pred EEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 210 ~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
+.|||||..+ .|++.+. ..+.+++.+++.+++||+.|+.|+|+ ++++|||||.+|||+|.++ ++||+|||++.
T Consensus 128 IvivMEYaS~GeLYDYiS----er~~LsErEaRhfFRQIvSAVhYCHk-nrVvHRDLKLENILLD~N~-NiKIADFGLSN 201 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYIS----ERGSLSEREARHFFRQIVSAVHYCHK-NRVVHRDLKLENILLDQNN-NIKIADFGLSN 201 (668)
T ss_pred EEEEEEecCCccHHHHHH----HhccccHHHHHHHHHHHHHHHHHHhh-ccceecccchhheeecCCC-Ceeeeccchhh
Confidence 8999999985 5665443 35779999999999999999999997 9999999999999999988 79999999999
Q ss_pred ccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
.+..+....++||+|.|.+||++.|..+-++.+|.|||||+||.|+.|..||+|.+....+.+|-..
T Consensus 202 ly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~G------------- 268 (668)
T KOG0611|consen 202 LYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRG------------- 268 (668)
T ss_pred hhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcc-------------
Confidence 8888888889999999999999998888899999999999999999999999999887777666441
Q ss_pred CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCC
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~ 424 (492)
.+ +.+.-+.++.-||+.||-.||++|.|++++..|-|+.
T Consensus 269 ----aY-------------rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 269 ----AY-------------REPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred ----cc-------------cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 11 1133577899999999999999999999999998875
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=381.41 Aligned_cols=284 Identities=33% Similarity=0.570 Sum_probs=227.7
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccC-CCceE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY 209 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~-~~~~~ 209 (492)
.+|.+.+.||+|+||.||+|.+..+++.||||++... .....+|+.+++.++||||++++++|..... .....
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 96 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQD 96 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccce
Confidence 4799999999999999999999999999999988542 1234479999999999999999998854332 23345
Q ss_pred EEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
+|+||||+++++...+. ..++...+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 97 ~~lv~e~~~~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~Nill~~~~-~~kl~Dfg~~~~ 168 (355)
T cd07874 97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLART 168 (355)
T ss_pred eEEEhhhhcccHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEECCCC-CEEEeeCccccc
Confidence 78999999988766442 347788899999999999999997 9999999999999999887 799999999986
Q ss_pred cCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC-
Q 011138 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN- 368 (492)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~- 368 (492)
...........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..++..++.|..+.+....
T Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (355)
T cd07874 169 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_pred CCCccccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence 6444444567899999999999665 48999999999999999999999999999889999999999988776554332
Q ss_pred ---------CCCcccCCCcccC---CCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCC
Q 011138 369 ---------PNYTEFKFPQIKA---HPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (492)
Q Consensus 369 ---------~~~~~~~~~~~~~---~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~ 429 (492)
+.+....++.... .+.........+.++++||.+||+.||++|||+.|+|+||||..+.++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~ 320 (355)
T cd07874 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP 320 (355)
T ss_pred HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence 2222222222110 011112233457789999999999999999999999999999876554
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-47 Score=370.97 Aligned_cols=256 Identities=25% Similarity=0.388 Sum_probs=206.3
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
|.+.+.||+|+||.||+|.+..+|+.||+|.+.... ....+|+.+++.++|+||+++++++ .+..+++
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~~ 76 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDALC 76 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeEE
Confidence 788999999999999999999999999999875322 2345799999999999999999888 4445689
Q ss_pred EEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
+||||+.++.+..... ......+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++....
T Consensus 77 lv~e~~~~g~L~~~~~-~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nill~~~~-~~kl~Dfg~~~~~~ 153 (285)
T cd05631 77 LVLTIMNGGDLKFHIY-NMGNPGFDEQRAIFYAAELCCGLEDLQR-ERIVYRDLKPENILLDDRG-HIRISDLGLAVQIP 153 (285)
T ss_pred EEEEecCCCcHHHHHH-hhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECCCC-CEEEeeCCCcEEcC
Confidence 9999998764432211 1123468899999999999999999997 9999999999999999877 79999999998765
Q ss_pred CCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 011138 292 PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (492)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~ 371 (492)
.........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+...+..+.
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~----------- 221 (285)
T cd05631 154 EGETVRGRVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ----------- 221 (285)
T ss_pred CCCeecCCCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc-----------
Confidence 44444556899999999999754 589999999999999999999999987665333333322111100
Q ss_pred cccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCC-----HHHhhCCCCCCCCCC
Q 011138 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-----ALEACAHPFFDDLRD 428 (492)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-----~~e~l~Hp~f~~~~~ 428 (492)
..++..+++++.+||++||+.||.+|++ ++++++||||+++..
T Consensus 222 --------------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05631 222 --------------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINF 269 (285)
T ss_pred --------------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence 0123457899999999999999999997 899999999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-47 Score=379.35 Aligned_cols=249 Identities=29% Similarity=0.455 Sum_probs=207.1
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
..+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++ .+..
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~ 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-----QDEN 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EcCC
Confidence 457999999999999999999999999999999986432 2345799999999999999999988 4455
Q ss_pred EEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 209 ~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
++|+||||+.++ +...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 92 ~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~ 165 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLR----KAGRFPNDVAKFYHAELVLAFEYLHS-KDIIYRDLKPENLLLDNKG-HVKVTDFGFA 165 (329)
T ss_pred EEEEEEcCCCCChHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEECCCC-CEEEeeccCc
Confidence 689999999865 444332 24568889999999999999999997 9999999999999999888 7999999999
Q ss_pred cccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
+.... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+..
T Consensus 166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~------------- 229 (329)
T PTZ00263 166 KKVPD--RTFTLCGTPEYLAPEVIQSKG-HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA------------- 229 (329)
T ss_pred eEcCC--CcceecCChhhcCHHHHcCCC-CCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc-------------
Confidence 86533 233568999999999996554 79999999999999999999999988776555544432
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCC-----HHHhhCCCCCCCCC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-----ALEACAHPFFDDLR 427 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-----~~e~l~Hp~f~~~~ 427 (492)
....+ +..++.++++||.+||+.||.+|++ +.++++||||.+..
T Consensus 230 ----~~~~~------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~ 278 (329)
T PTZ00263 230 ----GRLKF------------PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGAN 278 (329)
T ss_pred ----CCcCC------------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCC
Confidence 11111 2346889999999999999999997 79999999998754
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=374.40 Aligned_cols=278 Identities=31% Similarity=0.525 Sum_probs=211.1
Q ss_pred eeeeccCCceEEEEEEEc--CCCCEEEEEEeccch--hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEeeec
Q 011138 142 ERVVGTGSFGVVFQAKCL--ETGDSVAIKKVLQDK--RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (492)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~--~~g~~vAiK~~~~~~--~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E~~ 217 (492)
++.||+|+||+||+|+++ .+++.||+|.+.... ....+|+.+++.++||||++++++|... ....+|+||||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecC---CCcEEEEEEecc
Confidence 457999999999999965 467899999886532 3456899999999999999999988543 234688999999
Q ss_pred hhhHHHHhhhhhh-----cCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcC---CCCcEEEeeecCccc
Q 011138 218 SETVYRVSKHYTR-----MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP---HTHQLKICDFGSAKM 289 (492)
Q Consensus 218 ~~~l~~~~~~~~~-----~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~---~~~~vkL~DFG~a~~ 289 (492)
++++...+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ..+.+||+|||+++.
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 9887776543211 12358899999999999999999997 99999999999999942 223799999999976
Q ss_pred cCCCC----CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHHh
Q 011138 290 LVPGE----PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESG---------VDQLVEIIKIL 356 (492)
Q Consensus 290 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~---------~~~~~~i~~~~ 356 (492)
..... ......||+.|+|||++.+...++.++||||+||++|+|++|++||.+... .+++..+...+
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 53321 223467899999999998766789999999999999999999999975432 46677888889
Q ss_pred CCCCHHHHhhcCCCC---------cccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 357 GTPTREEIKCMNPNY---------TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 357 g~p~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
|.|....+....... ....+.......+........+.++.+||++||++||.+|||++|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 988877665432110 0000000000001011112346779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-47 Score=387.12 Aligned_cols=277 Identities=25% Similarity=0.353 Sum_probs=214.3
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEee
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E 215 (492)
..+|.+.+.||+|+||.||+|.+..+++.||||.... ....+|+.+++.|+|||||+++++|. ...+.++|||
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~lv~e 163 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--GGTATEAHILRAINHPSIIQLKGTFT-----YNKFTCLILP 163 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--hhhHHHHHHHHhCCCCCCCCEeEEEE-----ECCeeEEEEe
Confidence 3469999999999999999999999999999997543 34568999999999999999999883 3446889999
Q ss_pred echhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCC--
Q 011138 216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG-- 293 (492)
Q Consensus 216 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~-- 293 (492)
++.++++..+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+|+.....
T Consensus 164 ~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~-~~IvHrDiKP~NIll~~~~-~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 164 RYKTDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHE-NRIIHRDIKAENIFINHPG-DVCLGDFGAACFPVDINA 237 (391)
T ss_pred cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHhEEEcCCC-CEEEEeCCcccccccccc
Confidence 999877765432 3468889999999999999999997 9999999999999999887 7999999999753221
Q ss_pred CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCC-------ChHHHHHHHHHHhCCCCHHHHhh
Q 011138 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGE-------SGVDQLVEIIKILGTPTREEIKC 366 (492)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~-------~~~~~~~~i~~~~g~p~~~~~~~ 366 (492)
.......||+.|+|||++.+. .++.++|||||||++|||++|..||... ....++..++..+|.++.+....
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred cccccccCccCCCChhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 223356899999999999654 5899999999999999999999887543 23456777888777765332100
Q ss_pred cCCCCc---------ccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCC
Q 011138 367 MNPNYT---------EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (492)
Q Consensus 367 ~~~~~~---------~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~ 429 (492)
...... ....+. ....|... ..++.++.+||.+||++||.+|||+.|+|+||||+.+..+
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 385 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPG-SRPLWTNL--YELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP 385 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCC-CCCCHHHH--hhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence 000000 000000 00111111 1357789999999999999999999999999999987543
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-47 Score=378.30 Aligned_cols=245 Identities=28% Similarity=0.445 Sum_probs=201.2
Q ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEee
Q 011138 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E 215 (492)
++||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||++++++| ....++|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence 36999999999999999999999999986432 2234699999999999999999988 44557899999
Q ss_pred echhhHH-HHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC-C
Q 011138 216 YISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP-G 293 (492)
Q Consensus 216 ~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~-~ 293 (492)
|+.++.+ ..+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.... .
T Consensus 76 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivHrDlkp~NIll~~~~-~~kl~DfG~a~~~~~~~ 149 (323)
T cd05571 76 YANGGELFFHLS----RERVFSEDRARFYGAEIVSALGYLHS-CDVVYRDLKLENLMLDKDG-HIKITDFGLCKEGISDG 149 (323)
T ss_pred CCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECCCC-CEEEeeCCCCcccccCC
Confidence 9987543 3222 24568899999999999999999997 9999999999999999887 799999999875422 2
Q ss_pred CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 011138 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373 (492)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~ 373 (492)
......+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+.......+.. ..
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~-----------------~~ 211 (323)
T cd05571 150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-----------------EE 211 (323)
T ss_pred CcccceecCccccChhhhcCC-CCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc-----------------CC
Confidence 233456899999999999654 489999999999999999999999988766554444322 11
Q ss_pred cCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcC-----CHHHhhCCCCCCCCCC
Q 011138 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLRD 428 (492)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----t~~e~l~Hp~f~~~~~ 428 (492)
.. ++..+++++.+||.+||+.||++|| ++.++++||||+.+..
T Consensus 212 ~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~ 259 (323)
T cd05571 212 IR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINW 259 (323)
T ss_pred CC------------CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 11 2245789999999999999999999 8999999999987643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=368.14 Aligned_cols=282 Identities=33% Similarity=0.617 Sum_probs=229.0
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
.+|.+.+.||.|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++||||+++++++ ....+++
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~-----~~~~~~~ 80 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKSLT 80 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEE-----ecCCeEE
Confidence 46999999999999999999999999999999885321 2345799999999999999999998 4445689
Q ss_pred EEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
+||||+.+++...+.. ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++....
T Consensus 81 lv~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~ 155 (301)
T cd07873 81 LVFEYLDKDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHR-RKVLHRDLKPQNLLINERG-ELKLADFGLARAKS 155 (301)
T ss_pred EEEeccccCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHHHEEECCCC-cEEECcCcchhccC
Confidence 9999999877665432 23467889999999999999999997 9999999999999999887 79999999987543
Q ss_pred CCC-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC-
Q 011138 292 PGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP- 369 (492)
Q Consensus 292 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~- 369 (492)
... ......+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..+...++.|....+..+..
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 156 IPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred CCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcc
Confidence 222 223456789999999987766688999999999999999999999999998888888999998888776654321
Q ss_pred -CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCC
Q 011138 370 -NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (492)
Q Consensus 370 -~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~ 429 (492)
.+....++....... ......+++++++||.+||+.||.+|||+.|+++||||+.+...
T Consensus 236 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~ 295 (301)
T cd07873 236 EEFKSYNYPKYRADCL-HNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGER 295 (301)
T ss_pred ccccccccCccccccH-HhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccch
Confidence 122223333221111 12234678999999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-48 Score=356.75 Aligned_cols=284 Identities=37% Similarity=0.630 Sum_probs=228.7
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCC----EEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCC
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGD----SVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~----~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 206 (492)
..|++...||+|.||.||+|..+.++. .+|||++...+ ...-||+.+++.|+||||+.|..+|...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~---- 99 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH---- 99 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc----
Confidence 359999999999999999997665543 68999886542 2334899999999999999999998653
Q ss_pred ceEEEEEeeechhhHHHHhhhhhhc-CCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCC----CCcEEE
Q 011138 207 ELYLNLVLEYISETVYRVSKHYTRM-NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH----THQLKI 281 (492)
Q Consensus 207 ~~~~~lV~E~~~~~l~~~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~----~~~vkL 281 (492)
+..+++++||.+.+|+.++.+.+.. ...++...++.|+.||+.|+.|||+ +=|+||||||.||||..+ | .|||
T Consensus 100 d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~-NWvlHRDLKPaNIlvmgdgperG-~VKI 177 (438)
T KOG0666|consen 100 DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS-NWVLHRDLKPANILVMGDGPERG-RVKI 177 (438)
T ss_pred CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh-hheeeccCCcceEEEeccCCccC-eeEe
Confidence 3468999999999999988765443 3568899999999999999999997 889999999999999766 5 8999
Q ss_pred eeecCccccCCCC----CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC---------hHHH
Q 011138 282 CDFGSAKMLVPGE----PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES---------GVDQ 348 (492)
Q Consensus 282 ~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~---------~~~~ 348 (492)
+|||+++.+.+.- .....+.|.+|+|||+++|...|+.++||||+|||+.|||+-.+.|.+.. ..++
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 9999999874332 22346789999999999999999999999999999999999999997642 4578
Q ss_pred HHHHHHHhCCCCHHHHhhcC--CCCcc--cCCCc--ccCCCcccccC--CCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 349 LVEIIKILGTPTREEIKCMN--PNYTE--FKFPQ--IKAHPWHKIFH--KRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 349 ~~~i~~~~g~p~~~~~~~~~--~~~~~--~~~~~--~~~~~~~~~~~--~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
+..|++++|.|+...|+.+. |.+.. -.|+. .....+...++ +.-++.+.+|+.+||++||-+|+|++++|+|
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 99999999999999887653 33311 01111 11111222222 2345669999999999999999999999999
Q ss_pred CCCCCC
Q 011138 421 PFFDDL 426 (492)
Q Consensus 421 p~f~~~ 426 (492)
+||+.-
T Consensus 338 ~yF~~d 343 (438)
T KOG0666|consen 338 PYFTED 343 (438)
T ss_pred cccccC
Confidence 999964
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=377.80 Aligned_cols=284 Identities=34% Similarity=0.613 Sum_probs=227.2
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccC-CCceE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY 209 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~-~~~~~ 209 (492)
.+|.+.+.||+|+||+||+|.+..+++.||||++.... ....+|+.+++.++||||++++++|..... .....
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 46999999999999999999999999999999885432 234479999999999999999998743321 22345
Q ss_pred EEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
+|++||++++++..... ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 95 ~~~~~~~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~ 167 (343)
T cd07878 95 VYLVTNLMGADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHS-AGIIHRDLKPSNVAVNEDC-ELRILDFGLARQ 167 (343)
T ss_pred EEEEeecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCChhhEEECCCC-CEEEcCCcccee
Confidence 78999999877765443 3468999999999999999999997 9999999999999999887 799999999986
Q ss_pred cCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
... ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+..+.+.....
T Consensus 168 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07878 168 ADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245 (343)
T ss_pred cCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence 532 334568999999999997766789999999999999999999999999988888888988888887765543322
Q ss_pred CCcc---cCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCC
Q 011138 370 NYTE---FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430 (492)
Q Consensus 370 ~~~~---~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~ 430 (492)
.... ..++......+... ....++.+.+||.+||..||.+|||+.|+++||||....++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~ 308 (343)
T cd07878 246 EHARKYIQSLPHMPQQDLKKI-FRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPE 308 (343)
T ss_pred hhHHHHhhccccccchhHHHh-ccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCc
Confidence 1110 01111111111111 234678899999999999999999999999999999877654
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=374.06 Aligned_cols=320 Identities=35% Similarity=0.635 Sum_probs=247.7
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||||.+... .....+|+.+++.++|+||+++++++..........+|
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 84 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY 84 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence 4699999999999999999999999999999988531 12244699999999999999999987554444455689
Q ss_pred EEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
+|+||+.+++...+. ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++....
T Consensus 85 lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~-~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~ 157 (336)
T cd07849 85 IVQELMETDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTNC-DLKICDFGLARIAD 157 (336)
T ss_pred EEehhcccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECCCC-CEEECcccceeecc
Confidence 999999987765443 3468999999999999999999997 9999999999999999887 79999999987653
Q ss_pred CCCC----CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 292 PGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 292 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
.... .....||+.|+|||.+.+...++.++|||||||++|+|++|++||.+.+....+..+...++.|..+.+...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 3221 123578999999999866666899999999999999999999999998888888888888998887766443
Q ss_pred CCCCccc---CCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 011138 368 NPNYTEF---KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTLFN 444 (492)
Q Consensus 368 ~~~~~~~---~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~~~~~~~~~~~~~~~ 444 (492)
....... ..+.....++.. ..+.+++++.+||.+||+.||.+|||+.++++||||+.+.++........+ ..+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~--~~~~ 314 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNK-LFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEP--FPFD 314 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHH-HhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcccCCCC--CChh
Confidence 2111100 011111111211 123468899999999999999999999999999999998875443222122 1222
Q ss_pred CCcccccccccccccccccccCccchhHHHhcCCHHHHhhcccccccC
Q 011138 445 FTAQGKLILCFSYFGFSSYFLPHANCLAELAGASNELRQRLIPEHARK 492 (492)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 492 (492)
|. ++...+.|.++++|.+++++
T Consensus 315 ~~--------------------------~~~~~~~~~~~~~~~~~~~~ 336 (336)
T cd07849 315 FE--------------------------LFDDLPKEKLKELIFEEIMR 336 (336)
T ss_pred hc--------------------------cccccCHHHHHHHHHHHhcC
Confidence 22 44567899999999988764
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=377.96 Aligned_cols=253 Identities=26% Similarity=0.407 Sum_probs=204.0
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
+|.+.+.||+|+||+||+|.+..+|+.||||++.+.. ....+|+.+++.++|+||+++++++ .+..++
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~~ 76 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLNL 76 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCeE
Confidence 5899999999999999999999999999999986432 2345799999999999999999988 455579
Q ss_pred EEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 211 ~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
|+||||++++ +...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 77 ~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~-~givHrDlKp~NILi~~~~-~vkL~DFGla~~ 150 (363)
T cd05628 77 YLIMEFLPGGDMMTLLM----KKDTLTEEETQFYIAETVLAIDSIHQ-LGFIHRDIKPDNLLLDSKG-HVKLSDFGLCTG 150 (363)
T ss_pred EEEEcCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECCCC-CEEEeeccCccc
Confidence 9999999865 444332 24568999999999999999999997 9999999999999999887 799999999875
Q ss_pred cCCCC------------------------------------CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHH
Q 011138 290 LVPGE------------------------------------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAEL 333 (492)
Q Consensus 290 ~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~el 333 (492)
..... .....+||+.|+|||++.+. .++.++|||||||++|||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~el 229 (363)
T cd05628 151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEM 229 (363)
T ss_pred ccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CCCCchhhhhhHHHHHHH
Confidence 42211 01245799999999999765 489999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCC---C
Q 011138 334 LLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPS---L 410 (492)
Q Consensus 334 l~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~---~ 410 (492)
++|++||.+.+..+.+.++.... ....+|.. ..+++++++||.+|+. +|. .
T Consensus 230 l~G~~Pf~~~~~~~~~~~i~~~~---------------~~~~~p~~----------~~~s~~~~~li~~l~~-~~~~r~~ 283 (363)
T cd05628 230 LIGYPPFCSETPQETYKKVMNWK---------------ETLIFPPE----------VPISEKAKDLILRFCC-EWEHRIG 283 (363)
T ss_pred HhCCCCCCCCCHHHHHHHHHcCc---------------CcccCCCc----------CCCCHHHHHHHHHHcC-ChhhcCC
Confidence 99999999888776666654411 01112210 1368999999999775 454 4
Q ss_pred cCCHHHhhCCCCCCCCCC
Q 011138 411 RCTALEACAHPFFDDLRD 428 (492)
Q Consensus 411 R~t~~e~l~Hp~f~~~~~ 428 (492)
||+++|+++||||+++..
T Consensus 284 r~~~~ei~~hp~f~~~~~ 301 (363)
T cd05628 284 APGVEEIKTNPFFEGVDW 301 (363)
T ss_pred CCCHHHHhCCCCCCCCCH
Confidence 589999999999998643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=373.98 Aligned_cols=251 Identities=30% Similarity=0.451 Sum_probs=206.5
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCC-CEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCC
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETG-DSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g-~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 206 (492)
...+|.+.+.||+|+||.||+|.+..++ ..||+|.+.... ....+|+.+++.++||||+++++++ .+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~ 102 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----KD 102 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----Ee
Confidence 4457999999999999999999876655 689999885432 2345799999999999999999998 44
Q ss_pred ceEEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeec
Q 011138 207 ELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (492)
Q Consensus 207 ~~~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG 285 (492)
..++|+||||+.++ +...+. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 103 ~~~~~lv~Ey~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~-~ikL~DFG 176 (340)
T PTZ00426 103 ESYLYLVLEFVIGGEFFTFLR----RNKRFPNDVGCFYAAQIVLIFEYLQS-LNIVYRDLKPENLLLDKDG-FIKMTDFG 176 (340)
T ss_pred CCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECCCC-CEEEecCC
Confidence 45689999999765 444332 24568899999999999999999997 9999999999999999887 79999999
Q ss_pred CccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 011138 286 SAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (492)
Q Consensus 286 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~ 365 (492)
+++.... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+.......+...
T Consensus 177 ~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~---------- 243 (340)
T PTZ00426 177 FAKVVDT--RTYTLCGTPEYIAPEILLNV-GHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG---------- 243 (340)
T ss_pred CCeecCC--CcceecCChhhcCHHHHhCC-CCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcC----------
Confidence 9986532 23456899999999999654 4899999999999999999999999987766555554331
Q ss_pred hcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcC-----CHHHhhCCCCCCCCCC
Q 011138 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLRD 428 (492)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----t~~e~l~Hp~f~~~~~ 428 (492)
... ++..+++++++||++||+.||.+|+ ++.++++||||+++..
T Consensus 244 -------~~~------------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~ 292 (340)
T PTZ00426 244 -------IIY------------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW 292 (340)
T ss_pred -------CCC------------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 111 2235788999999999999999996 8999999999997643
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=377.95 Aligned_cols=253 Identities=30% Similarity=0.491 Sum_probs=205.4
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
+|.+.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||++++++| .+..++
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~ 76 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENYL 76 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCeE
Confidence 5999999999999999999999999999999986432 2345799999999999999999988 455579
Q ss_pred EEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 211 ~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
|+||||+.++ |.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 77 ~lv~E~~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~ 150 (364)
T cd05599 77 YLIMEYLPGGDMMTLLM----KKDTFTEEETRFYIAETILAIDSIHK-LGYIHRDIKPDNLLLDAKG-HIKLSDFGLCTG 150 (364)
T ss_pred EEEECCCCCcHHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCC-CEEEeeccccee
Confidence 9999999865 444332 23568999999999999999999997 9999999999999999888 799999999875
Q ss_pred cCCCC---------------------------------------CCccceeccCccCchhhcCCCCCCcchhhHHHHHHH
Q 011138 290 LVPGE---------------------------------------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVL 330 (492)
Q Consensus 290 ~~~~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil 330 (492)
+.... .....+||+.|+|||++.+. .++.++|||||||++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il 229 (364)
T cd05599 151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSLGVIM 229 (364)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC-CCCCeeeeecchhHH
Confidence 42211 01134699999999998654 589999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCC
Q 011138 331 AELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSL 410 (492)
Q Consensus 331 ~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~ 410 (492)
|||++|.+||.+.+..+.+..+.... ....+|. ...+++++++||.+||. ||.+
T Consensus 230 ~el~~G~~Pf~~~~~~~~~~~i~~~~---------------~~~~~~~----------~~~~s~~~~~li~~ll~-~p~~ 283 (364)
T cd05599 230 YEMLVGYPPFCSDNPQETYRKIINWK---------------ETLQFPD----------EVPLSPEAKDLIKRLCC-EAER 283 (364)
T ss_pred HHhhcCCCCCCCCCHHHHHHHHHcCC---------------CccCCCC----------CCCCCHHHHHHHHHHcc-CHhh
Confidence 99999999999887766655554310 0111111 11468999999999997 9999
Q ss_pred cCC---HHHhhCCCCCCCCCC
Q 011138 411 RCT---ALEACAHPFFDDLRD 428 (492)
Q Consensus 411 R~t---~~e~l~Hp~f~~~~~ 428 (492)
|++ +.++++||||+....
T Consensus 284 R~~~~~~~~ll~h~~~~~~~~ 304 (364)
T cd05599 284 RLGNNGVNEIKSHPFFKGVDW 304 (364)
T ss_pred cCCCCCHHHHhcCCCcCCCCH
Confidence 998 999999999997643
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=353.24 Aligned_cols=256 Identities=29% Similarity=0.444 Sum_probs=218.3
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchh-------hHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-------YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-------~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
...+|...++||+|.||.|-+|+.+.+|+.||||+++++.- ....|-++|+..+||.+..|.-.| +..
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-----Qt~ 240 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-----QTQ 240 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-----ccC
Confidence 34578999999999999999999999999999998866432 223588999999999999988777 455
Q ss_pred eEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 208 ~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
..+|+||||..|+-+- .+.. ....+++..+++|...|+.||.|||+ ++||+||||.+|+|+|++| .+||+|||++
T Consensus 241 drlCFVMeyanGGeLf--~HLs-rer~FsE~RtRFYGaEIvsAL~YLHs-~~ivYRDlKLENLlLDkDG-HIKitDFGLC 315 (516)
T KOG0690|consen 241 DRLCFVMEYANGGELF--FHLS-RERVFSEDRTRFYGAEIVSALGYLHS-RNIVYRDLKLENLLLDKDG-HIKITDFGLC 315 (516)
T ss_pred ceEEEEEEEccCceEe--eehh-hhhcccchhhhhhhHHHHHHhhhhhh-CCeeeeechhhhheeccCC-ceEeeecccc
Confidence 5699999999976332 2322 25679999999999999999999997 9999999999999999999 5999999999
Q ss_pred cccC-CCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 011138 288 KMLV-PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (492)
Q Consensus 288 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~ 366 (492)
+.-. .+....++||||.|+|||++.. ..|+.++|+|.+||++|||++|+.||...+....+..|+.
T Consensus 316 KE~I~~g~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~------------ 382 (516)
T KOG0690|consen 316 KEEIKYGDTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM------------ 382 (516)
T ss_pred hhcccccceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh------------
Confidence 7643 3455668999999999999965 4599999999999999999999999999988877777765
Q ss_pred cCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCC-----HHHhhCCCCCCCCCCCC
Q 011138 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-----ALEACAHPFFDDLRDPN 430 (492)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-----~~e~l~Hp~f~~~~~~~ 430 (492)
.+++|| ..++++++.|+..+|.+||.+|.. +.|+++|+||..+....
T Consensus 383 -----ed~kFP------------r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~ 434 (516)
T KOG0690|consen 383 -----EDLKFP------------RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEA 434 (516)
T ss_pred -----hhccCC------------ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHH
Confidence 455555 478999999999999999999984 88999999999877643
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=351.76 Aligned_cols=264 Identities=28% Similarity=0.464 Sum_probs=211.1
Q ss_pred ceeEe-eeeccCCceEEEEEEEcCCCCEEEEEEeccchhhHHHHHHHHHHc-CCCCccccceeeeeccCCCceEEEEEee
Q 011138 138 SYMAE-RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (492)
Q Consensus 138 ~y~~~-~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~~~~~lV~E 215 (492)
+|.+. ++||-|--|.|..|..+.||+.+|+|++.. ....++|+++.-+. .|||||.++++|...- .+..++.+|||
T Consensus 62 dY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-s~KARrEVeLHw~~s~h~~iV~IidVyeNs~-~~rkcLLiVmE 139 (400)
T KOG0604|consen 62 DYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-SPKARREVELHWMASGHPHIVSIIDVYENSY-QGRKCLLIVME 139 (400)
T ss_pred hheehhhhhccccCCceEEEEeccchhhhHHHHHhc-CHHHHhHhhhhhhhcCCCceEEeehhhhhhc-cCceeeEeeee
Confidence 45554 579999999999999999999999997644 44456799886555 5999999999974433 56778889999
Q ss_pred echhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCC--CcEEEeeecCccccCC
Q 011138 216 YISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT--HQLKICDFGSAKMLVP 292 (492)
Q Consensus 216 ~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~--~~vkL~DFG~a~~~~~ 292 (492)
+++|+ |+..+. .+..+.|++.++..|+.||+.|+.|||+ .+|.||||||||+|..... ..+||+|||+|+....
T Consensus 140 ~meGGeLfsriq--~~g~~afTErea~eI~~qI~~Av~~lH~-~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~ 216 (400)
T KOG0604|consen 140 CMEGGELFSRIQ--DRGDQAFTEREASEIMKQIGLAVRYLHS-MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE 216 (400)
T ss_pred cccchHHHHHHH--HcccccchHHHHHHHHHHHHHHHHHHHh-cchhhccCChhheeeecCCCCcceEecccccccccCC
Confidence 99975 444332 3345679999999999999999999997 8999999999999996433 2699999999998766
Q ss_pred CCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 011138 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372 (492)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~ 372 (492)
.....+.+.||+|.|||++ |...|+..+|+||+||++|.||+|.+||........---+...+ .. .
T Consensus 217 ~~~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI----------~~---g 282 (400)
T KOG0604|consen 217 PGDLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRI----------RT---G 282 (400)
T ss_pred CccccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHh----------hc---c
Confidence 6667788999999999998 66779999999999999999999999998766432111111100 01 3
Q ss_pred ccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
.+.||.. . |..+|++++|+|++||..+|.+|+|+.++++|||+.+...
T Consensus 283 qy~FP~p---E-----Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~ 330 (400)
T KOG0604|consen 283 QYEFPEP---E-----WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA 330 (400)
T ss_pred CccCCCh---h-----HhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence 4455542 2 3468999999999999999999999999999999987653
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=359.84 Aligned_cols=276 Identities=34% Similarity=0.545 Sum_probs=219.5
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
+|.+.+.||+|+||.||+|.+..+|+.||+|.+.... ....+|+.+++.++||||+++++++ .+..+++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL-----HSDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh-----ccCCceE
Confidence 4889999999999999999999999999999885321 2345799999999999999999998 4555689
Q ss_pred EEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
+|+||+++++...+.. ....+++..++.++.||+.||.|||+ +||+||||||+||+++.++ .+||+|||+++...
T Consensus 76 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~ 150 (284)
T cd07839 76 LVFEYCDQDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHS-HNVLHRDLKPQNLLINKNG-ELKLADFGLARAFG 150 (284)
T ss_pred EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEcCCC-cEEECccchhhccC
Confidence 9999999887765432 23568999999999999999999997 9999999999999999887 79999999987653
Q ss_pred CCC-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 292 PGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPL-FPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 292 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~p-f~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
... ......+++.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+.+.++.+....+.....
T Consensus 151 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 151 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred CCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence 222 223456789999999997766689999999999999999998877 566667777888888888877665543321
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
......++............+.+++++++||.+||+.||.+|||+.+++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 111111222111111112234678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-46 Score=367.85 Aligned_cols=242 Identities=31% Similarity=0.520 Sum_probs=198.8
Q ss_pred eccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEeeec
Q 011138 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (492)
Q Consensus 145 lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E~~ 217 (492)
||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||++++++| .+..++|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence 699999999999999999999999885421 2234699999999999999999988 4445689999999
Q ss_pred hhhHH-HHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCC-CC
Q 011138 218 SETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG-EP 295 (492)
Q Consensus 218 ~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~-~~ 295 (492)
.++.+ ..+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++..... ..
T Consensus 76 ~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~HrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~ 149 (312)
T cd05585 76 NGGELFHHLQ----REGRFDLSRARFYTAELLCALENLHK-FNVIYRDLKPENILLDYQG-HIALCDFGLCKLNMKDDDK 149 (312)
T ss_pred CCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHeEECCCC-cEEEEECcccccCccCCCc
Confidence 87543 3332 24568899999999999999999997 9999999999999999888 7999999999754322 22
Q ss_pred CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccC
Q 011138 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFK 375 (492)
Q Consensus 296 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 375 (492)
....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.. ....
T Consensus 150 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~-----------------~~~~ 211 (312)
T cd05585 150 TNTFCGTPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ-----------------EPLR 211 (312)
T ss_pred cccccCCcccCCHHHHcCC-CCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc-----------------CCCC
Confidence 3356799999999999764 489999999999999999999999998776655544432 1111
Q ss_pred CCcccCCCcccccCCCCChhHhhhhccccccCCCCcC---CHHHhhCCCCCCCCC
Q 011138 376 FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC---TALEACAHPFFDDLR 427 (492)
Q Consensus 376 ~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~---t~~e~l~Hp~f~~~~ 427 (492)
++..+++++++||.+||..||.+|| ++.++++||||.+..
T Consensus 212 ------------~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~ 254 (312)
T cd05585 212 ------------FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS 254 (312)
T ss_pred ------------CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCC
Confidence 2245789999999999999999997 579999999999863
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-46 Score=377.94 Aligned_cols=252 Identities=29% Similarity=0.477 Sum_probs=202.6
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
+|.+.+.||+|+||.||+|.+..+|+.||||++.+.. ....+|+++++.++|||||+++++| .+..++
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~ 76 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQYL 76 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCee
Confidence 5999999999999999999999999999999885432 2345799999999999999999998 455579
Q ss_pred EEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 211 ~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
|+||||++++ |...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 77 ~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~-~givHrDlkp~NIll~~~~-~~kl~DfGla~~ 150 (377)
T cd05629 77 YLIMEFLPGGDLMTMLI----KYDTFSEDVTRFYMAECVLAIEAVHK-LGFIHRDIKPDNILIDRGG-HIKLSDFGLSTG 150 (377)
T ss_pred EEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECCCC-CEEEeecccccc
Confidence 9999999764 444332 24568899999999999999999997 9999999999999999887 799999999863
Q ss_pred cCCCC------------------------------------------------CCccceeccCccCchhhcCCCCCCcch
Q 011138 290 LVPGE------------------------------------------------PNISYICSRYYRAPELIFGATEYTTAI 321 (492)
Q Consensus 290 ~~~~~------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~ 321 (492)
..... .....+||+.|+|||++.+. .++.++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~ 229 (377)
T cd05629 151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-GYGQEC 229 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC-CCCCce
Confidence 21100 00124799999999999654 489999
Q ss_pred hhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhc
Q 011138 322 DMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVS 401 (492)
Q Consensus 322 DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~ 401 (492)
|||||||++|||++|.+||.+.+..+.+..+.... ....+|. ...++.++++||.
T Consensus 230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---------------~~~~~p~----------~~~~s~~~~dli~ 284 (377)
T cd05629 230 DWWSLGAIMFECLIGWPPFCSENSHETYRKIINWR---------------ETLYFPD----------DIHLSVEAEDLIR 284 (377)
T ss_pred eeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccC---------------CccCCCC----------CCCCCHHHHHHHH
Confidence 99999999999999999999887766655554310 1111221 1246899999999
Q ss_pred cccccCCCCc---CCHHHhhCCCCCCCCC
Q 011138 402 RLLQYSPSLR---CTALEACAHPFFDDLR 427 (492)
Q Consensus 402 ~~L~~dP~~R---~t~~e~l~Hp~f~~~~ 427 (492)
+||. +|.+| +++.++++||||+++.
T Consensus 285 ~lL~-~~~~r~~r~~~~~~l~hp~~~~~~ 312 (377)
T cd05629 285 RLIT-NAENRLGRGGAHEIKSHPFFRGVD 312 (377)
T ss_pred HHhc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 9998 77765 5999999999998754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=369.81 Aligned_cols=245 Identities=27% Similarity=0.435 Sum_probs=199.5
Q ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEee
Q 011138 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E 215 (492)
+.||+|+||.||++.+..+|+.||||++.... ....+|+.+++.++||||+++++++ .+...+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence 36999999999999999999999999986432 2334799999999999999999888 44556899999
Q ss_pred echhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCC-C
Q 011138 216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG-E 294 (492)
Q Consensus 216 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~-~ 294 (492)
|++++.+... ......+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++..... .
T Consensus 76 y~~~g~L~~~---l~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll~~~~-~~kL~DfG~~~~~~~~~~ 150 (328)
T cd05593 76 YVNGGELFFH---LSRERVFSEDRTRFYGAEIVSALDYLHS-GKIVYRDLKLENLMLDKDG-HIKITDFGLCKEGITDAA 150 (328)
T ss_pred CCCCCCHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeEECCCC-cEEEecCcCCccCCCccc
Confidence 9987644321 1224568899999999999999999997 9999999999999999887 7999999998754222 2
Q ss_pred CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 011138 295 PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEF 374 (492)
Q Consensus 295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~ 374 (492)
.....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.. ...
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~-----------------~~~ 212 (328)
T cd05593 151 TMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-----------------EDI 212 (328)
T ss_pred ccccccCCcCccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc-----------------CCc
Confidence 23346799999999999654 489999999999999999999999988765544433321 111
Q ss_pred CCCcccCCCcccccCCCCChhHhhhhccccccCCCCcC-----CHHHhhCCCCCCCCC
Q 011138 375 KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLR 427 (492)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----t~~e~l~Hp~f~~~~ 427 (492)
. ++..+++++.+||.+||+.||.+|+ ++.++++||||....
T Consensus 213 ~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~ 258 (328)
T cd05593 213 K------------FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVN 258 (328)
T ss_pred c------------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 1 2245789999999999999999997 899999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=363.67 Aligned_cols=277 Identities=30% Similarity=0.555 Sum_probs=209.3
Q ss_pred eeeeccCCceEEEEEEEcC--CCCEEEEEEeccch--hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEeeec
Q 011138 142 ERVVGTGSFGVVFQAKCLE--TGDSVAIKKVLQDK--RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (492)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~--~g~~vAiK~~~~~~--~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E~~ 217 (492)
+..||+|+||.||+|.+.. ++..||+|.+.... ....+|+.+++.++||||+++++++... ....+++||||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e~~ 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSH---SDRKVWLLFDYA 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEecc---CCCeEEEEEeee
Confidence 4679999999999999654 66889999886542 3456899999999999999999988543 234688999999
Q ss_pred hhhHHHHhhhhh-----hcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEc----CCCCcEEEeeecCcc
Q 011138 218 SETVYRVSKHYT-----RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN----PHTHQLKICDFGSAK 288 (492)
Q Consensus 218 ~~~l~~~~~~~~-----~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~----~~~~~vkL~DFG~a~ 288 (492)
+++++..+.... .....+++..++.++.||+.||.|||+ +||+||||||+|||+. .++ .+||+|||+++
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~-~~kl~DfG~a~ 160 (317)
T cd07867 83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERG-RVKIADMGFAR 160 (317)
T ss_pred CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEccCCCCCC-cEEEeecccee
Confidence 998877654321 112357888999999999999999997 9999999999999993 334 79999999998
Q ss_pred ccCCCC----CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHH
Q 011138 289 MLVPGE----PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESG---------VDQLVEIIKI 355 (492)
Q Consensus 289 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~---------~~~~~~i~~~ 355 (492)
...... ......||+.|+|||++.+...++.++|||||||++|||++|.+||..... ..++..+...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence 654322 123457899999999997766689999999999999999999999975432 3567778888
Q ss_pred hCCCCHHHHhhcCC--CCcccC-------CCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 356 LGTPTREEIKCMNP--NYTEFK-------FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 356 ~g~p~~~~~~~~~~--~~~~~~-------~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
+|.+..+.+..... .+.... +................+..+++||.+||+.||.+|||+.|+|+||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 88887766654321 110000 000000000111112346779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=357.90 Aligned_cols=276 Identities=34% Similarity=0.626 Sum_probs=219.9
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++||||+++++++. +..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM-----QESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe-----eCCeEE
Confidence 488999999999999999999999999999987532 134567999999999999999999984 444689
Q ss_pred EEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
+||||+.+++...+.... .+..+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++....
T Consensus 76 ~v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~ 152 (285)
T cd07861 76 LIFEFLSMDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHS-RRVLHRDLKPQNLLIDNKG-VIKLADFGLARAFG 152 (285)
T ss_pred EEEecCCCCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEEcCCC-cEEECcccceeecC
Confidence 999999987766554322 23568999999999999999999997 9999999999999999887 79999999987543
Q ss_pred CCC-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC-
Q 011138 292 PGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP- 369 (492)
Q Consensus 292 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~- 369 (492)
... ......+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.+....+.....
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 153 IPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred CCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh
Confidence 221 223346789999999987766688999999999999999999999999988888888888888776655432210
Q ss_pred -CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 370 -NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 370 -~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
++. ..++....... ......+++++++||++||+.||.+|||+.+++.||||
T Consensus 233 ~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 233 PDYK-NTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHHH-hhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 000 01111111111 11224579999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=367.98 Aligned_cols=245 Identities=28% Similarity=0.443 Sum_probs=200.3
Q ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEee
Q 011138 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E 215 (492)
+.||+|+||.||++.+..+|..||+|++.... ....+|+.+++.++||||++++++| ....++|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCEEEEEEe
Confidence 36999999999999999999999999986432 2234699999999999999999988 44456899999
Q ss_pred echhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCC-C
Q 011138 216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG-E 294 (492)
Q Consensus 216 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~-~ 294 (492)
|++++.+... ......+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++..... .
T Consensus 76 ~~~~~~L~~~---l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~ 150 (323)
T cd05595 76 YANGGELFFH---LSRERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDGA 150 (323)
T ss_pred CCCCCcHHHH---HHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEEcCCC-CEEecccHHhccccCCCC
Confidence 9987644321 1224568899999999999999999997 9999999999999999887 7999999998754222 2
Q ss_pred CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 011138 295 PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEF 374 (492)
Q Consensus 295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~ 374 (492)
......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+.. ...
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~-----------------~~~ 212 (323)
T cd05595 151 TMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-----------------EEI 212 (323)
T ss_pred ccccccCCcCcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc-----------------CCC
Confidence 23356799999999999654 489999999999999999999999988776555544432 111
Q ss_pred CCCcccCCCcccccCCCCChhHhhhhccccccCCCCcC-----CHHHhhCCCCCCCCC
Q 011138 375 KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLR 427 (492)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----t~~e~l~Hp~f~~~~ 427 (492)
. ++..+++++.+||.+||..||.+|+ ++.++++||||....
T Consensus 213 ~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 213 R------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred C------------CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 1 2235789999999999999999998 899999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=368.65 Aligned_cols=255 Identities=29% Similarity=0.470 Sum_probs=208.2
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++ .+..++
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~~ 76 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEYL 76 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCEE
Confidence 5999999999999999999999999999999986432 2345799999999999999999988 455578
Q ss_pred EEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 211 ~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
|+||||++++ +..++. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 77 ~lv~e~~~g~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~kL~Dfg~a~~ 150 (333)
T cd05600 77 YLAMEYVPGGDFRTLLN----NLGVLSEDHARFYMAEMFEAVDALHE-LGYIHRDLKPENFLIDASG-HIKLTDFGLSKG 150 (333)
T ss_pred EEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCC-CEEEEeCcCCcc
Confidence 9999999865 444332 23568899999999999999999997 9999999999999999887 799999999976
Q ss_pred cCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+....+......
T Consensus 151 ~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----------- 216 (333)
T cd05600 151 IVT--YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET----------- 216 (333)
T ss_pred ccc--ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc-----------
Confidence 533 33456899999999999765 5899999999999999999999999988776665555431100
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
...|.... ....+++++.+||.+||..+|.+|+++.++++||||+++.
T Consensus 217 ----~~~~~~~~------~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~ 264 (333)
T cd05600 217 ----LQRPVYDD------PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVD 264 (333)
T ss_pred ----ccCCCCCc------cccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCC
Confidence 00111000 0024689999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=373.67 Aligned_cols=256 Identities=27% Similarity=0.457 Sum_probs=208.8
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
...+|.+.+.||+|+||.||+|++..+++.||+|++.+.. ....+|+.+++.++||||+++++++ .+.
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~ 115 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDD 115 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence 4457999999999999999999999999999999985421 2345799999999999999999888 555
Q ss_pred eEEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 208 LYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 208 ~~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
.++|+||||++++ +..++. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~-----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~-~~kL~DfG~ 188 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMS-----NYDIPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSG-HLKLADFGT 188 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEcCCC-CEEEEeccc
Confidence 6799999999865 443332 2357888999999999999999997 9999999999999999888 799999999
Q ss_pred ccccCCCC--CCccceeccCccCchhhcCC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 011138 287 AKMLVPGE--PNISYICSRYYRAPELIFGA---TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTR 361 (492)
Q Consensus 287 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~---~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~ 361 (492)
+....... .....+||+.|+|||++.+. ..++.++|||||||++|||++|.+||.+.+....+.++....
T Consensus 189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~----- 263 (370)
T cd05596 189 CMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHK----- 263 (370)
T ss_pred eeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC-----
Confidence 97654322 22356799999999998653 247899999999999999999999999888766666654311
Q ss_pred HHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCC--cCCHHHhhCCCCCCCCC
Q 011138 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSL--RCTALEACAHPFFDDLR 427 (492)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~--R~t~~e~l~Hp~f~~~~ 427 (492)
..+.+|. ...++.++++||++||+.+|.+ |++++++++||||++..
T Consensus 264 ----------~~~~~~~----------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~ 311 (370)
T cd05596 264 ----------NSLTFPD----------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQ 311 (370)
T ss_pred ----------CcCCCCC----------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCC
Confidence 0111221 1247899999999999999998 99999999999998743
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=376.72 Aligned_cols=252 Identities=29% Similarity=0.479 Sum_probs=203.1
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
.|.+.+.||+|+||.||+|++..+++.||||++.+.. ....+|+.+++.++|||||+++++| .+..++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~-----~~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEE-----EeCCEE
Confidence 4899999999999999999999999999999986432 2345799999999999999999998 444569
Q ss_pred EEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 211 ~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
|+|||||+++ +...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 77 ~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~-~~ivHrDlKp~NILl~~~g-~~kL~DFGla~~ 150 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHK-MGFIHRDIKPDNILIDRDG-HIKLTDFGLCTG 150 (382)
T ss_pred EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-CEEEeECCCCcc
Confidence 9999999865 4443322 3468899999999999999999997 9999999999999999888 799999999753
Q ss_pred cCCC------------------------------------------------CCCccceeccCccCchhhcCCCCCCcch
Q 011138 290 LVPG------------------------------------------------EPNISYICSRYYRAPELIFGATEYTTAI 321 (492)
Q Consensus 290 ~~~~------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 321 (492)
.... ......+||+.|+|||++.+. .|+.++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~ 229 (382)
T cd05625 151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLC 229 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC-CCCCee
Confidence 2100 001235799999999999755 489999
Q ss_pred hhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhc
Q 011138 322 DMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVS 401 (492)
Q Consensus 322 DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~ 401 (492)
|||||||++|||++|++||.+.+..+....+.... ....+|. ...+++++++||.
T Consensus 230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---------------~~~~~p~----------~~~~s~~~~~li~ 284 (382)
T cd05625 230 DWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQ---------------TSLHIPP----------QAKLSPEASDLII 284 (382)
T ss_pred eEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccC---------------CCcCCCC----------cccCCHHHHHHHH
Confidence 99999999999999999999887766655554310 0111111 1347899999999
Q ss_pred cccccCCCCcCC---HHHhhCCCCCCCCC
Q 011138 402 RLLQYSPSLRCT---ALEACAHPFFDDLR 427 (492)
Q Consensus 402 ~~L~~dP~~R~t---~~e~l~Hp~f~~~~ 427 (492)
+|+ .||.+|++ +.++++||||+.+.
T Consensus 285 ~l~-~~p~~R~~~~~~~ei~~hp~f~~~~ 312 (382)
T cd05625 285 KLC-RGPEDRLGKNGADEIKAHPFFKTID 312 (382)
T ss_pred HHc-cCHhHcCCCCCHHHHhcCCCcCCcC
Confidence 987 59999997 99999999998764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=374.75 Aligned_cols=254 Identities=28% Similarity=0.456 Sum_probs=201.8
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
.|.+.+.||+|+||+||+|++..+++.||||++.... ....+|+.+++.++||||+++++++ .+..++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-----~~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEE-----ecCCEE
Confidence 4889999999999999999999999999999985432 2345799999999999999999998 445579
Q ss_pred EEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 211 ~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
|+||||++++ +...+.. ...+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+++.
T Consensus 77 ~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDlKp~Nili~~~~-~~kL~DFGl~~~ 150 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHK-MGFIHRDIKPDNILIDLDG-HIKLTDFGLCTG 150 (381)
T ss_pred EEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCcHHHEEECCCC-CEEEeeCcCCcc
Confidence 9999999865 4443322 3568899999999999999999997 9999999999999999887 799999999753
Q ss_pred cCCCC------------------------------------------------CCccceeccCccCchhhcCCCCCCcch
Q 011138 290 LVPGE------------------------------------------------PNISYICSRYYRAPELIFGATEYTTAI 321 (492)
Q Consensus 290 ~~~~~------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~ 321 (492)
..... .....+||+.|+|||++.+. .++.++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~ 229 (381)
T cd05626 151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK-GYTQLC 229 (381)
T ss_pred cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC-CCCCcc
Confidence 21000 01235799999999999654 489999
Q ss_pred hhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhc
Q 011138 322 DMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVS 401 (492)
Q Consensus 322 DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~ 401 (492)
|||||||++|||++|.+||...+..+....+.... ....+|. ...+++++++||.
T Consensus 230 DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~---------------~~~~~~~----------~~~~s~~~~dli~ 284 (381)
T cd05626 230 DWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWE---------------NTLHIPP----------QVKLSPEAVDLIT 284 (381)
T ss_pred ceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccc---------------cccCCCC----------CCCCCHHHHHHHH
Confidence 99999999999999999999877665555543210 0111111 1247899999999
Q ss_pred cccc--cCCCCcCCHHHhhCCCCCCCCCC
Q 011138 402 RLLQ--YSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 402 ~~L~--~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
+||. .+|..|+++.++++||||+++..
T Consensus 285 ~ll~~~~~~~~R~~~~~~l~hp~f~~~~~ 313 (381)
T cd05626 285 KLCCSAEERLGRNGADDIKAHPFFSEVDF 313 (381)
T ss_pred HHccCcccccCCCCHHHHhcCcccCCCCh
Confidence 9654 45556999999999999997643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=371.78 Aligned_cols=253 Identities=31% Similarity=0.515 Sum_probs=208.3
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++||||+++++++ .+..++
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~ 76 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEHL 76 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCeE
Confidence 599999999999999999999999999999998543 23345799999999999999999988 455579
Q ss_pred EEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 211 ~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
|+||||+.++ +...+.. ...+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||++..
T Consensus 77 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~giiH~Dlkp~NIll~~~~-~~kL~Dfg~~~~ 150 (350)
T cd05573 77 YLVMEYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHK-LGFIHRDIKPDNILIDADG-HIKLADFGLCKK 150 (350)
T ss_pred EEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCC-CEEeecCCCCcc
Confidence 9999999764 4443332 2578999999999999999999997 9999999999999999888 799999999976
Q ss_pred cCCCC------------------------------CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCC
Q 011138 290 LVPGE------------------------------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPL 339 (492)
Q Consensus 290 ~~~~~------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~p 339 (492)
..... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~P 229 (350)
T cd05573 151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPP 229 (350)
T ss_pred CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCC
Confidence 54332 22345789999999999765 589999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCC-HHHhh
Q 011138 340 FPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-ALEAC 418 (492)
Q Consensus 340 f~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-~~e~l 418 (492)
|.+.+..+....+.... ....+|. ...+++++.+||.+||. ||.+|++ +.+++
T Consensus 230 f~~~~~~~~~~~i~~~~---------------~~~~~p~----------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll 283 (350)
T cd05573 230 FYSDTLQETYNKIINWK---------------ESLRFPP----------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIK 283 (350)
T ss_pred CCCCCHHHHHHHHhccC---------------CcccCCC----------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHh
Confidence 99887666555554311 0111111 12368999999999997 9999999 99999
Q ss_pred CCCCCCCCCC
Q 011138 419 AHPFFDDLRD 428 (492)
Q Consensus 419 ~Hp~f~~~~~ 428 (492)
+||||+++..
T Consensus 284 ~hp~~~~~~~ 293 (350)
T cd05573 284 SHPFFKGIDW 293 (350)
T ss_pred cCCCcCCCCH
Confidence 9999998654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=366.44 Aligned_cols=318 Identities=35% Similarity=0.618 Sum_probs=245.0
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
.+|.+.+.||+|+||+||+|.+..+|+.||||.+... .....+|+.+++.++|+||+++++++..........+
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 3599999999999999999999999999999987532 2234479999999999999999998765443334568
Q ss_pred EEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 211 ~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
|+||||+++++...+.. ...+++..+..++.||+.||.|||+ +|++||||||+||+++.++ .+||+|||++...
T Consensus 85 ~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~ 158 (337)
T cd07858 85 YIVYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLNANC-DLKICDFGLARTT 158 (337)
T ss_pred EEEEeCCCCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCC-CEEECcCcccccc
Confidence 99999999877665432 3568999999999999999999997 9999999999999999887 7999999999865
Q ss_pred CCC-CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 291 VPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 291 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
... .......++..|+|||.+.+...++.++|||||||++|+|++|++||.+.+....+..+...+|.+....+.....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 159 SEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred CCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 433 2233457899999999987655589999999999999999999999999888888888888888887766533211
Q ss_pred CCcc-c--CCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 011138 370 NYTE-F--KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTLFNFT 446 (492)
Q Consensus 370 ~~~~-~--~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~~~~~~~~~~~~~~~~~ 446 (492)
.... + ..+......+. ...+.+++++.+||++||+.||++|||+.++++||||..+.++...... ..+ +.|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~~--~~~--~~~~ 313 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVC--QTP--FSFD 313 (337)
T ss_pred hhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCccC--CCc--cchh
Confidence 1000 0 01111111111 1234689999999999999999999999999999999988765432221 111 1222
Q ss_pred cccccccccccccccccccCccchhHHHhcCCHHHHhhcccccc
Q 011138 447 AQGKLILCFSYFGFSSYFLPHANCLAELAGASNELRQRLIPEHA 490 (492)
Q Consensus 447 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 490 (492)
.|.++...+..+++|..|+
T Consensus 314 -------------------------~~~~~~~~~~~~~~~~~~~ 332 (337)
T cd07858 314 -------------------------FEEDALTEEDIKELIYNEM 332 (337)
T ss_pred -------------------------hhhhhcCHHHHHHHHHHHH
Confidence 1555688888888887775
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=366.03 Aligned_cols=248 Identities=29% Similarity=0.497 Sum_probs=202.1
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHH---HHcCCCCccccceeeeeccCCCce
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIM---RLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il---~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.++ +.++||||+++++++ .+..
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-----~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-----QTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-----EcCC
Confidence 678899999999999999999999999999986432 2233455554 466799999999998 4445
Q ss_pred EEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 209 ~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
.+|+||||+.++.+..... ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus 76 ~~~lv~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrdlkp~Nill~~~~-~~kL~Dfg~~~ 149 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHE-NKIVYRDLKLDNLLLDTEG-FVKIADFGLCK 149 (324)
T ss_pred EEEEEEcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECCCC-cEEeCcccCCc
Confidence 6899999999764432221 3468999999999999999999997 9999999999999999888 79999999987
Q ss_pred ccCC-CCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 289 MLVP-GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 289 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 150 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~------------ 216 (324)
T cd05589 150 EGMGFGDRTSTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND------------ 216 (324)
T ss_pred cCCCCCCcccccccCccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------
Confidence 5322 2233456799999999999654 4899999999999999999999999988776665555431
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcC-----CHHHhhCCCCCCCCC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLR 427 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----t~~e~l~Hp~f~~~~ 427 (492)
... ++..+++++.+||.+||+.||.+|| ++.++++||||+++.
T Consensus 217 -----~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 217 -----EVR------------YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN 264 (324)
T ss_pred -----CCC------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence 111 2235789999999999999999999 799999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=364.99 Aligned_cols=246 Identities=28% Similarity=0.500 Sum_probs=199.7
Q ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHc-CCCCccccceeeeeccCCCceEEEEEe
Q 011138 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
+.||+|+||.||+|+++.+++.||||++.+.. ....+|..++..+ +||||++++++| .+..++|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence 36999999999999999999999999986432 2234677888766 699999999998 4445689999
Q ss_pred eechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC-CC
Q 011138 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV-PG 293 (492)
Q Consensus 215 E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~-~~ 293 (492)
||++++.+... ......+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++... ..
T Consensus 76 Ey~~~g~L~~~---i~~~~~l~~~~~~~~~~ql~~~L~~lH~-~~ivH~dlkp~NIli~~~~-~~kL~DfG~~~~~~~~~ 150 (320)
T cd05590 76 EFVNGGDLMFH---IQKSRRFDEARARFYAAEITSALMFLHD-KGIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGIFNG 150 (320)
T ss_pred cCCCCchHHHH---HHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECCCC-cEEEeeCCCCeecCcCC
Confidence 99987544321 1224568899999999999999999997 9999999999999999887 79999999987542 22
Q ss_pred CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 011138 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373 (492)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~ 373 (492)
.......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.. ..
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~-----------------~~ 212 (320)
T cd05590 151 KTTSTFCGTPDYIAPEILQEM-LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN-----------------DE 212 (320)
T ss_pred CcccccccCccccCHHHHcCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc-----------------CC
Confidence 233456799999999999654 589999999999999999999999998877666555533 11
Q ss_pred cCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCH------HHhhCCCCCCCCCC
Q 011138 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA------LEACAHPFFDDLRD 428 (492)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~------~e~l~Hp~f~~~~~ 428 (492)
.. ++..+++++++||++||+.||.+|+++ .++++||||+.+..
T Consensus 213 ~~------------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~ 261 (320)
T cd05590 213 VV------------YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDW 261 (320)
T ss_pred CC------------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence 11 123478999999999999999999998 89999999998653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=363.67 Aligned_cols=246 Identities=31% Similarity=0.453 Sum_probs=198.8
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCE-EEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDS-VAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~-vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
..+.+.||+|+||+||+|.+. |+. ||||++... ...+.+|+.+|.+++|||||++++++..... .++
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~----~~~ 116 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG----SLC 116 (362)
T ss_pred hhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----ceE
Confidence 445556999999999999984 556 999998643 2356789999999999999999999843321 588
Q ss_pred EEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCC-cccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG-VCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~g-ivHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
|||||++++.+..+.+.. ....++...+..++.||++||+|||+ ++ ||||||||+|||++.+...+||+|||+++..
T Consensus 117 iVtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~-~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHS-EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREK 194 (362)
T ss_pred EEEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhc-CCCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence 999999977665544332 46789999999999999999999997 89 9999999999999988547999999999876
Q ss_pred CCC-CCCccceeccCccCchhhcC-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 291 VPG-EPNISYICSRYYRAPELIFG-ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 291 ~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
... ...+...||+.|||||++.+ ...|+.++||||||++||||+||..||.+....+....+......|.
T Consensus 195 ~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~-------- 266 (362)
T KOG0192|consen 195 VISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP-------- 266 (362)
T ss_pred ccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC--------
Confidence 543 33444799999999999975 35699999999999999999999999999887444444433211111
Q ss_pred CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
++...++.+..||.+||..||.+||+..+++.
T Consensus 267 -------------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 267 -------------------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred -------------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 22347889999999999999999999988764
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=368.65 Aligned_cols=255 Identities=27% Similarity=0.468 Sum_probs=207.7
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++|+||+++++++ .+..++
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~~ 76 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDNL 76 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeE
Confidence 5999999999999999999999999999999986532 2356799999999999999999888 445568
Q ss_pred EEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 211 ~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
|+||||++++ |...+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 77 ~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~lH~-~~i~H~Dlkp~NIll~~~~-~~kL~Dfg~a~~ 151 (330)
T cd05601 77 YLVMEYQPGGDLLSLLNR---YEDQFDEDMAQFYLAELVLAIHSVHQ-MGYVHRDIKPENVLIDRTG-HIKLADFGSAAR 151 (330)
T ss_pred EEEECCCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEcccCchHheEECCCC-CEEeccCCCCeE
Confidence 9999999764 4443322 23568999999999999999999997 9999999999999999887 799999999986
Q ss_pred cCCCCCC--ccceeccCccCchhhcC-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 011138 290 LVPGEPN--ISYICSRYYRAPELIFG-----ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (492)
Q Consensus 290 ~~~~~~~--~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~ 362 (492)
....... ....||+.|+|||++.. ...++.++|||||||++|+|++|..||...+....+.++....
T Consensus 152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~------ 225 (330)
T cd05601 152 LTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQ------ 225 (330)
T ss_pred CCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCC------
Confidence 6433322 23478999999999863 3457899999999999999999999998887766666554310
Q ss_pred HHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
....+|. ...+++++++||.+||. ||.+|||+.++++||||+.+..
T Consensus 226 ---------~~~~~~~----------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~ 271 (330)
T cd05601 226 ---------RFLKFPE----------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDW 271 (330)
T ss_pred ---------CccCCCC----------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCH
Confidence 0111221 12478999999999998 9999999999999999997643
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=371.34 Aligned_cols=255 Identities=29% Similarity=0.476 Sum_probs=206.7
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
...+|.+.+.||+|+||.||++.+..+++.||+|++.+. .....+|+.+++.++||||++++++| .+.
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~ 115 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----QDD 115 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcC
Confidence 345799999999999999999999999999999988542 22345799999999999999999988 455
Q ss_pred eEEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 208 LYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 208 ~~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
.++|+||||++++ |..++. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~-----~~~~~~~~~~~~~~qil~aL~~LH~-~~IvHrDLKp~NILl~~~~-~~kL~DFG~ 188 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMS-----NYDVPEKWAKFYTAEVVLALDAIHS-MGLIHRDVKPDNMLLDKHG-HLKLADFGT 188 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECCCC-CEEEEeccc
Confidence 5799999999865 444332 2357889999999999999999997 9999999999999999887 799999999
Q ss_pred ccccCCCC--CCccceeccCccCchhhcCCC---CCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 011138 287 AKMLVPGE--PNISYICSRYYRAPELIFGAT---EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTR 361 (492)
Q Consensus 287 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~ 361 (492)
+....... .....+||+.|+|||++.+.. .++.++|||||||++|+|++|.+||.+.+....+.++.....
T Consensus 189 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~---- 264 (370)
T cd05621 189 CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKN---- 264 (370)
T ss_pred ceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc----
Confidence 98653322 123567999999999996542 378899999999999999999999998887766666554211
Q ss_pred HHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCC--cCCHHHhhCCCCCCCC
Q 011138 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSL--RCTALEACAHPFFDDL 426 (492)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~--R~t~~e~l~Hp~f~~~ 426 (492)
.+.+|. ...++..+++||.+||+.++.+ |+++.|+++||||+..
T Consensus 265 -----------~~~~p~----------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 265 -----------SLNFPE----------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred -----------ccCCCC----------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 111221 1246899999999999866554 8999999999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=374.87 Aligned_cols=252 Identities=28% Similarity=0.449 Sum_probs=202.3
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
+|.+.+.||+|+||.||+|++..+|+.||||++.+. .....+|+.+|+.++||||+++++.| .+..++
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~ 76 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL 76 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCEE
Confidence 599999999999999999999999999999998542 22345799999999999999999988 445579
Q ss_pred EEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 211 ~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
|+||||++++ |.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|..
T Consensus 77 ~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~~~-~ikL~DFG~a~~ 150 (376)
T cd05598 77 YFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDRDG-HIKLTDFGLCTG 150 (376)
T ss_pred EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHEEECCCC-CEEEEeCCCCcc
Confidence 9999999865 4444332 3568889999999999999999997 9999999999999999887 799999999753
Q ss_pred cCCC--------------------------------------------CCCccceeccCccCchhhcCCCCCCcchhhHH
Q 011138 290 LVPG--------------------------------------------EPNISYICSRYYRAPELIFGATEYTTAIDMWS 325 (492)
Q Consensus 290 ~~~~--------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwS 325 (492)
+... ......+||+.|+|||++.+. .++.++||||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS 229 (376)
T cd05598 151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWS 229 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC-CCCcceeeee
Confidence 2100 001135799999999999654 4899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccc
Q 011138 326 IGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQ 405 (492)
Q Consensus 326 lGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~ 405 (492)
|||++|||++|+.||.+.+..+....+.... ....++. ...+++++.+||.+|+
T Consensus 230 lGvilyell~G~~Pf~~~~~~~~~~~i~~~~---------------~~~~~~~----------~~~~s~~~~~li~~l~- 283 (376)
T cd05598 230 VGVILYEMLVGQPPFLADTPAETQLKVINWE---------------TTLHIPS----------QAKLSREASDLILRLC- 283 (376)
T ss_pred ccceeeehhhCCCCCCCCCHHHHHHHHhccC---------------ccccCCC----------CCCCCHHHHHHHHHHh-
Confidence 9999999999999999887665554443210 0011111 1347899999999976
Q ss_pred cCCCCcC---CHHHhhCCCCCCCCC
Q 011138 406 YSPSLRC---TALEACAHPFFDDLR 427 (492)
Q Consensus 406 ~dP~~R~---t~~e~l~Hp~f~~~~ 427 (492)
.+|.+|+ ++.++++||||+.+.
T Consensus 284 ~~p~~R~~~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 284 CGAEDRLGKNGADEIKAHPFFKGID 308 (376)
T ss_pred cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence 5999999 999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=365.73 Aligned_cols=254 Identities=28% Similarity=0.373 Sum_probs=199.5
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
....|...+.||+|+||.||+|.+..+|+.||||++... ...+.+|+++++.++|+||+++++++ .+...
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~ 146 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGE 146 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCe
Confidence 345688899999999999999999999999999998543 23356899999999999999999988 44556
Q ss_pred EEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
+++||||+.++.+.. .....+..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 147 ~~lv~e~~~~~~L~~-------~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~-~~kL~DfG~~~~ 217 (353)
T PLN00034 147 IQVLLEFMDGGSLEG-------THIADEQFLADVARQILSGIAYLHR-RHIVHRDIKPSNLLINSAK-NVKIADFGVSRI 217 (353)
T ss_pred EEEEEecCCCCcccc-------cccCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCC-CEEEccccccee
Confidence 899999999764421 1234567788899999999999997 9999999999999999887 799999999986
Q ss_pred cCCCC-CCccceeccCccCchhhcC----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 011138 290 LVPGE-PNISYICSRYYRAPELIFG----ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (492)
Q Consensus 290 ~~~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~ 364 (492)
..... ......||..|+|||++.. ...++.++|||||||++|||++|+.||......+....+.......
T Consensus 218 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~----- 292 (353)
T PLN00034 218 LAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ----- 292 (353)
T ss_pred cccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC-----
Confidence 54322 2345689999999998743 2234568999999999999999999997543322222111110000
Q ss_pred hhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
. ......++.++++||.+||..||++|||+.|+++||||....
T Consensus 293 -----------~---------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 293 -----------P---------PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred -----------C---------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 0 001235788999999999999999999999999999999754
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=367.77 Aligned_cols=247 Identities=28% Similarity=0.437 Sum_probs=200.1
Q ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEee
Q 011138 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E 215 (492)
+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++||||++++++| ....++|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence 36999999999999999999999999986431 2234688999999999999999888 44456899999
Q ss_pred echhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC-CC
Q 011138 216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP-GE 294 (492)
Q Consensus 216 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~-~~ 294 (492)
|++++.+... ......+++..++.++.||+.||.|||+.+||+||||||+|||++.++ .+||+|||+++.... ..
T Consensus 76 ~~~~~~L~~~---l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~ 151 (325)
T cd05594 76 YANGGELFFH---LSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKDGA 151 (325)
T ss_pred CCCCCcHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC-CEEEecCCCCeecCCCCc
Confidence 9987644321 122456899999999999999999999426999999999999999887 799999999875432 22
Q ss_pred CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 011138 295 PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEF 374 (492)
Q Consensus 295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~ 374 (492)
......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+.. ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~-----------------~~~ 213 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-----------------EEI 213 (325)
T ss_pred ccccccCCcccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc-----------------CCC
Confidence 33356799999999999654 489999999999999999999999988776544444322 111
Q ss_pred CCCcccCCCcccccCCCCChhHhhhhccccccCCCCcC-----CHHHhhCCCCCCCCCC
Q 011138 375 KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLRD 428 (492)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----t~~e~l~Hp~f~~~~~ 428 (492)
. ++..+++++.+||.+||+.||++|+ ++.++++||||+....
T Consensus 214 ~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 260 (325)
T cd05594 214 R------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVW 260 (325)
T ss_pred C------------CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCH
Confidence 1 2235789999999999999999997 8999999999997643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=370.13 Aligned_cols=277 Identities=21% Similarity=0.322 Sum_probs=212.1
Q ss_pred cceeEeeeeccCCceEEEEEEEc--CCCCEEEEEEeccchhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEe
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCL--ETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~--~~g~~vAiK~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
.+|.+.+.||+|+||.||+|... .++..||+|.+... ....+|+.+++.++|||||+++++| .....+|+||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~~lv~ 165 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-KTPGREIDILKTISHRAIINLIHAY-----RWKSTVCMVM 165 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-ccHHHHHHHHHhcCCCCccceeeeE-----eeCCEEEEEe
Confidence 46999999999999999999754 35678999987654 3456899999999999999999988 4445689999
Q ss_pred eechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCC
Q 011138 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (492)
Q Consensus 215 E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~ 294 (492)
|++.++++..+. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++.......
T Consensus 166 e~~~~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlkp~Nill~~~~-~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 166 PKYKCDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHG-RGIIHRDVKTENIFLDEPE-NAVLGDFGAACKLDAHP 239 (392)
T ss_pred hhcCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcCCC-CEEEccCccccccCccc
Confidence 999988776552 24578999999999999999999997 9999999999999999887 79999999997654322
Q ss_pred C---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 295 P---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES---GVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 295 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~---~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
. .....||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.. ....+..+++.++..+.+......
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred ccccccccccccCccCHhHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 1 2346799999999999654 48999999999999999999999997754 356677777776654432111000
Q ss_pred C----CCcccCCCcccCCCcccc-cCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 369 P----NYTEFKFPQIKAHPWHKI-FHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 369 ~----~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
. .+..+.........+... ....++.++.+||++||++||++|||+.++|+||||+..
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 0 000011000000001111 112467889999999999999999999999999999864
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=363.56 Aligned_cols=252 Identities=25% Similarity=0.398 Sum_probs=207.4
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
..|...++||+|+||.||+|.+..+++.||||++.-+. ...++|+.+|.+++++||.++|+.|+... .++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~-----~Lw 87 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT-----KLW 87 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecc-----cHH
Confidence 35888899999999999999999999999999985432 34568999999999999999999995444 489
Q ss_pred EEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
++||||.|+....+ ......+.+..+..++++++.||.|||. ++.+|||||+.|||+..++ .+||+|||.+..+.
T Consensus 88 iiMey~~gGsv~~l---L~~~~~~~E~~i~~ilre~l~~l~ylH~-~~kiHrDIKaanil~s~~g-~vkl~DfgVa~ql~ 162 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDL---LKSGNILDEFEIAVILREVLKGLDYLHS-EKKIHRDIKAANILLSESG-DVKLADFGVAGQLT 162 (467)
T ss_pred HHHHHhcCcchhhh---hccCCCCccceeeeehHHHHHHhhhhhh-cceecccccccceeEeccC-cEEEEecceeeeee
Confidence 99999997644322 2234445788888899999999999997 9999999999999999886 89999999998775
Q ss_pred CCCC-CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 011138 292 PGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (492)
Q Consensus 292 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 370 (492)
.... ..+++|||+|||||++.+ ..|+.++||||||++.|||++|.+||....+...+..|-+
T Consensus 163 ~~~~rr~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk---------------- 225 (467)
T KOG0201|consen 163 NTVKRRKTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK---------------- 225 (467)
T ss_pred chhhccccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC----------------
Confidence 5443 378999999999999974 4599999999999999999999999988765333332211
Q ss_pred CcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
-.. ..+....++.+++||..||++||+.||+|.++|.|+|++...
T Consensus 226 --------~~P----P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 226 --------SAP----PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred --------CCC----CccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence 110 112235688999999999999999999999999999998743
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=357.00 Aligned_cols=284 Identities=35% Similarity=0.556 Sum_probs=226.3
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
..+|.+.+.||+|+||.||+|.+..+|+.||+|.+.... ....+|+.+++.++|+||+++++++... ....
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~ 82 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK---HLDS 82 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC---CCCe
Confidence 346999999999999999999999999999999885321 1234799999999999999999987532 2235
Q ss_pred EEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
+++||||+.+++..++... ...+++..+..++.||+.||.|||+ .||+||||||+||+++.++ .+||+|||++..
T Consensus 83 ~~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~-~~kL~dfg~~~~ 157 (309)
T cd07845 83 IFLVMEYCEQDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHE-NFIIHRDLKVSNLLLTDKG-CLKIADFGLART 157 (309)
T ss_pred EEEEEecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-CEEECccceeee
Confidence 7899999998776655432 3568899999999999999999997 9999999999999999887 799999999986
Q ss_pred cCCCC-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 290 LVPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 290 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
..... ......+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+....+....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred cCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 64332 22234568889999999776668999999999999999999999999999999999999999888776554332
Q ss_pred --CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 369 --PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 369 --~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
+....+.++......+... ...+++++.+||++||++||++|||+.++++||||++...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~ 298 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHK-FPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPL 298 (309)
T ss_pred cccccccccccCCCCCchHHh-ccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCC
Confidence 1112222222111111111 1236889999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=365.82 Aligned_cols=254 Identities=30% Similarity=0.487 Sum_probs=200.7
Q ss_pred ceeEeeeeccCCceEEEEEEEc---CCCCEEEEEEeccch--------hhHHHHHHHHHHcC-CCCccccceeeeeccCC
Q 011138 138 SYMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQDK--------RYKNRELQIMRLLN-HPNVVSLKHCFFSTTEK 205 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~---~~g~~vAiK~~~~~~--------~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~ 205 (492)
+|.+.+.||+|+||.||++++. .+|+.||+|++.+.. ....+|+.+++.++ |+||++++++| .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence 4899999999999999999864 578999999885421 22456999999994 99999999888 4
Q ss_pred CceEEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeee
Q 011138 206 DELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (492)
Q Consensus 206 ~~~~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DF 284 (492)
...++|+||||+.++ +...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+||
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nili~~~~-~~kl~Df 149 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIILALEHLHK-LGIVYRDIKLENILLDSEG-HVVLTDF 149 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHeEECCCC-CEEEeeC
Confidence 555689999999865 433332 24568899999999999999999997 9999999999999999887 7999999
Q ss_pred cCccccCCCC--CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 011138 285 GSAKMLVPGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (492)
Q Consensus 285 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~ 362 (492)
|+++...... ......||+.|+|||++.+...++.++|||||||++|||++|..||...........+...+..
T Consensus 150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~---- 225 (332)
T cd05614 150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK---- 225 (332)
T ss_pred cCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc----
Confidence 9997653322 2234679999999999976666889999999999999999999999754332222222111000
Q ss_pred HHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcC-----CHHHhhCCCCCCCCC
Q 011138 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLR 427 (492)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----t~~e~l~Hp~f~~~~ 427 (492)
. . ..++..+++.+++||.+||+.||++|| +++++++||||++..
T Consensus 226 ----~-----~------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 274 (332)
T cd05614 226 ----C-----D------------PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274 (332)
T ss_pred ----C-----C------------CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 0 0 012345789999999999999999999 788999999999764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=355.39 Aligned_cols=255 Identities=27% Similarity=0.394 Sum_probs=205.9
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
|++.+.||+|+||.||++.+..+++.||||++.... ....+|+.+++.++||||+++++++ ....++|
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 76 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDALC 76 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeEE
Confidence 889999999999999999999999999999885431 2234799999999999999999988 4445799
Q ss_pred EEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
+||||+.++.+..... ......+++..+..++.||+.||.|||+ .||+||||||+||+++.++ .++|+|||++....
T Consensus 77 lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~ 153 (285)
T cd05605 77 LVLTLMNGGDLKFHIY-NMGNPGFDEERAVFYAAEITCGLEDLHR-ERIVYRDLKPENILLDDYG-HIRISDLGLAVEIP 153 (285)
T ss_pred EEEeccCCCcHHHHHH-hcCcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHEEECCCC-CEEEeeCCCceecC
Confidence 9999998654432221 1223568999999999999999999997 9999999999999999877 79999999998764
Q ss_pred CCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 011138 292 PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (492)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~ 371 (492)
........+|++.|+|||++.+. .++.++||||+||++|+|++|..||.+.+.......+...+...
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~------------ 220 (285)
T cd05605 154 EGETIRGRVGTVGYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED------------ 220 (285)
T ss_pred CCCccccccCCCCccCcHHhcCC-CCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc------------
Confidence 44444456889999999999654 48999999999999999999999998866544433333221100
Q ss_pred cccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcC-----CHHHhhCCCCCCCCC
Q 011138 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLR 427 (492)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----t~~e~l~Hp~f~~~~ 427 (492)
. ..++..+++.+.+||.+||..||.+|| ++.++++||||....
T Consensus 221 -~------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05605 221 -Q------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTAN 268 (285)
T ss_pred -c------------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCC
Confidence 0 012235789999999999999999999 899999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-45 Score=362.62 Aligned_cols=249 Identities=28% Similarity=0.449 Sum_probs=202.1
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCC-CccccceeeeeccCCCceE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHP-NVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~-nIv~l~~~~~~~~~~~~~~ 209 (492)
+|.+.+.||+|+||.||+|.+..+++.||||++..+. .....|..++..+.|+ +|++++++| .+..+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-----EcCCE
Confidence 4889999999999999999999999999999986432 2234688889999765 577888887 34446
Q ss_pred EEEEeeechhhHH-HHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 210 LNLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 210 ~~lV~E~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
+|+||||++++.+ ..+. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++.
T Consensus 76 ~~lv~E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~-~~kL~Dfg~~~ 149 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQ----QVGKFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDAEG-HIKIADFGMCK 149 (324)
T ss_pred EEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEEcCCC-CEEEeecCcce
Confidence 8999999986533 3322 23568889999999999999999997 9999999999999999887 79999999987
Q ss_pred ccC-CCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 289 MLV-PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 289 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
... ........+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~------------ 216 (324)
T cd05587 150 ENIFGGKTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH------------ 216 (324)
T ss_pred ecCCCCCceeeecCCccccChhhhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC------------
Confidence 532 22233456799999999999764 4899999999999999999999999988776665555331
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCH-----HHhhCCCCCCCCC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA-----LEACAHPFFDDLR 427 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~-----~e~l~Hp~f~~~~ 427 (492)
... ++..+++++++||.+||+.||.+|++. .++++||||+.+.
T Consensus 217 -----~~~------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~ 264 (324)
T cd05587 217 -----NVS------------YPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRID 264 (324)
T ss_pred -----CCC------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 111 223578999999999999999999986 8999999998764
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=368.23 Aligned_cols=277 Identities=25% Similarity=0.375 Sum_probs=207.8
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEeee
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEY 216 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E~ 216 (492)
.+|.+.+.||+|+||.||+|.+..+++.||+|+.... ....|+.+++.++||||+++++++. ...+.++|||+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~ 138 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--TTLIEAMLLQNVNHPSVIRMKDTLV-----SGAITCMVLPH 138 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--ccHHHHHHHHhCCCCCCcChhheEE-----eCCeeEEEEEc
Confidence 4699999999999999999999999999999975433 2346999999999999999999984 33458899999
Q ss_pred chhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCCCC
Q 011138 217 ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN 296 (492)
Q Consensus 217 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~~~ 296 (492)
+.++++..+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++........
T Consensus 139 ~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~ 213 (357)
T PHA03209 139 YSSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHA-QRIIHRDVKTENIFINDVD-QVCIGDLGAAQFPVVAPAF 213 (357)
T ss_pred cCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEEecCccccccccCccc
Confidence 99887775533 34568999999999999999999997 9999999999999999887 7999999999754433344
Q ss_pred ccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCC-CCCCCCC---------hHHHHHHHHHHhCCCCHHHHhh
Q 011138 297 ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ-PLFPGES---------GVDQLVEIIKILGTPTREEIKC 366 (492)
Q Consensus 297 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~-~pf~~~~---------~~~~~~~i~~~~g~p~~~~~~~ 366 (492)
....||+.|+|||++.+. .++.++|||||||++|||+++. ++|.... ....+..++..++..+.....+
T Consensus 214 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 292 (357)
T PHA03209 214 LGLAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD 292 (357)
T ss_pred ccccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence 456799999999999665 4899999999999999999854 4444322 1234455555555433221100
Q ss_pred cCCCCc--ccCCCcccCCC---cccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 367 MNPNYT--EFKFPQIKAHP---WHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 367 ~~~~~~--~~~~~~~~~~~---~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
...... .+.+......+ +...-...++.++.+||.+||++||.+|||+.|+|+||||+++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~ 357 (357)
T PHA03209 293 PGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357 (357)
T ss_pred CccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence 000000 00000000001 1011112568889999999999999999999999999999864
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=353.71 Aligned_cols=285 Identities=34% Similarity=0.596 Sum_probs=224.1
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcC-CCCccccceeeeeccCCCceEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
+|.+.+.||+|+||.||+|.+..+|+.||||.+.... ....+|+.+++.+. ||||+++++++...........
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 5899999999999999999999999999999875432 23457999999995 6999999998865544445568
Q ss_pred EEEeeechhhHHHHhhhhhhc-CCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 211 NLVLEYISETVYRVSKHYTRM-NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 211 ~lV~E~~~~~l~~~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
|+||||+++++...+...... ...+++..++.++.||+.||.|||+ +||+||||||+||+++.+...+||+|||++..
T Consensus 82 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 82 YLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK-HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 899999998877765443322 3568999999999999999999997 99999999999999998344899999999875
Q ss_pred cCCC-CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 290 LVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 290 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
.... .......+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+.++.|....+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T cd07837 161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS 240 (295)
T ss_pred cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence 5322 222334678899999998766668999999999999999999999999999988888898888887766543321
Q ss_pred CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCC
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~ 424 (492)
.......++....... ....+.+++++.+||.+||.+||.+||++.+++.||||+
T Consensus 241 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 241 KLRDWHEFPQWKPQDL-SRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hccchhhcCcccchhH-HHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 1111111221111111 111235789999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=363.23 Aligned_cols=244 Identities=27% Similarity=0.485 Sum_probs=199.7
Q ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHc-CCCCccccceeeeeccCCCceEEEEEe
Q 011138 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
++||+|+||.||+|++..+|+.||||++..+. .....|..+++.+ +||||++++++| .+...+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF-----QTKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCeEEEEE
Confidence 36999999999999999999999999986532 2234688888766 799999999998 4445689999
Q ss_pred eechhhHH-HHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC-
Q 011138 215 EYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP- 292 (492)
Q Consensus 215 E~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~- 292 (492)
||++++.+ ..+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++.....
T Consensus 76 E~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~Nill~~~~-~~kL~Dfg~~~~~~~~ 149 (321)
T cd05591 76 EYVNGGDLMFQIQ----RSRKFDEPRSRFYAAEVTLALMFLHR-HGVIYRDLKLDNILLDAEG-HCKLADFGMCKEGILN 149 (321)
T ss_pred eCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCC-CEEEeecccceecccC
Confidence 99987543 3322 24568889999999999999999997 9999999999999999888 799999999875422
Q ss_pred CCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 011138 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372 (492)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~ 372 (492)
........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.. .
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~-----------------~ 211 (321)
T cd05591 150 GVTTTTFCGTPDYIAPEILQEL-EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH-----------------D 211 (321)
T ss_pred CccccccccCccccCHHHHcCC-CCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHc-----------------C
Confidence 2233456799999999998654 489999999999999999999999998887766665543 1
Q ss_pred ccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcC-------CHHHhhCCCCCCCCC
Q 011138 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-------TALEACAHPFFDDLR 427 (492)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-------t~~e~l~Hp~f~~~~ 427 (492)
... ++..+++++.+||.+||+.||.+|+ ++.++++||||..+.
T Consensus 212 ~~~------------~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~ 261 (321)
T cd05591 212 DVL------------YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEID 261 (321)
T ss_pred CCC------------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCC
Confidence 111 1234689999999999999999999 899999999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=363.43 Aligned_cols=287 Identities=32% Similarity=0.574 Sum_probs=226.3
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccC-CCceE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY 209 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~-~~~~~ 209 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||||.+.+. .....+|+.+++.++||||++++++|..... .+..+
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 95 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD 95 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence 4699999999999999999999999999999987532 1234479999999999999999998754332 22345
Q ss_pred EEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
.|+||||+.+++...+.. .++...+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 96 ~~lv~e~~~~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~ 167 (353)
T cd07850 96 VYLVMELMDANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLART 167 (353)
T ss_pred EEEEEeccCCCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCC-CEEEccCcccee
Confidence 789999999877765432 27888899999999999999997 8999999999999999888 799999999987
Q ss_pred cCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
...........+++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+.......+...++.|+.+.+.....
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T cd07850 168 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP 246 (353)
T ss_pred CCCCCCCCCCcccccccCHHHHhCC-CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 6544444456789999999999765 489999999999999999999999999998888999999999988765443221
Q ss_pred CC----------cccCCCcccC-CCc---ccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCCCC
Q 011138 370 NY----------TEFKFPQIKA-HPW---HKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTC 432 (492)
Q Consensus 370 ~~----------~~~~~~~~~~-~~~---~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~~~ 432 (492)
.. ....+..... ..+ ........++++++||.+||+.||++|||+.|+|+||||+.+-++..+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~~~ 323 (353)
T cd07850 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSEV 323 (353)
T ss_pred hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCccC
Confidence 11 1111111000 000 000122456789999999999999999999999999999987765444
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=354.38 Aligned_cols=251 Identities=26% Similarity=0.374 Sum_probs=198.9
Q ss_pred eccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEeeec
Q 011138 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (492)
Q Consensus 145 lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E~~ 217 (492)
||+|+||+||+|.+..+|+.||+|++.... .....|+.+++.++|+||++++++| .....+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence 699999999999999999999999985432 2234699999999999999999888 4445689999999
Q ss_pred hhhHHH-HhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCCC-
Q 011138 218 SETVYR-VSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP- 295 (492)
Q Consensus 218 ~~~l~~-~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~~- 295 (492)
+++.+. .+.........+++..+..++.||+.||.|||+ +||+||||||+||+++.++ .+||+|||++........
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~ 153 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ-RRIIYRDLKPENVLLDNDG-NVRISDLGLAVELKDGQSK 153 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEeeCccceecCCCCcc
Confidence 875443 332223344568999999999999999999997 9999999999999999877 799999999976543322
Q ss_pred CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccC
Q 011138 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFK 375 (492)
Q Consensus 296 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 375 (492)
.....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+....-. ...
T Consensus 154 ~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-------------~~~- 218 (280)
T cd05608 154 TKGYAGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILN-------------DSV- 218 (280)
T ss_pred ccccCCCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcc-------------cCC-
Confidence 2345789999999999765 4899999999999999999999999875433222222111000 000
Q ss_pred CCcccCCCcccccCCCCChhHhhhhccccccCCCCcC-----CHHHhhCCCCCCCCCC
Q 011138 376 FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLRD 428 (492)
Q Consensus 376 ~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----t~~e~l~Hp~f~~~~~ 428 (492)
.++..+++++.+|+.+||+.||++|+ +++++++||||+++..
T Consensus 219 -----------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~ 265 (280)
T cd05608 219 -----------TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNW 265 (280)
T ss_pred -----------CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCH
Confidence 12345789999999999999999999 8899999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=351.42 Aligned_cols=276 Identities=39% Similarity=0.733 Sum_probs=227.0
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
+|.+.+.||.|+||.||+|.+..+|..||+|++.... ....+|+.+++.++||||+++++++ .+..+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF-----PHGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeeE
Confidence 4899999999999999999999999999999885432 3456799999999999999999988 4455689
Q ss_pred EEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
+||||+++++...+.. ....+++..++.++.||+.||.|||+ +||+|+||||+||+++.++ .++|+|||++....
T Consensus 76 ~v~e~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~~~~~~-~~~l~dfg~~~~~~ 150 (286)
T cd07832 76 LVMEYMPSDLSEVLRD---EERPLPEAQVKSYMRMLLKGVAYMHA-NGIMHRDLKPANLLISADG-VLKIADFGLARLFS 150 (286)
T ss_pred EEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCHHHEEEcCCC-cEEEeeeeeccccc
Confidence 9999996666665433 23568999999999999999999997 9999999999999999877 79999999988664
Q ss_pred CCCC--CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC-
Q 011138 292 PGEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN- 368 (492)
Q Consensus 292 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~- 368 (492)
.... .....|+..|+|||++.+...++.++||||+||++|+|++|.+||.+.+....+..+...++.+....+....
T Consensus 151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 151 EEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred CCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccC
Confidence 4331 3345789999999998776667999999999999999999999999999888999999999988877665432
Q ss_pred -CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCC
Q 011138 369 -PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424 (492)
Q Consensus 369 -~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~ 424 (492)
+.+....++.....++... .+..+.++.+||++||..||++|||+.++++||||.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEI-FPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cchhhcccCCCCCcchHHHh-CCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 2233334443333333222 245679999999999999999999999999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=360.46 Aligned_cols=246 Identities=28% Similarity=0.493 Sum_probs=199.6
Q ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHc-CCCCccccceeeeeccCCCceEEEEEe
Q 011138 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
+.||+|+||+||+|.+..+++.||||++.+.. ....+|..+++.+ +||||+++++++ .+..++|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~-----~~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF-----QTKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 36999999999999999999999999986532 2234688888887 699999999988 4445689999
Q ss_pred eechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC-CC
Q 011138 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV-PG 293 (492)
Q Consensus 215 E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~-~~ 293 (492)
||+.++.+... ......+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++... ..
T Consensus 76 e~~~~~~L~~~---~~~~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~ 150 (318)
T cd05570 76 EYVNGGDLMFH---IQRSGRFDEPRARFYAAEIVLGLQFLHE-RGIIYRDLKLDNVLLDSEG-HIKIADFGMCKEGILGG 150 (318)
T ss_pred cCCCCCCHHHH---HHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEccCCCHHHeEECCCC-cEEecccCCCeecCcCC
Confidence 99987544321 1223468999999999999999999997 9999999999999999888 79999999986532 22
Q ss_pred CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 011138 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373 (492)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~ 373 (492)
......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+.. ..
T Consensus 151 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~-----------------~~ 212 (318)
T cd05570 151 VTTSTFCGTPDYIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE-----------------DE 212 (318)
T ss_pred CcccceecCccccCHHHhcCC-CCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc-----------------CC
Confidence 233446799999999999664 489999999999999999999999988776555444432 01
Q ss_pred cCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCH-----HHhhCCCCCCCCCC
Q 011138 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA-----LEACAHPFFDDLRD 428 (492)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~-----~e~l~Hp~f~~~~~ 428 (492)
.. ++..+++++.+||++||+.||.+||++ .++++||||+.+..
T Consensus 213 ~~------------~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 213 VR------------YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred CC------------CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 11 223578999999999999999999999 99999999988643
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=361.03 Aligned_cols=244 Identities=31% Similarity=0.515 Sum_probs=198.3
Q ss_pred eeeccCCceEEEEEEEc---CCCCEEEEEEeccch--------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 143 RVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQDK--------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~---~~g~~vAiK~~~~~~--------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
+.||+|+||.||++++. .+++.||||++.... ....+|+.+++.++||||++++++| .....+|
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~~ 76 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF-----QTGGKLY 76 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE-----ecCCeEE
Confidence 57999999999999864 578999999885431 2235799999999999999999988 3444689
Q ss_pred EEeeechhhHH-HHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 212 LVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 212 lV~E~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
+||||+.++.+ ..+. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus 77 lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~ 150 (323)
T cd05584 77 LILEYLSGGELFMHLE----REGIFMEDTACFYLSEISLALEHLHQ-QGIIYRDLKPENILLDAQG-HVKLTDFGLCKES 150 (323)
T ss_pred EEEeCCCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCC-CEEEeeCcCCeec
Confidence 99999987533 3322 24567888899999999999999997 9999999999999999887 7999999998754
Q ss_pred CC-CCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 291 VP-GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 291 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
.. ........||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+....+..+...
T Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~-------------- 215 (323)
T cd05584 151 IHEGTVTHTFCGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG-------------- 215 (323)
T ss_pred ccCCCcccccCCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--------------
Confidence 22 2233346799999999999654 4789999999999999999999999987766655554331
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcC-----CHHHhhCCCCCCCCC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLR 427 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----t~~e~l~Hp~f~~~~ 427 (492)
... ++..+++++.+||.+||+.||++|| ++.++++||||....
T Consensus 216 ---~~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~ 263 (323)
T cd05584 216 ---KLN------------LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVN 263 (323)
T ss_pred ---CCC------------CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCC
Confidence 111 2235789999999999999999999 899999999998653
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-46 Score=391.70 Aligned_cols=257 Identities=29% Similarity=0.481 Sum_probs=220.1
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
...+|.+.++||+|+||.|.+++.+.|++.||+|++.+. ...+..|..||..-+.+=|++++-.| .|.
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD~ 147 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QDE 147 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cCc
Confidence 345799999999999999999999999999999988653 34456799999998999999999888 889
Q ss_pred eEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 208 ~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
.|+|+||||++| +++.++..+ . .+|+..+++|+..|+.||.-||+ .|+|||||||+|||||..| .|||+|||.
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~---~-~~pE~~ArFY~aEiVlAldslH~-mgyVHRDiKPDNvLld~~G-HikLADFGs 221 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKF---D-RLPEDWARFYTAEIVLALDSLHS-MGYVHRDIKPDNVLLDKSG-HIKLADFGS 221 (1317)
T ss_pred cceEEEEecccCchHHHHHhhc---C-CChHHHHHHHHHHHHHHHHHHHh-ccceeccCCcceeEecccC-cEeeccchh
Confidence 999999999986 455555443 3 79999999999999999999998 8999999999999999999 599999999
Q ss_pred ccccCCCC--CCccceeccCccCchhhc----CCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 011138 287 AKMLVPGE--PNISYICSRYYRAPELIF----GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPT 360 (492)
Q Consensus 287 a~~~~~~~--~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~ 360 (492)
+-.+..+. .....+|||.|++||++. +.+.|+..+|+||+||++|||++|..||..++-.+.+.+|+...
T Consensus 222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk---- 297 (1317)
T KOG0612|consen 222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHK---- 297 (1317)
T ss_pred HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchh----
Confidence 87765333 234679999999999984 22569999999999999999999999999999999999998741
Q ss_pred HHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCC---HHHhhCCCCCCCCCC
Q 011138 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT---ALEACAHPFFDDLRD 428 (492)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t---~~e~l~Hp~f~~~~~ 428 (492)
..+.||.. ..+|+++++||+++|. +|+.|.. ++++.+||||.++.+
T Consensus 298 -----------~~l~FP~~----------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 298 -----------ESLSFPDE----------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred -----------hhcCCCcc----------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 34566631 2489999999999875 6888988 999999999998665
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=361.97 Aligned_cols=246 Identities=26% Similarity=0.485 Sum_probs=195.7
Q ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHc-CCCCccccceeeeeccCCCceEEEEEe
Q 011138 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
++||+|+||.||+|.+..+++.||||++.+.. ....+|..+++.+ +||||++++++| .+..++|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence 46999999999999999999999999986431 2345788999888 699999999988 4455789999
Q ss_pred eechhhHH-HHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc-CC
Q 011138 215 EYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VP 292 (492)
Q Consensus 215 E~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~-~~ 292 (492)
||++++.+ ..+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.. ..
T Consensus 76 e~~~~g~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~~ 149 (329)
T cd05588 76 EFVSGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNFLHE-RGIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEGIRP 149 (329)
T ss_pred eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCC-CEEECcCccccccccC
Confidence 99987543 3222 24578999999999999999999997 9999999999999999887 7999999998753 22
Q ss_pred CCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHHHhCCCCHHHH
Q 011138 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESG--------VDQLVEIIKILGTPTREEI 364 (492)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~--------~~~~~~i~~~~g~p~~~~~ 364 (492)
.......+||+.|+|||++.+. .++.++|+|||||++|+|++|+.||..... .+.+.+.+..
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--------- 219 (329)
T cd05588 150 GDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE--------- 219 (329)
T ss_pred CCccccccCCccccCHHHHcCC-CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc---------
Confidence 3334457899999999999764 489999999999999999999999964221 1111111110
Q ss_pred hhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCC------HHHhhCCCCCCCCCC
Q 011138 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT------ALEACAHPFFDDLRD 428 (492)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t------~~e~l~Hp~f~~~~~ 428 (492)
.... ++..++.++.+||++||+.||.+|++ +.++++||||..+..
T Consensus 220 -------~~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~ 270 (329)
T cd05588 220 -------KQIR------------IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW 270 (329)
T ss_pred -------CCCC------------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 0111 22357899999999999999999997 789999999987543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=359.19 Aligned_cols=244 Identities=27% Similarity=0.467 Sum_probs=196.4
Q ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHH-cCCCCccccceeeeeccCCCceEEEEEe
Q 011138 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRL-LNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~-l~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
+.||+|+||.||+|.+..+|+.||+|++.... .....|..++.. ++||||++++++| .+..++|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence 36999999999999999999999999986432 223457777765 4899999999988 4455799999
Q ss_pred eechhhHH-HHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC-
Q 011138 215 EYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP- 292 (492)
Q Consensus 215 E~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~- 292 (492)
||+.++.+ ..+. ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++....
T Consensus 76 E~~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~ 149 (316)
T cd05620 76 EFLNGGDLMFHIQ----DKGRFDLYRATFYAAEIVCGLQFLHS-KGIIYRDLKLDNVMLDRDG-HIKIADFGMCKENVFG 149 (316)
T ss_pred CCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCC-CEEeCccCCCeecccC
Confidence 99986533 3322 24568899999999999999999997 9999999999999999887 799999999875322
Q ss_pred CCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 011138 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372 (492)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~ 372 (492)
.......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.. +
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~--~--------------- 211 (316)
T cd05620 150 DNRASTFCGTPDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV--D--------------- 211 (316)
T ss_pred CCceeccCCCcCccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--C---------------
Confidence 2233456799999999999755 489999999999999999999999988776554443322 0
Q ss_pred ccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCH-HHhhCCCCCCCCC
Q 011138 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA-LEACAHPFFDDLR 427 (492)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~-~e~l~Hp~f~~~~ 427 (492)
... ++..++.++++||.+||+.||.+|+++ +++++||||+...
T Consensus 212 ~~~------------~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~ 255 (316)
T cd05620 212 TPH------------YPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTIN 255 (316)
T ss_pred CCC------------CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCC
Confidence 001 123478999999999999999999998 5899999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=367.18 Aligned_cols=253 Identities=26% Similarity=0.428 Sum_probs=204.0
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.++..++||||+++++.| .+..++
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~~ 76 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRNL 76 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCEE
Confidence 5899999999999999999999999999999985421 2345799999999999999999988 455578
Q ss_pred EEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 211 ~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
|+||||++++ +...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 77 ~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~~L~~lH~-~givHrDLkp~NIli~~~~-~vkL~DfG~~~~ 150 (360)
T cd05627 77 YLIMEFLPGGDMMTLLM----KKDTLSEEATQFYIAETVLAIDAIHQ-LGFIHRDIKPDNLLLDAKG-HVKLSDFGLCTG 150 (360)
T ss_pred EEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECCCC-CEEEeeccCCcc
Confidence 9999999865 444332 24568999999999999999999997 9999999999999999887 799999999865
Q ss_pred cCCCC------------------------------------CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHH
Q 011138 290 LVPGE------------------------------------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAEL 333 (492)
Q Consensus 290 ~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~el 333 (492)
..... .....+||+.|+|||++.+. .++.++|||||||++|||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyel 229 (360)
T cd05627 151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEM 229 (360)
T ss_pred cccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC-CCCCcceeccccceeeec
Confidence 42110 01245799999999999765 489999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCC
Q 011138 334 LLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT 413 (492)
Q Consensus 334 l~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t 413 (492)
++|.+||.+.+..+.+..+.... ....+|.. ..+++++++||.+|+. ||.+|++
T Consensus 230 ~tG~~Pf~~~~~~~~~~~i~~~~---------------~~~~~p~~----------~~~s~~~~~li~~l~~-~p~~R~~ 283 (360)
T cd05627 230 LIGYPPFCSETPQETYRKVMNWK---------------ETLVFPPE----------VPISEKAKDLILRFCT-DSENRIG 283 (360)
T ss_pred ccCCCCCCCCCHHHHHHHHHcCC---------------CceecCCC----------CCCCHHHHHHHHHhcc-ChhhcCC
Confidence 99999999887766655554310 01112210 1368899999999874 9999984
Q ss_pred ---HHHhhCCCCCCCCCC
Q 011138 414 ---ALEACAHPFFDDLRD 428 (492)
Q Consensus 414 ---~~e~l~Hp~f~~~~~ 428 (492)
+.++++||||+++..
T Consensus 284 ~~~~~ei~~hp~f~~~~~ 301 (360)
T cd05627 284 SNGVEEIKSHPFFEGVDW 301 (360)
T ss_pred CCCHHHHhcCCCCCCCCH
Confidence 799999999998653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=358.58 Aligned_cols=257 Identities=26% Similarity=0.441 Sum_probs=204.5
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
+|.+.+.||+|+||.||++++..+++.||||++.+. ...+.+|+.+++.++|+||++++++| .+..++
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~ 76 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENNL 76 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCeE
Confidence 599999999999999999999999999999998542 12345789999999999999999988 445579
Q ss_pred EEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 211 ~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
|+||||+.++ |..++. .....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 77 ~lv~e~~~g~~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~ 151 (331)
T cd05597 77 YLVMDYYVGGDLLTLLS---KFEDRLPEDMARFYLAEMVLAIDSVHQ-LGYVHRDIKPDNVLLDKNG-HIRLADFGSCLR 151 (331)
T ss_pred EEEEecCCCCcHHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEECCCCHHHEEECCCC-CEEEEECCceee
Confidence 9999999764 444432 224568899999999999999999997 9999999999999999887 799999999876
Q ss_pred cCCCCC--CccceeccCccCchhhcC----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 011138 290 LVPGEP--NISYICSRYYRAPELIFG----ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (492)
Q Consensus 290 ~~~~~~--~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~ 363 (492)
...... .....||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~------- 224 (331)
T cd05597 152 LLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK------- 224 (331)
T ss_pred cCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCC-------
Confidence 543322 123578999999999863 3457889999999999999999999998877666655554311
Q ss_pred HhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCC--cCCHHHhhCCCCCCCCCC
Q 011138 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSL--RCTALEACAHPFFDDLRD 428 (492)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~--R~t~~e~l~Hp~f~~~~~ 428 (492)
..+.++. ....+++++++||++||..++.+ |+++.++++||||.++..
T Consensus 225 --------~~~~~~~---------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~ 274 (331)
T cd05597 225 --------EHFQFPP---------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW 274 (331)
T ss_pred --------CcccCCC---------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence 0111111 11247899999999999765444 789999999999987653
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=359.50 Aligned_cols=249 Identities=27% Similarity=0.428 Sum_probs=202.6
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHc-CCCCccccceeeeeccCCCceE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
+|.+.+.||+|+||.||+|.+..+++.||||++.+.. .....|..++..+ +|++|+++++++ .+..+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence 4889999999999999999999999999999886432 1233577777776 488999998888 44456
Q ss_pred EEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 210 LNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 210 ~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
+|+||||++++ +...+. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus 76 ~~lv~E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~-~~kL~DfG~~~ 149 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQ----QVGRFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDSEG-HIKIADFGMCK 149 (323)
T ss_pred EEEEEcCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEecCCCHHHeEECCCC-cEEEccCCCce
Confidence 89999999865 433322 23568889999999999999999997 9999999999999999888 79999999987
Q ss_pred ccCC-CCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 289 MLVP-GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 289 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
.... .......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+...
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~------------ 216 (323)
T cd05616 150 ENMWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH------------ 216 (323)
T ss_pred ecCCCCCccccCCCChhhcCHHHhcCC-CCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------
Confidence 5432 2233456799999999999654 4899999999999999999999999988776666555431
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCH-----HHhhCCCCCCCCC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA-----LEACAHPFFDDLR 427 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~-----~e~l~Hp~f~~~~ 427 (492)
... ++..+++++.+||.+||+.||.+|++. .++++||||+.+.
T Consensus 217 -----~~~------------~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~ 264 (323)
T cd05616 217 -----NVA------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 264 (323)
T ss_pred -----CCC------------CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence 111 223578999999999999999999984 8999999998765
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=365.80 Aligned_cols=256 Identities=29% Similarity=0.460 Sum_probs=206.0
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
...+|.+.+.||+|+||.||+|.+..+++.||+|++.+. .....+|+.+++.++||||+++++++ .+.
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~ 115 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDD 115 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcC
Confidence 345799999999999999999999999999999988532 22345799999999999999999988 445
Q ss_pred eEEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 208 LYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 208 ~~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
.++|+||||++++ |..++. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NIll~~~~-~ikL~DfG~ 188 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMS-----NYDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSG-HLKLADFGT 188 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHEEECCCC-CEEEEeCCc
Confidence 5799999999865 444332 2357888999999999999999997 9999999999999999887 799999999
Q ss_pred ccccCCCC--CCccceeccCccCchhhcCCC---CCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 011138 287 AKMLVPGE--PNISYICSRYYRAPELIFGAT---EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTR 361 (492)
Q Consensus 287 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~ 361 (492)
+....... .....+||+.|+|||++.+.. .++.++|||||||++|||++|.+||.+.+....+.+|.....
T Consensus 189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~---- 264 (371)
T cd05622 189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN---- 264 (371)
T ss_pred eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC----
Confidence 98664322 223567999999999986532 378999999999999999999999998877666666543110
Q ss_pred HHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCC--cCCHHHhhCCCCCCCCC
Q 011138 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSL--RCTALEACAHPFFDDLR 427 (492)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~--R~t~~e~l~Hp~f~~~~ 427 (492)
...+|. ...+++++++||.+||..++.+ |+++.++++||||++..
T Consensus 265 -----------~~~~~~----------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 265 -----------SLTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred -----------cccCCC----------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence 111221 1357899999999999844443 78999999999998743
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=363.98 Aligned_cols=254 Identities=29% Similarity=0.456 Sum_probs=220.7
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
.+|..++.+|+|+||.+++++.+.++..|++|++.-. ++...+|+.+++++.|||||.+++.|+ .+..++
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~----~~~~~l 79 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE----EDGQLL 79 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh----cCCceE
Confidence 4699999999999999999999999999999998533 234568999999999999999999984 445569
Q ss_pred EEEeeechhhHH-HHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 211 NLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 211 ~lV~E~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
||||+||+|+.+ +.++... ...+++..+..|+.||+.|+.|||+ ++|+|||||+.|||+++++ .|||+|||+|+.
T Consensus 80 ~Ivm~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~-~~iLHRDlK~~Nifltk~~-~VkLgDfGlaK~ 155 (426)
T KOG0589|consen 80 CIVMEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHE-NRVLHRDLKCANIFLTKDK-KVKLGDFGLAKI 155 (426)
T ss_pred EEEEeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHh-hhhhcccchhhhhhccccC-ceeecchhhhhh
Confidence 999999997644 4443322 5779999999999999999999997 9999999999999999998 689999999999
Q ss_pred cCCCC-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 290 LVPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 290 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
+.+.. ...+.+||+.||.||++.+ .+|+.++|||||||++|||++-+++|.+.+-...+.+|.+....|
T Consensus 156 l~~~~~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~P--------- 225 (426)
T KOG0589|consen 156 LNPEDSLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSP--------- 225 (426)
T ss_pred cCCchhhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCC---------
Confidence 87776 6668899999999999965 459999999999999999999999999999988888888754333
Q ss_pred CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
.+...+.+++.||..||..+|..||++.++|.+|.++...
T Consensus 226 -------------------lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~~ 265 (426)
T KOG0589|consen 226 -------------------LPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRYL 265 (426)
T ss_pred -------------------CCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence 2245789999999999999999999999999999988443
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=358.79 Aligned_cols=275 Identities=25% Similarity=0.426 Sum_probs=204.6
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
.+|.+.+.||+|+||.||++.+..+|..||+|.+... ...+.+|+++++.++||||+++++++. +...++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 79 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEIS 79 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECCEEE
Confidence 4699999999999999999999999999999988543 134568999999999999999999884 334588
Q ss_pred EEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 212 lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
+||||++++ |.+++. ....+++..+..++.||+.||.|||+..+|+||||||+|||++.++ .+||+|||++...
T Consensus 80 lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~ 154 (331)
T cd06649 80 ICMEHMDGGSLDQVLK----EAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQL 154 (331)
T ss_pred EEeecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC-cEEEccCcccccc
Confidence 999999875 443332 2346889999999999999999999623699999999999999887 7999999998765
Q ss_pred CCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh----
Q 011138 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC---- 366 (492)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~---- 366 (492)
... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+. .. .++.+.......
T Consensus 155 ~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~-~~---~~~~~~~~~~~~~~~~ 228 (331)
T cd06649 155 IDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL-EA---IFGRPVVDGEEGEPHS 228 (331)
T ss_pred ccc-ccccCCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HH---HhcccccccccCCccc
Confidence 332 23456799999999999655 489999999999999999999999987665432 22 222221100000
Q ss_pred cCCCCcc-------c---CCCc---------ccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 367 MNPNYTE-------F---KFPQ---------IKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 367 ~~~~~~~-------~---~~~~---------~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
..+.... . ..+. +............+++++++||.+||++||++|||+.++++||||+...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred cCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 0000000 0 0000 0000000001124688999999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=355.46 Aligned_cols=263 Identities=29% Similarity=0.415 Sum_probs=215.5
Q ss_pred CCccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHcCCCCccccceeeeeccC
Q 011138 132 QPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE 204 (492)
Q Consensus 132 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 204 (492)
+|.....|..-++||+||||.||-|....||+.||+|++.+. +....+|..||.+++.+.||.+--.|
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf----- 254 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF----- 254 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee-----
Confidence 344455788889999999999999999999999999977432 23344799999999999999987666
Q ss_pred CCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeee
Q 011138 205 KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (492)
Q Consensus 205 ~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DF 284 (492)
+....+|+||..|.|+-+.+.. +...+..|++..+++|+.+|+.||++||+ .+||+|||||+|||+|.+| .|+|+|+
T Consensus 255 eTkd~LClVLtlMNGGDLkfHi-yn~g~~gF~e~ra~FYAAEi~cGLehlH~-~~iVYRDLKPeNILLDd~G-hvRISDL 331 (591)
T KOG0986|consen 255 ETKDALCLVLTLMNGGDLKFHI-YNHGNPGFDEQRARFYAAEIICGLEHLHR-RRIVYRDLKPENILLDDHG-HVRISDL 331 (591)
T ss_pred cCCCceEEEEEeecCCceeEEe-eccCCCCCchHHHHHHHHHHHhhHHHHHh-cceeeccCChhheeeccCC-CeEeecc
Confidence 3334599999999987554322 22234679999999999999999999998 9999999999999999998 6999999
Q ss_pred cCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 011138 285 GSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (492)
Q Consensus 285 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~ 364 (492)
|+|..+..+.+....+||..|||||++.+.. |+...|+|||||++|||+.|+.||........-.++-+..-.
T Consensus 332 GLAvei~~g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~------ 404 (591)
T KOG0986|consen 332 GLAVEIPEGKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE------ 404 (591)
T ss_pred ceEEecCCCCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc------
Confidence 9999998888888889999999999997665 999999999999999999999999765543332222221111
Q ss_pred hhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcC-----CHHHhhCCCCCCCCCC
Q 011138 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLRD 428 (492)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----t~~e~l~Hp~f~~~~~ 428 (492)
.. ..++...|+++++|.+.+|+.||.+|. +++++.+||||+++..
T Consensus 405 -------~~------------~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw 454 (591)
T KOG0986|consen 405 -------DP------------EEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNW 454 (591)
T ss_pred -------ch------------hhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCH
Confidence 11 123456899999999999999999998 5779999999998765
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=356.92 Aligned_cols=244 Identities=30% Similarity=0.483 Sum_probs=196.0
Q ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHH-cCCCCccccceeeeeccCCCceEEEEEe
Q 011138 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRL-LNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~-l~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
+.||+|+||.||+|.+..+++.||||++.... .....|..++.. ++||||+++++++ ....++|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 36999999999999999999999999886432 122346666654 4799999999988 4445689999
Q ss_pred eechhhHH-HHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCC
Q 011138 215 EYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (492)
Q Consensus 215 E~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (492)
||++++.+ ..+. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.....
T Consensus 76 e~~~gg~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~ 149 (316)
T cd05592 76 EYLNGGDLMFHIQ----SSGRFDEARARFYAAEIICGLQFLHK-KGIIYRDLKLDNVLLDKDG-HIKIADFGMCKENMNG 149 (316)
T ss_pred cCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHeEECCCC-CEEEccCcCCeECCCC
Confidence 99986544 3322 23568999999999999999999997 9999999999999999887 7999999999754322
Q ss_pred -CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 011138 294 -EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372 (492)
Q Consensus 294 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~ 372 (492)
......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~----------------- 211 (316)
T cd05592 150 EGKASTFCGTPDYIAPEILKGQ-KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND----------------- 211 (316)
T ss_pred CCccccccCCccccCHHHHcCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 233456799999999999765 4899999999999999999999999988765555544320
Q ss_pred ccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHH-HhhCCCCCCCCC
Q 011138 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL-EACAHPFFDDLR 427 (492)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~-e~l~Hp~f~~~~ 427 (492)
... ++..++.++.+||.+||+.||.+|+++. ++++||||..+.
T Consensus 212 ~~~------------~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05592 212 RPH------------FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGID 255 (316)
T ss_pred CCC------------CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCC
Confidence 001 2235789999999999999999999864 888999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=346.23 Aligned_cols=276 Identities=36% Similarity=0.650 Sum_probs=217.4
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
+|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++|+||+++++++ .+..+++
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 76 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF-----RRKRKLH 76 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEE-----eeCCEEE
Confidence 5999999999999999999999999999999875322 2345799999999999999999988 3445688
Q ss_pred EEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
+||||++++++.... .....+++..++.++.||+.||.|||+ .||+||||||+||+++.++ .+||+|||++....
T Consensus 77 ~v~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~ql~~~l~~LH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~ 151 (286)
T cd07847 77 LVFEYCDHTVLNELE---KNPRGVPEHLIKKIIWQTLQAVNFCHK-HNCIHRDVKPENILITKQG-QIKLCDFGFARILT 151 (286)
T ss_pred EEEeccCccHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCChhhEEEcCCC-cEEECccccceecC
Confidence 999999987665432 223468999999999999999999997 9999999999999999887 79999999998764
Q ss_pred CCC-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC--
Q 011138 292 PGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN-- 368 (492)
Q Consensus 292 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~-- 368 (492)
... ......++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+.++...........
T Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 152 GPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred CCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 433 23345678999999998776668899999999999999999999999988888887777766654433221111
Q ss_pred CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
..+.....|......-.......++..+.+||.+||+.||++||++.|++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 1111122222111110111224578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=336.77 Aligned_cols=283 Identities=30% Similarity=0.525 Sum_probs=232.5
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeec---cCCCce
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFST---TEKDEL 208 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~---~~~~~~ 208 (492)
.|.-..+||+|.||.||+|+.+.+|+.||+|++..+. ....+|+.+|..|+|+|++.+++.+-+. ...+..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 4777889999999999999999999999999764321 2234899999999999999998876432 234556
Q ss_pred EEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 209 ~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
.+|+||++|+.+|..++.. ....++..+++.++.+++.||.|+|+ ..|+|||+|++|+||+.++ .+||+|||+++
T Consensus 98 t~ylVf~~cehDLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr-~kilHRDmKaaNvLIt~dg-ilklADFGlar 172 (376)
T KOG0669|consen 98 TFYLVFDFCEHDLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHR-NKILHRDMKAANVLITKDG-ILKLADFGLAR 172 (376)
T ss_pred eeeeeHHHhhhhHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHH-hhHHhhcccHhhEEEcCCc-eEEeecccccc
Confidence 6999999999988776543 34678999999999999999999998 8999999999999999988 89999999997
Q ss_pred ccCCCC-----CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 011138 289 MLVPGE-----PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (492)
Q Consensus 289 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~ 363 (492)
.+.... ..+..+.|.+|++||.++|...|+++.|||..|||+.||.+|.+.|++.++..++..|...+|..+.+.
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 663221 234567799999999999999999999999999999999999999999999999999999999999998
Q ss_pred HhhcC--CCCcccCCCcccCCCcccc---cCC-CCChhHhhhhccccccCCCCcCCHHHhhCCCCCCC
Q 011138 364 IKCMN--PNYTEFKFPQIKAHPWHKI---FHK-RMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (492)
Q Consensus 364 ~~~~~--~~~~~~~~~~~~~~~~~~~---~~~-~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~ 425 (492)
|+.+. +.|..+..+.+.......+ ..+ .-.+++.||+.+||.+||.+|++++++++|.||..
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 87654 4444443333222222111 000 12468999999999999999999999999999985
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=359.92 Aligned_cols=245 Identities=28% Similarity=0.455 Sum_probs=196.4
Q ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEeccchh-------hHHHHH-HHHHHcCCCCccccceeeeeccCCCceEEEEEe
Q 011138 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-------YKNREL-QIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-------~~~~E~-~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
+.||+|+||+||+|.+..+|+.||||++..... ...+|. .+++.++||||+++++++ .+...+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~-----~~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE-----EeCCEEEEEE
Confidence 369999999999999999999999999854321 112333 356789999999999888 3445689999
Q ss_pred eechhhHH-HHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCC
Q 011138 215 EYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (492)
Q Consensus 215 E~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (492)
||+.++.+ ..+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.....
T Consensus 76 e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~givH~dikp~NIll~~~~-~~kl~Dfg~~~~~~~~ 149 (323)
T cd05575 76 DYVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYLHS-LNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGIEH 149 (323)
T ss_pred cCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECCCC-cEEEeccCCCcccccC
Confidence 99987543 3222 24568899999999999999999997 9999999999999999887 7999999998754222
Q ss_pred -CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 011138 294 -EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372 (492)
Q Consensus 294 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~ 372 (492)
......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~----------------- 211 (323)
T cd05575 150 SKTTSTFCGTPEYLAPEVLRKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK----------------- 211 (323)
T ss_pred CCccccccCChhhcChhhhcCC-CCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 223356799999999999654 4899999999999999999999999987766555544331
Q ss_pred ccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCH----HHhhCCCCCCCCCC
Q 011138 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA----LEACAHPFFDDLRD 428 (492)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~----~e~l~Hp~f~~~~~ 428 (492)
... +...+++++.+||.+||+.||.+||++ .++++||||..+..
T Consensus 212 ~~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~ 259 (323)
T cd05575 212 PLR------------LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW 259 (323)
T ss_pred CCC------------CCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 001 123578999999999999999999998 69999999987653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=371.35 Aligned_cols=274 Identities=24% Similarity=0.335 Sum_probs=206.8
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEeee
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEY 216 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E~ 216 (492)
..|.+.+.||+|+||.||+|.+..+++.||||.... ....+|+++|+.|+|+|||++++++.. ....++|||+
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--~~~~~E~~iL~~L~HpnIv~l~~~~~~-----~~~~~lv~e~ 241 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--ASSVHEARLLRRLSHPAVLALLDVRVV-----GGLTCLVLPK 241 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--cCHHHHHHHHHHCCCCCCCcEEEEEEE-----CCEEEEEEEc
Confidence 469999999999999999999999999999996432 335679999999999999999998743 3457899999
Q ss_pred chhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCCC-
Q 011138 217 ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP- 295 (492)
Q Consensus 217 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~~- 295 (492)
+.++++..+.. ....+++..++.|+.||+.||.|||+ +|||||||||+||||+.++ .+||+|||+++.......
T Consensus 242 ~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDLKP~NILl~~~~-~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 242 YRSDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHG-EGIIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWST 316 (461)
T ss_pred cCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEECcCCHHHEEECCCC-CEEEcccCCceeccccccc
Confidence 99887765533 23468999999999999999999997 9999999999999999887 799999999976533221
Q ss_pred --CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHHHhCCCCHHHH--
Q 011138 296 --NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES-------GVDQLVEIIKILGTPTREEI-- 364 (492)
Q Consensus 296 --~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~-------~~~~~~~i~~~~g~p~~~~~-- 364 (492)
.....||+.|+|||++.+. .++.++|||||||+||||++|..|+.... ...++.++++..+....+..
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred ccccccCCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 2245799999999999765 48999999999999999999876543221 13455556554443221100
Q ss_pred ------hhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCC
Q 011138 365 ------KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (492)
Q Consensus 365 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~ 425 (492)
..+.........+......|...+ .++.++.+||.+||++||.+|||+.|+|+||||+.
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYY--KLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhc--cccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 000000000111111222233221 46788999999999999999999999999999974
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=355.71 Aligned_cols=245 Identities=28% Similarity=0.478 Sum_probs=196.5
Q ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHH-cCCCCccccceeeeeccCCCceEEEEEe
Q 011138 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRL-LNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~-l~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
+.||+|+||.||+|.+..+++.||||++.... .....|..+++. ++||||+++++++. +..++|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ-----TKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE-----eCCEEEEEE
Confidence 36999999999999999999999999886532 223357777775 48999999999883 344689999
Q ss_pred eechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC-
Q 011138 215 EYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP- 292 (492)
Q Consensus 215 E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~- 292 (492)
||++++ +...+. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++....
T Consensus 76 ey~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~~~~ 149 (316)
T cd05619 76 EYLNGGDLMFHIQ----SCHKFDLPRATFYAAEIICGLQFLHS-KGIVYRDLKLDNILLDTDG-HIKIADFGMCKENMLG 149 (316)
T ss_pred eCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECCCC-CEEEccCCcceECCCC
Confidence 999865 443332 23568889999999999999999997 9999999999999999887 799999999875322
Q ss_pred CCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 011138 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372 (492)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~ 372 (492)
........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.. .
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~-----------------~ 211 (316)
T cd05619 150 DAKTCTFCGTPDYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM-----------------D 211 (316)
T ss_pred CCceeeecCCccccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------------C
Confidence 2233456789999999999654 489999999999999999999999988776554444321 0
Q ss_pred ccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHH-HhhCCCCCCCCCC
Q 011138 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL-EACAHPFFDDLRD 428 (492)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~-e~l~Hp~f~~~~~ 428 (492)
... ++..++.++++||.+||+.||.+|+++. ++++||||+.+..
T Consensus 212 ~~~------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05619 212 NPC------------YPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDW 256 (316)
T ss_pred CCC------------CCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCH
Confidence 001 1234688999999999999999999996 8999999998653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=346.40 Aligned_cols=275 Identities=36% Similarity=0.638 Sum_probs=219.2
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-----hhHHHHHHHHHHcC-CCCccccceeeeeccCCCceEEEE
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-----~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++++. |+||+++++++... ...++++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence 678889999999999999999999999999885432 12236888888885 99999999988543 1145899
Q ss_pred EeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 213 V~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
||||++++++..+.. ....+++..+..++.||+.||.|||+ .||+||||||+||+++. + .+||+|||++.....
T Consensus 78 v~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~p~ni~l~~-~-~~kl~dfg~~~~~~~ 151 (282)
T cd07831 78 VFELMDMNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHR-NGIFHRDIKPENILIKD-D-ILKLADFGSCRGIYS 151 (282)
T ss_pred EEecCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEcC-C-CeEEEeccccccccc
Confidence 999999887765543 23468899999999999999999997 99999999999999998 5 899999999987654
Q ss_pred CCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC-C
Q 011138 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN-Y 371 (492)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~-~ 371 (492)
........++..|+|||.+.+...++.++|||||||++|||++|.+||.+.+..+.+..+...++.+........... .
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 152 KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence 444455678999999998766566789999999999999999999999999988888888888888877553322211 1
Q ss_pred cccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
..+.++....... ..+...++.++.+||.+||.+||++||++.++++||||
T Consensus 232 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 232 MNYNFPSKKGTGL-RKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccCcccccccH-HHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1222222111111 11224578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=349.09 Aligned_cols=281 Identities=37% Similarity=0.632 Sum_probs=223.0
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch---------hhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~---------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
+|.+.+.||+|+||.||+|.+..+|+.||||.+.... ....+|+.+++.++|+||+++++++ .+..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF-----GHKS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee-----ecCC
Confidence 4888999999999999999999999999999985432 1234699999999999999999998 3455
Q ss_pred EEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 209 ~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
++++||||+.+++...+... ...+++..+..++.||+.||.|||+ +||+|+||||+|||++.++ .+||+|||++.
T Consensus 76 ~~~lv~e~~~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nill~~~~-~~~l~dfg~~~ 150 (298)
T cd07841 76 NINLVFEFMETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHS-NWILHRDLKPNNLLIASDG-VLKLADFGLAR 150 (298)
T ss_pred EEEEEEcccCCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCChhhEEEcCCC-CEEEccceeee
Confidence 78999999966666654321 1368899999999999999999997 9999999999999999887 79999999998
Q ss_pred ccCCCC-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 289 MLVPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 289 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
...... ......+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+..+.+..+...++.|....+...
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 151 SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGV 230 (298)
T ss_pred eccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhc
Confidence 664432 2233466888999999876666899999999999999999999999998888888888888888877665432
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~ 429 (492)
...............+. .......+.++.+||.+||..||.+|||+.|++.||||++...+
T Consensus 231 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~ 291 (298)
T cd07841 231 TSLPDYVEFKPFPPTPL-KQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAP 291 (298)
T ss_pred ccccccccccccCCcch-hhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCC
Confidence 21111111111111111 11234568899999999999999999999999999999986554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=352.39 Aligned_cols=281 Identities=36% Similarity=0.628 Sum_probs=216.9
Q ss_pred ceeEeeeeccCCceEEEEEEEcC--CCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLE--TGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~--~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
+|.+.+.||+|+||.||+|.+.. ++..||||.+.... ....+|+.+++.++||||+++++++... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence 48899999999999999999988 89999999986532 3345799999999999999999988432 225
Q ss_pred EEEEEeeechhhHHHHhhhhhhcC-CCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcC----CCCcEEEee
Q 011138 209 YLNLVLEYISETVYRVSKHYTRMN-QHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP----HTHQLKICD 283 (492)
Q Consensus 209 ~~~lV~E~~~~~l~~~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~----~~~~vkL~D 283 (492)
.+++||||+++++...+....... ..+++..++.++.||+.||.|||+ +||+||||||+|||++. ++ .+||+|
T Consensus 78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~h~dlkp~Nil~~~~~~~~~-~~kl~D 155 (316)
T cd07842 78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS-NWVLHRDLKPANILVMGEGPERG-VVKIGD 155 (316)
T ss_pred eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEEcCCCCccc-eEEECC
Confidence 689999999988777665443333 368899999999999999999997 99999999999999998 66 799999
Q ss_pred ecCccccCCCCC----CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH---------HHHH
Q 011138 284 FGSAKMLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGV---------DQLV 350 (492)
Q Consensus 284 FG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~---------~~~~ 350 (492)
||++........ .....+++.|+|||++.+...++.++|||||||++|+|++|++||.+.... ..+.
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 999876532221 224567899999999877666899999999999999999999999865532 3566
Q ss_pred HHHHHhCCCCHHHHhhcC--CCCccc----CCCcccCCCcccccC--CCCChhHhhhhccccccCCCCcCCHHHhhCCCC
Q 011138 351 EIIKILGTPTREEIKCMN--PNYTEF----KFPQIKAHPWHKIFH--KRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422 (492)
Q Consensus 351 ~i~~~~g~p~~~~~~~~~--~~~~~~----~~~~~~~~~~~~~~~--~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~ 422 (492)
.++..++.+....+.... +.+... .............+. ...+.++.++|.+||+.||++|||+.|+++|||
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~ 315 (316)
T cd07842 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315 (316)
T ss_pred HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence 777777777665543221 111110 000000001111111 257789999999999999999999999999999
Q ss_pred C
Q 011138 423 F 423 (492)
Q Consensus 423 f 423 (492)
|
T Consensus 316 f 316 (316)
T cd07842 316 F 316 (316)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=358.31 Aligned_cols=246 Identities=27% Similarity=0.516 Sum_probs=193.8
Q ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHc-CCCCccccceeeeeccCCCceEEEEEe
Q 011138 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
+.||+|+||.||+|.+..+++.||+|++.+.. ....+|+.++..+ +||||+++++++ .+...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEE-----EeCCEEEEEE
Confidence 46999999999999999999999999986431 2244688888776 799999999998 4445689999
Q ss_pred eechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC-CC
Q 011138 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV-PG 293 (492)
Q Consensus 215 E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~-~~ 293 (492)
||+.++.+... ......+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++... ..
T Consensus 76 E~~~~~~L~~~---~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~Nili~~~~-~~kL~DfG~~~~~~~~~ 150 (329)
T cd05618 76 EYVNGGDLMFH---MQRQRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPG 150 (329)
T ss_pred eCCCCCCHHHH---HHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECCCC-CEEEeeCCccccccCCC
Confidence 99997644321 1224568999999999999999999997 9999999999999999888 79999999987532 22
Q ss_pred CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHHHhCCCCHHHHh
Q 011138 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES--------GVDQLVEIIKILGTPTREEIK 365 (492)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~--------~~~~~~~i~~~~g~p~~~~~~ 365 (492)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||.... ....+.+.+..
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~---------- 219 (329)
T cd05618 151 DTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE---------- 219 (329)
T ss_pred CccccccCCccccCHHHHcCC-CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc----------
Confidence 333456899999999999765 48999999999999999999999995311 11111111110
Q ss_pred hcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCC------HHHhhCCCCCCCCC
Q 011138 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT------ALEACAHPFFDDLR 427 (492)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t------~~e~l~Hp~f~~~~ 427 (492)
.... ++..++.++.+||++||+.||.+|++ +.++++||||+.+.
T Consensus 220 ------~~~~------------~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 269 (329)
T cd05618 220 ------KQIR------------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 269 (329)
T ss_pred ------CCCC------------CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 0111 23457899999999999999999998 47999999998764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=349.61 Aligned_cols=279 Identities=37% Similarity=0.614 Sum_probs=224.5
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
.+|.+.+.||.|+||.||+|.+..+++.+|+|.+.... ....+|+.+++.++||||+++++++.... ..++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCcE
Confidence 35999999999999999999999999999999885322 12347999999999999999999875432 2468
Q ss_pred EEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 211 ~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
|+||||+.+++...+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++...
T Consensus 82 ~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~~~-~~~l~d~g~~~~~ 156 (293)
T cd07843 82 YMVMEYVEHDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHD-NWILHRDLKTSNLLLNNRG-ILKICDFGLAREY 156 (293)
T ss_pred EEEehhcCcCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECCCC-cEEEeecCceeec
Confidence 999999998776654431 2368999999999999999999997 9999999999999999887 7999999998866
Q ss_pred CCC-CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 291 VPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 291 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
... .......+++.|+|||.+.+...++.++|+|||||++|+|++|.+||...+..+.+..+...++.|....+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 157 GSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred cCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 443 2233456789999999987766678999999999999999999999999999889999999999888877654321
Q ss_pred --CCcccCCCcccCCCcccccCCC-CChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 370 --NYTEFKFPQIKAHPWHKIFHKR-MPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 370 --~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
......+.......+...++.. +++.+.+||++||+.||++|||+.|++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 1111111111222223334333 68899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=361.82 Aligned_cols=244 Identities=27% Similarity=0.483 Sum_probs=195.9
Q ss_pred eccCCceEEEEEEEcCCCCEEEEEEeccchh-------hHHHHHHHHHHc---CCCCccccceeeeeccCCCceEEEEEe
Q 011138 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-------YKNRELQIMRLL---NHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 145 lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-------~~~~E~~il~~l---~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
||+|+||+||+|++..+|+.||||++.+... ...+|..++..+ +||||++++++| .+...+|+||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence 7999999999999999999999999854321 122466666655 699999999988 4445689999
Q ss_pred eechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC-
Q 011138 215 EYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP- 292 (492)
Q Consensus 215 E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~- 292 (492)
||+.++ +...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++.....
T Consensus 76 e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH~-~~ivHrDlkp~Nili~~~~-~~kl~Dfg~a~~~~~~ 149 (330)
T cd05586 76 DYMSGGELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLHK-YDIVYRDLKPENILLDATG-HIALCDFGLSKANLTD 149 (330)
T ss_pred cCCCCChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCC-CEEEecCCcCcCCCCC
Confidence 999865 433322 24568999999999999999999997 9999999999999999887 799999999875432
Q ss_pred CCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 011138 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372 (492)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~ 372 (492)
.......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.. .
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~-----------------~ 212 (330)
T cd05586 150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF-----------------G 212 (330)
T ss_pred CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHc-----------------C
Confidence 22334567999999999997666689999999999999999999999988776554444422 1
Q ss_pred ccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcC----CHHHhhCCCCCCCCC
Q 011138 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC----TALEACAHPFFDDLR 427 (492)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~----t~~e~l~Hp~f~~~~ 427 (492)
...++. ..+++++++||++||..||.+|| ++.++++||||.+..
T Consensus 213 ~~~~~~-----------~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 213 KVRFPK-----------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred CCCCCC-----------ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 111221 23689999999999999999998 799999999998754
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=337.95 Aligned_cols=257 Identities=28% Similarity=0.473 Sum_probs=206.0
Q ss_pred ceeE-eeeeccCCceEEEEEEEcCCCCEEEEEEeccch----hhHHHHHHHHHHcC-CCCccccceeeeeccCCCceEEE
Q 011138 138 SYMA-ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 138 ~y~~-~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~----~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
-|.+ .+.||+|+|+.|--|+...+|..||||++.+.. ...-||++++..++ |+||++|+++| +++..+|
T Consensus 78 ~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~FY 152 (463)
T KOG0607|consen 78 MYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTRFY 152 (463)
T ss_pred HHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccceEE
Confidence 3554 368999999999999999999999999996543 33458999999986 99999999999 7777899
Q ss_pred EEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCC--cEEEeeecCcc
Q 011138 212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH--QLKICDFGSAK 288 (492)
Q Consensus 212 lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~--~vkL~DFG~a~ 288 (492)
||||-+.|+ ++..+. ....|.+.++..++..|+.||.|||. +||.||||||+|||-..... -||||||.++.
T Consensus 153 LVfEKm~GGplLshI~----~~~~F~E~EAs~vvkdia~aLdFlH~-kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgS 227 (463)
T KOG0607|consen 153 LVFEKMRGGPLLSHIQ----KRKHFNEREASRVVKDIASALDFLHT-KGIAHRDLKPENILCESPNKVSPVKICDFDLGS 227 (463)
T ss_pred EEEecccCchHHHHHH----HhhhccHHHHHHHHHHHHHHHHHHhh-cCcccccCCccceeecCCCCcCceeeecccccc
Confidence 999999875 443332 24679999999999999999999997 99999999999999854332 58999999875
Q ss_pred ccCCC--------CCCccceeccCccCchhhc----CCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH---------
Q 011138 289 MLVPG--------EPNISYICSRYYRAPELIF----GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD--------- 347 (492)
Q Consensus 289 ~~~~~--------~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~--------- 347 (492)
-..-. ....+.+|+..|||||++. ....|+.++|.||||||||.||.|.+||.|.-+.+
T Consensus 228 g~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~C 307 (463)
T KOG0607|consen 228 GIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVC 307 (463)
T ss_pred ccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCcc
Confidence 43211 1234678999999999972 34569999999999999999999999998754321
Q ss_pred ------HHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCC
Q 011138 348 ------QLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHP 421 (492)
Q Consensus 348 ------~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp 421 (492)
.+..|.. ..+.||+. .| ..+|.+++|||+.+|..|+.+|.++.++++||
T Consensus 308 r~CQ~~LFesIQE-----------------GkYeFPdk---dW-----ahIS~eakdlisnLlvrda~~rlsa~~vlnhP 362 (463)
T KOG0607|consen 308 RVCQNKLFESIQE-----------------GKYEFPDK---DW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLNHP 362 (463)
T ss_pred HHHHHHHHHHHhc-----------------cCCcCChh---hh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccCCc
Confidence 1111211 34556552 23 46899999999999999999999999999999
Q ss_pred CCCCCCCC
Q 011138 422 FFDDLRDP 429 (492)
Q Consensus 422 ~f~~~~~~ 429 (492)
|++.+...
T Consensus 363 w~~~~~~e 370 (463)
T KOG0607|consen 363 WVQRCAPE 370 (463)
T ss_pred cccccchh
Confidence 99987643
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=355.40 Aligned_cols=256 Identities=25% Similarity=0.422 Sum_probs=204.5
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
+|.+.+.||+|+||.||++++..+++.||+|++.+.. ....+|+.++..++|+||+++++++ .+...+
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~ 76 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENNL 76 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCEE
Confidence 5899999999999999999999999999999985421 2245788999999999999999988 445568
Q ss_pred EEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 211 ~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
|+||||+.++ +...+. .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 77 ~lv~ey~~~g~L~~~l~---~~~~~l~~~~~~~~~~qi~~al~~lH~-~~iiHrDlkp~Nili~~~~-~~kL~DfG~a~~ 151 (332)
T cd05623 77 YLVMDYYVGGDLLTLLS---KFEDRLPEDMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDMNG-HIRLADFGSCLK 151 (332)
T ss_pred EEEEeccCCCcHHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECCCC-CEEEeecchhee
Confidence 9999999864 444432 223568899999999999999999997 9999999999999999887 799999999876
Q ss_pred cCCCCC--CccceeccCccCchhhcC----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 011138 290 LVPGEP--NISYICSRYYRAPELIFG----ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (492)
Q Consensus 290 ~~~~~~--~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~ 363 (492)
...... ....+||+.|+|||++.+ ...++.++|||||||++|||++|+.||.+.+..+.+..+....
T Consensus 152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~------- 224 (332)
T cd05623 152 LMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK------- 224 (332)
T ss_pred cccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC-------
Confidence 533222 223579999999999862 3458899999999999999999999999887766666554310
Q ss_pred HhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCC--cCCHHHhhCCCCCCCCC
Q 011138 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSL--RCTALEACAHPFFDDLR 427 (492)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~--R~t~~e~l~Hp~f~~~~ 427 (492)
..+.+|. ....+++++++||++||..++.+ |+++.++++||||+.+.
T Consensus 225 --------~~~~~p~---------~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~ 273 (332)
T cd05623 225 --------ERFQFPA---------QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID 273 (332)
T ss_pred --------ccccCCC---------ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence 0111221 11357899999999999765554 68999999999999765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=347.93 Aligned_cols=282 Identities=34% Similarity=0.626 Sum_probs=223.0
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||||.+.... ....+|+++++.++||||+++++++ .+..+.
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVV-----HSEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEE-----ecCCeE
Confidence 35999999999999999999999999999999875321 3355799999999999999999998 444568
Q ss_pred EEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 211 ~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
|+||||+++++...+... ....+++..++.++.||+.||+|||+ +||+||||||+||+++.++..+||+|||++...
T Consensus 77 ~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 77 YLVFEYLDLDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (294)
T ss_pred EEEEecccccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence 999999988776654321 22335778888999999999999997 999999999999999865557999999999754
Q ss_pred CCCC-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC-
Q 011138 291 VPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN- 368 (492)
Q Consensus 291 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~- 368 (492)
.... ......+++.|+|||.+.+...++.++|||||||++|+|++|.+||...+..+.+.+++..++.|....+....
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 154 GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred CCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 3222 22345678999999998776668899999999999999999999999988888888888888888766654221
Q ss_pred -CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 369 -PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 369 -~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
+.+. ..++..... ......+.+++++.++|.+||+.||++||++.+++.||||.++..
T Consensus 234 ~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~ 292 (294)
T PLN00009 234 LPDYK-SAFPKWPPK-DLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292 (294)
T ss_pred chhhh-hhcccCCCC-CHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence 1110 011110000 011123457899999999999999999999999999999998753
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=359.34 Aligned_cols=244 Identities=29% Similarity=0.487 Sum_probs=199.4
Q ss_pred eeeccCCceEEEEEEE---cCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEE
Q 011138 143 RVVGTGSFGVVFQAKC---LETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~---~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
+.||+|+||.||++++ ..+|+.||+|++.... ....+|+++++.++||||+++++++ .+...+|+|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF-----QTEGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCCEEEEE
Confidence 5799999999999986 3578999999986432 2334699999999999999999988 444568999
Q ss_pred eeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 214 LEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 214 ~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
|||+.++ +...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++....
T Consensus 77 ~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~ 150 (318)
T cd05582 77 LDFLRGGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDEEG-HIKLTDFGLSKESID 150 (318)
T ss_pred EcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHeEECCCC-cEEEeeccCCcccCC
Confidence 9999864 443332 24568999999999999999999997 9999999999999999887 799999999976543
Q ss_pred C-CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 011138 293 G-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (492)
Q Consensus 293 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~ 371 (492)
. .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.+.
T Consensus 151 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~---------------- 213 (318)
T cd05582 151 HEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA---------------- 213 (318)
T ss_pred CCCceecccCChhhcCHHHHcCC-CCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC----------------
Confidence 3 233456789999999999654 4789999999999999999999999988776665555331
Q ss_pred cccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCC-----HHHhhCCCCCCCCC
Q 011138 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-----ALEACAHPFFDDLR 427 (492)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-----~~e~l~Hp~f~~~~ 427 (492)
... ++..+++++.+||++||+.||.+||+ +.+++.||||+.+.
T Consensus 214 -~~~------------~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~ 261 (318)
T cd05582 214 -KLG------------MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTID 261 (318)
T ss_pred -CCC------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence 111 12347899999999999999999999 67799999998764
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=346.68 Aligned_cols=276 Identities=34% Similarity=0.639 Sum_probs=218.0
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
.+|.+.+.||.|+||.||+|.+..+++.||||.+.... ....+|+.+++.++|+||+++++++ .+..+.|
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 79 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII-----HTKKTLT 79 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE-----ecCCeEE
Confidence 46999999999999999999999999999999885432 2345799999999999999999988 4445789
Q ss_pred EEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
+||||+.+++...+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++...
T Consensus 80 lv~e~~~~~L~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~ 154 (291)
T cd07844 80 LVFEYLDTDLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCHQ-RRVLHRDLKPQNLLISERG-ELKLADFGLARAKS 154 (291)
T ss_pred EEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCHHHEEEcCCC-CEEECccccccccC
Confidence 9999999877665432 23467889999999999999999997 8999999999999999887 79999999986542
Q ss_pred CC-CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 292 PG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES-GVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 292 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~-~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
.. .......++..|+|||++.+...++.++||||+||++|+|++|..||.+.. ..+++..+.+.++.+....+.....
T Consensus 155 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 155 VPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred CCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence 21 112234568899999998776668999999999999999999999998766 5667777888888887776654322
Q ss_pred C--CcccCCCcccCCCcccccCCCCC--hhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 370 N--YTEFKFPQIKAHPWHKIFHKRMP--PEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 370 ~--~~~~~~~~~~~~~~~~~~~~~~s--~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
. +....++.....+....+ ..++ .++.++|.+||+.||.+|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHA-PRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccccccCChhHHHhC-cCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 1 222222221111111111 2344 889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=346.65 Aligned_cols=275 Identities=35% Similarity=0.660 Sum_probs=219.0
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
+|.+.+.||.|+||.||+|++..+|+.||||.+..+. ....+|+++++.++||||+++++++ .+....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEE
Confidence 3889999999999999999999999999999885332 2456799999999999999999988 4445689
Q ss_pred EEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
+||||+.+++...+.. .....+++..+..++.||+.||+|||+ +|++||||+|+||+++.++ .+||+|||++....
T Consensus 76 ~v~e~~~~~l~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~H~~l~p~nill~~~~-~~~l~dfg~~~~~~ 151 (284)
T cd07860 76 LVFEFLHQDLKKFMDA--SPLSGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINTEG-AIKLADFGLARAFG 151 (284)
T ss_pred EEeeccccCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEEeeccchhhcc
Confidence 9999998776655432 123568899999999999999999997 9999999999999999887 79999999987653
Q ss_pred CCC-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC--
Q 011138 292 PGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN-- 368 (492)
Q Consensus 292 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~-- 368 (492)
... ......+++.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+.++.+..+.+....+....
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 152 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred cCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence 322 22334678899999998776667889999999999999999999999998888888888888887655432211
Q ss_pred CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
+.+ ...++......... ..+.+++++++||.+||+.||.+|||+.+++.||||
T Consensus 232 ~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 232 PDY-KPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHH-HhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 000 01122211111111 123578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=354.00 Aligned_cols=248 Identities=27% Similarity=0.442 Sum_probs=200.9
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcC-CCCccccceeeeeccCCCceEE
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
|...+.||+|+||.||+|.++.+|+.||||++.++. .....|..+++.+. |++|+++++++ .+...+
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~ 76 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDRL 76 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCEE
Confidence 778899999999999999999999999999886432 22346888888886 56777888887 444468
Q ss_pred EEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 211 ~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
|+||||++++ +...+ .....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 77 ~lv~Ey~~~g~L~~~i----~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivHrDikp~Nill~~~~-~ikL~Dfg~~~~ 150 (323)
T cd05615 77 YFVMEYVNGGDLMYHI----QQVGKFKEPQAVFYAAEISVGLFFLHR-RGIIYRDLKLDNVMLDSEG-HIKIADFGMCKE 150 (323)
T ss_pred EEEEcCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCC-CEEEeccccccc
Confidence 9999999865 33332 223568999999999999999999997 9999999999999999887 799999999875
Q ss_pred cCCC-CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 290 LVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 290 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
.... .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+....+..+...
T Consensus 151 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~------------- 216 (323)
T cd05615 151 HMVDGVTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH------------- 216 (323)
T ss_pred cCCCCccccCccCCccccCHHHHcCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------
Confidence 4322 223346799999999999654 4899999999999999999999999988766655555431
Q ss_pred CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCC-----HHHhhCCCCCCCCC
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-----ALEACAHPFFDDLR 427 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-----~~e~l~Hp~f~~~~ 427 (492)
... ++..++.++.+|+.+||+.||.+|++ ..++++||||+.+.
T Consensus 217 ----~~~------------~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~ 264 (323)
T cd05615 217 ----NVS------------YPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRID 264 (323)
T ss_pred ----CCC------------CCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence 111 22357889999999999999999997 47899999999764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=354.98 Aligned_cols=288 Identities=36% Similarity=0.660 Sum_probs=230.8
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
.+|.+.+.||.|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++||||++++++|.... .+..++
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCceE
Confidence 46999999999999999999999999999999885431 23447999999999999999999875433 344578
Q ss_pred EEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 211 ~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
|+||||+.+++...+. ....+++..++.++.||+.||.|||+ +||+||||||+||+++.++ .+||+|||++...
T Consensus 84 ~lv~e~~~~~l~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~~~-~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLMESDLHHIIH----SDQPLTEEHIRYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLVNEDC-ELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhhhhHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-cEEecccccceee
Confidence 9999999887665543 24558999999999999999999997 9999999999999999888 7999999998765
Q ss_pred CCCCC-----CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 011138 291 VPGEP-----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (492)
Q Consensus 291 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~ 365 (492)
..... .....|+..|+|||++.+...++.++|||||||++|+|++|++||.+.+...++..+...+|.|+...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 32221 1245789999999998665568999999999999999999999999999888899999999998877654
Q ss_pred hcCCCCcc---cCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCCCC
Q 011138 366 CMNPNYTE---FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTC 432 (492)
Q Consensus 366 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~~~ 432 (492)
........ ..++.....+|.. +.+.+++++.+||++||+.||.+||++.++++||||.....+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~ 306 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSK-IFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDE 306 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHH-HcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCccc
Confidence 32211100 0122222223322 224578999999999999999999999999999999988776553
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=352.04 Aligned_cols=252 Identities=26% Similarity=0.446 Sum_probs=198.6
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcC-CCCccccceeeeeccCCCceEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
.|++.+.||+||-+.||++.. .+.+.||+|++.... ....+|+..|.+|+ |.+||+||+|= -.+.++
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE-----v~d~~l 435 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE-----VTDGYL 435 (677)
T ss_pred hhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee-----ccCceE
Confidence 599999999999999999985 445667777663322 23458999999996 99999999986 446689
Q ss_pred EEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 211 ~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
||||||.+.+|-.++.... ...+...++.|..||+.|+.++|+ +||||.||||.|+|+-+ | .+||+|||+|..+
T Consensus 436 YmvmE~Gd~DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~-~gIVHSDLKPANFLlVk-G-~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 436 YMVMECGDIDLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQ-HGIVHSDLKPANFLLVK-G-RLKLIDFGIANAI 509 (677)
T ss_pred EEEeecccccHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHH-hceeecCCCcccEEEEe-e-eEEeeeechhccc
Confidence 9999999988887766533 334445899999999999999998 99999999999999984 4 6999999999988
Q ss_pred CCCCCC---ccceeccCccCchhhcCCC----------CCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 011138 291 VPGEPN---ISYICSRYYRAPELIFGAT----------EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILG 357 (492)
Q Consensus 291 ~~~~~~---~~~~gt~~y~aPE~~~~~~----------~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g 357 (492)
.++... .+.+||+.||+||.+.... ..++++||||||||||+|+.|++||....+ .+.++ ..+.
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--~~aKl-~aI~ 586 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--QIAKL-HAIT 586 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--HHHHH-Hhhc
Confidence 766543 3679999999999984321 256799999999999999999999965431 11221 1122
Q ss_pred CCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 358 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 358 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
.| + .++.||.+.. ..++.++++.||..||.+||++.++|+|||++-.
T Consensus 587 ~P----------~-~~Iefp~~~~-----------~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 587 DP----------N-HEIEFPDIPE-----------NDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ 633 (677)
T ss_pred CC----------C-ccccccCCCC-----------chHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence 22 1 4566666432 2349999999999999999999999999999864
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=355.91 Aligned_cols=244 Identities=27% Similarity=0.441 Sum_probs=195.9
Q ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEeccchh-------hHHHH-HHHHHHcCCCCccccceeeeeccCCCceEEEEEe
Q 011138 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-------YKNRE-LQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-------~~~~E-~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
+.||+|+||+||+|++..+++.||+|++..... ...+| ..+++.++||||+++++++ .+...+|+||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE-----EcCCeEEEEE
Confidence 369999999999999999999999999864321 11223 3457889999999999988 4445689999
Q ss_pred eechhhHH-HHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC-
Q 011138 215 EYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP- 292 (492)
Q Consensus 215 E~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~- 292 (492)
||+.++.+ ..+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++....
T Consensus 76 e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~-~giiHrDlkp~Nili~~~~-~~kl~DfG~a~~~~~~ 149 (325)
T cd05602 76 DYINGGELFYHLQ----RERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEH 149 (325)
T ss_pred eCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCC-CEEEccCCCCcccccC
Confidence 99987543 3322 24567888899999999999999997 9999999999999999887 799999999875422
Q ss_pred CCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 011138 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372 (492)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~ 372 (492)
.......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+...
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~----------------- 211 (325)
T cd05602 150 NGTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK----------------- 211 (325)
T ss_pred CCCcccccCCccccCHHHHcCC-CCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC-----------------
Confidence 2233456799999999999654 4899999999999999999999999988776655554331
Q ss_pred ccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHH----HhhCCCCCCCCC
Q 011138 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL----EACAHPFFDDLR 427 (492)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~----e~l~Hp~f~~~~ 427 (492)
... +.+.+++++.+||.+||+.||.+|+++. ++++|+||..+.
T Consensus 212 ~~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~ 258 (325)
T cd05602 212 PLQ------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPIN 258 (325)
T ss_pred CcC------------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCC
Confidence 000 2245789999999999999999999876 899999998653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=357.73 Aligned_cols=245 Identities=28% Similarity=0.483 Sum_probs=195.9
Q ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHH-HHHHHcCCCCccccceeeeeccCCCceEEEEEe
Q 011138 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNREL-QIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~-~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
+.||+|+||.||+|++..+|+.||||++.+.. ....+|. .+++.++||||+++++++ .....+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence 36999999999999999999999999985431 1122343 357789999999999888 4445689999
Q ss_pred eechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC-C
Q 011138 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP-G 293 (492)
Q Consensus 215 E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~-~ 293 (492)
||+.++.+... ......+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.... .
T Consensus 76 e~~~~~~L~~~---l~~~~~~~~~~~~~~~~qi~~al~~lH~-~givH~Dlkp~NIll~~~~-~~kL~DfG~~~~~~~~~ 150 (325)
T cd05604 76 DFVNGGELFFH---LQRERSFPEPRARFYAAEIASALGYLHS-INIVYRDLKPENILLDSQG-HVVLTDFGLCKEGIAQS 150 (325)
T ss_pred cCCCCCCHHHH---HHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCC-CEEEeecCCcccCCCCC
Confidence 99987644321 1234578999999999999999999997 9999999999999999888 799999999875422 2
Q ss_pred CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 011138 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373 (492)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~ 373 (492)
......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+... .
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~-----------------~ 212 (325)
T cd05604 151 DTTTTFCGTPEYLAPEVIRKQ-PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK-----------------P 212 (325)
T ss_pred CCcccccCChhhCCHHHHcCC-CCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC-----------------C
Confidence 233456799999999999654 4899999999999999999999999987766555544331 0
Q ss_pred cCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCH----HHhhCCCCCCCCC
Q 011138 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA----LEACAHPFFDDLR 427 (492)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~----~e~l~Hp~f~~~~ 427 (492)
. .+.+.++.++.++|++||+.||.+||++ .+++.||||....
T Consensus 213 ~------------~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~ 258 (325)
T cd05604 213 L------------VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLS 258 (325)
T ss_pred c------------cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence 0 0123478899999999999999999987 5899999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=347.22 Aligned_cols=254 Identities=28% Similarity=0.428 Sum_probs=201.6
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
|+..+.||+|+||.||+|.+..+++.||||.+.... ....+|+.+++.++|+||+.+++.+ .+..++|
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~ 76 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAY-----ETKDALC 76 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEE-----ecCCEEE
Confidence 778889999999999999999999999999875421 2234699999999999999999887 3445689
Q ss_pred EEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 212 lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
+||||+.++ +...+.. .....+++..+..++.|++.||.|||+ +||+||||||+||+++.++ .++|+|||++...
T Consensus 77 lv~e~~~g~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nil~~~~~-~~~l~Dfg~~~~~ 152 (285)
T cd05630 77 LVLTLMNGGDLKFHIYH--MGEAGFEEGRAVFYAAEICCGLEDLHQ-ERIVYRDLKPENILLDDHG-HIRISDLGLAVHV 152 (285)
T ss_pred EEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECCCC-CEEEeeccceeec
Confidence 999999865 4333322 223468899999999999999999997 9999999999999999887 7999999999765
Q ss_pred CCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 011138 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (492)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 370 (492)
..........|+..|+|||++.+. .++.++|||||||++|+|++|+.||...................
T Consensus 153 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~----------- 220 (285)
T cd05630 153 PEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV----------- 220 (285)
T ss_pred CCCccccCCCCCccccChHHHcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh-----------
Confidence 444444456789999999999654 48999999999999999999999998754321111111100000
Q ss_pred CcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCC-----HHHhhCCCCCCCCC
Q 011138 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-----ALEACAHPFFDDLR 427 (492)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-----~~e~l~Hp~f~~~~ 427 (492)
...+...+++++.+||.+||+.||.+||| +.|+++||||+.+.
T Consensus 221 --------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05630 221 --------------QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN 268 (285)
T ss_pred --------------hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccC
Confidence 00122457889999999999999999999 89999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=347.55 Aligned_cols=281 Identities=30% Similarity=0.550 Sum_probs=219.9
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchhh---HHHHHHHHHHcCC--C----CccccceeeeeccCCC
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRY---KNRELQIMRLLNH--P----NVVSLKHCFFSTTEKD 206 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~---~~~E~~il~~l~h--~----nIv~l~~~~~~~~~~~ 206 (492)
..+|.+.+.+|+|.||.|..+.+..++..||||+++.-.++ ..-|+++|.++.+ | -+|++.++| +-
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-----dy 162 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF-----DY 162 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh-----hc
Confidence 45799999999999999999999999999999988654433 3359999999952 2 278888888 55
Q ss_pred ceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCC-----------
Q 011138 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH----------- 275 (492)
Q Consensus 207 ~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~----------- 275 (492)
....|||+|.++-++++++... ...+++...++.+++||+.+++|||+ .+++|-||||||||+.+.
T Consensus 163 rghiCivfellG~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~-~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 163 RGHICIVFELLGLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHD-LKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred cCceEEEEeccChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHh-cceeecCCChheEEEeccceEEEeccCCc
Confidence 5669999999998888876542 24678999999999999999999998 899999999999998421
Q ss_pred --------CCcEEEeeecCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 011138 276 --------THQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD 347 (492)
Q Consensus 276 --------~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~ 347 (492)
...|||+|||.|+.. .+.....+.|..|+|||+++|-+ ++.++||||+||||+||.+|...|+..++.+
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~--~e~hs~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFD--HEHHSTIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred cceeccCCCcceEEEecCCccee--ccCcceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 115899999999864 34456788999999999998865 9999999999999999999999999999999
Q ss_pred HHHHHHHHhCCCCHHHHhhcC-CCC---cccCCCccc-----------CCCcccccC--CCCChhHhhhhccccccCCCC
Q 011138 348 QLVEIIKILGTPTREEIKCMN-PNY---TEFKFPQIK-----------AHPWHKIFH--KRMPPEALDLVSRLLQYSPSL 410 (492)
Q Consensus 348 ~~~~i~~~~g~p~~~~~~~~~-~~~---~~~~~~~~~-----------~~~~~~~~~--~~~s~~~~~Li~~~L~~dP~~ 410 (492)
+++.+..++|..+...+.... ..| ..+..|... ..++..... ...-.++.|||++||.+||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 999999999976666554331 000 011111110 001111100 111235889999999999999
Q ss_pred cCCHHHhhCCCCCCCCC
Q 011138 411 RCTALEACAHPFFDDLR 427 (492)
Q Consensus 411 R~t~~e~l~Hp~f~~~~ 427 (492)
|+|+.|+|.||||+.+.
T Consensus 397 RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 397 RITLREALSHPFFARLT 413 (415)
T ss_pred cccHHHHhcCHHhhcCC
Confidence 99999999999999764
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=355.18 Aligned_cols=246 Identities=28% Similarity=0.434 Sum_probs=194.9
Q ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHH-HHHHHHcCCCCccccceeeeeccCCCceEEEEEe
Q 011138 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRE-LQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E-~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
++||+|+||.||+|++..+|+.||+|++.+.. ....+| ..+++.++||||++++++| .+...+|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence 36999999999999999999999999985432 112233 3467889999999999888 4445689999
Q ss_pred eechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC-C
Q 011138 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP-G 293 (492)
Q Consensus 215 E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~-~ 293 (492)
||++++.+... ......+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+++.... .
T Consensus 76 e~~~~~~L~~~---l~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~ 150 (321)
T cd05603 76 DYVNGGELFFH---LQRERCFLEPRARFYAAEVASAIGYLHS-LNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGVEPE 150 (321)
T ss_pred cCCCCCCHHHH---HHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCC-CEEEccCCCCccCCCCC
Confidence 99987544221 1224568889999999999999999997 9999999999999999888 799999999875322 2
Q ss_pred CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 011138 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373 (492)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~ 373 (492)
......+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+.......+.. ..
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~-----------------~~ 212 (321)
T cd05603 151 ETTSTFCGTPEYLAPEVLRKE-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH-----------------KP 212 (321)
T ss_pred CccccccCCcccCCHHHhcCC-CCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc-----------------CC
Confidence 223456789999999998654 489999999999999999999999988776554444332 01
Q ss_pred cCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCH----HHhhCCCCCCCCCC
Q 011138 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA----LEACAHPFFDDLRD 428 (492)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~----~e~l~Hp~f~~~~~ 428 (492)
.. ++...+.++.++|.+||+.||.+|+++ .++++||||..+..
T Consensus 213 ~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~ 259 (321)
T cd05603 213 LQ------------LPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINW 259 (321)
T ss_pred CC------------CCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence 11 223468899999999999999999976 49999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=345.40 Aligned_cols=250 Identities=24% Similarity=0.366 Sum_probs=196.2
Q ss_pred eccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEeeec
Q 011138 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (492)
Q Consensus 145 lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E~~ 217 (492)
||+|+||.||++.+..+|+.||+|.+.... .....|+++++.++||||++++++| .+..++|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence 699999999999999999999999885321 2234699999999999999999888 4455789999999
Q ss_pred hhhHH-HHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCCCC
Q 011138 218 SETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN 296 (492)
Q Consensus 218 ~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~~~ 296 (492)
.++.+ ..+.. .....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .++|+|||++.........
T Consensus 76 ~g~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~~~-~~~l~Dfg~~~~~~~~~~~ 151 (277)
T cd05607 76 NGGDLKYHIYN--VGERGLEMERVIHYSAQITCGILHLHS-MDIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTI 151 (277)
T ss_pred CCCCHHHHHHh--ccccCCCHHHHHHHHHHHHHHHHHHHH-CCEEEccCChHhEEEcCCC-CEEEeeceeeeecCCCcee
Confidence 86544 33321 223457888889999999999999997 9999999999999999887 7999999999876544444
Q ss_pred ccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCC
Q 011138 297 ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKF 376 (492)
Q Consensus 297 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 376 (492)
....|++.|+|||++.+.. ++.++|||||||++|+|++|..||...........+....- . ....+
T Consensus 152 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~----------~---~~~~~ 217 (277)
T cd05607 152 TQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTL----------E---DEVKF 217 (277)
T ss_pred eccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhh----------c---ccccc
Confidence 4567899999999997655 89999999999999999999999976543222222211100 0 00000
Q ss_pred CcccCCCcccccCCCCChhHhhhhccccccCCCCcCCH----HHhhCCCCCCCCCC
Q 011138 377 PQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA----LEACAHPFFDDLRD 428 (492)
Q Consensus 377 ~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~----~e~l~Hp~f~~~~~ 428 (492)
....+++++++||.+||+.||.+||++ ++++.||||+.+..
T Consensus 218 -----------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 218 -----------EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINF 262 (277)
T ss_pred -----------ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCH
Confidence 112478999999999999999999999 67889999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=371.64 Aligned_cols=260 Identities=25% Similarity=0.365 Sum_probs=210.6
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccC---CCc
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE---KDE 207 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~---~~~ 207 (492)
.+|.+.+.||+|+||+||+|++..+|+.||||++... .....+|+.++..++|+||+++++.+..... ...
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 3699999999999999999999999999999988542 2234579999999999999999887754332 222
Q ss_pred eEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 208 ~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
.++++||||+.+ +|.+.+.........+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~-~~IiHrDLKP~NILl~~~~-~vkL~DFGl 189 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS-KHMIHRDIKSANILLCSNG-LVKLGDFGF 189 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEeCCC-CEEEEeccc
Confidence 357899999985 5555554444445678999999999999999999997 9999999999999999887 799999999
Q ss_pred ccccCCC---CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 011138 287 AKMLVPG---EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (492)
Q Consensus 287 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~ 363 (492)
++..... ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+....
T Consensus 190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~------- 261 (496)
T PTZ00283 190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRK-PYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR------- 261 (496)
T ss_pred CeeccccccccccccccCCcceeCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC-------
Confidence 9765322 223356799999999999654 48999999999999999999999998877655554443210
Q ss_pred HhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
. ..++..+++++.+||.+||..||.+||++.++++|||++.+.
T Consensus 262 ------------~---------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~ 304 (496)
T PTZ00283 262 ------------Y---------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFI 304 (496)
T ss_pred ------------C---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhh
Confidence 0 012345789999999999999999999999999999987643
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=382.03 Aligned_cols=263 Identities=28% Similarity=0.422 Sum_probs=210.6
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
...+|.+.+.||+|+||+||+|.+..++..||+|.+... ...+.+|+.+++.|+|||||+++++|... ...
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de---~~~ 87 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK---ANQ 87 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec---CCC
Confidence 345799999999999999999999999999999987532 23345799999999999999999988643 234
Q ss_pred EEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCC-------cccCCCCCCceEEcCC-----
Q 011138 209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG-------VCHRDIKPQNLLVNPH----- 275 (492)
Q Consensus 209 ~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~g-------ivHrDlKp~NILl~~~----- 275 (492)
.+||||||+.+ +|...+.........+++..++.|+.||+.||.|||+ .+ ||||||||+||||+.+
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs-~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHN-LKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-cccccccCCceeccCcHHHeEeecCccccc
Confidence 68899999985 5655555444445679999999999999999999996 44 9999999999999642
Q ss_pred -----------CCcEEEeeecCccccCCCCCCccceeccCccCchhhcCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 011138 276 -----------THQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLLGQPLFPGE 343 (492)
Q Consensus 276 -----------~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~ 343 (492)
...+||+|||++............+||+.|+|||++.+. ..++.++||||||||||+|++|..||...
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 124899999999876444444456899999999998643 35789999999999999999999999877
Q ss_pred ChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 344 SGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 344 ~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
+....+...+... | .++ ....+.++.+||.+||..||.+||++.|+|.||||
T Consensus 247 ~~~~qli~~lk~~--p---------------~lp-----------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~i 298 (1021)
T PTZ00266 247 NNFSQLISELKRG--P---------------DLP-----------IKGKSKELNILIKNLLNLSAKERPSALQCLGYQII 298 (1021)
T ss_pred CcHHHHHHHHhcC--C---------------CCC-----------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHH
Confidence 6655554443310 0 000 02357899999999999999999999999999999
Q ss_pred CCCCCC
Q 011138 424 DDLRDP 429 (492)
Q Consensus 424 ~~~~~~ 429 (492)
+.+..+
T Consensus 299 k~i~~p 304 (1021)
T PTZ00266 299 KNVGPP 304 (1021)
T ss_pred hhcCCC
Confidence 876543
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=354.90 Aligned_cols=256 Identities=25% Similarity=0.416 Sum_probs=204.0
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
+|.+.+.||+|+||.||++++..+++.||+|++.+.. ....+|+.+++.++|+||+++++++ .+..++
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~~ 76 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENYL 76 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCEE
Confidence 5999999999999999999999999999999885421 2245688999999999999999988 455679
Q ss_pred EEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 211 ~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
|+||||+.|+ |...+. .....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 77 ~lv~Ey~~gg~L~~~l~---~~~~~l~~~~~~~~~~qi~~~L~~lH~-~~iiHrDlkp~Nill~~~~-~~kl~DfG~a~~ 151 (331)
T cd05624 77 YLVMDYYVGGDLLTLLS---KFEDRLPEDMARFYIAEMVLAIHSIHQ-LHYVHRDIKPDNVLLDMNG-HIRLADFGSCLK 151 (331)
T ss_pred EEEEeCCCCCcHHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCchHHEEEcCCC-CEEEEeccceee
Confidence 9999999865 444332 223568899999999999999999997 9999999999999999887 799999999976
Q ss_pred cCCCCCC--ccceeccCccCchhhcCC----CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 011138 290 LVPGEPN--ISYICSRYYRAPELIFGA----TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (492)
Q Consensus 290 ~~~~~~~--~~~~gt~~y~aPE~~~~~----~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~ 363 (492)
....... ....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~------- 224 (331)
T cd05624 152 MNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHE------- 224 (331)
T ss_pred ccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCC-------
Confidence 5433221 235799999999998642 347889999999999999999999999877666555543310
Q ss_pred HhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCC--cCCHHHhhCCCCCCCCC
Q 011138 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSL--RCTALEACAHPFFDDLR 427 (492)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~--R~t~~e~l~Hp~f~~~~ 427 (492)
..+.+|. ....+++++++||.+||..++.+ |++++++++||||+...
T Consensus 225 --------~~~~~p~---------~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~ 273 (331)
T cd05624 225 --------ERFQFPS---------HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGID 273 (331)
T ss_pred --------CcccCCC---------ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCC
Confidence 0111221 11347899999999999976655 56899999999998754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=353.78 Aligned_cols=245 Identities=26% Similarity=0.494 Sum_probs=195.3
Q ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHc-CCCCccccceeeeeccCCCceEEEEEe
Q 011138 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
+.||+|+||.||+|.+..+++.||+|++.+.. ....+|+.++..+ +||||++++++| .+...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence 36999999999999999999999999986532 2245788888887 699999999988 4445689999
Q ss_pred eechhhHH-HHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC-C
Q 011138 215 EYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV-P 292 (492)
Q Consensus 215 E~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~-~ 292 (492)
||++++.+ ..+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++... .
T Consensus 76 e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~ 149 (327)
T cd05617 76 EYVNGGDLMFHMQ----RQRKLPEEHARFYAAEICIALNFLHE-RGIIYRDLKLDNVLLDADG-HIKLTDYGMCKEGLGP 149 (327)
T ss_pred eCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEeCCC-CEEEeccccceeccCC
Confidence 99987543 3222 23568999999999999999999997 9999999999999999888 79999999987532 2
Q ss_pred CCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCCHHHHhh
Q 011138 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES------GVDQLVEIIKILGTPTREEIKC 366 (492)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~------~~~~~~~i~~~~g~p~~~~~~~ 366 (492)
.......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.... ..+.+.+++..
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~----------- 217 (327)
T cd05617 150 GDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE----------- 217 (327)
T ss_pred CCceecccCCcccCCHHHHCCC-CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh-----------
Confidence 3334457899999999999654 58999999999999999999999996432 11222222210
Q ss_pred cCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCH------HHhhCCCCCCCCC
Q 011138 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA------LEACAHPFFDDLR 427 (492)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~------~e~l~Hp~f~~~~ 427 (492)
.... ++..++..+.+||.+||..||.+|+++ .++++||||+.+.
T Consensus 218 -----~~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 218 -----KPIR------------IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred -----CCCC------------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 0111 223578999999999999999999984 6999999999865
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=342.70 Aligned_cols=276 Identities=34% Similarity=0.634 Sum_probs=222.6
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
+|.+.+.||.|++|.||+|++..+|..||||.+... .....+|+.+++.++|+||+++++++. +....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIH-----TENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEe-----eCCcEEE
Confidence 488999999999999999999999999999988543 233457999999999999999999984 3345889
Q ss_pred EeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 213 V~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
||||+++++...+.... ....+++..+..++.||+.||.|||+ .||+||||||+||+++.++ .++|+|||++.....
T Consensus 76 v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~h~dl~p~ni~~~~~~-~~~l~d~g~~~~~~~ 152 (284)
T cd07836 76 VFEYMDKDLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHE-NRVLHRDLKPQNLLINKRG-ELKLADFGLARAFGI 152 (284)
T ss_pred EEecCCccHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECCCC-cEEEeecchhhhhcC
Confidence 99999988776654322 13468999999999999999999997 8999999999999999877 799999999875532
Q ss_pred CC-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 011138 293 GE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (492)
Q Consensus 293 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~ 371 (492)
.. ......++..|++||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.|....+.... ..
T Consensus 153 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 231 (284)
T cd07836 153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS-QL 231 (284)
T ss_pred CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh-cC
Confidence 21 22345678899999998776668899999999999999999999999999888889998888888776665433 11
Q ss_pred cc--cCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 372 TE--FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 372 ~~--~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
.. ..++........ .+.+.++.+++++|.+||+.||.+||++.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 232 PEYKPTFPRYPPQDLQ-QLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred chhcccccCCChHHHH-HHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 11 122222221121 1223568899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=341.96 Aligned_cols=276 Identities=33% Similarity=0.580 Sum_probs=213.4
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||||.+.... ....+|+.+++.++|+||+++++++ .+..+.|
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~~~~ 79 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII-----HTKETLT 79 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEE-----ecCCeEE
Confidence 46999999999999999999999999999999885331 2345799999999999999999988 3444688
Q ss_pred EEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
+||||+.++++..+.. ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||+++...
T Consensus 80 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~ 154 (291)
T cd07870 80 FVFEYMHTDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHG-QHILHRDLKPQNLLISYLG-ELKLADFGLARAKS 154 (291)
T ss_pred EEEecccCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEEcCCC-cEEEeccccccccC
Confidence 9999999877765432 23457788889999999999999997 8999999999999999887 89999999987542
Q ss_pred CC-CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHhhcC-
Q 011138 292 PG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESG-VDQLVEIIKILGTPTREEIKCMN- 368 (492)
Q Consensus 292 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~-~~~~~~i~~~~g~p~~~~~~~~~- 368 (492)
.. .......+++.|+|||.+.+...++.++|||||||++|+|++|..||.+.+. .+.+.++...++.|....+....
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 155 IPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred CCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence 21 1223456789999999987666688899999999999999999999987553 46667777777877766543221
Q ss_pred -CCCcccCCCcccCCCcccccCC--CCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 369 -PNYTEFKFPQIKAHPWHKIFHK--RMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 369 -~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
+.+....++......... .+. ..+.++.+||.+||+.||.+|||+.|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 235 LPNYKPEWFLPCKPQQLRV-VWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cccccchhccccCCcchhh-hccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 111111111111000000 011 136789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=356.32 Aligned_cols=251 Identities=19% Similarity=0.264 Sum_probs=196.7
Q ss_pred CCccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCC
Q 011138 132 QPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (492)
Q Consensus 132 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 205 (492)
+........++..||+|.||+||+|++.++ ||||++..+ -+.+++|+.++++-+|.||+-+++++.
T Consensus 387 WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~----- 458 (678)
T KOG0193|consen 387 WEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM----- 458 (678)
T ss_pred cccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc-----
Confidence 333444577889999999999999999655 999998543 245678999999999999999999983
Q ss_pred CceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeec
Q 011138 206 DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (492)
Q Consensus 206 ~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG 285 (492)
...+ .||+.+|+|..+....+ .....|.....+.|++||+.|+.|||. ++|||||||..|||+..++ +|||+|||
T Consensus 459 ~p~~-AIiTqwCeGsSLY~hlH--v~etkfdm~~~idIAqQiaqGM~YLHA-K~IIHrDLKSnNIFl~~~~-kVkIgDFG 533 (678)
T KOG0193|consen 459 NPPL-AIITQWCEGSSLYTHLH--VQETKFDMNTTIDIAQQIAQGMDYLHA-KNIIHRDLKSNNIFLHEDL-KVKIGDFG 533 (678)
T ss_pred CCce-eeeehhccCchhhhhcc--chhhhhhHHHHHHHHHHHHHhhhhhhh-hhhhhhhccccceEEccCC-cEEEeccc
Confidence 3333 79999999865443333 334678889999999999999999995 9999999999999999876 89999999
Q ss_pred CccccCC---CCCCccceeccCccCchhhcCC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 011138 286 SAKMLVP---GEPNISYICSRYYRAPELIFGA--TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPT 360 (492)
Q Consensus 286 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~ 360 (492)
++..... +.......|...|||||++... .+|+..+|||||||++|||++|..||...+....+..+-+.++.|.
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd 613 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPD 613 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCcc
Confidence 9965421 2223345678899999999633 4589999999999999999999999995544444444433322222
Q ss_pred HHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.-. ...+.+.++++|+..||.+++++||...+||.
T Consensus 614 ~s~------------------------~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 614 LSK------------------------IRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred chh------------------------hhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 111 11356789999999999999999999999876
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=343.38 Aligned_cols=255 Identities=27% Similarity=0.401 Sum_probs=205.9
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
|+..+.||+|+||+||+|.+..+|+.||+|.+.... ....+|+++++.++|+||+.++++| .....+|
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~ 76 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDALC 76 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEEE
Confidence 778889999999999999999999999999885321 2345799999999999999998887 4445689
Q ss_pred EEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
+||||+.++.+..... ......+++..+..++.|++.||.|||+ +||+||||||+||+++.++ .+||+|||++....
T Consensus 77 lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~iiH~dikp~Nili~~~~-~~kl~Dfg~~~~~~ 153 (285)
T cd05632 77 LVLTIMNGGDLKFHIY-NMGNPGFEEERALFYAAEILCGLEDLHR-ENTVYRDLKPENILLDDYG-HIRISDLGLAVKIP 153 (285)
T ss_pred EEEEeccCccHHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEECCCC-CEEEecCCcceecC
Confidence 9999999764432222 1223468999999999999999999997 9999999999999999887 79999999997654
Q ss_pred CCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 011138 292 PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (492)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~ 371 (492)
.........|+..|+|||++.+. .++.++|+|||||++|+|++|..||.+.........+........
T Consensus 154 ~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~----------- 221 (285)
T cd05632 154 EGESIRGRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE----------- 221 (285)
T ss_pred CCCcccCCCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc-----------
Confidence 44444456889999999999654 489999999999999999999999988765544444333211100
Q ss_pred cccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCC-----HHHhhCCCCCCCCC
Q 011138 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-----ALEACAHPFFDDLR 427 (492)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-----~~e~l~Hp~f~~~~ 427 (492)
..+...+++++.+|+.+||+.||++||+ +.++++|+||....
T Consensus 222 --------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05632 222 --------------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN 268 (285)
T ss_pred --------------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence 0122457889999999999999999999 88999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=370.50 Aligned_cols=253 Identities=27% Similarity=0.349 Sum_probs=206.1
Q ss_pred ceeEeeeeccCCceEEEEEEEcCC-CCEEEEEEeccc----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLET-GDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~-g~~vAiK~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
.|.+.+.||+|+||.||+|.+..+ ++.||+|.+..+ .....+|+.+++.++|||||+++++|. ....+||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~-----~~~~~~l 142 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFK-----SDDKLLL 142 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-----ECCEEEE
Confidence 499999999999999999998877 788999976432 234457999999999999999999983 3446899
Q ss_pred Eeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 213 VLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 213 V~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
||||+.++ |...+.........+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++...
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~~~~-~~kL~DFgla~~~~ 220 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS-RKMMHRDLKSANIFLMPTG-IIKLGDFGFSKQYS 220 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCcCHHhEEECCCC-cEEEEeCcCceecC
Confidence 99999864 544444333344568899999999999999999997 9999999999999999887 79999999998654
Q ss_pred CCC---CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 292 PGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 292 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
... .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+... ..
T Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~--~~--------- 288 (478)
T PTZ00267 221 DSVSLDVASSFCGTPYYLAPELWERK-RYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG--KY--------- 288 (478)
T ss_pred CccccccccccCCCccccCHhHhCCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CC---------
Confidence 322 13356799999999998654 5899999999999999999999999887766555554331 00
Q ss_pred CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
+ .++..+++++++||.+||..||++||++.+++.|||++.+
T Consensus 289 --------~---------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 289 --------D---------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred --------C---------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 0 0123478899999999999999999999999999998643
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=341.31 Aligned_cols=252 Identities=35% Similarity=0.562 Sum_probs=203.7
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchhh------HHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRY------KNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~------~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
|++++.||+|+||+||++.+..+++.||+|++...... ..+|+.+++.++||||+++++++.. ..++++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence 88999999999999999999999999999998654321 2348999999999999999999844 456889
Q ss_pred Eeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc-
Q 011138 213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML- 290 (492)
Q Consensus 213 V~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~- 290 (492)
||||+.+ .+...+. ....+++..+..++.||+.||.|||+ +||+|+||||+||+++.++ .++|+|||.+...
T Consensus 76 v~~~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~-~~i~H~dikp~NIl~~~~~-~~~l~Dfg~~~~~~ 149 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHS-KGIVHRDIKPENILLDENG-EVKLIDFGSSVKLS 149 (260)
T ss_dssp EEEEETTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHH-TTEEESSBSGGGEEESTTS-EEEESSGTTTEEST
T ss_pred ccccccccccccccc----cccccccccccccccccccccccccc-ccccccccccccccccccc-cccccccccccccc
Confidence 9999998 5555544 34678999999999999999999997 8999999999999999777 8999999999753
Q ss_pred CCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 011138 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (492)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 370 (492)
..........++..|+|||++.....++.++||||||+++|+|++|..||......+....+.+...........
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----- 224 (260)
T PF00069_consen 150 ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ----- 224 (260)
T ss_dssp STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT-----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc-----
Confidence 223334456789999999998634568999999999999999999999999875444444444332221111100
Q ss_pred CcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
.....++++.+||.+||+.||++||++.++++||||
T Consensus 225 -----------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 225 -----------------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp -----------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred -----------------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 001123789999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=363.27 Aligned_cols=254 Identities=24% Similarity=0.383 Sum_probs=210.2
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEecc-chhhH---HHHHHHHHHcCCCCccccceeeeeccCCCceEEEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-DKRYK---NRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~-~~~~~---~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
.|.|...||.|+||.||+|.++.++-..|.|+|.. ....+ .-|++||..++||+||+|++.||... .++|+
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~en-----kLwil 107 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN-----KLWIL 107 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC-----ceEEE
Confidence 47888899999999999999999988888898743 22222 35999999999999999999885544 38999
Q ss_pred eeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC-C
Q 011138 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV-P 292 (492)
Q Consensus 214 ~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~-~ 292 (492)
.|||+||..+-+. ......+.+.+++.+++|+|.||.|||+ ++|||||||..|||++-+| .|+|+|||.+.... .
T Consensus 108 iEFC~GGAVDaim--lEL~r~LtE~QIqvvc~q~ldALn~LHs-~~iIHRDLKAGNiL~TldG-dirLADFGVSAKn~~t 183 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIM--LELGRVLTEDQIQVVCYQVLDALNWLHS-QNIIHRDLKAGNILLTLDG-DIRLADFGVSAKNKST 183 (1187)
T ss_pred EeecCCchHhHHH--HHhccccchHHHHHHHHHHHHHHHHHhh-cchhhhhccccceEEEecC-cEeeecccccccchhH
Confidence 9999998665433 3456789999999999999999999997 9999999999999999998 79999999875432 2
Q ss_pred CCCCccceeccCccCchhhc----CCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 293 GEPNISYICSRYYRAPELIF----GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
.....+++|||+|||||++. ...+|++++||||||++|.||.-+.+|-..-+....+.+|.+. .|+
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS--ePP-------- 253 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EPP-------- 253 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc--CCC--------
Confidence 23456799999999999974 3456999999999999999999999999888887777777652 111
Q ss_pred CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
. ...+.+-+..+.||+.+||.+||..||+++++|+||||+++
T Consensus 254 ---------T-------LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 254 ---------T-------LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred ---------c-------ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 0 01123447789999999999999999999999999999954
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=349.91 Aligned_cols=289 Identities=39% Similarity=0.680 Sum_probs=232.3
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
+|.+.+.||.|+||.||+|++..+|+.||||++.... ....+|+.+++.++|+||+++++++..........+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4889999999999999999999999999999885422 3455799999999999999999988554433334689
Q ss_pred EEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
+||||+++++...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .++|+|||++....
T Consensus 81 lv~e~~~~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~-~gi~H~dlkp~nili~~~~-~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELMETDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHS-ANVIHRDLKPSNILVNSNC-DLKICDFGLARGVD 154 (330)
T ss_pred EEecchhhhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEcccCceEeec
Confidence 9999999876665432 3478899999999999999999997 9999999999999999887 89999999998765
Q ss_pred CCC----CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 292 PGE----PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 292 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
... ......+++.|+|||++.+...++.++|+|||||++|+|++|.+||.+.+..+.+..+...++.|....+...
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 442 2334578999999999977646899999999999999999999999999999999999999998887765422
Q ss_pred CCCC-ccc--CCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCCCCC
Q 011138 368 NPNY-TEF--KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCL 433 (492)
Q Consensus 368 ~~~~-~~~--~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~~~~ 433 (492)
.... ..+ .++.....++.. ....++.++.+||.+||+.||.+||++.++++||||++++++....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~ 302 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSK-LFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEP 302 (330)
T ss_pred cccchhhHHhhcccCCcchhHH-hcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCC
Confidence 1110 000 011111112222 2244789999999999999999999999999999999988765543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=350.18 Aligned_cols=286 Identities=31% Similarity=0.542 Sum_probs=216.8
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----hhhHHHHHHHHHHcCCCCccccceeeeeccCC-------
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK------- 205 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~------- 205 (492)
.+|.+.+.||.|+||.||+|.+..+|+.||+|++... .....+|+++++.++||||+++++++......
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 4699999999999999999999999999999988443 23355799999999999999999877443211
Q ss_pred --CceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEee
Q 011138 206 --DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICD 283 (492)
Q Consensus 206 --~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~D 283 (492)
.....|+||||+++++...+. ...+++..++.++.||+.||.|||+ .||+||||||+||+++.++..+||+|
T Consensus 85 ~~~~~~~~lv~e~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~-~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 85 LTELNSVYIVQEYMETDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccceEEEEeecccccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcCCCceEEECC
Confidence 123578999999986655432 2468899999999999999999997 99999999999999986665799999
Q ss_pred ecCccccCCCCC----CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 011138 284 FGSAKMLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTP 359 (492)
Q Consensus 284 FG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p 359 (492)
||++........ .....++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+....+......+
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999976532211 1234678899999988665668899999999999999999999999888877777776655444
Q ss_pred CHHHHhhcCCCCccc-C-CCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCC
Q 011138 360 TREEIKCMNPNYTEF-K-FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (492)
Q Consensus 360 ~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~ 429 (492)
............... . .......+... +.+.++.++++||.+||+.||.+|||+.+++.||||+.+..|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~ 309 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRD-LLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCP 309 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHH-HccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCC
Confidence 433222111000000 0 00000111111 223578999999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=341.68 Aligned_cols=276 Identities=36% Similarity=0.654 Sum_probs=218.2
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
+|.+.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+++++.++||||+++++++ .+..+.|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 76 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRLY 76 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeEE
Confidence 5899999999999999999999999999999874322 2345799999999999999999998 4555789
Q ss_pred EEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
+||||+.++++..... ....+++..+..++.||+.||.|||+ .||+||||+|+||+++.++ .++|+|||++....
T Consensus 77 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~~l~p~ni~~~~~~-~~~l~dfg~~~~~~ 151 (286)
T cd07846 77 LVFEFVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHS-HNIIHRDIKPENILVSQSG-VVKLCDFGFARTLA 151 (286)
T ss_pred EEEecCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCC-cEEEEeeeeeeecc
Confidence 9999999876654322 23458899999999999999999997 8999999999999999887 79999999987654
Q ss_pred CCC-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc--C
Q 011138 292 PGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM--N 368 (492)
Q Consensus 292 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~--~ 368 (492)
... ......++..|+|||++.+...++.++|||||||++|+|++|.+||...+..+....+....+.........+ .
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 152 APGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred CCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 332 2234568899999999876666889999999999999999999999988888888888877766443322111 1
Q ss_pred CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
+......++......-.....+.++..+.+|+.+||..||.+||++.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 1111222222221111112234678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=343.34 Aligned_cols=282 Identities=29% Similarity=0.486 Sum_probs=217.6
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccC---CCc
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE---KDE 207 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~---~~~ 207 (492)
.+|.+.+.||+|+||.||+|.+..+++.||||.+.... ....+|+.+++.++||||+++++++..... ...
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46999999999999999999999999999999875321 123469999999999999999998755432 233
Q ss_pred eEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 208 ~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
...++||||+++++...+.. ....+++..++.++.||+.||.|||+ +||+|+||||+||+++.++ .+||+|||++
T Consensus 92 ~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dl~p~nil~~~~~-~~kl~dfg~~ 166 (310)
T cd07865 92 GSFYLVFEFCEHDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHR-NKILHRDMKAANILITKDG-ILKLADFGLA 166 (310)
T ss_pred ceEEEEEcCCCcCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEECCCC-cEEECcCCCc
Confidence 45789999999877665432 23468999999999999999999997 8999999999999999887 8999999999
Q ss_pred cccCCCCC-----CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 011138 288 KMLVPGEP-----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (492)
Q Consensus 288 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~ 362 (492)
........ .....++..|+|||.+.+...++.++|||||||++|+|++|++||.+.+....+..+....|..+.+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 76532221 1234678899999998776667899999999999999999999999988877777777777776655
Q ss_pred HHhhcC--CCCcccCCCcccCCCcccc-cCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 363 EIKCMN--PNYTEFKFPQIKAHPWHKI-FHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 363 ~~~~~~--~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
.++... ..+....++.......... .+...++.+++||.+||..||.+|||++++++||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 443221 0111112222111111100 111246788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=343.24 Aligned_cols=281 Identities=35% Similarity=0.605 Sum_probs=221.4
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccC---CC
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE---KD 206 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~---~~ 206 (492)
..+|.+.+.||.|+||.||+|.+..+++.||||++.... ....+|+++++.++||||+++++++..... ..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 467999999999999999999999999999999874321 234579999999999999999998755432 23
Q ss_pred ceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 207 ~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
...+++||||+.+++...+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHE-NHILHRDIKAANILIDNQG-ILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCcCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-CEEECcCcc
Confidence 446889999999876654432 24568999999999999999999997 9999999999999999888 799999999
Q ss_pred ccccCCCCC------------CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 011138 287 AKMLVPGEP------------NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIK 354 (492)
Q Consensus 287 a~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~ 354 (492)
+........ .....+++.|+|||.+.+...++.++|||||||++|+|++|++||.+.+.......+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 976532211 12346788999999987666689999999999999999999999999999888888888
Q ss_pred HhCCCCHHHHhhcC--CCCcc-cCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 355 ILGTPTREEIKCMN--PNYTE-FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 355 ~~g~p~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
..+.+....+.... +.... ....... ..+.. ....+++++.+||.+||+.||.+|||+.+++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYP-RTLEE-RFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCC-ccHHH-HcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 88887766554322 11110 0001100 01111 113456889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=351.75 Aligned_cols=278 Identities=26% Similarity=0.427 Sum_probs=202.8
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
.+|.+.+.||+|+||.||+|.+..+|..+|+|.+... .....+|+++++.++||||++++++|.. ..++|
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 79 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEIS 79 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-----CCEEE
Confidence 4699999999999999999999999999999987543 1335689999999999999999999843 34689
Q ss_pred EEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 212 lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
+||||+.++ |.+.+.. ...+++..+..++.||+.||.|||+..+|+||||||+|||++.++ .+||+|||++...
T Consensus 80 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~ 154 (333)
T cd06650 80 ICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQL 154 (333)
T ss_pred EEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC-CEEEeeCCcchhh
Confidence 999999864 4444332 346888899999999999999999624799999999999999887 7999999998755
Q ss_pred CCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH--HhCCCCHHHHhh-c
Q 011138 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIK--ILGTPTREEIKC-M 367 (492)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~--~~g~p~~~~~~~-~ 367 (492)
... ......||..|+|||++.+. .++.++|||||||++|+|++|+.||......+.. .+.. ..+.+....... .
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 231 (333)
T cd06650 155 IDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE-LMFGCPVEGDPAESETSPRP 231 (333)
T ss_pred hhh-ccccCCCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH-HHhcCcccCCccccccCccc
Confidence 322 23345789999999999654 4899999999999999999999999876543222 1111 001111000000 0
Q ss_pred CC------CCcccCCCc---------ccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 368 NP------NYTEFKFPQ---------IKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 368 ~~------~~~~~~~~~---------~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
.. .+.....|. +....-...-...++.++++||.+||++||++|||+.|++.||||+...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 00 000000000 0000000000123578899999999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=339.13 Aligned_cols=274 Identities=35% Similarity=0.646 Sum_probs=218.2
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
|.+.+.||.|++|.||+|.+..+|..||+|++..+. ....+|+++++.++||||+++++++ .+..+.|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~-----~~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVV-----HSENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhhee-----ccCCeEEE
Confidence 567789999999999999999999999999885332 2345799999999999999999988 44457899
Q ss_pred EeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 213 V~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
||||+++.+...+.... ...+++..+..++.||+.||.|||+ +|++||||+|+||+++.++ .++|+|||++.....
T Consensus 76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~-~~~~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~ 151 (283)
T cd07835 76 VFEFLDLDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHS-HRVLHRDLKPQNLLIDREG-ALKLADFGLARAFGV 151 (283)
T ss_pred EEeccCcCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcCCC-cEEEeecccccccCC
Confidence 99999877666543321 2468899999999999999999997 8999999999999999877 899999999875432
Q ss_pred CC-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC--C
Q 011138 293 GE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN--P 369 (492)
Q Consensus 293 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~--~ 369 (492)
.. ......++..|+|||++.+...++.++|+|||||++|+|++|.+||.+.+....+.++.+..+.|....+.... +
T Consensus 152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 152 PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred CccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence 21 22334668899999988766567899999999999999999999999998888888888888888776553221 1
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
.+. ..++....... ....+.++.++.+||.+||+.||.+|||+.|++.||||
T Consensus 232 ~~~-~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 232 DYK-PTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhh-hhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 110 01121111111 11234678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=337.52 Aligned_cols=293 Identities=26% Similarity=0.435 Sum_probs=231.2
Q ss_pred CCCccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchhhHH---HHHHHHHHcC-----C---CCccccceee
Q 011138 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLN-----H---PNVVSLKHCF 199 (492)
Q Consensus 131 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~---~E~~il~~l~-----h---~nIv~l~~~~ 199 (492)
|......+|.+.++||.|.|++||+|.|..+.+.||+|+++....+.+ .|+++|++++ | .+||+|+++|
T Consensus 72 GD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F 151 (590)
T KOG1290|consen 72 GDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF 151 (590)
T ss_pred cccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence 334444679999999999999999999999999999999987766654 5999999884 2 4699999999
Q ss_pred eeccCCCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEc------
Q 011138 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN------ 273 (492)
Q Consensus 200 ~~~~~~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~------ 273 (492)
...+ .+..++|||+|+++..|+.++.... .+.++...++.|++||+.||.|||...||||-||||+|||+.
T Consensus 152 khsG-pNG~HVCMVfEvLGdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~ 228 (590)
T KOG1290|consen 152 KHSG-PNGQHVCMVFEVLGDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDP 228 (590)
T ss_pred eecC-CCCcEEEEEehhhhhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccch
Confidence 7666 5667899999999999999887644 467999999999999999999999878999999999999984
Q ss_pred --------------------------------------------------------------------------------
Q 011138 274 -------------------------------------------------------------------------------- 273 (492)
Q Consensus 274 -------------------------------------------------------------------------------- 273 (492)
T Consensus 229 ~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~ 308 (590)
T KOG1290|consen 229 AKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPR 308 (590)
T ss_pred hhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccC
Confidence
Q ss_pred ----------------------------CC--------------------------------------------------
Q 011138 274 ----------------------------PH-------------------------------------------------- 275 (492)
Q Consensus 274 ----------------------------~~-------------------------------------------------- 275 (492)
+.
T Consensus 309 ~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~ 388 (590)
T KOG1290|consen 309 INGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPE 388 (590)
T ss_pred CCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCc
Confidence 00
Q ss_pred -CCcEEEeeecCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCC------ChHHH
Q 011138 276 -THQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGE------SGVDQ 348 (492)
Q Consensus 276 -~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~------~~~~~ 348 (492)
.-.|||+|||.|... ....+..+.|..|+|||++.|.+ |+..+||||++|++|||+||..+|... .+.+.
T Consensus 389 ~di~vKIaDlGNACW~--~khFT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDH 465 (590)
T KOG1290|consen 389 CDIRVKIADLGNACWV--HKHFTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDH 465 (590)
T ss_pred cceeEEEeeccchhhh--hhhhchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHH
Confidence 003677888877654 23344567799999999999876 999999999999999999999999643 36788
Q ss_pred HHHHHHHhCCCCHHHHhhcC-------CCCcccCCCcccCCCccccc------CCCCChhHhhhhccccccCCCCcCCHH
Q 011138 349 LVEIIKILGTPTREEIKCMN-------PNYTEFKFPQIKAHPWHKIF------HKRMPPEALDLVSRLLQYSPSLRCTAL 415 (492)
Q Consensus 349 ~~~i~~~~g~p~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~------~~~~s~~~~~Li~~~L~~dP~~R~t~~ 415 (492)
++.|+..+|..+........ ..-.-.-+..++.+++..++ ...-..++.|||.-||+++|++|+||.
T Consensus 466 iA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~ 545 (590)
T KOG1290|consen 466 IALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAA 545 (590)
T ss_pred HHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHH
Confidence 99999999998876553211 11000112233333333322 222345678999999999999999999
Q ss_pred HhhCCCCCCCCCCC
Q 011138 416 EACAHPFFDDLRDP 429 (492)
Q Consensus 416 e~l~Hp~f~~~~~~ 429 (492)
++|+|||+..+..+
T Consensus 546 ~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 546 QCLKHPWLNPVAGP 559 (590)
T ss_pred HHhcCccccCCCCC
Confidence 99999999987654
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=321.02 Aligned_cols=261 Identities=26% Similarity=0.414 Sum_probs=208.6
Q ss_pred CCccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchhhH-----HHHHHHHHHc-CCCCccccceeeeeccCC
Q 011138 132 QPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-----NRELQIMRLL-NHPNVVSLKHCFFSTTEK 205 (492)
Q Consensus 132 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~-----~~E~~il~~l-~h~nIv~l~~~~~~~~~~ 205 (492)
.+...+..+....||.|+.|+|+++..+.+|...|||.+.+..... .+.+.++... +.|+||+.+++|....+
T Consensus 87 ~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d- 165 (391)
T KOG0983|consen 87 YQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD- 165 (391)
T ss_pred cccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch-
Confidence 3344445667778999999999999999999999999986543221 1234443333 48999999999977655
Q ss_pred CceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeec
Q 011138 206 DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (492)
Q Consensus 206 ~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG 285 (492)
+++.||.|..-...+++ +..+++|+..+-.+...++.||.||...+||+|||+||+|||+|..| ++||||||
T Consensus 166 ----V~IcMelMs~C~ekLlk---rik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G-niKlCDFG 237 (391)
T KOG0983|consen 166 ----VFICMELMSTCAEKLLK---RIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-NIKLCDFG 237 (391)
T ss_pred ----HHHHHHHHHHHHHHHHH---HhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC-CEEeeccc
Confidence 77899998754444333 34567999999999999999999999778999999999999999888 89999999
Q ss_pred CccccCCCCCCccceeccCccCchhhcC--CCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHH
Q 011138 286 SAKMLVPGEPNISYICSRYYRAPELIFG--ATEYTTAIDMWSIGCVLAELLLGQPLFPGES-GVDQLVEIIKILGTPTRE 362 (492)
Q Consensus 286 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwSlGvil~ell~G~~pf~~~~-~~~~~~~i~~~~g~p~~~ 362 (492)
++..+......+...|.+.|||||.+.- ...|+-.+||||||++|+||.||+.||.+.+ +-+.+.++.+. .|+
T Consensus 238 IsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~--ePP-- 313 (391)
T KOG0983|consen 238 ISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE--EPP-- 313 (391)
T ss_pred ccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc--CCC--
Confidence 9998887777888899999999999842 3458999999999999999999999999854 44555555441 111
Q ss_pred HHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
.+| .....|+++.+|+..||++|+.+||...++|+|||+..+.
T Consensus 314 ------------~L~----------~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 314 ------------LLP----------GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred ------------CCC----------cccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 011 1134799999999999999999999999999999998764
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=353.65 Aligned_cols=249 Identities=30% Similarity=0.554 Sum_probs=211.0
Q ss_pred eeeeccCCceEEEEEEEcCCCCEEEEEEecc------chhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEee
Q 011138 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ------DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (492)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~------~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E 215 (492)
.++||+|.||+||-|+.+.+|+.||||+|.+ .+..+++|+.||+.+.||.||.+.-.| +....+++|||
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~-----ET~ervFVVME 643 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF-----ETPERVFVVME 643 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee-----cCCceEEEEeh
Confidence 4789999999999999999999999999843 346677899999999999999997766 33335889999
Q ss_pred echhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCC--CcEEEeeecCccccCCC
Q 011138 216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT--HQLKICDFGSAKMLVPG 293 (492)
Q Consensus 216 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~--~~vkL~DFG~a~~~~~~ 293 (492)
-+.|+.+..+.... ...+++...++++.||+.||.|||. +||||+||||+|||+.... .++||||||+|+++...
T Consensus 644 Kl~GDMLEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~-knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 644 KLHGDMLEMILSSE--KGRLPERITKFLVTQILVALRYLHF-KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred hhcchHHHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhh-cceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence 99999998776533 4679999999999999999999997 9999999999999996543 47999999999999777
Q ss_pred CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 011138 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES-GVDQLVEIIKILGTPTREEIKCMNPNYT 372 (492)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~-~~~~~~~i~~~~g~p~~~~~~~~~~~~~ 372 (492)
.-..+.+|||.|+|||++... .|+..-|+||+|||+|--|.|..||..+. ..+++++ .
T Consensus 721 sFRrsVVGTPAYLaPEVLrnk-GyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQN--------------------A 779 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNK-GYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQN--------------------A 779 (888)
T ss_pred hhhhhhcCCccccCHHHHhhc-cccccccceeeeEEEEEEecccccCCCccchhHHhhc--------------------c
Confidence 777889999999999999755 49999999999999999999999995432 2233222 1
Q ss_pred ccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
.+-+| ..+| +.+++++.|||..+|+..-++|.+.++.|.|||++++.
T Consensus 780 aFMyP---p~PW-----~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 780 AFMYP---PNPW-----SEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred ccccC---CCch-----hhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence 22222 3455 45899999999999999999999999999999999765
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=338.13 Aligned_cols=276 Identities=38% Similarity=0.684 Sum_probs=222.9
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
+|.+.+.||+|+||.||+|.+..+++.||+|.+... .....+|+++++.++|+||+++++++.. ....+
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 76 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRLY 76 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEEE
Confidence 599999999999999999999999999999987532 2345679999999999999999999843 44689
Q ss_pred EEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
+||||++++++.... .....+++..+..++.||+.||.|||+ .||+||||+|+||+++.++ .+||+|||++....
T Consensus 77 iv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~ni~~~~~~-~~kl~d~g~~~~~~ 151 (288)
T cd07833 77 LVFEYVERTLLELLE---ASPGGLPPDAVRSYIWQLLQAIAYCHS-HNIIHRDIKPENILVSESG-VLKLCDFGFARALR 151 (288)
T ss_pred EEEecCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCC-CEEEEeeecccccC
Confidence 999999987766433 223558899999999999999999997 8999999999999999877 79999999988765
Q ss_pred CCC--CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc--
Q 011138 292 PGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM-- 367 (492)
Q Consensus 292 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~-- 367 (492)
... ......++..|+|||++.+...++.++|+|||||++|+|++|++||.+.+..+.+..+...++.........+
T Consensus 152 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07833 152 ARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS 231 (288)
T ss_pred CCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhccc
Confidence 443 3345678899999999977646899999999999999999999999998888888888887776665444322
Q ss_pred CCCCcccCCCcccCC-CcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 368 NPNYTEFKFPQIKAH-PWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
++.+....++..... .+...++..++.++++||++||..||++||++.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 222222233322111 12223444568999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=345.25 Aligned_cols=286 Identities=36% Similarity=0.612 Sum_probs=224.9
Q ss_pred ceeEeeeeccCCceEEEEEEEcCC--CCEEEEEEeccc------hhhHHHHHHHHHHc-CCCCccccceeeeeccCCCce
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLET--GDSVAIKKVLQD------KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~--g~~vAiK~~~~~------~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~~ 208 (492)
+|.+.+.||+|+||.||++.+..+ +..||||++... .....+|+.+++.+ +||||+++++++.... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence 488999999999999999999888 999999987532 12345799999999 5999999998754332 2334
Q ss_pred EEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 209 ~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
.+|++|||+++++...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus 80 ~~~~~~e~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~givH~dlkp~Nili~~~~-~~kl~Dfg~a~ 153 (332)
T cd07857 80 ELYLYEELMEADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIHS-ANVLHRDLKPGNLLVNADC-ELKICDFGLAR 153 (332)
T ss_pred cEEEEEecccCCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHeEEcCCC-CEEeCcCCCce
Confidence 578999999987766543 24568899999999999999999997 9999999999999999887 79999999997
Q ss_pred ccCCCC-----CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 011138 289 MLVPGE-----PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (492)
Q Consensus 289 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~ 363 (492)
...... ......||..|+|||.+.+...++.++|||||||++|+|++|.+||.+.+....+..++..+|.|+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 653221 122357899999999987656689999999999999999999999999998899999999999888765
Q ss_pred HhhcCCCC-cc--cCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCCC
Q 011138 364 IKCMNPNY-TE--FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431 (492)
Q Consensus 364 ~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~~ 431 (492)
+..+.... .. ..+.......+.. ..+.++.++.+||.+||+.||.+|||+.+++.||||+.++++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~ 303 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDD 303 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccc
Confidence 54332110 00 0011111111111 12346889999999999999999999999999999999887543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=346.26 Aligned_cols=283 Identities=34% Similarity=0.622 Sum_probs=223.0
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccC-CCceE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY 209 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~-~~~~~ 209 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++||||++++++|..... .....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 4699999999999999999999999999999988542 1234579999999999999999998854332 22334
Q ss_pred EEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
+|+||||+...+.... ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 95 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dlkp~NIll~~~~-~~kL~dfg~~~~ 166 (342)
T cd07879 95 FYLVMPYMQTDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHS-AGIIHRDLKPGNLAVNEDC-ELKILDFGLARH 166 (342)
T ss_pred EEEEecccccCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEeeCCCCcC
Confidence 6899999986544321 2458889999999999999999997 9999999999999999887 899999999875
Q ss_pred cCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
.. .......+++.|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..++...|.+....+.....
T Consensus 167 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 167 AD--AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred CC--CCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 42 2334567899999999987655689999999999999999999999999888888888888888777665443321
Q ss_pred CCcc---cCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCC
Q 011138 370 NYTE---FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430 (492)
Q Consensus 370 ~~~~---~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~ 430 (492)
.... ...+......+.. ..+.+++++.+||.+||+.||.+||++.+++.||||+.+++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~ 307 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFST-LFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD 307 (342)
T ss_pred cchHHHHhhcCCcccchHHH-HhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence 1000 0111111111211 1234788999999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=346.33 Aligned_cols=277 Identities=36% Similarity=0.570 Sum_probs=219.9
Q ss_pred cee-EeeeeccCCceEEEEEEEcCCCCEEEEEEeccchh------------------hHHHHHHHHHHcCCCCcccccee
Q 011138 138 SYM-AERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR------------------YKNRELQIMRLLNHPNVVSLKHC 198 (492)
Q Consensus 138 ~y~-~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~------------------~~~~E~~il~~l~h~nIv~l~~~ 198 (492)
+|. +.+.||.|+||+||+|.+..+++.||||++..... ...+|+++++.++|+||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 465 45789999999999999999999999998753211 24579999999999999999998
Q ss_pred eeeccCCCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCc
Q 011138 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQ 278 (492)
Q Consensus 199 ~~~~~~~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~ 278 (492)
+. ...+.|+||||+.+++...+.. ...+++..+..++.||+.||.|||+ +||+||||||+||+++.++ .
T Consensus 89 ~~-----~~~~~~lv~e~~~~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~-~~i~H~dl~~~nill~~~~-~ 157 (335)
T PTZ00024 89 YV-----EGDFINLVMDIMASDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHK-WYFMHRDLSPANIFINSKG-I 157 (335)
T ss_pred Ee-----cCCcEEEEEeccccCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHeEECCCC-C
Confidence 83 4446899999999887765543 3458889999999999999999997 9999999999999999887 7
Q ss_pred EEEeeecCccccCC---------------CCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 011138 279 LKICDFGSAKMLVP---------------GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGE 343 (492)
Q Consensus 279 vkL~DFG~a~~~~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~ 343 (492)
+||+|||++..... ........+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+.
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999876531 111123456889999999977666899999999999999999999999999
Q ss_pred ChHHHHHHHHHHhCCCCHHHHhhcC--CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCC
Q 011138 344 SGVDQLVEIIKILGTPTREEIKCMN--PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHP 421 (492)
Q Consensus 344 ~~~~~~~~i~~~~g~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp 421 (492)
+..+.+..+...++.|....+.... +.+..+... ...... ......+.++.+||.+||+.||++||+++|++.||
T Consensus 238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 238 NEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPR--KPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred CHHHHHHHHHHHhCCCchhhCcchhhcccccccCcC--CcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 9999999999999888776554321 111111100 000011 11234688999999999999999999999999999
Q ss_pred CCCCCCC
Q 011138 422 FFDDLRD 428 (492)
Q Consensus 422 ~f~~~~~ 428 (492)
||+....
T Consensus 315 ~~~~~~~ 321 (335)
T PTZ00024 315 YFKSDPL 321 (335)
T ss_pred ccCCCCC
Confidence 9997643
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=333.88 Aligned_cols=247 Identities=27% Similarity=0.453 Sum_probs=200.6
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch---------hhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~---------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
+|.+.+.||+|+||.||.|.+..+++.||+|.+.... ....+|+.+++.++||||+++++++ .+..
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~ 77 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL-----RDDE 77 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ccCC
Confidence 5899999999999999999999999999999875321 2345799999999999999999998 4444
Q ss_pred EEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 209 ~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
.+++||||++++ +.+.+.. ...+++..+..++.||+.||.|||+ .||+||||||+||+++.++ .++|+|||++
T Consensus 78 ~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nilv~~~~-~~~l~dfg~~ 151 (263)
T cd06625 78 TLSIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHS-NMIVHRDIKGANILRDSAG-NVKLGDFGAS 151 (263)
T ss_pred eEEEEEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEeecccc
Confidence 799999999865 4343322 3467888899999999999999997 8999999999999999877 7999999998
Q ss_pred cccCCCCCC----ccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 011138 288 KMLVPGEPN----ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (492)
Q Consensus 288 ~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~ 363 (492)
+........ ....++..|+|||++.+.. ++.++|||||||++|+|++|+.||...+.......+....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~------- 223 (263)
T cd06625 152 KRLQTICSSGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP------- 223 (263)
T ss_pred eeccccccccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccC-------
Confidence 765332211 2356788999999997654 8999999999999999999999998766554444332210
Q ss_pred HhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
....++..++.++.+||.+||..||.+|||+.++++||||
T Consensus 224 --------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 224 --------------------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred --------------------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 0011234578999999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=337.89 Aligned_cols=256 Identities=27% Similarity=0.426 Sum_probs=202.7
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-----hhHHHHHHH-HHHcCCCCccccceeeeeccCCCceEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQI-MRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-----~~~~~E~~i-l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
+|.+.+.||+|+||.||+|.+..+|+.||||.+.... .....|+.+ ++.++||||+++++++. ....+|
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~-----~~~~~~ 76 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF-----REGDVW 76 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe-----cCCcEE
Confidence 5899999999999999999999999999999885432 122235554 67788999999999884 334589
Q ss_pred EEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhC-CcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV-GVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~-givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
+||||+++++..++.........+++..+..++.||+.||.|||+ + +++||||||+|||++.++ .+||+|||++...
T Consensus 77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~i~h~dlkp~nil~~~~~-~~kl~dfg~~~~~ 154 (283)
T cd06617 77 ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS-KLSVIHRDVKPSNVLINRNG-QVKLCDFGISGYL 154 (283)
T ss_pred EEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECCCC-CEEEeeccccccc
Confidence 999999988777665544445678999999999999999999997 6 999999999999999887 7999999999865
Q ss_pred CCCCCCccceeccCccCchhhcCC---CCCCcchhhHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCHHHHhh
Q 011138 291 VPGEPNISYICSRYYRAPELIFGA---TEYTTAIDMWSIGCVLAELLLGQPLFPGE-SGVDQLVEIIKILGTPTREEIKC 366 (492)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DvwSlGvil~ell~G~~pf~~~-~~~~~~~~i~~~~g~p~~~~~~~ 366 (492)
..........++..|+|||++.+. ..++.++|+|||||++|+|++|+.||... ...+.+..+... .
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~-------- 224 (283)
T cd06617 155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE--P-------- 224 (283)
T ss_pred ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc--C--------
Confidence 433333345788999999988542 34688999999999999999999999653 223333333220 0
Q ss_pred cCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
...++ ...+++++.+||.+||..||.+||++.+++.||||....
T Consensus 225 ------~~~~~-----------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 225 ------SPQLP-----------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred ------CCCCC-----------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 00111 123688999999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=355.05 Aligned_cols=262 Identities=29% Similarity=0.426 Sum_probs=218.0
Q ss_pred ccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
.....|.+.+.||+|.|++|.+|++..+|..||||.+.+.. ....+|+++|+.|+|||||+++.+.. ..
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~-----t~ 127 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIE-----TE 127 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeee-----ec
Confidence 34456999999999999999999999999999999986542 22458999999999999999999984 34
Q ss_pred eEEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 208 LYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 208 ~~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
..+|+||||+.++ +.+. ...+..+.+..++.++.|+++|++|||+ ++|||||||.+||||+.+. ++||+|||+
T Consensus 128 ~~lylV~eya~~ge~~~y----l~~~gr~~e~~ar~~F~q~vsaveYcH~-k~ivHrdLk~eNilL~~~m-nikIaDfgf 201 (596)
T KOG0586|consen 128 ATLYLVMEYASGGELFDY----LVKHGRMKEKEARAKFRQIVSAVEYCHS-KNIVHRDLKAENILLDENM-NIKIADFGF 201 (596)
T ss_pred ceeEEEEEeccCchhHHH----HHhcccchhhhhhhhhHHHHHHHHHHhh-cceeccccchhhccccccc-ceeeecccc
Confidence 4599999999865 3333 3334556668899999999999999997 9999999999999999988 799999999
Q ss_pred ccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 011138 287 AKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (492)
Q Consensus 287 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~ 366 (492)
+..+..+....+++|++.|.|||++.|..+.++.+|+||+|++||.|+.|..||++.+-.+.-...+.
T Consensus 202 S~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~------------ 269 (596)
T KOG0586|consen 202 STFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR------------ 269 (596)
T ss_pred ceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee------------
Confidence 99998888888999999999999999998889999999999999999999999998764322111111
Q ss_pred cCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCCCCCCC
Q 011138 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPN 435 (492)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~~~~~~ 435 (492)
..+.+| --++.++.+||+++|..+|.+|++.++++.|.|.........+.+.
T Consensus 270 -----gk~rIp------------~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~~~l~p~ 321 (596)
T KOG0586|consen 270 -----GKYRIP------------FYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEARLLAPL 321 (596)
T ss_pred -----eeeccc------------ceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhhhhhhcc
Confidence 112222 2378899999999999999999999999999999876654333333
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=366.98 Aligned_cols=248 Identities=25% Similarity=0.449 Sum_probs=199.3
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEecc-ch---hhHHHHHHHHHHcC-CCCccccce-eeeeccCCC-ceE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-DK---RYKNRELQIMRLLN-HPNVVSLKH-CFFSTTEKD-ELY 209 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~-~~---~~~~~E~~il~~l~-h~nIv~l~~-~~~~~~~~~-~~~ 209 (492)
.++++.++|.+|||+.||+|.+...|..||+|++.. ++ ....+|+++|++|. |+|||.+++ +........ ..-
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 368999999999999999999998889999998743 33 33468999999997 999999999 444433333 355
Q ss_pred EEEEeeech-hhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCC--cccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 210 LNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG--VCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 210 ~~lV~E~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~g--ivHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
+.|.||||. |+|.+++..+.. ..|.+.++..|++|+++|+.+||. .. |||||||-|||||+.++ ..||||||.
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g-~~KLCDFGS 192 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADG-NYKLCDFGS 192 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCC-CEEeCcccc
Confidence 779999999 688888775443 449999999999999999999996 66 99999999999999888 799999999
Q ss_pred ccccCCCCCC----------ccceeccCccCchhhc--CCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 011138 287 AKMLVPGEPN----------ISYICSRYYRAPELIF--GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIK 354 (492)
Q Consensus 287 a~~~~~~~~~----------~~~~gt~~y~aPE~~~--~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~ 354 (492)
|.-....... +....|+.|+|||+|. .....+.|+|||||||+||-|+....||...... .|+.
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----aIln 268 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----AILN 268 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----eEEe
Confidence 8644222211 1234589999999983 3455899999999999999999999999775432 1221
Q ss_pred HhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 355 ILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 355 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
..|.||.. +.++..+++||+.||+.||.+||++.|++.
T Consensus 269 -----------------g~Y~~P~~----------p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~ 306 (738)
T KOG1989|consen 269 -----------------GNYSFPPF----------PNYSDRLKDLIRTMLQPNPDERPNIYQVLE 306 (738)
T ss_pred -----------------ccccCCCC----------ccHHHHHHHHHHHHhccCcccCCCHHHHHH
Confidence 34455542 357899999999999999999999998874
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=337.57 Aligned_cols=274 Identities=39% Similarity=0.739 Sum_probs=222.8
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
|.+.+.||.|++|.||+|.+..+|+.+++|.+.... ....+|+.+++.++|+||+++++++ .+...+++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVF-----RHKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhh-----ccCCCEEE
Confidence 567788999999999999999999999999875432 2345799999999999999999988 34456889
Q ss_pred EeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 213 V~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
||||+++++...+.. ....+++..+..++.||+.||.|||+ +||+|+||||+||+++.++ .+||+|||.+.....
T Consensus 76 v~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~~~-~~~l~df~~~~~~~~ 150 (283)
T cd05118 76 VFEFMDTDLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHS-HGILHRDLKPENLLINTEG-VLKLADFGLARSFGS 150 (283)
T ss_pred EEeccCCCHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHH-CCeeecCcCHHHEEECCCC-cEEEeeeeeeEecCC
Confidence 999999877665443 23578899999999999999999997 9999999999999999877 799999999976644
Q ss_pred CC-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC--
Q 011138 293 GE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP-- 369 (492)
Q Consensus 293 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~-- 369 (492)
.. ......++..|+|||.+.+...++.++|+|||||++|+|++|+.||.+.+..+.+..+...++.+..+.+.....
T Consensus 151 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 151 PVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred CcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh
Confidence 33 233456788999999997765689999999999999999999999999999899999988888887776655433
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
......++....... ....+.++.++++||.+||..||.+||++.++++||||
T Consensus 231 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 231 RNYKFSFPKKAGMPL-PKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhhhccccccCH-HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 122223332222111 11234578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=347.10 Aligned_cols=286 Identities=35% Similarity=0.670 Sum_probs=226.1
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHc-CCCCccccceeeeeccCCCce
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~~ 208 (492)
..+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.+ +||||+++++++.. .+..
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~~ 82 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---ENDK 82 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCCc
Confidence 34699999999999999999999999999999987432 12344799999999 99999999998743 2334
Q ss_pred EEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 209 ~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
.+|+||||+.+++...+.. ..+.+..++.++.||+.||.|||+ +||+||||||+||+++.++ .+||+|||++.
T Consensus 83 ~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~p~nill~~~~-~~kl~d~g~~~ 155 (337)
T cd07852 83 DIYLVFEYMETDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHS-GNVIHRDLKPSNILLNSDC-RVKLADFGLAR 155 (337)
T ss_pred eEEEEecccccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-cEEEeeccchh
Confidence 5789999999876654432 267788888999999999999997 9999999999999999888 89999999997
Q ss_pred ccCCCC------CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 011138 289 MLVPGE------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (492)
Q Consensus 289 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~ 362 (492)
...... ......||..|+|||.+.+...++.++|+|||||++|+|++|++||.+....+....+....+.+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 654322 22245789999999998766668899999999999999999999999999888888888888888776
Q ss_pred HHhhcCCCCcccCC---CcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCCCC
Q 011138 363 EIKCMNPNYTEFKF---PQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTC 432 (492)
Q Consensus 363 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~~~ 432 (492)
.+..+........+ +......... ..+.++.++.+||.+||+.||++|||+.++++||||+.+..+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~ 307 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDE-LLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDE 307 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhh-hccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCC
Confidence 55443322111111 1111111111 223478999999999999999999999999999999998765443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=338.60 Aligned_cols=260 Identities=26% Similarity=0.409 Sum_probs=204.2
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
+|++.+.||+|+||.||+|.+..+|..||+|.+... .....+|+.+++.++|+||+++++++ ....++|+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~l 76 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF-----FIEGAVYM 76 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhe-----ecCCeEEE
Confidence 588899999999999999999999999999987542 12345799999999999999999988 34456899
Q ss_pred EeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 213 V~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
||||++++.+..+.........+++..+..++.||+.||.|||+..||+||||||+||+++.++ .+||+|||++.....
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~ 155 (286)
T cd06622 77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLVA 155 (286)
T ss_pred EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC-CEEEeecCCcccccC
Confidence 9999997644432222222347899999999999999999999535999999999999999877 799999999876532
Q ss_pred CCCCccceeccCccCchhhcCCC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 293 GEPNISYICSRYYRAPELIFGAT-----EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
. ......+++.|+|||.+.+.. .++.++|+|||||++|+|++|..||...........+......+.
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------- 227 (286)
T cd06622 156 S-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP------- 227 (286)
T ss_pred C-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC-------
Confidence 2 223456888999999985432 358899999999999999999999977554333332222111100
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~ 429 (492)
+ .++..+++++.+||.+||+.||.+||++.++++||||...+..
T Consensus 228 ---------~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 228 ---------P---------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred ---------C---------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence 0 1223478999999999999999999999999999999987654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=340.35 Aligned_cols=259 Identities=29% Similarity=0.502 Sum_probs=208.7
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
+|.+.+.||+|+||.||+|.+..+++.||||.+.... ....+|+++++.++|+||+++++++ .+..+.
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~ 76 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETYL 76 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCEE
Confidence 5899999999999999999999999999999885432 2345799999999999999999988 445578
Q ss_pred EEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 211 ~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
|+||||+.++ +.+++. ......+++..++.++.||+.||.|||+ .||+||||||+||+++.++ .++|+|||++..
T Consensus 77 ~lv~e~~~~~~L~~~~~--~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~ 152 (316)
T cd05574 77 CLVMDYCPGGELFRLLQ--RQPGKCLSEEVARFYAAEVLLALEYLHL-LGIVYRDLKPENILLHESG-HIMLSDFDLSKQ 152 (316)
T ss_pred EEEEEecCCCCHHHHHH--hCCCCccCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChHHeEEcCCC-CEEEeecchhhc
Confidence 9999999864 444332 2224568999999999999999999997 9999999999999999887 799999999865
Q ss_pred cCCCCC------------------------------CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCC
Q 011138 290 LVPGEP------------------------------NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPL 339 (492)
Q Consensus 290 ~~~~~~------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~p 339 (492)
...... .....||..|+|||++.+. .++.++|||||||++|+|++|..|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~l~~g~~p 231 (316)
T cd05574 153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTTP 231 (316)
T ss_pred ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCchHHHHHHHHHHHHHhhCCCC
Confidence 422111 1134688999999999655 479999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCC----HH
Q 011138 340 FPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT----AL 415 (492)
Q Consensus 340 f~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t----~~ 415 (492)
|.+.+....+..+.. ....++. ...+++++++||.+||..||++||+ +.
T Consensus 232 f~~~~~~~~~~~~~~-----------------~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~ 284 (316)
T cd05574 232 FKGSNRDETFSNILK-----------------KEVTFPG----------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAA 284 (316)
T ss_pred CCCCchHHHHHHHhc-----------------CCccCCC----------ccccCHHHHHHHHHHccCCHhHCCCchhhHH
Confidence 988877666555432 1111111 0126899999999999999999999 99
Q ss_pred HhhCCCCCCCCCCCCCCC
Q 011138 416 EACAHPFFDDLRDPNTCL 433 (492)
Q Consensus 416 e~l~Hp~f~~~~~~~~~~ 433 (492)
++++||||+....+.-..
T Consensus 285 ~ll~~~~~~~~~~~~~~~ 302 (316)
T cd05574 285 EIKQHPFFRGVNWALIRH 302 (316)
T ss_pred HHHcCchhhcCChhhccc
Confidence 999999999877654443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=356.50 Aligned_cols=251 Identities=27% Similarity=0.446 Sum_probs=204.2
Q ss_pred eeccCCceEEEEEEEcCCCCEEEEEEeccc----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEeeechh
Q 011138 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE 219 (492)
Q Consensus 144 ~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E~~~~ 219 (492)
+||+|.||+||.|++..|...+|||-+... .+-+..|+.+.+.|+|.|||++++++ ....++-|.||-++|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCCC
Confidence 699999999999999999999999988432 23355899999999999999999997 555578899999998
Q ss_pred hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCCCCc-c
Q 011138 220 TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI-S 298 (492)
Q Consensus 220 ~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~~~~-~ 298 (492)
+.+..+.......-+-.+....+|.+||+.||+|||+ ..|||||||-+||||+...+.+||+|||.++.+..-.+.+ +
T Consensus 657 GSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHe-n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET 735 (1226)
T KOG4279|consen 657 GSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHE-NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET 735 (1226)
T ss_pred CcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhh-cceeeccccCCcEEEeeccceEEecccccchhhccCCccccc
Confidence 7666554433322223678889999999999999998 8999999999999999888899999999999886555543 6
Q ss_pred ceeccCccCchhhc-CCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCC
Q 011138 299 YICSRYYRAPELIF-GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFP 377 (492)
Q Consensus 299 ~~gt~~y~aPE~~~-~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 377 (492)
+.||..|||||+|. |...|+.++|||||||++.||.||++||..-.... +.++++ .
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq--AAMFkV---------------------G 792 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ--AAMFKV---------------------G 792 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh--Hhhhhh---------------------c
Confidence 88999999999995 44569999999999999999999999996533211 111111 1
Q ss_pred cccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 378 QIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 378 ~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
.. ..+..++..++.+++.||.+|+..||.+||+|.++|..||++.-
T Consensus 793 my---KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 793 MY---KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred ce---ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 11 11223456788999999999999999999999999999999865
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=335.08 Aligned_cols=275 Identities=38% Similarity=0.689 Sum_probs=221.5
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-----hhHHHHHHHHHHcC-CCCccccceeeeeccCCCceEEEE
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-----~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
|.+.+.||+|+||.||+|.+..+++.|+||.+.... ....+|+..++.++ |+||+++++++. +....++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-----~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFR-----ENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhh-----cCCcEEE
Confidence 678889999999999999999999999999875432 22346899999999 999999999984 3456889
Q ss_pred EeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 213 V~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
||||+.++++..+.... ...+++..+..++.||+.+|.|||+ +||+|+||+|+||+++.++ .++|+|||++.....
T Consensus 76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~dl~~~ni~i~~~~-~~~l~d~~~~~~~~~ 151 (283)
T cd07830 76 VFEYMEGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHK-HGFFHRDLKPENLLVSGPE-VVKIADFGLAREIRS 151 (283)
T ss_pred EEecCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcCCC-CEEEeecccceeccC
Confidence 99999887776544321 3468899999999999999999997 9999999999999999877 799999999987655
Q ss_pred CCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCC-
Q 011138 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY- 371 (492)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~- 371 (492)
........++..|+|||++.+...++.++|+|||||++|+|++|++||...+..+.+.++...++.|....+.......
T Consensus 152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 4444556789999999998666668999999999999999999999999999999999999999988776554321111
Q ss_pred -cccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 372 -TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 372 -~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
....++......... +.+..+.++.+||++||+.||++|||+.|++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 232 KLGFRFPQFAPTSLHQ-LIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccccccHHH-HcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 111222221111111 122347899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=335.08 Aligned_cols=261 Identities=25% Similarity=0.346 Sum_probs=206.9
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc---hhhHHHHHHHHHHc-CCCCccccceeeeeccCCCceEEE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~---~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
..+|.+.+.||+|+||.||+|.+..+++.+|+|.+... .....+|+.+++.+ +||||+++++++...........+
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~ 100 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW 100 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence 45799999999999999999999999999999988543 23445799999998 799999999998765444445688
Q ss_pred EEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 212 lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
+||||++++ +.+.+.........+++..++.++.||+.||.|||+ +||+||||||+||+++.++ .+||+|||++...
T Consensus 101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~nili~~~~-~~kl~dfg~~~~~ 178 (291)
T cd06639 101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN-NRIIHRDVKGNNILLTTEG-GVKLVDFGVSAQL 178 (291)
T ss_pred EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcCCC-CEEEeecccchhc
Confidence 999999864 444444333345678999999999999999999997 9999999999999999887 7999999998765
Q ss_pred CCCC-CCccceeccCccCchhhcCCC----CCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 011138 291 VPGE-PNISYICSRYYRAPELIFGAT----EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (492)
Q Consensus 291 ~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~ 365 (492)
.... ......|+..|+|||++.... .++.++|||||||++|+|++|++||........+..+.+. +.
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~---~~----- 250 (291)
T cd06639 179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN---PP----- 250 (291)
T ss_pred ccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC---CC-----
Confidence 4322 223456889999999985432 2678999999999999999999999877655554443220 00
Q ss_pred hcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCC
Q 011138 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424 (492)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~ 424 (492)
..+ ......+.++.+||.+||+.||++||++.++++||||+
T Consensus 251 --------~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 251 --------PTL----------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred --------CCC----------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 000 01124577899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=336.19 Aligned_cols=277 Identities=33% Similarity=0.602 Sum_probs=218.7
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
|.+.+.||.|+||.||+|.+..+|+.+|+|.+.... ....+|+.+++.++|+||+++++++.... ....++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence 678899999999999999999999999999986542 23457999999999999999999884321 256899
Q ss_pred EeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 213 V~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
||||+++++...+.. ....+++..+..++.||+.||+|||+ .|++|+||||+||+++.++ .+||+|||++.....
T Consensus 78 v~e~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~-~~~~h~dl~p~nil~~~~~-~~~l~d~g~~~~~~~ 152 (287)
T cd07840 78 VFEYMDHDLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHS-NGILHRDIKGSNILINNDG-VLKLADFGLARPYTK 152 (287)
T ss_pred EeccccccHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEEcCCC-CEEEccccceeeccC
Confidence 999999876665433 22468899999999999999999997 8999999999999999887 799999999986643
Q ss_pred CC--CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 011138 293 GE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (492)
Q Consensus 293 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 370 (492)
.. ......++..|+|||.+.+...++.++|||||||++|+|++|..||...+....+..+....+.+....+......
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence 32 1233466889999998876666899999999999999999999999999888888888888888876655432211
Q ss_pred --CcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 371 --YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 371 --~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
+................+...+++++.++|.+||..||.+||++.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00000000000001111222248999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=345.31 Aligned_cols=275 Identities=22% Similarity=0.370 Sum_probs=198.1
Q ss_pred EeeeeccC--CceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 141 AERVVGTG--SFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 141 ~~~~lG~G--~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
+.++||+| +||+||++.+..+|+.||+|++... .....+|+.+++.++||||++++++|. ...++|+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-----~~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----ADNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-----ECCEEEE
Confidence 45679999 7899999999999999999998543 134567999999999999999999884 3346899
Q ss_pred Eeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 213 VLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 213 V~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
||||++++ +.+++... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .++++|||.+....
T Consensus 77 v~e~~~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~Nil~~~~~-~~~l~~~~~~~~~~ 152 (327)
T cd08227 77 VTSFMAYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISVDG-KVYLSGLRSNLSMI 152 (327)
T ss_pred EEeccCCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCChhhEEEecCC-cEEEcccchhhccc
Confidence 99999865 44443221 23458889999999999999999997 9999999999999999887 79999998754332
Q ss_pred CCCC--------CccceeccCccCchhhcCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC--
Q 011138 292 PGEP--------NISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPT-- 360 (492)
Q Consensus 292 ~~~~--------~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~-- 360 (492)
.... .....++..|+|||++.+. ..++.++|||||||++|+|++|..||.............. +..+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~ 230 (327)
T cd08227 153 NHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN--GTVPCL 230 (327)
T ss_pred cccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc--CCcccc
Confidence 1111 1123567789999999653 3589999999999999999999999987654443333221 1111
Q ss_pred -------HHHHhhcCCC-------CcccCC----CcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCC
Q 011138 361 -------REEIKCMNPN-------YTEFKF----PQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422 (492)
Q Consensus 361 -------~~~~~~~~~~-------~~~~~~----~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~ 422 (492)
.+.+. +.+. +..... ...........+...+++++.+||.+||+.||++|||++++++|||
T Consensus 231 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~ 309 (327)
T cd08227 231 LDTTTIPAEELT-MKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 309 (327)
T ss_pred ccccchhhhhcc-cCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChh
Confidence 01000 0000 000000 0000000011123456789999999999999999999999999999
Q ss_pred CCCCC
Q 011138 423 FDDLR 427 (492)
Q Consensus 423 f~~~~ 427 (492)
|+++.
T Consensus 310 f~~~~ 314 (327)
T cd08227 310 FKQIK 314 (327)
T ss_pred hhhcc
Confidence 98764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=344.53 Aligned_cols=285 Identities=34% Similarity=0.578 Sum_probs=224.0
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccC-CCceE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY 209 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~-~~~~~ 209 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++..... .....
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 96 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence 46999999999999999999999999999999885421 234579999999999999999998754322 22335
Q ss_pred EEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
+|++++++++.+..... ...+++..++.++.||+.||.|||+ +||+||||||+||+++.++ .+||+|||++..
T Consensus 97 ~~lv~~~~~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~-~~kl~dfg~~~~ 169 (345)
T cd07877 97 VYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDC-ELKILDFGLARH 169 (345)
T ss_pred EEEEehhcccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEcCCC-CEEEeccccccc
Confidence 78999999777655433 2458889999999999999999997 9999999999999999887 799999999875
Q ss_pred cCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
.. .......++..|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+....+.+..........
T Consensus 170 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (345)
T cd07877 170 TD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 247 (345)
T ss_pred cc--ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence 42 2334567899999999987656688999999999999999999999998888888888888888777665543322
Q ss_pred CCccc---CCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCCC
Q 011138 370 NYTEF---KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431 (492)
Q Consensus 370 ~~~~~---~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~~ 431 (492)
..... ..+......+.. .....++++++||.+||+.||.+|+++.++++||||+++..+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~ 311 (345)
T cd07877 248 ESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 311 (345)
T ss_pred HhHHHHHHHhcccCCcchhh-hcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCc
Confidence 11000 001111111111 11246889999999999999999999999999999998776543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=345.04 Aligned_cols=284 Identities=35% Similarity=0.636 Sum_probs=224.9
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccC-CCceE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY 209 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~-~~~~~ 209 (492)
.+|.+.+.||+|+||.||+|++..+++.||||++... .....+|+.+++.++||||+++++++..... .....
T Consensus 15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07851 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD 94 (343)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence 4699999999999999999999999999999987532 1233469999999999999999988744332 22335
Q ss_pred EEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
+++|+||+++++.+++.. ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++ .+||+|||++..
T Consensus 95 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nill~~~~-~~kL~dfg~~~~ 167 (343)
T cd07851 95 VYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNEDC-ELKILDFGLARH 167 (343)
T ss_pred EEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCC-CEEEcccccccc
Confidence 889999998877665442 468999999999999999999997 8999999999999999877 799999999976
Q ss_pred cCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
... ......++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+++..+..+..
T Consensus 168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (343)
T cd07851 168 TDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245 (343)
T ss_pred ccc--cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccc
Confidence 532 234557889999999987655688999999999999999999999999888888888888888877665443321
Q ss_pred CCcc---cCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCC
Q 011138 370 NYTE---FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430 (492)
Q Consensus 370 ~~~~---~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~ 430 (492)
.... ...+......+... ...+++++.+||.+||..||.+|||+.++++||||++...+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~-~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~ 308 (343)
T cd07851 246 ESARNYIQSLPQMPKKDFKEV-FSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPE 308 (343)
T ss_pred hhHHHHHHhccccCCCCHHHH-hccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCc
Confidence 1100 00111111111111 134689999999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-45 Score=334.83 Aligned_cols=254 Identities=28% Similarity=0.406 Sum_probs=207.1
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc--hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEee
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E 215 (492)
.|.++.+||+|+||.||+|.++.+|+.+|||++..+ -+..-+|+.||++++.|++|++|+.|+...+ ++||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-----LWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-----LWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-----eEeehh
Confidence 377888999999999999999999999999998654 4455689999999999999999999976655 999999
Q ss_pred echhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCC-C
Q 011138 216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG-E 294 (492)
Q Consensus 216 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~-~ 294 (492)
||+.+....+.+ ..++.+.+.++..+++.-+.||+|||. ..-||||||..|||++.+| ..||+|||.|..+... .
T Consensus 109 YCGAGSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~-~~KIHRDIKAGNILLNT~G-~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 109 YCGAGSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHD-LKKIHRDIKAGNILLNTDG-IAKLADFGVAGQLTDTMA 184 (502)
T ss_pred hcCCCcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHH-HHHHHhhcccccEEEcccc-hhhhhhccccchhhhhHH
Confidence 999554433332 235789999999999999999999998 5778999999999999999 6999999999766332 3
Q ss_pred CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 011138 295 PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEF 374 (492)
Q Consensus 295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~ 374 (492)
...+.+|||.|||||++..- .|+.++||||||++..||..|++||........+..| -..|++. +
T Consensus 185 KRNTVIGTPFWMAPEVI~EI-GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI---PT~PPPT-----------F 249 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEI-GYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI---PTKPPPT-----------F 249 (502)
T ss_pred hhCccccCcccccHHHHHHh-ccchhhhHhhhcchhhhhhcCCCCcccccccceeEec---cCCCCCC-----------C
Confidence 45678999999999999654 4999999999999999999999999876543322211 1111110 1
Q ss_pred CCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 375 KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
+- ++.-+.++.|||++||.++|++|.|+.++|+|||+++..
T Consensus 250 ~K------------PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 250 KK------------PEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred CC------------hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 11 123478899999999999999999999999999998643
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=332.83 Aligned_cols=274 Identities=38% Similarity=0.679 Sum_probs=225.3
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
|.+.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.+++.++|+||+++++++. +..+.++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH-----TERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhh-----cCCceEE
Confidence 567788999999999999999999999999886531 23457999999999999999999883 4456899
Q ss_pred EeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 213 V~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
||||+++++...+... ...+++..+..++.|++.||.|||+ +||+||||+|+||+++.++ .+||+|||++.....
T Consensus 76 v~e~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~~l~~~ni~~~~~~-~~~l~d~g~~~~~~~ 150 (282)
T cd07829 76 VFEYCDMDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHS-HRILHRDLKPQNILINRDG-VLKLADFGLARAFGI 150 (282)
T ss_pred EecCcCcCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChheEEEcCCC-CEEEecCCcccccCC
Confidence 9999998776665432 1468899999999999999999997 9999999999999999877 799999999876543
Q ss_pred CC-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC-
Q 011138 293 GE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN- 370 (492)
Q Consensus 293 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~- 370 (492)
.. ......++..|+|||.+.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+....+..+...
T Consensus 151 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 151 PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred CccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence 32 2334556788999999876656899999999999999999999999999999999999999999988877654332
Q ss_pred CcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
+....++..........+ +.++.++.++|.+||..||++||++.++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 231 DYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 123344444333333333 3458899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=343.32 Aligned_cols=285 Identities=34% Similarity=0.640 Sum_probs=222.4
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccC-CCce
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDEL 208 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~-~~~~ 208 (492)
..+|.+.+.||+|+||.||+|.+..+|..||||++... .....+|+.+++.++||||++++++|..... ....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 34699999999999999999999999999999988432 1234579999999999999999998854332 1223
Q ss_pred EEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 209 ~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
.+++||||+++++..... ...+++..++.++.||+.||.|||+ .||+||||||+||+++.++ .+||+|||++.
T Consensus 94 ~~~lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~-~gi~H~dlkp~Nill~~~~-~~kl~dfg~~~ 166 (343)
T cd07880 94 DFYLVMPFMGTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHA-AGIIHRDLKPGNLAVNEDC-ELKILDFGLAR 166 (343)
T ss_pred eEEEEEecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEeeccccc
Confidence 568999999776655433 2468899999999999999999997 9999999999999999877 79999999997
Q ss_pred ccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
.... ......+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+....+..+++..+.++........
T Consensus 167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 167 QTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred cccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence 6532 23345778999999998765558899999999999999999999999988888888888877766654333221
Q ss_pred CCCcc---cCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCC
Q 011138 369 PNYTE---FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430 (492)
Q Consensus 369 ~~~~~---~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~ 430 (492)
..... ..++......+ ..+.+.+++++.++|.+||+.||.+|||+.+++.||||+...+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~ 308 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPE 308 (343)
T ss_pred chhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcc
Confidence 11000 01111111111 112356788999999999999999999999999999999887643
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=334.74 Aligned_cols=248 Identities=30% Similarity=0.516 Sum_probs=205.3
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
+|.+.+.||+|+||.||++.+..+++.||+|.+.... ....+|+++++.++||||+++++++ .+..++
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 76 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF-----QDDSNL 76 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCeE
Confidence 5999999999999999999999999999999885422 2345799999999999999999988 444568
Q ss_pred EEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 211 ~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
|+||||+.+ .+...+.. ...+++..+..++.||+.||.|||+ +||+||||+|.|||++.++ .+||+|||++..
T Consensus 77 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~-~~i~H~dl~p~nili~~~~-~~kl~dfg~~~~ 150 (290)
T cd05580 77 YLVMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHS-LDIVYRDLKPENLLLDSDG-YIKITDFGFAKR 150 (290)
T ss_pred EEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECCCC-CEEEeeCCCccc
Confidence 999999964 45444332 3568899999999999999999997 9999999999999999887 799999999987
Q ss_pred cCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
.... .....+++.|+|||.+.+. .++.++|+|||||++|+|++|..||...+..+....+..
T Consensus 151 ~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------- 212 (290)
T cd05580 151 VKGR--TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE--------------- 212 (290)
T ss_pred cCCC--CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---------------
Confidence 6443 3455789999999998654 478999999999999999999999988775444444332
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcC-----CHHHhhCCCCCCCCCC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLRD 428 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----t~~e~l~Hp~f~~~~~ 428 (492)
.... ++..+++.++++|.+||+.||.+|+ ++.++++||||+.+..
T Consensus 213 --~~~~------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 262 (290)
T cd05580 213 --GKVR------------FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDW 262 (290)
T ss_pred --CCcc------------CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCH
Confidence 0111 2234688999999999999999999 9999999999998763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=335.27 Aligned_cols=282 Identities=33% Similarity=0.538 Sum_probs=220.8
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccC-----
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE----- 204 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~----- 204 (492)
..+|.+.+.||+|+||.||+|.+..+|+.||||.+.... ....+|+.+++.++||||+++++++....+
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 346999999999999999999999999999999885321 234579999999999999999998754331
Q ss_pred CCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeee
Q 011138 205 KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (492)
Q Consensus 205 ~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DF 284 (492)
.+..++++|+||+++++...+.. ....+++..+..++.||+.||.|||+ .||+||||||+||+++.++ .+||+||
T Consensus 86 ~~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~~~-~~kl~df 160 (302)
T cd07864 86 KDKGAFYLVFEYMDHDLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHK-KNFLHRDIKCSNILLNNKG-QIKLADF 160 (302)
T ss_pred ccCCcEEEEEcccCccHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-cEEeCcc
Confidence 12337899999999877665432 23468899999999999999999997 8999999999999999887 7999999
Q ss_pred cCccccCCCC--CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 011138 285 GSAKMLVPGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (492)
Q Consensus 285 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~ 362 (492)
|++....... ......++..|+|||.+.+...++.++|||||||++|+|++|++||...+..+.+..+.+..+.+...
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA 240 (302)
T ss_pred cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 9997654333 22234568889999998765567899999999999999999999999988888888888888887766
Q ss_pred HHhhcC--CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 363 EIKCMN--PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 363 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
.++... +.+.......... .+.......++..+.+||.+||..||.+||++.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 241 VWPDVIKLPYFNTMKPKKQYR-RRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hcccccccccccccccccccc-cchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 554321 1111100000000 01111223578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=332.10 Aligned_cols=256 Identities=25% Similarity=0.393 Sum_probs=201.2
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc---hhhHHHHHHHHHHc-CCCCccccceeeeeccCC-CceEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK-DELYLN 211 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~---~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~-~~~~~~ 211 (492)
..|.+.+.||+|+||.||+|.+..+++.||+|.+... .....+|+.+++.+ +|+||++++++|...... ....+|
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 85 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence 4588899999999999999999999999999988543 33456799999998 699999999988654321 234688
Q ss_pred EEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 212 lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
+||||++++ +...+.. .....+++..+..++.||+.||.|||+ +||+||||||+||+++.++ .+||+|||++...
T Consensus 86 iv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivh~dl~~~nili~~~~-~~~l~Dfg~~~~~ 161 (272)
T cd06637 86 LVMEFCGAGSVTDLIKN--TKGNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQL 161 (272)
T ss_pred EEEEcCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHEEECCCC-CEEEccCCCceec
Confidence 999999864 4443332 123468889999999999999999997 9999999999999999887 7999999998765
Q ss_pred CCC-CCCccceeccCccCchhhcC----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 011138 291 VPG-EPNISYICSRYYRAPELIFG----ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (492)
Q Consensus 291 ~~~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~ 365 (492)
... .......|++.|+|||++.+ ...++.++|||||||++|+|++|..||...........+.. .
T Consensus 162 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~---~------- 231 (272)
T cd06637 162 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---N------- 231 (272)
T ss_pred ccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc---C-------
Confidence 322 22335678999999999853 23478899999999999999999999976554333322211 0
Q ss_pred hcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
..+ ......++.++.+||.+||..||.+|||+.+++.||||
T Consensus 232 ---------~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 232 ---------PAP--------RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred ---------CCC--------CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 000 01113467899999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=346.99 Aligned_cols=253 Identities=26% Similarity=0.423 Sum_probs=220.4
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
+..+...||-|+||.|-++........+|+|++++. ......|..||..++.|.||++|..| .|..|+
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~kyv 495 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSKYV 495 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccchhh
Confidence 456667899999999999987665556899977542 23344699999999999999999999 889999
Q ss_pred EEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 211 ~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
|++||-|-| .++..+. ..+.|....+++|+..++.|++|||+ +|||+|||||+|++++.+| .+||.|||+|+.
T Consensus 496 YmLmEaClGGElWTiLr----dRg~Fdd~tarF~~acv~EAfeYLH~-k~iIYRDLKPENllLd~~G-y~KLVDFGFAKk 569 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILR----DRGSFDDYTARFYVACVLEAFEYLHR-KGIIYRDLKPENLLLDNRG-YLKLVDFGFAKK 569 (732)
T ss_pred hhhHHhhcCchhhhhhh----hcCCcccchhhhhHHHHHHHHHHHHh-cCceeccCChhheeeccCC-ceEEeehhhHHH
Confidence 999999865 5665543 35678889999999999999999997 9999999999999999888 799999999999
Q ss_pred cCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
+..+....++||||.|.|||+++..+ .+.++|.||||+++||||+|.+||.+.++...+..|++.+..
T Consensus 570 i~~g~KTwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~----------- 637 (732)
T KOG0614|consen 570 IGSGRKTWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK----------- 637 (732)
T ss_pred hccCCceeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh-----------
Confidence 99999999999999999999998765 799999999999999999999999999999999999886422
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCC-----HHHhhCCCCCCCCCCC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-----ALEACAHPFFDDLRDP 429 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-----~~e~l~Hp~f~~~~~~ 429 (492)
+. ++..++..+.+||+++...+|.+|.. +.+|..|.||......
T Consensus 638 ----i~------------~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwe 686 (732)
T KOG0614|consen 638 ----IE------------FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWE 686 (732)
T ss_pred ----hh------------cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChh
Confidence 22 33568999999999999999999996 8899999999987653
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=350.14 Aligned_cols=249 Identities=29% Similarity=0.473 Sum_probs=210.6
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
|.-.+.||.|+||.||.|++..+.+.||||++.-.. ..+.+|+..|+.++|||++.+.+||.. ....+
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr-----e~TaW 102 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR-----EHTAW 102 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec-----cchHH
Confidence 666788999999999999999999999999985332 234479999999999999999999954 33478
Q ss_pred EEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
||||||-|+-.+++.-. .+++-+.++..|+.+.+.||.|||+ ++.||||||..|||++..+ .|||+|||.|...
T Consensus 103 LVMEYClGSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS-~~~IHRDiKAGNILLse~g-~VKLaDFGSAsi~- 176 (948)
T KOG0577|consen 103 LVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHS-HNRIHRDIKAGNILLSEPG-LVKLADFGSASIM- 176 (948)
T ss_pred HHHHHHhccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHH-hhHHhhhccccceEecCCC-eeeeccccchhhc-
Confidence 99999998766655432 3567888899999999999999997 9999999999999999888 8999999999875
Q ss_pred CCCCCccceeccCccCchhhc--CCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 292 PGEPNISYICSRYYRAPELIF--GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
.+..+++|||+|||||+|+ ..+.|+-++||||||++..||.-.+||+...+....+..|...
T Consensus 177 --~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN-------------- 240 (948)
T KOG0577|consen 177 --APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-------------- 240 (948)
T ss_pred --CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc--------------
Confidence 4556899999999999994 3466999999999999999999999999998888888877652
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
.-|.+....| +..++.||..||++-|.+|||.+++|.|+|...-+
T Consensus 241 -----esPtLqs~eW--------S~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~R 285 (948)
T KOG0577|consen 241 -----ESPTLQSNEW--------SDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRER 285 (948)
T ss_pred -----CCCCCCCchh--------HHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence 1122223333 67899999999999999999999999999987544
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=338.91 Aligned_cols=281 Identities=37% Similarity=0.713 Sum_probs=222.8
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
.++|.+.+.||.|+||.||+|.+..+|+.||||++.+. .....+|+.+++.++||||++++++|... ...
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----~~~ 84 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP----LED 84 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC----CCc
Confidence 45699999999999999999999999999999987432 23455799999999999999999987432 235
Q ss_pred EEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
.|+||||+++++...+. ...++...+..++.||+.||.|||+ +||+||||||.|||++.++ .+||+|||++..
T Consensus 85 ~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~-~~iiH~dl~p~Nili~~~~-~~~l~dfg~~~~ 157 (328)
T cd07856 85 IYFVTELLGTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHS-AGVVHRDLKPSNILINENC-DLKICDFGLARI 157 (328)
T ss_pred EEEEeehhccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEeECCCC-CEEeCccccccc
Confidence 78999999877665443 2457888889999999999999997 8999999999999999877 799999999875
Q ss_pred cCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
.. .......++..|+|||.+.+...++.++|||||||++|+|++|++||.+.........+.+.+|.++.+.+.....
T Consensus 158 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (328)
T cd07856 158 QD--PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS 235 (328)
T ss_pred cC--CCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence 42 2233457788999999986655689999999999999999999999999888888888888888887665542211
Q ss_pred CCcccC----CCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCCC
Q 011138 370 NYTEFK----FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431 (492)
Q Consensus 370 ~~~~~~----~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~~ 431 (492)
. .... ++.....++.. ..+.+++++.++|++||+.||++|||+.+++.||||...+++..
T Consensus 236 ~-~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~ 299 (328)
T cd07856 236 E-NTLRFVQSLPKREPVPFSE-KFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTD 299 (328)
T ss_pred h-hhHHHHhhccccCCCcHHH-HcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCcc
Confidence 1 0000 01101111111 12357889999999999999999999999999999998876533
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=335.05 Aligned_cols=251 Identities=25% Similarity=0.449 Sum_probs=198.8
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
+|++.+.||+|+||.||+|.+..+++.||+|.+..+ .....+|+.+++.++||||+++++++.. ..+.++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~l 76 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-----ENRISI 76 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-----CCEEEE
Confidence 478889999999999999999999999999988543 1234579999999999999999999843 345789
Q ss_pred EeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 213 V~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
||||++++.+... ..+++..+..++.||+.||.|||+ .||+|+||||+|||++.++ .+||+|||++.....
T Consensus 77 v~e~~~~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nill~~~~-~~~l~dfg~~~~~~~ 147 (279)
T cd06619 77 CTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWS-LKILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVN 147 (279)
T ss_pred EEecCCCCChHHh-------hcCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCCHHHEEECCCC-CEEEeeCCcceeccc
Confidence 9999998765432 346788889999999999999997 9999999999999999888 799999999976533
Q ss_pred CCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCHHHHhhcCC
Q 011138 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQ---LVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~---~~~i~~~~g~p~~~~~~~~~~ 369 (492)
. ......||..|+|||++.+. .++.++|+|||||++|+|++|..||......+. ..........+.
T Consensus 148 ~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------- 216 (279)
T cd06619 148 S-IAKTYVGTNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED--------- 216 (279)
T ss_pred c-cccCCCCChhhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC---------
Confidence 2 23346889999999999655 489999999999999999999999965332111 011111110000
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
.+. ......++++++||.+||+.||.+||++.++++||||....
T Consensus 217 ------~~~--------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 217 ------PPV--------LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred ------CCC--------CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 000 01124678999999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=332.80 Aligned_cols=262 Identities=23% Similarity=0.330 Sum_probs=206.1
Q ss_pred ccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc---hhhHHHHHHHHHHc-CCCCccccceeeeeccCCCceE
Q 011138 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~---~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
....+|.+.+.||+|+||.||+|.+..+++.+|+|++... .....+|+.+++.+ +||||+++++++......+..+
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 94 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQ 94 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence 4456799999999999999999999999999999987542 23456799999999 6999999999886555455567
Q ss_pred EEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 210 LNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 210 ~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
+++||||++++ +.+.+.........+++..+..++.||+.||.|||+ ++|+||||||+||+++.++ .+||+|||++.
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~~~-~~kl~dfg~~~ 172 (286)
T cd06638 95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV-NKTIHRDVKGNNILLTTEG-GVKLVDFGVSA 172 (286)
T ss_pred EEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh-CCccccCCCHHhEEECCCC-CEEEccCCcee
Confidence 89999999865 444443333334568889999999999999999997 9999999999999999887 79999999987
Q ss_pred ccCCCC-CCccceeccCccCchhhcC----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 011138 289 MLVPGE-PNISYICSRYYRAPELIFG----ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (492)
Q Consensus 289 ~~~~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~ 363 (492)
...... ......|++.|+|||++.. ...++.++|||||||++|+|++|..||........+..+...
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~-------- 244 (286)
T cd06638 173 QLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN-------- 244 (286)
T ss_pred ecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc--------
Confidence 654322 2234578999999999843 234788999999999999999999999876544333222110
Q ss_pred HhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
..+. ...+...+.++.+||.+||+.||++|||+.++++|+||
T Consensus 245 -----------~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 245 -----------PPPT-------LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred -----------CCCc-------ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 0000 00112357789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=345.09 Aligned_cols=250 Identities=26% Similarity=0.390 Sum_probs=191.0
Q ss_pred ccceeEeeeeccCCceEEEEEEEc-----CCCCEEEEEEeccc-----hhhHHHHHHHHHHc-CCCCccccceeeeeccC
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQD-----KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTE 204 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~-----~~g~~vAiK~~~~~-----~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~ 204 (492)
..+|++.+.||+|+||.||+|.+. .++..||||++... .....+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--- 82 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK--- 82 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC---
Confidence 457999999999999999999752 34678999988542 12345799999999 89999999998742
Q ss_pred CCceEEEEEeeechhh-HHHHhhhhhh-----------------------------------------------------
Q 011138 205 KDELYLNLVLEYISET-VYRVSKHYTR----------------------------------------------------- 230 (492)
Q Consensus 205 ~~~~~~~lV~E~~~~~-l~~~~~~~~~----------------------------------------------------- 230 (492)
....+++||||++++ |.+.+.....
T Consensus 83 -~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 83 -PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred -CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 223578999999864 4444332110
Q ss_pred -----cCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCCC---Cccceec
Q 011138 231 -----MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP---NISYICS 302 (492)
Q Consensus 231 -----~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt 302 (492)
....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++....... .....++
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDiKp~Nil~~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLAS-RKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCccceEEEcCCC-cEEEeecccccccccCcchhcccCCCCC
Confidence 02347778889999999999999997 9999999999999999887 799999999976533221 1233456
Q ss_pred cCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccC
Q 011138 303 RYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKA 381 (492)
Q Consensus 303 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~ 381 (492)
+.|+|||++.+. .++.++|||||||++|||++ |..||.+....+.+...+.. +. ...
T Consensus 240 ~~y~aPE~~~~~-~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~--------------~~~------ 297 (338)
T cd05102 240 LKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD-GT--------------RMR------ 297 (338)
T ss_pred ccccCcHHhhcC-CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc-CC--------------CCC------
Confidence 789999999654 48999999999999999997 99999886544443333221 00 000
Q ss_pred CCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 382 HPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 382 ~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.+..+++++.+||.+||..||.+|||+.++++
T Consensus 298 ------~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 298 ------APENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred ------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 12356889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=314.23 Aligned_cols=282 Identities=31% Similarity=0.625 Sum_probs=232.1
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-hhhHHHHHHHHHHcC-CCCccccceeeeeccCCCceEEEEEe
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
.+|++.+.+|+|-|+.||.|.+..+++.+.||+++.- +....||+.||+.|. ||||++|++...+.. .....||+
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~---SktpaLiF 114 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPE---SKTPSLIF 114 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCcc---ccCchhHh
Confidence 4699999999999999999999999999999998653 345679999999997 999999999874433 22356899
Q ss_pred eechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCC
Q 011138 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (492)
Q Consensus 215 E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~ 294 (492)
||+...-+. ..-..++...++.+++|++.||.|+|+ .||+|||+||.|++||.....++|+|+|+|....++.
T Consensus 115 E~v~n~Dfk------~ly~tl~d~dIryY~~elLkALdyCHS-~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 115 EYVNNTDFK------QLYPTLTDYDIRYYIYELLKALDYCHS-MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred hhhccccHH------HHhhhhchhhHHHHHHHHHHHHhHHHh-cCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 999875332 223457778899999999999999997 8999999999999999877789999999999998888
Q ss_pred CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCHHHHh-----hcC
Q 011138 295 PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLF-PGESGVDQLVEIIKILGTPTREEIK-----CMN 368 (492)
Q Consensus 295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf-~~~~~~~~~~~i~~~~g~p~~~~~~-----~~~ 368 (492)
.....+.+.+|--||++..-..|+..-|+|||||+|..|+..+.|| .|.++.+|+.+|.+++|+......- ..+
T Consensus 188 eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ld 267 (338)
T KOG0668|consen 188 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLD 267 (338)
T ss_pred eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCC
Confidence 8888899999999999988888999999999999999999988775 7889999999999999975433221 123
Q ss_pred CCCcccCCCcccCCCcccccCC----CCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCC
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHK----RMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~----~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~ 429 (492)
|.|..+ .......+|....+. -+++++.|||.++|.+|-++|+||.|++.||||..++..
T Consensus 268 p~~~~i-~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~ 331 (338)
T KOG0668|consen 268 PQFEDI-LGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREA 331 (338)
T ss_pred hhHhhH-hhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHH
Confidence 333321 112233455544432 357999999999999999999999999999999987653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=351.64 Aligned_cols=245 Identities=31% Similarity=0.460 Sum_probs=203.7
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchhhHHHHHHHHHHc-CCCCccccceeeeeccCCCceEEEEE
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
....|.+...+|.|+|+.|..+.+..+++.+++|++.+......+|+.++... +||||+++++.+ .+..+.|+|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~~~~~v 394 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVY-----EDGKEIYLV 394 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeeccee-----cCCceeeee
Confidence 45679999999999999999999999999999999988777777888776655 699999999999 777889999
Q ss_pred eeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEE-cCCCCcEEEeeecCccccCC
Q 011138 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV-NPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 214 ~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl-~~~~~~vkL~DFG~a~~~~~ 292 (492)
||++.|+.+.. + ......+. ..+..|++||+.|+.|||. +|||||||||+|||+ +..+ .++|+|||.++....
T Consensus 395 ~e~l~g~ell~--r-i~~~~~~~-~e~~~w~~~lv~Av~~LH~-~gvvhRDLkp~NIL~~~~~g-~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 395 MELLDGGELLR--R-IRSKPEFC-SEASQWAAELVSAVDYLHE-QGVVHRDLKPGNILLDGSAG-HLRLTYFGFWSELER 468 (612)
T ss_pred ehhccccHHHH--H-HHhcchhH-HHHHHHHHHHHHHHHHHHh-cCeeecCCChhheeecCCCC-cEEEEEechhhhCch
Confidence 99999764421 1 11222233 6788899999999999997 999999999999999 4666 799999999987654
Q ss_pred CCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 011138 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372 (492)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~ 372 (492)
. ..+.+-|..|.|||++. ...|+.++||||||++||+||+|+.||...... .+|...++.+..
T Consensus 469 ~--~~tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~----------- 531 (612)
T KOG0603|consen 469 S--CDTPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKF----------- 531 (612)
T ss_pred h--hcccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCcc-----------
Confidence 4 44557789999999996 455999999999999999999999999876655 334443333321
Q ss_pred ccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
...+|++++|||++||++||.+|+++.+++.||||
T Consensus 532 ----------------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 532 ----------------SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ----------------ccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 13589999999999999999999999999999999
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=345.67 Aligned_cols=241 Identities=26% Similarity=0.363 Sum_probs=198.0
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc---hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEe
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
.+.+++.||+|.||.||.|.+..+ ..||+|.+... ...+.+|++||+.|+|+|||++++++... .-+||||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~-----~piyIVt 280 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ-----EPIYIVT 280 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecC-----CceEEEE
Confidence 466778999999999999998532 47999988543 34455899999999999999999998432 2489999
Q ss_pred eech-hhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCC
Q 011138 215 EYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (492)
Q Consensus 215 E~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (492)
||+. |.|++.++. .....+.......++.|||.|++||++ +++|||||...||||+.+. .+||+|||+|+...++
T Consensus 281 E~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes-~~~IHRDLAARNiLV~~~~-~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLES-KNYIHRDLAARNILVDEDL-VVKISDFGLARLIGDD 356 (468)
T ss_pred EecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHh-CCccchhhhhhheeeccCc-eEEEcccccccccCCC
Confidence 9998 556666554 345678888899999999999999997 9999999999999999887 8999999999954333
Q ss_pred CCCcccee---ccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 294 EPNISYIC---SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 294 ~~~~~~~g---t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
. .....| ...|.|||.+... .++.++|||||||+||||+| |+.||.+.++.+.+..+.+....|.
T Consensus 357 ~-Y~~~~~~kfPIkWtAPEa~~~~-~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~--------- 425 (468)
T KOG0197|consen 357 E-YTASEGGKFPIKWTAPEALNYG-KFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR--------- 425 (468)
T ss_pred c-eeecCCCCCCceecCHHHHhhC-CcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC---------
Confidence 2 222222 4669999999654 59999999999999999997 9999999999988888866433332
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhh
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC 418 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l 418 (492)
+..+|+++.++++.||..+|++|||.+.+.
T Consensus 426 -------------------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 426 -------------------PEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred -------------------CCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 246899999999999999999999998654
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=359.49 Aligned_cols=282 Identities=20% Similarity=0.272 Sum_probs=198.6
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCC-EEEEE------------------Eecc---chhhHHHHHHHHHHcCCCCcc
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGD-SVAIK------------------KVLQ---DKRYKNRELQIMRLLNHPNVV 193 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~-~vAiK------------------~~~~---~~~~~~~E~~il~~l~h~nIv 193 (492)
..+|.+.+.||+|+||+||+|..+.... .+++| .+.. ....+.+|+.+|+.++|||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 3579999999999999999987643322 12222 1111 122346899999999999999
Q ss_pred ccceeeeeccCCCceEEEEEeeechhhHHHHhhhhh-hcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEE
Q 011138 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYT-RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV 272 (492)
Q Consensus 194 ~l~~~~~~~~~~~~~~~~lV~E~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl 272 (492)
++++++. +..+.|+|++++.++++..+.... ..........++.|+.||+.||.|||+ +|||||||||+|||+
T Consensus 227 ~l~~~~~-----~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~-~gIiHrDLKP~NILl 300 (501)
T PHA03210 227 KIEEILR-----SEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD-KKLIHRDIKLENIFL 300 (501)
T ss_pred cEeEEEE-----ECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEE
Confidence 9999983 344588999999887776543221 112234456778899999999999997 999999999999999
Q ss_pred cCCCCcEEEeeecCccccCCCCC--CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCC-CCC--CChHH
Q 011138 273 NPHTHQLKICDFGSAKMLVPGEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPL-FPG--ESGVD 347 (492)
Q Consensus 273 ~~~~~~vkL~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~p-f~~--~~~~~ 347 (492)
+.++ .+||+|||+++.+..... ....+||+.|+|||++.+. .++.++|||||||++|||++|..+ |.. .....
T Consensus 301 ~~~~-~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 301 NCDG-KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred CCCC-CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 9887 799999999987643322 2346899999999999765 489999999999999999998754 432 23456
Q ss_pred HHHHHHHHhCCCCHHHHhhcC----CCCcccCCCcccCCCccc-ccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCC
Q 011138 348 QLVEIIKILGTPTREEIKCMN----PNYTEFKFPQIKAHPWHK-IFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422 (492)
Q Consensus 348 ~~~~i~~~~g~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~ 422 (492)
++.+++..++.+..+ +.... .......+.... ..... .....++.++.++|.+||++||.+|||+.|+|+|||
T Consensus 379 ~~~~~~~~~~~~~~~-~p~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~ 456 (501)
T PHA03210 379 QLLKIIDSLSVCDEE-FPDPPCKLFDYIDSAEIDHAG-HSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL 456 (501)
T ss_pred HHHHHHHhcccChhh-cCCcHHHHHHHhhhhhcccCc-cchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence 666666655543322 11000 000000000000 00000 011246788999999999999999999999999999
Q ss_pred CCCCC
Q 011138 423 FDDLR 427 (492)
Q Consensus 423 f~~~~ 427 (492)
|....
T Consensus 457 f~~~~ 461 (501)
T PHA03210 457 FSAEE 461 (501)
T ss_pred hhcCC
Confidence 98753
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=325.06 Aligned_cols=281 Identities=33% Similarity=0.571 Sum_probs=228.7
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccC-CCceEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELYL 210 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~-~~~~~~ 210 (492)
+|.-.+.+|.|.- .|..|.|.-+++.||+|++... .+...+|..++..++|+||++++.+|..... .....+
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 6888899999998 8888999999999999987432 3345689999999999999999999844332 222347
Q ss_pred EEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 211 ~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
|+|||++..++...+. -.++-..+..+++|++.|++|||+ .||+||||||+||++..++ .+||.|||+|+..
T Consensus 97 y~v~e~m~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs-~~IihRdLkPsnivv~~~~-~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 97 YLVMELMDANLCQVIL------MELDHETISYILYQMLCGIKHLHS-AGIIHRDLKPSNIVVNSDC-TLKILDFGLARTE 168 (369)
T ss_pred HHHHHhhhhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHh-cceeecccCcccceecchh-heeeccchhhccc
Confidence 8999999998877654 234556788999999999999997 8999999999999999988 8999999999876
Q ss_pred CCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC--
Q 011138 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN-- 368 (492)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~-- 368 (492)
...-..+.++.|++|+|||++.+.. |...+||||+||++.||++|...|.|.+..++..++...+|.|.+..+..+.
T Consensus 169 ~~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~ 247 (369)
T KOG0665|consen 169 DTDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPT 247 (369)
T ss_pred CcccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHH
Confidence 5554567789999999999999877 9999999999999999999999999999999999999999999988776543
Q ss_pred --------CCCcccCCCcc-cCCCccccc--CCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 369 --------PNYTEFKFPQI-KAHPWHKIF--HKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 369 --------~~~~~~~~~~~-~~~~~~~~~--~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
+.|..+.|... +..-|.... .+.-+..++||+.+||..||++|++++++|+||||+-+-+
T Consensus 248 ~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~ 318 (369)
T KOG0665|consen 248 VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYD 318 (369)
T ss_pred HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecc
Confidence 33333333321 111222111 1223457899999999999999999999999999995543
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=314.18 Aligned_cols=256 Identities=28% Similarity=0.388 Sum_probs=204.4
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEecc----chhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ----DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~----~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
+|++.+.||+|||+.||+++...++..||+|++.- +.....+|++..++++|||+++++++............||+
T Consensus 22 Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll 101 (302)
T KOG2345|consen 22 RYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLL 101 (302)
T ss_pred eEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEE
Confidence 69999999999999999999999999999999843 33445689999999999999999999877665677789999
Q ss_pred eeech-hhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCC--cccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 214 LEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG--VCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 214 ~E~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~g--ivHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
++|.. |++++.+......+..+++..+..|+.+|++||++||+ .. ++||||||.|||+...+ .++|.|||.++..
T Consensus 102 ~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~-~~~~yAH~DiKP~NILls~~~-~~vl~D~GS~~~a 179 (302)
T KOG2345|consen 102 LPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE-KEPPYAHRDIKPANILLSDSG-LPVLMDLGSATQA 179 (302)
T ss_pred eehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc-cCCcccccCCCcceeEecCCC-ceEEEeccCcccc
Confidence 99998 55888888777777789999999999999999999997 77 99999999999999867 8999999998754
Q ss_pred CCCCC----------CccceeccCccCchhhcCC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 011138 291 VPGEP----------NISYICSRYYRAPELIFGA--TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358 (492)
Q Consensus 291 ~~~~~----------~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~ 358 (492)
.-.-. .....+|..|+|||++.-. ...+.++|||||||+||+|+.|..||...- ..-|.
T Consensus 180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~---------~~GgS 250 (302)
T KOG2345|consen 180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY---------QQGGS 250 (302)
T ss_pred ceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh---------hcCCe
Confidence 21111 1134679999999998322 236889999999999999999999994311 10000
Q ss_pred CCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 359 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
..- .-.+ ..+.+|.- ..+|+.+.+||+.||+.||.+||++.+++.+
T Consensus 251 laL---Av~n---~q~s~P~~----------~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 251 LAL---AVQN---AQISIPNS----------SRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred EEE---eeec---cccccCCC----------CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 000 0000 12333331 3479999999999999999999999999864
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=334.08 Aligned_cols=252 Identities=26% Similarity=0.422 Sum_probs=202.8
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
.+|.+.+.||+|+||.||+|.+..+++.||+|.+... .....+|+.+++.++|+||++++++|.. ..+.|+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-----~~~~~l 94 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWV 94 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-----CCEEEE
Confidence 3699999999999999999999999999999988543 2345579999999999999999998843 346899
Q ss_pred Eeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 213 VLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 213 V~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
||||+.++ +...+. ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++....
T Consensus 95 v~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~ql~~aL~~LH~-~gi~H~dLkp~Nill~~~~-~~kl~dfg~~~~~~ 167 (296)
T cd06654 95 VMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQIT 167 (296)
T ss_pred eecccCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCC-CEEECccccchhcc
Confidence 99999865 433322 2457888899999999999999997 9999999999999999887 89999999987653
Q ss_pred CCCC-CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 011138 292 PGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (492)
Q Consensus 292 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 370 (492)
.... .....|++.|+|||.+.+. .++.++|||||||++|+|++|+.||...+....+..+... +.+.
T Consensus 168 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~---------- 235 (296)
T cd06654 168 PEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPE---------- 235 (296)
T ss_pred ccccccCcccCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCCC----------
Confidence 3322 2345788999999998654 4789999999999999999999999877654443332210 0000
Q ss_pred CcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
...+..++..+.+||.+||..||++||++.++++||||...+
T Consensus 236 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 277 (296)
T cd06654 236 ---------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (296)
T ss_pred ---------------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence 001235788999999999999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=328.06 Aligned_cols=262 Identities=28% Similarity=0.414 Sum_probs=207.3
Q ss_pred ccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch---hhHHHHHHHHHHc-CCCCccccceeeeeccC-CCce
Q 011138 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLL-NHPNVVSLKHCFFSTTE-KDEL 208 (492)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~---~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~-~~~~ 208 (492)
...++|.+.+.||+|+||.||+|.+..+++.+++|++.... ....+|+.+++.+ +|+||+++++++..... .+..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 44568999999999999999999999999999999885432 3456899999998 69999999999866543 3456
Q ss_pred EEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 209 ~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
++++||||++++ +.+++.........+++..++.++.||+.||.|||+ .||+|+||+|+||+++.++ .+||+|||++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~~l~p~ni~~~~~~-~~~l~d~~~~ 160 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE-NKVIHRDIKGQNILLTKNA-EVKLVDFGVS 160 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEEccCC-eEEECCCccc
Confidence 688999999964 444443333335678899999999999999999997 9999999999999999887 7999999998
Q ss_pred cccCCCC-CCccceeccCccCchhhcCC----CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 011138 288 KMLVPGE-PNISYICSRYYRAPELIFGA----TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (492)
Q Consensus 288 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~ 362 (492)
....... ......|+..|+|||++... ..++.++|||||||++|+|++|.+||........+..+... +.
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~-- 235 (275)
T cd06608 161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN---PP-- 235 (275)
T ss_pred eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc---CC--
Confidence 7653322 22345789999999988532 34678999999999999999999999876555444443221 00
Q ss_pred HHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
+.+. .....++++++||.+||..||++|||+.++++|||+
T Consensus 236 --------------~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 236 --------------PTLK-------SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred --------------CCCC-------chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 0000 012357899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=335.78 Aligned_cols=277 Identities=25% Similarity=0.387 Sum_probs=201.9
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
+|.+.+.||+|+||.||++.+..+|..+|+|.+.... ....+|+++++.++||||++++++|. +..++|+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~l 76 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY-----SDGEISI 76 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCEEEE
Confidence 5899999999999999999999999999999875431 23457999999999999999999984 4446899
Q ss_pred Eeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 213 VLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 213 V~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
||||++++ +...+.. ...+++..+..++.||+.||.|||+..+|+||||||+|||++.++ .+||+|||++....
T Consensus 77 v~ey~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~ 151 (308)
T cd06615 77 CMEHMDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLI 151 (308)
T ss_pred EeeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC-cEEEccCCCccccc
Confidence 99999864 4443322 356889999999999999999999635899999999999999887 79999999987553
Q ss_pred CCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 011138 292 PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (492)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~ 371 (492)
.. ......|++.|+|||++.+. .++.++|+|||||++|+|++|..||...+... ...+...................
T Consensus 152 ~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 152 DS-MANSFVGTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-LEAMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred cc-ccccCCCCcCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCcchhh-HHHhhcCccccccccCCcccccC
Confidence 22 23456789999999998654 48899999999999999999999998765322 22222111000000000000000
Q ss_pred cccCCCc----------ccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 372 TEFKFPQ----------IKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 372 ~~~~~~~----------~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
.....+. .........-...++.++++||.+||..||++|||+.++++||||.+..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 294 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE 294 (308)
T ss_pred CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence 0000000 0000000000113678899999999999999999999999999998754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=333.58 Aligned_cols=257 Identities=26% Similarity=0.398 Sum_probs=203.7
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch----hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
..|++.+.||.|+||.||+|.+..+++.|++|.+.... ....+|+.+++.++||||+++++++. ....+|+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 86 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY-----WDGKLWI 86 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE-----eCCeEEE
Confidence 35999999999999999999999999999999985432 23456999999999999999999884 3346899
Q ss_pred EeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 213 V~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
||||++++.+.... ......+++..+..++.||+.||.|||+ +||+||||||+||+++.++ .+||+|||++.....
T Consensus 87 v~e~~~~~~l~~~~--~~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~~ 162 (292)
T cd06644 87 MIEFCPGGAVDAIM--LELDRGLTEPQIQVICRQMLEALQYLHS-MKIIHRDLKAGNVLLTLDG-DIKLADFGVSAKNVK 162 (292)
T ss_pred EEecCCCCcHHHHH--HhhcCCCCHHHHHHHHHHHHHHHHHHhc-CCeeecCCCcceEEEcCCC-CEEEccCccceeccc
Confidence 99999987554322 2223568889999999999999999997 9999999999999999777 799999999865422
Q ss_pred C-CCCccceeccCccCchhhcC----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 293 G-EPNISYICSRYYRAPELIFG----ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 293 ~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
. .......+++.|+|||++.+ ...++.++|||||||++|+|++|.+||...+....+.++... ..
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~------- 232 (292)
T cd06644 163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---EP------- 232 (292)
T ss_pred cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC---CC-------
Confidence 2 12234568899999999852 234688999999999999999999999876654444333220 00
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
+. ...+..++.++.+||.+||..||++||++.++++||||..+..
T Consensus 233 ---------~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 277 (292)
T cd06644 233 ---------PT-------LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTS 277 (292)
T ss_pred ---------cc-------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 00 0012346789999999999999999999999999999987653
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=332.89 Aligned_cols=253 Identities=28% Similarity=0.451 Sum_probs=205.5
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
.+|.+.+.||.|+||.||+|.+..+|+.||||.+... .....+|+.+++.++||||+++++++. +...+|+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~l 93 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL-----VGDELFV 93 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe-----cCceEEE
Confidence 3599999999999999999999999999999988532 234457999999999999999999883 4446899
Q ss_pred EeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 213 V~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
|+||+.++.+..... ...+++..+..++.|++.||.|||+ +|++||||||+||+++.++ .+||+|||++.....
T Consensus 94 v~e~~~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~-~~i~H~dL~p~Nili~~~~-~~kl~dfg~~~~~~~ 167 (296)
T cd06655 94 VMEYLAGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHA-NQVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITP 167 (296)
T ss_pred EEEecCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEccCccchhccc
Confidence 999998765543221 2458899999999999999999997 9999999999999999877 799999999876543
Q ss_pred CCC-CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 011138 293 GEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (492)
Q Consensus 293 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~ 371 (492)
... .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+....+..+... +.+.
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~----------- 234 (296)
T cd06655 168 EQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE----------- 234 (296)
T ss_pred ccccCCCcCCCccccCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcc-----------
Confidence 322 2345688999999998654 4789999999999999999999999887765554443221 0000
Q ss_pred cccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
. ..+..+++.+.+||.+||..||.+||++.+++.||||+...
T Consensus 235 --~------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 235 --L------------QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred --c------------CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 0 01235788999999999999999999999999999998755
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=335.02 Aligned_cols=261 Identities=23% Similarity=0.368 Sum_probs=202.5
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-----hhhHHHHHHHHHHcC-CCCccccceeeeeccCCCceEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
+|...+.||+|+||.||++.+..+|+.||||.+... .....+|+.++.++. |+||+++++++.. ....+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-----~~~~~ 79 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-----EGDCW 79 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-----CCcEE
Confidence 466778899999999999999999999999988542 223457888998886 9999999998843 33478
Q ss_pred EEeeechhhHHHHhhhh-hhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 212 LVLEYISETVYRVSKHY-TRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
++|||+...+..+.... ......+++..+..++.|++.||+|||+..||+||||||+|||++.++ .+||+|||++...
T Consensus 80 ~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~ 158 (288)
T cd06616 80 ICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG-NIKLCDFGISGQL 158 (288)
T ss_pred EEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC-cEEEeecchhHHh
Confidence 99999987655443321 222467899999999999999999999635999999999999999877 7999999999766
Q ss_pred CCCCCCccceeccCccCchhhcCC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 291 VPGEPNISYICSRYYRAPELIFGA--TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
..........|++.|+|||++.+. ..++.++|||||||++|+|++|+.||..... ....+.+.....
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~--------- 227 (288)
T cd06616 159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGD--------- 227 (288)
T ss_pred ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCC---------
Confidence 544444455789999999999665 3689999999999999999999999976542 222222211100
Q ss_pred CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
.+.+. ...+..++.++.+||.+||+.||.+|||+.+++.||||+...
T Consensus 228 -------~~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 228 -------PPILS-----NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred -------CCcCC-----CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 01100 011134789999999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=323.04 Aligned_cols=249 Identities=27% Similarity=0.451 Sum_probs=201.0
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
+|++.+.||+|+||.||++.+..+++.||+|.+..+. ....+|+++++.++|+||+++++.+. ....++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence 4899999999999999999999999999999885321 23457999999999999999988762 2334688
Q ss_pred EEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 212 lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
+||||++++ +.+.+.. .....+++..++.++.||+.||.|||+ .||+||||||+||+++.++ .++|+|||++...
T Consensus 77 lv~e~~~~~~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~l~~lH~-~~i~H~di~p~nil~~~~~-~~~l~df~~~~~~ 152 (257)
T cd08223 77 IVMGFCEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMALQYLHE-KHILHRDLKTQNVFLTRTN-IIKVGDLGIARVL 152 (257)
T ss_pred EEecccCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCchhEEEecCC-cEEEecccceEEe
Confidence 999999864 4444332 123468899999999999999999997 9999999999999999877 7999999999765
Q ss_pred CCCC-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 291 VPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 291 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
.... ......+++.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+....
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~------------- 218 (257)
T cd08223 153 ENQCDMASTLIGTPYYMSPELFSNK-PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK------------- 218 (257)
T ss_pred cccCCccccccCCcCccChhHhcCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-------------
Confidence 3322 22345689999999998654 48899999999999999999999998776554444433210
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
.+. .+..+++++.+||.+||+.||.+||++.+++.||||
T Consensus 219 ------~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 219 ------LPP---------MPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred ------CCC---------CccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 010 123478899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=328.46 Aligned_cols=278 Identities=35% Similarity=0.605 Sum_probs=216.6
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHc---CCCCccccceeeeeccCCCceE
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLL---NHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l---~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
|.+.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.+++.+ +|+||+++++++..........
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678899999999999999998899999999885321 2234687777766 5999999999986655444456
Q ss_pred EEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
++++|||+.+.+...+.... ...+++..++.++.||+.||.|||+ .||+|+||+|+||+++.++ .+||+|||++..
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~-~~i~h~~l~~~nili~~~~-~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHS-HRIVHRDLKPQNILVTSDG-QVKIADFGLARI 156 (287)
T ss_pred eEEEehhcccCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhEEEccCC-CEEEeccCccee
Confidence 89999999987766544321 2358899999999999999999997 8999999999999999887 899999999977
Q ss_pred cCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
...........++..|+|||++.+. .++.++|+|||||++|+|++|.+||.+.+..+.+..+....+.+....+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 157 YSFEMALTSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred ccCCcccccccccccccChHHhccC-CCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence 6544444455688999999999765 488999999999999999999999999998888888888776655433321110
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
.....++......+ ....+.+++.+.+||.+||+.||.+||++.++++||||
T Consensus 236 -~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 236 -LPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred -cchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00111111111111 11223567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=328.21 Aligned_cols=252 Identities=28% Similarity=0.482 Sum_probs=200.1
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch----------hhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~----------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
+|..++.||+|+||.||++.+..+++.||+|.+.... ..+.+|+.+++.++|+||+++++++ .+.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence 3788899999999999999999999999999885322 3445799999999999999999998 444
Q ss_pred eEEEEEeeechhhHH-HHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 208 LYLNLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 208 ~~~~lV~E~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
..+++||||+.++.+ +.+. ....+++..+..++.||+.||.|||+ +||+|+||||+||+++.++..+||+|||.
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~ql~~al~~LH~-~~i~H~~i~~~nil~~~~~~~~~l~dfg~ 150 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGLSYLHE-NQIIHRDVKGANLLIDSTGQRLRIADFGA 150 (268)
T ss_pred CeEEEEEeccCCCcHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEccccc
Confidence 568899999997544 3332 23568889999999999999999997 99999999999999987765799999999
Q ss_pred ccccCCCC-----CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 011138 287 AKMLVPGE-----PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTR 361 (492)
Q Consensus 287 a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~ 361 (492)
+....... ......++..|+|||.+.+. .++.++|+||+||++|+|++|..||...........+......
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--- 226 (268)
T cd06630 151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE-QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA--- 226 (268)
T ss_pred ccccccccccCCccccccccccceeCHhHhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc---
Confidence 87654321 12234678999999998654 4889999999999999999999999765443333222221000
Q ss_pred HHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCC
Q 011138 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424 (492)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~ 424 (492)
.. ...++..+++++.++|.+||..||.+||++.++++||||+
T Consensus 227 ------------~~---------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 227 ------------TT---------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred ------------CC---------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 00 0012235788999999999999999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=327.58 Aligned_cols=256 Identities=28% Similarity=0.380 Sum_probs=203.6
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
+|.+.+.||.|+||+||+|.+..++..+|+|++... .....+|+.+++.++|+||+++++.+ ......++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~i 76 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF-----VVGDELWL 76 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEE-----eeCCEEEE
Confidence 589999999999999999999999999999988543 23456899999999999999999887 33446889
Q ss_pred EeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 213 V~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
|||++.++.+............+++..+..++.||+.||.|||+ .||+||||||+||+++.++ .++|+|||++.....
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~-~~i~h~~l~p~ni~~~~~~-~~~l~df~~~~~~~~ 154 (267)
T cd06610 77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS-NGQIHRDIKAGNILLGEDG-SVKIADFGVSASLAD 154 (267)
T ss_pred EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcCCC-CEEEcccchHHHhcc
Confidence 99999865443222222223568899999999999999999997 9999999999999999887 799999999876643
Q ss_pred CCC-----CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 293 GEP-----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 293 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
... .....|+..|+|||++.....++.++|+|||||++|+|++|+.||...+....+.++... .+
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~------- 224 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DP------- 224 (267)
T ss_pred CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CC-------
Confidence 322 234568999999999876646899999999999999999999999877665544443321 00
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
. .++.. .....+++++.+||.+||..||++||++.+++.||||
T Consensus 225 ----~--~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 225 ----P--SLETG-------ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ----C--CcCCc-------cccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 0 00000 0013578999999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=329.86 Aligned_cols=250 Identities=26% Similarity=0.409 Sum_probs=203.7
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
+|.+.+.||.|+||.||+|.+..+++.||+|.+..+. ....+|+.+++.++|+||+++++++. +..++|+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~ 76 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFL-----KGSKLWI 76 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEE-----ECCeEEE
Confidence 5888999999999999999999999999999885432 23567999999999999999999884 3356899
Q ss_pred Eeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 213 VLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 213 V~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
|+||+.++ +.+.+.. ..+++..+..++.||+.||.|||+ +||+||||+|+||+++.++ .++|+|||+++...
T Consensus 77 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~ 149 (274)
T cd06609 77 IMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHE-EGKIHRDIKAANILLSEEG-DVKLADFGVSGQLT 149 (274)
T ss_pred EEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCC-CEEEcccccceeec
Confidence 99999875 4433321 278899999999999999999997 9999999999999999887 79999999998764
Q ss_pred CC-CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 011138 292 PG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (492)
Q Consensus 292 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 370 (492)
.. .......+++.|+|||.+.+.. ++.++|||||||++|+|++|..||...+.......+...
T Consensus 150 ~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~--------------- 213 (274)
T cd06609 150 STMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN--------------- 213 (274)
T ss_pred ccccccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc---------------
Confidence 43 2233567889999999996654 899999999999999999999999876644433333221
Q ss_pred CcccCCCcccCCCcccccCCC-CChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 371 YTEFKFPQIKAHPWHKIFHKR-MPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~-~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
..+. +... +++++.++|.+||..||++|||+.++++||||+....
T Consensus 214 ----~~~~---------~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 259 (274)
T cd06609 214 ----NPPS---------LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKK 259 (274)
T ss_pred ----CCCC---------CcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCc
Confidence 0000 1112 6888999999999999999999999999999987543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=331.27 Aligned_cols=253 Identities=26% Similarity=0.374 Sum_probs=203.0
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch----hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEe
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
|++.+.||+|+||.||+|.+..++..+++|.+.... ....+|+++++.++||||+++++++. ...+.++||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~~v~ 81 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWILI 81 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEe-----eCCEEEEEE
Confidence 788889999999999999999999999999885422 23457999999999999999999884 334688999
Q ss_pred eechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCC
Q 011138 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (492)
Q Consensus 215 E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~ 294 (492)
||++++.+..... .....+++..+..++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||++.......
T Consensus 82 e~~~~~~l~~~~~--~~~~~l~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 82 EFCAGGAVDAVML--ELERPLTEPQIRVVCKQTLEALNYLHE-NKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTI 157 (282)
T ss_pred EecCCCcHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEccCC-CEEEccccccccccccc
Confidence 9999765543221 223568899999999999999999997 9999999999999999887 79999999986543221
Q ss_pred -CCccceeccCccCchhhc----CCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 295 -PNISYICSRYYRAPELIF----GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 295 -~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
......+++.|+|||++. ....++.++|||||||++|+|++|.+||...+..+....+..... +
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~--~--------- 226 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP--P--------- 226 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCC--C---------
Confidence 223457899999999984 233477899999999999999999999988776655555433110 0
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
.. ..+..++.++++||.+||..||.+||++.++++||||...
T Consensus 227 ---~~------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 227 ---TL------------AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred ---CC------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 00 0123468899999999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=322.02 Aligned_cols=281 Identities=34% Similarity=0.566 Sum_probs=222.4
Q ss_pred EeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEe
Q 011138 141 AERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 141 ~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
-.+-||-|+||+||.+.|..+|+.||+|++..- ....-+|+.+|..++|.|++..++......-.--..+|+|+
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 345699999999999999999999999988432 22334799999999999999998875322211011256788
Q ss_pred eechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCC
Q 011138 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (492)
Q Consensus 215 E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~ 294 (492)
|++..++..++- ..+.++...++.+++||++||+|||+ .||.||||||.|+|++++. .+||||||+|+....++
T Consensus 137 ELmQSDLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHs-A~ILHRDIKPGNLLVNSNC-vLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 137 ELMQSDLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHT-ANILHRDIKPGNLLVNSNC-ILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHhhhhheec----cCCCCCcchhhhhHHHHHhhhHHHhh-cchhhccCCCccEEeccCc-eEEecccccccccchhh
Confidence 888877765543 35778889999999999999999997 8999999999999999998 89999999998764443
Q ss_pred C--CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 011138 295 P--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372 (492)
Q Consensus 295 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~ 372 (492)
. .+..+.|-+|+|||++.|...|+.++||||+|||+.|||..+..|...+..+++..|...+|+|..+.++.......
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 2 33467799999999999999999999999999999999999999999999999999999999999998864321111
Q ss_pred ------ccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 373 ------EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 373 ------~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
..+-|..... +...-+..-..++.+++.+||.+||.+|++.++++.|++..+.+-
T Consensus 291 ~H~LR~~~k~Ps~~vL-YtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~ 351 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRL-YKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRL 351 (449)
T ss_pred HHhhccCCCCCCccce-eeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccce
Confidence 1111111100 000011234467889999999999999999999999999988764
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=334.05 Aligned_cols=254 Identities=27% Similarity=0.415 Sum_probs=203.2
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||+|.+... .....+|+.+++.++|+||++++++| ....+.|+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~l 93 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELWV 93 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCEEEE
Confidence 4699999999999999999999999999999988532 23345799999999999999999998 44456899
Q ss_pred EeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 213 V~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
||||++++.+..... ...+++..+..++.|++.||.|||+ .||+||||||+|||++.++ .++|+|||++.....
T Consensus 94 v~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~-~~i~H~dL~p~Nili~~~~-~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 94 VMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLHS-NQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITP 167 (297)
T ss_pred eecccCCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEECcCccceEccC
Confidence 999998754432221 2457888899999999999999997 8999999999999999877 799999999876543
Q ss_pred CCC-CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 011138 293 GEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (492)
Q Consensus 293 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~ 371 (492)
... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+....+..+.. .+.+.
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~~----------- 234 (297)
T cd06656 168 EQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE----------- 234 (297)
T ss_pred CccCcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCCC-----------
Confidence 322 234578899999999865 4478999999999999999999999987654332221111 00000
Q ss_pred cccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
...+..++..+++||.+||..||.+||++.++++||||+..+.
T Consensus 235 --------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 235 --------------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred --------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 0012346888999999999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=326.63 Aligned_cols=250 Identities=28% Similarity=0.463 Sum_probs=196.9
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc---------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~---------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
++|...+.||+|+||.||+|.+..+|..||+|++... .....+|+.+++.++||||+++++++... ..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR---AE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC---CC
Confidence 3689999999999999999999999999999987432 12355799999999999999999887432 23
Q ss_pred eEEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 208 LYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 208 ~~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
..+++||||++++ +...+.. ...+++..++.++.||+.||+|||+ .||+||||||+||+++.++ .+||+|||+
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~-~~i~H~~l~p~nil~~~~~-~~~l~dfg~ 152 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHS-NMIVHRDIKGANILRDSAG-NVKLGDFGA 152 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCC-CEEEccCCC
Confidence 4688999999864 4443322 3457888899999999999999997 9999999999999999877 799999999
Q ss_pred ccccCCC----CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 011138 287 AKMLVPG----EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (492)
Q Consensus 287 a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~ 362 (492)
+...... .......++..|+|||.+.+. .++.++|||||||++|+|++|+.||........+..+.. .+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~---~~~-- 226 (266)
T cd06651 153 SKRLQTICMSGTGIRSVTGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT---QPT-- 226 (266)
T ss_pred ccccccccccCCccccCCccccccCHHHhCCC-CCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc---CCC--
Confidence 8754321 111234678899999999664 488999999999999999999999987654444333221 100
Q ss_pred HHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCC
Q 011138 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424 (492)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~ 424 (492)
. + .++..+++.+++|| +||..||++||++.|+++||||+
T Consensus 227 ----------~---~---------~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 227 ----------N---P---------QLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred ----------C---C---------CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 0 0 12234678899999 57778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=322.87 Aligned_cols=249 Identities=29% Similarity=0.455 Sum_probs=203.8
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
+|.+.+.||+|+||.||+|.+..+++.+|||.+... .....+|+.+++.++||||+++++.+ .....++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-----LEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-----ecCCEEE
Confidence 489999999999999999999999999999988542 23455799999999999999999987 3445689
Q ss_pred EEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 212 lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
+||||++++ +.+.+.. .....+++..+..++.|++.||.|||+ +||+||||||+||+++.++..+||+|||.+...
T Consensus 76 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (256)
T cd08220 76 IVMEYAPGGTLAEYIQK--RCNSLLDEDTILHFFVQILLALHHVHT-KLILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152 (256)
T ss_pred EEEecCCCCCHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence 999999864 4444332 123457889999999999999999997 999999999999999876657899999999876
Q ss_pred CCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 011138 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (492)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 370 (492)
..........|+..|+|||.+.+. .++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~-------------- 217 (256)
T cd08220 153 SSKSKAYTVVGTPCYISPELCEGK-PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGT-------------- 217 (256)
T ss_pred CCCccccccccCCcccCchhccCC-CCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcC--------------
Confidence 555444456789999999998654 47899999999999999999999998876655444443210
Q ss_pred CcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
++ .++..+++++++||.+||..||.+|||+.|+++||||
T Consensus 218 -----~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 218 -----FA---------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred -----CC---------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 00 0123468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=331.25 Aligned_cols=256 Identities=27% Similarity=0.388 Sum_probs=204.1
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch----hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
.+|.+.+.||.|+||.||++.+..++..||+|.+.... ....+|+.+++.++||||+++++.+. ....+|+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 79 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF-----YENKLWI 79 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe-----cCCeEEE
Confidence 46999999999999999999998899999999885432 23457999999999999999999884 3446899
Q ss_pred EeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 213 V~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
||||++++.+.... ......+++..++.++.|++.||.|||+ .||+|+||||+||+++.++ .++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~~--~~~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~nili~~~~-~~~l~d~g~~~~~~~ 155 (280)
T cd06611 80 LIEFCDGGALDSIM--LELERGLTEPQIRYVCRQMLEALNFLHS-HKVIHRDLKAGNILLTLDG-DVKLADFGVSAKNKS 155 (280)
T ss_pred EeeccCCCcHHHHH--HHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEECCCC-CEEEccCccchhhcc
Confidence 99999976443322 2223568999999999999999999997 9999999999999999887 799999998865432
Q ss_pred CC-CCccceeccCccCchhhcC----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 293 GE-PNISYICSRYYRAPELIFG----ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 293 ~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
.. ......+++.|+|||++.. ...++.++|+|||||++|+|++|++||...+....+..+... .+
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~-------- 225 (280)
T cd06611 156 TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS--EP-------- 225 (280)
T ss_pred cccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC--CC--------
Confidence 22 2234578999999999852 234678999999999999999999999877655444433220 00
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
+.+ ..+..++.++.+||.+||+.||.+||++.++++||||.+..
T Consensus 226 ---------~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (280)
T cd06611 226 ---------PTL-------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS 269 (280)
T ss_pred ---------CCc-------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence 000 01134688999999999999999999999999999998763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=326.53 Aligned_cols=246 Identities=31% Similarity=0.518 Sum_probs=198.0
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------------hhHHHHHHHHHHcCCCCccccceeeeeccC
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE 204 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 204 (492)
+|.++..||.|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---- 76 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSL---- 76 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE----
Confidence 3778899999999999999999999999999874321 23457999999999999999999873
Q ss_pred CCceEEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEee
Q 011138 205 KDELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICD 283 (492)
Q Consensus 205 ~~~~~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~D 283 (492)
+..+.++||||++++ +...+. ....+++..+..++.|++.||.|||+ .|++||||||+||+++.++ .+||+|
T Consensus 77 -~~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~~l~~~l~~lH~-~~ivH~di~p~nil~~~~~-~~~l~d 149 (267)
T cd06628 77 -DADHLNIFLEYVPGGSVAALLN----NYGAFEETLVRNFVRQILKGLNYLHN-RGIIHRDIKGANILVDNKG-GIKISD 149 (267)
T ss_pred -eCCccEEEEEecCCCCHHHHHH----hccCccHHHHHHHHHHHHHHHHHHHh-cCcccccCCHHHEEEcCCC-CEEecc
Confidence 344688999999865 433332 23567888899999999999999997 9999999999999999887 799999
Q ss_pred ecCccccCCCC-------CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 011138 284 FGSAKMLVPGE-------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKIL 356 (492)
Q Consensus 284 FG~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~ 356 (492)
||+++...... ......|+..|+|||.+.+. .++.++|+|||||++|+|++|+.||...+....+..+...
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~- 227 (267)
T cd06628 150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN- 227 (267)
T ss_pred cCCCcccccccccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc-
Confidence 99987664211 11234678899999998654 4789999999999999999999999876654444333220
Q ss_pred CCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 357 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 357 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
..+ .++..++.++.+||++||+.||.+||++.++++||||
T Consensus 228 ------------------~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 228 ------------------ASP---------EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred ------------------CCC---------cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 001 1223578899999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=329.30 Aligned_cols=256 Identities=26% Similarity=0.392 Sum_probs=200.8
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch---hhHHHHHHHHHHc-CCCCccccceeeeeccC-CCceEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLL-NHPNVVSLKHCFFSTTE-KDELYLN 211 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~---~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~-~~~~~~~ 211 (492)
..|.+.+.||.|+||.||+|.+..+++.||+|.+.... .....|+.+++.+ +|+||+++++++..... ....++|
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 95 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW 95 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence 46999999999999999999999999999999875432 3445788888888 69999999998864322 2345789
Q ss_pred EEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 212 lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
+||||++++ +..++... ....+++..+..++.||+.||.|||+ +||+||||||+||+++.++ .++|+|||++...
T Consensus 96 iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dl~~~nili~~~~-~~~l~dfg~~~~~ 171 (282)
T cd06636 96 LVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHA-HKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQL 171 (282)
T ss_pred EEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEeeCcchhhh
Confidence 999999864 44444321 23457888889999999999999997 9999999999999999887 7999999998754
Q ss_pred CCC-CCCccceeccCccCchhhcC----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 011138 291 VPG-EPNISYICSRYYRAPELIFG----ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (492)
Q Consensus 291 ~~~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~ 365 (492)
... .......|++.|+|||++.. ...++.++|+|||||++|+|++|..||........+..+... +
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~------ 242 (282)
T cd06636 172 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---P------ 242 (282)
T ss_pred hccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC---C------
Confidence 321 22334678999999999853 234788999999999999999999999766544333322110 0
Q ss_pred hcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
.+ ......++.++.+||.+||..||.+||++.|++.||||
T Consensus 243 ----------~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 243 ----------PP--------KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred ----------CC--------CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 00 00113468899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=328.08 Aligned_cols=250 Identities=26% Similarity=0.390 Sum_probs=197.0
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
+|.+.+.||+|+||.||+|++..+|+.||+|++... .....+|+.+++.++||||+++++++. ....+++|
T Consensus 10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~-----~~~~~~iv 84 (267)
T cd06646 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL-----SREKLWIC 84 (267)
T ss_pred hcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEE-----eCCEEEEE
Confidence 599999999999999999999999999999988532 234567999999999999999999884 33468899
Q ss_pred eeechhhHH-HHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 214 LEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 214 ~E~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
|||++++.+ ..+. ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++ .+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~~ 158 (267)
T cd06646 85 MEYCGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLAYLHS-KGKMHRDIKGANILLTDNG-DVKLADFGVAAKITA 158 (267)
T ss_pred EeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCC-CEEECcCccceeecc
Confidence 999986544 3332 23568889999999999999999997 9999999999999999887 799999999976533
Q ss_pred CC-CCccceeccCccCchhhcC--CCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 293 GE-PNISYICSRYYRAPELIFG--ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 293 ~~-~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
.. ......|++.|+|||.+.+ ...++.++|+|||||++|+|++|..||......+....+..
T Consensus 159 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~--------------- 223 (267)
T cd06646 159 TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK--------------- 223 (267)
T ss_pred cccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeec---------------
Confidence 22 2334578899999998842 33478899999999999999999999965543322221111
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~ 422 (492)
..+..+... ....++..+.+||++||..||++|||++++++|+|
T Consensus 224 --~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 224 --SNFQPPKLK-------DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred --CCCCCCCCc-------cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 001111100 11246889999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=343.76 Aligned_cols=241 Identities=24% Similarity=0.398 Sum_probs=200.7
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEeeech
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS 218 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E~~~ 218 (492)
...++-||.|+-|.||+|+. .++.||||++.. ..+.+++-|++|+||||+.+.+++ ...-.+|||||||.
T Consensus 126 IsELeWlGSGaQGAVF~Grl--~netVAVKKV~e---lkETdIKHLRkLkH~NII~FkGVC-----tqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRL--HNETVAVKKVRE---LKETDIKHLRKLKHPNIITFKGVC-----TQSPCYCIIMEFCA 195 (904)
T ss_pred hhhhhhhccCcccceeeeec--cCceehhHHHhh---hhhhhHHHHHhccCcceeeEeeee-----cCCceeEEeeeccc
Confidence 34456799999999999986 578999998743 345688999999999999999999 55557899999998
Q ss_pred -hhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCCCCc
Q 011138 219 -ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI 297 (492)
Q Consensus 219 -~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~~~~ 297 (492)
|-|+..++. .+.+.......|..+|+.|+.|||. +.|||||||.-||||.-+. .|||+|||.++........+
T Consensus 196 ~GqL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~-hKIIHRDLKSPNiLIs~~d-~VKIsDFGTS~e~~~~STkM 269 (904)
T KOG4721|consen 196 QGQLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHL-HKIIHRDLKSPNILISYDD-VVKISDFGTSKELSDKSTKM 269 (904)
T ss_pred cccHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHH-hhHhhhccCCCceEeeccc-eEEeccccchHhhhhhhhhh
Confidence 556665543 5678888889999999999999996 9999999999999999777 79999999999887777778
Q ss_pred cceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCC
Q 011138 298 SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFP 377 (492)
Q Consensus 298 ~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 377 (492)
.++||..|||||+|.. .+.+.++|||||||||||||||..||..-+....+. .
T Consensus 270 SFaGTVaWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw----G---------------------- 322 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW----G---------------------- 322 (904)
T ss_pred hhhhhHhhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccchheeEE----e----------------------
Confidence 9999999999999965 458999999999999999999999997755432221 1
Q ss_pred cccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 378 QIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 378 ~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
+..+.++...+...++-++=||+.||.-.|..||+..++|.|-=+
T Consensus 323 -VGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 323 -VGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred -ccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 122233344556788999999999999999999999999998433
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=320.70 Aligned_cols=248 Identities=25% Similarity=0.384 Sum_probs=201.0
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
+|.+.+.||+|+||.||+|.+..+|+.|++|.+... .....+|+.+++.++||||+++++++ .+....|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESF-----LDKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeee-----ccCCEEE
Confidence 378889999999999999999999999999987432 23345799999999999999999988 4445689
Q ss_pred EEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 212 lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
+||||+.++ +...+.. .....++...+..++.||+.||.|||+ .||+||||||+||+++.++ .+||+|||+++..
T Consensus 76 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~h~dl~~~nili~~~~-~~~l~df~~~~~~ 151 (256)
T cd08529 76 IVMEYAENGDLHKLLKM--QRGRPLPEDQVWRFFIQILLGLAHLHS-KKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLL 151 (256)
T ss_pred EEEEeCCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEeCCC-CEEEcccccceec
Confidence 999999764 4444332 124568888999999999999999997 9999999999999999887 7999999998866
Q ss_pred CCCCC-CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 291 VPGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 291 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
..... .....|++.|+|||++.+. .++.++|+|||||++|+|++|+.||...+..+....+...
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------------- 216 (256)
T cd08529 152 SDNTNFANTIVGTPYYLSPELCEDK-PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRG-------------- 216 (256)
T ss_pred cCccchhhccccCccccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--------------
Confidence 43322 2345688999999999654 4889999999999999999999999887755444443221
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
.++. +...++.++.++|.+||+.+|++||++.+++.|||+
T Consensus 217 -----~~~~---------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 217 -----VFPP---------VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred -----CCCC---------CccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 0111 112468899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=324.34 Aligned_cols=247 Identities=27% Similarity=0.445 Sum_probs=196.7
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch----------hhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~----------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
+|.+++.||+|+||.||+|.+ .+|+.+|+|.+.... ....+|+++++.++|+||+++++++ .+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTC-----LDD 74 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEe-----ecC
Confidence 378889999999999999986 578999999875321 2345799999999999999999988 444
Q ss_pred eEEEEEeeechhhHH-HHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 208 LYLNLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 208 ~~~~lV~E~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
.++++||||+.++.+ ..+. ....+++..+..++.||+.||.|||+ .||+|+||||+||+++.++ .++|+|||+
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~ 148 (265)
T cd06631 75 NTISIFMEFVPGGSISSILN----RFGPLPEPVFCKYTKQILDGVAYLHN-NCVVHRDIKGNNVMLMPNG-IIKLIDFGC 148 (265)
T ss_pred CeEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHhEEECCCC-eEEeccchh
Confidence 578999999987544 3332 23467889999999999999999997 8999999999999999887 899999999
Q ss_pred ccccCCC-------CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 011138 287 AKMLVPG-------EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTP 359 (492)
Q Consensus 287 a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p 359 (492)
+...... .......|+..|+|||++.+. .++.++|+|||||++|+|++|..||...+.......+....+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~-- 225 (265)
T cd06631 149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES-GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRG-- 225 (265)
T ss_pred hHhhhhccccccccccccccCCCccccChhhhcCC-CCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccC--
Confidence 8754211 112245688999999998654 488999999999999999999999987655444333322100
Q ss_pred CHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
..+. ++..++.++.+||++||..||.+||++.++++||||
T Consensus 226 ---------------~~~~---------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 226 ---------------LMPR---------LPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred ---------------CCCC---------CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0111 223578999999999999999999999999999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=332.21 Aligned_cols=255 Identities=27% Similarity=0.407 Sum_probs=203.5
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
.|.....||+|+||.||++.+..++..||||.+... .....+|+.+++.++|+||+++++.+. ...+.|+|
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~lv 97 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL-----VGDELWVV 97 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-----cCCeEEEE
Confidence 355567799999999999999999999999987542 233457999999999999999999883 34468999
Q ss_pred eeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCC
Q 011138 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (492)
Q Consensus 214 ~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (492)
|||++++.+..... ...+++..+..++.||+.||.|||+ +||+||||||+||+++.++ .+||+|||++......
T Consensus 98 ~e~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~-~~kL~dfg~~~~~~~~ 171 (292)
T cd06658 98 MEFLEGGALTDIVT----HTRMNEEQIATVCLSVLRALSYLHN-QGVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKE 171 (292)
T ss_pred EeCCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCC-CEEEccCcchhhcccc
Confidence 99998765543221 2457889999999999999999997 9999999999999999887 7999999998754322
Q ss_pred C-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 011138 294 E-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372 (492)
Q Consensus 294 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~ 372 (492)
. ......|+..|+|||.+.+. .++.++|+|||||++|||++|..||...+....+..+...+..
T Consensus 172 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 236 (292)
T cd06658 172 VPKRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPP-------------- 236 (292)
T ss_pred cccCceeecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--------------
Confidence 2 22345789999999998654 4889999999999999999999999887665544433221100
Q ss_pred ccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCC
Q 011138 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430 (492)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~ 430 (492)
.++ ....++..+.+||.+||..||.+|||+.++++||||.....+.
T Consensus 237 --~~~----------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~ 282 (292)
T cd06658 237 --RVK----------DSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPS 282 (292)
T ss_pred --ccc----------cccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence 000 0124688899999999999999999999999999999876554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=337.80 Aligned_cols=279 Identities=34% Similarity=0.568 Sum_probs=227.0
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchhhH---HHHHHHHHHcC------CCCccccceeeeeccCCCce
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK---NRELQIMRLLN------HPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~---~~E~~il~~l~------h~nIv~l~~~~~~~~~~~~~ 208 (492)
+|.+....|+|-|++|.+|.+...|..||||+|...+..- .+|++||++|+ --|+++|+.+| ....
T Consensus 433 RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F-----~hkn 507 (752)
T KOG0670|consen 433 RYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF-----KHKN 507 (752)
T ss_pred eeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh-----hhcc
Confidence 6888889999999999999999999999999998765443 47999999996 34799999998 6666
Q ss_pred EEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 209 ~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
++|||+|-+.-.|-.+++.+.. +-.+.+..++.|+.|+..||..|.. .||+|.||||+||||+.....+||||||.|.
T Consensus 508 HLClVFE~LslNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~-c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~ 585 (752)
T KOG0670|consen 508 HLCLVFEPLSLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKK-CGVLHADIKPDNILVNESKNILKLCDFGSAS 585 (752)
T ss_pred eeEEEehhhhchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHh-cCeeecccCccceEeccCcceeeeccCcccc
Confidence 7999999999999888888765 4568888999999999999999997 8999999999999999888889999999997
Q ss_pred ccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc-
Q 011138 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM- 367 (492)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~- 367 (492)
.... ...+.+..+..|.|||+|+|-. |+...|+||+||+||||.||+..|+|.++.+.+...+.+.|..+...+...
T Consensus 586 ~~~e-neitPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgq 663 (752)
T KOG0670|consen 586 FASE-NEITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQ 663 (752)
T ss_pred cccc-ccccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcc
Confidence 6543 3455677889999999999865 999999999999999999999999999999999999999998887766421
Q ss_pred ------C--CCCcccCCCcccC----------CC---ccccc--CCCCC-------hhHhhhhccccccCCCCcCCHHHh
Q 011138 368 ------N--PNYTEFKFPQIKA----------HP---WHKIF--HKRMP-------PEALDLVSRLLQYSPSLRCTALEA 417 (492)
Q Consensus 368 ------~--~~~~~~~~~~~~~----------~~---~~~~~--~~~~s-------~~~~~Li~~~L~~dP~~R~t~~e~ 417 (492)
. -+|.-.....+.. .| +...+ ...++ ..+++||.+||..||++|+|..|+
T Consensus 664 F~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqA 743 (752)
T KOG0670|consen 664 FKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQA 743 (752)
T ss_pred hhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHH
Confidence 1 1111000000000 00 00000 01122 258899999999999999999999
Q ss_pred hCCCCCCC
Q 011138 418 CAHPFFDD 425 (492)
Q Consensus 418 l~Hp~f~~ 425 (492)
|.||||+.
T Consensus 744 L~HpFi~~ 751 (752)
T KOG0670|consen 744 LKHPFITE 751 (752)
T ss_pred hcCCcccC
Confidence 99999974
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=321.81 Aligned_cols=248 Identities=34% Similarity=0.539 Sum_probs=200.7
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch---------hhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~---------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
+|...+.||+|+||.||+|.+..++..|++|.+.... ....+|+.+++.++|+||+++++++ .+..
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-----REED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-----ecCC
Confidence 3778889999999999999998899999999874322 3355799999999999999999987 4445
Q ss_pred EEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 209 ~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
.+++||||++++ +...+. ....+++..+..++.||+.||.|||+ .||+|+||+|+||+++.++ .+||+|||++
T Consensus 76 ~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~~~ni~~~~~~-~~kl~d~~~~ 149 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLK----KYGSFPEPVIRLYTRQILLGLEYLHD-RNTVHRDIKGANILVDTNG-VVKLADFGMA 149 (258)
T ss_pred eEEEEEEecCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEccCccc
Confidence 688999999864 433332 23457888899999999999999997 9999999999999999887 7999999998
Q ss_pred cccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
.............|+..|+|||.+.....++.++|+|||||++|+|++|..||......+....+....
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~----------- 218 (258)
T cd06632 150 KQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK----------- 218 (258)
T ss_pred eeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc-----------
Confidence 766444434456789999999998654448899999999999999999999997766444443332210
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
..+ .++..+++++.+||.+||+.||.+||++.+++.|||+
T Consensus 219 -------~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 219 -------ELP---------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred -------cCC---------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 000 1223578999999999999999999999999999997
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=323.75 Aligned_cols=247 Identities=30% Similarity=0.465 Sum_probs=202.2
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
+|.+.+.||.|+||.||+|.+..+++.||+|.+.+. .....+|+++++.++||||+++++++ .+..++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence 489999999999999999999999999999988543 23445799999999999999999988 555679
Q ss_pred EEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 211 ~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
++|+||+.++.+.... .....+++..+..++.||+.||.|||+ +||+|+||||+||+++.++ .++|+|||++...
T Consensus 76 ~lv~e~~~~~~L~~~l---~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~~~-~~~l~d~~~~~~~ 150 (258)
T cd05578 76 YLVVDLLLGGDLRYHL---SQKVKFSEEQVKFWICEIVLALEYLHS-KGIIHRDIKPDNILLDEQG-HVHITDFNIATKV 150 (258)
T ss_pred EEEEeCCCCCCHHHHH---HhcCCcCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEEcCCC-CEEEeeccccccc
Confidence 9999999875443221 112578899999999999999999997 8999999999999999888 7999999999876
Q ss_pred CCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCCHHHHhhcC
Q 011138 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESG--VDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~--~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
..........|+..|+|||.+.+.. ++.++|+|||||++|+|++|..||...+. .+.+..... .
T Consensus 151 ~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~---------- 216 (258)
T cd05578 151 TPDTLTTSTSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE---T---------- 216 (258)
T ss_pred CCCccccccCCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc---c----------
Confidence 5544445567889999999986544 89999999999999999999999987764 222222111 0
Q ss_pred CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCH--HHhhCCCCC
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA--LEACAHPFF 423 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~--~e~l~Hp~f 423 (492)
....++..++.++.++|.+||..||.+||++ .|+++||||
T Consensus 217 ---------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 217 ---------------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ---------------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 0011224568999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=329.77 Aligned_cols=254 Identities=28% Similarity=0.447 Sum_probs=211.5
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchhh-------HHHHHHHHHHcC-CCCccccceeeeeccCCC
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRY-------KNRELQIMRLLN-HPNVVSLKHCFFSTTEKD 206 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-------~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~ 206 (492)
...+|....+||+|+||.|.+|..+.+.+.||||+++++.-. ...|.++|.... -|.+++++.||. .
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQ-----T 421 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQ-----T 421 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhh-----h
Confidence 334688999999999999999999999999999988665321 235778887765 678899999983 3
Q ss_pred ceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 207 ~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
-..+|+||||+.|+-+ +.+. ..-..+.+..+.+|+.+|+-||-|||+ +|||+||||.+|||++.++ .|||+|||+
T Consensus 422 mDRLyFVMEyvnGGDL--Myhi-QQ~GkFKEp~AvFYAaEiaigLFFLh~-kgIiYRDLKLDNvmLd~eG-HiKi~DFGm 496 (683)
T KOG0696|consen 422 MDRLYFVMEYVNGGDL--MYHI-QQVGKFKEPVAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDSEG-HIKIADFGM 496 (683)
T ss_pred hhheeeEEEEecCchh--hhHH-HHhcccCCchhhhhhHHHHHHhhhhhc-CCeeeeeccccceEeccCC-ceEeeeccc
Confidence 3458999999997632 2222 234568888899999999999999997 9999999999999999999 599999999
Q ss_pred ccccC-CCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 011138 287 AKMLV-PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (492)
Q Consensus 287 a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~ 365 (492)
++.-. .+....+++|||.|+|||++. ..+|+..+|+||+||+|||||.|++||.+++..+.+..|+..
T Consensus 497 cKEni~~~~TTkTFCGTPdYiAPEIi~-YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh---------- 565 (683)
T KOG0696|consen 497 CKENIFDGVTTKTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH---------- 565 (683)
T ss_pred ccccccCCcceeeecCCCcccccceEE-ecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc----------
Confidence 97643 344456799999999999995 456999999999999999999999999999999988888762
Q ss_pred hcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCH-----HHhhCCCCCCCCCC
Q 011138 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA-----LEACAHPFFDDLRD 428 (492)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~-----~e~l~Hp~f~~~~~ 428 (492)
... +++.+|.++.++++.+|.+.|.+|+.. .+|-.||||+.+..
T Consensus 566 -------nvs------------yPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDW 614 (683)
T KOG0696|consen 566 -------NVS------------YPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDW 614 (683)
T ss_pred -------cCc------------CcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccH
Confidence 222 456799999999999999999999854 58999999997664
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=326.44 Aligned_cols=251 Identities=24% Similarity=0.387 Sum_probs=197.7
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch----hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
.+|.+.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++||||+++++++. +..++|+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~-----~~~~~~l 83 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL-----RRDKLWI 83 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----eCCEEEE
Confidence 36999999999999999999999999999999875432 23457999999999999999999883 3446899
Q ss_pred Eeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 213 VLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 213 V~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
||||++++ +.+.+. ....+++..++.++.||+.||.|||+ .||+|+||||+||+++.++ .+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~~ 157 (267)
T cd06645 84 CMEFCGGGSLQDIYH----VTGPLSESQIAYVSRETLQGLYYLHS-KGKMHRDIKGANILLTDNG-HVKLADFGVSAQIT 157 (267)
T ss_pred EEeccCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEECcceeeeEcc
Confidence 99999864 444332 24568899999999999999999997 8999999999999999877 79999999987553
Q ss_pred CCC-CCccceeccCccCchhhc--CCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 292 PGE-PNISYICSRYYRAPELIF--GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 292 ~~~-~~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
... ......|+..|+|||++. ....++.++|+|||||++|+|++|..||........+..+...
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~------------- 224 (267)
T cd06645 158 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS------------- 224 (267)
T ss_pred CcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc-------------
Confidence 221 223457899999999974 2334788999999999999999999999765543333222110
Q ss_pred CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCC
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~ 422 (492)
....+... ....++..+.+||.+||+.||++||++.++++|||
T Consensus 225 ----~~~~~~~~-------~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 225 ----NFQPPKLK-------DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred ----CCCCCccc-------ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 00000000 00136788999999999999999999999999999
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=320.93 Aligned_cols=252 Identities=26% Similarity=0.428 Sum_probs=204.1
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
+|.+.+.||.|+||.||+|.+..+|+.||+|.+... .....+|+.+++.++|+||+++++++.. .....++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence 488999999999999999999999999999987532 2234469999999999999999987753 2334578
Q ss_pred EEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHH-----hhCCcccCCCCCCceEEcCCCCcEEEeeec
Q 011138 212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-----HVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (492)
Q Consensus 212 lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH-----~~~givHrDlKp~NILl~~~~~~vkL~DFG 285 (492)
+||||+++ ++...+.........+++..++.++.||+.||.||| + .+|+|+||||+||+++.++ .+||+|||
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~-~~i~h~dl~p~nili~~~~-~~kl~d~g 155 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPG-NTVLHRDLKPANIFLDANN-NVKLGDFG 155 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCcccc-CcceecCCCHHHEEEecCC-CEEEeccc
Confidence 99999986 455555444444567899999999999999999999 7 7999999999999999877 89999999
Q ss_pred CccccCCCCC-CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 011138 286 SAKMLVPGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (492)
Q Consensus 286 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~ 364 (492)
++........ .....+++.|+|||.+.+.. ++.++|+|||||++|+|++|..||...+.......+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------- 224 (265)
T cd08217 156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE---------- 224 (265)
T ss_pred ccccccCCcccccccccCCCccChhhhcCCC-CCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhc----------
Confidence 9987654433 33467899999999986544 88999999999999999999999988764333332211
Q ss_pred hhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
..++ .++...+.++.+|+.+||..||.+||++.++++|||+
T Consensus 225 ---------~~~~---------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 225 ---------GKFR---------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ---------CCCC---------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 0011 1223568899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=322.02 Aligned_cols=251 Identities=28% Similarity=0.411 Sum_probs=201.7
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch--hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEe
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~--~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
.+|.+.+.||+|+||.||+|.+..++..|++|.+.... ....+|+.+++.++|+||+++++++. +..++|+|+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYF-----KNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCcEEEEE
Confidence 35999999999999999999999889999999886543 45568999999999999999999884 345689999
Q ss_pred eechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCC
Q 011138 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (492)
Q Consensus 215 E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~ 294 (492)
||++++.+.... ......+++..+..++.||+.||.|||+ .||+||||+|+||+++.++ .+||+|||++.......
T Consensus 78 e~~~~~~L~~~l--~~~~~~l~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~ni~~~~~~-~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 78 EYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLHS-NKKIHRDIKAGNILLNEEG-QAKLADFGVSGQLTDTM 153 (256)
T ss_pred ecCCCCcHHHHH--HhCccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEECCCC-cEEEcccccchhcccCc
Confidence 999975443221 2224568899999999999999999997 8999999999999999887 79999999998664333
Q ss_pred -CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 011138 295 -PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373 (492)
Q Consensus 295 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~ 373 (492)
......++..|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+...
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~------------------ 214 (256)
T cd06612 154 AKRNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK------------------ 214 (256)
T ss_pred cccccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC------------------
Confidence 22345678899999998655 5899999999999999999999999876544332221110
Q ss_pred cCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
..+. ...+..++.++.+||.+||+.||.+|||+.|++.||||
T Consensus 215 -~~~~-------~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 215 -PPPT-------LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred -CCCC-------CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 0000 00123467899999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=327.06 Aligned_cols=240 Identities=18% Similarity=0.228 Sum_probs=191.5
Q ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEee
Q 011138 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E 215 (492)
..||+|++|.||+|.. +|+.||||.+.... ....+|+.+|++++|||||++++++.... .+..++++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence 4699999999999987 78999999885431 33458999999999999999999885422 22346889999
Q ss_pred echhhH-HHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCC
Q 011138 216 YISETV-YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (492)
Q Consensus 216 ~~~~~l-~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~ 294 (492)
|+.++. .+.+. ....+++.....++.|++.||.|||+..+++||||||+|||++.++ .+||+|||+++....
T Consensus 103 y~~~g~L~~~l~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~-~~kl~dfg~~~~~~~-- 175 (283)
T PHA02988 103 YCTRGYLREVLD----KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY-KLKIICHGLEKILSS-- 175 (283)
T ss_pred eCCCCcHHHHHh----hCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC-cEEEcccchHhhhcc--
Confidence 999764 43332 2356888889999999999999999634999999999999999887 799999999986532
Q ss_pred CCccceeccCccCchhhcCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 011138 295 PNISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373 (492)
Q Consensus 295 ~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~ 373 (492)
......|+..|+|||++.+. ..++.++|||||||++|||++|..||.+.+..+.+..+..... .
T Consensus 176 ~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~---------------~ 240 (283)
T PHA02988 176 PPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNN---------------S 240 (283)
T ss_pred ccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC---------------C
Confidence 22356789999999998652 4589999999999999999999999998776655554433110 0
Q ss_pred cCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.. ++...++++++||.+||+.||++|||+.++++
T Consensus 241 ~~------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 241 LK------------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred CC------------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 11 11246889999999999999999999999985
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=326.40 Aligned_cols=247 Identities=26% Similarity=0.378 Sum_probs=189.4
Q ss_pred eeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHH---cCCCCccccceeeeeccCCCceEEEEE
Q 011138 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRL---LNHPNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 144 ~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~---l~h~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
.||+|+||.||++.+..+|+.||+|.+.... ....+|..+++. .+||||+.+++++. .....++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFH-----TPDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEe-----cCCeEEEE
Confidence 4899999999999999999999999875421 122344444443 47999999988883 33458899
Q ss_pred eeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCC
Q 011138 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (492)
Q Consensus 214 ~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (492)
|||+.++.+... ......+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .++|+|||++......
T Consensus 76 ~e~~~~~~L~~~---i~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dikp~Nil~~~~~-~~~l~dfg~~~~~~~~ 150 (279)
T cd05633 76 LDLMNGGDLHYH---LSQHGVFSEKEMRFYATEIILGLEHMHN-RFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKK 150 (279)
T ss_pred EecCCCCCHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCCCCCHHHEEECCCC-CEEEccCCcceecccc
Confidence 999997644322 1224568999999999999999999997 9999999999999999887 7999999998754322
Q ss_pred CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 011138 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373 (492)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~ 373 (492)
......||..|+|||.+.+...++.++|+||+||++|+|++|..||......... .+.....
T Consensus 151 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~---------------- 212 (279)
T cd05633 151 -KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTL---------------- 212 (279)
T ss_pred -CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhh----------------
Confidence 2234578999999999865555889999999999999999999999764322111 1111000
Q ss_pred cCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcC-----CHHHhhCCCCCCCCC
Q 011138 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLR 427 (492)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----t~~e~l~Hp~f~~~~ 427 (492)
. +...++..+++++.+||.+||..||.+|+ ++.++++||||+++.
T Consensus 213 -~--------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 213 -T--------VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred -c--------CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 0 00112345789999999999999999999 699999999999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=325.21 Aligned_cols=249 Identities=28% Similarity=0.410 Sum_probs=196.4
Q ss_pred eccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEeeec
Q 011138 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (492)
Q Consensus 145 lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E~~ 217 (492)
||+|+||+||+|.+..+|+.||+|.+... .....+|+.+++.++||||++++++| ......|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence 69999999999999999999999988532 12234699999999999999999888 4445689999999
Q ss_pred hhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCCCC
Q 011138 218 SET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN 296 (492)
Q Consensus 218 ~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~~~ 296 (492)
+++ +...+... ....+++..+..++.||+.||.|||+ +||+||||+|+||+++.++ .+||+|||.+.........
T Consensus 76 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~ 151 (277)
T cd05577 76 NGGDLKYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQ-RRIVYRDLKPENVLLDDHG-NVRISDLGLAVELKGGKKI 151 (277)
T ss_pred CCCcHHHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCC-CEEEccCcchhhhccCCcc
Confidence 865 43333221 12468999999999999999999997 9999999999999999887 7999999998766444444
Q ss_pred ccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCC
Q 011138 297 ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKF 376 (492)
Q Consensus 297 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 376 (492)
....++..|+|||++.+.. ++.++|||||||++|+|++|+.||...........+.... ...
T Consensus 152 ~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----------------~~~ 213 (277)
T cd05577 152 KGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT-----------------LEM 213 (277)
T ss_pred ccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcc-----------------ccc
Confidence 4567788999999987655 8899999999999999999999997765422111211100 000
Q ss_pred CcccCCCcccccCCCCChhHhhhhccccccCCCCcC-----CHHHhhCCCCCCCCCC
Q 011138 377 PQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLRD 428 (492)
Q Consensus 377 ~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----t~~e~l~Hp~f~~~~~ 428 (492)
...++..+++++.+||.+||+.||.+|| ++.++++||||.++..
T Consensus 214 --------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~ 262 (277)
T cd05577 214 --------AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNW 262 (277)
T ss_pred --------cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCCh
Confidence 0012235689999999999999999999 8999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=321.59 Aligned_cols=249 Identities=27% Similarity=0.436 Sum_probs=196.6
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc---------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~---------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
+|.+++.||+|+||.||.|.+..+|..||||.+..+ .....+|+.+++.++||||+++++++... ...
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~ 79 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP---MER 79 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC---CCc
Confidence 599999999999999999999999999999987421 12345799999999999999999987322 234
Q ss_pred EEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 209 ~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
.+++||||++++ +.+.+. ....+++..+..++.||+.||.|||+ +||+|+||||+||+++.++ .++|+|||++
T Consensus 80 ~~~~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~Dfg~~ 153 (265)
T cd06652 80 TLSIFMEHMPGGSIKDQLK----SYGALTENVTRKYTRQILEGVSYLHS-NMIVHRDIKGANILRDSVG-NVKLGDFGAS 153 (265)
T ss_pred eEEEEEEecCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEecCCC-CEEECcCccc
Confidence 688999999865 443332 22457888899999999999999997 9999999999999999877 7999999998
Q ss_pred cccCCC----CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 011138 288 KMLVPG----EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (492)
Q Consensus 288 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~ 363 (492)
...... .......|+..|+|||++.+. .++.++|||||||++|+|++|+.||........+.++.. .+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~--- 226 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGE-GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPT--- 226 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCC-CCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCC---
Confidence 754321 112235688999999998664 488999999999999999999999987654444333221 110
Q ss_pred HhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCC
Q 011138 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424 (492)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~ 424 (492)
. ...+..++..+.++|.+||. +|++||+++++++|||+.
T Consensus 227 ------------~---------~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 227 ------------N---------PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred ------------C---------CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 0 01223467889999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=321.08 Aligned_cols=253 Identities=27% Similarity=0.410 Sum_probs=202.5
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
.+|.+.+.||.|+||.||+|.+..+++.+|+|.+... .....+|+.+++.++||||+++++++ .+...+|+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~l 77 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY-----LRRDKLWI 77 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEE-----EeCCEEEE
Confidence 4699999999999999999999999999999988543 23456899999999999999999988 34446899
Q ss_pred EeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 213 V~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
+|||++++.+..... .....+++..+..++.|++.||.|||+ +||+|+||||+||+++.++ .+||+|||++.....
T Consensus 78 ~~e~~~~~~l~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~ 153 (262)
T cd06613 78 VMEYCGGGSLQDIYQ--VTRGPLSELQIAYVCRETLKGLAYLHE-TGKIHRDIKGANILLTEDG-DVKLADFGVSAQLTA 153 (262)
T ss_pred EEeCCCCCcHHHHHH--hhccCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCChhhEEECCCC-CEEECccccchhhhh
Confidence 999999765543221 223568899999999999999999997 9999999999999999877 799999999876543
Q ss_pred CC-CCccceeccCccCchhhcCC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 293 GE-PNISYICSRYYRAPELIFGA--TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 293 ~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
.. ......++..|+|||.+.+. ..++.++|+|||||++|+|++|.+||...+.......+...
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~-------------- 219 (262)
T cd06613 154 TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKS-------------- 219 (262)
T ss_pred hhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--------------
Confidence 22 23345788999999998654 25788999999999999999999999887765554443221
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~ 422 (492)
.+..+.. .....++.++.+||.+||..||.+|||+.+++.|+|
T Consensus 220 ---~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 220 ---NFPPPKL-------KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred ---cCCCccc-------cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 0000000 011245788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=321.32 Aligned_cols=244 Identities=30% Similarity=0.507 Sum_probs=197.0
Q ss_pred eccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEeeec
Q 011138 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (492)
Q Consensus 145 lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E~~ 217 (492)
||.|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++||||+++++++ .+...+|+||||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTF-----KDKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeE-----EcCCccEEEEecC
Confidence 699999999999999999999999885422 3355799999999999999999987 3445689999999
Q ss_pred hhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCCCC
Q 011138 218 SET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN 296 (492)
Q Consensus 218 ~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~~~ 296 (492)
+++ +.+.+.. ...++...+..++.||+.||.|||+ +|++|+||||+||+++.++ .++|+|||++.........
T Consensus 76 ~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~h~dl~~~nilv~~~~-~~~l~df~~~~~~~~~~~~ 149 (262)
T cd05572 76 LGGELWTILRD----RGLFDEYTARFYIACVVLAFEYLHN-RGIIYRDLKPENLLLDSNG-YVKLVDFGFAKKLKSGQKT 149 (262)
T ss_pred CCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEEcCCC-CEEEeeCCcccccCccccc
Confidence 864 4443322 3457889999999999999999997 9999999999999999887 7999999999876544334
Q ss_pred ccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 011138 297 ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES--GVDQLVEIIKILGTPTREEIKCMNPNYTEF 374 (492)
Q Consensus 297 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~--~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~ 374 (492)
....+++.|+|||.+.+. .++.++|+|||||++|+|++|..||.... ..+....+.... ...
T Consensus 150 ~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------~~~ 213 (262)
T cd05572 150 WTFCGTPEYVAPEIILNK-GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN---------------GKL 213 (262)
T ss_pred ccccCCcCccChhHhcCC-CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccC---------------CCC
Confidence 456789999999998654 48899999999999999999999998765 333333222100 011
Q ss_pred CCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCC-----HHHhhCCCCCCCCC
Q 011138 375 KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-----ALEACAHPFFDDLR 427 (492)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-----~~e~l~Hp~f~~~~ 427 (492)
. ++...++++.++|.+||..||.+|++ +.|+++||||+++.
T Consensus 214 ~------------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 259 (262)
T cd05572 214 E------------FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFD 259 (262)
T ss_pred C------------CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCC
Confidence 1 22345789999999999999999999 99999999999864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=327.14 Aligned_cols=253 Identities=29% Similarity=0.504 Sum_probs=200.7
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
+|.+.+.||+|+||.||++.+..+++.||+|.+.... ....+|+.+++.++||||+++++.+ ....++
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~ 76 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRHL 76 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCEE
Confidence 5899999999999999999999999999999885432 2334799999999999999999888 444578
Q ss_pred EEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 211 ~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
++||||++|+ +...+.. ...+++..+..++.|++.||.|||+ +||+||||||+||+++.++ .+||+|||+++.
T Consensus 77 ~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~NIll~~~~-~~~l~dfg~~~~ 150 (305)
T cd05609 77 CMVMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHN-YGIVHRDLKPDNLLITSMG-HIKLTDFGLSKI 150 (305)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHEEECCCC-CEEEeeCCCccc
Confidence 9999999875 4333322 3568889999999999999999997 9999999999999999877 799999999864
Q ss_pred cCCCC----------------CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 011138 290 LVPGE----------------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEII 353 (492)
Q Consensus 290 ~~~~~----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~ 353 (492)
..... ......++..|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+..+.+..+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~ 229 (305)
T cd05609 151 GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 229 (305)
T ss_pred cCcCccccccccccccchhhccccCCccCccccCchhccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 21000 01124578889999998654 48999999999999999999999998876655444433
Q ss_pred HHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCC---HHHhhCCCCCCCCCC
Q 011138 354 KILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT---ALEACAHPFFDDLRD 428 (492)
Q Consensus 354 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t---~~e~l~Hp~f~~~~~ 428 (492)
.. ....|. ....++.++.+||.+||+.||++||+ +.++++||||.....
T Consensus 230 ~~-----------------~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~ 281 (305)
T cd05609 230 SD-----------------DIEWPE---------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDW 281 (305)
T ss_pred hc-----------------ccCCCC---------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCH
Confidence 21 011111 01246889999999999999999998 799999999976543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=321.13 Aligned_cols=252 Identities=29% Similarity=0.493 Sum_probs=198.3
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch--------------hhHHHHHHHHHHcCCCCccccceeeeecc
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--------------RYKNRELQIMRLLNHPNVVSLKHCFFSTT 203 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~--------------~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 203 (492)
+|.+.+.||.|+||.||+|.+..+|+.||+|.+.... ....+|+.+++.++||||+++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~---- 77 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE---- 77 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe----
Confidence 5899999999999999999999999999999874210 1245699999999999999999987
Q ss_pred CCCceEEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEe
Q 011138 204 EKDELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC 282 (492)
Q Consensus 204 ~~~~~~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~ 282 (492)
.....+++||||+.++ +...+.. ...++...++.++.||+.||.|||+ +|++||||||+||+++.++ .++|+
T Consensus 78 -~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~~~nil~~~~~-~~~l~ 150 (272)
T cd06629 78 -TTEEYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHS-KGILHRDLKADNLLVDADG-ICKIS 150 (272)
T ss_pred -ccCCceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhh-CCeeecCCChhhEEEcCCC-eEEEe
Confidence 3445688999999865 4333322 2568888999999999999999997 8999999999999999887 89999
Q ss_pred eecCccccCCCC---CCccceeccCccCchhhcCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 011138 283 DFGSAKMLVPGE---PNISYICSRYYRAPELIFGAT-EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358 (492)
Q Consensus 283 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~ 358 (492)
|||++....... ......|+..|+|||.+.... .++.++|+|||||++|+|++|..||........+.++....
T Consensus 151 d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-- 228 (272)
T cd06629 151 DFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKR-- 228 (272)
T ss_pred eccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccc--
Confidence 999987543221 122356788999999986543 47899999999999999999999997655444333321100
Q ss_pred CCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 359 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
....++ ......++.++.+||.+||..||.+||++.++++||||
T Consensus 229 -------------~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 229 -------------SAPPIP--------PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred -------------cCCcCC--------ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 001111 11223578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=317.66 Aligned_cols=248 Identities=26% Similarity=0.468 Sum_probs=201.6
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
+|.+.+.||+|+||.||.+.+..+|+.||+|.+... .....+|+.+++.++||||+++++++ .+..+.+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence 489999999999999999999999999999987532 22456799999999999999999988 4555789
Q ss_pred EEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 212 lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
+||||+.+ .+...+.. .....+++..+..++.||+.||.|||+ +|++|+||+|+|||++.++ .++|+|||++...
T Consensus 76 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~l~~~nil~~~~~-~~~l~d~~~~~~~ 151 (256)
T cd08218 76 IVMDYCEGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTKDG-TIKLGDFGIARVL 151 (256)
T ss_pred EEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCC-CEEEeeccceeec
Confidence 99999986 44443322 122357888899999999999999997 9999999999999999877 7999999999765
Q ss_pred CCCCC-CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 291 VPGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 291 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
..... .....|++.|+|||++.+. .++.++|+|||||++|+|++|..||...+..+....+... .
T Consensus 152 ~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~----------- 217 (256)
T cd08218 152 NSTVELARTCIGTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG--S----------- 217 (256)
T ss_pred CcchhhhhhccCCccccCHHHhCCC-CCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcC--C-----------
Confidence 33221 2234678899999998654 4788999999999999999999999877666555544321 0
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
++ ..+..++.++.++|.+||+.||.+||++.+++.||||
T Consensus 218 ------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 218 ------YP---------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred ------CC---------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 00 0123468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=327.22 Aligned_cols=255 Identities=27% Similarity=0.428 Sum_probs=202.6
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEe
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
|.....||+|+||.||+|.+..+++.||||.+... .....+|+.+++.++||||++++++|. .....|+||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~iv~ 97 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL-----VGEELWVLM 97 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhee-----eCCeEEEEE
Confidence 44455799999999999999999999999987432 234457999999999999999999883 344688999
Q ss_pred eechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCC
Q 011138 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (492)
Q Consensus 215 E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~ 294 (492)
||++++.+..... ...+++..+..++.||+.||.|||+ .||+||||||+||+++.++ .+||+|||++.......
T Consensus 98 e~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dl~p~Nill~~~~-~~kL~dfg~~~~~~~~~ 171 (297)
T cd06659 98 EFLQGGALTDIVS----QTRLNEEQIATVCESVLQALCYLHS-QGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDV 171 (297)
T ss_pred ecCCCCCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHeEEccCC-cEEEeechhHhhccccc
Confidence 9998764443221 2457889999999999999999997 8999999999999999887 79999999987553322
Q ss_pred -CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 011138 295 -PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373 (492)
Q Consensus 295 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~ 373 (492)
......|+..|+|||++.+. .++.++|||||||++|+|++|+.||...+..+.+..+.. .+.
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~------------- 234 (297)
T cd06659 172 PKRKSLVGTPYWMAPEVISRT-PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD---SPP------------- 234 (297)
T ss_pred ccccceecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---cCC-------------
Confidence 22346789999999999654 489999999999999999999999987765554443321 000
Q ss_pred cCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCCC
Q 011138 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431 (492)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~~ 431 (492)
+. + .....++.++.++|.+||+.||.+||++.++++||||.+...+..
T Consensus 235 ---~~-----~--~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~~~ 282 (297)
T cd06659 235 ---PK-----L--KNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPEC 282 (297)
T ss_pred ---CC-----c--cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCccc
Confidence 00 0 011346888999999999999999999999999999998765433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=315.98 Aligned_cols=248 Identities=32% Similarity=0.510 Sum_probs=203.0
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
+|...+.||.|+||.||.+++..+++.+++|.+... .....+|+.++++++|+||+++++++. +...++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFM-----DDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEe-----cCCeEE
Confidence 489999999999999999999999999999987432 123457999999999999999999984 445689
Q ss_pred EEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 212 lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
+||||+.+ .+.+.+... ....+++..+..++.|++.||.|||+ .|++||||||+||+++.++ .+||+|||++...
T Consensus 76 ~~~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~ni~~~~~~-~~kl~d~~~~~~~ 151 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHK-AGILHRDIKTLNIFLTKAG-LIKLGDFGISKIL 151 (256)
T ss_pred EEEEecCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChHhEEEeCCC-CEEECcCcceEEc
Confidence 99999986 455444321 13568889999999999999999997 8999999999999999887 7999999999765
Q ss_pred CCCC-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 291 VPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 291 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
.... ......+++.|+|||++.+.. ++.++|+|||||++|+|++|..||...+..+....+.. +.+.
T Consensus 152 ~~~~~~~~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~~~~--------- 219 (256)
T cd08221 152 GSEYSMAETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ--GNYT--------- 219 (256)
T ss_pred ccccccccccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc--CCCC---------
Confidence 3332 223457899999999986554 78899999999999999999999988776665555532 1100
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
. ....++.++.++|.+||..||.+||++.++++|||+
T Consensus 220 --------~---------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 220 --------P---------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred --------C---------CccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 0 113468899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=316.34 Aligned_cols=249 Identities=26% Similarity=0.425 Sum_probs=200.8
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
+|.+.+.||+|+||.||++.+..+|..||+|.+... .....+|+.+++.++|+||+++++++ .+....+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence 488999999999999999999999999999988532 23456899999999999999999988 4445689
Q ss_pred EEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 212 lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
+|+||+.+ .+...+.. .....+++..+..++.||+.||.|||+ .+|+|+||||+||+++.++..+||+|||.+...
T Consensus 76 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (257)
T cd08225 76 IVMEYCDGGDLMKRINR--QRGVLFSEDQILSWFVQISLGLKHIHD-RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152 (257)
T ss_pred EEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence 99999976 44443322 122357888999999999999999997 999999999999999987656899999998766
Q ss_pred CCCCC-CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 291 VPGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 291 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
..... .....|++.|+|||++.+. .++.++|+|||||++|+|++|..||...+..+....+...
T Consensus 153 ~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------------- 217 (257)
T cd08225 153 NDSMELAYTCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQG-------------- 217 (257)
T ss_pred cCCcccccccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc--------------
Confidence 43322 2234688999999998654 4889999999999999999999999877655544433221
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
.++ .....++.++.++|.+||..+|++|||+.++++||||
T Consensus 218 -----~~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 218 -----YFA---------PISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred -----cCC---------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 000 0123468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=322.54 Aligned_cols=247 Identities=25% Similarity=0.385 Sum_probs=191.0
Q ss_pred eeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHH---HHHHHcCCCCccccceeeeeccCCCceEEEEE
Q 011138 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNREL---QIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 144 ~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~---~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
+||+|+||.||+|.+..+++.||||.+.+.. .....|. .+++...||||++++++| .+...+|+|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEEEE
Confidence 4899999999999999999999999875421 1122333 344456799999999888 444568999
Q ss_pred eeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCC
Q 011138 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (492)
Q Consensus 214 ~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (492)
|||+.|+.+... ......+++..++.++.|++.||.|||+ .+|+||||||+||+++.++ .+||+|||++......
T Consensus 76 ~e~~~g~~L~~~---l~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~nili~~~~-~~kl~dfg~~~~~~~~ 150 (278)
T cd05606 76 LDLMNGGDLHYH---LSQHGVFSEAEMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKK 150 (278)
T ss_pred EecCCCCcHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCCCCHHHEEECCCC-CEEEccCcCccccCcc
Confidence 999987654322 1224568999999999999999999997 9999999999999999887 7999999998755332
Q ss_pred CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 011138 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373 (492)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~ 373 (492)
......|+..|+|||++.+...++.++||||+||++|+|++|+.||.......... +...... ..
T Consensus 151 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~-------------~~ 215 (278)
T cd05606 151 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLT-------------MA 215 (278)
T ss_pred -CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-HHHHhhc-------------cC
Confidence 22345789999999999755568999999999999999999999998753221111 1110000 00
Q ss_pred cCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcC-----CHHHhhCCCCCCCCC
Q 011138 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLR 427 (492)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----t~~e~l~Hp~f~~~~ 427 (492)
. .++..++.++.++|.+||..||.+|+ ++.++++||||++..
T Consensus 216 ~------------~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 216 V------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred C------------CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence 0 12234689999999999999999999 999999999999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=337.22 Aligned_cols=249 Identities=23% Similarity=0.345 Sum_probs=190.8
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCC-----CEEEEEEeccch-----hhHHHHHHHHHHc-CCCCccccceeeeeccC
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETG-----DSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFSTTE 204 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g-----~~vAiK~~~~~~-----~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~ 204 (492)
..+|.+.+.||+|+||.||+|.+..+| ..||||++.... ....+|+.+++.+ +|+|||++++++
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~----- 111 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC----- 111 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe-----
Confidence 447999999999999999999865444 579999885432 2345799999999 899999999988
Q ss_pred CCceEEEEEeeechhh-HHHHhhhhh------------------------------------------------------
Q 011138 205 KDELYLNLVLEYISET-VYRVSKHYT------------------------------------------------------ 229 (492)
Q Consensus 205 ~~~~~~~lV~E~~~~~-l~~~~~~~~------------------------------------------------------ 229 (492)
.....+++||||+.++ +.+.+....
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 4444689999999854 444432211
Q ss_pred ------------hcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCCCC-
Q 011138 230 ------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN- 296 (492)
Q Consensus 230 ------------~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~~~- 296 (492)
.....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~Nil~~~~~-~~kL~DfGla~~~~~~~~~~ 269 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS-KNCIHRDVAARNVLLTDGR-VAKICDFGLARDIMNDSNYV 269 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCEEeccCchheEEEeCCC-eEEEeeceeeeeccCCccee
Confidence 011346778889999999999999997 9999999999999999777 7999999999765333211
Q ss_pred --ccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 011138 297 --ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373 (492)
Q Consensus 297 --~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~ 373 (492)
....++..|+|||++.+. .++.++|||||||++|+|++ |..||........+..+....
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~----------------- 331 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRG----------------- 331 (374)
T ss_pred eccCCCCccceeCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcc-----------------
Confidence 122345679999998654 48999999999999999997 999998765544444433210
Q ss_pred cCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
... ..+..+++++++||.+||+.||.+|||+.++++
T Consensus 332 ~~~----------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 332 YQM----------SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred cCc----------cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 011236899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=318.22 Aligned_cols=246 Identities=27% Similarity=0.454 Sum_probs=190.3
Q ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEeccc----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEeeech
Q 011138 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS 218 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E~~~ 218 (492)
..||+|+||.||+|.+..++..||+|.+... .....+|+.+++.++|+||+++++++ ....+.++|+||+.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~~ 88 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD-----SENGFFKIFMEQVP 88 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeee-----ccCCEEEEEEecCC
Confidence 4699999999999999999999999987543 23456899999999999999999988 44456899999998
Q ss_pred hh-HHHHhhhhhhcCCCc--CHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCCC
Q 011138 219 ET-VYRVSKHYTRMNQHV--PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295 (492)
Q Consensus 219 ~~-l~~~~~~~~~~~~~~--~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~~ 295 (492)
++ +...+... ...+ +...+..++.||+.||.|||+ +||+||||||+||+++.+...++|+|||++........
T Consensus 89 ~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~ 164 (268)
T cd06624 89 GGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHD-NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP 164 (268)
T ss_pred CCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence 65 44433221 1233 777888899999999999997 99999999999999987544899999999876533222
Q ss_pred -CccceeccCccCchhhcCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 011138 296 -NISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373 (492)
Q Consensus 296 -~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~ 373 (492)
.....|++.|+|||++.+. ..++.++|+|||||++|+|++|.+||.................
T Consensus 165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------- 228 (268)
T cd06624 165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK---------------- 228 (268)
T ss_pred ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhc----------------
Confidence 2234678999999998543 3478899999999999999999999975432211110000000
Q ss_pred cCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
. ...++..+++++++|+.+||+.+|.+|||+.+++.||||
T Consensus 229 -~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 229 -I---------HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred -c---------CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 0 011234578899999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=369.40 Aligned_cols=257 Identities=28% Similarity=0.443 Sum_probs=207.5
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
+.+|.-+..||.|.||.||.|.+..+|+..|+|-+.-. -....+|..++..|+|||+|++|++=...+ -
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe-----k 1308 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE-----K 1308 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHH-----H
Confidence 34677888999999999999999999999999976322 233458999999999999999998764433 3
Q ss_pred EEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
++|.||||.|+.+..+.. .++..++...+.|..|++.|+.|||+ +|||||||||+|||++.+| .+|++|||.|..
T Consensus 1309 v~IFMEyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~-~gIVHRDIK~aNI~Ld~~g-~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHE-HGIVHRDIKPANILLDFNG-LIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHHHHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHh-cCceecCCCccceeeecCC-cEEeecccceeE
Confidence 789999999765543332 24456778889999999999999998 9999999999999999888 899999999988
Q ss_pred cCCCCC-----CccceeccCccCchhhcCCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 011138 290 LVPGEP-----NISYICSRYYRAPELIFGAT--EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (492)
Q Consensus 290 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~--~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~ 362 (492)
+.+... .....||+.|||||+|.+.. ....+.||||||||+.||+||+.||...++.-++.--+...
T Consensus 1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~g------ 1457 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAG------ 1457 (1509)
T ss_pred ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhcc------
Confidence 765432 23578999999999997653 35679999999999999999999998765543333222211
Q ss_pred HHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCC
Q 011138 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (492)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~ 429 (492)
..|+ ++.+++.+.+|||.+||+.||.+|+++.|++.|.|-+...+.
T Consensus 1458 ------------h~Pq---------~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~ 1503 (1509)
T KOG4645|consen 1458 ------------HKPQ---------IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDE 1503 (1509)
T ss_pred ------------CCCC---------CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccccc
Confidence 1122 335689999999999999999999999999999998876654
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=326.03 Aligned_cols=253 Identities=21% Similarity=0.274 Sum_probs=189.9
Q ss_pred cceeEeeeeccCCceEEEEEEEcC----------------CCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccc
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLE----------------TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSL 195 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~----------------~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l 195 (492)
.+|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ..+.+|+.+++.++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 469999999999999999997532 34579999885431 235579999999999999999
Q ss_pred ceeeeeccCCCceEEEEEeeechh-hHHHHhhhhhh---------------cCCCcCHHHHHHHHHHHHHHHHHHHhhCC
Q 011138 196 KHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTR---------------MNQHVPILYVQLYTYQICRALNYLHHVVG 259 (492)
Q Consensus 196 ~~~~~~~~~~~~~~~~lV~E~~~~-~l~~~~~~~~~---------------~~~~~~~~~~~~i~~qi~~aL~yLH~~~g 259 (492)
++++.. ...+++||||+.+ ++.+.+..... ....+++..+..++.||+.||.|||+ +|
T Consensus 85 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~ 158 (304)
T cd05096 85 LGVCVD-----EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS-LN 158 (304)
T ss_pred EEEEec-----CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH-CC
Confidence 998843 3458999999986 44444432111 11346777889999999999999997 99
Q ss_pred cccCCCCCCceEEcCCCCcEEEeeecCccccCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-
Q 011138 260 VCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL- 335 (492)
Q Consensus 260 ivHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~- 335 (492)
|+||||||+|||++.++ .+||+|||+++....... .....++..|+|||++.+. .++.++|||||||++|+|++
T Consensus 159 ivH~dlkp~Nill~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~ 236 (304)
T cd05096 159 FVHRDLATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEILML 236 (304)
T ss_pred ccccCcchhheEEcCCc-cEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-CCCchhhhHHHHHHHHHHHHc
Confidence 99999999999999887 799999999976543321 1223457889999998654 48999999999999999986
Q ss_pred -CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCH
Q 011138 336 -GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA 414 (492)
Q Consensus 336 -G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~ 414 (492)
|..||...+..+.+..+...+..... ..+ ...+..+++.+.+||.+||+.||.+|||+
T Consensus 237 ~~~~p~~~~~~~~~~~~~~~~~~~~~~------------~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RPs~ 295 (304)
T cd05096 237 CKEQPYGELTDEQVIENAGEFFRDQGR------------QVY---------LFRPPPCPQGLYELMLQCWSRDCRERPSF 295 (304)
T ss_pred cCCCCCCcCCHHHHHHHHHHHhhhccc------------ccc---------ccCCCCCCHHHHHHHHHHccCCchhCcCH
Confidence 66788877665554443332110000 000 00123468899999999999999999999
Q ss_pred HHhh
Q 011138 415 LEAC 418 (492)
Q Consensus 415 ~e~l 418 (492)
.++.
T Consensus 296 ~~i~ 299 (304)
T cd05096 296 SDIH 299 (304)
T ss_pred HHHH
Confidence 9994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=326.43 Aligned_cols=250 Identities=28% Similarity=0.433 Sum_probs=202.2
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
.|.+.+.||+|+||.||+|.+..+|+.||+|.+.... ....+|+.+++.++||||+++++++. +....
T Consensus 16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~-----~~~~~ 90 (307)
T cd06607 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL-----REHTA 90 (307)
T ss_pred hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE-----eCCeE
Confidence 4899999999999999999999999999999875321 23457999999999999999999984 33457
Q ss_pred EEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 211 ~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
|+||||+.+++.+.+.. ....+++..+..++.||+.||.|||+ .||+||||+|+||+++.++ .+||+|||++...
T Consensus 91 ~lv~e~~~g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~-~~i~H~dl~p~nIl~~~~~-~~kL~dfg~~~~~ 165 (307)
T cd06607 91 WLVMEYCLGSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHS-HERIHRDIKAGNILLTEPG-TVKLADFGSASLV 165 (307)
T ss_pred EEEHHhhCCCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEECCCC-CEEEeecCcceec
Confidence 89999999877665432 23458899999999999999999997 9999999999999999887 7999999998754
Q ss_pred CCCCCCccceeccCccCchhhcC--CCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 291 VPGEPNISYICSRYYRAPELIFG--ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
.. .....+++.|+|||++.+ ...++.++|||||||++|+|++|.+||.+.+.......+... .
T Consensus 166 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~---------- 230 (307)
T cd06607 166 SP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--D---------- 230 (307)
T ss_pred CC---CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--C----------
Confidence 32 234578889999998842 345788999999999999999999999877655444333210 0
Q ss_pred CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
.+.. .....+.++++||.+||..||.+||++.+++.||||....
T Consensus 231 -------~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 231 -------SPTL--------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred -------CCCC--------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 0000 0123577899999999999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=341.58 Aligned_cols=249 Identities=27% Similarity=0.430 Sum_probs=202.6
Q ss_pred EeeeeccCCceEEEEEEEcCCCCEEEEEEec-----cch---hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 141 AERVVGTGSFGVVFQAKCLETGDSVAIKKVL-----QDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 141 ~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~-----~~~---~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
...+||+|+|-+||+|.|..+|..||.-.+. +.. ..+..|+.+|+.|+|||||++|+.+.+.. ..++.+
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~---n~~in~ 120 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD---NKTINF 120 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC---Cceeee
Confidence 4457999999999999999999999954331 222 34557999999999999999999886543 356889
Q ss_pred EeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhC--CcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV--GVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 213 V~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~--givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
|+|++..|.+. .|.+..+.+....++.|++||+.||.|||+ + .|||||||.+||+|+.+.+.|||+|+|+|+..
T Consensus 121 iTEL~TSGtLr---~Y~kk~~~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 121 ITELFTSGTLR---EYRKKHRRVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred eeecccCCcHH---HHHHHhccCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 99999866443 344456778888999999999999999996 5 59999999999999988889999999999876
Q ss_pred CCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 011138 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (492)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 370 (492)
.... ....+|||.|||||++. ..|+..+||||||+.|.||+|+..||.-..+..++.+-+.. |..+.
T Consensus 197 r~s~-aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S-GiKP~--------- 263 (632)
T KOG0584|consen 197 RKSH-AKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS-GIKPA--------- 263 (632)
T ss_pred hccc-cceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc-CCCHH---------
Confidence 4433 33489999999999995 45999999999999999999999999988877776653321 11111
Q ss_pred CcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
.|.+--.+++++||.+||.. ...|+|+.|+|+||||+.-
T Consensus 264 ----------------sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 264 ----------------ALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred ----------------HhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 12223368899999999999 9999999999999999863
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=333.21 Aligned_cols=277 Identities=20% Similarity=0.311 Sum_probs=195.8
Q ss_pred eeeccC--CceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEe
Q 011138 143 RVVGTG--SFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 143 ~~lG~G--~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
..||+| +||+||++.+..+|+.||+|++.... ..+.+|+.+++.++||||++++++| ....++++||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~-----~~~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF-----TTGSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeE-----ecCCceEEEE
Confidence 346666 99999999999999999999875322 3346789999999999999999998 3444689999
Q ss_pred eechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCC
Q 011138 215 EYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (492)
Q Consensus 215 E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (492)
||+.+ ++..++... ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+|++||+.+......
T Consensus 79 e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivHrDlkp~Nill~~~~-~~~~~~~~~~~~~~~~ 154 (328)
T cd08226 79 PFMAYGSANSLLKTY--FPEGMSEALIGNILFGALRGLNYLHQ-NGYIHRNIKASHILISGDG-LVSLSGLSHLYSLVRN 154 (328)
T ss_pred ecccCCCHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEeCCC-cEEEechHHHhhhhcc
Confidence 99986 444443332 13458889999999999999999997 9999999999999999887 7999999865332211
Q ss_pred CCC--------ccceeccCccCchhhcCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH--
Q 011138 294 EPN--------ISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE-- 362 (492)
Q Consensus 294 ~~~--------~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~-- 362 (492)
... ....++..|+|||++.+. ..++.++|||||||++|+|++|.+||........+..+.......+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd08226 155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT 234 (328)
T ss_pred CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccc
Confidence 110 012345679999998654 347899999999999999999999998876555444433211100000
Q ss_pred -------HHhhcCCCCc----ccCCC-----cccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 363 -------EIKCMNPNYT----EFKFP-----QIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 363 -------~~~~~~~~~~----~~~~~-----~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
.+......+. +.... ......+.......+++++++||++||+.||++|||+.++++||||+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 0000000000 00000 0000011111123467889999999999999999999999999999987
Q ss_pred CC
Q 011138 427 RD 428 (492)
Q Consensus 427 ~~ 428 (492)
..
T Consensus 315 ~~ 316 (328)
T cd08226 315 KE 316 (328)
T ss_pred HH
Confidence 65
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=319.90 Aligned_cols=265 Identities=24% Similarity=0.383 Sum_probs=200.8
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
+|...+.||.|++|.||+|.+..+++.||+|.+... .....+|+++++.++||||++++++|... +...+|+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~~l 78 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE---SSSSIGI 78 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc---CCCeEEE
Confidence 588999999999999999999999999999988643 23355799999999999999999988542 2345789
Q ss_pred Eeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 213 VLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 213 V~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
||||++++ |.+.+.........+++..+..++.||+.||.|||+ .|++|+||+|+||+++.++ .++|+|||++....
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~ 156 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS-RKIIHRDIKPSNILLTRKG-QVKLCDFGVSGELV 156 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEecCC-eEEEeecccccccc
Confidence 99999864 444444333345668889999999999999999997 9999999999999999887 79999999987543
Q ss_pred CCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHhhcCCC
Q 011138 292 PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGV-DQLVEIIKILGTPTREEIKCMNPN 370 (492)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~-~~~~~i~~~~g~p~~~~~~~~~~~ 370 (492)
... .....++..|+|||.+.+. .++.++|||||||++|+|++|..||...... ....+....+.....
T Consensus 157 ~~~-~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 225 (287)
T cd06621 157 NSL-AGTFTGTSFYMAPERIQGK-PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN--------- 225 (287)
T ss_pred ccc-cccccCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc---------
Confidence 222 2245678899999998654 5899999999999999999999999865220 000111111111000
Q ss_pred CcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
..++.... .....++++.+||.+||..||.+|||+.|++.||||+...
T Consensus 226 ---~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 226 ---PELKDEPG------NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred ---hhhccCCC------CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 00000000 0012467899999999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=317.42 Aligned_cols=245 Identities=33% Similarity=0.536 Sum_probs=191.7
Q ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEeccchh-------hHHHHHHH-HHHcCCCCccccceeeeeccCCCceEEEEEe
Q 011138 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-------YKNRELQI-MRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-------~~~~E~~i-l~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
+.||.|+||.||+|.+..+|+.||||.+.+... ....|..+ ...++|+||+++++++ .....+|+||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF-----QSKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE-----EcCCeEEEEE
Confidence 468999999999999999999999998854321 11234443 3455899999999988 3444689999
Q ss_pred eechhhHH-HHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCC
Q 011138 215 EYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (492)
Q Consensus 215 E~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (492)
||+.++.+ .++. ....+++..+..++.||+.||.|||+ .||+||||+|+||+++.++ .+||+|||++.....
T Consensus 77 e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~- 149 (260)
T cd05611 77 EYLNGGDCASLIK----TLGGLPEDWAKQYIAEVVLGVEDLHQ-RGIIHRDIKPENLLIDQTG-HLKLTDFGLSRNGLE- 149 (260)
T ss_pred eccCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCC-cEEEeecccceeccc-
Confidence 99986544 3332 23568899999999999999999997 9999999999999999877 799999999875432
Q ss_pred CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 011138 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373 (492)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~ 373 (492)
.....++..|+|||.+.+.. ++.++|||||||++|+|++|..||...+.......+... .
T Consensus 150 --~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-----------------~ 209 (260)
T cd05611 150 --NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSR-----------------R 209 (260)
T ss_pred --cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc-----------------c
Confidence 23456888999999987655 899999999999999999999999887665544433221 0
Q ss_pred cCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCC---HHHhhCCCCCCCCC
Q 011138 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT---ALEACAHPFFDDLR 427 (492)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t---~~e~l~Hp~f~~~~ 427 (492)
..++ ......+++++.++|.+||+.||++||+ +.|++.||||+++.
T Consensus 210 ~~~~--------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 210 INWP--------EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred cCCC--------CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence 0111 1112347899999999999999999995 47999999998764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=325.21 Aligned_cols=250 Identities=24% Similarity=0.364 Sum_probs=199.7
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
.|...+.||+|+||.||+|.+..++..||+|.+.... ....+|+.+++.++||||+++++++ .+..+.|+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 79 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY-----LKGTKLWI 79 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccc-----ccCCceEE
Confidence 3777888999999999999999999999999875322 2356799999999999999999988 44456899
Q ss_pred EeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 213 V~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
||||++++.+..... ...+++..++.++.||+.||.|||+ +|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~ 153 (277)
T cd06642 80 IMEYLGGGSALDLLK----PGPLEETYIATILREILKGLDYLHS-ERKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTD 153 (277)
T ss_pred EEEccCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhc-CCeeccCCChheEEEeCCC-CEEEccccccccccC
Confidence 999999754432211 2467888999999999999999997 9999999999999999877 799999999976543
Q ss_pred CCC-CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 011138 293 GEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (492)
Q Consensus 293 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~ 371 (492)
... .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||...........+..
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~----------------- 215 (277)
T cd06642 154 TQIKRNTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK----------------- 215 (277)
T ss_pred cchhhhcccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhc-----------------
Confidence 321 2234678899999998654 488999999999999999999999976544332222111
Q ss_pred cccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
...+ .+...++.++.+||.+||..+|.+||++.++++||||..+.
T Consensus 216 --~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06642 216 --NSPP---------TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT 260 (277)
T ss_pred --CCCC---------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence 0000 01234678899999999999999999999999999998765
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=319.34 Aligned_cols=255 Identities=29% Similarity=0.509 Sum_probs=199.1
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
+|...+.||.|+||.||+|.+..+++.||+|.+.... ....+|+++++.++||||+++++++. ....+++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~l 76 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFY-----NNGDISI 76 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeee-----cCCEEEE
Confidence 4778889999999999999999999999999875432 23457999999999999999999883 3456899
Q ss_pred Eeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 213 V~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
|+||+++ .+.+++.. ....+++..+..++.||+.||.|||+..|++|+||||+||+++.++ .++|+|||.+....
T Consensus 77 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~-~~~l~d~g~~~~~~ 152 (265)
T cd06605 77 CMEYMDGGSLDKILKE---VQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG-QIKLCDFGVSGQLV 152 (265)
T ss_pred EEEecCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC-CEEEeecccchhhH
Confidence 9999995 44444332 1267888999999999999999999537999999999999999877 79999999987653
Q ss_pred CCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHH-hCCCCHHHHhhcCC
Q 011138 292 PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESG-VDQLVEIIKI-LGTPTREEIKCMNP 369 (492)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~-~~~~~~i~~~-~g~p~~~~~~~~~~ 369 (492)
..... ...++..|+|||.+.+. .++.++|||||||++|+|++|..||...+. .+.....++. ...+
T Consensus 153 ~~~~~-~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------- 220 (265)
T cd06605 153 NSLAK-TFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP---------- 220 (265)
T ss_pred HHHhh-cccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC----------
Confidence 22222 26788999999998665 589999999999999999999999976421 1111111111 1000
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
.+.. ....+++++++||.+||..||.+|||+.+++.||||+.+.
T Consensus 221 ------~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~~ 264 (265)
T cd06605 221 ------PPRL--------PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKYE 264 (265)
T ss_pred ------CCCC--------ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhccc
Confidence 0000 0012688999999999999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=321.50 Aligned_cols=260 Identities=25% Similarity=0.387 Sum_probs=200.7
Q ss_pred ccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-----hhHHHHHHHHHHc-CCCCccccceeeeeccCCCc
Q 011138 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-----~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~ 207 (492)
....+|.+.+.||+|+||.||+|.+..+++.||||.+.... ....+|+.++..+ .||||+++++++ .+.
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~ 86 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYF-----ITD 86 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheee-----ecC
Confidence 34457999999999999999999999899999999985421 1223466656555 499999999998 444
Q ss_pred eEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 208 ~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
.++|+||||+++.+..+... ....+++..+..++.||+.||.|||+..||+||||+|+||+++.++ .+||+|||++
T Consensus 87 ~~~~~v~e~~~~~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~-~~kL~dfg~~ 162 (296)
T cd06618 87 SDVFICMELMSTCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG-NVKLCDFGIS 162 (296)
T ss_pred CeEEEEeeccCcCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC-CEEECccccc
Confidence 56899999998766555433 2347888899999999999999999525999999999999999877 8999999998
Q ss_pred cccCCCCCCccceeccCccCchhhcCC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHH
Q 011138 288 KMLVPGEPNISYICSRYYRAPELIFGA---TEYTTAIDMWSIGCVLAELLLGQPLFPGESGV-DQLVEIIKILGTPTREE 363 (492)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~-~~~~~i~~~~g~p~~~~ 363 (492)
.............++..|+|||.+.+. ..++.++|||||||++|+|++|+.||...... +.+..+.. ..
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~---- 235 (296)
T cd06618 163 GRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ---EE---- 235 (296)
T ss_pred hhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhc---CC----
Confidence 766444333445678899999998644 24788999999999999999999999764332 22222211 00
Q ss_pred HhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
...++. ...+++++.+||.+||..||.+||++.+++.||||+....
T Consensus 236 ---------~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 281 (296)
T cd06618 236 ---------PPSLPP----------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET 281 (296)
T ss_pred ---------CCCCCC----------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence 000000 0136788999999999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=322.20 Aligned_cols=256 Identities=29% Similarity=0.448 Sum_probs=199.7
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
.+|++.+.||+|+||+||++.+..+|+.||+|++... .....+|+++++.++||||+++++++ .+..+++
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 79 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF-----LNENNIC 79 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeE-----ecCCEEE
Confidence 4689999999999999999999999999999987543 23445799999999999999999998 3445689
Q ss_pred EEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
+||||++++.+.... .....+++..+..++.|++.||.|||+.+|++||||||+||+++.++ .++|+|||++....
T Consensus 80 lv~e~~~~~~L~~~~---~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~d~gl~~~~~ 155 (284)
T cd06620 80 MCMEFMDCGSLDRIY---KKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG-QIKLCDFGVSGELI 155 (284)
T ss_pred EEEecCCCCCHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC-cEEEccCCcccchh
Confidence 999999976544321 12346889999999999999999999636999999999999999877 79999999986542
Q ss_pred CCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH-------HHHHHHHhCCCCHHHH
Q 011138 292 PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQ-------LVEIIKILGTPTREEI 364 (492)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~-------~~~i~~~~g~p~~~~~ 364 (492)
.. ......|+..|+|||++.+. .++.++|+|||||++|+|++|..||......+. +..+.... +
T Consensus 156 ~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------~ 226 (284)
T cd06620 156 NS-IADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI-------V 226 (284)
T ss_pred hh-ccCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHH-------h
Confidence 22 22345789999999998654 588999999999999999999999986554211 11111100 0
Q ss_pred hhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
.. ....++ ...++.++.+||.+||..||.+|||+.|+++|+||.+-
T Consensus 227 ~~-----~~~~~~-----------~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 227 QE-----PPPRLP-----------SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred hc-----cCCCCC-----------chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 00 000000 01267889999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=320.42 Aligned_cols=252 Identities=27% Similarity=0.465 Sum_probs=200.6
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-----hhhHHHHHHHHHHcC---CCCccccceeeeeccCCCceE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLN---HPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~---h~nIv~l~~~~~~~~~~~~~~ 209 (492)
.|.+.+.||+|+||.||+|.+..+|+.||+|.+... .....+|+.+++.++ ||||+++++++. +..+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-----~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-----KGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-----eCCE
Confidence 377888999999999999999999999999987532 233557999999997 999999999883 3446
Q ss_pred EEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
.|+||||+.++.+..... ...+++..+..++.||+.||.|||+ .||+||||+|+||+++.++ .++|+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~ 150 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMK----AGPIAEKYISVIIREVLVALKYIHK-VGVIHRDIKAANILVTNTG-NVKLCDFGVAAL 150 (277)
T ss_pred EEEEEecCCCCcHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHHEEEcCCC-CEEEccCCceee
Confidence 889999998754432221 2368889999999999999999997 9999999999999999877 899999999977
Q ss_pred cCCCC-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 290 LVPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 290 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
..... ......|+..|+|||.+.+...++.++|+|||||++|+|++|..||.+.........+..
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~-------------- 216 (277)
T cd06917 151 LNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK-------------- 216 (277)
T ss_pred cCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc--------------
Confidence 64433 233457899999999987666678999999999999999999999987654332221110
Q ss_pred CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
...+.+ ....++.++.+++.+||+.||.+||++.+++.||||++..
T Consensus 217 -----~~~~~~--------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 217 -----SKPPRL--------EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred -----CCCCCC--------CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 000110 0112678999999999999999999999999999998754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=323.35 Aligned_cols=254 Identities=27% Similarity=0.436 Sum_probs=201.8
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
..+|.+.+.||+|+||.||++.+..++..||+|.+... .....+|+.+++.++||||+++++++. +....|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~ 92 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL-----VGDELW 92 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheee-----eCCcEE
Confidence 35799999999999999999999999999999987432 233457999999999999999999884 344588
Q ss_pred EEeeechhhHH-HHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 212 LVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 212 lV~E~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
+|+||+.++.+ ..+. ...+++..+..++.||+.||.|||+ +|++||||||+||+++.++ .+||+|||++...
T Consensus 93 lv~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~-~gi~H~dL~p~Nili~~~~-~~kL~dfg~~~~~ 165 (293)
T cd06647 93 VVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQI 165 (293)
T ss_pred EEEecCCCCcHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHh-CCEeeccCCHHHEEEcCCC-CEEEccCcceecc
Confidence 99999986543 3322 2357788899999999999999997 9999999999999999877 7999999988655
Q ss_pred CCCC-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 291 VPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 291 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
.... ......|++.|+|||.+.+. .++.++|+|||||++|+|++|..||...+....+..+.. .+.+
T Consensus 166 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~---------- 233 (293)
T cd06647 166 TPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTP---------- 233 (293)
T ss_pred cccccccccccCChhhcCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCC----------
Confidence 3332 22335688999999998654 478999999999999999999999987665433322211 0000
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
.+ ..+..++..+++||.+||..||++||++.+++.||||+..+.
T Consensus 234 -----~~----------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~ 277 (293)
T cd06647 234 -----EL----------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKP 277 (293)
T ss_pred -----CC----------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence 00 012346788999999999999999999999999999997653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=314.01 Aligned_cols=248 Identities=26% Similarity=0.445 Sum_probs=197.6
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc---------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~---------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
+|.+.+.||+|+||.||+|.+..+|+.||+|.+... ...+.+|+.+++.++|+||+++++++... ...
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---~~~ 79 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP---EEK 79 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC---CCC
Confidence 599999999999999999999999999999987421 12345799999999999999999987432 234
Q ss_pred EEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 209 ~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
.+++||||++++ +.+.+. ....+++..++.++.||+.||.|||+ .||+|+||||+||+++.++ .++|+|||++
T Consensus 80 ~~~~v~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~ 153 (264)
T cd06653 80 KLSIFVEYMPGGSIKDQLK----AYGALTENVTRRYTRQILQGVSYLHS-NMIVHRDIKGANILRDSAG-NVKLGDFGAS 153 (264)
T ss_pred EEEEEEEeCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCC-CEEECccccc
Confidence 578999999865 433332 23457888899999999999999997 9999999999999999877 7999999999
Q ss_pred cccCCC----CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 011138 288 KMLVPG----EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (492)
Q Consensus 288 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~ 363 (492)
+..... .......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||........+.++.. .+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~--- 226 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT---QPT--- 226 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc---CCC---
Confidence 765321 112245689999999999764 478999999999999999999999987655544433321 111
Q ss_pred HhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
...++..+++++.++|.+||+ +|.+||++.+++.|||.
T Consensus 227 ---------------------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 227 ---------------------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred ---------------------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 011334678999999999999 57999999999999994
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=322.48 Aligned_cols=249 Identities=28% Similarity=0.437 Sum_probs=202.1
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
|...+.||+|+||+||+|++..+|+.|+||++.... ....+|+.+++.++||||+++++++. +....|
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 97 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL-----KEHTAW 97 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEE-----eCCEEE
Confidence 667778999999999999999999999999885321 23457999999999999999999984 344688
Q ss_pred EEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
+||||+.++++..+.. ....+++..+..++.||+.||.|||+ +||+||||||+||+++.++ .+||+|||++....
T Consensus 98 lv~e~~~~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dl~p~nili~~~~-~~kL~dfg~~~~~~ 172 (313)
T cd06633 98 LVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTEPG-QVKLADFGSASKSS 172 (313)
T ss_pred EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChhhEEECCCC-CEEEeecCCCcccC
Confidence 9999999877765432 23568889999999999999999997 8999999999999999887 79999999986432
Q ss_pred CCCCCccceeccCccCchhhcC--CCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 292 PGEPNISYICSRYYRAPELIFG--ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
......|+..|+|||++.. ...++.++|||||||++|+|++|.+||...+....+..+... .
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~--~----------- 236 (313)
T cd06633 173 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--D----------- 236 (313)
T ss_pred ---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--C-----------
Confidence 2335678999999999842 344788999999999999999999999887765555544321 0
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
.+.. ....++..+++||.+||+.+|.+||++.+++.||||...+
T Consensus 237 ------~~~~--------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 237 ------SPTL--------QSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred ------CCCC--------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 0110 1123577899999999999999999999999999999643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=334.10 Aligned_cols=250 Identities=23% Similarity=0.341 Sum_probs=191.1
Q ss_pred ccceeEeeeeccCCceEEEEEEE-----cCCCCEEEEEEeccch-----hhHHHHHHHHHHc-CCCCccccceeeeeccC
Q 011138 136 TISYMAERVVGTGSFGVVFQAKC-----LETGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFSTTE 204 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~-----~~~g~~vAiK~~~~~~-----~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~ 204 (492)
..+|.+++.||+|+||.||+|.+ ..++..||||++.... ....+|+.+++.+ +||||+++++++
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~----- 108 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC----- 108 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee-----
Confidence 34799999999999999999974 3467789999885422 2345799999999 899999999988
Q ss_pred CCceEEEEEeeechh-hHHHHhhhhhh-----------------------------------------------------
Q 011138 205 KDELYLNLVLEYISE-TVYRVSKHYTR----------------------------------------------------- 230 (492)
Q Consensus 205 ~~~~~~~lV~E~~~~-~l~~~~~~~~~----------------------------------------------------- 230 (492)
.+....++|||||++ +|.+.+.....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 444458899999985 45444432110
Q ss_pred ------------------cCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 231 ------------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 231 ------------------~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nill~~~~-~~kl~DfG~a~~~~~ 266 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS-KNCIHRDLAARNILLTHGR-ITKICDFGLARDIRN 266 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCchhhEEEECCC-cEEEecCccceeccC
Confidence 01246778889999999999999997 9999999999999999776 799999999976543
Q ss_pred CCCC---ccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 293 GEPN---ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 293 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
.... ....++..|+|||++.+. .++.++|||||||++|||++ |..||........+.+.+...
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~------------ 333 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEG------------ 333 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhC------------
Confidence 2211 123345679999999654 48999999999999999997 899998765544444433210
Q ss_pred CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
... ..+...+.++++||.+||+.||++||++.++++.
T Consensus 334 -----~~~----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 334 -----YRM----------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred -----ccC----------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 000 0112357899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=320.42 Aligned_cols=249 Identities=25% Similarity=0.379 Sum_probs=200.3
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
.|...+.||.|+||.||+|.+..++..||||.+.... ....+|+.+++.++|+||+++++++ .+..+.|+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 79 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKGTKLWI 79 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECCEEEE
Confidence 4778889999999999999999999999999875332 2345799999999999999999998 34456899
Q ss_pred EeeechhhHH-HHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 213 VLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 213 V~E~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
||||++++.+ +.+. ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++....
T Consensus 80 v~e~~~~~~L~~~i~-----~~~l~~~~~~~~~~~l~~~l~~lh~-~~ivH~dl~p~Nil~~~~~-~~~l~dfg~~~~~~ 152 (277)
T cd06640 80 IMEYLGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHS-EKKIHRDIKAANVLLSEQG-DVKLADFGVAGQLT 152 (277)
T ss_pred EEecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCcCCChhhEEEcCCC-CEEEcccccceecc
Confidence 9999987543 3322 2457888899999999999999997 9999999999999999877 79999999997654
Q ss_pred CCCC-CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 011138 292 PGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (492)
Q Consensus 292 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 370 (492)
.... .....++..|+|||++.+. .++.++|+|||||++|+|++|..||...........+.. +
T Consensus 153 ~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~--~------------- 216 (277)
T cd06640 153 DTQIKRNTFVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK--N------------- 216 (277)
T ss_pred CCccccccccCcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc--C-------------
Confidence 3332 2234678899999998654 478999999999999999999999987654433322211 0
Q ss_pred CcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
..+ .+...++.++.+||.+||..||++||++.++++||||....
T Consensus 217 ----~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 217 ----NPP---------TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred ----CCC---------CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence 000 12234678899999999999999999999999999998654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=317.15 Aligned_cols=247 Identities=26% Similarity=0.373 Sum_probs=189.8
Q ss_pred ceeEeeee--ccCCceEEEEEEEcCCCCEEEEEEeccchhhHHHHHHHHHHc-CCCCccccceeeeeccCCCceEEEEEe
Q 011138 138 SYMAERVV--GTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 138 ~y~~~~~l--G~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
.|.+.+.+ |+|+||.||++.++.++..+|+|.+...... ..|+.+...+ +||||++++++|. ....+|+||
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~e~~~~~~~~~h~~iv~~~~~~~-----~~~~~~iv~ 88 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN-AIEPMVHQLMKDNPNFIKLYYSVT-----TLKGHVLIM 88 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc-hhhHHHHHHhhcCCCEEEEEEEEe-----cCCeeEEEE
Confidence 35555555 9999999999999999999999988543211 1234333333 6999999999984 344689999
Q ss_pred eechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCC
Q 011138 215 EYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (492)
Q Consensus 215 E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (492)
||+++ +|...+.. ...+++..++.++.||+.||.|||+ .||+||||||+||+++.++..++|+|||++.....
T Consensus 89 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~- 162 (267)
T PHA03390 89 DYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHK-HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT- 162 (267)
T ss_pred EcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC-
Confidence 99985 45444332 3478999999999999999999997 89999999999999998775799999999876532
Q ss_pred CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhcCCCCc
Q 011138 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQ-LVEIIKILGTPTREEIKCMNPNYT 372 (492)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~-~~~i~~~~g~p~~~~~~~~~~~~~ 372 (492)
.....++..|+|||++.+. .++.++|||||||++|+|++|..||........ ...+..... .
T Consensus 163 --~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------~ 225 (267)
T PHA03390 163 --PSCYDGTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQ--------------K 225 (267)
T ss_pred --CccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhc--------------c
Confidence 2245689999999999654 489999999999999999999999986543321 111111100 0
Q ss_pred ccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCC-HHHhhCCCCCCC
Q 011138 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-ALEACAHPFFDD 425 (492)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-~~e~l~Hp~f~~ 425 (492)
. ....+.+++.+.+||.+||+.||.+|++ .+++|+||||+.
T Consensus 226 ~------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 226 K------------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred c------------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 0 0112357899999999999999999996 599999999973
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=317.98 Aligned_cols=253 Identities=28% Similarity=0.463 Sum_probs=200.6
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEe
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
|...+.||+|+||.||++.+..+++.+++|++... .....+|+.+++.++||||+++++++. ...+.++|+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~-----~~~~~~~v~ 95 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL-----VGDELWVVM 95 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEE-----cCCeEEEEE
Confidence 44456899999999999999999999999987432 223457999999999999999999884 344588999
Q ss_pred eechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCC
Q 011138 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (492)
Q Consensus 215 E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~ 294 (492)
||+.++.+..... ...++...+..++.||+.||.|||+ +||+||||||+||+++.++ .++|+|||.+.......
T Consensus 96 e~~~~~~L~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~~l~d~g~~~~~~~~~ 169 (285)
T cd06648 96 EFLEGGALTDIVT----HTRMNEEQIATVCLAVLKALSFLHA-QGVIHRDIKSDSILLTSDG-RVKLSDFGFCAQVSKEV 169 (285)
T ss_pred eccCCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChhhEEEcCCC-cEEEcccccchhhccCC
Confidence 9998654432211 1457888899999999999999997 9999999999999999887 89999999887553322
Q ss_pred C-CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 011138 295 P-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373 (492)
Q Consensus 295 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~ 373 (492)
. .....|++.|+|||.+.+. .++.++|||||||++|+|++|..||...+....+..+... .+
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~--~~-------------- 232 (285)
T cd06648 170 PRRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN--LP-------------- 232 (285)
T ss_pred cccccccCCccccCHHHhcCC-CCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc--CC--------------
Confidence 2 2335689999999998654 4899999999999999999999999877655544443321 00
Q ss_pred cCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCC
Q 011138 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (492)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~ 429 (492)
+... ....++..+.+||.+||+.||++||++.++++||||+..+++
T Consensus 233 ---~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 278 (285)
T cd06648 233 ---PKLK-------NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPP 278 (285)
T ss_pred ---CCCc-------ccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCCc
Confidence 0000 112367899999999999999999999999999999987754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=313.04 Aligned_cols=251 Identities=33% Similarity=0.500 Sum_probs=202.7
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
+|.+.+.||.|+||.||+|.+..+|+.|+||++... .....+|+.++..++|+||+++++++ .....+++
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~l 76 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF-----YKEGEISI 76 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----ccCCeEEE
Confidence 588999999999999999999999999999988654 23456899999999999999999988 34456899
Q ss_pred Eeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 213 VLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 213 V~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
||||++++ +...+.. ...+++..+..++.||+.||.|||+..|++||||+|+||+++.++ .++|+|||++....
T Consensus 77 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~-~~~l~df~~~~~~~ 151 (264)
T cd06623 77 VLEYMDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKG-EVKIADFGISKVLE 151 (264)
T ss_pred EEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCC-CEEEccCccceecc
Confidence 99999954 4444332 266899999999999999999999427999999999999999887 89999999998764
Q ss_pred CCCCCc-cceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--hHHH-HHHHHHHhCCCCHHHHhhc
Q 011138 292 PGEPNI-SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES--GVDQ-LVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 292 ~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~--~~~~-~~~i~~~~g~p~~~~~~~~ 367 (492)
...... ...++..|+|||.+.+. .++.++|+||||+++|+|++|..||.... .... ...+.. ..
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~-------- 219 (264)
T cd06623 152 NTLDQCNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---GP-------- 219 (264)
T ss_pred cCCCcccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---CC--------
Confidence 433332 56788999999998654 58999999999999999999999997764 2222 211111 00
Q ss_pred CCCCcccCCCcccCCCcccccCCC-CChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKR-MPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
.+. +... ++..+.++|.+||..+|++||++.++++||||+...
T Consensus 220 --------~~~---------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~ 263 (264)
T cd06623 220 --------PPS---------LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD 263 (264)
T ss_pred --------CCC---------CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence 000 1123 688999999999999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=313.33 Aligned_cols=245 Identities=25% Similarity=0.452 Sum_probs=197.3
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
+|.+.+.||.|+||.||++.+..+++.||+|.+... .....+|+.+++.++|+||+++++++ .+..++|+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEEE
Confidence 488999999999999999999999999999987432 23345799999999999999999988 44457899
Q ss_pred Eeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 213 VLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 213 V~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
||||++++ +...+.. .....+++..+..++.||+.||.|||+ +||+|+||||+||+++.++ .++|+|||++....
T Consensus 76 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~ 151 (255)
T cd08219 76 VMEYCDGGDLMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIHE-KRVLHRDIKSKNIFLTQNG-KVKLGDFGSARLLT 151 (255)
T ss_pred EEeeCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEECCCC-cEEEcccCcceeec
Confidence 99999864 4443322 123457889999999999999999997 9999999999999999877 79999999987653
Q ss_pred CCC-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 011138 292 PGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (492)
Q Consensus 292 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 370 (492)
... ......|++.|+|||++.+. .++.++|+|||||++|+|++|..||...+.......+... .
T Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~--~------------ 216 (255)
T cd08219 152 SPGAYACTYVGTPYYVPPEIWENM-PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQG--S------------ 216 (255)
T ss_pred ccccccccccCCccccCHHHHccC-CcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcC--C------------
Confidence 322 22346789999999998654 4899999999999999999999999877655444443221 0
Q ss_pred CcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
++ .++..++.++.+||.+||+.||.+||++.+++.-
T Consensus 217 -----~~---------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 217 -----YK---------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -----CC---------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 00 0123467889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=310.81 Aligned_cols=250 Identities=30% Similarity=0.506 Sum_probs=203.1
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
+|.+.+.||.|+||.||++.+..++..|++|++... .....+|+++++.++|+|++++++.+. +..+.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~-----~~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFE-----EKGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEe-----cCCEEE
Confidence 488999999999999999999999999999988543 233557999999999999999999884 335688
Q ss_pred EEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 212 lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
+|+||+++ .+...+.........+++..+..++.||+.||.|||+ .|++|+||+|+||+++.++ .++|+|||.+...
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~H~dl~~~nil~~~~~-~~~l~d~~~~~~~ 153 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS-RKILHRDIKPQNIFLTSNG-LVKLGDFGISKVL 153 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHHeEEcCCC-cEEECCccceeec
Confidence 99999986 4555444333234678999999999999999999997 8999999999999999877 7999999999765
Q ss_pred CCCC-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 291 VPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 291 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
.... ......|++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||...+..+....+...
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-------------- 218 (258)
T cd08215 154 SSTVDLAKTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKG-------------- 218 (258)
T ss_pred ccCcceecceeeeecccChhHhccCC-CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcC--------------
Confidence 4332 233457899999999986544 889999999999999999999999877644433333221
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
..+. ++..++.++.++|.+||..||++|||+.++++||||
T Consensus 219 -----~~~~---------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 219 -----QYPP---------IPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred -----CCCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 0111 123468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=317.85 Aligned_cols=245 Identities=22% Similarity=0.251 Sum_probs=191.6
Q ss_pred cceeEeeeeccCCceEEEEEEEc---CCCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~---~~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
.+|.+.+.||+|+||.||+|.+. ..+..||+|.+.... ..+.+|+.+++.++||||+++++++. ...
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~ 79 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT-----RGN 79 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe-----cCC
Confidence 35999999999999999999765 456789999886432 23457999999999999999999884 334
Q ss_pred EEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 209 ~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
.+++||||++++.+..... .....+++..+..++.||+.||+|||+ +|++||||||+|||++.++ .+||+|||.+.
T Consensus 80 ~~~lv~e~~~~~~L~~~l~--~~~~~l~~~~~~~~~~~i~~al~~lH~-~~iiH~dikp~nili~~~~-~~~l~dfg~~~ 155 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLR--KHEGQLVAGQLMGMLPGLASGMKYLSE-MGYVHKGLAAHKVLVNSDL-VCKISGFRRLQ 155 (266)
T ss_pred CcEEEEEeCCCCcHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeeccccHhhEEEcCCC-cEEECCCcccc
Confidence 5889999999765543222 223468899999999999999999997 9999999999999999887 79999999876
Q ss_pred ccCCCCCCc--cceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 011138 289 MLVPGEPNI--SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (492)
Q Consensus 289 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~ 365 (492)
......... ...++..|+|||++.+. .++.++|||||||++|||++ |..||.+.+..+.+..+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~---------- 224 (266)
T cd05064 156 EDKSEAIYTTMSGKSPVLWAAPEAIQYH-HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG---------- 224 (266)
T ss_pred cccccchhcccCCCCceeecCHHHHhhC-CccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC----------
Confidence 532221111 23346789999998654 58999999999999999775 99999887766554443221
Q ss_pred hcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
...+ .+..++..+.+++.+||+.||.+||++.++++
T Consensus 225 --------~~~~----------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 225 --------FRLP----------APRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred --------CCCC----------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 0011 12346889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=311.98 Aligned_cols=251 Identities=29% Similarity=0.489 Sum_probs=197.1
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
+|.+.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++++++ .+...++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence 4889999999999999999999999999999885432 2445799999999999999999987 3445688
Q ss_pred EEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
+|+||+.++.+.... .....+++..++.++.|++.||.|||+ .||+|+||+|+||+++.++ .+||+|||++....
T Consensus 76 lv~e~~~~~~L~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~~~nil~~~~~-~~kl~d~g~~~~~~ 150 (264)
T cd06626 76 IFMEYCSGGTLEELL---EHGRILDEHVIRVYTLQLLEGLAYLHS-HGIVHRDIKPANIFLDHNG-VIKLGDFGCAVKLK 150 (264)
T ss_pred EEEecCCCCcHHHHH---hhcCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEcccccccccC
Confidence 999999865443221 123457888899999999999999997 9999999999999999877 79999999987764
Q ss_pred CCCCC-----ccceeccCccCchhhcCCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 011138 292 PGEPN-----ISYICSRYYRAPELIFGAT--EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (492)
Q Consensus 292 ~~~~~-----~~~~gt~~y~aPE~~~~~~--~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~ 364 (492)
..... ....++..|+|||++.+.. .++.++|||||||++|+|++|..||...+........... +.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~------ 223 (264)
T cd06626 151 NNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GH------ 223 (264)
T ss_pred CCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CC------
Confidence 33221 1346788999999986543 3788999999999999999999999765433222222111 10
Q ss_pred hhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
...+|. ...+++.+.+||.+||+.||.+|||+.+++.|||+
T Consensus 224 --------~~~~~~----------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 224 --------KPPIPD----------SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred --------CCCCCc----------ccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 011111 12358899999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=323.86 Aligned_cols=277 Identities=20% Similarity=0.277 Sum_probs=195.0
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
|.+++.+|.|++ ||.+++..+|+.||||++... .....+|+.+++.++|+||++++++|. +....++
T Consensus 4 ~~i~~~~~~~~~--v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~-----~~~~~~~ 76 (314)
T cd08216 4 TLIGKCFEDLMI--VHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI-----VDSELYV 76 (314)
T ss_pred hhhhHhhcCCce--EEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheee-----cCCeEEE
Confidence 344444555544 555556669999999998543 134568999999999999999999883 4445889
Q ss_pred EeeechhhHH-HHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 213 VLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 213 V~E~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
+|||++++.+ .++... ....+++..+..++.||+.||+|||+ +||+||||||+||+++.++ .+||+|||.+....
T Consensus 77 ~~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~-~~ivH~dlk~~Nili~~~~-~~kl~d~~~~~~~~ 152 (314)
T cd08216 77 VSPLMAYGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHS-KGFIHRSVKASHILLSGDG-KVVLSGLRYSVSMI 152 (314)
T ss_pred EEeccCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCcceEEEecCC-ceEEecCccceeec
Confidence 9999996544 333321 23458889999999999999999997 8999999999999999877 79999999886553
Q ss_pred CCCC--------CccceeccCccCchhhcCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 011138 292 PGEP--------NISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (492)
Q Consensus 292 ~~~~--------~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~ 362 (492)
.... .....++..|+|||++.+. ..++.++|+|||||++|+|++|..||........+.+.. .+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~--~~~~~~~ 230 (314)
T cd08216 153 KHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKV--RGTVPCL 230 (314)
T ss_pred cccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hccCccc
Confidence 2211 1234567889999998653 348899999999999999999999998766544333222 1211110
Q ss_pred HH----hhcCCCCcc----cCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCC
Q 011138 363 EI----KCMNPNYTE----FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (492)
Q Consensus 363 ~~----~~~~~~~~~----~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~ 429 (492)
.. ......... ...+. ............++.++.+||.+||..||++|||+.+++.||||+.++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~ 304 (314)
T cd08216 231 LDKSTYPLYEDSMSQSRSSNEHPN-NRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRR 304 (314)
T ss_pred cccCchhhhcCCcCcccccccccc-hhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhccc
Confidence 00 000000000 00000 01111122233456789999999999999999999999999999988743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=312.81 Aligned_cols=243 Identities=33% Similarity=0.563 Sum_probs=195.9
Q ss_pred eccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEeeec
Q 011138 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (492)
Q Consensus 145 lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E~~ 217 (492)
||.|+||.||++.+..+|+.|++|.+.... ....+|+++++.++||||+++++++ ......|+||||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence 689999999999999999999999885432 2345789999999999999999887 4455689999999
Q ss_pred hh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCC--
Q 011138 218 SE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE-- 294 (492)
Q Consensus 218 ~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~-- 294 (492)
.+ .+...+.. ...+++..+..++.||+.||.|||+ .||+||||+|+||+++.++ .++|+|||++.......
T Consensus 76 ~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~di~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~ 149 (265)
T cd05579 76 PGGDLASLLEN----VGSLDEDVARIYIAEIVLALEYLHS-NGIIHRDLKPDNILIDSNG-HLKLTDFGLSKVGLVRRQI 149 (265)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCCCHHHeEEcCCC-CEEEEecccchhcccCccc
Confidence 86 44444332 2368899999999999999999997 9999999999999999888 89999999987543321
Q ss_pred -------CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 295 -------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 295 -------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
......++..|+|||.+.+.. ++.++|||||||++|+|++|..||......+....+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------------- 215 (265)
T cd05579 150 NLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN------------- 215 (265)
T ss_pred ccccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-------------
Confidence 122356788999999986654 88999999999999999999999988776555444322
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCH---HHhhCCCCCCCC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA---LEACAHPFFDDL 426 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~---~e~l~Hp~f~~~ 426 (492)
....++.. ..++.++.+||.+||+.||.+|||+ .++++||||+++
T Consensus 216 ----~~~~~~~~----------~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 216 ----GKIEWPED----------VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred ----CCcCCCcc----------ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 01111110 1248899999999999999999999 999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=317.04 Aligned_cols=250 Identities=26% Similarity=0.378 Sum_probs=200.0
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEE
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
|.+.+.||.|+||.||+|.+..+++.||||.+.... ....+|+.+++.++||||+++++++ .+..+.|+|
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv 80 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKDTKLWII 80 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEE-----EeCCeEEEE
Confidence 778889999999999999999999999999875322 2355799999999999999999988 344468899
Q ss_pred eeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCC
Q 011138 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (492)
Q Consensus 214 ~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (492)
|||++++.+..... ...+++..+..++.|++.||.|||+ .|++|+||||+||+++.++ .++|+|||++......
T Consensus 81 ~e~~~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~Ni~i~~~~-~~~l~dfg~~~~~~~~ 154 (277)
T cd06641 81 MEYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDT 154 (277)
T ss_pred EEeCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHcc-CCeecCCCCHHhEEECCCC-CEEEeecccceecccc
Confidence 99998754432211 2457889999999999999999997 9999999999999999887 7999999998765432
Q ss_pred CC-CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 011138 294 EP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372 (492)
Q Consensus 294 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~ 372 (492)
.. .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||...........+...
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----------------- 216 (277)
T cd06641 155 QIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN----------------- 216 (277)
T ss_pred hhhhccccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC-----------------
Confidence 21 2235678899999998654 4788999999999999999999999776543333322110
Q ss_pred ccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
..+ .+...++.++.++|.+||..||.+||++.++++||||.+...
T Consensus 217 --~~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~~ 261 (277)
T cd06641 217 --NPP---------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAK 261 (277)
T ss_pred --CCC---------CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhhh
Confidence 000 012346889999999999999999999999999999987543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=351.29 Aligned_cols=141 Identities=26% Similarity=0.415 Sum_probs=121.1
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
.+|.+.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++ ....+
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~~ 78 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSANN 78 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECCE
Confidence 46999999999999999999999999999999986432 4456799999999999999999887 34446
Q ss_pred EEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 210 ~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
+||||||+.+ .|..++.. ...+++..++.|+.||+.||.|||. +|||||||||+||||+.++ .+||+|||+++
T Consensus 79 ~~lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKP~NILl~~~g-~vkL~DFGls~ 152 (669)
T cd05610 79 VYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHR-HGIIHRDLKPDNMLISNEG-HIKLTDFGLSK 152 (669)
T ss_pred EEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCccHHHEEEcCCC-CEEEEeCCCCc
Confidence 8999999975 45444332 3457888899999999999999997 8999999999999999887 79999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=319.41 Aligned_cols=254 Identities=28% Similarity=0.419 Sum_probs=201.5
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEe
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
|.....||+|+||.||++....+|+.||||++... .....+|+.+++.++|+||++++++|. ...+.++||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~ 96 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWVVM 96 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEE-----eCCEEEEEE
Confidence 34446799999999999999999999999987432 223457999999999999999999884 344689999
Q ss_pred eechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCC
Q 011138 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (492)
Q Consensus 215 E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~ 294 (492)
||++++.+..... ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++ .++|+|||++.......
T Consensus 97 e~~~~~~L~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~-~givH~dl~p~Nilv~~~~-~~~l~dfg~~~~~~~~~ 170 (292)
T cd06657 97 EFLEGGALTDIVT----HTRMNEEQIAAVCLAVLKALSVLHA-QGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEV 170 (292)
T ss_pred ecCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-CEEEcccccceeccccc
Confidence 9998765543221 2457888999999999999999997 8999999999999999887 79999999987553322
Q ss_pred -CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 011138 295 -PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373 (492)
Q Consensus 295 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~ 373 (492)
......|++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+....+.+..+...+ +
T Consensus 171 ~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~--~-------------- 233 (292)
T cd06657 171 PRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL--P-------------- 233 (292)
T ss_pred ccccccccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC--C--------------
Confidence 2234568899999998854 447899999999999999999999998776554443332210 0
Q ss_pred cCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCC
Q 011138 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430 (492)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~ 430 (492)
..+. ....+++++.++|.+||+.||.+||++.+++.||||.....+.
T Consensus 234 ~~~~----------~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~~~ 280 (292)
T cd06657 234 PKLK----------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPS 280 (292)
T ss_pred cccC----------CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCCCc
Confidence 0000 1124688999999999999999999999999999999877544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=316.42 Aligned_cols=256 Identities=23% Similarity=0.321 Sum_probs=195.5
Q ss_pred cccceeEeeeeccCCceEEEEEEEcC-----CCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccC
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTE 204 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~-----~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 204 (492)
...+|.+.+.||+|+||.||+|.++. .+..||+|.+.... ....+|+.+++.++||||+++++++
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~----- 78 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVV----- 78 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence 34579999999999999999997642 35579999875332 2234689999999999999999987
Q ss_pred CCceEEEEEeeechh-hHHHHhhhhhhc------CCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCC
Q 011138 205 KDELYLNLVLEYISE-TVYRVSKHYTRM------NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH 277 (492)
Q Consensus 205 ~~~~~~~lV~E~~~~-~l~~~~~~~~~~------~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~ 277 (492)
.+....|+||||+.+ +|.+.+...... ........+..++.||+.||.|||+ +||+||||||+|||++.++
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dikp~nili~~~~- 156 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-KKFVHRDLAARNCMVAHDF- 156 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCCChheEEEcCCC-
Confidence 333458899999985 455554332211 1234566788899999999999997 9999999999999999877
Q ss_pred cEEEeeecCccccCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 011138 278 QLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEII 353 (492)
Q Consensus 278 ~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~ 353 (492)
.+||+|||+++....... .....++..|+|||.+.+. .++.++|+|||||++|||++ |..||.+.+..+....+.
T Consensus 157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (288)
T cd05061 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 235 (288)
T ss_pred cEEECcCCccccccccccccccCCCcccccccCHHHhccC-CCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 799999999875533221 1123456789999998654 48999999999999999998 799998876554433332
Q ss_pred HHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC------CCCCCCC
Q 011138 354 KILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA------HPFFDDL 426 (492)
Q Consensus 354 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~------Hp~f~~~ 426 (492)
.. +. .. ++...++.++++|.+||+.||++|||+.++++ ||||.++
T Consensus 236 ~~-~~---------------~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 236 DG-GY---------------LD------------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred cC-CC---------------CC------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 10 00 00 11345789999999999999999999999986 9999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=327.37 Aligned_cols=251 Identities=25% Similarity=0.361 Sum_probs=191.5
Q ss_pred ccceeEeeeeccCCceEEEEEEEcC-----CCCEEEEEEeccch-----hhHHHHHHHHHHc-CCCCccccceeeeeccC
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFSTTE 204 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~-----~g~~vAiK~~~~~~-----~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~ 204 (492)
..+|++.+.||+|+||.||+|.+.. +++.||+|++.... ....+|+.+++++ +|+||+++++++...
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~-- 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP-- 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC--
Confidence 3479999999999999999997543 45789999875321 2344699999999 799999999987532
Q ss_pred CCceEEEEEeeechhh-HHHHhhhhhh-----------------------------------------------------
Q 011138 205 KDELYLNLVLEYISET-VYRVSKHYTR----------------------------------------------------- 230 (492)
Q Consensus 205 ~~~~~~~lV~E~~~~~-l~~~~~~~~~----------------------------------------------------- 230 (492)
...+++||||+.++ +...+.....
T Consensus 84 --~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 84 --GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred --CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 23578999999864 4333321110
Q ss_pred ----cCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCCC---Cccceecc
Q 011138 231 ----MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSR 303 (492)
Q Consensus 231 ----~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~ 303 (492)
....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++..+..... .....++.
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivHrDikp~Nill~~~~-~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLAS-RKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEeCCC-cEEEeccccchhcccCcchhhccCCCCCc
Confidence 12367888899999999999999997 9999999999999999877 799999999986533221 12334567
Q ss_pred CccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCC
Q 011138 304 YYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAH 382 (492)
Q Consensus 304 ~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~ 382 (492)
.|+|||++.+. .++.++|||||||++|||++ |..||.+....+.+...+... ....
T Consensus 240 ~y~aPE~~~~~-~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~---------------~~~~------- 296 (337)
T cd05054 240 KWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEG---------------TRMR------- 296 (337)
T ss_pred cccCcHHhcCC-CCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhcc---------------CCCC-------
Confidence 89999999765 48999999999999999997 999998755444433332210 0000
Q ss_pred CcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 383 PWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 383 ~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
.+...++++.+++.+||+.+|++||++.++++|
T Consensus 297 -----~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 297 -----APEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred -----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 113467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=311.86 Aligned_cols=245 Identities=22% Similarity=0.348 Sum_probs=194.2
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch---hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~---~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
..|.+.+.||+|+||.||+|.+..+++.||+|.+..+. ....+|+++++.++|+||+++++++ .....+++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEE-----cCCCCcEEE
Confidence 35889999999999999999999999999999886543 2345799999999999999999987 334458899
Q ss_pred eeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 214 LEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 214 ~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
|||++++ +.+.+.. .....+++..+..++.|++.||.|||+ +||+||||||+|||++.++ .+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~nil~~~~~-~~kl~df~~~~~~~~ 156 (263)
T cd05052 81 TEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTG 156 (263)
T ss_pred EEeCCCCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcCCC-cEEeCCCcccccccc
Confidence 9999854 4443322 123457888899999999999999997 9999999999999999877 799999999976543
Q ss_pred CCCC--ccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 293 GEPN--ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 293 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
.... ....++..|+|||.+.+. .++.++|||||||++|||++ |..||.+.+..+....+...
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-------------- 221 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG-------------- 221 (263)
T ss_pred ceeeccCCCCCccccCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC--------------
Confidence 3211 122335679999998654 48899999999999999998 99999887654443333210
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
+. ...+..++.++.+||.+||..||++||++.++++
T Consensus 222 ----~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 222 ----YR----------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred ----CC----------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 00 0122457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=314.58 Aligned_cols=245 Identities=34% Similarity=0.607 Sum_probs=200.9
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHcC-CCCccccceeeeeccCCCceE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~~~~ 209 (492)
+|.+.+.||+|+||.||+|.+..+|+.||+|++... .....+|..+++.++ |+||+++++++ .+...
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~ 76 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEEN 76 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCce
Confidence 599999999999999999999999999999988542 233457899999998 99999999988 44556
Q ss_pred EEEEeeech-hhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 210 LNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 210 ~~lV~E~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
+++||||+. +++.+.+.. ...+++..+..++.||+.||.|||+ .|++|+||||+||+++.++ .++|+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~-~~~~H~dl~~~ni~i~~~~-~~~l~df~~~~ 150 (280)
T cd05581 77 LYFVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHS-KGIIHRDLKPENILLDKDM-HIKITDFGTAK 150 (280)
T ss_pred EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCC-CEEecCCcccc
Confidence 899999995 455554432 3468999999999999999999997 9999999999999999887 79999999987
Q ss_pred ccCCCC---------------------CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 011138 289 MLVPGE---------------------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD 347 (492)
Q Consensus 289 ~~~~~~---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~ 347 (492)
...... ......++..|+|||++.+. .++.++|+|||||++|+|++|..||...+...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 229 (280)
T cd05581 151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229 (280)
T ss_pred ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCC-CCChhhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 653322 11234678899999998654 48899999999999999999999998877544
Q ss_pred HHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCH----HHhhCCCCC
Q 011138 348 QLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA----LEACAHPFF 423 (492)
Q Consensus 348 ~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~----~e~l~Hp~f 423 (492)
.+..+.. .... ++..+++.+.+||.+||+.||.+||++ .++++||||
T Consensus 230 ~~~~~~~-----------------~~~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 230 TFQKILK-----------------LEYS------------FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHHHHHh-----------------cCCC------------CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 4444332 1111 223468899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=317.19 Aligned_cols=255 Identities=29% Similarity=0.480 Sum_probs=199.2
Q ss_pred ceeEeeeeccCCceEEEEEEEc---CCCCEEEEEEeccc--------hhhHHHHHHHHHHc-CCCCccccceeeeeccCC
Q 011138 138 SYMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQD--------KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK 205 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~---~~g~~vAiK~~~~~--------~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~ 205 (492)
+|++.+.||.|+||.||+|.+. .+|..||+|.+... .....+|+.+++.+ +|+||++++++| .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence 3889999999999999999874 47899999988542 13345799999999 599999999888 4
Q ss_pred CceEEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeee
Q 011138 206 DELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (492)
Q Consensus 206 ~~~~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DF 284 (492)
....+|+||||+.++ +...+. ....+++..+..++.||+.||.|||+ .|++||||||+|||++.++ .+||+||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nil~~~~~-~~kl~df 149 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLS----QRERFKEQEVQIYSGEIVLALEHLHK-LGIIYRDIKLENILLDSNG-HVVLTDF 149 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEECCCC-CEEEeeC
Confidence 455789999999965 333322 23568889999999999999999997 9999999999999999887 7999999
Q ss_pred cCccccCCCC--CCccceeccCccCchhhcCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 011138 285 GSAKMLVPGE--PNISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTR 361 (492)
Q Consensus 285 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~ 361 (492)
|++....... ......|+..|+|||.+.+. ..++.++|||||||++|+|++|..||...........+...+...
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-- 227 (290)
T cd05613 150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-- 227 (290)
T ss_pred ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc--
Confidence 9997653322 22345689999999998643 246789999999999999999999997543322222222211000
Q ss_pred HHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcC-----CHHHhhCCCCCCCCCC
Q 011138 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLRD 428 (492)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----t~~e~l~Hp~f~~~~~ 428 (492)
. ..+++.+++.+.+|+.+||+.||.+|+ ++.+++.||||+....
T Consensus 228 -----------~------------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 276 (290)
T cd05613 228 -----------E------------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW 276 (290)
T ss_pred -----------C------------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence 0 002234788999999999999999997 8999999999998763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=313.35 Aligned_cols=249 Identities=28% Similarity=0.459 Sum_probs=195.6
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
.+|.+.+.||+|+||.||+|.+..+++.||||.+... .....+|+.+++.++||||+++++++.. ...
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-----DNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-----CCe
Confidence 3699999999999999999999999999999976421 1234579999999999999999998843 345
Q ss_pred EEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 210 ~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
.++||||+++ ++..++.........+++..+..++.||+.||.|||+ +||+|+||||+||+++.++ .++|+|||++.
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~nil~~~~~-~~~l~d~g~~~ 154 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS-RRVMHRDIKPANVFITATG-VVKLGDLGLGR 154 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCCHHHEEEcCCC-CEEECccccce
Confidence 8899999996 4555554444445568889999999999999999997 9999999999999999887 79999999987
Q ss_pred ccCCCCC-CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHhh
Q 011138 289 MLVPGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESG-VDQLVEIIKILGTPTREEIKC 366 (492)
Q Consensus 289 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~-~~~~~~i~~~~g~p~~~~~~~ 366 (492)
....... .....|++.|+|||.+.+.. ++.++|+|||||++|+|++|..||..... ...+...+...+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 225 (267)
T cd08228 155 FFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDY-------- 225 (267)
T ss_pred eccchhHHHhcCCCCccccChhhhccCC-CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCC--------
Confidence 6543221 22356888999999986654 78999999999999999999999965432 1222222221111
Q ss_pred cCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
+.. ....++.++.+||.+||..||++||++.++++
T Consensus 226 ----------~~~--------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 226 ----------PPL--------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred ----------CCC--------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 110 11236788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=330.85 Aligned_cols=252 Identities=28% Similarity=0.465 Sum_probs=201.2
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchh-------hHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-------YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-------~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
-|...+.||-|+||.|.++....|...||+|.+.+... ..+.|..||..-+.+-||+||-.| .|...+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF-----QDkdnL 704 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNL 704 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-----ccCCce
Confidence 48888999999999999999999999999998865432 234699999999999999999888 777789
Q ss_pred EEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 211 ~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
|+||||++|+ +..++- + -+-|++..+++|+.++..|+++.|+ .|+|||||||+|||||.+| .|||+|||+++-
T Consensus 705 YFVMdYIPGGDmMSLLI---r-mgIFeE~LARFYIAEltcAiesVHk-mGFIHRDiKPDNILIDrdG-HIKLTDFGLCTG 778 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLI---R-MGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDRDG-HIKLTDFGLCTG 778 (1034)
T ss_pred EEEEeccCCccHHHHHH---H-hccCHHHHHHHHHHHHHHHHHHHHh-ccceecccCccceEEccCC-ceeeeecccccc
Confidence 9999999975 333322 2 3568999999999999999999998 7999999999999999999 599999999853
Q ss_pred c---------CCCCC----------------------------------CccceeccCccCchhhcCCCCCCcchhhHHH
Q 011138 290 L---------VPGEP----------------------------------NISYICSRYYRAPELIFGATEYTTAIDMWSI 326 (492)
Q Consensus 290 ~---------~~~~~----------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSl 326 (492)
+ ..+.. ....+||+.|+|||++... .|+..+|+||.
T Consensus 779 fRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~-g~~q~cdwws~ 857 (1034)
T KOG0608|consen 779 FRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART-GYTQLCDWWSV 857 (1034)
T ss_pred ceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc-CccccchhhHh
Confidence 2 11100 0145899999999999654 49999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhcccccc
Q 011138 327 GCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQY 406 (492)
Q Consensus 327 Gvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~ 406 (492)
|||||||+.|++||...+..+...+++.. . . .++-.+..++++++.+||.++ ..
T Consensus 858 gvil~em~~g~~pf~~~tp~~tq~kv~nw---------~------~----------~l~~~~~~~ls~e~~~li~kL-c~ 911 (1034)
T KOG0608|consen 858 GVILYEMLVGQPPFLADTPGETQYKVINW---------R------N----------FLHIPYQGNLSKEALDLIQKL-CC 911 (1034)
T ss_pred hHHHHHHhhCCCCccCCCCCcceeeeeeh---------h------h----------ccccccccccCHHHHHHHHHH-hc
Confidence 99999999999999887765544444321 0 0 111123357899999999985 46
Q ss_pred CCCCcCC---HHHhhCCCCCCCCC
Q 011138 407 SPSLRCT---ALEACAHPFFDDLR 427 (492)
Q Consensus 407 dP~~R~t---~~e~l~Hp~f~~~~ 427 (492)
+++.|+. ++|+..||||+.+.
T Consensus 912 sad~RLGkng~d~vKaHpfFkgID 935 (1034)
T KOG0608|consen 912 SADSRLGKNGADQVKAHPFFKGID 935 (1034)
T ss_pred ChhhhhcccchhhhhcCccccccc
Confidence 7888884 77899999999754
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=350.45 Aligned_cols=249 Identities=24% Similarity=0.369 Sum_probs=191.0
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||||++..+ .....+|+.+++.++||||+++++++ .+...
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~-----~d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSIC-----SDGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEE-----eeCCE
Confidence 4699999999999999999999999999999998543 12345799999999999999999988 34446
Q ss_pred EEEEeeechhh-HHHHhhhhh-------hcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEE
Q 011138 210 LNLVLEYISET-VYRVSKHYT-------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKI 281 (492)
Q Consensus 210 ~~lV~E~~~~~-l~~~~~~~~-------~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL 281 (492)
.|+||||++|+ +...+.... .....++...+..++.||+.||.|||+ +||+||||||+|||++.++ .+||
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs-~GIIHRDLKPeNILLd~dg-~vKL 154 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS-KGVLHRDLKPDNILLGLFG-EVVI 154 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH-CCccccCCchheEEEcCCC-CEEE
Confidence 89999999865 444433211 112345566778899999999999997 9999999999999999887 7999
Q ss_pred eeecCccccCCCC-------------------CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 011138 282 CDFGSAKMLVPGE-------------------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPG 342 (492)
Q Consensus 282 ~DFG~a~~~~~~~-------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~ 342 (492)
+|||+++...... .....+||+.|+|||++.+. .++.++|||||||++|||++|..||..
T Consensus 155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-CCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 9999997651110 11134799999999998665 489999999999999999999999987
Q ss_pred CChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 343 ESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 343 ~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
......... .....|. .+ .+ ...+++.+.+++.+||..||++|++..+.+.
T Consensus 234 ~~~~ki~~~--~~i~~P~--------------~~-----~p-----~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 234 KKGRKISYR--DVILSPI--------------EV-----AP-----YREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred cchhhhhhh--hhccChh--------------hc-----cc-----cccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 554322211 1000000 00 00 1247889999999999999999998766553
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=317.49 Aligned_cols=248 Identities=23% Similarity=0.319 Sum_probs=195.0
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCC-----CEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCC
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETG-----DSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g-----~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 206 (492)
.+|.+.+.||+|+||.||+|.+...+ ..||+|.+.... ....+|+.+++.++||||+++++++ .+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~ 79 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVC-----TK 79 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEE-----cC
Confidence 46889999999999999999876655 679999885432 2346799999999999999999988 34
Q ss_pred ceEEEEEeeechh-hHHHHhhhhhh------------cCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEc
Q 011138 207 ELYLNLVLEYISE-TVYRVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN 273 (492)
Q Consensus 207 ~~~~~lV~E~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~ 273 (492)
....|++|||+.+ ++.+.+..... ....+++..+..++.||+.||.|||+ +||+||||||+||+++
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nil~~ 158 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS-HHFVHRDLAARNCLVG 158 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccccceEEEc
Confidence 4458899999985 45444432211 11457888899999999999999997 9999999999999999
Q ss_pred CCCCcEEEeeecCccccCCCC---CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 011138 274 PHTHQLKICDFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQL 349 (492)
Q Consensus 274 ~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~ 349 (492)
.++ .+||+|||+++...... ......+++.|+|||.+.+. .++.++|||||||++|||++ |..||.+.+..+..
T Consensus 159 ~~~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05048 159 EGL-TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI 236 (283)
T ss_pred CCC-cEEECCCcceeeccccccccccCCCcccccccCHHHhccC-cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 877 79999999997653322 12234568889999998654 48999999999999999997 99999887765544
Q ss_pred HHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 350 VEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 350 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
..+.+. . .+ ..+..+++++.+|+.+||+.||.+||++.++++|
T Consensus 237 ~~i~~~--~-----------------~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 237 EMIRSR--Q-----------------LL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHcC--C-----------------cC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 433221 0 00 0123578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=320.50 Aligned_cols=248 Identities=28% Similarity=0.429 Sum_probs=201.8
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
|...+.||+|+||.||++++..+|..||+|.+.... ....+|+++++.++|||++++++++. +....+
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 101 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL-----REHTAW 101 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----eCCeEE
Confidence 788889999999999999999999999999885321 23457999999999999999999884 334578
Q ss_pred EEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
+||||+.|.+++.+.. ....+++..+..++.||+.||.|||+ +||+||||+|+||+++.++ .+||+|||++....
T Consensus 102 lv~e~~~g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~dL~p~Nil~~~~~-~~kl~dfg~~~~~~ 176 (317)
T cd06635 102 LVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTEPG-QVKLADFGSASIAS 176 (317)
T ss_pred EEEeCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcccEEECCCC-CEEEecCCCccccC
Confidence 9999999877665432 23558889999999999999999997 9999999999999999877 79999999986543
Q ss_pred CCCCCccceeccCccCchhhcC--CCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 292 PGEPNISYICSRYYRAPELIFG--ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
. .....|++.|+|||.+.+ ...++.++|||||||++|+|++|.+||...+....+..+......
T Consensus 177 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~----------- 242 (317)
T cd06635 177 P---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP----------- 242 (317)
T ss_pred C---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCC-----------
Confidence 2 234578899999999842 344788999999999999999999999887665555554431100
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
. .....+++.+++||.+||+.+|.+||++.++++|+|+...
T Consensus 243 --------~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 243 --------T--------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred --------C--------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 0 0012357889999999999999999999999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=341.16 Aligned_cols=281 Identities=22% Similarity=0.297 Sum_probs=185.0
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCC----CCEEEEEEeccchhhHHHHHHH---HHHcCCCCccccceeeeeccC-CC
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLET----GDSVAIKKVLQDKRYKNRELQI---MRLLNHPNVVSLKHCFFSTTE-KD 206 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~----g~~vAiK~~~~~~~~~~~E~~i---l~~l~h~nIv~l~~~~~~~~~-~~ 206 (492)
...+|.+.+.||+|+||.||+|.+..+ +..||||++..... .|..+ ++...+.+++.++..|..... ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNERVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHHHHHhhchhhHHHHHHhhhccccccc
Confidence 446799999999999999999999988 99999998754322 22222 223334444444443322211 33
Q ss_pred ceEEEEEeeechhh-HHHHhhhhhh----------------cCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCc
Q 011138 207 ELYLNLVLEYISET-VYRVSKHYTR----------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQN 269 (492)
Q Consensus 207 ~~~~~lV~E~~~~~-l~~~~~~~~~----------------~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~N 269 (492)
...++|||||++++ +.+++..... .........+..++.||+.||.|||+ +||+||||||+|
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~-~gIiHRDLKP~N 285 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS-TGIVHRDVKPQN 285 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH-CCEEeCcCCHHH
Confidence 44578999999865 4444322100 00111234466799999999999997 999999999999
Q ss_pred eEEcCCCCcEEEeeecCccccCCCC--CCccceeccCccCchhhcCCC---------------------CCCcchhhHHH
Q 011138 270 LLVNPHTHQLKICDFGSAKMLVPGE--PNISYICSRYYRAPELIFGAT---------------------EYTTAIDMWSI 326 (492)
Q Consensus 270 ILl~~~~~~vkL~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---------------------~~~~~~DvwSl 326 (492)
||++.+...+||+|||+|+.+..+. .....++|+.|+|||.+.... .++.++|||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 9998654489999999997653322 234568899999999763221 24456799999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhcccccc
Q 011138 327 GCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQY 406 (492)
Q Consensus 327 Gvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~ 406 (492)
||+||||+++..+ ..+....+..++...+...........+.. .+.... ... .......++.+||.+||++
T Consensus 366 GviL~el~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~----~~~~~~--~~~-~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 366 GLIFLQMAFPNLR--SDSNLIQFNRQLKRNDYDLVAWRKLVEPRA----SPDLRR--GFE-VLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred HHHHHHHHhCcCC--CchHHHHHHHHHHhcCCcHHHHHHhhcccc----chhhhh--hhh-hccccchHHHHHHHHHccC
Confidence 9999999997654 344455555555544443222211111110 000000 000 0112345677999999999
Q ss_pred CCCCcCCHHHhhCCCCCCCCCC
Q 011138 407 SPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 407 dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
||++|||+.|+|+||||+....
T Consensus 437 dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 437 KGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred CcccCCCHHHHhCCcCcCCCCc
Confidence 9999999999999999987543
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=305.10 Aligned_cols=248 Identities=29% Similarity=0.483 Sum_probs=200.6
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch----hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
.|.+.+.||+|+||.||++.+..+++.+++|++.... ....+|+.+++.++|+||+++++++. .....+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL-----KKDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEe-----cCCeEEEE
Confidence 3888899999999999999999899999999885543 34568999999999999999999883 33458899
Q ss_pred eeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 214 LEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 214 ~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
+||+++. +.+.+.. ....+++..+..++.|++.||.|||+ +|++||||+|+||+++.++ .++|+|||.+.....
T Consensus 76 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~ 150 (253)
T cd05122 76 MEFCSGGSLKDLLKS---TNQTLTESQIAYVCKELLKGLEYLHS-NGIIHRDIKAANILLTSDG-EVKLIDFGLSAQLSD 150 (253)
T ss_pred EecCCCCcHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHhhc-CCEecCCCCHHHEEEccCC-eEEEeeccccccccc
Confidence 9999954 4333322 22568999999999999999999997 9999999999999999877 799999999987654
Q ss_pred CCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 011138 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372 (492)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~ 372 (492)
........++..|+|||.+.+.. ++.++|+|||||++|+|++|..||...+....+..+.. ..
T Consensus 151 ~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~--------------- 213 (253)
T cd05122 151 TKARNTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NG--------------- 213 (253)
T ss_pred cccccceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cC---------------
Confidence 44344567899999999986554 88999999999999999999999987754444433322 00
Q ss_pred ccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCC
Q 011138 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422 (492)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~ 422 (492)
.+... ....++..+.++|.+||+.||++|||+.+++.|||
T Consensus 214 ---~~~~~-------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 214 ---PPGLR-------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ---CCCcC-------cccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 00000 01124788999999999999999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=319.62 Aligned_cols=250 Identities=22% Similarity=0.314 Sum_probs=191.3
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCE--EEEEEeccc-----hhhHHHHHHHHHHc-CCCCccccceeeeeccCCC
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDS--VAIKKVLQD-----KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKD 206 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~--vAiK~~~~~-----~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~ 206 (492)
...+|.+.+.||+|+||.||+|.+..+|.. +|+|.+... .....+|+.++.++ +|+||+++++++ ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~ 79 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EH 79 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CC
Confidence 345799999999999999999998888765 577766432 12345799999999 899999999988 44
Q ss_pred ceEEEEEeeechh-hHHHHhhhhhh------------cCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEc
Q 011138 207 ELYLNLVLEYISE-TVYRVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN 273 (492)
Q Consensus 207 ~~~~~lV~E~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~ 273 (492)
..++|+||||+++ .+...+..... ....+++..++.++.||+.||+|||+ +||+||||||+|||++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dlkp~Nili~ 158 (303)
T cd05088 80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVG 158 (303)
T ss_pred CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEec
Confidence 4568999999985 45554432211 12357888999999999999999997 9999999999999999
Q ss_pred CCCCcEEEeeecCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 011138 274 PHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEI 352 (492)
Q Consensus 274 ~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i 352 (492)
.++ .+||+|||++.............++..|+|||.+.+. .++.++|||||||++|+|++ |.+||.+.+..+....+
T Consensus 159 ~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 236 (303)
T cd05088 159 ENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236 (303)
T ss_pred CCC-cEEeCccccCcccchhhhcccCCCcccccCHHHHhcc-CCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence 887 7999999998643211112222346679999988554 48899999999999999998 99999876654433322
Q ss_pred HHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 353 IKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 353 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
.. .... ..+..+++++.+||.+||+.||++||++.+++.+
T Consensus 237 ~~------------------~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 237 PQ------------------GYRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred hc------------------CCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11 0000 0112467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=312.61 Aligned_cols=251 Identities=20% Similarity=0.282 Sum_probs=192.6
Q ss_pred eeEeeeeccCCceEEEEEEEcCC---CCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccC-CCce
Q 011138 139 YMAERVVGTGSFGVVFQAKCLET---GDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDEL 208 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~---g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~-~~~~ 208 (492)
|.+++.||+|+||.||+|....+ +..||||.+..+. ....+|+.+++.++||||+++++++..... .+..
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56788999999999999987653 4789999886432 234579999999999999999998755443 3344
Q ss_pred EEEEEeeechhh-HHHHhhhhh--hcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeec
Q 011138 209 YLNLVLEYISET-VYRVSKHYT--RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (492)
Q Consensus 209 ~~~lV~E~~~~~-l~~~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG 285 (492)
+.++||||+.++ +...+.... .....+++..+..++.||+.||.|||+ .||+||||||+||+++.++ .+||+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN-RNFIHRDLAARNCMLREDM-TVCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchheEEECCCC-eEEECCcc
Confidence 578999999864 333332211 123468899999999999999999997 9999999999999999887 79999999
Q ss_pred CccccCCCCCC---ccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 011138 286 SAKMLVPGEPN---ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTR 361 (492)
Q Consensus 286 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~ 361 (492)
+++........ ....++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.+....+.+..+... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~--~--- 232 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG--N--- 232 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--C---
Confidence 99865433211 12234678999999854 458999999999999999999 99999887665544333220 0
Q ss_pred HHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
... .+..+++++.++|.+||+.||.+|||+.+++.+
T Consensus 233 -----------~~~------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 233 -----------RLK------------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred -----------CCC------------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 123468899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=310.53 Aligned_cols=249 Identities=24% Similarity=0.457 Sum_probs=196.6
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEecc---------chhhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ---------DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~---------~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
+|.+.+.||+|+||.||++.+..++..+++|.+.. ......+|+.+++.++||||+++++++ .+..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF-----LERD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH-----hcCC
Confidence 48899999999999999999988877777776532 112344688999999999999999988 3344
Q ss_pred EEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 209 ~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
..++||||+.++ +...+.........+++..++.++.|++.||.|||+ .|++|+||||+||+++. + .+||+|||++
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~~l~~~nili~~-~-~~~l~d~g~~ 152 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ-RRILHRDLKAKNIFLKN-N-LLKIGDFGVS 152 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-cCccccCCChhheEeec-C-CEeecccCce
Confidence 588999999864 444444333445678999999999999999999997 99999999999999985 3 5999999998
Q ss_pred cccCCCC-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 011138 288 KMLVPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (492)
Q Consensus 288 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~ 366 (492)
....... ......|++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+.. +.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~--~~-------- 221 (260)
T cd08222 153 RLLMGSCDLATTFTGTPYYMSPEALKHQ-GYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE--GP-------- 221 (260)
T ss_pred eecCCCcccccCCCCCcCccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc--CC--------
Confidence 7654332 22345678999999998554 478899999999999999999999977655444433321 00
Q ss_pred cCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
.+. ++..++.++.++|.+||..||++||++.++++||||
T Consensus 222 ---------~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 222 ---------TPS---------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred ---------CCC---------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 000 123568899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=306.30 Aligned_cols=250 Identities=34% Similarity=0.495 Sum_probs=200.0
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
+|.+.+.||+|++|.||+|.+..++..|++|.+.... ....+|+.++++++|+||+++++++.... ...++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 3788899999999999999999999999999885443 34567999999999999999999884321 25688
Q ss_pred EEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 212 lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
+|+||+.++ +.+.+.. ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||.+...
T Consensus 78 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~ 151 (260)
T cd06606 78 IFLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHS-NGIVHRDIKGANILVDSDG-VVKLADFGCAKRL 151 (260)
T ss_pred EEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcCCC-CEEEcccccEEec
Confidence 999999654 4443322 2378899999999999999999998 9999999999999999877 7999999999876
Q ss_pred CCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 291 VPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 291 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
..... .....++..|+|||.+.+.. ++.++|||||||++|+|++|..||....... ..+.....
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~---------- 218 (260)
T cd06606 152 GDIETGEGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGNPM--AALYKIGS---------- 218 (260)
T ss_pred ccccccccccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchH--HHHHhccc----------
Confidence 55443 34567889999999986544 8999999999999999999999998766221 11111100
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
.... ..++..++.++.+||.+||+.||.+||++.++++||||
T Consensus 219 -----~~~~---------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 219 -----SGEP---------PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred -----cCCC---------cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 0000 11234568899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=313.53 Aligned_cols=250 Identities=22% Similarity=0.281 Sum_probs=191.2
Q ss_pred cccceeEeeeeccCCceEEEEEEEcC-----CCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccC
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTE 204 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~-----~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 204 (492)
...+|++.+.||+|+||.||+|.+.. ++..||||++.... ....+|+.+++.++||||+++++++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~----- 78 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV----- 78 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence 34569999999999999999998642 45679999875322 2345799999999999999999987
Q ss_pred CCceEEEEEeeechhh-HHHHhhhhhhc------CCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCC
Q 011138 205 KDELYLNLVLEYISET-VYRVSKHYTRM------NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH 277 (492)
Q Consensus 205 ~~~~~~~lV~E~~~~~-l~~~~~~~~~~------~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~ 277 (492)
......++||||++++ +.+.+...... ...+++..+..++.|++.||.|||+ .|++||||||+|||++.++
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~vH~dlkp~Nil~~~~~- 156 (277)
T cd05062 79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAEDF- 156 (277)
T ss_pred cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCcchheEEEcCCC-
Confidence 4444688999999864 44443321111 1235677788899999999999997 9999999999999999887
Q ss_pred cEEEeeecCccccCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 011138 278 QLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEII 353 (492)
Q Consensus 278 ~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~ 353 (492)
.+||+|||+++....... .....+++.|+|||++.+. .++.++|||||||++|||++ |..||.+.+..+.+..+.
T Consensus 157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (277)
T cd05062 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM 235 (277)
T ss_pred CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 799999999875533221 1123457789999998654 48999999999999999998 789998876654444332
Q ss_pred HHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 354 KILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 354 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
.. .++. ++..+++.+.+||.+||+.||++|||+.+++++
T Consensus 236 ~~-------------------~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 236 EG-------------------GLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred cC-------------------CcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 20 0000 123467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=310.28 Aligned_cols=238 Identities=22% Similarity=0.319 Sum_probs=184.9
Q ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEeeec
Q 011138 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E~~ 217 (492)
+.||+|+||.||+|.+..+|+.||+|.+... .....+|+++++.++||||+++++++ .+...+++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC-----TQKQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----cCCCCeEEEEeec
Confidence 3699999999999999999999999987532 23356799999999999999999988 3444688999999
Q ss_pred hhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCCCC
Q 011138 218 SET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN 296 (492)
Q Consensus 218 ~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~~~ 296 (492)
.++ +.+.+. .....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++.........
T Consensus 76 ~~~~L~~~~~---~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~ 150 (252)
T cd05084 76 QGGDFLTFLR---TEGPRLKVKELIQMVENAAAGMEYLES-KHCIHRDLAARNCLVTEKN-VLKISDFGMSREEEDGVYA 150 (252)
T ss_pred cCCcHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEEcCCC-cEEECccccCccccccccc
Confidence 865 333332 223457889999999999999999997 9999999999999999877 7999999998754322111
Q ss_pred c---cceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 011138 297 I---SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372 (492)
Q Consensus 297 ~---~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~ 372 (492)
. ...++..|+|||.+.+. .++.++|||||||++|+|++ |..||...........+....
T Consensus 151 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~---------------- 213 (252)
T cd05084 151 STGGMKQIPVKWTAPEALNYG-RYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV---------------- 213 (252)
T ss_pred ccCCCCCCceeecCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCC----------------
Confidence 1 11224569999998654 48999999999999999997 999997765543333222100
Q ss_pred ccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.. .++...+..+.+|+.+||+.||++|||+.++++
T Consensus 214 ~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 214 RL------------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred CC------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 012346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=317.70 Aligned_cols=247 Identities=22% Similarity=0.294 Sum_probs=190.1
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCC--EEEEEEeccc-----hhhHHHHHHHHHHc-CCCCccccceeeeeccCCCceE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGD--SVAIKKVLQD-----KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~--~vAiK~~~~~-----~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
+|.+.+.||+|+||.||+|.+..++. .+++|.+... .....+|+.++.++ +||||+++++++ .....
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~~~~ 77 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC-----ENRGY 77 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEE-----ccCCc
Confidence 58999999999999999999877765 4688877532 12355799999999 799999999987 44446
Q ss_pred EEEEeeechh-hHHHHhhhhhh------------cCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCC
Q 011138 210 LNLVLEYISE-TVYRVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT 276 (492)
Q Consensus 210 ~~lV~E~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~ 276 (492)
+|+||||+++ ++.+.+..... ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~ 156 (297)
T cd05089 78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE-KQFIHRDLAARNVLVGENL 156 (297)
T ss_pred ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCcCCcceEEECCCC
Confidence 8899999985 45554432110 12357888999999999999999997 9999999999999999877
Q ss_pred CcEEEeeecCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 011138 277 HQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKI 355 (492)
Q Consensus 277 ~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~ 355 (492)
.+||+|||++..............+..|+|||++.+. .++.++|||||||++|||++ |..||.+....+....+...
T Consensus 157 -~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~ 234 (297)
T cd05089 157 -ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYS-VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 234 (297)
T ss_pred -eEEECCcCCCccccceeccCCCCcCccccCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Confidence 7999999998643221112222335579999998654 48999999999999999997 99999887765544433221
Q ss_pred hCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 356 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
. .. ..+..++.++.+||.+||..||.+||+++++++.
T Consensus 235 ~------------------~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 235 Y------------------RM----------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred C------------------CC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 00 0123478899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=308.75 Aligned_cols=243 Identities=21% Similarity=0.310 Sum_probs=191.5
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc---hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
..|.+.+.||+|+||.||++.+. .+..+|+|.+... .....+|+.+++.++||||+++++++ .....+++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC-----TQQKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEE-----ccCCCEEEE
Confidence 35888999999999999999865 4568999987543 23456799999999999999999988 344458999
Q ss_pred eeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 214 LEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 214 ~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
|||++++ +.+.+.. ....+++..+..++.||+.||.|||+ +||+||||||+||+++.++ .+||+|||.++....
T Consensus 78 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~~~-~~kl~d~g~~~~~~~ 152 (256)
T cd05114 78 TEFMENGCLLNYLRQ---RQGKLSKDMLLSMCQDVCEGMEYLER-NSFIHRDLAARNCLVSSTG-VVKVSDFGMTRYVLD 152 (256)
T ss_pred EEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcceEEEcCCC-eEEECCCCCccccCC
Confidence 9999865 4443321 22457888999999999999999997 9999999999999999877 799999999876533
Q ss_pred CCCC--ccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 293 GEPN--ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 293 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
.... ....++..|+|||++.+. .++.++|+|||||++|+|++ |+.||...+..+.+..+....
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~------------- 218 (256)
T cd05114 153 DEYTSSSGAKFPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF------------- 218 (256)
T ss_pred CceeccCCCCCchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-------------
Confidence 2211 122345689999998654 48999999999999999999 999998877666555543310
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
... .+...+.++.+|+.+||..||.+||++.++++
T Consensus 219 ---~~~------------~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 219 ---RLY------------RPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred ---CCC------------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 000 11235788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=318.40 Aligned_cols=251 Identities=27% Similarity=0.414 Sum_probs=201.7
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
.|...+.||+|+||.||+|++..+++.||+|.+... .....+|+.+++.++|+|++++++++.. ....
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 90 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHTA 90 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCee
Confidence 477788999999999999999999999999987532 1223479999999999999999998843 3458
Q ss_pred EEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 211 ~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
++||||+.+++...+.. ....+++..+..++.|++.||.|||+ +|++||||||+|||++.++ .+||+|||++...
T Consensus 91 ~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~ 165 (308)
T cd06634 91 WLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPG-LVKLGDFGSASIM 165 (308)
T ss_pred EEEEEccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHhEEECCCC-cEEECCcccceee
Confidence 89999999877655432 23457888999999999999999997 9999999999999999877 7999999998765
Q ss_pred CCCCCCccceeccCccCchhhcC--CCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 291 VPGEPNISYICSRYYRAPELIFG--ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
.. .....+++.|+|||.+.+ ...++.++|||||||++|+|++|..||...+..+....+....
T Consensus 166 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~------------ 230 (308)
T cd06634 166 AP---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE------------ 230 (308)
T ss_pred cC---cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcC------------
Confidence 32 234578899999999852 2347889999999999999999999998765544444332210
Q ss_pred CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
.+.. .....+..+++||.+||..+|.+||++.+++.|||+.....
T Consensus 231 -------~~~~--------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~ 275 (308)
T cd06634 231 -------SPAL--------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275 (308)
T ss_pred -------CCCc--------CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCC
Confidence 0000 11246788999999999999999999999999999998543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=322.37 Aligned_cols=263 Identities=26% Similarity=0.404 Sum_probs=210.3
Q ss_pred CccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchh-----------hHHHHHHHHHHcCCCCccccceeeee
Q 011138 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-----------YKNRELQIMRLLNHPNVVSLKHCFFS 201 (492)
Q Consensus 133 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-----------~~~~E~~il~~l~h~nIv~l~~~~~~ 201 (492)
|....+|.+..+||+|||+.||+|.+....+.||||+-...+. ..-+|..|.+.|+||.||++|++|..
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 4445689999999999999999999999999999997532211 12279999999999999999999853
Q ss_pred ccCCCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhh-CCcccCCCCCCceEEcCC--CCc
Q 011138 202 TTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV-VGVCHRDIKPQNLLVNPH--THQ 278 (492)
Q Consensus 202 ~~~~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~-~givHrDlKp~NILl~~~--~~~ 278 (492)
|...+|-|+|||+|..+++ +.+.++.+++.+++.|+.||+.||.||... ..|||-||||.|||+... .+.
T Consensus 539 ----DtdsFCTVLEYceGNDLDF---YLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGe 611 (775)
T KOG1151|consen 539 ----DTDSFCTVLEYCEGNDLDF---YLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGE 611 (775)
T ss_pred ----ccccceeeeeecCCCchhH---HHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccce
Confidence 3335899999999976654 455677899999999999999999999952 369999999999999533 247
Q ss_pred EEEeeecCccccCCCCCC--------ccceeccCccCchhhcC---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 011138 279 LKICDFGSAKMLVPGEPN--------ISYICSRYYRAPELIFG---ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD 347 (492)
Q Consensus 279 vkL~DFG~a~~~~~~~~~--------~~~~gt~~y~aPE~~~~---~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~ 347 (492)
+||+|||+++++..+... ....||.+|++||.+.- ....+.++||||+|||+|.++.|+.||.......
T Consensus 612 IKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ 691 (775)
T KOG1151|consen 612 IKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ 691 (775)
T ss_pred eEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH
Confidence 999999999988544322 24678999999999843 3457899999999999999999999997755443
Q ss_pred HHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCC
Q 011138 348 QLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (492)
Q Consensus 348 ~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~ 425 (492)
.+.+--.++ +.++..||.. +.++.++++||++||++--++|+...++..||||..
T Consensus 692 dILqeNTIl-------------kAtEVqFP~K----------PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 692 DILQENTIL-------------KATEVQFPPK----------PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred HHHhhhchh-------------cceeccCCCC----------CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 333211111 1255666653 358999999999999999999999999999999974
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=312.40 Aligned_cols=250 Identities=20% Similarity=0.265 Sum_probs=189.7
Q ss_pred eEeeeeccCCceEEEEEEEcCCCC--EEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccC-CCceEE
Q 011138 140 MAERVVGTGSFGVVFQAKCLETGD--SVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELYL 210 (492)
Q Consensus 140 ~~~~~lG~G~fg~Vy~~~~~~~g~--~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~-~~~~~~ 210 (492)
.+++.||+|+||.||+|.+..++. .||+|.+... .....+|+.+++.++|+||++++++++.... ......
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 467889999999999999887775 5899987432 2334579999999999999999987654332 222346
Q ss_pred EEEeeechhh-HHHHhhhh--hhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 211 NLVLEYISET-VYRVSKHY--TRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 211 ~lV~E~~~~~-l~~~~~~~--~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
++||||+.++ +...+... ......+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~ 159 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS-KSFIHRDLAARNCMLNENM-NVCVADFGLS 159 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhheEEcCCC-CEEECCCCcc
Confidence 7999999854 44333221 1123457889999999999999999997 9999999999999999887 7999999999
Q ss_pred cccCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 011138 288 KMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREE 363 (492)
Q Consensus 288 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~ 363 (492)
+....... .....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.+....+....+... .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~--~----- 231 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADR-VYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG--N----- 231 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCC-CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC--C-----
Confidence 87643321 1123456789999998654 58999999999999999999 89999886654433333210 0
Q ss_pred HhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
.. ..+..++..+.++|.+||+.||++|||+.+++++
T Consensus 232 -----------~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 232 -----------RL----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred -----------CC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00 0123467889999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=314.09 Aligned_cols=247 Identities=22% Similarity=0.327 Sum_probs=193.5
Q ss_pred cceeEeeeeccCCceEEEEEEEc-----CCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCC
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~-----~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 206 (492)
..|.+.+.||+|+||.||+|.+. .++..||||.+... .....+|+++++.++|+||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----- 79 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE----- 79 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec-----
Confidence 45889999999999999999874 34678999988543 2345689999999999999999998843
Q ss_pred ceEEEEEeeechhh-HHHHhhhh----------hhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCC
Q 011138 207 ELYLNLVLEYISET-VYRVSKHY----------TRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH 275 (492)
Q Consensus 207 ~~~~~lV~E~~~~~-l~~~~~~~----------~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~ 275 (492)
....++||||+.++ +...+... ......+++..+..++.||+.||.|||+ +||+||||||+||+++.+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~h~dlkp~nili~~~ 158 (280)
T cd05049 80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS-QHFVHRDLATRNCLVGYD 158 (280)
T ss_pred CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeeccccccceEEEcCC
Confidence 34589999999865 33333221 1112457888899999999999999997 999999999999999988
Q ss_pred CCcEEEeeecCccccCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 011138 276 THQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVE 351 (492)
Q Consensus 276 ~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~ 351 (492)
+ .+||+|||++........ .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....
T Consensus 159 ~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05049 159 L-VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC 236 (280)
T ss_pred C-eEEECCcccceecccCcceecCCCCcccceecChhhhccC-CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 7 899999999875432221 2234557889999999655 48999999999999999998 9999988776555444
Q ss_pred HHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 352 IIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 352 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
+... . .+ ..+..++..+++||.+||+.||.+||++.|+++
T Consensus 237 ~~~~--~-----------------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 237 ITQG--R-----------------LL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHcC--C-----------------cC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 4320 0 00 011346889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=306.22 Aligned_cols=249 Identities=28% Similarity=0.435 Sum_probs=201.5
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
+|.+.+.||.|+||.||++.+..+|+.+|+|.+... .....+|+.+++.++|+||+++++++. +....|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFL-----DGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhc-----cCCEEE
Confidence 488999999999999999999999999999987542 223347899999999999999999884 335688
Q ss_pred EEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 212 lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
+||||+++ ++...+.........+++..+..++.||+.||.|||+ .|++|+||+|.||+++.++ .+||+|||++...
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~-~~i~h~~l~~~ni~~~~~~-~~kl~d~g~~~~~ 153 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE-QKILHRDLKSANILLVAND-LVKIGDLGISKVL 153 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEEecCC-cEEEeeccchhhh
Confidence 99999976 4544444433334668888999999999999999997 9999999999999999876 7999999999876
Q ss_pred CCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 011138 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (492)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 370 (492)
... ......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+..
T Consensus 154 ~~~-~~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~---------------- 215 (256)
T cd08530 154 KKN-MAKTQIGTPHYMAPEVWKGR-PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR---------------- 215 (256)
T ss_pred ccC-CcccccCCccccCHHHHCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc----------------
Confidence 544 33345688999999998654 488899999999999999999999988765443333221
Q ss_pred CcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
..++. ....++.+++++|.+||..||.+||++.++++||++
T Consensus 216 ---~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 216 ---GKYPP---------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred ---CCCCC---------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 01111 112467899999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=321.29 Aligned_cols=244 Identities=23% Similarity=0.366 Sum_probs=189.8
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCE----EEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~----vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
.+|.+.+.||+|+||.||+|.+..+|+. ||+|.+... .....+|+.+++.++||||+++++++...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~----- 81 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 81 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-----
Confidence 3599999999999999999998776664 899987532 23345799999999999999999987431
Q ss_pred eEEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 208 LYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 208 ~~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
..++|+||+.++ +.+.+.. ....++...+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~-~~iiH~dlkp~Nill~~~~-~~kl~DfG~ 155 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEE-RRLVHRDLAARNVLVKTPQ-HVKITDFGL 155 (316)
T ss_pred -CceeeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEecCCC-cEEEccccc
Confidence 256899999854 4444332 23457888889999999999999997 9999999999999999887 799999999
Q ss_pred ccccCCCCCCc---cceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 011138 287 AKMLVPGEPNI---SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTRE 362 (492)
Q Consensus 287 a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~ 362 (492)
++......... ...++..|+|||.+.+. .++.++|||||||++|||++ |..||.+....+ +..+...
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-~~~~~~~------- 226 (316)
T cd05108 156 AKLLGADEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEK------- 226 (316)
T ss_pred cccccCCCcceeccCCccceeecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHhC-------
Confidence 98764433222 22346689999998654 48999999999999999997 999998765433 2333221
Q ss_pred HHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
...++ .+...+.++.+++.+||..||.+||++.+++.+
T Consensus 227 ----------~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 227 ----------GERLP----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred ----------CCCCC----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 01111 112357889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=304.56 Aligned_cols=246 Identities=34% Similarity=0.558 Sum_probs=201.2
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
+|.+.+.||+|+||.||++.+..+++.|++|.+.... ....+|+++++.++|+||+++++++. +..+.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE-----TSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE-----eCCEEE
Confidence 4888999999999999999999999999999885443 23457999999999999999999873 345688
Q ss_pred EEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 212 lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
+||||+++. +.+.+.. ...+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .++|+|||.+...
T Consensus 76 ~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~ 149 (254)
T cd06627 76 IILEYAENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHE-QGVIHRDIKAANILTTKDG-VVKLADFGVATKL 149 (254)
T ss_pred EEEecCCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEECCCC-CEEEeccccceec
Confidence 999999874 4333322 2568899999999999999999997 9999999999999999877 8999999999876
Q ss_pred CCCCC-CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 291 VPGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 291 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
..... .....++..|+|||.+.+.. ++.++||||+|+++|+|++|..||...+.......+...
T Consensus 150 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-------------- 214 (254)
T cd06627 150 NDVSKDDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD-------------- 214 (254)
T ss_pred CCCcccccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc--------------
Confidence 44332 23457889999999986554 889999999999999999999999876654444333210
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
.. ..++..+++.+.++|.+||..||++|||+.+++.||||
T Consensus 215 -----~~---------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 215 -----DH---------PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred -----CC---------CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 00 01234578999999999999999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=313.81 Aligned_cols=248 Identities=21% Similarity=0.310 Sum_probs=191.4
Q ss_pred cceeEeeeeccCCceEEEEEEEc----CCCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCL----ETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~----~~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
..|++.+.||+|+||.||+|.+. .++..||+|.+.... ..+.+|+.+++.++||||+++++++. ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVT-----QE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe-----cC
Confidence 46889999999999999999853 456789999885321 34567999999999999999999873 33
Q ss_pred eEEEEEeeechhh-HHHHhhhhh-------------hcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEc
Q 011138 208 LYLNLVLEYISET-VYRVSKHYT-------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN 273 (492)
Q Consensus 208 ~~~~lV~E~~~~~-l~~~~~~~~-------------~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~ 273 (492)
...|+||||+.++ +.+.+.... .....+++..+..++.||+.||.|||+ +||+||||||+|||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~nili~ 158 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS-HFFVHKDLAARNILIG 158 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-cCeehhccccceEEEc
Confidence 4588999999864 444432111 112347788889999999999999997 9999999999999999
Q ss_pred CCCCcEEEeeecCccccCCCC---CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 011138 274 PHTHQLKICDFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQL 349 (492)
Q Consensus 274 ~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~ 349 (492)
.++ .+||+|||+++...... ......++..|+|||.+.+. .++.++|||||||++|||++ |.+||.+.+..+..
T Consensus 159 ~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05090 159 EQL-HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI 236 (283)
T ss_pred CCC-cEEeccccccccccCCcceecccCCCccceecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 877 79999999997653322 12234456789999998654 48999999999999999998 99999887654333
Q ss_pred HHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 350 VEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 350 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
..+... . .. ..+..+++++.+++.+||+.||.+||++.+++++
T Consensus 237 ~~~~~~-~-----------------~~----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 237 EMVRKR-Q-----------------LL----------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHcC-C-----------------cC----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 332210 0 00 0123578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=309.89 Aligned_cols=250 Identities=29% Similarity=0.489 Sum_probs=194.7
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
.+|.+.+.||+|+||.||+|.+..+|..||||.+... .....+|+.+++.++|+||++++++|. +..+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----EDNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE-----eCCe
Confidence 3588899999999999999999999999999977431 123457999999999999999999884 3346
Q ss_pred EEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 210 ~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
.++||||+.+ .+.+++.........+++..+..++.||+.||.|||+ +|++|+||||+||+++.++ .++|+|||++.
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~~~-~~~l~dfg~~~ 154 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITATG-VVKLGDLGLGR 154 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-CEEECcchhhh
Confidence 8899999986 4555444434445668999999999999999999997 9999999999999999877 79999999987
Q ss_pred ccCCCCC-CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 289 MLVPGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 289 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
....... .....|+..|+|||.+.+. .++.++|+|||||++|+|++|..||.+..... ..+.+.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~----------- 220 (267)
T cd08229 155 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL--YSLCKKI----------- 220 (267)
T ss_pred ccccCCcccccccCCcCccCHHHhcCC-CccchhhHHHHHHHHHHHHhCCCCcccccchH--HHHhhhh-----------
Confidence 6543322 2245788999999998654 48899999999999999999999997644211 1111110
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
....++.. ....+++++++||.+||..||.+|||+.++++
T Consensus 221 ----~~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 221 ----EQCDYPPL--------PSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred ----hcCCCCCC--------CcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 00011110 11346889999999999999999999997753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=300.53 Aligned_cols=258 Identities=26% Similarity=0.475 Sum_probs=209.9
Q ss_pred CCccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHc-CCCCccccceeeeecc
Q 011138 132 QPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLL-NHPNVVSLKHCFFSTT 203 (492)
Q Consensus 132 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~ 203 (492)
+.....+|.+.++||+|+|..|.+++.++|.+.||+|++++. ....+.|..+..+- +||.+|-++.||
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf---- 320 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF---- 320 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh----
Confidence 334455799999999999999999999999999999988653 22345677777655 699999999999
Q ss_pred CCCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEee
Q 011138 204 EKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICD 283 (492)
Q Consensus 204 ~~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~D 283 (492)
+....+++|.||++|+-+ +.+.. ....+|+..+++|...|+.||.|||+ +|||+||||.+|||+|..+ .+||+|
T Consensus 321 -qtesrlffvieyv~ggdl--mfhmq-rqrklpeeharfys~ei~lal~flh~-rgiiyrdlkldnvlldaeg-hikltd 394 (593)
T KOG0695|consen 321 -QTESRLFFVIEYVNGGDL--MFHMQ-RQRKLPEEHARFYSAEICLALNFLHE-RGIIYRDLKLDNVLLDAEG-HIKLTD 394 (593)
T ss_pred -cccceEEEEEEEecCcce--eeehh-hhhcCcHHHhhhhhHHHHHHHHHHhh-cCeeeeeccccceEEccCC-ceeecc
Confidence 566679999999998733 33333 35679999999999999999999997 9999999999999999999 599999
Q ss_pred ecCcccc-CCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCC-------CChHHHHHHHHHH
Q 011138 284 FGSAKML-VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPG-------ESGVDQLVEIIKI 355 (492)
Q Consensus 284 FG~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~-------~~~~~~~~~i~~~ 355 (492)
+|+++.- .++....+++|||.|+|||++.|.. |+..+|+|+|||+++||+.|+.||+- .+..+.+.+++-.
T Consensus 395 ygmcke~l~~gd~tstfcgtpnyiapeilrgee-ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile 473 (593)
T KOG0695|consen 395 YGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE 473 (593)
T ss_pred cchhhcCCCCCcccccccCCCcccchhhhcccc-cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh
Confidence 9998764 4566677899999999999997765 99999999999999999999999952 3344455554321
Q ss_pred hCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCC------HHHhhCCCCCCCCCC
Q 011138 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT------ALEACAHPFFDDLRD 428 (492)
Q Consensus 356 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t------~~e~l~Hp~f~~~~~ 428 (492)
..+.+| ..+|-.+..+++..|.+||.+|.. ..++..|+||+.+..
T Consensus 474 ----------------kqirip------------rslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idw 524 (593)
T KOG0695|consen 474 ----------------KQIRIP------------RSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDW 524 (593)
T ss_pred ----------------hccccc------------ceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCH
Confidence 122222 346677889999999999999984 679999999997654
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=312.53 Aligned_cols=247 Identities=24% Similarity=0.333 Sum_probs=192.7
Q ss_pred cceeEeeeeccCCceEEEEEEEc-----CCCCEEEEEEeccch----hhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~-----~~g~~vAiK~~~~~~----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
.+|.+.+.||+|+||.||++.+. .++..+|+|.+.... ....+|+.+++.++||||+++++++ ...
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 79 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVC-----VEG 79 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence 46999999999999999999853 345679999885432 2356799999999999999999988 344
Q ss_pred eEEEEEeeechhh-HHHHhhhhh---------hcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCC
Q 011138 208 LYLNLVLEYISET-VYRVSKHYT---------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH 277 (492)
Q Consensus 208 ~~~~lV~E~~~~~-l~~~~~~~~---------~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~ 277 (492)
.++++||||+.++ +...+.... .....+++..+..++.||+.||+|||+ +||+||||||+|||++.++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~-~~i~H~dlkp~Nili~~~~- 157 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGENL- 157 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEccCC-
Confidence 4689999999854 444433211 112348899999999999999999997 9999999999999999887
Q ss_pred cEEEeeecCccccCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 011138 278 QLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEII 353 (492)
Q Consensus 278 ~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~ 353 (492)
.+||+|||+++....... .....++..|+|||++.+. .++.++|||||||++|+|++ |.+||......+.+..+.
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~ 236 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 236 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 799999999976533221 1223457789999998654 58999999999999999998 999998877655554443
Q ss_pred HHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 354 KILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 354 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.. . .+. .+..++.++.+|+.+||+.||.+|||+.+++.
T Consensus 237 ~~--~-----------------~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 237 QG--R-----------------VLQ---------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred cC--C-----------------cCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 21 0 000 11246789999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=308.10 Aligned_cols=244 Identities=19% Similarity=0.277 Sum_probs=191.4
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch---hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~---~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
.+|.+.+.||+|+||.||.|.+.. +..+|||.+.... ....+|+.+++.++||||+++++++ .....+++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC-----TKQRPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEE-----ccCCCcEEE
Confidence 359999999999999999998754 4569999876432 3456799999999999999999988 333457899
Q ss_pred eeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 214 LEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 214 ~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
|||+.++ +.+.+.. ....+++..+..++.||+.||.|||+ +||+|+||||+|||++.++ .+||+|||+++....
T Consensus 78 ~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~nili~~~~-~~kl~d~g~~~~~~~ 152 (256)
T cd05113 78 TEYMSNGCLLNYLRE---HGKRFQPSQLLEMCKDVCEGMAYLES-KQFIHRDLAARNCLVDDQG-CVKVSDFGLSRYVLD 152 (256)
T ss_pred EEcCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcCCC-CEEECCCccceecCC
Confidence 9999865 4443322 22368899999999999999999997 9999999999999999877 799999999876543
Q ss_pred CCCC--ccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 293 GEPN--ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 293 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
.... ....++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+......
T Consensus 153 ~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------- 220 (256)
T cd05113 153 DEYTSSVGSKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL----------- 220 (256)
T ss_pred CceeecCCCccChhhCCHHHHhcC-cccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC-----------
Confidence 3211 123456779999999654 48999999999999999998 99999877665544444331100
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
. .+...++.+++++.+||..||.+||++.+++.+
T Consensus 221 -----~------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 221 -----Y------------RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred -----C------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 0 112357899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=314.90 Aligned_cols=247 Identities=21% Similarity=0.265 Sum_probs=192.4
Q ss_pred cceeEeeeeccCCceEEEEEEEcCC-----CCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCC
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLET-----GDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~-----g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 206 (492)
..|.+.+.||+|+||.||+|.+..+ +..||||++.... ..+.+|+.+++.++||||+++++++ ..
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~-----~~ 79 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVV-----TK 79 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-----cC
Confidence 3588899999999999999987543 5789999986432 2345799999999999999999988 33
Q ss_pred ceEEEEEeeechhh-HHHHhhhh------------hhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEc
Q 011138 207 ELYLNLVLEYISET-VYRVSKHY------------TRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN 273 (492)
Q Consensus 207 ~~~~~lV~E~~~~~-l~~~~~~~------------~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~ 273 (492)
....++++||+.++ +...+... ......+++..+..++.|++.||.|||+ +||+||||||+|||++
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~-~gi~H~dlkp~Nil~~ 158 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS-HHVVHKDLATRNVLVF 158 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-cCccccccchhheEec
Confidence 44588999999854 43333211 1112357888899999999999999997 9999999999999999
Q ss_pred CCCCcEEEeeecCccccCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 011138 274 PHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQL 349 (492)
Q Consensus 274 ~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~ 349 (492)
.++ .+||+|||+++....... .....+++.|+|||.+.+.. ++.++|||||||++|||++ |..||.+....+.+
T Consensus 159 ~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05091 159 DKL-NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI 236 (283)
T ss_pred CCC-ceEecccccccccccchheeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 777 799999999876533221 12334577899999986544 8999999999999999998 89999887765555
Q ss_pred HHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 350 VEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 350 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
..+.... .. .++..++.++.+|+.+||+.||.+||++.++++
T Consensus 237 ~~i~~~~-------------------~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 237 EMIRNRQ-------------------VL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred HHHHcCC-------------------cC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 4443310 00 012357889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=305.60 Aligned_cols=242 Identities=27% Similarity=0.383 Sum_probs=194.3
Q ss_pred eeeccCCceEEEEEEEcCC---CCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEe
Q 011138 143 RVVGTGSFGVVFQAKCLET---GDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~---g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
+.||+|+||.||+|.+... +..||+|.+.... ....+|+.+++.++|+||+++++++. +...+++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCT-----EEEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeec-----CCCceEEEE
Confidence 3699999999999999866 8999999886542 34557999999999999999999883 345689999
Q ss_pred eech-hhHHHHhhhhhhc-----CCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 215 EYIS-ETVYRVSKHYTRM-----NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 215 E~~~-~~l~~~~~~~~~~-----~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
||+. +.+.+.+...... ...+++..+..++.||+.||+|||+ +||+||||||+||+++.++ .+||+|||.+.
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~nili~~~~-~~~l~dfg~~~ 153 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS-KKFVHRDLAARNCLVGEDL-VVKISDFGLSR 153 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc-CCcccCccCcceEEECCCC-cEEEccccccc
Confidence 9996 4555544432111 3678999999999999999999997 9999999999999999887 79999999998
Q ss_pred ccCCCC---CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 011138 289 MLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEI 364 (492)
Q Consensus 289 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~ 364 (492)
...... ......++..|+|||.+.+. .++.++|||||||++|+|++ |..||......+....+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--------- 223 (262)
T cd00192 154 DVYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG--------- 223 (262)
T ss_pred ccccccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---------
Confidence 764432 23345678899999998655 58999999999999999998 69999887655444443220
Q ss_pred hhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
. ....+..+++++.+++.+||..||.+||++.|+++|
T Consensus 224 -------~------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 224 -------Y------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred -------C------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0 001223568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=307.91 Aligned_cols=245 Identities=24% Similarity=0.344 Sum_probs=192.9
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch---hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~---~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
..+|++.+.||+|+||.||+|.+. ++..||+|.+.... ....+|+.+++.++|+||+++++++ .+....++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 78 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV-----TKEEPIYI 78 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEE-----cCCCCcEE
Confidence 356999999999999999999864 56789999875432 3455799999999999999999887 44455889
Q ss_pred Eeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 213 V~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
||||+.+ .+.+.+.. .....+++..+..++.||+.||.|||+ .|++||||||+||+++.++ .+||+|||++....
T Consensus 79 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~ 154 (261)
T cd05072 79 ITEYMAKGSLLDFLKS--DEGGKVLLPKLIDFSAQIAEGMAYIER-KNYIHRDLRAANVLVSESL-MCKIADFGLARVIE 154 (261)
T ss_pred EEecCCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEecCCC-cEEECCCccceecC
Confidence 9999975 45444332 223567888889999999999999997 9999999999999999887 79999999998654
Q ss_pred CCCC--CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 292 PGEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 292 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
.... .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||......+....+...
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~------------- 220 (261)
T cd05072 155 DNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG------------- 220 (261)
T ss_pred CCceeccCCCccceecCCHHHhccC-CCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-------------
Confidence 3221 1223456789999998654 48899999999999999998 99999887665544443221
Q ss_pred CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
...+ ....++.++.+|+.+||..||++||+++++.+
T Consensus 221 -----~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 221 -----YRMP----------RMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred -----CCCC----------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0111 11246889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=310.04 Aligned_cols=248 Identities=24% Similarity=0.319 Sum_probs=193.2
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCC-----CCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCC
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLET-----GDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~-----g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 205 (492)
..+|.+.+.||+|+||.||+|.+... +..||+|.+.... ....+|+.+++.++||||+++++++ .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~ 79 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----S 79 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-----c
Confidence 35799999999999999999988644 4789999875432 2345799999999999999999988 3
Q ss_pred CceEEEEEeeechh-hHHHHhhhhhh------cCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCc
Q 011138 206 DELYLNLVLEYISE-TVYRVSKHYTR------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQ 278 (492)
Q Consensus 206 ~~~~~~lV~E~~~~-~l~~~~~~~~~------~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~ 278 (492)
+..+.++||||+++ ++...+..... ....+++..+..++.||+.||.|||+ .||+||||||+|||++.++ .
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~di~p~nill~~~~-~ 157 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA-KKFVHRDLAARNCMVAEDL-T 157 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccChheEEEcCCC-C
Confidence 44568899999975 55554433221 12246778889999999999999997 9999999999999999888 7
Q ss_pred EEEeeecCccccCCCC---CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 011138 279 LKICDFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIK 354 (492)
Q Consensus 279 vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~ 354 (492)
+||+|||+++...... ......++..|+|||.+.+. .++.++|||||||++|||++ |..||.+.+..+....+..
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05032 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID 236 (277)
T ss_pred EEECCcccchhhccCcccccCCCCCccccccCHHHHhcC-CCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc
Confidence 9999999987654322 12234567889999998654 48999999999999999998 9999987765544333321
Q ss_pred HhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 355 ILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 355 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
+. ... ++...+.++.+||.+||+.||++|||+.++++
T Consensus 237 --~~--------------~~~------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 237 --GG--------------HLD------------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred --CC--------------CCC------------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00 001 12345889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=326.74 Aligned_cols=249 Identities=26% Similarity=0.380 Sum_probs=190.3
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCC-----CCEEEEEEeccc-----hhhHHHHHHHHHHcC-CCCccccceeeeeccC
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLET-----GDSVAIKKVLQD-----KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTE 204 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~-----g~~vAiK~~~~~-----~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~ 204 (492)
..+|++++.||+|+||.||+|.+... +..||||++... .....+|+.+++.+. |||||++++++
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~----- 110 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC----- 110 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE-----
Confidence 45799999999999999999987433 357999988542 233457999999996 99999999998
Q ss_pred CCceEEEEEeeechhh-HHHHhhhhh------------------------------------------------------
Q 011138 205 KDELYLNLVLEYISET-VYRVSKHYT------------------------------------------------------ 229 (492)
Q Consensus 205 ~~~~~~~lV~E~~~~~-l~~~~~~~~------------------------------------------------------ 229 (492)
.+...+|||||||.++ |.+.+....
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 4445689999999854 444332210
Q ss_pred --------------------------------------hcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceE
Q 011138 230 --------------------------------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLL 271 (492)
Q Consensus 230 --------------------------------------~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NIL 271 (492)
.....+++..+..++.||+.||.|||+ .||+||||||+|||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dikp~Nil 269 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS-KNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHhEE
Confidence 011347778888999999999999997 99999999999999
Q ss_pred EcCCCCcEEEeeecCccccCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHH
Q 011138 272 VNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVD 347 (492)
Q Consensus 272 l~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~ 347 (492)
++.++ .+||+|||+++....... .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.......
T Consensus 270 l~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 270 LAQGK-IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN-LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred EeCCC-EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 99877 799999999976533221 2234567889999998654 48999999999999999997 999998765443
Q ss_pred HHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 348 QLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 348 ~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.+...+.. ....+ .+..++.++.+||.+||+.||++||++.++.+
T Consensus 348 ~~~~~~~~-----------------~~~~~----------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 348 TFYNKIKS-----------------GYRMA----------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHHhc-----------------CCCCC----------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 33332221 00000 12346889999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=311.00 Aligned_cols=250 Identities=22% Similarity=0.292 Sum_probs=192.6
Q ss_pred ccceeEeeeeccCCceEEEEEEEcC-----CCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCC
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~-----~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 205 (492)
..+|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ....+|+.+++.++|+||+++++++.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----- 79 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSF----- 79 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----
Confidence 3469999999999999999999977 77889999875322 23457999999999999999999874
Q ss_pred CceEEEEEeeechh-hHHHHhhhhhh---cCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCC--CcE
Q 011138 206 DELYLNLVLEYISE-TVYRVSKHYTR---MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT--HQL 279 (492)
Q Consensus 206 ~~~~~~lV~E~~~~-~l~~~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~--~~v 279 (492)
+....++||||+.+ .+..++..... ....+++..+..++.||+.||.|||+ +|++||||||+|||++.++ ..+
T Consensus 80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 80 ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE-NHFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchheEEEeccCCCcce
Confidence 33347899999975 45544433221 12357888999999999999999997 9999999999999998653 259
Q ss_pred EEeeecCccccCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 011138 280 KICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKI 355 (492)
Q Consensus 280 kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~ 355 (492)
||+|||+++....... ......+..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~ 237 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG 237 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999986532211 11223356799999996544 8999999999999999996 99999887665443332210
Q ss_pred hCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 356 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
+ ... ++..++..+.+|+.+||+.||++||++.++++|
T Consensus 238 -~---------------~~~------------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 238 -G---------------RLD------------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred -C---------------cCC------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 000 123568899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=303.54 Aligned_cols=238 Identities=36% Similarity=0.589 Sum_probs=194.4
Q ss_pred eccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEeeec
Q 011138 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (492)
Q Consensus 145 lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E~~ 217 (492)
||.|+||.||++.+..+++.||+|.+.... ....+|+.+++.++|+||+++++.+ .+..+.|+||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence 699999999999999899999999885432 2456799999999999999999988 5556789999999
Q ss_pred h-hhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCC-CC
Q 011138 218 S-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG-EP 295 (492)
Q Consensus 218 ~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~-~~ 295 (492)
. +.+.+.+.. ...+++..+..++.||+.||.|||+ .|++|+||||+||+++.++ .++|+|||++...... ..
T Consensus 76 ~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~-~~~~H~~l~p~ni~~~~~~-~~~l~d~~~~~~~~~~~~~ 149 (250)
T cd05123 76 PGGELFSHLSK----EGRFSEERARFYAAEIVLALEYLHS-LGIIYRDLKPENILLDADG-HIKLTDFGLAKELSSEGSR 149 (250)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcceEEEcCCC-cEEEeecCcceecccCCCc
Confidence 5 455444332 3368889999999999999999997 9999999999999999887 7999999998765433 22
Q ss_pred CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccC
Q 011138 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFK 375 (492)
Q Consensus 296 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 375 (492)
.....++..|+|||.+.+.. ++.++|+|||||++|+|++|..||...+.......+.. ....
T Consensus 150 ~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-----------------~~~~ 211 (250)
T cd05123 150 TNTFCGTPEYLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-----------------DPLR 211 (250)
T ss_pred ccCCcCCccccChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-----------------CCCC
Confidence 34567788999999986544 78899999999999999999999987765333333322 0111
Q ss_pred CCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCH---HHhhCCCCC
Q 011138 376 FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA---LEACAHPFF 423 (492)
Q Consensus 376 ~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~---~e~l~Hp~f 423 (492)
++..++.++.++|++||..||++||++ .++++||||
T Consensus 212 ------------~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 212 ------------FPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred ------------CCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 223468899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=345.91 Aligned_cols=257 Identities=31% Similarity=0.441 Sum_probs=194.5
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCC------
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEK------ 205 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~------ 205 (492)
.+|+..++||+||||.||+++++-+|+.||||+|.-.. ....+|+.+|.+|+|||||++|..+......
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 46788899999999999999999999999999985432 2234799999999999999997543211000
Q ss_pred -------------------------------------------------------------------C------------
Q 011138 206 -------------------------------------------------------------------D------------ 206 (492)
Q Consensus 206 -------------------------------------------------------------------~------------ 206 (492)
+
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence 0
Q ss_pred ---------------------c--------eEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhh
Q 011138 207 ---------------------E--------LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257 (492)
Q Consensus 207 ---------------------~--------~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~ 257 (492)
. .++||-||||+..+++.+........ ....++.+++||+.||.|+|+
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH~- 715 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIHD- 715 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHHh-
Confidence 1 57899999999887776544322111 466789999999999999998
Q ss_pred CCcccCCCCCCceEEcCCCCcEEEeeecCccccC-------------------CCCCCccceeccCccCchhhcCCC--C
Q 011138 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV-------------------PGEPNISYICSRYYRAPELIFGAT--E 316 (492)
Q Consensus 258 ~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~~--~ 316 (492)
+|||||||||.||++++++ .|||+|||+|+... +....++.+||.-|+|||++.+.. .
T Consensus 716 ~giIHRDLKP~NIFLd~~~-~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 716 QGIIHRDLKPRNIFLDSRN-SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred CceeeccCCcceeEEcCCC-CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 8999999999999999887 79999999997621 111345679999999999997666 6
Q ss_pred CCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhH
Q 011138 317 YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEA 396 (492)
Q Consensus 317 ~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 396 (492)
|+.|+|+|||||||+||+. ||...-. .. .++..+.. ..+|.. ..|+..--+.-
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~TsME--Ra-~iL~~LR~---------------g~iP~~------~~f~~~~~~~e 847 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTSME--RA-SILTNLRK---------------GSIPEP------ADFFDPEHPEE 847 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCchHH--HH-HHHHhccc---------------CCCCCC------cccccccchHH
Confidence 9999999999999999986 5654322 22 22222211 112211 11122223456
Q ss_pred hhhhccccccCCCCcCCHHHhhCCCCCC
Q 011138 397 LDLVSRLLQYSPSLRCTALEACAHPFFD 424 (492)
Q Consensus 397 ~~Li~~~L~~dP~~R~t~~e~l~Hp~f~ 424 (492)
..+|++||+.||.+||||.|+|++.||-
T Consensus 848 ~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 848 ASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 7999999999999999999999999998
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=311.52 Aligned_cols=254 Identities=29% Similarity=0.447 Sum_probs=203.9
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch---hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~---~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
..|.+...||+|+||.||+|.+..++..|++|.+.... ....+|+++++.++|+||+++++++.. ....|+|
T Consensus 19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~lv 93 (286)
T cd06614 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLV-----GDELWVV 93 (286)
T ss_pred ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEE-----CCEEEEE
Confidence 45888899999999999999999899999999886543 345679999999999999999998843 3468999
Q ss_pred eeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 214 LEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 214 ~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
+||+++ .+.+.+... ...++...+..++.||+.||.|||+ .||+|+||||+||+++.++ .++|+|||++.....
T Consensus 94 ~e~~~~~~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~lH~-~gi~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~ 168 (286)
T cd06614 94 MEYMDGGSLTDIITQN---FVRMNEPQIAYVCREVLQGLEYLHS-QNVIHRDIKSDNILLSKDG-SVKLADFGFAAQLTK 168 (286)
T ss_pred EeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCChhhEEEcCCC-CEEECccchhhhhcc
Confidence 999995 454443321 1378889999999999999999997 9999999999999999887 799999998865532
Q ss_pred CC-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 011138 293 GE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (492)
Q Consensus 293 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~ 371 (492)
.. ......++..|+|||.+.+. .++.++|+|||||++|+|++|..||...+.......+... +.+.
T Consensus 169 ~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~----------- 235 (286)
T cd06614 169 EKSKRNSVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIPP----------- 235 (286)
T ss_pred chhhhccccCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCC-----------
Confidence 22 12334578899999998654 4899999999999999999999999877665444443221 0000
Q ss_pred cccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
++ ....++.++++||.+||+.||.+||++.+++.||||+...
T Consensus 236 ----~~----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 277 (286)
T cd06614 236 ----LK----------NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKAC 277 (286)
T ss_pred ----Cc----------chhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence 00 1123678999999999999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=333.36 Aligned_cols=207 Identities=29% Similarity=0.397 Sum_probs=170.9
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccC-CCceEEEE
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELYLNL 212 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~-~~~~~~~l 212 (492)
|...+.||+|+||.||+++++.+|+.||||.+... ....-+|+++|++|+|+|||++.+.=.+... --...-.+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 67778999999999999999999999999988542 2334479999999999999999775311110 00112358
Q ss_pred EeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcC--CC-CcEEEeeecCccc
Q 011138 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP--HT-HQLKICDFGSAKM 289 (492)
Q Consensus 213 V~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~--~~-~~vkL~DFG~a~~ 289 (492)
|||||.|+.+.-....-.....+++.++..++..++.||.|||+ +|||||||||+||++-. ++ ..-||+|||.|+.
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE-n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE-NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 99999976555444445566789999999999999999999997 99999999999999832 22 2579999999999
Q ss_pred cCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Q 011138 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGV 346 (492)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~ 346 (492)
+..+....+.+||+.|.+||++.....|+..+|.|||||++|++.||..||......
T Consensus 174 l~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 174 LDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred CCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 999998999999999999999976678999999999999999999999999664443
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=304.90 Aligned_cols=250 Identities=30% Similarity=0.516 Sum_probs=195.3
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEecc-------chhhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-------DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~-------~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
++|.+.+.||+|+||.||+|.+..+|+.||+|.+.. ......+|+++++.++|+||+++++++. +...
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~-----~~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI-----ENNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee-----cCCe
Confidence 469999999999999999999999999999998742 1234557999999999999999999984 3446
Q ss_pred EEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 210 ~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
.++||||+++ .+...+.........++...+..++.||+.||.|||+ .||+||||||+||+++.++ .++|+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~nil~~~~~-~~~l~d~~~~~ 154 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS-KRIMHRDIKPANVFITATG-VVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecCCcChhhEEECCCC-cEEEeccceee
Confidence 8899999986 5555544433445568899999999999999999997 9999999999999999887 79999999987
Q ss_pred ccCCCC-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 289 MLVPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 289 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
...... ......+++.|+|||.+.+. .++.++|+|||||++|+|++|..||...... .......+
T Consensus 155 ~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~----------- 220 (267)
T cd08224 155 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKI----------- 220 (267)
T ss_pred eccCCCcccceecCCccccCHHHhccC-CCCchhcHHHHHHHHHHHHHCCCCcccCCcc--HHHHHhhh-----------
Confidence 653322 22345788999999998654 4889999999999999999999999654311 11111110
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
....++.. ....++.++.++|.+||..+|++|||+.++++
T Consensus 221 ----~~~~~~~~--------~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 221 ----EKCDYPPL--------PADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred ----hcCCCCCC--------ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00001100 01246789999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=305.33 Aligned_cols=244 Identities=23% Similarity=0.318 Sum_probs=191.7
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch---hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~---~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
.+|.+.+.||+|+||.||+|.+. +++.||+|.+.... ....+|+.+++.++||||+++++++ .....+++|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv 79 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC-----TLEEPIYIV 79 (261)
T ss_pred hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEE-----ecCCCeeee
Confidence 46999999999999999999864 45789999986532 3456799999999999999999987 333458899
Q ss_pred eeech-hhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 214 LEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 214 ~E~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
|||+. +.+.+.+... ....+++..+..++.|++.||.|||+ +||+||||||+||+++.++ .+||+|||+++....
T Consensus 80 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~ 155 (261)
T cd05068 80 TELMKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEA-QNYIHRDLAARNVLVGENN-ICKVADFGLARVIKE 155 (261)
T ss_pred eecccCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCcceEEEcCCC-CEEECCcceEEEccC
Confidence 99996 4555544321 13468899999999999999999997 9999999999999999887 799999999987642
Q ss_pred CCCC--ccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 293 GEPN--ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 293 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
.... .....+..|+|||.+.+. .++.++|||||||++|+|++ |+.||.+.+....+..+.+..
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~------------- 221 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYN-RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY------------- 221 (261)
T ss_pred CcccccCCCcCceeccCccccccC-CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------------
Confidence 2111 111224579999988654 48999999999999999999 999998877655444442210
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
..+ ....+++.+.+++.+||..||.+||++.+++.
T Consensus 222 -----~~~----------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 222 -----RMP----------CPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred -----CCC----------CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 000 11346889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=306.51 Aligned_cols=243 Identities=21% Similarity=0.323 Sum_probs=190.5
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc---hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEe
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
+|.+.+.||+|+||.||+|.+. ++..+|+|.+... .....+|+.+++.++||||+++++++ ....+.|+||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~ 78 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC-----TKQRPIFIVT 78 (256)
T ss_pred HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCCceEEEE
Confidence 5889999999999999999875 5678999987543 23455799999999999999999887 4445688999
Q ss_pred eechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCC
Q 011138 215 EYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (492)
Q Consensus 215 E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (492)
||++++ +.+.+.. ....+++..+..++.||+.||.|||+ +||+||||||+||+++.++ .+||+|||+++.....
T Consensus 79 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~ni~i~~~~-~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 79 EYMANGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAMEYLES-NGFIHRDLAARNCLVGEDN-VVKVSDFGLARYVLDD 153 (256)
T ss_pred ecCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHhhEEECCCC-cEEECCcccceecccc
Confidence 999765 4443322 22367889999999999999999997 9999999999999999887 7999999998765332
Q ss_pred CCC--ccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 011138 294 EPN--ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (492)
Q Consensus 294 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 370 (492)
... ....++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+....
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-------------- 218 (256)
T cd05059 154 QYTSSQGTKFPVKWAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY-------------- 218 (256)
T ss_pred cccccCCCCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCC--------------
Confidence 211 112234579999998654 48999999999999999998 899998776655444332210
Q ss_pred CcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
.. ..+...+.++.+|+.+||..+|++|||+.++++.
T Consensus 219 ----~~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 219 ----RL----------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred ----cC----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 00 0113468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=307.05 Aligned_cols=245 Identities=23% Similarity=0.321 Sum_probs=191.2
Q ss_pred cceeEeeeeccCCceEEEEEEEcCC---CCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLET---GDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~---g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
.+|.+.+.||+|+||.||+|.+..+ ...||||.+.... ....+|+.+++.++||||+++++++ ....
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 78 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVV-----TKSR 78 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEE-----ecCC
Confidence 4689999999999999999998654 4579999875432 2345699999999999999999987 3344
Q ss_pred EEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 209 ~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
..++||||+.++ +.+.+. .....+++..+..++.|++.||.|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 79 ~~~iv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~di~p~nili~~~~-~~~l~dfg~~ 153 (266)
T cd05033 79 PVMIITEYMENGSLDKFLR---ENDGKFTVGQLVGMLRGIASGMKYLSE-MNYVHRDLAARNILVNSNL-VCKVSDFGLS 153 (266)
T ss_pred ceEEEEEcCCCCCHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcCCC-CEEECccchh
Confidence 588999999875 333322 223468899999999999999999997 9999999999999999887 7999999999
Q ss_pred cccCCCCCC-c--cceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 011138 288 KMLVPGEPN-I--SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREE 363 (492)
Q Consensus 288 ~~~~~~~~~-~--~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~ 363 (492)
......... . ...++..|+|||.+.+. .++.++|||||||++|+|++ |..||......+....+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-------- 224 (266)
T cd05033 154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG-------- 224 (266)
T ss_pred hcccccccceeccCCCCCccccChhhhccC-CCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcC--------
Confidence 876421111 1 22345789999998654 48999999999999999997 99999876655444433221
Q ss_pred HhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
...+ .+...++.+.+|+.+||+.||++||++.+++++
T Consensus 225 ----------~~~~----------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 225 ----------YRLP----------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred ----------CCCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0011 112468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=310.12 Aligned_cols=253 Identities=18% Similarity=0.213 Sum_probs=184.1
Q ss_pred ceeEeeeeccCCceEEEEEEEcCC---CCEEEEEEeccchhhHH---------------HHHHHHHHcCCCCccccceee
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLET---GDSVAIKKVLQDKRYKN---------------RELQIMRLLNHPNVVSLKHCF 199 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~---g~~vAiK~~~~~~~~~~---------------~E~~il~~l~h~nIv~l~~~~ 199 (492)
+|.+.++||+|+||.||+|.+..+ +..+|+|+......... .+...+..++|+||++++++.
T Consensus 13 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~ 92 (294)
T PHA02882 13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCG 92 (294)
T ss_pred ceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEee
Confidence 599999999999999999998877 67788886432221111 122334556899999999876
Q ss_pred eeccCCCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcE
Q 011138 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQL 279 (492)
Q Consensus 200 ~~~~~~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~v 279 (492)
.... ....+.+++||++...+...... ....++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+
T Consensus 93 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiHrDiKp~Nill~~~~-~~ 165 (294)
T PHA02882 93 SFKR-CRMYYRFILLEKLVENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHE-HGISHGDIKPENIMVDGNN-RG 165 (294)
T ss_pred eEec-CCceEEEEEEehhccCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-cE
Confidence 4433 22345678999887665554332 2235677888999999999999997 9999999999999999877 79
Q ss_pred EEeeecCccccCCCC--------CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 011138 280 KICDFGSAKMLVPGE--------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVE 351 (492)
Q Consensus 280 kL~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~ 351 (492)
+|+|||+|+...... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+......+..
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~-~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA-CVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 999999997653221 11234699999999998654 489999999999999999999999988743333222
Q ss_pred HHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 352 IIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 352 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
..+. ..+..... ... ..+..++++.+++..|+..+|++||+..++++
T Consensus 245 ~~~~------~~~~~~~~--~~~-------------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 245 AAKC------DFIKRLHE--GKI-------------KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HhHH------HHHHHhhh--hhh-------------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 2110 00000000 000 11245788999999999999999999999864
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=319.81 Aligned_cols=262 Identities=27% Similarity=0.350 Sum_probs=189.3
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
+.+|....+||+|+||.||+|.. .+|..||||++... ...+.+|+.++.+++|||+|+|++||..... ..+
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~----~~~ 148 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGE----HRL 148 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCc----eEE
Confidence 45677788999999999999985 45599999988542 3457899999999999999999999954331 478
Q ss_pred EEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhC--CcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV--GVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~--givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
||+||+..+.+....+..... .++|.....|+.++++||+|||... .|||||||++|||+|.+. +.||+|||+|+.
T Consensus 149 LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~-~aKlsDFGLa~~ 226 (361)
T KOG1187|consen 149 LVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF-NAKLSDFGLAKL 226 (361)
T ss_pred EEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC-CEEccCccCccc
Confidence 999999965444333322212 7899999999999999999999734 399999999999999888 899999999976
Q ss_pred cCC-CCCCccc-eeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHH-HHhCCCCHHHH
Q 011138 290 LVP-GEPNISY-ICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES--GVDQLVEII-KILGTPTREEI 364 (492)
Q Consensus 290 ~~~-~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~--~~~~~~~i~-~~~g~p~~~~~ 364 (492)
... ....... .||..|+|||.+.. ...+.++|||||||+|.||++|+.+.+... ....+.... ..+...
T Consensus 227 ~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~----- 300 (361)
T KOG1187|consen 227 GPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG----- 300 (361)
T ss_pred CCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc-----
Confidence 544 3332233 89999999999965 458999999999999999999998887543 111122211 111111
Q ss_pred hhcCCCCcccCCCcccCCCcccccCC-CCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 365 KCMNPNYTEFKFPQIKAHPWHKIFHK-RMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
...++.=|.+... .+.. ..-..+..+..+|++.+|.+||++.|++.
T Consensus 301 -----~~~eiiD~~l~~~----~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 301 -----KLREIVDPRLKEG----EYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred -----chhheeCCCccCC----CCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 0111111111100 0000 01123567888999999999999999743
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=310.72 Aligned_cols=249 Identities=24% Similarity=0.369 Sum_probs=192.5
Q ss_pred ccccceeEeeeeccCCceEEEEEEE-----cCCCCEEEEEEeccch-----hhHHHHHHHHHHc-CCCCccccceeeeec
Q 011138 134 KQTISYMAERVVGTGSFGVVFQAKC-----LETGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFST 202 (492)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~-----~~~g~~vAiK~~~~~~-----~~~~~E~~il~~l-~h~nIv~l~~~~~~~ 202 (492)
....+|.+.+.||+|+||.||+|.+ ..++..||+|.+.... ....+|+.+++++ +||||+++++++.
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-- 109 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT-- 109 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe--
Confidence 3345799999999999999999975 2355689999875432 2345799999999 7999999999883
Q ss_pred cCCCceEEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEE
Q 011138 203 TEKDELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKI 281 (492)
Q Consensus 203 ~~~~~~~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL 281 (492)
....+++||||+.++ +...+.. .....+++..+..++.||+.||.|||+ +||+|+||||+|||++.++ .+||
T Consensus 110 ---~~~~~~lv~e~~~~~~L~~~i~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~~l 182 (302)
T cd05055 110 ---IGGPILVITEYCCYGDLLNFLRR--KRESFLTLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNVLLTHGK-IVKI 182 (302)
T ss_pred ---cCCceEEEEEcCCCCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeehhhhccceEEEcCCC-eEEE
Confidence 334589999999854 4444322 112337899999999999999999997 9999999999999999777 7999
Q ss_pred eeecCccccCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 011138 282 CDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILG 357 (492)
Q Consensus 282 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g 357 (492)
+|||+++....... .....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+....+.+.+....
T Consensus 183 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~-- 259 (302)
T cd05055 183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE-- 259 (302)
T ss_pred CCCcccccccCCCceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHc--
Confidence 99999976533221 11234577899999986554 8999999999999999998 99999877655444443321
Q ss_pred CCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 358 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 358 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.+.. ..+..+++++.+|+.+||..||++|||+.++++
T Consensus 260 ---------------~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 260 ---------------GYRM----------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred ---------------CCcC----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0000 012346889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=307.11 Aligned_cols=245 Identities=22% Similarity=0.318 Sum_probs=195.8
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch----hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
..+|.+.+.||.|+||.||+|.+.. +..+|+|.+.... ....+|+.+++.++|+||+++++++ .+....+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 78 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC-----SVGEPVY 78 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeE-----ecCCCeE
Confidence 3469999999999999999999877 8999999886443 3456799999999999999999987 3444588
Q ss_pred EEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 212 lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
+||||+++ .+.+.+... ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||.+...
T Consensus 79 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~h~dl~~~nilv~~~~-~~kl~d~g~~~~~ 154 (261)
T cd05148 79 IITELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEE-QNSIHRDLAARNILVGEDL-VCKVADFGLARLI 154 (261)
T ss_pred EEEeecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccCcceEEEcCCc-eEEEccccchhhc
Confidence 99999986 555544321 23567888999999999999999997 9999999999999999887 7999999999765
Q ss_pred CCCCC-CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 291 VPGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 291 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
..... .....++..|+|||.+.+. .++.++|||||||++|+|++ |+.||.+.+..+.+..+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------- 223 (261)
T cd05148 155 KEDVYLSSDKKIPYKWTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM---------- 223 (261)
T ss_pred CCccccccCCCCceEecCHHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC----------
Confidence 33221 1123456789999998654 58899999999999999998 89999887766655554321100
Q ss_pred CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
..+..+++++.++|.+||+.||.+|||+.++++
T Consensus 224 ------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 224 ------------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred ------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 012346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=308.35 Aligned_cols=255 Identities=30% Similarity=0.487 Sum_probs=195.6
Q ss_pred ceeEeeeeccCCceEEEEEEEc---CCCCEEEEEEeccch--------hhHHHHHHHHHHc-CCCCccccceeeeeccCC
Q 011138 138 SYMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQDK--------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK 205 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~---~~g~~vAiK~~~~~~--------~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~ 205 (492)
+|.+.+.||+|+||.||++.+. .+++.||||.+.... ....+|+.+++.+ +||||+++++++ .
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----Q 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----e
Confidence 3888999999999999999864 467899999885421 2345799999999 599999999888 4
Q ss_pred CceEEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeee
Q 011138 206 DELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (492)
Q Consensus 206 ~~~~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DF 284 (492)
....+|+||||+.++ +...+. ....+++..++.++.|++.||.|||+ .|++||||||.||+++.++ .++|+||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lH~-~~~~H~dl~p~nil~~~~~-~~~l~df 149 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLY----QREHFTESEVRVYIAEIVLALDHLHQ-LGIIYRDIKLENILLDSEG-HVVLTDF 149 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHh----hcCCcCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCC-CEEEEEC
Confidence 445688999999865 333322 23568888999999999999999997 9999999999999999887 7999999
Q ss_pred cCccccCCCCC--CccceeccCccCchhhcCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 011138 285 GSAKMLVPGEP--NISYICSRYYRAPELIFGAT-EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTR 361 (492)
Q Consensus 285 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~ 361 (492)
|++........ .....|+..|+|||.+.+.. ..+.++|+||||+++|+|++|..||...........+.+..-.
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--- 226 (288)
T cd05583 150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK--- 226 (288)
T ss_pred ccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc---
Confidence 99876543322 22346889999999985532 3678999999999999999999999654332222222211000
Q ss_pred HHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCC---HHHhhCCCCCCCCCC
Q 011138 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT---ALEACAHPFFDDLRD 428 (492)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t---~~e~l~Hp~f~~~~~ 428 (492)
... ..+..++.++.+||.+||+.||++||| +.++|+||||+.+..
T Consensus 227 ----------~~~------------~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 227 ----------SKP------------PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred ----------cCC------------CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence 000 012346789999999999999999998 567899999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=309.20 Aligned_cols=247 Identities=23% Similarity=0.337 Sum_probs=192.2
Q ss_pred cceeEeeeeccCCceEEEEEEEc-----CCCCEEEEEEeccch----hhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~-----~~g~~vAiK~~~~~~----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
.+|.+.+.||+|+||.||+|++. .++..+++|.+.... ....+|+.+++.++|+||+++++++ .+.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVC-----GDG 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEE-----ccC
Confidence 45899999999999999999864 345679999875432 3456899999999999999999988 344
Q ss_pred eEEEEEeeechhh-HHHHhhhhh------------hcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcC
Q 011138 208 LYLNLVLEYISET-VYRVSKHYT------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP 274 (492)
Q Consensus 208 ~~~~lV~E~~~~~-l~~~~~~~~------------~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~ 274 (492)
...++||||++++ +.+.+.... .....+++..++.++.||+.||.|||+ +||+||||||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS-QHFVHRDLATRNCLVGA 158 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEcc
Confidence 4588999999754 444443211 112457889999999999999999997 99999999999999998
Q ss_pred CCCcEEEeeecCccccCCCC---CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 011138 275 HTHQLKICDFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLV 350 (492)
Q Consensus 275 ~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~ 350 (492)
++ .+||+|||++....... ......++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+.+.
T Consensus 159 ~~-~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 236 (291)
T cd05094 159 NL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236 (291)
T ss_pred CC-cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 87 89999999997653322 12234567889999998654 48899999999999999998 999998776654433
Q ss_pred HHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 351 EIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 351 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.+... ..+. .+...+.++.+|+.+||+.||.+||++.++++
T Consensus 237 ~~~~~-------------------~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 237 CITQG-------------------RVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHhCC-------------------CCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 32110 0000 11246789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=311.60 Aligned_cols=248 Identities=23% Similarity=0.334 Sum_probs=189.8
Q ss_pred ccceeEeeeeccCCceEEEEEEEcC-------CCCEEEEEEeccch-----hhHHHHHHHHHHc-CCCCccccceeeeec
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLE-------TGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFST 202 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~-------~g~~vAiK~~~~~~-----~~~~~E~~il~~l-~h~nIv~l~~~~~~~ 202 (492)
..+|.+++.||+|+||.||+|.+.. ++..+|+|.+..+. ....+|+.+++.+ +||||+++++++
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~--- 93 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC--- 93 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE---
Confidence 4579999999999999999998643 33579999886432 2344699999999 799999999988
Q ss_pred cCCCceEEEEEeeechh-hHHHHhhhhhh------------cCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCc
Q 011138 203 TEKDELYLNLVLEYISE-TVYRVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQN 269 (492)
Q Consensus 203 ~~~~~~~~~lV~E~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~N 269 (492)
.+....|+||||+++ ++.+.+..... ....+++..+..++.||+.||+|||+ +|++||||||+|
T Consensus 94 --~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~N 170 (307)
T cd05098 94 --TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS-KKCIHRDLAARN 170 (307)
T ss_pred --ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHHh
Confidence 334468899999985 55555433211 12357888899999999999999997 999999999999
Q ss_pred eEEcCCCCcEEEeeecCccccCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCh
Q 011138 270 LLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESG 345 (492)
Q Consensus 270 ILl~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~ 345 (492)
||++.++ .+||+|||+++....... .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+...
T Consensus 171 ill~~~~-~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 171 VLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred eEEcCCC-cEEECCCcccccccccchhhccccCCCccceeChHHhccC-CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 9999887 799999999876532211 1122345689999998654 48999999999999999998 8999977654
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 346 VDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 346 ~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.+....+ ... ... ..+..++.++++||.+||..+|.+||++.++++
T Consensus 249 ~~~~~~~-~~~---------------~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 294 (307)
T cd05098 249 EELFKLL-KEG---------------HRM------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294 (307)
T ss_pred HHHHHHH-HcC---------------CCC------------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 3333222 210 000 012356889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=317.38 Aligned_cols=250 Identities=25% Similarity=0.357 Sum_probs=188.5
Q ss_pred cceeEeeeeccCCceEEEEEEE-----cCCCCEEEEEEeccch-----hhHHHHHHHHHHc-CCCCccccceeeeeccCC
Q 011138 137 ISYMAERVVGTGSFGVVFQAKC-----LETGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK 205 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~-----~~~g~~vAiK~~~~~~-----~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~ 205 (492)
.+|.+.+.||+|+||.||+|.+ ..+++.||||++.... ....+|+.++..+ +||||+++++++...
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--- 83 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--- 83 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC---
Confidence 4699999999999999999985 3467899999985422 2345799999999 689999999977432
Q ss_pred CceEEEEEeeechhh-HHHHhhhhhh------------------------------------------------------
Q 011138 206 DELYLNLVLEYISET-VYRVSKHYTR------------------------------------------------------ 230 (492)
Q Consensus 206 ~~~~~~lV~E~~~~~-l~~~~~~~~~------------------------------------------------------ 230 (492)
...+++||||++++ +.+.+.....
T Consensus 84 -~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 84 -GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred -CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 23578999999864 4333322100
Q ss_pred ---------cCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCCC---Ccc
Q 011138 231 ---------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP---NIS 298 (492)
Q Consensus 231 ---------~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~~---~~~ 298 (492)
....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++........ ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCccCeEEEcCCC-cEEEEecccccccccCcchhhcCC
Confidence 01236777888999999999999997 9999999999999999877 899999999976532221 112
Q ss_pred ceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCC
Q 011138 299 YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFP 377 (492)
Q Consensus 299 ~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 377 (492)
..++..|+|||++.+. .++.++|||||||++|+|++ |..||........+...+... ....
T Consensus 241 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---------------~~~~-- 302 (343)
T cd05103 241 ARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG---------------TRMR-- 302 (343)
T ss_pred CCCCcceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhcc---------------CCCC--
Confidence 3446779999998654 48999999999999999996 999998765433333222110 0000
Q ss_pred cccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 378 QIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 378 ~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
.+..+++++.+++.+||+.||.+|||+.++++|
T Consensus 303 ----------~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 303 ----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred ----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 112357889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=307.68 Aligned_cols=257 Identities=26% Similarity=0.340 Sum_probs=187.5
Q ss_pred eeEeeeeccCCceEEEEEE----EcCCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 139 YMAERVVGTGSFGVVFQAK----CLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~----~~~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
|.+.+.||+|+||+||++. ...++..||+|.+... .....+|+++++.++||||+++++++.. .+..+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 82 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QGGKG 82 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCCce
Confidence 3888999999999998865 3457889999988643 2334579999999999999999987743 22346
Q ss_pred EEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
+++||||+.++.+..... ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 83 ~~lv~e~~~~~~l~~~~~----~~~l~~~~~~~i~~~l~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~ 156 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLP----KHKLNLAQLLLFAQQICEGMAYLHS-QHYIHRDLAARNVLLDNDR-LVKIGDFGLAKA 156 (283)
T ss_pred EEEEecCCCCCCHHHHHH----HcCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccChheEEEcCCC-cEEEeecccccc
Confidence 889999998754432221 2358999999999999999999997 9999999999999999887 799999999986
Q ss_pred cCCCCC----CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-hCCCCHHHH
Q 011138 290 LVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKI-LGTPTREEI 364 (492)
Q Consensus 290 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~-~g~p~~~~~ 364 (492)
...+.. .....++..|+|||.+.+. .++.++|||||||++|+|++|..||...... +..+... .+......+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~ 233 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKEN-KFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVRL 233 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhccc-CCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhhh
Confidence 643322 1123456779999998654 4899999999999999999999998654321 1111110 000000000
Q ss_pred hhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
. ...........+..++.++.+|+.+||+.||++|||+.++++
T Consensus 234 ~------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 234 I------------ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred h------------hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0 000000001123457889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=309.32 Aligned_cols=254 Identities=19% Similarity=0.243 Sum_probs=192.7
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCC----------------CEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccc
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETG----------------DSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSL 195 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g----------------~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l 195 (492)
.+|.+.+.||+|+||.||+|.+..++ ..||+|.+.... ....+|+++++.++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 46999999999999999999876544 458999886432 334579999999999999999
Q ss_pred ceeeeeccCCCceEEEEEeeechhh-HHHHhhhhhh-------cCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCC
Q 011138 196 KHCFFSTTEKDELYLNLVLEYISET-VYRVSKHYTR-------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKP 267 (492)
Q Consensus 196 ~~~~~~~~~~~~~~~~lV~E~~~~~-l~~~~~~~~~-------~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp 267 (492)
++++. +..+.++||||+.++ +...+..... ....+++..+..++.||+.||.|||+ +||+||||||
T Consensus 85 ~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~-~~i~H~dlkp 158 (296)
T cd05051 85 LGVCT-----VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES-LNFVHRDLAT 158 (296)
T ss_pred EEEEe-----cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccccch
Confidence 99883 334688999999854 4444332211 12368899999999999999999997 9999999999
Q ss_pred CceEEcCCCCcEEEeeecCccccCCCC---CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh--CCCCCCC
Q 011138 268 QNLLVNPHTHQLKICDFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL--GQPLFPG 342 (492)
Q Consensus 268 ~NILl~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~--G~~pf~~ 342 (492)
+||+++.++ .++|+|||+++...... ......+++.|+|||.+.+. .++.++|||||||++|+|++ |..||..
T Consensus 159 ~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 159 RNCLVGKNY-TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred hceeecCCC-ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 999999887 89999999987653322 12234567789999998654 48999999999999999998 7788877
Q ss_pred CChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 343 ESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 343 ~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.+..+.+..+........ ..... ..+..+++++.+||.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~-----------~~~~~----------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 237 LTDQQVIENAGHFFRDDG-----------RQIYL----------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred cChHHHHHHHHhcccccc-----------ccccC----------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 665555444433111000 00000 012346789999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=303.59 Aligned_cols=243 Identities=26% Similarity=0.360 Sum_probs=190.1
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch---hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~---~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
.+|.+.+.||+|+||.||+|.+..+ ..||+|++.... ....+|+.+++.++||||+++++++. . .+.++|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-----~-~~~~lv 78 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----E-EPIYIV 78 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-----C-CCcEEE
Confidence 4699999999999999999988665 469999886432 34567999999999999999988752 1 236799
Q ss_pred eeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 214 LEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 214 ~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
|||+++ ++.+.+.. .....+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .+||+|||.+.....
T Consensus 79 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~Nill~~~~-~~~L~dfg~~~~~~~ 154 (262)
T cd05071 79 TEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENL-VCKVADFGLARLIED 154 (262)
T ss_pred EEcCCCCcHHHHHhh--ccccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcccEEEcCCC-cEEeccCCceeeccc
Confidence 999986 44444432 123457888899999999999999997 9999999999999999887 799999999976543
Q ss_pred CCCC--ccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 293 GEPN--ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 293 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
.... ....++..|+|||++.+. .++.++|||||||++|+|++ |..||.+....+....+....
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~------------- 220 (262)
T cd05071 155 NEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY------------- 220 (262)
T ss_pred cccccccCCcccceecCHhHhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCC-------------
Confidence 3221 123456789999988544 48999999999999999999 899998876655444332210
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
..+ ....++..+.+||.+||+.||++||++.++++
T Consensus 221 -----~~~----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 221 -----RMP----------CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred -----CCC----------CccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 000 11346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=304.29 Aligned_cols=228 Identities=26% Similarity=0.353 Sum_probs=180.6
Q ss_pred CCceEEEEEEEcCCCCEEEEEEeccchhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEeeechhh-HHHHhh
Q 011138 148 GSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISET-VYRVSK 226 (492)
Q Consensus 148 G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E~~~~~-l~~~~~ 226 (492)
|.||.||++.+..+|+.||+|.+..... ..+|...+....||||+++++++ .+....++||||++++ +.+.+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-YSRERLTIIPHCVPNMVCLHKYI-----VSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh-hhhHHHHHHhcCCCceeehhhhe-----ecCCeEEEEEecCCCCCHHHHHH
Confidence 8999999999999999999999876543 33456666667799999999988 3445689999999864 444433
Q ss_pred hhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCCCCccceeccCcc
Q 011138 227 HYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR 306 (492)
Q Consensus 227 ~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~ 306 (492)
. ...+++..+..++.|++.||.|||+ +||+||||||+||+++.++ .++|+|||.+...... .....++..|+
T Consensus 78 ~----~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~~l~df~~~~~~~~~--~~~~~~~~~y~ 149 (237)
T cd05576 78 K----FLNIPEECVKRWAAEMVVALDALHR-EGIVCRDLNPNNILLDDRG-HIQLTYFSRWSEVEDS--CDGEAVENMYC 149 (237)
T ss_pred H----hcCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcCCC-CEEEecccchhccccc--cccCCcCcccc
Confidence 2 2458899999999999999999997 9999999999999999887 7999999987655322 23345677899
Q ss_pred CchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCccc
Q 011138 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHK 386 (492)
Q Consensus 307 aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (492)
|||.+.+. .++.++|+||+||++|+|++|..||...... + . ....+.
T Consensus 150 aPE~~~~~-~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~------------~----~~~~~~----------- 196 (237)
T cd05576 150 APEVGGIS-EETEACDWWSLGAILFELLTGKTLVECHPSG-----I------------N----THTTLN----------- 196 (237)
T ss_pred CCcccCCC-CCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c------------c----cccccC-----------
Confidence 99988544 4789999999999999999999887542210 0 0 000111
Q ss_pred ccCCCCChhHhhhhccccccCCCCcCCH-----HHhhCCCCC
Q 011138 387 IFHKRMPPEALDLVSRLLQYSPSLRCTA-----LEACAHPFF 423 (492)
Q Consensus 387 ~~~~~~s~~~~~Li~~~L~~dP~~R~t~-----~e~l~Hp~f 423 (492)
++..+++.+++||.+||+.||++|+++ .++++||||
T Consensus 197 -~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 197 -IPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred -CcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 223478899999999999999999986 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=309.36 Aligned_cols=249 Identities=23% Similarity=0.343 Sum_probs=192.3
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCC-----CCEEEEEEeccch-----hhHHHHHHHHHHc-CCCCccccceeeeeccC
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLET-----GDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFSTTE 204 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~-----g~~vAiK~~~~~~-----~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~ 204 (492)
..+|.+.+.||+|+||.||++.+... ...+|+|.+.... ....+|+.+++.+ +|+||+++++++
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~----- 85 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC----- 85 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE-----
Confidence 34699999999999999999987644 3789999885432 2345799999999 799999999988
Q ss_pred CCceEEEEEeeechhh-HHHHhhhhh------------hcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceE
Q 011138 205 KDELYLNLVLEYISET-VYRVSKHYT------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLL 271 (492)
Q Consensus 205 ~~~~~~~lV~E~~~~~-l~~~~~~~~------------~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NIL 271 (492)
.....+++||||+.++ +...+.... .....+++..+..++.||+.||.|||+ +||+||||||+|||
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~Nil 164 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS-KKCIHRDLAARNVL 164 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCccccccceeeEE
Confidence 3344589999999864 444433211 234568889999999999999999997 99999999999999
Q ss_pred EcCCCCcEEEeeecCccccCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHH
Q 011138 272 VNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVD 347 (492)
Q Consensus 272 l~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~ 347 (492)
++.++ .+||+|||+++....... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||.+....+
T Consensus 165 ~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 165 VTEDH-VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred EcCCC-eEEeCccccccccccccceeccCCCCCCccccCHHHhccC-CcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 99877 899999999986543221 1122345679999998554 58999999999999999997 999998776554
Q ss_pred HHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 348 QLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 348 ~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
....+... .... .+...+.++.+|+.+||..||++|||+.+++++
T Consensus 243 ~~~~~~~~----------------~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 243 LFKLLKEG----------------YRME------------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHcC----------------CcCC------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 44332210 0000 112467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=302.43 Aligned_cols=235 Identities=25% Similarity=0.348 Sum_probs=183.4
Q ss_pred eeccCCceEEEEEEE--cCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEee
Q 011138 144 VVGTGSFGVVFQAKC--LETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (492)
Q Consensus 144 ~lG~G~fg~Vy~~~~--~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E 215 (492)
.||+|+||.||+|.+ ..++..+|+|++.... ....+|+.+++.++||||+++++++ .+. ..++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~-~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC-----EAE-SWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----cCC-CcEEEEe
Confidence 589999999999964 5678899999875332 2345789999999999999999876 222 3579999
Q ss_pred echhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCC
Q 011138 216 YISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (492)
Q Consensus 216 ~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~ 294 (492)
|++++ +.+.+. ....+++..+..++.||+.||.|||+ +||+||||||.|||++.++ .+||+|||++.......
T Consensus 76 ~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~nill~~~~-~~kl~Dfg~~~~~~~~~ 149 (257)
T cd05116 76 LAELGPLNKFLQ----KNKHVTEKNITELVHQVSMGMKYLEE-TNFVHRDLAARNVLLVTQH-YAKISDFGLSKALGADE 149 (257)
T ss_pred cCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchhhEEEcCCC-eEEECCCccccccCCCC
Confidence 99965 444332 23468899999999999999999997 9999999999999999877 79999999997654332
Q ss_pred C----CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 295 P----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 295 ~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
. .....++..|+|||.+.. ..++.++|+|||||++|||++ |..||.+.+..+....+.+.
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~-------------- 214 (257)
T cd05116 150 NYYKAKTHGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG-------------- 214 (257)
T ss_pred CeeeecCCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC--------------
Confidence 2 112234578999998854 458899999999999999997 99999887665544433220
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.... .+..+++++.+||.+||+.||++||++++|..
T Consensus 215 --~~~~------------~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 215 --ERME------------CPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred --CCCC------------CCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 0000 12357899999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=301.54 Aligned_cols=242 Identities=23% Similarity=0.342 Sum_probs=190.2
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch--hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEe
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~--~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
.+|.+.+.||+|+||.||++.. .|..||+|.+..+. ....+|+.+++.++|+||++++++++.. ....++||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~lv~ 79 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLYIVT 79 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcC----CCceEEEE
Confidence 4699999999999999999976 48889999886543 2355799999999999999999876432 23478999
Q ss_pred eechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCC
Q 011138 215 EYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (492)
Q Consensus 215 E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (492)
||+++ .+.+.+.. .....+++..+..++.||+.||.|||+ +||+||||||+||+++.++ .+||+|||++......
T Consensus 80 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 80 EYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEA-NNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASST 155 (256)
T ss_pred ECCCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccccchheEEEcCCC-cEEecCCccceecccc
Confidence 99986 55554332 122347888899999999999999997 9999999999999999887 7999999998754322
Q ss_pred CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 011138 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372 (492)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~ 372 (492)
. ....++..|+|||++.+. .++.++|||||||++|+|++ |+.||...+..+....+.+.
T Consensus 156 ~--~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~----------------- 215 (256)
T cd05082 156 Q--DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG----------------- 215 (256)
T ss_pred C--CCCccceeecCHHHHccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-----------------
Confidence 2 233456789999998654 48999999999999999997 99999876554433333210
Q ss_pred ccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
. .......+++.+.+||.+||..||++|||+.++++
T Consensus 216 -~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 216 -Y----------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred -C----------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0 00112357899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=306.84 Aligned_cols=243 Identities=21% Similarity=0.318 Sum_probs=188.2
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCC----EEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGD----SVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~----~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
.+|.+.+.||+|+||+||+|.+..+|. .||+|.+... .....+|+.+++.++||||+++++++...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~----- 81 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS----- 81 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-----
Confidence 468999999999999999999887776 4899987532 22345789999999999999999887421
Q ss_pred eEEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 208 LYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 208 ~~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
..+++|||++++ +.+.+. .....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 82 -~~~l~~~~~~~g~l~~~l~---~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~iiH~dlkp~Nil~~~~~-~~kL~dfG~ 155 (279)
T cd05109 82 -TVQLVTQLMPYGCLLDYVR---ENKDRIGSQDLLNWCVQIAKGMSYLEE-VRLVHRDLAARNVLVKSPN-HVKITDFGL 155 (279)
T ss_pred -CcEEEEEcCCCCCHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccceEEEcCCC-cEEECCCCc
Confidence 256899999854 444332 223468899999999999999999997 9999999999999998777 799999999
Q ss_pred ccccCCCCCC---ccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 011138 287 AKMLVPGEPN---ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTRE 362 (492)
Q Consensus 287 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~ 362 (492)
++........ ....+++.|+|||.+.+. .++.++|||||||++|||++ |..||........ ..++.....+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~--- 230 (279)
T cd05109 156 ARLLDIDETEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI-PDLLEKGERL--- 230 (279)
T ss_pred eeecccccceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCcC---
Confidence 9866432221 122346789999998654 48999999999999999998 9999977654332 2222211000
Q ss_pred HHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
+ .+...+.++.++|.+||..||++||++.+++.
T Consensus 231 --------------~----------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 231 --------------P----------QPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred --------------C----------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 11246789999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=308.51 Aligned_cols=246 Identities=23% Similarity=0.380 Sum_probs=187.6
Q ss_pred ceeEeeeeccCCceEEEEEEEcC-----CCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~-----~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
+|++.+.||+|+||.||+|.+.. ....+|+|.+.... ....+|+.+++.++||||+++++++ ...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGAC-----SQD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecC
Confidence 37888999999999999998753 23578898875432 2345799999999999999999987 334
Q ss_pred eEEEEEeeechhh-HHHHhhhhh--------------------hcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCC
Q 011138 208 LYLNLVLEYISET-VYRVSKHYT--------------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIK 266 (492)
Q Consensus 208 ~~~~lV~E~~~~~-l~~~~~~~~--------------------~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlK 266 (492)
...++||||+.++ +...+.... .....+++..+..++.||+.||.|||+ +||+|||||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dik 154 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE-MKLVHRDLA 154 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH-CCeehhhhh
Confidence 4578999999854 433332211 112457888899999999999999997 999999999
Q ss_pred CCceEEcCCCCcEEEeeecCccccCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCC
Q 011138 267 PQNLLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPG 342 (492)
Q Consensus 267 p~NILl~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~ 342 (492)
|+|||++.++ .+||+|||+++....... .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+
T Consensus 155 p~nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 155 ARNVLVAEGR-KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred hheEEEcCCC-cEEeccccccccccCccchhcccCCCCCccccCHHHHccC-CcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 9999999877 899999999976533221 1223456789999998654 48999999999999999998 9999987
Q ss_pred CChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 343 ESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 343 ~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
....+... .... .+.. ..+..++.++.+|+.+||+.||.+||++.+++.
T Consensus 233 ~~~~~~~~-~~~~-----------------~~~~----------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 233 IAPERLFN-LLKT-----------------GYRM----------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CCHHHHHH-HHhC-----------------CCCC----------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 66443322 2210 0000 012357889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=305.11 Aligned_cols=244 Identities=25% Similarity=0.361 Sum_probs=190.5
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCC---EEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~---~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
.+|.+.+.||+|+||.||+|.+..++. .+|+|.+... .....+|+.+++.++||||+++++++ ....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 78 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSK 78 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCC
Confidence 469999999999999999999875544 7999987542 23456799999999999999999988 3344
Q ss_pred EEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 209 ~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
+.|+||||++++ +.+.+. .....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .++|+|||++
T Consensus 79 ~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~h~dlkp~nili~~~~-~~~l~dfg~~ 153 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLR---KHDGQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILVNSNL-VCKVSDFGLS 153 (267)
T ss_pred ccEEEEEcCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeehhhchhcEEECCCC-eEEeCCCCcc
Confidence 688999999865 433332 223467888999999999999999997 9999999999999999887 7999999999
Q ss_pred cccCCCCCC----ccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 011138 288 KMLVPGEPN----ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTRE 362 (492)
Q Consensus 288 ~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~ 362 (492)
......... ....++..|+|||.+.+. .++.++|+|||||++|++++ |..||...+..+....+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~------- 225 (267)
T cd05066 154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG------- 225 (267)
T ss_pred cccccccceeeecCCCccceeecCHhHhccC-ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-------
Confidence 765432211 112235679999999654 48999999999999999886 99999887665544443221
Q ss_pred HHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
...+ ....+++.+.+++.+||+.+|.+||++.++++
T Consensus 226 -----------~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 226 -----------YRLP----------APMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred -----------CcCC----------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 0111 11246889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=309.00 Aligned_cols=254 Identities=22% Similarity=0.271 Sum_probs=190.0
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCC--------------CEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccce
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETG--------------DSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKH 197 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g--------------~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~ 197 (492)
.+|++.+.||+|+||.||+|.+..++ ..||+|.+.... ....+|+++++.++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 46999999999999999999875432 358999886431 23457999999999999999999
Q ss_pred eeeeccCCCceEEEEEeeechhh-HHHHhhhhh--------hcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCC
Q 011138 198 CFFSTTEKDELYLNLVLEYISET-VYRVSKHYT--------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQ 268 (492)
Q Consensus 198 ~~~~~~~~~~~~~~lV~E~~~~~-l~~~~~~~~--------~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~ 268 (492)
++ ......++||||+.++ +.+.+.... .....+++..+..++.||+.||.|||+ +|++||||||+
T Consensus 85 ~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~ 158 (295)
T cd05097 85 VC-----VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS-LNFVHRDLATR 158 (295)
T ss_pred EE-----cCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh-cCeeccccChh
Confidence 88 3444588999999864 444332211 011236778889999999999999997 99999999999
Q ss_pred ceEEcCCCCcEEEeeecCccccCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh--CCCCCCCC
Q 011138 269 NLLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL--GQPLFPGE 343 (492)
Q Consensus 269 NILl~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~--G~~pf~~~ 343 (492)
|||++.++ .+||+|||++........ .....++..|+|||++.+. .++.++|||||||++|+|++ |..||...
T Consensus 159 Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 159 NCLVGNHY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred hEEEcCCC-cEEecccccccccccCcceeccCcCcCceeecChhhhccC-CcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence 99999877 799999999976533321 1123446789999998654 48999999999999999988 67888877
Q ss_pred ChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 344 SGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 344 ~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
+..+.+..+.+...... ...+. ..++.+++.+++||.+||+.||.+||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~------------~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 237 SDEQVIENTGEFFRNQG------------RQIYL---------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred ChHHHHHHHHHhhhhcc------------ccccC---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 66555444433110000 00000 012346889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=303.81 Aligned_cols=245 Identities=22% Similarity=0.322 Sum_probs=191.1
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCC---EEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~---~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
.+|...+.||+|+||.||+|.+..++. .+|+|.+... .....+|+++++.++|+||+++++++ .+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 79 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVV-----TKFK 79 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----ccCC
Confidence 358889999999999999999876665 7999987543 22345799999999999999999988 3444
Q ss_pred EEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 209 ~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
+.++||||++++.+.... ......+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .+||+|||++.
T Consensus 80 ~~~lv~e~~~~~~L~~~~--~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~ 155 (268)
T cd05063 80 PAMIITEYMENGALDKYL--RDHDGEFSSYQLVGMLRGIAAGMKYLSD-MNYVHRDLAARNILVNSNL-ECKVSDFGLSR 155 (268)
T ss_pred CcEEEEEcCCCCCHHHHH--HhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEEcCCC-cEEECCCccce
Confidence 588999999976443322 2223568888999999999999999997 9999999999999999877 79999999987
Q ss_pred ccCCCCCCc----cceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 011138 289 MLVPGEPNI----SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREE 363 (492)
Q Consensus 289 ~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~ 363 (492)
......... ....+..|+|||++.+. .++.++|||||||++|+|++ |..||...+..+....+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~------- 227 (268)
T cd05063 156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF------- 227 (268)
T ss_pred ecccccccceeccCCCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC-------
Confidence 654322111 11224579999998654 48999999999999999997 999998877655444443210
Q ss_pred HhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
..| ....++.++.+|+.+||+.||++||++.++++
T Consensus 228 -----------~~~----------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 228 -----------RLP----------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred -----------CCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 001 01246788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=305.93 Aligned_cols=246 Identities=23% Similarity=0.356 Sum_probs=190.1
Q ss_pred ceeEeeeeccCCceEEEEEEEc-----CCCCEEEEEEeccc----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 138 SYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~-----~~g~~vAiK~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
+|...+.||+|+||.||++... .++..+|+|.+... .....+|+++++.++|+||+++++++ .+..
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 80 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVC-----TEGR 80 (280)
T ss_pred hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEE-----ecCC
Confidence 5788899999999999999753 35678999987542 23456799999999999999999887 3344
Q ss_pred EEEEEeeechhh-HHHHhhhhhh-----------cCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCC
Q 011138 209 YLNLVLEYISET-VYRVSKHYTR-----------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT 276 (492)
Q Consensus 209 ~~~lV~E~~~~~-l~~~~~~~~~-----------~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~ 276 (492)
..++||||+.++ +.+.+..... ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS-LHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH-CCeecccccHhhEEEcCCC
Confidence 588999999854 4444332110 11357888999999999999999997 9999999999999999877
Q ss_pred CcEEEeeecCccccCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 011138 277 HQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEI 352 (492)
Q Consensus 277 ~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i 352 (492)
.+||+|||++........ .....+++.|+|||.+.+. .++.++|||||||++|+|++ |.+||......+.+..+
T Consensus 160 -~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05092 160 -VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237 (280)
T ss_pred -CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 799999999875532221 1233457789999998655 48999999999999999998 99999876665544443
Q ss_pred HHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 353 IKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 353 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
... .+ .. .+..+++.+.+||.+||+.||.+||++.+++.
T Consensus 238 ~~~--~~--------------~~------------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 238 TQG--RE--------------LE------------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HcC--cc--------------CC------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 221 00 00 11346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=301.20 Aligned_cols=243 Identities=24% Similarity=0.345 Sum_probs=190.3
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc---hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
.+|.+.+.||+|+||.||+|.+. .+..||+|.+... .....+|+.+++.++|+||+++++++. . ...++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-----~-~~~~lv 78 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-----E-EPIYIV 78 (260)
T ss_pred HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-----C-CCcEEE
Confidence 46999999999999999999865 5677999988643 234568999999999999999988762 1 136799
Q ss_pred eeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 214 LEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 214 ~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
|||+.+ ++.+.+.. .....+++..+..++.||+.||.|||+ +||+||||||+||+++.++ .++|+|||++.....
T Consensus 79 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~Nili~~~~-~~~l~dfg~~~~~~~ 154 (260)
T cd05070 79 TEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIER-MNYIHRDLRSANILVGDGL-VCKIADFGLARLIED 154 (260)
T ss_pred EEecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEEeCCc-eEEeCCceeeeeccC
Confidence 999986 44444322 123457889999999999999999997 9999999999999999877 799999999976543
Q ss_pred CCCC--ccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 293 GEPN--ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 293 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
.... ....++..|+|||.+.+. .++.++|+|||||++|+|++ |.+||.+.+..+.+..+....
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~------------- 220 (260)
T cd05070 155 NEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY------------- 220 (260)
T ss_pred cccccccCCCCCccccChHHHhcC-CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------------
Confidence 2211 123345679999998654 48899999999999999999 999998877655554442210
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
..+ .+...+.++.+|+.+||..||.+|||+.++..
T Consensus 221 -----~~~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 221 -----RMP----------CPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred -----CCC----------CCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 000 12346889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=300.52 Aligned_cols=245 Identities=26% Similarity=0.345 Sum_probs=193.8
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc---hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
..+|.+.+.||+|+||.||+|.+. .+..||||.+..+ .....+|+.+++.++|+||+++++++ ......++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~ 78 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC-----SEEEPIYI 78 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeee-----ecCCceEE
Confidence 457999999999999999999875 5578999988653 23456899999999999999999987 33345899
Q ss_pred Eeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 213 VLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 213 V~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
||||+.++ +.+.+.. .....+++..+..++.||+.||.|||+ +||+|+||||+||+++.++ .+||+|||++....
T Consensus 79 v~e~~~~~~L~~~i~~--~~~~~~~~~~~~~~~~~i~~al~~lh~-~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~ 154 (261)
T cd05034 79 VTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLES-RNYIHRDLAARNILVGENL-VCKIADFGLARLIE 154 (261)
T ss_pred EEeccCCCCHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcchheEEEcCCC-CEEECccccceecc
Confidence 99999864 4444322 123468889999999999999999997 8999999999999999887 79999999987654
Q ss_pred CCCC--CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 292 PGEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 292 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
.... .....++..|+|||.+.+. .++.++|+|||||++|+|++ |+.||.+.+....+..+......
T Consensus 155 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~---------- 223 (261)
T cd05034 155 DDEYTAREGAKFPIKWTAPEAANYG-RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM---------- 223 (261)
T ss_pred chhhhhhhccCCCccccCHHHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence 3211 1122345689999998654 48999999999999999998 99999887766655554331100
Q ss_pred CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
+ .+...+.++.+++.+||..||++||++.++++
T Consensus 224 --------~----------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 224 --------P----------RPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred --------C----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 0 11235788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=302.91 Aligned_cols=244 Identities=23% Similarity=0.351 Sum_probs=190.3
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCC---EEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~---~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
.|.+.+.||+|+||.||+|.+..+++ .||||.+... ...+.+|+.+++.++||||+++++++ .+...
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~~ 79 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSRP 79 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CCCCc
Confidence 58999999999999999999887765 5999987542 22455799999999999999999987 44445
Q ss_pred EEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
.++||||++++.+..... .....+++..+..++.|++.||.|||+ +|++||||||+||+++.++ .+||+|||++..
T Consensus 80 ~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~i~~~l~~al~~lH~-~g~~H~dl~p~nili~~~~-~~kl~dfg~~~~ 155 (269)
T cd05065 80 VMIITEFMENGALDSFLR--QNDGQFTVIQLVGMLRGIAAGMKYLSE-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRF 155 (269)
T ss_pred eEEEEecCCCCcHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccChheEEEcCCC-cEEECCCccccc
Confidence 889999998754432221 223568889999999999999999997 9999999999999999877 799999999876
Q ss_pred cCCCCCCcc---ce---eccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 011138 290 LVPGEPNIS---YI---CSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTRE 362 (492)
Q Consensus 290 ~~~~~~~~~---~~---gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~ 362 (492)
......... .. .+..|+|||.+.+. .++.++|||||||++|||++ |..||...+..+....+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~------- 227 (269)
T cd05065 156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD------- 227 (269)
T ss_pred cccCccccccccccCCCcceeecCHhHhccC-cccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-------
Confidence 543222111 11 13579999998654 48999999999999999886 99999887665544443211
Q ss_pred HHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
...+ .+..++.++.+++.+||..||.+||++.+++.
T Consensus 228 -----------~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 228 -----------YRLP----------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred -----------CcCC----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1111 11246788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=308.99 Aligned_cols=249 Identities=22% Similarity=0.330 Sum_probs=190.9
Q ss_pred cccceeEeeeeccCCceEEEEEEEcC-------CCCEEEEEEeccch-----hhHHHHHHHHHHc-CCCCccccceeeee
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLE-------TGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFS 201 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~-------~g~~vAiK~~~~~~-----~~~~~E~~il~~l-~h~nIv~l~~~~~~ 201 (492)
...+|.+++.||+|+||.||+|.+.. ....||+|.+.... ....+|+.+++.+ +||||+++++++
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-- 87 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC-- 87 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE--
Confidence 34579999999999999999998642 34579999876432 2345799999999 599999999988
Q ss_pred ccCCCceEEEEEeeechhh-HHHHhhhhhh------------cCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCC
Q 011138 202 TTEKDELYLNLVLEYISET-VYRVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQ 268 (492)
Q Consensus 202 ~~~~~~~~~~lV~E~~~~~-l~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~ 268 (492)
.+..++|+||||+.++ +...+..... ....+++..+..++.||+.||.|||+ +||+||||||+
T Consensus 88 ---~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~ 163 (314)
T cd05099 88 ---TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES-RRCIHRDLAAR 163 (314)
T ss_pred ---ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH-CCeeeccccce
Confidence 3445689999999864 5444433211 12457888899999999999999997 99999999999
Q ss_pred ceEEcCCCCcEEEeeecCccccCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCC
Q 011138 269 NLLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGES 344 (492)
Q Consensus 269 NILl~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~ 344 (492)
|||++.++ .+||+|||+++....... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||.+..
T Consensus 164 Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 164 NVLVTEDN-VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred eEEEcCCC-cEEEccccccccccccccccccccCCCCccccCHHHHccC-CcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence 99999887 799999999976532211 1122344679999998654 58999999999999999998 899998776
Q ss_pred hHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 345 GVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 345 ~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
..+.+..+... .... .+..++.++++||.+||..||.+|||+.++++
T Consensus 242 ~~~~~~~~~~~----------------~~~~------------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 242 VEELFKLLREG----------------HRMD------------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHHHHcC----------------CCCC------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 54444333210 0000 12346789999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=303.64 Aligned_cols=240 Identities=23% Similarity=0.332 Sum_probs=182.7
Q ss_pred eeccCCceEEEEEEEcCCCCE--EEEEEeccc-----hhhHHHHHHHHHHc-CCCCccccceeeeeccCCCceEEEEEee
Q 011138 144 VVGTGSFGVVFQAKCLETGDS--VAIKKVLQD-----KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (492)
Q Consensus 144 ~lG~G~fg~Vy~~~~~~~g~~--vAiK~~~~~-----~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~~~~~lV~E 215 (492)
.||+|+||.||+|.+..+|.. +|+|.+... .....+|+.+++.+ +||||+++++++ ....++++|||
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-----~~~~~~~lv~e 76 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLAIE 76 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEE-----ecCCCceEEEE
Confidence 589999999999999888764 688877532 12345799999999 799999999988 33445889999
Q ss_pred echh-hHHHHhhhhhh------------cCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEe
Q 011138 216 YISE-TVYRVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC 282 (492)
Q Consensus 216 ~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~ 282 (492)
|+.+ ++.+.+..... ....+++..+..++.||+.||+|||+ +|++||||||+|||++.++ .+||+
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nili~~~~-~~kl~ 154 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGENY-VAKIA 154 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccccceEEEcCCC-eEEEC
Confidence 9985 55554433211 12347888999999999999999997 9999999999999999887 79999
Q ss_pred eecCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 011138 283 DFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTR 361 (492)
Q Consensus 283 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~ 361 (492)
|||++..............+..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+....+...
T Consensus 155 dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~------ 227 (270)
T cd05047 155 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG------ 227 (270)
T ss_pred CCCCccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC------
Confidence 9999863321111112233567999999854 458999999999999999996 99999876654433332110
Q ss_pred HHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
... ..+..++.++.+|+.+||..||.+|||+.++++
T Consensus 228 ------------~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 228 ------------YRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred ------------CCC----------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 000 011246788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=318.62 Aligned_cols=252 Identities=23% Similarity=0.355 Sum_probs=192.7
Q ss_pred ccccceeEeeeeccCCceEEEEEEEc-----CCCCEEEEEEeccch-----hhHHHHHHHHHHcC-CCCccccceeeeec
Q 011138 134 KQTISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQDK-----RYKNRELQIMRLLN-HPNVVSLKHCFFST 202 (492)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-----~~g~~vAiK~~~~~~-----~~~~~E~~il~~l~-h~nIv~l~~~~~~~ 202 (492)
....+|.+++.||+|+||.||+|++. .+++.||+|++.... ....+|+.+|..+. |||||++++++..
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~- 112 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK- 112 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc-
Confidence 33456889999999999999999864 345689999986432 23457999999998 9999999998833
Q ss_pred cCCCceEEEEEeeechh-hHHHHhhhhhh---------------------------------------------------
Q 011138 203 TEKDELYLNLVLEYISE-TVYRVSKHYTR--------------------------------------------------- 230 (492)
Q Consensus 203 ~~~~~~~~~lV~E~~~~-~l~~~~~~~~~--------------------------------------------------- 230 (492)
...+++||||+.+ +|.+.+.....
T Consensus 113 ----~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 113 ----GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred ----CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 3458899999985 45444432110
Q ss_pred -------------------------------------------cCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCC
Q 011138 231 -------------------------------------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKP 267 (492)
Q Consensus 231 -------------------------------------------~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp 267 (492)
....+++..+..++.||+.||.|||+ +||+||||||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrdlkp 267 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS-KNCVHRDLAA 267 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc-CCcCcccCCc
Confidence 11235667788899999999999997 9999999999
Q ss_pred CceEEcCCCCcEEEeeecCccccCCCC---CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCC
Q 011138 268 QNLLVNPHTHQLKICDFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGE 343 (492)
Q Consensus 268 ~NILl~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~ 343 (492)
+|||++.++ .+||+|||+++...... ......+++.|+|||.+.+. .++.++|||||||++|||++ |..||...
T Consensus 268 ~NiLl~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 268 RNVLICEGK-LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN-LYTTLSDVWSFGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred ceEEEeCCC-EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC-CCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence 999999876 89999999997653222 12234567889999999654 48999999999999999998 89999876
Q ss_pred ChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 344 SGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 344 ~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
...+.+...+.. + ... ..+..++.++.+||.+||..||.+||++.++++.
T Consensus 346 ~~~~~~~~~~~~-~----------------~~~----------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 346 PMNEQFYNAIKR-G----------------YRM----------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred CchHHHHHHHHc-C----------------CCC----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 655544443321 0 000 0123468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=307.76 Aligned_cols=250 Identities=23% Similarity=0.334 Sum_probs=192.1
Q ss_pred cccceeEeeeeccCCceEEEEEEEc-------CCCCEEEEEEeccc-----hhhHHHHHHHHHHc-CCCCccccceeeee
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCL-------ETGDSVAIKKVLQD-----KRYKNRELQIMRLL-NHPNVVSLKHCFFS 201 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~-------~~g~~vAiK~~~~~-----~~~~~~E~~il~~l-~h~nIv~l~~~~~~ 201 (492)
...+|.+.+.||+|+||.||+|.+. .++..||+|.+... .....+|+.+++.+ +||||+++++++
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~-- 90 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC-- 90 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE--
Confidence 3457999999999999999999753 23457999987542 13355799999999 799999999988
Q ss_pred ccCCCceEEEEEeeechh-hHHHHhhhhhh------------cCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCC
Q 011138 202 TTEKDELYLNLVLEYISE-TVYRVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQ 268 (492)
Q Consensus 202 ~~~~~~~~~~lV~E~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~ 268 (492)
.....+|+||||+.+ ++...+..... ....+++..+..++.||+.||.|||+ +||+||||||+
T Consensus 91 ---~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~ 166 (304)
T cd05101 91 ---TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS-QKCIHRDLAAR 166 (304)
T ss_pred ---ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH-CCeeecccccc
Confidence 344468899999986 44444432211 12457788889999999999999997 99999999999
Q ss_pred ceEEcCCCCcEEEeeecCccccCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCC
Q 011138 269 NLLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGES 344 (492)
Q Consensus 269 NILl~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~ 344 (492)
|||++.++ .+||+|||+++....... .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+
T Consensus 167 Nili~~~~-~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 167 NVLVTENN-VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred eEEEcCCC-cEEECCCccceecccccccccccCCCCCceeeCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999877 799999999986643221 1223456789999998654 48999999999999999998 889998776
Q ss_pred hHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 345 GVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 345 ~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
..+....+... ... ..+..++.++++||.+||..+|.+||++.++++.
T Consensus 245 ~~~~~~~~~~~----------------~~~------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 245 VEELFKLLKEG----------------HRM------------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHHHcC----------------CcC------------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 55444333210 000 0123468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=303.24 Aligned_cols=236 Identities=17% Similarity=0.206 Sum_probs=178.9
Q ss_pred eeccCCceEEEEEEEcCC------------CCEEEEEEeccch----hhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 144 VVGTGSFGVVFQAKCLET------------GDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 144 ~lG~G~fg~Vy~~~~~~~------------g~~vAiK~~~~~~----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
.||+|+||.||+|+.... ...|++|.+.... ....+|+.+++.++||||+++++++. +.
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~-----~~ 76 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCV-----RD 76 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cC
Confidence 589999999999985322 2358888764432 23456889999999999999999884 33
Q ss_pred eEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCC------cEEE
Q 011138 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH------QLKI 281 (492)
Q Consensus 208 ~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~------~vkL 281 (492)
...++||||++++.+..... .....+++..+..++.||+.||.|||+ +||+||||||+|||++.++. .+|+
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMH--RKSDVLTTPWKFKVAKQLASALSYLED-KDLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred CCCEEEEecccCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHhhh-CCeECCCCCcccEEEecCCccCCCCceeEe
Confidence 34789999999776554322 223568899999999999999999997 99999999999999976542 2899
Q ss_pred eeecCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCC
Q 011138 282 CDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGTPT 360 (492)
Q Consensus 282 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell-~G~~pf~~~~~~~~~~~i~~~~g~p~ 360 (492)
+|||++..... .....++..|+|||.+.+...++.++|||||||++|+|+ +|..||......+.. ....
T Consensus 154 ~d~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~------ 223 (262)
T cd05077 154 SDPGIPITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYE------ 223 (262)
T ss_pred CCCCCCccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHh------
Confidence 99999865432 224567889999999865566899999999999999998 588888765432211 1111
Q ss_pred HHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
.... .....++++.+||.+||+.||.+||++.+|+++
T Consensus 224 -----------~~~~------------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 224 -----------GQCM------------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred -----------cCcc------------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 0000 011245789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=299.20 Aligned_cols=243 Identities=24% Similarity=0.326 Sum_probs=190.5
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch---hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~---~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
.+|.+.+.||+|+||.||+|.+..+ ..+|+|.+.... ....+|+.+++.++|+||+++++++. + ...++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~-~~~~~v 78 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-----E-EPIYIV 78 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-----C-CCcEEE
Confidence 4699999999999999999987655 469999875432 33457999999999999999988762 1 236799
Q ss_pred eeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 214 LEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 214 ~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
|||+.+ ++.+.+... ....+++..+..++.||+.||.|||+ .||+||||||+||+++.++ .++|+|||++.....
T Consensus 79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dl~~~Nill~~~~-~~~l~dfg~~~~~~~ 154 (260)
T cd05069 79 TEFMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIER-MNYIHRDLRAANILVGDNL-VCKIADFGLARLIED 154 (260)
T ss_pred EEcCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcCCC-eEEECCCccceEccC
Confidence 999986 555544321 23457888899999999999999997 8999999999999999887 799999999976533
Q ss_pred CCC--CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 293 GEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 293 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
... .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+....+....+....
T Consensus 155 ~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~------------- 220 (260)
T cd05069 155 NEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY------------- 220 (260)
T ss_pred CcccccCCCccchhhCCHHHhccC-CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------------
Confidence 221 1223456789999988654 48999999999999999999 999998876655544432210
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.. ..+..++..+.+|+.+||..||.+||+++++++
T Consensus 221 -----~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 221 -----RM----------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred -----CC----------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 00 012346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=298.60 Aligned_cols=241 Identities=25% Similarity=0.375 Sum_probs=190.8
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchh---hHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR---YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~---~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
.+|.+.+.||.|+||.||+|.. .|+.||+|.+..... ...+|+.+++.++|+||+++++++. +....++|
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v 78 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL-----QGNPLYIV 78 (256)
T ss_pred hhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEc-----CCCCeEEE
Confidence 3588999999999999999986 489999999866543 4557999999999999999999884 34458899
Q ss_pred eeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 214 LEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 214 ~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
|||+++ .+.+.+.. .....+++..+..++.|++.||.|||+ +||+||||||+||+++.++ .+||+|||.++....
T Consensus 79 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~Nili~~~~-~~~l~d~g~~~~~~~ 154 (256)
T cd05039 79 TEYMAKGSLVDYLRS--RGRAVITLAQQLGFALDVCEGMEYLEE-KNFVHRDLAARNVLVSEDL-VAKVSDFGLAKEASQ 154 (256)
T ss_pred EEecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccchhcccceEEEeCCC-CEEEccccccccccc
Confidence 999985 55544332 112368899999999999999999997 9999999999999999877 799999999986632
Q ss_pred CCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 011138 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (492)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~ 371 (492)
. .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+...
T Consensus 155 ~--~~~~~~~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---------------- 215 (256)
T cd05039 155 G--QDSGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG---------------- 215 (256)
T ss_pred c--cccCCCcccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC----------------
Confidence 2 2233446679999998654 48899999999999999997 99999876644433222110
Q ss_pred cccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
+. ...+..+++++.+||.+||..||++||++.+++.
T Consensus 216 --~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 216 --YR----------MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred --CC----------CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 00 0012346899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=297.04 Aligned_cols=262 Identities=24% Similarity=0.357 Sum_probs=205.3
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-----hhHHHHHHH-HHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQI-MRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-----~~~~~E~~i-l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
.+-...||.|+||+|++..++.+|+..|||++.... ..+..|.+. ++.-+.||||++|+..+..++ .+|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd-----cWi 140 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD-----CWI 140 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc-----eee
Confidence 334456999999999999999999999999985432 223345554 556679999999999876554 789
Q ss_pred EeeechhhHHHHhhh-hhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 213 VLEYISETVYRVSKH-YTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 213 V~E~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
.||+|.-++..+.+. +......+++..+..|+...+.||.||.....|||||+||+|||++..| .|||||||++..+.
T Consensus 141 CMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G-~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 141 CMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG-DVKLCDFGICGQLV 219 (361)
T ss_pred eHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC-CEeeecccchHhHH
Confidence 999998765544332 3344567899988899999999999999768999999999999999988 89999999998776
Q ss_pred CCCCCccceeccCccCchhhcCCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 292 PGEPNISYICSRYYRAPELIFGATE-YTTAIDMWSIGCVLAELLLGQPLFPGESG-VDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~DvwSlGvil~ell~G~~pf~~~~~-~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
..-..+...|...|||||.+..... |+-++||||||++|||+.||..||.+.+. .+++..+.. |.|+.-
T Consensus 220 ~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~--gdpp~l------- 290 (361)
T KOG1006|consen 220 DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI--GDPPIL------- 290 (361)
T ss_pred HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc--CCCCee-------
Confidence 6666667789999999999965443 89999999999999999999999988654 233333322 333211
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~ 429 (492)
.... -.-+.+..++.+|.-||.+|-..||...+++.+||++.+...
T Consensus 291 ----------~~~~----~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~ 336 (361)
T KOG1006|consen 291 ----------LFDK----ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVE 336 (361)
T ss_pred ----------cCcc----cccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhc
Confidence 1000 001368899999999999999999999999999999976543
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=300.62 Aligned_cols=237 Identities=24% Similarity=0.281 Sum_probs=182.7
Q ss_pred eeccCCceEEEEEEEc--CCCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEeee
Q 011138 144 VVGTGSFGVVFQAKCL--ETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEY 216 (492)
Q Consensus 144 ~lG~G~fg~Vy~~~~~--~~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E~ 216 (492)
.||+|+||.||+|.+. .++..||+|++.... ....+|+.+++.++||||+++++++ .. ...++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~-----~~-~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-----EA-EALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEE-----cC-CCeEEEEEe
Confidence 3899999999999765 445679999885432 2355799999999999999999876 22 247899999
Q ss_pred chhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCCCC
Q 011138 217 ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN 296 (492)
Q Consensus 217 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~~~ 296 (492)
++++.+.... ......+++..+..++.||+.||.|||+ +|++||||||+|||++.++ .+||+|||++.........
T Consensus 76 ~~~~~L~~~l--~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~~~ 151 (257)
T cd05115 76 ASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEG-KNFVHRDLAARNVLLVNQH-YAKISDFGLSKALGADDSY 151 (257)
T ss_pred CCCCCHHHHH--HhCCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeecccchheEEEcCCC-cEEeccCCccccccCCccc
Confidence 9865443221 1223568999999999999999999997 9999999999999999877 7999999999755333211
Q ss_pred ----ccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 011138 297 ----ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (492)
Q Consensus 297 ----~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~ 371 (492)
....++..|+|||.+.+. .++.++|||||||++|+|++ |..||......+....+.+. .
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--~------------- 215 (257)
T cd05115 152 YKARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG--K------------- 215 (257)
T ss_pred eeccCCCCCCcccCCHHHHccC-CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC--C-------------
Confidence 112235789999998654 48999999999999999996 99999887765544333221 0
Q ss_pred cccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.. .++...++++.+||.+||..||++||++.++++
T Consensus 216 -~~------------~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 216 -RL------------DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred -CC------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 022346899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=311.88 Aligned_cols=249 Identities=22% Similarity=0.332 Sum_probs=191.0
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCC-------CCEEEEEEeccch-----hhHHHHHHHHHHc-CCCCccccceeeeec
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLET-------GDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFST 202 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~-------g~~vAiK~~~~~~-----~~~~~E~~il~~l-~h~nIv~l~~~~~~~ 202 (492)
..+|.+++.||+|+||.||+|.+... +..||+|.+.... ....+|+.+++++ +||||+++++++
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~--- 87 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC--- 87 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE---
Confidence 34699999999999999999986432 2368999875421 3445799999999 799999999988
Q ss_pred cCCCceEEEEEeeechh-hHHHHhhhhh------------hcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCc
Q 011138 203 TEKDELYLNLVLEYISE-TVYRVSKHYT------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQN 269 (492)
Q Consensus 203 ~~~~~~~~~lV~E~~~~-~l~~~~~~~~------------~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~N 269 (492)
.....+++||||+++ ++.+.+.... .....+++..+..++.||+.||.|||+ +||+||||||+|
T Consensus 88 --~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~N 164 (334)
T cd05100 88 --TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS-QKCIHRDLAARN 164 (334)
T ss_pred --ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccce
Confidence 344468899999986 4444443221 112347778888999999999999997 999999999999
Q ss_pred eEEcCCCCcEEEeeecCccccCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCh
Q 011138 270 LLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESG 345 (492)
Q Consensus 270 ILl~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~ 345 (492)
||++.++ .+||+|||+++....... .....++..|+|||++.+. .++.++|||||||++|||++ |..||.+.+.
T Consensus 165 ill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 165 VLVTEDN-VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred EEEcCCC-cEEECCcccceecccccccccccCCCcCceEcCHHHhccC-CcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999887 799999999976533221 1122345679999999654 48899999999999999998 8999988765
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 346 VDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 346 ~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
.+....+... ... ..+..++.++.+||.+||+.+|.+||++.+++.+
T Consensus 243 ~~~~~~~~~~------------------~~~----------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 243 EELFKLLKEG------------------HRM----------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHcC------------------CCC----------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 5544333210 000 0123467899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=300.25 Aligned_cols=243 Identities=23% Similarity=0.338 Sum_probs=191.4
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch---hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~---~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
.+|++.++||+|+||.||+|.+ .+++.||+|.+.... ....+|+.+++.++|+||+++++++. + ...++|
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~-~~~~~v 78 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-----Q-EPIYII 78 (260)
T ss_pred HHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-----c-CCcEEE
Confidence 4699999999999999999985 467889999886533 34567999999999999999988752 1 237899
Q ss_pred eeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 214 LEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 214 ~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
|||+.+ .+.+.+.. .....+++..+..++.|++.||+|||+ .|++||||||+||+++.++ .++|+|||++.....
T Consensus 79 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~ 154 (260)
T cd05067 79 TEYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIER-KNYIHRDLRAANILVSETL-CCKIADFGLARLIED 154 (260)
T ss_pred EEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHHhEEEcCCC-CEEEccCcceeecCC
Confidence 999975 45444322 223568888999999999999999997 9999999999999999887 799999999976542
Q ss_pred CCC--CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 293 GEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 293 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
... .....++..|+|||++.+. .++.++|||||||++|+|++ |++||.+.+..+....+....
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~------------- 220 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY------------- 220 (260)
T ss_pred CCcccccCCcccccccCHHHhccC-CcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC-------------
Confidence 221 1223456789999998654 48899999999999999998 999998877655444432210
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
..+ .+...+.++.+||.+||..||++||++++++.
T Consensus 221 -----~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 221 -----RMP----------RPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred -----CCC----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 000 11346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=306.07 Aligned_cols=248 Identities=24% Similarity=0.301 Sum_probs=191.3
Q ss_pred ccceeEeeeeccCCceEEEEEEEcC-----CCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCC
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~-----~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 205 (492)
..+|.+.+.||+|+||.||+|.+.. ++..||+|.+... .....+|+.+++.++||||+++++++ .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~-----~ 78 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVC-----A 78 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEE-----c
Confidence 3469999999999999999998753 6788999987543 23455799999999999999999987 3
Q ss_pred CceEEEEEeeechh-hHHHHhhhhh------------------hcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCC
Q 011138 206 DELYLNLVLEYISE-TVYRVSKHYT------------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIK 266 (492)
Q Consensus 206 ~~~~~~lV~E~~~~-~l~~~~~~~~------------------~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlK 266 (492)
+...+++||||+++ .+...+.... .....+++..+..++.||+.||.|||+ +|++|||||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~-~~i~H~dl~ 157 (288)
T cd05050 79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE-RKFVHRDLA 157 (288)
T ss_pred CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCeeccccc
Confidence 34457899999986 4444443211 111346788889999999999999997 999999999
Q ss_pred CCceEEcCCCCcEEEeeecCccccCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCC
Q 011138 267 PQNLLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPG 342 (492)
Q Consensus 267 p~NILl~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~ 342 (492)
|+|||++.++ .+||+|||++........ .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+
T Consensus 158 p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 158 TRNCLVGENM-VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred HhheEecCCC-ceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999887 799999999875432221 1123446679999998654 48999999999999999997 8899987
Q ss_pred CChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 343 ESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 343 ~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.+..+....+... ... ..+..++.++.+||.+||+.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~-------------------~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 236 MAHEEVIYYVRDG-------------------NVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CCHHHHHHHHhcC-------------------CCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 7665544433220 000 012346789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=298.39 Aligned_cols=239 Identities=26% Similarity=0.343 Sum_probs=187.6
Q ss_pred eeeccCCceEEEEEEEcC-CCC--EEEEEEeccchh-----hHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEe
Q 011138 143 RVVGTGSFGVVFQAKCLE-TGD--SVAIKKVLQDKR-----YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~-~g~--~vAiK~~~~~~~-----~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
+.||+|+||.||+|.+.. .+. .||||.+..... ...+|+.+++.++||||+++++.+. + ...++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~-~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVL-----T-HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEc-----C-CeEEEEE
Confidence 368999999999999865 333 699998865433 3457999999999999999999874 3 4688999
Q ss_pred eechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCC
Q 011138 215 EYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (492)
Q Consensus 215 E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (492)
||+.+ .+...+..... ..+++..+..++.||+.||.|||+ +|++||||||+||+++.++ .+||+|||+++.....
T Consensus 75 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~di~p~nil~~~~~-~~kl~dfg~~~~~~~~ 150 (257)
T cd05040 75 ELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLES-KRFIHRDLAARNILLASDD-KVKIGDFGLMRALPQN 150 (257)
T ss_pred EecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHh-CCccccccCcccEEEecCC-EEEecccccccccccc
Confidence 99975 45544433211 468899999999999999999997 9999999999999999887 8999999999876432
Q ss_pred CC----CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 294 EP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 294 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
.. .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+....
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~------------ 217 (257)
T cd05040 151 EDHYVMEEHLKVPFAWCAPESLRTR-TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG------------ 217 (257)
T ss_pred ccceecccCCCCCceecCHHHhccc-CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC------------
Confidence 21 1124567789999998654 48999999999999999998 999998777666555443210
Q ss_pred CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.... .+..++..+.+|+.+||..+|.+||++.++++
T Consensus 218 ---~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 218 ---ERLE------------RPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred ---CcCC------------CCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 0000 11246789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=304.77 Aligned_cols=236 Identities=19% Similarity=0.271 Sum_probs=180.3
Q ss_pred eeccCCceEEEEEEEcCCCCE-------EEEEEeccch----hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 144 VVGTGSFGVVFQAKCLETGDS-------VAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 144 ~lG~G~fg~Vy~~~~~~~g~~-------vAiK~~~~~~----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
.||+|+||.||+|.+..++.. ||+|.+.... ....+|+.+++.++||||+++++++... ...++
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~~~l 76 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-----DESIM 76 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-----CCcEE
Confidence 599999999999998665543 8888775432 2345789999999999999999988543 34789
Q ss_pred EeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCc-------EEEeeec
Q 011138 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQ-------LKICDFG 285 (492)
Q Consensus 213 V~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~-------vkL~DFG 285 (492)
||||+.++.+.... ......+++..+..++.||+.||.|||+ +||+||||||+|||++.++.. ++++|||
T Consensus 77 v~e~~~~g~L~~~l--~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 77 VQEYVKFGSLDTYL--KKNKNLINISWKLEVAKQLAWALHFLED-KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred EEecCCCCcHHHHH--hcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 99999876443222 1223467888899999999999999997 999999999999999876532 7999999
Q ss_pred CccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 011138 286 SAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG-QPLFPGESGVDQLVEIIKILGTPTREEI 364 (492)
Q Consensus 286 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G-~~pf~~~~~~~~~~~i~~~~g~p~~~~~ 364 (492)
++..... .....+++.|+|||++.+...++.++|||||||++|+|++| .+||...+...... ...
T Consensus 154 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~---------- 219 (258)
T cd05078 154 ISITVLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYE---------- 219 (258)
T ss_pred cccccCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHH----------
Confidence 9865432 22456788999999997655689999999999999999998 56666554433221 111
Q ss_pred hhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
.... ++...+.++.+||.+||+.||++|||+.++++.
T Consensus 220 -------~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 220 -------DRHQ------------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred -------cccc------------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 0011 112356789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=304.57 Aligned_cols=243 Identities=21% Similarity=0.312 Sum_probs=186.2
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCE----EEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~----vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
.+|++.+.||+|+||.||+|.+..+|+. |++|.+.... .....|+.+++.++||||+++++++. +.
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-----~~ 81 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-----GA 81 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-----CC
Confidence 3688999999999999999999888774 7777764321 22345777889999999999999762 22
Q ss_pred eEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 208 ~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
..++|+||+.+ ++.+.+. .....+++..+..++.||+.||.|||+ +|++||||||+|||++.++ .+||+|||+
T Consensus 82 -~~~~i~e~~~~gsL~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~nili~~~~-~~kl~Dfg~ 155 (279)
T cd05111 82 -SLQLVTQLSPLGSLLDHVR---QHRDSLDPQRLLNWCVQIAKGMYYLEE-HRMVHRNLAARNILLKSDS-IVQIADFGV 155 (279)
T ss_pred -ccEEEEEeCCCCcHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcCCC-cEEEcCCcc
Confidence 36689999985 4544432 223568899999999999999999997 9999999999999999877 799999999
Q ss_pred ccccCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 011138 287 AKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTRE 362 (492)
Q Consensus 287 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~ 362 (492)
++....... .....++..|+|||.+.+. .++.++|||||||++|||++ |..||.+..... +.+++... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-~~~~~~~~-~---- 228 (279)
T cd05111 156 ADLLYPDDKKYFYSEHKTPIKWMALESILFG-RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-VPDLLEKG-E---- 228 (279)
T ss_pred ceeccCCCcccccCCCCCcccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHHCC-C----
Confidence 986543322 1234567789999998654 48999999999999999998 999998765433 22222210 0
Q ss_pred HHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
... .+...+.++.+++.+||..||++|||+.++++
T Consensus 229 ----------~~~------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 229 ----------RLA------------QPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred ----------cCC------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 000 01234678899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=300.91 Aligned_cols=245 Identities=22% Similarity=0.296 Sum_probs=181.5
Q ss_pred eeccCCceEEEEEEEcC--CCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEeee
Q 011138 144 VVGTGSFGVVFQAKCLE--TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEY 216 (492)
Q Consensus 144 ~lG~G~fg~Vy~~~~~~--~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E~ 216 (492)
.||+|+||.||+|.... ....+|+|.+.... ..+.+|+.+++.++|+||+++++.+ .....+|+||||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~-----~~~~~~~lv~e~ 76 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQC-----IESIPYLLVLEF 76 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEE-----CCCCceEEEEEe
Confidence 59999999999996533 34578888764321 2345799999999999999999988 334458899999
Q ss_pred chh-hHHHHhhhhhh-cCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCC
Q 011138 217 ISE-TVYRVSKHYTR-MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (492)
Q Consensus 217 ~~~-~l~~~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~ 294 (492)
+++ ++.+.+..... .....++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++.......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-ADFIHSDLALRNCQLTADL-SVKIGDYGLALEQYPED 154 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh-cCEecccccHhheEecCCC-cEEEeccccccccccch
Confidence 986 44444433221 12334677788999999999999997 9999999999999999887 89999999986543221
Q ss_pred C---CccceeccCccCchhhcC------CCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 011138 295 P---NISYICSRYYRAPELIFG------ATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEI 364 (492)
Q Consensus 295 ~---~~~~~gt~~y~aPE~~~~------~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~ 364 (492)
. .....+++.|+|||++.. ...++.++|||||||++|||++ |..||....+.+.+..+.....
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~------- 227 (269)
T cd05042 155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQD------- 227 (269)
T ss_pred heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccC-------
Confidence 1 122345678999999743 2346889999999999999998 8899988776665555433211
Q ss_pred hhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
..++. ......+++.+.+++..|+ .||++|||+.+++.
T Consensus 228 ---------~~~~~-------~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 228 ---------IKLPK-------PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred ---------ccCCC-------CcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 11111 0122357888999999998 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=304.38 Aligned_cols=256 Identities=26% Similarity=0.405 Sum_probs=187.6
Q ss_pred ceeEeeeeccCCceEEEEEE----EcCCCCEEEEEEeccch----hhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 138 SYMAERVVGTGSFGVVFQAK----CLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~----~~~~g~~vAiK~~~~~~----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
+|.+.+.||+|+||.||+|. +..++..||||.+.... ..+.+|+++++.++||||++++++++.. +...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~ 81 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GRRN 81 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC---CCCc
Confidence 58899999999999999997 44678999999985432 2456899999999999999999876543 2335
Q ss_pred EEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 210 ~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
+++||||+++ ++...+.. ....+++..+..++.||+.||.|||+ +||+||||||+||+++.++ .+||+|||++.
T Consensus 82 ~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH~-~~i~H~dlkp~nili~~~~-~~~l~dfg~~~ 156 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGS-KRYVHRDLATRNILVESEN-RVKIGDFGLTK 156 (284)
T ss_pred eEEEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHhhEEECCCC-eEEECCCcccc
Confidence 7899999975 45444322 23457889999999999999999997 9999999999999999887 79999999998
Q ss_pred ccCCCCCC----ccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH---
Q 011138 289 MLVPGEPN----ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTR--- 361 (492)
Q Consensus 289 ~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~--- 361 (492)
........ ....++..|+|||++.+. .++.++|||||||++|||++|..++...... . ....+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~---~~~~~~~~~~~~ 230 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPAE--F---MRMMGNDKQGQM 230 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCCcCCCcchh--h---hhhccccccccc
Confidence 76433221 112234569999998654 4899999999999999999998776543211 1 111111000
Q ss_pred --HHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 362 --EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 362 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
..+..... ....++ .+..++.++.+||.+||..||++|||+.++++
T Consensus 231 ~~~~~~~~~~--~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 231 IVYHLIELLK--NNGRLP----------APPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred chHHHHHHHh--cCCcCC----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 00000000 000011 12457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=297.31 Aligned_cols=244 Identities=20% Similarity=0.322 Sum_probs=191.1
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc---hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEe
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
.|.+.+.||+|+||.||+|.+. ++..+|+|.+... .....+|+++++.++||||+++++++ ....+.++||
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v~ 78 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC-----TERSPICLVF 78 (256)
T ss_pred HeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEE-----ccCCceEEEE
Confidence 5889999999999999999875 4778999988643 23456799999999999999999987 4444689999
Q ss_pred eechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCC
Q 011138 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (492)
Q Consensus 215 E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~ 294 (492)
||+.++.+.... ......+++..+..++.|++.||.|||+ .|++||||||+||+++.++ .+||+|||++.......
T Consensus 79 e~~~~~~L~~~~--~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~ 154 (256)
T cd05112 79 EFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLES-SNVIHRDLAARNCLVGENQ-VVKVSDFGMTRFVLDDQ 154 (256)
T ss_pred EcCCCCcHHHHH--HhCccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccccceEEEcCCC-eEEECCCcceeecccCc
Confidence 999876443221 2223457888899999999999999997 9999999999999999777 79999999987553221
Q ss_pred C--CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 011138 295 P--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (492)
Q Consensus 295 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~ 371 (492)
. .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||......+.+..+.+..
T Consensus 155 ~~~~~~~~~~~~~~aPe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--------------- 218 (256)
T cd05112 155 YTSSTGTKFPVKWSSPEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF--------------- 218 (256)
T ss_pred ccccCCCccchhhcCHhHhccC-CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC---------------
Confidence 1 1123346789999998654 48899999999999999998 999998776555444432100
Q ss_pred cccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
.. ..+...+.++.+|+.+||+.||++||++.+++++
T Consensus 219 ---~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 219 ---RL----------YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred ---CC----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 00 0112357899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=304.01 Aligned_cols=236 Identities=18% Similarity=0.225 Sum_probs=179.3
Q ss_pred eeccCCceEEEEEEEcCC------------------------CCEEEEEEeccch----hhHHHHHHHHHHcCCCCcccc
Q 011138 144 VVGTGSFGVVFQAKCLET------------------------GDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSL 195 (492)
Q Consensus 144 ~lG~G~fg~Vy~~~~~~~------------------------g~~vAiK~~~~~~----~~~~~E~~il~~l~h~nIv~l 195 (492)
.||+|+||.||+|....+ ...||+|.+.... ..+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 599999999999975322 2358888875432 234468889999999999999
Q ss_pred ceeeeeccCCCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCC
Q 011138 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH 275 (492)
Q Consensus 196 ~~~~~~~~~~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~ 275 (492)
++++.. ..+.++||||++++.+.... ......+++..+..++.||+.||+|||+ +||+||||||+|||++..
T Consensus 82 ~~~~~~-----~~~~~lv~ey~~~g~L~~~l--~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 82 HGVCVR-----GSENIMVEEFVEHGPLDVCL--RKEKGRVPVAWKITVAQQLASALSYLED-KNLVHGNVCAKNILLARL 153 (274)
T ss_pred EEEEEe-----CCceEEEEecCCCCcHHHHH--HhcCCCCCHHHHHHHHHHHHHHHHHHHc-CCccCCCCCcccEEEecc
Confidence 998843 33578999999987554332 2224568899999999999999999997 999999999999999754
Q ss_pred C------CcEEEeeecCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHH-hCCCCCCCCChHHH
Q 011138 276 T------HQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQ 348 (492)
Q Consensus 276 ~------~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell-~G~~pf~~~~~~~~ 348 (492)
+ ..+||+|||++...... ....++..|+|||.+.+...++.++|||||||++|||+ +|..||......+.
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred CcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3 13899999988644222 23457888999999876566899999999999999995 69999987654332
Q ss_pred HHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 349 LVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 349 ~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
.. .... ...+ +...++++.+||.+||+.||.+|||+.+++++
T Consensus 231 ~~-~~~~-----------------~~~~------------~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 231 ER-FYEK-----------------KHRL------------PEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HH-HHHh-----------------ccCC------------CCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 21 1110 0011 12245789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=300.79 Aligned_cols=249 Identities=23% Similarity=0.309 Sum_probs=192.4
Q ss_pred cceeEeeeeccCCceEEEEEEEcC-----CCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCC
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~-----~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 206 (492)
.+|.+.+.||.|+||.||+|+++. +.+.|++|.+.... ....+|+.+++.++|+||+++++++ .+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC-----RE 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE-----CC
Confidence 368999999999999999999754 34679999875432 2356799999999999999999987 44
Q ss_pred ceEEEEEeeechh-hHHHHhhhhhhc-----CCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEE
Q 011138 207 ELYLNLVLEYISE-TVYRVSKHYTRM-----NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLK 280 (492)
Q Consensus 207 ~~~~~lV~E~~~~-~l~~~~~~~~~~-----~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vk 280 (492)
..+.|+||||+++ .+.+++...... ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++ .++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dlkp~Nili~~~~-~~~ 157 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN-ARFVHRDLAARNCLVSSQR-EVK 157 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh-cCcccCcCccceEEEeCCC-cEE
Confidence 5568999999985 454444332211 1258899999999999999999997 9999999999999999887 799
Q ss_pred EeeecCccccCCCC--CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 011138 281 ICDFGSAKMLVPGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILG 357 (492)
Q Consensus 281 L~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g 357 (492)
|+|||++....... ......++..|+|||.+.+.. ++.++|||||||++|+|++ |..||........+..+..
T Consensus 158 l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~--- 233 (275)
T cd05046 158 VSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQA--- 233 (275)
T ss_pred EcccccccccCcccccccCCceeEEeecChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHc---
Confidence 99999986543221 222346678899999986544 7889999999999999998 8899976655443333221
Q ss_pred CCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 358 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 358 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
....++ ....++..+.++|.+||..||.+||++.+++++
T Consensus 234 --------------~~~~~~----------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 234 --------------GKLELP----------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred --------------CCcCCC----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 000010 123468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=300.32 Aligned_cols=249 Identities=23% Similarity=0.384 Sum_probs=194.2
Q ss_pred ceeEeeeeccCCceEEEEEEEcC-CCCEEEEEEeccch--------------hhHHHHHHHHHH-cCCCCccccceeeee
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLE-TGDSVAIKKVLQDK--------------RYKNRELQIMRL-LNHPNVVSLKHCFFS 201 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~-~g~~vAiK~~~~~~--------------~~~~~E~~il~~-l~h~nIv~l~~~~~~ 201 (492)
.|.+.+.||+|+||.||+|.+.. +++.+|+|.+.... ....+|+.++.. ++||||+++++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~-- 78 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF-- 78 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE--
Confidence 37888999999999999999887 68899999874211 112357777764 7999999999988
Q ss_pred ccCCCceEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEE
Q 011138 202 TTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLK 280 (492)
Q Consensus 202 ~~~~~~~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vk 280 (492)
.+..+.++||||+++ .+.+.+.........+++..++.++.|++.||.|||+..||+|+||||+|||++.++ .+|
T Consensus 79 ---~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~-~~~ 154 (269)
T cd08528 79 ---LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD-KVT 154 (269)
T ss_pred ---ccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC-cEE
Confidence 444568999999986 454544433344567899999999999999999999426899999999999999887 799
Q ss_pred EeeecCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 011138 281 ICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPT 360 (492)
Q Consensus 281 L~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~ 360 (492)
|+|||++.............|+..|+|||.+.+. .++.++|+|||||++|+|++|.+||...+.......+......|
T Consensus 155 l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~- 232 (269)
T cd08528 155 ITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNE-PYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP- 232 (269)
T ss_pred EecccceeecccccccccccCcccCcChhhhcCC-CCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc-
Confidence 9999999876544444456789999999999754 48999999999999999999999997765544433332211000
Q ss_pred HHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
.....+++++.+||.+||+.||++||++.|+..+
T Consensus 233 --------------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 233 --------------------------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred --------------------------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 0012467899999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=298.10 Aligned_cols=236 Identities=25% Similarity=0.352 Sum_probs=183.7
Q ss_pred eeeccCCceEEEEEEEcCCC---CEEEEEEeccchh-----hHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEe
Q 011138 143 RVVGTGSFGVVFQAKCLETG---DSVAIKKVLQDKR-----YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g---~~vAiK~~~~~~~-----~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
++||+|+||.||+|.+..++ ..||+|.+..... ...+|+.+++.++|+|||++++++. .. ..++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~-~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-----GE-PLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----CC-ceEEEE
Confidence 46999999999999876655 7899998864432 3457999999999999999998762 22 368999
Q ss_pred eechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCC
Q 011138 215 EYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (492)
Q Consensus 215 E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (492)
||+.++ +.+.+.. ...+++..+..++.|++.||.|||. .||+||||||+|||++.++ .+||+|||+++.....
T Consensus 75 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~nili~~~~-~~kl~df~~~~~~~~~ 148 (257)
T cd05060 75 ELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLES-KHFVHRDLAARNVLLVNRH-QAKISDFGMSRALGAG 148 (257)
T ss_pred EeCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhh-cCeeccCcccceEEEcCCC-cEEeccccccceeecC
Confidence 999854 5444332 3368899999999999999999997 9999999999999999887 7999999999866433
Q ss_pred CCCc----cceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 294 EPNI----SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 294 ~~~~----~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
.... ...++..|+|||.+.+. .++.++|||||||++|+|++ |.+||...+..+....+... .
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~--~---------- 215 (257)
T cd05060 149 SDYYRATTAGRWPLKWYAPECINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG--E---------- 215 (257)
T ss_pred CcccccccCccccccccCHHHhcCC-CCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC--C----------
Confidence 3211 11234679999998654 48999999999999999997 99999877664443333210 0
Q ss_pred CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.. ..+..++..+++||.+||..||.+||++.++++
T Consensus 216 ------~~----------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 216 ------RL----------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred ------cC----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00 012346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=302.68 Aligned_cols=248 Identities=20% Similarity=0.273 Sum_probs=191.2
Q ss_pred cceeEeeeeccCCceEEEEEEEcC----CCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLE----TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~----~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
.+|.+.+.||+|+||.||+|.+.. ++..|++|++.... ....+|+.+++.++|+||+++++++... .
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~----~ 81 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED----G 81 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC----C
Confidence 469999999999999999999876 35789999875432 2345799999999999999999986432 2
Q ss_pred eEEEEEeeechh-hHHHHhhhhhhc----CCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEe
Q 011138 208 LYLNLVLEYISE-TVYRVSKHYTRM----NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC 282 (492)
Q Consensus 208 ~~~~lV~E~~~~-~l~~~~~~~~~~----~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~ 282 (492)
...++++||+.+ .+...+...... ...+++..+..++.||+.||.|||+ +|++||||||+||+++.++ .+||+
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~p~nil~~~~~-~~kl~ 159 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK-RGVIHKDIAARNCVIDEEL-QVKIT 159 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCHhhEEEcCCC-cEEEC
Confidence 346799999985 444443322211 1468899999999999999999997 9999999999999999887 79999
Q ss_pred eecCccccCCCCCC---ccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 011138 283 DFGSAKMLVPGEPN---ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGT 358 (492)
Q Consensus 283 DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~ 358 (492)
|||+++.+...... ....++..|+|||++.+. .++.++|||||||++|++++ |++||...+..+....+..
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~---- 234 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD---- 234 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcC-CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc----
Confidence 99999865433211 123456779999998654 48999999999999999998 9999987665443222211
Q ss_pred CCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 359 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
...++ ....+++++.+++.+||..||++|||+.++++
T Consensus 235 --------------~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 235 --------------GYRLA----------QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred --------------CCCCC----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00000 11246789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=296.72 Aligned_cols=242 Identities=27% Similarity=0.383 Sum_probs=191.2
Q ss_pred eEeeeeccCCceEEEEEEEcCCC----CEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 140 MAERVVGTGSFGVVFQAKCLETG----DSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 140 ~~~~~lG~G~fg~Vy~~~~~~~g----~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
.+.+.||.|+||.||+|.+..++ ..||+|.+.... ....+|+.+++.++|+||+++++++. +....
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~ 76 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCT-----EEEPL 76 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEc-----CCCee
Confidence 45678999999999999998766 899999985433 34557999999999999999999883 33568
Q ss_pred EEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 211 ~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
++||||+.++ +.+.+.... ...+++..+..++.||+.||.|||+ .|++||||||+||+++.++ .++|+|||++..
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~h~dl~~~nil~~~~~-~~~l~dfg~~~~ 152 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLES-KNFIHRDLAARNCLVGENL-VVKISDFGLSRD 152 (258)
T ss_pred EEEEeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhc-CCeeecccccceEEEccCC-eEEEcccCCcee
Confidence 8999999864 444333211 1228999999999999999999997 8999999999999999887 799999999976
Q ss_pred cCCCCCCc--cceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 011138 290 LVPGEPNI--SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (492)
Q Consensus 290 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~ 366 (492)
........ ...+++.|+|||.+. ...++.++|+|||||++|+|++ |.+||...+.......+....
T Consensus 153 ~~~~~~~~~~~~~~~~~y~~Pe~~~-~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~---------- 221 (258)
T smart00219 153 LYDDDYYKKKGGKLPIRWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY---------- 221 (258)
T ss_pred cccccccccccCCCcccccChHHhc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC----------
Confidence 64432221 123678999999984 4458999999999999999998 899998866655554443210
Q ss_pred cCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.+ .....++.++.+++.+||..||++|||+.|+++
T Consensus 222 ---------~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 222 ---------RL---------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred ---------CC---------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 00 011236889999999999999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=303.87 Aligned_cols=254 Identities=21% Similarity=0.277 Sum_probs=188.7
Q ss_pred cceeEeeeeccCCceEEEEEEEcC----------------CCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCcccc
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLE----------------TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSL 195 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~----------------~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l 195 (492)
.+|.+.+.||+|+||.||++.+.. ++..||+|.+.... ....+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 359999999999999999986432 34579999886432 345579999999999999999
Q ss_pred ceeeeeccCCCceEEEEEeeechh-hHHHHhhhhhh-------cCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCC
Q 011138 196 KHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTR-------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKP 267 (492)
Q Consensus 196 ~~~~~~~~~~~~~~~~lV~E~~~~-~l~~~~~~~~~-------~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp 267 (492)
++++. +....++||||+.+ ++...+..... ....+++..+..++.||+.||.|||+ +||+||||||
T Consensus 85 ~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dlkp 158 (296)
T cd05095 85 LAVCI-----TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS-LNFVHRDLAT 158 (296)
T ss_pred EEEEe-----cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCeecccCCh
Confidence 99883 33458899999985 45444433211 11346777899999999999999997 9999999999
Q ss_pred CceEEcCCCCcEEEeeecCccccCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh--CCCCCCC
Q 011138 268 QNLLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL--GQPLFPG 342 (492)
Q Consensus 268 ~NILl~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~--G~~pf~~ 342 (492)
+|||++.++ .++|+|||+++.+..... .....+++.|+|||...+. .++.++|||||||++|||++ |..||..
T Consensus 159 ~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 159 RNCLVGKNY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred heEEEcCCC-CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 999999877 799999999976533321 1123346789999988654 48999999999999999998 7799987
Q ss_pred CChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 343 ESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 343 ~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.+..+.+......... ......++ .+..+++.+.+|+.+||+.||.+||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~-----------~~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 237 LSDEQVIENTGEFFRD-----------QGRQVYLP----------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred cChHHHHHHHHHHHhh-----------ccccccCC----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 6655444332221100 00000011 11246788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=323.79 Aligned_cols=265 Identities=25% Similarity=0.391 Sum_probs=217.1
Q ss_pred CccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc---hhhHHHHHHHHHHc-CCCCccccceeeeeccCCCce
Q 011138 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 133 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~---~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~~ 208 (492)
|...+-|++.++||.|.+|.||+++.+.+|+..|+|+...+ ....+.|.+|++.+ .|||++.+|++|+........
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 44556699999999999999999999999999999987543 34456788898887 599999999999887776677
Q ss_pred EEEEEeeechhhH-HHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 209 YLNLVLEYISETV-YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 209 ~~~lV~E~~~~~l-~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
.++||||||+||. .++.+... +..+.+..+..|++.++.||.+||. ..++|||||-.|||++.++ .|||+|||.+
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~-nkviHRDikG~NiLLT~e~-~VKLvDFGvS 170 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHN-NKVIHRDIKGQNVLLTENA-EVKLVDFGVS 170 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhh-cceeeecccCceEEEeccC-cEEEeeeeee
Confidence 8999999999654 45555544 7889999999999999999999997 8999999999999999998 7999999998
Q ss_pred cccCCC-CCCccceeccCccCchhhcCC----CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 011138 288 KMLVPG-EPNISYICSRYYRAPELIFGA----TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (492)
Q Consensus 288 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~ 362 (492)
..+... ....+.+|||+|||||++... ..|+..+|+||||++..||--|.+|+-+......+..|-. .|++.
T Consensus 171 aQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR---NPPPk 247 (953)
T KOG0587|consen 171 AQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NPPPK 247 (953)
T ss_pred eeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC---CCCcc
Confidence 766433 345678999999999999533 2377899999999999999999999987766555544422 22211
Q ss_pred HHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
.. -++.-+.++.+||..||.+|-.+||+..++|.|||+++..
T Consensus 248 ------------------Lk-----rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~ 289 (953)
T KOG0587|consen 248 ------------------LK-----RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP 289 (953)
T ss_pred ------------------cc-----chhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence 11 1234478899999999999999999999999999998543
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=295.81 Aligned_cols=236 Identities=23% Similarity=0.343 Sum_probs=183.2
Q ss_pred eeccCCceEEEEEEEcCCCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEeeech
Q 011138 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS 218 (492)
Q Consensus 144 ~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E~~~ 218 (492)
+||+|+||.||+|.. .++..||+|.+.... ....+|+.+++.++||||+++++++. .....++||||++
T Consensus 2 ~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~ 75 (250)
T cd05085 2 LLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT-----QRQPIYIVMELVP 75 (250)
T ss_pred ccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEe-----cCCccEEEEECCC
Confidence 689999999999985 468899999875432 23457999999999999999999883 3345889999998
Q ss_pred hhH-HHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCCCC-
Q 011138 219 ETV-YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN- 296 (492)
Q Consensus 219 ~~l-~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~~~- 296 (492)
++. ...+. .....+++..+..++.|++.||.|||+ +|++||||||+||+++.++ .+||+|||++.........
T Consensus 76 ~~~L~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~ 150 (250)
T cd05085 76 GGDFLSFLR---KKKDELKTKQLVKFALDAAAGMAYLES-KNCIHRDLAARNCLVGENN-VLKISDFGMSRQEDDGIYSS 150 (250)
T ss_pred CCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccChheEEEcCCC-eEEECCCccceecccccccc
Confidence 653 33322 223457888999999999999999997 9999999999999999877 7999999998754322211
Q ss_pred -ccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 011138 297 -ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEF 374 (492)
Q Consensus 297 -~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~ 374 (492)
....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+.... ..
T Consensus 151 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~----------------~~ 213 (250)
T cd05085 151 SGLKQIPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY----------------RM 213 (250)
T ss_pred CCCCCCcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC----------------CC
Confidence 11234567999999854 448899999999999999998 999998776554433332100 00
Q ss_pred CCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 375 KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
..+..++.++.+|+.+||..||++||++.++++
T Consensus 214 ------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 214 ------------SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred ------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 012346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=298.52 Aligned_cols=246 Identities=20% Similarity=0.219 Sum_probs=180.7
Q ss_pred eeeccCCceEEEEEEEc--CCCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEee
Q 011138 143 RVVGTGSFGVVFQAKCL--ETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~--~~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E 215 (492)
+.||+|+||.||+|.+. .++..+|+|.+.... ....+|+.+++.++||||+++++++ .+..++++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQC-----TEVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----cCCCCcEEEEE
Confidence 35899999999999864 355779999875432 2345799999999999999999987 34445889999
Q ss_pred echhh-HHHHhhhhhh-cCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCC
Q 011138 216 YISET-VYRVSKHYTR-MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (492)
Q Consensus 216 ~~~~~-l~~~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (492)
|++++ +.+.+..... .....+...++.++.|++.||.|||+ .||+||||||+||+++.++ .+||+|||+++.....
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dlkp~nil~~~~~-~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK-NNFIHSDLALRNCLLTADL-TVKIGDYGLSHNKYKE 153 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcCCC-cEEECCccccccccCc
Confidence 99854 4444432221 12245666778899999999999997 9999999999999999877 7999999998754322
Q ss_pred CC---CccceeccCccCchhhcCCC------CCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 011138 294 EP---NISYICSRYYRAPELIFGAT------EYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREE 363 (492)
Q Consensus 294 ~~---~~~~~gt~~y~aPE~~~~~~------~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~ 363 (492)
.. .....++..|+|||++.+.. .++.++|||||||++|||++ |..||......+........
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-------- 225 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVRE-------- 225 (269)
T ss_pred ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhc--------
Confidence 21 12345678899999985321 35789999999999999996 99999876654433322211
Q ss_pred HhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
....++. ..+....++.+.+++.+|+ .+|++|||+.+++.
T Consensus 226 --------~~~~~~~-------~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 226 --------QQLKLPK-------PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred --------ccCCCCC-------CccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 0001110 0011235778999999998 68999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=296.43 Aligned_cols=237 Identities=24% Similarity=0.355 Sum_probs=184.6
Q ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEeeec
Q 011138 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E~~ 217 (492)
+.||.|+||.||+|.+.. ++.||+|.+... .....+|+++++.++|+||+++++++ .+..+.++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC-----VQKQPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEE-----ecCCCeEEEEEcC
Confidence 369999999999999877 999999987543 23456799999999999999999988 3444588999999
Q ss_pred hhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCCCC
Q 011138 218 SET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN 296 (492)
Q Consensus 218 ~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~~~ 296 (492)
.++ +.+.+. .....++...+..++.|++.||.|||+ +|++||||||+|||++.++ .+||+|||++.........
T Consensus 75 ~~~~l~~~l~---~~~~~~~~~~~~~~~~~~~~~l~~lH~-~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~~ 149 (251)
T cd05041 75 PGGSLLTFLR---KKKNRLTVKKLLQMSLDAAAGMEYLES-KNCIHRDLAARNCLVGENN-VLKISDFGMSREEEGGIYT 149 (251)
T ss_pred CCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHh-CCEehhhcCcceEEEcCCC-cEEEeeccccccccCCcce
Confidence 765 433332 223457888889999999999999997 9999999999999999887 7999999998755322111
Q ss_pred ---ccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 011138 297 ---ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372 (492)
Q Consensus 297 ---~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~ 372 (492)
....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||...........+...
T Consensus 150 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~----------------- 211 (251)
T cd05041 150 VSDGLKQIPIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG----------------- 211 (251)
T ss_pred eccccCcceeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC-----------------
Confidence 112235679999998654 48999999999999999998 89999876654433332110
Q ss_pred ccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
... ..+..++.++.+|+.+||..+|.+|||+.++++
T Consensus 212 -~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 212 -YRM----------PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred -CCC----------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 000 012346889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=300.67 Aligned_cols=243 Identities=24% Similarity=0.351 Sum_probs=190.2
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCC----EEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGD----SVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~----~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
.+|.+.+.||+|+||.||+|.++.+|+ .||+|.+.... ....+|+.+++.++||||+++++++..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------ 80 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence 469999999999999999999877765 58999875432 334579999999999999999998853
Q ss_pred eEEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 208 LYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 208 ~~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
...++||||+.++ +.+.+. .....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~di~p~nil~~~~~-~~kL~dfg~ 155 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVR---NHKDNIGSQYLLNWCVQIAKGMSYLEE-KRLVHRDLAARNVLVKTPQ-HVKITDFGL 155 (279)
T ss_pred CceEEEEecCCCCcHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecccCcceEEEcCCC-eEEECCCcc
Confidence 2478999999864 443332 223458899999999999999999997 9999999999999999877 799999999
Q ss_pred ccccCCCCCCcc---ceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 011138 287 AKMLVPGEPNIS---YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTRE 362 (492)
Q Consensus 287 a~~~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~ 362 (492)
++.......... ..++..|+|||.+.. ..++.++|+|||||++|||++ |..||.+....+....+... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--~---- 228 (279)
T cd05057 156 AKLLDVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG--E---- 228 (279)
T ss_pred cccccCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC--C----
Confidence 987643332221 223567999999854 458899999999999999998 99999887654433333210 0
Q ss_pred HHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.++ .+...+.++.+++.+||..||.+||++.++++
T Consensus 229 ------------~~~----------~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 229 ------------RLP----------QPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred ------------CCC----------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 000 11235788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=302.73 Aligned_cols=254 Identities=24% Similarity=0.385 Sum_probs=186.7
Q ss_pred eeEeeeeccCCceEEEEEEE----cCCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 139 YMAERVVGTGSFGVVFQAKC----LETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~----~~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
|.+.+.||+|+||.||+|.. ..++..||+|.+... .....+|+.+++.++||||+++++++... +..+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~ 82 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GGNG 82 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CCCc
Confidence 78899999999999999974 457889999988533 13456799999999999999999887432 2345
Q ss_pred EEEEeeechhhHH-HHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 210 LNLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 210 ~~lV~E~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
.++||||++++.+ ..+. .....+++..+..++.||+.||+|||+ +||+||||||+||+++.++ .+||+|||+++
T Consensus 83 ~~lv~e~~~g~~L~~~l~---~~~~~~~~~~~~~i~~~i~~aL~~lH~-~gi~H~dlkp~Nil~~~~~-~~~l~dfg~~~ 157 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLP---RNKNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVESEH-QVKIGDFGLTK 157 (284)
T ss_pred eEEEEEccCCCCHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccchheEEEcCCC-CEEECCCcccc
Confidence 7899999986543 3322 223457889999999999999999997 9999999999999999877 79999999998
Q ss_pred ccCCCCC----CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH--
Q 011138 289 MLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE-- 362 (492)
Q Consensus 289 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~-- 362 (492)
....... .....++..|+|||++.+. .++.++|||||||++|+|+++..|+..... .. .+..+....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~~--~~---~~~~~~~~~~~~ 231 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPMT--LF---LKMIGPTHGQMT 231 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCccccc--hh---hhhccccccccc
Confidence 6643321 1234567789999998654 488999999999999999998876533211 11 1111110000
Q ss_pred ---HHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 363 ---EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 363 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.+..... .... ..+..++.++.+||.+||+.||.+||++.++++
T Consensus 232 ~~~~~~~~~~---~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 278 (284)
T cd05079 232 VTRLVRVLEE---GKRL----------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278 (284)
T ss_pred HHHHHHHHHc---CccC----------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0000000 0000 112357899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=296.45 Aligned_cols=243 Identities=27% Similarity=0.362 Sum_probs=189.3
Q ss_pred cceeEeeeeccCCceEEEEEEEcCC---CCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLET---GDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~---g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
.+|.+.+.||+|+||.||+|.+... ...||||...... ....+|+.+++.++||||+++++++. +.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~- 79 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT-----EN- 79 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEc-----CC-
Confidence 3588999999999999999987544 3468999875432 23557999999999999999999773 22
Q ss_pred EEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 209 ~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
..++||||+.++ +.+.+.. ....+++..+..++.||+.||.|||+ .|++||||||+|||++.++ .+||+|||++
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~H~dl~p~nili~~~~-~~~l~d~g~~ 154 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLES-KRFVHRDIAARNVLVSSPD-CVKLGDFGLS 154 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccChheEEEecCC-CeEEccCcee
Confidence 357999999854 4444322 23458899999999999999999997 9999999999999999877 7999999999
Q ss_pred cccCCCCCC--ccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 011138 288 KMLVPGEPN--ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEI 364 (492)
Q Consensus 288 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~ 364 (492)
+........ ....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-------- 225 (270)
T cd05056 155 RYLEDESYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE-------- 225 (270)
T ss_pred eecccccceecCCCCccccccChhhhccC-CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--------
Confidence 765433211 122335679999998544 58999999999999999996 999998877665554432210
Q ss_pred hhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.. ..+..++.++.+||.+||..+|.+|||+.+++.
T Consensus 226 ----------~~----------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 226 ----------RL----------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred ----------cC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 012357889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=299.62 Aligned_cols=242 Identities=26% Similarity=0.373 Sum_probs=184.6
Q ss_pred eEeeeeccCCceEEEEEEEc----CCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 140 MAERVVGTGSFGVVFQAKCL----ETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 140 ~~~~~lG~G~fg~Vy~~~~~----~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
.+.+.||.|.||.||+|... ..+..|+||.+... ...+.+|+++++.++||||+++++++.... ..
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~-----~~ 76 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE-----PL 76 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS-----SE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccc-----cc
Confidence 35678999999999999987 44678999998432 234567999999999999999999986322 27
Q ss_pred EEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 211 ~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
++||||+.+ .|.+.+... ....++...+..++.||+.||.|||+ ++|+|+||++.|||++.++ .+||+|||++..
T Consensus 77 ~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~iiH~~l~~~nill~~~~-~~Kl~~f~~~~~ 152 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHS-NNIIHGNLSPSNILLDSNG-QVKLSDFGLSRP 152 (259)
T ss_dssp EEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHH-TTEEEST-SGGGEEEETTT-EEEEESTTTGEE
T ss_pred ccccccccccccccccccc--cccccccccccccccccccccccccc-ccccccccccccccccccc-cccccccccccc
Confidence 899999985 455544332 24568899999999999999999997 8999999999999999888 899999999986
Q ss_pred cCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 011138 290 LVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (492)
Q Consensus 290 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~ 365 (492)
...... .....+...|+|||.+.+.. ++.++||||||+++|||++ |+.||...+..+....+.+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~--------- 222 (259)
T PF07714_consen 153 ISEKSKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ--------- 222 (259)
T ss_dssp TTTSSSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE---------
T ss_pred ccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccc---------
Confidence 622211 12345678899999996654 8999999999999999999 789998887666555552210
Q ss_pred hcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.. ..+..++..+.++|.+||..||.+||++.++++
T Consensus 223 -------~~------------~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 223 -------RL------------PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp -------ET------------TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred -------cc------------eeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 00 012357889999999999999999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=315.73 Aligned_cols=246 Identities=26% Similarity=0.343 Sum_probs=192.6
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCC---E-EEEEEeccc-------hhhHHHHHHHHHHcCCCCccccceeeeeccCC
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGD---S-VAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~---~-vAiK~~~~~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 205 (492)
.+-.+.++||+|+||.||+|..+..+. . ||+|....+ ....-+|+++|++++|||||++||+...
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~---- 232 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL---- 232 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC----
Confidence 345566899999999999998765432 3 899987632 1233479999999999999999998843
Q ss_pred CceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeec
Q 011138 206 DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (492)
Q Consensus 206 ~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG 285 (492)
..-++||||+|.|+.+. .+.......++..+...++.+.+.||+|||+ +++|||||-..|+|++.++ .+||+|||
T Consensus 233 -~~Pl~ivmEl~~gGsL~--~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~-k~~IHRDIAARNcL~~~~~-~vKISDFG 307 (474)
T KOG0194|consen 233 -EEPLMLVMELCNGGSLD--DYLKKNKKSLPTLEKLRFCYDAARGLEYLHS-KNCIHRDIAARNCLYSKKG-VVKISDFG 307 (474)
T ss_pred -CCccEEEEEecCCCcHH--HHHHhCCCCCCHHHHHHHHHHHHhHHHHHHH-CCCcchhHhHHHheecCCC-eEEeCccc
Confidence 33489999999986443 2333333469999999999999999999997 9999999999999999877 68999999
Q ss_pred CccccCCCCCCc-cceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 011138 286 SAKMLVPGEPNI-SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREE 363 (492)
Q Consensus 286 ~a~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~ 363 (492)
+++......... ..--...|+|||.+... .|+.++|||||||++||+++ |..||.+....+....|...
T Consensus 308 Ls~~~~~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~-------- 378 (474)
T KOG0194|consen 308 LSRAGSQYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKN-------- 378 (474)
T ss_pred cccCCcceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhc--------
Confidence 987543111111 11235679999999654 69999999999999999997 89999999988777777441
Q ss_pred HhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.+ ....+...+.++..++.+|+..||++|+++.++.+
T Consensus 379 ---------~~----------r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 379 ---------GY----------RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred ---------Cc----------cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 11 11122356889999999999999999999998875
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=293.73 Aligned_cols=243 Identities=23% Similarity=0.362 Sum_probs=189.7
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch---hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~---~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
.+|.+.+.||+|+||.||++.+. .+..+|+|.+.... ....+|+.+++.++|+||+++++++.. ...++|
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~~v 78 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIYII 78 (260)
T ss_pred cceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeEEE
Confidence 46999999999999999999854 56679999886543 345579999999999999999888732 347899
Q ss_pred eeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 214 LEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 214 ~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
|||+++ ++.+.+... ....+++..+..++.||+.||.|||+ .|++||||||+||+++.++ .+||+|||++.....
T Consensus 79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~ 154 (260)
T cd05073 79 TEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSASL-VCKIADFGLARVIED 154 (260)
T ss_pred EEeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcCCC-cEEECCCcceeeccC
Confidence 999975 555544321 23457788889999999999999997 9999999999999999877 899999999876533
Q ss_pred CCC--CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 293 GEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 293 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
... .....++..|+|||++.+. .++.++|+|||||++|+|++ |..||.+.+..+....+...
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-------------- 219 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-------------- 219 (260)
T ss_pred CCcccccCCcccccccCHhHhccC-CcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC--------------
Confidence 221 1123456779999998654 48999999999999999998 99999887655444333221
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
+..+ ....++.++.+++.+||+.||++||++.+++.
T Consensus 220 ----~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 220 ----YRMP----------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred ----CCCC----------CcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 0000 11346889999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=296.58 Aligned_cols=239 Identities=23% Similarity=0.352 Sum_probs=178.7
Q ss_pred eeeccCCceEEEEEEEcC---CCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEe
Q 011138 143 RVVGTGSFGVVFQAKCLE---TGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~---~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
+.||+|+||.||+|.+.. .+..||||.+... .....+|+.+++.++||||+++++++.. .....++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLP----SEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeec----CCCCcEEEE
Confidence 368999999999998754 3457999987432 1234579999999999999999986642 223467999
Q ss_pred eechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCC
Q 011138 215 EYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (492)
Q Consensus 215 E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (492)
||+.++ +...+. ......++..+..++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||+++.....
T Consensus 77 e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlk~~nili~~~~-~~kl~dfg~~~~~~~~ 151 (262)
T cd05058 77 PYMKHGDLRNFIR---SETHNPTVKDLIGFGLQVAKGMEYLAS-KKFVHRDLAARNCMLDESF-TVKVADFGLARDIYDK 151 (262)
T ss_pred ecCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcCCC-cEEECCccccccccCC
Confidence 999854 444332 222345667778899999999999997 8999999999999999887 7999999998754322
Q ss_pred C-----CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 294 E-----PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 294 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
. ......++..|+|||.+.+. .++.++|||||||++|||++ |.+||...+..+....+... .
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~--~--------- 219 (262)
T cd05058 152 EYYSVHNHTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG--R--------- 219 (262)
T ss_pred cceeecccccCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC--C---------
Confidence 1 11123456789999998654 48999999999999999999 57778766554433322110 0
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
... .+..+++.+.+++.+||..+|++||++.+++.
T Consensus 220 -----~~~------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 220 -----RLL------------QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred -----CCC------------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 000 11235788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=294.62 Aligned_cols=240 Identities=23% Similarity=0.360 Sum_probs=188.6
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc--hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEe
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
.+|.+.+.||+|+||.||++.. +++.||+|.+..+ .....+|+.+++.++||||+++++++.. . ..++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~-~~~~v~ 77 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH-----N-GLYIVM 77 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcC-----C-CcEEEE
Confidence 4699999999999999999864 7889999988543 2345679999999999999999988732 1 257999
Q ss_pred eechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCC
Q 011138 215 EYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (492)
Q Consensus 215 E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (492)
||+.+ .+...+... ....+++..+..++.|++.||.|||+ .|++||||||+||+++.++ .+||+|||++......
T Consensus 78 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~H~dl~p~nili~~~~-~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 78 ELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLES-KKLVHRDLAARNILVSEDG-VAKVSDFGLARVGSMG 153 (254)
T ss_pred ECCCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcCCC-cEEECCCccceecccc
Confidence 99985 555544321 23457888899999999999999997 9999999999999999887 7999999998754322
Q ss_pred CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 011138 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372 (492)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~ 372 (492)
......+..|+|||.+.+. .++.++|+|||||++|+|++ |++||...+..+....+.+.
T Consensus 154 --~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~----------------- 213 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKHK-KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG----------------- 213 (254)
T ss_pred --CCCCCCCceecCHHHhccC-CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC-----------------
Confidence 1223445679999998654 48899999999999999997 99999877654433332210
Q ss_pred ccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
+..+ ....+++.+.+|+.+||..+|.+||++.+++.
T Consensus 214 -~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 214 -YRME----------PPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred -CCCC----------CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0000 11346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=325.05 Aligned_cols=245 Identities=24% Similarity=0.348 Sum_probs=197.7
Q ss_pred ceeEeeeeccCCceEEEEEEEcC-----CCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~-----~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
+-...+.||+|+||+||+|+... +...||||.++.. ...++||++++..|+|||||+|++++.. .
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~-----~ 561 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE-----G 561 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc-----C
Confidence 45667789999999999998643 3356999988654 3457799999999999999999999943 3
Q ss_pred eEEEEEeeech-hhHHHHhhhhhhc------CC----CcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCC
Q 011138 208 LYLNLVLEYIS-ETVYRVSKHYTRM------NQ----HVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT 276 (492)
Q Consensus 208 ~~~~lV~E~~~-~~l~~~~~~~~~~------~~----~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~ 276 (492)
.-+|||+|||. |+|..++...... .. .++..+...|+.||+.||.||-+ +.+|||||-..|+||..+.
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~-~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS-HHFVHRDLATRNCLVGENL 640 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-Ccccccchhhhhceeccce
Confidence 34899999998 6666665432211 22 37788899999999999999997 8999999999999999888
Q ss_pred CcEEEeeecCccccCCCCCCc---cceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 011138 277 HQLKICDFGSAKMLVPGEPNI---SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEI 352 (492)
Q Consensus 277 ~~vkL~DFG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i 352 (492)
.|||+|||+++.+...+... ...-...|||||.|+-. .|+.++||||+||+|||+++ |..||.+.++.+.+..|
T Consensus 641 -~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~-kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i 718 (774)
T KOG1026|consen 641 -VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG-KFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI 718 (774)
T ss_pred -EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC-cccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence 89999999998764433221 22346789999999755 49999999999999999995 99999999998888777
Q ss_pred HHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhh
Q 011138 353 IKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC 418 (492)
Q Consensus 353 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l 418 (492)
.+. .. ++ .+...|.++.+|+..||+.+|.+||++.||=
T Consensus 719 ~~g-----------------~l-L~----------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 719 RAG-----------------QL-LS----------CPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred HcC-----------------Cc-cc----------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 541 00 11 2357899999999999999999999999873
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=302.96 Aligned_cols=244 Identities=23% Similarity=0.332 Sum_probs=187.8
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCC----EEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGD----SVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~----~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
..|+..+.||+|+||.||+|.+..+|. .||+|.+.... ....+|+.+++.++||||+++++++...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~----- 81 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP----- 81 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-----
Confidence 358888999999999999999988876 46888775432 1345799999999999999999987421
Q ss_pred eEEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 208 LYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 208 ~~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
..++|+||++++ +.+.+. .....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 82 -~~~~v~e~~~~g~l~~~~~---~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dikp~Nill~~~~-~~kL~Dfg~ 155 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVH---EHKDNIGSQLLLNWCVQIAKGMMYLEE-RRLVHRDLAARNVLVKSPN-HVKITDFGL 155 (303)
T ss_pred -CceeeehhcCCCCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHhh-cCeeccccccceeeecCCC-ceEEccccc
Confidence 246899999854 444332 223457888899999999999999997 9999999999999998777 799999999
Q ss_pred ccccCCCCCC---ccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 011138 287 AKMLVPGEPN---ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTRE 362 (492)
Q Consensus 287 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~ 362 (492)
++........ ....++..|+|||.+.+. .++.++|||||||++|||++ |..||.+....+ +..++...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~------ 227 (303)
T cd05110 156 ARLLEGDEKEYNADGGKMPIKWMALECIHYR-KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-IPDLLEKG------ 227 (303)
T ss_pred cccccCcccccccCCCccccccCCHHHhccC-CCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHCC------
Confidence 9865433221 123456789999998654 48999999999999999997 999998765433 23332210
Q ss_pred HHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
..++ .+...+.++.+++.+||..||++||++.++++.
T Consensus 228 -----------~~~~----------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 228 -----------ERLP----------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred -----------CCCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0000 112357789999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=296.43 Aligned_cols=242 Identities=22% Similarity=0.326 Sum_probs=184.9
Q ss_pred eeeccCCceEEEEEEEcCCC------CEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 143 RVVGTGSFGVVFQAKCLETG------DSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g------~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
+.||+|+||.||+|++...+ +.+|||.+... .....+|+.+++.++||||+++++++. +....+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL-----LNEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeec-----CCCCeE
Confidence 36999999999999976544 67999987543 234457999999999999999999883 344588
Q ss_pred EEeeechh-hHHHHhhhhhh---cCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCC----CcEEEee
Q 011138 212 LVLEYISE-TVYRVSKHYTR---MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT----HQLKICD 283 (492)
Q Consensus 212 lV~E~~~~-~l~~~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~----~~vkL~D 283 (492)
+||||+++ .+...+..... ....+++..+..++.||+.||.|||+ .+++|+||||+||+++.++ ..+||+|
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ-MHFIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh-CCcccCCCChheEEEecCCCCCCcceEECC
Confidence 99999985 44444432211 22347788899999999999999997 8999999999999998654 2699999
Q ss_pred ecCccccCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 011138 284 FGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTP 359 (492)
Q Consensus 284 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p 359 (492)
||++........ .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+...
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~---- 229 (269)
T cd05044 155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDG-KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG---- 229 (269)
T ss_pred cccccccccccccccCcccCCCccccCHHHHccC-CcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC----
Confidence 999876533221 1223456789999998654 48999999999999999998 99999877665544333210
Q ss_pred CHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.... .+..+++++.+||.+||..+|.+||++.++++
T Consensus 230 ------------~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 230 ------------GRLQ------------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ------------CccC------------CcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0000 12346889999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=293.90 Aligned_cols=245 Identities=20% Similarity=0.252 Sum_probs=180.3
Q ss_pred eeccCCceEEEEEEEcCC--CCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEeee
Q 011138 144 VVGTGSFGVVFQAKCLET--GDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEY 216 (492)
Q Consensus 144 ~lG~G~fg~Vy~~~~~~~--g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E~ 216 (492)
.||+|+||.||+|..... ...+++|.+... .....+|+.+++.++||||+++++++ .+....|+||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~-----~~~~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQC-----VEAIPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEe-----cCCCccEEEEec
Confidence 599999999999975433 345667765432 23455788999999999999999988 344568999999
Q ss_pred chh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCC-
Q 011138 217 ISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE- 294 (492)
Q Consensus 217 ~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~- 294 (492)
+.+ +|...+..........+...+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||++.......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nil~~~~~-~~~l~Dfg~~~~~~~~~~ 154 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK-HNFLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDY 154 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCeeccCCccceEEEcCCc-cEEecccccccccCcchh
Confidence 986 4544443322223456777788999999999999997 8999999999999999887 79999999986432211
Q ss_pred --CCccceeccCccCchhhcCC------CCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 011138 295 --PNISYICSRYYRAPELIFGA------TEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (492)
Q Consensus 295 --~~~~~~gt~~y~aPE~~~~~------~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~ 365 (492)
......++..|+|||++... ..++.++|||||||++|||++ |..||...+..+.+..+.+....
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~------- 227 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQV------- 227 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccc-------
Confidence 12245678899999987431 235789999999999999996 67899877766665554432100
Q ss_pred hcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.++ ...+...+++.+.+++..|| .||.+||++.++++
T Consensus 228 ---------~~~-------~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 228 ---------KLF-------KPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred ---------ccC-------CCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 000 00111236788999999999 68999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=296.15 Aligned_cols=250 Identities=21% Similarity=0.306 Sum_probs=188.2
Q ss_pred eeEeeeeccCCceEEEEEEEc---CCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCc-e
Q 011138 139 YMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE-L 208 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~---~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~-~ 208 (492)
|.+.+.||+|+||.||+|.+. .+++.||||.+..+. ....+|+.+++.++||||+++++++......+. .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999864 457899999885432 234579999999999999999998755433222 2
Q ss_pred EEEEEeeechhhHH-HHhhhh--hhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeec
Q 011138 209 YLNLVLEYISETVY-RVSKHY--TRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (492)
Q Consensus 209 ~~~lV~E~~~~~l~-~~~~~~--~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG 285 (492)
..++++||+.++.+ ..+... ......++...+..++.||+.||+|||+ +||+||||||+||+++.++ .+||+|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~nili~~~~-~~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS-KNFIHRDLAARNCMLNENM-TVCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccchhhEEEcCCC-CEEECccc
Confidence 34688999985433 332211 1112347888899999999999999997 9999999999999999877 79999999
Q ss_pred CccccCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 011138 286 SAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTR 361 (492)
Q Consensus 286 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~ 361 (492)
+++....... .....+++.|++||.+.+. .++.++|||||||++|+|++ |.+||.+.+..+....+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~------ 231 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADN-VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG------ 231 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcC-ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC------
Confidence 9986533221 1223456789999998654 47899999999999999998 89999877654443333220
Q ss_pred HHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.... .....+..+.+++.+||..+|.+||++.+++.
T Consensus 232 ----------~~~~------------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 232 ----------NRLK------------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred ----------CcCC------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0000 11246789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=293.49 Aligned_cols=235 Identities=22% Similarity=0.246 Sum_probs=179.2
Q ss_pred eeeccCCceEEEEEEEcCCC----------CEEEEEEeccch---hhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 143 RVVGTGSFGVVFQAKCLETG----------DSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g----------~~vAiK~~~~~~---~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
+.||+|+||.||+|.+..++ ..+++|.+.... ..+.+|+.+++.++||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR------DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec------CC
Confidence 36899999999999998776 358888765433 345679999999999999999998744 23
Q ss_pred EEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCC------cEEEee
Q 011138 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH------QLKICD 283 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~------~vkL~D 283 (492)
.++||||+.++.+..... .....++...+..++.||+.||.|||+ +||+||||||+|||++.++. .+||+|
T Consensus 75 ~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLH--REKNNVSLHWKLDVAKQLASALHYLED-KKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred cEEEEEcCCCCcHHHHHH--hhccCCCHHHHHHHHHHHHHHHHHHhh-CCeecccCccceEEEecCccccCCceeEEeCC
Confidence 679999999765443222 112368888999999999999999997 99999999999999986652 499999
Q ss_pred ecCccccCCCCCCccceeccCccCchhhcCC-CCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 011138 284 FGSAKMLVPGEPNISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTR 361 (492)
Q Consensus 284 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~ 361 (492)
||++..... .....++..|+|||++.+. ..++.++|||||||++|+|++ |..||...+..+.......
T Consensus 152 fg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~------- 221 (259)
T cd05037 152 PGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD------- 221 (259)
T ss_pred CCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc-------
Confidence 999986533 2234567789999998665 358999999999999999999 5888866543222111100
Q ss_pred HHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
....+ .....++.+||.+||..||.+|||+.++++
T Consensus 222 -----------~~~~~------------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 222 -----------QHRLP------------MPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred -----------CCCCC------------CCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00000 112378899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=310.02 Aligned_cols=274 Identities=21% Similarity=0.281 Sum_probs=182.5
Q ss_pred ccccceeEeeeeccCCceEEEEEEEc----------------CCCCEEEEEEeccchh------------------hHHH
Q 011138 134 KQTISYMAERVVGTGSFGVVFQAKCL----------------ETGDSVAIKKVLQDKR------------------YKNR 179 (492)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~----------------~~g~~vAiK~~~~~~~------------------~~~~ 179 (492)
....+|.+.++||+|+||+||+|.+. ..++.||||++..+.. ....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 34568999999999999999999752 2456799998854321 1123
Q ss_pred HHHHHHHcCCCCc-----cccceeeeeccC---CCceEEEEEeeechhh-HHHHhhhhh--------------------h
Q 011138 180 ELQIMRLLNHPNV-----VSLKHCFFSTTE---KDELYLNLVLEYISET-VYRVSKHYT--------------------R 230 (492)
Q Consensus 180 E~~il~~l~h~nI-----v~l~~~~~~~~~---~~~~~~~lV~E~~~~~-l~~~~~~~~--------------------~ 230 (492)
|+.++.+++|.++ ++++++|..... ......+|||||++++ |.+.+.... .
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6677777776654 667776643221 1223478999999864 333332100 0
Q ss_pred cCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCCCCcc--ceeccCccCc
Q 011138 231 MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS--YICSRYYRAP 308 (492)
Q Consensus 231 ~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~~~~~--~~gt~~y~aP 308 (492)
....+++..++.++.||+.+|.|||+ ++|+||||||+|||++.++ .+||+|||++.....+..... ..+|+.|+||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~-~~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHR-IGIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCchHhEEECCCC-cEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 11234567788999999999999997 8999999999999999887 799999999976543332222 2348899999
Q ss_pred hhhcCCCC-------------------C--CcchhhHHHHHHHHHHHhCCC-CCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 011138 309 ELIFGATE-------------------Y--TTAIDMWSIGCVLAELLLGQP-LFPGESGVDQLVEIIKILGTPTREEIKC 366 (492)
Q Consensus 309 E~~~~~~~-------------------~--~~~~DvwSlGvil~ell~G~~-pf~~~~~~~~~~~i~~~~g~p~~~~~~~ 366 (492)
|++..... | ....||||+||++|+|++|.. ||.+....... .+...... ..|..
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~---~~~~~~~~-~~~r~ 455 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE---LRQYDNDL-NRWRM 455 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH---HhhccchH-HHHHh
Confidence 99853211 1 124799999999999999875 77543211111 00000000 00100
Q ss_pred cCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCC---CCcCCHHHhhCCCCCCC
Q 011138 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSP---SLRCTALEACAHPFFDD 425 (492)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP---~~R~t~~e~l~Hp~f~~ 425 (492)
... ..+.|+ ....++++++||+.+||..+| .+|+|+.|+|+||||..
T Consensus 456 ~~~--~~~~~~----------~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 456 YKG--QKYDFS----------LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred hcc--cCCCcc----------cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 000 011111 224578999999999999876 68999999999999964
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=327.40 Aligned_cols=246 Identities=21% Similarity=0.350 Sum_probs=196.2
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCC-----EEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGD-----SVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~-----~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
.-.+.+.||+|.||.||.|....... .||||.+.+. ...+.+|..+|+.++|||||+++++++...
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~---- 768 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG---- 768 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC----
Confidence 46778899999999999998754332 3999988654 334558999999999999999999997633
Q ss_pred eEEEEEeeechh-hHHHHhhhhhh---cCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEee
Q 011138 208 LYLNLVLEYISE-TVYRVSKHYTR---MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICD 283 (492)
Q Consensus 208 ~~~~lV~E~~~~-~l~~~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~D 283 (492)
-.+|++|||.| +|+.+++..+. ....+.......++.||++|++||++ +++|||||...|+||+... .|||+|
T Consensus 769 -~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~-~~fvHRDLAaRNCLL~~~r-~VKIaD 845 (1025)
T KOG1095|consen 769 -PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES-KHFVHRDLAARNCLLDERR-VVKIAD 845 (1025)
T ss_pred -CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh-CCCcCcchhhhheeecccC-cEEEcc
Confidence 36799999985 55555544211 14567888899999999999999997 9999999999999999887 899999
Q ss_pred ecCccccCCCCCCc-c--ceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 011138 284 FGSAKMLVPGEPNI-S--YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTP 359 (492)
Q Consensus 284 FG~a~~~~~~~~~~-~--~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p 359 (492)
||+|+.+...+... . ..-...|||||.+.. ..++.++|||||||+|||+++ |..||.+.++.+.+......-
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg--- 921 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG--- 921 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC---
Confidence 99999553332211 1 122457999999975 459999999999999999997 999999999887776554421
Q ss_pred CHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.++ .+..+++.+.+++..||+.+|++||+...|++
T Consensus 922 ---------------RL~----------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 922 ---------------RLD----------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred ---------------ccC----------CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 111 12468899999999999999999999999987
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=291.23 Aligned_cols=259 Identities=25% Similarity=0.363 Sum_probs=187.5
Q ss_pred ceeEeeeeccCCceEEEEEEEc----CCCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 138 SYMAERVVGTGSFGVVFQAKCL----ETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~----~~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
.|.+.+.||+|+||.||+|... .++..||||.+.... ....+|+.+++.+.|+||+++++++.. .+..
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~~ 81 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGGR 81 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCCC
Confidence 4778899999999999999864 358899999886443 345689999999999999999987733 2244
Q ss_pred EEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 209 ~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
+.++||||+++ .+...+.. ....+++..+..++.||+.||+|||+ +||+||||||+||+++.++ .++|+|||++
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~nil~~~~~-~~~l~dfg~~ 156 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDYLGS-QRYIHRDLAARNILVESED-LVKISDFGLA 156 (284)
T ss_pred ceEEEEecCCCCCHHHHHHh---CccccCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcCCC-CEEEcccccc
Confidence 68899999976 44443322 22358889999999999999999997 9999999999999999887 7999999999
Q ss_pred cccCCCCCC----ccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-hCCCCHH
Q 011138 288 KMLVPGEPN----ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKI-LGTPTRE 362 (492)
Q Consensus 288 ~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~-~g~p~~~ 362 (492)
......... ....++..|+|||.+.+. .++.++|||||||++|+|++|..||........ .+... .+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~ 233 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFL--RMIGIAQGQMIVT 233 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhc--cccccccccccHH
Confidence 876432211 122345679999998654 588999999999999999999999865432110 00000 0000000
Q ss_pred HHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.+..... ....++ .+...+.++.+|+.+||..||.+|||+.++++
T Consensus 234 ~~~~~~~--~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 234 RLLELLK--EGERLP----------RPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHHHH--cCCcCC----------CCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000000 000011 11245788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=294.49 Aligned_cols=281 Identities=30% Similarity=0.501 Sum_probs=214.6
Q ss_pred cccceeEeeeeccCCceEEEEEEEcC---CCCEEEEEEecc--chhhHHHHHHHHHHcC-CCCccccceeeeeccCCCce
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLE---TGDSVAIKKVLQ--DKRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~---~g~~vAiK~~~~--~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~~~ 208 (492)
....|..+++||.|.|++||++.+.. ..+.||+|.+.. ......+|+++|..+. +.||+++.+++ ....
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~-----rnnd 108 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCF-----RNND 108 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhh-----ccCC
Confidence 34569999999999999999999877 788999998843 3445678999999885 89999999998 5556
Q ss_pred EEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 209 ~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
.+++||||++..-...+ ...++...++.|++.++.||.++|. +|||||||||.|+|.+.....-.|+|||+|.
T Consensus 109 ~v~ivlp~~~H~~f~~l------~~~l~~~~i~~Yl~~ll~Al~~~h~-~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDL------YRSLSLAEIRWYLRNLLKALAHLHK-NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred eeEEEecccCccCHHHH------HhcCCHHHHHHHHHHHHHHhhhhhc-cCccccCCCccccccccccCCceEEechhHH
Confidence 68999999996533222 2346688899999999999999997 9999999999999999888788999999985
Q ss_pred cc-----------------CC--CC--------------------------CCccceeccCccCchhhcCCCCCCcchhh
Q 011138 289 ML-----------------VP--GE--------------------------PNISYICSRYYRAPELIFGATEYTTAIDM 323 (492)
Q Consensus 289 ~~-----------------~~--~~--------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv 323 (492)
.. .+ +. ......||+.|+|||++.....-+.++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 11 00 00 00134689999999999988888999999
Q ss_pred HHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCCHHHHhhcCCC------------------CcccCCCcccC---
Q 011138 324 WSIGCVLAELLLGQPLFP-GESGVDQLVEIIKILGTPTREEIKCMNPN------------------YTEFKFPQIKA--- 381 (492)
Q Consensus 324 wSlGvil~ell~G~~pf~-~~~~~~~~~~i~~~~g~p~~~~~~~~~~~------------------~~~~~~~~~~~--- 381 (492)
||.|||+.-+++++.||- ..++.+.+.+|+..+|.-........... |.......+..
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 999999999999999975 45667778888877776444332211111 11110000000
Q ss_pred -CCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 382 -HPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 382 -~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
..+........+..+.||+.+||+.||.+|+|++++|.||||.+..
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD 388 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence 0122223344566899999999999999999999999999999654
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=312.63 Aligned_cols=252 Identities=29% Similarity=0.444 Sum_probs=193.0
Q ss_pred ceeEeeeeccCCceE-EEEEEEcCCCCEEEEEEeccchh-hHHHHHHHHHHcC-CCCccccceeeeeccCCCceEEEEEe
Q 011138 138 SYMAERVVGTGSFGV-VFQAKCLETGDSVAIKKVLQDKR-YKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~-Vy~~~~~~~g~~vAiK~~~~~~~-~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
-|.-.+++|.|+-|+ ||+|.. .|+.||||.+..... ..+||+..|+.-+ |||||++|+. +.+..++||..
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~-----E~d~qF~YIal 582 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCS-----EQDRQFLYIAL 582 (903)
T ss_pred eeccHHHcccCCCCcEEEEEee--CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEee-----ccCCceEEEEe
Confidence 355667899998875 699987 789999998866544 6789999999885 9999997654 37788999999
Q ss_pred eechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcC---CC-CcEEEeeecCcccc
Q 011138 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP---HT-HQLKICDFGSAKML 290 (492)
Q Consensus 215 E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~---~~-~~vkL~DFG~a~~~ 290 (492)
|.|..+|.+++...............+.++.|++.||++||+ .+||||||||+||||+. ++ ..++|+|||+++.+
T Consensus 583 ELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs-l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 583 ELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS-LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh-cccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 999999888776521111111114456788999999999997 89999999999999976 23 37999999999988
Q ss_pred CCCCC----CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 011138 291 VPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG-QPLFPGESGVDQLVEIIKILGTPTREEIK 365 (492)
Q Consensus 291 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G-~~pf~~~~~~~~~~~i~~~~g~p~~~~~~ 365 (492)
..+.. ..+..||-.|+|||++.+.. -+.++||+||||++|+.++| ..||...- +.-.+|+.
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~--~R~~NIl~----------- 727 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSL--ERQANILT----------- 727 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchH--Hhhhhhhc-----------
Confidence 66543 33567899999999997654 57799999999999999985 99996543 33344433
Q ss_pred hcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
..+..-.+ .+....+++|||.+||.+||..||+|.++|+||||-+.
T Consensus 728 ------~~~~L~~L---------~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 728 ------GNYTLVHL---------EPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred ------Cccceeee---------ccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 11111111 11112289999999999999999999999999999753
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=300.69 Aligned_cols=240 Identities=29% Similarity=0.441 Sum_probs=189.6
Q ss_pred eeEeeeeccCCceEEEEEEEcC--CC--CEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 139 YMAERVVGTGSFGVVFQAKCLE--TG--DSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~--~g--~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
..+.++||.|.||.||.|.... .| -.||||.-+.+ .+.+..|..+|+.++|||||+|++++....
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P------ 464 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP------ 464 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc------
Confidence 4456789999999999997643 23 34888977553 344557999999999999999999984322
Q ss_pred EEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 210 LNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 210 ~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
.+||||+++-| |...+ ......++......|++||+.||.|||+ +.+|||||...|||+.+.. .|||+|||+++
T Consensus 465 ~WivmEL~~~GELr~yL---q~nk~sL~l~tL~ly~~Qi~talaYLeS-krfVHRDIAaRNiLVsSp~-CVKLaDFGLSR 539 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYL---QQNKDSLPLRTLTLYCYQICTALAYLES-KRFVHRDIAARNILVSSPQ-CVKLADFGLSR 539 (974)
T ss_pred eeEEEecccchhHHHHH---HhccccchHHHHHHHHHHHHHHHHHHHh-hchhhhhhhhhheeecCcc-eeeecccchhh
Confidence 78999999844 44333 3345668888899999999999999997 9999999999999999887 89999999999
Q ss_pred ccCCCCCCcccee--ccCccCchhhcCCCCCCcchhhHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 011138 289 MLVPGEPNISYIC--SRYYRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (492)
Q Consensus 289 ~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell-~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~ 365 (492)
.+..........| ..-|||||.+. -..++.++|||.|||.+||++ .|..||.+-.+.+.+..|.+.-
T Consensus 540 ~~ed~~yYkaS~~kLPIKWmaPESIN-fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGe--------- 609 (974)
T KOG4257|consen 540 YLEDDAYYKASRGKLPIKWMAPESIN-FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGE--------- 609 (974)
T ss_pred hccccchhhccccccceeecCccccc-hhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCC---------
Confidence 8866554444444 45699999983 445899999999999999998 5999999977766555443311
Q ss_pred hcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhh
Q 011138 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC 418 (492)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l 418 (492)
.. ..++++|+.+..|+.+||++||.+||+..++.
T Consensus 610 ---------Rl----------P~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 610 ---------RL----------PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred ---------CC----------CCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 11 13467899999999999999999999876543
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=291.16 Aligned_cols=250 Identities=22% Similarity=0.278 Sum_probs=194.6
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
...+++.||+|.||.|.+|.- ..+..||+|+++.+ ...+.+|+++|.+|+|||||+|++++...+ -+|+
T Consensus 539 ~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De-----Picm 612 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD-----PLCM 612 (807)
T ss_pred heehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC-----chHH
Confidence 467889999999999999984 34689999998643 245668999999999999999999985443 3889
Q ss_pred Eeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 213 V~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
|+||++. +|-+++....... ..-.....|+.||+.||+||.+ .++|||||.+.|+|++.+. ++||+|||+++.+.
T Consensus 613 I~EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes-~nfVHrd~a~rNcLv~~e~-~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLES-LNFVHRDLATRNCLVDGEF-TIKIADFGMSRNLY 688 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHh-hchhhccccccceeecCcc-cEEecCcccccccc
Confidence 9999985 4444443322111 2333445699999999999997 8999999999999999988 79999999999776
Q ss_pred CCCCCc---cceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHH--hCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 011138 292 PGEPNI---SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELL--LGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (492)
Q Consensus 292 ~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell--~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~ 366 (492)
.++... ..+-...|||||.|.-.+ ++.++|+|+||+++||++ +...||...++.+...+....+..+......
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l- 766 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVL- 766 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceec-
Confidence 554332 234578899999997654 899999999999999987 5789998888777666655544333221110
Q ss_pred cCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
..+.-.+..+.+|+.+|+..|-.+||+.+++-.
T Consensus 767 --------------------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 767 --------------------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred --------------------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 122457888999999999999999999999843
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=302.97 Aligned_cols=249 Identities=23% Similarity=0.323 Sum_probs=200.6
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCC---CEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETG---DSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g---~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
+..+.++||+|+||.|++|.|...+ -.||||.+..+. ..+.+|+.+|.+|+|+|+++||++..+. -
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~q------p 184 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQ------P 184 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccc------h
Confidence 3556788999999999999987543 358999986653 3456899999999999999999998542 2
Q ss_pred EEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 210 ~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
+.||||++.+ +|++.+.. .....|.......|+.||+.||.||.. +++|||||...|||+-... .|||+|||+.+
T Consensus 185 ~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLes-krlvHRDLAARNlllaspr-tVKI~DFGLmR 260 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLES-KRLVHRDLAARNLLLASPR-TVKICDFGLMR 260 (1039)
T ss_pred hhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhh-hhhhhhhhhhhhheecccc-eeeeeccccee
Confidence 5699999985 55554433 345678888899999999999999996 9999999999999998766 89999999999
Q ss_pred ccCCCCCCcccee----ccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 011138 289 MLVPGEPNISYIC----SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREE 363 (492)
Q Consensus 289 ~~~~~~~~~~~~g----t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~ 363 (492)
.+..++......+ ...|+|||.+... .++.++|||++||++|||++ |..||.|....+.+.+|-+..
T Consensus 261 aLg~ned~Yvm~p~rkvPfAWCaPEsLrh~-kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~e------- 332 (1039)
T KOG0199|consen 261 ALGENEDMYVMAPQRKVPFAWCAPESLRHR-KFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGE------- 332 (1039)
T ss_pred ccCCCCcceEecCCCcCcccccCHhHhccc-cccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccc-------
Confidence 8876665543322 4569999999654 59999999999999999996 899999999887777664311
Q ss_pred HhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCC
Q 011138 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (492)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~ 425 (492)
.++ -++.+++++.++++.||..+|++|||...|...-+...
T Consensus 333 -----------rLp----------RPk~csedIY~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 333 -----------RLP----------RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred -----------cCC----------CCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 111 12457999999999999999999999999875545443
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=272.86 Aligned_cols=238 Identities=39% Similarity=0.665 Sum_probs=190.7
Q ss_pred CceEEEEEEEcCCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEeeechh-hHH
Q 011138 149 SFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE-TVY 222 (492)
Q Consensus 149 ~fg~Vy~~~~~~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E~~~~-~l~ 222 (492)
+||.||+|.+..+|+.+|+|++... .....+|+.+++.++|+||+++++++.. ....++|+||+++ .+.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-----EDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-----CCEEEEEEeCCCCCCHH
Confidence 5899999999999999999998543 3456689999999999999999998843 3468899999998 555
Q ss_pred HHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCCCCccceec
Q 011138 223 RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICS 302 (492)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt 302 (492)
..+.. ...++...+..++.+++.+|.|||+ .||+|+||+|.||+++.++ .++|+|||.+.............++
T Consensus 76 ~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~i~~~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~ 149 (244)
T smart00220 76 DLLKK----RGRLSEDEARFYARQILSALEYLHS-NGIIHRDLKPENILLDEDG-HVKLADFGLARQLDPGGLLTTFVGT 149 (244)
T ss_pred HHHHh----ccCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCcCHHHeEECCCC-cEEEccccceeeeccccccccccCC
Confidence 44332 2237888999999999999999997 8999999999999999887 7999999999877555445567789
Q ss_pred cCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCC
Q 011138 303 RYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAH 382 (492)
Q Consensus 303 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~ 382 (492)
..|++||.+.+. .++.++|+||||+++|+|++|..||........+.+.... .. .....
T Consensus 150 ~~~~~pE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~---~~-------------~~~~~---- 208 (244)
T smart00220 150 PEYMAPEVLLGK-GYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGK---PK-------------PPFPP---- 208 (244)
T ss_pred cCCCCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc---cC-------------CCCcc----
Confidence 999999998644 4788999999999999999999999874433333333221 00 00000
Q ss_pred CcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 383 PWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 383 ~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
....++.++.+++.+||..||++||++.++++||||
T Consensus 209 -----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 209 -----PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred -----ccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 001167899999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=307.29 Aligned_cols=244 Identities=24% Similarity=0.348 Sum_probs=204.1
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCC---EEEEEEecc-----chhhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQ-----DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~---~vAiK~~~~-----~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
.-.+.++||.|.||.||+|..+..|+ .||||.++. .+..+..|+.||-+++||||++|.++. ....-
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVV-----Tks~P 704 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVV-----TKSKP 704 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEE-----ecCce
Confidence 35688999999999999999887764 599999854 344556799999999999999999988 33445
Q ss_pred EEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
+.||.|||+.+.++.+.+ .....|...+..-+++.|+.|++||-+ .|+|||||...||||+.+- .+|++|||+++.
T Consensus 705 vMIiTEyMENGsLDsFLR--~~DGqftviQLVgMLrGIAsGMkYLsd-m~YVHRDLAARNILVNsnL-vCKVsDFGLSRv 780 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLR--QNDGQFTVIQLVGMLRGIASGMKYLSD-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRV 780 (996)
T ss_pred eEEEhhhhhCCcHHHHHh--hcCCceEeehHHHHHHHHHHHhHHHhh-cCchhhhhhhhheeeccce-EEEeccccceee
Confidence 889999999765554332 234668888899999999999999998 8999999999999999988 899999999998
Q ss_pred cCCCCC-Ccc-cee--ccCccCchhhcCCCCCCcchhhHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 011138 290 LVPGEP-NIS-YIC--SRYYRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (492)
Q Consensus 290 ~~~~~~-~~~-~~g--t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell-~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~ 364 (492)
+.++.+ ..+ ..| ...|.|||.|.- .+++.++||||+|++|||.+ .|..||...++.+.+..|.+.++.|++.
T Consensus 781 ledd~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPm-- 857 (996)
T KOG0196|consen 781 LEDDPEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPM-- 857 (996)
T ss_pred cccCCCccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCC--
Confidence 755442 222 222 467999999954 45999999999999999987 6999999999999999998877666543
Q ss_pred hhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
+.|..+..|+..||++|-.+||+..||++
T Consensus 858 --------------------------DCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 858 --------------------------DCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred --------------------------CCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 47889999999999999999999999886
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=291.17 Aligned_cols=242 Identities=23% Similarity=0.364 Sum_probs=195.4
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchh---hHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEe
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR---YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~---~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
+....++||-|.||.||.|.|+.-.-.||||.++.+.. .+..|..+|+.++|||+|+|+++| ....-+|||+
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVC-----T~EpPFYIiT 342 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----THEPPFYIIT 342 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhh-----ccCCCeEEEE
Confidence 45566789999999999999999999999999987754 445799999999999999999999 3444489999
Q ss_pred eech-hhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCC
Q 011138 215 EYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (492)
Q Consensus 215 E~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (492)
|||. |.|++.+....+ ..++......++.||..|++||.. +++|||||...|+|+..+. .||++|||+++.+..+
T Consensus 343 EfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEk-knFIHRDLAARNCLVgEnh-iVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENH-IVKVADFGLSRLMTGD 418 (1157)
T ss_pred ecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHH-hhhhhhhhhhhhccccccc-eEEeeccchhhhhcCC
Confidence 9997 677776654332 446666778889999999999997 9999999999999999876 8999999999987543
Q ss_pred CCCcccee---ccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 294 EPNISYIC---SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 294 ~~~~~~~g---t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
. .+...| ..-|.|||-+.- ..++.++|||+|||+|||+.| |-.||++.+-.+.+..+.+.+..
T Consensus 419 T-YTAHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM----------- 485 (1157)
T KOG4278|consen 419 T-YTAHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRM----------- 485 (1157)
T ss_pred c-eecccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccc-----------
Confidence 3 333333 566999998843 348899999999999999996 99999998765555444332111
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhh
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC 418 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l 418 (492)
+ -+..+++.+.+|++.||+++|.+||+..|+-
T Consensus 486 -----~------------~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 486 -----D------------GPEGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred -----c------------CCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 1 1246899999999999999999999988763
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=255.78 Aligned_cols=211 Identities=24% Similarity=0.431 Sum_probs=174.0
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-----hhHHHHHHHHH-HcCCCCccccceeeeeccCCCceEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMR-LLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-----~~~~~E~~il~-~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
....+..||+|+||.|-+.++..+|...|+|.+...- ....+|+.+.. ...+|.+|++|+.++...+ ++
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd-----vw 121 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD-----VW 121 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc-----EE
Confidence 3445567999999999999999999999999885322 22235666644 4469999999998855544 89
Q ss_pred EEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
|.||.|..++..+..+....+..+++..+-+|+..++.||.|||+...|||||+||+||||+.+| +||+||||++..+.
T Consensus 122 IcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G-qVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 122 ICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG-QVKICDFGISGYLV 200 (282)
T ss_pred EeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC-cEEEcccccceeeh
Confidence 99999998888777777778899999999999999999999999867999999999999999998 89999999998776
Q ss_pred CCCCCccceeccCccCchhhcC---CCCCCcchhhHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHH
Q 011138 292 PGEPNISYICSRYYRAPELIFG---ATEYTTAIDMWSIGCVLAELLLGQPLFPGE-SGVDQLVEIIK 354 (492)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DvwSlGvil~ell~G~~pf~~~-~~~~~~~~i~~ 354 (492)
+.-..+-..|...|||||.+.. ...|+-++||||||+++.||.+++.||... +.-+++.++++
T Consensus 201 dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 201 DSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred hhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 5555555678889999999843 335899999999999999999999999764 45555555544
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=325.28 Aligned_cols=252 Identities=22% Similarity=0.309 Sum_probs=181.9
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEeeec
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E~~ 217 (492)
.|...++||+|+||.||+|.+..+|..||||++........+|++++++++|||||++++++.. ....|+||||+
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~-----~~~~~lv~Ey~ 765 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRS-----EKGAYLIHEYI 765 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEc-----CCCCEEEEeCC
Confidence 3566778999999999999999999999999987655555678999999999999999999843 33478999999
Q ss_pred hhhHH-HHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHH---hhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCC
Q 011138 218 SETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLH---HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (492)
Q Consensus 218 ~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH---~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (492)
+++.+ +.+. .+++..+..++.||+.||+||| + .+|+||||||+||+++.++ ..++. ||.+.....
T Consensus 766 ~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~-~~iiH~dlkp~Nil~~~~~-~~~~~-~~~~~~~~~- 834 (968)
T PLN00113 766 EGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCS-PAVVVGNLSPEKIIIDGKD-EPHLR-LSLPGLLCT- 834 (968)
T ss_pred CCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCC-CCeecCCCCHHhEEECCCC-ceEEE-ecccccccc-
Confidence 86544 3332 3778889999999999999999 5 6999999999999999776 56665 666543321
Q ss_pred CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHhhcCCCCc
Q 011138 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGV-DQLVEIIKILGTPTREEIKCMNPNYT 372 (492)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~-~~~~~i~~~~g~p~~~~~~~~~~~~~ 372 (492)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+.+..+..-... .. .
T Consensus 835 --~~~~~~t~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~-------~ 902 (968)
T PLN00113 835 --DTKCFISSAYVAPETRETK-DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDC--HL-------D 902 (968)
T ss_pred --CCCccccccccCcccccCC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCcc--ch-------h
Confidence 2234788999999998654 5899999999999999999999999543211 11111111100000 00 0
Q ss_pred ccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
.+.-|.+... . ........++.+++.+||+.||++|||+.|+++.
T Consensus 903 ~~~~~~~~~~-~--~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 903 MWIDPSIRGD-V--SVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred heeCccccCC-C--CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0000110000 0 0001123457799999999999999999999874
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=284.90 Aligned_cols=202 Identities=26% Similarity=0.424 Sum_probs=175.9
Q ss_pred CCCccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchhhHH------------HHHHHHHHcC---CCCcccc
Q 011138 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------------RELQIMRLLN---HPNVVSL 195 (492)
Q Consensus 131 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~------------~E~~il~~l~---h~nIv~l 195 (492)
+.+++..+|...+.+|.|+||.|++|.++.+...|.||.+.+.+-... .|++||..|+ |+||+++
T Consensus 555 ~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKl 634 (772)
T KOG1152|consen 555 KEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKL 634 (772)
T ss_pred eeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhh
Confidence 345666789999999999999999999999999999999877653322 5999999998 9999999
Q ss_pred ceeeeeccCCCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCC
Q 011138 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH 275 (492)
Q Consensus 196 ~~~~~~~~~~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~ 275 (492)
+++| +++.|+||+||-.+.+ .+++ .+......+++.+++.|++||+.|+++||+ +||||||||-+||.++.+
T Consensus 635 LdfF-----Eddd~yyl~te~hg~g-IDLF-d~IE~kp~m~E~eAk~IFkQV~agi~hlh~-~~ivhrdikdenvivd~~ 706 (772)
T KOG1152|consen 635 LDFF-----EDDDYYYLETEVHGEG-IDLF-DFIEFKPRMDEPEAKLIFKQVVAGIKHLHD-QGIVHRDIKDENVIVDSN 706 (772)
T ss_pred hhee-----ecCCeeEEEecCCCCC-cchh-hhhhccCccchHHHHHHHHHHHhccccccc-cCceecccccccEEEecC
Confidence 9999 8888999999998765 2222 233446789999999999999999999997 999999999999999999
Q ss_pred CCcEEEeeecCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 011138 276 THQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPG 342 (492)
Q Consensus 276 ~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~ 342 (492)
| -+||+|||.|... ...+...++||..|.|||++.|..+.+..-|||++|++||.++....||..
T Consensus 707 g-~~klidfgsaa~~-ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 707 G-FVKLIDFGSAAYT-KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred C-eEEEeeccchhhh-cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 8 7999999998754 455677899999999999998888889999999999999999999989864
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=268.18 Aligned_cols=269 Identities=24% Similarity=0.315 Sum_probs=188.9
Q ss_pred ecCCCCCCCcccc-----ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEecc-chhhHHHHHHHHH--HcCCCCccccc
Q 011138 125 TVGGRNGQPKQTI-----SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-DKRYKNRELQIMR--LLNHPNVVSLK 196 (492)
Q Consensus 125 ~~~~~~~~~~~~~-----~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~-~~~~~~~E~~il~--~l~h~nIv~l~ 196 (492)
+.|+..|.|.... +-.+.+.||+|.||.||+|.+ -|+.||||++.. ++....||.+|.+ .|+|+||+.++
T Consensus 194 tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFI 271 (513)
T KOG2052|consen 194 TSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFI 271 (513)
T ss_pred cCCCCCCchhHhHHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhh
Confidence 4555566664432 578899999999999999998 689999999854 4555566777755 67999999987
Q ss_pred eeeeeccCCCceEEEEEeeech-hhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHh-------hCCcccCCCCCC
Q 011138 197 HCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH-------VVGVCHRDIKPQ 268 (492)
Q Consensus 197 ~~~~~~~~~~~~~~~lV~E~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~-------~~givHrDlKp~ 268 (492)
+.=.... ..-..++||.+|.+ |+|++.+.. ..++......++..++.||++||- ...|.|||||..
T Consensus 272 aaD~~~~-gs~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSK 345 (513)
T KOG2052|consen 272 AADNKDN-GSWTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSK 345 (513)
T ss_pred hccccCC-CceEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccc
Confidence 7532222 23346899999998 566665543 567888889999999999999992 135999999999
Q ss_pred ceEEcCCCCcEEEeeecCccccCCCC-----CCccceeccCccCchhhcCCCCC-----CcchhhHHHHHHHHHHHh---
Q 011138 269 NLLVNPHTHQLKICDFGSAKMLVPGE-----PNISYICSRYYRAPELIFGATEY-----TTAIDMWSIGCVLAELLL--- 335 (492)
Q Consensus 269 NILl~~~~~~vkL~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-----~~~~DvwSlGvil~ell~--- 335 (492)
||||.+++ .+.|+|+|+|....... .....+||..|||||++...-.. -..+||||||.|+||+..
T Consensus 346 NILVKkn~-~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~ 424 (513)
T KOG2052|consen 346 NILVKKNG-TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCE 424 (513)
T ss_pred cEEEccCC-cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhh
Confidence 99999998 89999999997765442 33467999999999999543221 136899999999999984
Q ss_pred --C-----CCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCC
Q 011138 336 --G-----QPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSP 408 (492)
Q Consensus 336 --G-----~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP 408 (492)
| ++||.+--+. .|..+++ ..-...-++.......|... ..-..+-.|++.||..||
T Consensus 425 ~ggi~eey~~Pyyd~Vp~-----------DPs~eeM---rkVVCv~~~RP~ipnrW~s~---~~l~~m~klMkeCW~~Np 487 (513)
T KOG2052|consen 425 SGGIVEEYQLPYYDVVPS-----------DPSFEEM---RKVVCVQKLRPNIPNRWKSD---PALRVMAKLMKECWYANP 487 (513)
T ss_pred cCCEehhhcCCcccCCCC-----------CCCHHHH---hcceeecccCCCCCcccccC---HHHHHHHHHHHHhhcCCc
Confidence 2 4777542211 1111111 11111112222222334221 122345688999999999
Q ss_pred CCcCCHHHhhC
Q 011138 409 SLRCTALEACA 419 (492)
Q Consensus 409 ~~R~t~~e~l~ 419 (492)
.-|.|+..+..
T Consensus 488 ~aRltALriKK 498 (513)
T KOG2052|consen 488 AARLTALRIKK 498 (513)
T ss_pred hhhhHHHHHHH
Confidence 99999877643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=288.29 Aligned_cols=255 Identities=26% Similarity=0.386 Sum_probs=205.5
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
.+|.+...+|.|.||.||+++++.+++..|+|+++-. ....++|+-+++.++|||||.+++.|...+ .+++
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~d-----klwi 89 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD-----KLWI 89 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhc-----CcEE
Confidence 4699999999999999999999999999999998543 345568999999999999999999985433 4899
Q ss_pred EeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 213 V~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
.||||+|+.++.+.+ ....+++.++..+.+..+.||+|||+ +|=+|||||-.|||++..+ .+|++|||.+..+..
T Consensus 90 cMEycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs-~gk~hRdiKGanilltd~g-DvklaDfgvsaqita 164 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHS-QGKIHRDIKGANILLTDEG-DVKLADFGVSAQITA 164 (829)
T ss_pred EEEecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhc-CCcccccccccceeecccC-ceeecccCchhhhhh
Confidence 999999887665443 35678899999999999999999997 8999999999999999888 799999998755422
Q ss_pred -CCCCccceeccCccCchhh--cCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 293 -GEPNISYICSRYYRAPELI--FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 293 -~~~~~~~~gt~~y~aPE~~--~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
-....+++||++|||||+- .....|...+|||++|+...|+---++|-........+..+-+.
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS-------------- 230 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKS-------------- 230 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhcc--------------
Confidence 2345678999999999986 23456999999999999999999888886555444444433331
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~ 425 (492)
.++-|..+.. ..-++.+-+|++.+|.++|.+||+++.+|+|||...
T Consensus 231 ---~~qpp~lkDk-------~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 231 ---GFQPPTLKDK-------TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred ---CCCCCcccCC-------ccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 1111221111 123677889999999999999999999999999874
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=267.98 Aligned_cols=268 Identities=25% Similarity=0.312 Sum_probs=188.3
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEecc-chhhHHHHHHHHHH--cCCCCccccceeeeeccCCCceEEEEEee
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-DKRYKNRELQIMRL--LNHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~-~~~~~~~E~~il~~--l~h~nIv~l~~~~~~~~~~~~~~~~lV~E 215 (492)
..+..+||+|.||.||+|.. +++.||||++.. ++....+|.+|.+. ++|+||+++++.=...+ .+..-++||++
T Consensus 212 l~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t-~~~~eywLVt~ 288 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT-ADRMEYWLVTE 288 (534)
T ss_pred hhhHHHhhcCccceeehhhc--cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCC-ccccceeEEee
Confidence 55667899999999999976 569999999954 45667788888775 57999999877532222 23445789999
Q ss_pred ech-hhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhh--------CCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 216 YIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV--------VGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 216 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~--------~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
|.+ |.|.++++. ..+++.....++..|++||+|||+. .+|+|||||..||||..|. +..|+|||+
T Consensus 289 fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl-TccIaDFGL 362 (534)
T KOG3653|consen 289 FHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL-TCCIADFGL 362 (534)
T ss_pred eccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC-cEEeeccce
Confidence 998 556655543 5689999999999999999999941 3699999999999999888 899999999
Q ss_pred ccccCCCCC---CccceeccCccCchhhcCCCCCC-----cchhhHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhC
Q 011138 287 AKMLVPGEP---NISYICSRYYRAPELIFGATEYT-----TAIDMWSIGCVLAELLLGQPLFP-GESGVDQLVEIIKILG 357 (492)
Q Consensus 287 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~-----~~~DvwSlGvil~ell~G~~pf~-~~~~~~~~~~i~~~~g 357 (492)
|.++.++.. ....+||..|||||++.|...+. .+.||||+|.|||||++...-+. +.-+.-++.=-.++-.
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 988865543 33579999999999998766555 46899999999999998654442 1111111100011112
Q ss_pred CCCHHHHhhcC-CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHH------HhhCCCC
Q 011138 358 TPTREEIKCMN-PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL------EACAHPF 422 (492)
Q Consensus 358 ~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~------e~l~Hp~ 422 (492)
.|..+++...- ....+-.+|. .|... ....-+++.+..||..||+.|+|+. ..+.|.|
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~----~W~~h---~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPD----AWRKH---AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChh----hhhcC---ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 34444333211 0001111111 12221 2345688999999999999999986 3455665
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=278.80 Aligned_cols=246 Identities=26% Similarity=0.397 Sum_probs=187.7
Q ss_pred eeEeeeeccCCceEEEEEEEcC-------CCCEEEEEEeccc-----hhhHHHHHHHHHHcC-CCCccccceeeeeccCC
Q 011138 139 YMAERVVGTGSFGVVFQAKCLE-------TGDSVAIKKVLQD-----KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEK 205 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~-------~g~~vAiK~~~~~-----~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~ 205 (492)
..+.+.||+|.||.|++|.... ....||||..... ...+..|+++|+.+. |+||+.+++++..
T Consensus 298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~---- 373 (609)
T KOG0200|consen 298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ---- 373 (609)
T ss_pred ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc----
Confidence 3566689999999999997431 1456999987533 344567999999986 9999999998843
Q ss_pred CceEEEEEeeech-hhHHHHhhhhh---h-------cC--CCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEE
Q 011138 206 DELYLNLVLEYIS-ETVYRVSKHYT---R-------MN--QHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV 272 (492)
Q Consensus 206 ~~~~~~lV~E~~~-~~l~~~~~~~~---~-------~~--~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl 272 (492)
...+++|+||+. |+++.++.+.+ . .. ..++......+++||+.|++||++ +++|||||-..|||+
T Consensus 374 -~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~-~~~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 374 -DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS-VPCVHRDLAARNVLI 451 (609)
T ss_pred -CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh-CCccchhhhhhhEEe
Confidence 456889999998 56666655443 0 01 138888899999999999999997 899999999999999
Q ss_pred cCCCCcEEEeeecCccccCCCCCCc--ccee--ccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHH
Q 011138 273 NPHTHQLKICDFGSAKMLVPGEPNI--SYIC--SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVD 347 (492)
Q Consensus 273 ~~~~~~vkL~DFG~a~~~~~~~~~~--~~~g--t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~ 347 (492)
..+. .+||+|||+|+......... ...| ...|||||.+.. ..|+.++|||||||+|||+++ |..||.+.....
T Consensus 452 ~~~~-~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~ 529 (609)
T KOG0200|consen 452 TKNK-VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE 529 (609)
T ss_pred cCCC-EEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH
Confidence 9886 89999999998654433222 1122 234999999976 569999999999999999997 999999855333
Q ss_pred HHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 348 QLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 348 ~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.+.+.++.. .... .+...++++.++++.||..+|++||+..++..
T Consensus 530 ~l~~~l~~G---------------~r~~------------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 530 ELLEFLKEG---------------NRME------------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHHHhcC---------------CCCC------------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 333322210 0111 22457899999999999999999999998775
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=270.82 Aligned_cols=241 Identities=25% Similarity=0.377 Sum_probs=189.5
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCC----EEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGD----SVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~----~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
.+..++||+|+||+||+|.+...|+ +||||++... ...+.+|+-+|..|+|||+++|++++....
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~------ 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST------ 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch------
Confidence 4455789999999999999877665 4788877432 334557999999999999999999985433
Q ss_pred EEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 210 LNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 210 ~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
+-||++|++.+ |++.++ .....+.......|..||++||.|||. +.+|||||-..||||.+-. .+||+|||+|+
T Consensus 772 ~qlvtq~mP~G~LlDyvr---~hr~~igsq~lLnw~~QIAkgM~YLe~-qrlVHrdLaaRNVLVksP~-hvkitdfgla~ 846 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVR---EHRDNIGSQDLLNWCYQIAKGMKYLEE-QRLVHRDLAARNVLVKSPN-HVKITDFGLAK 846 (1177)
T ss_pred HHHHHHhcccchHHHHHH---HhhccccHHHHHHHHHHHHHHHHHHHh-cchhhhhhhhhheeecCCC-eEEEEecchhh
Confidence 56899999954 554433 344668888899999999999999997 9999999999999999877 69999999999
Q ss_pred ccCCCCCCcccee---ccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 011138 289 MLVPGEPNISYIC---SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEI 364 (492)
Q Consensus 289 ~~~~~~~~~~~~g---t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~ 364 (492)
.+..+.......| .+-|||-|.+.. ..|+.++|||||||++||++| |..||.+....+.- ++++ .+
T Consensus 847 ll~~d~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~-dlle---~g----- 916 (1177)
T KOG1025|consen 847 LLAPDEKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP-DLLE---KG----- 916 (1177)
T ss_pred ccCcccccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh-HHHh---cc-----
Confidence 8877665544333 456999998854 459999999999999999997 99999987754332 2222 10
Q ss_pred hhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
. +++ .++..+-++.-++.+||..|+..||++.++..
T Consensus 917 -------e--RLs----------qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 917 -------E--RLS----------QPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred -------c--cCC----------CCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 1 111 23457889999999999999999999887653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-29 Score=231.20 Aligned_cols=207 Identities=36% Similarity=0.593 Sum_probs=173.0
Q ss_pred eccCCceEEEEEEEcCCCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEeeechh
Q 011138 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE 219 (492)
Q Consensus 145 lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E~~~~ 219 (492)
||+|++|.||++.+..+|+.+++|++.... ....+|+.+++.+.|++|+++++++. .....+++||++.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFE-----DENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeee-----cCCeEEEEEecCCC
Confidence 689999999999998889999999986654 35678999999999999999999883 33568899999994
Q ss_pred -hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcC-CCCcEEEeeecCccccCCCC-CC
Q 011138 220 -TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP-HTHQLKICDFGSAKMLVPGE-PN 296 (492)
Q Consensus 220 -~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~-~~~~vkL~DFG~a~~~~~~~-~~ 296 (492)
.+...+... ...++...+..++.+++.+|.|||+ .|++|+||+|.||+++. ++ .++|+|||.+....... ..
T Consensus 76 ~~l~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~H~dl~~~ni~~~~~~~-~~~l~d~~~~~~~~~~~~~~ 150 (215)
T cd00180 76 GSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHS-NGIIHRDLKPENILLDSDNG-KVKLADFGLSKLLTSDKSLL 150 (215)
T ss_pred CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHhhEEEeCCCC-cEEEecCCceEEccCCcchh
Confidence 554443321 1467888999999999999999997 89999999999999998 55 79999999997654332 13
Q ss_pred ccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCC
Q 011138 297 ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKF 376 (492)
Q Consensus 297 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 376 (492)
....+...|++||.+.....++.+.|+|++|+++|+|
T Consensus 151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------- 187 (215)
T cd00180 151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------- 187 (215)
T ss_pred hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence 3456788899999986543588999999999999999
Q ss_pred CcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCC
Q 011138 377 PQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHP 421 (492)
Q Consensus 377 ~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp 421 (492)
..+.+++.+||..||.+||++.++++|+
T Consensus 188 -----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -----------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -----------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1267999999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=291.49 Aligned_cols=207 Identities=19% Similarity=0.194 Sum_probs=147.0
Q ss_pred HcCC-CCccccceeeeeccC--CCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCccc
Q 011138 186 LLNH-PNVVSLKHCFFSTTE--KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCH 262 (492)
Q Consensus 186 ~l~h-~nIv~l~~~~~~~~~--~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givH 262 (492)
.++| +||+++++.|..... .....++++|||++++|..++.. ....+++..++.|++||+.||.|||+ +||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHS-QGIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHh-CCeee
Confidence 4455 588888887633221 12234678899998888776542 23568999999999999999999997 99999
Q ss_pred CCCCCCceEEcCCC------------------CcEEEeeecCccccCCC-----------------CCCccceeccCccC
Q 011138 263 RDIKPQNLLVNPHT------------------HQLKICDFGSAKMLVPG-----------------EPNISYICSRYYRA 307 (492)
Q Consensus 263 rDlKp~NILl~~~~------------------~~vkL~DFG~a~~~~~~-----------------~~~~~~~gt~~y~a 307 (492)
|||||+||||+..+ ..+||+|||+++..... ......+||++|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 99999999995422 25677777776532110 00112468999999
Q ss_pred chhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccc
Q 011138 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKI 387 (492)
Q Consensus 308 PE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (492)
||++.+.. |+.++|||||||+||||++|.+||.... ..+..+.... .|+.
T Consensus 184 PE~~~~~~-~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~-~~~~-------------------------- 233 (793)
T PLN00181 184 PEEDNGSS-SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV-LPPQ-------------------------- 233 (793)
T ss_pred hhhhccCC-CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-cChh--------------------------
Confidence 99997654 8999999999999999999998875322 1111111100 0000
Q ss_pred cCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 388 FHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 388 ~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
. ....+.+.+++.+||+.||.+||++.|+++||||...+
T Consensus 234 ~-~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~~ 272 (793)
T PLN00181 234 I-LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEPR 272 (793)
T ss_pred h-hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhhh
Confidence 0 01134567899999999999999999999999998754
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-31 Score=240.02 Aligned_cols=256 Identities=21% Similarity=0.283 Sum_probs=183.3
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch---hhHHHHHHHHHHc-CCCCccccceeeeeccCCCceEEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~---~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
+.|.+.+.||+|.||.+-+|.++.+...+++|.+.... ..+.+|..---.| .|.||+.-|+.-+... .++++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~----d~YvF 99 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS----DAYVF 99 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcC----ceEEE
Confidence 46999999999999999999999999999999886532 3444565543344 3899999888765433 26779
Q ss_pred EeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEE-cCCCCcEEEeeecCccccC
Q 011138 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV-NPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 213 V~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl-~~~~~~vkL~DFG~a~~~~ 291 (492)
++||++-+.+.. .. ....+.+...+.++.|+++||.|||+ +++||||||.+|||| +.+...|||||||+.+...
T Consensus 100 ~qE~aP~gdL~s--nv--~~~GigE~~~K~v~~ql~SAi~fMHs-knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 100 VQEFAPRGDLRS--NV--EAAGIGEANTKKVFAQLLSAIEFMHS-KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred eeccCccchhhh--hc--CcccccHHHHHHHHHHHHHHHHHhhc-cchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 999999543321 11 12567888899999999999999997 999999999999998 5566689999999987542
Q ss_pred CCCCCccceeccCccCchhhcCC----CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHhh
Q 011138 292 PGEPNISYICSRYYRAPELIFGA----TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD-QLVEIIKILGTPTREEIKC 366 (492)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~-~~~~i~~~~g~p~~~~~~~ 366 (492)
..-...--+..|.+||++... -...+.+|+|.||+++|.+|||.+||+.....+ .+.+.++-++.-.
T Consensus 175 --~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~------ 246 (378)
T KOG1345|consen 175 --TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN------ 246 (378)
T ss_pred --ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC------
Confidence 211122335669999987432 124667999999999999999999998543221 1222222111100
Q ss_pred cCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCc---CCHHHhhCCCCCCC
Q 011138 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR---CTALEACAHPFFDD 425 (492)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R---~t~~e~l~Hp~f~~ 425 (492)
. ..|. ....+++.+..+.++-|..+|++| .++......-|...
T Consensus 247 ------~-~~P~---------~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~ 292 (378)
T KOG1345|consen 247 ------P-ALPK---------KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK 292 (378)
T ss_pred ------c-cCch---------hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence 0 1111 113578999999999999999999 45555555566543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=232.07 Aligned_cols=203 Identities=33% Similarity=0.575 Sum_probs=165.8
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEE
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
|.+.+.||.|++|.||++....+++.+|+|.+... .....+|++.++.++|+|++++++++. .....++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~-----~~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFE-----DPEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeee-----cCCceEEE
Confidence 56778899999999999999888999999998653 345567999999999999999999873 33458899
Q ss_pred eeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 214 LEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 214 ~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
+|++.+ .+...+... ...+++..+..++.|++.+|.|||+ +|++|+||+|.||+++.++ .++|+|||.+.....
T Consensus 76 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~di~~~ni~v~~~~-~~~l~d~g~~~~~~~ 150 (225)
T smart00221 76 MEYCEGGDLFDYLRKK---GGKLSEEEARFYLRQILEALEYLHS-LGIVHRDLKPENILLGMDG-LVKLADFGLARFIHR 150 (225)
T ss_pred EeccCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEeeCceeeEecC
Confidence 999997 555544321 1117888899999999999999997 8999999999999999876 899999999987654
Q ss_pred CC--CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCC-CChHHHHHH
Q 011138 293 GE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPG-ESGVDQLVE 351 (492)
Q Consensus 293 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~-~~~~~~~~~ 351 (492)
.. ......++..|++||.+.+...++.++|+|+||+++|+|++|+.||.. .++...+.+
T Consensus 151 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~ 212 (225)
T smart00221 151 DLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSD 212 (225)
T ss_pred cccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHH
Confidence 43 334567888999999984444578899999999999999999999977 455544444
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-29 Score=263.73 Aligned_cols=258 Identities=25% Similarity=0.352 Sum_probs=192.6
Q ss_pred eEeeeeccCCceEEEEEEEcCCCCEEEEEEec----cchhh------HHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 140 MAERVVGTGSFGVVFQAKCLETGDSVAIKKVL----QDKRY------KNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 140 ~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~----~~~~~------~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
....++|.|++|.|+.+......+.++.|.+. ..... ...|..+-..|.|+|++..+..++....
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~----- 395 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG----- 395 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc-----
Confidence 45678999999999988887777777777543 11111 1246666677899999887776643322
Q ss_pred EEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
.+-+||||+++++.++.. ...+....+..++.|++.||+|||+ .||.||||||+|+++..++ .+||+|||.+..
T Consensus 396 ~~~~mE~~~~Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~-~GiahrdlK~enll~~~~g-~lki~Dfg~~~v 469 (601)
T KOG0590|consen 396 ILQSMEYCPYDLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHS-MGLAHRDLKLENLLVTENG-ILKIIDFGAASV 469 (601)
T ss_pred chhhhhcccHHHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHh-cCceeccCccccEEEecCC-ceEEeecCccee
Confidence 223499999977766554 2467778899999999999999997 8999999999999999988 899999999976
Q ss_pred cCCCCC-----CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 011138 290 LVPGEP-----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (492)
Q Consensus 290 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~ 364 (492)
...... ....+|+..|+|||++.+.......+||||.|++++.|++|+.||......+....-.
T Consensus 470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~----------- 538 (601)
T KOG0590|consen 470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN----------- 538 (601)
T ss_pred eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh-----------
Confidence 643322 3467899999999999888766778999999999999999999997655433321000
Q ss_pred hhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
+.. ..... ...+ ..+...++...+.+|.+||+.||.+|+|+++|++.+||+.+..
T Consensus 539 ---~~~-~~~~~---~~~~--~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 539 ---NYS-DQRNI---FEGP--NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred ---ccc-ccccc---ccCh--HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 000 00000 0000 1122457889999999999999999999999999999998753
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-27 Score=215.29 Aligned_cols=157 Identities=24% Similarity=0.229 Sum_probs=119.4
Q ss_pred CCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCCCCccceeccCccCchhh
Q 011138 232 NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311 (492)
Q Consensus 232 ~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~ 311 (492)
...+++..++.++.||+.||.|||+ ++ ||+|||++.++ .+|+ ||+++..... ...||+.|||||++
T Consensus 11 ~~~l~~~~~~~i~~qi~~~L~~lH~-~~------kp~Nil~~~~~-~~~~--fG~~~~~~~~----~~~g~~~y~aPE~~ 76 (176)
T smart00750 11 GRPLNEEEIWAVCLQCLRALRELHR-QA------KSGNILLTWDG-LLKL--DGSVAFKTPE----QSRVDPYFMAPEVI 76 (176)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHh-cC------CcccEeEcCcc-ceee--ccceEeeccc----cCCCcccccChHHh
Confidence 4569999999999999999999997 77 99999999887 7888 9998765332 23689999999999
Q ss_pred cCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCC
Q 011138 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQ-LVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHK 390 (492)
Q Consensus 312 ~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~-~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (492)
.+. .|+.++|||||||++|||++|+.||........ +..+........ +. ......
T Consensus 77 ~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------------~~------~~~~~~ 133 (176)
T smart00750 77 QGQ-SYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD----------------PR------DRSNLE 133 (176)
T ss_pred cCC-CCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC----------------cc------ccccHH
Confidence 765 489999999999999999999999976554332 222222110000 00 000001
Q ss_pred CCCh--hHhhhhccccccCCCCcCCHHHhhCCCCCCC
Q 011138 391 RMPP--EALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (492)
Q Consensus 391 ~~s~--~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~ 425 (492)
.++. ++++||.+||..||.+||++.+++.|+|+..
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 2233 6999999999999999999999999999763
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-27 Score=224.32 Aligned_cols=248 Identities=19% Similarity=0.263 Sum_probs=185.5
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCC-----CEEEEEEeccchhhH-----HHHHHHHHHcCCCCccccceeeeeccCCC
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETG-----DSVAIKKVLQDKRYK-----NRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g-----~~vAiK~~~~~~~~~-----~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 206 (492)
.++++..++-+|.||.||.|.+.... +.|.+|.++...... ..|...+..+.|||++.+.++.....+
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~-- 361 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA-- 361 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC--
Confidence 45777788999999999999776432 346667665544332 357778888899999999988754322
Q ss_pred ceEEEEEeeech-hhHHHHhhhh----hhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEE
Q 011138 207 ELYLNLVLEYIS-ETVYRVSKHY----TRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKI 281 (492)
Q Consensus 207 ~~~~~lV~E~~~-~~l~~~~~~~----~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL 281 (492)
.-+.++.+++ |.|..++... ....+.+.-.+...++.|++.|++|||+ +||||.||...|++|+..- +|||
T Consensus 362 --~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~-~~ViHkDiAaRNCvIdd~L-qVkl 437 (563)
T KOG1024|consen 362 --TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN-HGVIHKDIAARNCVIDDQL-QVKL 437 (563)
T ss_pred --cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh-cCcccchhhhhcceehhhe-eEEe
Confidence 3446677776 4454444321 1223445666777899999999999997 9999999999999999765 8999
Q ss_pred eeecCccccCCCCCCc---cceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 011138 282 CDFGSAKMLVPGEPNI---SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILG 357 (492)
Q Consensus 282 ~DFG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g 357 (492)
+|=.+++.+.+.+..- ..-....||+||.+.. ..|+.++|+|||||+||||+| |+.||...++.+...-+.+.
T Consensus 438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG-- 514 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG-- 514 (563)
T ss_pred ccchhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc--
Confidence 9999998876554321 1223567999999965 459999999999999999997 99999888876655544332
Q ss_pred CCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 358 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 358 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
+.+.+ +-+.|+++..++.-||..+|++||+.+|+..
T Consensus 515 ----------------yRlaQ----------P~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 515 ----------------YRLAQ----------PFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ----------------ceecC----------CCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 11111 2368999999999999999999999998753
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-26 Score=214.04 Aligned_cols=219 Identities=22% Similarity=0.312 Sum_probs=177.7
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEec--cchhhHHHHHHHHHHcC-CCCccccceeeeeccCCCceEEEE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL--QDKRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~--~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
...|.++++||+|+||.++.|++.-+++.||||.-. .+...+..|....+.|. .++|...|-+. ....+-.|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG~~NiL 101 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEGKYNIL 101 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeec-----cccchhhh
Confidence 346999999999999999999999999999999753 33445667999999886 68898876544 44556679
Q ss_pred EeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCC----CCcEEEeeecCcc
Q 011138 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH----THQLKICDFGSAK 288 (492)
Q Consensus 213 V~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~----~~~vkL~DFG~a~ 288 (492)
|||+++.+|.+++.. ....|+...+..++.|++.-++|+|. +.+|+|||||+|+||..- .+.|.|+|||+|+
T Consensus 102 VidLLGPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~-k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 102 VIDLLGPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHE-KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhhhhCcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHh-cceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 999999888776543 46789999999999999999999997 999999999999999543 3469999999998
Q ss_pred ccCCC--------CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCC---CChHHHHHHHHHHhC
Q 011138 289 MLVPG--------EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPG---ESGVDQLVEIIKILG 357 (492)
Q Consensus 289 ~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~---~~~~~~~~~i~~~~g 357 (492)
...+. ....+..||..||+-...+|.+ -+...|+-|||-+++++|.|..||+| .+..+.+.+|-....
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr 256 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKR 256 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccc
Confidence 77432 2334678999999999888876 68999999999999999999999987 455666666655444
Q ss_pred CCCHHHH
Q 011138 358 TPTREEI 364 (492)
Q Consensus 358 ~p~~~~~ 364 (492)
.-+.+.+
T Consensus 257 ~T~i~~L 263 (449)
T KOG1165|consen 257 STPIEVL 263 (449)
T ss_pred cCCHHHH
Confidence 4444443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=205.96 Aligned_cols=201 Identities=24% Similarity=0.346 Sum_probs=165.3
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch--hhHHHHHHHHHHcCC-CCccccceeeeeccCCCceEEEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--RYKNRELQIMRLLNH-PNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~--~~~~~E~~il~~l~h-~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
.+|.+++.||.|+||.+|+|....+|+.||||.-.... ..+..|..+.+.|++ ..|..+..++ ....|-.+|
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~-----~e~~ynvlV 89 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYG-----TEKDYNVLV 89 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhc-----cccccceee
Confidence 46999999999999999999999999999999875543 334579999999975 5677776666 555567799
Q ss_pred eeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEc--CCCCcEEEeeecCccccC
Q 011138 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN--PHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 214 ~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~--~~~~~vkL~DFG~a~~~~ 291 (492)
||+++.+|.+++... ...++...+..++-|++.-++|+|. +++|||||||+|+|.. ...+.+.|+|||+|+...
T Consensus 90 MdLLGPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~-r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 90 MDLLGPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHL-RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eeccCccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHh-hccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 999998888766543 4578889999999999999999996 9999999999999985 444579999999998764
Q ss_pred CCC--------CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 011138 292 PGE--------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD 347 (492)
Q Consensus 292 ~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~ 347 (492)
+.. ......||..|.+-....+.. -+...|+-|+|.+|..+..|..||++.....
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~t 228 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAAT 228 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhh
Confidence 322 234568999999988776544 5788999999999999999999999865443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-25 Score=222.03 Aligned_cols=251 Identities=20% Similarity=0.206 Sum_probs=188.5
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCC-CEEEEEEeccch----hhHHHHHHHHHHcCC----CCccccceeeeeccCCCce
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETG-DSVAIKKVLQDK----RYKNRELQIMRLLNH----PNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g-~~vAiK~~~~~~----~~~~~E~~il~~l~h----~nIv~l~~~~~~~~~~~~~ 208 (492)
+|.+.+.||+|+||.||.|.+..++ ..+|+|...... ..+..|..++..+.. +++..+++.+. ....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence 6999999999999999999988775 678988765431 146679999999873 57888877662 2445
Q ss_pred EEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCC----CcEEEeee
Q 011138 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT----HQLKICDF 284 (492)
Q Consensus 209 ~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~----~~vkL~DF 284 (492)
+-||||+.++.+|.++..... .+.++...+..++.|++.+|++||+ .|++||||||+|+++.... ..+.|.||
T Consensus 95 ~~~iVM~l~G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~-~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 95 FNFIVMSLLGPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHS-KGFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred eeEEEEeccCccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHh-cCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 678999999999888654433 5789999999999999999999997 9999999999999997653 47999999
Q ss_pred cCcc--ccCCCC--------C-CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 011138 285 GSAK--MLVPGE--------P-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEII 353 (492)
Q Consensus 285 G~a~--~~~~~~--------~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~ 353 (492)
|+++ ...... . .....||..|+++.+..+.. .+.+.|+||++.++.+|+.|..||.+........+..
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 9998 321111 1 22456999999999987655 7999999999999999999999998766433333322
Q ss_pred HHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 354 KILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 354 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
+.... ..... +....+.++.++...+-..+...+|....+...
T Consensus 251 ~~~~~---------------~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 251 KDPRK---------------LLTDR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred HHhhh---------------hcccc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 21100 00000 112245667777777766888888887766543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.1e-27 Score=247.08 Aligned_cols=224 Identities=29% Similarity=0.500 Sum_probs=168.8
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEe
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
...+|..++.|-.|+||.||.++++.+.+.+|+| +.++....++ |+.....|.+ |
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilRn---ilt~a~npfv--------------------v- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILRN---ILTFAGNPFV--------------------V- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhhc---cccccCCcce--------------------e-
Confidence 3456999999999999999999999999999994 5444433332 2222222222 2
Q ss_pred eechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCC
Q 011138 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (492)
Q Consensus 215 E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~ 294 (492)
|+...+++. -..++. +++.+++|||+ .||+|||+||+|++|+.-| .+|++|||+.++.....
T Consensus 136 ----gDc~tllk~----~g~lPv--------dmvla~Eylh~-ygivhrdlkpdnllIT~mG-hiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ----GDCATLLKN----IGPLPV--------DMVLAVEYLHS-YGIVHRDLKPDNLLITSMG-HIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ----chhhhhccc----CCCCcc--------hhhHHhHhhcc-CCeecCCCCCCcceeeecc-cccccchhhhhhhhhhc
Confidence 322222222 123332 34789999997 9999999999999999888 69999999987542110
Q ss_pred ----------------CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 011138 295 ----------------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358 (492)
Q Consensus 295 ----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~ 358 (492)
.....+|||.|+|||++...+ |+..+|||++|+|+||.+.|..||.+++.++.+...+....
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg-ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i- 275 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI- 275 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhc-cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc-
Confidence 012458999999999997655 99999999999999999999999999999988888776322
Q ss_pred CCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcC---CHHHhhCCCCCCCCCC
Q 011138 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC---TALEACAHPFFDDLRD 428 (492)
Q Consensus 359 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~---t~~e~l~Hp~f~~~~~ 428 (492)
.+|. - ...++++++++|.++|+.+|..|. .+.++.+|+||+.+..
T Consensus 276 ----------------~wpE--------~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw 323 (1205)
T KOG0606|consen 276 ----------------EWPE--------E-DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDW 323 (1205)
T ss_pred ----------------cccc--------c-CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeeccc
Confidence 2222 1 234789999999999999999997 5778999999998765
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-26 Score=226.63 Aligned_cols=157 Identities=20% Similarity=0.295 Sum_probs=121.4
Q ss_pred cccceeEeeeeccCCceEEEEEEEcC-CCCEEEEEEeccc---------hhhHHHHHHHHHHcCCCCccc-cceeeeecc
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLE-TGDSVAIKKVLQD---------KRYKNRELQIMRLLNHPNVVS-LKHCFFSTT 203 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~-~g~~vAiK~~~~~---------~~~~~~E~~il~~l~h~nIv~-l~~~~~~~~ 203 (492)
....|.+.+.||+|+||+||+|.+.. +++.||||++... ...+.+|+++|+.++|+||+. ++++ .
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence 34569999999999999999998876 6788899986422 234678999999999999985 4331 1
Q ss_pred CCCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCC-CCCceEEcCCCCcEEEe
Q 011138 204 EKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDI-KPQNLLVNPHTHQLKIC 282 (492)
Q Consensus 204 ~~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDl-Kp~NILl~~~~~~vkL~ 282 (492)
..||||||+.|+.+.... ... ...++.|++.+|.|||+ +||+|||| ||+|||++.++ .+||+
T Consensus 92 -----~~~LVmE~~~G~~L~~~~-------~~~---~~~~~~~i~~aL~~lH~-~gIiHrDL~KP~NILv~~~~-~ikLi 154 (365)
T PRK09188 92 -----KDGLVRGWTEGVPLHLAR-------PHG---DPAWFRSAHRALRDLHR-AGITHNDLAKPQNWLMGPDG-EAAVI 154 (365)
T ss_pred -----CcEEEEEccCCCCHHHhC-------ccc---hHHHHHHHHHHHHHHHH-CCCeeCCCCCcceEEEcCCC-CEEEE
Confidence 268999999987554211 011 14578899999999997 99999999 99999998777 79999
Q ss_pred eecCccccCCCCC---------CccceeccCccCchhhc
Q 011138 283 DFGSAKMLVPGEP---------NISYICSRYYRAPELIF 312 (492)
Q Consensus 283 DFG~a~~~~~~~~---------~~~~~gt~~y~aPE~~~ 312 (492)
|||+|+.+..... .....+++.|+|||.+.
T Consensus 155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 9999986643321 12456788899999884
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-24 Score=213.21 Aligned_cols=262 Identities=34% Similarity=0.477 Sum_probs=197.2
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHcCCC-CccccceeeeeccCCCceEE
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHP-NVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l~h~-nIv~l~~~~~~~~~~~~~~~ 210 (492)
|.+.+.||.|+||.||.+.+. ..+++|.+... .....+|+.+++.+.|+ +|+++++++ ......
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF-----QDEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE-----ecCCEE
Confidence 778889999999999999986 77899987443 23355799999999988 799999988 333337
Q ss_pred EEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 211 ~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
+++++++.++.+............+....+..++.|++.++.|+|+ .|++||||||+||+++..+..++++|||.++..
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~-~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~ 152 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS-KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLL 152 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeecCCCCeEEEeccCcceec
Confidence 8999999976554211111000268889999999999999999997 899999999999999987645999999999755
Q ss_pred CCCC-------CCccceeccCccCchhhcCC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCC
Q 011138 291 VPGE-------PNISYICSRYYRAPELIFGA--TEYTTAIDMWSIGCVLAELLLGQPLFPGESG---VDQLVEIIKILGT 358 (492)
Q Consensus 291 ~~~~-------~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwSlGvil~ell~G~~pf~~~~~---~~~~~~i~~~~g~ 358 (492)
.... ......||..|+|||.+.+. ..+....|+||+|++++++++|..||..... .......+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 232 (384)
T COG0515 153 PDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232 (384)
T ss_pred CCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC
Confidence 4332 23567899999999999764 4688999999999999999999999887764 4444444443322
Q ss_pred CCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 359 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
+. ...+.... ........+.+++.+++..+|..|.+..+...++|......
T Consensus 233 ~~-------------~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~ 283 (384)
T COG0515 233 PS-------------LASPLSPS------NPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKL 283 (384)
T ss_pred cc-------------cccccCcc------ccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCccc
Confidence 20 00000000 00112367899999999999999999999999977765443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-26 Score=232.01 Aligned_cols=236 Identities=29% Similarity=0.443 Sum_probs=187.1
Q ss_pred eeccCCceEEEEEEE---cCCCCEEEEEEeccc------hhhHHHHHHHHHHcC-CCCccccceeeeeccCCCceEEEEE
Q 011138 144 VVGTGSFGVVFQAKC---LETGDSVAIKKVLQD------KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 144 ~lG~G~fg~Vy~~~~---~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
.+|+|+||.|+++.. ...|..+|+|...+. ......|..++..++ ||.+|+++.+|.+ ...++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt-----~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT-----DGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc-----ccchhHh
Confidence 379999999987742 345677888876432 123345888999887 9999999888843 3448899
Q ss_pred eeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCC
Q 011138 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (492)
Q Consensus 214 ~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (492)
+++..|+.+ ..+ ......+.+..++.+...++.+++++|+ .||+|||+|++||+++.+| .+|+.|||+++.....
T Consensus 76 ld~~rgg~l--ft~-l~~~~~f~~~~~~~~~aelaLald~lh~-l~iiyrd~k~enilld~~G-hi~~tdfglske~v~~ 150 (612)
T KOG0603|consen 76 LDFLRGGDL--FTR-LSKEVMFDELDVAFYLAELALALDHLHK-LGIAYRDYKLENVLLLLEG-HIKLTDFGLSKEAVKE 150 (612)
T ss_pred hhhcccchh--hhc-cccCCchHHHHHHHHHHHHHHHHhhcch-hHHHHhcccccceeecccC-ccccCCchhhhHhHhh
Confidence 999987522 122 2234567788899999999999999997 8999999999999999999 5999999999877544
Q ss_pred CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 011138 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373 (492)
Q Consensus 294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~ 373 (492)
... |||..|||||++. ....++|+||||+++|||++|..||.+ +....|.+. .
T Consensus 151 ~~~---cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~-----------------~ 203 (612)
T KOG0603|consen 151 KIA---CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA-----------------E 203 (612)
T ss_pred hhc---ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh-----------------c
Confidence 433 9999999999996 367899999999999999999999987 555555551 1
Q ss_pred cCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCC-----HHHhhCCCCCCCCCC
Q 011138 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-----ALEACAHPFFDDLRD 428 (492)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-----~~e~l~Hp~f~~~~~ 428 (492)
.. ++..++.++++++..++..+|..|.. +.++++|+||+.+..
T Consensus 204 ~~------------~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~ 251 (612)
T KOG0603|consen 204 LE------------MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDW 251 (612)
T ss_pred cC------------CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeH
Confidence 11 22357889999999999999999985 479999999987654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=201.01 Aligned_cols=237 Identities=24% Similarity=0.328 Sum_probs=145.1
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchhh-------HHHHHHHHHHcC----------CCCccccceeee
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRY-------KNRELQIMRLLN----------HPNVVSLKHCFF 200 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-------~~~E~~il~~l~----------h~nIv~l~~~~~ 200 (492)
.+..++.||.|+|+.||.+.+..||+.+|+|++...... .++|.-....+. |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 367888999999999999999999999999987433221 122221211111 112222222221
Q ss_pred ec--------cCCCce----EEEEEeeechhhHHHHhhhhhhcCCC---cCHHHHHHHHHHHHHHHHHHHhhCCcccCCC
Q 011138 201 ST--------TEKDEL----YLNLVLEYISETVYRVSKHYTRMNQH---VPILYVQLYTYQICRALNYLHHVVGVCHRDI 265 (492)
Q Consensus 201 ~~--------~~~~~~----~~~lV~E~~~~~l~~~~~~~~~~~~~---~~~~~~~~i~~qi~~aL~yLH~~~givHrDl 265 (492)
.. ...... ..+++|+-+.+++..++......... +.......+..|+++.+++||+ .||||+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~-~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS-YGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh-cceEeccc
Confidence 11 111111 24678888888877765543322222 2223334566899999999997 99999999
Q ss_pred CCCceEEcCCCCcEEEeeecCccccCCCCCCccceeccCccCchhhcCC-------CCCCcchhhHHHHHHHHHHHhCCC
Q 011138 266 KPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA-------TEYTTAIDMWSIGCVLAELLLGQP 338 (492)
Q Consensus 266 Kp~NILl~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DvwSlGvil~ell~G~~ 338 (492)
||+|+|++.+| .++|+||+..... +........+..|.+||..... ..++.+.|.|+||+++|.|.||..
T Consensus 172 ~~~nfll~~~G-~v~Lg~F~~~~r~--g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 172 KPENFLLDQDG-GVFLGDFSSLVRA--GTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp SGGGEEE-TTS--EEE--GGGEEET--TEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred ceeeEEEcCCC-CEEEcChHHHeec--CceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 99999999998 7999999987644 3222224456789999987432 247889999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCc
Q 011138 339 LFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR 411 (492)
Q Consensus 339 pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R 411 (492)
||........ .+. .|.. . .++|+.+++||..||+.||.+|
T Consensus 249 Pf~~~~~~~~-----------------------~~~--------~f~~-C-~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEAD-----------------------PEW--------DFSR-C-RDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGST-----------------------SGG--------GGTT-S-S---HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCcccc-----------------------ccc--------cchh-c-CCcCHHHHHHHHHHccCCcccC
Confidence 9976542110 000 1111 1 2689999999999999999988
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.2e-23 Score=198.89 Aligned_cols=195 Identities=26% Similarity=0.369 Sum_probs=141.6
Q ss_pred CCCCccccceeeeeccC----------------------CCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHH
Q 011138 188 NHPNVVSLKHCFFSTTE----------------------KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245 (492)
Q Consensus 188 ~h~nIv~l~~~~~~~~~----------------------~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~ 245 (492)
.|||||++..+|.+.-. .....+|+||-....+|...+. .+..+....+.++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~-----~~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLW-----TRHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHh-----cCCCchHHHHHHHH
Confidence 49999999888743211 2234688999998887766543 35567778889999
Q ss_pred HHHHHHHHHHhhCCcccCCCCCCceEE--cCCC-CcEEEeeecCccccCC-------CCCCccceeccCccCchhhcCCC
Q 011138 246 QICRALNYLHHVVGVCHRDIKPQNLLV--NPHT-HQLKICDFGSAKMLVP-------GEPNISYICSRYYRAPELIFGAT 315 (492)
Q Consensus 246 qi~~aL~yLH~~~givHrDlKp~NILl--~~~~-~~vkL~DFG~a~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~ 315 (492)
|+++|+.|||+ +||.|||||.+|||| +.|+ ..+.|+|||++-.-.. ........|...-||||+.....
T Consensus 349 QlLEav~hL~~-hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 349 QLLEAVTHLHK-HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHHH-ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 99999999997 999999999999998 3232 3588999998742211 11122345677899999984332
Q ss_pred C-----CCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCC
Q 011138 316 E-----YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHK 390 (492)
Q Consensus 316 ~-----~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (492)
. .-.++|.|+.|.+.||+++...||.+..... + -..+|.+-++|. +++
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L-----------------~~r~Yqe~qLPa---------lp~ 480 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-L-----------------DTRTYQESQLPA---------LPS 480 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-e-----------------chhhhhhhhCCC---------Ccc
Confidence 1 1237899999999999999999998733110 0 011234444444 446
Q ss_pred CCChhHhhhhccccccCCCCcCCHH
Q 011138 391 RMPPEALDLVSRLLQYSPSLRCTAL 415 (492)
Q Consensus 391 ~~s~~~~~Li~~~L~~dP~~R~t~~ 415 (492)
.+++.+++|+..+|+.||++|+++.
T Consensus 481 ~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 481 RVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred cCChHHHHHHHHHhcCCccccCCcc
Confidence 7899999999999999999999854
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=186.16 Aligned_cols=135 Identities=18% Similarity=0.248 Sum_probs=103.3
Q ss_pred eeeeccCCceEEEEEEEcCCCCEEEEEEeccchh------------------------------hHHHHHHHHHHcCCCC
Q 011138 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR------------------------------YKNRELQIMRLLNHPN 191 (492)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~------------------------------~~~~E~~il~~l~h~n 191 (492)
...||+|+||.||+|.+. +|+.||||++..+.. ...+|+.++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 357999999999999986 899999999854311 1124999999998887
Q ss_pred ccccceeeeeccCCCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHH-HhhCCcccCCCCCCce
Q 011138 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL-HHVVGVCHRDIKPQNL 270 (492)
Q Consensus 192 Iv~l~~~~~~~~~~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yL-H~~~givHrDlKp~NI 270 (492)
+.....+. ... .+|||||++|+.+.... .....++...+..++.||+.+|.|| |+ .||+||||||+||
T Consensus 81 v~~p~~~~-----~~~--~~iVmE~i~g~~l~~~~---~~~~~~~~~~~~~i~~qi~~~L~~l~H~-~giiHrDlkP~NI 149 (190)
T cd05147 81 IPCPEPIL-----LKS--HVLVMEFIGDDGWAAPR---LKDAPLSESKARELYLQVIQIMRILYQD-CRLVHADLSEYNL 149 (190)
T ss_pred CCCCcEEE-----ecC--CEEEEEEeCCCCCcchh---hhcCCCCHHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHE
Confidence 75443322 111 26999999986432111 1135688889999999999999999 66 8999999999999
Q ss_pred EEcCCCCcEEEeeecCcccc
Q 011138 271 LVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 271 Ll~~~~~~vkL~DFG~a~~~ 290 (492)
|++. + .++|+|||+|...
T Consensus 150 li~~-~-~v~LiDFG~a~~~ 167 (190)
T cd05147 150 LYHD-G-KLYIIDVSQSVEH 167 (190)
T ss_pred EEEC-C-cEEEEEccccccC
Confidence 9984 4 6999999999743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.7e-22 Score=181.20 Aligned_cols=182 Identities=18% Similarity=0.140 Sum_probs=134.3
Q ss_pred eEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchh--------hHHHHHHHHHHcC-CCCccccceeeeeccCCCceEE
Q 011138 140 MAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR--------YKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 140 ~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~--------~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
.+...|++|+||+||.+.. .+..++.+.+..... ...+|+++|++|. |++|++++++. ..
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---------~~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD---------GR 73 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------CE
Confidence 3456899999999998764 677788776644322 4568999999996 58899987752 25
Q ss_pred EEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCC-CCCceEEcCCCCcEEEeeecCccc
Q 011138 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDI-KPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 211 ~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDl-Kp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
+++|||+.|..+.... +.. ...++.|++.+|.+||+ +||+|||| ||+|||++.++ .++|+|||+|..
T Consensus 74 ~lvmeyI~G~~L~~~~---------~~~-~~~~~~qi~~~L~~lH~-~GIvHrDL~kp~NILv~~~g-~i~LIDFG~A~~ 141 (218)
T PRK12274 74 HLDRSYLAGAAMYQRP---------PRG-DLAYFRAARRLLQQLHR-CGVAHNDLAKEANWLVQEDG-SPAVIDFQLAVR 141 (218)
T ss_pred EEEEeeecCccHHhhh---------hhh-hHHHHHHHHHHHHHHHH-CcCccCCCCCcceEEEcCCC-CEEEEECCCcee
Confidence 7999999986543110 001 13467899999999997 99999999 79999999877 799999999986
Q ss_pred cCCCCCC--------------ccceeccCccCchhhcCCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCC
Q 011138 290 LVPGEPN--------------ISYICSRYYRAPELIFGATEYT-TAIDMWSIGCVLAELLLGQPLFPGES 344 (492)
Q Consensus 290 ~~~~~~~--------------~~~~gt~~y~aPE~~~~~~~~~-~~~DvwSlGvil~ell~G~~pf~~~~ 344 (492)
....... .-...++.|++|+...--...+ ...++++.|+-+|.++|+..++.+++
T Consensus 142 ~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 142 GNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred cCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 5433321 0113578899998653222233 46788899999999999998886654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=4e-22 Score=185.48 Aligned_cols=170 Identities=14% Similarity=0.147 Sum_probs=125.5
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----hhh---------HHHHHHHHHHcCCCCccccceeeeecc
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRY---------KNRELQIMRLLNHPNVVSLKHCFFSTT 203 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----~~~---------~~~E~~il~~l~h~nIv~l~~~~~~~~ 203 (492)
.+|++.++||.|+||.||++.+ ++..+|||.+... ... .++|+..+.++.|++|..+.+++....
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred CceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 4699999999999999999755 5778999988532 111 468999999999999999998875433
Q ss_pred CC---CceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEE
Q 011138 204 EK---DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLK 280 (492)
Q Consensus 204 ~~---~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vk 280 (492)
.. -....+|||||++|..+.... .++. ....+|+.+|..||+ .|++||||||+||++++++ ++
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~-------~~~~----~~~~~i~~~l~~lH~-~gi~H~Dikp~Nili~~~g--i~ 174 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMP-------EISE----DVKAKIKASIESLHQ-HGMVSGDPHKGNFIVSKNG--LR 174 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhh-------hccH----HHHHHHHHHHHHHHH-cCCccCCCChHHEEEeCCC--EE
Confidence 11 123478999999986443221 1222 245699999999997 9999999999999999766 99
Q ss_pred EeeecCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHH
Q 011138 281 ICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELL 334 (492)
Q Consensus 281 L~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell 334 (492)
|+|||..+........ ...+.. ..|+.++|+|+||+++..+.
T Consensus 175 liDfg~~~~~~e~~a~-----------d~~vle-r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 175 IIDLSGKRCTAQRKAK-----------DRIDLE-RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEECCCcccccchhhH-----------HHHHHH-hHhcccccccceeEeehHHH
Confidence 9999988654221111 002333 34778999999999987665
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-22 Score=215.75 Aligned_cols=241 Identities=27% Similarity=0.434 Sum_probs=170.3
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHH--HHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKN--RELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~--~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
.|...+.||++.|=+|.+|++. .|. |.||++.+.. .+.+ +|++ ...++|||.+.+..+. .....
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-----~t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-----VTDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-----HhhHH
Confidence 4778889999999999999863 344 8899885543 1112 3444 6677899999876654 33345
Q ss_pred EEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
.|||-+|+...|++.+.. ..-+...+.+.|+.||+.||.-+|. .||+|||||.|||||+.-. =+.|+||..-+.
T Consensus 96 AylvRqyvkhnLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~-~gVcHGDIKsENILiTSWN-W~~LtDFAsFKP 169 (1431)
T KOG1240|consen 96 AYLVRQYVKHNLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHK-LGVCHGDIKSENILITSWN-WLYLTDFASFKP 169 (1431)
T ss_pred HHHHHHHHhhhhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHH-cCccccccccceEEEeeec-hhhhhcccccCC
Confidence 789999999998875432 3345667788999999999999998 8999999999999998655 489999987654
Q ss_pred c--CCCCCC-cc-ce----eccCccCchhhcCCC----------CCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 011138 290 L--VPGEPN-IS-YI----CSRYYRAPELIFGAT----------EYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLV 350 (492)
Q Consensus 290 ~--~~~~~~-~~-~~----gt~~y~aPE~~~~~~----------~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~ 350 (492)
. +.+.+. .+ +. .-.+|+|||.+.... ..+++-||||+||+++||++ |++||.- .++.
T Consensus 170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~ 245 (1431)
T KOG1240|consen 170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLL 245 (1431)
T ss_pred ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHH
Confidence 3 122211 11 11 234699999985422 14678899999999999997 8999942 2222
Q ss_pred HHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 351 EIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 351 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
.....- ....+.. +.+--+..++.||..|++.||++|.+|++.|+-
T Consensus 246 aYr~~~-~~~~e~~-----------------------Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 246 AYRSGN-ADDPEQL-----------------------LEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hHhccC-ccCHHHH-----------------------HHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 221110 0011100 001124568999999999999999999999975
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.3e-21 Score=177.28 Aligned_cols=136 Identities=18% Similarity=0.248 Sum_probs=104.7
Q ss_pred eeeeccCCceEEEEEEEcCCCCEEEEEEeccch------------------------------hhHHHHHHHHHHcCCCC
Q 011138 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------------------------------RYKNRELQIMRLLNHPN 191 (492)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------------------------------~~~~~E~~il~~l~h~n 191 (492)
.+.||+|+||.||+|.+. +|+.||||++.... ....+|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 457999999999999987 89999999885431 11246889999999998
Q ss_pred ccccceeeeeccCCCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceE
Q 011138 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLL 271 (492)
Q Consensus 192 Iv~l~~~~~~~~~~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NIL 271 (492)
|.....+... . .+|||||++|+.+.... . ....++...+..++.|++.+|.+||+..||+||||||+|||
T Consensus 81 i~~p~~~~~~-----~--~~lVmE~~~g~~~~~~~--l-~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIl 150 (190)
T cd05145 81 VPVPEPILLK-----K--NVLVMEFIGDDGSPAPR--L-KDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNIL 150 (190)
T ss_pred CCCceEEEec-----C--CEEEEEEecCCCchhhh--h-hhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEE
Confidence 8655443321 1 36999999976221110 1 12456778889999999999999994379999999999999
Q ss_pred EcCCCCcEEEeeecCcccc
Q 011138 272 VNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 272 l~~~~~~vkL~DFG~a~~~ 290 (492)
++ ++ .++|+|||+++..
T Consensus 151 l~-~~-~~~liDFG~a~~~ 167 (190)
T cd05145 151 YH-DG-KPYIIDVSQAVEL 167 (190)
T ss_pred EE-CC-CEEEEEcccceec
Confidence 98 55 7999999999765
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-19 Score=167.37 Aligned_cols=133 Identities=18% Similarity=0.231 Sum_probs=98.9
Q ss_pred eeeeccCCceEEEEEEEcCCCCEEEEEEeccc----hhhHHHHHHHHHHc-----CCCCccccceeeeeccCCCceE-EE
Q 011138 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLL-----NHPNVVSLKHCFFSTTEKDELY-LN 211 (492)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----~~~~~~E~~il~~l-----~h~nIv~l~~~~~~~~~~~~~~-~~ 211 (492)
.+.||+|+||.||. +..++.. +||++... .....+|+.+++.+ +||||+++++++.+.. +..+ +.
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~v~~ 81 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGYVYD 81 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeEEEE
Confidence 45799999999995 6667666 69987643 34567899999999 6799999999885532 2234 34
Q ss_pred EEeeech---hhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHH-HHHHhhCCcccCCCCCCceEEcCCC---CcEEEeee
Q 011138 212 LVLEYIS---ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL-NYLHHVVGVCHRDIKPQNLLVNPHT---HQLKICDF 284 (492)
Q Consensus 212 lV~E~~~---~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL-~yLH~~~givHrDlKp~NILl~~~~---~~vkL~DF 284 (492)
+||||++ ++|.+.+.. ..+++. ..++.|++.++ +|||+ ++||||||||+|||++..+ ..++|+||
T Consensus 82 ~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~-~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLD-NRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 7999955 466665532 234444 35678888888 99997 9999999999999997432 26999995
Q ss_pred cCc
Q 011138 285 GSA 287 (492)
Q Consensus 285 G~a 287 (492)
+-+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 444
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-20 Score=187.97 Aligned_cols=181 Identities=28% Similarity=0.464 Sum_probs=134.3
Q ss_pred ceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 207 ~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
..|+||.|++|....+.......+.....+....+.++.|+..|++| +|.+|||+||.||++..+. .+||.|||+
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y----k~~ihrdlkp~nif~~~d~-q~kIgDFgl 402 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY----KGLIHRDLKPSNIFFSDDD-QLKIGDFGL 402 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh----ccchhhhccccccccccch-hhhhhhhhh
Confidence 44689999999965554444445556667788889999999999999 5999999999999998777 899999999
Q ss_pred ccccCCCC-------CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCC
Q 011138 287 AKMLVPGE-------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG-QPLFPGESGVDQLVEIIKILGT 358 (492)
Q Consensus 287 a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G-~~pf~~~~~~~~~~~i~~~~g~ 358 (492)
........ ..+...||..||+||.|.+.. |+.++||||||+||+||+.- ...|. .....-.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~~f~T~~e------r~~t~~d---- 471 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLIQFSTQFE------RIATLTD---- 471 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHHHhccHHH------HHHhhhh----
Confidence 88765554 456789999999999998765 99999999999999999972 22221 1111000
Q ss_pred CCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCC
Q 011138 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424 (492)
Q Consensus 359 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~ 424 (492)
+ ....+| ..+..+ -++-.+|+.+||...|.+||++.+.--|+|.+
T Consensus 472 -----~-------r~g~ip--------~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 472 -----I-------RDGIIP--------PEFLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ 516 (516)
T ss_pred -----h-------hcCCCC--------hHHhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence 0 111122 111111 24457999999999999999888877787753
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.3e-19 Score=194.39 Aligned_cols=190 Identities=24% Similarity=0.382 Sum_probs=144.4
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchh-hHHHHHHHHHHcC---CCCccccceeeeeccCCCceEEE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-YKNRELQIMRLLN---HPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~E~~il~~l~---h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
...|.|.+.||+|+||.||+|.... |+.||+|+-....- .+.-=.+++.+|+ -+-|..+..++...+. -+
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~-----S~ 770 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNA-----SV 770 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCc-----ce
Confidence 3479999999999999999999766 99999997543211 1111123334444 2345555444432222 45
Q ss_pred EEeeech-hhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcC------CCCcEEEeee
Q 011138 212 LVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP------HTHQLKICDF 284 (492)
Q Consensus 212 lV~E~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~------~~~~vkL~DF 284 (492)
||+||.+ |+|++++. ..+.+++..+..+..|++..++.||. .||||+||||+|+||.. +...++|+||
T Consensus 771 lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~-~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHA-MGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred eeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHh-cceecccCCcceeEeecccCCCCcccceEEEec
Confidence 8999998 67777665 46778899999999999999999997 89999999999999942 2235999999
Q ss_pred cCcccc---CCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCC
Q 011138 285 GSAKML---VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337 (492)
Q Consensus 285 G~a~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~ 337 (492)
|.+.-+ .++......++|-.+-.+|+..|. .++..+|.|.|..+++.||.|+
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~gr-pWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGR-PWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCC-CCchhhhhHHHHHHHHHHHHHH
Confidence 998544 444455667889999999999765 4999999999999999999996
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.1e-19 Score=170.57 Aligned_cols=140 Identities=18% Similarity=0.152 Sum_probs=105.1
Q ss_pred ceeEeeeeccCCceEEEEEE-EcCCCCEEEEEEeccch----------------------------hhHHHHHHHHHHcC
Q 011138 138 SYMAERVVGTGSFGVVFQAK-CLETGDSVAIKKVLQDK----------------------------RYKNRELQIMRLLN 188 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~-~~~~g~~vAiK~~~~~~----------------------------~~~~~E~~il~~l~ 188 (492)
.|.+.+.||+|+||.||+|. +..+|+.||||++.... ....+|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48889999999999999998 67799999999885321 11357999999997
Q ss_pred CCCccccceeeeeccCCCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCC-cccCCCCC
Q 011138 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG-VCHRDIKP 267 (492)
Q Consensus 189 h~nIv~l~~~~~~~~~~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~g-ivHrDlKp 267 (492)
+. ++.+...+.. . ..++||||++|..+.... .....+....+..++.||+.+|.+||+ +| |+||||||
T Consensus 109 ~~-~i~~p~~~~~-~-----~~~lV~E~~~g~~L~~~~---~~~~~~~~~~~~~i~~qi~~~l~~LH~-~g~iiH~Dikp 177 (237)
T smart00090 109 EA-GVPVPKPIAW-R-----RNVLVMEFIGGDGLPAPR---LKDVEPEEEEEFELYDDILEEMRKLYK-EGELVHGDLSE 177 (237)
T ss_pred hc-CCCCCeeeEe-c-----CceEEEEEecCCcccccc---cccCCcchHHHHHHHHHHHHHHHHHHh-cCCEEeCCCCh
Confidence 63 3333333311 1 136999999986443211 112344555677899999999999997 89 99999999
Q ss_pred CceEEcCCCCcEEEeeecCcccc
Q 011138 268 QNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 268 ~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
+||+++ ++ .++|+|||.+...
T Consensus 178 ~NIli~-~~-~i~LiDFg~a~~~ 198 (237)
T smart00090 178 YNILVH-DG-KVVIIDVSQSVEL 198 (237)
T ss_pred hhEEEE-CC-CEEEEEChhhhcc
Confidence 999999 55 7999999998743
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.2e-20 Score=197.13 Aligned_cols=256 Identities=26% Similarity=0.316 Sum_probs=193.0
Q ss_pred ceeEeeeeccCCceEEEEEEEcC-CCCEEEEEEeccc---hhhH---HHHHHHHHHcC-CCCccccceeeeeccCCCceE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLE-TGDSVAIKKVLQD---KRYK---NRELQIMRLLN-HPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~-~g~~vAiK~~~~~---~~~~---~~E~~il~~l~-h~nIv~l~~~~~~~~~~~~~~ 209 (492)
.|.+.+.||+|+|+.|-.+.... +...+|.|.+... .... ..|..+-+.+. |+|++++++.. .+..+
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~~~~ 95 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SSPRS 95 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CCCcc
Confidence 48888889999999998887643 3445667765332 2222 34888888887 99999999887 55556
Q ss_pred EEEEeeechhhHHHHhhhh-hhcCCCcCHHHHHHHHHHHHHHHHHHH-hhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 210 LNLVLEYISETVYRVSKHY-TRMNQHVPILYVQLYTYQICRALNYLH-HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~qi~~aL~yLH-~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
.+++++|..|+.+- ... .......+...+..++.|+..++.|+| . .++.||||||+|.+++..+..++++|||+|
T Consensus 96 ~~~~~~~s~g~~~f--~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~-~~~~h~~ikP~n~~l~~s~~~l~~~df~~A 172 (601)
T KOG0590|consen 96 YLLSLSYSDGGSLF--SKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE-NGVTHRDIKPSNSLLDESGSALKIADFGLA 172 (601)
T ss_pred cccccCcccccccc--cccccCCccCCCCcchhhhhhhhccCccccCcc-cccccCCCCCccchhccCCCcccCCCchhh
Confidence 88999997765322 111 111225677788999999999999999 7 899999999999999876646999999999
Q ss_pred cccCC-CCC---Ccccee-ccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 011138 288 KMLVP-GEP---NISYIC-SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (492)
Q Consensus 288 ~~~~~-~~~---~~~~~g-t~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~ 362 (492)
..... ... ....+| ++.|+|||...+........|+||+|+++.-+++|..||..........
T Consensus 173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~------------ 240 (601)
T KOG0590|consen 173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY------------ 240 (601)
T ss_pred ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc------------
Confidence 87755 222 234678 9999999999876677889999999999999999999997654322110
Q ss_pred HHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCC
Q 011138 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (492)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~ 425 (492)
..+...+ .......+..++..+.+++.++|..+|..|.+..++..+||+..
T Consensus 241 -----------~~~~~~~-~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 241 -----------SSWKSNK-GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred -----------eeecccc-cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 0000100 11112234568899999999999999999999999999999998
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.9e-18 Score=156.29 Aligned_cols=131 Identities=18% Similarity=0.166 Sum_probs=100.4
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch--------------------------hhHHHHHHHHHHcCCCC-
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--------------------------RYKNRELQIMRLLNHPN- 191 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~--------------------------~~~~~E~~il~~l~h~n- 191 (492)
|.+.+.||+|+||.||++... +|+.||||++.... ....+|..++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 888899999999999999864 89999999864321 11346888899888874
Q ss_pred -ccccceeeeeccCCCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCce
Q 011138 192 -VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270 (492)
Q Consensus 192 -Iv~l~~~~~~~~~~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NI 270 (492)
++..++. ...++||||++|..+..... ......++.+|+.++.++|+ .||+||||||+||
T Consensus 96 ~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~-~gi~H~Dl~p~Ni 156 (198)
T cd05144 96 PVPKPIDW---------NRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYK-HGIIHGDLSEFNI 156 (198)
T ss_pred CCCceeec---------CCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHH-CCCCcCCCCcccE
Confidence 3333221 12479999999864432211 02356788899999999997 9999999999999
Q ss_pred EEcCCCCcEEEeeecCcccc
Q 011138 271 LVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 271 Ll~~~~~~vkL~DFG~a~~~ 290 (492)
+++.++ .++|+|||.+...
T Consensus 157 ll~~~~-~~~liDfg~~~~~ 175 (198)
T cd05144 157 LVDDDE-KIYIIDWPQMVST 175 (198)
T ss_pred EEcCCC-cEEEEECCccccC
Confidence 999877 8999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.5e-17 Score=153.92 Aligned_cols=130 Identities=21% Similarity=0.315 Sum_probs=100.2
Q ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEeccch------------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
+.||+|++|.||+|.+ +|..|++|+..... ....+|+.++..+.|++|+....++... ...
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP-----ENF 74 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC-----CCC
Confidence 4699999999999987 77889999754211 2245799999999999988776665332 236
Q ss_pred EEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 211 ~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
++||||++|..+...... . .. ....++.+|+.+|.+||+ .|++|||++|.|||++ ++ .++|+|||++..
T Consensus 75 ~lv~e~~~G~~L~~~~~~---~---~~-~~~~i~~~i~~~l~~lH~-~~i~H~Dl~p~Nil~~-~~-~~~liDf~~a~~ 143 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINS---N---GM-EELELSREIGRLVGKLHS-AGIIHGDLTTSNMILS-GG-KIYLIDFGLAEF 143 (211)
T ss_pred EEEEEEeCCcCHHHHHHh---c---cH-HHHHHHHHHHHHHHHHHh-CCcccCCCCcccEEEE-CC-CEEEEECCcccC
Confidence 799999987544322211 1 11 677889999999999997 9999999999999999 55 799999999875
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.9e-18 Score=154.95 Aligned_cols=239 Identities=16% Similarity=0.225 Sum_probs=168.7
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
..+.-+|.+..-|..|+|++.+ ..+.+|++... .+.+..|.-.|+-+.||||+.+++.+ .....+.+
T Consensus 192 lnl~tkl~e~hsgelwrgrwqg--ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgac-----nsppnlv~ 264 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQG--NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGAC-----NSPPNLVI 264 (448)
T ss_pred hhhhhhhccCCCcccccccccC--cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhc-----cCCCCceE
Confidence 3445568889999999999854 34555655321 24456788889999999999999988 34445889
Q ss_pred Eeeech-hhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCccc-CCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 213 VLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCH-RDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 213 V~E~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givH-rDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
|..|++ |+|+..+-. ...--++-.++..++..|++|+.|||+...++- --|....++||.+. +.+|. .+-++..
T Consensus 265 isq~mp~gslynvlhe--~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedl-taris-mad~kfs 340 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHE--QTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDL-TARIS-MADTKFS 340 (448)
T ss_pred eeeeccchHHHHHHhc--CccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchh-hhhee-cccceee
Confidence 999999 556655432 222335566788899999999999997444443 46888899999876 55543 2211111
Q ss_pred CCCCCCccceeccCccCchhhcCCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 291 VPGEPNISYICSRYYRAPELIFGATE--YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
-......-.|.||+||.+..... .-.++|+|||.+++|||.|...||..-++.+.-.+|.-
T Consensus 341 ---fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial-------------- 403 (448)
T KOG0195|consen 341 ---FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL-------------- 403 (448)
T ss_pred ---eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh--------------
Confidence 01112345788999999965432 34589999999999999999999988776654444321
Q ss_pred CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhh
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC 418 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l 418 (492)
..+...+++.++..+..|+.-|+..||.+||..+.++
T Consensus 404 -------------eglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 404 -------------EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred -------------ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 1111234567889999999999999999999987764
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.9e-17 Score=150.03 Aligned_cols=127 Identities=19% Similarity=0.301 Sum_probs=94.7
Q ss_pred eeccCCceEEEEEEEcCCCCEEEEEEeccc------------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQD------------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 144 ~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
.||+|+||.||+|.. +|..|++|..... .....+|+++++.+.|+++.....++... ...+
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP-----DNKT 73 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC-----CCCE
Confidence 389999999999984 6788999975321 12234799999999988766554444322 1257
Q ss_pred EEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
+||||++|..+...... .. ..++.|++.+|.+||+ .|++|||++|.||+++ ++ .++++|||++...
T Consensus 74 lv~e~~~g~~l~~~~~~---~~-------~~~~~~i~~~l~~lH~-~gi~H~Dl~~~Nil~~-~~-~~~liDfg~a~~~ 139 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEE---GN-------DELLREIGRLVGKLHK-AGIVHGDLTTSNIIVR-DD-KLYLIDFGLGKYS 139 (199)
T ss_pred EEEEEECCccHHHHHhh---cH-------HHHHHHHHHHHHHHHH-CCeecCCCCcceEEEE-CC-cEEEEECCCCcCC
Confidence 99999987644322110 00 0678899999999997 9999999999999999 55 7999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.3e-17 Score=165.98 Aligned_cols=206 Identities=25% Similarity=0.351 Sum_probs=146.1
Q ss_pred HHHcCCCCccccceeeeeccCCCceEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCccc
Q 011138 184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCH 262 (492)
Q Consensus 184 l~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givH 262 (492)
|+.+.|.|+.++++.++.. ..+++|.+||+. .+.+.+.. ....++......+++.|+.||.|||.+....|
T Consensus 1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~h 72 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSPIGYH 72 (484)
T ss_pred CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCcceee
Confidence 4678999999999998654 348899999995 45554433 34567777788889999999999997444499
Q ss_pred CCCCCCceEEcCCCCcEEEeeecCccccCCC---CCCccceeccCccCchhhcCCCC------CCcchhhHHHHHHHHHH
Q 011138 263 RDIKPQNLLVNPHTHQLKICDFGSAKMLVPG---EPNISYICSRYYRAPELIFGATE------YTTAIDMWSIGCVLAEL 333 (492)
Q Consensus 263 rDlKp~NILl~~~~~~vkL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~------~~~~~DvwSlGvil~el 333 (492)
+.|+..|+++|... .+||+|||+....... .......-...|.|||++.+... .+.+.|+||+|+++||+
T Consensus 73 g~l~s~nClvd~~w-~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei 151 (484)
T KOG1023|consen 73 GALKSSNCLVDSRW-VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEI 151 (484)
T ss_pred eeeccccceeeeeE-EEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHH
Confidence 99999999999888 8999999998765321 11111223456999999966421 36679999999999999
Q ss_pred HhCCCCCCCCChHHH---HHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCC
Q 011138 334 LLGQPLFPGESGVDQ---LVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSL 410 (492)
Q Consensus 334 l~G~~pf~~~~~~~~---~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~ 410 (492)
++...||........ +...++..+.+ ..-|.+.. . ..+++++..++..|+..+|.+
T Consensus 152 ~~r~~~~~~~~~~~~~~eii~~~~~~~~~--------------~~rP~i~~------~-~e~~~~l~~l~~~cw~e~P~~ 210 (484)
T KOG1023|consen 152 LFRSGPFDLRNLVEDPDEIILRVKKGGSN--------------PFRPSIEL------L-NELPPELLLLVARCWEEIPEK 210 (484)
T ss_pred HhccCccccccccCChHHHHHHHHhcCCC--------------CcCcchhh------h-hhcchHHHHHHHHhcccChhh
Confidence 999999976332221 22211111110 00111100 0 135668999999999999999
Q ss_pred cCCHHHhhC
Q 011138 411 RCTALEACA 419 (492)
Q Consensus 411 R~t~~e~l~ 419 (492)
||+++++..
T Consensus 211 rPs~~~i~~ 219 (484)
T KOG1023|consen 211 RPSIEQIRS 219 (484)
T ss_pred CccHHHHHh
Confidence 999998854
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.4e-16 Score=169.44 Aligned_cols=132 Identities=17% Similarity=0.258 Sum_probs=98.5
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEec-c---c--------hhhHHHHHHHHHHcCCCCccccceeeeeccCC
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL-Q---D--------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~-~---~--------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 205 (492)
.|...+.||+|+||+||++.+... .+++|+.. + . .....+|+++++.++|++|+..+.++...
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--- 408 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP--- 408 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC---
Confidence 456788999999999999987443 34444321 1 0 12345799999999999998876655332
Q ss_pred CceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeec
Q 011138 206 DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (492)
Q Consensus 206 ~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG 285 (492)
...++||||++|..+..... ....++.||+.+|.|||+ .||+||||||+|||++ ++ .++|+|||
T Consensus 409 --~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~-~giiHrDlkp~NILl~-~~-~~~liDFG 472 (535)
T PRK09605 409 --EEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHK-AGIVHGDLTTSNFIVR-DD-RLYLIDFG 472 (535)
T ss_pred --CCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHh-CCCccCCCChHHEEEE-CC-cEEEEeCc
Confidence 23579999998764432111 246688999999999997 9999999999999994 44 69999999
Q ss_pred Ccccc
Q 011138 286 SAKML 290 (492)
Q Consensus 286 ~a~~~ 290 (492)
+++..
T Consensus 473 la~~~ 477 (535)
T PRK09605 473 LGKYS 477 (535)
T ss_pred ccccC
Confidence 99753
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.7e-16 Score=144.06 Aligned_cols=131 Identities=22% Similarity=0.223 Sum_probs=91.2
Q ss_pred eeeeccCCceEEEEEEEcCCCCEEEEEEeccchhh-------H---------------------HHHHHHHHHcCCCC--
Q 011138 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRY-------K---------------------NRELQIMRLLNHPN-- 191 (492)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-------~---------------------~~E~~il~~l~h~n-- 191 (492)
.+.||+|+||+||+|.+. +|+.||||++...... . ..|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 457999999999999876 8999999987543211 0 23455555554332
Q ss_pred ccccceeeeeccCCCceEEEEEeeechhhHHH--HhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCc
Q 011138 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYR--VSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQN 269 (492)
Q Consensus 192 Iv~l~~~~~~~~~~~~~~~~lV~E~~~~~l~~--~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~N 269 (492)
+.+.+.+. ..++||||++++... .+.... . ...++.++.+++.++.++|..+||+||||||+|
T Consensus 81 ~~~~~~~~---------~~~lv~e~~~g~~~~~~~l~~~~-----~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~N 145 (187)
T cd05119 81 VPKPIDLN---------RHVLVMEFIGGDGIPAPRLKDVR-----L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYN 145 (187)
T ss_pred CCceEecC---------CCEEEEEEeCCCCccChhhhhhh-----h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhh
Confidence 33332221 247999999983211 011100 0 145778899999999999943799999999999
Q ss_pred eEEcCCCCcEEEeeecCcccc
Q 011138 270 LLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 270 ILl~~~~~~vkL~DFG~a~~~ 290 (492)
|+++ ++ .++|+|||.+...
T Consensus 146 ili~-~~-~~~liDfg~a~~~ 164 (187)
T cd05119 146 ILVD-DG-KVYIIDVPQAVEI 164 (187)
T ss_pred EEEE-CC-cEEEEECcccccc
Confidence 9999 55 7999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=9.3e-16 Score=134.38 Aligned_cols=130 Identities=21% Similarity=0.269 Sum_probs=102.5
Q ss_pred eeeeccCCceEEEEEEEcCCCCEEEEEEeccch--hhHHHHHHHHHHcCC--CCccccceeeeeccCCCceEEEEEeeec
Q 011138 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--RYKNRELQIMRLLNH--PNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (492)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~--~~~~~E~~il~~l~h--~nIv~l~~~~~~~~~~~~~~~~lV~E~~ 217 (492)
.+.||.|.++.||++... +..+++|...... ....+|+.+++.+.| .++++++.++ ......+++|||+
T Consensus 3 ~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~-----~~~~~~~~v~e~~ 75 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTK--DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASG-----ESDGWSYLLMEWI 75 (155)
T ss_pred ceecccccccceEEEEec--CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCCCccEEEEEec
Confidence 467999999999999974 3789999886554 356789999999987 4888887765 2334578999999
Q ss_pred hhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhh--CCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 218 SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV--VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 218 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~--~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
.+..+... +......++.+++.+|.+||.. .+++|+||+|+||+++..+ .++++|||.+..
T Consensus 76 ~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~-~~~l~Df~~~~~ 138 (155)
T cd05120 76 EGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK-ILGIIDWEYAGY 138 (155)
T ss_pred CCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc-EEEEEecccccC
Confidence 87643211 4445667788999999999963 2699999999999999755 799999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.62 E-value=6.2e-15 Score=140.20 Aligned_cols=133 Identities=16% Similarity=0.253 Sum_probs=95.0
Q ss_pred eeec-cCCceEEEEEEEcCCCCEEEEEEeccc-----------------hhhHHHHHHHHHHcCCCCc--cccceeeeec
Q 011138 143 RVVG-TGSFGVVFQAKCLETGDSVAIKKVLQD-----------------KRYKNRELQIMRLLNHPNV--VSLKHCFFST 202 (492)
Q Consensus 143 ~~lG-~G~fg~Vy~~~~~~~g~~vAiK~~~~~-----------------~~~~~~E~~il~~l~h~nI--v~l~~~~~~~ 202 (492)
..|| .||.|+||.+.. .+..++||.+... .....+|+.++..|.|++| ++.+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 788888888875 4788999977321 1123579999999998885 5666553322
Q ss_pred cCCCceEEEEEeeechh--hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEE
Q 011138 203 TEKDELYLNLVLEYISE--TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLK 280 (492)
Q Consensus 203 ~~~~~~~~~lV~E~~~~--~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vk 280 (492)
. ......++|||+++| ++...+. ...++.. .+.||+.+|.+||+ +||+||||||+|||++.++ .++
T Consensus 115 ~-~~~~~~~lV~e~l~G~~~L~~~l~-----~~~l~~~----~~~~i~~~l~~lH~-~GI~HrDlkp~NILv~~~~-~v~ 182 (239)
T PRK01723 115 H-GLFYRADILIERIEGARDLVALLQ-----EAPLSEE----QWQAIGQLIARFHD-AGVYHADLNAHNILLDPDG-KFW 182 (239)
T ss_pred c-CcceeeeEEEEecCCCCCHHHHHh-----cCCCCHH----HHHHHHHHHHHHHH-CCCCCCCCCchhEEEcCCC-CEE
Confidence 1 111123599999986 3443332 1234433 35689999999997 9999999999999999877 799
Q ss_pred EeeecCccc
Q 011138 281 ICDFGSAKM 289 (492)
Q Consensus 281 L~DFG~a~~ 289 (492)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999999875
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.3e-15 Score=162.74 Aligned_cols=269 Identities=25% Similarity=0.295 Sum_probs=188.4
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
.+.+.+.+-+-+|.++.++.+.-..+|...++|...... +...++-.++-.-.+|-++...-.| ....
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~rs 877 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCRS 877 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCCC
Confidence 345777778999999999999887888777777543322 2222343343334456666543322 2233
Q ss_pred EEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 209 ~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
.++||++|++++ +...+. .....+..-++.+...+..+++|||. ..++|||++|.|+|+..++ ..+++|||..
T Consensus 878 P~~L~~~~~~~~~~~Skl~----~~~~~saepaRs~i~~~vqs~e~L~s-~~r~h~~~~p~~~l~~~~g-h~~l~~~~t~ 951 (1205)
T KOG0606|consen 878 PLPLVGHYLNGGDLPSKLH----NSGCLSAEPARSPILERVQSLESLHS-SLRKHRDLKPDSLLIAYDG-HRPLTDFGTL 951 (1205)
T ss_pred CcchhhHHhccCCchhhhh----cCCCcccccccchhHHHHhhhhcccc-chhhcccccccchhhcccC-CcccCccccc
Confidence 478999999763 332211 12345555677788899999999996 6799999999999999888 5899999843
Q ss_pred cccCC------------------------------C--CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh
Q 011138 288 KMLVP------------------------------G--EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL 335 (492)
Q Consensus 288 ~~~~~------------------------------~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~ 335 (492)
....- + .......||+.|.+||...+.. .+..+|+|++|++++|.++
T Consensus 952 ~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~ 1030 (1205)
T KOG0606|consen 952 SKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLT 1030 (1205)
T ss_pred cccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhc
Confidence 22100 0 0112457899999999998766 6889999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHH
Q 011138 336 GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL 415 (492)
Q Consensus 336 G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~ 415 (492)
|.+||........+.+|... ....|. -+...+.++.+++.++|..+|.+|..+.
T Consensus 1031 g~pp~na~tpq~~f~ni~~~-----------------~~~~p~---------g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1031 GIPPFNAETPQQIFENILNR-----------------DIPWPE---------GPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCCCcchhhhhhccccC-----------------CCCCCC---------CccccChhhhhhhhhhhccCchhccCcc
Confidence 99999998887777665441 111111 1235788999999999999999999988
Q ss_pred ---HhhCCCCCCCCCCCCCCCCCCCCCCCC
Q 011138 416 ---EACAHPFFDDLRDPNTCLPNGRPLPTL 442 (492)
Q Consensus 416 ---e~l~Hp~f~~~~~~~~~~~~~~~~~~~ 442 (492)
++-.||||+++....-..-+...+|..
T Consensus 1085 ~~~e~k~~~~~~~~~~~~l~~q~~~~~p~~ 1114 (1205)
T KOG0606|consen 1085 GAAEVKGHPFFQDVDWENLALQKAEFVPQP 1114 (1205)
T ss_pred cccccccCCccCCCCccccccccCccCCCC
Confidence 899999999876644333333344433
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=6.6e-15 Score=150.17 Aligned_cols=247 Identities=26% Similarity=0.296 Sum_probs=187.0
Q ss_pred ceeEeeeecc--CCceEEEEEEE--cCCCCEEEEEEec------cchhhHHHHHHHHHHcC-CCCccccceeeeeccCCC
Q 011138 138 SYMAERVVGT--GSFGVVFQAKC--LETGDSVAIKKVL------QDKRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKD 206 (492)
Q Consensus 138 ~y~~~~~lG~--G~fg~Vy~~~~--~~~g~~vAiK~~~------~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~ 206 (492)
.+.+...+|. |.+|.||.+.+ ..++..+|+|.-. .+.....+|..-.+.++ |+|.++.+..+ .+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~-----e~ 189 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW-----EG 189 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc-----cc
Confidence 3556677999 99999999998 8899999999631 12233346777777775 99999977666 55
Q ss_pred ceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHH----HHHHHHhhCCcccCCCCCCceEEcCCCCcEEEe
Q 011138 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR----ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC 282 (492)
Q Consensus 207 ~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~----aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~ 282 (492)
...+|+-+|+|+..+... .......++...++.++.+... ||.++|. .+++|-|+||+||++..+....+++
T Consensus 190 ~~~lfiqtE~~~~sl~~~---~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs-~~~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 190 SGILFIQTELCGESLQSY---CHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHS-NNIVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred CCcceeeeccccchhHHh---hhcccccCCchhhhhHHhhhhhcccccccccCC-CcccccccchhheecccccceeecC
Confidence 556889999999766543 2334455888889999999999 9999997 9999999999999999884479999
Q ss_pred eecCccccCCCCCCc------cceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHH
Q 011138 283 DFGSAKMLVPGEPNI------SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGE--SGVDQLVEIIK 354 (492)
Q Consensus 283 DFG~a~~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~--~~~~~~~~i~~ 354 (492)
|||+...+.++.... ...|..-|++||+..+ -++...|++++|.++.+..+|..++... +...++..
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~--- 340 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ--- 340 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc---
Confidence 999998776554221 2256778999999854 3799999999999999999987666443 22111111
Q ss_pred HhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCC
Q 011138 355 ILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (492)
Q Consensus 355 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~ 425 (492)
.| ....|....+.++...+..|++.+|..|+++..+++|+++..
T Consensus 341 ---------------~~------------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 341 ---------------GY------------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred ---------------cc------------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 00 011122345667777999999999999999999999999874
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=3.6e-13 Score=127.42 Aligned_cols=242 Identities=19% Similarity=0.199 Sum_probs=159.6
Q ss_pred EEEEEEEcCCCCEEEEEEecc----ch--hhHHHH--HHHHHHcCCCCccccceeeeeccCCCceEEEEEeeech-hhHH
Q 011138 152 VVFQAKCLETGDSVAIKKVLQ----DK--RYKNRE--LQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS-ETVY 222 (492)
Q Consensus 152 ~Vy~~~~~~~g~~vAiK~~~~----~~--~~~~~E--~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E~~~-~~l~ 222 (492)
.||++-+...|.+|..-.+.. +. +...++ ..-|-++.|-|||+++.++.+....+.....++.||++ |.+.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 467777777776655332211 10 111112 23345567999999999876666556677889999998 5666
Q ss_pred HHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhh-CCcccCCCCCCceEEcCCCCcEEEeeecCccccCCC------CC
Q 011138 223 RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV-VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG------EP 295 (492)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~-~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~------~~ 295 (492)
.+++...+....+.....++|+.||+.||.|||+. ..|+|+.+..+-|++..++ -+|+. -+.-....+. ..
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ng-LIkig-~~ap~s~h~s~~~~~~~E 238 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNG-LIKIG-SVAPDSTHPSVNSTREAE 238 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCc-eEEec-ccCccccchhhhhhhHhh
Confidence 67777666677788888999999999999999952 3599999999999999776 56653 2211111110 01
Q ss_pred CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 011138 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPL-FPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEF 374 (492)
Q Consensus 296 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~p-f~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~ 374 (492)
.....+-++|.+||.=. ....+.++|||+||+...+|..|..- -.+.+....-..|...+
T Consensus 239 k~~~~~~~g~~a~~sg~-~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i------------------ 299 (458)
T KOG1266|consen 239 KSVNTSLPGFSAPESGT-TTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVI------------------ 299 (458)
T ss_pred hhccccCCccccCCcCc-ccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhhe------------------
Confidence 11234568899999642 23467789999999999999987633 22222211111111110
Q ss_pred CCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 375 KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
+ ..-...-+++|.+||+-.|..||++.+++.||.+-++..
T Consensus 300 -~-------------~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhs 339 (458)
T KOG1266|consen 300 -I-------------GLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHS 339 (458)
T ss_pred -e-------------eccCccccCcCcccccCCCCCCcchhhhhcCceeeecch
Confidence 0 001122468999999999999999999999999887654
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.2e-13 Score=142.33 Aligned_cols=142 Identities=17% Similarity=0.209 Sum_probs=87.8
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchh--------------------------------------hHH-
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR--------------------------------------YKN- 178 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~--------------------------------------~~~- 178 (492)
.|.. +.||+|++|.||+|+.+.+|+.||||++..... ...
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 3555 679999999999999888899999998853310 011
Q ss_pred -----HHHHHHHHcC----CCCccccceeeeeccCCCceEEEEEeeechhhHHHHhhhhhhcC---CCcCHHHHHHHHHH
Q 011138 179 -----RELQIMRLLN----HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMN---QHVPILYVQLYTYQ 246 (492)
Q Consensus 179 -----~E~~il~~l~----h~nIv~l~~~~~~~~~~~~~~~~lV~E~~~~~l~~~~~~~~~~~---~~~~~~~~~~i~~q 246 (492)
+|...+.++. +.+.+.+-.+|+.-. ..-+|||||+.|.-+.........+ ..+....+..++.|
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~s----t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYC----SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccC----CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 2332222221 333333333332111 1245999999986443222111111 12444445555555
Q ss_pred HHHHHHHHHhhCCcccCCCCCCceEEcCCC---CcEEEeeecCccccCC
Q 011138 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHT---HQLKICDFGSAKMLVP 292 (492)
Q Consensus 247 i~~aL~yLH~~~givHrDlKp~NILl~~~~---~~vkL~DFG~a~~~~~ 292 (492)
|+ . .|++|+|+||.||+++.++ ..++++|||++..+..
T Consensus 276 if-------~-~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 VF-------R-DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HH-------h-CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 54 3 6999999999999998765 2699999999976643
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.7e-12 Score=134.15 Aligned_cols=137 Identities=20% Similarity=0.246 Sum_probs=87.6
Q ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEeccch-hh-------------------------------------------HH
Q 011138 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-RY-------------------------------------------KN 178 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-~~-------------------------------------------~~ 178 (492)
+.||.|++|.||+|+. .+|+.||||+..... .. ..
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5699999999999985 579999999874321 00 11
Q ss_pred HHHHHHHHc----CCCCccccceeeeeccCCCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHH-HHHH
Q 011138 179 RELQIMRLL----NHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR-ALNY 253 (492)
Q Consensus 179 ~E~~il~~l----~h~nIv~l~~~~~~~~~~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~-aL~y 253 (492)
+|...+.++ .|.+-+.+-..|.... ..-+|||||++|..+........ .... ...++.+++. .+..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~----~~~vLvmE~i~G~~L~~~~~~~~--~~~~---~~~ia~~~~~~~l~q 272 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRT----SERVLTMEWIDGIPLSDIAALDE--AGLD---RKALAENLARSFLNQ 272 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhc----CCceEEEEeECCcccccHHHHHh--cCCC---HHHHHHHHHHHHHHH
Confidence 344444444 2333333333332211 12469999999864432221111 1111 2345555555 4678
Q ss_pred HHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 254 LH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
+|. .|++|+|+||.||+++.++ .++|+|||++..+.
T Consensus 273 l~~-~g~~H~D~hPgNilv~~~g-~i~liDfG~~~~l~ 308 (437)
T TIGR01982 273 VLR-DGFFHADLHPGNIFVLKDG-KIIALDFGIVGRLS 308 (437)
T ss_pred HHh-CCceeCCCCcccEEECCCC-cEEEEeCCCeeECC
Confidence 897 8999999999999998887 79999999997653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.6e-12 Score=131.58 Aligned_cols=180 Identities=22% Similarity=0.264 Sum_probs=127.0
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch----hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEe
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
|.+ ...+-++.+..-.|..+.++.+|.|....... ....+-++-|+.++||||+++++.+ +....+|||+
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~-----e~~~~~ylvT 88 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTT-----EEEGTLYLVT 88 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhh-----cccCceEEEe
Confidence 555 34444444433346667888999888775433 2345778889999999999999988 4444699999
Q ss_pred eechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCC
Q 011138 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (492)
Q Consensus 215 E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~ 294 (492)
|-+..--.. ++. +....+...+.||+.||.|||+..+++|++|.-..|+|+..| ..||++|-++.....-.
T Consensus 89 ErV~Pl~~~-lk~-------l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G-eWkLggle~v~~~~~~~ 159 (690)
T KOG1243|consen 89 ERVRPLETV-LKE-------LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG-EWKLGGLELVSKASGFN 159 (690)
T ss_pred eccccHHHH-HHH-------hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC-cEEEeeeEEEeccccCC
Confidence 998742111 111 224567778899999999998558999999999999999998 79999999875442221
Q ss_pred C-CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhC
Q 011138 295 P-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG 336 (492)
Q Consensus 295 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G 336 (492)
. .....---.|..|+.+... .-..|.|-|||++++++.|
T Consensus 160 ~~~~~~~~~~s~~~P~~~~~s---~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 160 APAKSLYLIESFDDPEEIDPS---EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cccccchhhhcccChhhcCcc---ccchhhhhHHHHHHHHhCc
Confidence 1 1111112236777765221 2467999999999999999
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.35 E-value=3.6e-12 Score=114.62 Aligned_cols=123 Identities=16% Similarity=0.212 Sum_probs=90.2
Q ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEeccch---hhHHHHHHHHHHcCCCCcc-ccceeeeeccCCCceEEEEEeeech
Q 011138 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVV-SLKHCFFSTTEKDELYLNLVLEYIS 218 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~---~~~~~E~~il~~l~h~nIv-~l~~~~~~~~~~~~~~~~lV~E~~~ 218 (492)
+.|+.|.++.||++.. .|..|++|...... ...++|+.+++.+.+.+++ +++.+. ... .++||||++
T Consensus 4 ~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~-----~~~--~~lv~e~i~ 74 (170)
T cd05151 4 SPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD-----PET--GVLITEFIE 74 (170)
T ss_pred eecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe-----CCC--CeEEEEecC
Confidence 4689999999999986 47889999875543 3456899999998765544 444332 111 358999999
Q ss_pred hhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCc-----ccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 219 ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGV-----CHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 219 ~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~gi-----vHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
|..+... . .....++.+++.+|..||. .++ +|+|++|.||+++ ++ .++++|||.+.
T Consensus 75 G~~l~~~--------~---~~~~~~~~~l~~~l~~LH~-~~~~~~~~~HgD~~~~Nil~~-~~-~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE--------D---FSDPENLEKIAKLLKKLHS-SPLPDLVPCHNDLLPGNFLLD-DG-RLWLIDWEYAG 135 (170)
T ss_pred CCccccc--------c---ccCHHHHHHHHHHHHHHhC-CCCCCceeecCCCCcCcEEEE-CC-eEEEEeccccc
Confidence 8643211 0 1123456799999999997 775 9999999999999 44 69999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.33 E-value=6e-12 Score=114.85 Aligned_cols=133 Identities=17% Similarity=0.178 Sum_probs=92.8
Q ss_pred eeeccCCceEEEEEEEcC------CCCEEEEEEecc--------------ch------------hh----HHHHHHHHHH
Q 011138 143 RVVGTGSFGVVFQAKCLE------TGDSVAIKKVLQ--------------DK------------RY----KNRELQIMRL 186 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~------~g~~vAiK~~~~--------------~~------------~~----~~~E~~il~~ 186 (492)
..||.|--+.||.|.... .+..+|||+.+. +. .. .++|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 368999999999998643 357899997621 10 01 1269999998
Q ss_pred cCC--CCccccceeeeeccCCCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHH-HhhCCcccC
Q 011138 187 LNH--PNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL-HHVVGVCHR 263 (492)
Q Consensus 187 l~h--~nIv~l~~~~~~~~~~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yL-H~~~givHr 263 (492)
+.. -++.+++++. .-+|||||++++.+.... . ....++...+..+..|++.+|..| |+ .||||+
T Consensus 83 l~~~Gv~vP~pi~~~---------~~~lvME~Ig~~~~~~~~--L-kd~~~~~~~~~~i~~~i~~~l~~l~H~-~glVHG 149 (197)
T cd05146 83 MQKAGIPCPEVVVLK---------KHVLVMSFIGDDQVPAPK--L-KDAKLNDEEMKNAYYQVLSMMKQLYKE-CNLVHA 149 (197)
T ss_pred HHHcCCCCCeEEEec---------CCEEEEEEcCCCCccchh--h-hccccCHHHHHHHHHHHHHHHHHHHHh-CCeecC
Confidence 863 4555665532 145899999864211000 0 012234455667788999999999 86 899999
Q ss_pred CCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 264 DIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 264 DlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
||++.|||++. + .+.|+|||.+...
T Consensus 150 DLs~~NIL~~~-~-~v~iIDF~qav~~ 174 (197)
T cd05146 150 DLSEYNMLWHD-G-KVWFIDVSQSVEP 174 (197)
T ss_pred CCCHHHEEEEC-C-cEEEEECCCceeC
Confidence 99999999974 4 6999999988644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.5e-12 Score=133.11 Aligned_cols=248 Identities=20% Similarity=0.188 Sum_probs=173.4
Q ss_pred ccceeEeeeeccCCceEEEEEEEc-CCCCEEEEEEeccchh------hHHHHHHHHHHcC-CCCccccceeeeeccCCCc
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCL-ETGDSVAIKKVLQDKR------YKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~g~~vAiK~~~~~~~------~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~~ 207 (492)
..+|..+..||.|.|+.|+.+... .++..|++|.+.+... .--.|+-+...+. |.+++.++..+...
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~----- 338 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL----- 338 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc-----
Confidence 346888899999999999988755 6788899997644322 2224666666554 88888877665322
Q ss_pred eEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 208 ~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
...|+=.|||.++...+.. .....+.+...+.+..|++.++.++|+ +.++|+|+||+||++..++...++.|||++
T Consensus 339 r~~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s-~~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHS-KLFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred ccccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccc-hhhhcccccccceeeccchhhhhccccccc
Confidence 2255889999876554332 233456677788899999999999997 899999999999999876447899999998
Q ss_pred cccCCCCCCccceeccCcc-CchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 011138 288 KMLVPGEPNISYICSRYYR-APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (492)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~-aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~ 366 (492)
+.+ .-........-.++ .+|++.....+..+.|++|||..+++.++|.+.-...... ..|..
T Consensus 415 t~~--~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~~i~~------------ 477 (524)
T KOG0601|consen 415 TRL--AFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---LTIRS------------ 477 (524)
T ss_pred ccc--ceecccccccccccccchhhccccccccccccccccccccccccCcccCcccccc---eeeec------------
Confidence 743 11122233334455 3666666667899999999999999999987443222111 11100
Q ss_pred cCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
-..|. ......++..+.+.++..|+..|+.+.++..|.-|...
T Consensus 478 -------~~~p~----------~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~ 520 (524)
T KOG0601|consen 478 -------GDTPN----------LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD 520 (524)
T ss_pred -------ccccC----------CCchHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence 00111 01234678889999999999999999999988877643
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.8e-10 Score=113.32 Aligned_cols=213 Identities=20% Similarity=0.278 Sum_probs=152.3
Q ss_pred ceEEEEEEEcCCCCEEEEEEeccchhh----HHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEeeechh--hHHH
Q 011138 150 FGVVFQAKCLETGDSVAIKKVLQDKRY----KNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE--TVYR 223 (492)
Q Consensus 150 fg~Vy~~~~~~~g~~vAiK~~~~~~~~----~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E~~~~--~l~~ 223 (492)
-.+.|++....+|..|.+|++.-++.. .-.-+++++++.|.|||.+.++|.+.. .++..+++|++|.++ +|++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCchHHH
Confidence 357799999999999999998433221 224688999999999999999987444 566678999999984 5554
Q ss_pred Hhhh-----------hhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 224 VSKH-----------YTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 224 ~~~~-----------~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
.... +...+...++..+|.|+.||..||.++|+ .|+.-+-|.|.+||++.+. +++|...|....+..
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs-sGLAck~L~~~kIlv~G~~-RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS-SGLACKTLDLKKILVTGKM-RIRISGCGIMDVLQE 445 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh-cCceeecccHhHeEeeCcc-eEEEecccceeeecC
Confidence 3221 11224567889999999999999999997 8999999999999999776 799998888766544
Q ss_pred CCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCC-CCCCChHHH-HHHHHHHhCCCCHHHHhhcCCC
Q 011138 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPL-FPGESGVDQ-LVEIIKILGTPTREEIKCMNPN 370 (492)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~p-f~~~~~~~~-~~~i~~~~g~p~~~~~~~~~~~ 370 (492)
+. . |.+.+ -.+-|.=.||.+++.|.||..- +......+. +..|
T Consensus 446 d~-----------~--~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I------------------ 490 (655)
T KOG3741|consen 446 DP-----------T--EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI------------------ 490 (655)
T ss_pred CC-----------C--cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh------------------
Confidence 33 0 11222 2356899999999999999633 111111111 1111
Q ss_pred CcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
...++.+++++|.-+...++++ -++.+++.
T Consensus 491 ------------------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp 520 (655)
T KOG3741|consen 491 ------------------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLP 520 (655)
T ss_pred ------------------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHH
Confidence 1346788888888888888875 45555554
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.3e-11 Score=127.87 Aligned_cols=155 Identities=22% Similarity=0.351 Sum_probs=115.2
Q ss_pred HHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCCC--------Ccc--ceeccCccCchhhcCCC
Q 011138 246 QICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP--------NIS--YICSRYYRAPELIFGAT 315 (492)
Q Consensus 246 qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~~--------~~~--~~gt~~y~aPE~~~~~~ 315 (492)
+++.||.|+|...++||+.|.|++|.++.++ ..||+.|+++....+... ... ..-...|.|||++.+ .
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~-~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANG-DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-T 184 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCc-ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-c
Confidence 3448999999878999999999999999888 799999998765433111 111 122567999999976 4
Q ss_pred CCCcchhhHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCCh
Q 011138 316 EYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPP 394 (492)
Q Consensus 316 ~~~~~~DvwSlGvil~ell-~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 394 (492)
..+.++|++|+||++|.+. .|+..+.+.+.......-....+. + ...+...+++
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~------------------~-------~~~~s~~~p~ 239 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNA------------------G-------AFGYSNNLPS 239 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccc------------------c-------cccccccCcH
Confidence 5789999999999999999 677777665433222211110000 0 0112257899
Q ss_pred hHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 395 EALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 395 ~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
++++=|.++|..|+..||++.+++..|||.+..
T Consensus 240 el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~ 272 (700)
T KOG2137|consen 240 ELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPG 272 (700)
T ss_pred HHHHHHHHHhcCCcccCcchhhhhcccccCCch
Confidence 999999999999999999999999999999754
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.2e-09 Score=96.32 Aligned_cols=139 Identities=17% Similarity=0.242 Sum_probs=94.5
Q ss_pred eeeeccCCceEEEEEEEcCCCCEEEEEEec-c-----------chhhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVL-Q-----------DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~-~-----------~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
...|-+|+-+.|+++.+ .|+.+.||.-. + ......+|+++|.++.--.|.-..-+|.+.. .
T Consensus 12 l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~-----~ 84 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY-----G 84 (229)
T ss_pred ceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC-----C
Confidence 45688999999999987 68888888431 1 1122346999998886434433322332221 2
Q ss_pred EEEEeeechh--hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcE--EEeeec
Q 011138 210 LNLVLEYISE--TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQL--KICDFG 285 (492)
Q Consensus 210 ~~lV~E~~~~--~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~v--kL~DFG 285 (492)
-+|+|||++| .+.+.+.... ...........++.+|=..+.-||. .+|||+||..+||++.+++.++ .|+|||
T Consensus 85 ~~i~ME~~~g~~~vk~~i~~~~--~~~~~d~~~~~~~~~iG~~igklH~-ndiiHGDLTTSNill~~~~~~~~~~lIdfg 161 (229)
T KOG3087|consen 85 GQIYMEFIDGASTVKDFILSTM--EDESEDEGLAELARRIGELIGKLHD-NDIIHGDLTTSNILLRSDGNQITPILIDFG 161 (229)
T ss_pred CeEEEEeccchhHHHHHHHHHc--cCcccchhHHHHHHHHHHHHHHhhh-CCeecccccccceEEecCCCcCceEEEeec
Confidence 4589999998 4444333221 2222223336778889999999997 8999999999999998887655 899999
Q ss_pred Ccccc
Q 011138 286 SAKML 290 (492)
Q Consensus 286 ~a~~~ 290 (492)
++...
T Consensus 162 ls~~s 166 (229)
T KOG3087|consen 162 LSSVS 166 (229)
T ss_pred chhcc
Confidence 98643
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=4.7e-09 Score=103.13 Aligned_cols=256 Identities=16% Similarity=0.193 Sum_probs=158.2
Q ss_pred EeeeeccCCceEEEEEEEcCCCCEEEEEEeccchhhH-HHHHHHHHHc-CCCCccc----cceeeeeccCCCceEEEEEe
Q 011138 141 AERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-NRELQIMRLL-NHPNVVS----LKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 141 ~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~-~~E~~il~~l-~h~nIv~----l~~~~~~~~~~~~~~~~lV~ 214 (492)
.++-||+|+-+.+|-.-. -+..|| |++....-.. .+-+..|... .||-+-. -....+.. .....+.++|
T Consensus 15 ~gr~LgqGgea~ly~l~e--~~d~VA-KIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~--~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE--VRDQVA-KIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGG--RRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecch--hhchhh-eeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCC--CccceeEEec
Confidence 345699999999986532 233344 7775432211 1223333322 3543322 11111111 2223366788
Q ss_pred eechhh--HHHHh--hhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 215 EYISET--VYRVS--KHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 215 E~~~~~--l~~~~--~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
..+.|. ...+. ...+.......+..+...++.|+.+..-||. .|.+-+|+.++|+|+..++ .|.|.|=..-...
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~-~Gh~vGDVn~~~~lVsd~~-~V~LVdsDsfqi~ 167 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE-HGHVVGDVNQNSFLVSDDS-KVVLVDSDSFQIN 167 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh-cCCcccccCccceeeecCc-eEEEEcccceeec
Confidence 888752 22211 1222334556788889999999999999997 8999999999999999887 7999987766555
Q ss_pred CCCCCCccceeccCccCchhhc----CCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 011138 291 VPGEPNISYICSRYYRAPELIF----GATEYTTAIDMWSIGCVLAELLLG-QPLFPGESGVDQLVEIIKILGTPTREEIK 365 (492)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwSlGvil~ell~G-~~pf~~~~~~~~~~~i~~~~g~p~~~~~~ 365 (492)
.++......+|...|.+||.-. ....-+...|.|.|||+++++|.| +.||.|.... .--+.|-+..+.
T Consensus 168 ~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~-------~~ap~p~E~~Ia 240 (637)
T COG4248 168 ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLI-------SDAPNPLETDIA 240 (637)
T ss_pred cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccccc-------CCCCCcchhhhh
Confidence 6666667789999999999753 112246789999999999999986 9999874311 000111111222
Q ss_pred hcCCC----CcccCCCcccCCCcccccCCCCChhHhhhhcccccc--CCCCcCCHH
Q 011138 366 CMNPN----YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQY--SPSLRCTAL 415 (492)
Q Consensus 366 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~--dP~~R~t~~ 415 (492)
...-- -.....|.....+| .-+++++..|..+|++. ++.-|||++
T Consensus 241 ~g~f~ya~~~~~g~~p~P~~~P~-----~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 241 HGRFAYASDQRRGLKPPPRSIPL-----SMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred cceeeechhccCCCCCCCCCCCh-----hhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 11101 11112222233333 35789999999999875 467899865
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.8e-09 Score=94.40 Aligned_cols=127 Identities=17% Similarity=0.274 Sum_probs=83.9
Q ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEe-ccc-----------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 143 RVVGTGSFGVVFQAKCLETGDSVAIKKV-LQD-----------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vAiK~~-~~~-----------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
..+++|+-+.+|.+.+ -|..+.+|.- .+. .....+|+.++..+.--.|...+-+++... ..
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~-----~~ 74 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPD-----NG 74 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCC-----CC
Confidence 3578999999999966 3445666642 111 112246999998886433333222222221 24
Q ss_pred EEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 211 ~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
.|+|||++|.++...... . . ..++..|=.-+.-||. .||||+||.++||++..+ .+.++|||++..
T Consensus 75 ~I~me~I~G~~lkd~l~~---~---~----~~~~r~vG~~vg~lH~-~givHGDLTtsNiIl~~~--~i~~IDfGLg~~ 140 (204)
T COG3642 75 LIVMEYIEGELLKDALEE---A---R----PDLLREVGRLVGKLHK-AGIVHGDLTTSNIILSGG--RIYFIDFGLGEF 140 (204)
T ss_pred EEEEEEeCChhHHHHHHh---c---c----hHHHHHHHHHHHHHHh-cCeecCCCccceEEEeCC--cEEEEECCcccc
Confidence 589999999776522211 1 1 2345566667778997 899999999999999855 499999999974
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.3e-09 Score=100.47 Aligned_cols=140 Identities=16% Similarity=0.187 Sum_probs=94.6
Q ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCC--CccccceeeeeccCCCceEEEEEee
Q 011138 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHP--NVVSLKHCFFSTTEKDELYLNLVLE 215 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~--nIv~l~~~~~~~~~~~~~~~~lV~E 215 (492)
+.|+.|.++.||++... +|+.+++|..... .....+|..+++.+.+. ++.+++.+..... .....++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEEE
Confidence 46899999999999863 3688999987543 23567899999999764 4566655442111 1123579999
Q ss_pred echhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 011138 216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH--------------------------------------- 256 (492)
Q Consensus 216 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~--------------------------------------- 256 (492)
|++|..+..... ...++......++.+++.+|.+||+
T Consensus 81 ~i~G~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 81 RVDGRVLRDRLL----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred EeCCEecCCCCC----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 998763321110 0234555555666666666666663
Q ss_pred ----------------hCCcccCCCCCCceEEcCC-CCcEEEeeecCccc
Q 011138 257 ----------------VVGVCHRDIKPQNLLVNPH-THQLKICDFGSAKM 289 (492)
Q Consensus 257 ----------------~~givHrDlKp~NILl~~~-~~~vkL~DFG~a~~ 289 (492)
...++|+|++|.||+++.+ ...+.|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1347999999999999973 22689999998863
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.98 E-value=2e-09 Score=97.99 Aligned_cols=121 Identities=23% Similarity=0.288 Sum_probs=76.6
Q ss_pred EEEEEEEcCCCCEEEEEEeccc------------------------------hhhHHHHHHHHHHcCCC--Cccccceee
Q 011138 152 VVFQAKCLETGDSVAIKKVLQD------------------------------KRYKNRELQIMRLLNHP--NVVSLKHCF 199 (492)
Q Consensus 152 ~Vy~~~~~~~g~~vAiK~~~~~------------------------------~~~~~~E~~il~~l~h~--nIv~l~~~~ 199 (492)
.||.|.. .+|..+|||+.... ....++|.+.|..+..- ++.+++++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3899885 56789999976321 01124799999999865 566665542
Q ss_pred eeccCCCceEEEEEeeech--hhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHH-HHhhCCcccCCCCCCceEEcCCC
Q 011138 200 FSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY-LHHVVGVCHRDIKPQNLLVNPHT 276 (492)
Q Consensus 200 ~~~~~~~~~~~~lV~E~~~--~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~y-LH~~~givHrDlKp~NILl~~~~ 276 (492)
. -+|||||++ |..+..+.... +.......++.+++..+.. +|+ .||||+||.+.|||++.+
T Consensus 80 -----~----~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~-~givHGDLs~~NIlv~~~- 143 (188)
T PF01163_consen 80 -----R----NVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHK-AGIVHGDLSEYNILVDDG- 143 (188)
T ss_dssp -----T----TEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHC-TTEEESS-STTSEEEETT-
T ss_pred -----C----CEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHh-cCceecCCChhhEEeecc-
Confidence 1 248999999 64333222211 1123355667788885555 576 899999999999999966
Q ss_pred CcEEEeeecCcccc
Q 011138 277 HQLKICDFGSAKML 290 (492)
Q Consensus 277 ~~vkL~DFG~a~~~ 290 (492)
.+.|+|||.+...
T Consensus 144 -~~~iIDf~qav~~ 156 (188)
T PF01163_consen 144 -KVYIIDFGQAVDS 156 (188)
T ss_dssp -CEEE--GTTEEET
T ss_pred -eEEEEecCcceec
Confidence 5999999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.91 E-value=3.5e-08 Score=95.16 Aligned_cols=133 Identities=14% Similarity=0.130 Sum_probs=87.5
Q ss_pred EEEEEEEcCCCCEEEEEEeccch---------------hhHHHHHHHHHHcCCCCcccc--ceeeeeccCCCceEEEEEe
Q 011138 152 VVFQAKCLETGDSVAIKKVLQDK---------------RYKNRELQIMRLLNHPNVVSL--KHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 152 ~Vy~~~~~~~g~~vAiK~~~~~~---------------~~~~~E~~il~~l~h~nIv~l--~~~~~~~~~~~~~~~~lV~ 214 (492)
.|+++.. .|+.|.||...... ....+|...+..|..-+|... +.++..........-+|||
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 3555443 56678888552211 125689998888865454443 3333221111123457999
Q ss_pred eechhh--HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCC------CCcEEEeeecC
Q 011138 215 EYISET--VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH------THQLKICDFGS 286 (492)
Q Consensus 215 E~~~~~--l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~------~~~vkL~DFG~ 286 (492)
|++++. +.+++.... ....+......++.+|+..+.-||+ .||+|+|+++.|||++.+ ...+.|+||+.
T Consensus 115 e~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~-~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r 191 (268)
T PRK15123 115 EDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHA-AGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHR 191 (268)
T ss_pred eeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHH-CcCccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence 999974 444433211 2344556677899999999999997 999999999999999752 23799999998
Q ss_pred ccc
Q 011138 287 AKM 289 (492)
Q Consensus 287 a~~ 289 (492)
+..
T Consensus 192 ~~~ 194 (268)
T PRK15123 192 AQI 194 (268)
T ss_pred ccc
Confidence 853
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=9.8e-09 Score=96.23 Aligned_cols=132 Identities=19% Similarity=0.175 Sum_probs=91.9
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEecc----------c----------------hhhHHHHHHHHHHcCCC-
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ----------D----------------KRYKNRELQIMRLLNHP- 190 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~----------~----------------~~~~~~E~~il~~l~h~- 190 (492)
-+.++..||-|--+.||.|.+. .|.++|||.=.. . ....++|.++|.+|...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 3667889999999999999864 789999995311 0 12235799999999755
Q ss_pred -CccccceeeeeccCCCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCc
Q 011138 191 -NVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQN 269 (492)
Q Consensus 191 -nIv~l~~~~~~~~~~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~N 269 (492)
.+.+.+++ +.-++|||+++|-.+.-.. +.......++..|+.-+.-+-. .||||+|+.+-|
T Consensus 171 ~~VP~P~~~---------nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~-~GiVHGDlSefN 232 (304)
T COG0478 171 VKVPKPIAW---------NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYR-RGIVHGDLSEFN 232 (304)
T ss_pred CCCCCcccc---------ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHH-cCccccCCchhe
Confidence 66666443 2356999999985433111 1122233344444444444444 799999999999
Q ss_pred eEEcCCCCcEEEeeecCccc
Q 011138 270 LLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 270 ILl~~~~~~vkL~DFG~a~~ 289 (492)
|+++.++ .+.++||--+..
T Consensus 233 IlV~~dg-~~~vIDwPQ~v~ 251 (304)
T COG0478 233 ILVTEDG-DIVVIDWPQAVP 251 (304)
T ss_pred EEEecCC-CEEEEeCccccc
Confidence 9999998 699999987653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.6e-09 Score=111.35 Aligned_cols=248 Identities=19% Similarity=0.136 Sum_probs=167.2
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchhhHHHHHHHHHHcCCCC-ccccceeeeeccCCCceEEEEEeee
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPN-VVSLKHCFFSTTEKDELYLNLVLEY 216 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~E~~il~~l~h~n-Iv~l~~~~~~~~~~~~~~~~lV~E~ 216 (492)
.|...+-+++|+++.+++.+...+...+ .+.+... ....-++++|.+++||| .+..++-+ +.+.+..++|++
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-l~~rl~~eLLdK~n~P~~~v~~~~d~-----~~E~~~~i~~~i 315 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-LSRRLAIELLDKVNNPNPVVRYLEDY-----DGEDYLWIPMRI 315 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-hhhHHHHHHHHHccCCCCcccccccC-----Ccccccchhhhh
Confidence 3566677999999999999876655444 6766554 44456899999999999 55444433 566788999999
Q ss_pred chhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCCCC
Q 011138 217 ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN 296 (492)
Q Consensus 217 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~~~ 296 (492)
++++-... .........+.......+.+.-+++++|||+ .-=+||| ||+..+. ..|..||+....+......
T Consensus 316 ~s~~rs~~-~~~~~se~~~~~~~~~~~~r~et~~l~~l~~-~~~~~~d----~~l~s~~--~~~~~~~~v~~~L~~~~~~ 387 (829)
T KOG0576|consen 316 CSTGRSSA-LEMTVSEIALEQYQFAYPLRKETRPLAELHS-SYKVHRD----NILGSEE--EVKLLDFAVPPQLTRTMKP 387 (829)
T ss_pred hcCCcccc-ccCChhhHhhhhhhhhhhhhhhccccccccc-ccccCcc----ccccccc--ccccccccCCcccCccccc
Confidence 98651000 0000011112223344455666789999997 4458998 8888754 5899999999877666566
Q ss_pred ccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCC
Q 011138 297 ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKF 376 (492)
Q Consensus 297 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 376 (492)
.+..+|+.++|||++.+.. +....|+|++|+--.+|.-|-+|-...- ...... . .....
T Consensus 388 ~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr~~P~----------------~~~~~~-g---~~p~s 446 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPRSSPP----------------AVLPMI-G---NGPNS 446 (829)
T ss_pred ccCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCCCCCc----------------cccCCC-C---CCCCc
Confidence 7889999999999986554 8889999999988778888877764411 000000 0 00001
Q ss_pred CcccC-CCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 377 PQIKA-HPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 377 ~~~~~-~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
+.+.. ..|...++ .++...|+..-|..|+....+|-|.+|....-
T Consensus 447 ~~L~~~~aw~~~~~-------~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl 492 (829)
T KOG0576|consen 447 PMLTDKSAWSPVFH-------RDFPAPCLNGLPPTPKVHMGACFSKVFNGCPL 492 (829)
T ss_pred cccchhhhcCcccc-------cCCcccccCCCCCCCcchhhHHHHHHhccCcc
Confidence 11111 22322221 26889999999999999999999999987654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.56 E-value=8.8e-07 Score=82.40 Aligned_cols=108 Identities=16% Similarity=0.257 Sum_probs=75.1
Q ss_pred HHHHHHHHHHcCCCCc--cccceeeeeccCCCceEEEEEeeechhh--HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHH
Q 011138 177 KNRELQIMRLLNHPNV--VSLKHCFFSTTEKDELYLNLVLEYISET--VYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252 (492)
Q Consensus 177 ~~~E~~il~~l~h~nI--v~l~~~~~~~~~~~~~~~~lV~E~~~~~--l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~ 252 (492)
..+|...+..|..-.| ++.+.+...... .....+||+|++++. +...+... ...+......++.+++..+.
T Consensus 58 a~~E~~~~~~L~~~Gi~tP~pva~~~~r~~-~~~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 58 AKREWRNLQRLREAGIPTPEPVAYGERRKG-GGYRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARLIA 132 (206)
T ss_pred HHHHHHHHHHHHHcCCCCCcEEEEEEEcCC-CceeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHHHH
Confidence 4578888877764443 344444333221 224467999999873 44433321 11455667788999999999
Q ss_pred HHHhhCCcccCCCCCCceEEcCCC--CcEEEeeecCcccc
Q 011138 253 YLHHVVGVCHRDIKPQNLLVNPHT--HQLKICDFGSAKML 290 (492)
Q Consensus 253 yLH~~~givHrDlKp~NILl~~~~--~~vkL~DFG~a~~~ 290 (492)
-||. .||+|+|+++.|||++.+. ..+.|+||+.++..
T Consensus 133 ~lH~-~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHD-AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHH-CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9997 9999999999999998764 35899999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.52 E-value=3.1e-06 Score=77.74 Aligned_cols=139 Identities=13% Similarity=0.086 Sum_probs=94.0
Q ss_pred eccCCceEEEEEEEcCCCCEEEEEEecc----------chhhHHHHHHHHHHcCCCC--ccccceeeeeccCCCceEEEE
Q 011138 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQ----------DKRYKNRELQIMRLLNHPN--VVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 145 lG~G~fg~Vy~~~~~~~g~~vAiK~~~~----------~~~~~~~E~~il~~l~h~n--Iv~l~~~~~~~~~~~~~~~~l 212 (492)
-|+||.+-|+.... .|+.+-+|.-.. ....+.+|...+..|..-+ ++++. ++-.........-+|
T Consensus 26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 46788888988654 345688886531 2344568999998886433 44443 221112223444679
Q ss_pred Eeeechh--hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCC-cEEEeeecCccc
Q 011138 213 VLEYISE--TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH-QLKICDFGSAKM 289 (492)
Q Consensus 213 V~E~~~~--~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~-~vkL~DFG~a~~ 289 (492)
|+|-++| +|...+... .-...+......++.+|+..+.-||+ .|+.|+|+-+.|||++.++. .++++||--++.
T Consensus 103 VTe~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~-~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 103 VTEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHS-VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9998884 444433221 12244566667889999999999997 99999999999999986552 499999987653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=3.1e-07 Score=95.92 Aligned_cols=134 Identities=22% Similarity=0.268 Sum_probs=82.2
Q ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEeccch--------------------------------------------hhHH
Q 011138 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--------------------------------------------RYKN 178 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~--------------------------------------------~~~~ 178 (492)
.-|+.++-|.||+|+.+ +|+.||||+...+- -...
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 45899999999999954 59999999863221 0012
Q ss_pred HHHHHHHHcC----CCCccccceeeeeccCCCceEEEEEeeechhhHHHHhhhhhhcCCCcC-----HHHHHHHHHHHHH
Q 011138 179 RELQIMRLLN----HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVP-----ILYVQLYTYQICR 249 (492)
Q Consensus 179 ~E~~il~~l~----h~nIv~l~~~~~~~~~~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~-----~~~~~~i~~qi~~ 249 (492)
+|..-+.+++ ...-+++=.+|+.-.. .-.|+|||+.|--......... ..++ ...+..++.|++.
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~----~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~ia~~~~~~f~~q~~~ 283 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTT----RRVLTMEWIDGIKISDIAALKS--AGIDRKELAELLVRAFLRQLLR 283 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccC----CcEEEEEeeCCEecccHHHHHh--cCCCHHHHHHHHHHHHHHHHHh
Confidence 4555555543 2222233334432221 1358999999843322221121 2233 2223333333332
Q ss_pred HHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 250 aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
.|+.|.|.+|.||+++.++ .+.+.|||+...+.+
T Consensus 284 --------dgffHaDpHpGNi~v~~~g-~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 --------DGFFHADPHPGNILVRSDG-RIVLLDFGIVGRLDP 317 (517)
T ss_pred --------cCccccCCCccceEEecCC-cEEEEcCcceecCCH
Confidence 5999999999999999998 799999999876543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.47 E-value=3.4e-06 Score=77.75 Aligned_cols=135 Identities=18% Similarity=0.228 Sum_probs=82.6
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchhh-------------HHHHHHHHHHcCCCCccccceeeeecc-
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRY-------------KNRELQIMRLLNHPNVVSLKHCFFSTT- 203 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-------------~~~E~~il~~l~h~nIv~l~~~~~~~~- 203 (492)
.|.+.+++-......|.+.. -+|+.+.+|........ ..+++..+..+....+..+-+.|....
T Consensus 32 ~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ek 109 (229)
T PF06176_consen 32 NYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEK 109 (229)
T ss_pred CceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeee
Confidence 57788888877777666654 37788999976432211 123444444443222222222221111
Q ss_pred --CCCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEE
Q 011138 204 --EKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKI 281 (492)
Q Consensus 204 --~~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL 281 (492)
..-....+|||||++|.-+.... .+++ .+...|..++.-||+ .|+.|+|..|.|++++.++ +++
T Consensus 110 k~~~~~~~~~ll~EYIeG~~l~d~~-------~i~e----~~~~ki~~~ikqlH~-~G~~HGD~hpgNFlv~~~~--i~i 175 (229)
T PF06176_consen 110 KIFRYTSSYVLLMEYIEGVELNDIE-------DIDE----DLAEKIVEAIKQLHK-HGFYHGDPHPGNFLVSNNG--IRI 175 (229)
T ss_pred eeccceeEEEEEEEEecCeecccch-------hcCH----HHHHHHHHHHHHHHH-cCCccCCCCcCcEEEECCc--EEE
Confidence 11122356899999985332111 1222 234567788999997 8999999999999999654 999
Q ss_pred eeecCcc
Q 011138 282 CDFGSAK 288 (492)
Q Consensus 282 ~DFG~a~ 288 (492)
+||+..+
T Consensus 176 ID~~~k~ 182 (229)
T PF06176_consen 176 IDTQGKR 182 (229)
T ss_pred EECcccc
Confidence 9998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.9e-06 Score=80.30 Aligned_cols=132 Identities=18% Similarity=0.176 Sum_probs=89.8
Q ss_pred eeccCCceEEEEEEEcCCCCEEEEEEeccchhh----------------------------HHHHHHHHHHcC--CCCcc
Q 011138 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRY----------------------------KNRELQIMRLLN--HPNVV 193 (492)
Q Consensus 144 ~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~----------------------------~~~E~~il~~l~--h~nIv 193 (492)
.|.+|--+.||+|.. .++..+|+|++...... .++|..-|+++. +=.+.
T Consensus 55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 688899999999974 67899999987432111 125777777774 34455
Q ss_pred ccceeeeeccCCCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEc
Q 011138 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN 273 (492)
Q Consensus 194 ~l~~~~~~~~~~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~ 273 (492)
+-+.++ . -.|||||++....- .=....-.+...++..+..+++..+.-|-...|+||+||..-|||+.
T Consensus 134 ~Pi~~~-----~----nVLvMEfIg~~g~p---AP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~ 201 (268)
T COG1718 134 EPIAFR-----N----NVLVMEFIGDDGLP---APRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH 201 (268)
T ss_pred Cceeec-----C----CeEEEEeccCCCCC---CCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE
Confidence 555544 1 35899999864111 00000112223357777788888888776437999999999999999
Q ss_pred CCCCcEEEeeecCcccc
Q 011138 274 PHTHQLKICDFGSAKML 290 (492)
Q Consensus 274 ~~~~~vkL~DFG~a~~~ 290 (492)
++ .+.|+|||-|...
T Consensus 202 -~~-~p~iID~~QaV~~ 216 (268)
T COG1718 202 -DG-EPYIIDVSQAVTI 216 (268)
T ss_pred -CC-eEEEEECcccccc
Confidence 44 6999999988654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.6e-06 Score=95.49 Aligned_cols=205 Identities=20% Similarity=0.277 Sum_probs=131.5
Q ss_pred HHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHH
Q 011138 177 KNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255 (492)
Q Consensus 177 ~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH 255 (492)
.+-|...+..+.|+|++.++.+-+.....+ ..+.+..++|... +...+ ..-..++...++.+..+++.||.|+|
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~----q~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLL----QSVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHH----hhccccCHHHHHHHHHHHhhhHHHHH
Confidence 345777788889999999887664433222 1222334555532 22222 22356788889999999999999999
Q ss_pred hhCCcccCCCCCC---ceEEcCCCCcEEEe--eecCccccCCCCCCccceeccCccCchhhcCCCCCCc--chhhHHHHH
Q 011138 256 HVVGVCHRDIKPQ---NLLVNPHTHQLKIC--DFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTT--AIDMWSIGC 328 (492)
Q Consensus 256 ~~~givHrDlKp~---NILl~~~~~~vkL~--DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~~DvwSlGv 328 (492)
+ ....|.-|... +..++.++ .+.++ ||+..+.............+..+.++|...... +.. ..|+|.+|.
T Consensus 304 ~-~~l~~v~L~~s~~~~~~~~~e~-~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~-~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 304 S-LSLEHVVLSASSSKESTVDGEG-VVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENT-AKKSRLTDLWCLGL 380 (1351)
T ss_pred H-hccceeEEecccccccccCccc-eeecchhhhcccccCCCcccchhhcCcccccccccccccc-chhhhhhHHHHHHH
Confidence 7 54433333332 22223333 45565 888887776655555666777888999875432 333 469999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCC
Q 011138 329 VLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSP 408 (492)
Q Consensus 329 il~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP 408 (492)
.+..+..|..+-... ..+... ++........+++.+|+.-++
T Consensus 381 l~~~~~~~~~i~~~~------~~~~~~--------------------------------l~~~~~~~~~d~~~~~~~~~~ 422 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKS------AVPVSL--------------------------------LDVLSTSELLDALPKCLDEDS 422 (1351)
T ss_pred HHhhhhhcCcccccc------cchhhh--------------------------------hccccchhhhhhhhhhcchhh
Confidence 999999876332110 000000 000111267899999999999
Q ss_pred CCcCCHHHhhCCCCCCCCC
Q 011138 409 SLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 409 ~~R~t~~e~l~Hp~f~~~~ 427 (492)
++|+++.+++.|+|.+--.
T Consensus 423 ~~Rl~~~~ll~~~f~~~~~ 441 (1351)
T KOG1035|consen 423 EERLSALELLTHPFLRFPT 441 (1351)
T ss_pred hhccchhhhhhchhccccc
Confidence 9999999999999987543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.32 E-value=6.1e-06 Score=77.70 Aligned_cols=75 Identities=19% Similarity=0.170 Sum_probs=50.7
Q ss_pred eeeeccCCceEEEEEEEcCCCCEEEEEEeccc--hhhHHHHHHHHHHcCCCC--ccccceeeeeccCCCceEEEEEeeec
Q 011138 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPN--VVSLKHCFFSTTEKDELYLNLVLEYI 217 (492)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~--~~~~~~E~~il~~l~h~n--Iv~l~~~~~~~~~~~~~~~~lV~E~~ 217 (492)
.+.|+.|..+.||++.... ..+++|..... .....+|..+++.+.... +.+++.+... .......+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~--~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTS--DEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEE--TEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeeccc--ccccccceEEEEEe
Confidence 3568999999999998643 58999987655 345568999998886433 4566553312 12233478999999
Q ss_pred hhh
Q 011138 218 SET 220 (492)
Q Consensus 218 ~~~ 220 (492)
+|.
T Consensus 78 ~g~ 80 (239)
T PF01636_consen 78 PGR 80 (239)
T ss_dssp SSE
T ss_pred ccc
Confidence 864
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.25 E-value=4.9e-06 Score=86.74 Aligned_cols=139 Identities=16% Similarity=0.211 Sum_probs=80.3
Q ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEeccchhh-----------------------------------------HHHHH
Q 011138 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRY-----------------------------------------KNREL 181 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-----------------------------------------~~~E~ 181 (492)
+-||..+.|.||+|+.+ +|+.||||+-+.+-+. +.+|.
T Consensus 167 ~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 56999999999999855 5999999975322100 01233
Q ss_pred HH----HHHcCCCC---ccccceeeeeccCCCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHH
Q 011138 182 QI----MRLLNHPN---VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254 (492)
Q Consensus 182 ~i----l~~l~h~n---Iv~l~~~~~~~~~~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yL 254 (492)
+- .+.+.|-+ -|.+=.+|+.... .-.|+||||+|.-.+.+..... ..++...+...+.+...-+ -+
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st----~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~i~~~l~~~~~~q-If 318 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLST----KRVLTMEYVDGIKINDLDAIDK--RGISPHDILNKLVEAYLEQ-IF 318 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCc----ceEEEEEecCCccCCCHHHHHH--cCCCHHHHHHHHHHHHHHH-HH
Confidence 32 33344555 1222233322211 2459999999843332222222 2344443332222221111 11
Q ss_pred HhhCCcccCCCCCCceEEcC---CCCcEEEeeecCccccC
Q 011138 255 HHVVGVCHRDIKPQNLLVNP---HTHQLKICDFGSAKMLV 291 (492)
Q Consensus 255 H~~~givHrDlKp~NILl~~---~~~~vkL~DFG~a~~~~ 291 (492)
+ .|++|+|=.|.||++++ .+..+.+-|||+...+.
T Consensus 319 ~--~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 319 K--TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred h--cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 2 59999999999999984 34589999999987653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.15 E-value=2.4e-05 Score=73.82 Aligned_cols=69 Identities=19% Similarity=0.155 Sum_probs=46.8
Q ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEeccc--hhhHHHHHHHHHHcCCCCc--cccceeeeeccCCCceEEEEEeeech
Q 011138 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNV--VSLKHCFFSTTEKDELYLNLVLEYIS 218 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~--~~~~~~E~~il~~l~h~nI--v~l~~~~~~~~~~~~~~~~lV~E~~~ 218 (492)
..||+|..+.||+. .|..+++|..... .....+|.++++.+..-.+ .+.+++. .+.....+|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeeeeecC
Confidence 35899999999984 2556778876542 2345789999998864433 4554443 22333678999998
Q ss_pred hh
Q 011138 219 ET 220 (492)
Q Consensus 219 ~~ 220 (492)
|.
T Consensus 78 G~ 79 (226)
T TIGR02172 78 GK 79 (226)
T ss_pred Cc
Confidence 84
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.02 E-value=6.9e-05 Score=84.12 Aligned_cols=77 Identities=18% Similarity=0.207 Sum_probs=50.5
Q ss_pred eeeeccCCceEEEEEEEcCCC--CEEEEEEecc-----chhhHHHHHHHHHHcC-CCCc--cccceeeeeccCCCceEEE
Q 011138 142 ERVVGTGSFGVVFQAKCLETG--DSVAIKKVLQ-----DKRYKNRELQIMRLLN-HPNV--VSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g--~~vAiK~~~~-----~~~~~~~E~~il~~l~-h~nI--v~l~~~~~~~~~~~~~~~~ 211 (492)
.+.|+.|.++.+|+......+ ..+++|+... ......+|..+|+.+. |.+| .+++.++... ......|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~--~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA--SVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC--CcCCCce
Confidence 356899999999998764332 3677776532 2345678999999996 6665 5555444211 1122357
Q ss_pred EEeeechhh
Q 011138 212 LVLEYISET 220 (492)
Q Consensus 212 lV~E~~~~~ 220 (492)
+||||++|.
T Consensus 121 lVME~v~G~ 129 (822)
T PLN02876 121 YIMEYLEGR 129 (822)
T ss_pred EEEEecCCc
Confidence 999999875
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.02 E-value=4.4e-05 Score=69.63 Aligned_cols=126 Identities=24% Similarity=0.308 Sum_probs=87.8
Q ss_pred cceeEeeeeccCCc-eEEEEEEEcCCCCEEEEEEecc---------------ch----------hhHHHHHHHHHHc---
Q 011138 137 ISYMAERVVGTGSF-GVVFQAKCLETGDSVAIKKVLQ---------------DK----------RYKNRELQIMRLL--- 187 (492)
Q Consensus 137 ~~y~~~~~lG~G~f-g~Vy~~~~~~~g~~vAiK~~~~---------------~~----------~~~~~E~~il~~l--- 187 (492)
.+++..+.||.|.- |.||+++. .|..||+|.+.. .. .-+..|.+..-+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 35888899999999 99999986 788999998311 00 1123466655444
Q ss_pred CCCCc--cccceeeeeccC-------------CCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHH
Q 011138 188 NHPNV--VSLKHCFFSTTE-------------KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252 (492)
Q Consensus 188 ~h~nI--v~l~~~~~~~~~-------------~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~ 252 (492)
.+.++ |++++++....+ .......||.||+.... .+. ..-+.+|++-|.
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~ 178 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLK 178 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHH
Confidence 56677 899998865521 11223468888877542 111 122458889999
Q ss_pred HHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 253 yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
.+|. .||+-+|+|+.|.. + -||+|||.+
T Consensus 179 ~~~k-~gI~~~Dv~~~ny~---~---G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHK-LGIVPRDVKPRNYR---G---GKLVDFSSS 206 (207)
T ss_pred HHHH-CCeeeccCcccccc---C---CEEEecccC
Confidence 9997 89999999999985 3 389999964
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.99 E-value=4e-05 Score=67.79 Aligned_cols=126 Identities=23% Similarity=0.308 Sum_probs=82.4
Q ss_pred eEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc--hhhHHHHHHHHHHcCCCCcc-ccceeeeeccCCCceEEEEEeee
Q 011138 140 MAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVV-SLKHCFFSTTEKDELYLNLVLEY 216 (492)
Q Consensus 140 ~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~--~~~~~~E~~il~~l~h~nIv-~l~~~~~~~~~~~~~~~~lV~E~ 216 (492)
...+.||+|.+|.||+|.+ .|..+|+|+-..+ ...++.|+++|..+.-.++- ++|.+- + .++.|||
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg-----~----~~i~me~ 93 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYG-----E----DFIRMEY 93 (201)
T ss_pred hhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEec-----h----hhhhhhh
Confidence 3457899999999999987 5779999977554 35567899999998865553 333221 1 2356999
Q ss_pred chhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCC-C-ceEEcCCCCcEEEeeecCccc
Q 011138 217 ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKP-Q-NLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 217 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp-~-NILl~~~~~~vkL~DFG~a~~ 289 (492)
+.|--+..... . .. +.-+..++..---|-. .||-|..|.- . ||+++ ++ .+.|+||..|+.
T Consensus 94 i~G~~L~~~~~--~----~~----rk~l~~vlE~a~~LD~-~GI~H~El~~~~k~vlv~-~~-~~~iIDFd~At~ 155 (201)
T COG2112 94 IDGRPLGKLEI--G----GD----RKHLLRVLEKAYKLDR-LGIEHGELSRPWKNVLVN-DR-DVYIIDFDSATF 155 (201)
T ss_pred hcCcchhhhhh--c----cc----HHHHHHHHHHHHHHHH-hccchhhhcCCceeEEec-CC-cEEEEEccchhh
Confidence 99843321111 0 01 1223355555444444 7999998863 3 56665 44 699999999974
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.0001 Score=70.38 Aligned_cols=66 Identities=15% Similarity=0.045 Sum_probs=41.7
Q ss_pred CceEEEEEEEcCCCCEEEEEEeccc-hhhHHHHHHHHHHcC-CCCccccceeeeeccCCCceEEEEEeeechhhH
Q 011138 149 SFGVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNLVLEYISETV 221 (492)
Q Consensus 149 ~fg~Vy~~~~~~~g~~vAiK~~~~~-~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~~~~~~lV~E~~~~~l 221 (492)
.-..||+... .+..+.+|+.... .....+|+.+++.+. +--+.+++++.. ....-++|||+++|..
T Consensus 11 ~~~~v~~~~~--~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~~~lv~e~i~G~~ 78 (244)
T cd05150 11 SGATVYRLDG--KNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGS-----DDGRAWLLTSAVPGVP 78 (244)
T ss_pred CcCeEEEEcC--CCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEe-----cCCccEEEEEeeCCcc
Confidence 3378898864 3467888876432 134567999998885 333445555442 1123568999998753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00066 Score=62.38 Aligned_cols=131 Identities=20% Similarity=0.307 Sum_probs=83.0
Q ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEeccch--------------------hhHHHHHHHHHHcC------CCCccccc
Q 011138 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--------------------RYKNRELQIMRLLN------HPNVVSLK 196 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~--------------------~~~~~E~~il~~l~------h~nIv~l~ 196 (492)
..||+|+.-.||.-- ......||+..... ....+|+.-...+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 469999999998643 44557889876554 44456777777666 78899999
Q ss_pred eeeeeccCCCceEEEEEeeech---hhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEc
Q 011138 197 HCFFSTTEKDELYLNLVLEYIS---ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN 273 (492)
Q Consensus 197 ~~~~~~~~~~~~~~~lV~E~~~---~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~ 273 (492)
++..+.. -..+|+|.+. |..-..+..+.. ...++. . +...+-.-..||-+ .+|+.+||+|.||++.
T Consensus 84 G~veT~~-----G~Glv~e~I~d~dG~~s~TL~~~l~-~~~~~~-~---~~~~L~~f~~~l~~-~~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNL-----GLGLVVELIRDADGNISPTLEDYLK-EGGLTE-E---LRQALDEFKRYLLD-HHIVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCC-----ceEEEEEEEECCCCCcCccHHHHHH-cCCccH-H---HHHHHHHHHHHHHH-cCCeecCCCcccEEEE
Confidence 9874433 2667888764 221111112221 233444 2 23344455567776 8999999999999995
Q ss_pred CCC--C-cEEEee-ecCc
Q 011138 274 PHT--H-QLKICD-FGSA 287 (492)
Q Consensus 274 ~~~--~-~vkL~D-FG~a 287 (492)
... . .+.|+| ||..
T Consensus 153 ~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred ecCCCceEEEEEeCCCCc
Confidence 432 2 467777 5543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.0004 Score=65.87 Aligned_cols=30 Identities=33% Similarity=0.421 Sum_probs=24.9
Q ss_pred CCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 258 ~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
.+++|+|+.|.|||++.++ ..-|+||+.+.
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~-i~giIDw~~a~ 193 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGR-LSAVIDFGCLG 193 (235)
T ss_pred ceEEeCCCCCCcEEEECCC-EEEEEeCcccC
Confidence 3589999999999998554 45799999875
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00092 Score=68.07 Aligned_cols=70 Identities=24% Similarity=0.320 Sum_probs=47.0
Q ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEecc-----------chhhHHHHHHHHHHcC---CCCccccceeeeeccCCCce
Q 011138 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-----------DKRYKNRELQIMRLLN---HPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~-----------~~~~~~~E~~il~~l~---h~nIv~l~~~~~~~~~~~~~ 208 (492)
+.||.|.+..||++.+...++.|.||.-.. .......|.+.|+.+. -.++++++++- . .
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D-----~--~ 104 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD-----E--E 104 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC-----C--C
Confidence 569999999999999754335899997421 1122346888888763 34577776642 2 1
Q ss_pred EEEEEeeechh
Q 011138 209 YLNLVLEYISE 219 (492)
Q Consensus 209 ~~~lV~E~~~~ 219 (492)
..++||||+++
T Consensus 105 ~~~lVME~L~~ 115 (401)
T PRK09550 105 LAVTVMEDLSD 115 (401)
T ss_pred CCEEEEecCCC
Confidence 24589999874
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.55 E-value=9.8e-05 Score=71.37 Aligned_cols=129 Identities=16% Similarity=0.188 Sum_probs=87.0
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEec----------cch----------------hhHHHHHHHHHHcCC--
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL----------QDK----------------RYKNRELQIMRLLNH-- 189 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~----------~~~----------------~~~~~E~~il~~l~h-- 189 (492)
-|.++..||-|--+.||.+-+ ..|.+.++|.-. ... -...+|...|+.|..
T Consensus 93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 367788899999999999975 568888988421 011 112368999998853
Q ss_pred CCccccceeeeeccCCCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCc
Q 011138 190 PNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQN 269 (492)
Q Consensus 190 ~nIv~l~~~~~~~~~~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~N 269 (492)
=-+.+.+++ ...|+|||++.|--+.-..+ .. .+..+...++.-+.-|-. +|+||+|..--|
T Consensus 172 fpVPkpiD~---------~RH~Vvmelv~g~Pl~~v~~------v~---d~~~ly~~lm~~Iv~la~-~GlIHgDFNEFN 232 (465)
T KOG2268|consen 172 FPVPKPIDH---------NRHCVVMELVDGYPLRQVRH------VE---DPPTLYDDLMGLIVRLAN-HGLIHGDFNEFN 232 (465)
T ss_pred CCCCCcccc---------cceeeHHHhhcccceeeeee------cC---ChHHHHHHHHHHHHHHHH-cCceecccchhe
Confidence 224444443 34678999998743321111 11 122334455555666776 899999999999
Q ss_pred eEEcCCCCcEEEeeecCc
Q 011138 270 LLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 270 ILl~~~~~~vkL~DFG~a 287 (492)
|+|+.++ .++++||--.
T Consensus 233 imv~dd~-~i~vIDFPQm 249 (465)
T KOG2268|consen 233 IMVKDDD-KIVVIDFPQM 249 (465)
T ss_pred eEEecCC-CEEEeechHh
Confidence 9999777 6999999754
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.54 E-value=3.5e-05 Score=87.05 Aligned_cols=216 Identities=14% Similarity=0.003 Sum_probs=137.9
Q ss_pred HHHHHHHHcCCCCccccceeeeeccCCCceEEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhh
Q 011138 179 RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257 (492)
Q Consensus 179 ~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~ 257 (492)
.|...++...|++++..+.-... ......+.+++|+.++ +...+..-......+....+.....+.+.+..-+|+.
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~p---s~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPP---SESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCC---CCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence 35555666789998876543322 2233356899999854 4454443333333344444444444446667776642
Q ss_pred CC----cccCCCCCCceEEcCCCCcEEEeeecCccccCC-CCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHH
Q 011138 258 VG----VCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP-GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAE 332 (492)
Q Consensus 258 ~g----ivHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~e 332 (492)
.+ .+|++||+-|.+|..+. ++|++++|+.++..+ ........+++.|++|++.. .-.++.++|+|..|+.+|+
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny-~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N-~ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNY-NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKN-EIKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred ccCCccchhhhhhhhccceecCC-cccccccccccccCchHhhhhhhhCCHHHHHHHHHH-HHhhhhHHHHHHHHHHHHH
Confidence 22 68999999999999777 799999999994332 23344567899999999874 4447888999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcC
Q 011138 333 LLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC 412 (492)
Q Consensus 333 ll~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~ 412 (492)
..-|.++|- ..+..+.+ +.-.+-.....+ ...|.++-.+...+|-+.-..||
T Consensus 1433 rs~~n~~fi-----~flq~~Lk-----------giidn~tf~sIe------------~l~pgdaNve~~~~Ll~K~~~rp 1484 (2724)
T KOG1826|consen 1433 RSDGNAYFI-----FFLQPALK-----------GIIDNHTFFSIE------------KLKPGDANVEALHRLLWKYMERP 1484 (2724)
T ss_pred HhcccHHHH-----HHHHHHHc-----------Cccccccccccc------------ccCCCcccHHHHHHHHHHhhhcc
Confidence 999987772 22222222 111111222222 12355566666666767778899
Q ss_pred CHHHhhCCCCCCCCC
Q 011138 413 TALEACAHPFFDDLR 427 (492)
Q Consensus 413 t~~e~l~Hp~f~~~~ 427 (492)
.-...+.-+.|...+
T Consensus 1485 ~q~isls~d~~a~~~ 1499 (2724)
T KOG1826|consen 1485 GQYISLSRDHFAVGL 1499 (2724)
T ss_pred hhhhhcccccccccc
Confidence 999998888887544
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0013 Score=62.22 Aligned_cols=68 Identities=22% Similarity=0.327 Sum_probs=43.7
Q ss_pred eeeccCCceEEEEEEEcC-CCCEEEEEEeccch---hhHHHHHHHHHHcCCCC-ccccceeeeeccCCCceEEEEEeeec
Q 011138 143 RVVGTGSFGVVFQAKCLE-TGDSVAIKKVLQDK---RYKNRELQIMRLLNHPN-VVSLKHCFFSTTEKDELYLNLVLEYI 217 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~-~g~~vAiK~~~~~~---~~~~~E~~il~~l~h~n-Iv~l~~~~~~~~~~~~~~~~lV~E~~ 217 (492)
+.|..|-...||++.... .++.|.+|+..... ...++|..+++.+...+ .++++..+ .+ .+||||+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~-----~~----~~l~e~i 74 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF-----QN----GLIYEFI 74 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe-----CC----cEEEEee
Confidence 457788888999987433 35788899764322 22347999999986433 34443322 11 2799998
Q ss_pred hh
Q 011138 218 SE 219 (492)
Q Consensus 218 ~~ 219 (492)
+|
T Consensus 75 ~G 76 (235)
T cd05157 75 PG 76 (235)
T ss_pred CC
Confidence 76
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00045 Score=66.46 Aligned_cols=132 Identities=19% Similarity=0.241 Sum_probs=73.8
Q ss_pred eccCCceEEEEEEEcCCCCEEEEEEeccchh----hHHHHHHHHHHcCCCCc-cccceeeeeccCCCceEEEEEeeechh
Q 011138 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKR----YKNRELQIMRLLNHPNV-VSLKHCFFSTTEKDELYLNLVLEYISE 219 (492)
Q Consensus 145 lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~----~~~~E~~il~~l~h~nI-v~l~~~~~~~~~~~~~~~~lV~E~~~~ 219 (492)
+..|-.+.+|+.. .+|+.+.+|....... ..++|..+++.+....+ .+++... . -++||||++|
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~-----~----~~~v~e~i~G 72 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN-----E----HWLLVEWLEG 72 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe-----C----CEEEEEeccC
Confidence 4567778889876 3567788887543321 34679999999874433 3333322 1 1479999987
Q ss_pred hHHHH------------h---hhhhhc---CCCcCH-HHHHHHHHHH---------HHHHHHHHh-------hCCcccCC
Q 011138 220 TVYRV------------S---KHYTRM---NQHVPI-LYVQLYTYQI---------CRALNYLHH-------VVGVCHRD 264 (492)
Q Consensus 220 ~l~~~------------~---~~~~~~---~~~~~~-~~~~~i~~qi---------~~aL~yLH~-------~~givHrD 264 (492)
..... . ...... ...+.. ..+..+..++ ...+..+-. ...++|+|
T Consensus 73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D 152 (256)
T TIGR02721 73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD 152 (256)
T ss_pred cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence 43221 1 000000 111111 1112222122 111222211 02589999
Q ss_pred CCCCceEEcCCCCcEEEeeecCccc
Q 011138 265 IKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 265 lKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
+.|.||+++.++ +.|+||..|..
T Consensus 153 l~~~Nil~~~~~--~~lIDwE~a~~ 175 (256)
T TIGR02721 153 VHAYNLVVTPQG--LKLIDWEYASD 175 (256)
T ss_pred CCcCcEEEeCCC--CEEEeccccCc
Confidence 999999999765 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.002 Score=63.42 Aligned_cols=75 Identities=8% Similarity=0.030 Sum_probs=50.1
Q ss_pred eeeeccCCceEEEEEEEcCCCCEEEEEEecc--chhhHHHHHHHHHHcCC---CCccccceeeeeccCCCceEEEEEeee
Q 011138 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ--DKRYKNRELQIMRLLNH---PNVVSLKHCFFSTTEKDELYLNLVLEY 216 (492)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~--~~~~~~~E~~il~~l~h---~nIv~l~~~~~~~~~~~~~~~~lV~E~ 216 (492)
.+.||.|..+.||+... .+| .+.+|.... ......+|...|+.|.. -.++++++++.... ....-+||||+
T Consensus 19 ~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~--~~g~~~LVmE~ 94 (297)
T PRK10593 19 VECISEQPYAALWALYD-SQG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQ--SPGPDVLLLER 94 (297)
T ss_pred eeecCCccceeEEEEEc-CCC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCC--cCCCeEEEEec
Confidence 35699999999999863 223 466676543 23577889999999863 35677776552211 12236799999
Q ss_pred chhh
Q 011138 217 ISET 220 (492)
Q Consensus 217 ~~~~ 220 (492)
++|.
T Consensus 95 i~G~ 98 (297)
T PRK10593 95 LRGV 98 (297)
T ss_pred cCCE
Confidence 8863
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0013 Score=64.84 Aligned_cols=136 Identities=19% Similarity=0.261 Sum_probs=91.4
Q ss_pred EeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------h------------------------hhHHHHHHHHHHcCCC
Q 011138 141 AERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------K------------------------RYKNRELQIMRLLNHP 190 (492)
Q Consensus 141 ~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~------------------------~~~~~E~~il~~l~h~ 190 (492)
+..+|..|--+.||.|. ..+|..+|||+++.. . -..++|++-|++|+.-
T Consensus 148 inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 44568889999999997 568999999987321 1 1123588888888754
Q ss_pred CccccceeeeeccCCCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCce
Q 011138 191 NVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270 (492)
Q Consensus 191 nIv~l~~~~~~~~~~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NI 270 (492)
.|.-.--+.. . .-.|||+|++..-+- .-......++...+..+-.|++.-+.-|-+..+.||.||.--|+
T Consensus 227 GIP~PePIlL------k-~hVLVM~FlGrdgw~---aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~ 296 (520)
T KOG2270|consen 227 GIPCPEPILL------K-NHVLVMEFLGRDGWA---APKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNL 296 (520)
T ss_pred CCCCCCceee------e-cceEeeeeccCCCCc---CcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhh
Confidence 4432211111 0 134899999853221 11112344566667777778888887775558999999999999
Q ss_pred EEcCCCCcEEEeeecCccc
Q 011138 271 LVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 271 Ll~~~~~~vkL~DFG~a~~ 289 (492)
|+. +| .+.|+|-+-+..
T Consensus 297 Lyh-dG-~lyiIDVSQSVE 313 (520)
T KOG2270|consen 297 LYH-DG-KLYIIDVSQSVE 313 (520)
T ss_pred eEE-CC-EEEEEEcccccc
Confidence 998 44 699999987753
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.00049 Score=62.86 Aligned_cols=102 Identities=22% Similarity=0.202 Sum_probs=75.1
Q ss_pred HHHHHHHHHcCC-CCccccceeeeeccCCCceEEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHH
Q 011138 178 NRELQIMRLLNH-PNVVSLKHCFFSTTEKDELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255 (492)
Q Consensus 178 ~~E~~il~~l~h-~nIv~l~~~~~~~~~~~~~~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH 255 (492)
..|.-+|+.+.+ +++++++|++ . -++|.||.+.+ ++... .....-...++.....|+.+++..+.+|+
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C-----G----~~~v~E~~~~~~~~~~~-~~l~~~~~~~w~~R~~iA~~lL~~l~~l~ 76 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC-----G----RFYVVEYVGAGSLYGIY-RPLSQFLQSPWEQRAKIALQLLELLEELD 76 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC-----C----CEEEEEeecCccccccc-cccccccccCHHHHHHHHHHHHHHHHHHh
Confidence 358889999986 6999999987 2 24689999853 32110 00011134678889999999999999998
Q ss_pred hh--CCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 256 HV--VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 256 ~~--~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
+. ..+.-.|++|+|+-++.++ .+|++|...+...
T Consensus 77 ~~~~~~~~lcDv~~~nfgv~~~~-~lk~iDld~v~~~ 112 (188)
T PF12260_consen 77 HGPLGFFYLCDVSPDNFGVNDDG-RLKLIDLDDVFVE 112 (188)
T ss_pred cCCCCcEEEeecchHHeEEeCCC-cEEEEechhcchh
Confidence 41 1366799999999999777 7999999977543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.00093 Score=65.65 Aligned_cols=143 Identities=11% Similarity=0.033 Sum_probs=77.2
Q ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEecc-chhhHHHHHHHHHHcCCCC--ccccceeeeecc-CCCceEEEEEeeech
Q 011138 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-DKRYKNRELQIMRLLNHPN--VVSLKHCFFSTT-EKDELYLNLVLEYIS 218 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~-~~~~~~~E~~il~~l~h~n--Iv~l~~~~~~~~-~~~~~~~~lV~E~~~ 218 (492)
+.|..|.-..+|+... ++..+++|+... .......|+.+++.|.+.+ +++++...-... .......++|+++++
T Consensus 20 ~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~ 97 (296)
T cd05153 20 EGISAGIENTNYFVTT--DSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLA 97 (296)
T ss_pred ecccCccccceEEEEe--CCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCC
Confidence 4577787788998764 345688898763 3344567898888885433 444433210000 011123578999997
Q ss_pred hhHHH---------H---hhhhhhcCCCc--------CHHHHH------------HHHHHHHHHHHHHHh------hCCc
Q 011138 219 ETVYR---------V---SKHYTRMNQHV--------PILYVQ------------LYTYQICRALNYLHH------VVGV 260 (492)
Q Consensus 219 ~~l~~---------~---~~~~~~~~~~~--------~~~~~~------------~i~~qi~~aL~yLH~------~~gi 260 (492)
|.... + +.........+ ...... .....+..++.++.. ..++
T Consensus 98 G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l 177 (296)
T cd05153 98 GEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGV 177 (296)
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcC
Confidence 63211 0 00000000000 000000 011112233444432 1479
Q ss_pred ccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 261 CHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 261 vHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
||+|+.|.|||++.++ .+.|+||+.+.
T Consensus 178 ~HgD~~~~Nil~~~~~-~~~iIDfe~a~ 204 (296)
T cd05153 178 IHADLFRDNVLFDGDE-LSGVIDFYFAC 204 (296)
T ss_pred CccCcCcccEEEeCCc-eEEEeehhhhc
Confidence 9999999999999765 56899999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0036 Score=61.92 Aligned_cols=144 Identities=15% Similarity=0.096 Sum_probs=77.3
Q ss_pred eeeeccCCceEEEEEEEcCCCCEEEEEEeccc--hhhHHHHHHHHHHcCCCC--ccccceeeeec-cCCCceEEEEEeee
Q 011138 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPN--VVSLKHCFFST-TEKDELYLNLVLEY 216 (492)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~--~~~~~~E~~il~~l~h~n--Iv~l~~~~~~~-~~~~~~~~~lV~E~ 216 (492)
.+.++.|.-..+|++.. .+| .+.+|+.... ......|.+++..|.... +++++...... ........++|++|
T Consensus 27 i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT-DVG-RYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred ccccCCccccceEEEEe-CCC-cEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 34577777788998863 334 5778876543 344557888888885322 34443311000 00112346789999
Q ss_pred chhhHH---------HH---hhhhhhcCCC----------cCH-HH--HH----------HHHHHHHHHHHHHHh-----
Q 011138 217 ISETVY---------RV---SKHYTRMNQH----------VPI-LY--VQ----------LYTYQICRALNYLHH----- 256 (492)
Q Consensus 217 ~~~~l~---------~~---~~~~~~~~~~----------~~~-~~--~~----------~i~~qi~~aL~yLH~----- 256 (492)
++|... .. +......... .+. .. .. .....+...++++..
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 876211 00 0000000000 000 00 00 001122334555531
Q ss_pred -hCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 257 -VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 257 -~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
..++||+|+.+.||+++.++ .+.|+||+.+.
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~~~-~~~vIDfd~~~ 216 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDGDS-VKGVIDFYFAC 216 (307)
T ss_pred CCCccCCCCCCcCcEEEECCc-eEEEeeccccc
Confidence 26899999999999999776 56899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0072 Score=60.08 Aligned_cols=30 Identities=30% Similarity=0.283 Sum_probs=25.5
Q ss_pred CCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 258 ~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
.|+||+|+.|.|||++.+. ..-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~-~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDR-LSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCc-eEEEEeccccc
Confidence 4899999999999998554 45799999875
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.00084 Score=68.71 Aligned_cols=171 Identities=20% Similarity=0.248 Sum_probs=108.4
Q ss_pred HHHHHHHHcCCCCccccceeeeeccCCCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhC
Q 011138 179 RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258 (492)
Q Consensus 179 ~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~ 258 (492)
-...+++.+.|+|..+++++--... ....+|||++..++.+...... ... .+++ | +
T Consensus 31 gr~~~lktl~~~~l~~yl~~~r~~~----~r~IVV~e~~~~Sled~~~~~~--l~~----------~s~~-~-------~ 86 (725)
T KOG1093|consen 31 GRFQYLKSLQHDNLCQYLDFSRGKH----ERVIVVMEHYTMSLEDILKTGN--LKD----------ESLL-A-------H 86 (725)
T ss_pred hhhHHHHhhcCccceeeEeeecCcc----ceEEEEehhhccchHHHHHhcc--cch----------hhhc-c-------c
Confidence 3577889999999999888652221 2377999999988776544311 100 0111 1 2
Q ss_pred CcccCCCCCCceEEcCCCCcEEEeeecCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCC
Q 011138 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQP 338 (492)
Q Consensus 259 givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~ 338 (492)
|+.|- | .++++| -++.. | |-. ..+++|||++|.++.++..|..
T Consensus 87 ~~~~~-----~--------~~~~td-~~~t~---------------~--~~~------~~pKsdVwsl~~i~~el~L~~~ 129 (725)
T KOG1093|consen 87 GVLHL-----N--------IIYITD-HFLTK---------------Y--PSP------IGPKSDVWSLGFIILELYLGIS 129 (725)
T ss_pred cccee-----h--------hhhccc-ccccc---------------C--CCC------CCcchhhhhHHHHHHHHHHhhH
Confidence 33331 1 244444 11110 0 111 1249999999999999999998
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhh
Q 011138 339 LFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC 418 (492)
Q Consensus 339 pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l 418 (492)
.|......+++..+.+..-.+..-..-.+. ..+.-.++....++..+|+-..|..||...++.
T Consensus 130 l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e-----------------~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~ 192 (725)
T KOG1093|consen 130 LEAELTESEYLEILLKYYTDDQELLSTAME-----------------HLIQLLADKKRLPLLKKCLWLEPIIRPLPMELS 192 (725)
T ss_pred HHHHHHHHHHHHHHHHhccCchhHHHHHHH-----------------HHHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence 888777777777666654333322111100 011123567788999999999999999999999
Q ss_pred CCCCCCCCC
Q 011138 419 AHPFFDDLR 427 (492)
Q Consensus 419 ~Hp~f~~~~ 427 (492)
.|+-|.++.
T Consensus 193 k~~i~~ev~ 201 (725)
T KOG1093|consen 193 KRCSFTEVY 201 (725)
T ss_pred cCccHHHHH
Confidence 999998763
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0099 Score=59.42 Aligned_cols=69 Identities=23% Similarity=0.221 Sum_probs=43.5
Q ss_pred eeccCCceEEEEEEEcCCCCEEEEEEeccc-----------hhhHHHHHHHHHHcC--CC-CccccceeeeeccCCCceE
Q 011138 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----------KRYKNRELQIMRLLN--HP-NVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 144 ~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-----------~~~~~~E~~il~~l~--h~-nIv~l~~~~~~~~~~~~~~ 209 (492)
.||.|....||++.+...++.|.||.-... .....-|...|+... -| .++++|++ |...
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~-------D~e~ 74 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF-------DTEM 74 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE-------cccc
Confidence 579999999999997543468999964211 112235788887664 23 45565543 2222
Q ss_pred EEEEeeechh
Q 011138 210 LNLVLEYISE 219 (492)
Q Consensus 210 ~~lV~E~~~~ 219 (492)
..+|||+++.
T Consensus 75 ~~~vMEdL~~ 84 (370)
T TIGR01767 75 AVTVMEDLSH 84 (370)
T ss_pred ceehHhhCcc
Confidence 4489999853
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.012 Score=59.58 Aligned_cols=71 Identities=21% Similarity=0.239 Sum_probs=45.7
Q ss_pred eeeeccCCceEEEEEEEcCCCCEEEEEEecc----------chhhHHHHHHHHHHcC--CC-CccccceeeeeccCCCce
Q 011138 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ----------DKRYKNRELQIMRLLN--HP-NVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~----------~~~~~~~E~~il~~l~--h~-nIv~l~~~~~~~~~~~~~ 208 (492)
.+.||.|.-..||++.+...++.|.||.-.. ......-|.++|+.+. .| .++++|.+ |..
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~-------D~e 106 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF-------DSV 106 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE-------CcH
Confidence 4578999999999999744467799996421 1122234888888764 33 46666543 222
Q ss_pred EEEEEeeechh
Q 011138 209 YLNLVLEYISE 219 (492)
Q Consensus 209 ~~~lV~E~~~~ 219 (492)
...+|||+++.
T Consensus 107 ~~~~vMEdL~~ 117 (409)
T PRK12396 107 MNCCVMEDLSD 117 (409)
T ss_pred HhhHHHHhCcc
Confidence 24589999853
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.011 Score=59.38 Aligned_cols=31 Identities=29% Similarity=0.668 Sum_probs=26.3
Q ss_pred CcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 259 givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
.++|+|+++.|||++.+...+.|+||..+..
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 6899999999999986434799999998853
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.019 Score=56.65 Aligned_cols=31 Identities=26% Similarity=0.474 Sum_probs=27.6
Q ss_pred CcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 259 givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
.++|+|+.+.||+|+.++ .+-+.||+++..-
T Consensus 199 ~lvHGD~~~gNlii~~~~-~~gVlDwe~~~lG 229 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGR-PTGVLDWELATLG 229 (321)
T ss_pred eeeeCCcccCCEEEeCCC-eeEEEeccccccC
Confidence 589999999999999888 5999999998754
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.02 Score=56.32 Aligned_cols=31 Identities=35% Similarity=0.570 Sum_probs=26.1
Q ss_pred CCcccCCCCCCceEEcCC---CCcEEEeeecCcc
Q 011138 258 VGVCHRDIKPQNLLVNPH---THQLKICDFGSAK 288 (492)
Q Consensus 258 ~givHrDlKp~NILl~~~---~~~vkL~DFG~a~ 288 (492)
.+++|+|+.+.|||++.+ .+.+.|+||..|.
T Consensus 179 ~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 179 VVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred ceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 368999999999999874 2279999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.022 Score=56.98 Aligned_cols=30 Identities=27% Similarity=0.434 Sum_probs=25.6
Q ss_pred cccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 260 VCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 260 ivHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
++|.|+.+.|||++++++.++++||..|..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 799999999999975544799999998853
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.034 Score=54.90 Aligned_cols=29 Identities=28% Similarity=0.602 Sum_probs=25.2
Q ss_pred CCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 258 ~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
.+++|+|+.+.||+++. + .+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~-~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-N-EVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-C-cEEEEECcccc
Confidence 57999999999999986 4 58999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.018 Score=55.97 Aligned_cols=31 Identities=23% Similarity=0.485 Sum_probs=25.6
Q ss_pred CcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 259 givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
.++|+|++|.|||++.++...-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999996453457999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.069 Score=54.47 Aligned_cols=69 Identities=20% Similarity=0.249 Sum_probs=45.1
Q ss_pred eeeeccCCceEEEEEEEcCCCCEEEEEEec-----c------chhhHHHHHHHHHHcC---CCCccccceeeeeccCCCc
Q 011138 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVL-----Q------DKRYKNRELQIMRLLN---HPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~-----~------~~~~~~~E~~il~~l~---h~nIv~l~~~~~~~~~~~~ 207 (492)
.+.||.|.-..||+..+ .+..|.||.-. . +......|...|+.+. ..++++++.+. .+.
T Consensus 37 ~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d-----ed~ 109 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD-----RTM 109 (418)
T ss_pred EEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC-----CCC
Confidence 45789999999999886 34568899653 1 1122234667776654 24677777654 222
Q ss_pred eEEEEEeeechh
Q 011138 208 LYLNLVLEYISE 219 (492)
Q Consensus 208 ~~~~lV~E~~~~ 219 (492)
-++|||++++
T Consensus 110 --~vlvME~L~~ 119 (418)
T PLN02756 110 --ALIGMRYLEP 119 (418)
T ss_pred --CEEEEeecCC
Confidence 4578999966
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.055 Score=53.55 Aligned_cols=31 Identities=13% Similarity=0.186 Sum_probs=27.1
Q ss_pred CCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 258 ~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
.++||+|+.+.|||++.++ .+.++||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~-~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETR-GGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcCCC-CEEEEEhhhccc
Confidence 3799999999999998776 689999998753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.031 Score=55.37 Aligned_cols=75 Identities=16% Similarity=0.274 Sum_probs=57.9
Q ss_pred CCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeee
Q 011138 205 KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (492)
Q Consensus 205 ~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DF 284 (492)
....|+|++|++.++.+... ......++..++.+.+..+.-|...-..=|||+...||||+ +| +|-|+||
T Consensus 296 de~~y~yl~~kdhgt~is~i--------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G-nvtLIDf 365 (488)
T COG5072 296 DETLYLYLHFKDHGTPISII--------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG-NVTLIDF 365 (488)
T ss_pred CCceEEEEEEecCCceeeee--------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC-ceEEEEe
Confidence 45668999999987654321 22345667778888888877777545688999999999999 66 7999999
Q ss_pred cCccc
Q 011138 285 GSAKM 289 (492)
Q Consensus 285 G~a~~ 289 (492)
-+++.
T Consensus 366 klsRl 370 (488)
T COG5072 366 KLSRL 370 (488)
T ss_pred eeeec
Confidence 99984
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.14 E-value=0.12 Score=50.56 Aligned_cols=72 Identities=15% Similarity=0.129 Sum_probs=43.4
Q ss_pred eeeeccCCceEEEEEEEcCCCCEEEEEEeccc-hhhHHHHHHHHHHcC---CCCccccceeeeeccCCCceEEEEEeeec
Q 011138 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRLLN---HPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (492)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-~~~~~~E~~il~~l~---h~nIv~l~~~~~~~~~~~~~~~~lV~E~~ 217 (492)
.+.++.|....+|+.. .+++.+.||+-... ...++.|.+-|+.|. --.+++++.+..... . -+|||||+
T Consensus 22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~---~--~fLlle~l 94 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDD---D--AFLLLEFL 94 (288)
T ss_dssp EEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SS---C--CEEEEE--
T ss_pred eEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecC---C--ceEEEEee
Confidence 3568889999999986 67888999977533 446778999999884 334667766553222 1 36999998
Q ss_pred hhh
Q 011138 218 SET 220 (492)
Q Consensus 218 ~~~ 220 (492)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 643
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.90 E-value=0.38 Score=49.10 Aligned_cols=29 Identities=31% Similarity=0.370 Sum_probs=24.4
Q ss_pred CCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 258 ~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
...+|.||-+.||+.+.+ .+.++||-.|.
T Consensus 227 ~VfCHNDL~~gNIL~~~~--~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFNQ--GIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecCC--CEEEEEecccc
Confidence 467999999999998754 49999998774
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.64 E-value=0.24 Score=45.94 Aligned_cols=86 Identities=16% Similarity=0.215 Sum_probs=57.3
Q ss_pred hHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHH
Q 011138 176 YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255 (492)
Q Consensus 176 ~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH 255 (492)
....+..++.++. .|+++.. .+...+.+|+|+|-.--.. + .-.+. -=+.+|.-.|
T Consensus 104 ~y~nky~v~Armh--GilrL~N-------Dn~~~yGvIlE~Cy~~~i~------------~---~N~i~-agi~~L~~fH 158 (308)
T PF07387_consen 104 LYFNKYRVFARMH--GILRLKN-------DNNYKYGVILERCYKIKIN------------F---SNFIT-AGIKDLMDFH 158 (308)
T ss_pred hhhhhhhHHHHhh--heeEeec-------CCCceeEEEEeeccCcccc------------h---hHHHH-HhHHHHHHhh
Confidence 3456888888764 5777642 2334467899998632100 0 01111 1145677778
Q ss_pred -hhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 256 -HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 256 -~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
+..+.+|+|-.|+||+-|+.| .+||.|-+..
T Consensus 159 ~~~~~~lHGD~np~NiM~D~~G-~lKlVDP~~L 190 (308)
T PF07387_consen 159 SENQHCLHGDCNPDNIMCDKFG-YLKLVDPVCL 190 (308)
T ss_pred ccCCCeecCCCChhheeecCCC-CEEecChhhh
Confidence 335799999999999999998 7999998864
|
The function of this family is unknown. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.59 E-value=1.2 Score=44.47 Aligned_cols=28 Identities=25% Similarity=0.348 Sum_probs=23.9
Q ss_pred CCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 258 ~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
.++||+|+.+.|||++ + .+.|+||+-+.
T Consensus 196 ~~liHgD~h~~NvL~~-d--~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D--GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C--CcEEEeCCCCC
Confidence 4789999999999995 4 37899999875
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.15 E-value=0.23 Score=50.09 Aligned_cols=61 Identities=26% Similarity=0.243 Sum_probs=36.0
Q ss_pred EEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCC
Q 011138 211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT 276 (492)
Q Consensus 211 ~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~ 276 (492)
.||-+|..|- +...++. ...++...+.++.-.+.||--+--..+++|.|+.|.||++..+.
T Consensus 321 vl~E~~~~Gl~v~~~v~~-----~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~ 382 (565)
T KOG1236|consen 321 VLVETYERGLSVLRFVKW-----KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNK 382 (565)
T ss_pred eeeeeccccccHHhhhhc-----ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEecC
Confidence 3555666653 2333222 33444555555555555554443246999999999999995443
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.10 E-value=0.12 Score=46.90 Aligned_cols=29 Identities=24% Similarity=0.335 Sum_probs=24.9
Q ss_pred CcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 259 givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
-.+|+|+.|.||+++.++ ++|+||+.|..
T Consensus 78 ~p~H~D~~~~N~~~~~~~--~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG--LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC--EEEEeCCcccC
Confidence 369999999999998654 89999999864
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=91.26 E-value=0.2 Score=46.45 Aligned_cols=30 Identities=37% Similarity=0.736 Sum_probs=19.7
Q ss_pred CCcccCCCCCCceEE-cCCCCcEEEeeecCcc
Q 011138 258 VGVCHRDIKPQNLLV-NPHTHQLKICDFGSAK 288 (492)
Q Consensus 258 ~givHrDlKp~NILl-~~~~~~vkL~DFG~a~ 288 (492)
..++|+||.|.|||+ +.++ .++|+||..|.
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~-~~~lIDfEya~ 173 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDG-EVKLIDFEYAG 173 (211)
T ss_dssp EEEE-S--SGGGEEETSSSS-CEEE--GTT-E
T ss_pred ceEeeccCccccEEeccCCC-eEEEecHHHHh
Confidence 358999999999999 4454 79999999875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=91.15 E-value=0.27 Score=48.12 Aligned_cols=131 Identities=21% Similarity=0.231 Sum_probs=84.1
Q ss_pred EeeeeccCCceEEEEEEEc------C----CCCEEEEEEeccc--------------hhh----------------HHHH
Q 011138 141 AERVVGTGSFGVVFQAKCL------E----TGDSVAIKKVLQD--------------KRY----------------KNRE 180 (492)
Q Consensus 141 ~~~~lG~G~fg~Vy~~~~~------~----~g~~vAiK~~~~~--------------~~~----------------~~~E 180 (492)
+..+|..|--+.|+-|.-- . .-..+|||+++.. -++ .++|
T Consensus 256 i~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEkE 335 (531)
T KOG2269|consen 256 IDGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEKE 335 (531)
T ss_pred hhhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHHH
Confidence 3456888888888877320 0 1245888866211 111 1235
Q ss_pred HHHHHHc-----CCCCccccceeeeeccCCCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHH
Q 011138 181 LQIMRLL-----NHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255 (492)
Q Consensus 181 ~~il~~l-----~h~nIv~l~~~~~~~~~~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH 255 (492)
..-|.++ .+|-+|.+..+ .|||-|++..-+. .-...+-.++..+.+..-.|++.++.-|-
T Consensus 336 mhNL~RMq~~GlpcP~vV~lkkh------------vLVMsFiGd~~~a---APkLK~v~l~d~E~~~aY~q~~~~M~~lY 400 (531)
T KOG2269|consen 336 MHNLSRMQKHGLPCPQVVKLKKH------------VLVMSFIGDQGLA---APKLKNVELTDDERRNAYDQVQSIMCRLY 400 (531)
T ss_pred HHHHHHHHhcCCCCCceeeeecc------------eEEEEeecCCCCC---CccccccccChHHHHHHHHHHHHHHHHHH
Confidence 5445544 36778877543 3899999753111 11112344777777777789998888774
Q ss_pred hhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 256 ~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
...-+||-||.--|+|...+ .|-++|-.-+.
T Consensus 401 ~Ec~LVHADlSEyN~Lw~~g--Kvw~IDVsQsv 431 (531)
T KOG2269|consen 401 KECLLVHADLSEYNLLWTPG--KVWVIDVSQSV 431 (531)
T ss_pred HhhheeecchhhhhheecCC--ceEEEechhcc
Confidence 33789999999999999965 58999987654
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=91.12 E-value=0.45 Score=43.61 Aligned_cols=32 Identities=16% Similarity=0.279 Sum_probs=26.3
Q ss_pred CCcccCCCCCCceEEcCCCC----cEEEeeecCccc
Q 011138 258 VGVCHRDIKPQNLLVNPHTH----QLKICDFGSAKM 289 (492)
Q Consensus 258 ~givHrDlKp~NILl~~~~~----~vkL~DFG~a~~ 289 (492)
..++|||+.+.||++..++. .+.|+||..+..
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~ 155 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY 155 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence 46899999999999975532 589999998853
|
subfamily of choline kinases |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 492 | ||||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-138 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-138 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-138 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-138 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-138 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-137 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-137 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-137 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-137 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-136 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-136 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-136 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-136 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-136 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-135 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-135 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-135 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-134 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-134 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-133 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-132 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-126 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-91 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 9e-87 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-46 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-45 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 9e-45 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-44 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-44 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-44 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-44 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-44 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-43 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-43 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-43 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-43 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-43 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-43 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-43 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-43 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-43 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-43 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-43 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-43 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-43 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-43 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-43 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-43 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-43 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-43 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-43 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-43 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-43 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-43 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-43 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-43 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-43 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-43 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-43 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-43 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-43 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-42 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-42 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-42 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-42 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-42 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-42 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-42 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-42 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-42 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-42 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-42 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-42 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-42 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-42 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-42 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-42 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-42 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-42 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-42 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-42 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-42 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-42 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-42 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-42 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-42 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-42 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-42 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-42 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-42 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-42 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-42 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-42 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-41 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-41 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-41 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-40 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-40 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-40 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-40 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-39 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-39 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-39 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-39 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-39 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-39 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-39 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-39 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-39 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-39 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 7e-39 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-39 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-39 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-39 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-39 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-39 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-39 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-39 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-39 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-39 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-39 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-38 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-38 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-38 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-38 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-38 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-38 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-38 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-38 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-38 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-38 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-38 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-38 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-38 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-38 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-38 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-38 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-38 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-38 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-38 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-38 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-38 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-38 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-38 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-38 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-38 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-38 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-38 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-38 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-38 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-38 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-38 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-38 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-38 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-38 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-38 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-38 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-38 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-38 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-37 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-37 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-37 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-37 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-37 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-37 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-37 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-37 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-36 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-36 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-35 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-34 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-34 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-34 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-34 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-33 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-33 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-33 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-33 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-33 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-33 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-33 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-33 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-33 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-33 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-33 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 6e-33 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 8e-33 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 9e-33 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-32 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-32 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-32 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-32 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-32 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-32 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-32 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-32 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-32 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-32 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-32 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-32 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-32 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-32 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-32 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-32 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-32 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-32 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-32 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-32 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-32 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-32 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-32 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 3e-32 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-32 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-32 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 7e-32 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-31 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-31 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-31 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-31 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-31 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-31 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-31 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-31 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-31 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-31 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-31 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-31 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-31 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-31 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-31 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-31 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-30 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-30 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-30 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-30 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-29 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-29 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-28 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-28 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 4e-28 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-27 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-27 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-27 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-27 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-27 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-27 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-24 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-24 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-24 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-24 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-24 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-24 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-24 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-24 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-24 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-24 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-24 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-24 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-24 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-24 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-24 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-24 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-24 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-24 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-24 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-24 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-24 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 8e-24 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-24 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-24 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-23 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-23 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-23 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-23 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-23 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-23 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-23 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-23 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 8e-22 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 9e-22 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-21 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-21 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-21 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-21 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-21 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-21 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-21 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-21 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-21 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-21 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-21 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-21 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-21 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-20 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-20 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-20 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-20 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-20 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-20 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-20 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-20 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-20 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-20 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-20 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-20 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-20 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-20 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-20 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-20 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-20 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-20 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-20 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-20 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-20 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-20 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-20 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-20 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-20 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-20 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-20 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-20 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-20 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-20 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-20 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-20 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-20 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-20 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-20 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-20 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-20 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-20 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-20 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-19 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-19 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-19 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-19 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-19 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-19 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-19 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-19 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-19 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-19 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-19 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-19 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-19 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-19 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-19 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 8e-19 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-18 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-18 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-18 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-18 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-18 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-18 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-18 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-18 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-18 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-18 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-18 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-18 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-18 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-18 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-18 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-18 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-18 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-18 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-18 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-18 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-18 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-18 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-17 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-17 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-17 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-17 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-17 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-17 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-17 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-17 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-17 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-17 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-17 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-17 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-17 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-17 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-17 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-17 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-17 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-17 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-17 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-17 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-17 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-17 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-17 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-17 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-17 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-17 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 3e-17 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-17 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-17 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-17 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-17 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-17 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-17 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-17 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-17 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-17 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-17 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-17 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-17 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-17 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-17 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-17 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-17 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-17 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-17 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-17 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-17 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-17 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-17 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-17 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-17 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-17 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-17 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-17 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-17 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-17 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-17 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-17 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-17 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-17 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-17 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-17 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-17 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-17 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-17 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-17 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-16 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-16 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-16 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-16 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-16 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-16 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-16 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-16 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-16 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-16 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-16 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-16 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-16 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 2e-16 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-16 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-16 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-16 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 2e-16 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-16 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-16 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-16 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-16 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-16 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-16 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-16 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-16 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-16 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-16 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-16 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-16 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-16 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-16 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-16 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-16 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-16 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 6e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-16 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-16 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 7e-16 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-16 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 9e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-15 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-15 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-15 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-15 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-15 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-15 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-15 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-15 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-15 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-15 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-15 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-15 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-15 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 7e-15 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-15 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-15 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-14 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-14 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 3e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-14 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 4e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-14 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-14 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-14 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-14 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-14 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-14 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-14 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 8e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-14 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-14 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-13 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-13 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-13 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-13 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-13 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-13 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-13 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-13 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-12 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-12 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-12 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-12 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-12 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-12 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-12 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-12 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-12 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-12 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-12 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-12 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-12 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-12 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-12 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-11 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-11 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-11 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-11 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-11 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-11 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-11 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-10 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 1e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-10 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 2e-10 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 2e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 6e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-09 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-09 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-09 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-09 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 7e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-09 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-09 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-08 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-08 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-08 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-08 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-08 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-08 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-08 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-08 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-08 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-08 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-08 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 4e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-08 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-08 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-08 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 6e-08 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-08 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-07 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-07 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-07 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-07 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-07 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-07 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-07 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-07 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-07 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-07 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-07 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-07 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-07 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-07 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-07 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-07 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 8e-07 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-07 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 8e-07 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-07 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-07 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-06 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-06 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-06 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-06 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-06 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-06 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-06 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-06 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-06 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-06 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-06 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-06 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-06 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-06 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-06 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-06 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-06 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-06 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-06 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-06 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-06 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-06 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-06 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-06 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-06 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 1e-05 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-05 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-05 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-04 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-04 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-04 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-04 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-04 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 8e-04 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-04 |
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 624 bits (1612), Expect = 0.0
Identities = 241/427 (56%), Positives = 301/427 (70%), Gaps = 45/427 (10%)
Query: 67 TSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAGQVIATTV 126
+ T + E Q P M++ +K+ G++ V+AT
Sbjct: 2 SGRPRTTSFAESCKPVQQPSAFGSMKVSRDKD----------------GSKVTTVVATP- 44
Query: 127 GGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRL 186
G+ Q +SY +V+G GSFGVV+QAK ++G+ VAIKKVLQDKR+KNRELQIMR
Sbjct: 45 -GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK 103
Query: 187 LNHPNVVSLKHCFFSTTEK-DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
L+H N+V L++ F+S+ EK DE+YLNLVL+Y+ ETVYRV++HY+R Q +P++YV+LY Y
Sbjct: 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYY 305
Q+ R+L Y+H G+CHRDIKPQNLL++P T LK+CDFGSAK LV GEPN+SYICSRYY
Sbjct: 164 QLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 222
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365
RAPELIFGAT+YT++ID+WS GCVLAELLLGQP+FPG+SGVDQLVEIIK+LGTPTRE+I+
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282
Query: 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425
MNPNYTEFKFPQIKAHPW K+F R PPEA+ L SRLL+Y+P+ R T LEACAH FFD+
Sbjct: 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 342
Query: 426 LRDPNTCLPNGRPLPTLFNFTAQGKLILCFSYFGFSSYFLPHANCLAELAGASNELRQRL 485
LRDPN LPNGR P LFNFT Q EL+ ++ L L
Sbjct: 343 LRDPNVKLPNGRDTPALFNFTTQ------------------------ELS-SNPPLATIL 377
Query: 486 IPEHARK 492
IP HAR
Sbjct: 378 IPPHARI 384
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 612 bits (1580), Expect = 0.0
Identities = 218/396 (55%), Positives = 283/396 (71%), Gaps = 29/396 (7%)
Query: 98 NVNHDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAK 157
+ + L +N + G+ G+ ++ I+Y +V+G GSFGVVFQAK
Sbjct: 2 SFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQRE-IAYTNCKVIGNGSFGVVFQAK 60
Query: 158 CLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK-DELYLNLVLEY 216
+E+ + VAIKKVLQDKR+KNRELQIMR++ HPNVV LK F+S +K DE++LNLVLEY
Sbjct: 61 LVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119
Query: 217 ISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT 276
+ ETVYR S+HY ++ Q +P+L ++LY YQ+ R+L Y+H + G+CHRDIKPQNLL++P +
Sbjct: 120 VPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI-GICHRDIKPQNLLLDPPS 178
Query: 277 HQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG 336
LK+ DFGSAK+L+ GEPN+SYICSRYYRAPELIFGAT YTT ID+WS GCV+AEL+ G
Sbjct: 179 GVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG 238
Query: 337 QPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEA 396
QPLFPGESG+DQLVEIIK+LGTP+RE+IK MNPNY E KFPQI+ HP+ K+F R PP+A
Sbjct: 239 QPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDA 298
Query: 397 LDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQGKLILCFS 456
+DL+SRLL+Y+PS R TA+EA HPFFD+LR +PNGR LP LFN+T +
Sbjct: 299 IDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKE-------- 350
Query: 457 YFGFSSYFLPHANCLAELAGASNELRQRLIPEHARK 492
EL+ +L RL+P+HA
Sbjct: 351 ----------------ELS-VRPDLISRLVPQHAEA 369
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 595 bits (1536), Expect = 0.0
Identities = 161/386 (41%), Positives = 231/386 (59%), Gaps = 36/386 (9%)
Query: 113 GNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ 172
G G+ A R+ K+ + ER+ G G+FG V K TG SVAIKKV+Q
Sbjct: 1 GPGSMMSLNAAAAADERS--RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ 58
Query: 173 DKRYKNRELQIMRLL---NHPNVVSLKHCFFSTTEK--DELYLNLVLEYISETVYRVSKH 227
D R++NRELQIM+ L +HPN+V L+ F++ E+ ++YLN+V+EY+ +T++R ++
Sbjct: 59 DPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRN 118
Query: 228 YTRMNQHVPILYVQLYTYQICRALNYLHHV-VGVCHRDIKPQNLLVNPHTHQLKICDFGS 286
Y R P + ++++ +Q+ R++ LH V VCHRDIKP N+LVN LK+CDFGS
Sbjct: 119 YYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS 178
Query: 287 AKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGV 346
AK L P EPN++YICSRYYRAPELIFG YTTA+D+WS+GC+ AE++LG+P+F G++
Sbjct: 179 AKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA 238
Query: 347 DQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHK---RMPPEALDLVSRL 403
QL EI+++LG P+RE ++ +NP++T+ K PW +F + EA DL+S L
Sbjct: 239 GQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSAL 298
Query: 404 LQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLP-TLFNFTAQGKLILCFSYFGFSS 462
LQY P R EA HP+FD+L DP T LPN + LP LF F
Sbjct: 299 LQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPN-------------- 344
Query: 463 YFLPHANCLAELAGASNELRQRLIPE 488
E+ S + +L+ +
Sbjct: 345 ----------EIEVMSEAQKAKLVRK 360
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 572 bits (1475), Expect = 0.0
Identities = 166/404 (41%), Positives = 243/404 (60%), Gaps = 67/404 (16%)
Query: 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHP 190
G + Y + +GTGSFG+V + +E+G A+KKVLQD RYKNREL IM++L+H
Sbjct: 1 GLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHV 60
Query: 191 NVVSLKHCFFSTTEK---------------------------------DELYLNLVLEYI 217
N++ L F++T ++ YLN+++EY+
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 218 SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH 277
+T+++V K + R + +P+ + +Y YQ+ RA+ ++H + G+CHRDIKPQNLLVN +
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL-GICHRDIKPQNLLVNSKDN 179
Query: 278 QLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337
LK+CDFGSAK L+P EP+++YICSR+YRAPEL+ GATEYT +ID+WSIGCV EL+LG+
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
Query: 338 PLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAL 397
PLF GE+ +DQLV II+I+GTPT+E++ MNP+YTE +FP +KA W KI + P A+
Sbjct: 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAI 299
Query: 398 DLVSRLLQYSPSLRCTALEACAHPFFDDLRDP-------NTCLPNG--RPLPTLFNFTAQ 448
DL+ ++L+Y P LR EA AHPFFD LR+ N+ P+G + +P LFNF+
Sbjct: 300 DLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPY 359
Query: 449 GKLILCFSYFGFSSYFLPHANCLAELAGASNELRQRLIPEHARK 492
EL+ + R++P++
Sbjct: 360 ------------------------ELSIIPGNVLNRILPKNFSP 379
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 307 bits (790), Expect = e-102
Identities = 106/296 (35%), Positives = 161/296 (54%), Gaps = 21/296 (7%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
+G GS+GVVF+ + +TG VAIKK L+ + RE+++++ L HPN+V+L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
F K L+L V EY TV R + VP V+ T+Q +A+N+ H
Sbjct: 71 F---RRKRRLHL--VFEYCDHTVLHELD---RYQRGVPEHLVKSITWQTLQAVNFCHKH- 121
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYRAPELIFGATEY 317
HRD+KP+N+L+ H+ +K+CDFG A++L P + + +R+YR+PEL+ G T+Y
Sbjct: 122 NCIHRDVKPENILITKHS-VIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQY 180
Query: 318 TTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM--NPNYTEFK 375
+D+W+IGCV AELL G PL+PG+S VDQL I K LG + N ++ K
Sbjct: 181 GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240
Query: 376 FPQIK-AHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430
P + P F + AL L+ L P+ R T + HP+F+++R+
Sbjct: 241 IPDPEDMEPLELKF-PNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE 295
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 300 bits (770), Expect = 5e-99
Identities = 98/295 (33%), Positives = 154/295 (52%), Gaps = 21/295 (7%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
VG GS+G+V + + +TG VAIKK L+ K RE+++++ L H N+V+L
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
+K YL V E++ T+ + + VQ Y +QI + + H
Sbjct: 93 C---KKKKRWYL--VFEFVDHTILDDLE---LFPNGLDYQVVQKYLFQIINGIGFCHSH- 143
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYRAPELIFGATEY 317
+ HRDIKP+N+LV+ + +K+CDFG A+ L PGE + +R+YRAPEL+ G +Y
Sbjct: 144 NIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKY 202
Query: 318 TTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE--EIKCMNPNYTEFK 375
A+D+W+IGC++ E+ +G+PLFPG+S +DQL I+ LG E+ NP + +
Sbjct: 203 GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262
Query: 376 FPQIKAH-PWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429
P+IK P + + ++ +DL + L P R E H FF
Sbjct: 263 LPEIKEREPLERRY-PKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFA 316
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 298 bits (765), Expect = 2e-98
Identities = 95/315 (30%), Positives = 154/315 (48%), Gaps = 34/315 (10%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-LQD----KR-YKNRELQIMRLLNHPNV 192
YM + +G G G+VF A + VAIKK+ L D K RE++I+R L+H N+
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL--REIKIIRRLDHDNI 70
Query: 193 VSLKHCF-----------FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
V + S TE + +Y+ V EY+ + V + + +H +
Sbjct: 71 VKVFEILGPSGSQLTDDVGSLTELNSVYI--VQEYMETDLANVLEQGPLLEEHA-----R 123
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS--- 298
L+ YQ+ R L Y+H V HRD+KP NL +N LKI DFG A+++ P +
Sbjct: 124 LFMYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 299 -YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILG 357
+ +++YR+P L+ YT AIDMW+ GC+ AE+L G+ LF G ++Q+ I++ +
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242
Query: 358 TPTREEIKCMNPNYTEF--KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL 415
E+ + + + P ++ + EA+D + ++L +SP R TA
Sbjct: 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPG-ISREAVDFLEQILTFSPMDRLTAE 301
Query: 416 EACAHPFFDDLRDPN 430
EA +HP+ P
Sbjct: 302 EALSHPYMSIYSFPM 316
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 296 bits (761), Expect = 1e-97
Identities = 89/303 (29%), Positives = 153/303 (50%), Gaps = 23/303 (7%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV--LQDKRYKNRELQIMR-LLNHPNVVSL 195
Y R +G G + VF+A + + V +K + ++ K+ K RE++I+ L PN+++L
Sbjct: 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK-REIKILENLRGGPNIITL 96
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+ V E+++ T ++ ++ Q + ++ Y Y+I +AL+Y H
Sbjct: 97 ADIVKDPVSRTPAL---VFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH 147
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGAT 315
+ G+ HRD+KP N++++ +L++ D+G A+ PG+ + SRY++ PEL+
Sbjct: 148 SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 316 EYTTAIDMWSIGCVLAELLLG-QPLFPGESGVDQLVEIIKILGTPTREEI--KCMNPNYT 372
Y ++DMWS+GC+LA ++ +P F G DQLV I K+LGT + K
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 266
Query: 373 EFK--FPQIKAHPWHKIFHKR----MPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426
F + W + H + PEALD + +LL+Y R TA EA HP+F +
Sbjct: 267 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326
Query: 427 RDP 429
Sbjct: 327 VKD 329
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 292 bits (751), Expect = 8e-96
Identities = 106/334 (31%), Positives = 173/334 (51%), Gaps = 42/334 (12%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-----LQD-KR-YKNRELQIMRLLNHPN 191
+ + ++G G++GVV A TG+ VAIKK+ R RE++I++ H N
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL--REIKILKHFKHEN 70
Query: 192 VVSLKHCFFSTTEKD--ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
++++ + + ++ E+Y+ + E + ++RV + H+ Q + YQ R
Sbjct: 71 IITIFNIQRPDSFENFNEVYI--IQELMQTDLHRVISTQMLSDDHI-----QYFIYQTLR 123
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS----------- 298
A+ LH V HRD+KP NLL+N LK+CDFG A+++ + S
Sbjct: 124 AVKVLHGS-NVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 299 YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358
++ +R+YRAPE++ + +Y+ A+D+WS GC+LAEL L +P+FPG QL+ I I+GT
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241
Query: 359 PTREEI--KCMNPNYTEF--KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA 414
P + +P E+ P A P K+F + + P+ +DL+ R+L + P+ R TA
Sbjct: 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR-VNPKGIDLLQRMLVFDPAKRITA 300
Query: 415 LEACAHPFFDDLRDPN---TCLPNGRPLPTLFNF 445
EA HP+ DPN P P+ F F
Sbjct: 301 KEALEHPYLQTYHDPNDEPEGEP---IPPSFFEF 331
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 291 bits (747), Expect = 4e-95
Identities = 94/315 (29%), Positives = 153/315 (48%), Gaps = 34/315 (10%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---------------RELQI 183
Y +R + +GS+G V G VAIK+V RE+++
Sbjct: 24 YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 184 MRLLNHPNVVSLKHCF--FSTTEKDELYLNLVLEYISETVYRV--SKHYTRMNQHVPILY 239
+ +HPN++ L+ F F +LYL V E + + +V + QH+
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYL--VTELMRTDLAQVIHDQRIVISPQHI---- 136
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY 299
Q + Y I L+ LH GV HRD+ P N+L+ + + ICDF A+ Y
Sbjct: 137 -QYFMYHILLGLHVLHEA-GVVHRDLHPGNILLA-DNNDITICDFNLAREDTADANKTHY 193
Query: 300 ICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTP 359
+ R+YRAPEL+ +T +DMWS GCV+AE+ + LF G + +QL +I++++GTP
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253
Query: 360 TREEIKCM-NP---NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL 415
E++ +P +Y + A W + P ALDL++++L+++P R +
Sbjct: 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRRISTE 312
Query: 416 EACAHPFFDDLRDPN 430
+A HP+F+ L DP
Sbjct: 313 QALRHPYFESLFDPL 327
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 289 bits (743), Expect = 9e-95
Identities = 105/312 (33%), Positives = 155/312 (49%), Gaps = 33/312 (10%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---------RELQIMRLLNHPNVVSL 195
+G G F V++A+ T VAIKK+ R + RE+++++ L+HPN++ L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
F K + L V +++ + + + +++ Y + L YLH
Sbjct: 78 LDAF---GHKSNISL--VFDFME---TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAPELIF 312
+ HRD+KP NLL++ LK+ DFG AK G PN +Y + +R+YRAPEL+F
Sbjct: 130 QH-WILHRDLKPNNLLLD-ENGVLKLADFGLAKSF--GSPNRAYTHQVVTRWYRAPELLF 185
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI---KCMNP 369
GA Y +DMW++GC+LAELLL P PG+S +DQL I + LGTPT EE C P
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT-EEQWPDMCSLP 244
Query: 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429
+Y F P H IF + LDL+ L ++P R TA +A +F + P
Sbjct: 245 DYVT--FKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR--P 299
Query: 430 NTCLPNGRPLPT 441
P P
Sbjct: 300 GPTPGCQLPRPN 311
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 289 bits (742), Expect = 2e-94
Identities = 102/308 (33%), Positives = 169/308 (54%), Gaps = 28/308 (9%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV--LQD----KR-YKNRELQIMRLLNHPN 191
Y +G G++G+V A VAIKK+ + +R RE++I+ H N
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL--REIKILLRFRHEN 86
Query: 192 VVSLKHCFFSTTEKD--ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
++ + + T + ++Y+ V + + +Y++ K N H+ + YQI R
Sbjct: 87 IIGINDIIRAPTIEQMKDVYI--VQDLMETDLYKLLKTQHLSNDHI-----CYFLYQILR 139
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS----YICSRYY 305
L Y+H V HRD+KP NLL+N T LKICDFG A++ P + Y+ +R+Y
Sbjct: 140 GLKYIHSA-NVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365
RAPE++ + YT +ID+WS+GC+LAE+L +P+FPG+ +DQL I+ ILG+P++E++
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257
Query: 366 CM-NPNYTEF--KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
C+ N + P PW+++F +ALDL+ ++L ++P R +A AHP+
Sbjct: 258 CIINLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316
Query: 423 FDDLRDPN 430
+ DP+
Sbjct: 317 LEQYYDPS 324
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 288 bits (739), Expect = 2e-94
Identities = 99/326 (30%), Positives = 167/326 (51%), Gaps = 33/326 (10%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---------RELQIMRLLN 188
+Y+ +G G++ V++ K T + VA+K++ R ++ RE+ +++ L
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI----RLEHEEGAPCTAIREVSLLKDLK 58
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
H N+V+L + L L V EY+ + ++ + + V+L+ +Q+
Sbjct: 59 HANIVTLHDII---HTEKSLTL--VFEYLD---KDLKQYLDDCGNIINMHNVKLFLFQLL 110
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYY 305
R L Y H V HRD+KPQNLL+N +LK+ DFG A+ P +Y + + +Y
Sbjct: 111 RGLAYCHRQ-KVLHRDLKPQNLLIN-ERGELKLADFGLARAK--SIPTKTYDNEVVTLWY 166
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE--- 362
R P+++ G+T+Y+T IDMW +GC+ E+ G+PLFPG + +QL I +ILGTPT E
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226
Query: 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
I + + +P+ +A R+ + DL+++LLQ+ R +A +A HPF
Sbjct: 227 GILSN-EEFKTYNYPKYRAEALLSHA-PRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284
Query: 423 FDDLRDPNTCLPNGRPLPTLFNFTAQ 448
F L + LP+ + L Q
Sbjct: 285 FLSLGERIHKLPDTTSIFALKEIQLQ 310
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 283 bits (727), Expect = 1e-92
Identities = 91/298 (30%), Positives = 156/298 (52%), Gaps = 30/298 (10%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
+G G++G V++A T ++VAIK++ + + RE+ +++ L H N++ LK
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
L+L + EY + K Y N V + ++ + YQ+ +N+ H
Sbjct: 102 I---HHNHRLHL--IFEYAENDL----KKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR- 151
Query: 259 GVCHRDIKPQNLLVNPHTH----QLKICDFGSAKMLVPGEPNISY---ICSRYYRAPELI 311
HRD+KPQNLL++ LKI DFG A+ G P + I + +YR PE++
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQFTHEIITLWYRPPEIL 209
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE---EIKCMN 368
G+ Y+T++D+WSI C+ AE+L+ PLFPG+S +DQL +I ++LG P + +
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL- 268
Query: 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426
P++ + FP+ + ++ + E LDL++ +L+ P R +A A HP+F
Sbjct: 269 PDWKQS-FPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 284 bits (730), Expect = 2e-92
Identities = 98/304 (32%), Positives = 157/304 (51%), Gaps = 24/304 (7%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNV 192
Y + VG+G++G V A TG VAIKK+ + REL++++ + H NV
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 193 VSLKHCFF---STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
+ L F + + + YL V+ ++ + ++ KH + Q YQ+ +
Sbjct: 87 IGLLDVFTPDETLDDFTDFYL--VMPFMGTDLGKLMKHEKLGEDRI-----QFLVYQMLK 139
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPE 309
L Y+H G+ HRD+KP NL VN LKI DFG A+ Y+ +R+YRAPE
Sbjct: 140 GLRYIHAA-GIIHRDLKPGNLAVNEDCE-LKILDFGLARQADSEMTG--YVVTRWYRAPE 195
Query: 310 LIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM-N 368
+I YT +D+WS+GC++AE++ G+ LF G +DQL EI+K+ GTP E ++ + +
Sbjct: 196 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255
Query: 369 PNYTEF--KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426
+ P+++ + I P A++L+ ++L R TA EA AHP+F+ L
Sbjct: 256 DEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314
Query: 427 RDPN 430
D
Sbjct: 315 HDTE 318
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 283 bits (726), Expect = 4e-92
Identities = 101/306 (33%), Positives = 160/306 (52%), Gaps = 29/306 (9%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQD----KR-YKNRELQIMRLLNHP 190
Y++ VG+G++G V A +G+ VAIKK+ Q KR Y REL +++ + H
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY--RELLLLKHMQHE 83
Query: 191 NVVSLKHCFFSTTEKD---ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQI 247
NV+ L F + + YL V+ ++ + ++ + + Q YQ+
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYL--VMPFMQTDLQKIMGL-KFSEEKI-----QYLVYQM 135
Query: 248 CRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRA 307
+ L Y+H GV HRD+KP NL VN LKI DFG A+ Y+ +R+YRA
Sbjct: 136 LKGLKYIHSA-GVVHRDLKPGNLAVNEDCE-LKILDFGLARHADAEMTG--YVVTRWYRA 191
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367
PE+I Y +D+WS+GC++AE+L G+ LF G+ +DQL +I+K+ G P E ++ +
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 251
Query: 368 -NPNYTEF--KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424
+ + PQ + ++F R P+A DL+ ++L+ R TA +A HPFF+
Sbjct: 252 NDKAAKSYIQSLPQTPRKDFTQLF-PRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 310
Query: 425 DLRDPN 430
RDP
Sbjct: 311 PFRDPE 316
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 281 bits (721), Expect = 6e-92
Identities = 101/294 (34%), Positives = 164/294 (55%), Gaps = 27/294 (9%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
VG G++GVV++AK G VA+K++ D + RE+ +++ L+HPN+VSL
Sbjct: 29 VGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
+ L L V E++ + K + +++Y YQ+ R + + H
Sbjct: 88 I---HSERCLTL--VFEFME---KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH- 138
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAPELIFGAT 315
+ HRD+KPQNLL+N LK+ DFG A+ G P SY + + +YRAP+++ G+
Sbjct: 139 RILHRDLKPQNLLIN-SDGALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 316 EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE---EIKCMNPNYT 372
+Y+T++D+WSIGC+ AE++ G+PLFPG + DQL +I ILGTP +++ + P +
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL-PLWK 254
Query: 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426
+ F + PW I E +DL+S +L + P+ R +A +A HP+F DL
Sbjct: 255 QRTFQVFEKKPWSSII-PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 278 bits (714), Expect = 3e-91
Identities = 97/294 (32%), Positives = 159/294 (54%), Gaps = 28/294 (9%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
+G G++GVV++A+ G++ A+KK+ +K + RE+ I++ L H N+V L
Sbjct: 10 IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
K L L V E++ + + ++ + + + + Q+ + Y H
Sbjct: 69 I---HTKKRLVL--VFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAPELIFGAT 315
V HRD+KPQNLL+N +LKI DFG A+ G P Y I + +YRAP+++ G+
Sbjct: 120 RVLHRDLKPQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 316 EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE---EIKCMNPNYT 372
+Y+T ID+WS+GC+ AE++ G PLFPG S DQL+ I +ILGTP + + + P Y
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL-PKY- 234
Query: 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426
+ F + PW K + +DL+S++L+ P+ R TA +A H +F +
Sbjct: 235 DPNFTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 279 bits (716), Expect = 2e-90
Identities = 101/306 (33%), Positives = 157/306 (51%), Gaps = 28/306 (9%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KR-YKNRELQIMRLLNHP 190
Y VG+G++G V A +TG VA+KK+ + KR Y REL++++ + H
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHE 88
Query: 191 NVVSLKHCFFSTTEKD---ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQI 247
NV+ L F + ++YL V + + + K + HV Q YQI
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVKCQKLTDDHV-----QFLIYQI 141
Query: 248 CRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRA 307
R L Y+H + HRD+KP NL VN +LKI DFG A+ Y+ +R+YRA
Sbjct: 142 LRGLKYIHSA-DIIHRDLKPSNLAVN-EDCELKILDFGLARHTADEMTG--YVATRWYRA 197
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367
PE++ Y +D+WS+GC++AELL G+ LFPG +DQL I++++GTP E +K +
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257
Query: 368 -NPNYTEF--KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424
+ + + Q+ + +F P A+DL+ ++L R TA +A AH +F
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 316
Query: 425 DLRDPN 430
DP+
Sbjct: 317 QYHDPD 322
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 275 bits (705), Expect = 2e-89
Identities = 90/317 (28%), Positives = 156/317 (49%), Gaps = 37/317 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---------RELQIMRLLNHPNVVSL 195
+G G++ V++ TG VA+K+V + + RE+ +M+ L H N+V L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIREISLMKELKHENIVRL 68
Query: 196 KHCFFSTTEKDELYLNLVLEYISE--TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+++L L V E++ Y S+ + + + V+ + +Q+ + L +
Sbjct: 69 YDVI---HTENKLTL--VFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAPEL 310
H + HRD+KPQNLL+N QLK+ DFG A+ G P ++ + + +YRAP++
Sbjct: 124 CHEN-KILHRDLKPQNLLIN-KRGQLKLGDFGLARAF--GIPVNTFSSEVVTLWYRAPDV 179
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE---EIKCM 367
+ G+ Y+T+ID+WS GC+LAE++ G+PLFPG + +QL I I+GTP + +
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239
Query: 368 NPNYTEFKFPQIKAHPWHKIFHK----RMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
P Y Q ++ + +D + LLQ +P +R +A +A HP+F
Sbjct: 240 -PKY-NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297
Query: 424 DDLRDPNTCLPNGRPLP 440
+ + R
Sbjct: 298 AEYYHH-ASMGGSRSHH 313
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 274 bits (702), Expect = 2e-89
Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 28/298 (9%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKHC 198
+G G++G VF+AK ET + VA+K+V D + RE+ +++ L H N+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
+L L V E+ + K++ N + V+ + +Q+ + L + H
Sbjct: 70 L---HSDKKLTL--VFEFCD---QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR- 120
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAPELIFGAT 315
V HRD+KPQNLL+N +LK+ +FG A+ G P Y + + +YR P+++FGA
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLANFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 316 EYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGTPTRE---EIKCMNPNY 371
Y+T+IDMWS GC+ AEL G+PLFPG DQL I ++LGTPT E + + P+Y
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL-PDY 236
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429
+ + ++ DL+ LL+ +P R +A EA HP+F D P
Sbjct: 237 KPYPMYPAT-TSLVNVV-PKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 274 bits (702), Expect = 3e-88
Identities = 98/331 (29%), Positives = 161/331 (48%), Gaps = 38/331 (11%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQD----KR-YKNRELQIMRLLNHP 190
Y + +G+G+ G+V A +VAIKK+ Q+ KR Y REL +M+ +NH
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 84
Query: 191 NVVSLKHCF---FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQI 247
N++ L + F S E ++Y+ V+E + + +V + ++ + YQ+
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYI--VMELMDANLCQVIQM-ELDHERM-----SYLLYQM 136
Query: 248 CRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRA 307
+ +LH G+ HRD+KP N++V LKI DFG A+ Y+ +RYYRA
Sbjct: 137 LCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367
PE+I G Y +D+WS+GC++ E++ G LFPG +DQ ++I+ LGTP E +K +
Sbjct: 195 PEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253
Query: 368 NPNYTEF--KFPQIKAHPWHKIFHKRMP-----------PEALDLVSRLLQYSPSLRCTA 414
P + P+ + + K+F + +A DL+S++L S R +
Sbjct: 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 313
Query: 415 LEACAHPFFDDLRDPNTCLPNGRPLPTLFNF 445
EA HP+ + DP+ P
Sbjct: 314 DEALQHPYINVWYDPSE-AEAPPPKIPDKQL 343
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 271 bits (696), Expect = 1e-87
Identities = 84/312 (26%), Positives = 142/312 (45%), Gaps = 26/312 (8%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLK-- 196
+G G+FG VF+A+ +TG VA+KKVL + + RE++I++LL H NVV+L
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 197 -HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
S + + + LV ++ + ++ + + + ++ + L Y+H
Sbjct: 85 CRTKASPYNRCKGSIYLVFDFCE---HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 141
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM--LVPGEPNISY---ICSRYYRAPEL 310
+ HRD+K N+L+ LK+ DFG A+ L Y + + +YR PEL
Sbjct: 142 RN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 199
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE---EIKCM 367
+ G +Y ID+W GC++AE+ P+ G + QL I ++ G+ T E +
Sbjct: 200 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 259
Query: 368 NPNYTEFKFPQIKAHPWHKIF-HKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426
Y + + + + P ALDL+ +LL P+ R + +A H FF
Sbjct: 260 -ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS- 317
Query: 427 RDPNTCLPNGRP 438
DP G
Sbjct: 318 -DPMPSDLKGML 328
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 268 bits (688), Expect = 5e-87
Identities = 84/306 (27%), Positives = 143/306 (46%), Gaps = 36/306 (11%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---------RELQIMRLLN---HPNV 192
+G G++G V++A+ +G VA+K V RE+ ++R L HPNV
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHY--TRMNQHVPILYVQLYTYQICRA 250
V L ++ E+ + LV E++ + + + Y +P ++ Q R
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHVDQDL----RTYLDKAPPPGLPAETIKDLMRQFLRG 132
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRA 307
L++LH + HRD+KP+N+LV +K+ DFG A++ ++ + + +YRA
Sbjct: 133 LDFLHAN-CIVHRDLKPENILVT-SGGTVKLADFGLARIY--SYQ-MALTPVVVTLWYRA 187
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367
PE++ +T Y T +DMWS+GC+ AE+ +PLF G S DQL +I ++G P ++
Sbjct: 188 PEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW--- 243
Query: 368 NPNYTE---FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424
P FP P + M L+ +L ++P R +A A H +
Sbjct: 244 -PRDVSLPRGAFPPRGPRPVQSVV-PEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH 301
Query: 425 DLRDPN 430
+ N
Sbjct: 302 KD-EGN 306
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 272 bits (698), Expect = 7e-87
Identities = 97/356 (27%), Positives = 157/356 (44%), Gaps = 75/356 (21%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQD-KR-YKNRELQIMRLLNHP 190
Y+ + ++G GS+G V+ A T +VAIKKV L D KR RE+ I+ L
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL--REITILNRLKSD 85
Query: 191 NVVSLKHCFFSTTEKD--ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
++ L ELY+ VLE + ++ + + +++ Y +
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYI--VLEIADSDLKKL----FKTPIFLTEEHIKTILYNLL 139
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS---------- 298
N++H G+ HRD+KP N L+N +K+CDFG A+ + +
Sbjct: 140 LGENFIHES-GIIHRDLKPANCLLNQDCS-VKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 299 -------------YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ-------- 337
++ +R+YRAPELI YT +ID+WS GC+ AELL
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257
Query: 338 ---PLFPGESG-----------------VDQLVEIIKILGTPTREEIKCM-NPNYTEF-- 374
PLFPG S DQL I I+GTPT +++K + P ++
Sbjct: 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIK 317
Query: 375 KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430
FP K + + + + ++L+ +L+++P+ R T +A HP+ D+R
Sbjct: 318 LFPHRKPINLKQKYPS-ISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK 372
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 273 bits (700), Expect = 7e-87
Identities = 96/316 (30%), Positives = 160/316 (50%), Gaps = 37/316 (11%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KR-YKNRELQIMRLLNHP 190
Y + +G+G+ G+V A +VAIKK+ + KR Y REL +M+ +NH
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 121
Query: 191 NVVSLKHCF---FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQI 247
N++SL + F + E ++YL V+E + + +V + ++ + YQ+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYL--VMELMDANLCQVIQM-ELDHERM-----SYLLYQM 173
Query: 248 CRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRA 307
+ +LH G+ HRD+KP N++V LKI DFG A+ Y+ +RYYRA
Sbjct: 174 LCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 231
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367
PE+I G Y +D+WS+GC++ E++ + LFPG +DQ ++I+ LGTP E +K +
Sbjct: 232 PEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290
Query: 368 NPNYTEF--KFPQIKAHPWHKIF-----------HKRMPPEALDLVSRLLQYSPSLRCTA 414
P + P+ + K+F +K +A DL+S++L P+ R +
Sbjct: 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 350
Query: 415 LEACAHPFFDDLRDPN 430
+A HP+ + DP
Sbjct: 351 DDALQHPYINVWYDPA 366
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 272 bits (697), Expect = 2e-86
Identities = 110/364 (30%), Positives = 162/364 (44%), Gaps = 83/364 (22%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KR-YKNRELQIMRLLNHP 190
Y ++GTGS+G V +A VAIKK+L+ KR RE+ I+ LNH
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL--REIAILNRLNHD 112
Query: 191 NVVSLKHCFFSTTEK--DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
+VV + + DELY +VLE ++ R ++ L+++ Y +
Sbjct: 113 HVVKVLDIVIPKDVEKFDELY--VVLEIADSDFKKL----FRTPVYLTELHIKTLLYNLL 166
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS---------- 298
+ Y+H G+ HRD+KP N LVN +K+CDFG A+ + E S
Sbjct: 167 VGVKYVHS-AGILHRDLKPANCLVNQDCS-VKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 299 ------------------YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL----- 335
++ +R+YRAPELI YT AID+WSIGC+ AELL
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284
Query: 336 ------GQPLFPGES--------------------GVDQLVEIIKILGTPTREEIKCM-N 368
PLFPG S DQL I ILGTP+ E+I+ +
Sbjct: 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEK 344
Query: 369 PNYTEF--KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426
+ + FP+ + + F +A+ L+ R+L ++P+ R T E AHPFF ++
Sbjct: 345 EDAKRYIRIFPKREGTDLAERF-PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403
Query: 427 RDPN 430
R
Sbjct: 404 RIAE 407
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 269 bits (689), Expect = 4e-86
Identities = 100/341 (29%), Positives = 172/341 (50%), Gaps = 61/341 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL---QD----KR-YKNRELQIMRLLN-H 189
Y + +G G++G+V+++ TG+ VA+KK+ Q+ +R + RE+ I+ L+ H
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF--REIMILTELSGH 68
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
N+V+L + + ++D +YL V +Y+ ++ V + H Q YQ+ +
Sbjct: 69 ENIVNLLNVLRADNDRD-VYL--VFDYMETDLHAVIRANILEPVHK-----QYVVYQLIK 120
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS----------- 298
+ YLH G+ HRD+KP N+L+N H +K+ DFG ++ V +
Sbjct: 121 VIKYLHSG-GLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTE 178
Query: 299 -----------YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD 347
Y+ +R+YRAPE++ G+T+YT IDMWS+GC+L E+L G+P+FPG S ++
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238
Query: 348 QLVEIIKILGTPTREEIKCM-NPNYTEF--KFPQIKAHPWHKIFHKRMP----------- 393
QL II ++ P+ E+++ + +P +
Sbjct: 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPK 298
Query: 394 ----PEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430
EALDL+ +LLQ++P+ R +A +A HPF +PN
Sbjct: 299 ADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPN 339
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 265 bits (681), Expect = 1e-85
Identities = 96/316 (30%), Positives = 154/316 (48%), Gaps = 37/316 (11%)
Query: 145 VGTGSFGVVFQAK-CLETGDSVAIKKVLQDKRYKN-------RELQIMRLLN---HPNVV 193
+G G++G VF+A+ G VA+K+V + RE+ ++R L HPNVV
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHY--TRMNQHVPILYVQLYTYQICRAL 251
L + E L LV E++ + + Y VP ++ +Q+ R L
Sbjct: 78 RLFDVCTVSRTDRETKLTLVFEHVDQDL----TTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAP 308
++LH V HRD+KPQN+LV + Q+K+ DFG A++ ++ + + +YRAP
Sbjct: 134 DFLHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARIY--SFQ-MALTSVVVTLWYRAP 188
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368
E++ ++ Y T +D+WS+GC+ AE+ +PLF G S VDQL +I+ ++G P E+
Sbjct: 189 EVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW---- 243
Query: 369 PNYTE---FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425
P F A P K + DL+ + L ++P+ R +A A +HP+F D
Sbjct: 244 PRDVALPRQAFHSKSAQPIEKFV-TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 302
Query: 426 LRDPNTCLPNGRPLPT 441
L LP
Sbjct: 303 L--ERCKENLDSHLPP 316
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 258 bits (660), Expect = 1e-81
Identities = 89/335 (26%), Positives = 150/335 (44%), Gaps = 44/335 (13%)
Query: 145 VGTGSFGVVFQAKCLE--TGDSVAIKKVLQDKRYKN--RELQIMRLLNHPNVVSLKHCFF 200
VG G++G V++AK + A+K++ + RE+ ++R L HPNV+SL+ F
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88
Query: 201 STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILY-----VQLYTYQICRALNYLH 255
S ++ + L+ +Y ++ + K + + + V+ YQI ++YLH
Sbjct: 89 SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 256 HVVGVCHRDIKPQNLLVN---PHTHQLKICDFGSAKMLVPGEPNISY------ICSRYYR 306
V HRD+KP N+LV P ++KI D G A++ P + + +YR
Sbjct: 146 AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF--NSPLKPLADLDPVVVTFWYR 202
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES---------GVDQLVEIIKILG 357
APEL+ GA YT AID+W+IGC+ AELL +P+F DQL I ++G
Sbjct: 203 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 262
Query: 358 TPTRE---------EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSP 408
P + E + ++ + + + + +A L+ +LL P
Sbjct: 263 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDP 322
Query: 409 SLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTLF 443
R T+ +A P+F + DP +
Sbjct: 323 IKRITSEQAMQDPYFLE--DPLPTSDVFAGCQIPY 355
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 1e-66
Identities = 94/328 (28%), Positives = 150/328 (45%), Gaps = 57/328 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNH------ 189
Y +V+G GSFG V +A + VA+K V +KR+ E++I+ L
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 190 PNVVSLKHCFFSTTEKDELYLN---LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
NV+ + F + N + E +S +Y + K Q + V+ + +
Sbjct: 159 MNVIHMLENF--------TFRNHICMTFELLSMNLYELIKK--NKFQGFSLPLVRKFAHS 208
Query: 247 ICRALNYLHHVVGVCHRDIKPQN-LLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYY 305
I + L+ LH + H D+KP+N LL +K+ DFGS+ + +YI SR+Y
Sbjct: 209 ILQCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE--HQRVYTYIQSRFY 265
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365
RAPE+I GA Y IDMWS+GC+LAELL G PL PGE DQL +I++LG P+++ +
Sbjct: 266 RAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324
Query: 366 -----------CMNPNYTEFKF---------------PQIKAHPWHKIFHKRMPPEA--- 396
P Y +++ P + + +
Sbjct: 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPL 384
Query: 397 -LDLVSRLLQYSPSLRCTALEACAHPFF 423
LD + + L++ P++R T +A HP+
Sbjct: 385 FLDFLKQCLEWDPAVRMTPGQALRHPWL 412
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 2e-65
Identities = 105/379 (27%), Positives = 162/379 (42%), Gaps = 81/379 (21%)
Query: 94 RDEKNVNHDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVV 153
R N +DD + + + NG R Y + ++G GSFG V
Sbjct: 30 RKVYNDGYDDDNYDYIVKNG----------EKWMDR---------YEIDSLIGKGSFGQV 70
Query: 154 FQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHP------NVVSLKHCFFSTTE 204
+A + VAIK + K + N E++++ L+N +V LK F
Sbjct: 71 VKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM---- 126
Query: 205 KDELYLN---LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV-VGV 260
+ N LV E +S +Y + ++ + V + + + Q+C AL +L + +
Sbjct: 127 ----FRNHLCLVFEMLSYNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPELSI 180
Query: 261 CHRDIKPQN-LLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTT 319
H D+KP+N LL NP +KI DFGS+ L G+ YI SR+YR+PE++ G Y
Sbjct: 181 IHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQYIQSRFYRSPEVLLGM-PYDL 237
Query: 320 AIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK-----------CMN 368
AIDMWS+GC+L E+ G+PLF G + VDQ+ +I+++LG P + +
Sbjct: 238 AIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPD 297
Query: 369 PNYTEFKFPQIKAH---PWHKIFH-----KRMPPEA----------------LDLVSRLL 404
+ K K P + H + P DL+ R+L
Sbjct: 298 GTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRML 357
Query: 405 QYSPSLRCTALEACAHPFF 423
Y P R A H FF
Sbjct: 358 DYDPKTRIQPYYALQHSFF 376
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 5e-65
Identities = 83/340 (24%), Positives = 144/340 (42%), Gaps = 44/340 (12%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLN-----HP 190
Y+ R +G G F V+ AK + VA+K V DK Y E+++++ +N
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 191 NVVSLKHC-----FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
+ + H F+ + +++ +V E + E + + K Y ++ +P++YV+ +
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISK 138
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQ-----LKICDFGSAKMLVPGEPNISYI 300
Q+ L+Y+H G+ H DIKP+N+L+ +KI D G+A E + I
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY--DEHYTNSI 196
Query: 301 CSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESG------VDQLVEIIK 354
+R YR+PE++ GA + D+WS C++ EL+ G LF + G D + +II+
Sbjct: 197 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255
Query: 355 ILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPP--------------EALDLV 400
+LG ++ F + K+ + E D +
Sbjct: 256 LLGELPSYLLR-NGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 314
Query: 401 SRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLP 440
S +LQ P R A HP+ D R L
Sbjct: 315 SPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELY 354
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 2e-63
Identities = 86/383 (22%), Positives = 147/383 (38%), Gaps = 85/383 (22%)
Query: 94 RDEKNVNHDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVV 153
R+ DD+ + S G + ++ R +G G+FG V
Sbjct: 11 RENLYFQGDDEIVHFSWKKG----------MLLNNA---------FLVIRKMGDGTFGRV 51
Query: 154 FQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNH-----PNVVSLKHCFFSTTEK 205
+ ++ A+K V K+Y E I++ + + N+V F
Sbjct: 52 LLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF------ 105
Query: 206 DELYLN---LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCH 262
+Y + L+ E + ++Y + I ++LY +I +ALNYL + + H
Sbjct: 106 --MYYDHMCLIFEPLGPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRKM-SLTH 160
Query: 263 RDIKPQN-LLVNPHTH-----------------------QLKICDFGSAKMLVPGEPNIS 298
D+KP+N LL +P+ +K+ DFG A + + S
Sbjct: 161 TDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFK--SDYHGS 218
Query: 299 YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358
I +R YRAPE+I + + DMWS GCVLAEL G LF ++ L + I+
Sbjct: 219 IINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQP 277
Query: 359 PTREEI---------KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEA--------LDLVS 401
+ + K +N + + +P+ + K+ P D +
Sbjct: 278 IPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLY 337
Query: 402 RLLQYSPSLRCTALEACAHPFFD 424
+LQ P+LR + E H F +
Sbjct: 338 SILQIDPTLRPSPAELLKHKFLE 360
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 1e-62
Identities = 85/337 (25%), Positives = 138/337 (40%), Gaps = 60/337 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGD-SVAIKKVLQDKRYKN---RELQIMRLLNHP---- 190
Y +G G+FG V + + G VA+K V RY E+Q++ LN
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 191 --NVVSLKHCFFSTTEKDELYLN---LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
V + F + +V E + + Y K + +++ Y
Sbjct: 76 TFRCVQMLEWFE--------HHGHICIVFELLGLSTYDFIKENGF--LPFRLDHIRKMAY 125
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLVN------------------PHTHQLKICDFGSA 287
QIC+++N+LH + H D+KP+N+L +K+ DFGSA
Sbjct: 126 QICKSVNFLHSN-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184
Query: 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD 347
E + + + +R+YRAPE+I ++ D+WSIGC+L E LG +FP +
Sbjct: 185 TYD--DEHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241
Query: 348 QLVEIIKILGTPTREEIK---------CMNPNYTEFKFPQIKAHPWHKIFHKRMPPE--- 395
L + +ILG + I+ ++ E K + M +
Sbjct: 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVE 301
Query: 396 ---ALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429
DL+ ++L+Y P+ R T EA HPFFD L+
Sbjct: 302 HERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 2e-62
Identities = 82/346 (23%), Positives = 131/346 (37%), Gaps = 60/346 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDS-VAIKKVLQDKRYKN---RELQIMRLLNHP---- 190
Y +G G+FG V + G S VA+K + +Y+ E+ +++ +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 191 --NVVSLKHCFFSTTEKDELYLN---LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
V + F + + E + + + K Q P+ +V+ Y
Sbjct: 81 KFLCVLMSDWF--------NFHGHMCIAFELLGKNTFEFLKENN--FQPYPLPHVRHMAY 130
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLVN------------------PHTHQLKICDFGSA 287
Q+C AL +LH + H D+KP+N+L +++ DFGSA
Sbjct: 131 QLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189
Query: 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD 347
E + + + +R+YR PE+I + D+WSIGC+L E G LF +
Sbjct: 190 TFD--HEHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246
Query: 348 QLVEIIKILGTPTREEIKCM---------NPNYTEFKFPQIKAHPWHKIFHKRMPPEAL- 397
LV + KILG I + E K M ++L
Sbjct: 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLE 306
Query: 398 -----DLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRP 438
DL+ R+L++ P+ R T EA HPFF L R
Sbjct: 307 HVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRN 352
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 2e-57
Identities = 65/314 (20%), Positives = 120/314 (38%), Gaps = 60/314 (19%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKN--RELQIMRLLNHPN- 191
Y + +G+G VFQ E AIK V ++ + E+ + L +
Sbjct: 30 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 192 -VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
++ L + Y+ +V+E + + K ++ + Y + A
Sbjct: 89 KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKKKSIDPWE----RKSYWKNMLEA 139
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI---SYICSRYYRA 307
++ +H G+ H D+KP N L+ LK+ DFG A + P ++ S + + Y
Sbjct: 140 VHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 196
Query: 308 PELIFGA----------TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILG 357
PE I ++ + D+WS+GC+L + G+ F +Q+ ++ I
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII--NQISKLHAI-- 252
Query: 358 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEA 417
++PN+ E +FP I + D++ L+ P R + E
Sbjct: 253 ---------IDPNH-EIEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPEL 290
Query: 418 CAHPFFDDLRDPNT 431
AHP+ P
Sbjct: 291 LAHPYVQIQTHPVN 304
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 3e-57
Identities = 73/338 (21%), Positives = 117/338 (34%), Gaps = 65/338 (19%)
Query: 101 HDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLE 160
L+P V+ G + + + + S+ +G GS+G VF+ + E
Sbjct: 21 QSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKE 80
Query: 161 TGDSVAIKKVL------QDKRYKNRELQIM-RLLNHPNVVSLKHCFFSTTEKDELYLNLV 213
G A+K+ + +D+ K E+ ++ HP V L+ + E LY L
Sbjct: 81 DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE---EGGILY--LQ 135
Query: 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN 273
E ++ +H +P V Y AL +LH G+ H D+KP N+ +
Sbjct: 136 TELCGPSLQ---QHCEAWGASLPEAQVWGYLRDTLLALAHLHS-QGLVHLDVKPANIFLG 191
Query: 274 PHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAEL 333
P K+ DFG L Y APEL+ Y TA D++S+G + E+
Sbjct: 192 PRGR-CKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL--QGSYGTAADVFSLGLTILEV 248
Query: 334 LLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMP 393
L G W ++ +P
Sbjct: 249 ACNMELPHG--------------------------------------GEGWQQLRQGYLP 270
Query: 394 P--------EALDLVSRLLQYSPSLRCTALEACAHPFF 423
P E ++ +L+ P LR TA A P
Sbjct: 271 PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 6e-57
Identities = 60/304 (19%), Positives = 112/304 (36%), Gaps = 27/304 (8%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKNRELQIMRLLNHPNVV 193
++ ++G G+ VF+ + +TGD AIK L+ + RE ++++ LNH N+V
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
L TT L ++E+ + + +P + + +
Sbjct: 71 KLFAIEEETT-TRHKVL--IMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGM 125
Query: 252 NYLHHVVGVCHRDIKPQNLLVNP---HTHQLKICDFGSAKMLVPGEPNISYICSRYYRAP 308
N+L G+ HR+IKP N++ K+ DFG+A+ L E +S + Y P
Sbjct: 126 NHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
Query: 309 ELIFGAT-------EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIK--ILGTP 359
++ A +Y +D+WSIG G F G + E++ I G P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419
+ + P + + +++ +L+ + A
Sbjct: 245 SGAISGVQKAENGPIDWS--GDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302
Query: 420 HPFF 423
Sbjct: 303 ETSD 306
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 2e-56
Identities = 69/301 (22%), Positives = 122/301 (40%), Gaps = 51/301 (16%)
Query: 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-RYKNRELQIMR-LLNHPNVVS 194
IS+ + V+G G+ G + + + VA+K++L + + +RE+Q++R HPNV+
Sbjct: 24 ISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIR 82
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
TEKD + + +E + T+ V + PI +Q Q L +
Sbjct: 83 YFC-----TEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQ----QTTSGLAH 133
Query: 254 LHHVVGVCHRDIKPQNLLVNPH----THQLKICDFGSAKMLVPGEPNISY---IC-SRYY 305
LH + + HRD+KP N+L++ + I DFG K L G + S + + +
Sbjct: 134 LHSL-NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 306 RAPELIFGATE--YTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTRE 362
APE++ + T +D++S GCV ++ G F G +
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF----------------GKSLQR 236
Query: 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
+ + P A +L+ +++ P R +A HPF
Sbjct: 237 QANILLGAC-SLDCLH----PEKHE-----DVIARELIEKMIAMDPQKRPSAKHVLKHPF 286
Query: 423 F 423
F
Sbjct: 287 F 287
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 2e-56
Identities = 54/347 (15%), Positives = 95/347 (27%), Gaps = 59/347 (17%)
Query: 124 TTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK------ 177
TTV Q ++ + G VVF + +E + A+K
Sbjct: 51 TTVDSLLSQGERK--LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELER 108
Query: 178 -NRELQIMRLLNHPNVVSLKHCF-------------------FSTTEKDELYLNLVLEYI 217
+ L + + S + D N +L
Sbjct: 109 LHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP 168
Query: 218 S-----ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV 272
+ E ++ IL + + T Q+ R L G+ H P NL +
Sbjct: 169 AASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS-KGLVHGHFTPDNLFI 227
Query: 273 NPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFG-ATEYTTAIDMWSIGCVLA 331
P L + D + G + Y E + +T A++ W +G +
Sbjct: 228 MPDGR-LMLGDVSALW--KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIY 284
Query: 332 ELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKR 391
+ F + + L P +
Sbjct: 285 RVWCLFLPFGLVTPGIKGSWKRPSLRVPGTD--------------------SLAFGSCTP 324
Query: 392 MPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD-PNTCLPNGR 437
+P L+ R L + R LEA P F L++ ++ L G+
Sbjct: 325 LPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEISSSLSTGQ 371
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 3e-56
Identities = 66/319 (20%), Positives = 121/319 (37%), Gaps = 60/319 (18%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPN- 191
Y + +G+G VFQ E AIK V ++ E+ + L +
Sbjct: 11 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 192 -VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
++ L + Y+ +V+E + + K ++ + Y + A
Sbjct: 70 KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKKKSIDPWE----RKSYWKNMLEA 120
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI---SYICSRYYRA 307
++ +H G+ H D+KP N L+ LK+ DFG A + P ++ S + + Y
Sbjct: 121 VHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177
Query: 308 PELIFG----------ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILG 357
PE I ++ + D+WS+GC+L + G+ F +Q+ ++ I
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII--NQISKLHAI-- 233
Query: 358 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEA 417
++PN+ E +FP I + D++ L+ P R + E
Sbjct: 234 ---------IDPNH-EIEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPEL 271
Query: 418 CAHPFFDDLRDPNTCLPNG 436
AHP+ P + G
Sbjct: 272 LAHPYVQIQTHPVNQMAKG 290
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 3e-56
Identities = 79/329 (24%), Positives = 133/329 (40%), Gaps = 56/329 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL------QDKRYKNRELQIMRLLNHPNV 192
Y ++G GSFG V + K T A+K + +D RE+++++ L+HPN+
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSK--HYTRMNQHVPILYVQLYTYQIC 248
+ L +D +V E + E + K ++ Q+
Sbjct: 84 MKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEH-------DAARIIKQVF 131
Query: 249 RALNYLHHVVGVCHRDIKPQN-LLVNPHTH-QLKICDFGSAKMLVPGEPNISYICSRYYR 306
+ Y+H + HRD+KP+N LL + +KI DFG + I + YY
Sbjct: 132 SGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366
APE++ G Y D+WS G +L LL G P F G++ + +I+ + ++
Sbjct: 191 APEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKN--EY--DIL--------KRVET 236
Query: 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426
+ W I +A DL+ ++L + PSLR TA + HP+
Sbjct: 237 GKYAFDL--------PQWRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283
Query: 427 RDPNTCLPNGRPLPTLF----NFTAQGKL 451
+ + L + F A+ KL
Sbjct: 284 SSETPTISDLPSLESAMTNIRQFQAEKKL 312
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 1e-55
Identities = 76/329 (23%), Positives = 131/329 (39%), Gaps = 56/329 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL------QDKRYKNRELQIMRLLNHPNV 192
Y + +G+G++G V + T AIK + E+ +++LL+HPN+
Sbjct: 39 YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYTRMNQHVPILYVQLYTYQIC 248
+ L F +D+ LV+E E + + + + Q+
Sbjct: 99 MKLYDFF-----EDKRNYYLVMECYKGGELFDEIIHRMKFNEV-------DAAVIIKQVL 146
Query: 249 RALNYLHHVVGVCHRDIKPQN-LLVNPHTH-QLKICDFGSAKMLVPGEPNISYICSRYYR 306
+ YLH + HRD+KP+N LL + +KI DFG + + + + + YY
Sbjct: 147 SGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYI 205
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366
APE++ +Y D+WSIG +L LL G P F G++ DQ EI+ +++
Sbjct: 206 APEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQT--DQ--EIL--------RKVEK 251
Query: 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426
+ W + A DL+ ++LQ+ R +A +A HP+ ++
Sbjct: 252 GKYTFDS--------PEWKNV-----SEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298
Query: 427 RDPNTCLPNGRPLPTLF----NFTAQGKL 451
L F KL
Sbjct: 299 CSKKESGIELPSLANAIENMRKFQNSQKL 327
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 2e-55
Identities = 74/314 (23%), Positives = 132/314 (42%), Gaps = 60/314 (19%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-RYKNRELQIMR-LLNHPNVVSLK 196
++E+++G GS G V + G VA+K++L D E++++ +HPNV+
Sbjct: 17 VVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYY 75
Query: 197 HCFFSTTEKDELYLNLVLEYISETVY-RVSKH--YTRMNQHVPILYVQLYTYQICRALNY 253
+E + +L + LE + + V + QI + +
Sbjct: 76 C-----SETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTH------------QLKICDFGSAKMLVPGE----PNI 297
LH + + HRD+KPQN+LV+ + ++ I DFG K L G+ N+
Sbjct: 131 LHSL-KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 298 SYIC-SRYYRAPELIFGATE------YTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQL 349
+ + +RAPEL+ + T +ID++S+GCV +L G+ F + +
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY--SRE 247
Query: 350 VEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPS 409
II+ F ++K + EA DL+S+++ + P
Sbjct: 248 SNIIRG-----------------IFSLDEMKCLHDRSL-----IAEATDLISQMIDHDPL 285
Query: 410 LRCTALEACAHPFF 423
R TA++ HP F
Sbjct: 286 KRPTAMKVLRHPLF 299
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 2e-55
Identities = 65/319 (20%), Positives = 117/319 (36%), Gaps = 60/319 (18%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPN- 191
Y + +G+G VFQ E AIK V ++ E+ + L +
Sbjct: 58 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 192 -VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
++ L + Y+ +V+E + + K ++ + Y + A
Sbjct: 117 KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKKKSIDPWE----RKSYWKNMLEA 167
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI---SYICSRYYRA 307
++ +H G+ H D+KP N L+ LK+ DFG A + P ++ S + + Y
Sbjct: 168 VHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMP 224
Query: 308 PELIFGA----------TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILG 357
PE I ++ + D+WS+GC+L + G+ F + I
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI---- 280
Query: 358 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEA 417
++PN+ E +FP I + D++ L+ P R + E
Sbjct: 281 ---------IDPNH-EIEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPEL 318
Query: 418 CAHPFFDDLRDPNTCLPNG 436
AHP+ P + G
Sbjct: 319 LAHPYVQIQTHPVNQMAKG 337
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 3e-55
Identities = 83/329 (25%), Positives = 139/329 (42%), Gaps = 56/329 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKN---RELQIMRLLNHPN 191
Y +RV+G GSFG V K TG A+K + ++ K K RE+Q+++ L+HPN
Sbjct: 28 YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYTRMNQHVPILYVQLYTYQI 247
++ L F +D+ Y LV E + E + K ++ + Q+
Sbjct: 88 IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISRKRFSEV-------DAARIIRQV 135
Query: 248 CRALNYLHHVVGVCHRDIKPQN-LLVNPHTH-QLKICDFGSAKMLVPGEPNISYICSRYY 305
+ Y+H + HRD+KP+N LL + ++I DFG + + I + YY
Sbjct: 136 LSGITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYY 194
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365
APE++ G Y D+WS G +L LL G P F G + + +I+ ++++
Sbjct: 195 IAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGAN--EY--DIL--------KKVE 240
Query: 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425
+ W K+ A DL+ ++L Y PS+R +A +A H +
Sbjct: 241 KGKYTFEL--------PQWKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287
Query: 426 LRDPNTCLP---NGRPLPTLFNFTAQGKL 451
+ + + F KL
Sbjct: 288 YTKEQISVDVPSLDNAILNIRQFQGTQKL 316
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 7e-55
Identities = 67/331 (20%), Positives = 113/331 (34%), Gaps = 58/331 (17%)
Query: 118 AGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL----QD 173
G ++ + ++ Y+ + +G G F V + L G A+K++L QD
Sbjct: 20 QGHMV--IIDNKH--------YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD 69
Query: 174 KRYKNRELQIMRLLNHPNVVSLKHCFF-STTEKDELYLNLVLEYISE-TVYRVSKHYTRM 231
+ RE + RL NHPN++ L K E + L+L + T++ +
Sbjct: 70 REEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW--LLLPFFKRGTLWNEIERLKDK 127
Query: 232 NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291
+ + ICR L +H G HRD+KP N+L+ Q + D GS
Sbjct: 128 GNFLTEDQILWLLLGICRGLEAIHA-KGYAHRDLKPTNILLG-DEGQPVLMDLGSMNQAC 185
Query: 292 PG----------EPNISYICSRYYRAPELIFGA--TEYTTAIDMWSIGCVLAELLLGQPL 339
+ + C+ YRAPEL D+WS+GCVL ++ G+
Sbjct: 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245
Query: 340 FPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDL 399
+ V + + + PQ R L
Sbjct: 246 YDMVFQKGDSVALA-VQN---------------QLSIPQ----------SPRHSSALWQL 279
Query: 400 VSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430
++ ++ P R + P
Sbjct: 280 LNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 1e-54
Identities = 70/297 (23%), Positives = 117/297 (39%), Gaps = 45/297 (15%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNV 192
Y +GTGS+G + + G + K++ +K+ E+ ++R L HPN+
Sbjct: 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
V ++ L +V+EY + V T+ Q++ +V Q+ AL
Sbjct: 68 VRYYDRII---DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 252 NYLH----HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYR 306
H V HRD+KP N+ ++ +K+ DFG A++L + YY
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366
+PE + Y D+WS+GC+L EL P F S +L I+
Sbjct: 184 SPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIR------------ 229
Query: 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
E KF +I R E ++++R+L R + E +P
Sbjct: 230 ------EGKFRRI---------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 2e-54
Identities = 83/320 (25%), Positives = 137/320 (42%), Gaps = 48/320 (15%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVA---IKKVLQDKRYKNRELQIMRLLNHPNVVSL 195
YM +G G FG+V + + + +K D+ +E+ I+ + H N++ L
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
F + L ++ E+IS + R++ +N+ + YV Q+C AL +
Sbjct: 67 HESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH----QVCEALQF 117
Query: 254 LHHVVGVCHRDIKPQNLL-VNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELI 311
LH + H DI+P+N++ + +KI +FG A+ L PG+ + + Y APE +
Sbjct: 118 LHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLFTAPEYYAPE-V 174
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
+TA DMWS+G ++ LL G F E+ +Q +II E I +
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--NQ--QII--------ENIMNAEYTF 222
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431
E F +I EA+D V RLL R TA EA HP+ +
Sbjct: 223 DEEAFKEIS-------------IEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIER-- 267
Query: 432 CLPNGRPLPTLFNFTAQGKL 451
+ + + TL + L
Sbjct: 268 --VSTKVIRTLKHRRYYHTL 285
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 3e-54
Identities = 87/361 (24%), Positives = 140/361 (38%), Gaps = 70/361 (19%)
Query: 120 QVIATTVGGRNGQPKQTIS--YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK 177
Q IA G + + I Y R +G+G++G V K AIK + + + K
Sbjct: 17 QGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDK 76
Query: 178 N-----------------RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS-- 218
E+ +++ L+HPN++ L F +D+ Y LV E+
Sbjct: 77 GRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGG 131
Query: 219 ETVYRVSK--HYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQN-LLVNPH 275
E ++ + QI + YLH + HRDIKP+N LL N +
Sbjct: 132 ELFEQIINRHKFDEC-------DAANIMKQILSGICYLHKH-NIVHRDIKPENILLENKN 183
Query: 276 TH-QLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELL 334
+ +KI DFG + + + YY APE++ +Y D+WS G ++ LL
Sbjct: 184 SLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILL 241
Query: 335 LGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPP 394
G P F G++ DQ +II ++++ + + W I
Sbjct: 242 CGYPPFGGQN--DQ--DII--------KKVEKGKYYFDF--------NDWKNI-----SD 276
Query: 395 EALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTLF----NFTAQGK 450
EA +L+ +L Y + RCTA EA + N + + L F K
Sbjct: 277 EAKELIKLMLTYDYNKRCTAEEALNSRWIKK-YANNINKSDQKTLCGALSNMRKFEGSQK 335
Query: 451 L 451
L
Sbjct: 336 L 336
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 7e-54
Identities = 83/306 (27%), Positives = 129/306 (42%), Gaps = 54/306 (17%)
Query: 131 GQPKQTIS--YMAERVVGTGSFGVVFQAKCLETGDSVAIK----KVLQDKRYKNRELQIM 184
G K I+ Y E +G GS+G V A T A K ++D +E++IM
Sbjct: 1 GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60
Query: 185 RLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYTRMNQHVPILYV 240
+ L+HPN++ L F +D + LV+E + E RV + +
Sbjct: 61 KSLDHPNIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRES-------DA 108
Query: 241 QLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH--QLKICDFGSAKMLVPGEPNIS 298
+ A+ Y H + V HRD+KP+N L + LK+ DFG A PG+ +
Sbjct: 109 ARIMKDVLSAVAYCHK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-MR 166
Query: 299 YIC-SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILG 357
+ YY +P+++ G Y D WS G ++ LL G P F + + +++I +
Sbjct: 167 TKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIRE--- 221
Query: 358 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEA 417
F FP W + P+A L+ RLL SP R T+L+A
Sbjct: 222 --------------GTFTFP---EKDWLNV-----SPQAESLIRRLLTKSPKQRITSLQA 259
Query: 418 CAHPFF 423
H +F
Sbjct: 260 LEHEWF 265
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 2e-53
Identities = 85/307 (27%), Positives = 131/307 (42%), Gaps = 44/307 (14%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK----KVLQDKRYKNRELQIMRLLNHPNVVS 194
Y +G+G+FGVV + TG K DK E+ IM L+HP +++
Sbjct: 53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L F +D+ + L+LE++S E R++ +M++ I Y++ Q C L
Sbjct: 113 LHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR----QACEGLK 163
Query: 253 YLHHVVGVCHRDIKPQNLL-VNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
++H + H DIKP+N++ +KI DFG A L P E + + APE I
Sbjct: 164 HMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE-I 221
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
DMW+IG + LL G F GE D E + + +K + +
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED--DL--ETL--------QNVKRCDWEF 269
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF-DDLRDPN 430
E F + PEA D + LLQ P R T +A HP+ D +
Sbjct: 270 DEDAFSSVS-------------PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLT 316
Query: 431 TCLPNGR 437
+ +P+ R
Sbjct: 317 SRIPSSR 323
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 4e-53
Identities = 81/338 (23%), Positives = 131/338 (38%), Gaps = 84/338 (24%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL---------QDKRYKNRELQIMRLLNH 189
Y + +G GS+GVV A +T AIK + +D E+++M+ L+H
Sbjct: 28 YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQL----- 242
PN+ L + +DE Y+ LV+E + +++ + V+
Sbjct: 88 PNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142
Query: 243 ------------------------------YTYQICRALNYLHHVVGVCHRDIKPQN-LL 271
QI AL+YLH+ G+CHRDIKP+N L
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ-GICHRDIKPENFLF 201
Query: 272 VNPHTHQLKICDFGSAKMLVPGEPNISYIC-----SRYYRAPELIFGATE-YTTAIDMWS 325
+ ++K+ DFG +K Y + Y+ APE++ E Y D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 326 IGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWH 385
G +L LL+G FPG + D + +++ + F ++
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLN-----------------KKLCFE---NPNYN 301
Query: 386 KIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+ P A DL+S LL + R A+ A HP+
Sbjct: 302 VL-----SPLARDLLSNLLNRNVDERFDAMRALQHPWI 334
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 1e-52
Identities = 68/313 (21%), Positives = 112/313 (35%), Gaps = 61/313 (19%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSL 195
+ V+G G+FG V +A+ AIKK+ + + E+ ++ LNH VV
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 196 KHCF--------FSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTY 245
+ T K + L + +EY + N +
Sbjct: 68 YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE----NLNQQRDEYWRLFR 123
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR-- 303
QI AL+Y+H G+ HRD+KP N+ ++ + +KI DFG AK + +
Sbjct: 124 QILEALSYIHSQ-GIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 304 -------------YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLV 350
Y A E++ G Y IDM+S+G + E++ P G V
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGME----RV 235
Query: 351 EIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSL 410
I+K L + +FP P F ++ L+ + P+
Sbjct: 236 NILKKLRSV-------------SIEFP-----PD---FDDNKMKVEKKIIRLLIDHDPNK 274
Query: 411 RCTALEACAHPFF 423
R A +
Sbjct: 275 RPGARTLLNSGWL 287
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 1e-52
Identities = 72/317 (22%), Positives = 129/317 (40%), Gaps = 58/317 (18%)
Query: 124 TTVGGRNGQPKQTIS--YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRY 176
+ G N + TI ++ +R +G+G+FG V + +G IK +
Sbjct: 7 HSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQ 66
Query: 177 KNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--------ETVYRVSKHY 228
E+++++ L+HPN++ + F +D + +V+E + K
Sbjct: 67 IEAEIEVLKSLDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQARGKAL 121
Query: 229 TRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH--QLKICDFGS 286
+ YV Q+ AL Y H V H+D+KP+N+L + +KI DFG
Sbjct: 122 SEG-------YVAELMKQMMNALAYFHSQ-HVVHKDLKPENILFQDTSPHSPIKIIDFGL 173
Query: 287 AKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGV 346
A++ E + + + Y APE+ + T D+WS G V+ LL G F G S +
Sbjct: 174 AELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTS-L 230
Query: 347 DQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQY 406
+++ + Y E + + P+A+DL+ ++L
Sbjct: 231 EEVQQKAT----------------YKEPNYAV---ECRP------LTPQAVDLLKQMLTK 265
Query: 407 SPSLRCTALEACAHPFF 423
P R +A + H +F
Sbjct: 266 DPERRPSAAQVLHHEWF 282
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 1e-52
Identities = 59/295 (20%), Positives = 110/295 (37%), Gaps = 27/295 (9%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKNRELQIMRLLNHPNVV 193
++ ++G G+ VF+ + +TGD AIK L+ + RE ++++ LNH N+V
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
L TT L ++E+ + + +P + + +
Sbjct: 71 KLFAIEEETT-TRHKVL--IMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGM 125
Query: 252 NYLHHVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAP 308
N+L G+ HR+IKP N++ K+ DFG+A+ L E +S + Y P
Sbjct: 126 NHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
Query: 309 ELIFGAT-------EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIK--ILGTP 359
++ A +Y +D+WSIG G F G + E++ I G P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA 414
+ + P + + +++ +L+
Sbjct: 245 SGAISGVQKAENGPIDWSG--DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-52
Identities = 75/312 (24%), Positives = 136/312 (43%), Gaps = 68/312 (21%)
Query: 131 GQPKQTIS-YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQ 182
+ I + ++G GSF V++A+ + TG VAIK + + YK E++
Sbjct: 4 TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVK 63
Query: 183 IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYV 240
I L HP+++ L + F + +Y LVLE E + +++
Sbjct: 64 IHCQLKHPSILELYNYFED---SNYVY--LVLEMCHNGEMNRYLKNRVKPFSENE----A 114
Query: 241 QLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGE----- 294
+ + +QI + YLH G+ HRD+ NLL+ + +KI DFG + ++ +P E
Sbjct: 115 RHFMHQIITGMLYLHS-HGILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMPHEKHYTL 172
Query: 295 ---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVE 351
PN Y +PE+ + + D+WS+GC+ LL+G+P F ++ + L +
Sbjct: 173 CGTPN--------YISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK 223
Query: 352 IIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR 411
++ +++ P + + EA DL+ +LL+ +P+ R
Sbjct: 224 VVLA-----------------DYEMP-----SF-------LSIEAKDLIHQLLRRNPADR 254
Query: 412 CTALEACAHPFF 423
+ HPF
Sbjct: 255 LSLSSVLDHPFM 266
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-52
Identities = 84/306 (27%), Positives = 138/306 (45%), Gaps = 56/306 (18%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------------RELQIMRL 186
Y+ + +G+G+ G V A +T VAI+ + + K E++I++
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196
Query: 187 LNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYT 244
LNHP ++ +K+ F + ++ Y+ VLE + E +V + + + +LY
Sbjct: 197 LNHPCIIKIKNFF----DAEDYYI--VLELMEGGELFDKVVGN-----KRLKEATCKLYF 245
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH--QLKICDFGSAKMLVPGEPNISYIC- 301
YQ+ A+ YLH G+ HRD+KP+N+L++ +KI DFG +K+L + +C
Sbjct: 246 YQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCG 303
Query: 302 SRYYRAPELIFGATE--YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTP 359
+ Y APE++ Y A+D WS+G +L L G P F L + I G
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG-- 360
Query: 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419
++ F W ++ +ALDLV +LL P R T EA
Sbjct: 361 -------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEALR 399
Query: 420 HPFFDD 425
HP+ D
Sbjct: 400 HPWLQD 405
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 185 bits (470), Expect = 3e-52
Identities = 76/290 (26%), Positives = 130/290 (44%), Gaps = 43/290 (14%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKNRELQIMRLLNHPNVVS 194
Y +GTG+FGVV + TG++ A K V DK +E+Q M +L HP +V+
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L F +D+ + ++ E++S E +V+ + +M++ + Y++ Q+C+ L
Sbjct: 219 LHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLC 269
Query: 253 YLHHVVGVCHRDIKPQNLL-VNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
++H H D+KP+N++ +++LK+ DFG L P + + + APE+
Sbjct: 270 HMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 328
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
G DMWS+G + LL G F GE+ + T +K + N
Sbjct: 329 EG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------------TLRNVKSCDWNM 375
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHP 421
+ F I + D + +LL P+ R T +A HP
Sbjct: 376 DDSAFSGIS-------------EDGKDFIRKLLLADPNTRMTIHQALEHP 412
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 5e-52
Identities = 85/308 (27%), Positives = 136/308 (44%), Gaps = 60/308 (19%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK----KVLQDKRYKN--------RELQIMRL 186
Y+ + +G+G+ G V A +T VAIK + + E++I++
Sbjct: 12 YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 187 LNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYTRMNQHVPILYVQL 242
LNHP ++ +K+ F + ++ Y+ VLE + E +V +K +L
Sbjct: 72 LNHPCIIKIKNFF----DAEDYYI--VLELMEGGELFDKVVGNKRLKEA-------TCKL 118
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH--QLKICDFGSAKMLVPGEPNISYI 300
Y YQ+ A+ YLH G+ HRD+KP+N+L++ +KI DFG +K+L + +
Sbjct: 119 YFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTL 176
Query: 301 C-SRYYRAPELIFGATE--YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILG 357
C + Y APE++ Y A+D WS+G +L L G P F L + I G
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG 235
Query: 358 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEA 417
++ F W ++ +ALDLV +LL P R T EA
Sbjct: 236 ---------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEA 272
Query: 418 CAHPFFDD 425
HP+ D
Sbjct: 273 LRHPWLQD 280
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 8e-52
Identities = 74/297 (24%), Positives = 121/297 (40%), Gaps = 52/297 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
Y ++G GSFG V + K T A+K + + RE+++++ L+HPN+
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSK--HYTRMNQHVPILYVQLYTYQIC 248
+ L +D +V E + E + K ++ Q+
Sbjct: 84 MKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEH-------DAARIIKQVF 131
Query: 249 RALNYLHHVVGVCHRDIKPQNLLV--NPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR 306
+ Y+H + HRD+KP+N+L+ +KI DFG + I + YY
Sbjct: 132 SGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366
APE++ G Y D+WS G +L LL G P F G++ D L +
Sbjct: 191 APEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET------------ 236
Query: 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
++ F W I +A DL+ ++L + PSLR TA + HP+
Sbjct: 237 -----GKYAFD---LPQWRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 8e-52
Identities = 82/327 (25%), Positives = 131/327 (40%), Gaps = 54/327 (16%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
Y +G G+F VV + + G A + K RE +I RLL HPN+
Sbjct: 13 YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSK--HYT-RMNQHVPILYVQLYTYQI 247
V L +E + L+ + ++ E + +Y+ H QI
Sbjct: 73 VRLHDSI-----SEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC--------IQQI 119
Query: 248 CRALNYLHHVVGVCHRDIKPQNLL-VNPHTH-QLKICDFGSAKMLVPGEPNISYIC-SRY 304
A+ + H + GV HR++KP+NLL + +K+ DFG A + + +
Sbjct: 120 LEAVLHCHQM-GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPG 178
Query: 305 YRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364
Y +PE + Y +D+W+ G +L LL+G P F E +I
Sbjct: 179 YLSPE-VLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA---------- 227
Query: 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424
+ FP + W + PEA DL++++L +PS R TA EA HP+
Sbjct: 228 -------GAYDFP---SPEWDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPWIS 272
Query: 425 DLRDPNTCLPNGRPLPTLFNFTAQGKL 451
+C+ + L F A+ KL
Sbjct: 273 HRSTVASCMHRQETVDCLKKFNARRKL 299
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 9e-52
Identities = 81/296 (27%), Positives = 128/296 (43%), Gaps = 64/296 (21%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYK--NRELQIMRLLNHPNVVSL 195
R +G G FG V+ A+ ++ +A+K ++ + RE++I L HPN++ L
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 196 KHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
F D + L+LEY TVYR + ++ ++ Y ++ AL+Y
Sbjct: 75 YGYF-----HDATRVYLILEYAPLGTVYRELQKLSKFDEQR----TATYITELANALSYC 125
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP-------GEPNISYICSRYYRA 307
H V HRDIKP+NLL+ LKI DFG + G + Y
Sbjct: 126 HS-KRVIHRDIKPENLLLGSAGE-LKIADFGWSVHAPSSRRTDLCGTLD--------YLP 175
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367
PE+I G + +D+WS+G + E L+G+P F + + I ++
Sbjct: 176 PEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------------ 222
Query: 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
EF FP + + A DL+SRLL+++PS R E HP+
Sbjct: 223 -----EFTFP-----DF-------VTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 1e-51
Identities = 81/308 (26%), Positives = 122/308 (39%), Gaps = 66/308 (21%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIK----KVLQDKRYKN---RELQIMR 185
P+ Y+ R +G G F F+ +T + A K +L + E+ I R
Sbjct: 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 70
Query: 186 LLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYT 244
L H +VV F D ++ +VLE ++ + K + + + Y
Sbjct: 71 SLAHQHVVGFHGFFED---NDFVF--VVLELCRRRSLLELHKRRKALTEPE----ARYYL 121
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGE--------P 295
QI YLH V HRD+K NL +N ++KI DFG + K+ GE P
Sbjct: 122 RQIVLGCQYLHR-NRVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTP 179
Query: 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKI 355
N Y APE++ ++ +D+WSIGC++ LL+G+P F L E
Sbjct: 180 N--------YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSC----LKE---- 222
Query: 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL 415
T IK E+ P + P A L+ ++LQ P+ R T
Sbjct: 223 ----TYLRIKK-----NEYSIP-----KH-------INPVAASLIQKMLQTDPTARPTIN 261
Query: 416 EACAHPFF 423
E FF
Sbjct: 262 ELLNDEFF 269
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 1e-51
Identities = 78/326 (23%), Positives = 128/326 (39%), Gaps = 53/326 (16%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
Y + +G G+F VV + TG A K + K RE +I R L HPN+
Sbjct: 31 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 90
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSK--HYT-RMNQHVPILYVQLYTYQI 247
V L ++E + LV + ++ E + Y+ H QI
Sbjct: 91 VRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC--------IQQI 137
Query: 248 CRALNYLHHVVGVCHRDIKPQNLLV--NPHTHQLKICDFGSAKMLVPGEPNISYICSRYY 305
++ Y H G+ HR++KP+NLL+ +K+ DFG A + E + + Y
Sbjct: 138 LESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY 196
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365
+PE + Y+ +D+W+ G +L LL+G P F E +I
Sbjct: 197 LSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA----------- 244
Query: 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425
+ +P + W + PEA L+ +L +P R TA +A P+ +
Sbjct: 245 ------GAYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290
Query: 426 LRDPNTCLPNGRPLPTLFNFTAQGKL 451
+ + + L F A+ KL
Sbjct: 291 RERVASAIHRQDTVDCLKKFNARRKL 316
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 2e-51
Identities = 57/295 (19%), Positives = 102/295 (34%), Gaps = 46/295 (15%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHC 198
+ ++G+G FG VF+AK G + IK+V + RE++ + L+H N+V C
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 199 FFSTTEKDELYLNLVLEYISETVYRV----------SKHYTRMNQHVPILYVQLYTYQIC 248
+ E ++ ++ R + + + QI
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAP 308
+ ++Y+H + +RD+KP N+ + T Q+KI DFG L + Y +P
Sbjct: 133 KGVDYIHS-KKLINRDLKPSNIFLV-DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSP 190
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368
E I +Y +D++++G +LAELL ++
Sbjct: 191 EQISS-QDYGKEVDLYALGLILAELL--HVCDTAFETSKFFTDLRDG------------- 234
Query: 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
I + L+ +LL P R E
Sbjct: 235 ------IISDI------------FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 2e-51
Identities = 84/334 (25%), Positives = 127/334 (38%), Gaps = 66/334 (19%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIK----KVLQDKRYKN---RELQIMR 185
P+ Y+ R +G G F F+ +T + A K +L + E+ I R
Sbjct: 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 96
Query: 186 LLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYT 244
L H +VV F D ++ +VLE ++ + K + + + Y
Sbjct: 97 SLAHQHVVGFHGFFED---NDFVF--VVLELCRRRSLLELHKRRKALTEPE----ARYYL 147
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGE--------P 295
QI YLH V HRD+K NL +N ++KI DFG + K+ GE P
Sbjct: 148 RQIVLGCQYLHR-NRVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTP 205
Query: 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKI 355
N Y APE++ ++ +D+WSIGC++ LL+G+P F L E
Sbjct: 206 N--------YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSC----LKE---- 248
Query: 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL 415
T IK E+ P + P A L+ ++LQ P+ R T
Sbjct: 249 ----TYLRIKK-----NEYSIP-----KH-------INPVAASLIQKMLQTDPTARPTIN 287
Query: 416 EACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQG 449
E FF P +P F+
Sbjct: 288 ELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSS 321
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-51
Identities = 83/331 (25%), Positives = 123/331 (37%), Gaps = 56/331 (16%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---------RELQIMRLLNH 189
Y V+G G F VV + ETG A+K V K + RE I +L H
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILY----VQLY 243
P++V L + + L +V E++ + + + K +Y Y
Sbjct: 86 PHIVELLETY-----SSDGMLYMVFEFMDGADLCFEIVKR-----ADAGFVYSEAVASHY 135
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQN-LLVNPH-THQLKICDFGSAKMLVPGEPNISYIC 301
QI AL Y H + HRD+KP LL + + +K+ FG A L
Sbjct: 136 MRQILEALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV 194
Query: 302 -SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPT 360
+ ++ APE + Y +D+W G +L LL G F G ++L E I
Sbjct: 195 GTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGIIK----- 246
Query: 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420
++K W I A DLV R+L P+ R T EA H
Sbjct: 247 -----------GKYKMN---PRQWSHI-----SESAKDLVRRMLMLDPAERITVYEALNH 287
Query: 421 PFFDDLRDPNTCLPNGRPLPTLFNFTAQGKL 451
P+ + + + L F A+ KL
Sbjct: 288 PWLKERDRYAYKIHLPETVEQLRKFNARRKL 318
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-51
Identities = 93/368 (25%), Positives = 148/368 (40%), Gaps = 54/368 (14%)
Query: 96 EKNVNHDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTIS--YMAERVVGTGSFGVV 153
++ ++ + G +G + +S + E +G G+ +V
Sbjct: 10 GVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIV 69
Query: 154 FQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211
++ K T A+K + + K E+ ++ L+HPN++ LK F + ++
Sbjct: 70 YRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF-----ETPTEIS 124
Query: 212 LVLEYIS--ETVYR-VSK-HYT-RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIK 266
LVLE ++ E R V K +Y+ R QI A+ YLH G+ HRD+K
Sbjct: 125 LVLELVTGGELFDRIVEKGYYSERDAADA--------VKQILEAVAYLHEN-GIVHRDLK 175
Query: 267 PQNLL-VNPHTH-QLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELIFGATEYTTAIDM 323
P+NLL P LKI DFG +K++ + +C + Y APE I Y +DM
Sbjct: 176 PENLLYATPAPDAPLKIADFGLSKIVEHQVL-MKTVCGTPGYCAPE-ILRGCAYGPEVDM 233
Query: 324 WSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHP 383
WS+G + LL G F E G + I C E+ F +
Sbjct: 234 WSVGIITYILLCGFEPFYDERGDQFMFRRIL----------NC------EYYFI---SPW 274
Query: 384 WHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTLF 443
W ++ A DLV +L+ P R T +A HP+ + N + L
Sbjct: 275 WDEV-----SLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTG-KAANFVHMDTA-QKKLQ 327
Query: 444 NFTAQGKL 451
F A+ KL
Sbjct: 328 EFNARRKL 335
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 5e-51
Identities = 79/307 (25%), Positives = 127/307 (41%), Gaps = 50/307 (16%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM-RLLNHPNVVSLKH 197
Y + +G GS+ V + T A+K + + KR E++I+ R HPN+++LK
Sbjct: 24 YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKD 83
Query: 198 CFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYT-RMNQHVPILYVQLYTYQICRALN 252
+ D Y+ +V E + E + ++ K ++ R V + I + +
Sbjct: 84 VY-----DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV--------LFTITKTVE 130
Query: 253 YLHHVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAP 308
YLH GV HRD+KP N+L + + ++ICDFG AK L + C + + AP
Sbjct: 131 YLHA-QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAP 189
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKIL-GTPTREEIKCM 367
E + Y A D+WS+G +L +L G F + +I G
Sbjct: 190 E-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG---------- 238
Query: 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF-DDL 426
+F W+ + A DLVS++L P R TA HP+
Sbjct: 239 -----KFSLS---GGYWNSV-----SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD 285
Query: 427 RDPNTCL 433
+ P L
Sbjct: 286 QLPQYQL 292
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 6e-51
Identities = 75/321 (23%), Positives = 128/321 (39%), Gaps = 47/321 (14%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM-RLLNHPNVVSLKHCFF 200
++V+G G G V + TG A+K +L D +E+ + P++V + +
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALK-LLYDSPKARQEVDHHWQASGGPHIVCILD-VY 91
Query: 201 STTEKDELYLNLVLEYIS------ETVYRVSKHYT-RMNQHVPILYVQLYTYQICRALNY 253
+ L +++E + R + +T R + I A+ +
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEI--------MRDIGTAIQF 143
Query: 254 LHHVVGVCHRDIKPQNLL-VNPHTH-QLKICDFGSAKMLVPGEPNISYIC-SRYYRAPEL 310
LH + HRD+KP+NLL + LK+ DFG AK + C + YY APE
Sbjct: 144 LHS-HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPE- 199
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370
+ G +Y + DMWS+G ++ LL G P F +G + + +
Sbjct: 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL------------ 247
Query: 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF-DDLRDP 429
++ FP W ++ +A L+ LL+ P+ R T + HP+ + P
Sbjct: 248 -GQYGFP---NPEWSEV-----SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVP 298
Query: 430 NTCLPNGRPLPTLFNFTAQGK 450
T L R L + + K
Sbjct: 299 QTPLHTARVLQEDKDHWDEVK 319
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 8e-51
Identities = 80/324 (24%), Positives = 129/324 (39%), Gaps = 45/324 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM-RLLNHPNVVSLKH 197
+ +V+G G G V Q T + A+K +LQD RE+++ R P++V +
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRI-V 121
Query: 198 CFFSTTEKDELYLNLVLEYIS------ETVYRVSKHYT-RMNQHVPILYVQLYTYQICRA 250
+ L +V+E + R + +T R + I A
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI--------MKSIGEA 173
Query: 251 LNYLHHVVGVCHRDIKPQNLL-VNPHTH-QLKICDFGSAKMLVPGEPNISYICSRYYRAP 308
+ YLH + + HRD+KP+NLL + + LK+ DFG AK + + YY AP
Sbjct: 174 IQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368
E + G +Y + DMWS+G ++ LL G P F G+ + I+
Sbjct: 233 E-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--------TRIR--- 280
Query: 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF-DDLR 427
+++FP W ++ E L+ LL+ P+ R T E HP+ +
Sbjct: 281 --MGQYEFP---NPEWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 330
Query: 428 DPNTCLPNGRPLPTLFNFTAQGKL 451
P T L R L +
Sbjct: 331 VPQTPLHTSRVL-KEDKERWEDVK 353
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 8e-51
Identities = 72/310 (23%), Positives = 119/310 (38%), Gaps = 58/310 (18%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK----------KVLQDKRYKNRELQIMRLLN 188
Y +G+G F +V + + TG A K + + RE+ I+R +
Sbjct: 7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYTRMNQHVPILYVQLYT 244
HPN+++L F +++ + L+LE +S E + + T +
Sbjct: 67 HPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDE-------ATQFL 114
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSAKMLVPGEPNISYIC 301
QI ++YLH + H D+KP+N+++ N ++K+ DFG A + G I
Sbjct: 115 KQILDGVHYLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIF 172
Query: 302 -SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPT 360
+ + APE I DMWSIG + LL G F GE+ + L I +
Sbjct: 173 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV----- 226
Query: 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420
+ F + A D + RLL P R T ++ H
Sbjct: 227 ------------NYDFD---EEYFSNT-----SELAKDFIRRLLVKDPKRRMTIAQSLEH 266
Query: 421 PFFDDLRDPN 430
+ +R N
Sbjct: 267 SWIKAIRRRN 276
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 8e-51
Identities = 78/325 (24%), Positives = 144/325 (44%), Gaps = 48/325 (14%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-NRELQIMRLL-NHPNVVSLK 196
+ ++ +G GSF + + ++ + A+K + + +E+ ++L HPN+V L
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLH 72
Query: 197 HCFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYT-RMNQHVPILYVQLYTYQICRAL 251
F D+L+ LV+E ++ E R+ KH++ ++ ++ A+
Sbjct: 73 EVF-----HDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI--------MRKLVSAV 119
Query: 252 NYLHHVVGVCHRDIKPQNLL-VNPHTH-QLKICDFGSAKMLVPGEPNISYIC-SRYYRAP 308
+++H V GV HRD+KP+NLL + + + ++KI DFG A++ P + C + +Y AP
Sbjct: 120 SHMHDV-GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP 178
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368
E + Y + D+WS+G +L +L GQ F ++I+ ++IK
Sbjct: 179 E-LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM-----KKIKKG- 231
Query: 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428
+F F W + EA DL+ LL P+ R + + D
Sbjct: 232 ----DFSFE---GEAWKNV-----SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD--- 276
Query: 429 PNTCLPNGRPLPTLFNFTAQGKLIL 453
+ L + PL T + G +
Sbjct: 277 -GSQLSS-NPLMTPDILGSSGAAVH 299
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 9e-51
Identities = 69/333 (20%), Positives = 119/333 (35%), Gaps = 60/333 (18%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK----------KVLQDKRYKNRELQIMRLLN 188
Y +G+G F +V + + TG A K + + RE+ I+R +
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYTRMNQHVPILYVQLYT 244
H NV++L + ++ + L+LE +S E + + + +
Sbjct: 74 HHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEE-------ATSFI 121
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSAKMLVPGEPNISYIC 301
QI +NYLH + H D+KP+N+++ N +K+ DFG A + G I
Sbjct: 122 KQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF 179
Query: 302 -SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPT 360
+ + APE I DMWSIG + LL G F G++ + L I +
Sbjct: 180 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV----- 233
Query: 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420
+ F + A D + +LL R T EA H
Sbjct: 234 ------------SYDFD---EEFFSHT-----SELAKDFIRKLLVKETRKRLTIQEALRH 273
Query: 421 PFFDDLRDPNTCLPNGRPLPT--LFNFTAQGKL 451
P+ + + + + + +
Sbjct: 274 PWITPVDNQQAMVRRESVVNLENFRKQYVRRRW 306
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-50
Identities = 79/322 (24%), Positives = 128/322 (39%), Gaps = 45/322 (13%)
Query: 112 NGNGTEAGQVIATTVGGRNGQPKQTIS-YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV 170
G R T++ + E+ +G G F V++A CL G VA+KKV
Sbjct: 6 QGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV 65
Query: 171 -------LQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE-TVY 222
+ + +E+ +++ LNHPNV+ F E +EL +VLE +
Sbjct: 66 QIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI---EDNELN--IVLELADAGDLS 120
Query: 223 RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC 282
R+ KH+ + + +P V Y Q+C AL ++H V HRDIKP N+ + T +K+
Sbjct: 121 RMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITA-TGVVKLG 178
Query: 283 DFGSAKMLVPGEPNI-SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFP 341
D G + S + + YY +PE I Y D+WS+GC+L E+ Q F
Sbjct: 179 DLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFY 237
Query: 342 GESG-VDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLV 400
G+ + L + I+ + +P + + E LV
Sbjct: 238 GDKMNLYSLCKKIE------------------QCDYPPLPS--------DHYSEELRQLV 271
Query: 401 SRLLQYSPSLRCTALEACAHPF 422
+ + P R
Sbjct: 272 NMCINPDPEKRPDVTYVYDVAK 293
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 3e-50
Identities = 77/316 (24%), Positives = 132/316 (41%), Gaps = 67/316 (21%)
Query: 125 TVGGRNGQPKQTIS-YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYK- 177
T + K TI + R +G G FG V+ A+ + +A+K ++ ++
Sbjct: 1 TALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 60
Query: 178 -NRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHV 235
RE++I L HPN++ + + F + +Y L+LE+ +Y+ + + R ++
Sbjct: 61 LRREIEIQSHLRHPNILRMYNYFHD---RKRIY--LMLEFAPRGELYKELQKHGRFDEQR 115
Query: 236 PILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE- 294
+++ ++ AL+Y H V HRDIKP+NLL+ LKI DFG + P
Sbjct: 116 SATFME----ELADALHYCHE-RKVIHRDIKPENLLMGYKGE-LKIADFGWSVH-APSLR 168
Query: 295 -------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD 347
+ Y PE+I G + +D+W G + E L+G P F S +
Sbjct: 169 RRTMCGTLD--------YLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 219
Query: 348 QLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYS 407
I+ + + KFP P+ + + DL+S+LL+Y
Sbjct: 220 THRRIVNV-----------------DLKFP-----PF-------LSDGSKDLISKLLRYH 250
Query: 408 PSLRCTALEACAHPFF 423
P R HP+
Sbjct: 251 PPQRLPLKGVMEHPWV 266
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 3e-50
Identities = 80/307 (26%), Positives = 133/307 (43%), Gaps = 43/307 (14%)
Query: 126 VGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIK----KVLQDKRYKNREL 181
V + G + ++G G FG V + + TG +A K + ++DK E+
Sbjct: 78 VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEI 137
Query: 182 QIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILY 239
+M L+H N++ L F + + + LV+EY+ E R+ + + IL+
Sbjct: 138 SVMNQLDHANLIQLYDAF-----ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF 192
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLL-VNPHTHQLKICDFGSAKMLVPGEPNIS 298
++ QIC + ++H + + H D+KP+N+L VN Q+KI DFG A+ P E
Sbjct: 193 MK----QICEGIRHMHQ-MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247
Query: 299 YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358
+ + APE + + DMWS+G + LL G F G++ D E +
Sbjct: 248 NFGTPEFLAPE-VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN--DA--ETL----- 297
Query: 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC 418
I + + +F I EA + +S+LL S R +A EA
Sbjct: 298 ---NNILACRWDLEDEEFQDIS-------------EEAKEFISKLLIKEKSWRISASEAL 341
Query: 419 AHPFFDD 425
HP+ D
Sbjct: 342 KHPWLSD 348
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 6e-50
Identities = 71/331 (21%), Positives = 121/331 (36%), Gaps = 65/331 (19%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK----------KVLQDKRYKNRELQIMRLLN 188
Y +G+G F VV + + TG A K + + RE+ I++ +
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYTRMNQHVPILYVQLYT 244
HPNV++L + +++ + L+LE ++ E + + T +
Sbjct: 73 HPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEE-------ATEFL 120
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSAKMLVPGEPNISYIC 301
QI + YLH + + H D+KP+N+++ N ++KI DFG A + G I
Sbjct: 121 KQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIF 178
Query: 302 -SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPT 360
+ + APE I DMWSIG + LL G F G++ + L + +
Sbjct: 179 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV----- 232
Query: 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420
++F + A D + RLL P R T ++ H
Sbjct: 233 ------------NYEFE---DEYFSNT-----SALAKDFIRRLLVKDPKKRMTIQDSLQH 272
Query: 421 PFFDDLRDPNTCLPNGRPLPTLFNFTAQGKL 451
P+ L + K
Sbjct: 273 PWIKPKDTQQ-------ALSRKASAVNMEKF 296
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 7e-50
Identities = 57/321 (17%), Positives = 124/321 (38%), Gaps = 52/321 (16%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN----------------REL 181
R + G F + + + A+K + + + + EL
Sbjct: 37 RTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94
Query: 182 QIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS-----ETVYRVSKHYTRMNQHVP 236
QI+ + + ++ + DE+Y+ + EY+ + +P
Sbjct: 95 QIITDIKNEYCLTC-EGIITN--YDEVYI--IYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 237 ILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN 296
I ++ + + +Y+H+ +CHRD+KP N+L++ + +K+ DFG ++ +V +
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR-VKLSDFGESEYMVDKK-- 206
Query: 297 ISYIC-SRYYRAPELIFGATEY-TTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIK 354
I + + PE + Y +D+WS+G L + F + + +L I+
Sbjct: 207 IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR 266
Query: 355 ILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA 414
+ I+ P F + + + E +D + L+ +P+ R T+
Sbjct: 267 ------TKNIEY--PLDRN-HFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITS 317
Query: 415 LEACAHPFF-----DDLRDPN 430
+A H + +DLR+ +
Sbjct: 318 EDALKHEWLADTNIEDLREFS 338
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 8e-50
Identities = 71/333 (21%), Positives = 121/333 (36%), Gaps = 60/333 (18%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK----------KVLQDKRYKNRELQIMRLLN 188
Y +G+G F +V + + TG A K + + RE+ I+R +
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYTRMNQHVPILYVQLYT 244
HPN+++L + ++ + L+LE +S E + + + +
Sbjct: 74 HPNIITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEE-------ATSFI 121
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSAKMLVPGEPNISYIC 301
QI +NYLH + H D+KP+N+++ N +K+ DFG A + G I
Sbjct: 122 KQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF 179
Query: 302 -SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPT 360
+ + APE I DMWSIG + LL G F G++ + L I +
Sbjct: 180 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV----- 233
Query: 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420
+ F + + A D + +LL R T EA H
Sbjct: 234 ------------SYDFD---EEFFSQT-----SELAKDFIRKLLVKETRKRLTIQEALRH 273
Query: 421 PFF--DDLRDPNTCLPNGRPLPTLFNFTAQGKL 451
P+ D + + L + +
Sbjct: 274 PWITPVDTQQAMVRRESVVNLENFKKQYVRRRW 306
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 9e-50
Identities = 69/305 (22%), Positives = 120/305 (39%), Gaps = 47/305 (15%)
Query: 128 GRNGQPKQTIS-YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRE 180
G Q++ Y+ + +G GSFG K E G IK++ +++ RE
Sbjct: 14 GTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRRE 73
Query: 181 LQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILY 239
+ ++ + HPN+V + F E LY +V++Y +++ +
Sbjct: 74 VAVLANMKHPNIVQYRESFE---ENGSLY--IVMDYCEGGDLFKRINA--QKGVLFQEDQ 126
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY 299
+ + QIC AL ++H + HRDIK QN+ + +++ DFG A++L
Sbjct: 127 ILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNSTVELARA 184
Query: 300 IC-SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358
+ YY +PE+ Y D+W++GCVL EL + F S + LV I
Sbjct: 185 CIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGS-MKNLVLKII---- 238
Query: 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC 418
++ +Y + LVS+L + +P R +
Sbjct: 239 --SGSFPPVSLHY---------------------SYDLRSLVSQLFKRNPRDRPSVNSIL 275
Query: 419 AHPFF 423
F
Sbjct: 276 EKGFI 280
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 1e-49
Identities = 82/317 (25%), Positives = 128/317 (40%), Gaps = 25/317 (7%)
Query: 127 GGRNGQPKQTI--SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----R 179
GGR+ + + +GTG FG V + +TG+ VAIK+ Q+ KN
Sbjct: 2 GGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL 61
Query: 180 ELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN-LVLEYIS--ETVYRVSKH--YTRMNQH 234
E+QIM+ LNHPNVVS + + L L +EY + +++ + +
Sbjct: 62 EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 121
Query: 235 VPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQ--LKICDFGSAKMLVP 292
+ I AL YLH + HRD+KP+N+++ P + KI D G AK L
Sbjct: 122 PIRTLLS----DISSALRYLHE-NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 176
Query: 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEI 352
GE ++ + Y APEL+ +YT +D WS G + E + G F Q
Sbjct: 177 GELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK 235
Query: 353 IKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC 412
++ + E I + KF + P H + + +L + R
Sbjct: 236 VR---EKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAG--KLERWLQCMLMWHQRQRG 290
Query: 413 TALEACAHPFFDDLRDP 429
T + F L
Sbjct: 291 TDPQNPNVGCFQALDSI 307
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-49
Identities = 75/306 (24%), Positives = 125/306 (40%), Gaps = 54/306 (17%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN---RELQIMRLLNHPNVVSLKHC 198
V+G G++G+V+ + L +AIK++ +D RY E+ + + L H N+V
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ---- 83
Query: 199 FFSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
+ + + ++ + +E + + R + + + + YT QI L YL
Sbjct: 84 -YLGSFSENGFIKIFMEQVPGGSLSALLR--SKWGPLKDNEQT--IGFYTKQILEGLKYL 138
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI-SYICSRYYRAPELIFG 313
H + HRDIK N+L+N ++ LKI DFG++K L P ++ + Y APE+I
Sbjct: 139 HDN-QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDK 197
Query: 314 ATE-YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372
Y A D+WS+GC + E+ G+P F +L E +
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKPPFY------ELGEPQAAM---------------- 235
Query: 373 EFKFPQIKAHPWHKIFHKRMP----PEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428
FK K HP +P EA + + + P R A + F
Sbjct: 236 -FKVGMFKVHP-------EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK 287
Query: 429 PNTCLP 434
P
Sbjct: 288 KKKTQP 293
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-49
Identities = 74/299 (24%), Positives = 119/299 (39%), Gaps = 55/299 (18%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
Y + +G G+F VV + TG A K + K RE +I R L HPN+
Sbjct: 8 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS--ETVYR-VSK-HYT-RMNQHVPILYVQLYTYQI 247
V L ++E + LV + ++ E V++ Y+ H QI
Sbjct: 68 VRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC--------IQQI 114
Query: 248 CRALNYLHHVVGVCHRDIKPQNLLV--NPHTHQLKICDFGSAKMLVPGEPNISYIC-SRY 304
++ Y H G+ HR++KP+NLL+ +K+ DFG A + E +
Sbjct: 115 LESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFAGTPG 172
Query: 305 YRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364
Y +PE + Y+ +D+W+ G +L LL+G P F E +I
Sbjct: 173 YLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA---------- 221
Query: 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+ +P + W + PEA L+ +L +P R TA +A P+
Sbjct: 222 -------GAYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPWI 265
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 3e-49
Identities = 71/331 (21%), Positives = 121/331 (36%), Gaps = 61/331 (18%)
Query: 140 MAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--------RELQIMRLLNH-P 190
+ + +G G F VV Q TG A K + KR + E+ ++ L P
Sbjct: 32 LTSKELGRGKFAVVRQCISKSTGQEYAAKFL--KKRRRGQDCRAEILHEIAVLELAKSCP 89
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYIS------ETVYRVSKHYTRMNQHVPILYVQLYT 244
V++L + ++ + L+LEY + + +++ + + V
Sbjct: 90 RVINLHEVY-----ENTSEIILILEYAAGGEIFSLCLPELAEMVSEND-------VIRLI 137
Query: 245 YQICRALNYLHHVVGVCHRDIKPQN-LLVNPH-THQLKICDFGSAKMLVPGEPNISYIC- 301
QI + YLH + H D+KPQN LL + + +KI DFG ++ + + I
Sbjct: 138 KQILEGVYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMG 195
Query: 302 SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTR 361
+ Y APE I TTA DMW+IG + LL F GE + + I ++
Sbjct: 196 TPEYLAPE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV------ 248
Query: 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHP 421
+ + + A D + LL +P R TA +H
Sbjct: 249 -----------NVDYS---EETFSSV-----SQLATDFIQSLLVKNPEKRPTAEICLSHS 289
Query: 422 FFDDLRDPNTCLPNGRPLPTLF-NFTAQGKL 451
+ N P + + + +
Sbjct: 290 WLQQWDFENLFHPEETSSSSQTQDHSVRSSE 320
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 3e-49
Identities = 67/318 (21%), Positives = 117/318 (36%), Gaps = 60/318 (18%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL-----QDKRYKNRELQIMRLLNHPNVV 193
+ + +G G FGVVF+AK + AIK++ + RE++ + L HP +V
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 194 SLKHCFF-------STTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTY 245
+ + ++YL + ++ E + +
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR-CTIEERERSVCLHIFL 125
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR-- 303
QI A+ +LH G+ HRD+KP N+ +K+ DFG + E + +
Sbjct: 126 QIAEAVEFLHS-KGLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 304 -----------YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEI 352
Y +PE I G Y+ +D++S+G +L ELL P F + + +
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL--YP-FSTQMERVRTLTD 239
Query: 353 IKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC 412
++ KFP + + P +V +L SP R
Sbjct: 240 VR------------------NLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERP 272
Query: 413 TALEACAHPFFDDLRDPN 430
A+ + F+DL P
Sbjct: 273 EAINIIENAVFEDLDFPG 290
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 4e-48
Identities = 76/312 (24%), Positives = 127/312 (40%), Gaps = 66/312 (21%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK------------KVLQDKRYK-NRELQIMR 185
Y + ++G G VV + T A+K + +Q+ R +E+ I+R
Sbjct: 19 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 186 LLN-HPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV--SKHYT-RMNQHVPILY 239
++ HPN++ LK + + + LV + + E + + + + +
Sbjct: 79 KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI---- 129
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY 299
+ + LH + + HRD+KP+N+L++ + +K+ DFG + L PGE +
Sbjct: 130 ----MRALLEVICALHKL-NIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEK-LRE 182
Query: 300 IC-SRYYRAPELIFGATE-----YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEII 353
+C + Y APE+I + Y +DMWS G ++ LL G P F + L I+
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 242
Query: 354 KILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT 413
++F + W DLVSR L P R T
Sbjct: 243 S-----------------GNYQFG---SPEWDDY-----SDTVKDLVSRFLVVQPQKRYT 277
Query: 414 ALEACAHPFFDD 425
A EA AHPFF
Sbjct: 278 AEEALAHPFFQQ 289
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 6e-48
Identities = 60/290 (20%), Positives = 116/290 (40%), Gaps = 42/290 (14%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSLKH 197
+G GSF V++ ET VA ++ K K+ E ++++ L HPN+V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 198 CFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH- 255
+ ST + + + LV E ++ T+ K + M V ++ + QI + L +LH
Sbjct: 93 SWESTVKGKK-CIVLVTELMTSGTLKTYLKRFKVMKIKV----LRSWCRQILKGLQFLHT 147
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGAT 315
+ HRD+K N+ + T +KI D G A + + I + + APE+
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-RASFAKAVIGTPEFMAPEMY--EE 204
Query: 316 EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFK 375
+Y ++D+++ G + E+ + + Q+ ++
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI------------------------YR 240
Query: 376 FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425
P F K PE +++ ++ + R + + H FF +
Sbjct: 241 RVTSGVKP--ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-47
Identities = 65/347 (18%), Positives = 124/347 (35%), Gaps = 52/347 (14%)
Query: 85 PKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTIS-YMAER 143
+ + + + L P + G ++ + + + ++ + +
Sbjct: 9 QAHSLASLAKTWSSGSAKLQRLGPETED----NEGVLLTEKLKPVDYEYREEVHWMTHQP 64
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKNRELQIMRLLNHPNVVSLKHCFFST 202
VG GSFG V + K +TG A+KKV L+ ++ EL L+ P +V L
Sbjct: 65 RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--FRVEELVACAGLSSPRIVPLYGA---- 118
Query: 203 TEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVC 261
++ ++N+ +E + ++ ++ K + + Y Q L YLH +
Sbjct: 119 -VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDR----ALYYLGQALEGLEYLHTR-RIL 172
Query: 262 HRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR------YYRAPELIFGAT 315
H D+K N+L++ + +CDFG A L P S + + APE++ G
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG-K 231
Query: 316 EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFK 375
+D+WS C++ +L G + ++I P
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS-EPPPI--------------- 275
Query: 376 FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
+I P + L+ P R +A+E
Sbjct: 276 -REIPPS---------CAPLTAQAIQEGLRKEPVHRASAMELRRKVG 312
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 7e-47
Identities = 80/388 (20%), Positives = 154/388 (39%), Gaps = 71/388 (18%)
Query: 66 STSEAATVARTERSGFDQLPKEMNEMRIRDEKNVNHDDKDLEPSIVNGNGTEAGQVIATT 125
A ++ + +RD+ + + + + + + +
Sbjct: 17 KERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQS 76
Query: 126 VGGRNGQPKQTIS------YMAERVVGTGSFGVVFQAKCLETGDSVAIK----------- 168
+G + P + Y + V+G G VV + TG A+K
Sbjct: 77 MGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSP 136
Query: 169 KVLQDKRYK-NRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRV 224
+ L++ R RE I+R + HP++++L + + ++ LV + + E +
Sbjct: 137 EQLEEVREATRRETHILRQVAGHPHIITLIDSY-----ESSSFMFLVFDLMRKGELFDYL 191
Query: 225 --SKHYT-RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKI 281
+ + + + + A+++LH + HRD+KP+N+L++ + Q+++
Sbjct: 192 TEKVALSEKETRSI--------MRSLLEAVSFLHAN-NIVHRDLKPENILLDDNM-QIRL 241
Query: 282 CDFGSAKMLVPGEPNISYIC-SRYYRAPELIFGATE-----YTTAIDMWSIGCVLAELLL 335
DFG + L PGE + +C + Y APE++ + + Y +D+W+ G +L LL
Sbjct: 242 SDFGFSCHLEPGEK-LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLA 300
Query: 336 GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPE 395
G P F + L I++ +++F + W
Sbjct: 301 GSPPFWHRRQILMLRMIME-----------------GQYQFS---SPEWDDR-----SST 335
Query: 396 ALDLVSRLLQYSPSLRCTALEACAHPFF 423
DL+SRLLQ P R TA +A HPFF
Sbjct: 336 VKDLISRLLQVDPEARLTAEQALQHPFF 363
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-46
Identities = 53/317 (16%), Positives = 97/317 (30%), Gaps = 80/317 (25%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNRELQ----IMRLLNHPN 191
+ +G+G FG VF+ G AIK+ L + L+ L H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
VV + E D + + EY + ++ R+ + ++ Q+ R
Sbjct: 73 VVRYFSAWA---EDDHMLI--QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPH------------------THQLKICDFGSAKMLVP 292
L Y+H + + H DIKP N+ ++ KI D G +
Sbjct: 128 LRYIHSM-SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI-- 184
Query: 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEI 352
P + A E++ + D++++ + +PL
Sbjct: 185 SSPQ-VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN---------- 233
Query: 353 IKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPP-------EALDLVSRLLQ 405
WH+I R+P E +L+ ++
Sbjct: 234 ----------------------------GDQWHEIRQGRLPRIPQVLSQEFTELLKVMIH 265
Query: 406 YSPSLRCTALEACAHPF 422
P R +A+ H
Sbjct: 266 PDPERRPSAMALVKHSV 282
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-46
Identities = 83/325 (25%), Positives = 129/325 (39%), Gaps = 55/325 (16%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIK----KVLQDKRYKNRELQIM-RLLNHPNVVSLK 196
E V+G G+ V L T A+K + + RE++++ + H NV+ L
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 197 HCFFSTTEKDELYLNLVLEYIS--ETVYRVSK--HYT-RMNQHVPILYVQLYTYQICRAL 251
F ++E LV E + + + K H+ V + AL
Sbjct: 78 EFF-----EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV--------VQDVASAL 124
Query: 252 NYLHHVVGVCHRDIKPQNLL-VNP-HTHQLKICDFGSAKMLVPGE-------PNISYIC- 301
++LH+ G+ HRD+KP+N+L +P +KICDF + P + C
Sbjct: 125 DFLHNK-GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCG 183
Query: 302 SRYYRAPELI----FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILG 357
S Y APE++ A+ Y D+WS+G +L LL G P F G G D + +
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243
Query: 358 TPTR---EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA 414
E I+ +++FP W I A DL+S+LL R +A
Sbjct: 244 ACQNMLFESIQEG-----KYEFP---DKDWAHI-----SCAAKDLISKLLVRDAKQRLSA 290
Query: 415 LEACAHPFFDDLRDPNTCLPNGRPL 439
+ HP+ P LP L
Sbjct: 291 AQVLQHPWVQG-CAPENTLPTPMVL 314
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-46
Identities = 54/350 (15%), Positives = 105/350 (30%), Gaps = 86/350 (24%)
Query: 123 ATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---- 178
V G+ +T + V+G +A ETG+S + +R +
Sbjct: 61 PFRVESELGERPRT--LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIK 118
Query: 179 ---RELQIMRLL-------------------------NHPNVVSLKHCFFSTTEKDELYL 210
E+ +RLL ++ ++ +L
Sbjct: 119 QMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 178
Query: 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNL 270
++ +T V ++ ++ + T Q+ R L LHH G+ H ++P ++
Sbjct: 179 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHTYLRPVDI 237
Query: 271 LVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI----------FGATEYTTA 320
+++ + + F V + SR + PEL T T +
Sbjct: 238 VLDQRGG-VFLTGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFS 293
Query: 321 IDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIK 380
D W++G V+ + ++ +
Sbjct: 294 FDAWALGLVIYWIWCADLPITKDAALG--------------------------------- 320
Query: 381 AHPWHKIFH--KRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428
IF K +P L+ L+Y R L+A P ++ LR
Sbjct: 321 --GSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 368
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 2e-45
Identities = 76/356 (21%), Positives = 127/356 (35%), Gaps = 72/356 (20%)
Query: 112 NGNGTEAGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL 171
GQ + +G RV+ G F V++A+ + +G A+K++L
Sbjct: 13 RDQSDFVGQTV--ELGELR--------LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLL 62
Query: 172 ----QDKRYKNRELQIMR-LLNHPNVVSLKHCFFSTTE----KDELYLNLVLEYISETVY 222
+ R +E+ M+ L HPN+V E +L L+ E +
Sbjct: 63 SNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFL-LLTELCKGQLV 121
Query: 223 RVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HVVGVCHRDIKPQNLLVNPHTHQLKI 281
K + V YQ CRA+ ++H + HRD+K +NLL++ +K+
Sbjct: 122 EFLKK-MESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ-GTIKL 179
Query: 282 CDFGSAKMLVPG-------------EPNISYICSRYYRAPELI--FGATEYTTAIDMWSI 326
CDFGSA + E I+ + YR PE+I + D+W++
Sbjct: 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWAL 239
Query: 327 GCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHK 386
GC+L L Q F + ++I+ N Y+ P
Sbjct: 240 GCILYLLCFRQHPFEDGA-------KLRIV-----------NGKYS---IPP-------- 270
Query: 387 IFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTL 442
H L+ +LQ +P R + E ++ P P+ L
Sbjct: 271 --HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ--EIAAARNVNPK-SPITEL 321
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-44
Identities = 76/318 (23%), Positives = 125/318 (39%), Gaps = 56/318 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN---RELQIMRLLNHP 190
Y+ ++G GS+G V + ET A+K K+ + + +E+Q++R L H
Sbjct: 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
NV+ L ++ ++ +Y +V+EY E + V + R Y Q
Sbjct: 67 NVIQLVDVLYNEEKQK-MY--MVMEYCVCGMQEMLDSVPEK--RFPVCQAHGYFC----Q 117
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN--ISYIC-SR 303
+ L YLH G+ H+DIKP NLL+ LKI G A+ L P + S
Sbjct: 118 LIDGLEYLHS-QGIVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQGSP 175
Query: 304 YYRAPELIFGATEYT-TAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362
++ PE+ G ++ +D+WS G L + G F G++ + +L E I
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-IYKLFE--NIGK----- 227
Query: 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
+ P P DL+ +L+Y P+ R + + H +
Sbjct: 228 ---------GSYAIP-----GD-------CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266
Query: 423 FDDLRDPNTCLPNGRPLP 440
F P P P
Sbjct: 267 FRKKHPPAEAPVPIPPSP 284
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 4e-44
Identities = 72/320 (22%), Positives = 122/320 (38%), Gaps = 73/320 (22%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN--------------- 178
Y + +G GS+GVV A A+K K+++ +
Sbjct: 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 179 ----------RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSK 226
+E+ I++ L+HPNVV L +D LY +V E ++ + +
Sbjct: 75 QPRGPIEQVYQEIAILKKLDHPNVVKL-VEVLDDPNEDHLY--MVFELVNQGPVMEVPTL 131
Query: 227 HYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286
+++ Y Q + + + YLH+ + HRDIKP NLLV +KI DFG
Sbjct: 132 --KPLSEDQARFYFQ----DLIKGIEYLHY-QKIIHRDIKPSNLLVG-EDGHIKIADFGV 183
Query: 287 AKMLVPGEPNISYIC-SRYYRAPELIFGAT-EYT-TAIDMWSIGCVLAELLLGQPLFPGE 343
+ + +S + + APE + ++ A+D+W++G L + GQ F E
Sbjct: 184 SNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243
Query: 344 SGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRL 403
+ L IK +FP + + DL++R+
Sbjct: 244 R-IMCLHSKIK----------------SQALEFPD----------QPDIAEDLKDLITRM 276
Query: 404 LQYSPSLRCTALEACAHPFF 423
L +P R E HP+
Sbjct: 277 LDKNPESRIVVPEIKLHPWV 296
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 5e-44
Identities = 74/312 (23%), Positives = 119/312 (38%), Gaps = 65/312 (20%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM-RLLNHPNVVSLKH 197
+ +V+G G G V Q T + A+ K+LQD RE+++ R P++V +
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVD 78
Query: 198 CFFSTTEKDELYLNLVLEYIS------ETVYRVSKHYT-RMNQHVPILYVQLYTYQICRA 250
+ L +V+E + R + +T R + I A
Sbjct: 79 -VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI--------MKSIGEA 129
Query: 251 LNYLHHVVGVCHRDIKPQNLL-VNPHTH-QLKICDFGSAKMLVPGEPNISYICSRYYRAP 308
+ YLH + + HRD+KP+NLL + + LK+ DFG A
Sbjct: 130 IQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFG--------------------FAK 168
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368
E +Y + DMWS+G ++ LL G P F G+ + I+
Sbjct: 169 ETT--GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--------TRIR--- 215
Query: 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF-DDLR 427
+++FP W ++ E L+ LL+ P+ R T E HP+ +
Sbjct: 216 --MGQYEFP---NPEWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265
Query: 428 DPNTCLPNGRPL 439
P T L R L
Sbjct: 266 VPQTPLHTSRVL 277
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 9e-44
Identities = 77/311 (24%), Positives = 125/311 (40%), Gaps = 47/311 (15%)
Query: 123 ATTVGGRNGQPKQTI-SYMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRY 176
T G + Y + +G+G+FGV + T + VA+K + +
Sbjct: 5 PVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ 64
Query: 177 KNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQH 234
RE+ R L HPN+V K + L +++EY S E R+ R ++
Sbjct: 65 --REIINHRSLRHPNIVRFKEVILT---PTHLA--IIMEYASGGELYERICNA-GRFSED 116
Query: 235 VPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH-QLKICDFGSAKMLVPG 293
+ Q Q+ ++Y H + +CHRD+K +N L++ +LKICDFG +K V
Sbjct: 117 EARFFFQ----QLLSGVSYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171
Query: 294 EPNISYICSRYYRAPELIFGATEYT-TAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEI 352
S + + Y APE++ EY D+WS G L +L+G F
Sbjct: 172 SQPKSTVGTPAYIAPEVLLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPE-------- 222
Query: 353 IKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC 412
T + I + ++ P R+ PE L+SR+ P+ R
Sbjct: 223 EPRDYRKTIQRILSV-----KYSIPD----------DIRISPECCHLISRIFVADPATRI 267
Query: 413 TALEACAHPFF 423
+ E H +F
Sbjct: 268 SIPEIKTHSWF 278
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-43
Identities = 77/296 (26%), Positives = 123/296 (41%), Gaps = 50/296 (16%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
+ + +G G++G V A T ++VA+K V + +E+ I ++LNH NVV
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
E + Y L LEY S E R+ M + + Q+ +
Sbjct: 69 KFYGHR---REGNIQY--LFLEYCSGGELFDRIEPD-IGMPEPDAQRFFH----QLMAGV 118
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN--ISYIC-SRYYRAP 308
YLH +G+ HRDIKP+NLL++ LKI DFG A + ++ +C + Y AP
Sbjct: 119 VYLHG-IGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 309 ELIFGATEYT-TAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367
EL+ E+ +D+WS G VL +L G+ P + D E ++
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQEYSDWK----EKKTYLN 229
Query: 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
PW K + L L+ ++L +PS R T + ++
Sbjct: 230 ---------------PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWY 265
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-43
Identities = 83/306 (27%), Positives = 132/306 (43%), Gaps = 68/306 (22%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDK--RYKNRELQIMRLLNHPNVVSL 195
+++G GSF V A+ L T AIK ++++ Y RE +M L+HP V L
Sbjct: 36 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
F +D+ L L Y E + + K ++ + YT +I AL Y
Sbjct: 96 YFTF-----QDDEKLYFGLSYAKNGELLKYIRK-IGSFDETC----TRFYTAEIVSALEY 145
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY-------YR 306
LH G+ HRD+KP+N+L+N H ++I DFG+AK+L S Y
Sbjct: 146 LHG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVL----SPESKQARANSFVGTAQYV 199
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366
+PEL+ + D+W++GC++ +L+ G P F + + + KI+
Sbjct: 200 SPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGN-EYLIFQ--KII---------- 245
Query: 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT------ALEACAH 420
E+ FP ++ P+A DLV +LL + R AH
Sbjct: 246 ----KLEYDFP------------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAH 289
Query: 421 PFFDDL 426
PFF+ +
Sbjct: 290 PFFESV 295
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 8e-43
Identities = 77/296 (26%), Positives = 123/296 (41%), Gaps = 50/296 (16%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
+ + +G G++G V A T ++VA+K V + +E+ I ++LNH NVV
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
E + Y L LEY S E R+ M + + Q+ +
Sbjct: 69 KFYGHR---REGNIQY--LFLEYCSGGELFDRIEPD-IGMPEPDAQRFFH----QLMAGV 118
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN--ISYIC-SRYYRAP 308
YLH +G+ HRDIKP+NLL++ LKI DFG A + ++ +C + Y AP
Sbjct: 119 VYLHG-IGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 309 ELIFGATEYT-TAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367
EL+ E+ +D+WS G VL +L G+ P + D E ++
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQEYSDWK----EKKTYLN 229
Query: 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
PW K + L L+ ++L +PS R T + ++
Sbjct: 230 ---------------PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWY 265
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 9e-43
Identities = 57/362 (15%), Positives = 110/362 (30%), Gaps = 89/362 (24%)
Query: 117 EAGQVIATTVGGRNGQPKQTISYMAER--------VVGTGSFGVVFQAKCLETGDSVAIK 168
A + +T GQP + S + ER V+G +A ETG+S +
Sbjct: 50 SAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVH 109
Query: 169 KVLQDKRYKN-------RELQIMRLL-------------------------NHPNVVSLK 196
+R + E+ +RLL ++ ++
Sbjct: 110 VPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVR 169
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
+L ++ +T V ++ ++ + T Q+ R L LHH
Sbjct: 170 LDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 229
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY----YRAPELIF 312
G+ H ++P +++++ + + F G +S I + A ++
Sbjct: 230 -YGLVHTYLRPVDIVLDQRGG-VFLTGFEHLV--RDGASAVSPIGRGFAPPETTAERMLP 285
Query: 313 GA----TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368
T T A D W++G + + ++ +
Sbjct: 286 FGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS------------------- 326
Query: 369 PNYTEFKFPQIKAHPWHKIFH--KRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426
IF K +P L+ L+Y R L+A P ++ L
Sbjct: 327 ----------------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370
Query: 427 RD 428
R
Sbjct: 371 RT 372
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 6e-42
Identities = 74/296 (25%), Positives = 128/296 (43%), Gaps = 50/296 (16%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDK--RYKNRELQIMRLLNHPNVVSL 195
R +G GSFG V + +T A+K K ++ R +ELQIM+ L HP +V+L
Sbjct: 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+ F +DE + +V++ + + Y + ++ + V+L+ ++ AL+Y
Sbjct: 81 WYSF-----QDEEDMFMVVDLLLGGDLRYHLQQN-VHFKEET----VKLFICELVMALDY 130
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIF- 312
L + + HRD+KP N+L++ H H + I DF A ML + ++ Y APE+
Sbjct: 131 LQNQ-RIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS 188
Query: 313 -GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
Y+ A+D WS+G ELL G+ + S +
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE--------------T 234
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEA-CAHPFFDDL 426
T +P E + L+ +LL+ +P R + L P+ +D+
Sbjct: 235 TVVTYPS------------AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-41
Identities = 72/362 (19%), Positives = 130/362 (35%), Gaps = 71/362 (19%)
Query: 100 NHDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTIS--YMAERVVGTGSFGVVFQAK 157
+H +V A G+ K+ + Y ++G+G FG V+
Sbjct: 4 SHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGI 63
Query: 158 CLETGDSVAIK-----KVLQDKRYKN-----RELQIMRLLNH--PNVVSLKHCFFSTTEK 205
+ VAIK ++ N E+ +++ ++ V+ L +F
Sbjct: 64 RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD-WFER--P 120
Query: 206 DELYLNLVLEYISETV----YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVC 261
D L +LE + + + + + + Q+ A+ + H+ GV
Sbjct: 121 DSFVL--ILERPEPVQDLFDFITER--GALQEELARSFFW----QVLEAVRHCHNC-GVL 171
Query: 262 HRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELIFGATEYT-T 319
HRDIK +N+L++ + +LK+ DFGS +L + +R Y PE I Y
Sbjct: 172 HRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRY-HRYHGR 228
Query: 320 AIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQI 379
+ +WS+G +L +++ G F + +I+ + F
Sbjct: 229 SAAVWSLGILLYDMVCGDIPFEHDE---------EIIR--------------GQVFFR-- 263
Query: 380 KAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN-TCLPNGRP 438
+R+ E L+ L PS R T E HP+ D+ P T +
Sbjct: 264 ----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHS 313
Query: 439 LP 440
L
Sbjct: 314 LS 315
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-41
Identities = 68/312 (21%), Positives = 123/312 (39%), Gaps = 39/312 (12%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKN--RELQIMRLLNHPNVVSLKHC 198
+G G+ GVVF+ +G +A K + ++ RELQ++ N P +V
Sbjct: 40 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99
Query: 199 FFSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
F+S E +++ +E++ + V + + +P + + + + L YL
Sbjct: 100 FYSDGE-----ISICMEHMDGGSLDQVLKKAGR-------IPEQILGKVSIAVIKGLTYL 147
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA 314
+ HRD+KP N+LVN ++K+CDFG + L+ N S++ +R Y +PE + G
Sbjct: 148 REKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQGT 205
Query: 315 TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEF 374
Y+ D+WS+G L E+ +G+ P + + + E
Sbjct: 206 H-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264
Query: 375 KFPQIKAHPWHKIF---------------HKRMPPEALDLVSRLLQYSPSLRCTALEACA 419
+ + P IF E D V++ L +P+ R +
Sbjct: 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324
Query: 420 HPFFDDLRDPNT 431
H F
Sbjct: 325 HAFIKRSDAEEV 336
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 5e-41
Identities = 85/318 (26%), Positives = 137/318 (43%), Gaps = 57/318 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--------RELQIMRLLNHP 190
Y + +G G+F V A+ + TG VAIK + DK N RE++IM++LNHP
Sbjct: 17 YRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNHP 74
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
N+V L TEK L L++EY S E + H RM + + QI
Sbjct: 75 NIVKLFEVI--ETEKT---LYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFR----QIV 124
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRA 307
A+ Y H + HRD+K +NLL++ +KI DFG + G + C + Y A
Sbjct: 125 SAVQYCHQ-KRIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVGGK-LDAFCGAPPYAA 181
Query: 308 PELIFGATEYT-TAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366
PEL G +Y +D+WS+G +L L+ G F G++ + +L E +
Sbjct: 182 PELFQG-KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELRERVL------------ 227
Query: 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426
+++ P + M + +L+ R L +P R T + + +
Sbjct: 228 ----RGKYRIP-----FY-------MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG 271
Query: 427 RDPNTCLPNGRPLPTLFN 444
+ + P P + +
Sbjct: 272 HEEDELKPFVEPELDISD 289
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 6e-41
Identities = 84/307 (27%), Positives = 130/307 (42%), Gaps = 52/307 (16%)
Query: 127 GGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------R 179
G ++ + Y+ +G G+FG V + TG VA+K + + K R
Sbjct: 1 GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60
Query: 180 ELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPI 237
E+Q ++L HP+++ L + + + +V+EY+S E + KH R+ +
Sbjct: 61 EIQNLKLFRHPHIIKLYQVIST---PTDFF--MVMEYVSGGELFDYICKH-GRVEEMEAR 114
Query: 238 LYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI 297
Q QI A++Y H V HRD+KP+N+L++ H KI DFG + M+ GE +
Sbjct: 115 RLFQ----QILSAVDYCHR-HMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEF-L 167
Query: 298 SYIC-SRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKIL 356
C S Y APE+I G +D+WS G +L LL G F E V L + KI
Sbjct: 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-VPTLFK--KIR 224
Query: 357 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALE 416
G F P + + L+ +LQ P R T +
Sbjct: 225 G--------------GVFYIP-----EY-------LNRSVATLLMHMLQVDPLKRATIKD 258
Query: 417 ACAHPFF 423
H +F
Sbjct: 259 IREHEWF 265
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 73/309 (23%), Positives = 129/309 (41%), Gaps = 59/309 (19%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDK--RYKNRELQIMRLLNHPNVVSL 195
+V+G G+FG V K A+K ++L+ E ++ + + +L
Sbjct: 80 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+ F +D+ L LV++Y + + +SK R+ + + + Y ++ A++
Sbjct: 140 HYAF-----QDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM----ARFYLAEMVIAIDS 190
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY-ICSRY-YRAPELI 311
+H + HRDIKP N+L++ + H +++ DFGS L+ S Y +PE++
Sbjct: 191 VHQ-LHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248
Query: 312 ----FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367
G Y D WS+G + E+L G+ F ES + + KI+ R
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYG--KIMNHKER------ 299
Query: 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT---ALEACAHPFF- 423
F+FP + A DL+ RL+ S R + HPFF
Sbjct: 300 ------FQFPT---------QVTDVSENAKDLIRRLIC-SREHRLGQNGIEDFKKHPFFS 343
Query: 424 ----DDLRD 428
D++R+
Sbjct: 344 GIDWDNIRN 352
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-40
Identities = 71/305 (23%), Positives = 111/305 (36%), Gaps = 70/305 (22%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN-----RELQIMRLLN 188
Y ++G G FG VF L VAIK +VL + E+ ++ +
Sbjct: 33 YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 189 ----HPNVVSLKHCFFSTTEKDELYLNLVLEYISETV----YRVSKHYTRMNQHVPILYV 240
HP V+ L +F T ++ L VLE Y K + + +
Sbjct: 93 AGGGHPGVIRL-LDWFET--QEGFML--VLERPLPAQDLFDYITEK--GPLGEGPSRCFF 145
Query: 241 QLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYI 300
Q+ A+ + H GV HRDIK +N+L++ K+ DFGS +L +
Sbjct: 146 G----QVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDF 198
Query: 301 C-SRYYRAPELIFGATEYT-TAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358
+R Y PE I +Y +WS+G +L +++ G F + +IL
Sbjct: 199 DGTRVYSPPEWISR-HQYHALPATVWSLGILLYDMVCGDIPFERDQ---------EILE- 247
Query: 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC 418
E FP + P+ L+ R L PS R + E
Sbjct: 248 -------------AELHFP------------AHVSPDCCALIRRCLAPKPSSRPSLEEIL 282
Query: 419 AHPFF 423
P+
Sbjct: 283 LDPWM 287
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-40
Identities = 69/358 (19%), Positives = 125/358 (34%), Gaps = 103/358 (28%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
+ + +G G FGVVF+AK + AIK++ R RE++ + L HP +V
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 194 SLKHCFF------------------------STTEKDELYLNLVLEYISETVYRVSKHYT 229
+ + ++ ++ + + + +
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 230 RMNQHVPILYVQL----------------------------YTYQICRALNYLHHVVGVC 261
+ + LY+Q+ QI A+ +LH G+
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK-GLM 186
Query: 262 HRDIKPQNLLVNPHTHQLKICDFGSAKML-------------VPGEPNISYICSRYYRAP 308
HRD+KP N+ +K+ DFG + + + ++ Y +P
Sbjct: 187 HRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368
E I G Y+ +D++S+G +L ELL + V II + R
Sbjct: 246 EQIHG-NNYSHKVDIFSLGLILFELL--YSFSTQ----MERVRIITDV----RNL----- 289
Query: 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426
KFP +F ++ P E +V +L SP+ R A + + F++L
Sbjct: 290 ------KFP--------LLFTQKYPQEH-MMVQDMLSPSPTERPEATDIIENAIFENL 332
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-40
Identities = 79/317 (24%), Positives = 123/317 (38%), Gaps = 73/317 (23%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKK-----VLQDKR--YKNRELQIMRLLNHPNVVSL 195
+V+G G+F V K +TG A+K +L+ E ++ + + L
Sbjct: 67 KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
F +DE YL LV+EY + + +SK R+ + + Y +I A++
Sbjct: 127 HFAF-----QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM----ARFYLAEIVMAIDS 177
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS--------YICSRYY 305
+H + G HRDIKP N+L++ H +++ DFGS L S Y+
Sbjct: 178 VHRL-GYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYL----- 230
Query: 306 RAPELI------FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTP 359
+PE++ G Y D W++G E+ GQ F +S + KI+
Sbjct: 231 -SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS-TAETYG--KIVHYK 286
Query: 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR---CTALE 416
P + +P EA D + RLL P R A +
Sbjct: 287 EH------------LSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGD 324
Query: 417 ACAHPFF-----DDLRD 428
HPFF D LRD
Sbjct: 325 FRTHPFFFGLDWDGLRD 341
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-40
Identities = 74/304 (24%), Positives = 123/304 (40%), Gaps = 59/304 (19%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVS 194
RV+G G FG VF + TG A K L KR K R E +I+ ++ +VS
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACK-KLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPIL---YVQLYTYQICR 249
L + F + K +L L V+ ++ + Y H +++ P YT QI
Sbjct: 250 LAYAFET---KTDLCL--VMTIMNGGDIRY----HIYNVDEDNPGFQEPRAIFYTAQIVS 300
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAP 308
L +LH + +RD+KP+N+L++ + ++I D G A L G+ + + AP
Sbjct: 301 GLEHLHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAP 358
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEII-KILGTPTREEIKCM 367
EL+ G EY ++D +++G L E++ + F + E+ ++L
Sbjct: 359 ELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVT------ 411
Query: 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR-----CTALEACAHPF 422
+ + P + D LLQ P R + HP
Sbjct: 412 --------------------YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL 451
Query: 423 FDDL 426
F D+
Sbjct: 452 FRDI 455
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 6e-40
Identities = 87/368 (23%), Positives = 155/368 (42%), Gaps = 59/368 (16%)
Query: 77 ERSGFDQLPKEMNEM--RIRDEKNVNHDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPK 134
ER+ + P+E E I+ + E +G+ ++ V + +
Sbjct: 85 ERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHR 144
Query: 135 QTIS-YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN--RELQIMRL 186
T++ + +++G G+FG V K TG A+K ++ + E ++++
Sbjct: 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 204
Query: 187 LNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYT 244
HP + +LK+ F + D L V+EY + E + +S+ + + Y
Sbjct: 205 SRHPFLTALKYSFQT---HDRLCF--VMEYANGGELFFHLSRE-----RVFSEDRARFYG 254
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SR 303
+I AL+YLH V +RD+K +NL+++ H +KI DFG K + + C +
Sbjct: 255 AEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTP 313
Query: 304 YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363
Y APE++ +Y A+D W +G V+ E++ G+ F + ++L E+I
Sbjct: 314 EYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELIL--------- 362
Query: 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR-----CTALEAC 418
E +FP + + PEA L+S LL+ P R A E
Sbjct: 363 -------MEEIRFP------------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIM 403
Query: 419 AHPFFDDL 426
H FF +
Sbjct: 404 QHRFFAGI 411
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-39
Identities = 77/295 (26%), Positives = 126/295 (42%), Gaps = 53/295 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN--RELQIMRLLNHPN 191
Y+ +G GSFG V A +T VA+K + + + RE+ ++LL HP+
Sbjct: 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETV--YRVSKHYTRMNQHVPILYVQLYTYQICR 249
++ L + ++ +V+EY + Y V K RM + + Q QI
Sbjct: 71 IIKLYDVITT---PTDIV--MVIEYAGGELFDYIVEKK--RMTEDEGRRFFQ----QIIC 119
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAP 308
A+ Y H + HRD+KP+NLL++ + +KI DFG + ++ G + C S Y AP
Sbjct: 120 AIEYCHR-HKIVHRDLKPENLLLDDN-LNVKIADFGLSNIMTDGNF-LKTSCGSPNYAAP 176
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368
E+I G +D+WS G VL +L+G+ F E + L + +
Sbjct: 177 EVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-IPNLFKKVN-------------- 221
Query: 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+ P + + P A L+ R++ P R T E P+F
Sbjct: 222 --SCVYVMP-----DF-------LSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 2e-39
Identities = 83/405 (20%), Positives = 152/405 (37%), Gaps = 65/405 (16%)
Query: 41 EANLVERSASSLEQHMASTSLEPVASTSEAATVARTERSGFDQLPKEMNEMRIRDEKNVN 100
E + S + ++ L S++A Q+P ++ + I +
Sbjct: 98 EEERLVCSREIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQ-- 155
Query: 101 HDDKDLEPSIVNGNGTEAGQVIATTVGGRNGQPKQTIS-YMAERVVGTGSFGVVFQAKCL 159
+L + T++ + R++G G FG V+ +
Sbjct: 156 ----NLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKA 211
Query: 160 ETGDSVAIKKVLQDKRYKNRE-----------LQIMRLLNHPNVVSLKHCFFSTTEKDEL 208
+TG A+K L KR K ++ L ++ + P +V + + F + D+L
Sbjct: 212 DTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT---PDKL 267
Query: 209 YLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIK 266
+L+ ++ + Y +S+H ++ Y +I L ++H+ V +RD+K
Sbjct: 268 SF--ILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHNR-FVVYRDLK 319
Query: 267 PQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSI 326
P N+L++ H H ++I D G A +P+ + + + Y APE++ Y ++ D +S+
Sbjct: 320 PANILLDEHGH-VRISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQKGVAYDSSADWFSL 377
Query: 327 GCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHK 386
GC+L +LL G F D+ L + P
Sbjct: 378 GCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--------------TMAVELPD-------- 415
Query: 387 IFHKRMPPEALDLVSRLLQYSPSLR--CT---ALEACAHPFFDDL 426
PE L+ LLQ + R C A E PFF L
Sbjct: 416 ----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-39
Identities = 36/315 (11%), Positives = 92/315 (29%), Gaps = 64/315 (20%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDS-----VAIK----KVLQDKRYKNRELQIMRLLN 188
++G G+F V++A + D+ +K + + ++ ++
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSM 125
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
+ ++ L V E S + ++ + + +P V + +
Sbjct: 126 QHMFMKFYSAHLF---QNGSVL--VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQ----------LKICDFGSA---KMLVPG 293
+ + +H + H DIKP N ++ + L + D G + K+ G
Sbjct: 181 MLYMIEQVHDC-EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239
Query: 294 EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEII 353
+ + ++ E++ + ID + + + +L G + G
Sbjct: 240 TIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEG-------- 290
Query: 354 KILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT 413
+ + + W++ FH +L
Sbjct: 291 ------GECKPEGLFRRL-------PHLDMWNEFFHV------------MLNIPDCHHLP 325
Query: 414 ALEACAHPFFDDLRD 428
+L+ +
Sbjct: 326 SLDLLRQKLKKVFQQ 340
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-39
Identities = 88/300 (29%), Positives = 131/300 (43%), Gaps = 54/300 (18%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVS 194
RV+G G FG V + TG A K L+ KR K R E QI+ +N VVS
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACK-KLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 248
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHV-PILYVQLYTYQICRAL 251
L + + + KD L L VL ++ + + H M Q P Y +IC L
Sbjct: 249 LAYAYET---KDALCL--VLTLMNGGDLKF----HIYHMGQAGFPEARAVFYAAEICCGL 299
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
LH + +RD+KP+N+L++ H H ++I D G A + G+ + + Y APE++
Sbjct: 300 EDLHRE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV 357
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
YT + D W++GC+L E++ GQ F REE+
Sbjct: 358 KN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRK------------KKIKREEV------- 397
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR-----CTALEACAHPFFDDL 426
+K P + + +R P+A L S+LL P+ R +A E HP F L
Sbjct: 398 ----ERLVKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-39
Identities = 69/303 (22%), Positives = 117/303 (38%), Gaps = 68/303 (22%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN-------RELQIMRL 186
Y +G+G+FG V+ A E V +K KVL+D ++ E+ I+
Sbjct: 26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 187 LNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETV----YRVSKHYTRMNQHVPILYVQL 242
+ H N++ + F + LV+E + + R+++ + +
Sbjct: 86 VEHANIIKVLD-IFEN--QGFFQ--LVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFR- 137
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC- 301
Q+ A+ YL + HRDIK +N+++ +K+ DFGSA L G+ C
Sbjct: 138 ---QLVSAVGYLRL-KDIIHRDIKDENIVIAED-FTIKLIDFGSAAYLERGKL-FYTFCG 191
Query: 302 SRYYRAPELIFGATEYT-TAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPT 360
+ Y APE++ G Y ++MWS+G L L+ + F +L E ++
Sbjct: 192 TIEYCAPEVLMG-NPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVE------ 238
Query: 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420
P + E + LVS LLQ P R T +
Sbjct: 239 -----------AAIHPP-----YL-------VSKELMSLVSGLLQPVPERRTTLEKLVTD 275
Query: 421 PFF 423
P+
Sbjct: 276 PWV 278
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 8e-39
Identities = 71/298 (23%), Positives = 125/298 (41%), Gaps = 43/298 (14%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKN--RELQI-MRLLNHPNVVSLKH 197
+G G++GVV + + + +G +A+K++ + + K +L I MR ++ P V+
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
F + + + +E + ++ + K Q +P + I +AL +LH
Sbjct: 74 ALFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFG---A 314
+ V HRD+KP N+L+N Q+K+CDFG + LV + Y APE I
Sbjct: 129 LSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQ 187
Query: 315 TEYTTAIDMWSIGCVLAELLLGQPLFPGESGV-DQLVEIIKILGTPTREEIKCMNPNYTE 373
Y+ D+WS+G + EL + + + QL ++++
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE--EPS-------------- 231
Query: 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431
PQ+ A + E +D S+ L+ + R T E HPFF T
Sbjct: 232 ---PQLPADKF--------SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGT 278
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 5e-38
Identities = 74/307 (24%), Positives = 122/307 (39%), Gaps = 68/307 (22%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDK--RYKNRELQIMRLLNHPNVVSL 195
+V+G G+FG V + T A+K ++++ + E IM N P VV L
Sbjct: 75 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+ F +D+ YL +V+EY+ + V +S + + + + YT ++ AL+
Sbjct: 135 FYAF-----QDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKW----ARFYTAEVVLALDA 183
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS--------YICSRYY 305
+H +G HRD+KP N+L++ H LK+ DFG+ + YI
Sbjct: 184 IHS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPDYI----- 236
Query: 306 RAPELIF---GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362
+PE++ G Y D WS+G L E+L+G F +S + KI+
Sbjct: 237 -SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-LVGTYS--KIMNHKNS- 291
Query: 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT---ALEACA 419
FP + EA +L+ L +R E
Sbjct: 292 -----------LTFP----------DDNDISKEAKNLICAFLT-DREVRLGRNGVEEIKR 329
Query: 420 HPFFDDL 426
H FF +
Sbjct: 330 HLFFKND 336
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 1e-37
Identities = 85/313 (27%), Positives = 133/313 (42%), Gaps = 55/313 (17%)
Query: 123 ATTVGGRNGQPKQTI-SYMAERVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRY 176
+ + I Y+ +G G+FG V K TG VA+K K+
Sbjct: 1 GPMAEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVV 60
Query: 177 KN--RELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMN 232
RE+Q ++L HP+++ L + ST +++ +V+EY+S E + K+ R++
Sbjct: 61 GKIRREIQNLKLFRHPHIIKL-YQVIST--PSDIF--MVMEYVSGGELFDYICKN-GRLD 114
Query: 233 QHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292
+ Q QI ++Y H V HRD+KP+N+L++ H KI DFG + M+
Sbjct: 115 EKESRRLFQ----QILSGVDYCHR-HMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSD 168
Query: 293 GEPNISYIC-SRYYRAPELIFGATEYT-TAIDMWSIGCVLAELLLGQPLFPGESGVDQLV 350
GE + C S Y APE+I G Y +D+WS G +L LL G F + V L
Sbjct: 169 GEF-LRTSCGSPNYAAPEVISG-RLYAGPEVDIWSSGVILYALLCGTLPFDDDH-VPTLF 225
Query: 351 EIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSL 410
+ KI F P + + P + L+ +LQ P
Sbjct: 226 K--KICD--------------GIFYTP-----QY-------LNPSVISLLKHMLQVDPMK 257
Query: 411 RCTALEACAHPFF 423
R T + H +F
Sbjct: 258 RATIKDIREHEWF 270
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-37
Identities = 78/304 (25%), Positives = 127/304 (41%), Gaps = 70/304 (23%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDK--RYKNRELQIMRLLNHPNVVSL 195
+ +GTGSFG V K E+G+ A+K KV++ K + E +I++ +N P +V L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+ F KD L +V+EY++ E + R + + Y QI Y
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFS-----HLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP------GEPNISYICSRYYRA 307
LH + + +RD+KP+NLL++ + +++ DFG AK + G P A
Sbjct: 157 LHS-LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWTLCGTPE--------ALA 206
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367
PE+I Y A+D W++G ++ E+ G P F + Q+ E KI+
Sbjct: 207 PEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQ-PIQIYE--KIVSGK-------- 254
Query: 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL-----EACAHPF 422
+FP + DL+ LLQ + R L + H +
Sbjct: 255 ------VRFP------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296
Query: 423 FDDL 426
F
Sbjct: 297 FATT 300
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 76/299 (25%), Positives = 130/299 (43%), Gaps = 57/299 (19%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN--RELQIMRLLNHPNVVSL 195
+++G G+FG V + TG A+K ++ + E ++++ HP + +L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
K+ F T ++ L V+EY + E + +S+ + + Y +I AL Y
Sbjct: 71 KYAF-QTHDR--LCF--VMEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEY 120
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY-YRAPELIF 312
LH V +RDIK +NL+++ H +KI DFG K + + C Y APE++
Sbjct: 121 LHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372
+Y A+D W +G V+ E++ G+ F + ++L E+I
Sbjct: 179 D-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELIL----------------ME 220
Query: 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR-----CTALEACAHPFFDDL 426
E +FP + + PEA L++ LL+ P R A E H FF +
Sbjct: 221 EIRFP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-37
Identities = 79/304 (25%), Positives = 129/304 (42%), Gaps = 70/304 (23%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDK--RYKNRELQIMRLLNHPNVVSL 195
R +GTGSFG V + G A+K V++ K + N E ++ ++ HP ++ +
Sbjct: 12 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 196 KHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
F +D + ++++YI E + K N + Y ++C AL Y
Sbjct: 72 WGTF-----QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV-----AKFYAAEVCLALEY 121
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP------GEPNISYICSRYYRA 307
LH + +RD+KP+N+L++ + H +KI DFG AK + G P+ Y A
Sbjct: 122 LHS-KDIIYRDLKPENILLDKNGH-IKITDFGFAKYVPDVTYTLCGTPD--------YIA 171
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367
PE++ Y +ID WS G ++ E+L G F + + E KIL
Sbjct: 172 PEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSN-TMKTYE--KIL----------- 216
Query: 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL-----EACAHPF 422
E +FP + DL+SRL+ S R L + HP+
Sbjct: 217 ---NAELRFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261
Query: 423 FDDL 426
F ++
Sbjct: 262 FKEV 265
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-36
Identities = 66/299 (22%), Positives = 113/299 (37%), Gaps = 46/299 (15%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKN--RELQI-MRLLNHPNVVSLKH 197
+G+G+ G V++ + +TG +A+K++ + K +L + ++ + P +V
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV 257
F + T+ + + +E + K RM +P + T I +AL YL
Sbjct: 92 TFITNTD-----VFIAMELMGTCA---EKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143
Query: 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI----FG 313
GV HRD+KP N+L++ Q+K+CDFG + LV + Y APE I
Sbjct: 144 HGVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPT 202
Query: 314 ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGV-DQLVEIIKILGTPTREEIKCMNPNYT 372
+Y D+WS+G L EL GQ + + L ++++ P
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--EEP------------- 247
Query: 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431
P + H + V L R + H F
Sbjct: 248 ----PLLPG-------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEV 295
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-36
Identities = 65/300 (21%), Positives = 116/300 (38%), Gaps = 43/300 (14%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKN--RELQI-MRLLNHPNVVSLKH 197
+G G++G V + +G +A+K++ + +K K +L + MR + P +V
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 198 CFFSTTEKDELYLNLVLEYI---SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
F + + +E + + Y+ Y+ ++ +P + T +ALN+L
Sbjct: 89 ALFREGD-----CWICMELMSTSFDKFYK--YVYSVLDDVIPEEILGKITLATVKALNHL 141
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA 314
+ + HRDIKP N+L++ + +K+CDFG + LV R Y APE I +
Sbjct: 142 KENLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPS 200
Query: 315 TE---YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
Y D+WS+G L EL G+ +P + V + +
Sbjct: 201 ASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV---------------VKG 245
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431
+ + + F + V+ L S R E HPF +
Sbjct: 246 DPPQLSNSEEREFSPSFI--------NFVNLCLTKDESKRPKYKELLKHPFILMYEERAV 297
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-36
Identities = 80/301 (26%), Positives = 133/301 (44%), Gaps = 59/301 (19%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSV---AIK-----KVLQDKRYKNR-ELQIMRLLNHPNVV 193
+V+G GSFG VF K + D+ A+K + R + + E I+ +NHP +V
Sbjct: 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 194 SLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
L + F T K LYL +L+++ + R+SK V+ Y ++ AL
Sbjct: 90 KLHYAF-QTEGK--LYL--ILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALAL 139
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPEL 310
++LH + G+ +RD+KP+N+L++ H +K+ DFG +K + E C + Y APE+
Sbjct: 140 DHLHSL-GIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370
+ +T + D WS G ++ E+L G F G+ + + IL
Sbjct: 198 VNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKD-RKETMT--MIL-------------- 239
Query: 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR-----CTALEACAHPFFDD 425
+ PQ + PEA L+ L + +P+ R E H FF
Sbjct: 240 KAKLGMPQ------------FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287
Query: 426 L 426
+
Sbjct: 288 I 288
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-36
Identities = 78/364 (21%), Positives = 135/364 (37%), Gaps = 84/364 (23%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK---NRELQIMRLL-----NHP 190
Y R +G G F V+ + ++ VA+K V + Y E+++++ + N P
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98
Query: 191 N---VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQI 247
N VV L F + ++ +V E + + + Q +P+ V+ Q+
Sbjct: 99 NREMVVQLLDDFKISGVNGT-HICMVFEVLGHHLLKWIIKSN--YQGLPLPCVKKIIQQV 155
Query: 248 CRALNYLHHVVGVCHRDIKPQNLLV----------------------------------- 272
+ L+YLH + H DIKP+N+L+
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 273 -------------NPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTT 319
N ++KI D G+A + I +R YR+ E++ G+ Y T
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNAC--WVHKHFTEDIQTRQYRSLEVLIGS-GYNT 272
Query: 320 AIDMWSIGCVLAELLLGQPLFPGESG------VDQLVEIIKILGTPTREEI-------KC 366
D+WS C+ EL G LF SG D + II++LG R+ I +
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332
Query: 367 MNPNYTEFKFPQIKAHPWHKIFHKRMP------PEALDLVSRLLQYSPSLRCTALEACAH 420
++K ++ ++ D + +L+ P R TA E H
Sbjct: 333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392
Query: 421 PFFD 424
P+ +
Sbjct: 393 PWLN 396
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 64/215 (29%), Positives = 99/215 (46%), Gaps = 18/215 (8%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLNHPNVVSLKHCF 199
E VVG G+FGVV +AK VAIK++ + K EL+ + +NHPN+V L
Sbjct: 13 EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGA- 69
Query: 200 FSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH-- 256
+ LV+EY ++Y V H + + + Q + + YLH
Sbjct: 70 --CLNP----VCLVMEYAEGGSLYNVL-HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATE 316
+ HRD+KP NLL+ LKICDFG+A + + S + APE+ G +
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI--QTHMTNNKGSAAWMAPEVFEG-SN 179
Query: 317 YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVE 351
Y+ D++S G +L E++ + F G +
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM 214
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-35
Identities = 82/303 (27%), Positives = 136/303 (44%), Gaps = 61/303 (20%)
Query: 143 RVVGTGSFGVVFQAKCL---ETGDSVAIK-----KVLQDKRYKNR---ELQIMRLLNHPN 191
RV+G G +G VFQ + + TG A+K ++++ + E I+ + HP
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
+V L + F T K LYL +LEY+S E ++ + + Y +I
Sbjct: 83 IVDLIYAF-QTGGK--LYL--ILEYLSGGELFMQLERE-GIFMEDT----ACFYLAEISM 132
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY-YRAP 308
AL +LH G+ +RD+KP+N+++N H +K+ DFG K + C Y AP
Sbjct: 133 ALGHLHQK-GIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 190
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368
E++ + + A+D WS+G ++ ++L G P F GE+ + ++ KIL
Sbjct: 191 EILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGEN-RKKTID--KIL------------ 234
Query: 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR-----CTALEACAHPFF 423
+ P + EA DL+ +LL+ + + R A E AHPFF
Sbjct: 235 --KCKLNLP------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280
Query: 424 DDL 426
+
Sbjct: 281 RHI 283
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 85/307 (27%), Positives = 140/307 (45%), Gaps = 61/307 (19%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSV---AIK-----KVLQDKRYKNR---ELQIMRLLNH-P 190
+V+GTG++G VF + + D+ A+K ++Q + E Q++ + P
Sbjct: 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
+V+L + F T K L+L +L+YI+ E +S+ + VQ+Y +I
Sbjct: 120 FLVTLHYAF-QTETK--LHL--ILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIV 169
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY-IC-SRYYR 306
AL +LH + G+ +RDIK +N+L++ + H + + DFG +K V E +Y C + Y
Sbjct: 170 LALEHLHKL-GIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 307 APELIFGATE-YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEII-KILGTPTREEI 364
AP+++ G + A+D WS+G ++ ELL G F + + EI +IL
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL-------- 279
Query: 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR-----CTALEACA 419
+E +PQ M A DL+ RLL P R A E
Sbjct: 280 ------KSEPPYPQ------------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 321
Query: 420 HPFFDDL 426
H FF +
Sbjct: 322 HLFFQKI 328
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 82/336 (24%), Positives = 134/336 (39%), Gaps = 58/336 (17%)
Query: 107 EPSIVNGNGTEAGQVIATTVGGRNGQPKQTIS-YMAERVVGTGSFGVVFQAKCLETGDSV 165
EP ++N N G + P S + +V+G GSFG V A+
Sbjct: 7 EPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFY 66
Query: 166 AIK-----KVLQDK--RYKNRELQIM-RLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217
A+K +L+ K ++ E ++ + + HP +V L F T +K LY VL+YI
Sbjct: 67 AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-QTADK--LYF--VLDYI 121
Query: 218 S--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH 275
+ E Y + + + + Y +I AL YLH + + +RD+KP+N+L++
Sbjct: 122 NGGELFYHLQRE-RCFLEPR----ARFYAAEIASALGYLHSL-NIVYRDLKPENILLDSQ 175
Query: 276 THQLKICDFGSAKMLVPGEPNISYICSRY-YRAPELIFGATEYTTAIDMWSIGCVLAELL 334
H + + DFG K + S C Y APE++ Y +D W +G VL E+L
Sbjct: 176 GH-IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEML 233
Query: 335 LGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPP 394
G P F + ++ + IL + +
Sbjct: 234 YGLPPFYSRN-TAEMYD--NIL--------------NKPLQLK------------PNITN 264
Query: 395 EALDLVSRLLQYSPSLR--CT--ALEACAHPFFDDL 426
A L+ LLQ + R +E +H FF +
Sbjct: 265 SARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 77/296 (26%), Positives = 127/296 (42%), Gaps = 54/296 (18%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN--RELQIMRL-LNHPNVVS 194
+++G GSFG VF A+ +T AIK VL D + E +++ L HP +
Sbjct: 23 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
+ F T E L+ V+EY++ + +Y + + Y +I L
Sbjct: 83 MFCTF-QTKEN--LFF--VMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQ 132
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY-YRAPELI 311
+LH G+ +RD+K N+L++ H +KI DFG K + G+ + C Y APE++
Sbjct: 133 FLHSK-GIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL 190
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
G +Y ++D WS G +L E+L+GQ F G+ ++L I+
Sbjct: 191 LG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSIR----------------M 232
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEA-CAHPFFDDL 426
+P + + EA DL+ +L P R HP F ++
Sbjct: 233 DNPFYP------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 75/300 (25%), Positives = 121/300 (40%), Gaps = 58/300 (19%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN--RELQIMRL-LNHPNVVS 194
V+G GSFG V ++ T + A+K V+QD + E +++ L P +
Sbjct: 26 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L CF T ++ LY V+EY++ + +Y + + H Y +I L
Sbjct: 86 LHSCF-QTMDR--LYF--VMEYVNGGDLMYHIQQVGRFKEPHA-----VFYAAEIAIGLF 135
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY-YRAPELI 311
+L G+ +RD+K N++++ H +KI DFG K + C Y APE+I
Sbjct: 136 FLQSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEII 193
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
Y ++D W+ G +L E+L GQ F GE D+L + I+
Sbjct: 194 AY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQ--SIM--------------E 235
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR-----CTALEACAHPFFDDL 426
+P K M EA+ + L+ P R + H FF +
Sbjct: 236 HNVAYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 79/301 (26%), Positives = 129/301 (42%), Gaps = 59/301 (19%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKRYKN--RELQIMRL-LNHPNVVS 194
RV+G GSFG V A+ ETGD A+K +LQD + E +I+ L NHP +
Sbjct: 29 RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L CF T ++ L+ V+E+++ + ++ + K + Y +I AL
Sbjct: 89 LFCCF-QTPDR--LFF--VMEFVNGGDLMFHIQKSRRFDEARA-----RFYAAEIISALM 138
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY-YRAPELI 311
+LH G+ +RD+K N+L++ H K+ DFG K + + C Y APE++
Sbjct: 139 FLHDK-GIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPDYIAPEIL 196
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
Y A+D W++G +L E+L G F E+ D L E I
Sbjct: 197 QE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-EDDLFEAIL----------------N 238
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR------CTALEACAHPFFDD 425
E +P + +A ++ + +P++R HPFF +
Sbjct: 239 DEVVYP------------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286
Query: 426 L 426
+
Sbjct: 287 I 287
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-34
Identities = 81/303 (26%), Positives = 125/303 (41%), Gaps = 46/303 (15%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
Y + V+G+G+ VV A C + VAIK++ +K + +E+Q M +HPN+V
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICR--- 249
S F KDEL+ LV++ +S +V + KH +H + + I R
Sbjct: 77 SYYTSFV---VKDELW--LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 250 -ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSR---- 303
L YLH G HRD+K N+L+ ++I DFG SA + G+ + R
Sbjct: 132 EGLEYLHK-NGQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNK--VRKTFV 187
Query: 304 ---YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPT 360
+ APE++ Y D+WS G EL G + + L+ ++
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ------ 241
Query: 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420
N P ++ K K+ ++S LQ P R TA E H
Sbjct: 242 -------ND------PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288
Query: 421 PFF 423
FF
Sbjct: 289 KFF 291
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 7e-34
Identities = 70/301 (23%), Positives = 127/301 (42%), Gaps = 50/301 (16%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKR--YKNRELQIMRL-LNHPNVVS 194
RV+G GS+ V + +T A+K V D+ + E + NHP +V
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L CF T + L+ V+EY++ + ++ + + +H + Y+ +I ALN
Sbjct: 75 LHSCF-QTESR--LFF--VIEYVNGGDLMFHMQRQRKLPEEHA-----RFYSAEISLALN 124
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELI 311
YLH G+ +RD+K N+L++ H +K+ D+G K + S C + Y APE++
Sbjct: 125 YLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 182
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
G +Y ++D W++G ++ E++ G+ F D + T + +
Sbjct: 183 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL------- 227
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR------CTALEACAHPFFDD 425
F I + + +A ++ L P R + HPFF +
Sbjct: 228 ----FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281
Query: 426 L 426
+
Sbjct: 282 V 282
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 70/301 (23%), Positives = 127/301 (42%), Gaps = 50/301 (16%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDKR--YKNRELQIMRL-LNHPNVVS 194
RV+G GS+ V + +T A++ V D+ + E + NHP +V
Sbjct: 58 RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L CF T + L+ V+EY++ + ++ + + +H + Y+ +I ALN
Sbjct: 118 LHSCF-QTESR--LFF--VIEYVNGGDLMFHMQRQRKLPEEHA-----RFYSAEISLALN 167
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELI 311
YLH G+ +RD+K N+L++ H +K+ D+G K + S C + Y APE++
Sbjct: 168 YLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 225
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
G +Y ++D W++G ++ E++ G+ F D + T + +
Sbjct: 226 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL------- 270
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR--CTALEAC----AHPFFDD 425
F I + + +A ++ L P R C HPFF +
Sbjct: 271 ----FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324
Query: 426 L 426
+
Sbjct: 325 V 325
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 6e-33
Identities = 54/311 (17%), Positives = 111/311 (35%), Gaps = 42/311 (13%)
Query: 146 GTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKN--RELQIMRLLNHPNVVSLKHCF 199
G V A+ TG+ V ++++ ++ EL + +L NHPN+V + F
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 200 FSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
+ +EL+ +V +++ + + + + L + + +AL+Y+HH +
Sbjct: 96 IA---DNELW--VVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHH-M 147
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKML--------VPGEPNISYICSRYYRAPEL 310
G HR +K ++L++ ++ + S + V + + + +PE+
Sbjct: 148 GYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 206
Query: 311 IF-GATEYTTAIDMWSIGCVLAELLLGQP----------LF-------PGESGVDQLVEI 352
+ Y D++S+G EL G L P +
Sbjct: 207 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAE 266
Query: 353 IKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC 412
+ ++ + T +H+ P V + LQ +P R
Sbjct: 267 ELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP 326
Query: 413 TALEACAHPFF 423
+A H FF
Sbjct: 327 SASTLLNHSFF 337
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 8e-33
Identities = 51/226 (22%), Positives = 87/226 (38%), Gaps = 34/226 (15%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----------RELQIMRLLNHP 190
E+ +G G FG+V + + ++ VAIK ++ RE+ IM LNHP
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYT--YQI 247
N+V L +V+E++ +Y ++ PI + I
Sbjct: 84 NIVKLYGL---MHNP----PRMVMEFVPCGDLYHRLL-----DKAHPIKWSVKLRLMLDI 131
Query: 248 CRALNYLH-HVVGVCHRDIKPQNLLVNPHTHQ----LKICDFGSAKMLVPGEPNISYICS 302
+ Y+ + HRD++ N+ + K+ DFG ++ V + +
Sbjct: 132 ALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV--HSVSGLLGN 189
Query: 303 RYYRAPELIFGATE-YTTAIDMWSIGCVLAELLLGQPLFPGESGVD 347
+ APE I E YT D +S +L +L G+ F S
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-32
Identities = 78/315 (24%), Positives = 134/315 (42%), Gaps = 55/315 (17%)
Query: 130 NGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL----QDKRYKNRELQIMR 185
G PK+ Y +G G+ G V+ A + TG VAI+++ K E+ +MR
Sbjct: 15 VGDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72
Query: 186 LLNHPNVVSLKHCFFSTTEKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILYV 240
+PN+V+ + DEL+ +V+EY +++ V T M++ I V
Sbjct: 73 ENKNPNIVNYLDSYLV---GDELW--VVMEYLAGGSLTDVV-----TETCMDEGQ-IAAV 121
Query: 241 QLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN-ISY 299
+ +AL +LH V HRDIK N+L+ +K+ DFG + P + +
Sbjct: 122 ---CRECLQALEFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTM 176
Query: 300 ICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTP 359
+ + Y+ APE++ Y +D+WS+G + E++ G+P + E+ + L +I GTP
Sbjct: 177 VGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTP 234
Query: 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419
+ IF D ++R L+ R +A E
Sbjct: 235 ELQN-----------------PEKLSAIFR--------DFLNRCLEMDVEKRGSAKELLQ 269
Query: 420 HPFFDDLRDPNTCLP 434
H F + ++ P
Sbjct: 270 HQFLKIAKPLSSLTP 284
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 8e-32
Identities = 76/305 (24%), Positives = 130/305 (42%), Gaps = 49/305 (16%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPN 191
+ R +G GSFG V+ A+ + + VAIKK+ + N +E++ ++ L HPN
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+ + C+ + + LV+EY + + + + + Q V I V T+ + L
Sbjct: 116 TIQYRGCYL---REHTAW--LVMEYCLGSASDLLEVHKKPLQEVEIAAV---THGALQGL 167
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
YLH + HRD+K N+L++ +K+ DFGSA ++ P S++ + Y+ APE+I
Sbjct: 168 AYLHS-HNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVI 222
Query: 312 FGATE--YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369
E Y +D+WS+G EL +P + + L I +
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------------NES 270
Query: 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429
P +++ W + F + V LQ P R T+ H F R P
Sbjct: 271 -------PALQSGHWSEYFR--------NFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 315
Query: 430 NTCLP 434
+
Sbjct: 316 TVIMD 320
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 9e-32
Identities = 75/300 (25%), Positives = 121/300 (40%), Gaps = 58/300 (19%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIK-----KVLQDK--RYKNRELQIMRLLN-HPNVVS 194
V+G GSFG V ++ T + A+K V+QD E +++ L P +
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
L CF T ++ LY V+EY++ + +Y + + R + Y +I L
Sbjct: 407 LHSCF-QTMDR--LYF--VMEYVNGGDLMYHIQQV-GRFKEPH----AVFYAAEIAIGLF 456
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELI 311
+L G+ +RD+K N++++ H +KI DFG K + C + Y APE+I
Sbjct: 457 FLQSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEII 514
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
Y ++D W+ G +L E+L GQ F GE D+L + I
Sbjct: 515 AY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIM----------------E 556
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR-----CTALEACAHPFFDDL 426
+P K M EA+ + L+ P R + H FF +
Sbjct: 557 HNVAYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-31
Identities = 67/302 (22%), Positives = 119/302 (39%), Gaps = 48/302 (15%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
+ +G GSFG VF+ T VAIK + ++ +E+ ++ + P V
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
+ T+ L +++EY+ + + + +++ I + +I + L+
Sbjct: 84 KYYGSYLKDTK-----LWIIMEYLGGGSALDLLEP-GPLDETQ-IATI---LREILKGLD 133
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYRAPELI 311
YLH HRDIK N+L++ ++K+ DFG + ++ +++ + ++ APE+I
Sbjct: 134 YLHS-EKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 191
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
+ Y + D+WS+G EL G+P + L I K PT E
Sbjct: 192 KQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK-NNPPTLEG-------- 241
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431
+ K + V L PS R TA E H F +
Sbjct: 242 -----------NYSKPLK--------EFVEACLNKEPSFRPTAKELLKHKFILRNAKKTS 282
Query: 432 CL 433
L
Sbjct: 283 YL 284
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-31
Identities = 64/220 (29%), Positives = 104/220 (47%), Gaps = 34/220 (15%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--------RELQIMRLLNHPNVV 193
E ++G G FG V++A + GD VA+K D +E ++ +L HPN++
Sbjct: 12 EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 194 SLK-HCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+L+ C ++ L LV+E+ + RV + +P + + QI R +
Sbjct: 70 ALRGVC----LKEPNLC--LVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGM 118
Query: 252 NYLHH--VVGVCHRDIKPQNLLVN-------PHTHQLKICDFGSAKMLVPGEPNISYICS 302
NYLH +V + HRD+K N+L+ LKI DFG A+ +S +
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGA 177
Query: 303 RYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPG 342
+ APE+I + ++ D+WS G +L ELL G+ F G
Sbjct: 178 YAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRG 216
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-31
Identities = 79/316 (25%), Positives = 135/316 (42%), Gaps = 55/316 (17%)
Query: 129 RNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL----QDKRYKNRELQIM 184
G P+ + +G GS G+V A+ +G VA+K + Q + E+ IM
Sbjct: 39 DQGDPRLL--LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIM 96
Query: 185 RLLNHPNVVSLKHCFFSTTEKDELYLNLVLEY-----ISETVYRVSKHYTRMNQHVPILY 239
R H NVV + + +EL+ +++E+ +++ V R+N+ I
Sbjct: 97 RDYQHFNVVEMYKSYLV---GEELW--VLMEFLQGGALTDIV-----SQVRLNEEQ-IAT 145
Query: 240 VQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN-IS 298
V + +AL YLH GV HRDIK ++L+ ++K+ DFG + P S
Sbjct: 146 V---CEAVLQALAYLHA-QGVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKS 200
Query: 299 YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358
+ + Y+ APE+I + Y T +D+WS+G ++ E++ G+P + +S V + ++
Sbjct: 201 LVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK-RLRDSPP 258
Query: 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC 418
P + +H + D + R+L P R TA E
Sbjct: 259 PKLKN-----------------SHKVSPVLR--------DFLERMLVRDPQERATAQELL 293
Query: 419 AHPFFDDLRDPNTCLP 434
HPF P +P
Sbjct: 294 DHPFLLQTGLPECLVP 309
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-31
Identities = 75/300 (25%), Positives = 122/300 (40%), Gaps = 47/300 (15%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLNHPNVVSLK 196
+ +G GS+G V++A ETG VAIK+V + + +E+ IM+ + P+VV
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90
Query: 197 HCFFSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
+F T+ L +V+EY + R+ ++ I + + L
Sbjct: 91 GSYFKNTD-----LWIVMEYCGAGSVSDIIRLRNKTLTEDE---IATI---LQSTLKGLE 139
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYRAPELI 311
YLH + HRDIK N+L+N K+ DFG + ++ + I + ++ APE+I
Sbjct: 140 YLHF-MRKIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI 197
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
Y D+WS+G E+ G+P + + + I PT
Sbjct: 198 QEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT-NPPPT----------- 244
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431
F+ P W F D V + L SP R TA + HPF + +
Sbjct: 245 --FRKP----ELWSDNFT--------DFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSI 290
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-31
Identities = 72/306 (23%), Positives = 122/306 (39%), Gaps = 52/306 (16%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL----QDKRYKNRELQIMRLLNHPNVVS 194
+ +G G+FG V++AK ETG A K + ++ E++I+ +HP +V
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
L ++ + L +++E+ + + Q I V Q+ A
Sbjct: 81 LLGAYYHDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQ---IQVV---CRQMLEA 129
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYRAPE 309
LN+LH + HRD+K N+L+ +++ DFG SAK L + S+I + Y+ APE
Sbjct: 130 LNFLHS-KRIIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPE 187
Query: 310 LIFGAT----EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365
++ T Y D+WS+G L E+ +P + + L++I K PT
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK-SDPPTLLT-- 244
Query: 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425
W F D + L +P R +A + HPF
Sbjct: 245 ---------------PSKWSVEFR--------DFLKIALDKNPETRPSAAQLLEHPFVSS 281
Query: 426 LRDPNT 431
+
Sbjct: 282 ITSNKA 287
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 7e-31
Identities = 72/310 (23%), Positives = 127/310 (40%), Gaps = 48/310 (15%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNRELQIMR-LLNHPNVVS 194
+ +VG G++G V++ + ++TG AIK + ++ +E+ +++ +H N+ +
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 195 LKHCFF-STTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
F + L LV+E+ + + +K T + I Y+ +I R
Sbjct: 86 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW--IAYI---CREILR 140
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG-SAKMLVPGEPNISYICSRYYRAP 308
L++LH V HRDIK QN+L+ ++K+ DFG SA++ ++I + Y+ AP
Sbjct: 141 GLSHLHQ-HKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 198
Query: 309 ELI----FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364
E+I Y D+WS+G E+ G P + L I +
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---------- 248
Query: 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424
NP P++K+ W K F + L + S R + HPF
Sbjct: 249 ---NP------APRLKSKKWSKKFQ--------SFIESCLVKNHSQRPATEQLMKHPFIR 291
Query: 425 DLRDPNTCLP 434
D +
Sbjct: 292 DQPNERQVRI 301
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-30
Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSL 195
+ +G GSFG V +A+ G VA+K +++ + RE+ IM+ L HPN+V
Sbjct: 42 KEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 196 K-HCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
T+ L +V EY+S ++YR+ H + + + Y + + +NY
Sbjct: 100 MGAV----TQPPNLS--IVTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 254 LH-HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI-SYICSRYYRAPELI 311
LH + HR++K NLLV+ + +K+CDFG +++ + S + + APE++
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVL 211
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPG 342
D++S G +L EL Q +
Sbjct: 212 RD-EPSNEKSDVYSFGVILWELATLQQPWGN 241
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 29/213 (13%), Positives = 72/213 (33%), Gaps = 26/213 (12%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSL 195
+ G +++ + G+ + +K + R N E +R+ +HPNV+ +
Sbjct: 15 LTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72
Query: 196 KHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYT--YQICRALN 252
+ L+ ++ ++Y + + + Q + R +
Sbjct: 73 LGA---CQSPPAPHPTLITHWMPYGSLY----NVLHEGTNFVVDQSQAVKFALDMARGMA 125
Query: 253 YLH-HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
+LH + + ++++++ +I + + + APE +
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDED-MTARISMADVKFSFQSP----GRMYAPAWVAPEAL 180
Query: 312 FG--ATEYTTAIDMWSIGCVLAELLLGQPLFPG 342
+ DMWS +L EL+ + F
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 47/215 (21%), Positives = 84/215 (39%), Gaps = 32/215 (14%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVL-QDKRYKNRELQI--MRLLNHPNVVS-LKH 197
+ +G G +G V+ K G+ VA+K ++ RE +I L+ H N++ +
Sbjct: 42 VKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 198 CFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH- 255
T +LYL + +Y ++Y K T + + Y L +LH
Sbjct: 100 DIKGTGSWTQLYL--ITDYHENGSLYDYLKSTT-----LDAKSMLKLAYSSVSGLCHLHT 152
Query: 256 ------HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICS-----RY 304
+ HRD+K +N+LV + I D G A + + + +
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 305 YRAPELIFGAT-----EYTTAIDMWSIGCVLAELL 334
Y PE++ + + DM+S G +L E+
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-29
Identities = 47/215 (21%), Positives = 86/215 (40%), Gaps = 32/215 (14%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVL-QDKRYKNRELQI--MRLLNHPNVVS-LKH 197
VG G +G V++ G++VA+K +D++ RE ++ +L H N++ +
Sbjct: 13 LECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 198 CFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH- 255
S +L+L + Y ++Y + T + + I L +LH
Sbjct: 71 DMTSRHSSTQLWL--ITHYHEMGSLYDYLQLTT-----LDTVSCLRIVLSIASGLAHLHI 123
Query: 256 ------HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICS-----RY 304
+ HRD+K +N+LV + I D G A M + + +
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQ-CCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 305 YRAPELI-----FGATEYTTAIDMWSIGCVLAELL 334
Y APE++ + +D+W+ G VL E+
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 9e-29
Identities = 55/221 (24%), Positives = 96/221 (43%), Gaps = 31/221 (14%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ--DKRYKN--RELQIMRLLNHPNVVSLKH 197
V+G G FG + ETG+ + +K++++ ++ + +E+++MR L HPNV+
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF-- 72
Query: 198 CFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
+ L + EYI T+ + K M+ P + I + YLH
Sbjct: 73 -IGVLYKDKRLN--FITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLHS 126
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR------------- 303
+ + HRD+ N LV + + DFG A+++V + + S
Sbjct: 127 -MNIIHRDLNSHNCLVR-ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 304 --YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPG 342
Y+ APE+I G Y +D++S G VL E++ P
Sbjct: 185 NPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 71/239 (29%), Positives = 109/239 (45%), Gaps = 39/239 (16%)
Query: 122 IATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------- 173
I + R Y +G G V+ A+ VAIK +
Sbjct: 5 IGKIINER---------YKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKEET 54
Query: 174 -KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRM 231
KR++ RE+ L+H N+VS+ E+D+ Y LV+EYI T+ Y
Sbjct: 55 LKRFE-REVHNSSQLSHQNIVSM----IDVDEEDDCYY-LVMEYIEGPTL----SEYIES 104
Query: 232 NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291
+ + + +T QI + + H + + HRDIKPQN+L++ LKI DFG AK L
Sbjct: 105 HGPLSVDTAINFTNQILDGIKHAHDM-RIVHRDIKPQNILIDS-NKTLKIFDFGIAKAL- 161
Query: 292 PGEPNISY----ICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGV 346
E +++ + + Y +PE G D++SIG VL E+L+G+P F GE+ V
Sbjct: 162 -SETSLTQTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETAV 218
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 54/224 (24%), Positives = 99/224 (44%), Gaps = 26/224 (11%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSL 195
+ +G+GSFG V++ K GD VA+K + E+ ++R H N++
Sbjct: 29 GQRIGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL- 84
Query: 196 KHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
F + +L +V ++ ++Y H + + Q R ++YL
Sbjct: 85 ---FMGYSTAPQLA--IVTQWCEGSSLYH---HLHASETKFEMKKLIDIARQTARGMDYL 136
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAPELI 311
H + HRD+K N+ ++ + +KI DFG A + + S + APE+I
Sbjct: 137 HA-KSIIHRDLKSNNIFLHED-NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 312 FGATE--YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEII 353
Y+ D+++ G VL EL+ GQ + + DQ++E++
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-28
Identities = 55/236 (23%), Positives = 99/236 (41%), Gaps = 46/236 (19%)
Query: 124 TTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLE-TGDSVAIKKVLQD-------KR 175
V G+ Y + + G G ++ A G V +K L
Sbjct: 76 DIVAGQ---------YEVKGCIAHGGLGWIYLALDRNVNGRPVVLK-GLVHSGDAEAQAM 125
Query: 176 YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN-LVLEYIS-ETVYRVSKHYTRMNQ 233
E Q + + HP++V + F T++ + +V+EY+ +++ R Q
Sbjct: 126 AM-AERQFLAEVVHPSIVQI-FNFVEHTDRHGDPVGYIVMEYVGGQSLKR------SKGQ 177
Query: 234 HVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML--- 290
+P+ Y +I AL+YLH + G+ + D+KP+N+++ QLK+ D G+ +
Sbjct: 178 KLPVAEAIAYLLEILPALSYLHSI-GLVYNDLKPENIMLTEE--QLKLIDLGAVSRINSF 234
Query: 291 --VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES 344
+ G P ++APE++ T A D++++G LA L L P G
Sbjct: 235 GYLYGTP--------GFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRY 280
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 48/215 (22%), Positives = 86/215 (40%), Gaps = 32/215 (14%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVL-QDKRYKNRELQI--MRLLNHPNVVS-LKH 197
+ +G G FG V++ K G+ VA+K +++R RE +I +L H N++ +
Sbjct: 47 QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 198 CFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH- 255
+L+L V +Y +++ YT V + + L +LH
Sbjct: 105 DNKDNGTWTQLWL--VSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHM 157
Query: 256 ------HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICS-----RY 304
+ HRD+K +N+LV + I D G A I + +
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 305 YRAPELIFGAT-----EYTTAIDMWSIGCVLAELL 334
Y APE++ + E D++++G V E+
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 44/223 (19%), Positives = 86/223 (38%), Gaps = 37/223 (16%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSL 195
++G G FG V+ + G+ VAI+ + ++ ++ RE+ R H NVV
Sbjct: 38 GELIGKGRFGQVYHGRWH--GE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 196 K-HCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
C L ++ T+Y V + + + + +I + + Y
Sbjct: 95 MGAC----MSPPHLA--IITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGY 145
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR------YYRA 307
LH G+ H+D+K +N+ + + I DFG + + R + A
Sbjct: 146 LHA-KGILHKDLKSKNVFYDNGK--VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLA 202
Query: 308 PELIFGATE--------YTTAIDMWSIGCVLAELLLGQPLFPG 342
PE+I + ++ D++++G + EL + F
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-27
Identities = 55/219 (25%), Positives = 90/219 (41%), Gaps = 28/219 (12%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL-----QDKRYK---NRELQIMRLLNHP 190
Y R+VG G G V++A+ VA+K ++ D ++ RE + L P
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
+VV + E D + + I+ + R + QI
Sbjct: 95 HVVPI----HDFGEIDGQLY-VDMRLINGVDL----AAMLRRQGPLAPPRAVAIVRQIGS 145
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI----SYICSRYY 305
AL+ H G HRD+KP+N+LV+ + DFG A + + + + + YY
Sbjct: 146 ALDAAHAA-GATHRDVKPENILVSA-DDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYY 201
Query: 306 RAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES 344
APE + T D++++ CVL E L G P + G+
Sbjct: 202 MAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQ 239
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 9e-27
Identities = 64/241 (26%), Positives = 108/241 (44%), Gaps = 37/241 (15%)
Query: 122 IATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL-----QDKRY 176
+ + R Y ++G G V A+ L VA+K VL +D +
Sbjct: 6 TPSHLSDR---------YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSF 55
Query: 177 KNR---ELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN---LVLEYIS-ETVYRVSKHYT 229
R E Q LNHP +V++ + T E + +V+EY+ T+ +
Sbjct: 56 YLRFRREAQNAAALNHPAIVAV----YDTGEAETPAGPLPYIVMEYVDGVTL----RDIV 107
Query: 230 RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289
+ C+ALN+ H G+ HRD+KP N++++ T+ +K+ DFG A+
Sbjct: 108 HTEGPMTPKRAIEVIADACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARA 165
Query: 290 LVPGEPNISY----ICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESG 345
+ +++ I + Y +PE G + D++S+GCVL E+L G+P F G+S
Sbjct: 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSP 224
Query: 346 V 346
V
Sbjct: 225 V 225
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 57/254 (22%), Positives = 103/254 (40%), Gaps = 37/254 (14%)
Query: 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL-QDKRYKNRELQI--MRLLNHPNV 192
++ V G FG V++A+ + VA+K QDK+ E ++ + + H N+
Sbjct: 23 SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENI 80
Query: 193 VS-LKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
+ + T+ +L+L + + + ++ + + N + + R
Sbjct: 81 LQFIGAEKRGTSVDVDLWL--ITAFHEKGSLS----DFLKANVVSWNELCHIA-ETMARG 133
Query: 251 LNYLHHVV---------GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC 301
L YLH + + HRDIK +N+L+ + I DFG A G+ S
Sbjct: 134 LAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGLALKFEAGK---SAGD 189
Query: 302 SRY------YRAPELIFGA----TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVE 351
+ Y APE++ GA + IDM+++G VL EL G L
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249
Query: 352 IIKILGTPTREEIK 365
+I P+ E+++
Sbjct: 250 EEEIGQHPSLEDMQ 263
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 52/231 (22%), Positives = 87/231 (37%), Gaps = 36/231 (15%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKNRELQIMRL--LNHPNVVSLKHC 198
++G G +G V++ VA+K +++ E I R+ + H N+
Sbjct: 18 LELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVG 75
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVS-KHYTRMNQHVPILYVQLYTYQICRALNYLH-- 255
T + LV+EY S Y ++ + +L + + R L YLH
Sbjct: 76 DERVTADGRMEYLLVMEYYP----NGSLXKYLSLHTSDWVSSCRL-AHSVTRGLAYLHTE 130
Query: 256 ------HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY----- 304
+ + HRD+ +N+LV I DFG + L
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGT-CVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 305 ----YRAPELIFGA------TEYTTAIDMWSIGCVLAELLLG-QPLFPGES 344
Y APE++ GA +DM+++G + E+ + LFPGES
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 56/237 (23%), Positives = 100/237 (42%), Gaps = 50/237 (21%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
+V+G+G+FG V++ + G+ VAIK++ + K E +M +++P+V
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ-HVPILYVQLYTYQICRAL 251
L + L+ + + + Y R ++ ++ Y+ + QI + +
Sbjct: 80 CRL----LGICLTSTVQ--LITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 252 NYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR--- 306
NYL +V HRD+ +N+LV +KI DFG AK+L E Y
Sbjct: 131 NYLEDRRLV---HRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEK--------EYHAEG 178
Query: 307 --------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD--QLVE 351
A E ++ YT D+WS G + EL+ G + G + ++E
Sbjct: 179 GKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 6e-21
Identities = 56/238 (23%), Positives = 100/238 (42%), Gaps = 49/238 (20%)
Query: 140 MAERVVGTGSFGVVFQAKCLETGDS--VAIKKV---LQDKRYKN---RELQIMRLLNHPN 191
+ ++ +G+G+FG V + VA+K + D K+ E +M+ L++P
Sbjct: 20 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+V + E + LV+E Y + N+HV + +Q+ +
Sbjct: 80 IVRM----IGICEAESWM--LVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGM 130
Query: 252 NYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR--- 306
YL + V HRD+ +N+L+ H KI DFG +K L E YY+
Sbjct: 131 KYLEESNFV---HRDLAARNVLLVTQ-HYAKISDFGLSKALRADEN--------YYKAQT 178
Query: 307 ---------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD--QLVE 351
APE + + ++++ D+WS G ++ E GQ + G G + ++E
Sbjct: 179 HGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 234
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 6e-21
Identities = 60/218 (27%), Positives = 104/218 (47%), Gaps = 46/218 (21%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
+ +G G+FG V + D+ VA+KK LQ ++ RE++I++ L H N+
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRA 250
V K L L++EY+ Y + Y + ++ I +++L YT QIC+
Sbjct: 74 VKYKGV---CYSAGRRNLKLIMEYLP---YGSLRDYLQKHKE-RIDHIKLLQYTSQICKG 126
Query: 251 LNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR-- 306
+ YL + HRD+ +N+LV + +++KI DFG K+L + +++
Sbjct: 127 MEYLGTKRYI---HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKE--------FFKVK 174
Query: 307 ----------APELIFGATEYTTAIDMWSIGCVLAELL 334
APE + ++++ A D+WS G VL EL
Sbjct: 175 EPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 211
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 45/218 (20%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
R +G G FG V + GD+ VA+K + + + +E++I+R L H N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRA 250
V K TE + L++E++ K Y N++ I Q Y QIC+
Sbjct: 86 VKYKGI---CTEDGGNGIKLIMEFLP---SGSLKEYLPKNKN-KINLKQQLKYAVQICKG 138
Query: 251 LNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR-- 306
++YL V HRD+ +N+LV HQ+KI DFG K + + YY
Sbjct: 139 MDYLGSRQYV---HRDLAARNVLVE-SEHQVKIGDFGLTKAIETDK--------EYYTVK 186
Query: 307 ----------APELIFGATEYTTAIDMWSIGCVLAELL 334
APE + + + A D+WS G L ELL
Sbjct: 187 DDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELL 223
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 63/235 (26%), Positives = 99/235 (42%), Gaps = 44/235 (18%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
R +G G FG V T D VA+K + D ++ +E+ I+R L H ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
+ K C + L LV+EY+ + Y + + + + L+ QIC +
Sbjct: 96 IKYKGC---CEDAGAASLQLVMEYVP---LGSLRDYLPRHS-IGLAQLLLFAQQICEGMA 148
Query: 253 YLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR---- 306
YLH H + HRD+ +N+L++ + +KI DFG AK + G YYR
Sbjct: 149 YLHAQHYI---HRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGH--------EYYRVRED 196
Query: 307 --------APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEI 352
APE + + A D+WS G L ELL + +L+ I
Sbjct: 197 GDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 1e-20
Identities = 57/220 (25%), Positives = 90/220 (40%), Gaps = 37/220 (16%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLNHPNVVSLKHCF 199
+ +G G FG V G+ VA+K + D + E +M L H N+V L
Sbjct: 26 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV- 82
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRALNYL--H 255
EK LY +V EY++ Y R + L ++ +C A+ YL +
Sbjct: 83 -IVEEKGGLY--IVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR------APE 309
+ V HRD+ +N+LV+ + K+ DFG K + APE
Sbjct: 137 NFV---HRDLAARNVLVSED-NVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPE 184
Query: 310 -LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD 347
L +++T D+WS G +L E+ G+ +P D
Sbjct: 185 ALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 222
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 44/235 (18%), Positives = 84/235 (35%), Gaps = 50/235 (21%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS-------VAIKKVLQDKRYKN----RELQIMRLLNHP 190
+G G+F +F+ E GD V +K + + R + +M L+H
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 191 NVVSLKH-CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL-YTYQIC 248
++V C DE LV E++ + Y + N++ + +L Q+
Sbjct: 73 HLVLNYGVC----VCGDENI--LVQEFVK---FGSLDTYLKKNKNCINILWKLEVAKQLA 123
Query: 249 RALNYL--HHVVGVCHRDIKPQNLLVNPHTHQL-------KICDFGSAKMLVPGEPNISY 299
A+++L + ++ H ++ +N+L+ + K+ D G + ++P +
Sbjct: 124 AAMHFLEENTLI---HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD----- 175
Query: 300 ICSRYYR------APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD 347
+ PE I A D WS G L E+ G
Sbjct: 176 ----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR 226
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 56/215 (26%), Positives = 89/215 (41%), Gaps = 37/215 (17%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLNHPNVVSLKHCF 199
+ +G G FG V G+ VA+K + D + E +M L H N+V L
Sbjct: 198 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV- 254
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRALNYL--H 255
EK LY +V EY++ Y R + L ++ +C A+ YL +
Sbjct: 255 -IVEEKGGLY--IVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR------APE 309
+ V HRD+ +N+LV+ + K+ DFG K + APE
Sbjct: 309 NFV---HRDLAARNVLVSED-NVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPE 356
Query: 310 -LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPG 342
L +++T D+WS G +L E+ G+ +P
Sbjct: 357 ALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPR 389
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-20
Identities = 48/238 (20%), Positives = 90/238 (37%), Gaps = 50/238 (21%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS---VAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
R++G G FG V +A+ + S VA+K + D + RE M+ +HP+V
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 193 VSLKH-CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHV----PILYVQL--YTY 245
L S + ++L ++ + + ++ + L +
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMK---HGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 246 QICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR 303
I + YL + + HRD+ +N ++ + + DFG ++ + G+
Sbjct: 145 DIACGMEYLSSRNFI---HRDLAARNCMLAED-MTVCVADFGLSRKIYSGD--------- 191
Query: 304 YYR------------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD 347
YYR A E L YT D+W+ G + E++ GQ + G +
Sbjct: 192 YYRQGCASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-20
Identities = 59/217 (27%), Positives = 102/217 (47%), Gaps = 44/217 (20%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIK--KVLQDKRYKN--RELQIMRLLNHPNVV 193
+ +G G+FG V + D+ VA+K + ++ ++ RE++I++ L H N+V
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRAL 251
K L L++EY+ R Y + ++ I +++L YT QIC+ +
Sbjct: 106 KYKGV---CYSAGRRNLKLIMEYLPYGSLR---DYLQKHKE-RIDHIKLLQYTSQICKGM 158
Query: 252 NYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR--- 306
YL + HRD+ +N+LV +++KI DFG K+L + YY+
Sbjct: 159 EYLGTKRYI---HRDLATRNILVENE-NRVKIGDFGLTKVLPQDK--------EYYKVKE 206
Query: 307 ---------APELIFGATEYTTAIDMWSIGCVLAELL 334
APE + ++++ A D+WS G VL EL
Sbjct: 207 PGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 242
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 4e-20
Identities = 57/236 (24%), Positives = 98/236 (41%), Gaps = 48/236 (20%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
+V+G+G+FG V++ + G+ VAIK++ + K E +M +++P+V
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ-HVPILYVQLYTYQICRAL 251
L + L+ + + Y R ++ ++ Y+ + QI + +
Sbjct: 80 CRL----LGICLTSTVQ--LITQLMPFGCLL---DYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 252 NYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR--- 306
NYL +V HRD+ +N+LV +KI DFG AK+L E Y
Sbjct: 131 NYLEDRRLV---HRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEK--------EYHAEG 178
Query: 307 --------APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD--QLVE 351
A E I YT D+WS G + EL+ G + G + ++E
Sbjct: 179 GKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 6e-20
Identities = 59/218 (27%), Positives = 93/218 (42%), Gaps = 46/218 (21%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
+G G+FG V + GD+ VA+K LQ RE+QI++ L+ +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVK-QLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ-HVPILYVQLYTYQICRAL 251
V + + + L LV+EY+ + + + ++ + + LY+ QIC+ +
Sbjct: 87 VKYRGVSYGPGRQS-LR--LVMEYLP---SGCLRDFLQRHRARLDASRLLLYSSQICKGM 140
Query: 252 NYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR--- 306
YL V HRD+ +N+LV +KI DFG AK+L + YY
Sbjct: 141 EYLGSRRCV---HRDLAARNILVE-SEAHVKIADFGLAKLLPLDK--------DYYVVRE 188
Query: 307 ---------APE-LIFGATEYTTAIDMWSIGCVLAELL 334
APE L ++ D+WS G VL EL
Sbjct: 189 PGQSPIFWYAPESLSDN--IFSRQSDVWSFGVVLYELF 224
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 1e-19
Identities = 51/226 (22%), Positives = 91/226 (40%), Gaps = 45/226 (19%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKH- 197
+ +G+G FG+V L VAIK + + + E ++M L+HP +V L
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY-TYQICRALNYL-- 254
C E+ + LV E++ + Y R + + L +C + YL
Sbjct: 72 C----LEQAPIC--LVTEFME---HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 122
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR-------- 306
V+ HRD+ +N LV + +K+ DFG + ++ + Y
Sbjct: 123 ACVI---HRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQ---------YTSSTGTKFPV 169
Query: 307 ---APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD 347
+PE F Y++ D+WS G ++ E+ G+ + S +
Sbjct: 170 KWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 213
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 49/236 (20%), Positives = 88/236 (37%), Gaps = 47/236 (19%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS---VAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
+++G G FG V + + + VA+K + D + E M+ +HPNV
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISE----TVYRVSKHYTRMNQHVPILYVQL-YTYQI 247
+ L + + ++L ++ T S+ T L L + I
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLET--GPKHIPLQTLLKFMVDI 156
Query: 248 CRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYY 305
+ YL + + HRD+ +N ++ + + DFG +K + G+ YY
Sbjct: 157 ALGMEYLSNRNFL---HRDLAARNCMLRDD-MTVCVADFGLSKKIYSGD---------YY 203
Query: 306 R------------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD 347
R A E L YT+ D+W+ G + E+ G +PG +
Sbjct: 204 RQGRIAKMPVKWIAIESLADRV--YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 52/222 (23%), Positives = 94/222 (42%), Gaps = 45/222 (20%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHC 198
+ +G G +G V++ + +VA+K + +D +E +M+ + HPN+V L
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRALNYL-- 254
T + Y ++ E+++ Y Y R + V L QI A+ YL
Sbjct: 78 ---CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR-------- 306
+ + HRD+ +N LV + H +K+ DFG ++ + Y
Sbjct: 130 KNFI---HRDLAARNCLVGEN-HLVKVADFGLSR----------LMTGDTYTAHAGAKFP 175
Query: 307 ----APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPG 342
APE L + +++ D+W+ G +L E+ G +PG
Sbjct: 176 IKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPG 215
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 52/231 (22%), Positives = 95/231 (41%), Gaps = 38/231 (16%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
+V+G+G FG V + + G+S V IK + ++ + + L+H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ-HVPILYVQLYTYQICRAL 251
V L L LV +Y+ + R ++ + + + QI + +
Sbjct: 78 VRL----LGLCPGSSLQ--LVTQYLPLGSLL---DHVRQHRGALGPQLLLNWGVQIAKGM 128
Query: 252 NYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR--- 306
YL H +V HR++ +N+L+ Q+++ DFG A +L P+ + +
Sbjct: 129 YYLEEHGMV---HRNLAARNVLLKSP-SQVQVADFGVADLL---PPDDKQLLYSEAKTPI 181
Query: 307 ---APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD--QLVE 351
A E I YT D+WS G + EL+ G + G + L+E
Sbjct: 182 KWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 1e-19
Identities = 55/233 (23%), Positives = 98/233 (42%), Gaps = 49/233 (21%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKH- 197
+ +G+G FGVV K D VA+K + + ++ +E Q M L+HP +V
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVS-KHYTRMNQHVPILYVQLY-TYQICRALNYL- 254
C +++ +Y +V EYIS +Y R + L Y +C + +L
Sbjct: 72 C----SKEYPIY--IVTEYIS----NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE 121
Query: 255 -HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR------- 306
H + HRD+ +N LV+ +K+ DFG + ++ + Y
Sbjct: 122 SHQFI---HRDLAARNCLVDRD-LCVKVSDFGMTRYVLDDQ---------YVSSVGTKFP 168
Query: 307 ----APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESG--VDQLVE 351
APE + +Y++ D+W+ G ++ E+ LG+ + + V V
Sbjct: 169 VKWSAPEVFHYF--KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 1e-19
Identities = 52/226 (23%), Positives = 97/226 (42%), Gaps = 33/226 (14%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHC 198
+ +G G +G V++ + +VA+K + +D +E +M+ + HPN+V L
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRALNYL-- 254
T + Y ++ E+++ Y Y R + V L QI A+ YL
Sbjct: 285 ---CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR------AP 308
+ + HR++ +N LV H +K+ DFG ++++ Y + AP
Sbjct: 337 KNFI---HRNLAARNCLVG-ENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAP 388
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD--QLVE 351
E + ++ D+W+ G +L E+ G +PG +L+E
Sbjct: 389 ESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 57/233 (24%), Positives = 95/233 (40%), Gaps = 49/233 (21%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS---VAIK--KVLQDKRYKN---RELQIMRLLNHPNVV 193
V+G G FG V+ L+ A+K + D + E IM+ +HPNV+
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL-YTYQICRALN 252
SL + +VL Y+ + +++ R H P + + + Q+ + +
Sbjct: 90 SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 142
Query: 253 YL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR---- 306
YL V HRD+ +N +++ +K+ DFG A+ + E YY
Sbjct: 143 YLASKKFV---HRDLAARNCMLDEK-FTVKVADFGLARDMYDKE---------YYSVHNK 189
Query: 307 ----------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD 347
A E L ++TT D+WS G +L EL+ G P +P + D
Sbjct: 190 TGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 240
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-19
Identities = 59/238 (24%), Positives = 96/238 (40%), Gaps = 49/238 (20%)
Query: 140 MAERVVGTGSFGVVFQAKCLETGDS--VAIKKVLQDKRYKNR-----ELQIMRLLNHPNV 192
+A+ +G G+FG V Q VAIK + Q + E QIM L++P +
Sbjct: 13 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ-HVPILYVQLYTYQICRAL 251
V L + + L LV+E + + +P+ V +Q+ +
Sbjct: 73 VRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGM 123
Query: 252 NYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR--- 306
YL + V HRD+ +N+L+ + H KI DFG +K L + YY
Sbjct: 124 KYLEEKNFV---HRDLAARNVLLV-NRHYAKISDFGLSKALGADDS--------YYTARS 171
Query: 307 ---------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD--QLVE 351
APE + F ++++ D+WS G + E L GQ + G + +E
Sbjct: 172 AGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 59/254 (23%), Positives = 97/254 (38%), Gaps = 60/254 (23%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS-----VAIKKV-----LQDKRYKNRELQIM-RLLNHP 190
+ +G G+FG V +A S VA+K + L ++ EL+++ L NH
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYIS-------------ETVYRVSKHYTRMNQHVPI 237
N+V+L T ++ EY + + + + +
Sbjct: 88 NIVNLLGA---CTIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 238 LYVQLYT--YQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293
L + YQ+ + + +L + + HRD+ +N+L+ KICDFG A+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCI---HRDLAARNILLTHG-RITKICDFGLARDIKND 198
Query: 294 EPNISYICSRYYR------------APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLF 340
Y APE IF YT D+WS G L EL LG +
Sbjct: 199 S---------NYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPY 248
Query: 341 PGESGVDQLVEIIK 354
PG + ++IK
Sbjct: 249 PGMPVDSKFYKMIK 262
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-19
Identities = 52/232 (22%), Positives = 96/232 (41%), Gaps = 47/232 (20%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHC 198
+G G FG V+ VA+K + Q + E +M+ L H +V L
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--- 73
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRALNYL-- 254
++ ++ +Y ++ EY+ + + + + +L QI + ++
Sbjct: 74 -YAVVTQEPIY--IITEYMENGSLV---DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR-------- 306
+ + HRD++ N+LV+ KI DFG A+++ E Y
Sbjct: 128 RNYI---HRDLRAANILVSDT-LSCKIADFGLARLIEDNE---------YTAREGAKFPI 174
Query: 307 ---APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESG--VDQLVE 351
APE + +G +T D+WS G +L E++ G+ +PG + V Q +E
Sbjct: 175 KWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 3e-19
Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 37/227 (16%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHC 198
E +G G FG V+ T VAIK + +E Q+M+ L H +V L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 244
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVS-KHYTRMNQHVPILYVQL--YTYQICRALNYL- 254
++ ++ +Y +V EY+S+ S + + + QL QI + Y+
Sbjct: 245 -YAVVSEEPIY--IVTEYMSKG----SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 297
Query: 255 -HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR------A 307
+ V HRD++ N+LV + K+ DFG A+++ E Y + + A
Sbjct: 298 RMNYV---HRDLRAANILVGEN-LVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 349
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD--QLVE 351
PE +T D+WS G +L EL G+ +PG + VE
Sbjct: 350 PEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 4e-19
Identities = 61/243 (25%), Positives = 103/243 (42%), Gaps = 51/243 (20%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDS---VAIK--KVLQDKRYKN---RELQIM 184
P + + ++RV+G G FGVV+ + ++ + AIK + + + RE +M
Sbjct: 17 PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLM 76
Query: 185 RLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVS-KHYTRMNQHVPILYVQL- 242
R LNHPNV++L + + ++L Y+ + R Q P + +
Sbjct: 77 RGLNHPNVLALIGI--MLPPEGLPH--VLLPYMC----HGDLLQFIRSPQRNPTVKDLIS 128
Query: 243 YTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYI 300
+ Q+ R + YL V HRD+ +N +++ + +K+ DFG A+ ++ E
Sbjct: 129 FGLQVARGMEYLAEQKFV---HRDLAARNCMLD-ESFTVKVADFGLARDILDRE------ 178
Query: 301 CSRYYR--------------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGES 344
YY A E L +TT D+WS G +L ELL G P +
Sbjct: 179 ---YYSVQQHRHARLPVKWTALESLQTYR--FTTKSDVWSFGVLLWELLTRGAPPYRHID 233
Query: 345 GVD 347
D
Sbjct: 234 PFD 236
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 4e-19
Identities = 55/237 (23%), Positives = 94/237 (39%), Gaps = 49/237 (20%)
Query: 142 ERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQDKRYKNR-----ELQIMRLLNHPNVV 193
E+++G+G G V + G VAIK + + R E IM +HPN++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 194 SLKH-CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL-YTYQICRAL 251
L+ T +V EY+ + R + + + + +
Sbjct: 114 RLEGVV----TRGRLAM--IVTEYME---NGSLDTFLRTHDGQFTIMQLVGMLRGVGAGM 164
Query: 252 NYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR--- 306
YL V HRD+ +N+LV+ + K+ DFG +++L E + Y
Sbjct: 165 RYLSDLGYV---HRDLAARNVLVDSN-LVCKVSDFGLSRVL---EDDPDA----AYTTTG 213
Query: 307 --------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD--QLVE 351
APE + F +++A D+WS G V+ E+L G+ + + D VE
Sbjct: 214 GKIPIRWTAPEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 4e-19
Identities = 57/232 (24%), Positives = 94/232 (40%), Gaps = 47/232 (20%)
Query: 140 MAERVVGTGSFGVVFQAKCLETGDS--VAIKKVLQDKRYKNR-----ELQIMRLLNHPNV 192
+A+ +G G+FG V Q VAIK + Q + E QIM L++P +
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 398
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ-HVPILYVQLYTYQICRAL 251
V L + + L LV+E + + +P+ V +Q+ +
Sbjct: 399 VRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGM 449
Query: 252 NYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR--- 306
YL + V HR++ +N+L+ + H KI DFG +K L + YY
Sbjct: 450 KYLEEKNFV---HRNLAARNVLLV-NRHYAKISDFGLSKALGADDS--------YYTARS 497
Query: 307 ---------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD 347
APE + F ++++ D+WS G + E L GQ + G +
Sbjct: 498 AGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-19
Identities = 56/231 (24%), Positives = 87/231 (37%), Gaps = 51/231 (22%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR-----ELQIMRLLNHPNVVSLK 196
+G G+FG VF + VA+K + + E +I++ +HPN+V L
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL- 177
Query: 197 H--CFFSTTEKDELYLNLVLEYISETVYRVS-KHYTRMNQHVPILYVQL-YTYQICRALN 252
C T+K +Y +V+E + + R + L +
Sbjct: 178 IGVC----TQKQPIY--IVMELVQGG----DFLTFLRTEGARLRVKTLLQMVGDAAAGME 227
Query: 253 YLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR---- 306
YL + HRD+ +N LV + LKI DFG ++ G Y
Sbjct: 228 YLESKCCI---HRDLAARNCLVTEK-NVLKISDFGMSREEADGV---------YAASGGL 274
Query: 307 --------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD 347
APE L +G Y++ D+WS G +L E LG +P S
Sbjct: 275 RQVPVKWTAPEALNYG--RYSSESDVWSFGILLWETFSLGASPYPNLSNQQ 323
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 8e-19
Identities = 53/232 (22%), Positives = 100/232 (43%), Gaps = 47/232 (20%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHC 198
E+ +G G FG V+ A + VA+K + E +M+ L H +V L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL--- 248
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL--YTYQICRALNYL-- 254
+ K+ +Y ++ E+++ + + ++ +L ++ QI + ++
Sbjct: 249 -HAVVTKEPIY--IITEFMA---KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR-------- 306
+ + HRD++ N+LV+ KI DFG A+++ E Y
Sbjct: 303 RNYI---HRDLRAANILVSAS-LVCKIADFGLARVIEDNE---------YTAREGAKFPI 349
Query: 307 ---APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD--QLVE 351
APE + FG +T D+WS G +L E++ G+ +PG S + + +E
Sbjct: 350 KWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 9e-19
Identities = 53/226 (23%), Positives = 99/226 (43%), Gaps = 45/226 (19%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKH- 197
+ +GTG FGVV K D VAIK + + ++ E ++M L+H +V L
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 198 CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY-TYQICRALNYL-- 254
C T++ ++ ++ EY++ +Y R +H L +C A+ YL
Sbjct: 88 C----TKQRPIF--IITEYMA---NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 138
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR-------- 306
+ HRD+ +N LVN +K+ DFG ++ ++ E Y
Sbjct: 139 KQFL---HRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDE---------YTSSVGSKFPV 185
Query: 307 ---APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD 347
PE L++ ++++ D+W+ G ++ E+ LG+ + + +
Sbjct: 186 RWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 229
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 9e-19
Identities = 54/230 (23%), Positives = 95/230 (41%), Gaps = 43/230 (18%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS---VAIK--KVLQDKRYKN---RELQIMRLLNHPNVV 193
V+G G FG V+ L+ A+K + D + E IM+ +HPNV+
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL-YTYQICRALN 252
SL + +VL Y+ + +++ R H P + + + Q+ + +
Sbjct: 154 SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 206
Query: 253 YL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR---- 306
+L V HRD+ +N +++ +K+ DFG A+ + E + +
Sbjct: 207 FLASKKFV---HRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFD------SVHNKTGA 256
Query: 307 -------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD 347
A E L ++TT D+WS G +L EL+ G P +P + D
Sbjct: 257 KLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 304
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 9e-19
Identities = 59/230 (25%), Positives = 101/230 (43%), Gaps = 48/230 (20%)
Query: 142 ERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQDKRYKNR-----ELQIMRLLNHPNVV 193
R++G G FG V++ +VA+K +D N+ E IM+ L+HP++V
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL-YTYQICRALN 252
L E++ + +++E Y HY N++ + + Y+ QIC+A+
Sbjct: 77 KL----IGIIEEEPTW--IIMELYP---YGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127
Query: 253 YL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR---- 306
YL + V HRDI +N+LV +K+ DFG ++ + + YY+
Sbjct: 128 YLESINCV---HRDIAVRNILVASP-ECVKLGDFGLSRYIEDED---------YYKASVT 174
Query: 307 -------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD 347
+PE + F +TTA D+W + E+L G+ F D
Sbjct: 175 RLPIKWMSPESINFRR--FTTASDVWMFAVCMWEILSFGKQPFFWLENKD 222
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 1e-18
Identities = 33/245 (13%), Positives = 54/245 (22%), Gaps = 57/245 (23%)
Query: 123 ATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL----QDKRYKN 178
A GR Y G +QA VA+ V
Sbjct: 26 ARIANGR---------YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQ 76
Query: 179 R---ELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI-SETVYRVSKHYTRMNQH 234
+ ++ P V + L +V E+I ++ V +
Sbjct: 77 ETLSRTLRLSRIDKPGVARV----LDVVHTRAGGL-VVAEWIRGGSLQEV------ADTS 125
Query: 235 VPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294
+ + A + H GV P + V+ G + P
Sbjct: 126 PSPVGAIRAMQSLAAAADAAHRA-GVALSIDHPSRVRVSID---------GDVVLAYPA- 174
Query: 295 PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIK 354
D+ IG L LL+ + P L +
Sbjct: 175 ----------TMPDA--------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER 216
Query: 355 ILGTP 359
Sbjct: 217 DTAGQ 221
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 1e-18
Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 37/227 (16%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHC 198
E +G G FG V+ T VAIK + +E Q+M+ L H +V L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 327
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVS-KHYTRMNQHVPILYVQL--YTYQICRALNYL- 254
++ ++ +Y +V EY+S+ S + + + QL QI + Y+
Sbjct: 328 -YAVVSEEPIY--IVTEYMSKG----SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 380
Query: 255 -HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR------A 307
+ V HRD++ N+LV + K+ DFG A+++ E Y + + A
Sbjct: 381 RMNYV---HRDLRAANILVGEN-LVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 432
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD--QLVE 351
PE +T D+WS G +L EL G+ +PG + VE
Sbjct: 433 PEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 55/245 (22%), Positives = 97/245 (39%), Gaps = 54/245 (22%)
Query: 143 RVVGTGSFGVVFQAKCLETGDS-----VAIKKV-----LQDKRYKNRELQIMRLLNHPNV 192
R +G GSFG+V++ VAIK V ++++ E +M+ N +V
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISE----TVYRVSKHYTRMNQHVPILYVQ---LYTY 245
V L ++ +++E ++ + R + N + +
Sbjct: 91 VRLLGV---VSQGQPTL--VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 246 QICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR 303
+I + YL + V HRD+ +N +V +KI DFG + + +
Sbjct: 146 EIADGMAYLNANKFV---HRDLAARNCMVAED-FTVKIGDFGMTRDIYETD--------- 192
Query: 304 YYR------------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQL 349
YYR +PE L G +TT D+WS G VL E+ L + + G S +Q+
Sbjct: 193 YYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLS-NEQV 249
Query: 350 VEIIK 354
+ +
Sbjct: 250 LRFVM 254
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 57/231 (24%), Positives = 94/231 (40%), Gaps = 47/231 (20%)
Query: 142 ERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQDKRYKNR-----ELQIMRLLNHPNVV 193
++VVG G FG V + SVAIK + K R E IM +HPN++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 194 SLKH-CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL-YTYQICRAL 251
L+ T+ + +V EY+ + R + + + I +
Sbjct: 110 RLEGVV----TKSKPVM--IVTEYME---NGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 252 NYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR--- 306
YL V HRD+ +N+L+N + K+ DFG ++L E + Y
Sbjct: 161 KYLSDMGYV---HRDLAARNILINSN-LVCKVSDFGLGRVL---EDDPEA----AYTTRG 209
Query: 307 --------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD 347
+PE + + ++T+A D+WS G VL E++ G+ + S D
Sbjct: 210 GKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 61/261 (23%), Positives = 103/261 (39%), Gaps = 63/261 (24%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDS-----VAIKKV----LQDKRYKNRELQI 183
++ I R +G G+FG VF A+C + VA+K + L ++ RE ++
Sbjct: 13 KRRDIVLK--RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70
Query: 184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYIS-----------ETVYRVSKHYTRMN 232
+ L H ++V + D L +V EY+ +
Sbjct: 71 LTNLQHEHIVKFYGV---CGDGDPLI--MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 233 QHVPILYVQLY--TYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288
+ Q+ QI + YL H V HRD+ +N LV + +KI DFG ++
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHFV---HRDLATRNCLVGAN-LLVKIGDFGMSR 181
Query: 289 MLVPGEPNISYICSRYYR------------APE-LIFGATEYTTAIDMWSIGCVLAELL- 334
+ + YYR PE +++ ++TT D+WS G +L E+
Sbjct: 182 DVYSTD---------YYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFT 230
Query: 335 LG-QPLFPGESGVDQLVEIIK 354
G QP + S +++E I
Sbjct: 231 YGKQP-WFQLS-NTEVIECIT 249
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-18
Identities = 58/251 (23%), Positives = 100/251 (39%), Gaps = 57/251 (22%)
Query: 143 RVVGTGSFGVVFQAKCL-----ETGDSVAIKKV-----LQDKRYKNRELQIM-RLLNHPN 191
+ +G G+FG V +A T +VA+K + + R EL+I+ + +H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYI-----------SETVYRVSKHYTRMNQHVPILYV 240
VV+L T L +++E+ + K +
Sbjct: 93 VVNLLGA--CTKPGGPLM--VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 241 QL--YTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN 296
L Y++Q+ + + +L + HRD+ +N+L++ + +KICDFG A+ +
Sbjct: 149 HLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEK-NVVKICDFGLARDI------ 198
Query: 297 ISYICSRYYR------------APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGE 343
Y APE IF YT D+WS G +L E+ LG +PG
Sbjct: 199 ---YKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGV 254
Query: 344 SGVDQLVEIIK 354
++ +K
Sbjct: 255 KIDEEFCRRLK 265
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 4e-18
Identities = 58/236 (24%), Positives = 98/236 (41%), Gaps = 50/236 (21%)
Query: 142 ERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQDKRYKNR-----ELQIMRLLNHPNVV 193
R +G G FG V Q + + +VAIK R E MR +HP++V
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL-YTYQICRALN 252
L ++ ++ +++E + + + ++ ++ L + Y YQ+ AL
Sbjct: 80 KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKYSLDLASLILYAYQLSTALA 130
Query: 253 YL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR---- 306
YL V HRDI +N+LV+ + +K+ DFG ++ + YY+
Sbjct: 131 YLESKRFV---HRDIAARNVLVSSN-DCVKLGDFGLSRYMEDST---------YYKASKG 177
Query: 307 -------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD--QLVE 351
APE + F +T+A D+W G + E+L G F G D +E
Sbjct: 178 KLPIKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-18
Identities = 61/251 (24%), Positives = 98/251 (39%), Gaps = 60/251 (23%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS-----VAIKKV----LQDKRYKNRELQIMRLLNHPNV 192
+ +G G+FG VF A+C VA+K + ++ RE +++ +L H ++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYI----------SETVYRVSKHYTRMNQHVPILYVQL 242
V TE L +V EY+ S P+ QL
Sbjct: 106 VRFFGV---CTEGRPLL--MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 243 --YTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS 298
Q+ + YL H V HRD+ +N LV +KI DFG ++ + +
Sbjct: 161 LAVASQVAAGMVYLAGLHFV---HRDLATRNCLVGQG-LVVKIGDFGMSRDIYSTD---- 212
Query: 299 YICSRYYR------------APE-LIFGATEYTTAIDMWSIGCVLAELL-LG-QPLFPGE 343
YYR PE +++ ++TT D+WS G VL E+ G QP +
Sbjct: 213 -----YYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQP-WYQL 264
Query: 344 SGVDQLVEIIK 354
S + ++ I
Sbjct: 265 S-NTEAIDCIT 274
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-18
Identities = 53/237 (22%), Positives = 96/237 (40%), Gaps = 48/237 (20%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKNR-----ELQIMRLLNHPNV 192
++V+G G FG V++ + VAIK + K R E IM +H N+
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 193 VSLKH-CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL-YTYQICRA 250
+ L+ ++ + ++ EY+ + R + + I
Sbjct: 109 IRLEGVI----SKYKPMM--IITEYME---NGALDKFLREKDGEFSVLQLVGMLRGIAAG 159
Query: 251 LNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR-- 306
+ YL + V HRD+ +N+LVN + K+ DFG +++L E + Y
Sbjct: 160 MKYLANMNYV---HRDLAARNILVNSN-LVCKVSDFGLSRVL---EDDPEAT---YTTSG 209
Query: 307 --------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESG--VDQLVE 351
APE + + +T+A D+WS G V+ E++ G+ + S V + +
Sbjct: 210 GKIPIRWTAPEAISYRK--FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 264
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 6e-18
Identities = 54/239 (22%), Positives = 87/239 (36%), Gaps = 52/239 (21%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS---VAIKKVLQDKRYKN-------RELQIMRLLNHPN 191
+G GSFGVV + + VA+K + D + RE+ M L+H N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQ-HVPILYVQLYTYQICRA 250
++ L + + + V E R +Q H + + Y Q+
Sbjct: 83 LIRL----YGVVLTPPMKM--VTELAP---LGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 251 LNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR-- 306
+ YL + HRD+ +NLL+ +KI DFG + L + +Y
Sbjct: 134 MGYLESKRFI---HRDLAARNLLLATR-DLVKIGDFGLMRALPQNDD--------HYVMQ 181
Query: 307 ----------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD--QLVE 351
APE L ++ A D W G L E+ GQ + G +G ++
Sbjct: 182 EHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 7e-18
Identities = 57/260 (21%), Positives = 99/260 (38%), Gaps = 68/260 (26%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS-----VAIKKV-----LQDKRYKNRELQIMRLLNHPN 191
+ +G G FG V +A VA+K + + R E +++ +NHP+
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEY-------------------ISETVYRVSKHYTRMN 232
V+ L ++ L L++EY + +
Sbjct: 88 VIKLYGA---CSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 233 QHVPILYVQL--YTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288
+ L + +QI + + YL +V HRD+ +N+LV ++KI DFG ++
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLV---HRDLAARNILVAEG-RKMKISDFGLSR 198
Query: 289 MLVPGEPNISYICSRYYR------------APELIFGATEYTTAIDMWSIGCVLAELL-L 335
+ Y A E +F YTT D+WS G +L E++ L
Sbjct: 199 DV---------YEEDSYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTL 248
Query: 336 G-QPLFPGESGVDQLVEIIK 354
G P +PG ++L ++K
Sbjct: 249 GGNP-YPGIP-PERLFNLLK 266
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 83.4 bits (205), Expect = 9e-18
Identities = 44/330 (13%), Positives = 91/330 (27%), Gaps = 74/330 (22%)
Query: 145 VGTGSFGVVFQAKCLETGDSVAIKKV-LQDKRYKN-----------RELQIMRLL----- 187
+G G FG VFQ VAIK + ++ N E+ I + L
Sbjct: 28 IGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85
Query: 188 ----NHPNVVSLKHCFFSTTEKDELYLNLVLEYISE--------TVYRVSKHYTRM---- 231
+ L L L Y S ++ + + +
Sbjct: 86 EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145
Query: 232 ---------NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC 282
+ + + +Q+ +L + HRD+ N+L+ + +
Sbjct: 146 GGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHY 205
Query: 283 DFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPG 342
+P L +YT + V ++ + + LF G
Sbjct: 206 TLNGKSSTIPS--------------CGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTG 251
Query: 343 ESGVDQLVEIIKILGTPTREEIKCMNP-------NYTEFKFPQIKAHPWHKIF--HKRMP 393
+ D +I +++ +P +Y K + K++
Sbjct: 252 DG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIK 309
Query: 394 PEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+ + +L +S +A +
Sbjct: 310 RKIQEFHRTMLNFS-----SATDLLCQHSL 334
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 2e-17
Identities = 58/236 (24%), Positives = 97/236 (41%), Gaps = 50/236 (21%)
Query: 142 ERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQDKRYKNR-----ELQIMRLLNHPNVV 193
R +G G FG V Q + + +VAIK R E MR +HP++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL-YTYQICRALN 252
L ++ ++ +++E + + + ++ + L + Y YQ+ AL
Sbjct: 455 KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKFSLDLASLILYAYQLSTALA 505
Query: 253 YL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR---- 306
YL V HRDI +N+LV+ + +K+ DFG ++ + YY+
Sbjct: 506 YLESKRFV---HRDIAARNVLVSSN-DCVKLGDFGLSRYMEDST---------YYKASKG 552
Query: 307 -------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESG--VDQLVE 351
APE + F +T+A D+W G + E+L G F G V +E
Sbjct: 553 KLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 62/260 (23%), Positives = 101/260 (38%), Gaps = 67/260 (25%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS-----VAIKKV-----LQDKRYKNRELQIM-RLLNHP 190
+V+G+G+FG V A + VA+K + ++ EL++M +L +H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEY------------------ISETVYRVSKHYTRMN 232
N+V+L T +Y L+ EY E Y K
Sbjct: 110 NIVNLLGA---CTLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 233 QHVPILYVQL--YTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288
+ + L + YQ+ + + +L V HRD+ +N+LV +KICDFG A+
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCV---HRDLAARNVLVTHG-KVVKICDFGLAR 220
Query: 289 MLVPGEPNISYICSRYYR------------APELIFGATEYTTAIDMWSIGCVLAEL--L 334
+ + Y APE +F YT D+WS G +L E+ L
Sbjct: 221 DI---------MSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSL 270
Query: 335 LGQPLFPGESGVDQLVEIIK 354
P +PG ++I+
Sbjct: 271 GVNP-YPGIPVDANFYKLIQ 289
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 58/250 (23%), Positives = 98/250 (39%), Gaps = 56/250 (22%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS-----VAIKKV-----LQDKRYKNRELQIM-RLLNHP 190
+ +G G+FG V +A G VA+K + +K EL+IM L H
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 191 NVVSLKHCFFSTTEKDELYL--------NLVLEYISETVYRVSKHYTRMNQHVPILYVQL 242
N+V+L T + + +L L ++ + + L
Sbjct: 111 NIVNLLGA---CTHGGPVLVITEYCCYGDL-LNFLRRKSRVLETDPAFAIANSTASTRDL 166
Query: 243 --YTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS 298
++ Q+ + + +L + + HRD+ +N+L+ H KI DFG A+ +
Sbjct: 167 LHFSSQVAQGMAFLASKNCI---HRDVAARNVLLTNG-HVAKIGDFGLARDI-------- 214
Query: 299 YICSRYYR------------APELIFGATEYTTAIDMWSIGCVLAELL-LG-QPLFPGES 344
+ Y APE IF YT D+WS G +L E+ LG P +PG
Sbjct: 215 -MNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNP-YPGIL 271
Query: 345 GVDQLVEIIK 354
+ +++K
Sbjct: 272 VNSKFYKLVK 281
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 54/245 (22%), Positives = 96/245 (39%), Gaps = 52/245 (21%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS-----VAIKKV-----LQDKRYKNRELQIMRLLNHPN 191
R +G G+FG V++ + + VA+K + QD+ E I+ NH N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISE----TVYRVSKHYTRMNQHVPILYVQLYTYQI 247
+V + + + +++E ++ + R ++ + +L + I
Sbjct: 95 IVRCIGV---SLQSLPRF--ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 248 CRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQL--KICDFGSAKMLVPGEPNISYICSR 303
YL +H + HRDI +N L+ KI DFG A+ +
Sbjct: 150 ACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS--------- 197
Query: 304 YYR------------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQL 349
YYR PE + G +T+ D WS G +L E+ LG +P +S ++
Sbjct: 198 YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEV 254
Query: 350 VEIIK 354
+E +
Sbjct: 255 LEFVT 259
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 55/245 (22%), Positives = 96/245 (39%), Gaps = 52/245 (21%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS-----VAIKKV-----LQDKRYKNRELQIMRLLNHPN 191
R +G G+FG V++ + + VA+K + QD+ E I+ NH N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISE----TVYRVSKHYTRMNQHVPILYVQLYTYQI 247
+V + + + ++LE ++ + R ++ + +L + I
Sbjct: 136 IVRCIGV---SLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 248 CRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQL--KICDFGSAKMLVPGEPNISYICSR 303
YL +H + HRDI +N L+ KI DFG A+ +
Sbjct: 191 ACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG--------- 238
Query: 304 YYR------------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQL 349
YYR PE + G +T+ D WS G +L E+ LG +P +S ++
Sbjct: 239 YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEV 295
Query: 350 VEIIK 354
+E +
Sbjct: 296 LEFVT 300
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 5e-17
Identities = 59/253 (23%), Positives = 91/253 (35%), Gaps = 62/253 (24%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS-----VAIKKV-----LQDKRYKNRELQIMRLLNHPN 191
+G FG V++ VAIK + + E + L HPN
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYIS-----------ETVYRVSKHYTRMNQHVPILYV 240
VV L T+ L ++ Y S V +
Sbjct: 74 VVCLLGV---VTKDQPLS--MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 241 QL--YTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN 296
QI + YL HHVV H+D+ +N+LV +KI D G + + +
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVV---HKDLATRNVLVYDK-LNVKISDLGLFREVYAAD-- 182
Query: 297 ISYICSRYYR------------APE-LIFGATEYTTAIDMWSIGCVLAELL-LG-QPLFP 341
YY+ APE +++G +++ D+WS G VL E+ G QP +
Sbjct: 183 -------YYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQP-YC 232
Query: 342 GESGVDQLVEIIK 354
G S +VE+I+
Sbjct: 233 GYS-NQDVVEMIR 244
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 58/270 (21%), Positives = 100/270 (37%), Gaps = 72/270 (26%)
Query: 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDS-----VAIKKV-----LQDKRYKNRELQ 182
P+ I Y+ R +G G+FG VFQA+ VA+K + + RE
Sbjct: 45 PRNNIEYV--RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 183 IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEY-------------------ISETVYR 223
+M ++PN+V L + L+ EY
Sbjct: 103 LMAEFDNPNIVKLLGV---CAVGKPMC--LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 157
Query: 224 VSKHYTRMNQHVPILYVQL--YTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQL 279
++ P+ + Q+ + YL V HRD+ +N LV + +
Sbjct: 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV---HRDLATRNCLVGEN-MVV 213
Query: 280 KICDFGSAKMLVPGEPNISYICSRYYR------------APE-LIFGATEYTTAIDMWSI 326
KI DFG ++ + + YY+ PE + + YTT D+W+
Sbjct: 214 KIADFGLSRNIYSAD---------YYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAY 262
Query: 327 GCVLAELL-LG-QPLFPGESGVDQLVEIIK 354
G VL E+ G QP + G + ++++ ++
Sbjct: 263 GVVLWEIFSYGLQP-YYGMA-HEEVIYYVR 290
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 59/254 (23%), Positives = 104/254 (40%), Gaps = 61/254 (24%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS-------VAIKKV-----LQDKRYKNRELQIM-RLLN 188
+ +G G FG V A+ + VA+K + +D E+++M +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYI-----------SETVYRVSKHYTRMNQHVPI 237
H N+++L T+ LY +++EY + +
Sbjct: 146 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 238 LYVQL--YTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293
+ L TYQ+ R + YL + HRD+ +N+LV + + +KI DFG A+ +
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTEN-NVMKIADFGLARDINNI 256
Query: 294 EPNISYICSRYYR------------APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLF 340
+ YY+ APE +F YT D+WS G ++ E+ LG +
Sbjct: 257 D---------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPY 306
Query: 341 PGESGVDQLVEIIK 354
PG V++L +++K
Sbjct: 307 PGIP-VEELFKLLK 319
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 60/254 (23%), Positives = 103/254 (40%), Gaps = 61/254 (24%)
Query: 142 ERVVGTGSFGVVFQAKCL-------ETGDSVAIKKV-----LQDKRYKNRELQIM-RLLN 188
+ +G G+FG V A+ + VA+K + +D E+++M +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYI-----------SETVYRVSKHYTRMNQHVPI 237
H N+++L T+ LY +++EY + N +
Sbjct: 134 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 238 LYVQL--YTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293
L YQ+ R + YL + HRD+ +N+LV + +KI DFG A+ +
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTED-NVMKIADFGLARDIHHI 244
Query: 294 EPNISYICSRYYR------------APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLF 340
+ YY+ APE +F YT D+WS G +L E+ LG +
Sbjct: 245 D---------YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPY 294
Query: 341 PGESGVDQLVEIIK 354
PG V++L +++K
Sbjct: 295 PGVP-VEELFKLLK 307
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 59/254 (23%), Positives = 105/254 (41%), Gaps = 61/254 (24%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS-------VAIKKV-----LQDKRYKNRELQIM-RLLN 188
+ +G G+FG V A+ + VA+K + +D E+++M +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYI-----------SETVYRVSKHYTRMNQHVPI 237
H N+++L T+ LY +++EY + +
Sbjct: 100 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 238 LYVQL--YTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293
+ L TYQ+ R + YL + HRD+ +N+LV + + +KI DFG A+ +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTEN-NVMKIADFGLARDINNI 210
Query: 294 EPNISYICSRYYR------------APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLF 340
+ YY+ APE +F YT D+WS G ++ E+ LG +
Sbjct: 211 D---------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 341 PGESGVDQLVEIIK 354
PG V++L +++K
Sbjct: 261 PGIP-VEELFKLLK 273
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 7e-16
Identities = 58/238 (24%), Positives = 97/238 (40%), Gaps = 60/238 (25%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS--VAIKKV-----LQDKRYKNRELQIM-RLLNHPNVV 193
+ V+G G+FG V +A+ + G AIK++ D R EL+++ +L +HPN++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 194 SLKHCFFSTTEKDELYLNLVLEYI-----------SETVYRVSKHYTRMNQHVPILYVQL 242
+L + LY L +EY S + + + QL
Sbjct: 90 NLLGA---CEHRGYLY--LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 243 --YTYQICRALNYL--HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS 298
+ + R ++YL + HRD+ +N+LV + + KI DFG ++
Sbjct: 145 LHFAADVARGMDYLSQKQFI---HRDLAARNILVGEN-YVAKIADFGLSRG--------- 191
Query: 299 YICSRYYR------------APE-LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPG 342
Y A E L + YTT D+WS G +L E++ LG + G
Sbjct: 192 ---QEVYVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCG 244
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 8e-16
Identities = 45/223 (20%), Positives = 83/223 (37%), Gaps = 43/223 (19%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLL-NHPNVVSL 195
Y R +G GSFGV+F+ L VAIK + E + +LL + ++
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+ ++ L+ LV++ + + + + + V + Q+ + +H
Sbjct: 72 YYFG-----QEGLHNVLVIDLLGPS---LEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 123
Query: 256 HVVGVCHRDIKPQNLLV----NPHTHQLKICDFGSAKMLVPGEPNISYICSRY-----YR 306
+ +RDIKP N L+ + + + + + DFG K Y YR
Sbjct: 124 E-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF---------YRDPVTKQHIPYR 173
Query: 307 APELIFGATEYTTAI------------DMWSIGCVLAELLLGQ 337
+ + G Y +I D+ ++G V L G
Sbjct: 174 EKKNLSGTARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 49/216 (22%), Positives = 89/216 (41%), Gaps = 31/216 (14%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLNH-PNVVSL 195
Y R +G+GSFG ++ + G+ VAIK ++ E +I +++ + ++
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+ C + Y +V+E + + + + ++ + V L Q+ + Y+H
Sbjct: 71 RWCG-----AEGDYNVMVMELLGPS---LEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 256 HVVGVCHRDIKPQNLLV--NPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFG 313
HRD+KP N L+ + + I DFG AK + +I YR + + G
Sbjct: 123 S-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH-QHIP---YRENKNLTG 177
Query: 314 ATEYTTAI------------DMWSIGCVLAELLLGQ 337
Y +I D+ S+G VL LG
Sbjct: 178 TARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 44/223 (19%), Positives = 83/223 (37%), Gaps = 43/223 (19%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIK--KVLQDKRYKNRELQIMRLL-NHPNVVSL 195
+ + +G G+FG + K L T + VAIK + + E + + L + + +
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+ Y +VLE + + + + ++ + V + Q+ + Y+H
Sbjct: 71 YYFG-----PCGKYNAMVLELLGPS---LEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH 122
Query: 256 HVVGVCHRDIKPQNLLV----NPHTHQLKICDFGSAKMLVPGEPNISYICSRY-----YR 306
+ +RD+KP+N L+ N + I DF AK YI YR
Sbjct: 123 S-KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE---------YIDPETKKHIPYR 172
Query: 307 APELIFGATEYTTAI------------DMWSIGCVLAELLLGQ 337
+ + G Y +I D+ ++G + L G
Sbjct: 173 EHKSLTGTARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 3e-15
Identities = 41/250 (16%), Positives = 85/250 (34%), Gaps = 49/250 (19%)
Query: 118 AGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK 177
G+V+ G + ++ + +G+G FG+++ A + A V + +
Sbjct: 27 EGKVLDDMEGNQ---------WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN 77
Query: 178 N---RELQIMRLLNHPNVVSLK--------------HCFFSTTEKDELYLNLVLEYISET 220
EL+ + + + + + T K Y +V+E +
Sbjct: 78 GPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID 137
Query: 221 VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP-HTHQL 279
+ + + N V ++ L Y+H H DIK NLL+ + Q+
Sbjct: 138 L----QKISGQNGTFKKSTVLQLGIRMLDVLEYIHE-NEYVHGDIKAANLLLGYKNPDQV 192
Query: 280 KICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAI------------DMWSIG 327
+ D+G + P + Y + G E+ T++ D+ +G
Sbjct: 193 YLADYGLSYRYCPNGNHKQYQ----ENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILG 247
Query: 328 CVLAELLLGQ 337
+ L G+
Sbjct: 248 YCMLRWLCGK 257
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 7e-15
Identities = 54/228 (23%), Positives = 93/228 (40%), Gaps = 63/228 (27%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR----ELQIMRLLNHPNVVSL-K 196
+ ++G G FG V++ L G VA+K+ + E++ + HP++VSL
Sbjct: 44 KFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIG 102
Query: 197 HCFFSTTEKDELYLNLVLEYIS-----ETVYRVSKHY------TRMNQHVPILYVQLYTY 245
C E++E+ L + +Y+ +Y R+
Sbjct: 103 FC----DERNEMIL--IYKYMENGNLKRHLYGSDLPTMSMSWEQRL-------------- 142
Query: 246 QIC----RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC 301
+IC R L+YLH + HRD+K N+L++ + KI DFG +K + +++
Sbjct: 143 EICIGAARGLHYLHTR-AIIHRDVKSINILLDENFVP-KITDFGISKKGTELDQ--THLS 198
Query: 302 SRY-----YRAPELIFGATEY------TTAIDMWSIGCVLAELLLGQP 338
+ Y P EY T D++S G VL E+L +
Sbjct: 199 TVVKGTLGYIDP-------EYFIKGRLTEKSDVYSFGVVLFEVLCARS 239
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 48/221 (21%), Positives = 90/221 (40%), Gaps = 41/221 (18%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLN-HPNVVSL 195
+ R +G+GSFG ++ ++T + VAIK ++ E +I R+L + ++
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+ + Y LV++ + + + + ++ + + V + Q+ + ++H
Sbjct: 69 RWFG-----VEGDYNVLVMDLLGPS---LEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 256 HVVGVCHRDIKPQNLLV--NPHTHQLKICDFGSAKMLVPGEPNISYICSRY-----YRAP 308
HRDIKP N L+ +Q+ I DFG AK Y + YR
Sbjct: 121 S-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK---------YRDTSTHQHIPYREN 170
Query: 309 ELIFGATEYTTAI------------DMWSIGCVLAELLLGQ 337
+ + G Y ++ D+ S+G VL L G
Sbjct: 171 KNLTGTARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 51/226 (22%), Positives = 95/226 (42%), Gaps = 58/226 (25%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR-----ELQIMRLLNHPNVVSLK 196
+ ++G G FG V++ + L G VA+K++ +++ E++++ + H N++ L+
Sbjct: 35 KNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93
Query: 197 -HCFFSTTEKDELYLNLVLEYIS-----ETVYRVSKHY------TRMNQHVPILYVQLYT 244
C E L V Y++ + + R
Sbjct: 94 GFC----MTPTERLL--VYPYMANGSVASCLRERPESQPPLDWPKRQR------------ 135
Query: 245 YQIC----RALNYLHHVVGVC--HRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS 298
I R L YLH HRD+K N+L++ + + DFG AK++ + +
Sbjct: 136 --IALGSARGLAYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLM---DYKDT 189
Query: 299 YICSRY-----YRAPE-LIFG-ATEYTTAIDMWSIGCVLAELLLGQ 337
++ + + APE L G ++E T D++ G +L EL+ GQ
Sbjct: 190 HVTTAVRGTIGHIAPEYLSTGKSSEKT---DVFGYGVMLLELITGQ 232
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 42/252 (16%), Positives = 79/252 (31%), Gaps = 50/252 (19%)
Query: 118 AGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQA-----KCLETGDSVAIKKVLQ 172
G++I + +G G FG ++ A + + + +K
Sbjct: 25 VGEIITDMAAAA---------WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPS 75
Query: 173 DKRYKNRELQIMRLLNHPNVVSLK--------------HCFFSTTEKDELYLNLVLEYIS 218
D EL+ + P + + + Y ++++
Sbjct: 76 DNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFG 135
Query: 219 ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP-HTH 277
+ K Y + V + +I L Y+H H DIK NLL+N +
Sbjct: 136 SDL---QKIYEANAKRFSRKTVLQLSLRILDILEYIHEH-EYVHGDIKASNLLLNYKNPD 191
Query: 278 QLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAI------------DMWS 325
Q+ + D+G A P + +Y G E+ T+I D+
Sbjct: 192 QVYLVDYGLAYRYCPEGVHKAYA----ADPKRCHDGTIEF-TSIDAHNGVAPSRRGDLEI 246
Query: 326 IGCVLAELLLGQ 337
+G + + L G
Sbjct: 247 LGYCMIQWLTGH 258
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 7e-13
Identities = 36/253 (14%), Positives = 83/253 (32%), Gaps = 52/253 (20%)
Query: 118 AGQVIATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDS--------VAIK- 168
G V+ G + + + + G++++A T ++K
Sbjct: 32 TGTVLTDKSGRQ---------WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL 82
Query: 169 -----------KVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217
Q + K ++ + L ++++ C +D+ LVL +
Sbjct: 83 DAKDGRLFNEQNFFQ-RAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRF-LVLPSL 140
Query: 218 SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP-HT 276
++ + + V ++ AL +LH H ++ +N+ V+P
Sbjct: 141 GRSLQSALDVSPK--HVLSERSVLQVACRLLDALEFLHEN-EYVHGNVTAENIFVDPEDQ 197
Query: 277 HQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAI------------DMW 324
Q+ + +G A P +++Y G E+ ++ D+
Sbjct: 198 SQVTLAGYGFAFRYCPSGKHVAY---VEGSRSPHE-GDLEF-ISMDLHKGCGPSRRSDLQ 252
Query: 325 SIGCVLAELLLGQ 337
S+G + + L G
Sbjct: 253 SLGYCMLKWLYGF 265
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 6e-12
Identities = 57/229 (24%), Positives = 89/229 (38%), Gaps = 68/229 (29%)
Query: 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNR--------ELQIMRLLNHPNVVSL 195
+G G FGVV++ + +VA+KK+ E+++M H N+V L
Sbjct: 38 KMGEGGFGVVYKG-YVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 196 K-HCFFSTTEKDELYLNLVLEYIS-----ETVYRVSKH-----YTRMNQHVPILYVQLYT 244
++ D+L L V Y+ + + + + R
Sbjct: 96 LGFS----SDGDDLCL--VYVYMPNGSLLDRLSCLDGTPPLSWHMRCK------------ 137
Query: 245 YQIC----RALNYLH--HVVGVCHRDIKPQNLLV----NPHTHQLKICDFGSAKMLVPGE 294
I +N+LH H + HRDIK N+L+ KI DFG A+
Sbjct: 138 --IAQGAANGINFLHENHHI---HRDIKSANILLDEAFTA-----KISDFGLAR-ASEKF 186
Query: 295 PNISYICSR----Y-YRAPELIFGATEYTTAIDMWSIGCVLAELLLGQP 338
+ + SR Y APE + G E T D++S G VL E++ G P
Sbjct: 187 AQ-TVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLP 232
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 9e-09
Identities = 34/125 (27%), Positives = 56/125 (44%), Gaps = 25/125 (20%)
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICS 302
Y++Q+ + + +L HRD+ +N+L++ + +KICDFG A+ +
Sbjct: 198 YSFQVAKGMEFLASR-KCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDP-------- 247
Query: 303 RYYR------------APELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQL 349
Y APE IF YT D+WS G +L E+ LG +PG ++
Sbjct: 248 -DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 305
Query: 350 VEIIK 354
+K
Sbjct: 306 CRRLK 310
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 41.1 bits (96), Expect = 6e-04
Identities = 22/86 (25%), Positives = 39/86 (45%), Gaps = 15/86 (17%)
Query: 142 ERVVGTGSFGVVFQAKCL-----ETGDSVAIKKV-----LQDKRYKNRELQIMRLL-NHP 190
+ +G G+FG V +A T +VA+K + + R EL+I+ + +H
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEY 216
NVV+L T L +++E+
Sbjct: 87 NVVNLLGA--CTKPGGPLM--VIVEF 108
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.9 bits (118), Expect = 2e-06
Identities = 45/322 (13%), Positives = 91/322 (28%), Gaps = 96/322 (29%)
Query: 158 CLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYI 217
L + ++K +++ N + + + S+ + ++D LY N +
Sbjct: 70 TLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIE-QRDRLY-NDNQVFA 127
Query: 218 SETVYRVSKHYTRMNQHV----PILYVQLY----------TYQICRALNYLHHV------ 257
V R+ + Y ++ Q + P V + +C + +
Sbjct: 128 KYNVSRL-QPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFW 186
Query: 258 --VGVCHRD---IKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIF 312
+ C+ ++ L+ +Q+ ++ S NI +
Sbjct: 187 LNLKNCNSPETVLEMLQKLL----YQID-PNWTS---RSDHSSNIKLRIHSIQAELRRLL 238
Query: 313 GATEYTTAI----DMWS--------IGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPT 360
+ Y + ++ + + C KIL T T
Sbjct: 239 KSKPYENCLLVLLNVQNAKAWNAFNLSC-------------------------KILLT-T 272
Query: 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRM---PPEALDLVSRLLQYSPS-LRCTALE 416
R T+F H + H M P E L+ + L P L E
Sbjct: 273 R------FKQVTDFLSAATTTHI--SLDHHSMTLTPDEVKSLLLKYLDCRPQDLP---RE 321
Query: 417 ACA-HPFF-----DDLRD-PNT 431
+P + +RD T
Sbjct: 322 VLTTNPRRLSIIAESIRDGLAT 343
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 492 | |||
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.85 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.74 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.15 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.05 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.0 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.59 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.43 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.25 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.23 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.09 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.09 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.0 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.99 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.37 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.29 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.26 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.24 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.22 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.09 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.96 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.94 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.92 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.91 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.84 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.35 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.11 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.56 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.02 |
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-63 Score=479.07 Aligned_cols=250 Identities=29% Similarity=0.435 Sum_probs=203.1
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
.++|++.+.||+|+||+||+|+++.+|+.||||++.+. .....+|+.+|+.++|||||+++++| .+..
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~ 86 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI-----KSKD 86 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECC
Confidence 35799999999999999999999999999999998543 23456899999999999999999998 4455
Q ss_pred EEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 209 ~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
.+|||||||+|++++.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+
T Consensus 87 ~~~ivmEy~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDiKP~NILl~~~~-~vkl~DFGla~ 160 (275)
T 3hyh_A 87 EIIMVIEYAGNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHR-HKIVHRDLKPENLLLDEHL-NVKIADFGLSN 160 (275)
T ss_dssp EEEEEEECCCEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEECTTC-CEEECCSSCC-
T ss_pred EEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCChHHeEECCCC-CEEEeecCCCe
Confidence 7999999999988876543 4679999999999999999999997 9999999999999999888 79999999998
Q ss_pred ccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
.........+.+||+.|||||++.+..+++.++|||||||++|+|++|++||.+.+..+.+..|...
T Consensus 161 ~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~------------- 227 (275)
T 3hyh_A 161 IMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG------------- 227 (275)
T ss_dssp --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-------------
T ss_pred ecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC-------------
Confidence 7766666667899999999999987776678999999999999999999999998877666666541
Q ss_pred CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCC
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~ 425 (492)
.+. +++.+|+++++||.+||+.||++|||+.|+++||||+.
T Consensus 228 ----~~~------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 228 ----VYT------------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp ----CCC------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred ----CCC------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 112 22458999999999999999999999999999999973
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-62 Score=498.88 Aligned_cols=287 Identities=36% Similarity=0.644 Sum_probs=238.8
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccC-CCceEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELYL 210 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~-~~~~~~ 210 (492)
+|.+++.||+|+||+||+|+++.+|+.||||++.+.. ....+|+.+|+.|+|||||++++++..... .+...+
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~ 134 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV 134 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence 5999999999999999999999999999999985432 234579999999999999999998754321 344568
Q ss_pred EEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 211 ~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
|||||||+|+|...+.. ...+++..++.|++||+.||.|||+ +|||||||||+|||++.++ .+||+|||+|+.+
T Consensus 135 ~ivmE~~~g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NIl~~~~~-~~Ki~DFGla~~~ 208 (398)
T 4b99_A 135 YVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHS-AQVIHRDLKPSNLLVNENC-ELKIGDFGMARGL 208 (398)
T ss_dssp EEEEECCSEEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTC-CEEECCCTTCBCC
T ss_pred EEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CcCcCCCcCccccccCCCC-CEEEeecceeeec
Confidence 99999999988776543 4679999999999999999999997 9999999999999999888 7999999999866
Q ss_pred CCC-----CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 011138 291 VPG-----EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (492)
Q Consensus 291 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~ 365 (492)
... ....+.+||+.|||||++.+..+|+.++||||+||++|||++|++||.+.+..+++..|+...|.|+...+.
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~ 288 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ 288 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 322 234567999999999999887778999999999999999999999999999999999999999999877654
Q ss_pred hcCCCCc---ccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCCC
Q 011138 366 CMNPNYT---EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431 (492)
Q Consensus 366 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~~ 431 (492)
....... ...+|.....+|...+ +.++++++|||.+||++||.+|||+.|+|+||||+++.++..
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~ 356 (398)
T 4b99_A 289 AVGAERVRAYIQSLPPRQPVPWETVY-PGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDD 356 (398)
T ss_dssp -----CHHHHHHSSCCCCCCCHHHHS-TTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGG
T ss_pred hhhhhhhhhhhhcCCCcCCCCHHHhC-CCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCcc
Confidence 4322111 1123333334444433 568999999999999999999999999999999999887654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-62 Score=481.58 Aligned_cols=251 Identities=33% Similarity=0.555 Sum_probs=217.3
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
.+|.+++.||+|+||+||+|+++.+|+.||||++.+. .....+|+++|+.|+|||||+++++| .+..+
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~ 106 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK 106 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence 4699999999999999999999999999999998543 23456899999999999999999999 55567
Q ss_pred EEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 210 ~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
+|||||||.| +|.+.+.. ...+++..++.|+.||+.||+|||+ +|||||||||+||||+.++ .+||+|||+|+
T Consensus 107 ~yivmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDlKPeNILl~~~g-~vKl~DFGla~ 180 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDM-HIQITDFGTAK 180 (311)
T ss_dssp EEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred EEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEEcCCC-CEEEEEcCCce
Confidence 9999999986 56555433 3579999999999999999999997 9999999999999999888 79999999998
Q ss_pred ccCCCC---CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 011138 289 MLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (492)
Q Consensus 289 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~ 365 (492)
.+.... ...+.+||+.|||||++.+.. |+.++|||||||++|+|++|++||.+.+..+.+.+|.+
T Consensus 181 ~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~----------- 248 (311)
T 4aw0_A 181 VLSPESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK----------- 248 (311)
T ss_dssp ECCTTTTCCCBCCCCSCGGGCCHHHHHHSC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-----------
T ss_pred ecCCCCCcccccCcccCcccCCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-----------
Confidence 774332 345679999999999997654 89999999999999999999999999988888777765
Q ss_pred hcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHH------hhCCCCCCCCCC
Q 011138 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALE------ACAHPFFDDLRD 428 (492)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e------~l~Hp~f~~~~~ 428 (492)
..+.+ +..+++++++||.+||++||.+|||+.| +++||||+++..
T Consensus 249 ------~~~~~------------p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw 299 (311)
T 4aw0_A 249 ------LEYDF------------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW 299 (311)
T ss_dssp ------TCCCC------------CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred ------CCCCC------------CcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCH
Confidence 22222 2458999999999999999999999988 589999998754
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-62 Score=485.25 Aligned_cols=252 Identities=27% Similarity=0.425 Sum_probs=214.4
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
.|.+.+.||+|+||+||+|+++.+|+.||||++... ...+.+|+.+|+.++|||||+++++|.. ..++|||
T Consensus 75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~~iv 149 (346)
T 4fih_A 75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWVV 149 (346)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEEE
T ss_pred hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEEE
Confidence 599999999999999999999999999999998532 3445689999999999999999999943 4469999
Q ss_pred eeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 214 LEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 214 ~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
||||+|+ |.+++. ...+++..++.|+.||+.||+|||+ +|||||||||+||||+.++ .+||+|||+|+.+..
T Consensus 150 mEy~~gg~L~~~l~-----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~~ 222 (346)
T 4fih_A 150 MEFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSK 222 (346)
T ss_dssp ECCCTTEEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEECCS
T ss_pred EeCCCCCcHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEECCCC-CEEEecCcCceecCC
Confidence 9999975 444332 2469999999999999999999997 9999999999999999888 799999999987654
Q ss_pred C-CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 011138 293 G-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (492)
Q Consensus 293 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~ 371 (492)
. ....+.+||+.|||||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..|.... ++
T Consensus 223 ~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~--~~----------- 288 (346)
T 4fih_A 223 EVPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL--PP----------- 288 (346)
T ss_dssp SSCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS--CC-----------
T ss_pred CCCcccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC--CC-----------
Confidence 3 345578999999999999654 58999999999999999999999999988877777665421 00
Q ss_pred cccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
.+ ..+..+|+++++||.+||++||++|||+.|+|+||||++...
T Consensus 289 ---~~----------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~ 332 (346)
T 4fih_A 289 ---RL----------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 332 (346)
T ss_dssp ---CC----------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred ---CC----------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence 00 012358999999999999999999999999999999997543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-60 Score=491.01 Aligned_cols=314 Identities=70% Similarity=1.229 Sum_probs=286.6
Q ss_pred ccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchhhHHHHHHHHHHcCCCCccccceeeeeccC-CCceEEEE
Q 011138 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELYLNL 212 (492)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~-~~~~~~~l 212 (492)
....+|.+.+.||+|+||.||+|++..+|+.||||++..+.....+|+++|+.++|||||+++++|+.... .+..++++
T Consensus 51 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp CEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred cccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 34557999999999999999999999999999999998777777789999999999999999999876543 45677899
Q ss_pred EeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 213 V~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
||||++++++..+..+......+++..++.++.||+.||.|||+ +||+||||||+||||+.++..+||+|||+++....
T Consensus 131 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 131 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209 (420)
T ss_dssp EEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred ehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence 99999998888777766667889999999999999999999997 99999999999999997765789999999998766
Q ss_pred CCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 011138 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372 (492)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~ 372 (492)
+......+||+.|+|||++.+...|+.++|||||||++|||++|++||.+.+..+++.++++.+|.|..+.+..+++.+.
T Consensus 210 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~ 289 (420)
T 1j1b_A 210 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 289 (420)
T ss_dssp TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCC
T ss_pred CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence 66667789999999999998776799999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q 011138 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQ 448 (492)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (492)
.+.+|.+...+|...+...+++++++||.+||++||.+|||+.|+++||||++++++....++...++.+++|...
T Consensus 290 ~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (420)
T 1j1b_A 290 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQ 365 (420)
T ss_dssp CCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCHH
T ss_pred hhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccccccCCCCCCCCccCCCCHH
Confidence 9999999999999999999999999999999999999999999999999999999888777777788888888754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-61 Score=488.33 Aligned_cols=331 Identities=50% Similarity=0.974 Sum_probs=286.8
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchhhHHHHHHHHHHcCCCCccccceeeeeccC-----------
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTE----------- 204 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~----------- 204 (492)
..+|.+++.||+|+||+||+|.+..+|+.||||++..+.....+|+.+++.++|||||+++++|.....
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 85 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDD 85 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC-------------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCcccccccccccc
Confidence 457999999999999999999999999999999998877777789999999999999999999876543
Q ss_pred ----------------------CCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCccc
Q 011138 205 ----------------------KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCH 262 (492)
Q Consensus 205 ----------------------~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givH 262 (492)
.+..++++||||+++++...+..+......+++..++.++.||+.||.|||+ +||+|
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~gi~H 164 (383)
T 3eb0_A 86 HNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGICH 164 (383)
T ss_dssp ------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEEC
T ss_pred cccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CcCcc
Confidence 4456789999999998888877776777889999999999999999999997 99999
Q ss_pred CCCCCCceEEcCCCCcEEEeeecCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 011138 263 RDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPG 342 (492)
Q Consensus 263 rDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~ 342 (492)
|||||+|||++.+.+.+||+|||+++............||+.|+|||++.+...++.++|||||||++|+|++|++||.+
T Consensus 165 ~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 244 (383)
T 3eb0_A 165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSG 244 (383)
T ss_dssp SCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCC
Confidence 99999999998544489999999999877777777789999999999998777799999999999999999999999999
Q ss_pred CChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCC
Q 011138 343 ESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422 (492)
Q Consensus 343 ~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~ 422 (492)
.+..+++..+++.+|.|+.+.+..+++.+....+|......|...++..+++++++||.+||++||.+|||+.|+|+|||
T Consensus 245 ~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 324 (383)
T 3eb0_A 245 ETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPF 324 (383)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred CChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCC-------CCCCCCCC--CCCCCCCCCCcccccccccccccccccccCccchhHHHhcCCHHHHhhccccccc
Q 011138 423 FDDLRD-------PNTCLPNG--RPLPTLFNFTAQGKLILCFSYFGFSSYFLPHANCLAELAGASNELRQRLIPEHAR 491 (492)
Q Consensus 423 f~~~~~-------~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 491 (492)
|+++++ +....+++ .++|.+++|... |+...+++++.+|+|+|.+
T Consensus 325 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~l~~~~~~~~~~~~~~~~~ 378 (383)
T 3eb0_A 325 FDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPY------------------------ELSIIPGNVLNRILPKNFS 378 (383)
T ss_dssp GHHHHHC------------------CCCCSCCCHH------------------------HHHHSCHHHHHHHSCC---
T ss_pred HHHHHhhccccccccccCCCcccCCCCCCCCCCHH------------------------HHhcCCHHHHhhcCchhhc
Confidence 997764 33344444 567777777766 8888899999999999875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-61 Score=487.06 Aligned_cols=253 Identities=27% Similarity=0.421 Sum_probs=215.4
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
..|.+.+.||+|+||.||+|+++.+|+.||||++... ...+.+|+.+|+.|+|||||+++++|.. ..++||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~~i 225 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWV 225 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEE-----CCEEEE
Confidence 4699999999999999999999999999999998532 3456789999999999999999999944 346999
Q ss_pred Eeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 213 VLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 213 V~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
|||||+|+ |.+++. ...+++..++.|+.||+.||+|||+ +|||||||||+||||+.++ .+||+|||+|+.+.
T Consensus 226 VmEy~~gG~L~~~i~-----~~~l~e~~~~~~~~qil~aL~ylH~-~~IiHRDiKp~NILl~~~g-~vKl~DFGla~~~~ 298 (423)
T 4fie_A 226 VMEFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVS 298 (423)
T ss_dssp EEECCTTEEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSTTTEEECTTC-CEEECCCTTCEECC
T ss_pred EEeCCCCCcHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEcCCC-CEEEecCccceECC
Confidence 99999975 444332 2469999999999999999999997 9999999999999999888 79999999998764
Q ss_pred CC-CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 011138 292 PG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (492)
Q Consensus 292 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 370 (492)
.. ....+.+||+.|||||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..|.... ++
T Consensus 299 ~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~--~~---------- 365 (423)
T 4fie_A 299 KEVPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL--PP---------- 365 (423)
T ss_dssp SSCCCBCCCEECTTTCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--CC----------
T ss_pred CCCccccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC--CC----------
Confidence 43 345678999999999999654 58999999999999999999999999988887777665421 00
Q ss_pred CcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
.+ ..+..+++++++||.+||++||++|||+.|+|+||||++...
T Consensus 366 ----~~----------~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~ 409 (423)
T 4fie_A 366 ----RL----------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 409 (423)
T ss_dssp ----CC----------SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred ----CC----------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence 00 012458999999999999999999999999999999997543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-61 Score=481.48 Aligned_cols=252 Identities=26% Similarity=0.427 Sum_probs=208.7
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
.++|++++.||+|+||+||+|+++.+|+.||||++... ...+.+|+.+|+.|+|||||+++++|. +...
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~-----~~~~ 97 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE-----ENGS 97 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEE-----ECCE
Confidence 35799999999999999999999999999999998543 234568999999999999999999984 4446
Q ss_pred EEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 210 ~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
+|||||||+| +|.+.+.. .....+++..++.|+.||+.||+|||+ +|||||||||+||||+.++ .+||+|||+|+
T Consensus 98 ~yiVmEy~~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g-~vKl~DFGla~ 173 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTKDG-TVQLGDFGIAR 173 (350)
T ss_dssp EEEEEECCTTCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCEETTCCGGGEEECTTC-CEEECSTTEES
T ss_pred EEEEEeCCCCCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECCCC-CEEEcccccce
Confidence 9999999986 56565542 223557899999999999999999997 9999999999999999888 79999999998
Q ss_pred ccCCCC-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 289 MLVPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 289 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
...... ...+.+||+.|||||++.+. .|+.++|||||||+||||++|++||.+.+..+.+.+|.+.
T Consensus 174 ~~~~~~~~~~~~~GT~~YmAPE~l~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~------------ 240 (350)
T 4b9d_A 174 VLNSTVELARACIGTPYYLSPEICENK-PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG------------ 240 (350)
T ss_dssp CCCHHHHHHHHHHSCCTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT------------
T ss_pred eecCCcccccccCCCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC------------
Confidence 764322 23456899999999999765 5999999999999999999999999999888888777652
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~ 425 (492)
.+|. ++..+|+++++||.+||++||++|||+.|+|+||||++
T Consensus 241 -------~~~~---------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 241 -------SFPP---------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp -------CCCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred -------CCCC---------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 1111 22457999999999999999999999999999999975
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-60 Score=463.02 Aligned_cols=251 Identities=23% Similarity=0.340 Sum_probs=206.9
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
|++.+.||+|+||+||+|.+..+|..||||++.... ..+.+|+.+|+.|+|||||+++++|.... .+..++||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~l 106 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEE
Confidence 478889999999999999999999999999985432 33568999999999999999999985543 34567899
Q ss_pred Eeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCC--cccCCCCCCceEEcC-CCCcEEEeeecCcc
Q 011138 213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG--VCHRDIKPQNLLVNP-HTHQLKICDFGSAK 288 (492)
Q Consensus 213 V~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~g--ivHrDlKp~NILl~~-~~~~vkL~DFG~a~ 288 (492)
|||||+| +|.+.+.. ...+++..++.|+.||+.||+|||+ +| ||||||||+||||+. ++ .+||+|||+|+
T Consensus 107 vmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~-~~~~IiHRDlKp~NILl~~~~g-~vKl~DFGla~ 180 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTG-SVKIGDLGLAT 180 (290)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCCCCCGGGEEESSTTS-CEEECCTTGGG
T ss_pred EEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCEEecccChhheeEECCCC-CEEEEeCcCCE
Confidence 9999986 45554432 4578999999999999999999997 88 999999999999985 55 79999999998
Q ss_pred ccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
.. ......+.+||+.|||||++.+ .|+.++|||||||+||||+||++||.+.+....+...+... .++
T Consensus 181 ~~-~~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~-~~~-------- 248 (290)
T 3fpq_A 181 LK-RASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG-VKP-------- 248 (290)
T ss_dssp GC-CTTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT-CCC--------
T ss_pred eC-CCCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcC-CCC--------
Confidence 54 3344557799999999999854 49999999999999999999999998876665554433210 000
Q ss_pred CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCC
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~ 425 (492)
..++..+++++++||.+||+.||++|||+.|+|+||||++
T Consensus 249 -----------------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 249 -----------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp -----------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred -----------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 1123457899999999999999999999999999999985
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-60 Score=482.42 Aligned_cols=311 Identities=66% Similarity=1.183 Sum_probs=284.9
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchhhHHHHHHHHHHcCCCCccccceeeeeccC-CCceEEEEE
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELYLNLV 213 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~-~~~~~~~lV 213 (492)
...+|.+.+.||+|+||+||+|++..+++ ||+|++..+.....+|+.+++.++||||++++++|+.... .+..++++|
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv 116 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence 34579999999999999999999877665 9999988777777789999999999999999999977664 567788999
Q ss_pred eeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEc-CCCCcEEEeeecCccccCC
Q 011138 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN-PHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 214 ~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~-~~~~~vkL~DFG~a~~~~~ 292 (492)
|||++++++.....+......+++..++.++.||+.||.|||+ +||+||||||+||||+ .++ .+||+|||+++....
T Consensus 117 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~-~~kL~DFG~a~~~~~ 194 (394)
T 4e7w_A 117 LEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS-IGICHRDIKPQNLLLDPPSG-VLKLIDFGSAKILIA 194 (394)
T ss_dssp EECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTT-EEEECCCTTCEECCT
T ss_pred eeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEcCCCC-cEEEeeCCCcccccC
Confidence 9999999888777766667889999999999999999999997 9999999999999999 455 899999999998776
Q ss_pred CCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 011138 293 GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372 (492)
Q Consensus 293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~ 372 (492)
+......+||+.|+|||++.+...|+.++|||||||++|||++|++||.+.+..+++..+++.+|.|..+.+..+++++.
T Consensus 195 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~ 274 (394)
T 4e7w_A 195 GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYM 274 (394)
T ss_dssp TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGS
T ss_pred CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence 77777889999999999998777799999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q 011138 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQ 448 (492)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (492)
...++.....+|...++..+++++++||.+||++||.+|||+.|+++||||++++++....++...++++++|...
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (394)
T 4e7w_A 275 EHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKE 350 (394)
T ss_dssp SSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCCCCTTSSCCCCSCCCCHH
T ss_pred hhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccccccCCCCCCCCCcCCCCHH
Confidence 9999999999999999999999999999999999999999999999999999999988888888889999988765
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-60 Score=471.76 Aligned_cols=255 Identities=24% Similarity=0.357 Sum_probs=212.6
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEeee
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEY 216 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E~ 216 (492)
..|.+.++||+|+||+||+|+++.+|+.||||++..+.. ..+|+.+|+.|+|||||+++++|. +..++||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-~~~E~~il~~l~HpnIV~l~~~~~-----~~~~~~ivmEy 131 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-RVEELVACAGLSSPRIVPLYGAVR-----EGPWVNIFMEL 131 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CTHHHHTTTTCCCTTBCCEEEEEE-----ETTEEEEEECC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-HHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEEEEec
Confidence 459999999999999999999999999999999976433 347999999999999999999984 44468999999
Q ss_pred chh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCCC
Q 011138 217 ISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295 (492)
Q Consensus 217 ~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~~ 295 (492)
|+| +|.+++.. ...+++..++.|+.||+.||+|||+ +|||||||||+||||+.++..+||+|||+|+.+.....
T Consensus 132 ~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 132 LEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHT-RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp CTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 986 55555443 3579999999999999999999997 99999999999999998875699999999987654321
Q ss_pred ------CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 296 ------NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 296 ------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
....+||+.|||||++.+. .|+.++|||||||++|||++|++||.+.+..+.+.+|... .++
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~--------- 274 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--PPP--------- 274 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--CCG---------
T ss_pred ccceecCCccccCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--CCC---------
Confidence 1235799999999999765 4999999999999999999999999988776666666541 110
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHh-------------hCCCCCCCCCCC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEA-------------CAHPFFDDLRDP 429 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~-------------l~Hp~f~~~~~~ 429 (492)
+ ..+++.+++++++||.+||++||.+|||+.|+ |+|||+.+++.|
T Consensus 275 ------~---------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P 332 (336)
T 4g3f_A 275 ------I---------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP 332 (336)
T ss_dssp ------G---------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred ------c---------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence 0 11335689999999999999999999999997 689999988765
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-60 Score=467.50 Aligned_cols=250 Identities=28% Similarity=0.461 Sum_probs=207.1
Q ss_pred cceeEeeeeccCCceEEEEEEEc---CCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~---~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
.+|++.+.||+|+||+||+|++. .+++.||||++.+. .....+|+.+|+.++|||||+++++|. +.
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~ 98 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQ-----TE 98 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEE-----ET
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----EC
Confidence 46999999999999999999874 46889999998542 234568999999999999999999984 44
Q ss_pred eEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 208 ~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
..+|||||||+| +|.+.+.. ...+++..++.|+.||+.||+|||+ +|||||||||+|||++.++ .+||+|||+
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g-~vKl~DFGl 172 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDEEG-HIKLTDFGL 172 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECTTS-CEEEESSEE
T ss_pred CEEEEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHeEEcCCC-CEEeccccc
Confidence 468999999986 45554432 4579999999999999999999997 9999999999999999888 799999999
Q ss_pred ccccCCC-CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 011138 287 AKMLVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (492)
Q Consensus 287 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~ 365 (492)
|+..... ....+.+||+.|||||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..|.+.
T Consensus 173 a~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~---------- 241 (304)
T 3ubd_A 173 SKESIDHEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA---------- 241 (304)
T ss_dssp EEC-----CCCCSCCCCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----------
T ss_pred ceeccCCCccccccccCcccCCHHHhccC-CCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC----------
Confidence 9865433 344568999999999999765 5999999999999999999999999999888888777651
Q ss_pred hcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCH-----HHhhCCCCCCCCC
Q 011138 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA-----LEACAHPFFDDLR 427 (492)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~-----~e~l~Hp~f~~~~ 427 (492)
.+.+ +..+|+++++||.+||++||++|||+ +|+++||||+++.
T Consensus 242 -------~~~~------------p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~id 289 (304)
T 3ubd_A 242 -------KLGM------------PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID 289 (304)
T ss_dssp -------CCCC------------CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred -------CCCC------------CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence 1222 24589999999999999999999984 7999999999864
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-59 Score=468.80 Aligned_cols=280 Identities=27% Similarity=0.450 Sum_probs=217.1
Q ss_pred ccccceeEeeeeccCCceEEEEEEEc---CCCCEEEEEEeccch--hhHHHHHHHHHHc-CCCCccccceeeeeccCCCc
Q 011138 134 KQTISYMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQDK--RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~---~~g~~vAiK~~~~~~--~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~ 207 (492)
...++|++.+.||+|+||+||+|+++ .+++.||||++.... ....+|+++|+.+ +|||||+++++|. +.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~-----~~ 92 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFR-----KN 92 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEE-----ET
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEE-----EC
Confidence 34457999999999999999999875 467899999886543 3456899999998 6999999999984 44
Q ss_pred eEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 208 ~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
.++|||||||+| ++.+.+ +.+++..++.|+.||+.||+|||+ +|||||||||+|||++.+.+.+||+|||+
T Consensus 93 ~~~~lvmE~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH~-~gIiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRIHQ-FGIVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp TEEEEEEECCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred CEEEEEEeCCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 569999999985 454443 348999999999999999999997 99999999999999988755899999999
Q ss_pred ccccCCCC-----------------------------CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCC
Q 011138 287 AKMLVPGE-----------------------------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ 337 (492)
Q Consensus 287 a~~~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~ 337 (492)
|+...... ...+.+||+.|||||++.+...|+.++||||+||++|||++|+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence 97553221 1234589999999999988777999999999999999999999
Q ss_pred CCCC-CCChHHHHHHHHHHhCCCCHHHHhhcCCC-------C--------------cccCCCcc----cCCCcccccCCC
Q 011138 338 PLFP-GESGVDQLVEIIKILGTPTREEIKCMNPN-------Y--------------TEFKFPQI----KAHPWHKIFHKR 391 (492)
Q Consensus 338 ~pf~-~~~~~~~~~~i~~~~g~p~~~~~~~~~~~-------~--------------~~~~~~~~----~~~~~~~~~~~~ 391 (492)
+||. +.++.+++..|.+.+|.+........... . ....+|.. .........+..
T Consensus 245 ~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 324 (361)
T 4f9c_A 245 YPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNE 324 (361)
T ss_dssp SSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTT
T ss_pred CCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccccc
Confidence 9984 56778899999999987654433211000 0 00011110 001111123457
Q ss_pred CChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 392 MPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 392 ~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
+|++++|||.+||++||++|+|++|+|+||||+++
T Consensus 325 is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 325 VPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred CCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 89999999999999999999999999999999986
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-58 Score=450.05 Aligned_cols=260 Identities=25% Similarity=0.427 Sum_probs=192.2
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccC-------
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTE------- 204 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~------- 204 (492)
.+|++.+.||+|+||+||+|+++.+|+.||||++.... ....+|+.+|+.|+|||||+++++|.....
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46999999999999999999999999999999985322 334589999999999999999999865442
Q ss_pred CCceEEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEee
Q 011138 205 KDELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICD 283 (492)
Q Consensus 205 ~~~~~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~D 283 (492)
.+..++|||||||.++ |.+.+.. .......+...++.|+.||+.||+|||+ +|||||||||+||||+.++ .+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~-~~~~~~~~~~~~~~i~~qi~~al~ylH~-~~IiHRDlKp~NILl~~~~-~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNG-RCTIEERERSVCLHIFLQIAEAVEFLHS-KGLMHRDLKPSNIFFTMDD-VVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHT-CCSGGGSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHh-cCCCChhHHHHHHHHHHHHHHHHHHHHH-CcCccccCcHHHeEECCCC-cEEEcc
Confidence 2455789999999864 5444432 2222334556788999999999999997 9999999999999999888 799999
Q ss_pred ecCccccCCCCC-------------CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 011138 284 FGSAKMLVPGEP-------------NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLV 350 (492)
Q Consensus 284 FG~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~ 350 (492)
||+|+....... ..+.+||+.|||||++.+. .|+.++|||||||++|||++ ||.+.. +...
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~ 235 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLY---PFSTQM--ERVR 235 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCC-CCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHH
Confidence 999987643321 2346899999999999765 59999999999999999996 776432 2222
Q ss_pred HHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCC
Q 011138 351 EIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430 (492)
Q Consensus 351 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~ 430 (492)
.+...... .+|. .....++++++||.+||+.||.+|||+.|+++||||+++..|.
T Consensus 236 ~~~~~~~~----------------~~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p~ 290 (299)
T 4g31_A 236 TLTDVRNL----------------KFPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG 290 (299)
T ss_dssp HHHHHHTT----------------CCCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC----
T ss_pred HHHHHhcC----------------CCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCCC
Confidence 22222111 1111 0123467789999999999999999999999999999876543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-56 Score=473.08 Aligned_cols=260 Identities=27% Similarity=0.445 Sum_probs=221.7
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
.++|.+.+.||+|+||+||+|.++.+|+.||||++... .....+|+.+|+.|+|||||+++++| .+..++|
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~~~~~ 230 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMV 230 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECSSEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEE
Confidence 35799999999999999999999999999999998543 33456899999999999999999999 5556799
Q ss_pred EEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCC-CCcEEEeeecCccc
Q 011138 212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH-THQLKICDFGSAKM 289 (492)
Q Consensus 212 lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~-~~~vkL~DFG~a~~ 289 (492)
||||||.| +|++.+. .....+++..++.|+.||+.||.|||+ +||+||||||+|||++.+ .+.+||+|||+|+.
T Consensus 231 iv~E~~~gg~L~~~i~---~~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~ 306 (573)
T 3uto_A 231 MIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306 (573)
T ss_dssp EEEECCCCCBHHHHHT---CTTSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred EEEeecCCCcHHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence 99999986 4554432 234579999999999999999999997 999999999999999854 23799999999998
Q ss_pred cCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
+.........+||+.|||||++.+. .|+.++|||||||++|||++|.+||.+.+..+.+..|...
T Consensus 307 ~~~~~~~~~~~GT~~y~APEv~~~~-~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~-------------- 371 (573)
T 3uto_A 307 LDPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC-------------- 371 (573)
T ss_dssp CCTTSEEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT--------------
T ss_pred ccCCCceeeeEECccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhC--------------
Confidence 8766666778999999999999765 4899999999999999999999999999988888777652
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~ 430 (492)
.+.++. ..+..+++++++||.+||++||.+|||+.|+|+||||+....+.
T Consensus 372 ---~~~~~~--------~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~ 421 (573)
T 3uto_A 372 ---DWNMDD--------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 421 (573)
T ss_dssp ---CCCCCS--------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred ---CCCCCc--------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence 112211 12346899999999999999999999999999999999876543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-56 Score=472.92 Aligned_cols=255 Identities=24% Similarity=0.373 Sum_probs=209.5
Q ss_pred CccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHH---HHHHHHcCCCCccccceeeeec
Q 011138 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRE---LQIMRLLNHPNVVSLKHCFFST 202 (492)
Q Consensus 133 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E---~~il~~l~h~nIv~l~~~~~~~ 202 (492)
+...++|.+.++||+|+||+||+|+++.+|+.||||++.+.. ....+| +.+++.++|||||+++++|
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f--- 261 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF--- 261 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE---
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE---
Confidence 455678999999999999999999999999999999985432 122334 5556667899999999999
Q ss_pred cCCCceEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEE
Q 011138 203 TEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKI 281 (492)
Q Consensus 203 ~~~~~~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL 281 (492)
.+..++|||||||.| +|...+.. ...+++..++.|+.||+.||+|||+ +|||||||||+||||+.++ .+||
T Consensus 262 --~~~~~lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~-~gIiHRDLKPeNILld~~G-~vKL 333 (689)
T 3v5w_A 262 --HTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHG-HVRI 333 (689)
T ss_dssp --ECSSEEEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECTTS-CEEE
T ss_pred --EECCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHeEEeCCC-CEEe
Confidence 555679999999986 45554432 3579999999999999999999997 9999999999999999988 7999
Q ss_pred eeecCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCC
Q 011138 282 CDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQ---LVEIIKILGT 358 (492)
Q Consensus 282 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~---~~~i~~~~g~ 358 (492)
+|||+|+..... ...+.+||+.|||||++.+...|+.++|||||||+||||++|++||.+.+..+. ...+..
T Consensus 334 ~DFGlA~~~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~---- 408 (689)
T 3v5w_A 334 SDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT---- 408 (689)
T ss_dssp CCCTTCEECSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH----
T ss_pred cccceeeecCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC----
Confidence 999999876443 345689999999999997655699999999999999999999999987543222 222221
Q ss_pred CCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCC-----HHHhhCCCCCCCCCC
Q 011138 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-----ALEACAHPFFDDLRD 428 (492)
Q Consensus 359 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-----~~e~l~Hp~f~~~~~ 428 (492)
.... ++..+|+++++||.+||+.||.+|++ ++||++||||+++..
T Consensus 409 -------------~~~~------------~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW 458 (689)
T 3v5w_A 409 -------------MAVE------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 458 (689)
T ss_dssp -------------CCCC------------CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCH
T ss_pred -------------CCCC------------CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCH
Confidence 1111 23468999999999999999999998 799999999998753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-54 Score=424.62 Aligned_cols=249 Identities=22% Similarity=0.312 Sum_probs=194.9
Q ss_pred ccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
....++.+++.||+|+||+||+|++. ..||||++... ...+.+|+.+|++++|||||++++++. +.
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-----~~ 104 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-----KD 104 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----CC
Confidence 33456889999999999999999853 35999988532 234568999999999999999999762 11
Q ss_pred eEEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 208 LYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 208 ~~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
.+|||||||+++ |.+.+. .....+++..+..|+.||+.||+|||+ +|||||||||+||||+.++ .+||+|||+
T Consensus 105 -~~~iVmEy~~gGsL~~~l~---~~~~~l~~~~~~~i~~qia~gL~yLH~-~~IiHRDlKp~NILl~~~~-~~Ki~DFGl 178 (307)
T 3omv_A 105 -NLAIVTQWCEGSSLYKHLH---VQETKFQMFQLIDIARQTAQGMDYLHA-KNIIHRDMKSNNIFLHEGL-TVKIGDFGL 178 (307)
T ss_dssp -SCEEEEECCSSCBHHHHHH---TSCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCSSSEEEETTE-EEEECCCSS
T ss_pred -eEEEEEEcCCCCCHHHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCccCHHHEEECCCC-cEEEeeccC
Confidence 268999999965 444432 234569999999999999999999997 9999999999999999887 899999999
Q ss_pred ccccCCCC---CCccceeccCccCchhhcCC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 011138 287 AKMLVPGE---PNISYICSRYYRAPELIFGA--TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTR 361 (492)
Q Consensus 287 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~ 361 (492)
|+...... .....+||+.|||||++.+. ..|+.++|||||||+||||+||+.||.+.+....+..++..
T Consensus 179 a~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~------ 252 (307)
T 3omv_A 179 ATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGR------ 252 (307)
T ss_dssp CBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHT------
T ss_pred ceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhc------
Confidence 98654322 23456899999999999643 35899999999999999999999999988877766665542
Q ss_pred HHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
....|... ..+..+++++.+||.+||+.||++|||+.|+++
T Consensus 253 -----------~~~~p~~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 253 -----------GYASPDLS------KLYKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp -----------TCCCCCST------TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred -----------CCCCCCcc------cccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 11111111 123468999999999999999999999997653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-54 Score=423.16 Aligned_cols=254 Identities=23% Similarity=0.343 Sum_probs=204.8
Q ss_pred ccceeEeeeeccCCceEEEEEEEc-----CCCCEEEEEEeccc----hhhHHHHHHHHHHcCCCCccccceeeeeccCCC
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~-----~~g~~vAiK~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 206 (492)
..+|.+.+.||+|+||+||+|++. .+|..||||++... ...+.+|+++|++|+|||||++++++. +
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~-----~ 86 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----E 86 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----S
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----e
Confidence 357999999999999999999875 36889999998643 234568999999999999999999984 3
Q ss_pred ceEEEEEeeechh-hHHHHhhhhh---------hcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCC
Q 011138 207 ELYLNLVLEYISE-TVYRVSKHYT---------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT 276 (492)
Q Consensus 207 ~~~~~lV~E~~~~-~l~~~~~~~~---------~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~ 276 (492)
...+|||||||++ +|.+.+.... .....+++..+..|+.||+.||.|||+ ++||||||||+||||+.++
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccCHhhEEECCCC
Confidence 3458999999985 5555554321 223568999999999999999999997 9999999999999999887
Q ss_pred CcEEEeeecCccccCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 011138 277 HQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEI 352 (492)
Q Consensus 277 ~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i 352 (492)
.+||+|||+|+....... .....||+.|||||++.+.. |+.++|||||||+||||+| |+.||.+.+..+.+..+
T Consensus 166 -~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 243 (299)
T 4asz_A 166 -LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 243 (299)
T ss_dssp -CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred -cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 799999999986643332 22357899999999997654 9999999999999999998 99999998887776666
Q ss_pred HHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 353 IKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 353 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
.+. .. .. .+..+|+++.+||.+||+.||++|||+.++ |+|++++.
T Consensus 244 ~~~--~~--------------~~------------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~ 288 (299)
T 4asz_A 244 TQG--RV--------------LQ------------RPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLA 288 (299)
T ss_dssp HHT--CC--------------CC------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHH
T ss_pred HcC--CC--------------CC------------CCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHH
Confidence 541 10 01 224579999999999999999999999999 56777653
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-53 Score=426.51 Aligned_cols=304 Identities=47% Similarity=0.890 Sum_probs=250.8
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchh---hHHHHHHHHHHcCCCCccccceeeeeccC--CCceEE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR---YKNRELQIMRLLNHPNVVSLKHCFFSTTE--KDELYL 210 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~---~~~~E~~il~~l~h~nIv~l~~~~~~~~~--~~~~~~ 210 (492)
..+|.+.+.||+|+||.||+|.+..+|+.||||++..+.. ...+|+..++.++||||++++++|..... ....++
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 101 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL 101 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence 4579999999999999999999999999999998865433 33457777788899999999999876543 456678
Q ss_pred EEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHH--hhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH--HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 211 ~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH--~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
++||||+++++...+.........+++..++.++.||+.||.||| + +||+||||||+|||++...+.+||+|||+++
T Consensus 102 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~ 180 (360)
T 3e3p_A 102 NVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180 (360)
T ss_dssp EEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT-TCCBCSCCCGGGEEEETTTTEEEECCCTTCB
T ss_pred EEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC-CCeecCcCCHHHEEEeCCCCcEEEeeCCCce
Confidence 999999999888776665666778899999999999999999999 8 8999999999999999733389999999998
Q ss_pred ccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
............||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+.+.++.|+.+.+....
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3e3p_A 181 KLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLN 260 (360)
T ss_dssp CCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred ecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcc
Confidence 87666666677899999999999777778999999999999999999999999999999999999999999999998888
Q ss_pred CCCcccCCCcccCCCcccccCC---CCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCCCCCCCCCCCC
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHK---RMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLP 440 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~---~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~~~~~~~~~~~ 440 (492)
+......+......+|...+.. ..++++++||.+||+.||.+|||+.|+|+||||+++.++....++...++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~ 335 (360)
T 3e3p_A 261 PSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDLP 335 (360)
T ss_dssp TTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCCCTTSCCCC
T ss_pred cchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccccCCCCCCCC
Confidence 7776666666555666555433 36789999999999999999999999999999999988777666655555
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-54 Score=424.92 Aligned_cols=248 Identities=23% Similarity=0.341 Sum_probs=195.6
Q ss_pred cceeEeeeeccCCceEEEEEEEc-----CCCCEEEEEEeccc----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~-----~~g~~vAiK~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
.+|.+.+.||+|+||+||+|++. .+++.||||++... ...+.+|+++|++|+|||||++++++. +.
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~-----~~ 115 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCT-----EG 115 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----EC
Confidence 46899999999999999999875 36889999998643 234568999999999999999999983 34
Q ss_pred eEEEEEeeechhh-HHHHhhhhh-----------hcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCC
Q 011138 208 LYLNLVLEYISET-VYRVSKHYT-----------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH 275 (492)
Q Consensus 208 ~~~~lV~E~~~~~-l~~~~~~~~-----------~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~ 275 (492)
..+|||||||+++ |.+++.... .....+++..+..|+.||+.||.|||+ ++||||||||+||||+.+
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG-LHFVHRDLATRNCLVGQG 194 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEETT
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHhhEEECCC
Confidence 4589999999964 555443321 123468999999999999999999997 999999999999999988
Q ss_pred CCcEEEeeecCccccCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 011138 276 THQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVE 351 (492)
Q Consensus 276 ~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~ 351 (492)
+ .+||+|||+|+....... ....+||+.|||||++.+. .|+.++|||||||+||||+| |+.||.+.+..+.+..
T Consensus 195 ~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~ 272 (329)
T 4aoj_A 195 L-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC 272 (329)
T ss_dssp T-EEEECCCC----------------CCCCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred C-cEEEcccccceeccCCCcceecCcccccccccChhhhcCC-CCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 8 899999999987643322 2346799999999999765 49999999999999999998 9999999888777666
Q ss_pred HHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 352 IIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 352 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
+.+.. ... ++..+++++.+||.+||+.||++|||+.|++++
T Consensus 273 i~~g~----------------~~~------------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 273 ITQGR----------------ELE------------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHTC----------------CCC------------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHcCC----------------CCC------------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 65421 011 224579999999999999999999999999763
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-53 Score=438.48 Aligned_cols=288 Identities=35% Similarity=0.560 Sum_probs=221.8
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
.+|.+.+.||+|+||+||+|.+..+|+.||||++... .....+|+.+|+.++|||||++++++......+...+
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 4699999999999999999999999999999998542 2334589999999999999999999866554555678
Q ss_pred EEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 211 ~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
|+||||+++++...+.. ...+++..++.++.||+.||+|||+ +|||||||||+||||+.++ .+||+|||+++..
T Consensus 133 ~lv~e~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~~~-~~kl~DFGla~~~ 206 (458)
T 3rp9_A 133 YVVLEIADSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHS-AGILHRDLKPANCLVNQDC-SVKVCDFGLARTV 206 (458)
T ss_dssp EEEECCCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTC-CEEECCCTTCBCT
T ss_pred EEEEeccccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCcCCCCCChhhEEECCCC-CEeecccccchhc
Confidence 99999999988776543 4569999999999999999999997 9999999999999999888 7999999999865
Q ss_pred CCCC----------------------------CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-------
Q 011138 291 VPGE----------------------------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL------- 335 (492)
Q Consensus 291 ~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~------- 335 (492)
.... .....+||++|+|||++.....|+.++|||||||++|||++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~ 286 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence 3221 23456889999999988666779999999999999999998
Q ss_pred ----CCCCCCCCC--------------------hHHHHHHHHHHhCCCCHHHHhhcCCCCc---ccCCCcccCCCccccc
Q 011138 336 ----GQPLFPGES--------------------GVDQLVEIIKILGTPTREEIKCMNPNYT---EFKFPQIKAHPWHKIF 388 (492)
Q Consensus 336 ----G~~pf~~~~--------------------~~~~~~~i~~~~g~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 388 (492)
|.++|.+.+ ..+++..|+..+|.|..+.+........ ...++......+...
T Consensus 287 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 365 (458)
T 3rp9_A 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER- 365 (458)
T ss_dssp SGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG-
T ss_pred ccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH-
Confidence 788887765 3678899999999999887765432100 011222222223222
Q ss_pred CCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCCC
Q 011138 389 HKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431 (492)
Q Consensus 389 ~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~~ 431 (492)
.+.+++++++||.+||++||.+|||+.|+|+||||+++..+..
T Consensus 366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~ 408 (458)
T 3rp9_A 366 FPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEV 408 (458)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGG
T ss_pred CCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCcc
Confidence 3467999999999999999999999999999999999887544
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-53 Score=439.86 Aligned_cols=284 Identities=32% Similarity=0.562 Sum_probs=226.8
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccC-CCceE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY 209 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~-~~~~~ 209 (492)
.+|.+.+.||+|+||+||+|.+..+|+.||||++... .....+|+.+|+.++|||||+++++|..... .+...
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 141 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 141 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence 4699999999999999999999999999999998643 2334589999999999999999999855432 23456
Q ss_pred EEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
+||||||++++++..+. ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 142 ~~lv~E~~~~~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDlkp~NIll~~~~-~~kl~DFG~a~~ 213 (464)
T 3ttj_A 142 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLART 213 (464)
T ss_dssp EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCCCCC--
T ss_pred EEEEEeCCCCCHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChHhEEEeCCC-CEEEEEEEeeee
Confidence 89999999998776543 348899999999999999999997 8999999999999999888 799999999987
Q ss_pred cCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
..........+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+++..|++.+|.|..+.+....+
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~ 292 (464)
T 3ttj_A 214 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292 (464)
T ss_dssp ---CCCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCH
T ss_pred cCCCcccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcch
Confidence 7655556678999999999999765 599999999999999999999999999999999999999999999887755432
Q ss_pred CCccc--CCCcccCCCcccccCCC-----------CChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCC
Q 011138 370 NYTEF--KFPQIKAHPWHKIFHKR-----------MPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (492)
Q Consensus 370 ~~~~~--~~~~~~~~~~~~~~~~~-----------~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~ 429 (492)
....+ ..+......+...++.. .++++++||.+||++||.+|||+.|+|+||||+.+.++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~ 365 (464)
T 3ttj_A 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP 365 (464)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCc
Confidence 11110 01111111121222111 25789999999999999999999999999999987664
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=419.35 Aligned_cols=248 Identities=22% Similarity=0.275 Sum_probs=201.0
Q ss_pred cceeEeeeeccCCceEEEEEEEc-----CCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCC
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~-----~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 206 (492)
..+++.+.||+|+||+||+|... .+++.||||++... ...+.+|+.+|++|+|||||++++++. +
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-----~ 100 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT-----K 100 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEE-----E
Confidence 45888999999999999999864 46789999998543 245678999999999999999999984 3
Q ss_pred ceEEEEEeeechh-hHHHHhhhhh------------hcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEc
Q 011138 207 ELYLNLVLEYISE-TVYRVSKHYT------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN 273 (492)
Q Consensus 207 ~~~~~lV~E~~~~-~l~~~~~~~~------------~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~ 273 (492)
...+|||||||++ +|.+++.... .....+++..+..|+.||+.||.|||+ ++||||||||+||||+
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS-HHVVHKDLATRNVLVY 179 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCccccceEEC
Confidence 3347899999985 5555553321 123468899999999999999999997 9999999999999999
Q ss_pred CCCCcEEEeeecCccccCCCC---CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 011138 274 PHTHQLKICDFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQL 349 (492)
Q Consensus 274 ~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~ 349 (492)
.++ .+||+|||+|+...... .....+||+.|||||++.+. .|+.++|||||||+||||+| |..||.+.+..+.+
T Consensus 180 ~~~-~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~ 257 (308)
T 4gt4_A 180 DKL-NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 257 (308)
T ss_dssp GGG-CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHH
T ss_pred CCC-CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 888 79999999998764332 23356899999999999765 49999999999999999998 89999998877666
Q ss_pred HHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 350 VEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 350 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
..+.... .. ..+..+++++.+|+.+||+.||++|||+.||+++
T Consensus 258 ~~i~~~~------------------~~----------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 258 EMIRNRQ------------------VL----------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHTTC------------------CC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCC------------------CC----------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 5554310 00 0224578999999999999999999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=409.10 Aligned_cols=281 Identities=33% Similarity=0.547 Sum_probs=230.1
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
.+|.+.+.||+|+||+||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++. +...+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEE-----eCCEE
Confidence 36999999999999999999999999999999985322 34458999999999999999999984 34468
Q ss_pred EEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 211 ~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
++||||++++++..+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus 77 ~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~-~~ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~~ 151 (292)
T 3o0g_A 77 TLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINRNG-ELKLANFGLARAF 151 (292)
T ss_dssp EEEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred EEEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEeecccceec
Confidence 99999999987775443 34679999999999999999999997 9999999999999999888 7999999999866
Q ss_pred CCC-CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 291 VPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPL-FPGESGVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 291 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~p-f~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
... .......||+.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+.+.++.|....+..+.
T Consensus 152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred CCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence 422 3344568899999999998776689999999999999999987666 77778888899999999998877665433
Q ss_pred CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
.......++............+.+++++++||.+||+.||++|||+.|+++||||+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 22111122222222222234456899999999999999999999999999999999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=427.18 Aligned_cols=285 Identities=33% Similarity=0.647 Sum_probs=223.2
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcC-CCCccccceeeeeccCCCceE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~~~~ 209 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.+. ||||++++++|... +...
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~~~ 85 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---NDRD 85 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT---TSSC
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC---CCCE
Confidence 4699999999999999999999999999999988432 223457999999997 99999999998542 2335
Q ss_pred EEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
+|+|||||++++...+.. ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+.
T Consensus 86 ~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~ 158 (388)
T 3oz6_A 86 VYLVFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHS-GGLLHRDMKPSNILLNAEC-HVKVADFGLSRS 158 (388)
T ss_dssp EEEEEECCSEEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred EEEEecccCcCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHeEEcCCC-CEEecCCccccc
Confidence 889999999987776543 468889999999999999999997 9999999999999999888 799999999976
Q ss_pred cCCC----------------------CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 011138 290 LVPG----------------------EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD 347 (492)
Q Consensus 290 ~~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~ 347 (492)
.... ......+||+.|+|||++.+...|+.++|||||||++|||++|++||.+.+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 5321 122346899999999999876779999999999999999999999999999999
Q ss_pred HHHHHHHHhCCCCHHHHhhcCCCCcccCCC------cccCCCcccc------------cCCCCChhHhhhhccccccCCC
Q 011138 348 QLVEIIKILGTPTREEIKCMNPNYTEFKFP------QIKAHPWHKI------------FHKRMPPEALDLVSRLLQYSPS 409 (492)
Q Consensus 348 ~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~------~~~~~~~~~~------------~~~~~s~~~~~Li~~~L~~dP~ 409 (492)
++..|+..++.|..+.+......+....+. ......+... ....+++++++||.+||++||.
T Consensus 239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 999999999999988776543222110000 0000001111 1126789999999999999999
Q ss_pred CcCCHHHhhCCCCCCCCCCCCC
Q 011138 410 LRCTALEACAHPFFDDLRDPNT 431 (492)
Q Consensus 410 ~R~t~~e~l~Hp~f~~~~~~~~ 431 (492)
+|||+.|+|+||||+.+.++..
T Consensus 319 ~R~t~~e~l~Hp~~~~~~~~~~ 340 (388)
T 3oz6_A 319 KRISANDALKHPFVSIFHNPNE 340 (388)
T ss_dssp GSCCHHHHTTSTTTTTTCCGGG
T ss_pred cCCCHHHHhCCHHHHHhcCCcc
Confidence 9999999999999999887654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-52 Score=410.31 Aligned_cols=279 Identities=35% Similarity=0.657 Sum_probs=228.5
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
.+|.+.+.||+|+||+||+|.+. +|+.||||++.... ....+|+.+++.++||||+++++++ .+...+
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~ 94 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI-----HSERCL 94 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCSSCE
T ss_pred hhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE-----ccCCEE
Confidence 46999999999999999999985 59999999985432 3355899999999999999999998 445568
Q ss_pred EEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 211 ~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
++||||+++++...+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus 95 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~ 169 (311)
T 3niz_A 95 TLVFEFMEKDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQ-HRILHRDLKPQNLLINSDG-ALKLADFGLARAF 169 (311)
T ss_dssp EEEEECCSEEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEET
T ss_pred EEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCchHhEEECCCC-CEEEccCcCceec
Confidence 99999999987776543 33568999999999999999999997 9999999999999999888 7999999999876
Q ss_pred CCC-CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 291 VPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 291 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
... .......||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.+....+.....
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 249 (311)
T 3niz_A 170 GIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE 249 (311)
T ss_dssp TSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTT
T ss_pred CCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhc
Confidence 422 2334568899999999998767789999999999999999999999999999999999999999988766544321
Q ss_pred C--CcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 370 N--YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 370 ~--~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
. +....+......+|.. +.+.+++++++||.+||++||.+|||+.|+|+||||+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 250 LPLWKQRTFQVFEKKPWSS-IIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp SHHHHSCCCCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred cchhhhcccccccCCcHHH-hCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 1 1111222222233332 2356889999999999999999999999999999999864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=420.76 Aligned_cols=251 Identities=24% Similarity=0.357 Sum_probs=202.7
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCC-----CEEEEEEeccc-----hhhHHHHHHHHHHcCC-CCccccceeeeeccC
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETG-----DSVAIKKVLQD-----KRYKNRELQIMRLLNH-PNVVSLKHCFFSTTE 204 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g-----~~vAiK~~~~~-----~~~~~~E~~il~~l~h-~nIv~l~~~~~~~~~ 204 (492)
..+|.+++.||+|+||+||+|.+..++ +.||||++... ...+.+|+.+|+.++| ||||+++++|...
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~-- 140 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-- 140 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT--
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec--
Confidence 457999999999999999999986543 67999998543 2345689999999976 8999999987432
Q ss_pred CCceEEEEEeeechh-hHHHHhhhhhh------------cCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceE
Q 011138 205 KDELYLNLVLEYISE-TVYRVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLL 271 (492)
Q Consensus 205 ~~~~~~~lV~E~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NIL 271 (492)
...+|||||||++ +|.+++..... ....+++..+..|+.||+.||+|||+ ++||||||||+|||
T Consensus 141 --~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~-~~iiHRDLK~~NIL 217 (353)
T 4ase_A 141 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNIL 217 (353)
T ss_dssp --TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEE
T ss_pred --CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh-CCeecCccCcccee
Confidence 2347899999985 55555543221 13458899999999999999999997 99999999999999
Q ss_pred EcCCCCcEEEeeecCccccCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHH
Q 011138 272 VNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVD 347 (492)
Q Consensus 272 l~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~ 347 (492)
++.++ .+||+|||+|+.+..+.. ....+||+.|||||++.+. .|+.++|||||||+||||+| |.+||.+.+..+
T Consensus 218 l~~~~-~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~ 295 (353)
T 4ase_A 218 LSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 295 (353)
T ss_dssp ECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred eCCCC-CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC-CCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 99888 799999999987654432 2346789999999999765 49999999999999999998 999999877666
Q ss_pred HHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 348 QLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 348 ~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
.+..++..-.. .. .+..+++++.+||.+||+.||++|||+.|+++|
T Consensus 296 ~~~~~i~~g~~---------------~~------------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 296 EFCRRLKEGTR---------------MR------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHHHTCC---------------CC------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCC---------------CC------------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 65555442110 11 224578999999999999999999999999987
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=409.28 Aligned_cols=255 Identities=28% Similarity=0.440 Sum_probs=217.4
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
...+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++ .+..
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~~ 87 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-----ETEK 87 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECC
Confidence 4457999999999999999999999999999999985432 2345799999999999999999998 4445
Q ss_pred EEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 209 ~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
.+|+||||+++ ++.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~NIll~~~~-~~kl~DFG~a 161 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQ-KRIVHRDLKAENLLLDADM-NIKIADFGFS 161 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECSTTCC
T ss_pred EEEEEEECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCCHHHEEEcCCC-CEEEeeccCc
Confidence 68999999975 55554432 3568999999999999999999997 9999999999999999888 7999999999
Q ss_pred cccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
.....+......+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~------------- 228 (328)
T 3fe3_A 162 NEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR------------- 228 (328)
T ss_dssp GGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------------
T ss_pred eecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------------
Confidence 8776666666789999999999998776556899999999999999999999999887776666654
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~ 429 (492)
..+.+| ..+++++.+||.+||+.||.+|||+.|+++||||+.....
T Consensus 229 ----~~~~~p------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~ 274 (328)
T 3fe3_A 229 ----GKYRIP------------FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEE 274 (328)
T ss_dssp ----CCCCCC------------TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTT
T ss_pred ----CCCCCC------------CCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCcc
Confidence 111222 3478999999999999999999999999999999976543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=426.18 Aligned_cols=288 Identities=32% Similarity=0.534 Sum_probs=230.9
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+|+.++||||+++++++..........+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 4699999999999999999999999999999998542 2344589999999999999999999865443333568
Q ss_pred EEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 211 ~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
|+||||++++|...+.. ...+++..++.++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+++..
T Consensus 106 ~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~-~~kL~DFGla~~~ 179 (432)
T 3n9x_A 106 YIVLEIADSDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHE-SGIIHRDLKPANCLLNQDC-SVKVCDFGLARTI 179 (432)
T ss_dssp EEEEECCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEEC
T ss_pred EEEEecCCcCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCHHHeEECCCC-CEEEccCCCcccc
Confidence 99999999988776543 4568999999999999999999997 9999999999999999888 7999999999876
Q ss_pred CCCC-----------------------CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-----------C
Q 011138 291 VPGE-----------------------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-----------G 336 (492)
Q Consensus 291 ~~~~-----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-----------G 336 (492)
.... .....+||++|+|||++.....|+.++|||||||++|||++ |
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~ 259 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR 259 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccc
Confidence 4322 12567899999999998777779999999999999999998 5
Q ss_pred CCCCCCCC-----------------hHHHHHHHHHHhCCCCHHHHhhcCCCCcc---cCCCcccCCCcccccCCCCChhH
Q 011138 337 QPLFPGES-----------------GVDQLVEIIKILGTPTREEIKCMNPNYTE---FKFPQIKAHPWHKIFHKRMPPEA 396 (492)
Q Consensus 337 ~~pf~~~~-----------------~~~~~~~i~~~~g~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~s~~~ 396 (492)
.++|.+.+ ..+++..|+..+|.|+.+.+......... ..++......+... .+.+++++
T Consensus 260 ~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~ 338 (432)
T 3n9x_A 260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQK-YPSISDDG 338 (432)
T ss_dssp CCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHH-STTSCHHH
T ss_pred cccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHH-CCCCCHHH
Confidence 56666654 46889999999999999877654321100 01111111222222 24689999
Q ss_pred hhhhccccccCCCCcCCHHHhhCCCCCCCCCCCCC
Q 011138 397 LDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431 (492)
Q Consensus 397 ~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~~ 431 (492)
++||.+||++||.+|||+.|+|+||||++++++..
T Consensus 339 ~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~ 373 (432)
T 3n9x_A 339 INLLESMLKFNPNKRITIDQALDHPYLKDVRKKKL 373 (432)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTT
T ss_pred HHHHHHHhcCCcccCCCHHHHhcChhhhhccCccc
Confidence 99999999999999999999999999999987654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-52 Score=413.85 Aligned_cols=301 Identities=32% Similarity=0.592 Sum_probs=236.8
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchh-----hHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-----YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-----~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||||++..... ...+|+.+++.++||||+++++++. +...++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEE-----CSSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEe-----eCCEEE
Confidence 369999999999999999999999999999999854332 2236999999999999999999983 344588
Q ss_pred EEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
+||||+++++...+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++...
T Consensus 77 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 77 LVFEYLDKDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHR-QKVLHRDLKPQNLLINERG-ELKLADFGLARAKS 151 (324)
T ss_dssp EEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCCGGGEEECTTC-CEEECSSSEEECC-
T ss_pred EEecccccCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCcCHHHEEECCCC-CEEEccCccccccc
Confidence 9999999988776543 24568899999999999999999997 9999999999999999888 79999999997653
Q ss_pred CC-CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 011138 292 PG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (492)
Q Consensus 292 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 370 (492)
.. .......||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+.+.++.|....+......
T Consensus 152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence 22 22335678999999999987677899999999999999999999999999999999999999999987766533211
Q ss_pred --CcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q 011138 371 --YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQ 448 (492)
Q Consensus 371 --~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (492)
+..+.++......+. ...+.+++++++||.+||+.||.+|||+.|+|+||||+++.......+....+..+.++..+
T Consensus 232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~q 310 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALL-SHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTSIFALKEIQLQ 310 (324)
T ss_dssp HHHHHTCCCCCCCCCHH-HHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCTTSCGGGSTTCCCC
T ss_pred hhhcccccccccchhhh-hhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCCCCcHhHHHHHHhh
Confidence 112222322222211 12356899999999999999999999999999999999988766655555555555444433
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=404.55 Aligned_cols=284 Identities=29% Similarity=0.512 Sum_probs=231.8
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch---------hhHHHHHHHHHHcC---CCCccccceeeeecc
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---------RYKNRELQIMRLLN---HPNVVSLKHCFFSTT 203 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~---------~~~~~E~~il~~l~---h~nIv~l~~~~~~~~ 203 (492)
..+|.+.+.||+|+||+||+|.+..+|+.||||++.... ....+|+.+++.++ ||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 346999999999999999999999999999999985321 24557888877765 999999999987766
Q ss_pred CCCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEee
Q 011138 204 EKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICD 283 (492)
Q Consensus 204 ~~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~D 283 (492)
.....++++||||+++++...+... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~~~-~~kl~D 163 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTSGG-TVKLAD 163 (308)
T ss_dssp SSSEEEEEEEEECCCCBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCTTTEEECTTS-CEEECS
T ss_pred CCCceeEEEEehhhhcCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCC-CEEEee
Confidence 5556678999999999887765532 22348999999999999999999997 9999999999999999887 799999
Q ss_pred ecCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 011138 284 FGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (492)
Q Consensus 284 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~ 363 (492)
||+++............||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+..+...++.++...
T Consensus 164 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (308)
T 3g33_A 164 FGLARIYSYQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 242 (308)
T ss_dssp CSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred CccccccCCCcccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 99998776666666788999999999997654 89999999999999999999999999999999999999999988765
Q ss_pred HhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
+..... .....++.....++. ...+.+++++.+||.+||++||.+|||+.|+|+||||++.
T Consensus 243 ~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 243 WPRDVS-LPRGAFPPRGPRPVQ-SVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp SCSSCS-SCGGGSCCCCCCCHH-HHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred ccchhh-ccccccCCCCCCcHH-HhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 543211 111222222222222 2345789999999999999999999999999999999874
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=413.49 Aligned_cols=286 Identities=34% Similarity=0.656 Sum_probs=236.8
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
.+|.+.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++..........+|
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 106 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence 36999999999999999999999999999999986422 3345899999999999999999998665544445688
Q ss_pred EEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
+||||+++++...+.. ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++...
T Consensus 107 iv~e~~~~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 107 IVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTTC-DLKICDFGLARVAD 179 (364)
T ss_dssp EEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEECC
T ss_pred EEEcccCcCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChHhEEECCCC-CEEEEeCcceEecC
Confidence 9999999988776543 468999999999999999999997 9999999999999999887 79999999998664
Q ss_pred CCCC----CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 292 PGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 292 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
.... ....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...+|.|..+.+.+.
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 3322 234589999999999877667899999999999999999999999999999999999999999998877653
Q ss_pred CCCC---cccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCC
Q 011138 368 NPNY---TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430 (492)
Q Consensus 368 ~~~~---~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~ 430 (492)
.... ....++.....+|.. +.+.+++++.+||.+||++||.+|||+.|+|+||||++..++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~ 324 (364)
T 3qyz_A 260 INLKARNYLLSLPHKNKVPWNR-LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 324 (364)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHH-HCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred hhhhHHHHHHhcCCccCCCHHH-hCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcc
Confidence 2110 001122222223332 2356899999999999999999999999999999999876543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=406.90 Aligned_cols=286 Identities=31% Similarity=0.560 Sum_probs=218.9
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++ .+...+|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~ 79 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI-----HTENKLT 79 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-----CCTTEEE
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE-----EECCeEE
Confidence 46999999999999999999999999999999985432 3456899999999999999999998 4455689
Q ss_pred EEeeechhhHHHHhhhhhh--cCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 212 LVLEYISETVYRVSKHYTR--MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
+||||+++++...+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 80 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 80 LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE-NKILHRDLKPQNLLINKRG-QLKLGDFGLARA 157 (317)
T ss_dssp EEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCSSCEE
T ss_pred EEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCChHHeEEcCCC-CEEECcCcccee
Confidence 9999999988776654332 22458899999999999999999997 9999999999999999888 799999999987
Q ss_pred cCCC-CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 290 LVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 290 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
.... .......||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+.+.+|.|....+....
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 6432 233456889999999999776668999999999999999999999999999999999999999988766554322
Q ss_pred --CCCcccCCCcccCCCc----ccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCC
Q 011138 369 --PNYTEFKFPQIKAHPW----HKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430 (492)
Q Consensus 369 --~~~~~~~~~~~~~~~~----~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~ 430 (492)
+.+.. .++......+ .......+++++++||.+||+.||.+|||+.|+|+||||++.....
T Consensus 238 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 304 (317)
T 2pmi_A 238 KLPKYNP-NIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHA 304 (317)
T ss_dssp GCTTCCT-TCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC--
T ss_pred hhhhccc-ccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchh
Confidence 11110 0111111111 1122346789999999999999999999999999999999877643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-51 Score=399.44 Aligned_cols=277 Identities=34% Similarity=0.647 Sum_probs=222.8
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
.+|.+.+.||+|+||.||+|.+ .+|+.||||++.... ....+|+.+++.++||||+++++++. +...+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSSCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEc-----cCCeE
Confidence 3699999999999999999998 689999999985332 34568999999999999999999984 33458
Q ss_pred EEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 211 ~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
++||||+++++...+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus 76 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~ 150 (288)
T 1ob3_A 76 VLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINREG-ELKIADFGLARAF 150 (288)
T ss_dssp EEEEECCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECCTTHHHHH
T ss_pred EEEEEecCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-CEEEeECcccccc
Confidence 99999999987766543 23568899999999999999999997 9999999999999999888 7999999999765
Q ss_pred CCC-CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC-
Q 011138 291 VPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN- 368 (492)
Q Consensus 291 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~- 368 (492)
... .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+.++.+....+....
T Consensus 151 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred CccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhc
Confidence 322 233456789999999999776678999999999999999999999999999999999999999988765543221
Q ss_pred -CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 369 -PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 369 -~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
+.+ ...++.....+|.. +...+++++++||.+||+.||++|||+.|+++||||++.
T Consensus 231 ~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 231 LPKY-DPNFTVYEPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp STTC-CTTCCCCCCCCGGG-TCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred cccc-ccccccccCccHHH-HhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 111 01122222222322 335689999999999999999999999999999999863
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=410.74 Aligned_cols=285 Identities=34% Similarity=0.621 Sum_probs=227.8
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccC-CCceE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY 209 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~-~~~~~ 209 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++||||+++++++..... .+...
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 3599999999999999999999999999999998432 1234589999999999999999999855432 22244
Q ss_pred EEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
+|+||||+++++..++.. ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 105 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 105 FYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNEDC-ELKILDFGLARQ 177 (367)
T ss_dssp CEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred EEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCHHHEEEcCCC-CEEEEeeecccc
Confidence 689999998777766543 468999999999999999999997 9999999999999999888 799999999986
Q ss_pred cCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
.. ......+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..|++.+|.|+.+.+..+..
T Consensus 178 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 178 AD--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp CC--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred cc--cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 53 3345678999999999998766799999999999999999999999999999999999999999999887654432
Q ss_pred CCcc---cCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCCC
Q 011138 370 NYTE---FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431 (492)
Q Consensus 370 ~~~~---~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~~ 431 (492)
.... ..+|......|... ...+++++.+||.+||+.||.+|||+.|+|+||||+++.++..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~ 319 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDFASI-LTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED 319 (367)
T ss_dssp HHHHHHHHHSCCCCCCCGGGT-CTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC----
T ss_pred HHHHHHHHhCCCCCCCCHHHH-CCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCcc
Confidence 1100 01222233333332 3568999999999999999999999999999999999887543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-51 Score=410.35 Aligned_cols=256 Identities=26% Similarity=0.416 Sum_probs=216.7
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----------hhhHHHHHHHHHHcCCCCccccceeeeeccCC
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 205 (492)
...|.+++.||+|+||.||+|.++.+|+.||||++... .....+|+.+|+.++||||++++++| .
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~ 85 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY-----E 85 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE-----E
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE-----E
Confidence 34699999999999999999999999999999998543 23467899999999999999999998 4
Q ss_pred CceEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCC---cEEE
Q 011138 206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH---QLKI 281 (492)
Q Consensus 206 ~~~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~---~vkL 281 (492)
+...+|+||||+.| +|.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++. .+||
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~~~vkl 160 (361)
T 2yab_A 86 NRTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKL 160 (361)
T ss_dssp CSSEEEEEEECCCSCBHHHHHT----TCSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred eCCEEEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEeCCCCCccCEEE
Confidence 45568999999975 5555443 24578999999999999999999997 99999999999999987653 6999
Q ss_pred eeecCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 011138 282 CDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTR 361 (492)
Q Consensus 282 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~ 361 (492)
+|||+++...........+||+.|+|||++.+. .|+.++|||||||++|+|++|.+||.+.+..+.+..|....
T Consensus 161 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~----- 234 (361)
T 2yab_A 161 IDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVS----- 234 (361)
T ss_dssp CCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC-----
T ss_pred EecCCceEcCCCCccccCCCCccEECchHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-----
Confidence 999999887666666678899999999999654 58999999999999999999999999988877777665421
Q ss_pred HHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
+.++ ..++..+++++++||.+||..||.+|||+.|+++||||+...
T Consensus 235 ------------~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 235 ------------YDFD--------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (361)
T ss_dssp ------------CCCC--------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred ------------CCCC--------chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence 1111 112346899999999999999999999999999999999653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-51 Score=406.50 Aligned_cols=282 Identities=31% Similarity=0.600 Sum_probs=226.8
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
...+|.+.+.||+|+||+||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++. +..
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~ 106 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH-----HNH 106 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE-----ETT
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe-----cCC
Confidence 4457999999999999999999999999999999985432 22347999999999999999999984 344
Q ss_pred EEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCC----CcEEEeee
Q 011138 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT----HQLKICDF 284 (492)
Q Consensus 209 ~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~----~~vkL~DF 284 (492)
.+|+||||+++++...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ ..+||+||
T Consensus 107 ~~~lv~e~~~~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df 181 (329)
T 3gbz_A 107 RLHLIFEYAENDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHS-RRCLHRDLKPQNLLLSVSDASETPVLKIGDF 181 (329)
T ss_dssp EEEEEEECCSEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred EEEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEECCCCCHHHEEEecCCCCccceEEECcC
Confidence 6899999999987776543 3568999999999999999999997 9999999999999995332 25999999
Q ss_pred cCccccCCC-CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 011138 285 GSAKMLVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (492)
Q Consensus 285 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~ 363 (492)
|+++..... ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++.|....
T Consensus 182 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 182 GLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261 (329)
T ss_dssp THHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred CCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence 999765422 2334567899999999998766789999999999999999999999999999999999999999888765
Q ss_pred HhhcC--CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 364 IKCMN--PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 364 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
+.... +.+ ...++......+...+...+++++++||.+||+.||.+|||+.|+|+||||++..
T Consensus 262 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 262 WPGVTALPDW-KQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326 (329)
T ss_dssp STTGGGSTTC-CTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred hhhhhhhhhh-hhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence 54321 111 1233444444444445556899999999999999999999999999999999764
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=404.41 Aligned_cols=283 Identities=34% Similarity=0.590 Sum_probs=229.6
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch---------hhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~---------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||++++++| .+.
T Consensus 10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~ 84 (346)
T 1ua2_A 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GHK 84 (346)
T ss_dssp ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CCT
T ss_pred cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE-----eeC
Confidence 46999999999999999999999999999999885321 2345899999999999999999998 344
Q ss_pred eEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 208 ~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
..+++||||+++++...+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 85 ~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a 159 (346)
T 1ua2_A 85 SNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDENG-VLKLADFGLA 159 (346)
T ss_dssp TCCEEEEECCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECCCGGG
T ss_pred CceEEEEEcCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCCHHHEEEcCCC-CEEEEecccc
Confidence 45889999999987765433 23468888999999999999999997 9999999999999999888 7999999999
Q ss_pred cccCCC-CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 011138 288 KMLVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (492)
Q Consensus 288 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~ 366 (492)
+..... .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++...+.|..+.+..
T Consensus 160 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 160 KSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 239 (346)
T ss_dssp STTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred eeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhh
Confidence 876432 2344568999999999997766689999999999999999999999999999999999999999998776654
Q ss_pred cCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCC
Q 011138 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430 (492)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~ 430 (492)
.........+......++.. +...+++++++||.+||+.||.+|||+.|+++||||++...+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~ 302 (346)
T 1ua2_A 240 MCSLPDYVTFKSFPGIPLHH-IFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT 302 (346)
T ss_dssp TTSSTTCCCCCCCCCCCHHH-HCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCC
T ss_pred hccCcccccccccCCCChHH-hhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCC
Confidence 43221212222222222222 2356789999999999999999999999999999999865543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-51 Score=408.99 Aligned_cols=253 Identities=28% Similarity=0.478 Sum_probs=208.4
Q ss_pred ccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHc-CCCCccccceeeeeccCC
Q 011138 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK 205 (492)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~ 205 (492)
....+|.+.+.||+|+||.||+|+++.+|+.||||++.+.. ....+|..+++.+ +||||++++++| .
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~ 94 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----Q 94 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----E
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----E
Confidence 34457999999999999999999999999999999986532 2345799999988 699999999998 4
Q ss_pred CceEEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeee
Q 011138 206 DELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (492)
Q Consensus 206 ~~~~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DF 284 (492)
+...+|+||||+.|+ |...+.. ...+++..++.|+.||+.||.|||+ +||+||||||+||||+.++ .+||+||
T Consensus 95 ~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~g-~ikL~DF 168 (353)
T 3txo_A 95 TPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHD-KGIIYRDLKLDNVLLDHEG-HCKLADF 168 (353)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCC
T ss_pred eCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCHHHEEECCCC-CEEEccc
Confidence 455699999999864 4444332 3569999999999999999999997 9999999999999999888 7999999
Q ss_pred cCccccC-CCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 011138 285 GSAKMLV-PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (492)
Q Consensus 285 G~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~ 363 (492)
|+++... ........+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..|..
T Consensus 169 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--------- 238 (353)
T 3txo_A 169 GMCKEGICNGVTTATFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN--------- 238 (353)
T ss_dssp TTCBCSCC---------CCGGGCCHHHHHHH-HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---------
T ss_pred cceeecccCCccccccCCCcCeEChhhcCCC-CcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHc---------
Confidence 9998643 23344567899999999999754 489999999999999999999999999988887777765
Q ss_pred HhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCH------HHhhCCCCCCCCC
Q 011138 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA------LEACAHPFFDDLR 427 (492)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~------~e~l~Hp~f~~~~ 427 (492)
....+ +..+++++++||++||+.||.+||++ .++++||||+++.
T Consensus 239 --------~~~~~------------p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~ 288 (353)
T 3txo_A 239 --------DEVVY------------PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID 288 (353)
T ss_dssp --------CCCCC------------CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCC
T ss_pred --------CCCCC------------CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCC
Confidence 12222 23578999999999999999999998 8999999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=401.38 Aligned_cols=251 Identities=27% Similarity=0.440 Sum_probs=212.5
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
..+|.+.+.||+|+||.||+|+++.+|+.||||++.+. .....+|+.+++.++||||++++++| .+..
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-----~~~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE-----EeCC
Confidence 35799999999999999999999999999999998643 22345799999999999999999998 4445
Q ss_pred EEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 209 ~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
.+|+||||++|+ +...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 79 ~~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g-~vkL~DFG~a 152 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDG-HIKITDFGLC 152 (337)
T ss_dssp EEEEEEECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCCHHHEEECCCC-CEEEeeccch
Confidence 689999999874 444332 23568999999999999999999997 9999999999999999888 7999999999
Q ss_pred cccC-CCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 011138 288 KMLV-PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (492)
Q Consensus 288 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~ 366 (492)
+... .+......+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+..+....+..
T Consensus 153 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~------------ 219 (337)
T 1o6l_A 153 KEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM------------ 219 (337)
T ss_dssp BCSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------------
T ss_pred hhcccCCCcccccccChhhCChhhhcCC-CCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc------------
Confidence 8643 33345567999999999999654 589999999999999999999999998887666666554
Q ss_pred cCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcC-----CHHHhhCCCCCCCCC
Q 011138 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLR 427 (492)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----t~~e~l~Hp~f~~~~ 427 (492)
....+ +..+++++++||.+||+.||.+|| ++.|+++||||+.+.
T Consensus 220 -----~~~~~------------p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~ 268 (337)
T 1o6l_A 220 -----EEIRF------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp -----CCCCC------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred -----CCCCC------------CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence 11222 235799999999999999999999 899999999998764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-50 Score=395.19 Aligned_cols=283 Identities=36% Similarity=0.637 Sum_probs=224.9
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
.+|.+.+.||+|+||+||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++. +...+
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 77 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR-----RKRRL 77 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee-----cCCeE
Confidence 46999999999999999999999999999999885432 33457999999999999999999984 33458
Q ss_pred EEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 211 ~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
++||||++++++.... .....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++...
T Consensus 78 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~i~~~l~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~ 152 (311)
T 4agu_A 78 HLVFEYCDHTVLHELD---RYQRGVPEHLVKSITWQTLQAVNFCHK-HNCIHRDVKPENILITKHS-VIKLCDFGFARLL 152 (311)
T ss_dssp EEEEECCSEEHHHHHH---HTSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred EEEEEeCCCchHHHHH---hhhcCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCChhhEEEcCCC-CEEEeeCCCchhc
Confidence 8999999987665432 234568999999999999999999997 9999999999999999887 7999999999876
Q ss_pred CCC-CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc--
Q 011138 291 VPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM-- 367 (492)
Q Consensus 291 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~-- 367 (492)
... .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+.++..........
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 153 TGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp C------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred cCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence 432 23345688999999999987677899999999999999999999999999999999999998888776544322
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~ 429 (492)
...+.....+............+.+++++.+||.+||+.||.+|||+.|+++||||+++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 294 (311)
T 4agu_A 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI 294 (311)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence 22222333333222221222235689999999999999999999999999999999998754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=410.34 Aligned_cols=285 Identities=34% Similarity=0.598 Sum_probs=218.8
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccC-CCceE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY 209 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~-~~~~~ 209 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++||||+++++++..... .....
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 4699999999999999999999999999999998542 2334589999999999999999999854321 12244
Q ss_pred EEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
+|+||||++++|..++.. ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 109 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~-~~kL~DFG~a~~ 181 (367)
T 2fst_X 109 VYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDC-ELKILDFGLARH 181 (367)
T ss_dssp CEEEEECCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECC------
T ss_pred EEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHhhEEECCCC-CEEEeecccccc
Confidence 789999998777665432 568999999999999999999997 9999999999999999888 799999999986
Q ss_pred cCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
.. ......+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..|.+.+|.|..+.+.....
T Consensus 182 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 259 (367)
T 2fst_X 182 TA--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259 (367)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred cc--ccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 53 2344678999999999998766799999999999999999999999999999999999999999999887765432
Q ss_pred CCcc---cCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCCC
Q 011138 370 NYTE---FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431 (492)
Q Consensus 370 ~~~~---~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~~ 431 (492)
.... ..++......+...+ ..+++++.+||.+||++||.+|||+.|+|+||||+++.++..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~ 323 (367)
T 2fst_X 260 ESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 323 (367)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHT-TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGG
T ss_pred HHHHHHHhccCCCCCCCHHHHC-CCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCC
Confidence 1100 012222222333322 467999999999999999999999999999999999887654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-51 Score=407.83 Aligned_cols=252 Identities=27% Similarity=0.425 Sum_probs=211.6
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
..++|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++||||+++++++. +.
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~ 81 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT-----TP 81 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE-----CS
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eC
Confidence 445799999999999999999999999999999998543 234568999999999999999999984 44
Q ss_pred eEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 208 ~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
..+++||||++|++++.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 82 ~~~~lv~E~~~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~-~~kl~DFG~s 155 (336)
T 3h4j_B 82 TDIVMVIEYAGGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHR-HKIVHRDLKPENLLLDDNL-NVKIADFGLS 155 (336)
T ss_dssp SEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HTCCCCCCSTTTEEECTTC-CEEECCSSCT
T ss_pred CEEEEEEECCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCchhhEEEcCCC-CEEEEEeccc
Confidence 46899999999888776543 3568999999999999999999997 8999999999999999887 7999999999
Q ss_pred cccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
.....+......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+........
T Consensus 156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~----------------- 218 (336)
T 3h4j_B 156 NIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK----------------- 218 (336)
T ss_dssp BTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC-----------------
T ss_pred eeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH-----------------
Confidence 887666666678899999999999776655889999999999999999999997654211100
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
.+.. ....++..+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 219 ----------~i~~--~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 219 ----------KVNS--CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp ----------CCCS--SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred ----------HHHc--CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 0000 0011334689999999999999999999999999999999853
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=401.39 Aligned_cols=255 Identities=29% Similarity=0.432 Sum_probs=215.0
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc---hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||+|.+... .....+|+.+++.++||||+++++++. +...+++|
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~lv 79 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE-----SMEELVMI 79 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTEEEEE
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEe-----cCCEEEEE
Confidence 4699999999999999999999999999999998543 234568999999999999999999984 33468999
Q ss_pred eeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcC--CCCcEEEeeecCcccc
Q 011138 214 LEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP--HTHQLKICDFGSAKML 290 (492)
Q Consensus 214 ~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~--~~~~vkL~DFG~a~~~ 290 (492)
|||+++ ++.+.+. .....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++ .+||+|||+++..
T Consensus 80 ~e~~~g~~L~~~l~---~~~~~~~~~~~~~i~~qi~~al~~lH~-~givH~Dlkp~NIl~~~~~~~-~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 80 FEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSS-TIKIIEFGQARQL 154 (321)
T ss_dssp ECCCCCCBHHHHHT---SSSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCC-CEEECCCTTCEEC
T ss_pred EEeCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEccCCCC-CEEEEECCCCeEC
Confidence 999986 4554432 223468999999999999999999997 99999999999999986 44 7999999999887
Q ss_pred CCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 011138 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (492)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 370 (492)
..+.......||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+......++..
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~-------- 225 (321)
T 1tki_A 155 KPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE-------- 225 (321)
T ss_dssp CTTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH--------
T ss_pred CCCCccccccCChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChh--------
Confidence 666555667899999999999654 48999999999999999999999999988887777776532211111
Q ss_pred CcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
.++.+++++++||.+||..||.+|||+.|+|+||||++..
T Consensus 226 -----------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 226 -----------------AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp -----------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred -----------------hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 1235799999999999999999999999999999998643
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=409.39 Aligned_cols=284 Identities=32% Similarity=0.563 Sum_probs=217.2
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccC-CCceE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY 209 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~-~~~~~ 209 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++||||+++++++..... .+...
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 4699999999999999999999999999999998542 1234579999999999999999999854331 23346
Q ss_pred EEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
+|+||||+++++...+. ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 105 ~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 105 VYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLART 176 (371)
T ss_dssp EEEEEECCSEEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECCCCC---
T ss_pred eEEEEEcCCCCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEcCCC-CEEEEEeecccc
Confidence 89999999998776553 358889999999999999999997 9999999999999999887 799999999987
Q ss_pred cCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
...........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+++.++.|..+.+..+.+
T Consensus 177 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 255 (371)
T 2xrw_A 177 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 255 (371)
T ss_dssp -------------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCH
T ss_pred cccccccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 6544445567899999999999765 489999999999999999999999999999999999999999998876654322
Q ss_pred CCccc--CCCcccCCCcccccC-----------CCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCC
Q 011138 370 NYTEF--KFPQIKAHPWHKIFH-----------KRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (492)
Q Consensus 370 ~~~~~--~~~~~~~~~~~~~~~-----------~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~ 429 (492)
....+ ..+......+...++ ...++++++||.+||+.||.+|||+.|+|+||||+.+.++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~ 328 (371)
T 2xrw_A 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDP 328 (371)
T ss_dssp HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCH
T ss_pred HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCc
Confidence 11000 001100111111111 1125789999999999999999999999999999987654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-50 Score=410.38 Aligned_cols=288 Identities=30% Similarity=0.511 Sum_probs=212.8
Q ss_pred ceeE-eeeeccCCceEEEEEEEc--CCCCEEEEEEeccch--hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 138 SYMA-ERVVGTGSFGVVFQAKCL--ETGDSVAIKKVLQDK--RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 138 ~y~~-~~~lG~G~fg~Vy~~~~~--~~g~~vAiK~~~~~~--~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
.|.+ +++||+|+||+||+|++. .+++.||||++.... ....+|+.+|+.++|||||+++++|... ....+|+
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---~~~~~~l 97 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVWL 97 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEET---TTTEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecC---CCCeEEE
Confidence 4776 568999999999999966 578999999986542 3456899999999999999999998653 2346889
Q ss_pred EeeechhhHHHHhhhhhhc-----CCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEE----cCCCCcEEEee
Q 011138 213 VLEYISETVYRVSKHYTRM-----NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV----NPHTHQLKICD 283 (492)
Q Consensus 213 V~E~~~~~l~~~~~~~~~~-----~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl----~~~~~~vkL~D 283 (492)
||||++++++..+...... ...+++..++.++.||+.||.|||+ +||+||||||+|||| +.++ .+||+|
T Consensus 98 v~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~NIll~~~~~~~~-~~kl~D 175 (405)
T 3rgf_A 98 LFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERG-RVKIAD 175 (405)
T ss_dssp EEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECCSSTTTT-CEEECC
T ss_pred EEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeCCCcCHHHeEEecCCCCCC-cEEEEE
Confidence 9999999888776543322 2248999999999999999999997 999999999999999 4445 799999
Q ss_pred ecCccccCCC----CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh---------HHHHH
Q 011138 284 FGSAKMLVPG----EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESG---------VDQLV 350 (492)
Q Consensus 284 FG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~---------~~~~~ 350 (492)
||+++..... ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+... .+++.
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 9999866432 2234568899999999998766799999999999999999999999987654 47889
Q ss_pred HHHHHhCCCCHHHHhhcCCCC---------cccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCC
Q 011138 351 EIIKILGTPTREEIKCMNPNY---------TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHP 421 (492)
Q Consensus 351 ~i~~~~g~p~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp 421 (492)
.++..+|.|....|....... ....++......+........++++++||.+||++||.+|||+.|+|+||
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp 335 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 999999999876654332110 00000000000011112223478899999999999999999999999999
Q ss_pred CCCCCCCCC
Q 011138 422 FFDDLRDPN 430 (492)
Q Consensus 422 ~f~~~~~~~ 430 (492)
||++...+.
T Consensus 336 ~f~~~~~~~ 344 (405)
T 3rgf_A 336 YFLEDPLPT 344 (405)
T ss_dssp GGTSSSCCC
T ss_pred hhccCCCCc
Confidence 999865443
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=395.22 Aligned_cols=249 Identities=27% Similarity=0.512 Sum_probs=213.2
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
..+|.+.+.||+|+||.||+|++..+|+.||||++.+. .....+|+.+++.++||||++++++| .+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE-----EeCC
Confidence 45799999999999999999999999999999998543 23345799999999999999999998 4455
Q ss_pred EEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 209 ~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
.+|+||||+.| ++...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g-~~kL~Dfg~a 153 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDKNG-HIKITDFGFA 153 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTS-CEEECCCSSC
T ss_pred EEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChheEEEcCCC-CEEEeecCcc
Confidence 68999999986 55554432 4568999999999999999999997 9999999999999999888 7999999999
Q ss_pred cccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
+... ......+||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+.+..+..
T Consensus 154 ~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~------------- 217 (318)
T 1fot_A 154 KYVP--DVTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN------------- 217 (318)
T ss_dssp EECS--SCBCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH-------------
T ss_pred eecC--CccccccCCccccCHhHhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------------
Confidence 8653 234467899999999999654 489999999999999999999999999888777777665
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcC-----CHHHhhCCCCCCCCC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLR 427 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----t~~e~l~Hp~f~~~~ 427 (492)
....+ +..+++++++||.+||+.||.+|+ +++++++||||+++.
T Consensus 218 ----~~~~~------------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~ 266 (318)
T 1fot_A 218 ----AELRF------------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 266 (318)
T ss_dssp ----CCCCC------------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred ----CCCCC------------CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence 11222 235789999999999999999999 899999999999765
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=411.82 Aligned_cols=280 Identities=33% Similarity=0.568 Sum_probs=227.5
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch---hhHHHHHHHHHHc------CCCCccccceeeeeccCCCc
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLL------NHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~---~~~~~E~~il~~l------~h~nIv~l~~~~~~~~~~~~ 207 (492)
.+|.+.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.+ +|+||+++++++.. .
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~-----~ 171 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF-----R 171 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE-----T
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc-----C
Confidence 46999999999999999999999999999999997654 3345789998888 57799999998843 3
Q ss_pred eEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCC-cEEEeeecC
Q 011138 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH-QLKICDFGS 286 (492)
Q Consensus 208 ~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~-~vkL~DFG~ 286 (492)
..+|+||||+++++.+.+.... ...+++..++.++.||+.||.|||+ +|||||||||+||||+.++. .+||+|||+
T Consensus 172 ~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 172 NHICMTFELLSMNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHK-NRIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp TEEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH-HTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred CeEEEEEeccCCCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 4689999999998887765422 3458999999999999999999997 89999999999999998772 299999999
Q ss_pred ccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 011138 287 AKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (492)
Q Consensus 287 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~ 366 (492)
+... .......+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+.+..+++..++..+|.|+...+..
T Consensus 249 a~~~--~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~ 325 (429)
T 3kvw_A 249 SCYE--HQRVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA 325 (429)
T ss_dssp CEET--TCCCCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred ceec--CCcccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence 9754 33345678999999999997654 89999999999999999999999999999999999999999999886643
Q ss_pred cCCCC---cccCCC---------------------------cccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHH
Q 011138 367 MNPNY---TEFKFP---------------------------QIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALE 416 (492)
Q Consensus 367 ~~~~~---~~~~~~---------------------------~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e 416 (492)
..... ....+| ......|...+....++++++||.+||++||.+|||+.|
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e 405 (429)
T 3kvw_A 326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ 405 (429)
T ss_dssp BTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHH
Confidence 32100 000000 011223334445556889999999999999999999999
Q ss_pred hhCCCCCCCCC
Q 011138 417 ACAHPFFDDLR 427 (492)
Q Consensus 417 ~l~Hp~f~~~~ 427 (492)
+|+||||++..
T Consensus 406 ~L~Hpw~~~~~ 416 (429)
T 3kvw_A 406 ALRHPWLRRRL 416 (429)
T ss_dssp HHTSTTTC---
T ss_pred HhCChhhccCC
Confidence 99999999753
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=406.00 Aligned_cols=253 Identities=26% Similarity=0.504 Sum_probs=207.6
Q ss_pred ccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHc-CCCCccccceeeeeccCC
Q 011138 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK 205 (492)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~ 205 (492)
....+|.+.++||+|+||.||+|+++.+++.||||++.+.. ....+|..+++.+ +|||||+++++| .
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~ 123 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----Q 123 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE-----E
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE-----E
Confidence 34567999999999999999999999999999999986532 2345799999877 899999999998 4
Q ss_pred CceEEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeee
Q 011138 206 DELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (492)
Q Consensus 206 ~~~~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DF 284 (492)
+...+|+||||+.|+ |...+.. ...+++..++.|+.||+.||.|||+ +||+||||||+||||+.++ .+||+||
T Consensus 124 ~~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~~~g-~ikL~DF 197 (396)
T 4dc2_A 124 TESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDSEG-HIKLTDY 197 (396)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEECCCC-CEEEeec
Confidence 455699999999874 4443332 3569999999999999999999997 9999999999999999888 7999999
Q ss_pred cCcccc-CCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh--------HHHHHH-HHH
Q 011138 285 GSAKML-VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESG--------VDQLVE-IIK 354 (492)
Q Consensus 285 G~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~--------~~~~~~-i~~ 354 (492)
|+++.. .........+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+... .+.+.. +..
T Consensus 198 Gla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~ 276 (396)
T 4dc2_A 198 GMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 276 (396)
T ss_dssp TTCBCCCCTTCCBCCCCBCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH
T ss_pred ceeeecccCCCccccccCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc
Confidence 999863 334455678999999999999765 489999999999999999999999975321 111222 221
Q ss_pred HhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCH------HHhhCCCCCCCCC
Q 011138 355 ILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA------LEACAHPFFDDLR 427 (492)
Q Consensus 355 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~------~e~l~Hp~f~~~~ 427 (492)
.... ++..+++++++||++||+.||.+|+++ .|+++||||+++.
T Consensus 277 -----------------~~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~ 326 (396)
T 4dc2_A 277 -----------------KQIR------------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 326 (396)
T ss_dssp -----------------CCCC------------CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred -----------------cccC------------CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCC
Confidence 1112 234589999999999999999999995 7999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=411.13 Aligned_cols=259 Identities=24% Similarity=0.408 Sum_probs=215.7
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
..+|.+.++||+|+||+||+|+++.+|+.||||++.+.. ....+|+.+++.++||||++++++| .+..
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~~ 147 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF-----QDDN 147 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE-----ECSS
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----eeCC
Confidence 346999999999999999999999999999999985422 2356899999999999999999998 4555
Q ss_pred EEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 209 ~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
.+|||||||.| +|...+.. ....+++..++.|+.||+.||.|||+ +|||||||||+||||+.++ .+||+|||++
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILl~~~g-~vkL~DFGla 222 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDMNG-HIRLADFGSC 222 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred EEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeeEcCCC-CEEEcchhhh
Confidence 69999999975 45554432 24679999999999999999999997 9999999999999999888 7999999999
Q ss_pred cccCCCCC--CccceeccCccCchhhc----CCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 011138 288 KMLVPGEP--NISYICSRYYRAPELIF----GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTR 361 (492)
Q Consensus 288 ~~~~~~~~--~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~ 361 (492)
+....... ....+||+.|+|||++. +...|+.++|||||||++|||++|++||.+.+..+.+.+|+....
T Consensus 223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---- 298 (437)
T 4aw2_A 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE---- 298 (437)
T ss_dssp EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH----
T ss_pred hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc----
Confidence 76644332 23468999999999996 245589999999999999999999999999988888887764211
Q ss_pred HHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCC--cCCHHHhhCCCCCCCCCC
Q 011138 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSL--RCTALEACAHPFFDDLRD 428 (492)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~--R~t~~e~l~Hp~f~~~~~ 428 (492)
.+.+|. ....+++++++||++||..+|++ |++++|+++||||+++..
T Consensus 299 -----------~~~~p~---------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w 347 (437)
T 4aw2_A 299 -----------RFQFPT---------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDW 347 (437)
T ss_dssp -----------HCCCCS---------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCT
T ss_pred -----------cccCCc---------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCH
Confidence 122222 11347999999999999998888 999999999999998754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=402.88 Aligned_cols=285 Identities=34% Similarity=0.622 Sum_probs=229.0
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCC-CceE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK-DELY 209 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~-~~~~ 209 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++||||+++++++...... ....
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 4699999999999999999999999999999998643 23345799999999999999999998544321 1223
Q ss_pred EEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
+|+||||+.+++...+ ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 122 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~ 193 (371)
T 4exu_A 122 FYLVMPFMQTDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVNEDC-ELKILDFGLARH 193 (371)
T ss_dssp CEEEEECCCEEHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECSTTCC--
T ss_pred EEEEEccccccHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCcCHHHeEECCCC-CEEEEecCcccc
Confidence 4899999998776543 3458999999999999999999997 9999999999999999888 799999999986
Q ss_pred cCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
.. .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.|..+.+.....
T Consensus 194 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 271 (371)
T 4exu_A 194 AD--AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 271 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred cc--cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence 53 3344578899999999998766799999999999999999999999999999999999999999998876654332
Q ss_pred CCcc---cCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCCCC
Q 011138 370 NYTE---FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTC 432 (492)
Q Consensus 370 ~~~~---~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~~~ 432 (492)
.... ..++......+. .+.+.+++++++||.+||+.||.+|||+.|+|+||||+.++.+...
T Consensus 272 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~ 336 (371)
T 4exu_A 272 KAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEE 336 (371)
T ss_dssp HHHHHHHHHSCCCCCCCHH-HHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGC
T ss_pred hhhhhhhhccCCCcchhHH-HhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcccc
Confidence 1100 011111111121 1235679999999999999999999999999999999998776544
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-50 Score=400.40 Aligned_cols=252 Identities=27% Similarity=0.473 Sum_probs=211.9
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHc-CCCCccccceeeeeccCCC
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKD 206 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~ 206 (492)
...+|.+.+.||+|+||.||+|+++.+|+.||||++.+.. ....+|..+++.+ +||||++++++| .+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~-----~~ 89 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QT 89 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----EC
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE-----Ee
Confidence 3457999999999999999999999999999999986532 2345789999877 899999999998 44
Q ss_pred ceEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeec
Q 011138 207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (492)
Q Consensus 207 ~~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG 285 (492)
...+|+||||+.| +|...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 90 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g-~vkL~DFG 163 (345)
T 1xjd_A 90 KENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDKDG-HIKIADFG 163 (345)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCChhhEEECCCC-CEEEeECh
Confidence 5568999999986 45444432 3568999999999999999999997 9999999999999999888 79999999
Q ss_pred CccccCC-CCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 011138 286 SAKMLVP-GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (492)
Q Consensus 286 ~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~ 364 (492)
+++.... .......+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+..+.+..|...
T Consensus 164 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--------- 233 (345)
T 1xjd_A 164 MCKENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--------- 233 (345)
T ss_dssp TCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---------
T ss_pred hhhhcccCCCcccCCCCCcccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC---------
Confidence 9986432 2344567899999999999765 4899999999999999999999999998877766666441
Q ss_pred hhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHH-HhhCCCCCCCCC
Q 011138 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL-EACAHPFFDDLR 427 (492)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~-e~l~Hp~f~~~~ 427 (492)
... ++..+++++++||.+||+.||.+||++. ++++||||+++.
T Consensus 234 --------~~~------------~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~ 277 (345)
T 1xjd_A 234 --------NPF------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277 (345)
T ss_dssp --------CCC------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred --------CCC------------CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence 111 2235789999999999999999999998 999999999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=407.35 Aligned_cols=258 Identities=28% Similarity=0.368 Sum_probs=209.5
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc---------hhhHHHHHHHHHHcCCCCccccceeeeeccCCC
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~---------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 206 (492)
...|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++||||++++++|..
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----- 97 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS----- 97 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----
Confidence 34799999999999999999999999999999998532 3446789999999999999999999843
Q ss_pred ceEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCC--cEEEee
Q 011138 207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH--QLKICD 283 (492)
Q Consensus 207 ~~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~--~vkL~D 283 (492)
...+|+|||||.+ +|...+.........+++..++.++.||+.||.|||+ +||+||||||+|||++.++. .+||+|
T Consensus 98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivHrDlkp~NIl~~~~~~~~~vkl~D 176 (351)
T 3c0i_A 98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-NNIIHRDVKPHCVLLASKENSAPVKLGG 176 (351)
T ss_dssp TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECSSSTTCCEEECC
T ss_pred CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChHHeEEecCCCCCcEEEec
Confidence 3468999999985 5555554444445568999999999999999999997 99999999999999986542 499999
Q ss_pred ecCccccCCCCC-CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 011138 284 FGSAKMLVPGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (492)
Q Consensus 284 FG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~ 362 (492)
||++........ ....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.. .+.+..+.........
T Consensus 177 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~- 253 (351)
T 3c0i_A 177 FGVAIQLGESGLVAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNP- 253 (351)
T ss_dssp CTTCEECCTTSCBCCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCH-
T ss_pred CcceeEecCCCeeecCCcCCcCccCHHHHcCC-CCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCc-
Confidence 999987654332 3456899999999999654 48999999999999999999999998753 3334444331111111
Q ss_pred HHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
..+..+++++++||.+||+.||.+|||+.|+++||||++.
T Consensus 254 ------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 254 ------------------------RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp ------------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred ------------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 1123578999999999999999999999999999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=394.45 Aligned_cols=255 Identities=25% Similarity=0.393 Sum_probs=214.5
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----------hhhHHHHHHHHHHcCCCCccccceeeeeccCC
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 205 (492)
...|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++||||++++++| .
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~ 84 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----E 84 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence 35699999999999999999999999999999988542 24467899999999999999999998 4
Q ss_pred CceEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCC---cEEE
Q 011138 206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH---QLKI 281 (492)
Q Consensus 206 ~~~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~---~vkL 281 (492)
+...+++||||+.+ +|.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++. .+||
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~~kl 159 (326)
T 2y0a_A 85 NKTDVILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKI 159 (326)
T ss_dssp CSSEEEEEEECCCSCBHHHHHT----TSSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESCSSSSSCCEEE
T ss_pred eCCEEEEEEEcCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHH-CCeEcCCCCHHHEEEecCCCCCCCEEE
Confidence 44568999999975 5555443 24568999999999999999999997 99999999999999987652 6999
Q ss_pred eeecCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 011138 282 CDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTR 361 (492)
Q Consensus 282 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~ 361 (492)
+|||+++............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.......+
T Consensus 160 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~- 237 (326)
T 2y0a_A 160 IDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE- 237 (326)
T ss_dssp CCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCC-
T ss_pred EECCCCeECCCCCccccccCCcCcCCceeecCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcC-
Confidence 999999877655555667899999999999654 589999999999999999999999999887777766654211111
Q ss_pred HHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
..++..+++++++||.+||+.||.+|||+.|+|+||||+..
T Consensus 238 ------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 238 ------------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp ------------------------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred ------------------------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 11224578999999999999999999999999999999864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=399.66 Aligned_cols=287 Identities=32% Similarity=0.599 Sum_probs=227.2
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch---------------hhHHHHHHHHHHcCCCCccccceeeee
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---------------RYKNRELQIMRLLNHPNVVSLKHCFFS 201 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~---------------~~~~~E~~il~~l~h~nIv~l~~~~~~ 201 (492)
.+|.+.+.||+|+||.||+|.+.. |+.||||++.... ....+|+.+++.++||||+++++++..
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 100 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH 100 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred cceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence 469999999999999999998754 9999999884321 345689999999999999999999977
Q ss_pred ccCCCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEE
Q 011138 202 TTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKI 281 (492)
Q Consensus 202 ~~~~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL 281 (492)
.......++|+||||+++++...+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||
T Consensus 101 ~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~-~~kl 175 (362)
T 3pg1_A 101 FEEPAMHKLYLVTELMRTDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHE-AGVVHRDLHPGNILLADNN-DITI 175 (362)
T ss_dssp CCTTTCCEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEE
T ss_pred ccCCCcceEEEEEccCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CcCEecCCChHHEEEcCCC-CEEE
Confidence 66666678899999999988876542 24568999999999999999999997 9999999999999999887 7999
Q ss_pred eeecCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 011138 282 CDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTR 361 (492)
Q Consensus 282 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~ 361 (492)
+|||+++............||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.|..
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 255 (362)
T 3pg1_A 176 CDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255 (362)
T ss_dssp CCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred EecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence 99999986655555566789999999999977667999999999999999999999999999999999999999999987
Q ss_pred HHHhhcCCC----CcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCC
Q 011138 362 EEIKCMNPN----YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430 (492)
Q Consensus 362 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~ 430 (492)
+.+...... +............|. ...+.+++.+.+||.+||+.||.+|||+.|+++||||+.+..+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 327 (362)
T 3pg1_A 256 EDVVMFSSPSARDYLRNSLSNVPARAWT-AVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPL 327 (362)
T ss_dssp HHHHHTSCHHHHHHTTTCCCCCCCCCHH-HHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGG
T ss_pred HHhhhccchhhhHHHHhhcccCChhhHH-hhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCcc
Confidence 765432210 000111111222222 23356789999999999999999999999999999999987643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=418.19 Aligned_cols=285 Identities=28% Similarity=0.415 Sum_probs=222.6
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
..+|.+.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++|||||+++++| .+...
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~~~ 84 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEEGH 84 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECSSE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EECCE
Confidence 457999999999999999999999999999999985432 3456899999999999999999998 45556
Q ss_pred EEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCC--CCcEEEeeecC
Q 011138 210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH--THQLKICDFGS 286 (492)
Q Consensus 210 ~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~--~~~vkL~DFG~ 286 (492)
+|+|||||.| ++.+.+.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.+ ...+||+|||+
T Consensus 85 ~~lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~-~givHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQ-MGVVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp EEEEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred EEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 8999999986 45454432 4568999999999999999999997 999999999999999842 23799999999
Q ss_pred ccccCCCCC-CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 011138 287 AKMLVPGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (492)
Q Consensus 287 a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~ 365 (492)
+........ .....||+.|+|||++.+. .|+.++|||||||++|+|++|.+||.+.+..+.+..+...
T Consensus 160 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~---------- 228 (444)
T 3soa_A 160 AIEVEGEQQAWFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAG---------- 228 (444)
T ss_dssp CBCCCTTCCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT----------
T ss_pred eEEecCCCceeecccCCcccCCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC----------
Confidence 987644332 3457899999999999654 5899999999999999999999999998887777776552
Q ss_pred hcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 011138 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTLFNF 445 (492)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~~~~~~~~~~~~~~~~ 445 (492)
.+.++. ..+..+++++++||.+||+.||.+|||+.|+|+||||+.......+......+..+.+|
T Consensus 229 -------~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~~~~~~~~~~~~~~~l~~~ 293 (444)
T 3soa_A 229 -------AYDFPS--------PEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKF 293 (444)
T ss_dssp -------CCCCCT--------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHHHHHSCCCCCHHHHHHHHHH
T ss_pred -------CCCCCc--------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCCccccccchhhHHHHHHHHH
Confidence 112221 11245799999999999999999999999999999998643222222222223344555
Q ss_pred Ccccccccccc
Q 011138 446 TAQGKLILCFS 456 (492)
Q Consensus 446 ~~~~~~~~~~~ 456 (492)
....++..++.
T Consensus 294 ~~~~klk~~~~ 304 (444)
T 3soa_A 294 NARRKLKGAIL 304 (444)
T ss_dssp HHHHHHHTTCS
T ss_pred HHHHHHHHHHH
Confidence 55555444333
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=407.18 Aligned_cols=255 Identities=29% Similarity=0.464 Sum_probs=214.3
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
..+|.+.+.||+|+||+||+|+++.+|+.||||++.+. .....+|+.+++.++|||||+++++| .+..
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~ 142 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDDR 142 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECC
Confidence 45799999999999999999999999999999998542 23356899999999999999999998 4555
Q ss_pred EEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 209 ~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
++|+|||||+| +|..++. ...+++..++.|+.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 143 ~~~lV~E~~~gg~L~~~l~-----~~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~~~g-~ikL~DFG~a 215 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMS-----NYDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSG-HLKLADFGTC 215 (410)
T ss_dssp EEEEEECCCTTEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeeECCCC-CEEEecccee
Confidence 79999999976 4544432 2458999999999999999999997 9999999999999999888 7999999999
Q ss_pred cccCCCC--CCccceeccCccCchhhcCCCC---CCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 011138 288 KMLVPGE--PNISYICSRYYRAPELIFGATE---YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (492)
Q Consensus 288 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~---~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~ 362 (492)
+...... ...+.+||+.|+|||++.+... |+.++|||||||++|||++|++||.+.+..+.+.+|+....
T Consensus 216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~----- 290 (410)
T 3v8s_A 216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN----- 290 (410)
T ss_dssp EECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH-----
T ss_pred EeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc-----
Confidence 8764433 2336789999999999975432 78899999999999999999999999988888887765210
Q ss_pred HHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCC--cCCHHHhhCCCCCCCCC
Q 011138 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSL--RCTALEACAHPFFDDLR 427 (492)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~--R~t~~e~l~Hp~f~~~~ 427 (492)
.+.+|. +..+++++++||++||+.+|.+ |+++.|+++||||+++.
T Consensus 291 ----------~~~~p~----------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~ 337 (410)
T 3v8s_A 291 ----------SLTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 337 (410)
T ss_dssp ----------HCCCCT----------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred ----------cccCCC----------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence 112221 1357999999999999999988 99999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=405.97 Aligned_cols=259 Identities=27% Similarity=0.448 Sum_probs=213.8
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
..+|.+.+.||+|+||.||+|+++.+|+.||||++.+. .....+|..++..++||||++++++| .+..
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~~ 134 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF-----QDEN 134 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE-----ECSS
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----eeCC
Confidence 45799999999999999999999999999999998642 23356899999999999999999998 4555
Q ss_pred EEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 209 ~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
++||||||+.| +|...+.. ....+++..++.|+.||+.||.|||+ +|||||||||+|||++.++ .+||+|||++
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILld~~g-~vkL~DFGla 209 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSK---FGERIPAEMARFYLAEIVMAIDSVHR-LGYVHRDIKPDNILLDRCG-HIRLADFGSC 209 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHH---HSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred EEEEEEcCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccCHHHeeecCCC-CEEEeechhh
Confidence 79999999975 55554432 23578999999999999999999997 9999999999999999888 7999999999
Q ss_pred cccCCCCC--CccceeccCccCchhhcC------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 011138 288 KMLVPGEP--NISYICSRYYRAPELIFG------ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTP 359 (492)
Q Consensus 288 ~~~~~~~~--~~~~~gt~~y~aPE~~~~------~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p 359 (492)
+....... ....+||+.|+|||++.+ ...|+.++|||||||++|||++|++||.+.+..+.+.+|....
T Consensus 210 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--- 286 (412)
T 2vd5_A 210 LKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK--- 286 (412)
T ss_dssp EECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH---
T ss_pred eeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---
Confidence 87654432 234689999999999963 3458999999999999999999999999998888777776421
Q ss_pred CHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCc---CCHHHhhCCCCCCCCCCC
Q 011138 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR---CTALEACAHPFFDDLRDP 429 (492)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R---~t~~e~l~Hp~f~~~~~~ 429 (492)
....+|. ++..+++++++||++||. +|.+| ++++|+++||||+++...
T Consensus 287 ------------~~~~~p~---------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~ 337 (412)
T 2vd5_A 287 ------------EHLSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWD 337 (412)
T ss_dssp ------------HHCCCC-------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCST
T ss_pred ------------cCcCCCc---------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHH
Confidence 0111221 123589999999999999 99998 489999999999987543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=401.03 Aligned_cols=255 Identities=27% Similarity=0.431 Sum_probs=213.5
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
..+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++|||||++++++ .+..+
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~ 102 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF 102 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence 357999999999999999999999999999999985432 3456899999999999999999998 44556
Q ss_pred EEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCC--CcEEEeeecC
Q 011138 210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT--HQLKICDFGS 286 (492)
Q Consensus 210 ~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~--~~vkL~DFG~ 286 (492)
.|+||||+.+ .+.+.+. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ ..+||+|||+
T Consensus 103 ~~lv~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp EEEEECCCCSCBHHHHHT----TCSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 8999999986 4544433 23568999999999999999999997 9999999999999998653 2599999999
Q ss_pred ccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 011138 287 AKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (492)
Q Consensus 287 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~ 366 (492)
+.............||+.|+|||++.+. .|+.++|||||||++|+|++|.+||.+.+..+.+..+...
T Consensus 178 a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~----------- 245 (362)
T 2bdw_A 178 AIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG----------- 245 (362)
T ss_dssp CBCCTTCCSCCCSCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-----------
T ss_pred ceEecCCcccccCCCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC-----------
Confidence 9877655555567899999999999654 5899999999999999999999999998877766666542
Q ss_pred cCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
.+.++. ..+..+++++++||.+||+.||.+|||+.++|+||||+..
T Consensus 246 ------~~~~~~--------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 246 ------AYDYPS--------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp ------CCCCCT--------TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred ------CCCCCc--------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 111211 1123579999999999999999999999999999999854
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=395.84 Aligned_cols=253 Identities=26% Similarity=0.504 Sum_probs=206.7
Q ss_pred ccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHc-CCCCccccceeeeeccCC
Q 011138 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK 205 (492)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~ 205 (492)
....+|.+.+.||+|+||.||+|+++.+|+.||||++.+.. ....+|..+++.+ +||||++++++| .
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~ 80 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----Q 80 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----E
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE-----E
Confidence 34567999999999999999999999999999999986432 2345799999988 899999999998 4
Q ss_pred CceEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeee
Q 011138 206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (492)
Q Consensus 206 ~~~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DF 284 (492)
+...+|+||||+.+ +|...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+||
T Consensus 81 ~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g-~~kL~DF 154 (345)
T 3a8x_A 81 TESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDSEG-HIKLTDY 154 (345)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCG
T ss_pred eCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEECCCC-CEEEEec
Confidence 45568999999986 45444332 3568999999999999999999997 9999999999999999888 7999999
Q ss_pred cCccccC-CCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh--------HHHH-HHHHH
Q 011138 285 GSAKMLV-PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESG--------VDQL-VEIIK 354 (492)
Q Consensus 285 G~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~--------~~~~-~~i~~ 354 (492)
|+++... ........+||+.|+|||++.+. .|+.++|||||||++|||++|.+||..... ...+ ..+..
T Consensus 155 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~ 233 (345)
T 3a8x_A 155 GMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 233 (345)
T ss_dssp GGCBCSCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH
T ss_pred cccccccCCCCcccccCCCccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc
Confidence 9998643 33345567899999999999765 489999999999999999999999975321 1112 22221
Q ss_pred HhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCH------HHhhCCCCCCCCC
Q 011138 355 ILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA------LEACAHPFFDDLR 427 (492)
Q Consensus 355 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~------~e~l~Hp~f~~~~ 427 (492)
.... ++..+++++++||.+||+.||.+||++ .|+++||||+++.
T Consensus 234 -----------------~~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 283 (345)
T 3a8x_A 234 -----------------KQIR------------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283 (345)
T ss_dssp -----------------CCCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred -----------------CCCC------------CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence 1111 234579999999999999999999996 7999999999765
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=400.72 Aligned_cols=256 Identities=29% Similarity=0.431 Sum_probs=211.7
Q ss_pred ccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCC
Q 011138 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (492)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 206 (492)
....+|.+.+.||+|+||.||+|.+..+|+.||||++.+.. ....+|+.+|+.++|||||+++++| .+
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~ 86 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF-----QD 86 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----EC
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence 34567999999999999999999999999999999985432 3445799999999999999999998 44
Q ss_pred ceEEEEEeeechhhHH-HHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeec
Q 011138 207 ELYLNLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (492)
Q Consensus 207 ~~~~~lV~E~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG 285 (492)
...+|+||||+.|+.+ ..+. ....+++..++.|+.||+.||.|||+ +||+||||||+||||+.++ .+||+|||
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~~g-~vkL~DFG 160 (384)
T 4fr4_A 87 EEDMFMVVDLLLGGDLRYHLQ----QNVHFKEETVKLFICELVMALDYLQN-QRIIHRDMKPDNILLDEHG-HVHITDFN 160 (384)
T ss_dssp SSEEEEEECCCTTEEHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEECCCC-CEEEeccc
Confidence 4568999999986543 3332 24579999999999999999999997 9999999999999999888 79999999
Q ss_pred CccccCCCCCCccceeccCccCchhhcCC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCCH
Q 011138 286 SAKMLVPGEPNISYICSRYYRAPELIFGA--TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD--QLVEIIKILGTPTR 361 (492)
Q Consensus 286 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~--~~~~i~~~~g~p~~ 361 (492)
+++...........+||+.|+|||++.+. ..|+.++|||||||++|+|++|..||...+... .+...+..
T Consensus 161 ~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~------ 234 (384)
T 4fr4_A 161 IAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET------ 234 (384)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH------
T ss_pred eeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh------
Confidence 99987666666788999999999999642 348999999999999999999999998644322 22221111
Q ss_pred HHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCC-HHHhhCCCCCCCCCC
Q 011138 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-ALEACAHPFFDDLRD 428 (492)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-~~e~l~Hp~f~~~~~ 428 (492)
.... ++..+++++.+||.+||+.||.+||+ +.++++||||+++..
T Consensus 235 ----------~~~~------------~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w 280 (384)
T 4fr4_A 235 ----------TVVT------------YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW 280 (384)
T ss_dssp ----------CCCC------------CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred ----------cccC------------CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence 1111 22457899999999999999999998 899999999998653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=388.57 Aligned_cols=253 Identities=26% Similarity=0.416 Sum_probs=210.7
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
..+|.+.+.||+|+||+||+|.+..+|+.||||++... .....+|+.+++.++||||++++++|.. ...+|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~ 93 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELW 93 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE-----CCEEE
Confidence 34699999999999999999999999999999988532 3445689999999999999999999854 33588
Q ss_pred EEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 212 lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
+||||+.++ +.+.+. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++...
T Consensus 94 lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~ 166 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQI 166 (297)
T ss_dssp EEEECCTTCBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred EEEECCCCCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEECCCC-CEEEeeCCCceec
Confidence 999999764 444332 2358899999999999999999997 9999999999999999888 7999999999876
Q ss_pred CCCC-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 291 VPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 291 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
.... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+....+..+.... .+.
T Consensus 167 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~~--------- 235 (297)
T 3fxz_A 167 TPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPE--------- 235 (297)
T ss_dssp CSTTCCBCCCCSCGGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-SCC---------
T ss_pred CCcccccCCccCCcCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCC---------
Confidence 4433 33456899999999999765 48999999999999999999999999888777666654421 110
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
.. .+..+++.+.+||.+||+.||.+|||+.|+++||||+...
T Consensus 236 ----~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 236 ----LQ------------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp ----CS------------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred ----CC------------CccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence 00 1235789999999999999999999999999999998653
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=396.41 Aligned_cols=288 Identities=27% Similarity=0.462 Sum_probs=226.7
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccC---CC
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE---KD 206 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~---~~ 206 (492)
..+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++..... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 457999999999999999999999999999999884332 234589999999999999999998865331 11
Q ss_pred ceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 207 ~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
...+|+||||+++++...+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 96 ~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~ 170 (351)
T 3mi9_A 96 KGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITRDG-VLKLADFGL 170 (351)
T ss_dssp -CEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTT
T ss_pred CceEEEEEeccCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcCCC-CEEEccchh
Confidence 346889999999987765543 23568999999999999999999997 9999999999999999888 799999999
Q ss_pred ccccCCC-----CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 011138 287 AKMLVPG-----EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTR 361 (492)
Q Consensus 287 a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~ 361 (492)
++..... .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.++.
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 9765321 22345678999999999987677899999999999999999999999999999999999999988876
Q ss_pred HHHhhcCCC--CcccCCCcccCCCccccc-CCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 362 EEIKCMNPN--YTEFKFPQIKAHPWHKIF-HKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 362 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~-~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
..+...... +................+ ....++++++||.+||+.||.+|||+.|+|+||||+....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM 320 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSC
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCC
Confidence 654432211 111111100000000000 0013778999999999999999999999999999987543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=396.46 Aligned_cols=250 Identities=27% Similarity=0.454 Sum_probs=213.1
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
...+|.+.+.||+|+||.||+|++..+|+.||||++.+.. ....+|+.+++.++||||++++++| .+.
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~ 113 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDN 113 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcC
Confidence 3457999999999999999999999999999999985432 3345799999999999999999998 445
Q ss_pred eEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 208 ~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
..+|+||||+.| ++...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 114 ~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g-~~kL~DFg~ 187 (350)
T 1rdq_E 114 SNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQG-YIQVTDFGF 187 (350)
T ss_dssp SEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTT
T ss_pred CEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCccceEEECCCC-CEEEccccc
Confidence 568999999975 55554432 3568999999999999999999997 9999999999999999888 799999999
Q ss_pred ccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 011138 287 AKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (492)
Q Consensus 287 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~ 366 (492)
++.... .....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..|...
T Consensus 188 a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~----------- 253 (350)
T 1rdq_E 188 AKRVKG--RTWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----------- 253 (350)
T ss_dssp CEECSS--CBCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred ceeccC--CcccccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC-----------
Confidence 987633 34467899999999999765 4899999999999999999999999998877777666551
Q ss_pred cCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCC-----HHHhhCCCCCCCCC
Q 011138 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-----ALEACAHPFFDDLR 427 (492)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-----~~e~l~Hp~f~~~~ 427 (492)
... ++..+++++++||.+||+.||.+||+ +.++++||||+.+.
T Consensus 254 ------~~~------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~ 301 (350)
T 1rdq_E 254 ------KVR------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp ------CCC------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred ------CCC------------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCC
Confidence 112 22357999999999999999999998 99999999999754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=396.25 Aligned_cols=254 Identities=19% Similarity=0.234 Sum_probs=184.3
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchh-h--HHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEe
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-Y--KNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~--~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
+|.+.+.||+|+||+||+|++ +|+.||||++..... . .++|+.++..++|||||++++++.... .....+||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~lV~ 80 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLVS 80 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEEEe
Confidence 589999999999999999987 689999999865432 2 234556667889999999999986543 2334689999
Q ss_pred eechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhC--------CcccCCCCCCceEEcCCCCcEEEeeec
Q 011138 215 EYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV--------GVCHRDIKPQNLLVNPHTHQLKICDFG 285 (492)
Q Consensus 215 E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~--------givHrDlKp~NILl~~~~~~vkL~DFG 285 (492)
|||++ +|.+.+. ...+++..+..++.|++.||.|||+ + |||||||||+||||+.++ .+||+|||
T Consensus 81 Ey~~~gsL~~~l~-----~~~l~~~~~~~i~~~ia~gl~ylH~-~~~~~~~~~~IiHRDlKp~NILl~~~~-~~Ki~DFG 153 (303)
T 3hmm_A 81 DYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHM-EIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLG 153 (303)
T ss_dssp ECCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHC-CBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCCT
T ss_pred cCCCCCcHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHH-hhhhccCCCCEeeccCCcccEEECCCC-CEEEEeCC
Confidence 99996 4554443 2468899999999999999999996 6 999999999999999888 79999999
Q ss_pred CccccCCCCC-----CccceeccCccCchhhcCCC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCChHH--------
Q 011138 286 SAKMLVPGEP-----NISYICSRYYRAPELIFGAT-----EYTTAIDMWSIGCVLAELLLGQPLFPGESGVD-------- 347 (492)
Q Consensus 286 ~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~-----~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~-------- 347 (492)
+|+....... ....+||+.|||||++.+.. .|+.++|||||||+||||+||.+||......+
T Consensus 154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~ 233 (303)
T 3hmm_A 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence 9987644332 22458999999999996542 36779999999999999999988775432110
Q ss_pred ---HHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 348 ---QLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 348 ---~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
....+.+..- ... ....+|.. ......++.+.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~----------~~~-~rp~~p~~-------~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 234 SDPSVEEMRKVVC----------EQK-LRPNIPNR-------WQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp SSCCHHHHHHHHT----------TSC-CCCCCCGG-------GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred ccchHHHHHHHHh----------ccc-CCCCCCcc-------ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 0011111000 000 00011110 001123457889999999999999999999975
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=394.64 Aligned_cols=280 Identities=33% Similarity=0.592 Sum_probs=228.9
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
..+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++. +...
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~ 98 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-----KKKR 98 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee-----cCCE
Confidence 457999999999999999999999999999999884432 23457999999999999999999984 3445
Q ss_pred EEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
+|+||||++++++..+. .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 99 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~ 173 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLE---LFPNGLDYQVVQKYLFQIINGIGFCHS-HNIIHRDIKPENILVSQSG-VVKLCDFGFART 173 (331)
T ss_dssp EEEEEECCSEEHHHHHH---HSTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCCTTC--
T ss_pred EEEEEecCCcchHHHHH---hhccCCCHHHHHHHHHHHHHHHHHHHH-CCEEccCcChheEEEcCCC-cEEEEeCCCcee
Confidence 89999999988766442 234568999999999999999999997 9999999999999999888 899999999976
Q ss_pred cCCC-CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh--
Q 011138 290 LVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC-- 366 (492)
Q Consensus 290 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~-- 366 (492)
.... .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+.+.....
T Consensus 174 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (331)
T 4aaa_A 174 LAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN 253 (331)
T ss_dssp ----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred ecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhh
Confidence 5432 2334567899999999997766789999999999999999999999999999999999999998877665432
Q ss_pred cCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCC
Q 011138 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (492)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~ 425 (492)
..+.+....++............+.+++++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 23444445555544444333444578999999999999999999999999999999985
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=393.27 Aligned_cols=288 Identities=34% Similarity=0.619 Sum_probs=228.5
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++...........|
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 90 (353)
T 2b9h_A 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY 90 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence 46999999999999999999999999999999985322 2345799999999999999999987544333445689
Q ss_pred EEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
+||||+.+++...+.. ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++...
T Consensus 91 lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 91 IIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHG-SNVIHRDLKPSNLLINSNC-DLKVCDFGLARIID 163 (353)
T ss_dssp EEECCCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTC-CEEECCCTTCEECC
T ss_pred EEEeccCccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEcCCC-cEEEEecccccccc
Confidence 9999999887766543 468999999999999999999997 9999999999999999887 79999999998654
Q ss_pred CCCC-----------CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 011138 292 PGEP-----------NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPT 360 (492)
Q Consensus 292 ~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~ 360 (492)
.... .....||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....|.|.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence 2211 22357899999999987766799999999999999999999999999999999999999888876
Q ss_pred HHHHh-hcCCC-Ccc--cCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCCCC
Q 011138 361 REEIK-CMNPN-YTE--FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTC 432 (492)
Q Consensus 361 ~~~~~-~~~~~-~~~--~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~~~ 432 (492)
..... +.... ... ..++......+. ...+.+++++.+||.+||+.||.+|||+.|+++||||+....+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~ 318 (353)
T 2b9h_A 244 SDNDLRCIESPRAREYIKSLPMYPAAPLE-KMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDE 318 (353)
T ss_dssp STTTTTTCCCHHHHHHHHTSCCCCCCCHH-HHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSS
T ss_pred hhccccccccchhhHHhhcccCCCCcchh-hhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcccc
Confidence 32211 10000 000 011111111111 1234689999999999999999999999999999999998776543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=389.43 Aligned_cols=256 Identities=27% Similarity=0.405 Sum_probs=206.4
Q ss_pred ccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------------------------------hhHHHHHHH
Q 011138 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------------------------------RYKNRELQI 183 (492)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------------------------------~~~~~E~~i 183 (492)
....+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 44567999999999999999999999999999999985432 335689999
Q ss_pred HHHcCCCCccccceeeeeccCCCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccC
Q 011138 184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHR 263 (492)
Q Consensus 184 l~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHr 263 (492)
++.++||||+++++++... ....+|+||||++++.+... .....+++..++.++.||+.||.|||+ +||+||
T Consensus 90 l~~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~ 161 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEV----PTLKPLSEDQARFYFQDLIKGIEYLHY-QKIIHR 161 (298)
T ss_dssp HHTCCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCS----SCSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred HHhCCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecc
Confidence 9999999999999988542 23468899999987544321 124578999999999999999999997 999999
Q ss_pred CCCCCceEEcCCCCcEEEeeecCccccCCCCC-CccceeccCccCchhhcCCCC--CCcchhhHHHHHHHHHHHhCCCCC
Q 011138 264 DIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP-NISYICSRYYRAPELIFGATE--YTTAIDMWSIGCVLAELLLGQPLF 340 (492)
Q Consensus 264 DlKp~NILl~~~~~~vkL~DFG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~--~~~~~DvwSlGvil~ell~G~~pf 340 (492)
||||+|||++.++ .+||+|||+++....... .....||+.|+|||++.+... ++.++|||||||++|+|++|..||
T Consensus 162 Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 240 (298)
T 2zv2_A 162 DIKPSNLLVGEDG-HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240 (298)
T ss_dssp CCCGGGEEECTTS-CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCCHHHEEECCCC-CEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence 9999999999888 799999999987643322 235689999999999965442 478899999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 341 PGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 341 ~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
.+.+.......+.. ....++. ...+++++.+||.+||+.||.+|||+.|+++|
T Consensus 241 ~~~~~~~~~~~~~~-----------------~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 241 MDERIMCLHSKIKS-----------------QALEFPD----------QPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp CCSSHHHHHHHHHH-----------------CCCCCCS----------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred CCccHHHHHHHHhc-----------------ccCCCCC----------ccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 88776554444433 1111111 13578999999999999999999999999999
Q ss_pred CCCCC
Q 011138 421 PFFDD 425 (492)
Q Consensus 421 p~f~~ 425 (492)
|||++
T Consensus 294 p~~~~ 298 (298)
T 2zv2_A 294 PWVTR 298 (298)
T ss_dssp HHHHC
T ss_pred ccccC
Confidence 99963
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=398.43 Aligned_cols=252 Identities=26% Similarity=0.426 Sum_probs=211.9
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHc-CCCCccccceeeeeccCCC
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKD 206 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~ 206 (492)
...+|.+.+.||+|+||.||+|+++.+|+.||||++.+.. ....+|..++..+ +||||++++++| .+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~ 92 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT 92 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----EC
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----Ec
Confidence 3457999999999999999999999999999999986532 2345788999887 799999999998 44
Q ss_pred ceEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeec
Q 011138 207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (492)
Q Consensus 207 ~~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG 285 (492)
...+|+||||+.| +|...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~~g-~vkL~DFG 166 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDSEG-HIKIADFG 166 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEEcCCC-cEEEEeCC
Confidence 5579999999986 55544432 3568999999999999999999997 9999999999999999888 79999999
Q ss_pred CccccC-CCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 011138 286 SAKMLV-PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (492)
Q Consensus 286 ~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~ 364 (492)
+++... ........+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..|..
T Consensus 167 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~---------- 235 (353)
T 2i0e_A 167 MCKENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME---------- 235 (353)
T ss_dssp TCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----------
T ss_pred cccccccCCcccccccCCccccChhhhcCC-CcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh----------
Confidence 998643 23345567899999999999654 489999999999999999999999999888777777665
Q ss_pred hhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCC-----HHHhhCCCCCCCCC
Q 011138 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-----ALEACAHPFFDDLR 427 (492)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-----~~e~l~Hp~f~~~~ 427 (492)
....+ +..+++++++||.+||+.||.+||+ +.++++||||+.+.
T Consensus 236 -------~~~~~------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~ 284 (353)
T 2i0e_A 236 -------HNVAY------------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 284 (353)
T ss_dssp -------CCCCC------------CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCC
T ss_pred -------CCCCC------------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCC
Confidence 11222 2357999999999999999999995 69999999999764
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-49 Score=392.04 Aligned_cols=282 Identities=30% Similarity=0.552 Sum_probs=221.3
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-hhhHHHHHHHHHHcC-CCCccccceeeeeccCCCceEEEEEe
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++ ||||+++++++... ...+.++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~---~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccC---CCCceEEEE
Confidence 4699999999999999999999999999999998643 455678999999997 99999999988532 244578999
Q ss_pred eechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCC
Q 011138 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (492)
Q Consensus 215 E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~ 294 (492)
||+.++.+.... ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++..+||+|||+++......
T Consensus 113 e~~~~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 113 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp ECCCCCCHHHHG------GGCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred eccCchhHHHHH------HhCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 999875443221 247888999999999999999997 9999999999999999776689999999998776666
Q ss_pred CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCCHHHHhh-cCCCCc
Q 011138 295 PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFP-GESGVDQLVEIIKILGTPTREEIKC-MNPNYT 372 (492)
Q Consensus 295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~-~~~~~~~~~~i~~~~g~p~~~~~~~-~~~~~~ 372 (492)
......||+.|+|||++.+...++.++|||||||++|+|++|..||. +.+..+.+..+...++.+....... ......
T Consensus 186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 265 (330)
T 3nsz_A 186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265 (330)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccc
Confidence 66677899999999999776679999999999999999999999984 5566777777777776544322211 110000
Q ss_pred c---cCCCcccCCCcccc----cCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 373 E---FKFPQIKAHPWHKI----FHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 373 ~---~~~~~~~~~~~~~~----~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
. ..........|... ....+++++++||.+||++||.+|||+.|+|+||||+++..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 328 (330)
T 3nsz_A 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 328 (330)
T ss_dssp THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence 0 00000011112111 12347999999999999999999999999999999998754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=393.84 Aligned_cols=276 Identities=27% Similarity=0.455 Sum_probs=220.4
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch---hhHHHHHHHHHHcC-----CCCccccceeeeeccCCCce
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLN-----HPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~---~~~~~E~~il~~l~-----h~nIv~l~~~~~~~~~~~~~ 208 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.+. |||||++++++.. ..
T Consensus 35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~-----~~ 109 (360)
T 3llt_A 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY-----YD 109 (360)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE-----TT
T ss_pred CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE-----CC
Confidence 46999999999999999999999999999999986433 33457999999997 9999999999844 33
Q ss_pred EEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcC--------------
Q 011138 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP-------------- 274 (492)
Q Consensus 209 ~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~-------------- 274 (492)
.+|+||||+++++.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.
T Consensus 110 ~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 110 HMCLIFEPLGPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp EEEEEECCCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred eeEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCcccEEEccccccccccchhccc
Confidence 58999999988887766542 22458999999999999999999997 99999999999999975
Q ss_pred -----------CCCcEEEeeecCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 011138 275 -----------HTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGE 343 (492)
Q Consensus 275 -----------~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~ 343 (492)
++ .+||+|||+++... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.
T Consensus 187 ~~~~~~~~~~~~~-~~kl~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 187 DGKKIQIYRTKST-GIKLIDFGCATFKS--DYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp TCCEEEEEEESCC-CEEECCCTTCEETT--SCCCSCCSCGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccCCC-CEEEEeccCceecC--CCCcCccCcccccCcHHHcCC-CCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 44 79999999998643 334467899999999999765 4899999999999999999999999999
Q ss_pred ChHHHHHHHHHHhCCCCHHHHhhcCCCCc---------ccCCCcccCCC--------cccccCCCCChhHhhhhcccccc
Q 011138 344 SGVDQLVEIIKILGTPTREEIKCMNPNYT---------EFKFPQIKAHP--------WHKIFHKRMPPEALDLVSRLLQY 406 (492)
Q Consensus 344 ~~~~~~~~i~~~~g~p~~~~~~~~~~~~~---------~~~~~~~~~~~--------~~~~~~~~~s~~~~~Li~~~L~~ 406 (492)
+..+.+..+....+.++...+........ ...+|...... ....+....++++.+||.+||+.
T Consensus 263 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 342 (360)
T 3llt_A 263 EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQI 342 (360)
T ss_dssp SHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCS
T ss_pred cHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcC
Confidence 99999999998888887765543221100 00111100000 00001122357888999999999
Q ss_pred CCCCcCCHHHhhCCCCCC
Q 011138 407 SPSLRCTALEACAHPFFD 424 (492)
Q Consensus 407 dP~~R~t~~e~l~Hp~f~ 424 (492)
||.+|||+.|+|+||||+
T Consensus 343 dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 343 DPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp SGGGSCCHHHHTTSGGGC
T ss_pred ChhhCCCHHHHhcCcccC
Confidence 999999999999999996
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=397.99 Aligned_cols=257 Identities=29% Similarity=0.454 Sum_probs=214.2
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
...|.+.+.||+|+||.||+|.+..+|+.||+|++... .....+|+.+|+.++||||++++++| .+...++
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~~ 124 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMV 124 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEE-----EeCCEEE
Confidence 35799999999999999999999999999999998643 33456899999999999999999998 4445689
Q ss_pred EEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCC-CCcEEEeeecCccc
Q 011138 212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH-THQLKICDFGSAKM 289 (492)
Q Consensus 212 lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~-~~~vkL~DFG~a~~ 289 (492)
+||||+.+ +|.+.+. .....+++..++.++.||+.||.|||+ +||+||||||+|||++.+ ...+||+|||+++.
T Consensus 125 lv~E~~~gg~L~~~l~---~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 125 LILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATK 200 (387)
T ss_dssp EEEECCCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccchHHeEEecCCCCceEEEeccccee
Confidence 99999986 4444332 223468999999999999999999997 999999999999999753 23799999999988
Q ss_pred cCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
...........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~-------------- 265 (387)
T 1kob_A 201 LNPDEIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC-------------- 265 (387)
T ss_dssp CCTTSCEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC--------------
T ss_pred cCCCcceeeeccCCCccCchhccCC-CCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 7655555567899999999999654 4899999999999999999999999998877777666541
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
.+.++. ..+..+++++++||.+||+.||.+|||+.|+++||||+...
T Consensus 266 ---~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 266 ---DWEFDE--------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp ---CCCCCS--------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred ---CCCCCc--------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 111111 12245799999999999999999999999999999998754
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=384.14 Aligned_cols=289 Identities=33% Similarity=0.560 Sum_probs=233.4
Q ss_pred ccccceeEeeeeccCCceEEEEEEEc-CCCCEEEEEEeccc------hhhHHHHHHHHHHc---CCCCccccceeeeecc
Q 011138 134 KQTISYMAERVVGTGSFGVVFQAKCL-ETGDSVAIKKVLQD------KRYKNRELQIMRLL---NHPNVVSLKHCFFSTT 203 (492)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~g~~vAiK~~~~~------~~~~~~E~~il~~l---~h~nIv~l~~~~~~~~ 203 (492)
....+|.+.+.||+|+||.||+|.+. .+|+.||||++... .....+|+.+++.+ +||||+++++++....
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 34457999999999999999999995 67899999988532 12455788888777 8999999999986544
Q ss_pred CCCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEee
Q 011138 204 EKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICD 283 (492)
Q Consensus 204 ~~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~D 283 (492)
......+++||||+.+++...+.... ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~-~gi~H~dlkp~Nili~~~~-~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSG-QIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECS
T ss_pred cCCCceEEEEEecCCCCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHHHeEEcCCC-CEEEec
Confidence 44666789999999988877654322 3458999999999999999999997 9999999999999999887 799999
Q ss_pred ecCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 011138 284 FGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (492)
Q Consensus 284 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~ 363 (492)
||+++............||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+...++.|....
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 164 FGLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred CcccccccCCCCccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 9999876544444567889999999999655 489999999999999999999999999999999999999999888766
Q ss_pred HhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCC
Q 011138 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (492)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~ 429 (492)
+...... ....+......+ ...+...+++++++||.+||+.||.+|||+.|+++||||+++...
T Consensus 243 ~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 306 (326)
T 1blx_A 243 WPRDVAL-PRQAFHSKSAQP-IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 306 (326)
T ss_dssp SCTTCSS-CGGGSCCCCCCC-GGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred Ccccccc-chhhhcccCcch-hhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchh
Confidence 5432111 011111111111 223446789999999999999999999999999999999987643
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=391.29 Aligned_cols=284 Identities=34% Similarity=0.628 Sum_probs=226.3
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCC-CceE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEK-DELY 209 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~-~~~~ 209 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++...... ....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 36999999999999999999999999999999985431 2345799999999999999999998543321 1123
Q ss_pred EEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
+|+||||+.+++...+ ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 104 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~ 175 (353)
T 3coi_A 104 FYLVMPFMQTDLQKIM------GLKFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVNEDC-ELKILDFGLARH 175 (353)
T ss_dssp CEEEEECCSEEGGGTT------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECTTC-CEEECSTTCTTC
T ss_pred EEEEeccccCCHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEeECCCC-cEEEeecccccC
Confidence 5899999998765433 2458999999999999999999997 9999999999999999887 799999999976
Q ss_pred cCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
.. .......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..|.|+.+.+..+..
T Consensus 176 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 176 AD--AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred CC--CCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence 43 2344568899999999997756789999999999999999999999999999999999999999998776654332
Q ss_pred CCcc---cCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCCC
Q 011138 370 NYTE---FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431 (492)
Q Consensus 370 ~~~~---~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~~ 431 (492)
.... ..++......+.. ....+++++.+||.+||+.||.+|||+.++++||||+.+..+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~ 317 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEE 317 (353)
T ss_dssp HHHHHHHHTSCBCSSCCTTT-TCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGG
T ss_pred HHHHHHHHhCcCCCCccHHH-hcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccc
Confidence 1100 0111111111211 23467999999999999999999999999999999998876543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=396.77 Aligned_cols=256 Identities=28% Similarity=0.448 Sum_probs=208.9
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchhhHHHHHHHHHHc-CCCCccccceeeeeccCCCceEEEEEe
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
..+|.+.+.||+|+||.||+|.++.+|+.||||++.+......+|++++..+ +||||++++++| .+..++|+||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 95 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVY-----DDGKYVYVVT 95 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEE-----EcCCEEEEEE
Confidence 4579999999999999999999999999999999987766667899999888 799999999998 4555799999
Q ss_pred eechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCC---cEEEeeecCcccc
Q 011138 215 EYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH---QLKICDFGSAKML 290 (492)
Q Consensus 215 E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~---~vkL~DFG~a~~~ 290 (492)
||+.| ++.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||+..+.+ .+||+|||+++..
T Consensus 96 E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~-~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 96 ELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHA-QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 99986 55554432 4568999999999999999999997 99999999999999854322 4999999999876
Q ss_pred CCC-CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHHhCCCCHHHHhh
Q 011138 291 VPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGE---SGVDQLVEIIKILGTPTREEIKC 366 (492)
Q Consensus 291 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~---~~~~~~~~i~~~~g~p~~~~~~~ 366 (492)
... ......+||+.|+|||++.+. .|+.++|||||||++|+|++|.+||.+. +..+.+..+..
T Consensus 171 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~------------ 237 (342)
T 2qr7_A 171 RAENGLLMTPCYTANFVAPEVLERQ-GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS------------ 237 (342)
T ss_dssp BCTTCCBCCSSCCSSCCCHHHHHHH-HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH------------
T ss_pred cCCCCceeccCCCccccCHHHhcCC-CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc------------
Confidence 433 234467899999999999654 4889999999999999999999999863 22333333322
Q ss_pred cCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
..+.++ ..++..+++++++||.+||..||.+|||+.++++||||.++.
T Consensus 238 -----~~~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~ 285 (342)
T 2qr7_A 238 -----GKFSLS--------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD 285 (342)
T ss_dssp -----CCCCCC--------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGG
T ss_pred -----CCcccC--------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcc
Confidence 111111 112346899999999999999999999999999999998753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=379.58 Aligned_cols=269 Identities=26% Similarity=0.408 Sum_probs=219.8
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
..+|.+.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++ .+...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 79 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF 79 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE-----EcCCE
Confidence 356999999999999999999999999999999985432 3345799999999999999999998 44456
Q ss_pred EEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCC--CcEEEeeecC
Q 011138 210 LNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT--HQLKICDFGS 286 (492)
Q Consensus 210 ~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~--~~vkL~DFG~ 286 (492)
.++||||+.++ +...+.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++ ..+||+|||+
T Consensus 80 ~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~ 154 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGL 154 (284)
T ss_dssp EEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcCcCCCCHHHEEEecCCCCCcEEEeecee
Confidence 88999999864 4443332 3568999999999999999999997 9999999999999997654 2499999999
Q ss_pred ccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 011138 287 AKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (492)
Q Consensus 287 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~ 366 (492)
+.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~---------- 223 (284)
T 3kk8_A 155 AIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA---------- 223 (284)
T ss_dssp CEECCSSCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC----------
T ss_pred eEEcccCccccCCCCCcCCcCchhhcCC-CCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcc----------
Confidence 9877655555567899999999999665 48999999999999999999999999988776666654421
Q ss_pred cCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCCCCCCCCCCCC
Q 011138 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLP 440 (492)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~~~~~~~~~~~ 440 (492)
+.++. .....+++++.+||.+||+.||.+|||+.|+++||||++.............++
T Consensus 224 -------~~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~~~~~~~~~ 282 (284)
T 3kk8_A 224 -------YDYPS--------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVD 282 (284)
T ss_dssp -------CCCCT--------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGGSCCCCCCCC
T ss_pred -------ccCCc--------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHhHhhcCCCcc
Confidence 11111 112357899999999999999999999999999999998776555555444443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=388.79 Aligned_cols=256 Identities=27% Similarity=0.345 Sum_probs=207.8
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
..+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++||||+++++++ .+....
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~ 80 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQ 80 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecCCeE
Confidence 35799999999999999999999999999999988533 24456899999999999999999988 445568
Q ss_pred EEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 211 ~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
|+||||+.++ +.+.+ .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~-~~kl~Dfg~a~~ 154 (323)
T 3tki_A 81 YLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD-NLKISDFGLATV 154 (323)
T ss_dssp EEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCCTTCEE
T ss_pred EEEEEcCCCCcHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccccchHHEEEeCCC-CEEEEEeeccce
Confidence 9999999864 43332 234568999999999999999999997 9999999999999999887 799999999976
Q ss_pred cCCC---CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 011138 290 LVPG---EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (492)
Q Consensus 290 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~ 366 (492)
.... ......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+.............
T Consensus 155 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--------- 225 (323)
T 3tki_A 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--------- 225 (323)
T ss_dssp CEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTC---------
T ss_pred eccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccc---------
Confidence 5322 2233568999999999998776568899999999999999999999987665433332222100
Q ss_pred cCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
... . .+..+++++.+||.+||+.||.+|||+.|+++||||+....
T Consensus 226 -------~~~-----~-----~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 270 (323)
T 3tki_A 226 -------TYL-----N-----PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (323)
T ss_dssp -------TTS-----T-----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred -------ccC-----C-----ccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence 000 0 11357899999999999999999999999999999987543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=398.10 Aligned_cols=259 Identities=27% Similarity=0.422 Sum_probs=197.1
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc---hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
..+|.+.+.||+|+||+||+|++..+|+.||||++... .....+|+.+++.++||||+++++++. +...+|+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~~l 93 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVIL-----TPTHLAI 93 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEe-----eCCEEEE
Confidence 34699999999999999999999999999999998653 244668999999999999999999984 4446899
Q ss_pred Eeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCC-cEEEeeecCcccc
Q 011138 213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH-QLKICDFGSAKML 290 (492)
Q Consensus 213 V~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~-~vkL~DFG~a~~~ 290 (492)
||||+.+ .+...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++. .+||+|||+++..
T Consensus 94 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~-~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 94 IMEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred EEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 9999975 55544332 3568999999999999999999997 99999999999999986652 4999999999865
Q ss_pred CCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 011138 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (492)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 370 (492)
.........+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+......+..++..+..
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~------------ 236 (361)
T 3uc3_A 169 VLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS------------ 236 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHT------------
T ss_pred cccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhc------------
Confidence 44455556789999999999987664455699999999999999999999886554433333332111
Q ss_pred CcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
..+.+|. ...+++++++||.+||+.||.+|||+.|+++||||....
T Consensus 237 -~~~~~~~----------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 282 (361)
T 3uc3_A 237 -VKYSIPD----------DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNL 282 (361)
T ss_dssp -TCCCCCT----------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred -CCCCCCC----------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence 1111111 124789999999999999999999999999999997643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=379.81 Aligned_cols=255 Identities=27% Similarity=0.443 Sum_probs=206.0
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
..+|.+.+.||+|+||.||+|.+..+|..||+|++.... ....+|+.+++.++||||+++++++ .+...+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~ 95 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHNM 95 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhe-----ecCCeE
Confidence 357999999999999999999999999999999986543 4567899999999999999999998 444568
Q ss_pred EEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcC---CCCcEEEeeecC
Q 011138 211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP---HTHQLKICDFGS 286 (492)
Q Consensus 211 ~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~---~~~~vkL~DFG~ 286 (492)
++||||+.+ ++.+.+.........+++..++.++.||+.||.|||+ +||+||||||+|||++. ++ .+||+|||+
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIl~~~~~~~~-~~kl~Dfg~ 173 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS-QHVVHKDLKPENILFQDTSPHS-PIKIIDFGL 173 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEESSSSTTC-CEEECCCCC
T ss_pred EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCCCHHHEEEecCCCCC-CEEEEeeec
Confidence 999999986 6666665554556779999999999999999999997 99999999999999953 34 799999999
Q ss_pred ccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 011138 287 AKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (492)
Q Consensus 287 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~ 366 (492)
+.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+... .+
T Consensus 174 a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~--~~------- 242 (285)
T 3is5_A 174 AELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK--EP------- 242 (285)
T ss_dssp CCC----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC-------
T ss_pred ceecCCcccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccC--Cc-------
Confidence 987665555566789999999999853 4899999999999999999999999988765554443321 00
Q ss_pred cCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCC
Q 011138 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (492)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~ 425 (492)
.++ .....+++++.+||.+||+.||.+|||+.|+++||||++
T Consensus 243 --------~~~---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 243 --------NYA---------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp --------CCC---------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred --------ccc---------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 000 011236899999999999999999999999999999985
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=396.09 Aligned_cols=252 Identities=26% Similarity=0.445 Sum_probs=206.8
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchh-------hHHHHHHH-HHHcCCCCccccceeeeeccCCC
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-------YKNRELQI-MRLLNHPNVVSLKHCFFSTTEKD 206 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-------~~~~E~~i-l~~l~h~nIv~l~~~~~~~~~~~ 206 (492)
...+|.+.+.||+|+||.||+|+++.+++.||||++.+... ...+|..+ ++.++|||||+++++| .+
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~-----~~ 110 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QT 110 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE-----EC
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----Ee
Confidence 34579999999999999999999999999999999865431 22345555 5678999999999998 44
Q ss_pred ceEEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeec
Q 011138 207 ELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (492)
Q Consensus 207 ~~~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG 285 (492)
...+|+||||+.|+ +...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 111 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~~g-~ikL~DFG 184 (373)
T 2r5t_A 111 ADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDSQG-HIVLTDFG 184 (373)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEECCCC-CEEEeeCc
Confidence 55799999999864 4444332 3568899999999999999999997 9999999999999999888 79999999
Q ss_pred CccccC-CCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 011138 286 SAKMLV-PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (492)
Q Consensus 286 ~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~ 364 (492)
+++... ........+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+..+.+..|...
T Consensus 185 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--------- 254 (373)
T 2r5t_A 185 LCKENIEHNSTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK--------- 254 (373)
T ss_dssp BCGGGBCCCCCCCSBSCCCCCCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS---------
T ss_pred cccccccCCCccccccCCccccCHHHhCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc---------
Confidence 998643 33345567899999999999754 4899999999999999999999999998887777776551
Q ss_pred hhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCH----HHhhCCCCCCCCC
Q 011138 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA----LEACAHPFFDDLR 427 (492)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~----~e~l~Hp~f~~~~ 427 (492)
... ++..+++++++||.+||+.||.+|+++ .++++||||+.+.
T Consensus 255 --------~~~------------~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~ 301 (373)
T 2r5t_A 255 --------PLQ------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN 301 (373)
T ss_dssp --------CCC------------CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred --------ccC------------CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence 111 224589999999999999999999987 6999999999764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=407.98 Aligned_cols=252 Identities=29% Similarity=0.424 Sum_probs=214.8
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
...+|.+++.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++. +.
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~-----~~ 88 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS-----TP 88 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CS
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----EC
Confidence 4457999999999999999999999999999999985432 34568999999999999999999983 34
Q ss_pred eEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 208 ~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
..+|+||||+.+ ++.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 89 ~~~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDLkp~NIll~~~~-~vkL~DFG~ 162 (476)
T 2y94_A 89 SDIFMVMEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHR-HMVVHRDLKPENVLLDAHM-NAKIADFGL 162 (476)
T ss_dssp SEEEEEEECCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEECTTC-CEEECCCSS
T ss_pred CEEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcccccHHHEEEecCC-CeEEEeccc
Confidence 468999999975 5555432 24578999999999999999999997 9999999999999999887 799999999
Q ss_pred ccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 011138 287 AKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (492)
Q Consensus 287 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~ 366 (492)
+.....+......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~----------- 231 (476)
T 2y94_A 163 SNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG----------- 231 (476)
T ss_dssp CEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTT-----------
T ss_pred hhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC-----------
Confidence 988766666667889999999999987665688999999999999999999999988776666655431
Q ss_pred cCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
.+. .+..+++++++||.+||+.||.+|||+.|+++||||+..
T Consensus 232 ------~~~------------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 232 ------IFY------------TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp ------CCC------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred ------CcC------------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 111 123478999999999999999999999999999999863
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=387.12 Aligned_cols=253 Identities=30% Similarity=0.489 Sum_probs=204.4
Q ss_pred ccccceeEeeeeccCCceEEEEEEEc---CCCCEEEEEEeccch--------hhHHHHHHHHHHcCCCCccccceeeeec
Q 011138 134 KQTISYMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQDK--------RYKNRELQIMRLLNHPNVVSLKHCFFST 202 (492)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~---~~g~~vAiK~~~~~~--------~~~~~E~~il~~l~h~nIv~l~~~~~~~ 202 (492)
....+|.+.+.||+|+||.||+|++. .+|+.||||++.+.. ....+|+.+++.++||||+++++++.
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-- 91 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ-- 91 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE--
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE--
Confidence 33457999999999999999999985 689999999986431 23457999999999999999999984
Q ss_pred cCCCceEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEE
Q 011138 203 TEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKI 281 (492)
Q Consensus 203 ~~~~~~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL 281 (492)
+...+|+||||+.+ .+...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||
T Consensus 92 ---~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~Nill~~~~-~~kl 162 (327)
T 3a62_A 92 ---TGGKLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQ-KGIIYRDLKPENIMLNHQG-HVKL 162 (327)
T ss_dssp ---CSSCEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEECTTS-CEEE
T ss_pred ---cCCEEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCEEcccCCHHHeEECCCC-cEEE
Confidence 34458999999985 45444332 3568899999999999999999997 9999999999999999887 7999
Q ss_pred eeecCccccCC-CCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 011138 282 CDFGSAKMLVP-GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPT 360 (492)
Q Consensus 282 ~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~ 360 (492)
+|||+++.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.+.
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~----- 236 (327)
T 3a62_A 163 TDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC----- 236 (327)
T ss_dssp CCCSCC----------CTTSSCCTTSCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-----
T ss_pred EeCCcccccccCCccccccCCCcCccCHhhCcCC-CCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC-----
Confidence 99999975432 2234456899999999999654 4899999999999999999999999998887777766551
Q ss_pred HHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcC-----CHHHhhCCCCCCCCC
Q 011138 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLR 427 (492)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----t~~e~l~Hp~f~~~~ 427 (492)
... ++..+++++++||.+||..||.+|| ++.++++||||+++.
T Consensus 237 ------------~~~------------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~ 284 (327)
T 3a62_A 237 ------------KLN------------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN 284 (327)
T ss_dssp ------------CCC------------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred ------------CCC------------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCC
Confidence 111 2235789999999999999999999 889999999999764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=383.59 Aligned_cols=256 Identities=25% Similarity=0.382 Sum_probs=214.9
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----------hhhHHHHHHHHHHcCCCCccccceeeeeccCC
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 205 (492)
..+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++||||+++++++ .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~ 85 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY-----E 85 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE-----e
Confidence 35699999999999999999999999999999988542 23467899999999999999999998 4
Q ss_pred CceEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCC---cEEE
Q 011138 206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH---QLKI 281 (492)
Q Consensus 206 ~~~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~---~vkL 281 (492)
+...+++||||+.+ ++.+.+.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++. .+||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivH~dikp~NIl~~~~~~~~~~~kl 160 (321)
T 2a2a_A 86 NRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKL 160 (321)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred cCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChHHEEEecCCCCcCCEEE
Confidence 44568999999975 55554432 4568999999999999999999997 99999999999999987763 5999
Q ss_pred eeecCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 011138 282 CDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTR 361 (492)
Q Consensus 282 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~ 361 (492)
+|||++.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.......+
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~- 238 (321)
T 2a2a_A 161 IDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD- 238 (321)
T ss_dssp CCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC-
T ss_pred ccCccceecCccccccccCCCCCccCcccccCC-CCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccC-
Confidence 999999877665555667899999999999654 489999999999999999999999999887776666544211111
Q ss_pred HHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
..++..+++++.+||.+||..||.+|||+.|+++||||+.+.
T Consensus 239 ------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 239 ------------------------EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp ------------------------HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred ------------------------hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 112245789999999999999999999999999999998764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=395.47 Aligned_cols=285 Identities=20% Similarity=0.340 Sum_probs=207.2
Q ss_pred cccceeEeeeeccC--CceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCC
Q 011138 135 QTISYMAERVVGTG--SFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (492)
Q Consensus 135 ~~~~y~~~~~lG~G--~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 206 (492)
...+|.+.+.||+| +||.||+|++..+|+.||||++.... ....+|+.+++.++|||||+++++|..
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----- 97 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA----- 97 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE-----
Confidence 34579999999999 99999999999999999999986432 345579999999999999999999843
Q ss_pred ceEEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeec
Q 011138 207 ELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (492)
Q Consensus 207 ~~~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG 285 (492)
...+|+||||+.++ +.+++.. .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~~~-~~kl~dfg 173 (389)
T 3gni_B 98 DNELWVVTSFMAYGSAKDLICT--HFMDGMNELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISVDG-KVYLSGLR 173 (389)
T ss_dssp TTEEEEEEECCTTCBHHHHHHH--TCTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCGG
T ss_pred CCEEEEEEEccCCCCHHHHHhh--hcccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCC-CEEEcccc
Confidence 34589999999864 4444332 223568999999999999999999997 9999999999999999888 79999999
Q ss_pred CccccCCC--------CCCccceeccCccCchhhcCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 011138 286 SAKMLVPG--------EPNISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKIL 356 (492)
Q Consensus 286 ~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~ 356 (492)
++...... ......+||+.|+|||++.+. ..|+.++|||||||++|+|++|++||.+.+..+.+..+....
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 253 (389)
T 3gni_B 174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT 253 (389)
T ss_dssp GCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----
T ss_pred cceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence 88644211 112234789999999999764 458999999999999999999999999877766665543311
Q ss_pred CC--------CCHHHHhhcC-----CCCc-----ccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhh
Q 011138 357 GT--------PTREEIKCMN-----PNYT-----EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC 418 (492)
Q Consensus 357 g~--------p~~~~~~~~~-----~~~~-----~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l 418 (492)
-. +......... .... ....+. ........++..+++++++||.+||+.||.+|||+.|+|
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell 332 (389)
T 3gni_B 254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPS-NGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL 332 (389)
T ss_dssp -----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred CCccccccccccccccccccccccccccccccccCccccc-cCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 00 0000000000 0000 000000 000011124456899999999999999999999999999
Q ss_pred CCCCCCCCCCC
Q 011138 419 AHPFFDDLRDP 429 (492)
Q Consensus 419 ~Hp~f~~~~~~ 429 (492)
+||||+++...
T Consensus 333 ~hp~f~~~~~~ 343 (389)
T 3gni_B 333 NHSFFKQIKRR 343 (389)
T ss_dssp TSGGGGGC---
T ss_pred cCHHHHHHhhc
Confidence 99999987653
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-48 Score=387.47 Aligned_cols=255 Identities=29% Similarity=0.441 Sum_probs=194.3
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc--hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
...|.+.+.||+|+||.||+|.+..+++.||||++... .....+|+.+++.++||||+++++++. +...+++|
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~lv 126 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFE-----TPTEISLV 126 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEE-----CSSEEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEe-----cCCeEEEE
Confidence 34699999999999999999999999999999998653 334568999999999999999999983 44468999
Q ss_pred eeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcC---CCCcEEEeeecCccc
Q 011138 214 LEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP---HTHQLKICDFGSAKM 289 (492)
Q Consensus 214 ~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~---~~~~vkL~DFG~a~~ 289 (492)
|||+.+ ++.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++ .+||+|||+++.
T Consensus 127 ~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIll~~~~~~~-~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 127 LELVTGGELFDRIV----EKGYYSERDAADAVKQILEAVAYLHE-NGIVHRDLKPENLLYATPAPDA-PLKIADFGLSKI 200 (349)
T ss_dssp ECCCCSCBHHHHHT----TCSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESSSSTTC-CEEECCCC----
T ss_pred EEeCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCcccEEEecCCCCC-CEEEccCccccc
Confidence 999985 4544433 24568999999999999999999997 99999999999999975 45 799999999987
Q ss_pred cCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCCCCHHHHhhcC
Q 011138 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLV-EIIKILGTPTREEIKCMN 368 (492)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~-~i~~~~g~p~~~~~~~~~ 368 (492)
...........||+.|+|||++.+. .++.++|||||||++|+|++|..||......+.+. .+...
T Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~------------- 266 (349)
T 2w4o_A 201 VEHQVLMKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNC------------- 266 (349)
T ss_dssp ------------CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTT-------------
T ss_pred cCcccccccccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhC-------------
Confidence 6554445567899999999999765 48999999999999999999999998776655333 33221
Q ss_pred CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
...++ ..++..++.++++||.+||+.||++|||+.|+++||||++..
T Consensus 267 ----~~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 267 ----EYYFI--------SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp ----CCCCC--------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred ----CCccC--------CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 01111 112245799999999999999999999999999999998754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=395.97 Aligned_cols=253 Identities=28% Similarity=0.431 Sum_probs=205.5
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEe
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
|...+.||+|+||.||+|.+..+|+.||+|++... ...+.+|+.+++.++||||+++++++ .+...++|||
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~~lv~ 165 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF-----ESKNDIVLVM 165 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEEEEEE
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEEEEE
Confidence 34467899999999999999999999999998653 34556899999999999999999998 3444689999
Q ss_pred eechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEE--cCCCCcEEEeeecCccccC
Q 011138 215 EYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV--NPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 215 E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl--~~~~~~vkL~DFG~a~~~~ 291 (492)
||+++ +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||+ +.++ .+||+|||+++...
T Consensus 166 E~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~-~~kl~DFG~a~~~~ 240 (373)
T 2x4f_A 166 EYVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQ-MYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYK 240 (373)
T ss_dssp ECCTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEETTTT-EEEECCCSSCEECC
T ss_pred eCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEecCCCC-cEEEEeCCCceecC
Confidence 99986 44444322 23458899999999999999999997 999999999999999 4444 79999999998876
Q ss_pred CCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 011138 292 PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (492)
Q Consensus 292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~ 371 (492)
........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 241 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~-------------- 305 (373)
T 2x4f_A 241 PREKLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRW-------------- 305 (373)
T ss_dssp TTCBCCCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC--------------
T ss_pred CccccccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC--------------
Confidence 6555556789999999999865 4589999999999999999999999999988888777765211
Q ss_pred cccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
.++. .....+++++++||.+||+.||.+|||+.|+++||||++..
T Consensus 306 ---~~~~--------~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~ 350 (373)
T 2x4f_A 306 ---DLED--------EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK 350 (373)
T ss_dssp ---CSCS--------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred ---CCCh--------hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence 1111 11235799999999999999999999999999999999754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=413.27 Aligned_cols=256 Identities=29% Similarity=0.455 Sum_probs=211.2
Q ss_pred ccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHcCCCCccccceeeeeccCCC
Q 011138 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (492)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 206 (492)
....+|.+.+.||+|+||.||+|.+..+|+.||||++.+. .....+|+.+|+.++|||||+++++| .+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~ 255 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ET 255 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE-----ee
Confidence 4456799999999999999999999999999999998543 23345799999999999999999988 44
Q ss_pred ceEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeec
Q 011138 207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (492)
Q Consensus 207 ~~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG 285 (492)
...+|+||||+.| +|...+.. .....+++..++.|+.||+.||.|||+ +|||||||||+||||+.++ .+||+|||
T Consensus 256 ~~~l~lVmEy~~gg~L~~~l~~--~~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHrDLKPeNILld~~g-~vKL~DFG 331 (576)
T 2acx_A 256 KDALCLVLTLMNGGDLKFHIYH--MGQAGFPEARAVFYAAEICCGLEDLHR-ERIVYRDLKPENILLDDHG-HIRISDLG 331 (576)
T ss_dssp SSEEEEEECCCCSCBHHHHHHS--SSSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTS-CEEECCCT
T ss_pred CCEEEEEEEcCCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCchheEEEeCCC-CeEEEecc
Confidence 4569999999976 44444332 123458999999999999999999997 9999999999999999888 79999999
Q ss_pred CccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCCHH
Q 011138 286 SAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGV---DQLVEIIKILGTPTRE 362 (492)
Q Consensus 286 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~---~~~~~i~~~~g~p~~~ 362 (492)
+++....+......+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+.. ..+...+..
T Consensus 332 la~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~------- 403 (576)
T 2acx_A 332 LAVHVPEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE------- 403 (576)
T ss_dssp TCEECCTTCCEECCCSCGGGCCHHHHTTC-EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-------
T ss_pred cceecccCccccccCCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-------
Confidence 99887666555667999999999999764 4899999999999999999999999876432 222222211
Q ss_pred HHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcC-----CHHHhhCCCCCCCCC
Q 011138 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLR 427 (492)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----t~~e~l~Hp~f~~~~ 427 (492)
.... ++..+++++++||.+||+.||.+|| ++.|+++||||+++.
T Consensus 404 ---------~~~~------------~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~ 452 (576)
T 2acx_A 404 ---------VPEE------------YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452 (576)
T ss_dssp ---------CCCC------------CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCC
T ss_pred ---------cccc------------CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCC
Confidence 0111 2345799999999999999999999 789999999999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=379.67 Aligned_cols=258 Identities=26% Similarity=0.387 Sum_probs=198.0
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
...+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....++...++.++||||+++++++.. ..
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-----~~ 79 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR-----EG 79 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec-----cC
Confidence 3457999999999999999999999999999999985432 112234555778899999999999843 33
Q ss_pred EEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhC-CcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV-GVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 209 ~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~-givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
..++||||+++++...+.........+++..++.++.||+.||.|||+ + ||+||||||+|||++.++ .+||+|||++
T Consensus 80 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~ 157 (290)
T 3fme_A 80 DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-KLSVIHRDVKPSNVLINALG-QVKMCDFGIS 157 (290)
T ss_dssp SEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HSCCCCCCCSGGGCEECTTC-CEEBCCC---
T ss_pred CEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECCCC-CEEEeecCCc
Confidence 488999999998877776655666789999999999999999999997 7 999999999999999887 7999999999
Q ss_pred cccCCCCCCccceeccCccCchhh---cCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHH
Q 011138 288 KMLVPGEPNISYICSRYYRAPELI---FGATEYTTAIDMWSIGCVLAELLLGQPLFPGES-GVDQLVEIIKILGTPTREE 363 (492)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~-~~~~~~~i~~~~g~p~~~~ 363 (492)
+............||+.|+|||++ .....++.++|||||||++|+|++|..||.... ....+..+... ..
T Consensus 158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~----- 231 (290)
T 3fme_A 158 GYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE-PS----- 231 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHS-CC-----
T ss_pred ccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhcc-CC-----
Confidence 877555555556899999999997 344568999999999999999999999998743 33333333221 00
Q ss_pred HhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
+. .....+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 232 -------------~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 232 -------------PQ--------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp -------------CC--------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred -------------CC--------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 00 0113578999999999999999999999999999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=405.61 Aligned_cols=255 Identities=27% Similarity=0.416 Sum_probs=206.2
Q ss_pred ccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCC
Q 011138 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (492)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 206 (492)
....+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||++++++|..
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~----- 219 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT----- 219 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE-----
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee-----
Confidence 34467999999999999999999999999999999986432 223468899999999999999999843
Q ss_pred ceEEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeec
Q 011138 207 ELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (492)
Q Consensus 207 ~~~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG 285 (492)
...+|+||||++++ |...+. ....+++..++.++.||+.||.|||+.+||+||||||+||||+.++ .+||+|||
T Consensus 220 ~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~-~~kl~DFG 294 (446)
T 4ejn_A 220 HDRLCFVMEYANGGELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFG 294 (446)
T ss_dssp TTEEEEEECCCSSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSS-CEEECCCC
T ss_pred CCEEEEEEeeCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCC-CEEEccCC
Confidence 34589999999875 433332 2357899999999999999999999427999999999999999888 79999999
Q ss_pred CccccCC-CCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 011138 286 SAKMLVP-GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (492)
Q Consensus 286 ~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~ 364 (492)
+++.... .......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+..+....+..
T Consensus 295 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~---------- 363 (446)
T 4ejn_A 295 LCKEGIKDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM---------- 363 (446)
T ss_dssp CCCTTCC-----CCSSSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----------
T ss_pred CceeccCCCcccccccCCccccCHhhcCCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHh----------
Confidence 9986432 3334567899999999999654 489999999999999999999999999887776666654
Q ss_pred hhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcC-----CHHHhhCCCCCCCCCC
Q 011138 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLRD 428 (492)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----t~~e~l~Hp~f~~~~~ 428 (492)
....+ +..+++++.+||.+||+.||.+|| ++.|+++||||+++..
T Consensus 364 -------~~~~~------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~ 413 (446)
T 4ejn_A 364 -------EEIRF------------PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVW 413 (446)
T ss_dssp -------CCCCC------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred -------CCCCC------------CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCH
Confidence 11222 235789999999999999999999 9999999999998753
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=406.32 Aligned_cols=257 Identities=28% Similarity=0.464 Sum_probs=212.7
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEecc------chhhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ------DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~------~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
...+|.+.+.||+|+||+||+|.+..+|+.||||++.. ......+|+.+++.++|||||++++++ .+..
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~ 94 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSS 94 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE-----EcCC
Confidence 34579999999999999999999999999999999843 234456899999999999999999998 4455
Q ss_pred EEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCC--CcEEEeeec
Q 011138 209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT--HQLKICDFG 285 (492)
Q Consensus 209 ~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~--~~vkL~DFG 285 (492)
.+|+|||||.+ .+...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++..+ ..+||+|||
T Consensus 95 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 169 (486)
T 3mwu_A 95 SFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFG 169 (486)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEESSSSTTCCEEECSCS
T ss_pred EEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEEECC
Confidence 68999999986 45444332 3568999999999999999999997 9999999999999996432 269999999
Q ss_pred CccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 011138 286 SAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (492)
Q Consensus 286 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~ 365 (492)
+++...........+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+....
T Consensus 170 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~--------- 238 (486)
T 3mwu_A 170 LSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK--------- 238 (486)
T ss_dssp CTTTBCCC----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC---------
T ss_pred cCeECCCCCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------
Confidence 9987766665667789999999999965 38999999999999999999999999988877777665521
Q ss_pred hcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
+.++. ..+..+++++++||.+||+.||.+|||+.++|+||||+....
T Consensus 239 --------~~~~~--------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 239 --------YAFDL--------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp --------CCSCS--------GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred --------CCCCC--------cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 11110 112457999999999999999999999999999999997654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=405.15 Aligned_cols=257 Identities=26% Similarity=0.402 Sum_probs=211.1
Q ss_pred ccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCC
Q 011138 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (492)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 206 (492)
....+|.+.+.||+|+||.||+|+++.+|+.||||++.+.. ....+|+.+++.++||||++++++| .+
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~ 256 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF-----ET 256 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----ee
Confidence 44568999999999999999999999999999999985432 3345799999999999999999988 44
Q ss_pred ceEEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeec
Q 011138 207 ELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (492)
Q Consensus 207 ~~~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG 285 (492)
...+|+||||+.|+ |...+.........+++..++.|+.||+.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 257 ~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~-~gIvHrDLKP~NILl~~~g-~vkL~DFG 334 (543)
T 3c4z_A 257 KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ-RNIIYRDLKPENVLLDDDG-NVRISDLG 334 (543)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTS-CEEECCCT
T ss_pred CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH-cCCcccCCChHHEEEeCCC-CEEEeecc
Confidence 45689999999864 444444333334579999999999999999999997 9999999999999999888 79999999
Q ss_pred CccccCCCCC-CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCC
Q 011138 286 SAKMLVPGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESG----VDQLVEIIKILGTPT 360 (492)
Q Consensus 286 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~----~~~~~~i~~~~g~p~ 360 (492)
+++....... ....+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+. .+....+..
T Consensus 335 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~------ 407 (543)
T 3c4z_A 335 LAVELKAGQTKTKGYAGTPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE------ 407 (543)
T ss_dssp TCEECCTTCCCBCCCCSCTTTSCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH------
T ss_pred eeeeccCCCcccccccCCccccChhhhcCC-CCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh------
Confidence 9987654443 3346899999999999764 589999999999999999999999987642 222222322
Q ss_pred HHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCC-----HHHhhCCCCCCCCC
Q 011138 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-----ALEACAHPFFDDLR 427 (492)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-----~~e~l~Hp~f~~~~ 427 (492)
.... ++..+++++++||.+||+.||.+||+ +.++++||||+++.
T Consensus 408 -----------~~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~ 456 (543)
T 3c4z_A 408 -----------QAVT------------YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS 456 (543)
T ss_dssp -----------CCCC------------CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCC
T ss_pred -----------cccC------------CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCC
Confidence 1111 22457999999999999999999996 58999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=391.62 Aligned_cols=282 Identities=27% Similarity=0.411 Sum_probs=222.2
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch---hhHHHHHHHHHHcC--------CCCccccceeeeeccCC
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLN--------HPNVVSLKHCFFSTTEK 205 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~---~~~~~E~~il~~l~--------h~nIv~l~~~~~~~~~~ 205 (492)
.+|.+.+.||+|+||+||+|.+..+|+.||||++.... ....+|+.+++.++ |+||++++++|.... .
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~-~ 115 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG-V 115 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE-T
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC-C
Confidence 46999999999999999999999999999999997543 34457999999986 788999999885433 2
Q ss_pred CceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhC-CcccCCCCCCceEEcCCC--------
Q 011138 206 DELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV-GVCHRDIKPQNLLVNPHT-------- 276 (492)
Q Consensus 206 ~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~-givHrDlKp~NILl~~~~-------- 276 (492)
+..++|+||||++++++..+... ....+++..++.++.||+.||.|||+ + ||+||||||+||||+.++
T Consensus 116 ~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~-~~givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 116 NGTHICMVFEVLGHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp TEEEEEEEECCCCCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred CCceEEEEEeccCccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHeeEeccchhhhhhhh
Confidence 45678999999998888765432 23568999999999999999999997 8 999999999999998664
Q ss_pred ----------------------------------------CcEEEeeecCccccCCCCCCccceeccCccCchhhcCCCC
Q 011138 277 ----------------------------------------HQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATE 316 (492)
Q Consensus 277 ----------------------------------------~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 316 (492)
..+||+|||++.... ......+||+.|+|||++.+..
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~- 269 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH--KHFTEDIQTRQYRSLEVLIGSG- 269 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETT--BCSCSCCSCGGGCCHHHHHTSC-
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccc--ccCccCCCCCcccCChhhcCCC-
Confidence 269999999998653 2344568999999999997654
Q ss_pred CCcchhhHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCCHHHHhhcCCCCccc----CCCccc-CCCcc
Q 011138 317 YTTAIDMWSIGCVLAELLLGQPLFPGES------GVDQLVEIIKILGTPTREEIKCMNPNYTEF----KFPQIK-AHPWH 385 (492)
Q Consensus 317 ~~~~~DvwSlGvil~ell~G~~pf~~~~------~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~----~~~~~~-~~~~~ 385 (492)
++.++|||||||++|+|++|+.||.+.+ ..+.+..+.+.+|.++...+.........+ .+..+. ..+|.
T Consensus 270 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (397)
T 1wak_A 270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWG 349 (397)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCC
T ss_pred CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcc
Confidence 8999999999999999999999998765 567788889999998877654322110000 000000 00010
Q ss_pred --------cccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCC
Q 011138 386 --------KIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (492)
Q Consensus 386 --------~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~ 425 (492)
..+....++++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 350 LFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp HHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred hhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 0012234567899999999999999999999999999974
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=381.59 Aligned_cols=285 Identities=31% Similarity=0.530 Sum_probs=219.8
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch----hhHHHHHHHHHHcCCCCccccceeeeeccC--------
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTE-------- 204 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~-------- 204 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++.....
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 36999999999999999999999999999999885432 344589999999999999999998743211
Q ss_pred -CCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEee
Q 011138 205 -KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICD 283 (492)
Q Consensus 205 -~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~D 283 (492)
.+...+|+||||+++++.+.+. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++..+||+|
T Consensus 91 ~~~~~~~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 91 LTELNSVYIVQEYMETDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp CCSCSEEEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred ccccCceeEEeeccCCCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 2345688999999988776553 2568899999999999999999997 99999999999999985555899999
Q ss_pred ecCccccCCC----CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 011138 284 FGSAKMLVPG----EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTP 359 (492)
Q Consensus 284 FG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p 359 (492)
||+++..... .......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 244 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9999865322 123345679999999998776679999999999999999999999999999988888888887776
Q ss_pred CHHHHhhcCCCCccc---CCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCC
Q 011138 360 TREEIKCMNPNYTEF---KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (492)
Q Consensus 360 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~ 429 (492)
..+...........+ .... ...++ ..+.+.+++++++||.+||+.||.+|||+.|+++||||+....+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 245 HEEDRQELLSVIPVYIRNDMTE-PHKPL-TQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315 (320)
T ss_dssp CHHHHHHHHTTSCHHHHHHTTS-CCCCH-HHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred chhhhhhhhhcCcccccccccC-CCCCh-hHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence 665543322111000 0000 00011 12335689999999999999999999999999999999987654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-48 Score=373.69 Aligned_cols=254 Identities=30% Similarity=0.458 Sum_probs=213.7
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
..+|.+.+.||+|+||.||+|.+..++..||+|++... .....+|+.+++.++||||+++++++ .+...++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 82 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF-----EDNTDIY 82 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCeEE
Confidence 34699999999999999999999999999999998543 34566899999999999999999998 4445689
Q ss_pred EEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEE---cCCCCcEEEeeecCc
Q 011138 212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSA 287 (492)
Q Consensus 212 lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl---~~~~~~vkL~DFG~a 287 (492)
+||||+.+ .+.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||+ +.++ .+||+|||++
T Consensus 83 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~-~~~l~Dfg~~ 156 (277)
T 3f3z_A 83 LVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHK-LNVAHRDLKPENFLFLTDSPDS-PLKLIDFGLA 156 (277)
T ss_dssp EEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSTTC-CEEECCCTTC
T ss_pred EEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEecCCCCC-cEEEEecccc
Confidence 99999986 44444332 3568999999999999999999997 999999999999999 5555 7999999999
Q ss_pred cccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
.............||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+..+....+.......+..
T Consensus 157 ~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----- 229 (277)
T 3f3z_A 157 ARFKPGKMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEK----- 229 (277)
T ss_dssp EECCTTSCBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH-----
T ss_pred eeccCccchhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCch-----
Confidence 877666666677899999999998543 8999999999999999999999999988877776665522211111
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
.+..+++++.+||.+||+.||.+|||+.++++||||++..
T Consensus 230 --------------------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 230 --------------------DWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp --------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred --------------------hhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence 1124789999999999999999999999999999998643
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-48 Score=405.58 Aligned_cols=256 Identities=28% Similarity=0.438 Sum_probs=213.9
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-----------------hhhHHHHHHHHHHcCCCCcccccee
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----------------KRYKNRELQIMRLLNHPNVVSLKHC 198 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-----------------~~~~~~E~~il~~l~h~nIv~l~~~ 198 (492)
..+|.+.+.||+|+||+||+|.+..+++.||||++... .....+|+.+++.++|||||+++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 35699999999999999999999999999999998542 2345689999999999999999999
Q ss_pred eeeccCCCceEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCC
Q 011138 199 FFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH 277 (492)
Q Consensus 199 ~~~~~~~~~~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~ 277 (492)
| .+..++|+|||||.+ .+...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.
T Consensus 115 ~-----~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~ 184 (504)
T 3q5i_A 115 F-----EDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHK-HNIVHRDIKPENILLENKNS 184 (504)
T ss_dssp E-----ECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESSTTC
T ss_pred E-----EcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCcHHHEEEecCCC
Confidence 8 455578999999986 45454432 3568999999999999999999997 99999999999999987653
Q ss_pred --cEEEeeecCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 011138 278 --QLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKI 355 (492)
Q Consensus 278 --~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~ 355 (492)
.+||+|||+++...........+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+...
T Consensus 185 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 262 (504)
T 3q5i_A 185 LLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG 262 (504)
T ss_dssp CSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred CccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 599999999988766666667889999999999853 4899999999999999999999999998887777776552
Q ss_pred hCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 356 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
.-.... ..+..+++++++||.+||++||.+|||+.|+|+||||+....
T Consensus 263 ~~~~~~-------------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 263 KYYFDF-------------------------NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp CCCCCH-------------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred CCCCCc-------------------------cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 111111 112458999999999999999999999999999999997654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=382.10 Aligned_cols=257 Identities=25% Similarity=0.408 Sum_probs=198.6
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccC------
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE------ 204 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~------ 204 (492)
..+|.+.+.||+|+||.||+|++..+|+.||||++... .....+|+.+++.++|||||+++++|.....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 35799999999999999999999999999999998532 2445689999999999999999998865432
Q ss_pred ----------------------------------------------CCceEEEEEeeechhh-HHHHhhhhhhcCCCcCH
Q 011138 205 ----------------------------------------------KDELYLNLVLEYISET-VYRVSKHYTRMNQHVPI 237 (492)
Q Consensus 205 ----------------------------------------------~~~~~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~ 237 (492)
....++++|||||.++ +.+++.. ........+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNR-RCSLEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHT-CCSGGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhc-ccCccchhh
Confidence 2234589999999874 4444433 222334566
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCC-------------CCccceeccC
Q 011138 238 LYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE-------------PNISYICSRY 304 (492)
Q Consensus 238 ~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~-------------~~~~~~gt~~ 304 (492)
..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++...... ......||+.
T Consensus 164 ~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHS-KGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHHh-CCeeecCCCcccEEEeCCC-CEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 6788999999999999997 9999999999999999887 89999999998765432 2234579999
Q ss_pred ccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCc
Q 011138 305 YRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPW 384 (492)
Q Consensus 305 y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (492)
|+|||++.+. .++.++|||||||++|+|++|..|+.. ....+...... .++.
T Consensus 242 y~aPE~~~~~-~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~----------------~~~~------ 293 (332)
T 3qd2_B 242 YMSPEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNL----------------KFPL------ 293 (332)
T ss_dssp GSCHHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTT----------------CCCH------
T ss_pred ccChHHhcCC-CCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhcc----------------CCCc------
Confidence 9999999765 489999999999999999998776521 11111111111 1110
Q ss_pred ccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 385 HKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 385 ~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
.....++++.+||.+||+.||.+|||+.|+++||||+++
T Consensus 294 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 294 ---LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332 (332)
T ss_dssp ---HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred ---ccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence 112346788999999999999999999999999999874
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=382.62 Aligned_cols=247 Identities=27% Similarity=0.357 Sum_probs=196.8
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHH-cCCCCccccceeeeeccCCCceE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRL-LNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~-l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
.+|.+.+.||+|+||+||+|.+..+|+.||||++.... ....+|+..+.. .+||||+++++++. +...
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-----~~~~ 131 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-----EGGI 131 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-----eCCE
Confidence 47999999999999999999999999999999875421 112234444444 48999999999984 3446
Q ss_pred EEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
+|+||||+++++...+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 132 ~~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~~~-~~kl~DFG~a~~ 206 (311)
T 3p1a_A 132 LYLQTELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHS-QGLVHLDVKPANIFLGPRG-RCKLGDFGLLVE 206 (311)
T ss_dssp EEEEEECCCCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECGGG-CEEECCCTTCEE
T ss_pred EEEEEeccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECCCC-CEEEccceeeee
Confidence 8999999998887765432 4569999999999999999999997 8999999999999999887 799999999987
Q ss_pred cCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
...........||+.|+|||++.+ .++.++|||||||++|||++|..||.+..... .+.. +..
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~--~~~---------- 269 (311)
T 3p1a_A 207 LGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---QLRQ--GYL---------- 269 (311)
T ss_dssp CC------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HHTT--TCC----------
T ss_pred cccCCCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHhc--cCC----------
Confidence 755555556779999999999865 48999999999999999999987775533221 1111 000
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~ 425 (492)
...++..+++++.+||.+||+.||.+|||+.|+++||||++
T Consensus 270 ---------------~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 270 ---------------PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp ---------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred ---------------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 01123457999999999999999999999999999999985
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=392.08 Aligned_cols=260 Identities=27% Similarity=0.408 Sum_probs=199.0
Q ss_pred ccceeEe-eeeccCCceEEEEEEEcCCCCEEEEEEeccchhhHHHHHHHH-HHcCCCCccccceeeeeccCCCceEEEEE
Q 011138 136 TISYMAE-RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM-RLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 136 ~~~y~~~-~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~E~~il-~~l~h~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
..+|.+. ++||+|+||+||+|.+..+|+.||||++... ....+|+.++ +.++||||++++++|.... .+..++|||
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~~~~~lv 137 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIV 137 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-hhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCCcEEEEE
Confidence 3457776 7999999999999999999999999998643 4456788887 5568999999999885422 345678999
Q ss_pred eeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcC---CCCcEEEeeecCccc
Q 011138 214 LEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP---HTHQLKICDFGSAKM 289 (492)
Q Consensus 214 ~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~---~~~~vkL~DFG~a~~ 289 (492)
||||.| +|.+.+.. .....+++..++.|+.||+.||.|||+ +||+||||||+|||++. ++ .+||+|||+++.
T Consensus 138 ~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~~-~~kl~DFG~a~~ 213 (400)
T 1nxk_A 138 MECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAKE 213 (400)
T ss_dssp EECCCSEEHHHHHHC--C---CCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSTTC-CEEECCCTTCEE
T ss_pred EEeCCCCcHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCcceEEEecCCCCc-cEEEEecccccc
Confidence 999986 56555432 123468999999999999999999997 99999999999999987 44 799999999987
Q ss_pred cCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCCHHHHh
Q 011138 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD----QLVEIIKILGTPTREEIK 365 (492)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~----~~~~i~~~~g~p~~~~~~ 365 (492)
..........+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+... ....+..
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~----------- 281 (400)
T 1nxk_A 214 TTSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM----------- 281 (400)
T ss_dssp CC-----------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH-----------
T ss_pred cCCCCccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc-----------
Confidence 655555567789999999999855 458999999999999999999999998765432 1222221
Q ss_pred hcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
..+.++. ..+..+++++++||.+||+.||.+|||+.|+++||||.+..
T Consensus 282 ------~~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 282 ------GQYEFPN--------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp ------TCCCCCT--------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred ------CcccCCC--------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 1112221 11245799999999999999999999999999999998643
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=406.70 Aligned_cols=256 Identities=31% Similarity=0.515 Sum_probs=215.5
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
...+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++|||||+++++| .+.
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~ 98 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----EDK 98 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeC
Confidence 345799999999999999999999999999999998432 34466899999999999999999998 455
Q ss_pred eEEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEc---CCCCcEEEee
Q 011138 208 LYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN---PHTHQLKICD 283 (492)
Q Consensus 208 ~~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~---~~~~~vkL~D 283 (492)
.++|+||||+.++ +.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++ .+||+|
T Consensus 99 ~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~-~~kl~D 172 (484)
T 3nyv_A 99 GYFYLVGEVYTGGELFDEII----SRKRFSEVDAARIIRQVLSGITYMHK-NKIVHRDLKPENLLLESKSKDA-NIRIID 172 (484)
T ss_dssp SEEEEEECCCCSCBHHHHHH----TCSCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTC-CEEECC
T ss_pred CEEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEecCCCCC-cEEEEe
Confidence 5789999999864 444332 24568999999999999999999997 9999999999999994 344 799999
Q ss_pred ecCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 011138 284 FGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (492)
Q Consensus 284 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~ 363 (492)
||+++...........+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+.+.
T Consensus 173 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-------- 242 (484)
T 3nyv_A 173 FGLSTHFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKG-------- 242 (484)
T ss_dssp TTHHHHBCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------
T ss_pred eeeeEEcccccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--------
Confidence 999987766665667789999999999965 4899999999999999999999999998887777776552
Q ss_pred HhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
.+.++. ..+..+++++++||.+||++||.+|||+.|+|+||||+....
T Consensus 243 ---------~~~~~~--------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 243 ---------KYTFEL--------PQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp ---------CCCCCS--------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred ---------CCCCCC--------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 111110 112457999999999999999999999999999999987654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=390.00 Aligned_cols=281 Identities=32% Similarity=0.565 Sum_probs=218.1
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchh---hHHHHHHHHHHcC-CCC-----ccccceeeeeccCCC
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR---YKNRELQIMRLLN-HPN-----VVSLKHCFFSTTEKD 206 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~---~~~~E~~il~~l~-h~n-----Iv~l~~~~~~~~~~~ 206 (492)
..+|.+.+.||+|+||+||+|.+..+|+.||||++..... ...+|+.+++.++ |+| |+++++++..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~----- 127 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF----- 127 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE-----
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc-----
Confidence 4579999999999999999999999999999999975542 3456889998886 553 8888888843
Q ss_pred ceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHh-hCCcccCCCCCCceEEcC--CCCcEEEee
Q 011138 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH-VVGVCHRDIKPQNLLVNP--HTHQLKICD 283 (492)
Q Consensus 207 ~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~-~~givHrDlKp~NILl~~--~~~~vkL~D 283 (492)
...+|+||||+++++.+.+.... ...+++..++.++.||+.||.|||. ..|||||||||+||||+. ++ .+||+|
T Consensus 128 ~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~-~~kL~D 204 (382)
T 2vx3_A 128 RNHLCLVFEMLSYNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRS-AIKIVD 204 (382)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSC-CEEECC
T ss_pred CCceEEEEecCCCCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCC-cEEEEe
Confidence 34689999999998887765422 2458999999999999999999993 169999999999999953 44 799999
Q ss_pred ecCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 011138 284 FGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (492)
Q Consensus 284 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~ 363 (492)
||+++... ......+||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.+..+...++.|+...
T Consensus 205 FG~a~~~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 281 (382)
T 2vx3_A 205 FGSSCQLG--QRIYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI 281 (382)
T ss_dssp CTTCEETT--CCCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred ccCceecc--cccccccCCccccChHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 99998763 334567899999999999765 489999999999999999999999999999999999999999988776
Q ss_pred HhhcCCC---Cc-----ccC----------CCcccCCCcccccCC-----------------CCChhHhhhhccccccCC
Q 011138 364 IKCMNPN---YT-----EFK----------FPQIKAHPWHKIFHK-----------------RMPPEALDLVSRLLQYSP 408 (492)
Q Consensus 364 ~~~~~~~---~~-----~~~----------~~~~~~~~~~~~~~~-----------------~~s~~~~~Li~~~L~~dP 408 (492)
+...... +. .+. +.......+...+.. ..++++++||.+||++||
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP 361 (382)
T 2vx3_A 282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP 361 (382)
T ss_dssp HTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCT
T ss_pred HHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCCh
Confidence 5432100 00 000 000000000000000 001478999999999999
Q ss_pred CCcCCHHHhhCCCCCCCCC
Q 011138 409 SLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 409 ~~R~t~~e~l~Hp~f~~~~ 427 (492)
++|||+.|+|+||||++..
T Consensus 362 ~~Rpta~e~L~hp~f~~~~ 380 (382)
T 2vx3_A 362 KTRIQPYYALQHSFFKKTA 380 (382)
T ss_dssp TTSCCHHHHTTSGGGCC--
T ss_pred hhCCCHHHHhcCcccccCC
Confidence 9999999999999999764
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-48 Score=396.22 Aligned_cols=256 Identities=31% Similarity=0.471 Sum_probs=198.2
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------------hhHHHHHHHHHHcCCCCccccceeeeecc
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------------RYKNRELQIMRLLNHPNVVSLKHCFFSTT 203 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------------~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 203 (492)
..+|.+.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+|+.++|||||++++++.
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--- 210 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD--- 210 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE---
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe---
Confidence 357999999999999999999999999999999986432 13568999999999999999999872
Q ss_pred CCCceEEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCC--CcEE
Q 011138 204 EKDELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT--HQLK 280 (492)
Q Consensus 204 ~~~~~~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~--~~vk 280 (492)
.. .+|+||||+.++ +.+. ......+++..++.++.||+.||.|||+ +||+||||||+|||++.++ ..+|
T Consensus 211 --~~-~~~lv~e~~~~g~L~~~----l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 211 --AE-DYYIVLELMEGGELFDK----VVGNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp --SS-EEEEEEECCTTCBGGGG----TSSSCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSSSCCEE
T ss_pred --cC-ceEEEEEcCCCCcHHHH----HhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCCCcceEE
Confidence 22 267999999875 3332 2234678999999999999999999997 9999999999999997543 2599
Q ss_pred EeeecCccccCCCCCCccceeccCccCchhhcC--CCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 011138 281 ICDFGSAKMLVPGEPNISYICSRYYRAPELIFG--ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358 (492)
Q Consensus 281 L~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~ 358 (492)
|+|||+++...........+||+.|+|||++.+ ...|+.++|||||||++|+|++|.+||........+...+.....
T Consensus 283 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~ 362 (419)
T 3i6u_A 283 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 362 (419)
T ss_dssp ECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC
T ss_pred EeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC
Confidence 999999987765555567789999999999853 345888999999999999999999999876544333333221100
Q ss_pred CCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 359 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
. +....+..+++++.+||.+||+.||.+|||+.|+|+||||++.
T Consensus 363 ----------------~--------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 363 ----------------N--------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp ----------------C--------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred ----------------C--------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 0 0011224579999999999999999999999999999999863
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-48 Score=385.56 Aligned_cols=261 Identities=30% Similarity=0.483 Sum_probs=208.1
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc---------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~---------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
.+|.+.+.||+|+||.||+|.+..+++.||||++... .....+|+.+++.++||||+++++++ .+.
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~ 100 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY-----EDE 100 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh-----ccC
Confidence 4799999999999999999999999999999988543 23456799999999999999999998 445
Q ss_pred eEEEEEeeechh-hHHHHhhhhhh------------------------------------cCCCcCHHHHHHHHHHHHHH
Q 011138 208 LYLNLVLEYISE-TVYRVSKHYTR------------------------------------MNQHVPILYVQLYTYQICRA 250 (492)
Q Consensus 208 ~~~~lV~E~~~~-~l~~~~~~~~~------------------------------------~~~~~~~~~~~~i~~qi~~a 250 (492)
.++++||||+.+ +|.+.+..+.. ....+++..++.++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 568999999975 45444421111 01224677788999999999
Q ss_pred HHHHHhhCCcccCCCCCCceEEcCCCC-cEEEeeecCccccCCCC-----CCccceeccCccCchhhcCC-CCCCcchhh
Q 011138 251 LNYLHHVVGVCHRDIKPQNLLVNPHTH-QLKICDFGSAKMLVPGE-----PNISYICSRYYRAPELIFGA-TEYTTAIDM 323 (492)
Q Consensus 251 L~yLH~~~givHrDlKp~NILl~~~~~-~vkL~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-~~~~~~~Dv 323 (492)
|.|||+ +||+||||||+|||++.++. .+||+|||+++...... ......||+.|+|||++.+. ..++.++||
T Consensus 181 l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 259 (345)
T 3hko_A 181 LHYLHN-QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259 (345)
T ss_dssp HHHHHH-TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred HHHHHH-CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence 999997 89999999999999986542 69999999997653211 23456799999999999642 558999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccc
Q 011138 324 WSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRL 403 (492)
Q Consensus 324 wSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~ 403 (492)
|||||++|+|++|+.||.+.+..+.+..+.... ..++. .....+++++.+||.+|
T Consensus 260 wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~-----------------~~~~~--------~~~~~~~~~~~~li~~~ 314 (345)
T 3hko_A 260 WSAGVLLHLLLMGAVPFPGVNDADTISQVLNKK-----------------LCFEN--------PNYNVLSPLARDLLSNL 314 (345)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------------CCTTS--------GGGGGSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcc-----------------cccCC--------cccccCCHHHHHHHHHH
Confidence 999999999999999999988887777766521 11111 01134789999999999
Q ss_pred cccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 404 LQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 404 L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
|+.||.+|||+.++++||||+++.+
T Consensus 315 l~~~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 315 LNRNVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp SCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred cCCChhHCCCHHHHhcChhhccChH
Confidence 9999999999999999999998765
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=403.67 Aligned_cols=254 Identities=28% Similarity=0.477 Sum_probs=210.7
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
..+|.+.+.||+|+||+||+|.+..++..||||++... .....+|+.+++.++|||||+++++| .+...
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~ 110 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-----EDKRN 110 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence 34699999999999999999999999999999998543 23456899999999999999999998 44556
Q ss_pred EEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCC--CcEEEeeecC
Q 011138 210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT--HQLKICDFGS 286 (492)
Q Consensus 210 ~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~--~~vkL~DFG~ 286 (492)
+|+|||||.+ .+.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++..+ ..+||+|||+
T Consensus 111 ~~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~ 185 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHK-HNIVHRDLKPENLLLESKEKDALIKIVDFGL 185 (494)
T ss_dssp EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChhhEEEeCCCCCCcEEEEECCC
Confidence 8999999986 45444332 3568999999999999999999997 9999999999999997643 2599999999
Q ss_pred ccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 011138 287 AKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (492)
Q Consensus 287 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~ 366 (492)
+............+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+....
T Consensus 186 a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~---------- 253 (494)
T 3lij_A 186 SAVFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGK---------- 253 (494)
T ss_dssp CEECBTTBCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC----------
T ss_pred CeECCCCccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------
Confidence 988766666667889999999999853 48999999999999999999999999988877777765521
Q ss_pred cCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
+.++. ..+..+++++++||.+||+.||.+|||+.|+|+||||++.
T Consensus 254 -------~~~~~--------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 254 -------YTFDS--------PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp -------CCCCS--------GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred -------CCCCc--------hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 11111 1124589999999999999999999999999999999865
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=383.13 Aligned_cols=251 Identities=27% Similarity=0.417 Sum_probs=210.5
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
..|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++.. ...
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~ 128 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT 128 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCe
Confidence 35999999999999999999999999999999985321 234589999999999999999999844 335
Q ss_pred EEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
.++||||+.|++.+.+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 129 ~~lv~e~~~g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~ 203 (348)
T 1u5q_A 129 AWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPG-LVKLGDFGSASI 203 (348)
T ss_dssp EEEEEECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTT-EEEECCCTTCBS
T ss_pred EEEEEecCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCC-CEEEeeccCcee
Confidence 889999999887776543 24578999999999999999999997 9999999999999999887 899999999976
Q ss_pred cCCCCCCccceeccCccCchhhcC--CCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 290 LVPGEPNISYICSRYYRAPELIFG--ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
... .....||+.|+|||++.+ ...++.++|||||||++|||++|.+||.+.+..+.+..+....
T Consensus 204 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~----------- 269 (348)
T 1u5q_A 204 MAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE----------- 269 (348)
T ss_dssp SSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-----------
T ss_pred cCC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-----------
Confidence 532 335689999999999853 3458999999999999999999999999888777666554410
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
.+. .....+++++++||.+||+.||.+|||+.++++||||....
T Consensus 270 --------~~~--------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 270 --------SPA--------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp --------CCC--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred --------CCC--------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence 000 01134689999999999999999999999999999998643
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=372.57 Aligned_cols=253 Identities=31% Similarity=0.477 Sum_probs=208.0
Q ss_pred ccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHcCCCCccccceeeeeccCCC
Q 011138 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (492)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 206 (492)
....+|.+.+.||+|+||.||+|.+..+++.||||++... .....+|+.+++.++||||+++++++ .+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~ 80 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HD 80 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----EC
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE-----ec
Confidence 3456799999999999999999999999999999998543 23456799999999999999999998 44
Q ss_pred ceEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeec
Q 011138 207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (492)
Q Consensus 207 ~~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG 285 (492)
....++||||+++ .+...+.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~dlkp~Nili~~~~-~~~l~Dfg 154 (279)
T 3fdn_A 81 ATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGSAG-ELKIADFG 154 (279)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTCEECCCCGGGEEECTTS-CEEECSCC
T ss_pred CCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHhEEEcCCC-CEEEEecc
Confidence 4568999999986 44444332 3568899999999999999999997 9999999999999999888 79999999
Q ss_pred CccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 011138 286 SAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (492)
Q Consensus 286 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~ 365 (492)
++..... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 155 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---------- 222 (279)
T 3fdn_A 155 WSVHAPS-SRRTDLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------- 222 (279)
T ss_dssp EESCC---------CCCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT----------
T ss_pred ccccCCc-ccccccCCCCCccCHhHhccC-CCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhC----------
Confidence 9865432 233456899999999999654 4899999999999999999999999988776666655441
Q ss_pred hcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
... ++..+++++.+||.+||+.||.+|||+.|+++||||+....
T Consensus 223 -------~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 223 -------EFT------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp -------CCC------------CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred -------CCC------------CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence 111 22347899999999999999999999999999999987553
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=381.30 Aligned_cols=259 Identities=29% Similarity=0.475 Sum_probs=185.6
Q ss_pred cceeEe---eeeccCCceEEEEEEEcCCCCEEEEEEeccc-hhhHHHHHHHHHHcC-CCCccccceeeeeccCCCceEEE
Q 011138 137 ISYMAE---RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 137 ~~y~~~---~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
.+|.+. +.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.+. ||||+++++++ .+....|
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~-----~~~~~~~ 82 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVF-----HDQLHTF 82 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSSEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEE-----EcCCEEE
Confidence 356664 7899999999999999999999999998654 345668999999997 99999999998 4555689
Q ss_pred EEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCC--cEEEeeecCcc
Q 011138 212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH--QLKICDFGSAK 288 (492)
Q Consensus 212 lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~--~vkL~DFG~a~ 288 (492)
+||||+.+ ++.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++. .+||+|||+++
T Consensus 83 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~ 157 (325)
T 3kn6_A 83 LVMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHD-VGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157 (325)
T ss_dssp EEECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred EEEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence 99999986 55554432 4679999999999999999999997 99999999999999976542 69999999998
Q ss_pred ccCCCC-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCHHHH
Q 011138 289 MLVPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQ---LVEIIKILGTPTREEI 364 (492)
Q Consensus 289 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~---~~~i~~~~g~p~~~~~ 364 (492)
...... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.... ...+...+..
T Consensus 158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~------ 230 (325)
T 3kn6_A 158 LKPPDNQPLKTPCFTLHYAAPELLNQN-GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK------ 230 (325)
T ss_dssp ECCC----------------------C-CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTT------
T ss_pred ecCCCCCcccccCCCcCccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHc------
Confidence 654332 33456789999999999654 489999999999999999999999987543211 1111111100
Q ss_pred hhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
..+.++ ...+..+++++++||.+||+.||.+|||+.|+++||||++..
T Consensus 231 -------~~~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 231 -------GDFSFE--------GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp -------TCCCCC--------SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred -------CCCCCC--------cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 011111 111235799999999999999999999999999999999754
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=415.88 Aligned_cols=252 Identities=26% Similarity=0.425 Sum_probs=213.3
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHc-CCCCccccceeeeeccCCC
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKD 206 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~ 206 (492)
...+|.+.+.||+|+||.||+|.++.+|+.||||++.+.. ....+|..++..+ +||||++++++| .+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~~ 413 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT 413 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----BC
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----Ee
Confidence 4467999999999999999999999999999999986432 2345688888877 699999999988 55
Q ss_pred ceEEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeec
Q 011138 207 ELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (492)
Q Consensus 207 ~~~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG 285 (492)
...+||||||+.|+ |...+.. ...+++..++.|+.||+.||.|||+ +|||||||||+||||+.++ .+||+|||
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~gIiHrDLKp~NILl~~~g-~ikL~DFG 487 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDSEG-HIKIADFG 487 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TSEECCCCCSTTEEECSSS-CEEECCCT
T ss_pred CCEEEEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeccCChhhEEEcCCC-cEEEeecc
Confidence 56799999999864 4444332 3569999999999999999999997 9999999999999999888 79999999
Q ss_pred CccccC-CCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 011138 286 SAKMLV-PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (492)
Q Consensus 286 ~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~ 364 (492)
+++... .+......+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..|..
T Consensus 488 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~---------- 556 (674)
T 3pfq_A 488 MCKENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME---------- 556 (674)
T ss_dssp TCEECCCTTCCBCCCCSCSSSCCHHHHTCC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHS----------
T ss_pred eeeccccCCcccccccCCCcccCHhhhcCC-CCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHh----------
Confidence 998643 33445567899999999999654 589999999999999999999999999888777777654
Q ss_pred hhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCH-----HHhhCCCCCCCCC
Q 011138 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA-----LEACAHPFFDDLR 427 (492)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~-----~e~l~Hp~f~~~~ 427 (492)
.... ++..+++++++||++||+.||.+|+++ .||++||||+.+.
T Consensus 557 -------~~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~ 605 (674)
T 3pfq_A 557 -------HNVA------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 605 (674)
T ss_dssp -------SCCC------------CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred -------CCCC------------CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence 1122 234689999999999999999999998 9999999999865
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=372.36 Aligned_cols=256 Identities=29% Similarity=0.441 Sum_probs=211.5
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
...+|.+.+.||+|+||.||+|.+..+++.||+|++... .....+|+.+++.++||||+++++++ .+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~ 87 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----EDN 87 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECS
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee-----ccC
Confidence 345799999999999999999999999999999998543 23345799999999999999999998 444
Q ss_pred eEEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 208 LYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 208 ~~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
..+++||||+.++ +...+. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 88 ~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~dfg~ 161 (294)
T 2rku_A 88 DFVFVVLELCRRRSLLELHK----RRKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNEDL-EVKIGDFGL 161 (294)
T ss_dssp SEEEEEEECCTTCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTT
T ss_pred CEEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEcCCC-CEEEEeccC
Confidence 5689999999864 444332 23568999999999999999999997 9999999999999999887 799999999
Q ss_pred ccccCCC-CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 011138 287 AKMLVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (492)
Q Consensus 287 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~ 365 (492)
+...... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+....+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----------- 229 (294)
T 2rku_A 162 ATKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK----------- 229 (294)
T ss_dssp CEECCSTTCCBCCCCSCCSSCCHHHHTTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT-----------
T ss_pred ceecccCccccccccCCCCcCCcchhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh-----------
Confidence 9866422 233456789999999999654 489999999999999999999999998876665554432
Q ss_pred hcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCCC
Q 011138 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431 (492)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~~ 431 (492)
.... ++..+++++.+||.+||+.||.+|||+.|+++||||+....+..
T Consensus 230 ------~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~~ 277 (294)
T 2rku_A 230 ------NEYS------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPAR 277 (294)
T ss_dssp ------TCCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSC
T ss_pred ------ccCC------------CccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCCC
Confidence 1111 22357899999999999999999999999999999997655443
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=384.67 Aligned_cols=253 Identities=27% Similarity=0.443 Sum_probs=210.8
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------------hhHHHHHHHHHHc-CCCCccccceeeeecc
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------------RYKNRELQIMRLL-NHPNVVSLKHCFFSTT 203 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------------~~~~~E~~il~~l-~h~nIv~l~~~~~~~~ 203 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.+ +||||+++++++
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~---- 169 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY---- 169 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE----
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE----
Confidence 46999999999999999999999999999999885431 2345799999999 799999999988
Q ss_pred CCCceEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEe
Q 011138 204 EKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC 282 (492)
Q Consensus 204 ~~~~~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~ 282 (492)
......|+||||+.+ .+.+.+.. ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+
T Consensus 170 -~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~gi~H~Dlkp~NIl~~~~~-~ikl~ 242 (365)
T 2y7j_A 170 -ESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHA-NNIVHRDLKPENILLDDNM-QIRLS 242 (365)
T ss_dssp -EBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEEC
T ss_pred -eeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC-CEEEE
Confidence 334468999999987 45444332 3568999999999999999999997 9999999999999999887 79999
Q ss_pred eecCccccCCCCCCccceeccCccCchhhcCC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 011138 283 DFGSAKMLVPGEPNISYICSRYYRAPELIFGA-----TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILG 357 (492)
Q Consensus 283 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g 357 (492)
|||++..+.........+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+....+..+.....
T Consensus 243 DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 322 (365)
T 2y7j_A 243 DFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY 322 (365)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred ecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence 99999887666666678899999999998632 3478899999999999999999999998877666665544211
Q ss_pred CCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCC
Q 011138 358 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (492)
Q Consensus 358 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~ 425 (492)
.+... .+..+++++.+||.+||+.||.+|||+.++++||||+.
T Consensus 323 ~~~~~-------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 323 QFSSP-------------------------EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp CCCHH-------------------------HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred CCCCc-------------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 11111 11357899999999999999999999999999999973
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-47 Score=382.85 Aligned_cols=290 Identities=29% Similarity=0.476 Sum_probs=223.0
Q ss_pred CccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch---hhHHHHHHHHHHcC-----------CCCcccccee
Q 011138 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLN-----------HPNVVSLKHC 198 (492)
Q Consensus 133 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~---~~~~~E~~il~~l~-----------h~nIv~l~~~ 198 (492)
+....+|.+.+.||+|+||.||+|.+..+|+.||||++..+. ....+|+.+++.++ ||||++++++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 334457999999999999999999999999999999987543 34557999998886 8999999999
Q ss_pred eeeccCCCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhC-CcccCCCCCCceEEcCCC-
Q 011138 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV-GVCHRDIKPQNLLVNPHT- 276 (492)
Q Consensus 199 ~~~~~~~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~-givHrDlKp~NILl~~~~- 276 (492)
+.... .+..++++||||+++++...+.... ...+++..++.++.||+.||.|||+ + ||+||||||+|||++.++
T Consensus 95 ~~~~~-~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~-~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 95 FNHKG-PNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEEE-TTEEEEEEEECCCCEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEEEEEET
T ss_pred hhccC-CCCceEEEEEecCCCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHh-cCCEEecCCChHHeEEeccCC
Confidence 86543 3445789999999888877665432 3458999999999999999999997 8 999999999999995322
Q ss_pred ----CcEEEeeecCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC------hH
Q 011138 277 ----HQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES------GV 346 (492)
Q Consensus 277 ----~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~------~~ 346 (492)
..+||+|||+++... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+ ..
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~--~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTTEEEEEECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CcCcceEEEcccccccccC--CCCCCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 269999999998653 2344568999999999997654 8999999999999999999999998754 56
Q ss_pred HHHHHHHHHhCCCCHHHHhhcCCC-------CcccCCCcccCCCcc------cccCCCCChhHhhhhccccccCCCCcCC
Q 011138 347 DQLVEIIKILGTPTREEIKCMNPN-------YTEFKFPQIKAHPWH------KIFHKRMPPEALDLVSRLLQYSPSLRCT 413 (492)
Q Consensus 347 ~~~~~i~~~~g~p~~~~~~~~~~~-------~~~~~~~~~~~~~~~------~~~~~~~s~~~~~Li~~~L~~dP~~R~t 413 (492)
+.+..+...+|.++...+...... -.-..+......+.. ..++..+++++.+||.+||+.||.+|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 678888899998887655432100 000000000000000 0122345678999999999999999999
Q ss_pred HHHhhCCCCCCCCCCC
Q 011138 414 ALEACAHPFFDDLRDP 429 (492)
Q Consensus 414 ~~e~l~Hp~f~~~~~~ 429 (492)
+.|+|+||||++....
T Consensus 328 ~~ell~hp~f~~~~~~ 343 (373)
T 1q8y_A 328 AGGLVNHPWLKDTLGM 343 (373)
T ss_dssp HHHHHTCGGGTTCTTC
T ss_pred HHHHhhChhhhcccCc
Confidence 9999999999986543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=377.74 Aligned_cols=258 Identities=26% Similarity=0.365 Sum_probs=207.8
Q ss_pred cceeEe-eeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcC-CCCccccceeeeeccCCCce
Q 011138 137 ISYMAE-RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 137 ~~y~~~-~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~~~ 208 (492)
..|.+. +.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.+. ||||++++++| .+..
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~-----~~~~ 102 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY-----ENTS 102 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSS
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE-----EeCC
Confidence 468887 8999999999999999999999999988542 244568999999995 69999999998 4455
Q ss_pred EEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcC---CCCcEEEeee
Q 011138 209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP---HTHQLKICDF 284 (492)
Q Consensus 209 ~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~---~~~~vkL~DF 284 (492)
.+++||||+.++ +...+. ......+++..++.++.||+.||.|||+ +||+||||||+|||++. ++ .+||+||
T Consensus 103 ~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~i~~ql~~~L~~LH~-~givH~Dikp~NIl~~~~~~~~-~~kL~Df 178 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCL--PELAEMVSENDVIRLIKQILEGVYYLHQ-NNIVHLDLKPQNILLSSIYPLG-DIKIVDF 178 (327)
T ss_dssp EEEEEEECCTTEEGGGGGS--SCC-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESCBTTBC-CEEECCG
T ss_pred eEEEEEEecCCCcHHHHHH--HhcccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCChHHEEEecCCCCC-cEEEeeC
Confidence 689999999875 433322 1224668999999999999999999997 99999999999999987 45 7999999
Q ss_pred cCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 011138 285 GSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (492)
Q Consensus 285 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~ 364 (492)
|+++............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+........
T Consensus 179 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---- 253 (327)
T 3lm5_A 179 GMSRKIGHACELREIMGTPEYLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYS---- 253 (327)
T ss_dssp GGCEEC---------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----
T ss_pred ccccccCCccccccccCCcCccCCeeecCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccC----
Confidence 999877655555567899999999999654 489999999999999999999999999888777776655221111
Q ss_pred hhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCC
Q 011138 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (492)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~ 429 (492)
......+++++.+||.+||+.||.+|||+.++|+||||+++...
T Consensus 254 ---------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~ 297 (327)
T 3lm5_A 254 ---------------------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE 297 (327)
T ss_dssp ---------------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTT
T ss_pred ---------------------chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccc
Confidence 01124578999999999999999999999999999999987543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=383.80 Aligned_cols=245 Identities=24% Similarity=0.398 Sum_probs=206.0
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------------hhHHHHHHHHHHcCCCCccccceeeeecc
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------------RYKNRELQIMRLLNHPNVVSLKHCFFSTT 203 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------------~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 203 (492)
..+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||++++++|
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~---- 98 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF---- 98 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE----
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE----
Confidence 357999999999999999999999999999999986532 1334799999999999999999998
Q ss_pred CCCceEEEEEeeechh--hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEE
Q 011138 204 EKDELYLNLVLEYISE--TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKI 281 (492)
Q Consensus 204 ~~~~~~~~lV~E~~~~--~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL 281 (492)
.+...+++||||+.+ .+...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||
T Consensus 99 -~~~~~~~lv~e~~~~g~~l~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~-~~kL 171 (335)
T 3dls_A 99 -ENQGFFQLVMEKHGSGLDLFAFID----RHPRLDEPLASYIFRQLVSAVGYLRL-KDIIHRDIKDENIVIAEDF-TIKL 171 (335)
T ss_dssp -ECSSEEEEEEECCTTSCBHHHHHH----TCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTS-CEEE
T ss_pred -eeCCEEEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEeccCHHHEEEcCCC-cEEE
Confidence 445568999999865 4444433 24568999999999999999999997 9999999999999999887 7999
Q ss_pred eeecCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 011138 282 CDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTR 361 (492)
Q Consensus 282 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~ 361 (492)
+|||+++...........+||+.|+|||++.+...++.++|||||||++|+|++|..||...... ..
T Consensus 172 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~------- 238 (335)
T 3dls_A 172 IDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VE------- 238 (335)
T ss_dssp CCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TT-------
T ss_pred eecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hh-------
Confidence 99999988766666667789999999999987765688999999999999999999999652210 00
Q ss_pred HHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
... ..+..+++++.+||.+||+.||.+|||+.++++||||++.
T Consensus 239 ----------~~~------------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 239 ----------AAI------------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp ----------TCC------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred ----------hcc------------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 000 0123478999999999999999999999999999999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=377.26 Aligned_cols=253 Identities=27% Similarity=0.427 Sum_probs=208.0
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
..|...+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++||||+++++++... ..+++
T Consensus 45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~l 119 (321)
T 2c30_A 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVG-----EELWV 119 (321)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEEE
T ss_pred hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-----CEEEE
Confidence 3588888999999999999999999999999998533 23456899999999999999999998543 35889
Q ss_pred EeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 213 V~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
||||+.++.+..... ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++.....
T Consensus 120 v~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~ 193 (321)
T 2c30_A 120 LMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHA-QGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISK 193 (321)
T ss_dssp EECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEECCS
T ss_pred EEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCC-cEEEeeeeeeeeccc
Confidence 999998754433221 2468999999999999999999997 9999999999999999887 799999999987644
Q ss_pred CC-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 011138 293 GE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (492)
Q Consensus 293 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~ 371 (492)
.. ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.... +
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~--~------------ 258 (321)
T 2c30_A 194 DVPKRKSLVGTPYWMAPEVISRS-LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP--P------------ 258 (321)
T ss_dssp SSCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS--C------------
T ss_pred CccccccccCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--C------------
Confidence 32 33456899999999999654 58999999999999999999999999887766655543310 0
Q ss_pred cccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
+... ....+++++.+||.+||+.||++|||+.++++||||.+..
T Consensus 259 -----~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 259 -----PKLK-------NSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp -----CCCT-------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred -----CCcC-------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence 0000 1124789999999999999999999999999999998754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=377.73 Aligned_cols=253 Identities=30% Similarity=0.447 Sum_probs=211.3
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
.+|.+.+.||+|+||.||+|.+..+++.||+|++... .....+|+.+++.++||||+++++++ .+...
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~ 115 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----EDNDF 115 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecCCe
Confidence 4699999999999999999999999999999998543 23456799999999999999999998 44456
Q ss_pred EEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 210 ~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
+|+||||+.+ .+.+++.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++.
T Consensus 116 ~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~ 189 (335)
T 2owb_A 116 VFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNEDL-EVKIGDFGLAT 189 (335)
T ss_dssp EEEEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred EEEEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCchhEEEcCCC-CEEEeeccCce
Confidence 8999999986 44443322 3568999999999999999999997 9999999999999999887 79999999998
Q ss_pred ccCCC-CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 289 MLVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 289 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
..... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+.+..+...
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~------------ 256 (335)
T 2owb_A 190 KVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------------ 256 (335)
T ss_dssp ECCSTTCCBCCCCSCCSSCCHHHHHTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT------------
T ss_pred ecccCcccccccCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC------------
Confidence 76422 334456799999999999754 4899999999999999999999999988776665555431
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~ 430 (492)
.+. ++..+++++.+||.+||+.||.+|||+.|+++||||+....+.
T Consensus 257 -----~~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~ 302 (335)
T 2owb_A 257 -----EYS------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 302 (335)
T ss_dssp -----CCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred -----CCC------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCccc
Confidence 111 1235789999999999999999999999999999998765443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=370.12 Aligned_cols=252 Identities=29% Similarity=0.472 Sum_probs=184.1
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
..+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++ .+..
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 84 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF-----EDSN 84 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE-----ECSS
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE-----ccCC
Confidence 357999999999999999999999999999999985432 3456899999999999999999998 4455
Q ss_pred EEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 209 ~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
..++||||++++ +...+. .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 85 ~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nili~~~~-~~kl~dfg~~ 159 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLK---NRVKPFSENEARHFMHQIITGMLYLHS-HGILHRDLTLSNLLLTRNM-NIKIADFGLA 159 (278)
T ss_dssp EEEEEEECCTTEEHHHHHH---TCSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSSCCGGGEEECTTC-CEEECCCTTC
T ss_pred eEEEEEecCCCCcHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCC-CEEEEeecce
Confidence 689999999764 444332 223568999999999999999999997 9999999999999999887 7999999999
Q ss_pred cccCCC-CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 011138 288 KMLVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (492)
Q Consensus 288 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~ 366 (492)
...... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+.+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------ 226 (278)
T 3cok_A 160 TQLKMPHEKHYTLCGTPNYISPEIATRS-AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL------------ 226 (278)
T ss_dssp EECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS------------
T ss_pred eeccCCCCcceeccCCCCcCCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh------------
Confidence 865422 233456789999999998654 489999999999999999999999987654332221100
Q ss_pred cCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
..+. ++..++.++.+||.+||+.||.+|||+.++++||||.+..
T Consensus 227 -----~~~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 227 -----ADYE------------MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp -----SCCC------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred -----cccC------------CccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 0111 2245789999999999999999999999999999998643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=381.04 Aligned_cols=275 Identities=21% Similarity=0.313 Sum_probs=206.0
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++... +..++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~~~ 85 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHKV 85 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecC---CCceEE
Confidence 46999999999999999999999999999999986432 3455899999999999999999987543 233578
Q ss_pred EEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEE----cCCCCcEEEeeecC
Q 011138 212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV----NPHTHQLKICDFGS 286 (492)
Q Consensus 212 lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl----~~~~~~vkL~DFG~ 286 (492)
+||||+.+ ++...+.. ......+++..++.++.||+.||.|||+ +||+||||||+|||+ +.++ .+||+|||+
T Consensus 86 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~~-~~kL~Dfg~ 162 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDGQS-VYKLTDFGA 162 (319)
T ss_dssp EEEECCTTCBHHHHHHS-GGGTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEECTTSCE-EEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHH-hccccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEeccCCCCc-eEEEccCCC
Confidence 99999985 55554443 2223448999999999999999999997 999999999999998 5555 799999999
Q ss_pred ccccCCCCCCccceeccCccCchhhcC-------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHH
Q 011138 287 AKMLVPGEPNISYICSRYYRAPELIFG-------ATEYTTAIDMWSIGCVLAELLLGQPLFPGESG----VDQLVEIIKI 355 (492)
Q Consensus 287 a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~----~~~~~~i~~~ 355 (492)
++............||+.|+|||++.. ...++.++|||||||++|||++|..||..... .+.+..+...
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred ceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 988766666667789999999999852 34589999999999999999999999975443 2333333332
Q ss_pred hCCCCHHHHhhcCC-CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCC
Q 011138 356 LGTPTREEIKCMNP-NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422 (492)
Q Consensus 356 ~g~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~ 422 (492)
.| ...+..... ....+.+.. ..+....+...+++.+.+||.+||+.||++|||+.|+|+||=
T Consensus 243 --~p-~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 243 --KP-SGAISGVQKAENGPIDWSG--DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp --CC-TTCCEEEECSTTCCEEEES--SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred --CC-cccchhhhcccCCccccCc--cCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 22 111110000 000000000 000011122345678999999999999999999999999873
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=374.55 Aligned_cols=257 Identities=28% Similarity=0.432 Sum_probs=196.7
Q ss_pred ccceeEe-eeeccCCceEEEEEEEcCCCCEEEEEEeccc----hhhHHHHHHHHHHc-CCCCccccceeeeeccCCCceE
Q 011138 136 TISYMAE-RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 136 ~~~y~~~-~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
...|.+. +.||+|+||.||+|.+..+|+.||||++... .....+|+.+++++ +||||+++++++.. ...
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~-----~~~ 85 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE-----EDR 85 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-----CCE
Confidence 3468884 7899999999999999999999999998543 24456899999985 79999999999843 346
Q ss_pred EEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCC--cEEEeeecC
Q 011138 210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH--QLKICDFGS 286 (492)
Q Consensus 210 ~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~--~vkL~DFG~ 286 (492)
+|+||||+.+ ++.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++. .+||+|||+
T Consensus 86 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~ 160 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILCEHPNQVSPVKICDFDL 160 (316)
T ss_dssp EEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred EEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence 8999999985 55554432 3568999999999999999999997 99999999999999987662 399999999
Q ss_pred ccccCCCC--------CCccceeccCccCchhhcCC----CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH-------
Q 011138 287 AKMLVPGE--------PNISYICSRYYRAPELIFGA----TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD------- 347 (492)
Q Consensus 287 a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~------- 347 (492)
+....... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 240 (316)
T 2ac3_A 161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE 240 (316)
T ss_dssp CC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----
T ss_pred ccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc
Confidence 87653211 12245699999999998641 347899999999999999999999998764321
Q ss_pred --------HHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 348 --------QLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 348 --------~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
....+.. ..+.+|. .....+++++++||.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~i~~-----------------~~~~~~~--------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 241 ACPACQNMLFESIQE-----------------GKYEFPD--------KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp CCHHHHHHHHHHHHH-----------------CCCCCCH--------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cchhHHHHHHHHHhc-----------------cCcccCc--------hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 1122211 1111111 111357899999999999999999999999999
Q ss_pred CCCCCCCC
Q 011138 420 HPFFDDLR 427 (492)
Q Consensus 420 Hp~f~~~~ 427 (492)
||||++..
T Consensus 296 hp~~~~~~ 303 (316)
T 2ac3_A 296 HPWVQGCA 303 (316)
T ss_dssp STTCC---
T ss_pred ChhhcCCC
Confidence 99999764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=370.06 Aligned_cols=256 Identities=25% Similarity=0.409 Sum_probs=208.1
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----------hhhHHHHHHHHHHcCCCCccccceeeeeccCCC
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 206 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||+|++... .....+|+.+++.++||||+++++++. +
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~ 79 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE-----N 79 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec-----C
Confidence 4699999999999999999999999999999988542 344678999999999999999999983 4
Q ss_pred ceEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCC---cEEEe
Q 011138 207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH---QLKIC 282 (492)
Q Consensus 207 ~~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~---~vkL~ 282 (492)
....++||||+.+ .+.+.+.. ...+++..+..++.||+.||.|||+ +||+||||||+||+++.++. .+||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~~~~kl~ 154 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHS-KRIAHFDLKPENIMLLDKNVPNPRIKLI 154 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSSSSCCEEEC
T ss_pred CCeEEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChHHEEEecCCCCCCceEEE
Confidence 4468999999974 55554432 3568999999999999999999997 99999999999999986652 69999
Q ss_pred eecCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 011138 283 DFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (492)
Q Consensus 283 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~ 362 (492)
|||++.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+........
T Consensus 155 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 231 (283)
T 3bhy_A 155 DFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD-- 231 (283)
T ss_dssp CCTTCEECC--------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC--
T ss_pred ecccceeccCCCcccccCCCcCccCcceecCC-CCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCc--
Confidence 99999877555555567899999999999654 489999999999999999999999999887666655543111100
Q ss_pred HHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
......+++.+.+||.+||..||.+|||+.++++||||+.++.
T Consensus 232 -----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 232 -----------------------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp -----------------------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred -----------------------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 1122457899999999999999999999999999999997654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=368.57 Aligned_cols=257 Identities=28% Similarity=0.431 Sum_probs=213.1
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------------hhhHHHHHHHHHHcC-CCCccccceeeee
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------------KRYKNRELQIMRLLN-HPNVVSLKHCFFS 201 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------------~~~~~~E~~il~~l~-h~nIv~l~~~~~~ 201 (492)
..+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.+. ||||+++++++
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~-- 93 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY-- 93 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE--
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee--
Confidence 45799999999999999999999999999999998532 123457999999996 99999999998
Q ss_pred ccCCCceEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEE
Q 011138 202 TTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLK 280 (492)
Q Consensus 202 ~~~~~~~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vk 280 (492)
.+....++||||+.+ .+.+.+.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+|
T Consensus 94 ---~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~k 164 (298)
T 1phk_A 94 ---ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDDDM-NIK 164 (298)
T ss_dssp ---ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEE
T ss_pred ---ccCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEcCCC-cEE
Confidence 445568999999985 55554432 3568999999999999999999997 9999999999999999887 799
Q ss_pred EeeecCccccCCCCCCccceeccCccCchhhc-----CCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 011138 281 ICDFGSAKMLVPGEPNISYICSRYYRAPELIF-----GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKI 355 (492)
Q Consensus 281 L~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~ 355 (492)
|+|||++.............||+.|+|||++. ....++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 244 (298)
T 1phk_A 165 LTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 244 (298)
T ss_dssp ECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred EecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC
Confidence 99999998776665566678999999999985 2345789999999999999999999999988776666555441
Q ss_pred hCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 356 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
. ..++. ..+..+++++.+||.+||+.||.+|||+.|+++||||++...
T Consensus 245 ~-----------------~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (298)
T 1phk_A 245 N-----------------YQFGS--------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV 292 (298)
T ss_dssp C-----------------CCCCT--------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred C-----------------cccCc--------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence 1 11111 011357899999999999999999999999999999998653
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=375.87 Aligned_cols=281 Identities=29% Similarity=0.499 Sum_probs=219.9
Q ss_pred cceeEeeeeccCCceEEEEEEE-cCCCCEEEEEEeccch---hhHHHHHHHHHHcCCCC------ccccceeeeeccCCC
Q 011138 137 ISYMAERVVGTGSFGVVFQAKC-LETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPN------VVSLKHCFFSTTEKD 206 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~-~~~g~~vAiK~~~~~~---~~~~~E~~il~~l~h~n------Iv~l~~~~~~~~~~~ 206 (492)
.+|.+.+.||+|+||.||+|.+ ..+|+.||||++.... ....+|+.+++.++|+| |+++++++. +
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~-----~ 88 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE-----H 88 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE-----E
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc-----c
Confidence 4699999999999999999998 5688999999986543 34567999999987654 899999883 3
Q ss_pred ceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCC-----------
Q 011138 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH----------- 275 (492)
Q Consensus 207 ~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~----------- 275 (492)
..++|+||||+++++.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.+
T Consensus 89 ~~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 89 HGHICIVFELLGLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHS-NKLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp TTEEEEEEECCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred CCcEEEEEcCCCCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEEEeccccccccCCccc
Confidence 3468999999988888766542 22468899999999999999999997 999999999999999863
Q ss_pred -------CCcEEEeeecCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 011138 276 -------THQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQ 348 (492)
Q Consensus 276 -------~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~ 348 (492)
...+||+|||+++... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDD--EHHSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETT--SCCCSSCSCGGGCCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred cccccccCCCceEeeCcccccCc--cccccccCCccccChHHhhCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 2269999999998643 334466899999999999754 489999999999999999999999999999888
Q ss_pred HHHHHHHhCCCCHHHHhhcCCCCc----ccCCCcc---------cCCCcc--cccCCCCChhHhhhhccccccCCCCcCC
Q 011138 349 LVEIIKILGTPTREEIKCMNPNYT----EFKFPQI---------KAHPWH--KIFHKRMPPEALDLVSRLLQYSPSLRCT 413 (492)
Q Consensus 349 ~~~i~~~~g~p~~~~~~~~~~~~~----~~~~~~~---------~~~~~~--~~~~~~~s~~~~~Li~~~L~~dP~~R~t 413 (492)
+..+.+..+.++...+........ ...++.. ...++. .......++++.+||.+||+.||.+|||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 888988888877765543221000 0000000 000000 0011234578899999999999999999
Q ss_pred HHHhhCCCCCCCCCC
Q 011138 414 ALEACAHPFFDDLRD 428 (492)
Q Consensus 414 ~~e~l~Hp~f~~~~~ 428 (492)
+.|+++||||+.++.
T Consensus 323 ~~ell~hp~f~~~~~ 337 (339)
T 1z57_A 323 LREALKHPFFDLLKK 337 (339)
T ss_dssp HHHHTTSGGGGGGGC
T ss_pred HHHHhcCHHHHHHhc
Confidence 999999999998753
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=386.50 Aligned_cols=263 Identities=16% Similarity=0.136 Sum_probs=188.8
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHc--CCCCccccceee-------ee
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLL--NHPNVVSLKHCF-------FS 201 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l--~h~nIv~l~~~~-------~~ 201 (492)
.|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.| +||||++++..+ ..
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence 5999999999999999999999999999999986532 2334676655555 599988866433 22
Q ss_pred ccC------------CCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHH------HHHHHHHHHHHHHHHhhCCcccC
Q 011138 202 TTE------------KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYV------QLYTYQICRALNYLHHVVGVCHR 263 (492)
Q Consensus 202 ~~~------------~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~------~~i~~qi~~aL~yLH~~~givHr 263 (492)
... .....+||||||++++|.+++..... .++.... ..++.||+.||.|||+ +||+||
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~-~~ivHr 218 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQS-KGLVHG 218 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHH-TTEEET
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHH-CCCccC
Confidence 111 01145899999999888887765422 2333333 5666999999999997 999999
Q ss_pred CCCCCceEEcCCCCcEEEeeecCccccCCCCCCccceeccCccCchhhcCC-CCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 011138 264 DIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLLGQPLFPG 342 (492)
Q Consensus 264 DlKp~NILl~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~ 342 (492)
||||+||||+.++ .+||+|||+++... .......+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+
T Consensus 219 Dikp~NIll~~~~-~~kL~DFG~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 219 HFTPDNLFIMPDG-RLMLGDVSALWKVG--TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp TCSGGGEEECTTS-CEEECCGGGEEETT--CEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred cCCHHHEEECCCC-CEEEEecceeeecC--CCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999888 79999999998653 222256778999999999641 4589999999999999999999999987
Q ss_pred CChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCC
Q 011138 343 ESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422 (492)
Q Consensus 343 ~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~ 422 (492)
..... ...+............+.......+++++.+||.+||+.||++|||+.++++|||
T Consensus 296 ~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 355 (371)
T 3q60_A 296 VTPGI--------------------KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE 355 (371)
T ss_dssp CCTTC--------------------TTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHH
T ss_pred cCccc--------------------ccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHH
Confidence 64210 0011111111111111111223468999999999999999999999999999999
Q ss_pred CCCCC
Q 011138 423 FDDLR 427 (492)
Q Consensus 423 f~~~~ 427 (492)
|+++.
T Consensus 356 f~~~~ 360 (371)
T 3q60_A 356 FLQLQ 360 (371)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 98764
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=366.62 Aligned_cols=252 Identities=29% Similarity=0.417 Sum_probs=201.2
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
...+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++. +.
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 83 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS-----TP 83 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CS
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe-----cC
Confidence 3457999999999999999999999999999999985432 24568999999999999999999883 34
Q ss_pred eEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 208 ~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
..+|+||||+.+ ++.+.+.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~~l~dfg~ 157 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHR-HMVVHRDLKPENVLLDAHM-NAKIADFGL 157 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HCSSCCCCCGGGEEECTTS-CEEECCCCG
T ss_pred CeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChhhEEECCCC-CEEEeeccc
Confidence 468999999975 55554432 3468899999999999999999997 8999999999999999887 799999999
Q ss_pred ccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 011138 287 AKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (492)
Q Consensus 287 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~ 366 (492)
+.............||+.|+|||++.+....+.++|||||||++|+|++|..||...+.......+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----------- 226 (276)
T 2h6d_A 158 SNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG----------- 226 (276)
T ss_dssp GGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred ccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC-----------
Confidence 987655554556789999999999976654578999999999999999999999887765555444331
Q ss_pred cCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
... ++..+++++.+||.+||+.||.+|||+.++++||||++.
T Consensus 227 ------~~~------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 227 ------VFY------------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp ------CCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ------ccc------------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 011 123478999999999999999999999999999999864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=371.41 Aligned_cols=258 Identities=26% Similarity=0.408 Sum_probs=211.4
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc--------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~--------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
.+|.+.+.||+|+||.||+|.+..+++.||+|++... .....+|+.+++.++||||++++++++.. +..
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~ 81 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE---EKQ 81 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC------
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC---CCC
Confidence 4699999999999999999999999999999998543 23456899999999999999999987532 233
Q ss_pred EEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 209 ~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
.+|+||||+.+++...+... ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++.
T Consensus 82 ~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~NIl~~~~~-~~kl~dfg~~~ 157 (305)
T 2wtk_C 82 KMYMVMEYCVCGMQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHS-QGIVHKDIKPGNLLLTTGG-TLKISALGVAE 157 (305)
T ss_dssp CEEEEEECCSEEHHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCCTTCE
T ss_pred eEEEEehhccCCHHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEcCCC-cEEeecccccc
Confidence 58899999998876655432 24568999999999999999999997 9999999999999999887 79999999998
Q ss_pred ccCCCC---CCccceeccCccCchhhcCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 011138 289 MLVPGE---PNISYICSRYYRAPELIFGAT-EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (492)
Q Consensus 289 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~ 364 (492)
...... ......||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+..+....+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~--------- 228 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--------- 228 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC---------
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC---------
Confidence 654321 223457899999999996533 2477999999999999999999999988766655554431
Q ss_pred hhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCC
Q 011138 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430 (492)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~ 430 (492)
... ++..+++++.+||.+||..||.+|||+.|+++||||++...+.
T Consensus 229 --------~~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 274 (305)
T 2wtk_C 229 --------SYA------------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA 274 (305)
T ss_dssp --------CCC------------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred --------CCC------------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence 111 2235789999999999999999999999999999999866543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=366.10 Aligned_cols=252 Identities=23% Similarity=0.341 Sum_probs=205.4
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
.|.+.+.||+|+||.||+|.+..++..||+|++.... ....+|+.+++.++||||+++++++.... .+..+++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~ 105 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIV 105 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCceEE
Confidence 4999999999999999999999999999999885432 33457999999999999999999886544 3456789
Q ss_pred EEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCC--cccCCCCCCceEEc-CCCCcEEEeeecCc
Q 011138 212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG--VCHRDIKPQNLLVN-PHTHQLKICDFGSA 287 (492)
Q Consensus 212 lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~g--ivHrDlKp~NILl~-~~~~~vkL~DFG~a 287 (492)
+||||+++ ++.+.+.. ...+++..++.++.||+.||.|||+ +| |+||||||+|||++ .++ .+||+|||++
T Consensus 106 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~~-~~kl~Dfg~~ 179 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTG-SVKIGDLGLA 179 (290)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTS-CEEECCTTGG
T ss_pred EEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEECCCCHHHEEEECCCC-CEEEeeCCCc
Confidence 99999976 55554432 3568899999999999999999997 88 99999999999998 455 8999999999
Q ss_pred cccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
.... ........||+.|+|||++.+ .++.++|||||||++|+|++|..||..................
T Consensus 180 ~~~~-~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------- 247 (290)
T 1t4h_A 180 TLKR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--------- 247 (290)
T ss_dssp GGCC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC---------
T ss_pred cccc-ccccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC---------
Confidence 7543 233445679999999998854 3899999999999999999999999886665554443221000
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~ 425 (492)
...++...++++.+||.+||+.||.+|||+.++++||||++
T Consensus 248 -----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 248 -----------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp -----------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred -----------------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 01123456789999999999999999999999999999986
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=383.46 Aligned_cols=252 Identities=25% Similarity=0.374 Sum_probs=198.2
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcC--CCCccccceeeeeccCCCceE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLN--HPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~--h~nIv~l~~~~~~~~~~~~~~ 209 (492)
.|.+.+.||+|+||.||+|.+.. |+.||||++.... ....+|+.+|+.++ ||||+++++++. ...+
T Consensus 57 ~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~-----~~~~ 130 (390)
T 2zmd_A 57 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TDQY 130 (390)
T ss_dssp EEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSE
T ss_pred ceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe-----cCCE
Confidence 59999999999999999998764 9999999985432 34568999999997 599999999884 3445
Q ss_pred EEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
+|||||+.+++|.+++.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ ++ .+||+|||+++.
T Consensus 131 ~~lv~E~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~-~~-~~kl~DFG~a~~ 203 (390)
T 2zmd_A 131 IYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV-DG-MLKLIDFGIANQ 203 (390)
T ss_dssp EEEEEECCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCCGGGEEES-SS-CEEECCCSSSCC
T ss_pred EEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEEE-CC-eEEEEecCcccc
Confidence 899999877777776543 3468888999999999999999997 9999999999999996 44 799999999987
Q ss_pred cCCCCC---CccceeccCccCchhhcCC----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHH
Q 011138 290 LVPGEP---NISYICSRYYRAPELIFGA----------TEYTTAIDMWSIGCVLAELLLGQPLFPGESGV-DQLVEIIKI 355 (492)
Q Consensus 290 ~~~~~~---~~~~~gt~~y~aPE~~~~~----------~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~-~~~~~i~~~ 355 (492)
...... ....+||+.|+|||++.+. ..|+.++|||||||++|+|++|.+||...... ..+..++.
T Consensus 204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~- 282 (390)
T 2zmd_A 204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID- 282 (390)
T ss_dssp C---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC-
T ss_pred ccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC-
Confidence 643322 2356899999999999652 35899999999999999999999999875432 22322221
Q ss_pred hCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCC
Q 011138 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (492)
Q Consensus 356 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~ 429 (492)
. . .... ++...++++.+||.+||+.||.+|||+.|+++||||+....+
T Consensus 283 --~-----------~-~~~~------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~ 330 (390)
T 2zmd_A 283 --P-----------N-HEIE------------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 330 (390)
T ss_dssp --T-----------T-SCCC------------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC--
T ss_pred --c-----------c-ccCC------------CCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCcc
Confidence 0 0 0111 123357899999999999999999999999999999865543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=365.58 Aligned_cols=252 Identities=27% Similarity=0.457 Sum_probs=210.8
Q ss_pred ccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHcCCCCccccceeeeeccCCC
Q 011138 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (492)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 206 (492)
....+|.+.+.||+|+||.||+|.+..+++.||||++... .....+|+.+++.++||||+++++++ .+
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~ 85 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF-----HD 85 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----EC
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE-----Ec
Confidence 3446799999999999999999999999999999998543 23456899999999999999999998 34
Q ss_pred ceEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeec
Q 011138 207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (492)
Q Consensus 207 ~~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG 285 (492)
...+++||||+.+ ++.+.+.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~Dfg 159 (284)
T 2vgo_A 86 RKRIYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHE-RKVIHRDIKPENLLMGYKG-ELKIADFG 159 (284)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECTTC-CEEECCCT
T ss_pred CCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEEcCCC-CEEEeccc
Confidence 4568999999986 55554432 3468899999999999999999997 9999999999999999887 79999999
Q ss_pred CccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 011138 286 SAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (492)
Q Consensus 286 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~ 365 (492)
++..... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+...
T Consensus 160 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---------- 227 (284)
T 2vgo_A 160 WSVHAPS-LRRRTMCGTLDYLPPEMIEGK-THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV---------- 227 (284)
T ss_dssp TCEECSS-SCBCCCCSCGGGCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT----------
T ss_pred ccccCcc-cccccccCCCCcCCHHHhccC-CCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc----------
Confidence 9875532 233456899999999999754 4899999999999999999999999988776655554331
Q ss_pred hcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
... ++..+++++++||.+||..||.+|||+.++++||||+...
T Consensus 228 -------~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 228 -------DLK------------FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp -------CCC------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred -------ccC------------CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 111 2235789999999999999999999999999999998654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=364.01 Aligned_cols=255 Identities=27% Similarity=0.345 Sum_probs=205.9
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++. +....|
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 81 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQY 81 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEE-----cCCEEE
Confidence 47999999999999999999999999999999985432 44568999999999999999999884 334588
Q ss_pred EEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 212 lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
+||||+++ ++.+.+ .....+++..+..++.||+.||.|||+ +||+||||||+||+++.++ .+||+|||++...
T Consensus 82 lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~ 155 (276)
T 2yex_A 82 LFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD-NLKISDFGLATVF 155 (276)
T ss_dssp EEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHH----hhccCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCChHHEEEccCC-CEEEeeCCCcccc
Confidence 99999986 444332 234568999999999999999999997 9999999999999999887 7999999999765
Q ss_pred CCCC---CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 291 VPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 291 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
.... ......||+.|+|||++.+...++.++|||||||++|+|++|..||................
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----------- 224 (276)
T 2yex_A 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK----------- 224 (276)
T ss_dssp EETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTT-----------
T ss_pred CCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhc-----------
Confidence 3221 23356789999999999766655789999999999999999999998766543322221100
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
....+ ....+++++.+||.+||+.||.+|||+.|+++||||++...
T Consensus 225 -----~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (276)
T 2yex_A 225 -----KTYLN----------PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (276)
T ss_dssp -----CTTST----------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred -----ccccC----------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence 00000 11357899999999999999999999999999999997543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=376.14 Aligned_cols=252 Identities=24% Similarity=0.361 Sum_probs=198.3
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCC--CCccccceeeeeccCCCce
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNH--PNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h--~nIv~l~~~~~~~~~~~~~ 208 (492)
..|.+.+.||+|+||.||+|.+ .+++.||||++.... ....+|+.+++.++| |||+++++++ .+..
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~-----~~~~ 82 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----ITDQ 82 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSS
T ss_pred CEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeE-----eeCC
Confidence 3599999999999999999987 568999999985332 334679999999987 9999999998 4445
Q ss_pred EEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 209 ~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
++|+|||+.++++.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ ++ .+||+|||+++
T Consensus 83 ~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~iiHrDikp~NIll~-~~-~~kl~DFG~a~ 155 (343)
T 3dbq_A 83 YIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV-DG-MLKLIDFGIAN 155 (343)
T ss_dssp EEEEEECCCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEE-TT-EEEECCCSSSC
T ss_pred EEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEE-CC-cEEEeeccccc
Confidence 7899999888887776543 4578999999999999999999997 9999999999999998 45 79999999998
Q ss_pred ccCCCCC---CccceeccCccCchhhcC----------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHH
Q 011138 289 MLVPGEP---NISYICSRYYRAPELIFG----------ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGV-DQLVEIIK 354 (492)
Q Consensus 289 ~~~~~~~---~~~~~gt~~y~aPE~~~~----------~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~-~~~~~i~~ 354 (492)
....... ....+||+.|+|||++.+ ...++.++|||||||++|+|++|+.||...... ..+..+..
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 235 (343)
T 3dbq_A 156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 235 (343)
T ss_dssp CC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred ccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc
Confidence 7643332 235689999999999864 245899999999999999999999999875432 22222211
Q ss_pred HhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 355 ILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 355 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
.. .... ++...++++.+||.+||+.||.+|||+.|+++||||+....
T Consensus 236 ---~~------------~~~~------------~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 282 (343)
T 3dbq_A 236 ---PN------------HEIE------------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 282 (343)
T ss_dssp ---TT------------SCCC------------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred ---CC------------cccC------------CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence 00 0111 22346789999999999999999999999999999986544
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-47 Score=374.71 Aligned_cols=255 Identities=32% Similarity=0.485 Sum_probs=203.6
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------------hhHHHHHHHHHHcCCCCccccceeeeeccC
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE 204 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 204 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++..
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 86 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA--- 86 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES---
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC---
Confidence 47999999999999999999999999999999985432 235689999999999999999998732
Q ss_pred CCceEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCC--cEEE
Q 011138 205 KDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH--QLKI 281 (492)
Q Consensus 205 ~~~~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~--~vkL 281 (492)
.. +|+||||+.+ ++.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++. .+||
T Consensus 87 --~~-~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~~~kl 158 (322)
T 2ycf_A 87 --ED-YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKI 158 (322)
T ss_dssp --SS-EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSSSCCEEE
T ss_pred --Cc-eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEecCCCCCeEEE
Confidence 22 6899999986 4544332 24578999999999999999999997 99999999999999986552 4999
Q ss_pred eeecCccccCCCCCCccceeccCccCchhhc--CCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 011138 282 CDFGSAKMLVPGEPNISYICSRYYRAPELIF--GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTP 359 (492)
Q Consensus 282 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p 359 (492)
+|||+++............||+.|+|||++. +...++.++|||||||++|+|++|..||........+...+.....
T Consensus 159 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~- 237 (322)
T 2ycf_A 159 TDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY- 237 (322)
T ss_dssp CCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCC-
T ss_pred ccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcc-
Confidence 9999998764443334567999999999984 3455899999999999999999999999876544333332221100
Q ss_pred CHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
. +....+..+++++.+||.+||..||.+|||+.++++||||++.
T Consensus 238 ---------------~--------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 238 ---------------N--------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp ---------------C--------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred ---------------c--------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 0 0001123578999999999999999999999999999999863
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=365.30 Aligned_cols=252 Identities=19% Similarity=0.255 Sum_probs=202.4
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHc-CCCCccccceeeeeccCCCc
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~ 207 (492)
...+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.++..+ +||||+++++++.. .
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-----~ 83 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-----D 83 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-----T
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-----C
Confidence 345799999999999999999999999999999998642 23345788899998 89999999999843 3
Q ss_pred eEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCC----------
Q 011138 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT---------- 276 (492)
Q Consensus 208 ~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~---------- 276 (492)
..+++||||+++ +|.+.+.........+++..++.++.||+.||.|||+ +||+||||||+|||++.++
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~~~~~~~~~~~~~ 162 (289)
T 1x8b_A 84 DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS-MSLVHMDIKPSNIFISRTSIPNAASEEGD 162 (289)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-------------
T ss_pred CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeecCCCHHHEEEcCCCCCcccccccc
Confidence 468899999976 6777666554445778999999999999999999997 9999999999999998432
Q ss_pred --------CcEEEeeecCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 011138 277 --------HQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQ 348 (492)
Q Consensus 277 --------~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~ 348 (492)
..+||+|||++...... ....||+.|+|||++.+...++.++|||||||++|+|++|.+|+.....
T Consensus 163 ~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--- 236 (289)
T 1x8b_A 163 EDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--- 236 (289)
T ss_dssp -------CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---
T ss_pred cccccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---
Confidence 26999999999876432 2356999999999997765677899999999999999999988755432
Q ss_pred HHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 349 LVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 349 ~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
...+.. ..++ .++..+++++.+||.+||+.||.+|||+.|+++||||++.
T Consensus 237 ~~~~~~-------------------~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 237 WHEIRQ-------------------GRLP---------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHHHHT-------------------TCCC---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHHHHc-------------------CCCC---------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 222211 0111 1234579999999999999999999999999999999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=376.56 Aligned_cols=280 Identities=28% Similarity=0.471 Sum_probs=219.3
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCC-CEEEEEEeccch---hhHHHHHHHHHHcCCCC------ccccceeeeeccCCC
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETG-DSVAIKKVLQDK---RYKNRELQIMRLLNHPN------VVSLKHCFFSTTEKD 206 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g-~~vAiK~~~~~~---~~~~~E~~il~~l~h~n------Iv~l~~~~~~~~~~~ 206 (492)
.+|.+.+.||+|+||.||+|.+..++ +.||||++.... ....+|+.+++.++|++ ++.+++++. .
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~-----~ 93 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN-----F 93 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE-----E
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee-----e
Confidence 46999999999999999999998877 689999986533 34557999999998766 888888773 3
Q ss_pred ceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEE--------------
Q 011138 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV-------------- 272 (492)
Q Consensus 207 ~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl-------------- 272 (492)
...+|+||||++++++..+... ....+++..++.++.||+.||.|||+ +||+||||||+|||+
T Consensus 94 ~~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 94 HGHMCIAFELLGKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHE-NQLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp TTEEEEEEECCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred CCeEEEEEeccCCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEeccccccccccccc
Confidence 3468999999998888765432 23468999999999999999999997 999999999999999
Q ss_pred -----cCCCCcEEEeeecCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 011138 273 -----NPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD 347 (492)
Q Consensus 273 -----~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~ 347 (492)
+.++ .+||+|||+++... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+
T Consensus 171 ~~~~~~~~~-~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 171 CEEKSVKNT-SIRVADFGSATFDH--EHHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CCEEEESCC-CEEECCCTTCEETT--SCCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccCCC-cEEEeecCcccccc--ccccCCcCCCcccCCeeeecC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 3444 79999999998643 334467899999999999755 48999999999999999999999999999999
Q ss_pred HHHHHHHHhCCCCHHHHhhcCCCCc----ccCCCcc---------cCCCccc--ccCCCCChhHhhhhccccccCCCCcC
Q 011138 348 QLVEIIKILGTPTREEIKCMNPNYT----EFKFPQI---------KAHPWHK--IFHKRMPPEALDLVSRLLQYSPSLRC 412 (492)
Q Consensus 348 ~~~~i~~~~g~p~~~~~~~~~~~~~----~~~~~~~---------~~~~~~~--~~~~~~s~~~~~Li~~~L~~dP~~R~ 412 (492)
.+..+.+.++.++...+........ ...++.. ...++.. ......+.++.+||.+||+.||.+||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 9999999998888766543221000 0000000 0000000 01112345789999999999999999
Q ss_pred CHHHhhCCCCCCCCCC
Q 011138 413 TALEACAHPFFDDLRD 428 (492)
Q Consensus 413 t~~e~l~Hp~f~~~~~ 428 (492)
|+.|+++||||+++..
T Consensus 327 t~~e~l~hp~f~~~~~ 342 (355)
T 2eu9_A 327 TLAEALLHPFFAGLTP 342 (355)
T ss_dssp CHHHHTTSGGGGGCCH
T ss_pred CHHHHhcChhhcCCCh
Confidence 9999999999998754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=368.49 Aligned_cols=253 Identities=28% Similarity=0.451 Sum_probs=209.1
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++||||+++++++ .+...+|+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 83 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY-----ESTTHYYL 83 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhc-----ccCCEEEE
Confidence 4699999999999999999999999999999998643 23456899999999999999999988 44456899
Q ss_pred Eeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEE---cCCCCcEEEeeecCcc
Q 011138 213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSAK 288 (492)
Q Consensus 213 V~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl---~~~~~~vkL~DFG~a~ 288 (492)
||||+.+ ++.+.+.. ...+++..+..++.||+.||.|||+ +||+||||||+|||+ +.++ .+||+|||++.
T Consensus 84 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dikp~NIl~~~~~~~~-~~kl~Dfg~~~ 157 (304)
T 2jam_A 84 VMQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHE-NGIVHRDLKPENLLYLTPEENS-KIMITDFGLSK 157 (304)
T ss_dssp EECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCSCCGGGCEESSSSTTC-CEEBCSCSTTC
T ss_pred EEEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEecCCCCC-CEEEccCCcce
Confidence 9999975 55554432 3568899999999999999999997 999999999999999 5555 79999999997
Q ss_pred ccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
.... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+....
T Consensus 158 ~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~------------ 223 (304)
T 2jam_A 158 MEQN-GIMSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGY------------ 223 (304)
T ss_dssp CCCC-BTTHHHHSCCCBCCTTTBSSC-SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCC------------
T ss_pred ecCC-CccccccCCCCccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC------------
Confidence 5432 234456799999999998654 58999999999999999999999999888776666655411
Q ss_pred CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
+.++ ..++..+++++.+||.+||..||.+|||+.|+++||||+...
T Consensus 224 -----~~~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 224 -----YEFE--------SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp -----CCCC--------TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred -----CCCC--------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 1111 112346799999999999999999999999999999998753
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=396.32 Aligned_cols=253 Identities=18% Similarity=0.253 Sum_probs=193.7
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHH---HHHHcCCCCccccce-------ee
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQ---IMRLLNHPNVVSLKH-------CF 199 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~---il~~l~h~nIv~l~~-------~~ 199 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||||++... ...+.+|+. +++.++|||||++++ ++
T Consensus 73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~ 152 (377)
T 3byv_A 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152 (377)
T ss_dssp EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence 4699999999999999999999999999999998532 244568994 455568999999984 43
Q ss_pred eecc---------CCCce---EEEEEeeechhhHHHHhhhhhhcC---CCcCHHHHHHHHHHHHHHHHHHHhhCCcccCC
Q 011138 200 FSTT---------EKDEL---YLNLVLEYISETVYRVSKHYTRMN---QHVPILYVQLYTYQICRALNYLHHVVGVCHRD 264 (492)
Q Consensus 200 ~~~~---------~~~~~---~~~lV~E~~~~~l~~~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~yLH~~~givHrD 264 (492)
.... +.+.. ..||||||++|+|.+.+....... ..+++..+..|+.||+.||.|||+ +||+|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrD 231 (377)
T 3byv_A 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHTY 231 (377)
T ss_dssp ECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH-TTEECSC
T ss_pred hccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecCC
Confidence 2211 11111 378999999988887766533221 234457778899999999999997 9999999
Q ss_pred CCCCceEEcCCCCcEEEeeecCccccCCCCCCccceeccCccCchhhcCC----------CCCCcchhhHHHHHHHHHHH
Q 011138 265 IKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA----------TEYTTAIDMWSIGCVLAELL 334 (492)
Q Consensus 265 lKp~NILl~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DvwSlGvil~ell 334 (492)
|||+||||+.++ .+||+|||+++.. +......+| +.|+|||++.+. ..|+.++|||||||++|||+
T Consensus 232 ikp~NIll~~~~-~~kL~DFG~a~~~--~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ell 307 (377)
T 3byv_A 232 LRPVDIVLDQRG-GVFLTGFEHLVRD--GARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307 (377)
T ss_dssp CCGGGEEECTTC-CEEECCGGGCEET--TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHH
T ss_pred CCHHHEEEcCCC-CEEEEechhheec--CCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHH
Confidence 999999999887 8999999999854 333445677 999999999765 25899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCH
Q 011138 335 LGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA 414 (492)
Q Consensus 335 ~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~ 414 (492)
+|+.||.+.+.......+ +. ....+++++.+||.+||+.||.+|||+
T Consensus 308 tg~~Pf~~~~~~~~~~~~-----------------------~~----------~~~~~~~~~~~li~~~L~~dp~~Rpt~ 354 (377)
T 3byv_A 308 CADLPITKDAALGGSEWI-----------------------FR----------SCKNIPQPVRALLEGFLRYPKEDRLLP 354 (377)
T ss_dssp HSSCCC------CCSGGG-----------------------GS----------SCCCCCHHHHHHHHHHTCSSGGGCCCH
T ss_pred HCCCCCcccccccchhhh-----------------------hh----------hccCCCHHHHHHHHHHcCCCchhCCCH
Confidence 999999765432111100 00 114579999999999999999999999
Q ss_pred HHhhCCCCCCCCC
Q 011138 415 LEACAHPFFDDLR 427 (492)
Q Consensus 415 ~e~l~Hp~f~~~~ 427 (492)
.|+++||||++++
T Consensus 355 ~e~l~hp~f~~~~ 367 (377)
T 3byv_A 355 LQAMETPEYEQLR 367 (377)
T ss_dssp HHHHTSHHHHHHH
T ss_pred HHHhhChHHHHHH
Confidence 9999999998764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-47 Score=372.97 Aligned_cols=260 Identities=25% Similarity=0.369 Sum_probs=205.7
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
..+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++.... ....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCCc
Confidence 346999999999999999999999999999999986432 23457999999999999999999885544 2334
Q ss_pred EEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 209 ~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
+.|+||||+++ +|.+++.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISATN-AVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEETTS-CEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEcCCC-CEEEeeccCc
Confidence 56899999975 55544432 3568999999999999999999997 9999999999999999887 7999999999
Q ss_pred cccCCCC----CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 011138 288 KMLVPGE----PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (492)
Q Consensus 288 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~ 363 (492)
+...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+......++
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--- 239 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP--- 239 (311)
T ss_dssp ------------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCH---
T ss_pred ccccccccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCc---
Confidence 7654322 22345789999999999765 489999999999999999999999999887776666554211111
Q ss_pred HhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
......+++++.+||.+||+.||.+||++.+++.|+|++....
T Consensus 240 ----------------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 240 ----------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp ----------------------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred ----------------------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 1122457999999999999999999999999999999986543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=379.52 Aligned_cols=257 Identities=29% Similarity=0.473 Sum_probs=202.8
Q ss_pred cccceeEeeeeccCCceEEEEEEEc---CCCCEEEEEEeccc--------hhhHHHHHHHHHHc-CCCCccccceeeeec
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQD--------KRYKNRELQIMRLL-NHPNVVSLKHCFFST 202 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~---~~g~~vAiK~~~~~--------~~~~~~E~~il~~l-~h~nIv~l~~~~~~~ 202 (492)
...+|.+.+.||+|+||.||+|++. .+|+.||||++... .....+|+.+++.+ +||||+++++++..
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 130 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT- 130 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE-
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee-
Confidence 4467999999999999999999984 58999999988542 23345799999999 69999999998843
Q ss_pred cCCCceEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEE
Q 011138 203 TEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKI 281 (492)
Q Consensus 203 ~~~~~~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL 281 (492)
...+++||||+.+ +|...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||
T Consensus 131 ----~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kl 200 (355)
T 1vzo_A 131 ----ETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDSNG-HVVL 200 (355)
T ss_dssp ----TTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEE
T ss_pred ----CceEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-cEEE
Confidence 3458899999986 55554432 3568999999999999999999997 9999999999999999888 7999
Q ss_pred eeecCccccCCCC--CCccceeccCccCchhhcCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 011138 282 CDFGSAKMLVPGE--PNISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358 (492)
Q Consensus 282 ~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~ 358 (492)
+|||+++...... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||...........+...+-
T Consensus 201 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~- 279 (355)
T 1vzo_A 201 TDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL- 279 (355)
T ss_dssp SCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH-
T ss_pred eeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh-
Confidence 9999997653222 23346899999999999753 3478999999999999999999999976543222222222110
Q ss_pred CCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcC-----CHHHhhCCCCCCCCC
Q 011138 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLR 427 (492)
Q Consensus 359 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----t~~e~l~Hp~f~~~~ 427 (492)
. ... .++..+++.+++||.+||+.||.+|| ++.++++||||+.+.
T Consensus 280 -------~-----~~~------------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~ 329 (355)
T 1vzo_A 280 -------K-----SEP------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329 (355)
T ss_dssp -------H-----CCC------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred -------c-----cCC------------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence 0 000 12245789999999999999999999 999999999999764
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=365.00 Aligned_cols=256 Identities=25% Similarity=0.406 Sum_probs=204.5
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||+|++... .....+|+.+++.++||||+++++++.. ...+++
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 93 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH-----DGKLWI 93 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----C-CEEE
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee-----CCeEEE
Confidence 4699999999999999999999999999999988543 2345679999999999999999999843 345889
Q ss_pred EeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 213 V~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
||||++++.+.... ......+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++.....
T Consensus 94 v~e~~~~~~l~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 94 MIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQMLEALNFLHS-KRIIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLK 169 (302)
T ss_dssp EEECCTTEEHHHHH--HHHTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECTTS-CEEECCCHHHHHHHH
T ss_pred EEEeCCCCcHHHHH--HhhccCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEECCCC-CEEEEECCCCccccc
Confidence 99999875444322 1224568999999999999999999997 9999999999999999887 799999998753311
Q ss_pred -CCCCccceeccCccCchhhc----CCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 293 -GEPNISYICSRYYRAPELIF----GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 293 -~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
........||+.|+|||++. ....++.++|||||||++|+|++|..||...+....+..+... .+
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~-------- 239 (302)
T 2j7t_A 170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--DP-------- 239 (302)
T ss_dssp HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CC--------
T ss_pred cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhcc--CC--------
Confidence 11223467899999999984 3445899999999999999999999999988876666555441 00
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
+. ...+..++.++.+||.+||..||.+|||+.++++||||+.+.
T Consensus 240 ---------~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 240 ---------PT-------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp ---------CC-------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred ---------cc-------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 00 011235688999999999999999999999999999999865
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=359.55 Aligned_cols=259 Identities=26% Similarity=0.389 Sum_probs=211.0
Q ss_pred ccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
....+|.+.+.||+|+||.||+|.+..+|+.||+|++... .....+|+.+++.++||||+++++++.... .
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~ 79 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT---N 79 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG---G
T ss_pred CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC---C
Confidence 3456799999999999999999999999999999998542 234567999999999999999999875432 3
Q ss_pred eEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCC-----cccCCCCCCceEEcCCCCcEEE
Q 011138 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG-----VCHRDIKPQNLLVNPHTHQLKI 281 (492)
Q Consensus 208 ~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~g-----ivHrDlKp~NILl~~~~~~vkL 281 (492)
..+++||||+++ +|.+.+.........+++..+..++.||+.||.|||+ +| |+||||||+|||++.++ .+||
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~ivH~dl~p~NIl~~~~~-~~kl 157 (279)
T 2w5a_A 80 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDGKQ-NVKL 157 (279)
T ss_dssp TEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HC------CCCCCSGGGEEECSSS-CEEE
T ss_pred ceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc-ccCCCCeeEEeccchhhEEEcCCC-CEEE
Confidence 358899999985 6666665544445668999999999999999999997 88 99999999999999887 7999
Q ss_pred eeecCccccCCCCC-CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 011138 282 CDFGSAKMLVPGEP-NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPT 360 (492)
Q Consensus 282 ~DFG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~ 360 (492)
+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+...
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~----- 231 (279)
T 2w5a_A 158 GDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG----- 231 (279)
T ss_dssp CCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-----
T ss_pred ecCchheeeccccccccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhc-----
Confidence 99999976543221 2245789999999999765 4899999999999999999999999988766555544331
Q ss_pred HHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
.++ .++..+++++.+||.+||+.||.+|||+.|+++|+|+.+-
T Consensus 232 --------------~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 232 --------------KFR---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp --------------CCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred --------------ccc---------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 001 1223578999999999999999999999999999999863
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=365.29 Aligned_cols=261 Identities=25% Similarity=0.390 Sum_probs=204.8
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc---hhhHHHHHHHHHHc-CCCCccccceeeeeccC-CCceEE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTE-KDELYL 210 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~---~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~-~~~~~~ 210 (492)
..+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.+ +||||+++++++..... .....+
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 102 (326)
T 2x7f_A 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 102 (326)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceE
Confidence 44699999999999999999999999999999998543 34567899999999 79999999999865432 114568
Q ss_pred EEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 211 ~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
++||||+++ ++.+++... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 103 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~ 178 (326)
T 2x7f_A 103 WLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQ 178 (326)
T ss_dssp EEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECTTC-CEEECCCTTTC-
T ss_pred EEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCcHHHEEEcCCC-CEEEeeCcCcee
Confidence 899999986 555554432 23568899999999999999999997 9999999999999999887 799999999976
Q ss_pred cCCCC-CCccceeccCccCchhhcC----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 011138 290 LVPGE-PNISYICSRYYRAPELIFG----ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (492)
Q Consensus 290 ~~~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~ 364 (492)
..... ......||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+....+..+... +
T Consensus 179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~----- 250 (326)
T 2x7f_A 179 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---P----- 250 (326)
T ss_dssp ------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---C-----
T ss_pred cCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC---c-----
Confidence 53322 2345679999999999862 345889999999999999999999999887766655544331 0
Q ss_pred hhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
.+. .....+++++.+||.+||..||.+|||+.++++||||++..
T Consensus 251 -----------~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 251 -----------APR--------LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp -----------CCC--------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred -----------ccc--------CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 000 11235789999999999999999999999999999998753
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=363.33 Aligned_cols=255 Identities=27% Similarity=0.468 Sum_probs=210.3
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
.+|.+.+.||+|+||.||+|.+..+++.||||++... .....+|+.+++.++||||+++++++ .+...+
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 96 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSSSF 96 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEE-----eCCCeE
Confidence 4799999999999999999999999999999998542 23456899999999999999999998 344568
Q ss_pred EEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCC--CcEEEeeecCc
Q 011138 211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT--HQLKICDFGSA 287 (492)
Q Consensus 211 ~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~--~~vkL~DFG~a 287 (492)
++||||+.+ .+.+.+.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++ ..+||+|||++
T Consensus 97 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 999999975 45444332 3468999999999999999999997 9999999999999997643 26999999999
Q ss_pred cccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------ 237 (287)
T 2wei_A 172 TCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG------------ 237 (287)
T ss_dssp GTBCCCSSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred eeecCCCccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC------------
Confidence 87765555556779999999999865 3899999999999999999999999988776655555431
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
.+.++. ..+..+++++.+||.+||..||.+|||+.++++||||++...
T Consensus 238 -----~~~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 285 (287)
T 2wei_A 238 -----KYAFDL--------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (287)
T ss_dssp -----CCCCCS--------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred -----CCCCCc--------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence 011100 011357899999999999999999999999999999987643
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=369.41 Aligned_cols=268 Identities=26% Similarity=0.399 Sum_probs=190.9
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
...+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++||||+++++++.. ...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 87 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV-----KDE 87 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEES-----SSC
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee-----cCC
Confidence 345799999999999999999999999999999987533 2334579999999999999999998843 334
Q ss_pred EEEEeeechh-hHHHHhhhhhh----cCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeee
Q 011138 210 LNLVLEYISE-TVYRVSKHYTR----MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (492)
Q Consensus 210 ~~lV~E~~~~-~l~~~~~~~~~----~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DF 284 (492)
.++||||+.+ .+.+.+..... ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+||
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~df 165 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK-NGQIHRDVKAGNILLGEDG-SVQIADF 165 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECTTC-CEEECCC
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCCChhhEEEcCCC-CEEEEec
Confidence 8899999975 55555443221 23558999999999999999999997 9999999999999999887 7999999
Q ss_pred cCccccCCCC------CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 011138 285 GSAKMLVPGE------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358 (492)
Q Consensus 285 G~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~ 358 (492)
|++....... ......||+.|+|||++.+...++.++|||||||++|+|++|..||........+...... .
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~ 243 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN--D 243 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTS--S
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhcc--C
Confidence 9987654322 1234578999999999865445899999999999999999999999987766555443321 1
Q ss_pred CCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 359 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
+. ..............+++++.+||.+||+.||.+|||+.++++||||++...
T Consensus 244 ~~-----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 296 (303)
T 2vwi_A 244 PP-----------------SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296 (303)
T ss_dssp CC-----------------CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred CC-----------------ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence 10 000000001123467899999999999999999999999999999998654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=370.66 Aligned_cols=265 Identities=24% Similarity=0.382 Sum_probs=184.9
Q ss_pred cccceeEe-eeeccCCceEEEEEEEcCCCCEEEEEEeccchhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEE
Q 011138 135 QTISYMAE-RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 135 ~~~~y~~~-~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
...+|.+. ++||+|+||.||+|.+..+|+.||||++........+....++.++||||++++++|.... .+..++++|
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~lv 104 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMH-HGKRCLLII 104 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCceEEEE
Confidence 34579985 5799999999999999999999999999776655555556678889999999999885433 345678999
Q ss_pred eeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCC--CcEEEeeecCcccc
Q 011138 214 LEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT--HQLKICDFGSAKML 290 (492)
Q Consensus 214 ~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~--~~vkL~DFG~a~~~ 290 (492)
|||+.+ +|.+.+.. .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ ..+||+|||+++..
T Consensus 105 ~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~ 181 (336)
T 3fhr_A 105 MECMEGGELFSRIQE--RGDQAFTEREAAEIMRDIGTAIQFLHS-HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181 (336)
T ss_dssp EECCTTEEHHHHHHT--C-CCCCBHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EeccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence 999986 56555443 223468999999999999999999997 9999999999999997643 25999999999865
Q ss_pred CCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 011138 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (492)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 370 (492)
.. .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+...+..
T Consensus 182 ~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------ 247 (336)
T 3fhr_A 182 TQ-NALQTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL------------ 247 (336)
T ss_dssp -----------------------C-HHHHHHHHHHHHHHHHHHHHSSCCC------------------------------
T ss_pred cc-cccccCCCCcCccChhhhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc------------
Confidence 42 233456889999999998544 4889999999999999999999999776543322111110000
Q ss_pred CcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
....++. ..+..+++++++||.+||+.||.+|||+.|+++||||++.
T Consensus 248 -~~~~~~~--------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 248 -GQYGFPN--------PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ----CCCT--------TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred -cccccCc--------hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 0111111 1224579999999999999999999999999999999874
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=376.29 Aligned_cols=280 Identities=24% Similarity=0.396 Sum_probs=204.7
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
..+|.+.+.||+|+||.||+|.+..+|+.||+|++... .....+|+.+++.++||||+++++++.. ...+
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 106 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI 106 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-----TTEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-----CCEE
Confidence 35799999999999999999999999999999998643 2345689999999999999999999843 3458
Q ss_pred EEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 211 ~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
|+||||+.+ +|.+.+.. ...+++..+..++.||+.||.|||+..||+||||||+|||++.++ .+||+|||++..
T Consensus 107 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~ 181 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQ 181 (360)
T ss_dssp EEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHH
T ss_pred EEEEECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCC-CEEEEECCCCcc
Confidence 899999986 55554432 346889999999999999999999723999999999999999888 799999999875
Q ss_pred cCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh-CCCCHHHHhhc-
Q 011138 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKIL-GTPTREEIKCM- 367 (492)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~-g~p~~~~~~~~- 367 (492)
... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+....+.... +.+........
T Consensus 182 ~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3eqc_A 182 LID-SMANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 259 (360)
T ss_dssp HHH-HC----CCCCTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------
T ss_pred ccc-ccccCCCCCCCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCccc
Confidence 422 223456899999999999664 58999999999999999999999999877654433221111 11100000000
Q ss_pred -CCCCcccCCCc------------ccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 368 -NPNYTEFKFPQ------------IKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 368 -~~~~~~~~~~~------------~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
...+..+.... +............+++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp --------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred CCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 00000000000 0000000111234788999999999999999999999999999998754
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=361.62 Aligned_cols=254 Identities=28% Similarity=0.418 Sum_probs=204.6
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch--hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEe
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~--~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
..|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++.. ...+|+||
T Consensus 29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~ 103 (314)
T 3com_A 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFK-----NTDLWIVM 103 (314)
T ss_dssp -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEEEE
T ss_pred hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEEEEEe
Confidence 35999999999999999999999999999999986543 456689999999999999999999854 33588999
Q ss_pred eechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCC
Q 011138 215 EYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (492)
Q Consensus 215 E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (492)
||+++ .+.+.+. .....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++......
T Consensus 104 e~~~~~~L~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIR---LRNKTLTEDEIATILQSTLKGLEYLHF-MRKIHRDIKAGNILLNTEG-HAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHH---HHTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCcCHHHEEECCCC-CEEEeecccchhhhhh
Confidence 99987 4444433 224678999999999999999999997 9999999999999999887 7999999999765433
Q ss_pred C-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 011138 294 E-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372 (492)
Q Consensus 294 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~ 372 (492)
. ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+... .+
T Consensus 179 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~------------- 242 (314)
T 3com_A 179 MAKRNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN--PP------------- 242 (314)
T ss_dssp BSCBCCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CC-------------
T ss_pred ccccCccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC--CC-------------
Confidence 2 23456789999999999654 4899999999999999999999999887765554443221 00
Q ss_pred ccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
..+ ..+..+++++.+||.+||..||.+|||+.++++||||+...
T Consensus 243 -~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 243 -PTF----------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp -CCC----------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred -ccc----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 000 01234688999999999999999999999999999999754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=358.73 Aligned_cols=249 Identities=26% Similarity=0.400 Sum_probs=207.3
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
..|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++||||+++++++.. ...++
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 96 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKLW 96 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeEE
Confidence 3599999999999999999999999999999998533 2456689999999999999999998843 33588
Q ss_pred EEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 212 lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
+||||++++ +.+.+. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++...
T Consensus 97 lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~ 169 (303)
T 3a7i_A 97 IIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSEHG-EVKLADFGVAGQL 169 (303)
T ss_dssp EEEECCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred EEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChheEEECCCC-CEEEeecccceec
Confidence 999999874 444332 3568999999999999999999997 9999999999999999887 7999999999766
Q ss_pred CCCC-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 291 VPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 291 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
.... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+... .+
T Consensus 170 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~---------- 236 (303)
T 3a7i_A 170 TDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN--NP---------- 236 (303)
T ss_dssp BTTBCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CC----------
T ss_pred CccccccCccCCCcCccCHHHHhcC-CCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC--CC----------
Confidence 4333 23456789999999999654 4889999999999999999999999887766555444321 00
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
+ .+...+++++.+||.+||..||.+|||+.++++||||...
T Consensus 237 -------~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 237 -------P---------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp -------C---------CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred -------C---------CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 0 1224578999999999999999999999999999999764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=361.91 Aligned_cols=254 Identities=23% Similarity=0.378 Sum_probs=194.7
Q ss_pred ccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
....+|.+.+.||+|+||+||+|.+ +|+.||||++.... ....+|+.+++.++||||+++++++ .+.
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~ 106 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV-----TQP 106 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CST
T ss_pred CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EEC
Confidence 3445799999999999999999987 68899999985432 2345799999999999999999998 344
Q ss_pred eEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCC--cccCCCCCCceEEcCCCCcEEEeee
Q 011138 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG--VCHRDIKPQNLLVNPHTHQLKICDF 284 (492)
Q Consensus 208 ~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~g--ivHrDlKp~NILl~~~~~~vkL~DF 284 (492)
..+++||||+.+ ++.+.+.. ......+++..+..++.||+.||.|||+ +| |+||||||+|||++.++ .+||+||
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~ivH~Dikp~NIll~~~~-~~kL~Df 183 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKY-TVKVCDF 183 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHS-TTHHHHSCHHHHHHHHHHHHHHHHHHHT-SSSCCCCTTCCGGGEEECTTC-CEEECCC
T ss_pred CceEEEEecCCCCcHHHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEECCCCChhhEEEeCCC-cEEECCC
Confidence 457899999986 55554432 1112348899999999999999999997 89 99999999999999887 7999999
Q ss_pred cCccccCCCC-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 011138 285 GSAKMLVPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (492)
Q Consensus 285 G~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~ 363 (492)
|+++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 184 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~------- 255 (309)
T 3p86_A 184 GLSRLKASTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC------- 255 (309)
T ss_dssp C-----------------CCTTSCHHHHTTC-CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSC-------
T ss_pred CCCccccccccccccCCCCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-------
Confidence 9997543322 23456899999999999765 48999999999999999999999999887766555443210
Q ss_pred HhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC--CCCCCC
Q 011138 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA--HPFFDD 425 (492)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~--Hp~f~~ 425 (492)
... .++..+++++.+||.+||+.||.+|||+.++++ ++|++.
T Consensus 256 --------~~~------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 256 --------KRL------------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp --------CCC------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred --------CCC------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 001 123467899999999999999999999999987 555554
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=358.97 Aligned_cols=257 Identities=25% Similarity=0.405 Sum_probs=197.9
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEe
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
|....+||+|+||.||+|.+..+++.||||.+... .....+|+.+++.++||||+++++++.. ...+++||
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~ 98 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-----NGFIKIFM 98 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEEEE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-----CCcEEEEE
Confidence 33344899999999999999999999999988543 2345689999999999999999999843 34588999
Q ss_pred eechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCC
Q 011138 215 EYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (492)
Q Consensus 215 E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (492)
||+.+ .+...+.. ......+++..++.++.||+.||.|||+ +||+||||||+|||++...+.+||+|||++......
T Consensus 99 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 99 EQVPGGSLSALLRS-KWGPLKDNEQTIGFYTKQILEGLKYLHD-NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp ECCSEEEHHHHHHH-TTCCCTTCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred EeCCCCCHHHHHHh-hccCCCccHHHHHHHHHHHHHHHHHHHh-CCEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 99975 44444432 2223456788899999999999999997 999999999999999873338999999999866432
Q ss_pred C-CCccceeccCccCchhhcCC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 011138 294 E-PNISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371 (492)
Q Consensus 294 ~-~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~ 371 (492)
. ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||..................
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------- 243 (295)
T 2clq_A 177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV------------- 243 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC-------------
T ss_pred CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc-------------
Confidence 2 23356789999999998653 23789999999999999999999999765433322111111100
Q ss_pred cccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
...++..+++++.+||.+||+.||++||++.++++||||+....
T Consensus 244 -------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 287 (295)
T 2clq_A 244 -------------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK 287 (295)
T ss_dssp -------------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred -------------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence 00123457899999999999999999999999999999997543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=357.64 Aligned_cols=258 Identities=25% Similarity=0.363 Sum_probs=197.9
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch---hhHHHHHHHHHHcCCCCccccceeeeeccC--------C
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTE--------K 205 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~---~~~~~E~~il~~l~h~nIv~l~~~~~~~~~--------~ 205 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++..... .
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence 46999999999999999999999999999999986543 334579999999999999999998865321 3
Q ss_pred CceEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeee
Q 011138 206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (492)
Q Consensus 206 ~~~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DF 284 (492)
+...+|+||||+++ ++.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~Nil~~~~~-~~kl~df 160 (303)
T 1zy4_A 86 KKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHS-QGIIHRDLKPMNIFIDESR-NVKIGDF 160 (303)
T ss_dssp CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECCC
T ss_pred cCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHh-CCeecccCCHHhEEEcCCC-CEEEeeC
Confidence 35678999999976 56555432 23457788899999999999999997 9999999999999999887 7999999
Q ss_pred cCccccCCC---------------CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Q 011138 285 GSAKMLVPG---------------EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQL 349 (492)
Q Consensus 285 G~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~ 349 (492)
|++...... .......||+.|+|||++.+...++.++|||||||++|+|++ ||.........
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~ 237 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI 237 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence 999765321 122356789999999999776678999999999999999998 55433222222
Q ss_pred HHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 350 VEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 350 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
...+.. ....+| ..+....++.+++||.+||+.||.+|||+.++++||||+..
T Consensus 238 ~~~~~~----------------~~~~~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 238 LKKLRS----------------VSIEFP--------PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHHS----------------TTCCCC--------TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred HHhccc----------------cccccC--------ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 221110 001111 11334578889999999999999999999999999999853
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=359.97 Aligned_cols=255 Identities=27% Similarity=0.381 Sum_probs=201.3
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
.+|.+.+.||+|+||.||+|.+..+++.||||++... .....+|+.+++.++||||+++++++ .+...
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~~~ 85 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EEDDC 85 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----ECSSE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----eeCCe
Confidence 4699999999999999999999999999999988432 13456899999999999999999988 44556
Q ss_pred EEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 210 ~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
+|+||||+++ ++.+.+.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus 86 ~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~ 159 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHD-MRIVHRDIKPQNILIDSNK-TLKIFDFGIAK 159 (294)
T ss_dssp EEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCCSSST
T ss_pred EEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCC-CEEEEeCCCcc
Confidence 8999999986 55554432 3568999999999999999999997 9999999999999999888 79999999998
Q ss_pred ccCCCC--CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 011138 289 MLVPGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (492)
Q Consensus 289 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~ 366 (492)
...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.....+.. ..
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~--~~------- 229 (294)
T 4eqm_A 160 ALSETSLTQTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQD--SV------- 229 (294)
T ss_dssp TC-------------CCSSCCHHHHHTCC-CCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSS--CC-------
T ss_pred ccccccccccCccccCccccCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc--cC-------
Confidence 664332 223467999999999997654 899999999999999999999999988776655444321 00
Q ss_pred cCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
+. ....+...+++.+.++|.+||+.||.+||+..+.+.+.|..-+.
T Consensus 230 ----------~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 230 ----------PN-----VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp ----------CC-----HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred ----------CC-----cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 00 01113356899999999999999999999777777777765443
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=369.26 Aligned_cols=273 Identities=19% Similarity=0.342 Sum_probs=206.7
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch---------------------hhHHHHHHHHHHcCCCCccc
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---------------------RYKNRELQIMRLLNHPNVVS 194 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~---------------------~~~~~E~~il~~l~h~nIv~ 194 (492)
..+|.+.+.||+|+||.||+|.+ +|+.||||++.... ....+|+.+++.++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 45799999999999999999998 89999999985432 55678999999999999999
Q ss_pred cceeeeeccCCCceEEEEEeeechh-hHHHHhh----hhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCc
Q 011138 195 LKHCFFSTTEKDELYLNLVLEYISE-TVYRVSK----HYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQN 269 (492)
Q Consensus 195 l~~~~~~~~~~~~~~~~lV~E~~~~-~l~~~~~----~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~N 269 (492)
+++++. +...+|+||||+++ +|.+.+. ........+++..++.++.||+.||.|||+.+||+||||||+|
T Consensus 108 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N 182 (348)
T 2pml_X 108 CEGIIT-----NYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182 (348)
T ss_dssp CSEEEE-----SSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred EEEEEe-----eCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence 999984 34468999999987 4433211 0111146789999999999999999999942799999999999
Q ss_pred eEEcCCCCcEEEeeecCccccCCCCCCccceeccCccCchhhcCCCCCCc-chhhHHHHHHHHHHHhCCCCCCCCCh-HH
Q 011138 270 LLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTT-AIDMWSIGCVLAELLLGQPLFPGESG-VD 347 (492)
Q Consensus 270 ILl~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~DvwSlGvil~ell~G~~pf~~~~~-~~ 347 (492)
||++.++ .+||+|||++...... ......||+.|+|||++.+...++. ++|||||||++|+|++|..||.+.+. .+
T Consensus 183 il~~~~~-~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 183 ILMDKNG-RVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp EEECTTS-CEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred EEEcCCC-cEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 9999888 7999999999875433 3345678999999999976645666 99999999999999999999998776 44
Q ss_pred HHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 348 QLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 348 ~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
....+... .+.. ......+..+. . ..........+++++.+||.+||+.||.+|||+.|+++||||++..
T Consensus 261 ~~~~i~~~--~~~~------~~~~~~~~~~~-~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 261 LFNNIRTK--NIEY------PLDRNHFLYPL-T-NKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp HHHHHTSC--CCCC------CCSSSSSTTTT-C-C--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred HHHHHhcc--CcCC------ccchhhhhccc-c-ccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 33333221 0000 00000000000 0 0000112256899999999999999999999999999999999753
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=360.31 Aligned_cols=258 Identities=25% Similarity=0.377 Sum_probs=189.2
Q ss_pred ccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
....+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....++..+++.++||||+++++++. +.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~-----~~ 96 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI-----TN 96 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe-----cC
Confidence 34567999999999999999999999999999999985432 12234555688889999999999984 34
Q ss_pred eEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhC-CcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV-GVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 208 ~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~-givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
..+++||||+++.+..+.. .....+++..+..++.||+.||.|||+ + ||+||||||+|||++.++ .+||+|||+
T Consensus 97 ~~~~lv~e~~~~~~~~l~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~ 171 (318)
T 2dyl_A 97 TDVFIAMELMGTCAEKLKK---RMQGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERG-QIKLCDFGI 171 (318)
T ss_dssp SEEEEEECCCSEEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHH-HHCCCCCCCCGGGEEECTTS-CEEECCCTT
T ss_pred CcEEEEEeccCCcHHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHh-hCCEEeCCCCHHHEEECCCC-CEEEEECCC
Confidence 4689999999654444332 224678999999999999999999996 5 999999999999999887 799999999
Q ss_pred ccccCCCCCCccceeccCccCchhhc----CCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCH
Q 011138 287 AKMLVPGEPNISYICSRYYRAPELIF----GATEYTTAIDMWSIGCVLAELLLGQPLFPGES-GVDQLVEIIKILGTPTR 361 (492)
Q Consensus 287 a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~-~~~~~~~i~~~~g~p~~ 361 (492)
+.............||+.|+|||++. ....++.++|||||||++|+|++|+.||.... ..+.+..+... .+
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~-- 247 (318)
T 2dyl_A 172 SGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE--EP-- 247 (318)
T ss_dssp C--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHS--CC--
T ss_pred chhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhcc--CC--
Confidence 98765555555678999999999985 23458899999999999999999999998744 33444444331 00
Q ss_pred HHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
..++ ....+++++.+||.+||+.||.+||++.++++||||++..
T Consensus 248 ------------~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 248 ------------PLLP----------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE 291 (318)
T ss_dssp ------------CCCC----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred ------------CCCC----------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence 0011 1124789999999999999999999999999999998654
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=363.83 Aligned_cols=262 Identities=26% Similarity=0.359 Sum_probs=185.1
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-----hhHHHHHH-HHHHcCCCCccccceeeeeccCCCce
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQ-IMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-----~~~~~E~~-il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
...+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+. +++.++||||+++++++. +..
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~-----~~~ 94 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF-----REG 94 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE-----CSS
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE-----eCC
Confidence 3457999999999999999999999999999999985432 12223444 677789999999999984 334
Q ss_pred EEEEEeeechhhHHHHhhhhhh-cCCCcCHHHHHHHHHHHHHHHHHHHhhC-CcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 209 YLNLVLEYISETVYRVSKHYTR-MNQHVPILYVQLYTYQICRALNYLHHVV-GVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 209 ~~~lV~E~~~~~l~~~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~yLH~~~-givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
..++||||+.+++...+..... ....+++..+..++.||+.||.|||+ . ||+||||||+|||++.++ .+||+|||+
T Consensus 95 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~ 172 (327)
T 3aln_A 95 DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE-NLKIIHRDIKPSNILLDRSG-NIKLCDFGI 172 (327)
T ss_dssp EEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH-HHSCCCSCCCGGGEEEETTT-EEEECCCSS
T ss_pred ceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc-cCCEeECCCCHHHEEEcCCC-CEEEccCCC
Confidence 6889999999987776554322 35678999999999999999999997 7 999999999999999887 899999999
Q ss_pred ccccCCCCCCccceeccCccCchhhc---CCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHH
Q 011138 287 AKMLVPGEPNISYICSRYYRAPELIF---GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD-QLVEIIKILGTPTRE 362 (492)
Q Consensus 287 a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~-~~~~i~~~~g~p~~~ 362 (492)
++............||+.|+|||++. ....++.++|||||||++|+|++|..||.+..... .+..+
T Consensus 173 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---------- 242 (327)
T 3aln_A 173 SGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV---------- 242 (327)
T ss_dssp SCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCC----------
T ss_pred ceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHH----------
Confidence 98765544445568999999999983 23458999999999999999999999998654211 11000
Q ss_pred HHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
.....+. +.......+++++.+||.+||+.||.+|||+.++++||||....
T Consensus 243 ---------~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 243 ---------VKGDPPQ-----LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp ---------CCSCCCC-----CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred ---------hcCCCCC-----CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 0000011 11112245789999999999999999999999999999998643
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=365.44 Aligned_cols=247 Identities=26% Similarity=0.417 Sum_probs=203.4
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch----------hhHHHHHHHHHHcC--CCCccccceeeeecc
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----------RYKNRELQIMRLLN--HPNVVSLKHCFFSTT 203 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~----------~~~~~E~~il~~l~--h~nIv~l~~~~~~~~ 203 (492)
..+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.+. |+||+++++++
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~---- 117 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF---- 117 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE----
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE----
Confidence 346999999999999999999999999999999985432 23347999999996 59999999998
Q ss_pred CCCceEEEEEeeech--hhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEE
Q 011138 204 EKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKI 281 (492)
Q Consensus 204 ~~~~~~~~lV~E~~~--~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL 281 (492)
.+...+++|||++. +++.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.+.+.+||
T Consensus 118 -~~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 118 -ERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp -ECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEE
T ss_pred -ecCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeCCCCHHHEEEeCCCCCEEE
Confidence 34446889999997 556655433 3568899999999999999999997 999999999999999844348999
Q ss_pred eeecCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 011138 282 CDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTR 361 (492)
Q Consensus 282 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~ 361 (492)
+|||+++.... .......||+.|+|||++.+...++.++|||||||++|+|++|..||..... +..
T Consensus 192 ~Dfg~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~------- 257 (320)
T 3a99_A 192 IDFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR------- 257 (320)
T ss_dssp CCCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH-------
T ss_pred eeCcccccccc-ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhc-------
Confidence 99999987643 3344567999999999997766568899999999999999999999965321 111
Q ss_pred HHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
... .+...+++++.+||.+||+.||.+|||+.++++||||++...
T Consensus 258 ----------~~~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 302 (320)
T 3a99_A 258 ----------GQV------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 302 (320)
T ss_dssp ----------CCC------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred ----------ccc------------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence 000 122457899999999999999999999999999999998653
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=360.69 Aligned_cols=247 Identities=19% Similarity=0.216 Sum_probs=198.1
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc--hhhHHHHHHHHHHc-CCCCccccceeeeeccCCCceEEEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~--~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.+ +||||+++++++.. ..+.++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----~~~~~lv 83 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC-----GKYNAMV 83 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEE-----TTEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEec-----CCccEEE
Confidence 4699999999999999999999999999999988543 34567899999999 89999999998843 3468999
Q ss_pred eeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCc-----EEEeeecCcc
Q 011138 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQ-----LKICDFGSAK 288 (492)
Q Consensus 214 ~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~-----vkL~DFG~a~ 288 (492)
|||++++|.+++... ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++ . +||+|||+++
T Consensus 84 ~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~Nill~~~~-~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 84 LELLGPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHS-KNLIYRDVKPENFLIGRPG-NKTQQVIHIIDFALAK 158 (330)
T ss_dssp EECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECCGG-GTCTTSEEECCCTTCE
T ss_pred EEeCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeeccCC-CCCCceEEEEEcccce
Confidence 999977777765432 4579999999999999999999997 9999999999999998776 4 9999999998
Q ss_pred ccCCCCC--------CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhC
Q 011138 289 MLVPGEP--------NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGV---DQLVEIIKILG 357 (492)
Q Consensus 289 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~---~~~~~i~~~~g 357 (492)
....... .....||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+.. +.+..+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~ 237 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGK-EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR 237 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCC-CCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence 7643322 2457899999999999764 4899999999999999999999999885433 33333322111
Q ss_pred CCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 358 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 358 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
..+... +....+ ++.+||.+||..||.+||++.++++
T Consensus 238 ~~~~~~------------------------~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 238 ATPIEV------------------------LCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HSCHHH------------------------HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cCCHHH------------------------HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 111110 112234 8999999999999999999988775
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=358.42 Aligned_cols=253 Identities=25% Similarity=0.433 Sum_probs=199.0
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
..+|.+++.||+|+||+||+|.+..+|+.||+|++... ...+.+|+.+++.++||||+++++++.. ...++
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~ 83 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-----DKRLN 83 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-----CCeeE
Confidence 35799999999999999999999999999999988542 2345689999999999999999999853 34588
Q ss_pred EEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 212 lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
+||||+.+ ++.+.+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus 84 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~ 158 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHS-MNIIHRDLNSHNCLVRENK-NVVVADFGLARLM 158 (310)
T ss_dssp EEEECCTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEECTTS-CEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCcCeEEECCCC-CEEEeecccceec
Confidence 99999987 45444332 24668999999999999999999997 9999999999999999887 7999999999765
Q ss_pred CCCCCC---------------ccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 011138 291 VPGEPN---------------ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKI 355 (492)
Q Consensus 291 ~~~~~~---------------~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~ 355 (492)
...... ...+||+.|+|||++.+. .++.++|||||||++|+|++|..||..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~----- 232 (310)
T 3s95_A 159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR-SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF----- 232 (310)
T ss_dssp C--------------------CCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS-----
T ss_pred ccccccccccccccccccccccccCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH-----
Confidence 332211 146799999999999664 58999999999999999999999987543211000
Q ss_pred hCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 356 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
...........++..+++++.+||.+||+.||++|||+.++++ |++.++
T Consensus 233 ---------------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~ 281 (310)
T 3s95_A 233 ---------------------GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLR 281 (310)
T ss_dssp ---------------------SBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHH
T ss_pred ---------------------hhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHH
Confidence 0000000001123467899999999999999999999999987 666543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=369.36 Aligned_cols=254 Identities=20% Similarity=0.215 Sum_probs=202.2
Q ss_pred ccceeEeeeeccCCceEEEEEE-----EcCCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCC
Q 011138 136 TISYMAERVVGTGSFGVVFQAK-----CLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~-----~~~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 205 (492)
..+|.+.+.||+|+||.||+|. +..+++.||||++... .....+|+.+++.++|||||++++++.
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~----- 144 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL----- 144 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe-----
Confidence 4579999999999999999999 4457789999998532 233557999999999999999999983
Q ss_pred CceEEEEEeeechh-hHHHHhhhhhh---cCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCC--CcE
Q 011138 206 DELYLNLVLEYISE-TVYRVSKHYTR---MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT--HQL 279 (492)
Q Consensus 206 ~~~~~~lV~E~~~~-~l~~~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~--~~v 279 (492)
+....++||||+.+ +|.+++..... ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ ..+
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEEecCCCCceE
Confidence 34447899999975 66665544321 22458899999999999999999997 9999999999999998544 259
Q ss_pred EEeeecCccccCC---CCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 011138 280 KICDFGSAKMLVP---GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKI 355 (492)
Q Consensus 280 kL~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~ 355 (492)
||+|||+++.... ........||+.|+|||++.+. .++.++|||||||++|||++ |..||.+.+..+.+..+...
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~ 302 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 302 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999975421 2233456789999999999765 48999999999999999998 99999998876665554331
Q ss_pred hCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCC
Q 011138 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424 (492)
Q Consensus 356 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~ 424 (492)
.. . ..+..+++++.+||.+||+.||.+|||+.++++|.|+-
T Consensus 303 ~~----------------~------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 303 GR----------------M------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp CC----------------C------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC----------------C------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 10 0 01235789999999999999999999999999988764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=364.02 Aligned_cols=250 Identities=22% Similarity=0.335 Sum_probs=199.8
Q ss_pred cccceeEeeeeccCCceEEEEEEEc-------CCCCEEEEEEeccch-----hhHHHHHHHHHHc-CCCCccccceeeee
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCL-------ETGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFS 201 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~-------~~g~~vAiK~~~~~~-----~~~~~E~~il~~l-~h~nIv~l~~~~~~ 201 (492)
...+|.+++.||+|+||.||+|.+. .++..||||++.... ....+|+.+++.+ +||||+++++++
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~-- 156 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC-- 156 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE--
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE--
Confidence 3457999999999999999999875 345679999986432 3356899999999 899999999998
Q ss_pred ccCCCceEEEEEeeechh-hHHHHhhhhhh------------cCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCC
Q 011138 202 TTEKDELYLNLVLEYISE-TVYRVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQ 268 (492)
Q Consensus 202 ~~~~~~~~~~lV~E~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~ 268 (492)
.+...+|+||||+.+ +|.+++..... ....+++..+..++.||+.||.|||+ +||+||||||+
T Consensus 157 ---~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~ 232 (370)
T 2psq_A 157 ---TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAAR 232 (370)
T ss_dssp ---CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGG
T ss_pred ---ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchh
Confidence 344458899999986 56555543221 12457889999999999999999997 99999999999
Q ss_pred ceEEcCCCCcEEEeeecCccccCCCC---CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCC
Q 011138 269 NLLVNPHTHQLKICDFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGES 344 (492)
Q Consensus 269 NILl~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~ 344 (492)
||||+.++ .+||+|||+++...... ......+|+.|+|||++.+. .|+.++|||||||++|||++ |..||.+..
T Consensus 233 NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 233 NVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp GEEECTTC-CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hEEECCCC-CEEEccccCCcccCcccceecccCCCcccceECHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999888 79999999998654332 22345678899999999765 48999999999999999999 999999877
Q ss_pred hHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 345 GVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 345 ~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
..+.+..+.... .. ..+..+++++.+||.+||+.||.+|||+.|++++
T Consensus 311 ~~~~~~~~~~~~----------------~~------------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 311 VEELFKLLKEGH----------------RM------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp GGGHHHHHHTTC----------------CC------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcCC----------------CC------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 665554432210 00 1223578999999999999999999999999863
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=349.89 Aligned_cols=249 Identities=18% Similarity=0.224 Sum_probs=201.2
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc--hhhHHHHHHHHHHc-CCCCccccceeeeeccCCCceEEEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~--~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.+ +|+||+++++++ .+....++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~~lv 84 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHNVLV 84 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeec-----CCCceeEEE
Confidence 3699999999999999999999999999999988543 34567899999999 799999999987 334468899
Q ss_pred eeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCC----cEEEeeecCccc
Q 011138 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH----QLKICDFGSAKM 289 (492)
Q Consensus 214 ~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~----~vkL~DFG~a~~ 289 (492)
|||++++|.+++... ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++. .+||+|||+++.
T Consensus 85 ~e~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 85 IDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp EECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEecCCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 999977777765432 3468999999999999999999997 99999999999999986652 399999999987
Q ss_pred cCCCCC--------CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCC
Q 011138 290 LVPGEP--------NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES---GVDQLVEIIKILGT 358 (492)
Q Consensus 290 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~---~~~~~~~i~~~~g~ 358 (492)
...... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+ ..+.+..+......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 643322 3456799999999999664 48999999999999999999999998853 33333333332211
Q ss_pred CCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 359 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
++.. .+...+++++.+||.+||+.||.+||++.++++
T Consensus 240 ~~~~------------------------~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 240 TPLR------------------------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp SCHH------------------------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ccHH------------------------HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 1111 112357899999999999999999999999876
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=357.57 Aligned_cols=261 Identities=19% Similarity=0.261 Sum_probs=187.4
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCC---EEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCC
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~---~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 206 (492)
..+|.+.+.||+|+||.||+|.+..++. .||||++... .....+|+.+++.++||||+++++++......+
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 3469999999999999999999877765 8999988543 234568999999999999999999985543221
Q ss_pred -ceEEEEEeeechh-hHHHHhhhhhh--cCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEe
Q 011138 207 -ELYLNLVLEYISE-TVYRVSKHYTR--MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC 282 (492)
Q Consensus 207 -~~~~~lV~E~~~~-~l~~~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~ 282 (492)
....++||||+.+ ++...+..... ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~Dikp~NIli~~~~-~~kl~ 179 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS-RNFIHRDLAARNCMLAEDM-TVCVA 179 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTS-CEEEC
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc-CCcccCCCCcceEEEcCCC-CEEEe
Confidence 1224899999987 45554433221 12258899999999999999999997 9999999999999999887 79999
Q ss_pred eecCccccCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 011138 283 DFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGT 358 (492)
Q Consensus 283 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~ 358 (492)
|||+++....... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-- 256 (323)
T 3qup_A 180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN-- 256 (323)
T ss_dssp CCCC-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC--
T ss_pred eccccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC--
Confidence 9999986643322 2234567889999999765 48999999999999999999 999999888776665554310
Q ss_pred CCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCC-------HHHhhCCCCCCCCC
Q 011138 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-------ALEACAHPFFDDLR 427 (492)
Q Consensus 359 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-------~~e~l~Hp~f~~~~ 427 (492)
.. ..+..+++++.+||.+||+.||.+||| +.++++|||+....
T Consensus 257 --------------~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~ 306 (323)
T 3qup_A 257 --------------RL------------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS 306 (323)
T ss_dssp --------------CC------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred --------------CC------------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence 00 112457899999999999999999999 77888999998743
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=347.51 Aligned_cols=246 Identities=20% Similarity=0.321 Sum_probs=200.6
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc---hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
...+|.+.+.||+|+||.||+|.+. +++.||+|++... .....+|+.+++.++||||+++++++ .+...++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 81 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAPIC 81 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSEE
T ss_pred ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCceE
Confidence 3457999999999999999999976 5778999998653 34567899999999999999999998 3444588
Q ss_pred EEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 212 lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
+||||++++ +.+.+. .....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus 82 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~ 156 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFV 156 (269)
T ss_dssp EEEECCTTCBHHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECGGG-CEEECCTTGGGGB
T ss_pred EEEEeCCCCcHHHHHH---hcCcccCHHHHHHHHHHHHHHHHHHHh-CCeecCCcchheEEEcCCC-CEEeccccccccc
Confidence 999999875 444432 223568999999999999999999997 9999999999999999887 7999999999865
Q ss_pred CCCC--CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 291 VPGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 291 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
.... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~---------- 225 (269)
T 4hcu_A 157 LDDQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR---------- 225 (269)
T ss_dssp CCHHHHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC----------
T ss_pred cccccccccCcccccccCCHHHhcCCC-CCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCcc----------
Confidence 3322 223455678899999996554 8999999999999999999 9999998887666655533100
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
...+..+++++.+||.+||+.||.+|||+.++++|
T Consensus 226 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 226 ------------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp ------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 01123468999999999999999999999999875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=375.03 Aligned_cols=272 Identities=22% Similarity=0.328 Sum_probs=201.4
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+++++.++||||+++++++... +....|
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~~~~~ 85 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHKV 85 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccC---CCCeeE
Confidence 4699999999999999999999999999999998643 23445899999999999999999987543 233578
Q ss_pred EEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEE----cCCCCcEEEeeecC
Q 011138 212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV----NPHTHQLKICDFGS 286 (492)
Q Consensus 212 lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl----~~~~~~vkL~DFG~ 286 (492)
+||||+.+ ++...+.. ......+++..++.++.||+.||.|||+ +||+||||||+|||+ +.++ .+||+|||+
T Consensus 86 lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~~~-~~kL~DFG~ 162 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDGQS-VYKLTDFGA 162 (396)
T ss_dssp EEECCCTTEEHHHHTTS-GGGTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEECTTSCE-EEEECCGGG
T ss_pred EEEecCCCCCHHHHHHh-hhcccCCCHHHHHHHHHHHHHHHHHHHH-CCEEECCcCHHHEEEeecCCCce-eEEEecCCC
Confidence 99999975 55554433 2223348999999999999999999997 999999999999998 5554 699999999
Q ss_pred ccccCCCCCCccceeccCccCchhhcCC-------CCCCcchhhHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHH
Q 011138 287 AKMLVPGEPNISYICSRYYRAPELIFGA-------TEYTTAIDMWSIGCVLAELLLGQPLFPGES----GVDQLVEIIKI 355 (492)
Q Consensus 287 a~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DvwSlGvil~ell~G~~pf~~~~----~~~~~~~i~~~ 355 (492)
++............||+.|+|||++.+. ..++.++|||||||++|||++|+.||.... ..+.+..+..
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~- 241 (396)
T 4eut_A 163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT- 241 (396)
T ss_dssp CEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH-
T ss_pred ceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc-
Confidence 9877665555667899999999998541 347889999999999999999999997533 2333333332
Q ss_pred hCCCCHHHHhhcCC-CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 356 LGTPTREEIKCMNP-NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 356 ~g~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
+.|. ..+..... ....+.+.. ..+....+...+++.+.+||.+||+.||++||++.++++
T Consensus 242 -~~p~-~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 242 -GKPS-GAISGVQKAENGPIDWSG--DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp -SCCT-TCCEEEECSTTCCEEEES--SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred -CCCc-ccchhheeccCCCcccCc--cCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 2222 11111000 000000000 000011122345678899999999999999999999754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=357.82 Aligned_cols=246 Identities=22% Similarity=0.327 Sum_probs=197.9
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCE---EEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCC
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDS---VAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~---vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 206 (492)
...+|.+.+.||+|+||.||+|.+..+|+. ||||++... ...+.+|+.+++.++||||+++++++ .+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 121 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV-----TR 121 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CG
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence 345799999999999999999999866654 999998643 23456799999999999999999998 44
Q ss_pred ceEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeec
Q 011138 207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (492)
Q Consensus 207 ~~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG 285 (492)
...+|+||||+.+ +|.+++. .....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~-~~kl~Dfg 196 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLR---THDGQFTIMQLVGMLRGVGAGMRYLSD-LGYVHRDLAARNVLVDSNL-VCKVSDFG 196 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHH---TTTTCSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCCS
T ss_pred CCccEEEeeCCCCCcHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEECCCC-CEEECCCC
Confidence 4458899999976 5544432 223568999999999999999999997 9999999999999999887 79999999
Q ss_pred CccccCCCCC----CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 011138 286 SAKMLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPT 360 (492)
Q Consensus 286 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~ 360 (492)
+++....... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+....+.....
T Consensus 197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~--- 272 (325)
T 3kul_A 197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYR--- 272 (325)
T ss_dssp SCEECC----CCEECC---CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC---
T ss_pred cccccccCccceeeccCCCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCC---
Confidence 9987643321 1223457789999999755 48999999999999999998 9999998887766655543110
Q ss_pred HHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.+ .+..+++++.+||.+||..||.+|||+.++++
T Consensus 273 ---------------~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 273 ---------------LP----------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp ---------------CC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CC----------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 00 12357899999999999999999999999886
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=352.44 Aligned_cols=252 Identities=24% Similarity=0.349 Sum_probs=195.4
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcC--CCCccccceeeeeccCCCce
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLN--HPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~--h~nIv~l~~~~~~~~~~~~~ 208 (492)
.+|.+.+.||+|+||.||+|.+. +|+.||||++... .....+|+.+++.++ ||||+++++++. +..
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~~~ 101 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TDQ 101 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE-----CSS
T ss_pred ceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee-----cCC
Confidence 46999999999999999999874 5899999998532 234468999999997 599999999883 444
Q ss_pred EEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 209 ~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
++|+|||+.++++.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. + .+||+|||+++
T Consensus 102 ~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~~-~-~~kL~Dfg~~~ 174 (313)
T 3cek_A 102 YIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIVD-G-MLKLIDFGIAN 174 (313)
T ss_dssp EEEEEECCCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEET-T-EEEECCCSSSC
T ss_pred EEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEEEC-C-eEEEeeccccc
Confidence 6899999887887776543 3568899999999999999999997 99999999999999974 4 79999999998
Q ss_pred ccCCCCC---CccceeccCccCchhhcCC----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHH
Q 011138 289 MLVPGEP---NISYICSRYYRAPELIFGA----------TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD-QLVEIIK 354 (492)
Q Consensus 289 ~~~~~~~---~~~~~gt~~y~aPE~~~~~----------~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~-~~~~i~~ 354 (492)
....... .....||+.|+|||++.+. ..++.++|||||||++|+|++|..||....... .+..+..
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 254 (313)
T 3cek_A 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 254 (313)
T ss_dssp C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHh
Confidence 6643322 2345789999999998641 358889999999999999999999998754332 2222211
Q ss_pred HhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 355 ILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 355 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
. . .... ++...++++.+||.+||+.||.+||++.|+++||||+....
T Consensus 255 ---~-----------~-~~~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 301 (313)
T 3cek_A 255 ---P-----------N-HEIE------------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 301 (313)
T ss_dssp ---T-----------T-SCCC------------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC--
T ss_pred ---c-----------c-cccC------------CcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCC
Confidence 0 0 0011 22345789999999999999999999999999999987543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=371.60 Aligned_cols=257 Identities=28% Similarity=0.414 Sum_probs=190.3
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-hhHHHHHHHHHHc-CCCCccccceeeeeccCCCceEEEEEee
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~~~~~lV~E 215 (492)
.|.+.+.||+|+||+||.+. ..+|+.||||++..+. ....+|+.+++.+ +|||||++++++ .+..++|||||
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~~~~lv~E 89 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSE-----TTDRFLYIALE 89 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEEEC
T ss_pred eeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCeEEEEEe
Confidence 47888999999999998754 5689999999986543 3456899999876 899999999887 44557899999
Q ss_pred echhhHHHHhhhhhhcCCC---cCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCC------------CcEE
Q 011138 216 YISETVYRVSKHYTRMNQH---VPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT------------HQLK 280 (492)
Q Consensus 216 ~~~~~l~~~~~~~~~~~~~---~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~------------~~vk 280 (492)
||+++|.+.+......... ..+..+..++.||+.||.|||+ +||+||||||+|||++.++ ..+|
T Consensus 90 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 90 LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp CCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred cCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 9998887776543222111 1223456799999999999997 9999999999999997532 2799
Q ss_pred EeeecCccccCCCCC-----CccceeccCccCchhhcC------CCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHH
Q 011138 281 ICDFGSAKMLVPGEP-----NISYICSRYYRAPELIFG------ATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQ 348 (492)
Q Consensus 281 L~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~------~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~ 348 (492)
|+|||+++....... .....||+.|+|||++.+ ...++.++|||||||++|||++ |..||......+
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~- 247 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE- 247 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence 999999987654322 224579999999999965 2458999999999999999998 999997655432
Q ss_pred HHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCC
Q 011138 349 LVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (492)
Q Consensus 349 ~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~ 425 (492)
..+... ...++.... .....+++++.+||.+||+.||.+|||+.++++||||..
T Consensus 248 -~~i~~~-----------------~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 248 -SNIIRG-----------------IFSLDEMKC-----LHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp -HHHHHT-----------------CCCCCCCTT-----CCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred -HHHhcC-----------------CCCcccccc-----cccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 223221 111111100 011235688999999999999999999999999999974
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=360.68 Aligned_cols=268 Identities=23% Similarity=0.269 Sum_probs=197.7
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchh---hHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR---YKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~---~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
..+|.+.+.||+|+||.||+|++. |+.||||++..... ...+|+.+++.++|||||++++++.... .....+++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~~~~l 99 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVDVDLWL 99 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCCceEEE
Confidence 357999999999999999999874 79999999865432 3346888899999999999999986544 22455789
Q ss_pred Eeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhC----------CcccCCCCCCceEEcCCCCcEEE
Q 011138 213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV----------GVCHRDIKPQNLLVNPHTHQLKI 281 (492)
Q Consensus 213 V~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~----------givHrDlKp~NILl~~~~~~vkL 281 (492)
||||+.+ +|.+++.. ..+++..+..++.||+.||.|||+ . ||+||||||+|||++.++ .+||
T Consensus 100 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~-~~~~l~~~~~~~ivH~Dlkp~Nill~~~~-~~kL 172 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHE-DIPGLKDGHKPAISHRDIKSKNVLLKNNL-TACI 172 (322)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTC-CEEEETTEEECEEECSCCSGGGEEECTTC-CEEE
T ss_pred EEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHh-hccccccccCCCEEeCCCChHhEEECCCC-eEEE
Confidence 9999986 55555432 458999999999999999999997 8 999999999999999887 7999
Q ss_pred eeecCccccCCCCC---CccceeccCccCchhhcCC----CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 011138 282 CDFGSAKMLVPGEP---NISYICSRYYRAPELIFGA----TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIK 354 (492)
Q Consensus 282 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~ 354 (492)
+|||+++....... .....||+.|+|||++.+. ..++.++|||||||++|||++|+.||.+............
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 99999976643332 3346899999999999763 2356688999999999999999999987654322222222
Q ss_pred HhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 355 ILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 355 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
..+.|....+...... ....|.+. ..| -....++++.+||.+||+.||++|||+.++++
T Consensus 253 ~~~~~~~~~~~~~~~~--~~~~~~~~-~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 253 IGQHPSLEDMQEVVVH--KKKRPVLR-DYW---QKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HCSSCCHHHHHHHHTT--SCCCCCCC-GGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hccCCchhhhhhhhhc--ccCCCCcc-ccc---cccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 2233333322211000 00001000 000 01123456999999999999999999999975
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=361.52 Aligned_cols=252 Identities=24% Similarity=0.335 Sum_probs=200.4
Q ss_pred cccceeEeeeeccCCceEEEEEE-----EcCCCCEEEEEEeccch-----hhHHHHHHHHHHc-CCCCccccceeeeecc
Q 011138 135 QTISYMAERVVGTGSFGVVFQAK-----CLETGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFSTT 203 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~-----~~~~g~~vAiK~~~~~~-----~~~~~E~~il~~l-~h~nIv~l~~~~~~~~ 203 (492)
...+|.+++.||+|+||.||+|. ...+++.||||++.... ....+|+.+++.+ +|||||++++++...
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~- 98 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 98 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC-
Confidence 34579999999999999999998 45677899999986532 3356899999999 789999999988432
Q ss_pred CCCceEEEEEeeechh-hHHHHhhhhhhc---------------------------------------------------
Q 011138 204 EKDELYLNLVLEYISE-TVYRVSKHYTRM--------------------------------------------------- 231 (492)
Q Consensus 204 ~~~~~~~~lV~E~~~~-~l~~~~~~~~~~--------------------------------------------------- 231 (492)
...+++||||+.+ +|.+.+......
T Consensus 99 ---~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 99 ---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp ---TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred ---CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 2347899999986 555554432210
Q ss_pred -----------CCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCCC---Cc
Q 011138 232 -----------NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP---NI 297 (492)
Q Consensus 232 -----------~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~~---~~ 297 (492)
...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++....... ..
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~-~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~ 253 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKG 253 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTSCTTCEEC-
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcCCC-cEEEEeccceeeecccccchhcc
Confidence 1228899999999999999999997 9999999999999999887 799999999986543322 23
Q ss_pred cceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCC
Q 011138 298 SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKF 376 (492)
Q Consensus 298 ~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~ 376 (492)
...||+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.+...+.....+
T Consensus 254 ~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~----------------- 315 (359)
T 3vhe_A 254 DARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM----------------- 315 (359)
T ss_dssp -CEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC-----------------
T ss_pred ccCCCceeEChhhhcCC-CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC-----------------
Confidence 46789999999999764 48999999999999999998 999999877666555544421110
Q ss_pred CcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 377 PQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 377 ~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
..+..+++++.+||.+||+.||.+|||+.|+++|
T Consensus 316 ----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 316 ----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 0123578999999999999999999999999875
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=372.05 Aligned_cols=253 Identities=25% Similarity=0.379 Sum_probs=189.6
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-hhHHHHHHHHHHc-CCCCccccceeeeeccCCCceEEEEEee
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-RYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~~~~~lV~E 215 (492)
+|.+.++||+|+||+||. ....+|+.||||++.... ....+|+.+|+.+ +|||||++++++ .+..++|||||
T Consensus 25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~-----~~~~~~~lv~E 98 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTE-----KDRQFQYIAIE 98 (432)
T ss_dssp EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEE-----EETTEEEEEEE
T ss_pred EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCEEEEEEE
Confidence 599999999999999764 345689999999985432 3456899999999 799999999987 44456899999
Q ss_pred echhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCC----CcEEEeeecCccccC
Q 011138 216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT----HQLKICDFGSAKMLV 291 (492)
Q Consensus 216 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~----~~vkL~DFG~a~~~~ 291 (492)
||++++.+.+... ........+..++.||+.||.|||+ +||+||||||+|||++.++ ..+||+|||+++...
T Consensus 99 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 99 LCAATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHS-LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp CCSEEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHH-TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred CCCCCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHH-CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 9999887766432 2234444567899999999999997 9999999999999995322 258899999998764
Q ss_pred CCC----CCccceeccCccCchhhcC--CCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 011138 292 PGE----PNISYICSRYYRAPELIFG--ATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEI 364 (492)
Q Consensus 292 ~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~ 364 (492)
... .....+||+.|+|||++.+ ...++.++|||||||++|||++ |..||........ ..+ .+...
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-~~~---~~~~~---- 246 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-NIL---LGACS---- 246 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-HHH---TTCCC----
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-HHH---hccCC----
Confidence 332 2345679999999999964 3447889999999999999999 9999965543221 111 11100
Q ss_pred hhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
.+... .....+..+++||.+||+.||.+|||+.++++||||..+
T Consensus 247 -----------~~~~~-------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 247 -----------LDCLH-------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp -----------CTTSC-------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred -----------ccccC-------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 00000 011235678999999999999999999999999999864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=343.28 Aligned_cols=244 Identities=27% Similarity=0.416 Sum_probs=188.5
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc--------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~--------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
..+|.+.+.||+|+||.||+|.+ +|+.||||++... .....+|+.+++.++||||+++++++ .+.
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC-----LKE 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCC
T ss_pred hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----ecC
Confidence 34699999999999999999997 4899999987543 23456799999999999999999998 444
Q ss_pred eEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCC---cccCCCCCCceEEcCC-------CC
Q 011138 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG---VCHRDIKPQNLLVNPH-------TH 277 (492)
Q Consensus 208 ~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~g---ivHrDlKp~NILl~~~-------~~ 277 (492)
..+++||||+.++.+..... ...+++..+..++.||+.||.|||+ +| |+||||||+|||++.+ ..
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~-~~~~~i~H~dikp~Nil~~~~~~~~~~~~~ 153 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHD-EAIVPIIHRDLKSSNILILQKVENGDLSNK 153 (271)
T ss_dssp --CEEEEECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHH-SSSSCCCCSCCSGGGEEESSCCSSSCCSSC
T ss_pred CceEEEEEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCchHHEEEecccccccccCc
Confidence 56889999998654443221 4578999999999999999999997 88 8999999999999862 23
Q ss_pred cEEEeeecCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 011138 278 QLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILG 357 (492)
Q Consensus 278 ~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g 357 (492)
.+||+|||++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 154 ~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-- 229 (271)
T 3dtc_A 154 ILKITDFGLAREWHRT-TKMSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN-- 229 (271)
T ss_dssp CEEECCCCC--------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS--
T ss_pred ceEEccCCcccccccc-cccCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC--
Confidence 7999999999765433 23356899999999999765 4899999999999999999999999988766555443321
Q ss_pred CCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 358 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 358 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
... ..++..+++++.+||.+||+.||.+|||+.|+++|
T Consensus 230 ---------------~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 230 ---------------KLA----------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp ---------------CCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCC----------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 000 11234578999999999999999999999999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=346.10 Aligned_cols=245 Identities=22% Similarity=0.323 Sum_probs=195.2
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-----------hhHHHHHHHHHHcCCCCccccceeeeeccC
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE 204 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-----------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 204 (492)
..+|.+.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~----- 92 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM----- 92 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE-----
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee-----
Confidence 357999999999999999999999999999999884321 3456899999999999999999987
Q ss_pred CCceEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCC--cccCCCCCCceEEcCCCC----
Q 011138 205 KDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG--VCHRDIKPQNLLVNPHTH---- 277 (492)
Q Consensus 205 ~~~~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~g--ivHrDlKp~NILl~~~~~---- 277 (492)
.+.. ++||||+.+ ++.+.+. .....+++..+..++.||+.||.|||+ +| |+||||||+|||++.++.
T Consensus 93 ~~~~--~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~ivH~dikp~Nil~~~~~~~~~~ 166 (287)
T 4f0f_A 93 HNPP--RMVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPV 166 (287)
T ss_dssp TTTT--EEEEECCTTCBHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCSCCSGGGEEESCCCTTCSC
T ss_pred cCCC--eEEEEecCCCCHHHHHh---cccCCccHHHHHHHHHHHHHHHHHHHh-CCCCeecCCCCcceEEEeccCCCCce
Confidence 3333 589999985 5544432 234578999999999999999999997 89 999999999999987662
Q ss_pred cEEEeeecCccccCCCCCCccceeccCccCchhhcC-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHH
Q 011138 278 QLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFG-ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQL-VEIIKI 355 (492)
Q Consensus 278 ~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~-~~i~~~ 355 (492)
.+||+|||+++.. ........||+.|+|||++.+ ...++.++|||||||++|+|++|+.||...+..... ......
T Consensus 167 ~~kl~Dfg~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 244 (287)
T 4f0f_A 167 CAKVADFGLSQQS--VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE 244 (287)
T ss_dssp CEEECCCTTCBCC--SSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH
T ss_pred eEEeCCCCccccc--cccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc
Confidence 2999999999754 233445789999999999843 334788999999999999999999999876543321 111111
Q ss_pred hCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 356 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 356 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.+. ...++..+++++.+||.+||+.||.+|||+.++++
T Consensus 245 ~~~--------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 245 EGL--------------------------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp SCC--------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCC--------------------------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 100 01123467899999999999999999999999975
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=350.47 Aligned_cols=251 Identities=23% Similarity=0.336 Sum_probs=206.8
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchhhHHHHHHHHHHcCCCCccccceeeeeccC-----------C
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-----------K 205 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~-----------~ 205 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||||++........+|+.+++.++||||+++++++..... .
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 90 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS 90 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CC
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccccc
Confidence 46999999999999999999999999999999998777778899999999999999999998743211 2
Q ss_pred CceEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeee
Q 011138 206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (492)
Q Consensus 206 ~~~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DF 284 (492)
....+++||||+++ +|.+.+... ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+||
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~Df 166 (284)
T 2a19_B 91 KTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHS-KKLINRDLKPSNIFLVDTK-QVKIGDF 166 (284)
T ss_dssp EEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETT-EEEECCC
T ss_pred CcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHEEEcCCC-CEEECcc
Confidence 24568899999996 566655432 23568899999999999999999997 9999999999999999887 8999999
Q ss_pred cCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 011138 285 GSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (492)
Q Consensus 285 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~ 364 (492)
|++.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.... .....+..
T Consensus 167 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~---------- 233 (284)
T 2a19_B 167 GLVTSLKNDGKRTRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRD---------- 233 (284)
T ss_dssp TTCEESSCCSCCCCCCSCCTTSCHHHHHCS-CCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHT----------
T ss_pred hhheeccccccccccCCcccccChhhhccC-CCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhc----------
Confidence 999887666556667899999999999754 48999999999999999999998874211 11111100
Q ss_pred hhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCC
Q 011138 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (492)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~ 425 (492)
. .++..+++++++||.+||..||.+|||+.|+++|.|.-.
T Consensus 234 ---------~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 234 ---------G------------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp ---------T------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred ---------c------------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 0 012347889999999999999999999999999987653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=357.66 Aligned_cols=258 Identities=16% Similarity=0.151 Sum_probs=195.5
Q ss_pred cceeEeeeeccCCceEEEEEEEcCC-----CCEEEEEEeccchhhHHHHHH---------------HHHHcCCCCccccc
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLET-----GDSVAIKKVLQDKRYKNRELQ---------------IMRLLNHPNVVSLK 196 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~-----g~~vAiK~~~~~~~~~~~E~~---------------il~~l~h~nIv~l~ 196 (492)
.+|.+.+.||+|+||.||+|.+..+ ++.||||++........+|+. .++.++||||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 3699999999999999999998764 588999998665544444444 44556799999999
Q ss_pred eeeeeccCCCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEc--C
Q 011138 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN--P 274 (492)
Q Consensus 197 ~~~~~~~~~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~--~ 274 (492)
+++.... .+..++||||||++++|..++.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++ .
T Consensus 115 ~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~-~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 115 GSGLHDK-NGKSYRFMIMDRFGSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHE-HEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEEE-TTEEEEEEEEECEEEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEESSC
T ss_pred eeeeecc-CCcceEEEEEeCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeEEecCCHHHEEEecCC
Confidence 9986643 34567899999996666665543 24679999999999999999999997 8999999999999998 6
Q ss_pred CCCcEEEeeecCccccCCCCC--------CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Q 011138 275 HTHQLKICDFGSAKMLVPGEP--------NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGV 346 (492)
Q Consensus 275 ~~~~vkL~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~ 346 (492)
++ .+||+|||+++.+..... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+....
T Consensus 190 ~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 190 PD-QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp TT-CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CC-eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 66 799999999976543221 23456999999999997654 899999999999999999999999864433
Q ss_pred HHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 347 DQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 347 ~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
............+....+.. ..+ ....+++++.+||.+||..||.+||++.++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~-------~~~-----------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 268 PKYVRDSKIRYRENIASLMD-------KCF-----------PAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHHHCHHHHHH-------HHS-----------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHHhhhhHHHHHH-------Hhc-----------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 33332222111111111100 000 01357899999999999999999999998875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=352.62 Aligned_cols=251 Identities=26% Similarity=0.413 Sum_probs=185.0
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch----hhHHHHHHHHHHcC-CCCccccceeeeeccC---CCce
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----RYKNRELQIMRLLN-HPNVVSLKHCFFSTTE---KDEL 208 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~----~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~---~~~~ 208 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.+. ||||+++++++..... .+..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 36999999999999999999999999999999884432 33457999999996 9999999998854332 4556
Q ss_pred EEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCC--cccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG--VCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 209 ~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~g--ivHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
.+++||||+.|++.+.+.... ....+++..++.++.||+.||.|||+ +| |+||||||+|||++.++ .+||+|||+
T Consensus 108 ~~~lv~e~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~ 184 (337)
T 3ll6_A 108 EFLLLTELCKGQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQG-TIKLCDFGS 184 (337)
T ss_dssp EEEEEEECCSEEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCCCCCGGGCEECTTS-CEEBCCCTT
T ss_pred eEEEEEEecCCCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEEccCCcccEEECCCC-CEEEecCcc
Confidence 789999999998887765433 34569999999999999999999997 89 99999999999999887 799999999
Q ss_pred ccccCCCCC-------------CccceeccCccCchhhc--CCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 011138 287 AKMLVPGEP-------------NISYICSRYYRAPELIF--GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVE 351 (492)
Q Consensus 287 a~~~~~~~~-------------~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~ 351 (492)
++....... .....||+.|+|||++. ....++.++|||||||++|+|++|..||........+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 264 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG 264 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence 987643221 11456899999999983 234578999999999999999999999976443221110
Q ss_pred HHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCC
Q 011138 352 IIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHP 421 (492)
Q Consensus 352 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp 421 (492)
....+ .....++.+.+||.+||+.||.+|||+.|+++|-
T Consensus 265 ---------------------~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 265 ---------------------KYSIP----------PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp ----------------------CCCC----------TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred ---------------------cccCC----------cccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 00111 1134677899999999999999999999999873
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=342.73 Aligned_cols=246 Identities=20% Similarity=0.295 Sum_probs=200.1
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc---hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
...+|.+.+.||+|+||.||+|.+. ++..||+|++... .....+|+.+++.++||||+++++++ .+...++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 79 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC-----SKEYPIY 79 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSEE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCceE
Confidence 3457999999999999999999865 5778999998653 34456899999999999999999988 4445588
Q ss_pred EEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 212 lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
+||||++++ +.+.+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++...
T Consensus 80 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~ 154 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLES-HQFIHRDLAARNCLVDRDL-CVKVSDFGMTRYV 154 (268)
T ss_dssp EEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCSGGGEEECTTC-CEEECCTTCEEEC
T ss_pred EEEEccCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCcceEEECCCC-CEEEccCccceec
Confidence 999999765 5554433 23458999999999999999999997 9999999999999999887 7999999999865
Q ss_pred CCCCC--CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 291 VPGEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 291 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
..... .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||...+..+....+....
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~----------- 222 (268)
T 3sxs_A 155 LDDQYVSSVGTKFPVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH----------- 222 (268)
T ss_dssp CTTCEEECCSCCCCGGGCCHHHHHHSE-EETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-----------
T ss_pred chhhhhcccCCCcCcccCCHHHHhccC-CchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC-----------
Confidence 43321 22345577899999996544 8999999999999999998 999999888776655543310
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
.. ..+..+++++.+||.+||+.||.+|||+.++++|
T Consensus 223 -----~~------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 223 -----RL------------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp -----CC------------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -----CC------------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 0123468899999999999999999999999975
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=345.79 Aligned_cols=247 Identities=19% Similarity=0.288 Sum_probs=198.4
Q ss_pred ccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc---hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
....+|.+.+.||+|+||.||+|.+. ++..||||++... .....+|+.+++.++||||+++++++ .+...+
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~ 94 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQRPI 94 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEE-----ecCCCe
Confidence 44557999999999999999999875 6778999998653 34566899999999999999999998 444458
Q ss_pred EEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 211 ~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
++||||+.+ ++.+.+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++.
T Consensus 95 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~ 169 (283)
T 3gen_A 95 FIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVNDQG-VVKVSDFGLSRY 169 (283)
T ss_dssp EEEECCCTTCBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECTTS-CEEECSTTGGGG
T ss_pred EEEEeccCCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCccceEEEcCCC-CEEEcccccccc
Confidence 899999975 45554432 23568999999999999999999997 9999999999999999887 799999999976
Q ss_pred cCCCC--CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 011138 290 LVPGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (492)
Q Consensus 290 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~ 366 (492)
..... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||...+..+....+......
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-------- 240 (283)
T 3gen_A 170 VLDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL-------- 240 (283)
T ss_dssp BCCHHHHSTTSTTSCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC--------
T ss_pred ccccccccccCCccCcccCCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCC--------
Confidence 53321 122345678899999997654 8999999999999999998 99999988876666655431100
Q ss_pred cCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
..+..+++++.+||.+||+.||.+|||+.++++|
T Consensus 241 --------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 241 --------------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp --------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --------------------CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 0123468899999999999999999999999875
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=353.45 Aligned_cols=245 Identities=27% Similarity=0.434 Sum_probs=196.1
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch----------hhHHHHHHHHHHc----CCCCccccceeeeec
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----------RYKNRELQIMRLL----NHPNVVSLKHCFFST 202 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~----------~~~~~E~~il~~l----~h~nIv~l~~~~~~~ 202 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.+ +||||+++++++
T Consensus 31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~--- 107 (312)
T 2iwi_A 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF--- 107 (312)
T ss_dssp --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE---
Confidence 46999999999999999999999999999999985432 2233699999999 899999999988
Q ss_pred cCCCceEEEEEeee-ch-hhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEc-CCCCcE
Q 011138 203 TEKDELYLNLVLEY-IS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN-PHTHQL 279 (492)
Q Consensus 203 ~~~~~~~~~lV~E~-~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~-~~~~~v 279 (492)
.+....++|||+ +. +++.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++ .+
T Consensus 108 --~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~-~~ 179 (312)
T 2iwi_A 108 --ETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHS-RGVVHRDIKDENILIDLRRG-CA 179 (312)
T ss_dssp -------CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HTEECCCCSGGGEEEETTTT-EE
T ss_pred --ecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChhhEEEeCCCC-eE
Confidence 334457899998 55 455555433 3468999999999999999999997 8999999999999998 555 89
Q ss_pred EEeeecCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 011138 280 KICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTP 359 (492)
Q Consensus 280 kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p 359 (492)
||+|||++..... .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.... .+..
T Consensus 180 kl~dfg~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~----- 247 (312)
T 2iwi_A 180 KLIDFGSGALLHD-EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILE----- 247 (312)
T ss_dssp EECCCSSCEECCS-SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH-----
T ss_pred EEEEcchhhhccc-CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhh-----
Confidence 9999999987643 334466799999999999776655669999999999999999999996532 1111
Q ss_pred CHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
.... ++..+++++.+||.+||+.||++|||+.|+++||||+....
T Consensus 248 ------------~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 248 ------------AELH------------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp ------------TCCC------------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred ------------hccC------------CcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence 0111 22457899999999999999999999999999999997654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=356.06 Aligned_cols=248 Identities=23% Similarity=0.304 Sum_probs=199.4
Q ss_pred ccceeEeeeeccCCceEEEEEEEc-----CCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCC
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~-----~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 205 (492)
..+|.+.+.||+|+||.||+|.+. .+++.||||++... ...+.+|+.+++.++||||+++++++ .
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~ 120 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC-----A 120 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----C
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----c
Confidence 457999999999999999999987 45689999998643 23456899999999999999999998 3
Q ss_pred CceEEEEEeeechh-hHHHHhhhhhhc--------------------CCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCC
Q 011138 206 DELYLNLVLEYISE-TVYRVSKHYTRM--------------------NQHVPILYVQLYTYQICRALNYLHHVVGVCHRD 264 (492)
Q Consensus 206 ~~~~~~lV~E~~~~-~l~~~~~~~~~~--------------------~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrD 264 (492)
+...+|+||||+.+ +|.+.+...... ...+++..++.++.||+.||.|||+ +||+|||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~D 199 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRD 199 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCC
Confidence 34458899999986 565555432111 2568999999999999999999997 9999999
Q ss_pred CCCCceEEcCCCCcEEEeeecCccccCCCC---CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCC
Q 011138 265 IKPQNLLVNPHTHQLKICDFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLF 340 (492)
Q Consensus 265 lKp~NILl~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf 340 (492)
|||+|||++.++ .+||+|||+++...... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||
T Consensus 200 lkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 200 LATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp CSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCcceEEECCCC-eEEEeecCCCcccccCccccccCCCcccceecChhhhccCC-cCcccccHHHHHHHHHHHhcCCCcC
Confidence 999999999887 79999999997653222 223456789999999997654 8999999999999999998 99999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 341 PGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 341 ~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.+.+..+....+... . .+ .++..+++++.+||.+||+.||.+||++.++++
T Consensus 278 ~~~~~~~~~~~~~~~--~-----------------~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 278 YGMAHEEVIYYVRDG--N-----------------IL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp TTSCHHHHHHHHHTT--C-----------------CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCChHHHHHHHhCC--C-----------------cC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 988776655544321 0 00 122457899999999999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=356.97 Aligned_cols=251 Identities=22% Similarity=0.320 Sum_probs=201.2
Q ss_pred ccccceeEeeeeccCCceEEEEEEEcCC-------CCEEEEEEeccch-----hhHHHHHHHHHHc-CCCCccccceeee
Q 011138 134 KQTISYMAERVVGTGSFGVVFQAKCLET-------GDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFF 200 (492)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~-------g~~vAiK~~~~~~-----~~~~~E~~il~~l-~h~nIv~l~~~~~ 200 (492)
....+|.+++.||+|+||.||+|.+..+ +..||||++.... ....+|+++++.+ +|||||++++++
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~- 144 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC- 144 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee-
Confidence 3446799999999999999999997643 3579999986432 3355899999999 899999999998
Q ss_pred eccCCCceEEEEEeeechh-hHHHHhhhhhh------------cCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCC
Q 011138 201 STTEKDELYLNLVLEYISE-TVYRVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKP 267 (492)
Q Consensus 201 ~~~~~~~~~~~lV~E~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp 267 (492)
.+...+++||||+.+ +|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||
T Consensus 145 ----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp 219 (382)
T 3tt0_A 145 ----TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAA 219 (382)
T ss_dssp ----CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCG
T ss_pred ----ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCc
Confidence 334457899999986 56655543221 12458999999999999999999997 9999999999
Q ss_pred CceEEcCCCCcEEEeeecCccccCCCC---CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCC
Q 011138 268 QNLLVNPHTHQLKICDFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGE 343 (492)
Q Consensus 268 ~NILl~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~ 343 (492)
+||||+.++ .+||+|||+++...... ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.
T Consensus 220 ~NIll~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt~g~~p~~~~ 297 (382)
T 3tt0_A 220 RNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297 (382)
T ss_dssp GGEEECTTC-CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ceEEEcCCC-cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999887 79999999998664332 23345678999999999765 48999999999999999999 99999988
Q ss_pred ChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 344 SGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 344 ~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
+..+....+.... .. ..+..+++++.+||.+||+.||.+|||+.|++++
T Consensus 298 ~~~~~~~~~~~~~----------------~~------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 298 PVEELFKLLKEGH----------------RM------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp CHHHHHHHHHTTC----------------CC------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHcCC----------------CC------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7655544433210 00 0124578999999999999999999999999874
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=354.16 Aligned_cols=252 Identities=23% Similarity=0.327 Sum_probs=200.1
Q ss_pred cccceeEeeeeccCCceEEEEEEEc-----CCCCEEEEEEeccc-----hhhHHHHHHHHHHc-CCCCccccceeeeecc
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQD-----KRYKNRELQIMRLL-NHPNVVSLKHCFFSTT 203 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~-----~~g~~vAiK~~~~~-----~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~ 203 (492)
...+|.+.+.||+|+||.||+|.+. .++..||||++... .....+|+.+++.+ +||||+++++++.
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~--- 119 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT--- 119 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe---
Confidence 3457999999999999999999973 46678999998543 23456899999999 8999999999983
Q ss_pred CCCceEEEEEeeechh-hHHHHhhhhhhc-------------------CCCcCHHHHHHHHHHHHHHHHHHHhhCCcccC
Q 011138 204 EKDELYLNLVLEYISE-TVYRVSKHYTRM-------------------NQHVPILYVQLYTYQICRALNYLHHVVGVCHR 263 (492)
Q Consensus 204 ~~~~~~~~lV~E~~~~-~l~~~~~~~~~~-------------------~~~~~~~~~~~i~~qi~~aL~yLH~~~givHr 263 (492)
+...+++||||+++ +|.+.+...... ...+++..+..++.||+.||.|||+ +||+||
T Consensus 120 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~ 196 (344)
T 1rjb_A 120 --LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHR 196 (344)
T ss_dssp --SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEET
T ss_pred --eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCcccC
Confidence 33458899999975 666655432211 1347889999999999999999997 999999
Q ss_pred CCCCCceEEcCCCCcEEEeeecCccccCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCC
Q 011138 264 DIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPL 339 (492)
Q Consensus 264 DlKp~NILl~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~p 339 (492)
||||+|||++.++ .+||+|||++........ .....||+.|+|||++.+. .++.++|||||||++|+|++ |..|
T Consensus 197 Dikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 197 DLAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp TCSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred CCChhhEEEcCCC-cEEeCCCccCcccccCccceeccCccCccCccCHHHhccC-CCChhHhHHHHHHHHHHHHcCCCCC
Confidence 9999999999887 899999999986643332 2245678899999999765 48999999999999999998 9999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 340 FPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 340 f~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
|.+......+..++... ... ..+..+++++.+||.+||..||.+|||+.++++
T Consensus 275 ~~~~~~~~~~~~~~~~~-----------------~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 327 (344)
T 1rjb_A 275 YPGIPVDANFYKLIQNG-----------------FKM----------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 327 (344)
T ss_dssp STTCCCSHHHHHHHHTT-----------------CCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccCCcHHHHHHHHhcC-----------------CCC----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99877665555544410 000 112357899999999999999999999999998
Q ss_pred CC
Q 011138 420 HP 421 (492)
Q Consensus 420 Hp 421 (492)
|-
T Consensus 328 ~l 329 (344)
T 1rjb_A 328 FL 329 (344)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=347.24 Aligned_cols=250 Identities=24% Similarity=0.329 Sum_probs=201.1
Q ss_pred ccceeEeeeeccCCceEEEEEEE-----cCCCCEEEEEEeccc-----hhhHHHHHHHHHHc-CCCCccccceeeeeccC
Q 011138 136 TISYMAERVVGTGSFGVVFQAKC-----LETGDSVAIKKVLQD-----KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTE 204 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~-----~~~g~~vAiK~~~~~-----~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~ 204 (492)
..+|.+.+.||+|+||.||+|.+ ..+++.||||++... .....+|+.+++.+ +||||+++++++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~---- 97 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT---- 97 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe----
Confidence 45799999999999999999985 457789999998643 23456899999999 8999999999983
Q ss_pred CCceEEEEEeeechh-hHHHHhhhhhh--------------cCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCc
Q 011138 205 KDELYLNLVLEYISE-TVYRVSKHYTR--------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQN 269 (492)
Q Consensus 205 ~~~~~~~lV~E~~~~-~l~~~~~~~~~--------------~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~N 269 (492)
+....++||||+.+ ++.+.+..... ....+++..+..++.||+.||.|||+ +||+||||||+|
T Consensus 98 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~N 175 (313)
T 1t46_A 98 -IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARN 175 (313)
T ss_dssp -SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGG
T ss_pred -cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccce
Confidence 33457899999976 56655543221 12358999999999999999999997 999999999999
Q ss_pred eEEcCCCCcEEEeeecCccccCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCh
Q 011138 270 LLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESG 345 (492)
Q Consensus 270 ILl~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~ 345 (492)
||++.++ .+||+|||++........ .....||+.|+|||++.+. .++.++|||||||++|+|++ |..||.+...
T Consensus 176 il~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 176 ILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp EEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred EEEcCCC-CEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 9999887 899999999987644332 2245678899999999765 48999999999999999998 9999998776
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 346 VDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 346 ~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
...+..+...... ...+..+++++.+||.+||+.||.+|||+.+++++
T Consensus 254 ~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 254 DSKFYKMIKEGFR---------------------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp SHHHHHHHHHTCC---------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhHHHHHhccCCC---------------------------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 6655555442100 01123578999999999999999999999999863
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=349.43 Aligned_cols=250 Identities=22% Similarity=0.334 Sum_probs=199.3
Q ss_pred cccceeEeeeeccCCceEEEEEEEc-----CCCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccC
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTE 204 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~-----~~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 204 (492)
...+|.+.+.||+|+||.||+|.+. .++..||||++.... ....+|+.+++.++||||+++++++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~----- 95 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC----- 95 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE-----
Confidence 3457999999999999999999883 456899999986432 3445799999999999999999988
Q ss_pred CCceEEEEEeeechh-hHHHHhhhhhh--------------------cCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccC
Q 011138 205 KDELYLNLVLEYISE-TVYRVSKHYTR--------------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHR 263 (492)
Q Consensus 205 ~~~~~~~lV~E~~~~-~l~~~~~~~~~--------------------~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHr 263 (492)
.+...+++||||+.+ +|.+.+..... ....+++..+..++.||+.||.|||+ +||+||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~ 174 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE-MKLVHR 174 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH-CCCccc
Confidence 334458899999984 56555543222 12348899999999999999999997 999999
Q ss_pred CCCCCceEEcCCCCcEEEeeecCccccCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCC
Q 011138 264 DIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPL 339 (492)
Q Consensus 264 DlKp~NILl~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~p 339 (492)
||||+|||++.++ .+||+|||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..|
T Consensus 175 dikp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 175 DLAARNILVAEGR-KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CCSGGGEEEETTT-EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccchheEEEcCCC-CEEEccccccccccccccceeccCCCCcccccChhhhcCC-CcCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999999999887 899999999986643322 2334668889999999764 48999999999999999999 9999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 340 FPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 340 f~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
|.+.........+.... . ...+..+++++.+||.+||+.||.+|||+.++++
T Consensus 253 ~~~~~~~~~~~~~~~~~----------------~------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~ 304 (314)
T 2ivs_A 253 YPGIPPERLFNLLKTGH----------------R------------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK 304 (314)
T ss_dssp STTCCGGGHHHHHHTTC----------------C------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHhhcCC----------------c------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99877655444332210 0 0122457899999999999999999999999986
Q ss_pred C
Q 011138 420 H 420 (492)
Q Consensus 420 H 420 (492)
+
T Consensus 305 ~ 305 (314)
T 2ivs_A 305 D 305 (314)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=347.56 Aligned_cols=253 Identities=23% Similarity=0.335 Sum_probs=193.0
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-hhHHHHHHHHHH--cCCCCccccceeeeeccCCCceEEEE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-RYKNRELQIMRL--LNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-~~~~~E~~il~~--l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
..+|.+.+.||+|+||+||+|++ +|+.||||++.... ....+|.+++.. ++||||+++++++.... .....+++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~~~l 83 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQLWL 83 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCceeEE
Confidence 34799999999999999999987 78999999986543 334567788777 78999999999876543 34566889
Q ss_pred Eeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHH--------hhCCcccCCCCCCceEEcCCCCcEEEee
Q 011138 213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH--------HVVGVCHRDIKPQNLLVNPHTHQLKICD 283 (492)
Q Consensus 213 V~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH--------~~~givHrDlKp~NILl~~~~~~vkL~D 283 (492)
||||+.+ +|.+.+. ...+++..+..++.||+.||.||| + +||+||||||+|||++.++ .+||+|
T Consensus 84 v~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~Nill~~~~-~~kl~D 156 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK-PAIAHRDLKSKNILVKKNG-QCCIAD 156 (301)
T ss_dssp EECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB-CEEECSCCCGGGEEECTTS-CEEECC
T ss_pred ehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC-CCeecCCCChHhEEEcCCC-CEEEee
Confidence 9999986 5555442 356899999999999999999999 8 8999999999999999887 799999
Q ss_pred ecCccccCCCCC-----CccceeccCccCchhhcCCC-----CCCcchhhHHHHHHHHHHHhC----------CCCCCCC
Q 011138 284 FGSAKMLVPGEP-----NISYICSRYYRAPELIFGAT-----EYTTAIDMWSIGCVLAELLLG----------QPLFPGE 343 (492)
Q Consensus 284 FG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~-----~~~~~~DvwSlGvil~ell~G----------~~pf~~~ 343 (492)
||+++....... .....||+.|+|||++.+.. .++.++|||||||++|||++| ..||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 999976543322 22348999999999997653 244789999999999999999 8888653
Q ss_pred Ch----HHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 344 SG----VDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 344 ~~----~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.. ...+..+.... ...+.+. ...+....++++.+||.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~-----------------~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 237 VPNDPSFEDMRKVVCVD-----------------QQRPNIP----NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp SCSSCCHHHHHHHHTTS-----------------CCCCCCC----GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCCcchhhhhHHHhcc-----------------CCCCCCC----hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 22 12222221100 0001000 01122335678999999999999999999999975
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=362.31 Aligned_cols=248 Identities=21% Similarity=0.287 Sum_probs=199.3
Q ss_pred CccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 133 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
.....+|.+.+.||+|+||.||+|.+..+|+.||||++.... ..+.+|+.+|+.++|||||++++++ .+.
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~ 184 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC-----TQK 184 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEE-----CSS
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----ecC
Confidence 344568999999999999999999999999999999986432 2345799999999999999999998 333
Q ss_pred eEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 208 ~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
..+|+||||+++ ++.+.+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 185 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nil~~~~~-~~kl~DfG~ 259 (377)
T 3cbl_A 185 QPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLES-KCCIHRDLAARNCLVTEKN-VLKISDFGM 259 (377)
T ss_dssp SSCEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCGGG
T ss_pred CCcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCcccCHHHEEEcCCC-cEEECcCCC
Confidence 457899999985 55554432 23458899999999999999999997 9999999999999999887 799999999
Q ss_pred ccccCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 011138 287 AKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTRE 362 (492)
Q Consensus 287 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~ 362 (492)
++....... .....+++.|+|||++.+. .++.++|||||||++|||++ |..||.+.+..+....+...
T Consensus 260 s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~------- 331 (377)
T 3cbl_A 260 SREEADGVYAASGGLRQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG------- 331 (377)
T ss_dssp CEECTTSEEECCSSCCEEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTT-------
T ss_pred ceecCCCceeecCCCCCCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-------
Confidence 976433211 1123457889999999754 48999999999999999998 99999988765544433221
Q ss_pred HHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
... ..+..+++++.+||.+||+.||.+|||+.++++
T Consensus 332 -----------~~~----------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 332 -----------GRL----------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp -----------CCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------CCC----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 000 022357899999999999999999999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=342.07 Aligned_cols=249 Identities=20% Similarity=0.242 Sum_probs=199.0
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc--hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEe
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++|++++..+.++... ..+.++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----~~~~~lv~ 84 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNVMVM 84 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEE----TTEEEEEE
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCC----CCceEEEE
Confidence 4699999999999999999999999999999987543 34567899999999999988777666432 33578999
Q ss_pred eechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEc---CCCCcEEEeeecCccccC
Q 011138 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN---PHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 215 E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~---~~~~~vkL~DFG~a~~~~ 291 (492)
||+++++.+++.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++ .++ .+||+|||++....
T Consensus 85 e~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~-~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 85 ELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKYR 159 (296)
T ss_dssp ECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTT-CEEECCCTTCEECB
T ss_pred EecCCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHeEEecCCCCC-eEEEeeCCCccccc
Confidence 9997777766542 23568999999999999999999997 9999999999999994 555 79999999998764
Q ss_pred CCCC--------CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCC
Q 011138 292 PGEP--------NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESG---VDQLVEIIKILGTPT 360 (492)
Q Consensus 292 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~---~~~~~~i~~~~g~p~ 360 (492)
.... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+. .+.+..+......++
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred ccccccccccccccccccccccCChhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 4322 24568999999999997654 89999999999999999999999987432 233333332111111
Q ss_pred HHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.. .+...+++++.+||.+||+.||.+|||+.++++
T Consensus 239 ~~------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 239 IE------------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HH------------------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hH------------------------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 10 122457899999999999999999999999876
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=352.49 Aligned_cols=245 Identities=21% Similarity=0.307 Sum_probs=193.1
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCE----EEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCC
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~----vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 206 (492)
..+|.+.+.||+|+||.||+|.+..+|+. ||+|.+.... ....+|+.+++.++||||+++++++. +
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~ 86 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-----G 86 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-----B
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----C
Confidence 34699999999999999999999988876 6777663321 23457999999999999999999872 2
Q ss_pred ceEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeec
Q 011138 207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (492)
Q Consensus 207 ~~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG 285 (492)
...++||||+.+ ++.+.+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 87 -~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~-~~kl~Dfg 160 (325)
T 3kex_A 87 -SSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEE-HGMVHRNLAARNVLLKSPS-QVQVADFG 160 (325)
T ss_dssp -SSEEEEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHH-TTCCCSCCSSTTEEESSSS-CEEECSCS
T ss_pred -CccEEEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCCccchheEEECCCC-eEEECCCC
Confidence 237799999985 45444332 23468888999999999999999997 9999999999999999887 79999999
Q ss_pred CccccCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 011138 286 SAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTR 361 (492)
Q Consensus 286 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~ 361 (492)
+++....... .....||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+...
T Consensus 161 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~------ 233 (325)
T 3kex_A 161 VADLLPPDDKQLLYSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG------ 233 (325)
T ss_dssp GGGGSCCCTTCCC-----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT------
T ss_pred cccccCcccccccccCCCCcccccChHHhccCC-CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC------
Confidence 9987644332 23456788999999997654 8999999999999999999 99999987655544433221
Q ss_pred HHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
.... .+..++.++.+||.+||..||.+|||+.++++|
T Consensus 234 ----------~~~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 234 ----------ERLA------------QPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp ----------CBCC------------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred ----------CCCC------------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0001 123467889999999999999999999999886
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=346.38 Aligned_cols=249 Identities=18% Similarity=0.241 Sum_probs=195.6
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCC-------CEEEEEEeccch----hhHHHHHHHHHHcCCCCccccceeeeecc
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETG-------DSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTT 203 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g-------~~vAiK~~~~~~----~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 203 (492)
...+|.+.+.||+|+||.||+|.+..++ ..||+|++.... ....+|+.+++.++||||+++++++.
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--- 82 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCV--- 82 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC---
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE---
Confidence 3457999999999999999999998877 469999985432 34568999999999999999999984
Q ss_pred CCCceEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCc----
Q 011138 204 EKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQ---- 278 (492)
Q Consensus 204 ~~~~~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~---- 278 (492)
+....++||||+.+ +|.+.+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .
T Consensus 83 --~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~-~~~~~ 155 (289)
T 4fvq_A 83 --CGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEE-NTLIHGNVCAKNILLIREE-DRKTG 155 (289)
T ss_dssp --CTTCCEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEEECC-BGGGT
T ss_pred --eCCCCEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhh-CCeECCCcCcceEEEecCC-ccccc
Confidence 33347899999985 55555433 23348899999999999999999997 9999999999999998776 4
Q ss_pred ----EEEeeecCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCChHHHHHHHH
Q 011138 279 ----LKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG-QPLFPGESGVDQLVEII 353 (492)
Q Consensus 279 ----vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G-~~pf~~~~~~~~~~~i~ 353 (492)
+||+|||++.... ......||+.|+|||++.+...++.++|||||||++|+|++| .+||...+. .....+.
T Consensus 156 ~~~~~kl~Dfg~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-~~~~~~~ 231 (289)
T 4fvq_A 156 NPPFIKLSDPGISITVL---PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-QRKLQFY 231 (289)
T ss_dssp BCCEEEECCCCSCTTTS---CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-HHHHHHH
T ss_pred ccceeeeccCccccccc---CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-HHHHHHh
Confidence 9999999987542 223457899999999997656689999999999999999995 455554443 3333322
Q ss_pred HHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 354 KILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 354 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
.. ... ++...++++.+||.+||+.||.+|||+.++++| |+++..
T Consensus 232 ~~-----------------~~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--l~~l~~ 275 (289)
T 4fvq_A 232 ED-----------------RHQ------------LPAPKAAELANLINNCMDYEPDHRPSFRAIIRD--LNSLFT 275 (289)
T ss_dssp HT-----------------TCC------------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH--HHTCC-
T ss_pred hc-----------------cCC------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH--HHHhcC
Confidence 21 001 123457889999999999999999999999984 555444
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=342.11 Aligned_cols=249 Identities=20% Similarity=0.242 Sum_probs=197.4
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc--hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEe
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++|++++..+..+... ..+.++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----~~~~~lv~ 84 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNVMVM 84 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEE----TTEEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCC----CCceEEEE
Confidence 4699999999999999999999999999999986433 34567899999999999988887766443 33678999
Q ss_pred eechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEE---cCCCCcEEEeeecCccccC
Q 011138 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 215 E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl---~~~~~~vkL~DFG~a~~~~ 291 (492)
||+++++.+++.. ....+++..+..++.||+.||.|||+ +||+||||||+|||+ +.++ .+||+|||+++...
T Consensus 85 e~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~~~~~~-~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 85 ELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKYR 159 (296)
T ss_dssp ECCCCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECCGGGTT-CEEECCCTTCEECB
T ss_pred EccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeeeeccCCCC-eEEEecCccceecc
Confidence 9997777766542 24568999999999999999999997 999999999999999 5565 79999999998764
Q ss_pred CCCC--------CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCC
Q 011138 292 PGEP--------NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGV---DQLVEIIKILGTPT 360 (492)
Q Consensus 292 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~---~~~~~i~~~~g~p~ 360 (492)
.... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.. ..+..+.......+
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCC-CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 4322 23568899999999997654 899999999999999999999999875432 22333222111111
Q ss_pred HHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
. ..+...+++++.+||.+||+.||.+|||+.++++
T Consensus 239 ~------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 239 I------------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp H------------------------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred h------------------------hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 0 0122457899999999999999999999999886
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=350.52 Aligned_cols=256 Identities=15% Similarity=0.157 Sum_probs=191.3
Q ss_pred cceeEeeeeccCCceEEEEEEEcC---CCCEEEEEEeccchhh---------------HHHHHHHHHHcCCCCcccccee
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLE---TGDSVAIKKVLQDKRY---------------KNRELQIMRLLNHPNVVSLKHC 198 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~---~g~~vAiK~~~~~~~~---------------~~~E~~il~~l~h~nIv~l~~~ 198 (492)
.+|.+.+.||+|+||.||+|.+.. ++..||||++...... ..+|+.+++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 469999999999999999999987 8899999998654321 2356777888899999999999
Q ss_pred eeeccCCCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCC-C
Q 011138 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT-H 277 (492)
Q Consensus 199 ~~~~~~~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~-~ 277 (492)
+.... .+..++|+||||++++|.+++.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .
T Consensus 117 ~~~~~-~~~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 117 GLTEF-KGRSYRFMVMERLGIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHE-NEYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEES-SSCEEEEEEEECEEEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEESSSTT
T ss_pred ccccc-CCCcEEEEEEeccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCcCHHHEEEccCCCC
Confidence 86543 34567899999996666665443 2378999999999999999999997 9999999999999998654 2
Q ss_pred cEEEeeecCccccCCCC--------CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-hHHH
Q 011138 278 QLKICDFGSAKMLVPGE--------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES-GVDQ 348 (492)
Q Consensus 278 ~vkL~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~-~~~~ 348 (492)
.+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.. ....
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 69999999997653221 11356799999999999765 48999999999999999999999996532 2222
Q ss_pred HHHHH-HHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 349 LVEII-KILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 349 ~~~i~-~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
..... ......+.....+.. ...+++++.+||.+||..||.+||++.++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 270 VQTAKTNLLDELPQSVLKWAP--------------------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHHHHTTTHHHHHHSC--------------------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHhhcccccHHHHhhcc--------------------ccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 22222 211111111111100 1257899999999999999999999999886
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=343.81 Aligned_cols=247 Identities=26% Similarity=0.345 Sum_probs=188.3
Q ss_pred CccccceeEeeeeccCCceEEEEEEEcCC---CCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccC
Q 011138 133 PKQTISYMAERVVGTGSFGVVFQAKCLET---GDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE 204 (492)
Q Consensus 133 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~---g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 204 (492)
.....+|.+.+.||+|+||.||+|.+..+ +..||+|++... .....+|+.+++.++||||+++++++.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---- 86 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT---- 86 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC----
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc----
Confidence 34456799999999999999999998654 457999987542 233557999999999999999999872
Q ss_pred CCceEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEee
Q 011138 205 KDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICD 283 (492)
Q Consensus 205 ~~~~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~D 283 (492)
+ ...|+||||+.+ ++.+.+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|
T Consensus 87 -~-~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~D 159 (281)
T 1mp8_A 87 -E-NPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSND-CVKLGD 159 (281)
T ss_dssp -S-SSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECC
T ss_pred -c-CccEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHEEECCCC-CEEECc
Confidence 1 136799999986 45554432 23468899999999999999999997 9999999999999999877 899999
Q ss_pred ecCccccCCCCC--CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 011138 284 FGSAKMLVPGEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPT 360 (492)
Q Consensus 284 FG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~ 360 (492)
||+++....... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+.+..+....
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~---- 234 (281)
T 1mp8_A 160 FGLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE---- 234 (281)
T ss_dssp -------------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC----
T ss_pred cccccccCcccccccccCCCcccccChhhcccC-CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC----
Confidence 999986643322 2234567889999999654 48999999999999999996 999999887766655543310
Q ss_pred HHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.. .++..+++++.+||.+||..||.+|||+.++++
T Consensus 235 ------------~~------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 235 ------------RL------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp ------------CC------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------CC------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 00 122467899999999999999999999999876
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=356.36 Aligned_cols=264 Identities=21% Similarity=0.220 Sum_probs=197.0
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
..+|.+.+.||+|+||.||+|.+ .+|+.||||++... .....+|+.+++.++||||+++++++ .+...++
T Consensus 38 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 111 (321)
T 2qkw_B 38 TNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC-----DERNEMI 111 (321)
T ss_dssp CCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEEC-----CCTTCCE
T ss_pred HhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeEE
Confidence 34699999999999999999995 57899999987543 23456899999999999999999988 3344578
Q ss_pred EEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 212 lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
+||||+.+ ++.+.+.........+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT-RAIIHRDVKSINILLDENF-VPKITDFGISKKG 189 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCSTTEEECTTC-CEEECCCTTCEEC
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC-CCeecCCCCHHHEEECCCC-CEEEeeccccccc
Confidence 99999986 4444433322223468899999999999999999997 9999999999999999887 7999999999764
Q ss_pred CCCC---CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 291 VPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 291 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
.... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+....+.... .. ..
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~-----~~--~~ 261 (321)
T 2qkw_B 190 TELDQTHLSTVVKGTLGYIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV-----ES--HN 261 (321)
T ss_dssp SSSSCCCCBCCCEEETTTCCHHHHHHC-BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTH-----HH--HT
T ss_pred ccccccccccccCCCccccCHHHhcCC-CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhh-----hc--cc
Confidence 3221 22345789999999999765 48999999999999999999999998654322111100000 00 00
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
. ..+...........+....+.++.+||.+||+.||++|||+.|+++|
T Consensus 262 ~-----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 262 N-----GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp T-----TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred c-----ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 01111111111112223456789999999999999999999999875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=342.84 Aligned_cols=248 Identities=21% Similarity=0.332 Sum_probs=203.0
Q ss_pred ccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch---hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~---~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
....+|.+.+.||+|+||.||+|.+..++..||||++..+. ....+|+.+++.++||||+++++++ .+...+
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~ 84 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPF 84 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCCE
Confidence 44567999999999999999999999999999999986543 3456899999999999999999988 444458
Q ss_pred EEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 211 ~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
++||||+.+ ++.+.+.. .....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 85 ~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENH-LVKVADFGLSRL 160 (288)
T ss_dssp EEEEECCTTEEHHHHHHH--CCTTTSCHHHHHHHHHHHHHHHHHHHH-HTCCCSCCSGGGEEECGGG-CEEECCCCGGGT
T ss_pred EEEEEcCCCCcHHHHHHh--cccCCccHhHHHHHHHHHHHHHHHHHH-CCccCCCCCcceEEEcCCC-CEEEccCcccee
Confidence 899999985 55555433 223568999999999999999999997 8999999999999999887 799999999986
Q ss_pred cCCCCC--CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 011138 290 LVPGEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (492)
Q Consensus 290 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~ 366 (492)
...... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+.......+....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~---------- 229 (288)
T 3kfa_A 161 MTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---------- 229 (288)
T ss_dssp SCSSSSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC----------
T ss_pred ccCCccccccCCccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccC----------
Confidence 643322 2235678899999999765 48999999999999999999 999998877655444432210
Q ss_pred cCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
. ...+..+++++.+||.+||..||.+|||+.++++
T Consensus 230 --------~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 230 --------R----------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp --------C----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------C----------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 0 0122457899999999999999999999999975
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=352.42 Aligned_cols=251 Identities=22% Similarity=0.301 Sum_probs=199.9
Q ss_pred ccccceeEeeeeccCCceEEEEEEEcCCCCEE--EEEEeccc-----hhhHHHHHHHHHHc-CCCCccccceeeeeccCC
Q 011138 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSV--AIKKVLQD-----KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEK 205 (492)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~v--AiK~~~~~-----~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~ 205 (492)
....+|.+.+.||+|+||.||+|.+..+|..+ |+|.+... .....+|+.+++.+ +||||+++++++.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~----- 96 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE----- 96 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeee-----
Confidence 34468999999999999999999999888865 99987542 23456899999999 8999999999984
Q ss_pred CceEEEEEeeechh-hHHHHhhhhh------------hcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEE
Q 011138 206 DELYLNLVLEYISE-TVYRVSKHYT------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV 272 (492)
Q Consensus 206 ~~~~~~lV~E~~~~-~l~~~~~~~~------------~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl 272 (492)
+..++|+||||+++ +|.+.+.... .....+++..++.++.||+.||.|||+ +||+||||||+|||+
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~ 175 (327)
T 1fvr_A 97 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILV 175 (327)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred eCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCccceEEE
Confidence 33468999999975 6666554322 223568999999999999999999997 999999999999999
Q ss_pred cCCCCcEEEeeecCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 011138 273 NPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVE 351 (492)
Q Consensus 273 ~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~ 351 (492)
+.++ .+||+|||+++............+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....
T Consensus 176 ~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~ 253 (327)
T 1fvr_A 176 GENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 253 (327)
T ss_dssp CGGG-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred cCCC-eEEEcccCcCccccccccccCCCCCccccChhhhccc-cCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Confidence 9887 7999999999754333334455678899999999654 48999999999999999998 9999998876554443
Q ss_pred HHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 352 IIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 352 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
+... ... ..+..+++++.+||.+||..||.+|||+.++++|
T Consensus 254 ~~~~------------------~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 254 LPQG------------------YRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp GGGT------------------CCC----------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhcC------------------CCC----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 3210 000 1123578999999999999999999999999874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=353.44 Aligned_cols=265 Identities=21% Similarity=0.272 Sum_probs=198.8
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
.+|.+.+.||+|+||.||+|.+ .+|+.||||++.... ....+|+.+++.++||||+++++++. +....+
T Consensus 30 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 103 (326)
T 3uim_A 30 DNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM-----TPTERL 103 (326)
T ss_dssp TSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC-----CSSCCE
T ss_pred hccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe-----cCCceE
Confidence 4699999999999999999984 578999999985432 24578999999999999999999984 334478
Q ss_pred EEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhC---CcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV---GVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 212 lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~---givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
+||||+.+ ++...+.........+++..+..++.||+.||.|||+ + ||+||||||+|||++.++ .+||+|||++
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~~ 181 (326)
T 3uim_A 104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD-HCDPKIIHRDVKAANILLDEEF-EAVVGDFGLA 181 (326)
T ss_dssp EEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHH-SSSSCEECCCCSGGGEEECTTC-CEEECCCSSC
T ss_pred EEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCchhhEEECCCC-CEEeccCccc
Confidence 99999986 5666555444445568999999999999999999997 8 999999999999999887 7999999999
Q ss_pred cccCCCCC--CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHhCCCCH
Q 011138 288 KMLVPGEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES----GVDQLVEIIKILGTPTR 361 (492)
Q Consensus 288 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~----~~~~~~~i~~~~g~p~~ 361 (492)
+....... .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.... ....+.....
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------- 253 (326)
T 3uim_A 182 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK------- 253 (326)
T ss_dssp EECCSSSSCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT-------
T ss_pred cccCcccccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH-------
Confidence 86643322 23456899999999996654 8999999999999999999999995211 1001111110
Q ss_pred HHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCC
Q 011138 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424 (492)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~ 424 (492)
...................+....++++.+||.+||+.||.+|||+.++++|-+-.
T Consensus 254 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 254 -------GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp -------TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred -------HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 00011111111111111122233457899999999999999999999999875543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=351.90 Aligned_cols=245 Identities=22% Similarity=0.342 Sum_probs=190.5
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEE----EEEEecc-----chhhHHHHHHHHHHcCCCCccccceeeeeccCCC
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSV----AIKKVLQ-----DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~v----AiK~~~~-----~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 206 (492)
..+|.+.+.||+|+||+||+|.+..+|+.+ |+|.+.. ....+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---- 89 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---- 89 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS----
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC----
Confidence 356999999999999999999998888765 7776632 223456899999999999999999988532
Q ss_pred ceEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeec
Q 011138 207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (492)
Q Consensus 207 ~~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG 285 (492)
. .++|+||+.+ ++...+. .....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 90 -~-~~~v~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIll~~~~-~~kl~Dfg 162 (327)
T 3poz_A 90 -T-VQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQ-HVKITDFG 162 (327)
T ss_dssp -S-EEEEEECCTTCBHHHHHH---HSTTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETT-EEEECCTT
T ss_pred -C-eEEEEEecCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCChheEEECCCC-CEEEccCc
Confidence 2 5688898885 4444432 234568999999999999999999997 9999999999999999887 89999999
Q ss_pred CccccCCCCCC---ccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 011138 286 SAKMLVPGEPN---ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTR 361 (492)
Q Consensus 286 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~ 361 (492)
+++........ ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~----- 236 (327)
T 3poz_A 163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----- 236 (327)
T ss_dssp HHHHHTTTCC-------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-----
T ss_pred ceeEccCCcccccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC-----
Confidence 99876433322 234568899999999765 48999999999999999999 999999877655443332210
Q ss_pred HHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
..+ .+..++.++.+||.+||+.||.+||++.++++|
T Consensus 237 -------------~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 237 -------------RLP----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp -------------CCC----------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred -------------CCC----------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 000 123468899999999999999999999999875
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=385.93 Aligned_cols=283 Identities=27% Similarity=0.333 Sum_probs=206.3
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccC-CCceEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELYL 210 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~-~~~~~~ 210 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++||||+++++++..... ......
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 5699999999999999999999999999999987543 2335579999999999999999998633111 224457
Q ss_pred EEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCC--cEEEeeecCc
Q 011138 211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH--QLKICDFGSA 287 (492)
Q Consensus 211 ~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~--~vkL~DFG~a 287 (492)
|+||||+.+ +|...+.. ......+++..++.++.||+.||.|||+ +||+||||||+|||++.++. .+||+|||++
T Consensus 94 ~LVmEy~~ggsL~~~L~~-~~~~~~lse~~i~~I~~QLl~aL~yLHs-~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQ-FENCCGLKEGPIRTLLSDISSALRYLHE-NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp CCEEECCSSCBHHHHHHS-SSCTTCCCSSHHHHHHHHHHHHHHHHHH-TTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred EEEEEeCCCCCHHHHHHh-cccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 899999975 55554433 2223468888999999999999999997 99999999999999987652 3899999999
Q ss_pred cccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+........... .......+...
T Consensus 172 ~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i---~~~~~~~~~~~ 247 (676)
T 3qa8_A 172 KELDQGELCTEFVGTLQYLAPELLEQK-KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV---REKSNEHIVVY 247 (676)
T ss_dssp CBTTSCCCCCCCCSCCTTCSSCSSCCS-CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTC---C------CCSC
T ss_pred cccccccccccccCCcccCChHHhccC-CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhh---hcccchhhhhh
Confidence 887666666677899999999999654 58999999999999999999999998765432211110 00000111111
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
........++.. .+....+...+++++.+||.+||.+||.+|||+.++++||||+.+.
T Consensus 248 ~~l~g~~~~~~~--lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~ 305 (676)
T 3qa8_A 248 DDLTGAVKFSSV--LPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD 305 (676)
T ss_dssp CCCSSSCCCCSS--SCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHH
T ss_pred hhhccccccccc--cCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHH
Confidence 111111122211 1122223445788999999999999999999999999999998644
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=348.88 Aligned_cols=250 Identities=24% Similarity=0.338 Sum_probs=200.9
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCC-----EEEEEEeccc-----hhhHHHHHHHHHHc-CCCCccccceeeeecc
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGD-----SVAIKKVLQD-----KRYKNRELQIMRLL-NHPNVVSLKHCFFSTT 203 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~-----~vAiK~~~~~-----~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~ 203 (492)
...+|.+.+.||+|+||.||+|.+..+++ .||+|.+... .....+|+.+++.+ +||||+++++++.
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--- 120 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT--- 120 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe---
Confidence 34579999999999999999999987665 7999998643 23456899999999 8999999999983
Q ss_pred CCCceEEEEEeeechh-hHHHHhhhhhh----------cCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEE
Q 011138 204 EKDELYLNLVLEYISE-TVYRVSKHYTR----------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV 272 (492)
Q Consensus 204 ~~~~~~~~lV~E~~~~-~l~~~~~~~~~----------~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl 272 (492)
+...+++||||+++ +|.+.+..... ....+++..+..++.||+.||.|||+ +||+||||||+|||+
T Consensus 121 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 --HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS-KNCIHRDVAARNVLL 197 (333)
T ss_dssp --SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGCEE
T ss_pred --cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCcccceEEE
Confidence 33458899999986 66665543322 13467899999999999999999997 999999999999999
Q ss_pred cCCCCcEEEeeecCccccCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHH
Q 011138 273 NPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQ 348 (492)
Q Consensus 273 ~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~ 348 (492)
+.++ .+||+|||++........ .....||+.|+|||++.+. .++.++|||||||++|+|++ |..||.+......
T Consensus 198 ~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 275 (333)
T 2i1m_A 198 TNGH-VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275 (333)
T ss_dssp EGGG-EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred CCCC-eEEECccccccccccccceeecCCCCCCccccCHHHhccC-CCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence 9877 899999999986543322 2245678899999999765 48999999999999999998 9999998776666
Q ss_pred HHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 349 LVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 349 ~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
+..+...... . ..+...++++.+||.+||+.||.+|||+.++++
T Consensus 276 ~~~~~~~~~~-----------------~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 276 FYKLVKDGYQ-----------------M----------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHHHHTCC-----------------C----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCCC-----------------C----------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 5555442100 0 012346889999999999999999999999986
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=344.65 Aligned_cols=257 Identities=24% Similarity=0.384 Sum_probs=192.1
Q ss_pred ccceeEeeeeccCCceEEEEEE----EcCCCCEEEEEEeccch----hhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 136 TISYMAERVVGTGSFGVVFQAK----CLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~----~~~~g~~vAiK~~~~~~----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
..+|++.+.||+|+||.||+|+ +..+|+.||||++.... ....+|+.+++.++||||+++++++.... .
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---R 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH---H
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---C
Confidence 3579999999999999999998 56789999999986532 34568999999999999999999875432 2
Q ss_pred eEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 208 ~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
..+++||||+.+ +|.+.+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~ 160 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVENEN-RVKIGDFGL 160 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHH---CGGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECCCCS
T ss_pred CceEEEEEeCCCCCHHHHHHh---cccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHhhEEEcCCC-eEEEccCcc
Confidence 247899999976 55554433 23458899999999999999999997 9999999999999999887 899999999
Q ss_pred ccccCCCCC----CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 011138 287 AKMLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (492)
Q Consensus 287 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~ 362 (492)
++....... .....+|..|+|||++.+.. ++.++|||||||++|+|++|..||..... . .....+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~~~~~~~~--~---~~~~~~~~~~~ 234 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPA--E---FMRMIGNDKQG 234 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTTCTTCSHHH--H---HHHHHCTTCCT
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCC-CChHHHHHHHHHHHHHHHhcccccCCChH--H---HHhhhcCcccc
Confidence 987643321 22345678899999997654 89999999999999999999999865321 1 11111111110
Q ss_pred HH------hhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 363 EI------KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 363 ~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.. ..... ... ...+..+++++.+||.+||+.||.+|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~---~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 235 QMIVFHLIELLKN---NGR----------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHHHHHHHT---TCC----------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred chhHHHHHHHHhc---cCc----------CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00 00000 000 0123467899999999999999999999999875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=348.89 Aligned_cols=259 Identities=24% Similarity=0.390 Sum_probs=199.7
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++||||+++++++.... ......++
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~l 107 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAWL 107 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeEE
Confidence 4699999999999999999999999999999988432 234568999999999999999999986433 34556889
Q ss_pred Eeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 213 V~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
||||+.+ +|...+.........+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++....
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dlkp~NIl~~~~~-~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA-KGYAHRDLKPTNILLGDEG-QPVLMDLGSMNQAC 185 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTS-CEEECCCSSCEESC
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcCCC-CEEEEecCcchhcc
Confidence 9999987 6666665554456779999999999999999999997 8999999999999999887 79999999987542
Q ss_pred CCCC----------CccceeccCccCchhhcCCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCC
Q 011138 292 PGEP----------NISYICSRYYRAPELIFGAT--EYTTAIDMWSIGCVLAELLLGQPLFPGESGV-DQLVEIIKILGT 358 (492)
Q Consensus 292 ~~~~----------~~~~~gt~~y~aPE~~~~~~--~~~~~~DvwSlGvil~ell~G~~pf~~~~~~-~~~~~i~~~~g~ 358 (492)
.... .....||+.|+|||++.+.. .++.++|||||||++|+|++|+.||...... ..+.....
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---- 261 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ---- 261 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH----
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh----
Confidence 2111 12345799999999986543 2688999999999999999999999531110 00111111
Q ss_pred CCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 359 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
....++ ....+++++.+||.+||+.||.+|||+.++++| |+.+.
T Consensus 262 -------------~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~ 305 (317)
T 2buj_A 262 -------------NQLSIP----------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ--LEALQ 305 (317)
T ss_dssp -------------CC--CC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHTC
T ss_pred -------------ccCCCC----------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH--hhhcC
Confidence 011111 113578999999999999999999999999985 44443
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=342.95 Aligned_cols=250 Identities=30% Similarity=0.492 Sum_probs=188.4
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
..+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++||||+++++++.. ..
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~ 105 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DN 105 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TT
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----CC
Confidence 34699999999999999999999999999999998531 2334579999999999999999999854 33
Q ss_pred EEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 209 ~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
.+++||||+.+ ++.+++.........+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIl~~~~~-~~kl~Dfg~~ 183 (310)
T 2wqm_A 106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITATG-VVKLGDLGLG 183 (310)
T ss_dssp EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCC---
T ss_pred cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCcHHHEEEcCCC-CEEEEeccce
Confidence 58899999986 6666665555556778999999999999999999997 9999999999999999887 7999999999
Q ss_pred cccCCCC-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHh
Q 011138 288 KMLVPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESG-VDQLVEIIKILGTPTREEIK 365 (492)
Q Consensus 288 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~-~~~~~~i~~~~g~p~~~~~~ 365 (492)
....... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+... ...+...+..
T Consensus 184 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---------- 252 (310)
T 2wqm_A 184 RFFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ---------- 252 (310)
T ss_dssp ---------------CCSSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT----------
T ss_pred eeecCCCccccccCCCeeEeChHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc----------
Confidence 7654322 23346789999999999654 489999999999999999999999976532 1122221111
Q ss_pred hcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
..++.. ....+++++.+||.+||..||.+|||+.++++
T Consensus 253 --------~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 253 --------CDYPPL--------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp --------TCSCCC--------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------ccCCCC--------cccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 011110 11357899999999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=344.24 Aligned_cols=255 Identities=18% Similarity=0.261 Sum_probs=192.1
Q ss_pred cccceeEeeeeccCCceEEEEEEEcC---CCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCC
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLE---TGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~---~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 205 (492)
...+|.+.+.||+|+||.||+|.+.. ++..||||++.... ....+|+.+++.++||||+++++++......
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 34579999999999999999998765 55689999985331 3355799999999999999999998665544
Q ss_pred CceEEEEEeeechh-hHHHHhhhhh--hcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEe
Q 011138 206 DELYLNLVLEYISE-TVYRVSKHYT--RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC 282 (492)
Q Consensus 206 ~~~~~~lV~E~~~~-~l~~~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~ 282 (492)
.....++||||+.+ ++...+.... .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~~~~-~~kl~ 189 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN-RNFLHRDLAARNCMLRDDM-TVCVA 189 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCSGGGEEECTTS-CEEEC
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcCCC-cEEEe
Confidence 44457899999986 4544442211 234568999999999999999999997 9999999999999999887 79999
Q ss_pred eecCccccCCCC---CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 011138 283 DFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGT 358 (492)
Q Consensus 283 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~ 358 (492)
|||+++...... ......+++.|+|||++.+. .++.++|||||||++|+|++ |.+||.+....+....+....
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-- 266 (313)
T 3brb_A 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH-- 266 (313)
T ss_dssp SCSCC----------------CCGGGSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC--
T ss_pred ecCcceecccccccCcccccCCCccccCchhhcCC-CccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC--
Confidence 999997654332 12234568899999999654 58999999999999999999 999999887766555443310
Q ss_pred CCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 359 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
.. .++..+++++.+||.+||..||.+|||+.++++|
T Consensus 267 --------------~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 267 --------------RL------------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp --------------CC------------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --------------CC------------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 1224578999999999999999999999999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=344.77 Aligned_cols=251 Identities=24% Similarity=0.355 Sum_probs=199.2
Q ss_pred ccceeEeeeeccCCceEEEEEEE-----cCCCCEEEEEEeccch-----hhHHHHHHHHHHc-CCCCccccceeeeeccC
Q 011138 136 TISYMAERVVGTGSFGVVFQAKC-----LETGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFSTTE 204 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~-----~~~g~~vAiK~~~~~~-----~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~ 204 (492)
..+|.+.+.||+|+||.||+|.+ ..+++.||||++.... ....+|+.+++.+ +||||+++++++...
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-- 103 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-- 103 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT--
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC--
Confidence 35799999999999999999985 3577899999986532 3355899999999 699999999987432
Q ss_pred CCceEEEEEeeechh-hHHHHhhhhhhc------------CCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceE
Q 011138 205 KDELYLNLVLEYISE-TVYRVSKHYTRM------------NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLL 271 (492)
Q Consensus 205 ~~~~~~~lV~E~~~~-~l~~~~~~~~~~------------~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NIL 271 (492)
...+++||||+.+ +|.+.+...... ...+++..+..++.||+.||.|||+ +||+||||||+|||
T Consensus 104 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil 180 (316)
T 2xir_A 104 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNIL 180 (316)
T ss_dssp --TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEE
T ss_pred --CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceEE
Confidence 2347899999986 555554432211 1238899999999999999999997 99999999999999
Q ss_pred EcCCCCcEEEeeecCccccCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHH
Q 011138 272 VNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVD 347 (492)
Q Consensus 272 l~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~ 347 (492)
++.++ .+||+|||+++....... .....||+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+
T Consensus 181 ~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~ 258 (316)
T 2xir_A 181 LSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258 (316)
T ss_dssp ECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred ECCCC-CEEECCCccccccccCccceeccCCCcceeecCchhhcccc-ccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence 99877 799999999986643332 22456789999999997654 8999999999999999998 999998877555
Q ss_pred HHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 348 QLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 348 ~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
.+...+..... .. .+..+++++.+||.+||+.||.+|||+.++++|
T Consensus 259 ~~~~~~~~~~~---------------~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 259 EFCRRLKEGTR---------------MR------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHHHTCC---------------CC------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhccCcc---------------CC------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 55444332110 00 123478999999999999999999999999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=343.23 Aligned_cols=247 Identities=25% Similarity=0.308 Sum_probs=188.4
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
...+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++.. .
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~ 106 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-----D 106 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----T
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-----C
Confidence 3457999999999999999999999999999999985432 345679999999999999999999843 3
Q ss_pred eEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 208 ~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
..+|+||||+.+ .+.+.+.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~NIl~~~~~-~~kl~Dfg~ 180 (309)
T 2h34_A 107 GQLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHA-AGATHRDVKPENILVSADD-FAYLVDFGI 180 (309)
T ss_dssp TEEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECSCCC
T ss_pred CeEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CcCCcCCCChHHEEEcCCC-CEEEecCcc
Confidence 458899999986 55554432 3568999999999999999999997 9999999999999999887 799999999
Q ss_pred ccccCCCC--CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 011138 287 AKMLVPGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (492)
Q Consensus 287 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~ 364 (492)
+....... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.. .+...+.. ..+
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~-~~~----- 252 (309)
T 2h34_A 181 ASATTDEKLTQLGNTVGTLYYMAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQ-AIP----- 252 (309)
T ss_dssp ----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHS-CCC-----
T ss_pred CccccccccccccccCCCcCccCHHHHcCC-CCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhcc-CCC-----
Confidence 97654332 22356789999999999654 5899999999999999999999999876543 22222221 000
Q ss_pred hhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcC-CHHHhhC
Q 011138 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-TALEACA 419 (492)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-t~~e~l~ 419 (492)
....++..+++++.+||.+||+.||.+|| ++.++++
T Consensus 253 -------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 253 -------------------RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp -------------------CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred -------------------CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 01113356899999999999999999999 7777764
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=368.93 Aligned_cols=253 Identities=19% Similarity=0.222 Sum_probs=193.1
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHcCC-CCcccccee---------e
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNH-PNVVSLKHC---------F 199 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l~h-~nIv~l~~~---------~ 199 (492)
..|..+++||+|+||+||+|.+..+|+.||||++... ...+.+|+.+++.+.| +|+..+..+ .
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 3588999999999999999999999999999988622 2345689999999987 332222111 1
Q ss_pred ------------eeccCCCceEEEEEeeechhhHHHHhhhh---hhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCC
Q 011138 200 ------------FSTTEKDELYLNLVLEYISETVYRVSKHY---TRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRD 264 (492)
Q Consensus 200 ------------~~~~~~~~~~~~lV~E~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrD 264 (492)
..........++++|+++.+++.+++... ......+++..+..++.||+.||.|||+ +||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~iiHrD 236 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHTY 236 (413)
T ss_dssp ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEECSC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCC
Confidence 10000112336789999988887766433 2224457777888899999999999997 9999999
Q ss_pred CCCCceEEcCCCCcEEEeeecCccccCCCCCCccceeccCccCchhhc---------CCCCCCcchhhHHHHHHHHHHHh
Q 011138 265 IKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIF---------GATEYTTAIDMWSIGCVLAELLL 335 (492)
Q Consensus 265 lKp~NILl~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~~~DvwSlGvil~ell~ 335 (492)
|||+||||+.++ .+||+|||+++... ......+| +.|+|||++. ....++.++|||||||++|||++
T Consensus 237 iKp~NILl~~~~-~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 237 LRPVDIVLDQRG-GVFLTGFEHLVRDG--ASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp CCGGGEEECTTC-CEEECCGGGCEETT--EEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred cccceEEEecCC-eEEEEeccceeecC--CccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 999999999888 69999999987653 22445677 9999999993 34458889999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHH
Q 011138 336 GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL 415 (492)
Q Consensus 336 G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~ 415 (492)
|+.||.+.+..+.... .++ ....+++++.+||.+||+.||.+||++.
T Consensus 313 g~~Pf~~~~~~~~~~~-----------------------~~~----------~~~~~~~~~~~li~~~l~~dP~~Rpt~~ 359 (413)
T 3dzo_A 313 ADLPNTDDAALGGSEW-----------------------IFR----------SCKNIPQPVRALLEGFLRYPKEDRLLPL 359 (413)
T ss_dssp SSCCCCTTGGGSCSGG-----------------------GGS----------SCCCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCCCCcchhhhHHH-----------------------HHh----------hcccCCHHHHHHHHHHccCChhhCcCHH
Confidence 9999977543211110 000 1135789999999999999999999999
Q ss_pred HhhCCCCCCCCC
Q 011138 416 EACAHPFFDDLR 427 (492)
Q Consensus 416 e~l~Hp~f~~~~ 427 (492)
++++||||+++.
T Consensus 360 ~~l~~~~~~~~~ 371 (413)
T 3dzo_A 360 QAMETPEYEQLR 371 (413)
T ss_dssp HHTTSHHHHHHH
T ss_pred HHHhCHHHHHHH
Confidence 999999998764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=345.96 Aligned_cols=251 Identities=22% Similarity=0.327 Sum_probs=198.4
Q ss_pred ccccceeEeeeeccCCceEEEEEEEc-------CCCCEEEEEEeccch-----hhHHHHHHHHHHc-CCCCccccceeee
Q 011138 134 KQTISYMAERVVGTGSFGVVFQAKCL-------ETGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFF 200 (492)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-------~~g~~vAiK~~~~~~-----~~~~~E~~il~~l-~h~nIv~l~~~~~ 200 (492)
....+|.+.+.||+|+||.||+|.+. .++..||||++.... ....+|+.+++.+ +||||+++++++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~- 110 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC- 110 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE-
Confidence 34467999999999999999999976 467889999986432 3345799999999 899999999988
Q ss_pred eccCCCceEEEEEeeechh-hHHHHhhhhhh------------cCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCC
Q 011138 201 STTEKDELYLNLVLEYISE-TVYRVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKP 267 (492)
Q Consensus 201 ~~~~~~~~~~~lV~E~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp 267 (492)
.+...+|+||||+.+ +|.+.+..... ....+++..+..++.||+.||.|||+ +||+||||||
T Consensus 111 ----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp 185 (334)
T 2pvf_A 111 ----TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAA 185 (334)
T ss_dssp ----CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSG
T ss_pred ----ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCcc
Confidence 344458899999986 56555543221 12348889999999999999999997 9999999999
Q ss_pred CceEEcCCCCcEEEeeecCccccCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCC
Q 011138 268 QNLLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGE 343 (492)
Q Consensus 268 ~NILl~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~ 343 (492)
+|||++.++ .+||+|||+++....... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.
T Consensus 186 ~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 186 RNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp GGEEECTTC-CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ceEEEcCCC-CEEEccccccccccccccccccCCCCcccceeChHHhcCC-CcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 999999887 799999999986643321 2334668899999999765 48999999999999999999 99999988
Q ss_pred ChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 344 SGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 344 ~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
+..+....+.... .. ..+..+++++.+||.+||..||.+|||+.+++++
T Consensus 264 ~~~~~~~~~~~~~----------------~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 264 PVEELFKLLKEGH----------------RM------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp CHHHHHHHHHHTC----------------CC------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHhcCC----------------CC------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7665554443310 00 0123578999999999999999999999999864
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=341.95 Aligned_cols=245 Identities=30% Similarity=0.406 Sum_probs=185.2
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch--hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~--~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
..+|.+.+.||+|+||.||+|.+ .++.||||++.... ....+|+.+++.++||||+++++++. +. .++|
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~--~~lv 77 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL-----NP--VCLV 77 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT-----TT--TEEE
T ss_pred HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----CC--cEEE
Confidence 34799999999999999999987 47899999986543 34568999999999999999999873 22 5799
Q ss_pred eeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhh--CCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 214 LEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV--VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 214 ~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~--~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
|||+.+ ++.+.+.. ......++...+..++.||+.||.|||+. +||+||||||+|||++.++..+||+|||++...
T Consensus 78 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 78 MEYAEGGSLYNVLHG-AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp EECCTTCBHHHHHHC-SSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EEcCCCCCHHHHHhc-cCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 999986 55554432 22223467888999999999999999952 589999999999999887745899999999755
Q ss_pred CCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 011138 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (492)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 370 (492)
.. ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||................+.
T Consensus 157 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~------------ 221 (307)
T 2eva_A 157 QT--HMTNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT------------ 221 (307)
T ss_dssp ----------CCTTSSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC------------
T ss_pred cc--ccccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC------------
Confidence 32 23345799999999999654 5899999999999999999999999865432211111110000
Q ss_pred CcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.+ .+...+++.+.+||.+||+.||.+|||+.++++
T Consensus 222 -----~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 222 -----RP---------PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp -----CC---------CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----CC---------CcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00 122457899999999999999999999999987
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=347.04 Aligned_cols=258 Identities=22% Similarity=0.287 Sum_probs=204.7
Q ss_pred ccccceeEeeeeccCCceEEEEEEEc-----CCCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeecc
Q 011138 134 KQTISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTT 203 (492)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-----~~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 203 (492)
....+|.+.+.||+|+||.||+|.+. .+++.||||++.... ....+|+.+++.++||||+++++++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~---- 97 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV---- 97 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE----
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE----
Confidence 34457999999999999999999876 467889999985432 2345799999999999999999988
Q ss_pred CCCceEEEEEeeechh-hHHHHhhhhhhc------CCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCC
Q 011138 204 EKDELYLNLVLEYISE-TVYRVSKHYTRM------NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT 276 (492)
Q Consensus 204 ~~~~~~~~lV~E~~~~-~l~~~~~~~~~~------~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~ 276 (492)
.+....++||||+.+ +|.+.+...... ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++
T Consensus 98 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 98 -SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEECTTC
T ss_pred -ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCCccCCCccceEEEcCCC
Confidence 334457899999985 666555432211 2456889999999999999999997 9999999999999999887
Q ss_pred CcEEEeeecCccccCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 011138 277 HQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEI 352 (492)
Q Consensus 277 ~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i 352 (492)
.+||+|||+++....... .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+
T Consensus 176 -~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 253 (322)
T 1p4o_A 176 -TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253 (322)
T ss_dssp -CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred -eEEECcCccccccccccccccccCCCCCCCccChhhhccCC-CCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH
Confidence 799999999976533221 22446789999999997654 8999999999999999999 89999988766555544
Q ss_pred HHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC------CCCCCC
Q 011138 353 IKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH------PFFDDL 426 (492)
Q Consensus 353 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H------p~f~~~ 426 (492)
... ..+ ..+..+++++.+||.+||+.||.+|||+.++++| +||+++
T Consensus 254 ~~~-------------------~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~ 305 (322)
T 1p4o_A 254 MEG-------------------GLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 305 (322)
T ss_dssp HTT-------------------CCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred HcC-------------------CcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCccc
Confidence 321 000 0123578999999999999999999999999976 666654
Q ss_pred C
Q 011138 427 R 427 (492)
Q Consensus 427 ~ 427 (492)
.
T Consensus 306 ~ 306 (322)
T 1p4o_A 306 S 306 (322)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=337.42 Aligned_cols=248 Identities=26% Similarity=0.340 Sum_probs=195.3
Q ss_pred CccccceeEeeeeccCCceEEEEEEEcC---CCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccC
Q 011138 133 PKQTISYMAERVVGTGSFGVVFQAKCLE---TGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE 204 (492)
Q Consensus 133 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~---~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 204 (492)
.....+|.+.+.||+|+||.||+|.+.. ++..||+|.+... .....+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---- 83 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE---- 83 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC----
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc----
Confidence 3445679999999999999999998754 3446999998653 234567999999999999999999873
Q ss_pred CCceEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEee
Q 011138 205 KDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICD 283 (492)
Q Consensus 205 ~~~~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~D 283 (492)
+. ..|+||||+.+ ++.+.+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|
T Consensus 84 -~~-~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~kl~D 156 (281)
T 3cc6_A 84 -EE-PTWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLES-INCVHRDIAVRNILVASPE-CVKLGD 156 (281)
T ss_dssp -SS-SCEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEEETT-EEEECC
T ss_pred -CC-CCEEEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEECCCC-cEEeCc
Confidence 22 24799999986 45444432 23568899999999999999999997 9999999999999999887 899999
Q ss_pred ecCccccCCCCC--CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 011138 284 FGSAKMLVPGEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPT 360 (492)
Q Consensus 284 FG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~ 360 (492)
||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||......+....+.....
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~--- 232 (281)
T 3cc6_A 157 FGLSRYIEDEDYYKASVTRLPIKWMSPESINFR-RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR--- 232 (281)
T ss_dssp CCGGGCC---------CCCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCC---
T ss_pred cCCCcccccccccccccCCCCcceeCchhhccC-CCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCC---
Confidence 999986543321 2334568899999999654 48999999999999999998 9999988776665554433110
Q ss_pred HHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
. ..+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 233 -------------~------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 233 -------------L------------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp -------------C------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------C------------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 0 0123478999999999999999999999999864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=347.46 Aligned_cols=243 Identities=23% Similarity=0.344 Sum_probs=188.5
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEE----EEEEecc-----chhhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSV----AIKKVLQ-----DKRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~v----AiK~~~~-----~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
.+|.+.+.||+|+||.||+|.+..+|+.| |+|.+.. ......+|+.+++.++||||+++++++...
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----- 89 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 89 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-----
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-----
Confidence 46999999999999999999999888866 5665532 234566899999999999999999988432
Q ss_pred eEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 208 ~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
. .++|+||+.+ .+.+.+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~-~~kL~DfG~ 163 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQ-HVKITDFGL 163 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETT-EEEECCTTC
T ss_pred C-ceEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhh-CCCcCCCCCHHHEEEcCCC-CEEEccCcc
Confidence 2 5678888875 45544332 24568999999999999999999997 9999999999999999887 899999999
Q ss_pred ccccCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 011138 287 AKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTRE 362 (492)
Q Consensus 287 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~ 362 (492)
++....... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+....+....
T Consensus 164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~------ 236 (327)
T 3lzb_A 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE------ 236 (327)
T ss_dssp ----------------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC------
T ss_pred eeEccCccccccccCCCccccccCHHHHcCC-CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC------
Confidence 986643322 2234567889999999765 48999999999999999999 999999877665544332210
Q ss_pred HHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
..+ .+..++.++.+||.+||..||.+||++.|+++
T Consensus 237 ------------~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 237 ------------RLP----------QPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp ------------CCC----------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------CCC----------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 000 12357889999999999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=334.78 Aligned_cols=245 Identities=16% Similarity=0.217 Sum_probs=196.9
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
...+|.+.+.||+|+||.||+|.+ +|+.||||++... .....+|+.+++.++||||+++++++... +..
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~ 82 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PAP 82 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TSS
T ss_pred CHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CCC
Confidence 445799999999999999999998 4889999998643 23456799999999999999999988432 124
Q ss_pred EEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCC--cccCCCCCCceEEcCCCCcEEEeeec
Q 011138 209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG--VCHRDIKPQNLLVNPHTHQLKICDFG 285 (492)
Q Consensus 209 ~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~g--ivHrDlKp~NILl~~~~~~vkL~DFG 285 (492)
.+++||||+.+ +|.+.+.. .....+++..+..++.||+.||.|||+ +| |+||||||+|||++.++ .++|+|||
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~-~~~l~~~~ 158 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDM-TARISMAD 158 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHHTT-SSSCCTTCCCSGGGEEECTTS-CEEEEGGG
T ss_pred CeEeeecccCCCcHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHHhc-CCCceecCCCccceEEEcCCc-ceeEEecc
Confidence 57899999986 66555432 122358999999999999999999997 89 99999999999999887 79999999
Q ss_pred CccccCCCCCCccceeccCccCchhhcCCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 011138 286 SAKMLVPGEPNISYICSRYYRAPELIFGATE--YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (492)
Q Consensus 286 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~ 363 (492)
++... ......||+.|+|||++.+... ++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 159 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~----- 229 (271)
T 3kmu_A 159 VKFSF----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR----- 229 (271)
T ss_dssp SCCTT----SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCC-----
T ss_pred ceeee----cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCC-----
Confidence 87543 2234578999999999976432 333799999999999999999999988877666555431100
Q ss_pred HhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
..++..+++++.+||.+||+.||.+|||+.++++
T Consensus 230 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 230 ----------------------PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp ----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0123457999999999999999999999999985
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=335.00 Aligned_cols=245 Identities=20% Similarity=0.323 Sum_probs=198.9
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc---hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
..+|.+.+.||+|+||.||+|.+. +++.||+|++... .....+|+.+++.++||||+++++++. +...+++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 80 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPICL 80 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSCEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCCeEE
Confidence 457999999999999999999986 6788999998654 345668999999999999999999883 3345789
Q ss_pred Eeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 213 V~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
||||+++ ++.+.+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++....
T Consensus 81 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~ 155 (267)
T 3t9t_A 81 VTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVL 155 (267)
T ss_dssp EECCCTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECGGG-CEEECCTTGGGGBC
T ss_pred EEeCCCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEECCCC-CEEEcccccccccc
Confidence 9999986 45554432 23568899999999999999999997 9999999999999999877 79999999997653
Q ss_pred CCC--CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 292 PGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 292 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
... ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~----------- 223 (267)
T 3t9t_A 156 DDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR----------- 223 (267)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-----------
T ss_pred cccccccccccccccccChhhhcCC-CccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc-----------
Confidence 221 12234667889999999654 48999999999999999999 9999998877665555433100
Q ss_pred CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
...+..+++++.+||.+||+.||.+|||+.+++++
T Consensus 224 -----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 224 -----------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp -----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00123468899999999999999999999999863
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=355.29 Aligned_cols=246 Identities=24% Similarity=0.347 Sum_probs=186.3
Q ss_pred cccceeEeeeeccCCceEEEEEEEc---CCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCC
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~---~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 206 (492)
...+|.+.+.||+|+||.||+|++. .++..||||++... ...+.+|+.+++.++||||+++++++ .+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~ 117 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV-----TK 117 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CS
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----ee
Confidence 3457999999999999999999876 46778999998543 23456899999999999999999998 33
Q ss_pred ceEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeec
Q 011138 207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (492)
Q Consensus 207 ~~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG 285 (492)
...+++||||+++ +|.+++. .....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~-~~kl~Dfg 192 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILINSNL-VCKVSDFG 192 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHH---TTTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCC-
T ss_pred CCceEEEEeCCCCCcHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEEcCCC-CEEECcCc
Confidence 4457899999975 5555443 223568999999999999999999997 9999999999999999887 79999999
Q ss_pred CccccCCCCC----CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 011138 286 SAKMLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPT 360 (492)
Q Consensus 286 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~ 360 (492)
+++....... .....+|+.|+|||++.+. .++.++|||||||++|||++ |..||.+.+..+....+....
T Consensus 193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~---- 267 (373)
T 2qol_A 193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY---- 267 (373)
T ss_dssp ---------------------CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTE----
T ss_pred cccccccCCccceeccCCCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----
Confidence 9987643321 1123457789999999765 48999999999999999997 999999887766554443211
Q ss_pred HHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
..+ .+..++.++.+||.+||+.||.+||++.++++
T Consensus 268 --------------~~~----------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 268 --------------RLP----------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp --------------ECC----------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------CCC----------CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 111 11347889999999999999999999998875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=348.06 Aligned_cols=255 Identities=20% Similarity=0.215 Sum_probs=197.2
Q ss_pred cccceeEeeeeccCCceEEEEEE-----EcCCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccC
Q 011138 135 QTISYMAERVVGTGSFGVVFQAK-----CLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE 204 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~-----~~~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 204 (492)
...+|.+.+.||+|+||.||+|. +..++..||||++... .....+|+.+++.++||||+++++++.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---- 103 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL---- 103 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc----
Confidence 34579999999999999999998 5668899999998532 234557999999999999999999983
Q ss_pred CCceEEEEEeeechh-hHHHHhhhhhh---cCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCC--Cc
Q 011138 205 KDELYLNLVLEYISE-TVYRVSKHYTR---MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT--HQ 278 (492)
Q Consensus 205 ~~~~~~~lV~E~~~~-~l~~~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~--~~ 278 (492)
+....|+||||+.+ +|.+++..... ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ ..
T Consensus 104 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 104 -QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp -SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCC
T ss_pred -CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeecCcCCHhHEEEecCCCcce
Confidence 33447899999964 56665543221 11458889999999999999999997 9999999999999998433 26
Q ss_pred EEEeeecCccccCCCC---CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 011138 279 LKICDFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIK 354 (492)
Q Consensus 279 vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~ 354 (492)
+||+|||++....... ......||+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 260 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 260 (327)
T ss_dssp EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred EEECccccccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc
Confidence 9999999987543222 22345678999999999765 48999999999999999998 9999998776655544432
Q ss_pred HhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCC
Q 011138 355 ILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424 (492)
Q Consensus 355 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~ 424 (492)
.. . + ..+..+++.+.+||.+||+.||.+||++.++++|.|+-
T Consensus 261 ~~----------------~---~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 261 GG----------------R---M---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp TC----------------C---C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC----------------C---C---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 10 0 0 01235789999999999999999999999999998875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=365.38 Aligned_cols=248 Identities=21% Similarity=0.340 Sum_probs=201.8
Q ss_pred ccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc---hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
....+|.+.+.||+|+||.||+|.+..++..||||++..+ ...+.+|+.+|+.++|||||++++++. +...+
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-----~~~~~ 291 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPF 291 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSC
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEe-----cCCcE
Confidence 3456799999999999999999999999999999998654 344568999999999999999999983 33457
Q ss_pred EEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 211 ~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
||||||+.+ +|.+.+... ....+++..+..++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+++.
T Consensus 292 ~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~ 367 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRNLAARNCLVGENH-LVKVADFGLSRL 367 (495)
T ss_dssp EEEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECGGG-CEEECCTTCEEC
T ss_pred EEEEEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChhhEEECCCC-cEEEeeccccee
Confidence 899999985 565554432 23568899999999999999999997 9999999999999999877 799999999987
Q ss_pred cCCCC--CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 011138 290 LVPGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (492)
Q Consensus 290 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~ 366 (492)
..... ......+++.|+|||++.+. .++.++|||||||++|||++ |..||.+.+..+....+...
T Consensus 368 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~----------- 435 (495)
T 1opk_A 368 MTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD----------- 435 (495)
T ss_dssp CTTCCEECCTTCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-----------
T ss_pred ccCCceeecCCCcCCcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----------
Confidence 64322 12234567889999999755 48999999999999999998 99999988765544433221
Q ss_pred cCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
... ..+..+++++.+||.+||+.||.+|||+.++++
T Consensus 436 -------~~~----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 436 -------YRM----------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp -------CCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------CCC----------CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 000 122457899999999999999999999999976
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=337.56 Aligned_cols=244 Identities=26% Similarity=0.386 Sum_probs=186.8
Q ss_pred cccceeEe-eeeccCCceEEEEEEEcCCCCEEEEEEeccchhhHHHHHHHH-HHcCCCCccccceeeeeccCCCceEEEE
Q 011138 135 QTISYMAE-RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM-RLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 135 ~~~~y~~~-~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~E~~il-~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
...+|.+. +.||+|+||.||+|.+..+|+.||||++... ....+|+.++ +.++||||++++++|.... .+..++++
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~l 92 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLI 92 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-HHHHHHHHHHHHhccCCCchhHHhhhhhhc-CCCceEEE
Confidence 34468776 8899999999999999999999999998654 3456788887 6678999999999885422 33567899
Q ss_pred Eeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcC---CCCcEEEeeecCcc
Q 011138 213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP---HTHQLKICDFGSAK 288 (492)
Q Consensus 213 V~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~---~~~~vkL~DFG~a~ 288 (492)
||||+.+ ++.+.+.. .....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++ .+||+|||++.
T Consensus 93 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~-~~kl~Dfg~a~ 168 (299)
T 3m2w_A 93 VMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAK 168 (299)
T ss_dssp EECCCCSCBHHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSTTC-CEEECCCTTCE
T ss_pred EEeecCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEecCCCCC-cEEEecccccc
Confidence 9999986 66665543 223468999999999999999999997 99999999999999987 44 79999999986
Q ss_pred ccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
... ...++.++|||||||++|+|++|..||.+.........+ .
T Consensus 169 ~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~---------------~ 211 (299)
T 3m2w_A 169 ETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---------------K 211 (299)
T ss_dssp ECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS---------------C
T ss_pred ccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH---------------H
Confidence 432 133788999999999999999999999775532211000 0
Q ss_pred CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
..... ....+....+..+++++.+||.+||+.||.+|||+.|+++||||++..
T Consensus 212 ---~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 212 ---TRIRM---GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp ---CSSCT---TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred ---HHHhh---ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 00000 000111112245799999999999999999999999999999998754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=349.93 Aligned_cols=254 Identities=14% Similarity=0.142 Sum_probs=195.9
Q ss_pred cceeEeeeeccCCceEEEEEEEcCC--------CCEEEEEEeccchhhHHHHHHHHHHcCCCCcccc-------------
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLET--------GDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSL------------- 195 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~--------g~~vAiK~~~~~~~~~~~E~~il~~l~h~nIv~l------------- 195 (492)
.+|.+.+.||+|+||.||+|.+..+ ++.||||++... ....+|+.+++.++||||+++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~ 120 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP 120 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-chHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence 3699999999999999999999874 889999998655 456789999999999999984
Q ss_pred --ceeeeeccCCCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEc
Q 011138 196 --KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN 273 (492)
Q Consensus 196 --~~~~~~~~~~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~ 273 (492)
++++.. ...++|+||||++++|.+++... ....+++..+..++.||+.||.|||+ +||+||||||+|||++
T Consensus 121 ~~~~~~~~----~~~~~~lv~e~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 121 TCMGFGVH----QDKYRFLVLPSLGRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHE-NEYVHGNVTAENIFVD 193 (352)
T ss_dssp CCCEEEEE----TTTEEEEEEECCCEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCGGGEEEE
T ss_pred chhhcccc----CCcEEEEEecCCCcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEEc
Confidence 444422 23468899999977777766532 13568999999999999999999997 9999999999999999
Q ss_pred CCCC-cEEEeeecCccccCCCC--------CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 011138 274 PHTH-QLKICDFGSAKMLVPGE--------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES 344 (492)
Q Consensus 274 ~~~~-~vkL~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~ 344 (492)
.++. .+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+..
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 7652 69999999997654322 12345899999999999664 48999999999999999999999998764
Q ss_pred -hHHHHHHHHHHh-CCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 345 -GVDQLVEIIKIL-GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 345 -~~~~~~~i~~~~-g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
..+.+......+ ..+. .++. ....+..+++++.+||.+||+.||.+|||+.++++
T Consensus 273 ~~~~~~~~~~~~~~~~~~--------------~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 273 PNTEDIMKQKQKFVDKPG--------------PFVG------PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TCHHHHHHHHHHHHHSCC--------------CEEC------TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cCHHHHHHHHHhccCChh--------------hhhh------hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 333333333211 1110 0000 00011357899999999999999999999999876
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=339.22 Aligned_cols=247 Identities=22% Similarity=0.309 Sum_probs=185.6
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
..+|.+.+.||+|+||.||+|++. ..||||++... .....+|+.+++.++||||++++++. .+ ..
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~-~~ 93 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-----TA-PQ 93 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CS-SS
T ss_pred ccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-----cC-Cc
Confidence 346999999999999999999853 45999988532 23456899999999999999999864 11 23
Q ss_pred EEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 210 LNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 210 ~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
+++||||+.++ +...+. .....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++.
T Consensus 94 ~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~ 168 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLHA-KSIIHRDLKSNNIFLHEDN-TVKIGDFGLAT 168 (289)
T ss_dssp CEEEEECCCEEEHHHHHT---TC---CCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEETTT-EEEECCCC---
T ss_pred cEEEEEecCCCcHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceEEECCCC-CEEEccceecc
Confidence 67999999864 444332 234568999999999999999999997 9999999999999999887 89999999997
Q ss_pred ccCCC---CCCccceeccCccCchhhc--CCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 011138 289 MLVPG---EPNISYICSRYYRAPELIF--GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363 (492)
Q Consensus 289 ~~~~~---~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~ 363 (492)
..... .......||+.|+|||++. ....++.++|||||||++|+|++|+.||.+....+.+..+......++
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--- 245 (289)
T 3og7_A 169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP--- 245 (289)
T ss_dssp ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC---
T ss_pred ccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc---
Confidence 55321 2223467899999999985 234578899999999999999999999998877776666554321110
Q ss_pred HhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.+ ..+...+++++.+||.+||..||.+|||+.++++
T Consensus 246 -----------~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 246 -----------DL---------SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp -----------CT---------TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------ch---------hhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 00 0122457899999999999999999999999875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=335.18 Aligned_cols=245 Identities=26% Similarity=0.305 Sum_probs=195.9
Q ss_pred cceeEee-eeccCCceEEEEEEEc--CCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 137 ISYMAER-VVGTGSFGVVFQAKCL--ETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 137 ~~y~~~~-~lG~G~fg~Vy~~~~~--~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
.+|.+.+ .||+|+||.||+|.+. .++..||||++... .....+|+.+++.++||||+++++++. . .
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~----~- 82 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-A----E- 82 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-S----S-
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-C----C-
Confidence 4577766 9999999999999864 46788999998653 234558999999999999999999872 1 1
Q ss_pred EEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 209 ~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
.+++||||+.++ +...+. .....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 83 ~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~ 157 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVNRH-YAKISDFGLS 157 (287)
T ss_dssp SEEEEEECCTTEEHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEETT-EEEECCCTTC
T ss_pred CcEEEEEeCCCCCHHHHHH---hCCccCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCchheEEEcCCC-CEEECcccce
Confidence 278999999874 444332 234568999999999999999999997 9999999999999999877 8999999999
Q ss_pred cccCCCCC----CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 011138 288 KMLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTRE 362 (492)
Q Consensus 288 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~ 362 (492)
........ .....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+..+....+... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~--~---- 230 (287)
T 1u59_A 158 KALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG--K---- 230 (287)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT--C----
T ss_pred eeeccCcceeeccccccccccccCHHHhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcC--C----
Confidence 87643322 2234568899999999654 48999999999999999998 99999987766555444321 0
Q ss_pred HHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCC
Q 011138 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHP 421 (492)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp 421 (492)
.. .++..+++++.+||.+||..||.+||++.++++|.
T Consensus 231 ----------~~------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 231 ----------RM------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp ----------CC------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred ----------cC------------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 00 12246799999999999999999999999999763
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=346.11 Aligned_cols=262 Identities=24% Similarity=0.309 Sum_probs=196.9
Q ss_pred cccceeEeeeeccCCceEEEEEE----EcCCCCEEEEEEeccch----hhHHHHHHHHHHcCCCCccccceeeeeccCCC
Q 011138 135 QTISYMAERVVGTGSFGVVFQAK----CLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~----~~~~g~~vAiK~~~~~~----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 206 (492)
...+|.+.+.||+|+||.||+|. +..+++.||||++.... ....+|+.+++.++||||++++++++. .+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~ 97 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---PG 97 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---SS
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---CC
Confidence 34579999999999999999998 46789999999986542 335689999999999999999998754 23
Q ss_pred ceEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeec
Q 011138 207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (492)
Q Consensus 207 ~~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG 285 (492)
...+|+||||+++ ++.+++... ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~~~-~~kl~Dfg 172 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGS-RRCVHRDLAARNILVESEA-HVKIADFG 172 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETT-EEEECCGG
T ss_pred CceEEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChhhEEECCCC-CEEEcccc
Confidence 4568899999965 455544322 2458999999999999999999997 9999999999999999887 89999999
Q ss_pred CccccCCCCC----CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-CCC
Q 011138 286 SAKMLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILG-TPT 360 (492)
Q Consensus 286 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g-~p~ 360 (492)
++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|..||........ ....... .+.
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~ 249 (327)
T 3lxl_A 173 LAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN-IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL--RMMGCERDVPA 249 (327)
T ss_dssp GCEECCTTCSEEECSSCCCSCGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH--HHCC----CCH
T ss_pred cceecccCCccceeeccCCccccccCHHHhccC-CCChHHhHHHHHHHHHHHHhCCCCCccccchhh--hhccccccccc
Confidence 9987643322 2335678889999999765 479999999999999999999999975432211 0000000 000
Q ss_pred HHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
...+..... ... ....+..+++++.+||.+||+.||.+|||+.++++
T Consensus 250 ~~~~~~~~~--~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 296 (327)
T 3lxl_A 250 LSRLLELLE--EGQ----------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGP 296 (327)
T ss_dssp HHHHHHHHH--TTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhh--ccc----------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000000000 000 00123467999999999999999999999999965
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=356.11 Aligned_cols=247 Identities=23% Similarity=0.320 Sum_probs=197.9
Q ss_pred CCccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch--hhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 132 QPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 132 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~--~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
+.....+|.+.+.||+|+||.||+|.+ +|+.||||++..+. ..+.+|+.+|+.++|||||++++++.... ..
T Consensus 188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~ 261 (450)
T 1k9a_A 188 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GG 261 (450)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTT----SC
T ss_pred cccChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCC----Cc
Confidence 344556899999999999999999987 47899999986543 44568999999999999999999875322 24
Q ss_pred EEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 210 ~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
+|+||||+.+ +|.+.+... ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~ 337 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDN-VAKVSDFGLTK 337 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTS-CEEECCCTTCE
T ss_pred eEEEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEECCCC-CEEEeeCCCcc
Confidence 8899999986 565555432 22347889999999999999999997 9999999999999999887 79999999998
Q ss_pred ccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
..... .....+++.|+|||++.+. .++.++|||||||++|||++ |..||.+.+..+....+.+..
T Consensus 338 ~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~----------- 403 (450)
T 1k9a_A 338 EASST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY----------- 403 (450)
T ss_dssp ECC--------CCCTTTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC-----------
T ss_pred ccccc--ccCCCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----------
Confidence 54322 2234678899999999765 48999999999999999998 999999877665554443210
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.. ..+..+++++.+||.+||..||.+|||+.++++
T Consensus 404 -------~~----------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 404 -------KM----------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp -------CC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------CC----------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 00 122457899999999999999999999999874
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=343.73 Aligned_cols=256 Identities=23% Similarity=0.282 Sum_probs=193.9
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc--------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~--------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
|..++.||+|+||.||+|.+ +++.||||++... .....+|+.+++.++||||+++++++. +....
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 105 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSS-----DGDDL 105 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSC
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEe-----cCCce
Confidence 55668899999999999985 6899999988532 234568999999999999999999883 33457
Q ss_pred EEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 211 ~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
++||||+.+ ++.+.+.. ......+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++..
T Consensus 106 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~~ 182 (307)
T 2nru_A 106 CLVYVYMPNGSLLDRLSC-LDGTPPLSWHMRCKIAQGAANGINFLHE-NHHIHRDIKSANILLDEAF-TAKISDFGLARA 182 (307)
T ss_dssp EEEEECCTTCBHHHHHHT-GGGCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHh-ccCCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecCCCCHHHEEEcCCC-cEEEeecccccc
Confidence 899999975 55554433 2334568999999999999999999997 9999999999999999887 799999999976
Q ss_pred cCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 011138 290 LVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (492)
Q Consensus 290 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~ 366 (492)
...... .....||+.|+|||++.+ .++.++|||||||++|+|++|.+||........+..+...+..........
T Consensus 183 ~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (307)
T 2nru_A 183 SEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY 260 (307)
T ss_dssp CCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHH
T ss_pred cccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhh
Confidence 543221 224578999999999854 378999999999999999999999987655443333333221111000000
Q ss_pred cCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
... .++ ......++.+.+||.+||..||.+|||+.+++++
T Consensus 261 ~~~-----~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 261 IDK-----KMN---------DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp SCS-----SCS---------CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccc-----ccc---------ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 000 000 0112346789999999999999999999999863
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=340.05 Aligned_cols=259 Identities=23% Similarity=0.344 Sum_probs=193.9
Q ss_pred cceeEeeeeccCCceEEEEEE----EcCCCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 137 ISYMAERVVGTGSFGVVFQAK----CLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~----~~~~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
..|.+.+.||+|+||.||+|. +..+|+.||||++.... ....+|+.+++.++||||+++++++... +.
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 97 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GG 97 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CC
Confidence 359999999999999999998 56789999999986432 4456899999999999999999988543 22
Q ss_pred eEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 208 ~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
..+++||||+.+ ++.+.+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~kl~Dfg~ 172 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVESEH-QVKIGDFGL 172 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETT-EEEECCCTT
T ss_pred ceEEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCchheEEEcCCC-CEEECcccc
Confidence 457899999986 55554422 23568999999999999999999997 9999999999999999887 899999999
Q ss_pred ccccCCCCC----CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 011138 287 AKMLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (492)
Q Consensus 287 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~ 362 (492)
+........ .....||..|+|||++.+.. ++.++|||||||++|+|++|..||.... .......+.....
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~ 246 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDSSPM-----ALFLKMIGPTHGQ 246 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHH-----HHHHHHHCSCCGG
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHccCCCcchh-----hHHhhccCCcccc
Confidence 987654332 23456788899999997654 7899999999999999999998864321 1111111111111
Q ss_pred HHh-hcCCCC-cccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 363 EIK-CMNPNY-TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 363 ~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
... ...... ... ....+..+++++.+||.+||+.||.+|||+.++++
T Consensus 247 ~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 247 MTVTRLVNTLKEGK----------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp GHHHHHHHHHHTTC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred cCHHHHHHHHhccC----------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 000 000000 000 01123468899999999999999999999999875
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=356.07 Aligned_cols=249 Identities=21% Similarity=0.242 Sum_probs=196.1
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc--hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
..+|.++++||+|+||.||+|.+..+|+.||||++... .....+|+.+++.|+|++++..+.+|.. ...+.+||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~----~~~~~~lv 81 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGV----EGDYNVLV 81 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEE----ETTEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEe----eCCEEEEE
Confidence 35699999999999999999999999999999987533 3456789999999998666555555433 23367899
Q ss_pred eeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEE---cCCCCcEEEeeecCcccc
Q 011138 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSAKML 290 (492)
Q Consensus 214 ~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl---~~~~~~vkL~DFG~a~~~ 290 (492)
|||++++|.+++.. ....+++..++.|+.||+.||.|||+ +|||||||||+|||| +.++ .+||+|||+++..
T Consensus 82 me~~g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~-~vkL~DFGla~~~ 156 (483)
T 3sv0_A 82 MDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKY 156 (483)
T ss_dssp EECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECCGGGTT-CEEECCCTTCEEC
T ss_pred EECCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCcceEEEecCCCCC-eEEEEeCCcceec
Confidence 99998777776543 24579999999999999999999997 999999999999999 4555 7999999999876
Q ss_pred CCCCC--------CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCC
Q 011138 291 VPGEP--------NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGV---DQLVEIIKILGTP 359 (492)
Q Consensus 291 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~---~~~~~i~~~~g~p 359 (492)
..... .....||+.|+|||++.+.. ++.++|||||||+||||++|+.||.+.... +.+..+....-..
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT 235 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc
Confidence 44322 22568999999999997654 899999999999999999999999875542 2333332211111
Q ss_pred CHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhh
Q 011138 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC 418 (492)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l 418 (492)
..+ .+...+++++.+||.+||..||.+||++.+++
T Consensus 236 ~~~------------------------~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~ 270 (483)
T 3sv0_A 236 SIE------------------------ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLK 270 (483)
T ss_dssp CHH------------------------HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHH
T ss_pred cHH------------------------HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHH
Confidence 111 11235789999999999999999999988765
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=343.25 Aligned_cols=247 Identities=22% Similarity=0.326 Sum_probs=191.1
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCC----CEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCC
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETG----DSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g----~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 205 (492)
...+|.+.+.||+|+||.||+|.+..++ ..||||++... .....+|+.+++.++||||+++++++ .
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~ 116 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-----S 116 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----C
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----e
Confidence 3346999999999999999999987654 35999998643 22345799999999999999999998 4
Q ss_pred CceEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeee
Q 011138 206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (492)
Q Consensus 206 ~~~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DF 284 (492)
+...+++||||+.+ ++...+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+||
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~-~~kl~Df 191 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNSNL-VCKVSDF 191 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCC
T ss_pred cCCCcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChheEEECCCC-cEEECCC
Confidence 44458899999987 45444332 24568999999999999999999997 9999999999999999887 7999999
Q ss_pred cCccccCCCCC----CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 011138 285 GSAKMLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTP 359 (492)
Q Consensus 285 G~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p 359 (492)
|+++....... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~--- 267 (333)
T 1mqb_A 192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF--- 267 (333)
T ss_dssp CC-----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC---
T ss_pred CcchhhccccccccccCCCCccccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCC---
Confidence 99986643221 1223457889999999654 48999999999999999998 999998887665554443210
Q ss_pred CHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
..+ .+..+++++.+||.+||+.||.+||++.+++++
T Consensus 268 ---------------~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 268 ---------------RLP----------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp ---------------CCC----------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ---------------cCC----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 011 123578999999999999999999999998863
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=333.92 Aligned_cols=248 Identities=23% Similarity=0.342 Sum_probs=192.6
Q ss_pred CCCccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch--hhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 131 GQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 131 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~--~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
+......+|.+.+.||+|+||.||+|.+ +|+.||||++..+. ....+|+.+++.++||||+++++++.. ...
T Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~ 88 (278)
T 1byg_A 15 GWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKG 88 (278)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECC----C--
T ss_pred cccCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEc----CCC
Confidence 3445566899999999999999999987 58899999986543 345689999999999999999998743 223
Q ss_pred EEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 209 ~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
.+++||||+.+ ++.+.+.... ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~ 164 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDN-VAKVSDFGLT 164 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTS-CEEECCCCC-
T ss_pred ceEEEEecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCcceEEEeCCC-cEEEeecccc
Confidence 57899999986 6665554321 2237888899999999999999997 9999999999999999887 7999999999
Q ss_pred cccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 011138 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (492)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~ 366 (492)
..... ......+++.|+|||++.+. .++.++|||||||++|+|++ |..||...+..+....+...
T Consensus 165 ~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~----------- 230 (278)
T 1byg_A 165 KEASS--TQDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG----------- 230 (278)
T ss_dssp -------------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-----------
T ss_pred ccccc--cccCCCccccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-----------
Confidence 75532 22345678999999999654 48999999999999999998 99999887765544433210
Q ss_pred cCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.. ...+..+++++.+||.+||..||.+|||+.++++
T Consensus 231 -------~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 231 -------YK----------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp -------CC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------CC----------CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 00 0122457899999999999999999999999875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=357.85 Aligned_cols=247 Identities=23% Similarity=0.345 Sum_probs=199.4
Q ss_pred CccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc---hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 133 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
.....+|.+.+.||+|+||.||+|.+. ++..||||++... ...+.+|+.+|+.++|||||++++++. + ..
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-----~-~~ 256 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-----K-EP 256 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-----S-SS
T ss_pred eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-----C-Cc
Confidence 344568999999999999999999975 4778999998653 345568999999999999999999873 1 23
Q ss_pred EEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 210 ~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
+|+||||+.+ +|.+.+.... ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~-~~kl~DFG~a~ 332 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSASL-VCKIADFGLAR 332 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECTTC-CEEECSTTGGG
T ss_pred cEEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEECCCC-cEEEeeCCCce
Confidence 6899999985 5665554321 2357888899999999999999997 9999999999999999887 79999999998
Q ss_pred ccCCCC--CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 011138 289 MLVPGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (492)
Q Consensus 289 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~ 365 (492)
...... ......+|+.|+|||++.+. .++.++|||||||++|||++ |+.||.+.+..+.+..+.....
T Consensus 333 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-------- 403 (454)
T 1qcf_A 333 VIEDNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR-------- 403 (454)
T ss_dssp GBCCHHHHTTCSSSSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC--------
T ss_pred EcCCCceeccCCCcccccccCHHHhccC-CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------
Confidence 653321 12234467889999999654 48999999999999999999 9999999887766665544211
Q ss_pred hcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.+ .+..+++++.+||.+||..||.+|||+.+++.
T Consensus 404 ----------~~----------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 404 ----------MP----------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp ----------CC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------CC----------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 11 12357899999999999999999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=334.12 Aligned_cols=247 Identities=23% Similarity=0.358 Sum_probs=192.8
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCC---EEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCC
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~---~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 206 (492)
....|.+.+.||+|+||.||+|.+..++. .||+|++.... ....+|+.+++.++||||+++++++....
T Consensus 19 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 95 (298)
T 3pls_A 19 ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE--- 95 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS---
T ss_pred cceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC---
Confidence 34468899999999999999999766555 79999885422 33458999999999999999999984322
Q ss_pred ceEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeec
Q 011138 207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (492)
Q Consensus 207 ~~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG 285 (492)
...++||||+.+ ++.+.+. .....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 96 -~~~~~v~e~~~~~~L~~~~~---~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nili~~~~-~~kl~Dfg 169 (298)
T 3pls_A 96 -GLPHVLLPYMCHGDLLQFIR---SPQRNPTVKDLISFGLQVARGMEYLAE-QKFVHRDLAARNCMLDESF-TVKVADFG 169 (298)
T ss_dssp -SCCEEEECCCTTCBHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTC-CEEECCTT
T ss_pred -CCcEEEEecccCCCHHHHHh---ccccCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcCCC-cEEeCcCC
Confidence 234789999975 5555443 234668899999999999999999997 9999999999999999887 79999999
Q ss_pred CccccCCC-----CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 011138 286 SAKMLVPG-----EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTP 359 (492)
Q Consensus 286 ~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p 359 (492)
+++..... .......+|+.|+|||.+.+. .++.++|||||||++|+|++ |.+||...+..+....+....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~--- 245 (298)
T 3pls_A 170 LARDILDREYYSVQQHRHARLPVKWTALESLQTY-RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR--- 245 (298)
T ss_dssp SSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC---
T ss_pred CcccccCCcccccccCcCCCCCccccChhhhccC-CCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC---
Confidence 99755322 223345678999999999654 48999999999999999999 555566555544443332210
Q ss_pred CHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.. ..+..+++++.+||.+||+.||.+|||+.++++
T Consensus 246 ---------------~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 246 ---------------RL----------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp ---------------CC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CC----------CCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 00 012357899999999999999999999999876
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=346.63 Aligned_cols=279 Identities=21% Similarity=0.290 Sum_probs=194.4
Q ss_pred ccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-hhHHHHHHH--HHHcCCCCccccceeeeeccCCCceEE
Q 011138 134 KQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-RYKNRELQI--MRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-~~~~~E~~i--l~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
....+|.+.+.||+|+||.||+|++ +|+.||||++.... .....|.++ +..++||||+++++++......+...+
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 3445799999999999999999976 78999999986443 223334444 445899999999987765555666778
Q ss_pred EEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhC---------CcccCCCCCCceEEcCCCCcEE
Q 011138 211 NLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV---------GVCHRDIKPQNLLVNPHTHQLK 280 (492)
Q Consensus 211 ~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~---------givHrDlKp~NILl~~~~~~vk 280 (492)
++||||+++ +|.+++.. ...++..+..++.||+.||.|||+ + ||+||||||+||||+.++ .+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHT-ELPRGDHYKPAISHRDLNSRNVLVKNDG-TCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHC-CBCCGGGCBCCEECSSCSGGGEEECTTS-CEE
T ss_pred EEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHh-hhccccccccceeecccccceEEEcCCC-cEE
Confidence 999999976 55555432 345788899999999999999997 8 999999999999999887 799
Q ss_pred EeeecCccccCCCC---------CCccceeccCccCchhhcCC------CCCCcchhhHHHHHHHHHHHhCCCCCC-CCC
Q 011138 281 ICDFGSAKMLVPGE---------PNISYICSRYYRAPELIFGA------TEYTTAIDMWSIGCVLAELLLGQPLFP-GES 344 (492)
Q Consensus 281 L~DFG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~------~~~~~~~DvwSlGvil~ell~G~~pf~-~~~ 344 (492)
|+|||+++...... ......||+.|+|||++.+. ..++.++|||||||++|||++|..||. +..
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 99999998654321 12245799999999999653 235678999999999999999966653 332
Q ss_pred hHHHHHHHHHHh-CCCCHHHHhhc-CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHh-----
Q 011138 345 GVDQLVEIIKIL-GTPTREEIKCM-NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEA----- 417 (492)
Q Consensus 345 ~~~~~~~i~~~~-g~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~----- 417 (492)
..+....+.... ..|....+... ........+|.. |. ....+++++.+||.+||+.||++|||+.|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~ 314 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA----WK--ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA 314 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT----CC--CCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcc----cc--cccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence 211111111111 22222222111 000011111110 00 011245689999999999999999999999
Q ss_pred -hCCCCCCCCC
Q 011138 418 -CAHPFFDDLR 427 (492)
Q Consensus 418 -l~Hp~f~~~~ 427 (492)
+-++|-++-.
T Consensus 315 ~ll~~~~~~~~ 325 (336)
T 3g2f_A 315 ELMMIWERNKS 325 (336)
T ss_dssp HHHHCCCC---
T ss_pred HHHHHHHhccc
Confidence 4578877543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=333.53 Aligned_cols=242 Identities=24% Similarity=0.287 Sum_probs=193.1
Q ss_pred cceeEee-eeccCCceEEEEEEE--cCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 137 ISYMAER-VVGTGSFGVVFQAKC--LETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 137 ~~y~~~~-~lG~G~fg~Vy~~~~--~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
.+|.+.+ .||+|+||.||+|.+ ..+++.||||++... .....+|+.+++.++||||+++++++ ..
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~----- 89 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA----- 89 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES-----
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC-----
Confidence 4699988 999999999999954 567889999998643 23456899999999999999999987 21
Q ss_pred eEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 208 ~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
..+++||||+.+ ++.+.+.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nil~~~~~-~~kl~Dfg~ 163 (291)
T 1xbb_A 90 ESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQH-YAKISDFGL 163 (291)
T ss_dssp SSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETT-EEEECCCTT
T ss_pred CCcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHh-CCeEcCCCCcceEEEeCCC-cEEEccCCc
Confidence 136799999985 45544432 4568999999999999999999997 9999999999999999887 899999999
Q ss_pred ccccCCCCCC----ccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 011138 287 AKMLVPGEPN----ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTR 361 (492)
Q Consensus 287 a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~ 361 (492)
+......... ....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+... .
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--~--- 237 (291)
T 1xbb_A 164 SKALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG--E--- 237 (291)
T ss_dssp CEECCTTCSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--C---
T ss_pred ceeeccCCCcccccccCCCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--C---
Confidence 9876443321 2234578899999996554 8899999999999999999 99999988765544443221 0
Q ss_pred HHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.. .++..+++++.+||.+||+.||.+||++.++++
T Consensus 238 -----------~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 238 -----------RM------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp -----------CC------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----------CC------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 122457899999999999999999999999875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=350.29 Aligned_cols=243 Identities=16% Similarity=0.181 Sum_probs=188.9
Q ss_pred cceeEeeeeccCCceEEEEE-----EEcCCCCEEEEEEeccc-hhhHHHHHHHHHHcC---CCCccccceeeeeccCCCc
Q 011138 137 ISYMAERVVGTGSFGVVFQA-----KCLETGDSVAIKKVLQD-KRYKNRELQIMRLLN---HPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~-----~~~~~g~~vAiK~~~~~-~~~~~~E~~il~~l~---h~nIv~l~~~~~~~~~~~~ 207 (492)
.+|.+.+.||+|+||+||+| .+..+++.||||++... .....+|+.+++.++ |+||+++++++.. .
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~-----~ 139 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF-----Q 139 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC-----S
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeec-----C
Confidence 46999999999999999999 46778999999998654 345567899999987 9999999999843 3
Q ss_pred eEEEEEeeechh-hHHHHhhhhhh-cCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcC-----------
Q 011138 208 LYLNLVLEYISE-TVYRVSKHYTR-MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP----------- 274 (492)
Q Consensus 208 ~~~~lV~E~~~~-~l~~~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~----------- 274 (492)
...||||||+.+ +|.+++..... ....+++..++.|+.||+.||+|||+ +|||||||||+||||+.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD-CEIIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECGGGTCC------
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEecccccCccccccc
Confidence 347899999984 56666554333 34679999999999999999999997 99999999999999987
Q ss_pred CCCcEEEeeecCccccC---CCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 011138 275 HTHQLKICDFGSAKMLV---PGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVE 351 (492)
Q Consensus 275 ~~~~vkL~DFG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~ 351 (492)
++ .+||+|||+|+... ........+||+.|+|||++.+.. |+.++|||||||++|||++|+.||......
T Consensus 219 ~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~----- 291 (365)
T 3e7e_A 219 SA-GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGG----- 291 (365)
T ss_dssp CT-TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETT-----
T ss_pred cC-CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCC-----
Confidence 55 79999999996542 233344578999999999997654 899999999999999999999999653220
Q ss_pred HHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 352 IIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 352 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
.+........ ...++.+.+++.+||+.+|.+|++..+.+.+
T Consensus 292 ---------------------~~~~~~~~~~-------~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 292 ---------------------ECKPEGLFRR-------LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp ---------------------EEEECSCCTT-------CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred ---------------------ceeechhccc-------cCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 0000000000 0236778999999999999999776655543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=336.76 Aligned_cols=246 Identities=22% Similarity=0.326 Sum_probs=192.5
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCC---CEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETG---DSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g---~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
...|.+.+.||+|+||.||+|.+..++ ..||+|.+.... ....+|+.+++.++||||+++++++.. ..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~ 99 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SE 99 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC----SS
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc----CC
Confidence 346999999999999999999975443 358999885422 334589999999999999999998643 23
Q ss_pred eEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 208 ~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
...++||||+.+ +|.+.+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~kl~Dfg~ 174 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLAS-KKFVHRDLAARNCMLDEKF-TVKVADFGL 174 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTC-CEEECSCGG
T ss_pred CceEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEECCCC-CEEECcccc
Confidence 357799999987 55554432 34567889999999999999999997 9999999999999999887 799999999
Q ss_pred ccccCCCC-----CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 011138 287 AKMLVPGE-----PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPT 360 (492)
Q Consensus 287 a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~ 360 (492)
++...... ......||+.|+|||++.+. .++.++|||||||++|+|++ |.+||.+.+..+....+.....
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~--- 250 (298)
T 3f66_A 175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR--- 250 (298)
T ss_dssp GCCCSCGGGCBC-----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC---
T ss_pred cccccccchhccccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC---
Confidence 97654322 22345678899999999765 48999999999999999999 7778877766555544433100
Q ss_pred HHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
...+..+++++.+||.+||+.||.+|||+.++++
T Consensus 251 -------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 251 -------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp -------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0112357899999999999999999999999885
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=329.95 Aligned_cols=245 Identities=22% Similarity=0.307 Sum_probs=196.9
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc---hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
...+|.+.+.||+|+||.||+|.+. ++..||||.+... .....+|+.+++.++||||+++++++. +. ..+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~-~~~ 83 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-----QE-PIY 83 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SS-SCE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-----CC-CcE
Confidence 3457999999999999999999964 5678999998653 345668999999999999999999873 21 267
Q ss_pred EEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 212 lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
+||||+.+ +|.+.+... ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++...
T Consensus 84 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSDTL-SCKIADFGLARLI 159 (279)
T ss_dssp EEEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred EEEecCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHhhEEEcCCC-CEEECCCcccccc
Confidence 99999975 555544321 12368899999999999999999997 9999999999999999887 7999999999876
Q ss_pred CCCC--CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 291 VPGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 291 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
.... ......+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+.+..+....
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~----------- 227 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY----------- 227 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-----------
T ss_pred cCcccccccCCCCccCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhccc-----------
Confidence 4332 12234568899999999654 48999999999999999999 999999887766555443210
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
....+..+++++.+||.+||..||.+|||+.++++
T Consensus 228 -----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 228 -----------------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp -----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00122457899999999999999999999999876
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=342.91 Aligned_cols=252 Identities=22% Similarity=0.306 Sum_probs=186.2
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchh-hHHHHHHHHHHc--CCCCccccceeeeeccCCCceEEEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR-YKNRELQIMRLL--NHPNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~E~~il~~l--~h~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
.+|.+.+.||+|+||.||+|++ +|+.||||++..... ...+|.+++..+ +||||+++++++.... .....+|+|
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~lv 113 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGT-GSWTQLYLI 113 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GGGCEEEEE
T ss_pred cceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CCCCceEEE
Confidence 4699999999999999999987 489999999855432 334566666554 8999999999886543 222568899
Q ss_pred eeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhC--------CcccCCCCCCceEEcCCCCcEEEeee
Q 011138 214 LEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV--------GVCHRDIKPQNLLVNPHTHQLKICDF 284 (492)
Q Consensus 214 ~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~--------givHrDlKp~NILl~~~~~~vkL~DF 284 (492)
|||+.+ +|.+.+.. ..+++..+..++.||+.||.|||+ + ||+||||||+|||++.++ .+||+||
T Consensus 114 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kl~Df 186 (337)
T 3mdy_A 114 TDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHT-EIFSTQGKPAIAHRDLKSKNILVKKNG-TCCIADL 186 (337)
T ss_dssp ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHS-CBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCC
T ss_pred EeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHH-hhhhhccCCCEEecccchHHEEECCCC-CEEEEeC
Confidence 999986 56555432 468999999999999999999996 8 999999999999999887 7999999
Q ss_pred cCccccCCCCCC-----ccceeccCccCchhhcCCCCCCc------chhhHHHHHHHHHHHhC----------CCCCCCC
Q 011138 285 GSAKMLVPGEPN-----ISYICSRYYRAPELIFGATEYTT------AIDMWSIGCVLAELLLG----------QPLFPGE 343 (492)
Q Consensus 285 G~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~------~~DvwSlGvil~ell~G----------~~pf~~~ 343 (492)
|+++........ ....||+.|+|||++.+.. ++. ++|||||||++|||++| ..||...
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 999765433221 2457999999999996654 344 39999999999999999 6777543
Q ss_pred Ch----HHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 344 SG----VDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 344 ~~----~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.. ......+....+ ....++. ......+++++.+||.+||+.||.+|||+.++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~--------------~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (337)
T 3mdy_A 266 VPSDPSYEDMREIVCIKK--------------LRPSFPN-------RWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324 (337)
T ss_dssp SCSSCCHHHHHHHHTTSC--------------CCCCCCG-------GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cCCCCchhhhHHHHhhhc--------------cCccccc-------cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHH
Confidence 21 111111111000 0000110 0011245678999999999999999999999987
Q ss_pred C
Q 011138 420 H 420 (492)
Q Consensus 420 H 420 (492)
|
T Consensus 325 ~ 325 (337)
T 3mdy_A 325 T 325 (337)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=354.71 Aligned_cols=253 Identities=25% Similarity=0.338 Sum_probs=197.9
Q ss_pred CccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc---hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 133 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
.....+|.+.+.||+|+||.||+|.+.. +..||||++... ...+.+|+.+|+.++||||+++++++.. ..
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~ 252 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 252 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------Cc
Confidence 3445679999999999999999999864 467999998653 3456789999999999999999998732 23
Q ss_pred EEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 210 ~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
+|+||||+.+ +|.+.+... ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~ 328 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENL-VCKVADFGLAR 328 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-CEEECCCCTTC
T ss_pred eEEEehhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEECCCC-CEEECCCccce
Confidence 6899999986 565554321 23458899999999999999999997 9999999999999999877 79999999998
Q ss_pred ccCCCCC--CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 011138 289 MLVPGEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (492)
Q Consensus 289 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~ 365 (492)
....... .....+++.|+|||++.+. .++.++|||||||++|||++ |..||.+....+.+..+....
T Consensus 329 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~--------- 398 (452)
T 1fmk_A 329 LIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--------- 398 (452)
T ss_dssp --------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC---------
T ss_pred ecCCCceecccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---------
Confidence 6543221 2234567889999999765 48999999999999999999 999999988766655543311
Q ss_pred hcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC--CCCCCC
Q 011138 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA--HPFFDD 425 (492)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~--Hp~f~~ 425 (492)
..+ .+..+++++.+||.+||+.||.+|||+.++++ +.+|..
T Consensus 399 ---------~~~----------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 399 ---------RMP----------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp ---------CCC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ---------CCC----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 001 12357899999999999999999999999987 355544
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=350.25 Aligned_cols=246 Identities=22% Similarity=0.327 Sum_probs=185.7
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCC---CEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETG---DSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g---~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
...|.+.+.||+|+||.||+|.+..++ ..||+|.+... ...+.+|+.+++.++||||++++++++.. .
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~----~ 163 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----E 163 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC----S
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC----C
Confidence 346999999999999999999875433 46899987532 23456799999999999999999986432 2
Q ss_pred eEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 208 LYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 208 ~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
...++||||+.+ +|.+++. .....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 164 ~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~-~~kL~DFG~ 238 (373)
T 3c1x_A 164 GSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDEKF-TVKVADFGL 238 (373)
T ss_dssp SCCEEEEECCTTCBHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCC--
T ss_pred CCeEEEEECCCCCCHHHHHh---hcccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCccchheEEECCCC-CEEEeeccc
Confidence 346799999986 5555443 223567888999999999999999997 9999999999999999887 799999999
Q ss_pred ccccCCCCC-----CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 011138 287 AKMLVPGEP-----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPT 360 (492)
Q Consensus 287 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~ 360 (492)
++....... .....+|+.|+|||++.+. .++.++|||||||++|||++ |.+||.+.+..+....+... .
T Consensus 239 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~--~-- 313 (373)
T 3c1x_A 239 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG--R-- 313 (373)
T ss_dssp -------------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT--C--
T ss_pred cccccccccccccccCCCCCcccccChHHhcCC-CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC--C--
Confidence 986533221 2234668899999999765 48999999999999999999 78899877665544443321 0
Q ss_pred HHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.. ..+..+++++.+||.+||..||.+|||+.++++
T Consensus 314 ------------~~------------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~ 348 (373)
T 3c1x_A 314 ------------RL------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 348 (373)
T ss_dssp ------------CC------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------CC------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 012357899999999999999999999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=354.81 Aligned_cols=247 Identities=17% Similarity=0.179 Sum_probs=183.7
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------------hhHHHHHHHHHHcC---------CCCcccc
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------------RYKNRELQIMRLLN---------HPNVVSL 195 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------------~~~~~E~~il~~l~---------h~nIv~l 195 (492)
.+|.+.+.||+|+||+||+|++ +|+.||||++.... ....+|+.+++.++ |||||++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 4699999999999999999998 78999999986542 45678999999986 5555554
Q ss_pred -----------------ceeeeecc--------CCCceEEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHH
Q 011138 196 -----------------KHCFFSTT--------EKDELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICR 249 (492)
Q Consensus 196 -----------------~~~~~~~~--------~~~~~~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 249 (492)
+++|.... ..+...+|||||||.++ ++..+. ...+++..++.++.||+.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHHH
Confidence 44442210 01245689999999765 444332 256899999999999999
Q ss_pred HHHHHH-hhCCcccCCCCCCceEEcCCC-------------------CcEEEeeecCccccCCCCCCccceeccCccCch
Q 011138 250 ALNYLH-HVVGVCHRDIKPQNLLVNPHT-------------------HQLKICDFGSAKMLVPGEPNISYICSRYYRAPE 309 (492)
Q Consensus 250 aL~yLH-~~~givHrDlKp~NILl~~~~-------------------~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE 309 (492)
||.||| + +||+||||||+||||+.++ ..+||+|||+|+.... ...+||+.|+|||
T Consensus 173 aL~~lH~~-~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aPE 247 (336)
T 2vuw_A 173 SLAVAEAS-LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHHH-HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCSG
T ss_pred HHHHHHHh-CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccChh
Confidence 999999 8 8999999999999998764 2699999999987643 2458999999999
Q ss_pred hhcCCCCCCcchhhHHHHHH-HHHHHhCCCCCCCCChHHHH-HHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccc
Q 011138 310 LIFGATEYTTAIDMWSIGCV-LAELLLGQPLFPGESGVDQL-VEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKI 387 (492)
Q Consensus 310 ~~~~~~~~~~~~DvwSlGvi-l~ell~G~~pf~~~~~~~~~-~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (492)
++.+.. +.++||||||++ .++++.|..||.+......+ ..+.... .++.. ....
T Consensus 248 ~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~------------------~~~~~----~~~~ 303 (336)
T 2vuw_A 248 LFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQM------------------TFKTK----CNTP 303 (336)
T ss_dssp GGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTC------------------CCSSC----CCSH
T ss_pred hhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhh------------------ccCcc----cchh
Confidence 997654 889999998777 77888999999542111111 1221110 00000 0001
Q ss_pred cCCCCChhHhhhhccccccCCCCcCCHHHhh-CCCCCC
Q 011138 388 FHKRMPPEALDLVSRLLQYSPSLRCTALEAC-AHPFFD 424 (492)
Q Consensus 388 ~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l-~Hp~f~ 424 (492)
.++.+++++++||++||++| |+.|+| +||||+
T Consensus 304 ~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 304 AMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred hhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 22347889999999999987 999999 999996
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=333.65 Aligned_cols=248 Identities=25% Similarity=0.342 Sum_probs=189.1
Q ss_pred cceeEeeeeccCCceEEEEEEEcC-CCC--EEEEEEeccc-------hhhHHHHHHHHHHcCCCCccccceeeeeccCCC
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLE-TGD--SVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~-~g~--~vAiK~~~~~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 206 (492)
.+|.+.+.||+|+||.||+|.+.. ++. .||||++... .....+|+.+++.++||||+++++++..
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 92 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT----- 92 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc-----
Confidence 469999999999999999998643 333 6899987532 2344589999999999999999998843
Q ss_pred ceEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeec
Q 011138 207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (492)
Q Consensus 207 ~~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG 285 (492)
.. .++||||+.+ ++.+.+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 93 ~~-~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nili~~~~-~~kl~Dfg 166 (291)
T 1u46_A 93 PP-MKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLATRD-LVKIGDFG 166 (291)
T ss_dssp SS-CEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETT-EEEECCCT
T ss_pred CC-ceeeEecccCCCHHHHHHh---ccCCcCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEEcCCC-CEEEcccc
Confidence 22 6799999985 55554432 23568899999999999999999997 9999999999999999887 89999999
Q ss_pred CccccCCCCC----CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 011138 286 SAKMLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPT 360 (492)
Q Consensus 286 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~ 360 (492)
++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+.+..+...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~----- 240 (291)
T 1u46_A 167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE----- 240 (291)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS-----
T ss_pred ccccccccccchhhhccCCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHcc-----
Confidence 9987644332 2234568889999999765 47899999999999999999 99999988876655554331
Q ss_pred HHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCC
Q 011138 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (492)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~ 425 (492)
...++ .+..+++++.+||.+||..||.+|||+.++++ +|++
T Consensus 241 ------------~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~--~l~~ 281 (291)
T 1u46_A 241 ------------GERLP----------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD--FLLE 281 (291)
T ss_dssp ------------CCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred ------------CCCCC----------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHH--HHHH
Confidence 00111 12357899999999999999999999999987 4443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=358.34 Aligned_cols=251 Identities=25% Similarity=0.349 Sum_probs=200.5
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc---hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
...+|.+.+.||+|+||.||+|.+.. +..||||++... ...+.+|+.+|+.++|||||++++++.. ..+|
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~~ 337 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY 337 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee------ccce
Confidence 34579999999999999999999864 467999998653 2456789999999999999999998732 2378
Q ss_pred EEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 212 lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
|||||+.+ +|.+++... ....+++..+..++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+++..
T Consensus 338 lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENL-VCKVADFGLARLI 413 (535)
T ss_dssp EEECCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-CEEECCTTSTTTC
T ss_pred EeeehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEEcCCC-cEEEcccccceec
Confidence 99999986 565554322 23458889999999999999999997 9999999999999999877 7999999999865
Q ss_pred CCCC--CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 291 VPGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 291 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
.... ......++..|+|||++.+. .++.++|||||||+||||++ |+.||.+....+.+..+....
T Consensus 414 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~----------- 481 (535)
T 2h8h_A 414 EDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY----------- 481 (535)
T ss_dssp CCHHHHTTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC-----------
T ss_pred CCCceecccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----------
Confidence 3221 12234567889999999765 48999999999999999999 999999888766655543311
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC--CCCCCC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA--HPFFDD 425 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~--Hp~f~~ 425 (492)
..+ .+..+++++.+||.+||+.||++|||+.++++ ..+|..
T Consensus 482 -------~~~----------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 482 -------RMP----------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp -------CCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred -------CCC----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 010 12357899999999999999999999999987 244443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=335.32 Aligned_cols=253 Identities=25% Similarity=0.344 Sum_probs=190.6
Q ss_pred eeEeeeeccCCceEEEEEEE----cCCCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 139 YMAERVVGTGSFGVVFQAKC----LETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~----~~~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
|.+.+.||+|+||.||++.. ..+|+.||||++.... ....+|+.+++.++||||+++++++... +...
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~ 109 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA---GAAS 109 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---TTTE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC---CCce
Confidence 59999999999999988754 4578999999986542 3456899999999999999999998543 2346
Q ss_pred EEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 210 ~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
+++||||+.+ ++.+.+. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++.
T Consensus 110 ~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~i~~~l~~~l~~LH~-~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~a~ 182 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYLHA-QHYIHRDLAARNVLLDNDR-LVKIGDFGLAK 182 (318)
T ss_dssp EEEEECCCTTCBHHHHGG-----GSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEECCGGGCE
T ss_pred EEEEEecccCCcHHHHHh-----hCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEEcCCC-CEEECCccccc
Confidence 8899999986 5555443 2348999999999999999999997 9999999999999999887 79999999998
Q ss_pred ccCCCCC----CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH-
Q 011138 289 MLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE- 363 (492)
Q Consensus 289 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~- 363 (492)
....... .....+|+.|+|||++.+.. ++.++|||||||++|+|++|..||....... ....+......
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-----~~~~~~~~~~~~ 256 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKF-----LELIGIAQGQMT 256 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-----HHHHCSCCHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCcccccchhh-----hhhhcccccchh
Confidence 7654332 23456788899999997654 7899999999999999999999997532210 00011110000
Q ss_pred ---HhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 364 ---IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 364 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
+..... ... ....+..+++++.+||.+||+.||.+|||+.++++
T Consensus 257 ~~~~~~~~~--~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 257 VLRLTELLE--RGE----------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHHHHHH--TTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHh--ccc----------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 000000 000 00123457899999999999999999999999985
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=362.28 Aligned_cols=242 Identities=26% Similarity=0.308 Sum_probs=190.4
Q ss_pred ceeEee-eeccCCceEEEEEEEc--CCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 138 SYMAER-VVGTGSFGVVFQAKCL--ETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 138 ~y~~~~-~lG~G~fg~Vy~~~~~--~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
+|.+.+ .||+|+||.||+|.+. .++..||||++... ...+.+|+.+|+.++|||||++++++.. . .
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-----~-~ 409 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-----E-A 409 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-----S-S
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-----C-C
Confidence 455555 8999999999999875 35667999998642 3446689999999999999999998732 1 2
Q ss_pred EEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 210 LNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 210 ~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
+++||||+.++ |.+.+. .....+++..+..++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+++
T Consensus 410 ~~lv~E~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~-~vkL~DFGla~ 484 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRNLAARNVLLVNRH-YAKISDFGLSK 484 (613)
T ss_dssp EEEEEECCTTCBHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECCCSTTT
T ss_pred eEEEEEeCCCCcHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCcCCHHHEEEcCCC-cEEEeeccCcc
Confidence 78999999875 444332 224568999999999999999999997 9999999999999999887 89999999998
Q ss_pred ccCCCCCC----ccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 011138 289 MLVPGEPN----ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREE 363 (492)
Q Consensus 289 ~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~ 363 (492)
........ ....+|+.|+|||++.+. .++.++|||||||++|||++ |+.||.+.+..+.+..+....
T Consensus 485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~------- 556 (613)
T 2ozo_A 485 ALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK------- 556 (613)
T ss_dssp TCC--------------CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC-------
T ss_pred cccCCCceeeeccCCCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-------
Confidence 76433221 123456889999999754 48999999999999999998 999999988776655543310
Q ss_pred HhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.. .++..+++++.+||.+||..||.+||++.++++
T Consensus 557 ---------~~------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 557 ---------RM------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp ---------CC------------CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred ---------CC------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 00 122457899999999999999999999998753
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=363.34 Aligned_cols=237 Identities=24% Similarity=0.302 Sum_probs=188.7
Q ss_pred eeeeccCCceEEEEEEE--cCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEE
Q 011138 142 ERVVGTGSFGVVFQAKC--LETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~--~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
.+.||+|+||.||+|.+ ..+++.||||++... ...+.+|+.+|+.++|||||++++++. +. .+++|
T Consensus 374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-----~~-~~~lv 447 (635)
T 4fl3_A 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-----AE-SWMLV 447 (635)
T ss_dssp EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-----SS-SEEEE
T ss_pred CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cC-CEEEE
Confidence 45899999999999955 456789999998643 234568999999999999999999872 22 26799
Q ss_pred eeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 214 LEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 214 ~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
|||+.++ |.+.+. ....+++..+..|+.||+.||.|||+ +|||||||||+||||+.++ .+||+|||+++....
T Consensus 448 ~E~~~~g~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDLkp~NILl~~~~-~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 448 MEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRA 521 (635)
T ss_dssp EECCTTEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECCTTHHHHTTC
T ss_pred EEccCCCCHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeCCCCChHhEEEeCCC-CEEEEEcCCcccccc
Confidence 9999865 444432 24568999999999999999999997 9999999999999999887 899999999987644
Q ss_pred CCC----CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 293 GEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 293 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
... .....+|+.|+|||++.+. .++.++|||||||++|||++ |+.||.+.+..+....+....
T Consensus 522 ~~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~----------- 589 (635)
T 4fl3_A 522 DENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE----------- 589 (635)
T ss_dssp -------------CGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-----------
T ss_pred CccccccccCCCCceeeeChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----------
Confidence 332 2234567889999999654 48999999999999999998 999999988766555543311
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.. .++..+++++.+||.+||..||++||++.++++
T Consensus 590 -----~~------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 590 -----RM------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp -----CC------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----CC------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 00 122457899999999999999999999999874
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=337.47 Aligned_cols=253 Identities=20% Similarity=0.246 Sum_probs=192.3
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-hhhHHHHHHHHHH--cCCCCccccceeeeeccCCCceEEEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRL--LNHPNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-~~~~~~E~~il~~--l~h~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
.+|.+.+.||+|+||.||+|++ +|+.||||++... .....+|.++++. ++||||+++++++.... .....+|+|
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~~~~~~lv 118 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV 118 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SSCCCEEEE
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-CccceeEEE
Confidence 4699999999999999999997 5899999998654 3345678999988 78999999999885433 222358899
Q ss_pred eeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHH--------hhCCcccCCCCCCceEEcCCCCcEEEeee
Q 011138 214 LEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH--------HVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (492)
Q Consensus 214 ~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH--------~~~givHrDlKp~NILl~~~~~~vkL~DF 284 (492)
|||+.+ +|.+.+.. ..+++..+..++.||+.||.||| + +||+||||||+|||++.++ .+||+||
T Consensus 119 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~NIll~~~~-~~kL~Df 191 (342)
T 1b6c_B 119 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK-PAIAHRDLKSKNILVKKNG-TCCIADL 191 (342)
T ss_dssp ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB-CEEECSCCSGGGEEECTTS-CEEECCC
T ss_pred EeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc-CCeeeCCCCHHHEEECCCC-CEEEEEC
Confidence 999987 56655432 46889999999999999999999 7 8999999999999999887 7999999
Q ss_pred cCccccCCCC-----CCccceeccCccCchhhcCCCC-----CCcchhhHHHHHHHHHHHhC----------CCCCCCCC
Q 011138 285 GSAKMLVPGE-----PNISYICSRYYRAPELIFGATE-----YTTAIDMWSIGCVLAELLLG----------QPLFPGES 344 (492)
Q Consensus 285 G~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DvwSlGvil~ell~G----------~~pf~~~~ 344 (492)
|++....... ......||+.|+|||++.+... ++.++|||||||++|+|++| ..||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 9997664433 2234579999999999966432 23689999999999999999 78887643
Q ss_pred h----HHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 345 G----VDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 345 ~----~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
. .+.+...+.... ....++. ......+++.+.+||.+||+.||.+|||+.++++|
T Consensus 272 ~~~~~~~~~~~~~~~~~--------------~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 272 PSDPSVEEMRKVVCEQK--------------LRPNIPN-------RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CSSCCHHHHHHHHTTSC--------------CCCCCCG-------GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cCcccHHHHHHHHHHHH--------------hCCCCcc-------cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 2 122222111000 0000110 00112345679999999999999999999999875
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=333.02 Aligned_cols=250 Identities=20% Similarity=0.257 Sum_probs=193.1
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
...+|.+.+.||+|+||.||+|.+.. .||+|++... .....+|+.+++.++||||+++++++.. ..
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~ 102 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS-----PP 102 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC-----SS
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec-----CC
Confidence 34569999999999999999999754 4999988532 1234579999999999999999999843 33
Q ss_pred EEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 209 ~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
.+++||||+.+ ++.+.+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++ ++ .+||+|||++
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~NIl~~-~~-~~~l~Dfg~~ 176 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHA-KGILHKDLKSKNVFYD-NG-KVVITDFGLF 176 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHH-TTCCCCCCCSTTEEEC----CCEECCCSCC
T ss_pred ceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChhhEEEe-CC-CEEEeecCCc
Confidence 58899999985 45444322 23468899999999999999999997 9999999999999998 45 7999999998
Q ss_pred cccCC------CCCCccceeccCccCchhhcC--------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 011138 288 KMLVP------GEPNISYICSRYYRAPELIFG--------ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEII 353 (492)
Q Consensus 288 ~~~~~------~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~ 353 (492)
+.... ........||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.........+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 256 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG 256 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHH
T ss_pred cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc
Confidence 65421 122234568999999999864 2347899999999999999999999999887665554443
Q ss_pred HHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 354 KILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 354 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
... .+. .....+++++.+||.+||..||.+|||+.++++ .|+.+.
T Consensus 257 ~~~-------------------~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l~ 301 (319)
T 2y4i_B 257 TGM-------------------KPN--------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKLP 301 (319)
T ss_dssp TTC-------------------CCC--------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC-
T ss_pred cCC-------------------CCC--------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHHH
Confidence 210 000 011246889999999999999999999999987 455544
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=331.93 Aligned_cols=258 Identities=24% Similarity=0.391 Sum_probs=194.2
Q ss_pred cccceeEeeeeccCCceEEEEEE----EcCCCCEEEEEEeccch----hhHHHHHHHHHHcCCCCccccceeeeeccCCC
Q 011138 135 QTISYMAERVVGTGSFGVVFQAK----CLETGDSVAIKKVLQDK----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~----~~~~g~~vAiK~~~~~~----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 206 (492)
...+|.+.+.||+|+||.||+|. +..+|+.||||++.... ....+|+.+++.++||||+++++++....
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 115 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG--- 115 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-----
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC---
Confidence 34579999999999999999998 45689999999986432 34568999999999999999999875422
Q ss_pred ceEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeec
Q 011138 207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (492)
Q Consensus 207 ~~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG 285 (492)
...+++||||+++ +|.+.+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~~~~-~~kL~Dfg 190 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVENEN-RVKIGDFG 190 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETT-EEEECCCT
T ss_pred CCceEEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEEcCCC-cEEEecCc
Confidence 2347899999986 55554432 23468899999999999999999997 9999999999999999887 89999999
Q ss_pred CccccCCCCC----CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 011138 286 SAKMLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTR 361 (492)
Q Consensus 286 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~ 361 (492)
++........ .....++..|+|||++.+.. ++.++|||||||++|+|++|..||.... . ...+..+....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~~~~~~--~---~~~~~~~~~~~ 264 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPP--A---EFMRMIGNDKQ 264 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCGGGSHH--H---HHHHHHCTTCC
T ss_pred chhhccccccccccccCCCCceeEECchhhcCCC-CCchhhHHHHHHHHHHHHhcCCCCCCCH--H---HHHHhhccccc
Confidence 9987644322 22345678899999997654 8899999999999999999999986421 1 11111221111
Q ss_pred HHH------hhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 362 EEI------KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 362 ~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
... ..... .... ..+..+++++.+||.+||..||.+|||+.++++
T Consensus 265 ~~~~~~~~~~~~~~---~~~~----------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 265 GQMIVFHLIELLKN---NGRL----------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp THHHHHHHHHHHHT---TCCC----------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhhhHHHHHHHhhc---CCCC----------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 00000 0000 122457899999999999999999999999875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=355.26 Aligned_cols=246 Identities=26% Similarity=0.347 Sum_probs=195.6
Q ss_pred ccccceeEeeeeccCCceEEEEEEEcCC---CCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCC
Q 011138 134 KQTISYMAERVVGTGSFGVVFQAKCLET---GDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (492)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~---g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 205 (492)
....+|.+.+.||+|+||.||+|.+..+ +..||||++.... ....+|+.+++.++||||+++++++.
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~----- 461 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT----- 461 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----
Confidence 4456799999999999999999998654 4579999875432 34557999999999999999999872
Q ss_pred CceEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeee
Q 011138 206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (492)
Q Consensus 206 ~~~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DF 284 (492)
+. .+|+||||+.+ +|.+.+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+||
T Consensus 462 ~~-~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDikp~NILl~~~~-~vkL~DF 535 (656)
T 2j0j_A 462 EN-PVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSND-CVKLGDF 535 (656)
T ss_dssp SS-SCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECCC
T ss_pred cC-ceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchHhEEEeCCC-CEEEEec
Confidence 11 26799999985 45544432 23468899999999999999999997 9999999999999999887 8999999
Q ss_pred cCccccCCCCC--CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 011138 285 GSAKMLVPGEP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTR 361 (492)
Q Consensus 285 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~ 361 (492)
|+++....... .....+|+.|+|||++.+. .++.++|||||||++|||++ |.+||.+.+..+.+..+.....
T Consensus 536 G~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~---- 610 (656)
T 2j0j_A 536 GLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER---- 610 (656)
T ss_dssp CCCCSCCC----------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCC----
T ss_pred CCCeecCCCcceeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC----
Confidence 99987643322 2234567899999999755 58999999999999999997 9999999887776666544110
Q ss_pred HHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
. .++..+++++.+||.+||..||.+|||+.++++
T Consensus 611 ------------~------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 611 ------------L------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp ------------C------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------C------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0 022457899999999999999999999999875
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=365.56 Aligned_cols=242 Identities=24% Similarity=0.342 Sum_probs=195.8
Q ss_pred cceeEeeeeccCCceEEEEEEEcC-CCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLE-TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~-~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
.+|.+.+.||+|+||.||+|.+.. +|+.||||++.... ....+|+.+++.++|||||++++++......+....
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 579999999999999999999976 78999999885321 234579999999999999999999877665455567
Q ss_pred EEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 211 ~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
||||||++|+.+... ....+++..+..|+.||+.||.|||+ +|||||||||+|||++.+ .+||+|||+++..
T Consensus 160 ~lv~E~~~g~~L~~~-----~~~~l~~~~~~~~~~qi~~aL~~lH~-~giiHrDlkp~NIll~~~--~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRS-----KGQKLPVAEAIAYLLEILPALSYLHS-IGLVYNDLKPENIMLTEE--QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEECCCCEECC---------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECSS--CEEECCCTTCEET
T ss_pred EEEEEeCCCCcHHHH-----HhCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecccChHHeEEeCC--cEEEEecccchhc
Confidence 999999987544321 12368999999999999999999997 999999999999999964 6999999999876
Q ss_pred CCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 011138 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (492)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 370 (492)
... ....||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+....
T Consensus 232 ~~~---~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~------------------------ 282 (681)
T 2pzi_A 232 NSF---GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVD------------------------ 282 (681)
T ss_dssp TCC---SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECS------------------------
T ss_pred ccC---CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccc------------------------
Confidence 433 456799999999999654 589999999999999999999998652110
Q ss_pred CcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
..+. .. .....++.+.+||.+||+.||.+||+..+++.|+|+.-+
T Consensus 283 ----~~~~--~~-----~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 283 ----GLPE--DD-----PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp ----SCCT--TC-----HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ----cccc--cc-----cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 0000 00 001246789999999999999999999999999998643
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=312.15 Aligned_cols=220 Identities=15% Similarity=0.056 Sum_probs=171.7
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
.+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++.. ...
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~~ 105 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-----RAG 105 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-----CCc
Confidence 46999999999999999999999999999999985431 345679999999999999999999843 345
Q ss_pred EEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 210 ~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
.|+||||+.| +|.+++. .......+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+++|
T Consensus 106 ~~lv~e~~~g~~L~~~l~------~~~~~~~~~~i~~ql~~aL~~lH~-~givH~Dikp~NIll~~~g-~~kl~~~~--- 174 (286)
T 3uqc_A 106 GLVVAEWIRGGSLQEVAD------TSPSPVGAIRAMQSLAAAADAAHR-AGVALSIDHPSRVRVSIDG-DVVLAYPA--- 174 (286)
T ss_dssp EEEEEECCCEEEHHHHHT------TCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEETTS-CEEECSCC---
T ss_pred EEEEEEecCCCCHHHHHh------cCCChHHHHHHHHHHHHHHHHHHH-CCCccCCCCcccEEEcCCC-CEEEEecc---
Confidence 8999999986 4444432 123555688899999999999997 9999999999999999887 79998554
Q ss_pred ccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
|++ .++.++|||||||++|+|++|+.||.+.+..+.+...
T Consensus 175 ----------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---------------- 214 (286)
T 3uqc_A 175 ----------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---------------- 214 (286)
T ss_dssp ----------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC----------------
T ss_pred ----------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH----------------
Confidence 333 2789999999999999999999999876532111000
Q ss_pred CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
...-. ........+...+++++.+||.+||+.||.+| |+.|+++
T Consensus 215 -----~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 215 -----ERDTA-GQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp -----CBCTT-SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred -----HHHhc-cCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 00000 00001112345689999999999999999999 9999987
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-33 Score=298.33 Aligned_cols=180 Identities=15% Similarity=0.060 Sum_probs=123.6
Q ss_pred eeccCCceEEEEEEEcCCCCEEEEEEeccc--------------hhhHHHHHHHHHHc-CCCCccccceeeeeccCCCce
Q 011138 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQD--------------KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 144 ~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~--------------~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~~~ 208 (492)
..+.|++|.+..++....|+.||||.+.++ ...+.+|+++|+++ .|+||+++++++ ++..
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~ 315 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQ 315 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSS
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECC
Confidence 467888888888777778999999998543 13356899999999 699999999998 6666
Q ss_pred EEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 209 ~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
.+||||||++|+ |.+.+.. ...++. ..|+.||+.||+|||+ +|||||||||+||||+.++ .+||+|||+|
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~----~~~l~~---~~I~~QIl~AL~ylH~-~GIIHRDIKPeNILL~~dg-~vKL~DFGlA 386 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAA----GEEIDR---EKILGSLLRSLAALEK-QGFWHDDVRPWNVMVDARQ-HARLIDFGSI 386 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHT----TCCCCH---HHHHHHHHHHHHHHHH-TTCEESCCCGGGEEECTTS-CEEECCCTTE
T ss_pred EEEEEEecCCCCcHHHHHHh----CCCCCH---HHHHHHHHHHHHHHHH-CCceeccCchHhEEECCCC-CEEEeecccC
Confidence 799999999975 4444432 345554 3578999999999997 9999999999999999888 7999999999
Q ss_pred cccCCC-CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCC
Q 011138 288 KMLVPG-EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPL 339 (492)
Q Consensus 288 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~p 339 (492)
+..... ....+.+||+.|||||++.+. +..++|+||+|+++|+|++|..+
T Consensus 387 r~~~~~~~~~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 387 VTTPQDCSWPTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred eeCCCCCccccCceechhhccHHHhCCC--CCCcccccccccchhhhccccch
Confidence 876433 344567999999999999653 67789999999998887665433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-27 Score=253.38 Aligned_cols=179 Identities=19% Similarity=0.243 Sum_probs=133.0
Q ss_pred eEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 140 MAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 140 ~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
...+.||+|+||.||+|. ..+..+++|+.... .....+|+++++.++||||+++..++....
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~---- 412 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD---- 412 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT----
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC----
Confidence 456789999999999994 46889999976321 122468999999999999996555544322
Q ss_pred eEEEEEeeech-hhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 208 LYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 208 ~~~~lV~E~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
..||||||++ ++|.+.+.. +..++.||+.||.|||+ +||+||||||+|||++. .+||+|||+
T Consensus 413 -~~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~-~gIiHrDiKp~NILl~~---~~kL~DFGl 475 (540)
T 3en9_A 413 -NKRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHK-NDVIHNDLTTSNFIFDK---DLYIIDFGL 475 (540)
T ss_dssp -TTEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHH-TTEECTTCCTTSEEESS---SEEECCCTT
T ss_pred -ccEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHH-CcCccCCCCHHHEEECC---eEEEEECcc
Confidence 2479999998 455554332 45789999999999997 99999999999999997 699999999
Q ss_pred ccccCCCCC--------CccceeccCccCchhhcCC-CCCCcchhhHHHHHHHHHHHhCCCCCC
Q 011138 287 AKMLVPGEP--------NISYICSRYYRAPELIFGA-TEYTTAIDMWSIGCVLAELLLGQPLFP 341 (492)
Q Consensus 287 a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwSlGvil~ell~G~~pf~ 341 (492)
++....... ....+||+.|||||++.+. ..|+..+|+|+..+-..+.+.++.+|.
T Consensus 476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 987644322 1356899999999999641 237888999999999998888877763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-24 Score=211.51 Aligned_cols=140 Identities=16% Similarity=0.159 Sum_probs=110.9
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----------------------hhhHHHHHHHHHHcCCCCcccc
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----------------------KRYKNRELQIMRLLNHPNVVSL 195 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----------------------~~~~~~E~~il~~l~h~nIv~l 195 (492)
.|.+++.||+|+||.||+|.+ .+|+.||||++... .....+|+.+|+.++ | +++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 367779999999999999999 88999999998532 223568999999999 5 777
Q ss_pred ceeeeeccCCCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCC
Q 011138 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH 275 (492)
Q Consensus 196 ~~~~~~~~~~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~ 275 (492)
++++.. ...|+||||++|+.+..+. ......++.||+.||.|||+ +||+||||||+|||++ +
T Consensus 167 ~~~~~~------~~~~lvmE~~~g~~L~~l~----------~~~~~~i~~qi~~~l~~lH~-~giiHrDlkp~NILl~-~ 228 (282)
T 1zar_A 167 PKVYAW------EGNAVLMELIDAKELYRVR----------VENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVS-E 228 (282)
T ss_dssp CCEEEE------ETTEEEEECCCCEEGGGCC----------CSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEE-T
T ss_pred CeEEec------cceEEEEEecCCCcHHHcc----------hhhHHHHHHHHHHHHHHHHH-CCCEeCCCCHHHEEEE-C
Confidence 776522 2358999999875332111 12245789999999999997 9999999999999999 6
Q ss_pred CCcEEEeeecCccccCCCCCCccceeccCccCchhhc
Q 011138 276 THQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIF 312 (492)
Q Consensus 276 ~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~ 312 (492)
+ .+||+|||+|+. +..|+|||++.
T Consensus 229 ~-~vkl~DFG~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 229 E-GIWIIDFPQSVE------------VGEEGWREILE 252 (282)
T ss_dssp T-EEEECCCTTCEE------------TTSTTHHHHHH
T ss_pred C-cEEEEECCCCeE------------CCCCCHHHHHH
Confidence 6 899999999863 34588999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.4e-21 Score=184.69 Aligned_cols=135 Identities=19% Similarity=0.262 Sum_probs=102.6
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCE--EEEEEeccch----------------------------hhHHHHHHHHHHc
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDS--VAIKKVLQDK----------------------------RYKNRELQIMRLL 187 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~--vAiK~~~~~~----------------------------~~~~~E~~il~~l 187 (492)
-|.+.+.||+|+||.||+|.+..+|+. ||||++.... ....+|+.+|+.+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 388999999999999999998788999 9999864321 1356799999999
Q ss_pred CCCCccccceeeeeccCCCceEEEEEeeechh------hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHH-hhCCc
Q 011138 188 NHPNVVSLKHCFFSTTEKDELYLNLVLEYISE------TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH-HVVGV 260 (492)
Q Consensus 188 ~h~nIv~l~~~~~~~~~~~~~~~~lV~E~~~~------~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH-~~~gi 260 (492)
.|++|....-+.. ...+|||||+++ .+.+... ..++..+..++.||+.||.||| + +||
T Consensus 128 ~~~~i~~p~~~~~-------~~~~lVmE~~g~~g~~~~~L~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~-~gi 192 (258)
T 1zth_A 128 KEAGVSVPQPYTY-------MKNVLLMEFIGEDELPAPTLVELGR-------ELKELDVEGIFNDVVENVKRLYQE-AEL 192 (258)
T ss_dssp HHTTCCCCCEEEE-------ETTEEEEECCEETTEECCBHHHHGG-------GGGGSCHHHHHHHHHHHHHHHHHT-SCE
T ss_pred HhCCCCCCeEEEc-------CCCEEEEEecCCCCCccccHHHHhh-------ccChHHHHHHHHHHHHHHHHHHHH-CCE
Confidence 9886532211111 125799999953 2332211 1234457789999999999999 8 899
Q ss_pred ccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 261 CHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 261 vHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
+||||||+|||++. .++|+|||+|...
T Consensus 193 vHrDlkp~NILl~~---~~~liDFG~a~~~ 219 (258)
T 1zth_A 193 VHADLSEYNIMYID---KVYFIDMGQAVTL 219 (258)
T ss_dssp ECSSCSTTSEEESS---SEEECCCTTCEET
T ss_pred EeCCCCHHHEEEcC---cEEEEECcccccC
Confidence 99999999999996 5999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.74 E-value=1.4e-18 Score=173.96 Aligned_cols=140 Identities=14% Similarity=0.105 Sum_probs=91.6
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------------------hhHHHHHHHHHHcCCCCccccceeee
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------------------RYKNRELQIMRLLNHPNVVSLKHCFF 200 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------------------~~~~~E~~il~~l~h~nIv~l~~~~~ 200 (492)
|.++..||+|+||.||+|.+ .+|+.||||++.... .....+..+.....|+|++++++...
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 99999999999999999986 479999999864210 00111222222233444444433221
Q ss_pred eccC-CCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCC--
Q 011138 201 STTE-KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH-- 277 (492)
Q Consensus 201 ~~~~-~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~-- 277 (492)
.... .+....+|||||++|..+..+. ....+..++.||+.+|.|||+ +|||||||||.|||++.++.
T Consensus 176 ~vp~p~~~~~~~LVME~i~G~~L~~l~---------~~~~~~~l~~qll~~l~~lH~-~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 176 PVPEPIAQSRHTIVMSLVDALPMRQVS---------SVPDPASLYADLIALILRLAK-HGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp SCCCEEEEETTEEEEECCSCEEGGGCC---------CCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEEEEECSS
T ss_pred CCCeeeeccCceEEEEecCCccHhhhc---------ccHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEEEeCCCCcc
Confidence 1100 0000125999999876432111 112345678999999999997 89999999999999986652
Q ss_pred -------cEEEeeecCccc
Q 011138 278 -------QLKICDFGSAKM 289 (492)
Q Consensus 278 -------~vkL~DFG~a~~ 289 (492)
.+.|+||+-+..
T Consensus 246 d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CTTSEEEEEEECCCTTCEE
T ss_pred cccccccceEEEEeCCccc
Confidence 288999998754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=1.1e-11 Score=118.24 Aligned_cols=135 Identities=15% Similarity=0.147 Sum_probs=101.7
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEecc----chhhHHHHHHHHHHcC-CCCccccceeeeeccCCCceEEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ----DKRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~----~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
.|.+...++.|+++.||++.. .|..+++|.... ......+|+.+++.+. +.+++++++++. +....|+
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~~~l 87 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HDGWSNL 87 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEEEE
T ss_pred cceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-----cCCceEE
Confidence 588888999999999999974 478999998853 3345788999999995 667888888763 2345789
Q ss_pred EeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhh-----------------------------------
Q 011138 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV----------------------------------- 257 (492)
Q Consensus 213 V~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~----------------------------------- 257 (492)
||||++|..+... .. +......++.++..+|..||+.
T Consensus 88 v~e~i~G~~l~~~--~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 88 LMSEADGVLCSEE--YE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEECCSSEEHHHH--CC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEEecCCeehhhc--cC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 9999998654321 00 1112346778999999999960
Q ss_pred -----------------------CCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 258 -----------------------VGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 258 -----------------------~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
..++|+|++|.|||++.++ .+.|+||+.+.
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~lIDwe~a~ 212 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK-VSGFIDLGRSG 212 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTE-EEEECCCTTCE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCc-EEEEEEchhcc
Confidence 3489999999999998543 56799999874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.15 E-value=8.6e-11 Score=111.48 Aligned_cols=132 Identities=17% Similarity=0.093 Sum_probs=92.0
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-hhhHHHHHHHHHHcCCCC--ccccceeeeeccCCCceEEEEEe
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRLLNHPN--VVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-~~~~~~E~~il~~l~h~n--Iv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
.|.+..+.+.|..+.||++. ..+|..+++|+.... .....+|+.+++.+.+.+ +.+++++.. +....++||
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~-----~~~~~~~v~ 94 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRDWLLL 94 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCEEEEE
T ss_pred CCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEecc-----CCCCCEEEE
Confidence 35555444566779999996 456788999987543 244678999999997544 456776652 223478999
Q ss_pred eechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCC-----------------------------------
Q 011138 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG----------------------------------- 259 (492)
Q Consensus 215 E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~g----------------------------------- 259 (492)
||++|..+. .. ... ...++.+++..|..||+ ..
T Consensus 95 e~i~G~~l~-~~-------~~~---~~~~~~~l~~~l~~lh~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 95 GEVPGQDLL-SS-------HLA---PAEKVSIMADAMRRLHT-LDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp ECCSSEETT-TS-------CCC---HHHHHHHHHHHHHHHTT-SCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EecCCcccC-cC-------cCC---HhHHHHHHHHHHHHHhC-CCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 999986432 10 011 12456677778888885 33
Q ss_pred -----------------------cccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 260 -----------------------VCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 260 -----------------------ivHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
++|+|++|.|||++.++ .+.|+|||.+.
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~liD~~~a~ 213 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGR-FSGFIDCGRLG 213 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTE-EEEECCCTTCE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCc-EEEEEcchhcc
Confidence 99999999999998654 56799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.05 E-value=3.8e-10 Score=112.81 Aligned_cols=139 Identities=15% Similarity=0.177 Sum_probs=99.2
Q ss_pred eeeeccCCceEEEEEEEcCCCCEEEEEEec--cc-----hhhHHHHHHHHHHcCC--CCccccceeeeeccCCCceEEEE
Q 011138 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVL--QD-----KRYKNRELQIMRLLNH--PNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~--~~-----~~~~~~E~~il~~l~h--~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
.+.|+.|.++.||++.. .+..+++|+.. .. .....+|..+++.|.. ..+++++.++.... .....|+
T Consensus 43 ~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~--~~g~~~~ 118 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES--VIGRAFY 118 (359)
T ss_dssp EEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT--TTSSCEE
T ss_pred EEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC--ccCCeEE
Confidence 45689999999999875 35678889775 22 3456789999999984 45777777653221 1123578
Q ss_pred EeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhh-----------------------------------
Q 011138 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV----------------------------------- 257 (492)
Q Consensus 213 V~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~----------------------------------- 257 (492)
||||++|..+.. .....++......++.+++..|..||+.
T Consensus 119 vme~v~G~~l~~-----~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 119 IMEFVSGRVLWD-----QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp EEECCCCBCCCC-----TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EEEecCCeecCC-----CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 999999854311 1123456777788899999999999951
Q ss_pred ----------------------CCcccCCCCCCceEEcCCCC-cEEEeeecCccc
Q 011138 258 ----------------------VGVCHRDIKPQNLLVNPHTH-QLKICDFGSAKM 289 (492)
Q Consensus 258 ----------------------~givHrDlKp~NILl~~~~~-~vkL~DFG~a~~ 289 (492)
.+++|+|++|.|||++.++. .+.|+||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36999999999999987652 368999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.00 E-value=3.3e-10 Score=110.61 Aligned_cols=183 Identities=14% Similarity=0.151 Sum_probs=111.2
Q ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEeccc--hhhHHHHHHHHHHcC-CCCc--cccceeeeeccCCCceEEEEEeeec
Q 011138 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLN-HPNV--VSLKHCFFSTTEKDELYLNLVLEYI 217 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~--~~~~~~E~~il~~l~-h~nI--v~l~~~~~~~~~~~~~~~~lV~E~~ 217 (492)
+.++.|....||++. ..+++|+.... .....+|..+|+.+. +..| .+++... .........|+||+++
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~--~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTG--MPSETYQMSFAGFTKI 98 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEEC--CCCSSCSCSCEEEECC
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeec--CCCCCCCcceEEEccc
Confidence 358999999999863 45889986543 345678999999884 3332 3332221 1111112347899999
Q ss_pred hhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhh----------------------------------------
Q 011138 218 SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHV---------------------------------------- 257 (492)
Q Consensus 218 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~---------------------------------------- 257 (492)
+|..+.... ...++......++.|++..|..||+.
T Consensus 99 ~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLL-----LNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHH-----HHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCccc-----cccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 985332110 12345555666677777777777730
Q ss_pred -----------------CCcccCCCCCCceEEcCC-CCcEEEeeecCccccCCCCCCccceeccCc---cCchhhc----
Q 011138 258 -----------------VGVCHRDIKPQNLLVNPH-THQLKICDFGSAKMLVPGEPNISYICSRYY---RAPELIF---- 312 (492)
Q Consensus 258 -----------------~givHrDlKp~NILl~~~-~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y---~aPE~~~---- 312 (492)
..++|+|++|.||+++.+ +..+.|+||+.+....+. ........+ ..|+...
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~---~Dl~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD---NDFISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT---HHHHTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH---HHHHHHHhhccccCHHHHHHHHH
Confidence 247999999999999974 336889999998653221 111111111 2232211
Q ss_pred CCCC---------CCcchhhHHHHHHHHHHHhCCCCC
Q 011138 313 GATE---------YTTAIDMWSIGCVLAELLLGQPLF 340 (492)
Q Consensus 313 ~~~~---------~~~~~DvwSlGvil~ell~G~~pf 340 (492)
.... .....+.|++|.++|.+.+|..+|
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0000 122368999999999999998776
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=2.2e-06 Score=83.45 Aligned_cols=134 Identities=17% Similarity=0.143 Sum_probs=81.3
Q ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEeccc--hhhHHHHHHHHHHcCCC---CccccceeeeeccCCCceEEEEEeeec
Q 011138 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHP---NVVSLKHCFFSTTEKDELYLNLVLEYI 217 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~--~~~~~~E~~il~~l~h~---nIv~l~~~~~~~~~~~~~~~~lV~E~~ 217 (492)
+.++.|....||+. |..+++|+-... .....+|..+|+.|.+. .+.+++.+.. . .....++|||++
T Consensus 25 ~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~--~--~~g~~~~v~e~i 95 (306)
T 3tdw_A 25 ESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK--R--SDGNPFVGYRKV 95 (306)
T ss_dssp EEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE--C--TTSCEEEEEECC
T ss_pred eecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc--c--CCCceEEEEecc
Confidence 45788988999987 567888975432 23456899999999753 2445444432 1 122356999999
Q ss_pred hhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 011138 218 SETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH----------------------------------------- 256 (492)
Q Consensus 218 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~----------------------------------------- 256 (492)
+|..+..... ..++......++.|+...|..||+
T Consensus 96 ~G~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 96 QGQILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp CSEECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred CCeECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 8753321100 111222222333333333333331
Q ss_pred ------------------hCCcccCCCCCCceEEcC---CCCcEEEeeecCcccc
Q 011138 257 ------------------VVGVCHRDIKPQNLLVNP---HTHQLKICDFGSAKML 290 (492)
Q Consensus 257 ------------------~~givHrDlKp~NILl~~---~~~~vkL~DFG~a~~~ 290 (492)
...++|+|++|.|||++. ++..+.|+||+.+...
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 125699999999999987 3434589999988653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=8.4e-06 Score=77.45 Aligned_cols=131 Identities=14% Similarity=0.036 Sum_probs=81.8
Q ss_pred eccCCc-eEEEEEEEcCCCCEEEEEEeccc-hhhHHHHHHHHHHcCC-CCccccceeeeeccCCCceEEEEEeeechhhH
Q 011138 145 VGTGSF-GVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRLLNH-PNVVSLKHCFFSTTEKDELYLNLVLEYISETV 221 (492)
Q Consensus 145 lG~G~f-g~Vy~~~~~~~g~~vAiK~~~~~-~~~~~~E~~il~~l~h-~nIv~l~~~~~~~~~~~~~~~~lV~E~~~~~l 221 (492)
+..|.- +.||+......+..+.+|+-... .....+|..+|+.|.. --+.+++.+.. +....++|||+++|..
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~-----~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIR-----TPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEEEEEEECCCSEE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEE-----ECCeEEEEEEeeCCcc
Confidence 333443 47898877667788999976543 2345689999998862 23556666552 2234679999998753
Q ss_pred HHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHh---------------------------------------------
Q 011138 222 YRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH--------------------------------------------- 256 (492)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~--------------------------------------------- 256 (492)
+...... .......+..++...|.-||.
T Consensus 107 ~~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 107 AFQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 3211100 001122334455555555552
Q ss_pred ------------hCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 257 ------------VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 257 ------------~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
...++|+|+.+.|||++.++ .+-|+||+.+.
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~-~~~viDwe~a~ 222 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGK-LIGCIDVGRVG 222 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTE-EEEECCCTTCE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCe-EEEEEECcccc
Confidence 01279999999999999655 56799999875
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.09 E-value=1.1e-05 Score=79.15 Aligned_cols=72 Identities=17% Similarity=0.298 Sum_probs=40.9
Q ss_pred eeccCCceEEEEEEEcCCCCEEEEEEeccchhhHHHHHHHHHHcCC--CCcccccee----eeeccCCCceEEEEEeeec
Q 011138 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNH--PNVVSLKHC----FFSTTEKDELYLNLVLEYI 217 (492)
Q Consensus 144 ~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~E~~il~~l~h--~nIv~l~~~----~~~~~~~~~~~~~lV~E~~ 217 (492)
.|+.|..+.||++.. .+..+++|+..........|..+++.|.. -.+++++.. ++. .+....++||+|+
T Consensus 39 ~l~gG~~n~~~~v~~--~~~~~vlk~~~~~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~---~~~~~~~~l~~~i 113 (346)
T 2q83_A 39 VIQGNQMALVWKVHT--DSGAVCLKRIHRPEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYS---KHGSFLFVVYDWI 113 (346)
T ss_dssp ECC----CEEEEEEE--TTEEEEEEEECSCHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCE---EETTEEEEEEECC
T ss_pred eccccccCcEEEEEe--CCCCEEEEecCCCHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEE---EECCEEEEEEEee
Confidence 466677899999875 23458999887655445567777776642 123444331 000 1122467899999
Q ss_pred hhh
Q 011138 218 SET 220 (492)
Q Consensus 218 ~~~ 220 (492)
+|.
T Consensus 114 ~G~ 116 (346)
T 2q83_A 114 EGR 116 (346)
T ss_dssp CCB
T ss_pred cCc
Confidence 863
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=1e-05 Score=81.66 Aligned_cols=71 Identities=18% Similarity=0.185 Sum_probs=45.0
Q ss_pred eeeeccCCceEEEEEEEcCCCCEEEEEEeccc-----------hhhHHHHHHHHHHcCC--CC-ccccceeeeeccCCCc
Q 011138 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----------KRYKNRELQIMRLLNH--PN-VVSLKHCFFSTTEKDE 207 (492)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-----------~~~~~~E~~il~~l~h--~n-Iv~l~~~~~~~~~~~~ 207 (492)
.+.||.|.++.||++....+++.|+||..... .....+|.++++.+.. +. +.+++.+ . .+.
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d---~~~ 109 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D---TEM 109 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E---TTT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--c---CCc
Confidence 35789999999999976556788999975321 1234579999988753 33 3454432 1 111
Q ss_pred eEEEEEeeechh
Q 011138 208 LYLNLVLEYISE 219 (492)
Q Consensus 208 ~~~~lV~E~~~~ 219 (492)
.++|||++++
T Consensus 110 --~~lvmE~l~g 119 (397)
T 2olc_A 110 --AVTVMEDLSH 119 (397)
T ss_dssp --TEEEECCCTT
T ss_pred --cEEEEEeCCC
Confidence 3589999976
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.99 E-value=1e-05 Score=80.23 Aligned_cols=77 Identities=10% Similarity=0.100 Sum_probs=49.8
Q ss_pred eeee-ccCCceEEEEEEEc--C----CCCEEEEEEeccch-------hhHHHHHHHHHHcCC---CCccccceeeeeccC
Q 011138 142 ERVV-GTGSFGVVFQAKCL--E----TGDSVAIKKVLQDK-------RYKNRELQIMRLLNH---PNVVSLKHCFFSTTE 204 (492)
Q Consensus 142 ~~~l-G~G~fg~Vy~~~~~--~----~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h---~nIv~l~~~~~~~~~ 204 (492)
.+.| +.|....+|+.... . ++..+++|+..... ....+|..+++.|.. -.+.+++.+.....
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~- 103 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD- 103 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST-
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC-
Confidence 4567 88889999988643 1 26678899765432 456789999998853 24666666542111
Q ss_pred CCceEEEEEeeechhh
Q 011138 205 KDELYLNLVLEYISET 220 (492)
Q Consensus 205 ~~~~~~~lV~E~~~~~ 220 (492)
.....++||||++|.
T Consensus 104 -~~g~~~~v~e~l~G~ 118 (357)
T 3ats_A 104 -VLGTPFFLMDYVEGV 118 (357)
T ss_dssp -TTSSCEEEEECCCCB
T ss_pred -ccCCceEEEEecCCC
Confidence 112346899999863
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00052 Score=69.63 Aligned_cols=77 Identities=10% Similarity=-0.060 Sum_probs=46.5
Q ss_pred CCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCCCCcccee--ccCccCchhhcCCCC--CCcchhhHHHHHHHHHH
Q 011138 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC--SRYYRAPELIFGATE--YTTAIDMWSIGCVLAEL 333 (492)
Q Consensus 258 ~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~--~~~~~DvwSlGvil~el 333 (492)
..++|+|++|.|||++.++ ++|+||+.+....+........+ ...|++|+....... -....++..+...+|+.
T Consensus 232 ~~liHGDl~~~Nil~~~~~--~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS--TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CEEECSCCSGGGEEECSSC--EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC--CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 6899999999999998654 99999998865322111111111 234666665421110 11123445777777877
Q ss_pred HhC
Q 011138 334 LLG 336 (492)
Q Consensus 334 l~G 336 (492)
+.+
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.29 E-value=0.0013 Score=62.85 Aligned_cols=70 Identities=16% Similarity=0.166 Sum_probs=48.8
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----hhhHHHHHHHHHHcCCC---CccccceeeeeccCCCceEEE
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHP---NVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----~~~~~~E~~il~~l~h~---nIv~l~~~~~~~~~~~~~~~~ 211 (492)
..-.+.+|.|..+.||+.. ..+|+.|.+|+.... ...+++|...|+.|..- .+++++.+- . -+
T Consensus 17 v~~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~-----~----~~ 86 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVE-LADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD-----D----RT 86 (288)
T ss_dssp EEEEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE-----T----TE
T ss_pred eEEEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc-----C----ce
Confidence 3445679999999999997 468999999976432 23567899999998532 234444321 1 25
Q ss_pred EEeeech
Q 011138 212 LVLEYIS 218 (492)
Q Consensus 212 lV~E~~~ 218 (492)
+||||+.
T Consensus 87 lv~e~l~ 93 (288)
T 3f7w_A 87 LAMEWVD 93 (288)
T ss_dssp EEEECCC
T ss_pred EEEEeec
Confidence 7899985
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.26 E-value=0.001 Score=64.13 Aligned_cols=65 Identities=17% Similarity=0.112 Sum_probs=41.1
Q ss_pred eeeeccCCceEEEEEEEcCCCCEEEEEEeccch---hhHHHHHHHHHHcCCCCc-cccceeeeeccCCCceEEEEEeeec
Q 011138 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNV-VSLKHCFFSTTEKDELYLNLVLEYI 217 (492)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~---~~~~~E~~il~~l~h~nI-v~l~~~~~~~~~~~~~~~~lV~E~~ 217 (492)
.+.|+.|....+|++ ..+.+|+..... ....+|..+++.+....+ .+++.+. .+. -++|+||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~-----~~~--~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD-----PAT--GVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC-----TTT--CCEEEECC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE-----CCC--CEEEEeec
Confidence 456888999999998 458888775432 223578888888753333 3444432 211 24789999
Q ss_pred -hh
Q 011138 218 -SE 219 (492)
Q Consensus 218 -~~ 219 (492)
+|
T Consensus 90 ~~g 92 (301)
T 3dxq_A 90 AGA 92 (301)
T ss_dssp TTC
T ss_pred CCC
Confidence 54
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0019 Score=62.66 Aligned_cols=143 Identities=12% Similarity=0.041 Sum_probs=74.8
Q ss_pred eeeeccCCceEEEEEEEcCCCCEEEEEEecc--chhhHHHHHHHHHHcCCCC--ccccceeeeeccC--CCceEEEEEee
Q 011138 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ--DKRYKNRELQIMRLLNHPN--VVSLKHCFFSTTE--KDELYLNLVLE 215 (492)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~--~~~~~~~E~~il~~l~h~n--Iv~l~~~~~~~~~--~~~~~~~lV~E 215 (492)
.+.|+.|....+|++... +| .+++|.... .......|..+++.|.... +.+++... .... ......++||+
T Consensus 27 ~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~-~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRK-DGELLGELSGRPAALIS 103 (322)
T ss_dssp EEEECC---EEEEEEEES-SC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBT-TCCSCEEETTEEEEEEE
T ss_pred eeccCCCcccceEEEEeC-Cc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCC-CCCEEEEECCEEEEEEE
Confidence 346788888999998752 33 688998765 3445667888888875322 33333210 0000 00123578999
Q ss_pred echhhHH------------HHhhhhhhc----CCC----cCHHHHHH---------------HHHHHHHHHHHHHh----
Q 011138 216 YISETVY------------RVSKHYTRM----NQH----VPILYVQL---------------YTYQICRALNYLHH---- 256 (492)
Q Consensus 216 ~~~~~l~------------~~~~~~~~~----~~~----~~~~~~~~---------------i~~qi~~aL~yLH~---- 256 (492)
|++|... ..+...... ... ........ +...+...+.+|+.
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 9876311 000000000 000 01000000 00113344555542
Q ss_pred --hCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 257 --VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 257 --~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
..+++|+|+.+.|||++.++ .+.|+||+.+.
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~-~~~lIDf~~a~ 216 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDE-LSGLIDFYFAC 216 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTE-EEEECCCTTCE
T ss_pred cCCcccCCCCCCccCEEEeCCc-eEEEecchhcc
Confidence 14799999999999998654 45799999875
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0026 Score=64.61 Aligned_cols=69 Identities=19% Similarity=0.240 Sum_probs=47.0
Q ss_pred eeeeccCCceEEEEEEEcC-------CCCEEEEEEecc-ch-hhHHHHHHHHHHcCCCCc-cccceeeeeccCCCceEEE
Q 011138 142 ERVVGTGSFGVVFQAKCLE-------TGDSVAIKKVLQ-DK-RYKNRELQIMRLLNHPNV-VSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~-------~g~~vAiK~~~~-~~-~~~~~E~~il~~l~h~nI-v~l~~~~~~~~~~~~~~~~ 211 (492)
.+.|+.|....||++.... ++..+.+|+... .. ....+|..+++.|...++ +++++.+ .+ .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~----g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC----C
Confidence 3568888889999998642 357899998744 22 344579999998864444 5665544 22 2
Q ss_pred EEeeechh
Q 011138 212 LVLEYISE 219 (492)
Q Consensus 212 lV~E~~~~ 219 (492)
+|+||++|
T Consensus 149 ~v~e~l~G 156 (429)
T 1nw1_A 149 RLEEYIPS 156 (429)
T ss_dssp EEECCCCE
T ss_pred EEEEEeCC
Confidence 78999875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.09 E-value=0.0044 Score=63.40 Aligned_cols=69 Identities=14% Similarity=0.246 Sum_probs=45.6
Q ss_pred eeeeccCCceEEEEEEEcCCCCEEEEEEeccchh---hHHHHHHHHHHcCCCCc-cccceeeeeccCCCceEEEEEeeec
Q 011138 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR---YKNRELQIMRLLNHPNV-VSLKHCFFSTTEKDELYLNLVLEYI 217 (492)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~---~~~~E~~il~~l~h~nI-v~l~~~~~~~~~~~~~~~~lV~E~~ 217 (492)
.+.|+.|-...+|++.....+..+.+|+...... ...+|..+++.|...++ +++++++ .+ .+||||+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~-----~~----G~v~e~I 183 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF-----TN----GRIEEFM 183 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE-----TT----EEEEECC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe-----CC----eEEEEee
Confidence 4568888889999998654457888998743221 23589999999975555 4566554 22 1489998
Q ss_pred hh
Q 011138 218 SE 219 (492)
Q Consensus 218 ~~ 219 (492)
+|
T Consensus 184 ~G 185 (458)
T 2qg7_A 184 DG 185 (458)
T ss_dssp CS
T ss_pred CC
Confidence 75
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0042 Score=60.32 Aligned_cols=72 Identities=13% Similarity=0.017 Sum_probs=44.2
Q ss_pred eeccCCceEEEEEEEcCCCCEEEEEEecc---chhhHHHHHHHHHHcCCCC--ccccceeeeeccC--CCceEEEEEeee
Q 011138 144 VVGTGSFGVVFQAKCLETGDSVAIKKVLQ---DKRYKNRELQIMRLLNHPN--VVSLKHCFFSTTE--KDELYLNLVLEY 216 (492)
Q Consensus 144 ~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~---~~~~~~~E~~il~~l~h~n--Iv~l~~~~~~~~~--~~~~~~~lV~E~ 216 (492)
.|+ |....||++.. .+|+.+++|.... .......|..+++.|.... +++++.. .... ......++||++
T Consensus 33 ~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 33 PLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEEEEEC
T ss_pred eec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEEEEEe
Confidence 356 77889998753 4566799998853 2445567888888885322 4444432 1100 012245789999
Q ss_pred chh
Q 011138 217 ISE 219 (492)
Q Consensus 217 ~~~ 219 (492)
++|
T Consensus 109 i~G 111 (328)
T 1zyl_A 109 VGG 111 (328)
T ss_dssp CCC
T ss_pred cCC
Confidence 976
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0026 Score=61.70 Aligned_cols=72 Identities=15% Similarity=0.080 Sum_probs=51.8
Q ss_pred eeeeccCCceEEEEEEEcCCCCEEEEEEeccc-hhhHHHHHHHHHHcC---CCCccccceeeeeccCCCceEEEEEeeec
Q 011138 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRLLN---HPNVVSLKHCFFSTTEKDELYLNLVLEYI 217 (492)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-~~~~~~E~~il~~l~---h~nIv~l~~~~~~~~~~~~~~~~lV~E~~ 217 (492)
.+.|+.|....+|+... ++..+++|+.... .....+|...|+.|. ...+++++.+.. .....++||||+
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~-----~~g~~~lvme~l 113 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGN-----SQGHSFLLLEAL 113 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE-----CSSEEEEEEECC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEee-----cCCceEEEEEec
Confidence 35689999999999874 5678889977543 345678999998885 245777766542 223478999999
Q ss_pred hhh
Q 011138 218 SET 220 (492)
Q Consensus 218 ~~~ 220 (492)
+|.
T Consensus 114 ~G~ 116 (312)
T 3jr1_A 114 NKS 116 (312)
T ss_dssp CCC
T ss_pred cCC
Confidence 753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0025 Score=63.26 Aligned_cols=68 Identities=12% Similarity=0.164 Sum_probs=41.1
Q ss_pred eeeccCCceEEEEEEEcC--------CCCEEEEEEeccchh---hHHHHHHHHHHcCCCC-ccccceeeeeccCCCceEE
Q 011138 143 RVVGTGSFGVVFQAKCLE--------TGDSVAIKKVLQDKR---YKNRELQIMRLLNHPN-VVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~--------~g~~vAiK~~~~~~~---~~~~E~~il~~l~h~n-Iv~l~~~~~~~~~~~~~~~ 210 (492)
+.|+.|....+|++.... .+..+.+|+...... ...+|..+++.|...+ +.++++.+ .+
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~~---- 109 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF-----NG---- 109 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE-----TT----
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec-----CC----
Confidence 457788888999987542 136788997654322 2367899998886434 34665433 11
Q ss_pred EEEeeechh
Q 011138 211 NLVLEYISE 219 (492)
Q Consensus 211 ~lV~E~~~~ 219 (492)
++||||++|
T Consensus 110 ~~v~e~i~G 118 (369)
T 3c5i_A 110 GRIEEWLYG 118 (369)
T ss_dssp EEEEECCCS
T ss_pred cEEEEEecC
Confidence 478999876
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0051 Score=61.31 Aligned_cols=138 Identities=18% Similarity=0.242 Sum_probs=76.3
Q ss_pred eeeccCCceEEEEEEEcC-------CCCEEEEEEecc---chhhHHHHHHHHHHcCCCC-ccccceeeeeccCCCceEEE
Q 011138 143 RVVGTGSFGVVFQAKCLE-------TGDSVAIKKVLQ---DKRYKNRELQIMRLLNHPN-VVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~-------~g~~vAiK~~~~---~~~~~~~E~~il~~l~h~n-Iv~l~~~~~~~~~~~~~~~~ 211 (492)
+.|..|-...+|++.... +++.+.+|+.-. ......+|..+++.|..-+ ..++++++ .+ .
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~----g 126 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVF-----PE----G 126 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TT----E
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CC----c
Confidence 346667777888887532 357888997633 2334458999998885322 35555544 22 1
Q ss_pred EEeeechhhHHH------------H---hhhhhhc----CCCc--CHHHHHHHHHHHHH-------------------HH
Q 011138 212 LVLEYISETVYR------------V---SKHYTRM----NQHV--PILYVQLYTYQICR-------------------AL 251 (492)
Q Consensus 212 lV~E~~~~~l~~------------~---~~~~~~~----~~~~--~~~~~~~i~~qi~~-------------------aL 251 (492)
+||||++|..+. + +...... .... -...+..+..|+-. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 799999763221 1 1111111 1111 12345555544422 23
Q ss_pred HHHHh-------hCCcccCCCCCCceEEcCC---CCcEEEeeecCccc
Q 011138 252 NYLHH-------VVGVCHRDIKPQNLLVNPH---THQLKICDFGSAKM 289 (492)
Q Consensus 252 ~yLH~-------~~givHrDlKp~NILl~~~---~~~vkL~DFG~a~~ 289 (492)
..|.+ ...++|+|+.+.|||++.+ ...+.|+||..+..
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 33321 1359999999999999876 23799999998853
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0024 Score=62.29 Aligned_cols=33 Identities=36% Similarity=0.505 Sum_probs=27.3
Q ss_pred CCcccCCCCCCceEEcCC---CCcEEEeeecCcccc
Q 011138 258 VGVCHRDIKPQNLLVNPH---THQLKICDFGSAKML 290 (492)
Q Consensus 258 ~givHrDlKp~NILl~~~---~~~vkL~DFG~a~~~ 290 (492)
..++|+|+.+.|||++.+ ...+.|+||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 579999999999999864 126899999988653
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.35 E-value=0.01 Score=58.17 Aligned_cols=31 Identities=29% Similarity=0.540 Sum_probs=26.8
Q ss_pred CCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 258 ~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
..++|+|+.+.||+++.++ .+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~-~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEE-SIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGG-CEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCC-eEEEEECCCCee
Confidence 4699999999999998665 699999988764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.11 E-value=0.042 Score=49.76 Aligned_cols=90 Identities=16% Similarity=0.087 Sum_probs=57.0
Q ss_pred cCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCCCCccceeccCccCchh
Q 011138 231 MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPEL 310 (492)
Q Consensus 231 ~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~ 310 (492)
.+.++.+.+++.++.|.+.+|.-+-..+.-..+=+-|..|+|..+| .|.+.+ +.+. .....+.|||.
T Consensus 42 ~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG-~V~f~~-~~s~-----------~~~~~~~~pe~ 108 (229)
T 2yle_A 42 YNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDG-AVTLAP-AADD-----------AGEPPPVAGKL 108 (229)
T ss_dssp HTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTS-CEEECC-C-----------------------CC
T ss_pred cCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCC-ceeccc-cccc-----------ccccCCCChhh
Confidence 4688999999999999999987662101212333456899999888 676553 1110 11234668887
Q ss_pred hcCCCCCCcchhhHHHHHHHHHHHh
Q 011138 311 IFGATEYTTAIDMWSIGCVLAELLL 335 (492)
Q Consensus 311 ~~~~~~~~~~~DvwSlGvil~ell~ 335 (492)
.. ...+.+.=|||||+++|..+-
T Consensus 109 ~~--~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 109 GY--SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp SS--SSSCHHHHHHHHHHHHHHHHT
T ss_pred cc--ccchHHHHHHHHHHHHHHHhh
Confidence 62 335788899999999999884
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.02 E-value=0.14 Score=51.56 Aligned_cols=70 Identities=14% Similarity=0.193 Sum_probs=44.7
Q ss_pred eeeeccCCceEEEEEEEcCC-------CCEEEEEEeccch---hhHHHHHHHHHHcCCCC-ccccceeeeeccCCCceEE
Q 011138 142 ERVVGTGSFGVVFQAKCLET-------GDSVAIKKVLQDK---RYKNRELQIMRLLNHPN-VVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~-------g~~vAiK~~~~~~---~~~~~E~~il~~l~h~n-Iv~l~~~~~~~~~~~~~~~ 210 (492)
.+.|..|-...+|++..... +..|.+|+..... ....+|..+++.|...+ ..++++.+ .+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~-----~~---- 145 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF-----PE---- 145 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE-----TT----
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc-----CC----
Confidence 34567788888999876421 5789999764322 22457999998886333 34555433 21
Q ss_pred EEEeeechhh
Q 011138 211 NLVLEYISET 220 (492)
Q Consensus 211 ~lV~E~~~~~ 220 (492)
++||||++|.
T Consensus 146 ~~I~efI~G~ 155 (424)
T 3mes_A 146 GRIEEFIDGE 155 (424)
T ss_dssp EEEEECCCSE
T ss_pred CEEEEEeCCc
Confidence 4789998763
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 492 | ||||
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-122 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-72 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-71 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-71 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-69 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-69 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-67 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-67 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-67 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-66 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-66 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-65 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-64 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-62 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-62 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-61 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-60 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-60 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-60 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-60 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-60 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-59 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-59 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-59 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-57 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-57 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-57 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-53 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-53 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-52 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-52 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-51 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-49 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-48 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-47 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-45 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-43 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-43 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-43 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-41 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-41 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-40 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-39 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-39 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-39 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-39 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-39 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-38 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-38 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-38 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-36 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-36 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-35 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-34 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-34 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-33 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-32 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-32 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-30 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-20 |
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 359 bits (923), Expect = e-122
Identities = 233/371 (62%), Positives = 285/371 (76%), Gaps = 28/371 (7%)
Query: 122 IATTVGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNREL 181
+ T G +P Q +SY +V+G GSFGVV+QAK ++G+ VAIKKVLQDKR+KNREL
Sbjct: 6 VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 64
Query: 182 QIMRLLNHPNVVSLKHCFFSTTE-KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYV 240
QIMR L+H N+V L++ F+S+ E KDE+YLNLVL+Y+ ETVYRV++HY+R Q +P++YV
Sbjct: 65 QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 241 QLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYI 300
+LY YQ+ R+L Y+H G+CHRDIKPQNLL++P T LK+CDFGSAK LV GEPN+SYI
Sbjct: 125 KLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183
Query: 301 CSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPT 360
CSRYYRAPELIFGAT+YT++ID+WS GCVLAELLLGQP+FPG+SGVDQLVEIIK+LGTPT
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420
RE+I+ MNPNYTEFKFPQIKAHPW K+F R PPEA+ L SRLL+Y+P+ R T LEACAH
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303
Query: 421 PFFDDLRDPNTCLPNGRPLPTLFNFTAQGKLILCFSYFGFSSYFLPHANCLAELAGASNE 480
FFD+LRDPN LPNGR P LFNFT Q EL+ ++
Sbjct: 304 SFFDELRDPNVKLPNGRDTPALFNFTTQ------------------------ELS-SNPP 338
Query: 481 LRQRLIPEHAR 491
L LIP HAR
Sbjct: 339 LATILIPPHAR 349
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (587), Expect = 4e-72
Identities = 101/304 (33%), Positives = 166/304 (54%), Gaps = 20/304 (6%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV--LQDKRYKN---RELQIMRLLNHPNVV 193
Y +G G++G+V A VAIKK+ + + Y RE++I+ H N++
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+ + T + + LV + +Y++ K QH+ ++ + YQI R L Y
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKY 124
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI----SYICSRYYRAPE 309
+H V HRD+KP NLL+N T LKICDFG A++ P + Y+ +R+YRAPE
Sbjct: 125 IHSA-NVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 310 LIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM-- 367
++ + YT +ID+WS+GC+LAE+L +P+FPG+ +DQL I+ ILG+P++E++ C+
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 368 -NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426
P PW+++F +ALDL+ ++L ++P R +A AHP+ +
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301
Query: 427 RDPN 430
DP+
Sbjct: 302 YDPS 305
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (579), Expect = 3e-71
Identities = 69/305 (22%), Positives = 122/305 (40%), Gaps = 31/305 (10%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
+ +G G+ GVVF+ +G +A K + + + RELQ++ N P +V
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
F E+ + +E++ + +P + + + + L Y
Sbjct: 68 GFYGAF---YSDGEISI--CMEHMDGGSLD---QVLKKAGRIPEQILGKVSIAVIKGLTY 119
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFG 313
L + HRD+KP N+LVN +K+CDFG + L+ N S++ +R Y +PE + G
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG 177
Query: 314 ATEYTTAIDMWSIGCVLAELLLGQPLFPGESG-VDQLVEIIKILGTPTREEIKCMNPNYT 372
T Y+ D+WS+G L E+ +G+ P +L+ ++ G + P
Sbjct: 178 -THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 373 EFKF--------------PQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC 418
+ I P K+ E D V++ L +P+ R +
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296
Query: 419 AHPFF 423
H F
Sbjct: 297 VHAFI 301
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (574), Expect = 9e-71
Identities = 97/297 (32%), Positives = 147/297 (49%), Gaps = 21/297 (7%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---------RELQIMRLLNHPNVV 193
+G G F V++A+ T VAIKK+ R + RE+++++ L+HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
L F K + L V +++ + + + +++ Y + L Y
Sbjct: 64 GLLDAF---GHKSNISL--VFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEY 115
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV-PGEPNISYICSRYYRAPELIF 312
LH + HRD+KP NLL++ + LK+ DFG AK P + +R+YRAPEL+F
Sbjct: 116 LHQHW-ILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 173
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372
GA Y +DMW++GC+LAELLL P PG+S +DQL I + LGTPT E+ M
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233
Query: 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429
F P H IF + LDL+ L ++P R TA +A +F + P
Sbjct: 234 YVTFKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 289
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 6e-69
Identities = 101/308 (32%), Positives = 167/308 (54%), Gaps = 23/308 (7%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
+ +G G++GVV++A+ TG+ VA+KK+ D + RE+ +++ LNHPN+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
V L E L LV E++ + + + +P+ ++ Y +Q+ + L
Sbjct: 64 VKLLDVI-----HTENKLYLVFEFLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLA 116
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYRAPELI 311
+ H V HRD+KPQNLL+N +K+ DFG A+ VP + + +YRAPE++
Sbjct: 117 FCHSHR-VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN--P 369
G Y+TA+D+WS+GC+ AE++ + LFPG+S +DQL I + LGTP + P
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429
+Y + FP+ + K+ + + L+S++L Y P+ R +A A AHPFF D+ P
Sbjct: 235 DY-KPSFPKWARQDFSKVV-PPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292
Query: 430 NTCLPNGR 437
+P+ R
Sbjct: 293 ---VPHLR 297
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 221 bits (563), Expect = 9e-69
Identities = 90/300 (30%), Positives = 153/300 (51%), Gaps = 21/300 (7%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-NRELQIMRLLN-HPNVVSLK 196
Y R +G G + VF+A + + V +K + K+ K RE++I+ L PN+++L
Sbjct: 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLA 96
Query: 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH 256
+ LV E+++ T ++ ++ Q + ++ Y Y+I +AL+Y H
Sbjct: 97 DIV---KDPVSRTPALVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCHS 147
Query: 257 VVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATE 316
+ G+ HRD+KP N++++ +L++ D+G A+ PG+ + SRY++ PEL+
Sbjct: 148 M-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 206
Query: 317 YTTAIDMWSIGCVLAELLLGQ-PLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFK 375
Y ++DMWS+GC+LA ++ + P F G DQLV I K+LGT + + +
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266
Query: 376 FPQI----KAHPWHKIFHKR----MPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427
F I W + H + PEALD + +LL+Y R TA EA HP+F +
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 1e-67
Identities = 94/317 (29%), Positives = 154/317 (48%), Gaps = 23/317 (7%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV------LQDKRYKNRELQIMRLLNHPNV 192
Y VG+G++G V A +TG VA+KK+ + + REL++++ + H NV
Sbjct: 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
+ L F +E ++ ++ ++ +VQ YQI R L
Sbjct: 80 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD----HVQFLIYQILRGLK 135
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIF 312
Y+H + HRD+KP NL VN KI DFG A+ + Y+ +R+YRAPE++
Sbjct: 136 YIHSA-DIIHRDLKPSNLAVNEDCEL-KILDFGLARH--TDDEMTGYVATRWYRAPEIML 191
Query: 313 GATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372
Y +D+WS+GC++AELL G+ LFPG +DQL I++++GTP E +K ++
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251
Query: 373 EF---KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429
Q+ + +F P A+DL+ ++L R TA +A AH +F DP
Sbjct: 252 RNYIQSLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310
Query: 430 NTCLPNGRPLPTLFNFT 446
+ P+ ++ +
Sbjct: 311 DD-----EPVADPYDQS 322
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 2e-67
Identities = 81/309 (26%), Positives = 142/309 (45%), Gaps = 22/309 (7%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
Y +G G+FG VF+A+ +TG VA+KKVL + + RE++I++LL H NV
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 193 VSLKHCFFSTTE---KDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
V+L + + + + LV ++ + + + + ++ +
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG---LLSNVLVKFTLSEIKRVMQMLLN 128
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI-----SYICSRY 304
L Y+H + HRD+K N+L+ LK+ DFG A+ + + + + + +
Sbjct: 129 GLYYIHRN-KILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 305 YRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364
YR PEL+ G +Y ID+W GC++AE+ P+ G + QL I ++ G+ T E
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 365 KCMNPNYTEFKFPQIKAHP---WHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHP 421
++ K +K ++ P ALDL+ +LL P+ R + +A H
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306
Query: 422 FFDDLRDPN 430
FF P+
Sbjct: 307 FFWSDPMPS 315
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 3e-67
Identities = 97/299 (32%), Positives = 153/299 (51%), Gaps = 18/299 (6%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
Y +G G++G VF+AK ET + VA+K+V D + RE+ +++ L H N+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
V L + L LV E+ + + + ++ N + V+ + +Q+ + L
Sbjct: 64 VRLHDVL-----HSDKKLTLVFEFCDQDLKK---YFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYRAPELI 311
+ H V HRD+KPQNLL+N + K+ +FG A+ +P + + + +YR P+++
Sbjct: 116 FCHSR-NVLHRDLKPQNLLINRNGEL-KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 312 FGATEYTTAIDMWSIGCVLAELLLG-QPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370
FGA Y+T+IDMWS GC+ AEL +PLFPG DQL I ++LGTPT E+ M
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429
+P A ++ DL+ LL+ +P R +A EA HP+F D P
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 1e-66
Identities = 98/302 (32%), Positives = 158/302 (52%), Gaps = 20/302 (6%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
Y + VG+G++G V A TG VAIKK+ + + + REL++++ + H NV
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 193 VSLKHCFFS-TTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+ L F T D LV+ ++ + ++ KH + + +Q YQ+ + L
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGL 134
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
Y+H G+ HRD+KP NL VN KI DFG A+ Y+ +R+YRAPE+I
Sbjct: 135 RYIHAA-GIIHRDLKPGNLAVNEDCEL-KILDFGLARQ--ADSEMTGYVVTRWYRAPEVI 190
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
YT +D+WS+GC++AE++ G+ LF G +DQL EI+K+ GTP E ++ + +
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250
Query: 372 TEF---KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428
+ P+++ + I P A++L+ ++L R TA EA AHP+F+ L D
Sbjct: 251 AKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309
Query: 429 PN 430
Sbjct: 310 TE 311
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 215 bits (548), Expect = 3e-66
Identities = 72/309 (23%), Positives = 125/309 (40%), Gaps = 41/309 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL----QDKRYKNRELQIMRLLNHPNVVS 194
Y +GTG+FGVV + TG++ A K V+ DK +E+Q M +L HP +V+
Sbjct: 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
L F +D+ + ++ E++S + + + Y Q+C+ L ++
Sbjct: 88 LHDAF-----EDDNEMVMIYEFMSGGELF--EKVADEHNKMSEDEAVEYMRQVCKGLCHM 140
Query: 255 HHVVGVCHRDIKPQNLLVNPH-THQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFG 313
H H D+KP+N++ +++LK+ DFG L P + + + APE+ G
Sbjct: 141 HEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG 199
Query: 314 ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373
DMWS+G + LL G F GE+ + L +
Sbjct: 200 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA---------- 248
Query: 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP--NT 431
+ + D + +LL P+ R T +A HP+ P ++
Sbjct: 249 ---------------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293
Query: 432 CLPNGRPLP 440
+P+ R
Sbjct: 294 QIPSSRYTK 302
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 2e-65
Identities = 95/299 (31%), Positives = 152/299 (50%), Gaps = 17/299 (5%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDS-VAIKKVLQDKRYKN------RELQIMRLL---N 188
Y +G G++G VF+A+ L+ G VA+K+V + RE+ ++R L
Sbjct: 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
HPNVV L + E L LV E++ + + VP ++ +Q+
Sbjct: 69 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTY--LDKVPEPGVPTETIKDMMFQLL 126
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAP 308
R L++LH V HRD+KPQN+LV + Q+K+ DFG A++ S + + +YRAP
Sbjct: 127 RGLDFLHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368
E++ + Y T +D+WS+GC+ AE+ +PLF G S VDQL +I+ ++G P E+ +
Sbjct: 185 EVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP-RD 242
Query: 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427
F A P K + DL+ + L ++P+ R +A A +HP+F DL
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTD-IDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 208 bits (529), Expect = 2e-64
Identities = 93/295 (31%), Positives = 155/295 (52%), Gaps = 20/295 (6%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
Y +G G++GVV++A+ G++ A+KK+ +K + RE+ I++ L H N+
Sbjct: 4 YHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
V L + L LV E++ + + + + + + + Q+ +
Sbjct: 63 VKLYDVIH-----TKKRLVLVFEHLDQDLKK---LLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML-VPGEPNISYICSRYYRAPELI 311
Y H V HRD+KPQNLL+N +LKI DFG A+ +P I + +YRAP+++
Sbjct: 115 YCHDR-RVLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN- 370
G+ +Y+T ID+WS+GC+ AE++ G PLFPG S DQL+ I +ILGTP + +
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425
+ F + PW K + +DL+S++L+ P+ R TA +A H +F +
Sbjct: 233 KYDPNFTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 4e-62
Identities = 74/294 (25%), Positives = 117/294 (39%), Gaps = 44/294 (14%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
+ + +G G++G V A T ++VA+K V + +E+ I ++LNH NVV
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
L LEY S + +P Q + +Q+ + Y
Sbjct: 67 KFYGHRREGN-----IQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI---SYICSRYYRAPEL 310
LH + G+ HRDIKP+NLL++ + LKI DFG A + + Y APEL
Sbjct: 119 LHGI-GITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370
+ + +D+WS G VL +L G+ + S Q K T
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL---------- 226
Query: 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424
+PW KI L L+ ++L +PS R T + +++
Sbjct: 227 -----------NPWKKI-----DSAPLALLHKILVENPSARITIPDIKKDRWYN 264
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 4e-62
Identities = 76/304 (25%), Positives = 125/304 (41%), Gaps = 32/304 (10%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIM-RLLNHPNVVSLKHCFF 200
+V+G G G V Q T + A+K +LQD RE+++ R P++V + +
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDVYE 75
Query: 201 STTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
+ + L +V+E + ++ + R +Q I A+ YLH +
Sbjct: 76 NLYAGRK-CLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHS-IN 131
Query: 260 VCHRDIKPQNLLVNPHTHQ--LKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEY 317
+ HRD+KP+NLL LK+ DFG AK + + YY APE++ +Y
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP-EKY 190
Query: 318 TTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFP 377
+ DMWS+G ++ LL G P F G+ + + +++FP
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG-------------QYEFP 237
Query: 378 QIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF-DDLRDPNTCLPNG 436
+ + E L+ LL+ P+ R T E HP+ + P T L
Sbjct: 238 NPE--------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 289
Query: 437 RPLP 440
R L
Sbjct: 290 RVLK 293
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 202 bits (515), Expect = 2e-61
Identities = 77/305 (25%), Positives = 122/305 (40%), Gaps = 40/305 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKNRELQIMRLLNHPNVVS 194
Y +G+G+FGVV + TG K + DK E+ IM L+HP +++
Sbjct: 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
L F +D+ + L+LE++S + + + V Y Q C L ++
Sbjct: 91 LHDAF-----EDKYEMVLILEFLSGG--ELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 143
Query: 255 HHVVGVCHRDIKPQNLLV-NPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFG 313
H + H DIKP+N++ +KI DFG A L P E + + APE++
Sbjct: 144 HEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR 202
Query: 314 ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373
DMW+IG + LL G F GE ++ L + + +
Sbjct: 203 -EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF--------- 252
Query: 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF-DDLRDPNTC 432
+ PEA D + LLQ P R T +A HP+ D + +
Sbjct: 253 ----------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 296
Query: 433 LPNGR 437
+P+ R
Sbjct: 297 IPSSR 301
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 1e-60
Identities = 66/294 (22%), Positives = 115/294 (39%), Gaps = 44/294 (14%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKNRELQIMRLLNHPNVVS 194
+ +G G+FG V++A+ ET A K + ++ E+ I+ +HPN+V
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
L F E L +++E+ + + + + +Q+ Q ALNYL
Sbjct: 74 LLDAF-----YYENNLWILIEFCAGGAVD--AVMLELERPLTESQIQVVCKQTLDALNYL 126
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV-PGEPNISYICSRYYRAPELIFG 313
H + HRD+K N+L +K+ DFG + + S+I + Y+ APE++
Sbjct: 127 HDN-KIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 184
Query: 314 AT----EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369
T Y D+WS+G L E+ +P + + L++I
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI----------------- 227
Query: 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
K+ P R D + + L+ + R T + HPF
Sbjct: 228 ---------AKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 198 bits (505), Expect = 2e-60
Identities = 70/305 (22%), Positives = 123/305 (40%), Gaps = 49/305 (16%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPN 191
+ R +G GSFG V+ A+ + + VAIKK+ + N +E++ ++ L HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+ + C+ E LV+EY + + + + + + + + T+ + L
Sbjct: 77 TIQYRGCYL-----REHTAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGL 128
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
YLH + HRD+K N+L++ +K+ DFGSA ++ P S++ + Y+ APE+I
Sbjct: 129 AYLHSH-NMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVI 183
Query: 312 FGATE--YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369
E Y +D+WS+G EL +P + + L I +
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--------------- 228
Query: 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429
+ + + V LQ P R T+ H F R P
Sbjct: 229 ------------NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276
Query: 430 NTCLP 434
+
Sbjct: 277 TVIMD 281
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 2e-60
Identities = 58/289 (20%), Positives = 116/289 (40%), Gaps = 40/289 (13%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSL 195
+ +G GSF V++ ET VA ++ K K+ E ++++ L HPN+V
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+ + +T K + + LV E ++ + Y + + + I ++ + QI + L +LH
Sbjct: 74 -YDSWESTVKGKKCIVLVTELMTSGTLK---TYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 256 -HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA 314
+ HRD+K N+ + T +KI D G A L + I + + APE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYEE- 187
Query: 315 TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEF 374
+Y ++D+++ G + E+ + + Q+
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR---------------------- 224
Query: 375 KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+ + F K PE +++ ++ + R + + H FF
Sbjct: 225 ----VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 3e-60
Identities = 92/328 (28%), Positives = 160/328 (48%), Gaps = 32/328 (9%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNV 192
Y + +G+G+ G+V A +VAIKK+ + + + REL +M+ +NH N+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 193 VSLKHCFFS-TTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+SL + F T ++ + LV+E + + +V + + + YQ+ +
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV------IQMELDHERMSYLLYQMLCGI 132
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
+LH + HRD+KP N++V KI DFG A+ Y+ +RYYRAPE+I
Sbjct: 133 KHLHSAG-IIHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
G Y +D+WS+GC++ E++ + LFPG +DQ ++I+ LGTP E +K + P
Sbjct: 191 LG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249
Query: 372 TEF--KFPQIKAHPWHKIF-----------HKRMPPEALDLVSRLLQYSPSLRCTALEAC 418
+ P+ + K+F +K +A DL+S++L P+ R + +A
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309
Query: 419 AHPFFDDLRDPNTCLPNGRPLPTLFNFT 446
HP+ + DP P P +++
Sbjct: 310 QHPYINVWYDPAEVEA---PPPQIYDKQ 334
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 199 bits (507), Expect = 4e-60
Identities = 90/349 (25%), Positives = 154/349 (44%), Gaps = 49/349 (14%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSL 195
Y+ R +G G F V+ AK + VA+K V DK Y E+++++ +N +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 196 KH----------CFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTY 245
F+ + +++ +V E + E + + K Y ++ +P++YV+ +
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISK 132
Query: 246 QICRALNYLHHVVGVCHRDIKPQNLLVNPHTH-----QLKICDFGSAKMLVPGEPNISYI 300
Q+ L+Y+H G+ H DIKP+N+L+ Q+KI D G+A E + I
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSI 190
Query: 301 CSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESG------VDQLVEIIK 354
+R YR+PE++ GA + D+WS C++ EL+ G LF + G D + +II+
Sbjct: 191 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249
Query: 355 ILGTPTREEIKCMNPNYTEF-------KFPQIKAHPWHKI------FHKRMPPEALDLVS 401
+LG ++ T F ++K P + F K E D +S
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309
Query: 402 RLLQYSPSLRCTALEACAHPFFDD------LRDPNT-CLPNGRPLPTLF 443
+LQ P R A HP+ D +R P+ +G +P F
Sbjct: 310 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 358
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (498), Expect = 7e-60
Identities = 82/293 (27%), Positives = 130/293 (44%), Gaps = 50/293 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPN 191
+ R +G G FG V+ A+ ++ +A+K + + + K RE++I L HPN
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
++ L F D + L+LEY TVYR + ++ ++ Y ++ A
Sbjct: 68 ILRLYGYF-----HDATRVYLILEYAPLGTVYRELQKLSKFDEQR----TATYITELANA 118
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPEL 310
L+Y H V HRDIKP+NLL+ LKI DFG + P + + Y PE+
Sbjct: 119 LSYCHSK-RVIHRDIKPENLLLGSAGE-LKIADFGWSVH-APSSRRTTLCGTLDYLPPEM 175
Query: 311 IFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370
I G + +D+WS+G + E L+G+P F + + I ++
Sbjct: 176 IEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------------- 219
Query: 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
EF FP + A DL+SRLL+++PS R E HP+
Sbjct: 220 --EFTFP------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 2e-59
Identities = 68/296 (22%), Positives = 118/296 (39%), Gaps = 45/296 (15%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVL------QDKRYKNRELQIMRLLNHPNV 192
Y +GTGS+G + + G + K++ +K+ E+ ++R L HPN+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
V T L +V+EY + V T+ Q++ +V Q+ AL
Sbjct: 66 VRYYDRIIDRTNT---TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 252 NYLH----HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI-SYICSRYYR 306
H V HRD+KP N+ ++ + +K+ DFG A++L +++ + YY
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDTSFAKAFVGTPYYM 181
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366
+PE + Y D+WS+GC+L EL P F S + +I +
Sbjct: 182 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG----------- 229
Query: 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
KF +I E ++++R+L R + E +P
Sbjct: 230 --------KFRRIPYR---------YSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 2e-59
Identities = 72/301 (23%), Positives = 125/301 (41%), Gaps = 43/301 (14%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV----LQDKRYKNRELQIMRLLNHPNVVS 194
Y +G G+ G V+ A + TG VAI+++ K E+ +MR +PN+V+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
+ DEL++ V+EY + S + + + +AL +L
Sbjct: 82 YLDSY---LVGDELWV--VMEY----LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFL 132
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPELIFG 313
H V HRDIK N+L+ +K+ DFG + P + S + + Y+ APE++
Sbjct: 133 HSN-QVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190
Query: 314 ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTE 373
Y +D+WS+G + E++ G+P + E+ + L I GTP E
Sbjct: 191 -KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTP-------------E 235
Query: 374 FKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCL 433
+ P +++ D ++R L R +A E H F + ++
Sbjct: 236 LQNP------------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLT 283
Query: 434 P 434
P
Sbjct: 284 P 284
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 5e-59
Identities = 74/289 (25%), Positives = 119/289 (41%), Gaps = 38/289 (13%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV---LQDKRYKNRELQIMRLLNHPNVVSL 195
YM +G G FG+V + + + K V D+ +E+ I+ + H N++ L
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
F + L ++ E+IS + + + + Y +Q+C AL +LH
Sbjct: 67 HESF-----ESMEELVMIFEFISGL--DIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 256 HVVGVCHRDIKPQNLLV-NPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA 314
+ H DI+P+N++ + +KI +FG A+ L PG+ + Y APE+
Sbjct: 120 SH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH- 177
Query: 315 TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEF 374
+TA DMWS+G ++ LL G F E+ + I+ T E
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF---------- 227
Query: 375 KFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
K + EA+D V RLL R TA EA HP+
Sbjct: 228 ---------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 2e-57
Identities = 87/313 (27%), Positives = 136/313 (43%), Gaps = 58/313 (18%)
Query: 132 QPKQTI--SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYK-------NRELQ 182
QP++ + +++G GSF V A+ L T AIK + + K RE
Sbjct: 1 QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 60
Query: 183 IMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQL 242
+M L+HP V L F + ++LY L Y Y R +
Sbjct: 61 VMSRLDHPFFVKLYFTF---QDDEKLYF--GLSYAKNGELL---KYIRKIGSFDETCTRF 112
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI---SY 299
YT +I AL YLH + HRD+KP+N+L+N H ++I DFG+AK+L P S+
Sbjct: 113 YTAEIVSALEYLHGKG-IIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSF 170
Query: 300 ICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTP 359
+ + Y +PEL+ + D+W++GC++ +L+ G P F + +IIK+
Sbjct: 171 VGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL---- 225
Query: 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC- 418
E+ FP+ + P+A DLV +LL + R E
Sbjct: 226 -------------EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEG 260
Query: 419 -----AHPFFDDL 426
AHPFF+ +
Sbjct: 261 YGPLKAHPFFESV 273
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 189 bits (482), Expect = 4e-57
Identities = 72/292 (24%), Positives = 115/292 (39%), Gaps = 42/292 (14%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
Y V+GTG+F V A+ T VAIK + + E+ ++ + HPN+V
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+L + LYL +++ +S +Q+ A+ Y
Sbjct: 71 ALDDIY---ESGGHLYL--IMQLVSGGELF---DRIVEKGFYTERDASRLIFQVLDAVKY 122
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTH--QLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
LH + + HRD+KP+NLL ++ I DFG +KM PG + + Y APE++
Sbjct: 123 LHDLG-IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL 181
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
Y+ A+D WSIG + LL G P F E+ +I+K
Sbjct: 182 AQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP--------- 231
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423
+ + A D + L++ P R T +A HP+
Sbjct: 232 ----------------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 267
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 188 bits (479), Expect = 4e-57
Identities = 76/304 (25%), Positives = 122/304 (40%), Gaps = 54/304 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-------------LQDKRYKNRELQIMR 185
Y + ++G G VV + T A+K + + + +E+ I+R
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 186 LLN-HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYT 244
++ HPN++ LK + + + LV + + + Y + +
Sbjct: 65 KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELF---DYLTEKVTLSEKETRKIM 116
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY 304
+ + LH + + HRD+KP+N+L++ + +K+ DFG + L PGE +
Sbjct: 117 RALLEVICALHKL-NIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPS 174
Query: 305 YRAPELIFGATE-----YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTP 359
Y APE+I + Y +DMWS G ++ LL G P F + L I
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI------- 227
Query: 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419
M+ NY +F P+ DLVSR L P R TA EA A
Sbjct: 228 -------MSGNY-QFGSPE----------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
Query: 420 HPFF 423
HPFF
Sbjct: 270 HPFF 273
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 4e-53
Identities = 66/303 (21%), Positives = 116/303 (38%), Gaps = 56/303 (18%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN----------RELQIMRLLN 188
Y ++G+G FG V+ + VAIK V +D+ E+ +++ ++
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 189 --HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
V+ L F L+LE + + + + + +Q
Sbjct: 66 SGFSGVIRLLDWFE-----RPDSFVLILERPEP--VQDLFDFITERGALQEELARSFFWQ 118
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYR 306
+ A+ + H+ GV HRDIK +N+L++ + +LK+ DFGS L+ + +R Y
Sbjct: 119 VLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYS 176
Query: 307 APELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366
PE I + + +WS+G +L +++ G F + EII+
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR------------ 218
Query: 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426
F +R+ E L+ L PS R T E HP+ D+
Sbjct: 219 -----------------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261
Query: 427 RDP 429
P
Sbjct: 262 LLP 264
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 4e-53
Identities = 67/322 (20%), Positives = 125/322 (38%), Gaps = 51/322 (15%)
Query: 134 KQTIS--YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN----------REL 181
++ + Y +G+G F VV + + TG A K + + + + RE+
Sbjct: 5 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 64
Query: 182 QIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQ 241
I++ + HPNV++L + +++ + L+LE ++ + + +
Sbjct: 65 SILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELF---DFLAEKESLTEEEAT 116
Query: 242 LYTYQICRALNYLHHVVGVCHRDIKPQNLLV---NPHTHQLKICDFGSAKMLVPGEPNIS 298
+ QI + Y H + + H D+KP+N+++ N ++KI DFG A + G +
Sbjct: 117 EFLKQILNGVYY-LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 175
Query: 299 YICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGT 358
+ + APE++ DMWSIG + LL G F G++ + L + +
Sbjct: 176 IFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 234
Query: 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC 418
E + A D + RLL P R T ++
Sbjct: 235 FEDE-------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 269
Query: 419 AHPFFDDLRDPNTCLPNGRPLP 440
HP+ +D L + P
Sbjct: 270 QHPWIKP-KDTQQALSSAWSHP 290
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 4e-52
Identities = 71/298 (23%), Positives = 125/298 (41%), Gaps = 50/298 (16%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQ--------IMRLLNHP 190
++ +++G GSFG VF A+ +T AIK + +D + +++ + HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
+ + F + + L V+EY++ ++ + + Y +I
Sbjct: 64 FLTHMFCTF-----QTKENLFFVMEYLNGGDLM---YHIQSCHKFDLSRATFYAAEIILG 115
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC-SRYYRAPE 309
L +LH G+ +RD+K N+L++ H KI DFG K + G+ + C + Y APE
Sbjct: 116 LQFLHSK-GIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPE 173
Query: 310 LIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369
++ G +Y ++D WS G +L E+L+GQ F G+ + I+ NP
Sbjct: 174 ILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------------HSIRMDNP 220
Query: 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC-AHPFFDDL 426
Y + + EA DL+ +L P R HP F ++
Sbjct: 221 FYPRW-----------------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 178 bits (452), Expect = 5e-52
Identities = 68/303 (22%), Positives = 122/303 (40%), Gaps = 52/303 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----------RYKNRELQIMRLLN 188
+ R++G G FG V+ + +TG A+K + + + + L ++ +
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
P +V + + F D+L +L+ ++ ++ + ++ Y +I
Sbjct: 66 CPFIVCMSYAF---HTPDKLSF--ILDLMNGGDLH---YHLSQHGVFSEADMRFYAAEII 117
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAP 308
L ++H+ V +RD+KP N+L++ H H ++I D G A +P+ S + Y AP
Sbjct: 118 LGLEHMHNR-FVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHASV-GTHGYMAP 174
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368
E++ Y ++ D +S+GC+L +LL G F D+ EI ++ T E
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVE------ 227
Query: 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-----ALEACAHPFF 423
PE L+ LLQ + R A E PFF
Sbjct: 228 -------------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268
Query: 424 DDL 426
L
Sbjct: 269 RSL 271
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 176 bits (446), Expect = 1e-51
Identities = 72/300 (24%), Positives = 127/300 (42%), Gaps = 54/300 (18%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKV-------LQDKRYKNRELQIMRLLNHPN 191
+ R +GTGSFG V + G A+K + L+ + N E ++ ++ HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
++ + F +D + ++++YI R +Q P + Y ++C AL
Sbjct: 66 IIRMWGTF-----QDAQQIFMIMDYIEGGELF---SLLRKSQRFPNPVAKFYAAEVCLAL 117
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELI 311
YLH + +RD+KP+N+L++ + H +KI DFG AK + + + + Y APE++
Sbjct: 118 EYLHS-KDIIYRDLKPENILLDKNGH-IKITDFGFAKYV--PDVTYTLCGTPDYIAPEVV 173
Query: 312 FGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNY 371
Y +ID WS G ++ E+L G F + + +I+
Sbjct: 174 ST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----------------- 215
Query: 372 TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDL 426
E +FP + DL+SRL+ S R + HP+F ++
Sbjct: 216 AELRFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 167 bits (423), Expect = 8e-49
Identities = 64/295 (21%), Positives = 110/295 (37%), Gaps = 43/295 (14%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPN 191
Y ++G G V A+ L VA+K + D RE Q LNHP
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRAL 251
+V++ + +V+EY+ R + C+AL
Sbjct: 69 IVAV-YDTGEAETPAGPLPYIVMEYVDGVTLR---DIVHTEGPMTPKRAIEVIADACQAL 124
Query: 252 NYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI----SYICSRYYRA 307
N+ H G+ HRD+KP N++++ + +K+ DFG A+ + ++ + I + Y +
Sbjct: 125 NFSHQN-GIIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 308 PELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367
PE G D++S+GCVL E+L G+P F G+S V + ++ P
Sbjct: 183 PEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA----- 236
Query: 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
H+ + + +V + L +P R
Sbjct: 237 --------------------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 7e-48
Identities = 54/290 (18%), Positives = 106/290 (36%), Gaps = 47/290 (16%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVVSL 195
+ +G+GSFG V++ K VA+K + E+ ++R H N++
Sbjct: 13 GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
L +V ++ + + H + ++ + Q + ++YLH
Sbjct: 70 MGYS------TAPQLAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISY---ICSRYYRAPELIF 312
+ HRD+K N+ ++ +KI DFG A + + + S + APE+I
Sbjct: 122 AK-SIIHRDLKSNNIFLHEDLT-VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 313 G--ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370
Y+ D+++ G VL EL+ GQ + + DQ++ ++
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG---------------- 223
Query: 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420
+ P + P L++ L+ R + A
Sbjct: 224 -RGYLSPDLSKVR------SNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 1e-47
Identities = 66/296 (22%), Positives = 114/296 (38%), Gaps = 51/296 (17%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSL 195
+++G G+FG V + TG A+K + ++ E ++++ HP + +L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
K+ F D L + E + +S+ + + Y +I AL Y
Sbjct: 71 KYAF---QTHDRLCFVMEYANGGELFFHLSRERVFTEERA-----RFYGAEIVSALEY-L 121
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGAT 315
H V +RDIK +NL+++ H +KI DFG K + + C +
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 316 EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFK 375
+Y A+D W +G V+ E++ G+ F + I+ E +
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-----------------EEIR 223
Query: 376 FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR-----CTALEACAHPFFDDL 426
FP + + PEA L++ LL+ P R A E H FF +
Sbjct: 224 FP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (399), Expect = 4e-45
Identities = 54/313 (17%), Positives = 102/313 (32%), Gaps = 54/313 (17%)
Query: 126 VGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQI 183
VG R Y R +G+GSFG ++ + G+ VAIK ++ E +I
Sbjct: 5 VGNR---------YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI 55
Query: 184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY 243
+++ + + + Y +V+E + ++ + ++ + V L
Sbjct: 56 YKMMQGGVGIPTIRWCGA----EGDYNVMVMELLGPSLED---LFNFCSRKFSLKTVLLL 108
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC--DFGSAKMLVPGEPNI---- 297
Q+ + Y+H HRD+KP N L+ + DFG AK +
Sbjct: 109 ADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 167
Query: 298 ----SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEII 353
+ + Y + G E + D+ S+G VL LG + G + +
Sbjct: 168 RENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 226
Query: 354 KILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT 413
+I I+ + Y P E ++ +
Sbjct: 227 RISEKKMSTPIEVLCKGY---------------------PSEFATYLNFCRSLRFDDKPD 265
Query: 414 A---LEACAHPFF 423
+ + F
Sbjct: 266 YSYLRQLFRNLFH 278
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-44
Identities = 56/281 (19%), Positives = 105/281 (37%), Gaps = 43/281 (15%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQIMRLLNHPNVVSLKHCFF 200
+ +G G FG V G+ VA+K + D + E +M L H N+V L
Sbjct: 13 QTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 70
Query: 201 STTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGV 260
+++ L +V EY+++ +R + + ++ +C A+ YL
Sbjct: 71 ----EEKGGLYIVTEYMAKGSLV-DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-NF 124
Query: 261 CHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTA 320
HRD+ +N+LV+ K+ DFG K + + + APE + +++T
Sbjct: 125 VHRDLAARNVLVSEDNV-AKVSDFGLTKEASSTQD--TGKLPVKWTAPEALRE-KKFSTK 180
Query: 321 IDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQI 379
D+WS G +L E+ G+ +P D + + K + P
Sbjct: 181 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY----------------KMDAPD- 223
Query: 380 KAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420
PP +++ ++R + L+
Sbjct: 224 -----------GCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 153 bits (388), Expect = 1e-43
Identities = 50/280 (17%), Positives = 96/280 (34%), Gaps = 33/280 (11%)
Query: 126 VGGRNGQPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN--RELQI 183
VG Y R +G GSFGV+F+ L VAIK + E +
Sbjct: 3 VGVH---------YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT 53
Query: 184 MRLLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLY 243
+LL + + F + L+ LV++ + ++ + + V +
Sbjct: 54 YKLLAGCTGIPNVYYFGQ----EGLHNVLVIDLLGPSLE---DLLDLCGRKFSVKTVAMA 106
Query: 244 TYQICRALNYLHHVVGVCHRDIKPQNLLVN----PHTHQLKICDFGSAKMLVPGEPNI-- 297
Q+ + +H + +RDIKP N L+ + + + + DFG K
Sbjct: 107 AKQMLARVQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 165
Query: 298 ------SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVE 351
+ + Y + G E + D+ ++G V L G + G +
Sbjct: 166 PYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 224
Query: 352 IIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKR 391
+I ++ + + E +F + + + F
Sbjct: 225 YERIGEKKQSTPLRELCAGFPE-EFYKYMHYARNLAFDAT 263
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 1e-43
Identities = 77/308 (25%), Positives = 131/308 (42%), Gaps = 55/308 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKV--------LQDKRYKNRELQIMRLL 187
+ +V+GTG++G VF + + +TG A+K + + + E Q++ +
Sbjct: 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85
Query: 188 NH-PNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQ 246
P +V+L + F + E L+L+L+YI+ + + VQ+Y +
Sbjct: 86 RQSPFLVTLHYAF-----QTETKLHLILDYINGGELF---THLSQRERFTEHEVQIYVGE 137
Query: 247 ICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC---SR 303
I AL +LH + G+ +RDIK +N+L++ + H + + DFG +K V E +Y
Sbjct: 138 IVLALEHLHKL-GIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIE 195
Query: 304 YYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREE 363
Y + G + + A+D WS+G ++ ELL G F + + EI + +
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS---- 251
Query: 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR-----CTALEAC 418
E +PQ M A DL+ RLL P R A E
Sbjct: 252 ---------EPPYPQ------------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK 290
Query: 419 AHPFFDDL 426
H FF +
Sbjct: 291 EHLFFQKI 298
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 153 bits (387), Expect = 6e-43
Identities = 63/295 (21%), Positives = 112/295 (37%), Gaps = 54/295 (18%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN-------RELQIMRLLNHPNVVSL 195
+ +GTGSFG V K E+G+ A+K + + K K E +I++ +N P +V L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
+ F + + + + + R + + Y QI YLH
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRR--------IGRFSEPHARFYAAQIVLTFEYLH 158
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGAT 315
+ + +RD+KP+NLL++ + +++ DFG AK + + APE+I
Sbjct: 159 S-LDLIYRDLKPENLLIDQQGY-IQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILS-K 213
Query: 316 EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFK 375
Y A+D W++G ++ E+ G P F + + +I
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----------------------- 250
Query: 376 FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSP-----SLRCTALEACAHPFFDD 425
F + DL+ LLQ +L+ + H +F
Sbjct: 251 ------VSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-41
Identities = 59/293 (20%), Positives = 103/293 (35%), Gaps = 47/293 (16%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSL 195
+G G FG V+ VA+K + Q + E +M+ L H +V L
Sbjct: 15 LKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 196 KHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLH 255
++ +Y+ + EY+ E V T + I + QI + ++
Sbjct: 74 YAVV----TQEPIYI--ITEYM-ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 256 HVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC--SRYYRAPELIFG 313
HRD++ N+LV+ KI DFG A+++ E + APE I
Sbjct: 127 ER-NYIHRDLRAANILVSDTLSC-KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 314 ATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372
+T D+WS G +L E++ G+ +PG + + + + +
Sbjct: 185 G-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------------------ 225
Query: 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA--HPFF 423
+ + P E L+ + P R T + FF
Sbjct: 226 ----------GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 6e-41
Identities = 62/290 (21%), Positives = 105/290 (36%), Gaps = 47/290 (16%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHC 198
E +G G FG V+ VAIK + +E Q+M+ L H +V L
Sbjct: 22 EVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
++ +Y+ V EY+S+ +++ + + QI + Y+ +
Sbjct: 81 V----SEEPIYI--VTEYMSKGSLL-DFLKGETGKYLRLPQLVDMAAQIASGMAYVERM- 132
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI--SYICSRYYRAPELIFGATE 316
HRD++ N+LV + K+ DFG A+++ E + APE
Sbjct: 133 NYVHRDLRAANILVGENLV-CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GR 190
Query: 317 YTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFK 375
+T D+WS G +L EL G+ +PG + L ++ + P E
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC----------- 239
Query: 376 FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA--HPFF 423
P DL+ + + P R T A +F
Sbjct: 240 -----------------PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 6e-40
Identities = 50/283 (17%), Positives = 98/283 (34%), Gaps = 43/283 (15%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHCF 199
+ +G+G FG+V D VAIK + + + E ++M L+HP +V L
Sbjct: 11 QEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
E+ + LV E++ +S + + +C + YL
Sbjct: 70 ---LEQAPIC--LVFEFMEHG--CLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE-AC 121
Query: 260 VCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC--SRYYRAPELIFGATEY 317
V HRD+ +N LV + +K+ DFG + ++ + S + +PE+ + Y
Sbjct: 122 VIHRDLAARNCLVGENQV-IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRY 179
Query: 318 TTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFP 377
++ D+WS G ++ E+ + ++VE I
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS----------------------- 216
Query: 378 QIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420
+ + +++ + P R
Sbjct: 217 ----TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 2e-39
Identities = 52/284 (18%), Positives = 107/284 (37%), Gaps = 45/284 (15%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHCF 199
+ +GTG FGVV K VAIK + + ++ E ++M L+H +V L
Sbjct: 10 KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 200 FSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG 259
T++ ++ ++ EY++ + + M + +C A+ YL
Sbjct: 69 ---TKQRPIF--IITEYMANG--CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES-KQ 120
Query: 260 VCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS--YICSRYYRAPELIFGATEY 317
HRD+ +N LVN +K+ DFG ++ ++ E S + PE++ +++
Sbjct: 121 FLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKF 178
Query: 318 TTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKF 376
++ D+W+ G ++ E+ LG+ + + + I + L
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL----------------RLYR 222
Query: 377 PQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420
P + + ++ R T ++
Sbjct: 223 PHL------------ASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 142 bits (359), Expect = 2e-39
Identities = 62/309 (20%), Positives = 113/309 (36%), Gaps = 54/309 (17%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDS---VAIKKVL-----QDKRYKNRELQIMRLLNH 189
E+V+G G FG V G VAIK + + +R E IM +H
Sbjct: 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86
Query: 190 PNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICR 249
PNV+ L+ T+ + ++ E++ + + ++ + I
Sbjct: 87 PNVIHLEGVV---TKSTPVM--IITEFMENGSLD--SFLRQNDGQFTVIQLVGMLRGIAA 139
Query: 250 ALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR------ 303
+ YL + HRD+ +N+LVN + K+ DFG ++ L + +Y +
Sbjct: 140 GMKYLAD-MNYVHRDLAARNILVNSNLV-CKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197
Query: 304 YYRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGTPTRE 362
+ APE I ++T+A D+WS G V+ E++ G+ + + D + I + P
Sbjct: 198 RWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM 256
Query: 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPF 422
+ P L+ Q + R +
Sbjct: 257 DC----------------------------PSALHQLMLDCWQKDRNHRPKFGQIVNT-L 287
Query: 423 FDDLRDPNT 431
+R+PN+
Sbjct: 288 DKMIRNPNS 296
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 4e-39
Identities = 54/300 (18%), Positives = 109/300 (36%), Gaps = 37/300 (12%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKR---YKNRELQIMRLLNHPNVVS 194
+ + + +G G FG V++ K G+ VA+K + ++ E+ +L H N++
Sbjct: 4 TIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61
Query: 195 LKHCFFSTTEKDELYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+ L LV +Y +++ YT + + L +
Sbjct: 62 F-IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAH 115
Query: 254 LHHVV-------GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS-----YIC 301
LH + + HRD+K +N+LV I D G A I +
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 302 SRYYRAPELIFGA-----TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKIL 356
++ Y APE++ + E D++++G V E+ + G QL +
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVP 233
Query: 357 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALE 416
P+ EE++ + +++ + ++ ++ + + R TAL
Sbjct: 234 SDPSVEEMRKV------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 7e-39
Identities = 59/299 (19%), Positives = 105/299 (35%), Gaps = 56/299 (18%)
Query: 142 ERVVGTGSFGVVFQAKC--LETGDSVAIKKVLQDKRYKN------RELQIMRLLNHPNVV 193
++ +G+G+FG V + + +VA+K + + E +M+ L++P +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
+ E + L V+E Y + N+HV + +Q+ + Y
Sbjct: 72 RMIGIC----EAESWML--VMEMAELGPLN---KYLQQNRHVKDKNIIELVHQVSMGMKY 122
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNIS----YICSRYYRAPE 309
L HRD+ +N+L+ H KI DFG +K L E + APE
Sbjct: 123 LEES-NFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 310 LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368
I ++++ D+WS G ++ E GQ + G G + + K
Sbjct: 181 CINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG--------- 230
Query: 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA---HPFFD 424
P E DL++ Y R + ++D
Sbjct: 231 -------------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 9e-39
Identities = 65/314 (20%), Positives = 112/314 (35%), Gaps = 70/314 (22%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS-----VAIKKVLQDKRYKN-----RELQIM-RLLNHP 190
+V+G+G+FG V A + VA+K + + EL++M +L +H
Sbjct: 42 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 101
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYIS------------------ETVYRVSKHYTRMN 232
N+V+L T +Y L+ EY E Y K
Sbjct: 102 NIVNLLGAC---TLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 233 QHVPILYVQL--YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290
+ + L + YQ+ + + +L HRD+ +N+LV +KICDFG A+ +
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRDLAARNVLVTHGKV-VKICDFGLARDI 214
Query: 291 VPGEPNISYICSR---YYRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGV 346
+ + +R + APE +F YT D+WS G +L E+ LG +PG
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 347 DQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQY 406
++I+ N + P E ++ +
Sbjct: 274 ANFYKLIQ---------------NGFKMDQP------------FYATEEIYIIMQSCWAF 306
Query: 407 SPSLRCTALEACAH 420
R + +
Sbjct: 307 DSRKRPSFPNLTSF 320
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 1e-38
Identities = 56/288 (19%), Positives = 96/288 (33%), Gaps = 51/288 (17%)
Query: 143 RVVGTGSFGVVFQAKCLETGDS---VAIKKVLQDKRYKN-------RELQIMRLLNHPNV 192
+G GSFGVV + + VA+K + D + RE+ M L+H N+
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALN 252
+ L + + +V E + H + + Y Q+ +
Sbjct: 74 IRLYGVVLTP------PMKMVTELAPLGSLL--DRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 253 YLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI---SYICSRYYRAPE 309
YL HRD+ +NLL+ +KI DFG + L + + + +
Sbjct: 126 YLESK-RFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 310 LIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368
++ A D W G L E+ GQ + G +G L +I K R E
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE----- 238
Query: 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALE 416
P + +++ + + P R T +
Sbjct: 239 ----------------------DCPQDIYNVMVQCWAHKPEDRPTFVA 264
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-38
Identities = 66/304 (21%), Positives = 112/304 (36%), Gaps = 53/304 (17%)
Query: 143 RVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
+V+G+G+FG V++ + G+ VAIK++ + K E +M +++P+V
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
L ++T + L+ + + + + ++ Y+ + QI + +NY
Sbjct: 75 RLLGICLTST------VQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR---YYRAPEL 310
L + HRD+ +N+LV H +KI DFG AK+L E + + A E
Sbjct: 127 LED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 311 IFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369
I YT D+WS G + EL+ G + G EI IL R
Sbjct: 185 ILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIP----ASEISSILEKGERLPQ----- 234
Query: 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429
+ ++ + R E F RDP
Sbjct: 235 -------------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIE-FSKMARDP 274
Query: 430 NTCL 433
L
Sbjct: 275 QRYL 278
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 2e-38
Identities = 65/303 (21%), Positives = 106/303 (34%), Gaps = 54/303 (17%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS--VAIKKVLQDKRYKN-----RELQIMRLLNHPNVVS 194
+ +G G+FG V Q VAIK + Q + RE QIM L++P +V
Sbjct: 14 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73
Query: 195 LKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYL 254
L + + L L V+E + K + +P+ V +Q+ + YL
Sbjct: 74 LIGVC----QAEALML--VMEMAGGGP--LHKFLVGKREEIPVSNVAELLHQVSMGMKYL 125
Query: 255 HHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR----YYRAPEL 310
HRD+ +N+L+ + KI DFG +K L + + + + APE
Sbjct: 126 EEK-NFVHRDLAARNVLLVNRHY-AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183
Query: 311 IFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369
I ++++ D+WS G + E L GQ + G + + I + E
Sbjct: 184 INF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC----- 237
Query: 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA---HPFFDDL 426
PPE L+S Y R L ++
Sbjct: 238 -----------------------PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274
Query: 427 RDP 429
Sbjct: 275 SKV 277
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 138 bits (348), Expect = 7e-38
Identities = 53/280 (18%), Positives = 109/280 (38%), Gaps = 41/280 (14%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKN---RELQIMRLLNHPNVVSLKHC 198
+ +G G +G V++ + +VA+K + +D +E +M+ + HPN+V L
Sbjct: 22 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 199 FFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVV 258
T + Y+ + + + + V +LY QI A+ YL
Sbjct: 82 C---TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY---MATQISSAMEYLEKK- 134
Query: 259 GVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSR--YYRAPELIFGATE 316
HRD+ +N LV + H +K+ DFG ++++ + APE + +
Sbjct: 135 NFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK 192
Query: 317 YTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKF 376
++ D+W+ G +L E+ + Q+ E+++ +++
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-----------------KDYRM 235
Query: 377 PQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALE 416
+ P + +L+ Q++PS R + E
Sbjct: 236 E----------RPEGCPEKVYELMRACWQWNPSDRPSFAE 265
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 7e-36
Identities = 66/293 (22%), Positives = 103/293 (35%), Gaps = 50/293 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDS---VAIKKVLQDKRYKN-----RELQIMRLLNHP 190
R +G G FG V Q + + VAIK +E MR +HP
Sbjct: 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRA 250
++V L E + +++E + R + + + LY YQ+ A
Sbjct: 69 HIVKLIGVI------TENPVWIIMELCTLGELR--SFLQVRKYSLDLASLILYAYQLSTA 120
Query: 251 LNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC--SRYYRAP 308
L YL HRDI +N+LV+ + +K+ DFG ++ + + + AP
Sbjct: 121 LAYLESK-RFVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367
E I +T+A D+W G + E+L+ G F G D + I P
Sbjct: 179 ESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC--- 234
Query: 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420
PP L+++ Y PS R E A
Sbjct: 235 -------------------------PPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 8e-36
Identities = 53/293 (18%), Positives = 106/293 (36%), Gaps = 51/293 (17%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS---VAIKKVLQDKRYKN-----RELQIMRLLNHPNVV 193
V+G G FG V+ L+ A+K + + E IM+ +HPNV+
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 194 SLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNY 253
SL + E +VL Y+ R + + + + Q+ + + +
Sbjct: 92 SLLGICL----RSEGSPLVVLPYMKHGDLR--NFIRNETHNPTVKDLIGFGLQVAKGMKF 145
Query: 254 LHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRY-----YRAP 308
HRD+ +N +++ +K+ DFG A+ + E + + + + A
Sbjct: 146 -LASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 309 ELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367
E + ++TT D+WS G +L EL+ G P +P + D V +++
Sbjct: 204 ESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ------------- 249
Query: 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420
+ + P +++ + +R + E +
Sbjct: 250 ---------------GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 3e-35
Identities = 64/305 (20%), Positives = 110/305 (36%), Gaps = 65/305 (21%)
Query: 142 ERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQDKRYKN-----RELQIM-RLLNHP 190
+ +G G+FG V +A + +VA+K + EL+++ L NH
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 191 NVVSLKHCFFSTTEKDELYLNLVLEYIS----ETVYRVSKHYTRMNQHVPILY------- 239
N+V+L T + + EY R + ++ P +
Sbjct: 88 NIVNLLGAC---TIGGPTLV--ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 240 ----VQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295
+ ++YQ+ + + +L HRD+ +N+L+ KICDFG A+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTHGRIT-KICDFGLARDIKNDSN 200
Query: 296 NISYICSR---YYRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVE 351
+ +R + APE IF YT D+WS G L EL LG +PG + +
Sbjct: 201 YVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 352 IIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLR 411
+IK + + + P E D++ P R
Sbjct: 260 MIK---------------------------EGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292
Query: 412 CTALE 416
T +
Sbjct: 293 PTFKQ 297
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 1e-34
Identities = 54/292 (18%), Positives = 100/292 (34%), Gaps = 50/292 (17%)
Query: 138 SYMAERVVGTGSFGVVFQAKCLETGDS----VAIKKVLQDKRYKN-----RELQIMRLLN 188
++V+G G FG V++ + VAIK + K E IM +
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
H N++ L+ + ++ EY+ K + +L + I
Sbjct: 68 HHNIIRLEGVIS-----KYKPMMIITEYMENGALD--KFLREKDGEFSVLQLVGMLRGIA 120
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC----SRY 304
+ YL + + HRD+ +N+LVN + K+ DFG +++L
Sbjct: 121 AGMKYLAN-MNYVHRDLAARNILVNSNLV-CKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 305 YRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364
+ APE I ++T+A D+WS G V+ E++ E ++++ I
Sbjct: 179 WTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN---------- 227
Query: 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALE 416
+ P L+ + Q + R +
Sbjct: 228 -----------------DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFAD 262
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 4e-34
Identities = 60/299 (20%), Positives = 109/299 (36%), Gaps = 54/299 (18%)
Query: 142 ERVVGTGSFGVVFQAKCLETGDS--VAIKKV-----LQDKRYKNRELQIM-RLLNHPNVV 193
+ V+G G+FG V +A+ + G AIK++ D R EL+++ +L +HPN++
Sbjct: 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74
Query: 194 SLKHCFFSTTEKDELYL-----------NLVLEYISETVYRVSKHYTRMNQHVPILYVQL 242
+L + LYL + + + + +
Sbjct: 75 NLLGAC---EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 243 YTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICS 302
+ + R ++YL HRD+ +N+LV + + KI DFG ++
Sbjct: 132 FAADVARGMDYLSQK-QFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGRLP 189
Query: 303 RYYRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGTPTR 361
+ A E + + YTT D+WS G +L E++ LG + G + E+ + L R
Sbjct: 190 VRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT----CAELYEKLPQGYR 244
Query: 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420
E E DL+ + + P R + +
Sbjct: 245 LEKP------------------------LNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 126 bits (317), Expect = 2e-33
Identities = 59/309 (19%), Positives = 104/309 (33%), Gaps = 71/309 (22%)
Query: 143 RVVGTGSFGVVFQAKC-----LETGDSVAIKKVLQDKRYKN-----RELQIMRLLNHPNV 192
R +G G+FG VFQA+ E VA+K + ++ RE +M ++PN+
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78
Query: 193 VSLKHCFFSTTEKDELYLNLVLEYIS---------------------ETVYRVSKHYTRM 231
V + L + EY++ + ++ +
Sbjct: 79 V---KLLGVCAVGKPMCL--LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133
Query: 232 NQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291
+ Q+ + YL HRD+ +N LV + +KI DFG ++ +
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSER-KFVHRDLATRNCLVGENMV-VKIADFGLSRNIY 191
Query: 292 PGEPNI---SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVD 347
+ + + PE IF YTT D+W+ G VL E+ G + G + +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250
Query: 348 QLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYS 407
+ + I A P + P E +L+
Sbjct: 251 VIYYVRD----------------------GNILACP------ENCPLELYNLMRLCWSKL 282
Query: 408 PSLRCTALE 416
P+ R +
Sbjct: 283 PADRPSFCS 291
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 1e-32
Identities = 64/309 (20%), Positives = 112/309 (36%), Gaps = 66/309 (21%)
Query: 139 YMAERVVGTGSFGVVFQAKCLETGDS-------VAIKKVLQDKRYKN-----RELQIM-R 185
+ + +G G+FG V A+ + VA+K + D K+ E+++M
Sbjct: 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74
Query: 186 LLNHPNVVSLKHCFFSTTEKDELYLNLVLEYISET-------------VYRVSKHYTRMN 232
+ H N+++L T+ LY+ ++EY S+ +
Sbjct: 75 IGKHKNIINLLGAC---TQDGPLYV--IVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 233 QHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292
+ + + YQ+ R + YL HRD+ +N+LV KI DFG A+ +
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVM-KIADFGLARDIHH 187
Query: 293 GEPN---ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQ 348
+ + + APE +F YT D+WS G +L E+ LG +PG V++
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEE 245
Query: 349 LVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSP 408
L +++K P E ++ P
Sbjct: 246 LFKLLK---------------EGHRMDKP------------SNCTNELYMMMRDCWHAVP 278
Query: 409 SLRCTALEA 417
S R T +
Sbjct: 279 SQRPTFKQL 287
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 2e-32
Identities = 59/306 (19%), Positives = 107/306 (34%), Gaps = 54/306 (17%)
Query: 139 YMAERVVGTGSFGVVFQAKC-----LETGDSVAIKKVLQD------KRYKNRELQIMRLL 187
+ +G G+FG V +A T +VA+K + + + + ++ +
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74
Query: 188 NHPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVP---------IL 238
+H NVV+L + + T R ++ + P +
Sbjct: 75 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 134
Query: 239 YVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNI- 297
++ Y++Q+ + + +L HRD+ +N+L++ +KICDFG A+ + +
Sbjct: 135 HLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDPDYVR 192
Query: 298 --SYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG-QPLFPGESGVDQLVEIIK 354
+ APE IF YT D+WS G +L E+ +PG ++ +K
Sbjct: 193 KGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251
Query: 355 ILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA 414
T + P PE + PS R T
Sbjct: 252 ---------------EGTRMRAPDY------------TTPEMYQTMLDCWHGEPSQRPTF 284
Query: 415 LEACAH 420
E H
Sbjct: 285 SELVEH 290
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 2e-30
Identities = 57/312 (18%), Positives = 110/312 (35%), Gaps = 63/312 (20%)
Query: 142 ERVVGTGSFGVVFQAKC-----LETGDSVAIKKV-----LQDKRYKNRELQIMRLLNHPN 191
R +G GSFG+V++ E VAIK V ++++ E +M+ N +
Sbjct: 25 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 84
Query: 192 VVSLKHCFFSTTEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPIL------YVQLYT 244
VV ++ + ++E ++ + + + P+L +
Sbjct: 85 VV---RLLGVVSQGQPTLV--IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 245 YQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYIC--- 301
+I + YL+ HRD+ +N +V +KI DFG + + +
Sbjct: 140 GEIADGMAYLNAN-KFVHRDLAARNCMVAEDFT-VKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 302 SRYYRAPELIFGATEYTTAIDMWSIGCVLAELL-LGQPLFPGESGVDQLVEIIKILGTPT 360
+ +PE + +TT D+WS G VL E+ L + + G S L +++
Sbjct: 198 PVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME------ 250
Query: 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTA------ 414
P +L+ QY+P +R +
Sbjct: 251 ----------------------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288
Query: 415 LEACAHPFFDDL 426
++ P F ++
Sbjct: 289 IKEEMEPGFREV 300
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 85.2 bits (210), Expect = 6e-20
Identities = 29/204 (14%), Positives = 53/204 (25%), Gaps = 32/204 (15%)
Query: 143 RVVGTGSFGVVFQAKCLETGDSVAIKKV--------------LQDKRYKNRELQIMRLLN 188
+++G G VF E +K + +
Sbjct: 6 KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 189 HPNVVSLKHCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQIC 248
+ L+ +++E + V + I
Sbjct: 65 FRALQKLQGLAV-PKVYAWEGNAVLMEL----------IDAKELYRVRVENPDEVLDMIL 113
Query: 249 RALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAP 308
+ +H + H D+ N+LV + I DF + + GE I R R
Sbjct: 114 EEVAKFYHRG-IVHGDLSQYNVLV--SEEGIWIIDFPQSVEV--GEEGWREILERDVRNI 168
Query: 309 ELIFGATEYTTAIDMWSIGCVLAE 332
F Y T D+ S + +
Sbjct: 169 ITYFS-RTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 492 | |||
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.22 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.81 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.61 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.87 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.59 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.62 |
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-65 Score=513.18 Aligned_cols=329 Identities=70% Similarity=1.210 Sum_probs=295.8
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchhhHHHHHHHHHHcCCCCccccceeeeeccC-CCceEEEEEee
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELYLNLVLE 215 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~-~~~~~~~lV~E 215 (492)
.+|...++||+|+||+||+|+++.+|+.||||++..+.....+|+++|+.++|||||+++++|+.... .+..++|||||
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E 99 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 99 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence 36999999999999999999999999999999998877777799999999999999999999876543 56678999999
Q ss_pred echhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCCC
Q 011138 216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGEP 295 (492)
Q Consensus 216 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~~ 295 (492)
||+++++..+.........+++..++.|+.||+.||+|||+ +||+||||||+|||++.++..+||+|||+++.......
T Consensus 100 y~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~ 178 (350)
T d1q5ka_ 100 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178 (350)
T ss_dssp CCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC
T ss_pred ccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCcceEEEecCCCceeEecccchhhccCCcc
Confidence 99998887777666677789999999999999999999997 99999999999999998766899999999998877777
Q ss_pred CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccC
Q 011138 296 NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFK 375 (492)
Q Consensus 296 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~ 375 (492)
..+.+||+.|+|||++.+...|+.++||||+||++|||++|++||.+.+..+++.++++.+|.+..+.+....+.+....
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~ 258 (350)
T d1q5ka_ 179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 258 (350)
T ss_dssp CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCC
T ss_pred cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhcc
Confidence 77889999999999998877899999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccccc
Q 011138 376 FPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNTCLPNGRPLPTLFNFTAQGKLILCF 455 (492)
Q Consensus 376 ~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 455 (492)
++.....+|.......+++++++||.+||++||++|||+.|+|+||||++++++...+++....+.+++|..+
T Consensus 259 ~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~------- 331 (350)
T d1q5ka_ 259 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQ------- 331 (350)
T ss_dssp CCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCHH-------
T ss_pred ccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCCCCCCCCCCCCccCCCCHh-------
Confidence 9999888888888889999999999999999999999999999999999999988888888888888887755
Q ss_pred ccccccccccCccchhHHHhcCCHHHHhhccccccc
Q 011138 456 SYFGFSSYFLPHANCLAELAGASNELRQRLIPEHAR 491 (492)
Q Consensus 456 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 491 (492)
|+. .++++...++|+|+|
T Consensus 332 -----------------e~~-~~~~~~~~~~p~~~r 349 (350)
T d1q5ka_ 332 -----------------ELS-SNPPLATILIPPHAR 349 (350)
T ss_dssp -----------------HHT-TCGGGHHHHSCTTTT
T ss_pred -----------------hcc-CCccccccCCCcccc
Confidence 553 455677889999987
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-59 Score=460.46 Aligned_cols=278 Identities=34% Similarity=0.599 Sum_probs=230.3
Q ss_pred EeeeeccCCceEEEEEEEcCCCCEEEEEEeccch---------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 141 AERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 141 ~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~---------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
..++||+|+||+||+|+++.+|+.||||++.... ....+|+.+|+.++|||||+++++| .+..++|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~-----~~~~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GHKSNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CCTTCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee-----ccCCcee
Confidence 3578999999999999999999999999985332 2355899999999999999999999 4445689
Q ss_pred EEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
|||||+.++++..+. .....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+...
T Consensus 77 ivmE~~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDiKp~NIli~~~~-~~KL~DFG~a~~~~ 151 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDENG-VLKLADFGLAKSFG 151 (299)
T ss_dssp EEEECCSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECCCGGGSTTT
T ss_pred ehhhhhcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhc-cceecccCCcceEEecCCC-ccccccCccccccC
Confidence 999999987665433 335678899999999999999999997 9999999999999999887 89999999998764
Q ss_pred CCC-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 011138 292 PGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (492)
Q Consensus 292 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 370 (492)
... .....+||+.|+|||++.+...|+.++|||||||++|||++|.+||.+.+..+++..|.+.+|.|..+.+......
T Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 152 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred CCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhcc
Confidence 432 3445789999999999987777899999999999999999999999999999999999999999988766544333
Q ss_pred CcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCC
Q 011138 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (492)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~ 429 (492)
.....+......++... .+.+++++++||.+||++||++|||+.|+|+||||++...+
T Consensus 232 ~~~~~~~~~~~~~~~~~-~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p 289 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHI-FSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 289 (299)
T ss_dssp TTCCCCCCCCCCCHHHH-CTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred chhhhhccCCCCChHHh-cccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCC
Confidence 23233333333333332 34689999999999999999999999999999999976543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-59 Score=450.94 Aligned_cols=248 Identities=31% Similarity=0.488 Sum_probs=212.1
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
..+|.+++.||+|+||+||+|+++.+|+.||||++.+. .....+|+.+++.++|||||++++++ .+..
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~ 79 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDAT 79 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE-----EECC
Confidence 35799999999999999999999999999999998542 23456899999999999999999998 4555
Q ss_pred EEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 209 ~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
.+|||||||+++ +...+.. ...+++..++.|+.||+.||+|||+ +|||||||||+|||++.++ .+||+|||+|
T Consensus 80 ~~~ivmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~-~~ivHrDiKp~Nill~~~~-~~kl~DFG~a 153 (263)
T d2j4za1 80 RVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGSAG-ELKIADFGWS 153 (263)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEECCCCSC
T ss_pred EEEEEEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeeeeccccceecCCC-CEeeccccee
Confidence 689999999864 4444332 3569999999999999999999997 9999999999999999888 7999999999
Q ss_pred cccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
+.... ......+||+.|||||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+..+.+
T Consensus 154 ~~~~~-~~~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~------------- 218 (263)
T d2j4za1 154 VHAPS-SRRTTLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR------------- 218 (263)
T ss_dssp SCCCC-CCCEETTEEGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT-------------
T ss_pred eecCC-CcccccCCCCcccCHHHHcCC-CCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHc-------------
Confidence 86543 344567899999999999765 489999999999999999999999999887776666543
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~ 425 (492)
..+. +++.+|+++++||.+||+.||.+|||+.|+|+||||+.
T Consensus 219 ----~~~~------------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 219 ----VEFT------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp ----TCCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred ----CCCC------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 1112 22457999999999999999999999999999999974
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-60 Score=454.06 Aligned_cols=253 Identities=28% Similarity=0.359 Sum_probs=209.0
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
.++|++.+.||+|+||+||+|+++.+|+.||||++... .....+|+.+|+.++|||||++++++. +...+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~-----~~~~~ 78 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ 78 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeec-----cCcee
Confidence 35799999999999999999999999999999998543 234568999999999999999999994 34468
Q ss_pred EEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 211 ~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
|||||||.++ |.+.+ .....+++..++.++.||+.||+|||+ +|||||||||+|||++.++ .+||+|||+|+.
T Consensus 79 ~ivmEy~~gg~L~~~l----~~~~~l~e~~~~~i~~qi~~al~ylH~-~~IiHrDiKp~NILl~~~~-~~KL~DFG~a~~ 152 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERD-NLKISDFGLATV 152 (271)
T ss_dssp EEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred EEEEeccCCCcHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCccCcccHHHEEECCCC-CEEEccchhhee
Confidence 9999999864 44433 234679999999999999999999997 9999999999999999887 799999999987
Q ss_pred cCCCC---CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 011138 290 LVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (492)
Q Consensus 290 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~ 366 (492)
..... .....+||+.|||||++.+...++.++|||||||++|||++|++||...+..............
T Consensus 153 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~-------- 224 (271)
T d1nvra_ 153 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-------- 224 (271)
T ss_dssp CEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT--------
T ss_pred eccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--------
Confidence 64322 2345789999999999987766678999999999999999999999876655444433321100
Q ss_pred cCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCC
Q 011138 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (492)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~ 425 (492)
+ .. .+..+++++++||.+||+.||++|||++|+|+||||++
T Consensus 225 ---------~----~~-----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 225 ---------Y----LN-----PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp ---------T----ST-----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred ---------C----CC-----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 0 00 12357999999999999999999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-59 Score=454.02 Aligned_cols=250 Identities=26% Similarity=0.405 Sum_probs=212.3
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
+|.+.+.||+|+||+||+|.++.+|+.||||++... .....+|+.+|+.++|||||+++++|.. ..++|||
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~iv 95 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWVV 95 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEEE
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE-----CCEEEEE
Confidence 699999999999999999999999999999998533 2346689999999999999999999843 3468999
Q ss_pred eeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCC
Q 011138 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (492)
Q Consensus 214 ~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (492)
||||+|+.+..+.. ...+++..++.|+.||+.||.|||+ +|||||||||+|||++.++ .+||+|||+|+.....
T Consensus 96 mEy~~gg~L~~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~~~-~vkl~DFG~a~~~~~~ 169 (293)
T d1yhwa1 96 MEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPE 169 (293)
T ss_dssp EECCTTCBHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEECCST
T ss_pred EEecCCCcHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCcHHHeEECCCC-cEeeccchhheeeccc
Confidence 99999754433221 2469999999999999999999997 9999999999999999887 7999999999876543
Q ss_pred C-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 011138 294 E-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPNYT 372 (492)
Q Consensus 294 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~ 372 (492)
. .....+||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+..+.... .+
T Consensus 170 ~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~-~~------------- 234 (293)
T d1yhwa1 170 QSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TP------------- 234 (293)
T ss_dssp TCCBCCCCSCGGGCCHHHHSSS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-SC-------------
T ss_pred cccccccccCCCccChhhhcCC-CCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-CC-------------
Confidence 3 44567899999999999764 58999999999999999999999999988887777765521 11
Q ss_pred ccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCC
Q 011138 373 EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (492)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~ 425 (492)
.+ ..++.+++++++||.+||+.||.+|||+.|+|+||||+.
T Consensus 235 --~~----------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 235 --EL----------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp --CC----------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred --CC----------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 00 122457999999999999999999999999999999984
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-59 Score=450.72 Aligned_cols=251 Identities=33% Similarity=0.553 Sum_probs=211.2
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
.+|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+|+++|+.++|||||+++++| .+..+
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-----ECSSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE-----EECCE
Confidence 57999999999999999999999999999999985421 3456899999999999999999998 45567
Q ss_pred EEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 210 LNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 210 ~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
+|||||||+|+ |.+.+. ....+++..++.++.||+.||+|||+ +|||||||||+|||++.++ .+||+|||+|+
T Consensus 83 ~~ivmEy~~gg~L~~~~~----~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~NIll~~~~-~vkl~DFG~a~ 156 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDM-HIQITDFGTAK 156 (288)
T ss_dssp EEEEECCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred EEEEEEccCCCCHHHhhh----ccCCCCHHHHHHHHHHHHHHHHhhcc-ccEEcCcCCccccccCCCc-eEEecccccce
Confidence 89999999864 444433 24679999999999999999999997 9999999999999999888 79999999998
Q ss_pred ccCCCC---CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 011138 289 MLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (492)
Q Consensus 289 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~ 365 (492)
.+.... .....+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+.+.+|.+
T Consensus 157 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~----------- 224 (288)
T d1uu3a_ 157 VLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK----------- 224 (288)
T ss_dssp ECC----------CCCCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT-----------
T ss_pred ecccCCcccccccccCCccccCceeeccC-CCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHc-----------
Confidence 764332 23456899999999999765 489999999999999999999999999888777776654
Q ss_pred hcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHH------hhCCCCCCCCCC
Q 011138 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALE------ACAHPFFDDLRD 428 (492)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e------~l~Hp~f~~~~~ 428 (492)
..+.+ +..+++++++||.+||+.||.+|||++| +++||||+++..
T Consensus 225 ------~~~~~------------p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w 275 (288)
T d1uu3a_ 225 ------LEYDF------------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW 275 (288)
T ss_dssp ------TCCCC------------CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred ------CCCCC------------CccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCH
Confidence 11222 2458999999999999999999999998 588999998753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-58 Score=450.18 Aligned_cols=283 Identities=34% Similarity=0.624 Sum_probs=233.0
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
++|.+.+.||+|+||+||+|+++.+|+.||||++..+ .....+|+++|++++|||||+++++|. +...+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~-----~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccc-----cccce
Confidence 4699999999999999999999999999999998543 234568999999999999999999994 44468
Q ss_pred EEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 211 ~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
|+||||+.++++..... .....+++..++.++.||+.||.|||+ +|||||||||+|||++.++ .+||+|||+|+..
T Consensus 77 ~iv~e~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~-~~IiHrDiKpeNIl~~~~~-~~kl~DFG~a~~~ 152 (298)
T d1gz8a_ 77 YLVFEFLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINTEG-AIKLADFGLARAF 152 (298)
T ss_dssp EEEEECCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECSTTHHHHH
T ss_pred eEEEeecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhc-CCEEccccCchheeecccC-cceeccCCcceec
Confidence 99999999887665432 334679999999999999999999997 9999999999999999888 7999999999876
Q ss_pred CC-CCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 291 VP-GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 291 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
.. ........||+.|+|||++.....++.++|||||||++|+|++|+.||.+.+..+.+.++.+..+.|....+.....
T Consensus 153 ~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp CCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred cCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence 43 33445678999999999998777789999999999999999999999999999999999999999887665543211
Q ss_pred C-CcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCC
Q 011138 370 N-YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (492)
Q Consensus 370 ~-~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~ 429 (492)
. .....++......+.. ....+++++++||++||++||.+|||+.|+|+||||+++.+|
T Consensus 233 ~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSK-VVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp STTCCTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred ccccccccccccccchhh-hccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 1 0111122222222221 234688999999999999999999999999999999988654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-57 Score=446.87 Aligned_cols=285 Identities=33% Similarity=0.563 Sum_probs=235.2
Q ss_pred cceeEeeeeccCCceEEEEEEEcCC-CCEEEEEEeccc------hhhHHHHHHHHHHc---CCCCccccceeeeeccCCC
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLET-GDSVAIKKVLQD------KRYKNRELQIMRLL---NHPNVVSLKHCFFSTTEKD 206 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~-g~~vAiK~~~~~------~~~~~~E~~il~~l---~h~nIv~l~~~~~~~~~~~ 206 (492)
.+|++.+.||+|+||+||+|++..+ ++.||||++... .....+|+.+|+.| +|||||+++++|.......
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 5799999999999999999999766 567999998532 22355788888776 7999999999987666566
Q ss_pred ceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 207 ~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
..+++++|||+.++++..... .....+++..++.++.||+.||+|||+ +|||||||||+|||++.++ .+||+|||+
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDiKp~NILi~~~~-~~kl~dfg~ 162 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSG-QIKLADFGL 162 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECSCCS
T ss_pred CceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecCCCccEEEEcCCC-Ceeecchhh
Confidence 778999999999886654432 335678999999999999999999997 9999999999999999888 799999999
Q ss_pred ccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 011138 287 AKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (492)
Q Consensus 287 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~ 366 (492)
++............||+.|+|||++.+. .|+.++||||+||++|||++|++||.+.+..+++..+++.++.|....+..
T Consensus 163 ~~~~~~~~~~~~~~gT~~Y~APE~~~~~-~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (305)
T d1blxa_ 163 ARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241 (305)
T ss_dssp CCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred hhhhcccccCCCcccChhhcCcchhcCC-CCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccc
Confidence 9876655566678999999999999765 499999999999999999999999999999999999999999998776643
Q ss_pred cCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
..... ...+......+ ...+...+++++++||.+||++||++|||+.|+|+||||+++..
T Consensus 242 ~~~~~-~~~~~~~~~~~-~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 242 DVALP-RQAFHSKSAQP-IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp TCSSC-GGGSCCCCCCC-GGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccch-hhhhccccccc-hhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 22111 11111111111 12345678999999999999999999999999999999998754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-58 Score=451.67 Aligned_cols=253 Identities=29% Similarity=0.478 Sum_probs=199.1
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
+.|.+.+.||+|+||+||+|+++.+|+.||||++.... ....+|+.+|+.++|||||+++++| .+..++|
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~~~ 83 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGHLY 83 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-----ECSSEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence 45999999999999999999999999999999985432 2345799999999999999999998 4556799
Q ss_pred EEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcC---CCCcEEEeeecCc
Q 011138 212 LVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP---HTHQLKICDFGSA 287 (492)
Q Consensus 212 lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~---~~~~vkL~DFG~a 287 (492)
||||||+| +|.+.+.. ...+++..++.++.||+.||+|||+ +|||||||||+|||+.. ++ .+||+|||+|
T Consensus 84 lvmE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~Nil~~~~~~~~-~vkl~DFG~a 157 (307)
T d1a06a_ 84 LIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHD-LGIVHRDLKPENLLYYSLDEDS-KIMISDFGLS 157 (307)
T ss_dssp EEECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTC-CEEECCC---
T ss_pred EEEeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhh-ceeeeEEecccceeecccCCCc-eEEEecccee
Confidence 99999985 56555432 4679999999999999999999997 99999999999999953 44 7999999999
Q ss_pred cccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
+.........+.+||+.|||||++.+. .|+.++|||||||++|+|++|++||.+.+..+....+.+.
T Consensus 158 ~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~------------ 224 (307)
T d1a06a_ 158 KMEDPGSVLSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA------------ 224 (307)
T ss_dssp ---------------CTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTT------------
T ss_pred EEccCCCeeeeeeeCccccCcHHHcCC-CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhcc------------
Confidence 877666666678999999999999765 5899999999999999999999999998877777666542
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
...++ ...++.+|+++++||.+||++||.+|||+.|+++||||++.
T Consensus 225 -----~~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 225 -----EYEFD--------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp -----CCCCC--------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred -----CCCCC--------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 11111 11234689999999999999999999999999999999863
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.9e-58 Score=458.06 Aligned_cols=257 Identities=29% Similarity=0.454 Sum_probs=218.2
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
.+.|++.+.||+|+||+||+|.++.+|+.||||++... .....+|+.+|+.|+|||||+++++| .+...+|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~ 102 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMV 102 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence 34699999999999999999999999999999998543 23456899999999999999999998 4555789
Q ss_pred EEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcC-CCCcEEEeeecCccc
Q 011138 212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNP-HTHQLKICDFGSAKM 289 (492)
Q Consensus 212 lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~-~~~~vkL~DFG~a~~ 289 (492)
||||||+|+ |.+.+ ......+++..++.|+.||+.||.|||+ +|||||||||+||||+. +.+.+||+|||+|+.
T Consensus 103 ivmE~~~gg~L~~~~---~~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~ 178 (352)
T d1koba_ 103 LILEFLSGGELFDRI---AAEDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATK 178 (352)
T ss_dssp EEEECCCCCBHHHHT---TCTTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EEEEcCCCChHHHHH---HhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccccccccccccCCCeEEEeeccccee
Confidence 999999965 43332 2334569999999999999999999997 99999999999999973 223799999999998
Q ss_pred cCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
...........||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+..|.+.
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~-------------- 243 (352)
T d1koba_ 179 LNPDEIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC-------------- 243 (352)
T ss_dssp CCTTSCEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC--------------
T ss_pred cCCCCceeeccCcccccCHHHHcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 8777767778999999999999664 5899999999999999999999999999988888777652
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
.+.++. ..+..+++++++||.+||++||.+|||+.|+|+||||+...
T Consensus 244 ---~~~~~~--------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 244 ---DWEFDE--------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp ---CCCCCS--------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred ---CCCCCc--------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 111111 12346899999999999999999999999999999998643
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-58 Score=443.61 Aligned_cols=254 Identities=26% Similarity=0.391 Sum_probs=203.0
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
.++|++.+.||+|+||+||+|+++.+|+.||||++.... ..+.+|+++|++++|||||++++++... ....
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~---~~~~ 79 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTT 79 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC---CCCE
Confidence 357999999999999999999999999999999985432 2355899999999999999999988542 2335
Q ss_pred EEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCC-----cccCCCCCCceEEcCCCCcEEEee
Q 011138 210 LNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG-----VCHRDIKPQNLLVNPHTHQLKICD 283 (492)
Q Consensus 210 ~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~g-----ivHrDlKp~NILl~~~~~~vkL~D 283 (492)
+|||||||++ +|.+++.........+++..++.++.||+.||.|||+ +| ||||||||+||||+.++ .+||+|
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~-~~~~~~~IiHrDiKp~NIll~~~~-~vkl~D 157 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDGKQ-NVKLGD 157 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-HCC---------CCGGGEEECTTS-CEEECC
T ss_pred EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-hcCCCCCEEeCcCchhhcCcCCCC-cEEEee
Confidence 8899999985 5666666555567789999999999999999999997 66 99999999999999887 799999
Q ss_pred ecCccccCCCC-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 011138 284 FGSAKMLVPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (492)
Q Consensus 284 FG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~ 362 (492)
||+|+...... .....+||+.|||||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..+...
T Consensus 158 FG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~------- 229 (269)
T d2java1 158 FGLARILNHDTSFAKAFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG------- 229 (269)
T ss_dssp HHHHHHC-----------CCCSCCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-------
T ss_pred ccceeecccCCCccccCCCCcccCCHHHHcCC-CCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC-------
Confidence 99998765433 33467899999999999654 5899999999999999999999999998877766666441
Q ss_pred HHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCC
Q 011138 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFF 423 (492)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f 423 (492)
.++. ++..+|+++++||.+||+.||.+|||++|+++|||+
T Consensus 230 ------------~~~~---------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 230 ------------KFRR---------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp ------------CCCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ------------CCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 0111 224579999999999999999999999999999996
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-58 Score=440.49 Aligned_cols=251 Identities=23% Similarity=0.347 Sum_probs=205.5
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
|++.+.||+|+||+||+|.+..+++.||+|++.... ..+.+|+++|++++|||||+++++|.... .+...+||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEEE
Confidence 578889999999999999999999999999885432 33568999999999999999999986543 34567899
Q ss_pred Eeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCC--cccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 213 VLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVG--VCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 213 V~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~g--ivHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
|||||+++ |.+.+.. ...+++..++.++.||+.||+|||+ +| ||||||||+||||+.+.+.+||+|||+|+.
T Consensus 90 vmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~-~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHH-CCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 99999875 4444332 3578999999999999999999997 88 999999999999975333799999999986
Q ss_pred cCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
.. .......+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+......+.+.+.. +.++
T Consensus 165 ~~-~~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~~~~--------- 231 (270)
T d1t4ha_ 165 KR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKP--------- 231 (270)
T ss_dssp CC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCC---------
T ss_pred cc-CCccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-CCCC---------
Confidence 43 334456789999999999854 4899999999999999999999999887665555443321 0000
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~ 424 (492)
..++...++++++||.+||++||++|||++|+|+||||+
T Consensus 232 ----------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 232 ----------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp ----------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ----------------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 112345789999999999999999999999999999996
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-57 Score=452.08 Aligned_cols=252 Identities=27% Similarity=0.430 Sum_probs=215.4
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
..+|.+++.||+|+||.||+|+++.+|+.||||++.+. .....+|+.+|+.++|||||+++++| .+..
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~ 78 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----cccc
Confidence 35799999999999999999999999999999998643 23345899999999999999999999 5566
Q ss_pred EEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 209 ~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
++|+|||||+|+.+... ......+++..++.|+.||+.||+|||+ +|||||||||+|||++.++ .+||+|||+|+
T Consensus 79 ~~~iv~ey~~gg~L~~~---~~~~~~~~e~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NILl~~~g-~vkl~DFG~a~ 153 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFH---LSRERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDG-HIKITDFGLCK 153 (337)
T ss_dssp EEEEEEECCTTCBHHHH---HHHHSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCTTCB
T ss_pred ccccceeccCCCchhhh---hhcccCCcHHHHHHHHHHHhhhhhhhhh-cCccccccCHHHeEecCCC-CEEEeeccccc
Confidence 79999999997644322 2234678999999999999999999997 9999999999999999888 79999999998
Q ss_pred ccCC-CCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 289 MLVP-GEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 289 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
.... .......+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..+..
T Consensus 154 ~~~~~~~~~~~~~GT~~Y~aPE~~~~~-~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~------------- 219 (337)
T d1o6la_ 154 EGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM------------- 219 (337)
T ss_dssp CSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------------
T ss_pred ccccCCcccccceeCHHHhhhhhccCC-CCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhc-------------
Confidence 7643 3445568999999999999765 489999999999999999999999999988777666654
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCC-----HHHhhCCCCCCCCC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-----ALEACAHPFFDDLR 427 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-----~~e~l~Hp~f~~~~ 427 (492)
..+.+ ++.+|+++++||++||++||.+|++ +.|+++||||+++.
T Consensus 220 ----~~~~~------------p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~ 268 (337)
T d1o6la_ 220 ----EEIRF------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp ----CCCCC------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred ----CCCCC------------CccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCC
Confidence 12222 3468999999999999999999994 89999999998763
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.8e-58 Score=457.77 Aligned_cols=258 Identities=27% Similarity=0.426 Sum_probs=218.4
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
++|.+.+.||+|+||.||+|+++.+|+.||||++... .....+|+.+|+.++|||||+++++|. +...+||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~i 100 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE-----DDNEMVM 100 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE-----ETTEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEE
Confidence 4799999999999999999999999999999998543 234568999999999999999999984 4446899
Q ss_pred Eeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCC-CCcEEEeeecCcccc
Q 011138 213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH-THQLKICDFGSAKML 290 (492)
Q Consensus 213 V~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~-~~~vkL~DFG~a~~~ 290 (492)
|||||+| +|.+.+. .....+++..++.|+.||+.||.|||+ +|||||||||+|||++.+ .+.+||+|||+|+..
T Consensus 101 vmE~~~gg~L~~~l~---~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 101 IYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp EECCCCSCBHHHHHT---CTTSCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred EEEcCCCCCHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 9999986 4544432 234569999999999999999999997 999999999999999643 237999999999987
Q ss_pred CCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 011138 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (492)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 370 (492)
..........||+.|||||++.+.. |+.++|||||||++|+|++|++||.+.+..+.+..|.....
T Consensus 177 ~~~~~~~~~~gT~~Y~aPEv~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~------------- 242 (350)
T d1koaa2 177 DPKQSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW------------- 242 (350)
T ss_dssp CTTSCEEEECSCTTTCCHHHHHTCC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-------------
T ss_pred ccccccceecCcccccCHHHHcCCC-CChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-------------
Confidence 7666667789999999999997654 89999999999999999999999999988888877765311
Q ss_pred CcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCC
Q 011138 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (492)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~ 429 (492)
.++. .....+++++++||.+||++||.+|||+.|+|+||||+....+
T Consensus 243 ----~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~ 289 (350)
T d1koaa2 243 ----NMDD--------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 289 (350)
T ss_dssp ----CSCC--------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred ----CCCc--------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence 1111 1224589999999999999999999999999999999986543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-58 Score=447.78 Aligned_cols=254 Identities=26% Similarity=0.374 Sum_probs=211.1
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
+.|++.+.||+|+||+||+|+++.+|+.||||++... .....+|+++|+.++|||||+++++|.. ...+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCeEEE
Confidence 3599999999999999999999999999999998542 2345689999999999999999999843 346899
Q ss_pred EeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 213 V~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
|||||.++.+.... ......+++..++.++.||+.||.|||+ +|||||||||+|||++.++ .+||+|||+|+....
T Consensus 87 vmEy~~~g~L~~~~--~~~~~~l~e~~~~~i~~qi~~gL~ylH~-~~ivHrDiKp~NIll~~~~-~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 87 LIEFCAGGAVDAVM--LELERPLTESQIQVVCKQTLDALNYLHD-NKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTR 162 (288)
T ss_dssp EEECCTTEEHHHHH--HHHTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTCEECHH
T ss_pred EEecCCCCcHHHHH--HhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEEeecChhheeECCCC-CEEEEechhhhccCC
Confidence 99999876543321 2234569999999999999999999997 9999999999999999888 799999999976532
Q ss_pred C-CCCccceeccCccCchhhcC----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 293 G-EPNISYICSRYYRAPELIFG----ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 293 ~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
. ......+||+.|+|||++.. ...|+.++|||||||++|||++|++||.+.+..+.+.++.+. .++
T Consensus 163 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~--~~~------- 233 (288)
T d2jfla1 163 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS--EPP------- 233 (288)
T ss_dssp HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS--CCC-------
T ss_pred CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC--CCC-------
Confidence 2 12335789999999999842 345899999999999999999999999998888887777652 100
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~ 425 (492)
.+ ..+..+++++++||.+||+.||.+|||+.|+|+||||+.
T Consensus 234 -------~~----------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 234 -------TL----------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp -------CC----------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred -------CC----------CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 00 012457999999999999999999999999999999974
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-57 Score=445.12 Aligned_cols=255 Identities=25% Similarity=0.412 Sum_probs=216.4
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----------hhhHHHHHHHHHHcCCCCccccceeeeeccCCC
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 206 (492)
++|.+++.||+|+||+||+|+++.+|+.||||++.+. ...+.+|+.+|+.++|||||+++++| .+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~ 84 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----EN 84 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EE
Confidence 4699999999999999999999999999999998532 23456899999999999999999998 45
Q ss_pred ceEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCC---cEEEe
Q 011138 207 ELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH---QLKIC 282 (492)
Q Consensus 207 ~~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~---~vkL~ 282 (492)
...+|||||||++ +|.+.+.. ...+++..++.++.||+.||+|||+ +|||||||||+|||++.++. .+||+
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~-~~ivHrDiKp~Nill~~~~~~~~~vkl~ 159 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKII 159 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred CCEEEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhh-cceeecccccceEEEecCCCcccceEec
Confidence 5679999999986 45554432 3579999999999999999999997 99999999999999987653 49999
Q ss_pred eecCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 011138 283 DFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (492)
Q Consensus 283 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~ 362 (492)
|||+|+....+.......||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+..+.+..+...-.
T Consensus 160 DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~----- 233 (293)
T d1jksa_ 160 DFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY----- 233 (293)
T ss_dssp CCTTCEECTTSCBCSCCCCCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC-----
T ss_pred chhhhhhcCCCccccccCCCCcccCHHHHcCC-CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-----
Confidence 99999887666666678999999999999654 589999999999999999999999999888887777654211
Q ss_pred HHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
.+ ...+++.+|+++++||++||+.||.+|||++|+|+||||+...
T Consensus 234 ------------~~--------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 278 (293)
T d1jksa_ 234 ------------EF--------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278 (293)
T ss_dssp ------------CC--------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred ------------CC--------CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 11 1112346899999999999999999999999999999998653
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.3e-58 Score=448.54 Aligned_cols=249 Identities=27% Similarity=0.416 Sum_probs=211.3
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
.|...+.||+|+||+||+|++..+|+.||||++.... ....+|+.+|+.++|||||+++++|.. ..++
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~~ 90 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHTA 90 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-----CCEE
Confidence 5999999999999999999999999999999985432 234579999999999999999999843 3458
Q ss_pred EEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 211 ~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
|||||||.++++.... .....+++..++.|+.||+.||.|||+ +|||||||||+||||+.++ .+||+|||+|+..
T Consensus 91 ~iv~E~~~~g~l~~~~---~~~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~~~-~~Kl~DFG~a~~~ 165 (309)
T d1u5ra_ 91 WLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPG-LVKLGDFGSASIM 165 (309)
T ss_dssp EEEEECCSEEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTT-EEEECCCTTCBSS
T ss_pred EEEEEecCCCchHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEECCCC-CEEEeeccccccc
Confidence 9999999987665432 234679999999999999999999997 9999999999999999887 8999999999865
Q ss_pred CCCCCCccceeccCccCchhhcCC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 291 VPGEPNISYICSRYYRAPELIFGA--TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
.. ....+||+.|||||++.+. ..|+.++|||||||++|||++|..||.+.+..+.+..+....
T Consensus 166 ~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~------------ 230 (309)
T d1u5ra_ 166 AP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE------------ 230 (309)
T ss_dssp SS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC------------
T ss_pred CC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC------------
Confidence 33 3457899999999999643 358999999999999999999999999988877777765510
Q ss_pred CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
.+. ..+..+|+++++||.+||+.||.+|||++|+|+||||+..
T Consensus 231 -------~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 231 -------SPA--------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp -------CCC--------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred -------CCC--------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 010 0123578999999999999999999999999999999864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.7e-57 Score=446.48 Aligned_cols=249 Identities=28% Similarity=0.489 Sum_probs=214.2
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
.+|++.+.||+|+||+||+|+++.+|+.||||++.+. .....+|+.+|+.++|||||++++++ .+..+
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeE-----eeCCe
Confidence 4699999999999999999999999999999998543 23456899999999999999999998 45557
Q ss_pred EEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
+|+|||||.|+.+... ......+++..++.++.||+.||.|||+ +|||||||||+||||+.++ .+||+|||+|+.
T Consensus 79 ~~ivmE~~~gg~l~~~---~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NILl~~~g-~vkL~DFG~a~~ 153 (316)
T d1fota_ 79 IFMIMDYIEGGELFSL---LRKSQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDKNG-HIKITDFGFAKY 153 (316)
T ss_dssp EEEEECCCCSCBHHHH---HHHTSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTS-CEEECCCSSCEE
T ss_pred eeeEeeecCCcccccc---ccccccccccHHHHHHHHHHHhhhhhcc-CcEEccccCchheeEcCCC-CEEEecCccceE
Confidence 9999999997654332 2335678889999999999999999997 9999999999999999888 799999999987
Q ss_pred cCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
.. ....+.+||+.|||||++.+. .|+.++|||||||++|+|++|+.||.+.+..+.+.++.+.
T Consensus 154 ~~--~~~~~~~Gt~~Y~APE~l~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-------------- 216 (316)
T d1fota_ 154 VP--DVTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-------------- 216 (316)
T ss_dssp CS--SCBCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC--------------
T ss_pred ec--cccccccCcccccCHHHHcCC-CCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC--------------
Confidence 64 334567899999999999655 4899999999999999999999999998888877777651
Q ss_pred CCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcC-----CHHHhhCCCCCCCCC
Q 011138 370 NYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLR 427 (492)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----t~~e~l~Hp~f~~~~ 427 (492)
... ++..+++++++||.+||+.||.+|+ |++++++||||+++.
T Consensus 217 ---~~~------------~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~ 264 (316)
T d1fota_ 217 ---ELR------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 264 (316)
T ss_dssp ---CCC------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred ---CCC------------CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCC
Confidence 122 2245799999999999999999996 899999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-58 Score=451.58 Aligned_cols=279 Identities=25% Similarity=0.399 Sum_probs=205.4
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
.++|.+.+.||+|+||+||+|+++.+|+.||+|++..+ .....+|+.+|+.++|||||+++++| .+...+
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~~ 79 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGEI 79 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEE-----ECSSEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEE
Confidence 45799999999999999999999999999999998543 23456899999999999999999999 444568
Q ss_pred EEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 211 NLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 211 ~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
|||||||.|+ |..++.. ...+++..++.++.||+.||.|||+.+||+||||||+||||+.++ .+||+|||+|+.
T Consensus 80 ~iVmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~ 154 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQ 154 (322)
T ss_dssp EEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHH
T ss_pred EEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC-CEEEeeCCCccc
Confidence 9999999964 4444432 356899999999999999999999624999999999999999888 799999999986
Q ss_pred cCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhcC
Q 011138 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQ-LVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~-~~~i~~~~g~p~~~~~~~~~ 368 (492)
... ....+.+||+.|||||++.+. .|+.++||||+||++|||++|+.||.+.+..+. ...+....|.+.........
T Consensus 155 ~~~-~~~~~~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
T d1s9ja_ 155 LID-SMANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232 (322)
T ss_dssp HHH-HTC---CCSSCCCCHHHHHCS-CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred cCC-CccccccCCccccCchHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence 543 234467999999999999875 499999999999999999999999988664332 22233333322211100000
Q ss_pred CC-----CcccCCCc---------ccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 369 PN-----YTEFKFPQ---------IKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 369 ~~-----~~~~~~~~---------~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
.. +.....+. .............++++++|||.+||++||.+|||++|+|+||||++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp -------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 00 00000000 000000011112468899999999999999999999999999999864
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-56 Score=446.51 Aligned_cols=283 Identities=34% Similarity=0.612 Sum_probs=229.5
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccC-CCceE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY 209 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~-~~~~~ 209 (492)
.+|.+.+.||+|+||+||+|.++.+|+.||||++.... ....+|+.+|+.++|||||+++++|..... .....
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 46999999999999999999999999999999986432 234579999999999999999999865442 23445
Q ss_pred EEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
+|+|||||+..+..... ...+++..++.++.||+.||.|||+ +|||||||||+|||++.++ .+||+|||+|+.
T Consensus 98 ~~lv~e~~~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~-~~IiHrDiKp~NIL~~~~~-~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 98 FYLVMPFMGTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNEDC-ELKILDFGLARQ 170 (346)
T ss_dssp CEEEEECCSEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred EEEEEecccccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCcchhhccccc-ccccccccceec
Confidence 78999999876665543 2569999999999999999999997 9999999999999999888 799999999986
Q ss_pred cCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
. .......+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+....+.++.+.+.....
T Consensus 171 ~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 171 A--DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp C--CSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred c--CCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence 5 34455678999999999998877789999999999999999999999999999999999999999999887654432
Q ss_pred CCc---ccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCC
Q 011138 370 NYT---EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (492)
Q Consensus 370 ~~~---~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~ 429 (492)
... ...++......+.. ....++++++|||.+||++||.+|||+.|+|+||||+.+.++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310 (346)
T ss_dssp HHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred hhhhhhhccCCcccccchHH-hccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence 110 01122223333332 235689999999999999999999999999999999988754
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.6e-56 Score=435.82 Aligned_cols=277 Identities=33% Similarity=0.607 Sum_probs=225.9
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
++|.+.+.||+|+||+||+|+++ +|+.||||++... .....+|+.+|+.++|||||+++++|. +...+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKKRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSSCE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecc-----cCCce
Confidence 47999999999999999999985 7899999998543 234568999999999999999999994 44458
Q ss_pred EEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 211 ~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
++||||+.++++..+. .....+++..++.++.||+.||+|||+ +|||||||||+|||++.++ .+||+|||++...
T Consensus 76 ~i~~e~~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~IvHrDiKp~NIll~~~~-~~kl~DfG~a~~~ 150 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINREG-ELKIADFGLARAF 150 (286)
T ss_dssp EEEEECCSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTS-CEEECCTTHHHHH
T ss_pred eEEEEeehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhcc-CcEEecCCCCceeeEcCCC-CEEecccccceec
Confidence 8999999988776543 335679999999999999999999997 8999999999999999888 7999999999876
Q ss_pred CCCC-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 291 VPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 291 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
.... ......|++.|+|||++.+...++.++|||||||++|||++|++||.+.+..+++.++.+.++.|....+.....
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred ccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhh
Confidence 4332 334567899999999998878789999999999999999999999999999999999999999988776543321
Q ss_pred CC-cccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCC
Q 011138 370 NY-TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (492)
Q Consensus 370 ~~-~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~ 425 (492)
.. ....+......++. .+...++++++|||++||++||++|||+.|+|+||||++
T Consensus 231 ~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWE-SFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp STTCCTTCCCCCCCCGG-GTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hhhcccccccccCcchh-hhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 11 01112222222222 234568999999999999999999999999999999985
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-56 Score=446.22 Aligned_cols=249 Identities=27% Similarity=0.436 Sum_probs=213.4
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
.++|++.+.||+|+||.||+|+++.+|+.||||++.+.. ....+|+.+|+.++|||||+++++| .+..
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~ 114 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-----cccc
Confidence 457999999999999999999999999999999985432 2345899999999999999999998 4555
Q ss_pred EEEEEeeechhhHH-HHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 209 YLNLVLEYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 209 ~~~lV~E~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
.+++||||+.++.+ ..+. ....+++..++.|+.||+.||.|||+ +|||||||||+||||+.++ .+||+|||+|
T Consensus 115 ~~~~v~e~~~~g~l~~~l~----~~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHRDIKP~NILl~~~g-~ikL~DFG~a 188 (350)
T d1rdqe_ 115 NLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQG-YIQVTDFGFA 188 (350)
T ss_dssp EEEEEEECCTTCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred ccccccccccccchhhhHh----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCcCCHHHcccCCCC-CEEeeeceee
Confidence 68999999987543 3332 23579999999999999999999997 9999999999999999888 7999999999
Q ss_pred cccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 288 KMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
+.... .....+||+.|||||++.+. .|+.++|||||||++|||++|++||.+.+....+..|...
T Consensus 189 ~~~~~--~~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~------------ 253 (350)
T d1rdqe_ 189 KRVKG--RTWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG------------ 253 (350)
T ss_dssp EECSS--CBCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred eeccc--ccccccCccccCCHHHHcCC-CCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC------------
Confidence 87643 34567999999999999765 4899999999999999999999999998887777777551
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcC-----CHHHhhCCCCCCCCC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLR 427 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----t~~e~l~Hp~f~~~~ 427 (492)
... ++..+++++.+||++||+.||.+|+ |++++++||||+++.
T Consensus 254 -----~~~------------~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~ 301 (350)
T d1rdqe_ 254 -----KVR------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp -----CCC------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred -----CCC------------CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCC
Confidence 111 2245899999999999999999995 999999999999764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.6e-56 Score=431.26 Aligned_cols=254 Identities=28% Similarity=0.442 Sum_probs=216.5
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------------hhHHHHHHHHHHcC-CCCccccceeeeec
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------------RYKNRELQIMRLLN-HPNVVSLKHCFFST 202 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------------~~~~~E~~il~~l~-h~nIv~l~~~~~~~ 202 (492)
.+|++.+.||+|+||+||+|+++.+|+.||||++.+.. ....+|+.+++.++ |||||+++++|
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--- 79 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY--- 79 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE---
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec---
Confidence 46999999999999999999999999999999985431 13457999999997 99999999999
Q ss_pred cCCCceEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEE
Q 011138 203 TEKDELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKI 281 (492)
Q Consensus 203 ~~~~~~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL 281 (492)
.+..++|||||||++ +|.+.+.. ...+++..++.|+.||+.||+|||+ +||+||||||+|||++.++ .+||
T Consensus 80 --~~~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~~~-~~kl 151 (277)
T d1phka_ 80 --ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDDDM-NIKL 151 (277)
T ss_dssp --ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTC-CEEE
T ss_pred --ccCcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEcCCC-CeEE
Confidence 555679999999985 56655432 4579999999999999999999997 9999999999999999888 7999
Q ss_pred eeecCccccCCCCCCccceeccCccCchhhcC-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 011138 282 CDFGSAKMLVPGEPNISYICSRYYRAPELIFG-----ATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKIL 356 (492)
Q Consensus 282 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~ 356 (492)
+|||+++....+......+||+.|+|||++.+ ...++.++||||+||++|+|++|+.||.+.+..+.+..+...
T Consensus 152 ~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~- 230 (277)
T d1phka_ 152 TDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG- 230 (277)
T ss_dssp CCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-
T ss_pred ccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC-
Confidence 99999998776666667889999999999853 344788999999999999999999999999887777776652
Q ss_pred CCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 357 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 357 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
...++. .....+|+++++||.+||+.||.+|||++|+|+||||++.
T Consensus 231 ----------------~~~~~~--------~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 231 ----------------NYQFGS--------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp ----------------CCCCCT--------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred ----------------CCCCCC--------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 111111 1124689999999999999999999999999999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-57 Score=443.78 Aligned_cols=255 Identities=28% Similarity=0.422 Sum_probs=216.6
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch---hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~---~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
.++|.+++.||+|+||+||+|.++.+|+.||||++.... ....+|+++|+.++|||||+++++|. +..++||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~~l 78 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE-----SMEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEEE
Confidence 357999999999999999999999999999999996543 34568999999999999999999984 4446999
Q ss_pred Eeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCC-CcEEEeeecCcccc
Q 011138 213 VLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT-HQLKICDFGSAKML 290 (492)
Q Consensus 213 V~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~-~~vkL~DFG~a~~~ 290 (492)
|||||.| +|.+.+.. ....+++..++.|+.||+.||+|||+ +||+||||||+|||++.++ ..+||+|||+++..
T Consensus 79 vmE~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~-~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 79 IFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 9999986 45554432 23468999999999999999999997 9999999999999997543 37999999999887
Q ss_pred CCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 011138 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (492)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 370 (492)
..........||+.|+|||++.+. .|+.++|||||||++|+|++|.+||.+.+..+.+..|.+....++.
T Consensus 155 ~~~~~~~~~~~t~~y~ape~~~~~-~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~--------- 224 (321)
T d1tkia_ 155 KPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE--------- 224 (321)
T ss_dssp CTTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH---------
T ss_pred ccCCcccccccccccccchhccCC-CCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCh---------
Confidence 666656677899999999998654 5899999999999999999999999999988888888763211111
Q ss_pred CcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCC
Q 011138 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDD 425 (492)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~ 425 (492)
..++.+|+++++||.+||+.||.+|||+.|+++||||++
T Consensus 225 ----------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 225 ----------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp ----------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred ----------------hhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 122457999999999999999999999999999999975
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.6e-56 Score=446.72 Aligned_cols=254 Identities=24% Similarity=0.370 Sum_probs=206.1
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHH---HHHHHHcCCCCccccceeeeeccCC
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRE---LQIMRLLNHPNVVSLKHCFFSTTEK 205 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E---~~il~~l~h~nIv~l~~~~~~~~~~ 205 (492)
.++|.+.++||+|+||.||+|+++.+|+.||||++.+.. ....+| +.+++.++|||||+++++| .
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~-----~ 77 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----H 77 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----E
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE-----E
Confidence 357999999999999999999999999999999985432 122234 5566667899999999998 4
Q ss_pred CceEEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeee
Q 011138 206 DELYLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDF 284 (492)
Q Consensus 206 ~~~~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DF 284 (492)
+...+|||||||.| +|...+.. ...+++..++.|+.||+.||.|||+ +|||||||||+|||++.++ .+||+||
T Consensus 78 ~~~~~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~-~~iiHrDlKP~NILl~~~g-~iKl~DF 151 (364)
T d1omwa3 78 TPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHG-HVRISDL 151 (364)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECSSS-CEEECCC
T ss_pred ECCEEEEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHH-CCccceeeccceeEEcCCC-cEEEeee
Confidence 45568999999985 45444432 4568899999999999999999997 9999999999999999888 7999999
Q ss_pred cCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 011138 285 GSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEI 364 (492)
Q Consensus 285 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~ 364 (492)
|+|+..... .....+||+.|+|||++.+...|+.++|||||||++|||++|+.||.+.+..+...........
T Consensus 152 Gla~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~------ 224 (364)
T d1omwa3 152 GLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM------ 224 (364)
T ss_dssp TTCEECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC------
T ss_pred ceeeecCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC------
Confidence 999876443 3446789999999999976667999999999999999999999999876544332222111000
Q ss_pred hhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCC-----HHHhhCCCCCCCCC
Q 011138 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCT-----ALEACAHPFFDDLR 427 (492)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t-----~~e~l~Hp~f~~~~ 427 (492)
. ..++..+++++++||.+||++||.+||| ++|+++||||+++.
T Consensus 225 --------~------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~ 272 (364)
T d1omwa3 225 --------A------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272 (364)
T ss_dssp --------C------------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred --------C------------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCC
Confidence 0 1123468999999999999999999999 79999999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-55 Score=438.84 Aligned_cols=285 Identities=34% Similarity=0.659 Sum_probs=231.2
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
+|++++.||+|+||+||+|.++.+|+.||||++.... ....+|+.+|+.|+||||+++++++.........++|+
T Consensus 9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l 88 (345)
T d1pmea_ 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL 88 (345)
T ss_dssp TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence 5999999999999999999999999999999986432 23457999999999999999999986655455556778
Q ss_pred EeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCC
Q 011138 213 VLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVP 292 (492)
Q Consensus 213 V~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~ 292 (492)
||++++++|.+++.. ..+++..++.++.||+.||+|||+ +|||||||||+||||+.++ .+||+|||+|+....
T Consensus 89 ~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~-~~iiHRDIKp~NILl~~~~-~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 89 VTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADP 161 (345)
T ss_dssp EEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTC-CEEECCCTTCEECCG
T ss_pred EEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCcceEEECCCC-CEEEcccCceeeccC
Confidence 888887888876643 469999999999999999999997 9999999999999999887 799999999976543
Q ss_pred CC----CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 293 GE----PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 293 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
.. .....+||+.|+|||++.....|+.++||||+||++|+|++|++||.+.+..++...+...++.+.........
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence 32 23456799999999998766678999999999999999999999999999999999999988888876543321
Q ss_pred CCC---cccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCC
Q 011138 369 PNY---TEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPN 430 (492)
Q Consensus 369 ~~~---~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~ 430 (492)
... .....+.....+|... ...+++++++||.+||++||.+|||+.|+|+||||+....+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~ 305 (345)
T d1pmea_ 242 NLKARNYLLSLPHKNKVPWNRL-FPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 305 (345)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHH-CTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred hhhhhcccccCCccCCCCHHHh-CCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCc
Confidence 100 0112333333334332 346799999999999999999999999999999999876643
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-56 Score=432.53 Aligned_cols=245 Identities=27% Similarity=0.421 Sum_probs=205.1
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch----------hhHHHHHHHHHHcC--CCCccccceeeeeccC
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----------RYKNRELQIMRLLN--HPNVVSLKHCFFSTTE 204 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~----------~~~~~E~~il~~l~--h~nIv~l~~~~~~~~~ 204 (492)
.+|++++.||+|+||+||+|++..+|+.||||++.++. ....+|+.+|++++ |||||+++++|
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~----- 78 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF----- 78 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE-----
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE-----
Confidence 36999999999999999999999999999999986432 12347999999997 89999999998
Q ss_pred CCceEEEEEeeechh--hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEe
Q 011138 205 KDELYLNLVLEYISE--TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC 282 (492)
Q Consensus 205 ~~~~~~~lV~E~~~~--~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~ 282 (492)
.+...+|+||||+.+ .+...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.+...+||+
T Consensus 79 ~~~~~~~lv~e~~~~~~~l~~~~~----~~~~l~e~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NIll~~~~~~vkl~ 153 (273)
T d1xwsa_ 79 ERPDSFVLILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLI 153 (273)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEEC
T ss_pred eeCCeEEEEEEeccCcchHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCcccceEEecCCCeEEEC
Confidence 455568999999974 3333332 24679999999999999999999997 9999999999999998765589999
Q ss_pred eecCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 011138 283 DFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (492)
Q Consensus 283 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~ 362 (492)
|||+|+... .....+..||+.|+|||++.+...++.++|||||||++|||++|+.||.+.+ .+.+
T Consensus 154 DFG~a~~~~-~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~-------- 218 (273)
T d1xwsa_ 154 DFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR-------- 218 (273)
T ss_dssp CCTTCEECC-SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH--------
T ss_pred ccccceecc-cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhh--------
Confidence 999998653 3345567899999999999877767888999999999999999999997632 1222
Q ss_pred HHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCC
Q 011138 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLR 427 (492)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~ 427 (492)
.... ++..+|+++++||.+||+.||++|||++|+++||||+++.
T Consensus 219 ---------~~~~------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 219 ---------GQVF------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp ---------CCCC------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred ---------cccC------------CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 1111 2346899999999999999999999999999999999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-55 Score=435.59 Aligned_cols=250 Identities=27% Similarity=0.480 Sum_probs=209.8
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHH-HHcCCCCccccceeeeeccCCCce
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIM-RLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il-~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
++|.+++.||+|+||+||+|+++.+|+.||||++.++. ....+|..++ +.++|||||+++++| .+..
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-----~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----ECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE-----ccCC
Confidence 46999999999999999999999999999999986432 1233566655 578999999999998 5555
Q ss_pred EEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 209 YLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 209 ~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
++|||||||+++ |...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 77 ~~yivmEy~~~g~L~~~i~----~~~~~~e~~~~~~~~qi~~al~ylH~-~~iiHrDikp~NiL~~~~~-~~kl~DFG~a 150 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDKDG-HIKIADFGMC 150 (320)
T ss_dssp EEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred ceeEEEeecCCCcHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCcccceeecCCC-ceeccccchh
Confidence 799999999874 444433 34578999999999999999999997 9999999999999999887 7999999999
Q ss_pred cccCCCC-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 011138 288 KMLVPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (492)
Q Consensus 288 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~ 366 (492)
+...... .....+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+..+.+..|..
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~------------ 217 (320)
T d1xjda_ 151 KENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM------------ 217 (320)
T ss_dssp BCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------------
T ss_pred hhcccccccccccCCCCCcCCHHHHcCC-CCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc------------
Confidence 8664333 34457899999999999765 489999999999999999999999999888777766654
Q ss_pred cCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHH-HhhCCCCCCCCC
Q 011138 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL-EACAHPFFDDLR 427 (492)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~-e~l~Hp~f~~~~ 427 (492)
.... +++.+|+++++||++||+.||.+|||+. ++++||||+++.
T Consensus 218 -----~~~~------------~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~ 262 (320)
T d1xjda_ 218 -----DNPF------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 262 (320)
T ss_dssp -----CCCC------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred -----CCCC------------CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCC
Confidence 1111 2245899999999999999999999995 899999999864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.3e-55 Score=434.82 Aligned_cols=282 Identities=30% Similarity=0.550 Sum_probs=227.1
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc-hhhHHHHHHHHHHcC-CCCccccceeeeeccCCCceEEEEEe
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD-KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
++|++++.||+|+||+||+|+++.+|+.||||++... .....+|+++|+.+. ||||++++++|... ...++++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~---~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEec---CCCceeEEE
Confidence 5799999999999999999999999999999998654 345678999999995 99999999988532 334588999
Q ss_pred eechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCCC
Q 011138 215 EYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPGE 294 (492)
Q Consensus 215 E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~~ 294 (492)
|||.++.+.. ..+.+++..++.++.||+.||+|||+ +|||||||||+||||+.++..+||+|||+|+......
T Consensus 112 e~~~~~~L~~------~~~~l~e~~i~~i~~qil~aL~~LH~-~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 112 EHVNNTDFKQ------LYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp ECCCSCBGGG------TTTSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred eecCCCcHHH------HhcCCCHHHHHHHHHHHHHHHHHHhh-cccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 9999765432 13568999999999999999999997 9999999999999999776579999999999887777
Q ss_pred CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 011138 295 PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGE-SGVDQLVEIIKILGTPTREEIKCMNPNYTE 373 (492)
Q Consensus 295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~-~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~ 373 (492)
.....+||+.|+|||++.+...|+.++||||+||++|+|++|+.||... +..++...+.+.+|.|....+.........
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 264 (328)
T d3bqca1 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264 (328)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence 7778899999999999988777899999999999999999999999754 456677778888887655444322111111
Q ss_pred cCCC----cccCCCcccc----cCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCC
Q 011138 374 FKFP----QIKAHPWHKI----FHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRD 428 (492)
Q Consensus 374 ~~~~----~~~~~~~~~~----~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~ 428 (492)
..+. ......|... ....++++++|||++||++||.+|||++|+|+||||+++.+
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 1111 0111111111 22457899999999999999999999999999999998754
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=423.49 Aligned_cols=283 Identities=34% Similarity=0.548 Sum_probs=230.8
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
.+|++.+.||+|+||+||+|+++.+|+.||||++..+ .....+|+.+|+.++|||||+++++| .+...+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-----~~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccc-----ccccce
Confidence 3699999999999999999999999999999998533 23446899999999999999999998 445568
Q ss_pred EEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 211 ~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
++||+++.++.+.... .....+++..++.++.|++.||+|||+ +|||||||||+|||++.++ .+||+|||.++..
T Consensus 77 ~iv~~~~~~~~l~~~~---~~~~~~~~~~~~~~~~q~~~aL~~lH~-~~IvHrDiKP~NIli~~~~-~~kl~DFG~a~~~ 151 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINRNG-ELKLANFGLARAF 151 (292)
T ss_dssp EEEEECCSEEHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred eEEeeecccccccccc---ccccccchhHHHHHHHHHHHHHHHhhc-CCEeeecccCcccccccCC-ceeeeecchhhcc
Confidence 8999999987665433 345678999999999999999999997 9999999999999999887 7999999999876
Q ss_pred CCCC-CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 291 VPGE-PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPL-FPGESGVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 291 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~p-f~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
.... ......+++.|+|||++.+...++.++|||||||++|||++|+.| |.+.+..+++..+....+.+....+....
T Consensus 152 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred cCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence 4433 344557789999999998777789999999999999999999887 55667777888888888888776554433
Q ss_pred CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCC
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~ 429 (492)
........+..............+++++++||.+||+.||.+|||++|+|+||||+++.+|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~~ 292 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSCC
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCCC
Confidence 2222222222222222333446789999999999999999999999999999999987654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-55 Score=437.52 Aligned_cols=264 Identities=26% Similarity=0.388 Sum_probs=209.3
Q ss_pred ccceeEe-eeeccCCceEEEEEEEcCCCCEEEEEEeccchhhHHHHHHHHH-HcCCCCccccceeeeeccCCCceEEEEE
Q 011138 136 TISYMAE-RVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRYKNRELQIMR-LLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 136 ~~~y~~~-~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~E~~il~-~l~h~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
.++|.+. ++||+|+||+||+|+++.+|+.||||++... ....+|+.++. .++|||||+++++|.... ....++|||
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~~~~~iv 87 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIV 87 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-HHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCCCEEEEE
Confidence 4579876 5699999999999999999999999998654 44667999865 458999999999985433 345678999
Q ss_pred eeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCC--CcEEEeeecCcccc
Q 011138 214 LEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT--HQLKICDFGSAKML 290 (492)
Q Consensus 214 ~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~--~~vkL~DFG~a~~~ 290 (492)
||||+| +|.+.+.. .....+++..++.|+.||+.||+|||+ +||+||||||+|||++.+. ..+||+|||+|+..
T Consensus 88 mEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH~-~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~ 164 (335)
T d2ozaa1 88 MECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164 (335)
T ss_dssp EECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHHH-cCCccccccccccccccccccccccccccceeeec
Confidence 999985 66665542 223579999999999999999999997 9999999999999998532 26999999999987
Q ss_pred CCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 011138 291 VPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (492)
Q Consensus 291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 370 (492)
.........+||+.|||||++.+. .|+.++|||||||++|+|+||++||.+.+..+....+.... .
T Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~-~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i-------------~ 230 (335)
T d2ozaa1 165 TSHNSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI-------------R 230 (335)
T ss_dssp CCCCCCCCCSCCCSSCCCCCCCGG-GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CC-------------C
T ss_pred cCCCccccccCCcccCCcHHHcCC-CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHH-------------h
Confidence 777677778999999999999654 58999999999999999999999998876544443332210 0
Q ss_pred CcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
...+.+|. ..+..+|+++++||++||++||++|||+.|+++||||++.
T Consensus 231 ~~~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 231 MGQYEFPN--------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp SCSSSCCT--------THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred cCCCCCCC--------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 01122221 1123579999999999999999999999999999999753
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-54 Score=427.55 Aligned_cols=286 Identities=28% Similarity=0.448 Sum_probs=223.9
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccC---CC
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE---KD 206 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~---~~ 206 (492)
..+|.+.+.||+|+||+||+|++..+|+.||||++... .....+|+.+|+.++||||+++++++..... ..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 45799999999999999999999999999999988433 2335689999999999999999998855332 22
Q ss_pred ceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 207 ELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 207 ~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
...+|+||||+.++++.... .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~-~~ivHrDlKp~NILl~~~~-~~kl~dfg~ 163 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITRDG-VLKLADFGL 163 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTS-CEEECCCTT
T ss_pred CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhcc-CCEEecCcCchheeecCCC-cEEeeecce
Confidence 34588999999988766433 334678999999999999999999997 9999999999999999888 799999999
Q ss_pred ccccCCC-----CCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 011138 287 AKMLVPG-----EPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTR 361 (492)
Q Consensus 287 a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~ 361 (492)
++..... ......+||+.|+|||++.+...|+.++|||||||++|||++|++||.+.+..+.+..+.+.++.+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9765422 23345689999999999988777999999999999999999999999999999999999999999887
Q ss_pred HHHhhcCCCCcccCCCcccC--CCcccc-cCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 362 EEIKCMNPNYTEFKFPQIKA--HPWHKI-FHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~--~~~~~~-~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
+.+...........+..... ...... .....+++++|||.+||++||++|||+.|+|+||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 65543321111111111100 000000 011247789999999999999999999999999999853
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-54 Score=432.89 Aligned_cols=284 Identities=32% Similarity=0.556 Sum_probs=221.1
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccC-CCceE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY 209 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~-~~~~~ 209 (492)
.+|++.+.||+|+||+||+|.++.+|+.||||++... .....+|+.+|+.++|||||+++++|..... .+..+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 3699999999999999999999999999999998543 1235589999999999999999999865432 35568
Q ss_pred EEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
+|+|||||.++++... ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+|++|||+++.
T Consensus 97 ~~iv~Ey~~~~l~~~~------~~~~~~~~i~~~~~qil~gl~~LH~-~giiHrDlKP~Nil~~~~~-~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDC-TLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEEHHHHH------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCCCC---
T ss_pred eEEEEeccchHHHHhh------hcCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCcccccccccc-ceeeechhhhhc
Confidence 9999999999877654 3568999999999999999999997 8999999999999999888 799999999987
Q ss_pred cCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
..........+||+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+.......++..++.+..+.+.....
T Consensus 169 ~~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 169 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp ------------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred cccccccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 7666666778899999999999765 589999999999999999999999999999999999999999998887754332
Q ss_pred CC----------cccCCCccc---CCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCC
Q 011138 370 NY----------TEFKFPQIK---AHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDP 429 (492)
Q Consensus 370 ~~----------~~~~~~~~~---~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~ 429 (492)
.. .....+... ............++++++||++||++||++||||+|+|+||||+...++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~ 320 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP 320 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCc
Confidence 11 111111100 0000111112357789999999999999999999999999999987653
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=427.59 Aligned_cols=285 Identities=34% Similarity=0.582 Sum_probs=227.9
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch------hhHHHHHHHHHHcCCCCccccceeeeeccC-CCceE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK------RYKNRELQIMRLLNHPNVVSLKHCFFSTTE-KDELY 209 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~-~~~~~ 209 (492)
.+|++.+.||+|+||+||+|+++.+|+.||||++.+.. ....+|+.+|+.++|||||+++++|..... .+..+
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 46999999999999999999999999999999986432 234589999999999999999999855443 23334
Q ss_pred EEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
+++++++++++|.+++. .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+|++|||++..
T Consensus 98 ~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~-~giiHrDiKp~NILi~~~~-~~kl~dfg~a~~ 170 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDC-ELKILDFGLARH 170 (348)
T ss_dssp CEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTC-CEEECCC----C
T ss_pred EEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCCccccccccc-cccccccchhcc
Confidence 55566655566666542 3569999999999999999999997 9999999999999999888 799999999975
Q ss_pred cCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 011138 290 LVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMNP 369 (492)
Q Consensus 290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~ 369 (492)
. .....+..||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+.+..+.+..+.......
T Consensus 171 ~--~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (348)
T d2gfsa1 171 T--DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248 (348)
T ss_dssp C--TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred c--CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccc
Confidence 4 34455678999999999988877789999999999999999999999999999999999999999988776543321
Q ss_pred CCc---ccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCCCCCCC
Q 011138 370 NYT---EFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDLRDPNT 431 (492)
Q Consensus 370 ~~~---~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~~~~~~ 431 (492)
... ...++......+... ...++++++|||.+||++||.+|||+.|+|+||||+++.++..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~ 312 (348)
T d2gfsa1 249 ESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 312 (348)
T ss_dssp HHHHHHHTTSCCCCCCCHHHH-STTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTS
T ss_pred hhhhhhhhhcccCCCcchhhh-cCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCcc
Confidence 110 011222222223222 2468999999999999999999999999999999999876543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.4e-53 Score=409.45 Aligned_cols=256 Identities=25% Similarity=0.366 Sum_probs=201.2
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch-------hhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK-------RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-------~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
++|++.+.||+|+||+||+|++..+|+.||||++..+. ..+.+|+.+|+.++|||||++++++.... ....+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~~ 85 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGPL 85 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCce
Confidence 46999999999999999999999999999999985431 23468999999999999999999986544 34456
Q ss_pred EEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
+|||||||+|+.+... ......+++..++.++.||+.||+|||+ +|||||||||+|||++.++ .++|+|||.+..
T Consensus 86 ~~lvmE~~~g~~L~~~---~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~iiHrDiKP~NIll~~~~-~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDI---VHTEGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISATN-AVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHH---HHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTS-CEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhh---hcccCCCCHHHHHHHHHHHHHHHHHHHh-CCccCccccCcccccCccc-cceeehhhhhhh
Confidence 8899999997644322 2224579999999999999999999997 9999999999999999888 799999999875
Q ss_pred cCCCC----CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 011138 290 LVPGE----PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (492)
Q Consensus 290 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~ 365 (492)
..... .....+||+.|+|||++.+. .|+.++|||||||++|||+||++||.+.+..+.+.+++..-..
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~------- 232 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI------- 232 (277)
T ss_dssp CC----------------TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC-------
T ss_pred hccccccccccccccCcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCC-------
Confidence 53222 33456899999999999664 5899999999999999999999999998888777776652111
Q ss_pred hcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCC
Q 011138 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFD 424 (492)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~ 424 (492)
.+ ...++.+|+++.+||.+||++||.+||+..+.+.|+|++
T Consensus 233 ----------~~--------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 233 ----------PP--------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp ----------CG--------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ----------CC--------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 11 113356899999999999999999999555555566653
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-52 Score=407.89 Aligned_cols=253 Identities=21% Similarity=0.321 Sum_probs=203.1
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc---hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
...+|.+.+.||+|+||+||+|.+..+|+.||||++..+ ...+.+|+.+|+.++|||||+++++|. +...++
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~ 89 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFY 89 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSCE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEe-----eCCeeE
Confidence 345799999999999999999999999999999998654 344568999999999999999999983 334578
Q ss_pred EEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 212 LVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 212 lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
||||||+++ +...+.. .....+++..+..++.||+.||+|||+ +||+||||||+||||+.++ .+||+|||+|+..
T Consensus 90 iv~E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlKp~NILl~~~~-~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENH-LVKVADFGLSRLM 165 (287)
T ss_dssp EEEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-CEEECCCCCTTTC
T ss_pred EEeecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHHH-CCcccCccccCeEEECCCC-cEEEccccceeec
Confidence 999999964 4444322 234678999999999999999999997 9999999999999999888 8999999999876
Q ss_pred CCCCCC--ccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 291 VPGEPN--ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 291 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
...... ....||+.|+|||++.+. .|+.++|||||||++|||++|..||........+.+++..
T Consensus 166 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~------------- 231 (287)
T d1opja_ 166 TGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK------------- 231 (287)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT-------------
T ss_pred CCCCceeeccccccccccChHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhc-------------
Confidence 443322 234689999999999765 4899999999999999999976666555545555444431
Q ss_pred CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCCCCCCCC
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAHPFFDDL 426 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~Hp~f~~~ 426 (492)
... ..++..+++++++||.+||+.||.+|||+.|+++ ||+.+
T Consensus 232 ----~~~----------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~~ 273 (287)
T d1opja_ 232 ----DYR----------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ--AFETM 273 (287)
T ss_dssp ----TCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred ----CCC----------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHHH
Confidence 000 0123468999999999999999999999999975 45443
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=404.79 Aligned_cols=249 Identities=22% Similarity=0.291 Sum_probs=196.1
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
...+|.+++.||+|+||+||+|+. +..||||++... ...+.+|+.+|++++|||||++++++. + .
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-----~-~ 76 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-----A-P 76 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----S-S
T ss_pred ccccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-----c-c
Confidence 345699999999999999999974 346999998432 234568999999999999999998752 1 1
Q ss_pred EEEEEeeechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 209 YLNLVLEYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 209 ~~~lV~E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
.++||||||++ +|.+.+. .....+++..+..|+.||+.||+|||+ +|||||||||+||||+.++ .+||+|||+|
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~gl~yLH~-~~ivHrDlKp~NiLl~~~~-~~Kl~DFGla 151 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLHA-KSIIHRDLKSNNIFLHEDL-TVKIGDFGLA 151 (276)
T ss_dssp SCEEEEECCCEEEHHHHHH---TSCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEETTS-SEEECCCCCS
T ss_pred EEEEEEecCCCCCHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHhc-CCEeccccCHHHEEEcCCC-CEEEccccce
Confidence 36899999985 4554432 234568999999999999999999997 9999999999999999888 7999999999
Q ss_pred cccCCCC---CCccceeccCccCchhhcCC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 011138 288 KMLVPGE---PNISYICSRYYRAPELIFGA--TEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTRE 362 (492)
Q Consensus 288 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~ 362 (492)
+...... ......||+.|||||++.+. ..|+.++|||||||++|||+||+.||.+.+....+..++.....+
T Consensus 152 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~--- 228 (276)
T d1uwha_ 152 TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS--- 228 (276)
T ss_dssp CC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCC---
T ss_pred eeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC---
Confidence 8664322 23356899999999999643 348999999999999999999999999988777766655431111
Q ss_pred HHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
|. ....+..+++++.+||.+||+.||.+|||+.|+++|
T Consensus 229 --------------p~------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 229 --------------PD------LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp --------------CC------GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------Cc------chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 10 011234678999999999999999999999999876
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-52 Score=412.22 Aligned_cols=250 Identities=23% Similarity=0.345 Sum_probs=201.5
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCCC-----EEEEEEeccc-----hhhHHHHHHHHHHc-CCCCccccceeeeeccC
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETGD-----SVAIKKVLQD-----KRYKNRELQIMRLL-NHPNVVSLKHCFFSTTE 204 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g~-----~vAiK~~~~~-----~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~ 204 (492)
..+|.+++.||+|+||+||+|++..+++ .||+|.+... ...+.+|+.+|+++ +|||||++++++
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~----- 110 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC----- 110 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE-----
Confidence 3579999999999999999999876654 6999988543 23456799999988 899999999998
Q ss_pred CCceEEEEEeeechh-hHHHHhhhhhh-------------------cCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCC
Q 011138 205 KDELYLNLVLEYISE-TVYRVSKHYTR-------------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRD 264 (492)
Q Consensus 205 ~~~~~~~lV~E~~~~-~l~~~~~~~~~-------------------~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrD 264 (492)
.+...+|||||||++ +|.+.+..... ....+++..++.|+.||+.||+|||+ +||||||
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~-~~IiHRD 189 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRD 189 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEETT
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecc
Confidence 444458999999986 55555433211 12458889999999999999999997 9999999
Q ss_pred CCCCceEEcCCCCcEEEeeecCccccCCCCCC---ccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCC
Q 011138 265 IKPQNLLVNPHTHQLKICDFGSAKMLVPGEPN---ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLF 340 (492)
Q Consensus 265 lKp~NILl~~~~~~vkL~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf 340 (492)
|||+|||++.++ .+||+|||+|+........ ....||+.|||||++.+. .|+.++|||||||++|||++ |.+||
T Consensus 190 lKp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 190 LAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp CSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CchhccccccCC-eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC-CCCcceeccchhHHHHHHHhCCCCCC
Confidence 999999999888 8999999999876444322 346789999999999765 48999999999999999997 99999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 341 PGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 341 ~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
.+.+..+.+.+++.. ...++ .+..+|+++++||.+||+.||++|||++||++|
T Consensus 268 ~~~~~~~~~~~~~~~-----------------~~~~~----------~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 268 PGIPVDANFYKLIQN-----------------GFKMD----------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp TTCCCSHHHHHHHHT-----------------TCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHhc-----------------CCCCC----------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 988777777766552 11111 234579999999999999999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.4e-52 Score=406.25 Aligned_cols=246 Identities=23% Similarity=0.323 Sum_probs=188.6
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCC---EEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGD---SVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~---~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
..|.+.++||+|+||+||+|.++.+|+ .||||.+... ...+.+|+.+|++++|||||++++++. +..
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~-----~~~ 100 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVT-----KST 100 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SSS
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----eCC
Confidence 469999999999999999999987765 5899987432 234568999999999999999999983 333
Q ss_pred EEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 209 ~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
.+|+|||||+++.+..+. ......+++..+..++.||+.||.|||+ +|||||||||+||||+.++ .+||+|||+|+
T Consensus 101 ~~~iv~Ey~~~g~L~~~~--~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHrDlKp~NILl~~~~-~~Kl~DFGla~ 176 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYLAD-MNYVHRDLAARNILVNSNL-VCKVSDFGLSR 176 (299)
T ss_dssp SCEEEEECCTTEEHHHHH--HTTTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCC----
T ss_pred EEEEEEEecCCCcceeee--ccccCCCCHHHHHHHHHHHHHHHHHHhh-CCCccCccccceEEECCCC-cEEECCcccce
Confidence 488999999976544322 2234568999999999999999999997 9999999999999999888 79999999998
Q ss_pred ccCCCCCC------ccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 011138 289 MLVPGEPN------ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTR 361 (492)
Q Consensus 289 ~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~ 361 (492)
........ ....||+.|||||++.+. .|+.++|||||||++|||+| |++||.+.+..+.+..+.+..
T Consensus 177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~----- 250 (299)
T d1jpaa_ 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDY----- 250 (299)
T ss_dssp -------------------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-----
T ss_pred EccCCCCcceeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----
Confidence 76443221 124578999999999764 58999999999999999998 899999988776665554311
Q ss_pred HHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 362 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
..+ .+..+++++.+||.+||+.||.+|||+.|++++
T Consensus 251 -------------~~~----------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 251 -------------RLP----------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp -------------CCC----------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred -------------CCC----------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 111 123578999999999999999999999998764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-52 Score=397.51 Aligned_cols=243 Identities=20% Similarity=0.330 Sum_probs=189.1
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc---hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEe
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
+|.+.+.||+|+||+||+|.+. +++.||||++..+ ...+.+|+++++.++|||||++++++.. ...+++||
T Consensus 6 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-----~~~~~lv~ 79 (263)
T d1sm2a_ 6 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICLVF 79 (263)
T ss_dssp CEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCEEEE
T ss_pred HcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceecc-----CCceEEEE
Confidence 5999999999999999999975 5778999998643 3456689999999999999999999843 33478999
Q ss_pred eechhhHH-HHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCC
Q 011138 215 EYISETVY-RVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (492)
Q Consensus 215 E~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (492)
|||.++.+ +.+. .....+++..+..++.||+.||+|||+ ++|+||||||+||||+.++ .+||+|||+++.....
T Consensus 80 E~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qia~gl~~lH~-~~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~~~~~ 154 (263)
T d1sm2a_ 80 EFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDD 154 (263)
T ss_dssp ECCTTCBHHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCTTCSGGGEEECGGG-CEEECSCC--------
T ss_pred EecCCCcHHHHhh---ccccCCCHHHHHHHHHHHHHHHHhhhc-cceeecccchhheeecCCC-CeEecccchheeccCC
Confidence 99986544 3322 234568889999999999999999997 9999999999999999888 7999999999876443
Q ss_pred CC--CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 011138 294 EP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (492)
Q Consensus 294 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 370 (492)
.. .....||+.|+|||++.+. .|+.++|||||||++|||+| |.+||...+..+.+..+.....
T Consensus 155 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~------------- 220 (263)
T d1sm2a_ 155 QYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR------------- 220 (263)
T ss_dssp ----------CTTSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC-------------
T ss_pred CceeecceecCcccCChHHhcCC-CCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCC-------------
Confidence 32 2246789999999999765 48999999999999999998 5777777666655555544110
Q ss_pred CcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
. ..+...++++.+||.+||+.||++|||++|+++|
T Consensus 221 ---~------------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 221 ---L------------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp ---C------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---C------------CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 0 1123568999999999999999999999999876
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-52 Score=400.04 Aligned_cols=252 Identities=22% Similarity=0.296 Sum_probs=200.9
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc---hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEE
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLN 211 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~ 211 (492)
...+|++.+.||+|+||.||+|.+. ++..||||++..+ ...+.+|+.+|++++|||||++++++. +. .+|
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-----~~-~~~ 83 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-----QE-PIY 83 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SS-SCE
T ss_pred CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeec-----cC-CeE
Confidence 3457999999999999999999975 6788999998653 344678999999999999999999762 11 257
Q ss_pred EEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccC
Q 011138 212 LVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLV 291 (492)
Q Consensus 212 lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~ 291 (492)
||||||+++.+..... ......+++..+..|+.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+|+...
T Consensus 84 iv~Ey~~~g~L~~~~~-~~~~~~l~~~~~~~i~~qi~~gl~~lH~-~~ivHrDiKp~NIll~~~~-~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 84 IITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSDTL-SCKIADFGLARLIE 160 (272)
T ss_dssp EEEECCTTCBHHHHTT-SHHHHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTS-CEEECCCTTCEECS
T ss_pred EEEEeCCCCcHHHHHh-hcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccchhheeeeccc-ceeeccccceEEcc
Confidence 9999999754432221 1223458999999999999999999997 9999999999999999888 79999999998765
Q ss_pred CCC--CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 292 PGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG-QPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 292 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G-~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
... ......||+.|+|||++.+. .|+.++|||||||++|||+|| .+||...+..+.+..+....
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~------------ 227 (272)
T d1qpca_ 161 DNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY------------ 227 (272)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC------------
T ss_pred CCccccccccCCcccccChHHHhCC-CCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC------------
Confidence 433 23346789999999999755 489999999999999999995 56666666555544443210
Q ss_pred CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC--CCCCCC
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA--HPFFDD 425 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~--Hp~f~~ 425 (492)
. ...+..+++++.+||.+||+.||++|||++++++ |+||+.
T Consensus 228 ------~----------~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 228 ------R----------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp ------C----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------C----------CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 0 0122457899999999999999999999999998 788863
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-52 Score=395.26 Aligned_cols=245 Identities=20% Similarity=0.275 Sum_probs=202.3
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc---hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
.+|.+.+.||+|+||+||+|+++ +++.||||++..+ ...+.+|+.++++++|||||++++++. +...+++|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~-----~~~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----CSSSEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEe-----eCCceEEE
Confidence 35889999999999999999974 7889999998653 355678999999999999999999983 33458999
Q ss_pred eeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCC
Q 011138 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (492)
Q Consensus 214 ~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (492)
|||+.++.+... .......+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.....
T Consensus 78 ~Ey~~~g~l~~~--~~~~~~~~~~~~~~~i~~qi~~gl~~LH~-~~iiH~dlk~~Nill~~~~-~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 78 TEYMANGCLLNY--LREMRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDD 153 (258)
T ss_dssp EECCTTEEHHHH--HHSGGGCCCHHHHHHHHHHHHHHHHHHHH-TTBCCSCCSGGGEEECTTC-CEEECCCSSCCBCSSS
T ss_pred EEccCCCcHHHh--hhccccCCcHHHHHHHHHHHHHHHHHHhh-cCcccccccceeEEEcCCC-cEEECcchhheeccCC
Confidence 999986543322 12334568889999999999999999997 9999999999999999887 7999999999866443
Q ss_pred CC--CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 011138 294 EP--NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMNPN 370 (492)
Q Consensus 294 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~ 370 (492)
.. .....||+.|+|||++.+.. |+.++|||||||++|||+| |+.||.+.+..+....+.+...
T Consensus 154 ~~~~~~~~~~t~~y~aPE~~~~~~-~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~------------- 219 (258)
T d1k2pa_ 154 EYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR------------- 219 (258)
T ss_dssp SCCCCCCSCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC-------------
T ss_pred CceeecccCCCCCcCCcHHhcCCC-CCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCC-------------
Confidence 32 23467899999999997654 8999999999999999998 8999999987776665543110
Q ss_pred CcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 371 YTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
.. .+...++++.+||.+||+.||++|||+.++++|
T Consensus 220 ---~~------------~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 220 ---LY------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp ---CC------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---CC------------CcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 01 223578999999999999999999999999987
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=399.18 Aligned_cols=249 Identities=26% Similarity=0.308 Sum_probs=199.7
Q ss_pred cceeEeee-eccCCceEEEEEEEcC--CCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 137 ISYMAERV-VGTGSFGVVFQAKCLE--TGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 137 ~~y~~~~~-lG~G~fg~Vy~~~~~~--~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
.+|.+.+. ||+|+||+||+|.++. ++..||||++... ...+.+|+++|++++|||||++++++.. .
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-----~- 81 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-----E- 81 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-----S-
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----C-
Confidence 46888885 9999999999998754 4457999998542 2345689999999999999999998732 1
Q ss_pred EEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 209 ~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
.+|||||||+++.+.... ......+++..+..++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+|+
T Consensus 82 ~~~lvmE~~~~g~L~~~l--~~~~~~l~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~Nill~~~~-~~Kl~DFGla~ 157 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVNRH-YAKISDFGLSK 157 (285)
T ss_dssp SEEEEEECCTTEEHHHHH--TTCTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEETT-EEEECCCTTCE
T ss_pred eEEEEEEeCCCCcHHHHh--hccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCcCchhheeeccCC-ceeeccchhhh
Confidence 268999999975443221 2234578999999999999999999997 9999999999999999887 89999999998
Q ss_pred ccCCCCC----CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 011138 289 MLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREE 363 (492)
Q Consensus 289 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~ 363 (492)
....... .....||+.|+|||++.+. .++.++|||||||++|||+| |++||.+.+..+.+..+.+. .
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~--~----- 229 (285)
T d1u59a_ 158 ALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG--K----- 229 (285)
T ss_dssp ECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT--C-----
T ss_pred cccccccccccccccccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--C-----
Confidence 7644332 2245689999999999765 48999999999999999998 99999988876665555331 0
Q ss_pred HhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHh---hCCCCCC
Q 011138 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEA---CAHPFFD 424 (492)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~---l~Hp~f~ 424 (492)
.. .+++.+|+++.+||.+||+.||++|||+.++ |+|+|+.
T Consensus 230 ---------~~------------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 230 ---------RM------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp ---------CC------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------CC------------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 00 1234689999999999999999999999877 6788875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=407.53 Aligned_cols=256 Identities=29% Similarity=0.477 Sum_probs=206.2
Q ss_pred ccceeEeeeeccCCceEEEEEEEc---CCCCEEEEEEeccc--------hhhHHHHHHHHHHcCC-CCccccceeeeecc
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCL---ETGDSVAIKKVLQD--------KRYKNRELQIMRLLNH-PNVVSLKHCFFSTT 203 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~---~~g~~vAiK~~~~~--------~~~~~~E~~il~~l~h-~nIv~l~~~~~~~~ 203 (492)
..+|.+++.||+|+||+||+|++. .+|+.||||++.+. .....+|+++|++++| |||+++++++
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~---- 98 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF---- 98 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE----
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee----
Confidence 357999999999999999999874 47899999988532 2334579999999977 8999999998
Q ss_pred CCCceEEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEe
Q 011138 204 EKDELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKIC 282 (492)
Q Consensus 204 ~~~~~~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~ 282 (492)
.+...+++||||+.++ +...+. ....+++..++.++.||+.||.|||+ +|||||||||+|||++.++ .+||+
T Consensus 99 -~~~~~~~~v~e~~~~~~L~~~i~----~~~~~~e~~~~~~~~Qi~~al~~lH~-~~ivHrDiKp~Nill~~~~-~vkL~ 171 (322)
T d1vzoa_ 99 -QTETKLHLILDYINGGELFTHLS----QRERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDSNG-HVVLT 171 (322)
T ss_dssp -EETTEEEEEECCCCSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTS-CEEES
T ss_pred -ccCCceeeeeecccccHHHHHHH----hcccccHHHHHHHHHHHHHHHHHhhc-CCEEeccCCccceeecCCC-CEEEe
Confidence 4445689999999865 444332 24567889999999999999999997 9999999999999999887 79999
Q ss_pred eecCccccCCCC--CCccceeccCccCchhhcCCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 011138 283 DFGSAKMLVPGE--PNISYICSRYYRAPELIFGAT-EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTP 359 (492)
Q Consensus 283 DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p 359 (492)
|||+++...... ......|++.|+|||.+.+.. .++.++|||||||+||+|++|..||.+.+..+....+.+....+
T Consensus 172 DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~ 251 (322)
T d1vzoa_ 172 DFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 251 (322)
T ss_dssp CSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC
T ss_pred eccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC
Confidence 999998653322 234578999999999997543 47889999999999999999999998876665555554421100
Q ss_pred CHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcC-----CHHHhhCCCCCCCCC
Q 011138 360 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRC-----TALEACAHPFFDDLR 427 (492)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~-----t~~e~l~Hp~f~~~~ 427 (492)
.. .++..+++++++||.+||++||.+|| |++|+++||||+++.
T Consensus 252 -------------~~------------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 252 -------------EP------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp -------------CC------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred -------------CC------------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 00 12346899999999999999999999 589999999999865
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=398.13 Aligned_cols=241 Identities=24% Similarity=0.323 Sum_probs=191.6
Q ss_pred eeeccCCceEEEEEEEc--CCCCEEEEEEeccc------hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEe
Q 011138 143 RVVGTGSFGVVFQAKCL--ETGDSVAIKKVLQD------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~--~~g~~vAiK~~~~~------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
+.||+|+||+||+|.+. .+++.||||++... ...+.+|+.+|++++|||||++++++. +.. .+|||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-----~~~-~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-----AES-WMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----SSS-EEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec-----cCC-EEEEE
Confidence 57999999999999864 45678999998542 234568999999999999999999873 222 57999
Q ss_pred eechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccccCCC
Q 011138 215 EYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKMLVPG 293 (492)
Q Consensus 215 E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~~~~ 293 (492)
|||+++ |.+++. ....+++..+..|+.||+.||+|||+ +|||||||||+|||++.++ .+||+|||+++.....
T Consensus 87 E~~~~g~L~~~l~----~~~~l~~~~~~~i~~qi~~gl~ylH~-~~iiHrDlKp~Nill~~~~-~~kl~DFGla~~~~~~ 160 (277)
T d1xbba_ 87 EMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRAD 160 (277)
T ss_dssp ECCTTEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETT-EEEECCCTTCEECCTT
T ss_pred EcCCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHhhHHh-CCcccCCCcchhhcccccC-cccccchhhhhhcccc
Confidence 999865 444332 35679999999999999999999997 9999999999999999888 8999999999876443
Q ss_pred CC----CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 011138 294 EP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCMN 368 (492)
Q Consensus 294 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~ 368 (492)
.. .....||+.|||||++.+. .|+.++|||||||++|||++ |++||.+.+..+....+.+. .
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~--~---------- 227 (277)
T d1xbba_ 161 ENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG--E---------- 227 (277)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--C----------
T ss_pred ccccccccccCCCceecCchhhcCC-CCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC--C----------
Confidence 32 2235689999999999765 48999999999999999997 99999988776555444321 0
Q ss_pred CCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHh---hCCCCCC
Q 011138 369 PNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEA---CAHPFFD 424 (492)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~---l~Hp~f~ 424 (492)
... ++..+|+++.+||.+||+.||.+|||+.++ |+|+|++
T Consensus 228 ----~~~------------~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 228 ----RMG------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp ----CCC------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ----CCC------------CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 001 224579999999999999999999999998 4566653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=392.20 Aligned_cols=255 Identities=24% Similarity=0.316 Sum_probs=197.9
Q ss_pred CccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc---hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 133 PKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 133 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~---~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
.....+|++++.||+|+||+||+|++..+ +.||||++..+ ...+.+|+.+|++++|||||++++++. +. .
T Consensus 13 ~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-----~~-~ 85 (285)
T d1fmka3 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----EE-P 85 (285)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SS-S
T ss_pred EcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-----cC-C
Confidence 34456899999999999999999998654 67999998544 345678999999999999999999872 22 2
Q ss_pred EEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCccc
Q 011138 210 LNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKM 289 (492)
Q Consensus 210 ~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~ 289 (492)
+++|||||.++.+..... ......+++..+..++.||+.||+|||+ +||+||||||+||||+.++ .+||+|||+|+.
T Consensus 86 ~~lv~Ey~~~g~l~~~~~-~~~~~~l~~~~~~~i~~~i~~gl~~LH~-~~ivH~DlKp~NIll~~~~-~~kl~DfGla~~ 162 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENL-VCKVADFGLARL 162 (285)
T ss_dssp CEEEECCCTTCBHHHHHS-HHHHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG-CEEECCCCTTC-
T ss_pred eEEEEEecCCCchhhhhh-hcccccchHHHHHHHHHHHHHHHHHHhh-hheecccccceEEEECCCC-cEEEcccchhhh
Confidence 579999999764433222 2234568999999999999999999997 9999999999999999887 899999999986
Q ss_pred cCCCC--CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 011138 290 LVPGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG-QPLFPGESGVDQLVEIIKILGTPTREEIKC 366 (492)
Q Consensus 290 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G-~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~ 366 (492)
..... ......||+.|+|||++.+. .++.++|||||||++|||++| .+||.+....+.+..+.+..
T Consensus 163 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~---------- 231 (285)
T d1fmka3 163 IEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY---------- 231 (285)
T ss_dssp -------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC----------
T ss_pred ccCCCceeeccccccccccChHHHhCC-CCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC----------
Confidence 64333 22346789999999999755 489999999999999999995 55556665555554443311
Q ss_pred cCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC--CCCCCCC
Q 011138 367 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA--HPFFDDL 426 (492)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~--Hp~f~~~ 426 (492)
.. ..+..+++++++||.+||+.||++||+++++++ |+||+..
T Consensus 232 --------~~----------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 232 --------RM----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp --------CC----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred --------CC----------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 00 122457999999999999999999999999988 8999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=391.76 Aligned_cols=246 Identities=26% Similarity=0.345 Sum_probs=189.6
Q ss_pred ccceeEeeeeccCCceEEEEEEEcCCC---CEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLETG---DSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~~g---~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
..+|++++.||+|+||.||+|.+..++ ..||||.+... ...+.+|+.+|+.++|||||++++++. +
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-----~- 79 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-----E- 79 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----S-
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----c-
Confidence 457999999999999999999987553 46899987532 233558999999999999999999872 1
Q ss_pred eEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCc
Q 011138 208 LYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSA 287 (492)
Q Consensus 208 ~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a 287 (492)
..+|+||||++++.+.... ......+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+|
T Consensus 80 ~~~~iv~E~~~~g~l~~~~--~~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDlKp~NIll~~~~-~~Kl~DfG~a 155 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSND-CVKLGDFGLS 155 (273)
T ss_dssp SSCEEEEECCTTEEHHHHH--HHTTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETT-EEEECC----
T ss_pred CeEEEEEEeccCCcHHhhh--hccCCCCCHHHHHHHHHHHHHHhhhhcc-cCeeccccchhheeecCCC-cEEEccchhh
Confidence 2378999999966443221 2334568999999999999999999997 9999999999999999887 8999999999
Q ss_pred cccCCCC--CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 011138 288 KMLVPGE--PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEI 364 (492)
Q Consensus 288 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~ 364 (492)
+...... ......||+.|+|||++.+. .|+.++|||||||++|||++ |.+||.+.+..+.+..+....
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~apE~l~~~-~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~-------- 226 (273)
T d1mp8a_ 156 RYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-------- 226 (273)
T ss_dssp ---------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC--------
T ss_pred eeccCCcceeccceecCcccchhhHhccC-CCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------
Confidence 8764332 22345679999999999755 48999999999999999997 899999988877766654310
Q ss_pred hhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
.. .+++.+|+++++||.+||+.||.+|||+.|+++|
T Consensus 227 --------~~------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 227 --------RL------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp --------CC------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------CC------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 00 1234689999999999999999999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-50 Score=388.47 Aligned_cols=244 Identities=22% Similarity=0.292 Sum_probs=186.0
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCC----CEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCce
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETG----DSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDEL 208 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g----~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~ 208 (492)
.|.+.++||+|+||.||+|.+..++ ..||||++... ...+.+|+.+|++++|||||++++++. +..
T Consensus 8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~-----~~~ 82 (283)
T d1mqba_ 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-----KYK 82 (283)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSS
T ss_pred HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe-----cCC
Confidence 5999999999999999999987655 46999998532 223568999999999999999999984 334
Q ss_pred EEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 209 YLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 209 ~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
.+++|||||.++.+... .......+++..+..++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+++
T Consensus 83 ~~~~v~e~~~~~~l~~~--~~~~~~~~~~~~~~~i~~~i~~gl~~lH~-~~iiHrDlKp~NILl~~~~-~~Kl~DFGla~ 158 (283)
T d1mqba_ 83 PMMIITEYMENGALDKF--LREKDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNSNL-VCKVSDFGLSR 158 (283)
T ss_dssp SEEEEEECCTTEEHHHH--HHHTTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTC-CEEECCCCC--
T ss_pred ceEEEEEecccCcchhh--hhcccccccHHHHHHHHHHHHHhhhhccc-cccccCccccceEEECCCC-eEEEcccchhh
Confidence 48899999997655432 22334678999999999999999999997 9999999999999999888 89999999998
Q ss_pred ccCCCCC----CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhCCCCHHH
Q 011138 289 MLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ-PLFPGESGVDQLVEIIKILGTPTREE 363 (492)
Q Consensus 289 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~-~pf~~~~~~~~~~~i~~~~g~p~~~~ 363 (492)
....... .....||+.|||||++.+. .|+.++|||||||++|||++|. +||.+.+..+.+..+...
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~-------- 229 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-------- 229 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT--------
T ss_pred cccCCCccceEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc--------
Confidence 7644322 2235689999999999665 5899999999999999999965 445555444433333221
Q ss_pred HhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 364 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
... ..+..+++++.+||.+||+.||++|||+.|+++
T Consensus 230 ----------~~~----------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 230 ----------FRL----------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp ----------CCC----------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----------CCC----------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 000 122457899999999999999999999999976
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-50 Score=395.40 Aligned_cols=244 Identities=22% Similarity=0.331 Sum_probs=193.1
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCC----EEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCc
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGD----SVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~----~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~ 207 (492)
.+|++.++||+|+||+||+|.+..+|+ .||+|++... .+.+.+|+.+|+.++|||||++++++...
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~----- 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-----
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----
Confidence 359999999999999999999988886 5788877432 23456899999999999999999998432
Q ss_pred eEEEEEeeech-hhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 208 LYLNLVLEYIS-ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 208 ~~~~lV~E~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
. .++||||+. ++++..+ ......+++..+..|+.||+.||.|||+ +|||||||||+||||+.++ .+||+|||+
T Consensus 84 ~-~~~v~e~~~~~~l~~~~---~~~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlKp~NIll~~~~-~~kl~DFGl 157 (317)
T d1xkka_ 84 T-VQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQ-HVKITDFGL 157 (317)
T ss_dssp S-EEEEEECCTTCBHHHHH---HHTSSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETT-EEEECCCSH
T ss_pred C-eeEEEEeccCCcccccc---cccccCCCHHHHHHHHHHHHHHHHHHHH-cCcccCcchhhcceeCCCC-CeEeecccc
Confidence 2 456777776 4555543 2335678999999999999999999997 9999999999999999888 899999999
Q ss_pred ccccCCCCCC---ccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 011138 287 AKMLVPGEPN---ISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTRE 362 (492)
Q Consensus 287 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~ 362 (492)
|+........ ....||+.|+|||++.+. .|+.++|||||||++|||+| |.+||.+.+..+....+.+..
T Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~------ 230 (317)
T d1xkka_ 158 AKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE------ 230 (317)
T ss_dssp HHHTTTTCC--------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC------
T ss_pred ceecccccccccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC------
Confidence 9876543322 234689999999999765 48999999999999999998 899998877665544443310
Q ss_pred HHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 363 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
.. ..++.+++++.+||.+||+.||.+|||+.|+++|
T Consensus 231 ------------~~----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 231 ------------RL----------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp ------------CC----------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------CC----------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 00 0224578999999999999999999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=387.89 Aligned_cols=251 Identities=24% Similarity=0.338 Sum_probs=189.1
Q ss_pred ccceeEeeeeccCCceEEEEEEEcC-----CCCEEEEEEeccch-----hhHHHHHHHHHHc-CCCCccccceeeeeccC
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFSTTE 204 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~-----~g~~vAiK~~~~~~-----~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~ 204 (492)
..+|.+++.||+|+||.||+|.+.. +++.||||++.... ....+|..++.++ +|+|||.+++++...
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-- 89 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-- 89 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST--
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC--
Confidence 3579999999999999999999754 45689999985432 2334566666666 689999998877432
Q ss_pred CCceEEEEEeeechh-hHHHHhhhhhh------------cCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceE
Q 011138 205 KDELYLNLVLEYISE-TVYRVSKHYTR------------MNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLL 271 (492)
Q Consensus 205 ~~~~~~~lV~E~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NIL 271 (492)
...+++|||||++ ++...+..... ....+++..+..|+.||+.||.|||+ +|||||||||+|||
T Consensus 90 --~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~ivHrDlKp~NIL 166 (299)
T d1ywna1 90 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNIL 166 (299)
T ss_dssp --TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEE
T ss_pred --CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh-CCCcCCcCCcccee
Confidence 3347899999985 45555433221 13458899999999999999999997 99999999999999
Q ss_pred EcCCCCcEEEeeecCccccCCCC---CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCChHH
Q 011138 272 VNPHTHQLKICDFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG-QPLFPGESGVD 347 (492)
Q Consensus 272 l~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G-~~pf~~~~~~~ 347 (492)
|+.++ .+||+|||+|+...... ......||+.|+|||++.+. .|+.++|||||||++|||++| .+||.+.+..+
T Consensus 167 l~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 167 LSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp ECGGG-CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred ECCCC-cEEEccCcchhhccccccccccCceeeCccccchhHhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 99887 79999999998654332 23356899999999999765 489999999999999999986 67898877666
Q ss_pred HHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 348 QLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 348 ~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
.+..++..-..+ . .+..+++++++||.+||+.||.+|||+.|+++|
T Consensus 245 ~~~~~~~~~~~~---------------~------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 245 EFCRRLKEGTRM---------------R------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHHHTCCC---------------C------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCCC---------------C------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 666555421110 1 224578999999999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=379.88 Aligned_cols=248 Identities=22% Similarity=0.319 Sum_probs=194.6
Q ss_pred CCccccceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch--hhHHHHHHHHHHcCCCCccccceeeeeccCCCceE
Q 011138 132 QPKQTISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK--RYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELY 209 (492)
Q Consensus 132 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~--~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~ 209 (492)
+.....+|++.+.||+|+||.||+|.+ .|..||||++..+. +.+.+|++++++++|||||++++++... ...
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~ 75 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGG 75 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------C
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEec----CCc
Confidence 444556799999999999999999998 57899999996543 4567899999999999999999987432 233
Q ss_pred EEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 210 LNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 210 ~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
+|+||||++++ +.+.+.. .....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+++
T Consensus 76 ~~lv~ey~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~al~ylH~-~~ivH~dlkp~Nil~~~~~-~~kl~dfg~s~ 151 (262)
T d1byga_ 76 LYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDN-VAKVSDFGLTK 151 (262)
T ss_dssp CEEEECCCTTEEHHHHHHH--HHHHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTS-CEEECCCCC--
T ss_pred EEEEEeccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHhhcccccc-CceeccccchHhheecCCC-CEeecccccce
Confidence 78999999865 5444432 223357899999999999999999997 9999999999999999888 79999999998
Q ss_pred ccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 011138 289 MLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPTREEIKCM 367 (492)
Q Consensus 289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~ 367 (492)
.... ......+|+.|+|||++.+. .++.++|||||||++|||+| |++||...+..+.+..+.+.
T Consensus 152 ~~~~--~~~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~------------ 216 (262)
T d1byga_ 152 EASS--TQDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG------------ 216 (262)
T ss_dssp ------------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT------------
T ss_pred ecCC--CCccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC------------
Confidence 6532 33456789999999999765 48999999999999999998 79999887776665554321
Q ss_pred CCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 368 NPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
.. + .++..+++++++||++||..||.+|||+.+++++
T Consensus 217 ----~~---~---------~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 217 ----YK---M---------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp ----CC---C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----CC---C---------CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 00 0 1234578999999999999999999999999863
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-49 Score=380.38 Aligned_cols=243 Identities=25% Similarity=0.330 Sum_probs=188.4
Q ss_pred cceeEeeeeccCCceEEEEEEEcCC-C--CEEEEEEeccc-------hhhHHHHHHHHHHcCCCCccccceeeeeccCCC
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLET-G--DSVAIKKVLQD-------KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKD 206 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~-g--~~vAiK~~~~~-------~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 206 (492)
.+|++.+.||+|+||.||+|+...+ + ..||||++..+ ...+.+|+.+|+.++|||||++++++..
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~----- 82 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT----- 82 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----
Confidence 3699999999999999999986533 3 36899987532 1345689999999999999999998832
Q ss_pred ceEEEEEeeechhh-HHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeec
Q 011138 207 ELYLNLVLEYISET-VYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFG 285 (492)
Q Consensus 207 ~~~~~lV~E~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG 285 (492)
. .+++|||||.++ +.+.+. .....+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||
T Consensus 83 ~-~~~lv~e~~~~~~l~~~~~---~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDikp~NIll~~~~-~vkl~DfG 156 (273)
T d1u46a_ 83 P-PMKMVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLATRD-LVKIGDFG 156 (273)
T ss_dssp S-SCEEEEECCTTCBHHHHHH---HHGGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETT-EEEECCCT
T ss_pred c-chheeeeeecCcchhhhhh---cccCCCCHHHHHHHHHHHHHHHHHhhh-CCEeeeeecHHHhcccccc-ceeeccch
Confidence 2 257999999864 333322 224568999999999999999999997 9999999999999999887 89999999
Q ss_pred CccccCCCCC----CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 011138 286 SAKMLVPGEP----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGESGVDQLVEIIKILGTPT 360 (492)
Q Consensus 286 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~~~~~~~~i~~~~g~p~ 360 (492)
+++....... .....|+..|+|||++.+. .++.++|||||||++|||++ |.+||.+.+..+.+..+.+.
T Consensus 157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~----- 230 (273)
T d1u46a_ 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE----- 230 (273)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS-----
T ss_pred hhhhcccCCCcceecCccccCcccCCHHHHhCC-CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhC-----
Confidence 9987644432 2234578899999999764 58999999999999999998 89999999888777766541
Q ss_pred HHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhh
Q 011138 361 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEAC 418 (492)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l 418 (492)
...++ .+..+|+++++||.+||..||.+|||+.+++
T Consensus 231 ------------~~~~~----------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~ 266 (273)
T d1u46a_ 231 ------------GERLP----------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266 (273)
T ss_dssp ------------CCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ------------CCCCC----------CcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 11111 2246789999999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.3e-48 Score=390.50 Aligned_cols=285 Identities=28% Similarity=0.451 Sum_probs=213.0
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch---hhHHHHHHHHHHcC-----------CCCccccceeeeec
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK---RYKNRELQIMRLLN-----------HPNVVSLKHCFFST 202 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~---~~~~~E~~il~~l~-----------h~nIv~l~~~~~~~ 202 (492)
.+|++++.||+|+||+||+|+++.+|+.||||++.++. ....+|+.+++.++ |+|||++++++...
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 35999999999999999999999999999999997654 33457999988875 57899999887543
Q ss_pred cCCCceEEEEEeeech--hhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCC---
Q 011138 203 TEKDELYLNLVLEYIS--ETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTH--- 277 (492)
Q Consensus 203 ~~~~~~~~~lV~E~~~--~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~--- 277 (492)
. ..+.+++|+++. ++.... ........+++..++.++.||+.||.|||+..||+||||||+||||+.++.
T Consensus 93 ~---~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 93 G---PNGVHVVMVFEVLGENLLAL--IKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp E---TTEEEEEEEECCCCEEHHHH--HHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred c---ccceeeeeeecccccccccc--cccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccc
Confidence 2 223445555543 333322 233445678899999999999999999995479999999999999976542
Q ss_pred --cEEEeeecCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC------hHHHH
Q 011138 278 --QLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGES------GVDQL 349 (492)
Q Consensus 278 --~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~------~~~~~ 349 (492)
.+||+|||.+... .......+||+.|+|||++.+. .|+.++||||+||++++|++|+.||.... ..+.+
T Consensus 168 ~~~~kl~dfg~s~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 168 LIQIKIADLGNACWY--DEHYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEEEECCCTTCEET--TBCCCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred cceeeEeeccccccc--ccccccccccccccChhhcccc-CCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 4999999999765 3344567899999999999765 48999999999999999999999997543 44667
Q ss_pred HHHHHHhCCCCHHHHhhcCCC-------CcccCCCcccCCCccc------ccCCCCChhHhhhhccccccCCCCcCCHHH
Q 011138 350 VEIIKILGTPTREEIKCMNPN-------YTEFKFPQIKAHPWHK------IFHKRMPPEALDLVSRLLQYSPSLRCTALE 416 (492)
Q Consensus 350 ~~i~~~~g~p~~~~~~~~~~~-------~~~~~~~~~~~~~~~~------~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e 416 (492)
..++..+|.++.+.+...... ............++.. .+....+++++|||.+||++||.+|||+.|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 888899999887766432110 0001111111111111 122345678999999999999999999999
Q ss_pred hhCCCCCCCCCCC
Q 011138 417 ACAHPFFDDLRDP 429 (492)
Q Consensus 417 ~l~Hp~f~~~~~~ 429 (492)
+|+||||+++...
T Consensus 325 ~L~Hp~f~~~~~~ 337 (362)
T d1q8ya_ 325 LVNHPWLKDTLGM 337 (362)
T ss_dssp HHTCGGGTTCTTC
T ss_pred HhcCcccCCCCCc
Confidence 9999999976543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-49 Score=387.46 Aligned_cols=250 Identities=22% Similarity=0.299 Sum_probs=199.4
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCCCE--EEEEEecc-----chhhHHHHHHHHHHc-CCCCccccceeeeeccCCC
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETGDS--VAIKKVLQ-----DKRYKNRELQIMRLL-NHPNVVSLKHCFFSTTEKD 206 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g~~--vAiK~~~~-----~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~ 206 (492)
..++|.++++||+|+||+||+|+++.+|.. ||||++.. ....+.+|+++|+.+ +|||||++++++..
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~----- 82 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH----- 82 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec-----
Confidence 446799999999999999999999888875 67787642 223466899999998 79999999999854
Q ss_pred ceEEEEEeeechh-hHHHHhhhh------------hhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEc
Q 011138 207 ELYLNLVLEYISE-TVYRVSKHY------------TRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVN 273 (492)
Q Consensus 207 ~~~~~lV~E~~~~-~l~~~~~~~------------~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~ 273 (492)
...+++||||+++ ++.+++... ......+++..+..++.||+.||.|||+ +||+||||||+|||++
T Consensus 83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~-~~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVG 161 (309)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC
T ss_pred CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc-CCccccccccceEEEc
Confidence 3358999999995 455544321 1234678999999999999999999997 9999999999999999
Q ss_pred CCCCcEEEeeecCccccCCCCCCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCC-CCCCCCChHHHHHHH
Q 011138 274 PHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ-PLFPGESGVDQLVEI 352 (492)
Q Consensus 274 ~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~-~pf~~~~~~~~~~~i 352 (492)
.++ .+||+|||+++............||+.|+|||.+.+. .|+.++|||||||++|||++|. +||.+.+..+.+..+
T Consensus 162 ~~~-~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i 239 (309)
T d1fvra_ 162 ENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 239 (309)
T ss_dssp GGG-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred CCC-ceEEccccccccccccccccceecCCcccchHHhccC-CCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 887 7999999999876555455566789999999999765 4899999999999999999964 678877766555444
Q ss_pred HHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 353 IKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 353 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
.+. ... ..+..+++++++||.+||+.||++|||+.|+++|
T Consensus 240 ~~~------------------~~~----------~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 240 PQG------------------YRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp GGT------------------CCC----------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred Hhc------------------CCC----------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 221 000 1224578999999999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-48 Score=382.17 Aligned_cols=248 Identities=22% Similarity=0.281 Sum_probs=197.8
Q ss_pred ccceeEeeeeccCCceEEEEEEEcC-----CCCEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCC
Q 011138 136 TISYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEK 205 (492)
Q Consensus 136 ~~~y~~~~~lG~G~fg~Vy~~~~~~-----~g~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 205 (492)
.++|++.+.||+|+||+||+|+++. +++.||||++..+ ...+.+|+.+|+.++||||+++++++.
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~----- 86 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA----- 86 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec-----
Confidence 4579999999999999999999753 5678999998543 234568999999999999999999984
Q ss_pred CceEEEEEeeechh-hHHHHhhhhh--------------------hcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCC
Q 011138 206 DELYLNLVLEYISE-TVYRVSKHYT--------------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRD 264 (492)
Q Consensus 206 ~~~~~~lV~E~~~~-~l~~~~~~~~--------------------~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrD 264 (492)
....+++||||+.+ ++.+.+.... .....+++..+..|+.||+.||+|||+ +||||||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~-~~ivHrD 165 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRD 165 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc-CCeEeeE
Confidence 33447899999985 4555443211 113457888999999999999999997 9999999
Q ss_pred CCCCceEEcCCCCcEEEeeecCccccCCCC---CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCC-CCC
Q 011138 265 IKPQNLLVNPHTHQLKICDFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQ-PLF 340 (492)
Q Consensus 265 lKp~NILl~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~-~pf 340 (492)
|||+||||+.++ .+||+|||+|+...... ...+..||+.|+|||++.+. .|+.++|||||||++|||++|. +||
T Consensus 166 lKp~NILld~~~-~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 166 LATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp CSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred EcccceEECCCC-cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC-CCChhhhhccchhhHHHHHccCCCCC
Confidence 999999999887 79999999998664332 22356789999999999765 4999999999999999999985 788
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 341 PGESGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 341 ~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
.+.+..+.+..+.+. ..+. .+..+++++.+||.+||+.||.+|||+.|+++
T Consensus 244 ~~~~~~e~~~~v~~~-------------------~~~~---------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 244 YGMAHEEVIYYVRDG-------------------NILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TTSCHHHHHHHHHTT-------------------CCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHcC-------------------CCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 888877766655331 0111 23468899999999999999999999999964
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=380.15 Aligned_cols=249 Identities=22% Similarity=0.337 Sum_probs=192.6
Q ss_pred cccceeEeeeeccCCceEEEEEEEcCCC-------CEEEEEEeccch-----hhHHHHHHHHHHc-CCCCccccceeeee
Q 011138 135 QTISYMAERVVGTGSFGVVFQAKCLETG-------DSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFS 201 (492)
Q Consensus 135 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~g-------~~vAiK~~~~~~-----~~~~~E~~il~~l-~h~nIv~l~~~~~~ 201 (492)
...+|++++.||+|+||.||+|+...++ ..||||++..+. ....+|..++.++ +|||||++++++
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~-- 88 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC-- 88 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccc--
Confidence 3468999999999999999999976654 479999985532 2344688888877 799999999998
Q ss_pred ccCCCceEEEEEeeechhh-HHHHhhhhh------------hcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCC
Q 011138 202 TTEKDELYLNLVLEYISET-VYRVSKHYT------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQ 268 (492)
Q Consensus 202 ~~~~~~~~~~lV~E~~~~~-l~~~~~~~~------------~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~ 268 (492)
.+...+++|||||.++ +...+.... .....+++..+..++.||+.||+|||+ +|||||||||+
T Consensus 89 ---~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~-~~ivHrDiKp~ 164 (299)
T d1fgka_ 89 ---TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAAR 164 (299)
T ss_dssp ---CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGG
T ss_pred ---ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh-CCEEeeeeccc
Confidence 3444588999999864 544443221 123568999999999999999999997 99999999999
Q ss_pred ceEEcCCCCcEEEeeecCccccCCCC---CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCC
Q 011138 269 NLLVNPHTHQLKICDFGSAKMLVPGE---PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGES 344 (492)
Q Consensus 269 NILl~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~~ 344 (492)
|||++.++ .+||+|||+++...... ......||+.|+|||++.+. .|+.++|||||||++|||++ |.+||.+.+
T Consensus 165 NiLl~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 165 NVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp GEEECTTC-CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ceeecCCC-CeEeccchhhccccccccccccccCCCChhhhhhhHhcCC-CCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 99999888 79999999998664332 23346789999999999765 59999999999999999997 799998877
Q ss_pred hHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 345 GVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 345 ~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
..+....+... . ... ++..+++++++||.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~i~~~--~--------------~~~------------~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 243 VEELFKLLKEG--H--------------RMD------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHHHTT--C--------------CCC------------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcC--C--------------CCC------------CCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 65444333220 0 001 22457999999999999999999999999985
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.3e-48 Score=377.23 Aligned_cols=258 Identities=21% Similarity=0.260 Sum_probs=198.1
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc--hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEee
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVLE 215 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~--~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~E 215 (492)
+|++++.||+|+||+||+|++..+|+.||||++... .....+|+++++.++|+|++.++..+... ....++|||
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~----~~~~~ivme 83 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNVMVME 83 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEE----TTEEEEEEE
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEec----CCEEEEEEE
Confidence 599999999999999999999999999999987543 34567899999999988877666555332 335789999
Q ss_pred echhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCC--CCcEEEeeecCccccCCC
Q 011138 216 YISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH--THQLKICDFGSAKMLVPG 293 (492)
Q Consensus 216 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~--~~~vkL~DFG~a~~~~~~ 293 (492)
|+++++..... .....+++..+..++.||+.||+|||+ +|||||||||+|||++.. ...+||+|||+|+.....
T Consensus 84 ~~~~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 84 LLGPSLEDLFN---FCSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp CCCCBHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EcCCchhhhhh---hccCCCcHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 99988766443 234679999999999999999999997 999999999999998642 236999999999876433
Q ss_pred C--------CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 011138 294 E--------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKILGTPTREEIK 365 (492)
Q Consensus 294 ~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~g~p~~~~~~ 365 (492)
. .....+||+.|||||++.+. .++.++|||||||++|||++|..||...........+.+.....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~------ 232 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK------ 232 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTB-CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH------
T ss_pred ccccceeccccCCcCCCccccCHHHHhCC-CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc------
Confidence 2 12356899999999999765 48999999999999999999999998876554444332211000
Q ss_pred hcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHH---HhhCCCCCCC
Q 011138 366 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTAL---EACAHPFFDD 425 (492)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~---e~l~Hp~f~~ 425 (492)
...+ ...+.+.+|+++.+||.+||+.||.+||++. ++|+|+|.+.
T Consensus 233 --------~~~~-------~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 233 --------MSTP-------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp --------HHSC-------HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred --------CCCC-------hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 0000 0112246899999999999999999999987 5577877654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=377.45 Aligned_cols=251 Identities=24% Similarity=0.321 Sum_probs=200.7
Q ss_pred ccccceeEeeeeccCCceEEEEEEEc-----CCCCEEEEEEeccch-----hhHHHHHHHHHHc-CCCCccccceeeeec
Q 011138 134 KQTISYMAERVVGTGSFGVVFQAKCL-----ETGDSVAIKKVLQDK-----RYKNRELQIMRLL-NHPNVVSLKHCFFST 202 (492)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-----~~g~~vAiK~~~~~~-----~~~~~E~~il~~l-~h~nIv~l~~~~~~~ 202 (492)
....+|.+++.||+|+||.||+|++. .+++.||||++.... ..+.+|+.+++.+ +|||||++++++.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~-- 97 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT-- 97 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe--
Confidence 34468999999999999999999863 467789999986432 2345799999999 6999999999983
Q ss_pred cCCCceEEEEEeeechhh-HHHHhhhhh--------------hcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCC
Q 011138 203 TEKDELYLNLVLEYISET-VYRVSKHYT--------------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKP 267 (492)
Q Consensus 203 ~~~~~~~~~lV~E~~~~~-l~~~~~~~~--------------~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp 267 (492)
+...++||||||+++ +...+.... .....+++..+..|+.||+.||+|||+ +|||||||||
T Consensus 98 ---~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~-~~ivHrDLKp 173 (311)
T d1t46a_ 98 ---IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAA 173 (311)
T ss_dssp ---SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSG
T ss_pred ---eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccccc
Confidence 334488999999865 444433211 123468899999999999999999997 9999999999
Q ss_pred CceEEcCCCCcEEEeeecCccccCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHh-CCCCCCCC
Q 011138 268 QNLLVNPHTHQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLL-GQPLFPGE 343 (492)
Q Consensus 268 ~NILl~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-G~~pf~~~ 343 (492)
+|||++.++ .+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||+| |.+||.+.
T Consensus 174 ~NIl~~~~~-~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwS~G~~l~ellt~g~p~~~~~ 251 (311)
T d1t46a_ 174 RNILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (311)
T ss_dssp GGEEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ccccccccC-cccccccchheeccCCCcceEeeecccChHHcCHHHhcCC-CCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence 999999887 899999999987654332 2346889999999999754 58999999999999999998 77778887
Q ss_pred ChHHHHHHHHHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 344 SGVDQLVEIIKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 344 ~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
+..+.+.++++.--.+ ..+..+++++.+||.+||+.||.+|||+.++++
T Consensus 252 ~~~~~~~~~i~~~~~~---------------------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 252 PVDSKFYKMIKEGFRM---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp CSSHHHHHHHHHTCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHhcCCCC---------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 7777777766531110 122357899999999999999999999999985
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-48 Score=377.95 Aligned_cols=256 Identities=22% Similarity=0.273 Sum_probs=203.2
Q ss_pred ccccceeEeeeeccCCceEEEEEEEcC-----CCCEEEEEEeccch-----hhHHHHHHHHHHcCCCCccccceeeeecc
Q 011138 134 KQTISYMAERVVGTGSFGVVFQAKCLE-----TGDSVAIKKVLQDK-----RYKNRELQIMRLLNHPNVVSLKHCFFSTT 203 (492)
Q Consensus 134 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~-----~g~~vAiK~~~~~~-----~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 203 (492)
....+|.+++.||+|+||.||+|.+.. ++..||||++.... ..+.+|+.++++++|||||++++++.
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~--- 93 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS--- 93 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC---
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe---
Confidence 344679999999999999999998753 45789999986432 23458999999999999999999883
Q ss_pred CCCceEEEEEeeechhh-HHHHhhhhh------hcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCC
Q 011138 204 EKDELYLNLVLEYISET-VYRVSKHYT------RMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT 276 (492)
Q Consensus 204 ~~~~~~~~lV~E~~~~~-l~~~~~~~~------~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~ 276 (492)
....+++|||||.++ +..++.... .....+++..+..++.||+.||.|||+ ++|+||||||+||||+.++
T Consensus 94 --~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~-~~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 94 --QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp --SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEECTTC
T ss_pred --cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeceEcCCceeecCCc
Confidence 333478999999864 444332211 112346788899999999999999997 9999999999999999888
Q ss_pred CcEEEeeecCccccCCCCC---CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCChHHHHHHH
Q 011138 277 HQLKICDFGSAKMLVPGEP---NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLG-QPLFPGESGVDQLVEI 352 (492)
Q Consensus 277 ~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G-~~pf~~~~~~~~~~~i 352 (492)
++||+|||+|+....... .....||+.|+|||.+.+. .++.++|||||||++|||+|| .+||.+.+..+.+..+
T Consensus 171 -~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~-~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i 248 (308)
T d1p4oa_ 171 -TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248 (308)
T ss_dssp -CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred -eEEEeecccceeccCCcceeeccceecccccCCHHHHccC-CCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 899999999986643322 2345789999999999765 489999999999999999998 5889888877766665
Q ss_pred HHHhCCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC------CCCCCC
Q 011138 353 IKILGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA------HPFFDD 425 (492)
Q Consensus 353 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~------Hp~f~~ 425 (492)
.+.. .+. .+..+++.+.+||.+||+.||.+|||+.++++ +|+|++
T Consensus 249 ~~~~-------------------~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 249 MEGG-------------------LLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299 (308)
T ss_dssp HTTC-------------------CCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred HhCC-------------------CCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence 4310 000 12457899999999999999999999999987 666654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-47 Score=371.48 Aligned_cols=245 Identities=21% Similarity=0.282 Sum_probs=188.2
Q ss_pred eeEeeeeccCCceEEEEEEEcCCC---CEEEEEEeccc-----hhhHHHHHHHHHHcCCCCccccceeeeeccCCCceEE
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETG---DSVAIKKVLQD-----KRYKNRELQIMRLLNHPNVVSLKHCFFSTTEKDELYL 210 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g---~~vAiK~~~~~-----~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~ 210 (492)
+...++||+|+||+||+|.+..++ ..||||++... ...+.+|+++|++++|||||++++++... ...+
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~ 104 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGSP 104 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET----TTEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec----CCce
Confidence 444688999999999999986654 35899988532 23456899999999999999999987543 2358
Q ss_pred EEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCCCcEEEeeecCcccc
Q 011138 211 NLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHTHQLKICDFGSAKML 290 (492)
Q Consensus 211 ~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~~~vkL~DFG~a~~~ 290 (492)
++|||||+++.+..+. ......+++..+..++.||+.||.|||+ +||+||||||+||||+.++ .+||+|||+++..
T Consensus 105 ~lv~E~~~~g~l~~~~--~~~~~~~~~~~~~~i~~qia~gL~~lH~-~~iiHrDLK~~NILl~~~~-~~kL~DFG~~~~~ 180 (311)
T d1r0pa_ 105 LVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDEKF-TVKVADFGLARDM 180 (311)
T ss_dssp EEEEECCTTCBHHHHH--HCTTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTC-CEEECSSGGGCCT
T ss_pred EEEEEEeecCchhhhh--ccccccchHHHHHHHHHHHHHhhhhhcc-cCcccCCccHHhEeECCCC-CEEEecccchhhc
Confidence 8999999976554332 2234567788889999999999999997 9999999999999999887 8999999999876
Q ss_pred CCCCC-----CccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCCHHHH
Q 011138 291 VPGEP-----NISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQL-VEIIKILGTPTREEI 364 (492)
Q Consensus 291 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~-~~i~~~~g~p~~~~~ 364 (492)
..... .....||+.|+|||++.+. .++.++|||||||++|||++|..||........+ ..+.. |.
T Consensus 181 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~--g~------ 251 (311)
T d1r0pa_ 181 YDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--GR------ 251 (311)
T ss_dssp TTTTCCCTTCTTCSSCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHT--TC------
T ss_pred cccccccceecccccccccccChHHHhcC-CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHc--CC------
Confidence 43322 2235789999999998765 4899999999999999999977777654433222 22211 00
Q ss_pred hhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhCC
Q 011138 365 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACAH 420 (492)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~H 420 (492)
.. ..++.+++++.+||.+||+.||++||++.|+++|
T Consensus 252 --------~~------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 252 --------RL------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp --------CC------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------CC------------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 00 1224578999999999999999999999999987
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3e-46 Score=364.03 Aligned_cols=249 Identities=19% Similarity=0.235 Sum_probs=198.2
Q ss_pred cceeEeeeeccCCceEEEEEEEcCCCCEEEEEEecc--chhhHHHHHHHHHHcCC-CCccccceeeeeccCCCceEEEEE
Q 011138 137 ISYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ--DKRYKNRELQIMRLLNH-PNVVSLKHCFFSTTEKDELYLNLV 213 (492)
Q Consensus 137 ~~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~--~~~~~~~E~~il~~l~h-~nIv~l~~~~~~~~~~~~~~~~lV 213 (492)
.+|.+++.||+|+||+||+|++..+|+.||||++.. +.....+|+++++.|.| +||+.+++++. .....++|
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~~~~v 79 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGLHNVLV 79 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETTEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEee-----cCCccEEE
Confidence 359999999999999999999999999999998744 33456789999999986 89999988873 34457899
Q ss_pred eeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCC----CCcEEEeeecCccc
Q 011138 214 LEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPH----THQLKICDFGSAKM 289 (492)
Q Consensus 214 ~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~----~~~vkL~DFG~a~~ 289 (492)
|||+++++...+.. ....++...+..++.|++.||+|||+ +||+||||||+|||++.+ .+.+||+|||+|+.
T Consensus 80 me~~~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~-~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 80 IDLLGPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp EECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEecCCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99999887775433 34568999999999999999999997 999999999999999742 23799999999987
Q ss_pred cCCCC--------CCccceeccCccCchhhcCCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCC
Q 011138 290 LVPGE--------PNISYICSRYYRAPELIFGATEYTTAIDMWSIGCVLAELLLGQPLFPGESGVD---QLVEIIKILGT 358 (492)
Q Consensus 290 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~---~~~~i~~~~g~ 358 (492)
..... .....+||+.|||||++.+. .++.++|||||||++|||++|..||.+..... ....+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCC-CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 64321 23356899999999999765 58999999999999999999999998754432 23333222111
Q ss_pred CCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 359 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 359 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
++... +.+.+|+++.+|+..|+..+|++||+.+.+.+
T Consensus 235 ~~~~~------------------------l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 235 TPLRE------------------------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp SCHHH------------------------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CChHH------------------------hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 11111 22457899999999999999999999776654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=367.81 Aligned_cols=266 Identities=19% Similarity=0.209 Sum_probs=185.4
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccchhh-H--HHHHHHHHHcCCCCccccceeeeeccCCCceEEEEEe
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDKRY-K--NRELQIMRLLNHPNVVSLKHCFFSTTEKDELYLNLVL 214 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-~--~~E~~il~~l~h~nIv~l~~~~~~~~~~~~~~~~lV~ 214 (492)
+|.+.+.||+|+||+||+|+. +|+.||||++..+... . ++|+..++.++|||||++++++.... .....+|+||
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~lv~ 80 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLVS 80 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEEEE
Confidence 589999999999999999986 6899999998654322 2 23455556789999999999986654 4445689999
Q ss_pred eechh-hHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHh-------hCCcccCCCCCCceEEcCCCCcEEEeeecC
Q 011138 215 EYISE-TVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHH-------VVGVCHRDIKPQNLLVNPHTHQLKICDFGS 286 (492)
Q Consensus 215 E~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~-------~~givHrDlKp~NILl~~~~~~vkL~DFG~ 286 (492)
|||.+ +|...+.. ..+++..+..++.|++.||.|||+ .+|||||||||+||||+.++ .+||+|||+
T Consensus 81 Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~-~~Kl~DFGl 154 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGL 154 (303)
T ss_dssp ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS-CEEECCCTT
T ss_pred ecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC-CeEEEecCc
Confidence 99986 44444432 468899999999999999999994 15999999999999999888 899999999
Q ss_pred ccccCCCC-----CCccceeccCccCchhhcCCC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 011138 287 AKMLVPGE-----PNISYICSRYYRAPELIFGAT-----EYTTAIDMWSIGCVLAELLLGQPLFPGESGVDQLVEIIKIL 356 (492)
Q Consensus 287 a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DvwSlGvil~ell~G~~pf~~~~~~~~~~~i~~~~ 356 (492)
++...... ......||+.|+|||++.+.. .++.++|||||||+||||+||.+||......+..... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~-~~~ 233 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD-LVP 233 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT-TSC
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh-ccc
Confidence 98764433 223468999999999986532 2567899999999999999999887543211000000 000
Q ss_pred CCCCHHHHhhcCCCCcccCCCcccCCCcccccCCCCChhHhhhhccccccCCCCcCCHHHhhC
Q 011138 357 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEALDLVSRLLQYSPSLRCTALEACA 419 (492)
Q Consensus 357 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e~l~ 419 (492)
..+....+..... ....-|.+. ..........++.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~--~~~~~p~~~----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 234 SDPSVEEMRKVVC--EQKLRPNIP----NRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp SSCCHHHHHHHHT--TSCCCCCCC----GGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred ccchHHHHHHHHh--ccccCCCCC----cccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 0001010100000 000001100 00011123356889999999999999999999976
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=7.2e-26 Score=205.07 Aligned_cols=159 Identities=18% Similarity=0.139 Sum_probs=116.3
Q ss_pred eeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccch----------------------hhHHHHHHHHHHcCCCCccccc
Q 011138 139 YMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQDK----------------------RYKNRELQIMRLLNHPNVVSLK 196 (492)
Q Consensus 139 y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~----------------------~~~~~E~~il~~l~h~nIv~l~ 196 (492)
|.+++.||+|+||+||+|.+ .+|+.||||++.... ....+|...+..+.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 56889999999999999987 479999999864211 1123588889999999999876
Q ss_pred eeeeeccCCCceEEEEEeeechhhHHHHhhhhhhcCCCcCHHHHHHHHHHHHHHHHHHHhhCCcccCCCCCCceEEcCCC
Q 011138 197 HCFFSTTEKDELYLNLVLEYISETVYRVSKHYTRMNQHVPILYVQLYTYQICRALNYLHHVVGVCHRDIKPQNLLVNPHT 276 (492)
Q Consensus 197 ~~~~~~~~~~~~~~~lV~E~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~yLH~~~givHrDlKp~NILl~~~~ 276 (492)
++. . .++||||+++.... .++...+..++.||+.+|.|||+ +||+||||||+|||++.+
T Consensus 81 ~~~-----~----~~lvme~~~~~~~~----------~l~~~~~~~i~~ql~~~l~~lH~-~giiHrDiKP~NILv~~~- 139 (191)
T d1zara2 81 AWE-----G----NAVLMELIDAKELY----------RVRVENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVSEE- 139 (191)
T ss_dssp EEE-----T----TEEEEECCCCEEGG----------GCCCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEETT-
T ss_pred Eec-----C----CEEEEEeecccccc----------chhhHHHHHHHHHHHHHHHHHhh-CCEEEccCChhheeeeCC-
Confidence 643 2 25899999975321 23334467889999999999997 999999999999999965
Q ss_pred CcEEEeeecCccccCCCCCCccceeccCccC------chhhcCCCCCCcchhhHHHHHH
Q 011138 277 HQLKICDFGSAKMLVPGEPNISYICSRYYRA------PELIFGATEYTTAIDMWSIGCV 329 (492)
Q Consensus 277 ~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~~DvwSlGvi 329 (492)
.++|+|||+|+....... ..|.. .+.+ . ..|+.++|+||+.--
T Consensus 140 -~~~liDFG~a~~~~~~~~-------~~~l~rd~~~~~~~f-~-r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 140 -GIWIIDFPQSVEVGEEGW-------REILERDVRNIITYF-S-RTYRTEKDINSAIDR 188 (191)
T ss_dssp -EEEECCCTTCEETTSTTH-------HHHHHHHHHHHHHHH-H-HHHCCCCCHHHHHHH
T ss_pred -CEEEEECCCcccCCCCCc-------HHHHHHHHHHHHHHH-c-CCCCCcccHHHHHHH
Confidence 499999999976532111 01111 1222 1 347889999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.22 E-value=1.8e-06 Score=79.46 Aligned_cols=78 Identities=15% Similarity=0.134 Sum_probs=51.5
Q ss_pred ceeEeeeeccCCceEEEEEEEcCCCCEEEEEEeccc----hhhHHHHHHHHHHcC-CCCccccceeeeeccCCCceEEEE
Q 011138 138 SYMAERVVGTGSFGVVFQAKCLETGDSVAIKKVLQD----KRYKNRELQIMRLLN-HPNVVSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 138 ~y~~~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~~----~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~~~~~~l 212 (492)
.|++.+..+.++.+.||+.. ..++.+.+|+.... .....+|..+++.|. +=-+.+++.+. .+....++
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~~~~~~~l 87 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGWSNL 87 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEEE
T ss_pred ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE-----ecCCceEE
Confidence 46666665555667899875 46677888987543 234678999998885 32245665554 22235679
Q ss_pred EeeechhhHH
Q 011138 213 VLEYISETVY 222 (492)
Q Consensus 213 V~E~~~~~l~ 222 (492)
||++++|..+
T Consensus 88 v~~~l~G~~~ 97 (263)
T d1j7la_ 88 LMSEADGVLC 97 (263)
T ss_dssp EEECCSSEEH
T ss_pred EEEecccccc
Confidence 9999987543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.81 E-value=3e-05 Score=70.48 Aligned_cols=69 Identities=13% Similarity=0.082 Sum_probs=44.5
Q ss_pred ccCC-ceEEEEEEEcCCCCEEEEEEeccch-hhHHHHHHHHHHcCCCC--ccccceeeeeccCCCceEEEEEeeechhh
Q 011138 146 GTGS-FGVVFQAKCLETGDSVAIKKVLQDK-RYKNRELQIMRLLNHPN--VVSLKHCFFSTTEKDELYLNLVLEYISET 220 (492)
Q Consensus 146 G~G~-fg~Vy~~~~~~~g~~vAiK~~~~~~-~~~~~E~~il~~l~h~n--Iv~l~~~~~~~~~~~~~~~~lV~E~~~~~ 220 (492)
..|. -+.||+.. ...+..+.+|...... ....+|...++.|.... +.+++.+. .+....++||++++|.
T Consensus 19 ~~G~s~~~v~r~~-~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~-----~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 19 TIGCSDAAVFRLS-AQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVV-----TEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp SCTTSSCEEEEEE-CTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEE-----ECSSCEEEEEECCSSE
T ss_pred CCcccCCeEEEEE-eCCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeec-----ccccceEEEEEeeecc
Confidence 3443 46789886 3556778889765433 34678999998885433 45555544 2223467999999763
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.61 E-value=0.00011 Score=71.52 Aligned_cols=71 Identities=18% Similarity=0.164 Sum_probs=43.6
Q ss_pred eeeeccCCceEEEEEEEcCCCCEEEEEEecc-----------chhhHHHHHHHHHHcC-C--CCccccceeeeeccCCCc
Q 011138 142 ERVVGTGSFGVVFQAKCLETGDSVAIKKVLQ-----------DKRYKNRELQIMRLLN-H--PNVVSLKHCFFSTTEKDE 207 (492)
Q Consensus 142 ~~~lG~G~fg~Vy~~~~~~~g~~vAiK~~~~-----------~~~~~~~E~~il~~l~-h--~nIv~l~~~~~~~~~~~~ 207 (492)
.+.||.|....||++.+..+|+.|.||.-.. .......|.+.|+.+. + ..+++++.+ . .+.
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d---~~~ 105 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D---TEM 105 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E---TTT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--c---CCC
Confidence 3468999999999998777788999996421 1122346888888774 2 234555432 2 221
Q ss_pred eEEEEEeeechh
Q 011138 208 LYLNLVLEYISE 219 (492)
Q Consensus 208 ~~~~lV~E~~~~ 219 (492)
.++|||++++
T Consensus 106 --~~lvmE~L~~ 115 (392)
T d2pula1 106 --AVTVMEDLSH 115 (392)
T ss_dssp --TEEEECCCTT
T ss_pred --CEEEEeccCC
Confidence 3479999875
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.87 E-value=0.00068 Score=63.86 Aligned_cols=69 Identities=14% Similarity=-0.023 Sum_probs=40.0
Q ss_pred ceEEEEEEEcCCCCEEEEEEeccc---hhhHHHHHHHHHHcCCCCcc--ccceeeeeccCCCceEEEEEeeechh
Q 011138 150 FGVVFQAKCLETGDSVAIKKVLQD---KRYKNRELQIMRLLNHPNVV--SLKHCFFSTTEKDELYLNLVLEYISE 219 (492)
Q Consensus 150 fg~Vy~~~~~~~g~~vAiK~~~~~---~~~~~~E~~il~~l~h~nIv--~l~~~~~~~~~~~~~~~~lV~E~~~~ 219 (492)
--.||++. ..+|..|++|+.... ...+..|...+..|....|. ..+..--........+.+.|+++++|
T Consensus 35 EN~vy~v~-~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 35 ENRVYQFQ-DEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SSEEEEEC-CTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cceeEEEE-cCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 36899987 467889999987543 34566788888887533221 11111000000122346678888764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.59 E-value=0.0062 Score=58.65 Aligned_cols=68 Identities=19% Similarity=0.246 Sum_probs=45.2
Q ss_pred eeeccCCceEEEEEEEcC-------CCCEEEEEEeccc--hhhHHHHHHHHHHcCCCCc-cccceeeeeccCCCceEEEE
Q 011138 143 RVVGTGSFGVVFQAKCLE-------TGDSVAIKKVLQD--KRYKNRELQIMRLLNHPNV-VSLKHCFFSTTEKDELYLNL 212 (492)
Q Consensus 143 ~~lG~G~fg~Vy~~~~~~-------~g~~vAiK~~~~~--~~~~~~E~~il~~l~h~nI-v~l~~~~~~~~~~~~~~~~l 212 (492)
+.|+.|-.-.+|++.... .++.|.+++.-.. .....+|..+++.+.-.++ .++++++ .+ .+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~-----~~----g~ 118 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----GR 118 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----EE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEc-----CC----ce
Confidence 468888888999987643 3456777776422 2334579999998863344 4666665 22 36
Q ss_pred Eeeechh
Q 011138 213 VLEYISE 219 (492)
Q Consensus 213 V~E~~~~ 219 (492)
||||+.|
T Consensus 119 I~efi~g 125 (395)
T d1nw1a_ 119 LEEYIPS 125 (395)
T ss_dssp EECCCCE
T ss_pred EEEEecc
Confidence 8999875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.62 E-value=0.033 Score=51.26 Aligned_cols=30 Identities=27% Similarity=0.269 Sum_probs=26.1
Q ss_pred CCcccCCCCCCceEEcCCCCcEEEeeecCcc
Q 011138 258 VGVCHRDIKPQNLLVNPHTHQLKICDFGSAK 288 (492)
Q Consensus 258 ~givHrDlKp~NILl~~~~~~vkL~DFG~a~ 288 (492)
.|+||+|+.++||+++.+. ..-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~-v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDE-LSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTE-EEEECCCTTCE
T ss_pred cccccCCcchhhhhccccc-ceeEecccccc
Confidence 4899999999999999765 56899999875
|